Name,Ab or Nb,Binds to,Doesn't Bind to,Neutralising Vs,Not Neutralising Vs,Protein + Epitope,Origin,VH or VHH,VL,Heavy V Gene,Heavy J Gene,Light V Gene,Light J Gene,CDRH3,CDRL3,Structures,ABB Homology Model (if no structure),Sources,Date Added,Last Updated,Update Description,Notes/Following Up?
C050,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLFQPGGSLRLSCAASGFSVRNNYVSWVRQAPGKGLEWVSVIYSGGTTYYADSVKGRFTISRDISENTLYLQMNSLRAEDTAVYYCAREGDVEGLHDFWSGYSRDRYYFDYWGQGTLVTVSS,QSALTQPASVSGSPGQSIIISCTGTSGDIGGYNYVSWYQQHPGKAPKLMIYDVSFRPSGVSNRFSGSKSDNTASLTISGLQAEDEADYYCSSFTGNNTRVFGTGTKVTVL,IGHV3-53 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ1 (Human),AREGDVEGLHDFWSGYSRDRYYFDY,SSFTGNNTRV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C050_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C057,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVQSGAEVKRPGASVKLSCKASGYIFTDYSIHWVRQAPGQGLEWMGWVNPNSGGGNSAQKFMDWVTMARDTSITTVYMELSRLRSDDTAVYYCARGPLFHKLVYDSWSGYHDGFDIWGQGTMVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGAYKFVSWYQQHPGKAPQLIIYEVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTNASTWVFGGGTELTVL,IGHV1-2 (Human),IGHJ3 (Human),IGLV2-14 (Human),IGLJ3 (Human),ARGPLFHKLVYDSWSGYHDGFDI,SSYTNASTWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C057_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C058,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVQSGAEVKKPGASVKVSCKASGYIFTDYSMHWVRQAPGQGLEWIGWVNPNSGGTNYAQKFQGWVTMARDTSITTVYMELSRLKSDDTAVYFCARGPLFHRLVYDFWSGYHDGFDMWGQGTMVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGGYKFVSWYQQHPGKAPKLMIYEVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCNSYTSSSTWVFGGGTKLTVL,IGHV1-2 (Human),IGHJ3 (Human),IGLV2-14 (Human),IGLJ3 (Human),ARGPLFHRLVYDFWSGYHDGFDM,NSYTSSSTWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C058_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C059,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVQSGAEVKKPGASIKVSCKASGYTFTDYSMHWVRQAPGQGLEWMGWINPNSGGTKYAQKFQGWVTMTRDMSITTVYMELTRLRSDATAVFYCARGPLFHKLVYDSWTGYHDGFDIWGQGTMVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQHYPGKAPKLMIYEVTHRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSSTNSSTWVFGGGTKMTVL,IGHV1-2 (Human),IGHJ3 (Human),IGLV2-14 (Human),IGLJ3 (Human),ARGPLFHKLVYDSWTGYHDGFDI,SSSTNSSTWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C059_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C060,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLVQPGGSQRLSCAASGFTVSSNYMSWIRQAPGKGLEWVSVIYSGGSAYYVDSVKGRFTISRDNSKNTLYLQMNSLRPEDTAVYYCARIANYMDVWGKGTTVTVSS,EIVMTQSPATLSVSPGERATLSCRASQSVSSHLAWYQQKPGQAPRLLIYGASTRATGIPTRFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNWPPLTFGGGTKVEIK,IGHV3-66 (Human),IGHJ6 (Human),IGKV3-15 (Human),IGKJ4 (Human),ARIANYMDV,QQYNNWPPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C060_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C062,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLVKPGGSLRLTCAASGFTFSTYSMNWVRQAPGKGLEWVSSISSSSSYIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARERGYYGGKTPPFLGGQGTLVTVSS,NFMLTQPHSVSESPGKTVTISCTGSSGSIASNYVQWYQQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSSNYWVFGGGTKLTVL,IGHV3-21 (Human),IGHJ4 (Human),IGLV6-57 (Human),IGLJ3 (Human),ARERGYYGGKTPPFL,QSYDSSNYWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C062_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C063,Ab,SARS-CoV2 (weak),,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVQSGAEVKKPGDSLKISCKASGYSFTRYWIGWVRQMPGKGLDWMGIIYPGDSDTRYSSSFQGQVTISADKSISTAYLQWSSLKASDTSLYYCVRRASSTNFEFWGQGTLVTVSS,SYELTQPPSVSVAPGQTATITCGGNNIGSKTVHWYQQKPGQAPVVVVYDDSDRPSGIPERFSGSKSGSTATLTITRVEAGDEADYYCQVWDSTSDHYVFGTGTKVAVI,IGHV5-51 (Human),IGHJ4 (Human),IGLV3-21 (Human),IGLJ1 (Human),VRRASSTNFEF,QVWDSTSDHYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C063_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C064,Ab,SARS-CoV2 (weak),,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Patient,EVQLLESGGDLVQPGGSLRLSCAASGFTFSNYAMSWVRQAPGKGLEWVSAISGSGGNTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKAVHYGGNSDRRFSEPSAPFDYWGQGTLVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGSYNLVSWYQQHPGKAPKLMIYEGSKRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCCSYAGSSTPYVFGTGTKVTVL,IGHV3-23 (Human),IGHJ4 (Human),IGLV2-23 (Human),IGLJ1 (Human),AKAVHYGGNSDRRFSEPSAPFDY,CSYAGSSTPYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C064_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C065,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Patient,QVQLQESGPGLVKPSQTLSLTCTVSGGSISSSNYYWSWIRQHPGKGLEWIGYIDYSGGTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARVSTTVTTYLVGGFDIWGQGTMVTVSS,IRMTQSPSSLSASVGDRVTITCQASQDITNYLNWYQQKPGKAPKLLLYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPWTFGQGTKVEIK,IGHV4-31 (Human),IGHJ3 (Human),IGKV1-33 (Human),IGKJ1 (Human),ARVSTTVTTYLVGGFDI,QQYDNLPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C065_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C066,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLIQPGGSLRLSCAASGLLVSRNYMTWVRQAPGKGLEWVSVIYSGGSTFYADSVRGRFTISRDNSKNTLYLQMDSLRAEDTAVYYCARDVGDYYGMDVWGQGTTVTVSS,DIQLTQSPAFLSASVGDRVTITCRASQGMSNYLAWYQQKPGKAPNLLIYTASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQLLNSYPQLTFGGGTKVEIK,IGHV3-53 (Human),IGHJ6 (Human),IGKV1-9 (Human),IGKJ4 (Human),ARDVGDYYGMDV,QLLNSYPQLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C066_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C067,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,VQLVESGGGVVQPGRSLRLSCAASGFSFRIFGMNWVRQAPGKGLDWVAGISHDGSDKYFADSVKGRFTISRDNSKNTLYLQMNSLRADDTAVYYCARDMEVDYYDRSGHYHVFHAFDIWGQGTMVTVSS,DIVMTQSPDSLAVSLGARATINCKSSQSILYSSDNKSSLAWYQQKPGHPPKLLIYWASTRESGVPDRFSGSESGTDFTLTISNLQGEDVAVYYCQQYYSIPRSFGQGTKLEIK,IGHV3-30 (Human),IGHJ3 (Human),IGKV4-1 (Human),IGKJ2 (Human),ARDMEVDYYDRSGHYHVFHAFDI,QQYYSIPRS,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C067_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C068,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVESGGGVVQPGRSLRLSCVASGFSFSTYGMHWVRQAPGKGLEWVALIWSDGSNKYYGDAAEGRFTISRDNSNNTLYLQMNNLRAEDTALYYCARDHSSSSFVYYYYMDVWGKGTTVTVSS,QSALTQPRSVSGSPGQSVTISCTGTSSDIGGYNYVSWYQQHPDKAPKFIIFDVSKRPSGVPDRFSGSKSGNTASLTISGLQAEDEADYYCCSYAGPYPYVFGTGTKVTVL,IGHV3-33 (Human),IGHJ6 (Human),IGLV2-11 (Human),IGLJ1 (Human),ARDHSSSSFVYYYYMDV,CSYAGPYPYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C068_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C069,Ab,SARS-CoV2 (weak),,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVQSGAEVKKPGSSVNVSCKASGGTFSTYAIHWVRQAPGQGLEWMGGIIPLFHTANYAQKFQGRVTITADESTSTAYMELSSLRSEDTAMYYCAINTQWDLVPRWGRGTLVTVSS,EIVLTQSPGTLSLAPGERATLSCRASQSVNSNYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGFSLYSFGQGTKLEIK,IGHV1-69 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ2 (Human),AINTQWDLVPR,QQYGFSLYS,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C069_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C081,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLVKPGGSLRLSCAASGFTFSSAWMSWVRQAPGKGLEWVGRIKTKTDGGTKDYAAPVKGRFTISRDDSKNTLYLQMNSLKTEDTAVYYCTTTNDYGDYSPAYWGQGTLVTVSS,DIQLTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTAFTLTISSLQPEDFATYYCQQSYSTPLTFGGGTKVEIK,IGHV3-15 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ4 (Human),TTTNDYGDYSPAY,QQSYSTPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C081_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C083,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLVKPGGSLRLSCAASGFTFSSYSMNWVRQAPGKGLEWVSSISSSTSYIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARERYGDNWGQGTLVTVSS,QLVLTQSPSASASLGASVKLTCTLSSGHSSYAIAWHQQQPEKGPRYLMSLNSDGSHSKGDGIPDRFSGSSSGAERYLTISSLQSEDEADYYCQTWGPWVFGGGTKLTVL,IGHV3-21 (Human),IGHJ4 (Human),IGLV4-69 (Human),IGLJ3 (Human),ARERYGDN,QTWGPWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C083_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C085,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLQESGPGLVKPSETLSLTCTVSGDSMSSYFWTWIRQPPGKGLECIGYFYPSGSTNYNPSLKSRVTISIDTSKNQFSLKLSSVTAADTAVYYCARLKQQLVGFGWFDPWGQGTLVTVSS,QSVLTQPPSVSGAPGQRVTISCTGSSSNIGADYDVHWYQQFPGTAPKVLIYANTNRPSGVPERFSGSKSGTSASLAITGLQAEDEADYYCQSYDHSLNWVFGGGTKLTVL,IGHV4-59 (Human),IGHJ5 (Human),IGLV1-40 (Human),IGLJ3 (Human),ARLKQQLVGFGWFDP,QSYDHSLNWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C085_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C086,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLQESGPGLVKPSETLSLTCTVSGDSISTYFWAWIRQPPGRGLECIGSFFPSGSTYYNPSLKSRVTISVDTSKNQFSLKLNSVTAADTAVYYCARLKQQLVGFGWFDPWGQGSLVTVSS,QSVLTQPPSVSGAPGQRVTISCTGSISNIGADYEVHWYVQFPGTAPKVLIYANTNRPSGVPERFSASKSGTSASLAITGLQAEDEADYYCQSYDHRLHWVFGGGTKLTVL,IGHV4-59 (Human),IGHJ5 (Human),IGLV1-40 (Human),IGLJ2 (Human),ARLKQQLVGFGWFDP,QSYDHRLHWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C086_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C088,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVQSGAEAKKPGASVKVSCKTSGYTFTNYFMHWVRQAPGQGPEWMGIIDSSDGGASYAQKFQGRVTMTRDTSTSTVYMELRSLKFEDTAVYYCARASTSTTSWSDALSLGSWGQGTLVTVSS,QSVLTQPPSVSGAPGQRVTISCTGSSSNIGGGSVVHWYQQLPGTAPKLLIYANSNRPSGVPDRFSGSKSGTSASLAIAGLQAEDEADYYCQSWDNGLSASGVVFGGGTKLTVL,IGHV1-46 (Human),IGHJ5 (Human),IGLV1-40 (Human),IGLJ2 (Human),ARASTSTTSWSDALSLGS,QSWDNGLSASGVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C088_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C089,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFRTYAMHWVRQAPGKGLEWVAVILSDGNNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAIFYCAREQEANYYDISGYYHWGESLGYWGQGTLVTVSS,DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYGASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFASYYCQKVNSHPPGLTFGGGTKVEIK,IGHV3-33 (Human),IGHJ4 (Human),IGKV1-9 (Human),IGKJ4 (Human),AREQEANYYDISGYYHWGESLGY,QKVNSHPPGLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C089_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C090,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFRTYAMHWVRQAPGKGLEWVAVILSDGNNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAIFYCAREQEANYYDISGYYHWGESLGYWGQGTLVTVSS,DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKFLIYGASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFASYYCQKVNSYPPGLTFGGGTKVEIK,IGHV3-33 (Human),IGHJ4 (Human),IGKV1-9 (Human),IGKJ4 (Human),AREQEANYYDISGYYHWGESLGY,QKVNSYPPGLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C090_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C518,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLIQPGGSLRLSCAASGITVSSNYMSWVRQAPGKGLEWVSVMYAGGSSFYADSVKGRFTISRDNSKNTLYLQMNSLRVEDTAVYYCARDLIALGVDVWGQGTTVTVSS,DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQLLNSYPMCSFGQGTKLEIK,IGHV3-53 (Human),IGHJ6 (Human),IGKV1-9 (Human),IGKJ2 (Human),ARDLIALGVDV,QLLNSYPMCS,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C518_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C519,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLQESGPGLVKPSETLSLTCAVSGGSISSYYWSWIRQPPGKGLEWIGYIDTSGSTNYNPSLKSRVTMSVDTSKNQFSLNVNSVTAADTAVYFCGVCAGDCYAASVFDYRGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDIIFYLNWYQQKPGKAPKLLIYDASNLKTGVPSRFSGSGSGTDFAFTISSLQPEDIATYYCQQYDNLPLTFGGGTKVEIK,IGHV4-4 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ4 (Human),GVCAGDCYAASVFDY,QQYDNLPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C519_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C502,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVQSGAEVKKPGSSVKVSCKASGDTFSSHAINWVRQAPGQGLEWMGRSIPMLGVTTSAQKFKGRVTITADHSTSTVFMDLSSLRSDDTAIYYCARGVVGATPGSFDLWGQGTMVTVSS,EIVMTQSPATLSVSPGKRATLSCRASQSVRSNLAWYQQRPGQAPRLLIYDAATRATGIPTRFSGSGSGTEFTLTISSLQSEDFAVYYCQQYDNGLTFGGGTKVEIK,IGHV1-69 (Human),IGHJ3 (Human),IGKV3-15 (Human),IGKJ4 (Human),ARGVVGATPGSFDL,QQYDNGLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C502_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C503,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLQESGPGLVQPSGTLSLSCTVTGGSISSNNWWSWVRQSPVKGLEWIGEIYHNGNINYNPSLKSRVTMSIDKSKNHFSLKLSSVTAADTAVYYCARGDVLDWFDPWGQGTLVTVS,QSALTQPASVSGSPGQSITFSCTGTSSDVGAYNYISWYQQHPGKAPKLMIYDVNNRPSGVSRRFSGSKSGNTASLTISGLQSEDEADYFCSSYAGNSTVRFGGGTKLTVL,IGHV4-4 (Human),IGHJ5 (Human),IGLV2-14 (Human),IGLJ2 (Human),ARGDVLDWFDP,SSYAGNSTVR,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C503_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C504,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Patient,QVQLQESGPGLVKPSETLSLTCTVSGGSISSSYWNWIRQSPGKGLEWIGYIYYDGYTTFNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAFYYCAAGLKGRSSSWYEYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYATSSLQSGVPSRFSGSGSGTDFTLTITSLQPEDFATYYCQQTYSSPHTFGQGTKLEIK,IGHV4-59 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ2 (Human),AAGLKGRSSSWYEY,QQTYSSPHT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C504_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C505,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLLESGGGLVQPGGSLRLSCADSGFSFSTYGMSWVRQAPGKGLEWVSTISGSGDNTYHADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKNIAEMSTFDDYFYYYGMDVWGQGTTVTVSS,SYELTQPPSVSVSPGQTASITCSGDKLGDKYACWYQQKPGQSPVMVIYQDTKRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCQAWDSSTFYVFGTGTKVTVL,IGHV3-23 (Human),IGHJ6 (Human),IGLV3-1 (Human),IGLJ1 (Human),AKNIAEMSTFDDYFYYYGMDV,QAWDSSTFYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C505_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C506,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYDMHWVRQGTGKGLEWVSVIGTAGDAYYPGSVKGRFTISRENAKNSLYLQMNSLRAGDTAVYYCARMVYDSSGFKGYFDLWGRGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISNLQPEDFATYYCQQSYSTSMYTFGQGTKLEIK,IGHV3-13 (Human),IGHJ2 (Human),IGKV1-39 (Human),IGKJ2 (Human),ARMVYDSSGFKGYFDL,QQSYSTSMYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C506_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C507,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAIHWVRQAPGKGLEWVAVISFDGSNKYYRDSVKGRFTISRDNGKNTLYLQMNSLRAEDTAVYYCAKAALGYCTNGVCYCDNWGQGTLVTVSS,NFMLTQPHSVSESPGKTVTISCTGSSGSIASNYVQWYQQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLSISGLKTEDEADYYCQSYDINSLWVFGGGTRLTVL,IGHV3-30 (Human),IGHJ4 (Human),IGLV6-57 (Human),IGLJ3 (Human),AKAALGYCTNGVCYCDN,QSYDINSLWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C507_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C509,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLQESGPGLVKPSGTLSLTCAVSGGSISSSNWWSWVRQPPGKGLEWIGEIYNSGSTNYNPSLKSRVTILVDKSKNQFSLKLSSVTAADTAVYYCAGSYSNYIGGVWFDPWGQGTLVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSTYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRNNWLTFGGGTKVEIK,IGHV4-4 (Human),IGHJ5 (Human),IGKV3-11 (Human),IGKJ4 (Human),AGSYSNYIGGVWFDP,QQRNNWLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C509_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C510,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Patient,QVQLQQWGAGLLKPSETLSRTCAVYGGSFSGYYWSWFRQSPGKGLEWIGEINHSGSTNYNPSLKNRVTISVDTSKNQFSLMLSSVTAADTAVYYCARGGFGVVINYYYSGMDVWGRGTTVTVSS,DIVMTQSPLSLPVTPGEPASISCRSSQSLLHSNGYNYLDWYLQKSGQSPQLLIYLGSNRASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQALQTPPTFGQGTKVEIK,IGHV4-34 (Human),IGHJ6 (Human),IGKV2-28 (Human),IGKJ1 (Human),ARGGFGVVINYYYSGMDV,MQALQTPPT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C510_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C511,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLVQPGGSLRLSCAATEITVSSNYMTWVRQAPGKGLEWVSVIYPGGSTFYADSVKGRFSISRDNSKNTLYLQMNSLRAEDTAVYYCARDLVVYGLDCWGQGTLVTVSS,DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNTYPPPFGGGTKVEIK,IGHV3-66 (Human),IGHJ4 (Human),IGKV1-9 (Human),IGKJ4 (Human),ARDLVVYGLDC,QQLNTYPPP,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C511_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C513,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLLESGGGLVQPGGSLRLSCVASGFSFSTYAMSWVRQAPGQGLEWVSTITGTSIGTYYADSVKGRFTISRDNSKNTVFLQMKSLRAEDAAVYYCANHPLASGDEYYYYYMDVWGKGTTVTVSS,EIVLTQSPDTLSLSPGERATLSCRASQSVHSKQLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSIRALTFGGGTKVEIK,IGHV3-23 (Human),IGHJ6 (Human),IGKV3-20 (Human),IGKJ4 (Human),ANHPLASGDEYYYYYMDV,QQYGSIRALT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C513_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C514,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLVQPGGSLRLSCAASEFIVTRNYMSWVRQAPGKGLEWVSLIYPGGSTFYADSVKGRFTISRDNSKNTLFLHMNSLRAEDTAVYYCARDLAGRLDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDINNFLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIAIYYCQQYDSLSRLTFGGGTKVEIK,IGHV3-66 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ4 (Human),ARDLAGRLDY,QQYDSLSRLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C514_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C515,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLVQPGGSLRLSCAASGFIVSSNYMSWVRQAPGKGLEWVSILYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLVVYGADYWGQGTLVTVSS,DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPPPFGGGTKVEIK,IGHV3-66 (Human),IGHJ4 (Human),IGKV1-9 (Human),IGKJ4 (Human),ARDLVVYGADY,QQLNSYPPP,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C515_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C516,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGRIIPMLVIATYARKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCARGVVAATPGNFDIWGQGTMVTVSS,EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNGLTFGGGTKVEIK,IGHV1-69 (Human),IGHJ3 (Human),IGKV3-15 (Human),IGKJ4 (Human),ARGVVAATPGNFDI,QQYNNGLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C516_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C517,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLVQPGGSLRLSCAASEFIVSRNYMSWVRQAPGKGLEWVSLIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAMYYCARDIAGRLDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDISKYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDFATYYCQHYDSLSRLTFGGGTKVEIK,IGHV3-66 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ4 (Human),ARDIAGRLDY,QHYDSLSRLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C517_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C597,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVQSGPEVKKPGTSVKVSCKASGFTFTNSAVQWVRQSRRQRLEWIGWIVVGSGNTNYAQKFQERVTITRDMSTSTAYMELSSLRSEDTAVYYCAAVDCNSTSCYDAFDIWGQGTMVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSFRSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGSDFTLTISRLEPEDFAVYYCQQYDISPWTFGQGTKVEIK,IGHV1-58 (Human),IGHJ3 (Human),IGKV3-20 (Human),IGKJ1 (Human),AAVDCNSTSCYDAFDI,QQYDISPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C597_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C598,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVQSGPEVKKPGTSVKVSCKASGFTFSSSAVQWVRQARGQRLEWIGWIVVGSGNTNYAQKFQERVTITRDMSTSTAYMELSSLRSEDTAVFYCAAPYCNVTTCFDGFNIWGRGTMVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVRSSYFAWYQQKPGQAPRLLIYAASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFALYYCQQYGSSPWTFGQGTKVEIK,IGHV1-58 (Human),IGHJ3 (Human),IGKV3-20 (Human),IGKJ1 (Human),AAPYCNVTTCFDGFNI,QQYGSSPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C598_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C523,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Patient,QVQLQESGPGLVKPSETLSLTCTVSGASISSHYWSWIRQPPGKGLEWIGYIHYIGSTNYNPSLKSRVTILLDTSKNQFSLRLRSVTAADTAVYYCARGWPYCGVDCYSGFDYWGQGTLVTVSS,QSVLTQPPSASGTPGQRVTISCSGSSSNIGSNTVNWYQQLPGTAPKLLIYSNNQRPSGVPDRFSGSKSGTSASLAISGLQSEDEADYYCAAWDDSLNGLWVFGGGTKLTVL,IGHV4-59 (Human),IGHJ4 (Human),IGLV1-44 (Human),IGLJ3 (Human),ARGWPYCGVDCYSGFDY,AAWDDSLNGLWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C523_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C524,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGDLIQPGGSLRLSCAASGFSVSNSYMSWVRQAPGKGLEWVSIIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYFCAKTPRGDYDSSGTSAYWGQGTLVTVSS,QLVLTQSPSASASLGASVNLTCTLSSGHSSYAIAWHQQQPEKGPRFLMKLSSDGSHNKGDGIPDRFSGSSSGAERFLTISSLQSEDEADYYCQTWGIGSDWVFGGGTKLTVL,IGHV3-53 (Human),IGHJ4 (Human),IGLV4-69 (Human),IGLJ3 (Human),AKTPRGDYDSSGTSAY,QTWGIGSDWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C524_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C525,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGRLVQPGRSLRLSCAASGFTFDDYAIHWVRQAPGKGLEWVSGISWNSGSIGYADSVRGRFTISRDNAKNSLYLQMNSLRAEDTALYYCAKGLDSSSSASPDYWGQGTLVTVSS,DIQMTQSPSSVSASVGDRVTITCRASQDISSWLAWYQQKPGKAPKLLIYLASSLQSGVPSRFSGSGSGTDFILTISSLQPEDFGTYYCQQGNSFPLTFGGGTKVEIK,IGHV3-9 (Human),IGHJ4 (Human),IGKV1D-1 (Human),IGKJ4 (Human),AKGLDSSSSASPDY,QQGNSFPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C525_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C526,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVQSGAEVKKPGASVKVSCKASGHTFTTYYLHWVRQAPGQGLEWMGRIDPSGGSTTYAQKFQGRVTMTRDTSTSTVYMELSSLRSEDTALYYCARGGYCGSTSCSPDDYFDYWGQGTLVTVSS,SYELTQPPSVSVAPGKTARITCGGNNIGSKSVHWYQQKPGQAPVLVIYYDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDSSSDHYYVFGTGTKVTVL,IGHV1-46 (Human),IGHJ4 (Human),IGLV3-21 (Human),IGLJ1 (Human),ARGGYCGSTSCSPDDYFDY,QVWDSSSDHYYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C526_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C527,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVALIGYDGTDKYYAENVKGRFTISRDNSKNTLFLQMNSLRGGDTAVYLCARDGIPFRYGMDVWGQGTTVTVSS,DIQMTQSPSTLSASVGDRVTITCRASQSIDIWLAWYQQKPGKAPKFLIHKASTLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQHYHSYSGTFGQGTKVEIK,IGHV3-33 (Human),IGHJ6 (Human),IGKV1-5 (Human),IGKJ1 (Human),ARDGIPFRYGMDV,QHYHSYSGT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C527_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C528,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFRNYDMHWVRQVAGKGLEWVSAIGTSGDTYYPDSVKGRFTISRENAKNSVYLQMNNLRAGDTAVYFCVRDREISGWTGWYFDLWGRGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQTIHNYLNWYQQIPGKAPRLLIYATNTLQSGVPSRFSGSGSGTDFTLTITGLQPEDFATYYCQQSYSTPPITFGQGTRLEIK,IGHV3-13 (Human),IGHJ2 (Human),IGKV1-39 (Human),IGKJ5 (Human),VRDREISGWTGWYFDL,QQSYSTPPIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C528_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C529,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLLESGGGLVQPGGSLRLSCAASGFTFNNYAMNWVRQAPGRGLEWVSGISGSGANTYYADSVKGRFTISRDNPKNTLSLQMNSLRAEDTALYYCAKVLSPTYYDSWSGPDAFDFWGQGTMVTVSS,DIQMTQSPSTLSASVGDRVTITCRASQTISPWLAWYQQKPGKAPNLLIYKASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNSYSSWTFGQGTKVEIK,IGHV3-23 (Human),IGHJ3 (Human),IGKV1-5 (Human),IGKJ1 (Human),AKVLSPTYYDSWSGPDAFDF,QQYNSYSSWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C529_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C530,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVESGGGVAQPGRSLRLSCAASGFTFSRYGMHWVRQAPGKGLEWVAVIWHDGSDKYCADFVKGRFTISRDNSKNTLYMQMDSLRAEDTAVYYCARGGRPDHETGIAVLGEYYFDSWGQGTLVTVSS,SYELTQPPSVSVSPGQTARITCSGDAFPLQYGYWYQQKPGQAPVLVIYKDKERPSGISERFSGSSSGTTVTLTISGVQAEDEADYYCQSADTNGVVFGGGTSLTVL,IGHV3-33 (Human),IGHJ4 (Human),IGLV3-25 (Human),IGLJ2 (Human),ARGGRPDHETGIAVLGEYYFDS,QSADTNGVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C530_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C531,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLVQPGRSLRLSCVATGFTFDDFAMHWVRQAPGKGLEWVSGISWNGGIIGYVDSVKGRFTISRDNAKNSLYLQMNSLRPEDTALYYCVKGYRYYYDILTGYYNDAGAFDYWGQGTLVTVSS,DIQSTQSPSFLSASVGDRVAITCRASQGISSYLAWYQQKPGKAPKLLIYPASTLQSGVPSGFSGSGSGTEFTLTISSLQPEDFATYYCQQLNDYPFTFGPGTKVDIK,IGHV3-9 (Human),IGHJ4 (Human),IGKV1-9 (Human),IGKJ3 (Human),VKGYRYYYDILTGYYNDAGAFDY,QQLNDYPFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C531_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C532,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVQSGAEVKKPGESLKISCKGSGYRFTNYWIGWVRQMPGKGLEWIGNIFPGDSDSRYSPSFQGQVTISVDMSITTAYLHWSSLKASDTAIYYCARLSERWYSPFDSWGQGTLVTVSS,EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGFPARFSGSGSGTEFTLTISSLQSEDFAVYFCQQYNNWPPGGFTFGPGTKVDIK,IGHV5-51 (Human),IGHJ5 (Human),IGKV3-15 (Human),IGKJ3 (Human),ARLSERWYSPFDS,QQYNNWPPGGFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C532_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C533,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGSLVKPGGSLRLSCVASGLTFNHAWMSWVRQAPGKGLEWVGRIKSKIDGGTTDYAAPVKGRFTISRDDSKSTQYLQMNSLKTEDTAVYYCTTDCFWRLGGTTCYEHDAFDVWGQGTMVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQAIATFLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISNLQPEDFATYYCQQSYNSLHFGGGTKVEIK,IGHV3-15 (Human),IGHJ3 (Human),IGKV1-39 (Human),IGKJ4 (Human),TTDCFWRLGGTTCYEHDAFDV,QQSYNSLH,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C533_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C534,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVQSGAEVKKPGSSVRVSCKASGGTFSRNVISWVRQAPGQGLEWMGGIIPMFATANYAQKFQGRVTITADESSSTAYMELSSLRSEDTAVYYCAREDFILVSAPIRENSYYYYGMDVWGQGTTVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSNYLAWYQQKPGQAPRLLIYDASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGGSPRTFGQGTKVEIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV3-20 (Human),IGKJ1 (Human),AREDFILVSAPIRENSYYYYGMDV,QQYGGSPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C534_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C535,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGALVQPGRSLRLSCAASGFTFDDYAMHWVRQAPGKGLEWVSSISWNGVSIGYADSVRGRFTISRDNAKNSLYLQMNSLKIGDTAFYYCARGLDGSSSASPDSWGQGTLVTVSS,DIQMTQSPSSVSASVGDRVTITCRASQGIGSWLAWYQQKPGKAPKLLIYLASSLQSGVPSRFSGSGSGTYFTLTISGLQPEDFATYYCQQGNSFPLTFGGGTKVEIK,IGHV3-9 (Human),IGHJ4 (Human),IGKV1D-1 (Human),IGKJ4 (Human),ARGLDGSSSASPDS,QQGNSFPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C535_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C536,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVESGGGLVKPGRSLRLSCTVSGFTFGAYAMSWFRQAPGKGLEWVGFIRSKTYGGTTEYAASLKGRFTISRDDSKSIAFLQMNSLKTEDTAVYFCSRGGYYDGSPYYWNRPDAFDIWGLGTMVTVS,QSVLTQPPSASGTPGQRITISCSGSSSNIGSNTVNWYQQLPGTAPKLLIYSNNQRPSGVPDRFSGSKSGTSASLAISGVQSEDEADYYCAAWDDSLNGPDVVFGGGTKLTVL,IGHV3-49 (Human),IGHJ3 (Human),IGLV1-44 (Human),IGLJ2 (Human),SRGGYYDGSPYYWNRPDAFDI,AAWDDSLNGPDVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C536_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C537,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Patient,QLQLQESGPGLVKPSETLSLTCTVSGGAISSRNYHWGWIRQPPGKGLEWIGSIYYSGSTYYSPSLKSRVTISVDTSKNQFSLRLSSVTAADTAVYYCARLETSGWYTEDVFDIWGQGTMVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLLPEDFATYYCQRSYSAMYTFGQGTKLEIK,IGHV4-39 (Human),IGHJ3 (Human),IGKV1-39 (Human),IGKJ2 (Human),ARLETSGWYTEDVFDI,QRSYSAMYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C537_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C538,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Patient,QLQLQESGPGLVKPSETLSLTCTVSGGSISSSSYYWAWIRQPPGKGLEWIGNIYYSGITYYSPSLKSRVTISVDTSKNQFSLKLRSVTAADTAVYYCARQHRYGSGSSELLWGQGTLVTVSS,QSALTQPPSASGSPGQSVTISCTGTSSDVGSYNYVSWYQQHPGKAPKLMIYEVTKRPSGVPDRFSGSKSGNTASLTVSGLQADDEADYYCSSYAGSSNLIFGGGTKLTVL,IGHV4-39 (Human),IGHJ4 (Human),IGLV2-8 (Human),IGLJ2 (Human),ARQHRYGSGSSELL,SSYAGSSNLI,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C538_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C539,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLVQPGRSLRLSCAASGFTFDDYALHWVRQAPGKGLEWVSGISWNGDSIGYADSVKGRFTISRDNAKNSLSLQMNSLTAEDTALYYCAKGVEYSSSSNCDYWGQGTLVTVSS,DIQMTQSPSSVSASVGDRVTITCRASQDISSWLAWYQQKPGKAPKLLISLASGLQSGVPSRFSGSGSETDFTLTISSLQPEDFATYYCQQTNSFPLTFGGGTKVEI,IGHV3-9 (Human),IGHJ4 (Human),IGKV1D-1 (Human),IGKJ4 (Human),AKGVEYSSSSNCDY,QQTNSFPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C539_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C540,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFRNYDMHWVRQVAGKGLEWVSAIGTSGDTYYPDSVKGRFTISRENAKNSVYLQMNNLRAGDTAVYFCVRDREISGWTGWYFDLWGRGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQTIHNYLNWYQQIPGKAPRLLIYATNTLQSGVPSRFSGSGSGTDFTLTITGLQPEDFATYYCQQSYSTPPITFGQGTRLEIK,IGHV3-13 (Human),IGHJ2 (Human),IGKV1-39 (Human),IGKJ5 (Human),VRDREISGWTGWYFDL,QQSYSTPPIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C540_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C542,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLVQPGGSLRLSCAASGLTVTSNYMSWVRQAPGRGLEWVSLIYPGGTTYYADSVKGRFTVSRDNSKNTLYLQMDSLRAEDTGVYYCARETLGRGGDCWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDISNFLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSRSGTDFTFTISSLQPDDIATYYCQQYDNLPRSFGQGTKLEIK,IGHV3-66 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ2 (Human),ARETLGRGGDC,QQYDNLPRS,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C542_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C543,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVESGGGVVQPGRSLRLSCTASGFTFSTAGMHWVRQAPGKGLEWVAVISYDGSNKDYADSVKGRFTISRDNSKSTLYLQMNSLRPEDTAVYYCAKDTPGGDDIMTGWGLYGMDVWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYHQKPGKAPKLLIYAAISLQSGVPSRFSGSGFGTDFTLTISSLQPEDFAIYYCQQSYSTPWTFGQGTKVEIK,IGHV3-30 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ1 (Human),AKDTPGGDDIMTGWGLYGMDV,QQSYSTPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C543_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C544,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFSSHDINWVRQATGQGLEWVGWMNPNSGNTGSAQSFQGRVTLTRNASISTAYLELSSLRSEDTAVYFCARGFSLTWYFDLWGRGTLVTVSS,SYELTQPPSVSAAPGKTARITCGGNNIGGKNVHWYQQKPGQAPVLVVFDDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQLWDSTSDHPDVVFGGGTQLTVL,IGHV1-8 (Human),IGHJ2 (Human),IGLV3-21 (Human),IGLJ2 (Human),ARGFSLTWYFDL,QLWDSTSDHPDVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C544_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C545,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Patient,EVQLLESGGGLVKPGGSLRLSCAASGFTFSDYSMTWVRQAPGKGLEWVSFISSSSTYIYYADSVKGRFTISRDNAKSSLYLQMNRLRAEDTAVYYCTRVQVGARGWADYWGQGTLVTVSS,NFMLTQPLSVSESPGKTVTISCTRSSGSIASNYVQWYQQRPGGAPTTVIYEDTQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSCDTINWVFGGGTKLTVV,IGHV3-21 (Human),IGHJ4 (Human),IGLV6-57 (Human),IGLJ3 (Human),TRVQVGARGWADY,QSCDTINWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C545_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C546,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Patient,EVQLLESGGGLVHPGGSLRLSCAASGFTFSTYAMHWVRQAPGKGLEWVSAISGSGTGTFYADSVKGRFSISRDNSKNTLYLQMNSLRAEDTAVYYCATERIAVSDTRMYNWFDPWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTLTCRASQGISTYLNWYQQKPGKAPNLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSAPPWTFGQGTKVEIK,IGHV3-23 (Human),IGHJ5 (Human),IGKV1-39 (Human),IGKJ1 (Human),ATERIAVSDTRMYNWFDP,QQSYSAPPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C546_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C547,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDTPGGDDILTGWGLYGMDVWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAAFSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPWTFGQGTKVEIK,IGHV3-30 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ1 (Human),AKDTPGGDDILTGWGLYGMDV,QQSYSTPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C547_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C550,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVQSGAEVKKPGESLKISCKGSGYRFTNYWIGWVRQMPGKGLEWMGIIYPGDSDTRYSPSFQGQVTISADKSITTAYLQWSSLKASDTAMYYCARLSDRWYSPFDPWGQGTLVTVSS,EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNWPPGGFTFGPGTKVDIK,IGHV1-69 (Human),IGHJ6 (Human),IGLV9-49 (Human),IGLJ3 (Human),ARLSDRWYSPFDP,QQYNNWPPGGFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C550_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C552,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVALISYDGSNKHYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARAGTTNSDYFDYWGQGTLVTVSS,SYELTQPPSVSVAPGKTARITCGGNNIGSKSVHWYQQKPGQAPVLVIYYDTDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDSSSALWVFGGGTKLTVL,IGHV1-69 (Human),IGHJ6 (Human),IGLV9-49 (Human),IGLJ3 (Human),ARAGTTNSDYFDY,QVWDSSSALWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C552_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C553,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSNYEIHWVRQAPGKGLEWVAGISYDGSTKYYADSVKGRFTISRDNSKNTLYLQMNSLRPEDTAVFYCARAGTTNSDYFDYWGQGTLVTVSS,SYELTQPPSVSVAPGMTARITCGGNTIGSKSVHWYQQKAGQAPVLVIYYDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDSSSVLWVFGGGTKLTVL,IGHV5-51 (Human),IGHJ5 (Human),IGKV3-15 (Human),IGKJ3 (Human),ARAGTTNSDYFDY,QVWDSSSVLWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C553_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C554,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLVKPGGSLRLSCAASGFTFSNAWMSWVRQAPGKGLEWVGRIKSKTDGGTTDYAAPVKGRFTISRDDSKNTLYLQMNSLKTEDTAVYYCTTDDPGSYYYGMDVWGQGTTVTVSS,QTVVTQEPSLTVSPGGTVTLTCGSSTGAVTSGHYPYWFQQKPGQAPRTLIYDTSNKHSWTPARFSGSLLGGKAALTLSGAQPEDEAEYYCLLSYSGARVFGGGTKLTVL,IGHV3-30 (Human),IGHJ4 (Human),IGLV3-21 (Human),IGLJ3 (Human),TTDDPGSYYYGMDV,LLSYSGARV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C554_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C555,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLVKPGGSLRLSCAASGLTFSTTWMSWVRQAPGKGLEWVGRIKSKGDGGTTDFAGPVKGRFSISRDDSKNTLYLHMNSLKTEDTAVYYCTTDDPGSYYYGMDVWGQGTTVTVSS,QTVVTQEPSLTVSPGGTVTLTCASSTGAVTSGHYPYWFQQKPGQAPRTLIYATSNKHSWTPARFSGSLLGGKAALTLSGAQPEDEADYYCLLSYSGARVFGGGTKLTVL,IGHV3-30 (Human),IGHJ4 (Human),IGLV3-21 (Human),IGLJ3 (Human),TTDDPGSYYYGMDV,LLSYSGARV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C555_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C556,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTYYYMHWVRQAPGQGLEWMGIINPSGGSTSYAQKFQGRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARPLLPGETGSLNRLDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTLWTFGQGTKVEIK,IGHV3-15 (Human),IGHJ6 (Human),IGLV7-46 (Human),IGLJ3 (Human),ARPLLPGETGSLNRLDY,QQSYSTLWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C556_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C558,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVQSGAEVKKPGESLKISCKVSGYTFTNYWIGWVRQMPGKGLEWMGIIYPGDSDTRYSPSFQGQVTISADKSIITAYLQWSSLKASDTAMYYCARVPSSSDYGDYGGFEYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPCSFGQGTKLEIK,IGHV1-46 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ1 (Human),ARVPSSSDYGDYGGFEY,QQSYSTPCS,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C558_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C559,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVQSGAEVKKPGESLKISCKVSGYTFTNYWIGWVRQMPGKGLEWMGIIFPGDSDTRYSPSFQGQVTISADRSITTAYLQWRSLKASDTAMYYCARVPSSSDYGDYGGFEYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQTITIYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPCSFGQGTKLEIK,IGHV1-46 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ1 (Human),ARVPSSSDYGDYGGFEY,QQSYSTPCS,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C559_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C560,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLVQPGRSLRLSCAASGFTFDDYAMHWVRQAPGKGLEWVSGVSWNSGTIGYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTALYYCAKIADIVRAYDFWSGQHFDAFDIWGQGTMVTVSS,QSVLTQPPSASGTPGQRVTISCSGSSSNIGSNTVNWYQQLPGTAPKLLIYSNNQRPSGVPDRFSGSKSGTSASLAISGLQSEDEADYYCAAWDDSLVVFGGGTKLTVL,IGHV3-9 (Human),IGHJ3 (Human),IGLV1-44 (Human),IGLJ2 (Human),AKIADIVRAYDFWSGQHFDAFDI,AAWDDSLVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C560_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C561,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLVQPGRSLRLSCAASGFTFDDYAIHWVRQAPGKGLEWVSGVSWNSGTIGYADSVKGRFFISRDNAKNSLYLQMNSLRAEDTAWYYCAKIADLVGAYDFRSGQHFAAFDVWGQGTMVTVSS,QSVLTQPPSASGTPGQRVTISCSGSSSNIGSNTVNWYQHLPGTAPKLLIYSNNQRPSGVPDRFSGSKSGTSASLAISGLQSEDEADYYCASWDDSLVVFGGGTKLTVL,IGHV3-9 (Human),IGHJ3 (Human),IGLV1-44 (Human),IGLJ2 (Human),AKIADLVGAYDFRSGQHFAAFDV,ASWDDSLVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C561_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C562,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGVVQPGKSLRLSCAASGFTFRSYAMHWVRQAPGKGLEWVAVIWDDGSSKHYSDSVKGHFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDSNVDTVMVTWFDYWGQGTMVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISNYLNWYQQKPGKAPNLLIYTASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPPWTFGQGTKVEIK,IGHV3-33 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ1 (Human),ARDSNVDTVMVTWFDY,QQSYSTPPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C562_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C563,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLVKPGGSLRLSCAASGFPFTNAWMSWVRQAPGKGLEWVGHIKDYTDGGTTDYAAPVKGKFTISRDDSKNTLYLHMNSLKTEDTAVYYCSTVGSYYYDSRGPTSDAFDIWGQGTLVTVSS,DIVMTQSPDSLAVSLGERATINCKSSQSVLYSSNKKNYLAWYRQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYSTPYTFGQGTKLEIK,IGHV3-15 (Human),IGHJ3 (Human),IGKV4-1 (Human),IGKJ2 (Human),STVGSYYYDSRGPTSDAFDI,QQYYSTPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C563_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C564,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Patient,EVQLLESGGGLVQPGTSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSAISSSGGSTYYADSVKGRFTISRDNSKNTLYLHMNSLRAEDTAVYYCATERIAVAGTRMYNWFDPWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTLTCRASQSISSYLNWYQQKPGKAPNLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSAPPWTFGQGTKVEIK,IGHV3-23 (Human),IGHJ5 (Human),IGKV1-39 (Human),IGKJ1 (Human),ATERIAVAGTRMYNWFDP,QQSYSAPPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C564_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C213,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLVKPGGSLRLSCAASGFTFSSYSMNWVRQAPGKGLEWVSSISSSSSYIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARVQVGARGWVDYWGQGTLVTVSS,NFMLTQPHSVSESPGKTVTISCTRSSGSIASNYVQWYQQRPGSAPTTVIYEDNERPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDRINWVFGGGTKLTVL,IGHV3-21 (Human),IGHJ4 (Human),IGLV6-57 (Human),IGLJ3 (Human),ARVQVGARGWVDY,QSYDRINWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C213_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C217,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLVKPGGSLRLSCAASGFTFSSYSMNWVRQAPGKGLEWVSFISSRSSYIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARVQVGARGWVDYWGQGTLVTVSS,NFMLTQPHSVSESPGKTVTISCTRSSGSIASNYVQWYQQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSINWVFGGGTKLTVL,IGHV3-21 (Human),IGHJ4 (Human),IGLV6-57 (Human),IGLJ3 (Human),ARVQVGARGWVDY,QSYDSINWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C217_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C073,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Patient,QLQLQESGPGLVKPSETLSLTCTVSGASIPSSTSYWGWIRQPPGKGLEWIGSIYYTGSTYYNPSLKSRVTISVDTSKNHFSLILSSVTAADTAVYYCARRSITLAGRDCLDFWGQGTLVTVSS,DIQLTQSPSSLSASVGDRLTITCRASQSITTSLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLAISSLQPEDFATYYCQQSYIPLLTFGGGTKVDIK,IGHV4-39 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ3 (Human),ARRSITLAGRDCLDF,QQSYIPLLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C073_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C077,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYAMHWVRQAPGQRLEWMGWINTDNGNTKYSQKFQGRVTITRDTSASTAYMELSSLRSEDTAVYYCAREGALTNWFDPWGQGTLVTVSS,SYELTQPPSVSVAPGQTARIPCGGNNIGSKSVHWYQQKPGQAPVLVVYDDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDSSSDLHVVFGGGTKLTVL,IGHV1-4 (Human),IGHJ5 (Human),IGLV3-21 (Human),IGLJ2 (Human),AREGALTNWFDP,QVWDSSSDLHVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C077_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C078,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Patient,QVQLQQWGAGLLKPSETLSLTCAVYGGSLSAYYWSWIRQPPGKGLEWIGEINNGGTTNYNPSLKSRVTLSVDTSKNQFSLELSSVTAADTAIYYCARPGITATTGFDFWGQGSLVTVSS,DIQLTQSPSSLSASVGDRVTITCRASQSISTYLNWYHQKPGKAPKVLIYAASSLQGGVPSTFSGSGSGTDFTLTISSLQPDDFGTYYCQQSYNMPLTFGGGTKVEIK,IGHV4-34 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ4 (Human),ARPGITATTGFDF,QQSYNMPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C078_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C091,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYTISWVRQAPGQGLEWMGRIIPILGIANYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCARDSGYSGYGSTYYMDVWGKGTTVTVSS,QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWYQQLPGTAPKLLIYGNSNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSSLSGSVFGTVTKVTVL,IGHV1-69 (Human),IGHJ6 (Human),IGLV1-40 (Human),IGLJ1 (Human),ARDSGYSGYGSTYYMDV,QSYDSSLSGSV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C091_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C092,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGSFTNHFISWVRQAPGQGLEWMGRIIPILGTANYAQNFQGRVMMTADKSTSTAYMELSSLRSEDTAVYYCARDSGYSGYGSTYYMDVWGKGTTVTVSS,QSVLTQPPSVSGAPGQRVTISCTGSNSNIGAGYDVHWYQQLPGAAPKLLIYGNNNRPSGVPDRFSGSKSDTSASLAITGLQVEDEADYYCQSYDSSLSDSVFGSGTKVTVL,IGHV1-69 (Human),IGHJ6 (Human),IGLV1-40 (Human),IGLJ1 (Human),ARDSGYSGYGSTYYMDV,QSYDSSLSDSV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C092_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C093,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLQESGPGLVKPSETLSLTCTVSGGSISSYYWSWIRQPPGKGLEWIGYIHYSGSTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARHYDILTALSWFDPWGQGTLVTVSS,QSVLTQPPSVSAAPGQKVTISCSGSSSNIGNNYVSWYQQLPGTAPKLLIYDNNKRPSGIPDRFSGSKSGTSATLGITGLQTGDEADYYCGTWDSSLSAYWVFGGGTKLTVL,IGHV4-59 (Human),IGHJ5 (Human),IGLV1-51 (Human),IGLJ3 (Human),ARHYDILTALSWFDP,GTWDSSLSAYWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C093_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C094,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLQESGPGLVKPSETLSLTCNVSGVSISTDYWSWIRQPPGKGLEWIGYIYYSGNTKDYNPSLKSRVTISVDTSKNQFSLMLSSVTAADTAVYYCARHYDILTSLSWFDPWGQGTLVTVSS,QSVLTQPPSVSAAPGQKVTISCSITNSNLGNIYVSWYQQLPGTAPKLLIYGNNKRPSGIPDRFSGSKSGTSATLGITGLQTGDEAHYYCGTWDSSLSANWVFGGGTKLTVL,IGHV4-59 (Human),IGHJ5 (Human),IGLV1-51 (Human),IGLJ3 (Human),ARHYDILTSLSWFDP,GTWDSSLSANWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C094_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C034,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGRIIPILGIANYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCARDSEYSSSWYSRGYYGMDVWGQGTTVTVSS,DIVMTQSPLSLPVTPGEPASISCRSSQSLLHSNGYNYLDWYLQKPGQSPQLLIYLGSNRASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQALQTPPTFGGGTKVEIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV2-28 (Human),IGKJ4 (Human),ARDSEYSSSWYSRGYYGMDV,MQALQTPPT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C034_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C035,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLVQPGGSLRLSCAASGFIFSSYWMTWVRQAPGKGLEWVASIKYNGNERNYVDSVKGRFTISRDNARNSLFLQLNNLGAEDTAVYYCARQPESTIWYYFDYWGQGTLVTVSS,SYELTQPPSVSVSPGQTARVTCSGHALPDQYTYWYQQRPGRAPVLVIYVNNQRPSGIPDRFSATTSGTTVTLTISGVQAEDEADYYCQSADSSGSYVVFGGGTKLTVL,IGHV3-7 (Human),IGHJ4 (Human),IGLV3-25 (Human),IGLJ2 (Human),ARQPESTIWYYFDY,QSADSSGSYVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C035_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C521,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLVRPGGSLTLSCVASGFTVGSNFMSWVRQAPGKGLEWVSLIYNSGGTHYADSVKGRFTISRDRSKNTLYLQMNSLRAEDTAIYYCANHGYYYYMDVWGKGTTVTVS,QSALTQPASVSGSPGQSITISCTGTGSDIGAYNYVSWHQHHPGKAPKLIIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCTSYTNTTTPWVFGGGTKVTVL,IGHV3-66 (Human),IGHJ6 (Human),IGLV2-14 (Human),IGKJ3 (Human),ANHGYYYYMDV,TSYTNTTTPWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C521_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C522,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLIQPGGSLRLSCAASEFIVSRNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDESKNTLYLQMNSLRAEDTAIYYCARDRGGGILDYWGQGTLVTVS,DIQMTQSPSSLSASVGDRVTITCQASQDINIFLNWYQQKPGKAPKLLIYDASSLETGVPSRFSGSGSGTDFTFTISSLQPEDFATYYCQQYGNLPKYTFGQGTKLEIK,IGHV3-53 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ2 (Human),ARDRGGGILDY,QQYGNLPKYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C522_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C095,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,VQLVEAGGGVVQPGRSLRLSCAASGLAFSIYGMHWVRQAPGKGLEWVAIVAQDGSKKYYADSVKGRFTISRDNSKNTLYLEMNSLRTEDTAVYYCVKEGRPSDTVVVVAFDYWGQGSLVTVSS,DIQLTQSPSSLSASVGDRVTITCRASQSISNYLNWYQQKPGKAPKVIIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSHSIPRTFGQGTKVEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ1 (Human),VKEGRPSDTVVVVAFDY,QQSHSIPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C095_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C096,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLVKPGGSLRLSCVASGFTFRNAWMNWVRQAPGKGLEWVGRIKANSDGGTIDYAEPVQGRFTISREDSRNSLYLQMNSLKTEDTAVYYCTTGPQYDDFGHSYIVDSWGPGTLVTVSS,DIVMTQSPLSLPVTLGEPASISCRSSQSLLHSNGFHFLEWYLQKPGQSPQLLIYVGSNRASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQTLQTPLTFGGGTKVEIK,IGHV3-15 (Human),IGHJ4 (Human),IGKV2-28 (Human),IGKJ4 (Human),TTGPQYDDFGHSYIVDS,MQTLQTPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C096_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C097,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLQESGPGLVKPSQTLSLTCTVSGGSISSGPYYWSWIRQHPGKGLEWIGYIYYSGSTYYNPSLKSRVTISVDTSKKQFSLNLNSVTAADTAVYYCARVWQYYDSTGSFDYWGQGTLVTVSS,DIVMTQSPLSLPVTPGEPASISCRSSRGLLHSNGYNYLDWYLQKPGQSPQLLIYLGSNRASGVPDRFSGSGSVTDFTLNISRVEAEDVGVYYCMQALQTPFTFGPGTKVDIK,IGHV4-31 (Human),IGHJ4 (Human),IGKV2-28 (Human),IGKJ3 (Human),ARVWQYYDSTGSFDY,MQALQTPFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C097_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C043,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QLVQSGPEVKKPGTSVKVSCKASGFTFYNSAVQWVRQARGQRLEWVGWIVVGSGNTDYAQKFQERVTMTRDLSTNTAYMEVNSLRSEDTAVYYCAAPYCSGGTCLDGFDIWGQGTMVTVSS,EIVLTQSPGTLSLSPGERGTLSCRASQSVRSNYLAWYKQRPGQAPRLLVYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK,IGHV1-58 (Human),IGHJ3 (Human),IGKV3-20 (Human),IGKJ1 (Human),AAPYCSGGTCLDGFDI,QQYGSSPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C043_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C044,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYSMNWVRQAPGKGLEWVSYISSSSSTIYYADSVKGRFTISRDNAKNSLYLQMNSLRDEDTAVYYCAREAHDGALTDYGDYLNWFDPWGQGTLVTVSS,SYELTQPPSVSVAPGKTARITCGGNNIGSKSVHWYQQKPGQAPVLVIYYDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDSSSDHLYWVFGGGTKLTVL,IGHV3-48 (Human),IGHJ5 (Human),IGLV3-21 (Human),IGLJ3 (Human),AREAHDGALTDYGDYLNWFDP,QVWDSSSDHLYWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C044_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C045,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFSTYSMNWVRQAPGKGLEWVSYISSSSSTIHYADSVKGRFTISRDNAKNSLYLQMNSLRDEDTAVYYCAREAHDGALTDYGDYLNWFDPWGQGTLVTVSS,SYELTQPPSVSVAPGKTARITCGGTNIGSKNVHWYQQKPGQAPVLVIYYDNDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDTTSDHFYWVFGGGTKLTVL,IGHV3-48 (Human),IGHJ5 (Human),IGLV3-21 (Human),IGLJ3 (Human),AREAHDGALTDYGDYLNWFDP,QVWDTTSDHFYWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C045_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C046,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLAQPGRSLRLSCAASGFTFDDYAMHWVRQAPGKGLEWVSGINWNSGSLGYADSVKGRFTISRGIAKNSLYLQMNSLRPEDTAFYYCAKAGVRGIAAAGPDLNFDYWGQGTLVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFIGSGSGTDFTLTISSLEPEDFAVYYCQQRITFGQGTRLEIK,IGHV3-9 (Human),IGHJ4 (Human),IGKV3-11 (Human),IGKJ5 (Human),AKAGVRGIAAAGPDLNFDY,QQRIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C046_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C047,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Patient,QVQLQESGPGLVKPSETLSLTCTVSGGSISSTTYYWDWIRQSPGKGLEWIGSIFYTGITYYSPSLKSRVTISVDTSKNQFSLRLNSMTAADTAVYYCARRLRQLWFGPWFDPWGQGTLVTVSS,QSALTQPPSASGSPGQSVTISCTGTRSDVGDYNYVSWYQQHPDKAPKLIIYEVTKRPSGVPDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYAGSNNVMFGGGTKLTVL,IGHV4-39 (Human),IGHJ5 (Human),IGLV2-8 (Human),IGLJ3 (Human),ARRLRQLWFGPWFDP,SSYAGSNNVM,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C047_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C048,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,VQLQESGPGLVKPSETLSLTCAVSGGSVSSGNYYWNWIRQPPGKGLEWIGYIYYSGSTNYNPSLKSRVTISVDTSKNQFSLKLNSVTAADTAVYHCARETYYYDSSGYYISDAFDIWGQGTMVTVSS,DIQMTQSPSTLSASVGDRVTITCRASQSISSWLAWYQQKPGKAPKLLIYKASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNSFSYTFGQGTKLEIK,IGHV4-61 (Human),IGHJ3 (Human),IGKV1-5 (Human),IGKJ2 (Human),ARETYYYDSSGYYISDAFDI,QQYNSFSYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C048_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C049,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLQESGPGLVKPSETLSLTCTVSGGSVSSGTFYWSWIRQPPGKGLEWIGYIHYSGSTNYNPSLKSRVTISVDTSKNQFSLRLSSVTAADTAVYYCARESFYYDRSGYYGSDAFDIWGQGTMVTVSS,DIQMTQSPSTLSSSVGDRVTITCRASQNISRWLAWYQQKPGKAPKLLIYKASTLESGVPSRFSGSGSGTKFTLTISSLQPDDFATYYCQQYNSYLYTFGQGTKLEIK,IGHV4-61 (Human),IGHJ3 (Human),IGKV1-5 (Human),IGKJ2 (Human),ARESFYYDRSGYYGSDAFDI,QQYNSYLYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C049_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C710,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Patient,QVQLQESGPGLVKPSETLSLTCIVSGGSINSTTYYWDWIRQSPGKGLEWIGSIFYTGITYYSPSLKTRVTISVDTSKNQFSLRLNSMTAADTAVYYCARRLRQLWFGPWFDPWGQGTLVTVSS,QSALTQPPSASGSPGQSVTISCTGTRSDVGDYNYVSWYQQHPDKAPKLIIFEVTKRPSGVPDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYAGSSNVMFGGGTKLTVL,IGHV4-39 (Human),IGHJ5 (Human),IGLV2-8 (Human),IGLJ3 (Human),ARRLRQLWFGPWFDP,SSYAGSSNVM,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C710_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C703,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Patient,EVQLLESGGGLVQPGGSLRLSCAGSGFTFSHYALSWVRQAPGKGLEWVSCISGTGGNSHYADSVKGRFTSSRDNSKNILYLQMNSLRAEDTAVYFCAKGGDFWSGYLIPFDSWGQGTLVTVSS,SYELTQSPSVSVAPGKTARITCGGDSIGSKNVHWYQQKPGQAPVLVMYYDNDRPSGIPERFSGYNSGNTATLSISRVEAGDEADYYCLVWDGSGDPWVFGGGTKLTVL,IGHV3-23 (Human),IGHJ4 (Human),IGLV3-21 (Human),IGLJ3 (Human),AKGGDFWSGYLIPFDS,LVWDGSGDPWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C703_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C704,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Patient,VQLVESGGGVVQPGRSLRLSCAASGFTFSRYGMHWVRQAPGKGLEWVAVSSYDGSNEYYANSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKTGASYCGGDCPFHFDYWGQGTLVTVSS,IRMTQSPSSLSASVGDRVTITCQASQDINNYLNWYQQKPGKAPKLLIYDASDLETGVPSRFSGGGSGTDFTFTISSLQPEDIATYYCQHYNNLPITFGQGTRLEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ5 (Human),AKTGASYCGGDCPFHFDY,QHYNNLPIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C704_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C706,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLVKPGGSLRLSCAASGFTFSNVWMSWVRQAPGKGLEWVGRIKSKIDGGTTEYAAPVKGRFIISRDDSKNTLSLQMNSLKTEDTAVYYCTTDHGREPPVHWGQGTLVTVSS,EIVLTQSPGTLSLSPGERASLSCRARQSVYSNYLAWYQHKSGQAPRLLFYGASSRATDIPDRFSASGSGTDFTLTISRLEPEDFAVYYCLQYGPSPTFGPGTRLEIK,IGHV3-15 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ5 (Human),TTDHGREPPVH,LQYGPSPT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C706_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C707,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLVKPGGSLRLSCAASGFTFSSYSMNWVRQAPGKGLAWVSSISSSNNIIYYADSVKGRFTISRDDAKDSLYLHMKSLRADDTAVYFCARVPSWAPYQLLPGPFDYWGQGILVTVSS,IRMTQSPSSLSASVGDRVTITCQASQAIASYLSWYQHKPGRAPKLLIYDASNLEIGVPSRFSGSGSGTDFTFTISSLQSEDNATYYCQQYESLPGTFGGGTKVEIK,IGHV3-21 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ4 (Human),ARVPSWAPYQLLPGPFDY,QQYESLPGT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C707_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C708,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLVQPGGSLRLSCAASGFSFSTYWMSWVRQAPGKGLEWVADIKQDGSEKYFVDSVKGRFTISRDNAKNSLYLHLNSLRAEDTAVYYCAREMAGSGNYYWFGYGMDVWGQGTTVTVSS,IRMTQSPSSVSASVGDRVTITCRASQGISSWLAWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSESGTDFTLTISSLQPEDFATYYCQQANSFPLTFGGGTKVEIK,IGHV3-7 (Human),IGHJ6 (Human),IGKV1D-12 (Human),IGKJ4 (Human),AREMAGSGNYYWFGYGMDV,QQANSFPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C708_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C709,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVQSGAEVRKPGASVKVSCMASGYTFNTYDINWVRQGTGQGLEWMGWMNPNSGNTGHAQKFQGRVAMTVNTSMNTAYMELSSLRSEDTAVYYCARGADMLNVAVGADFDYWGQGTLVTVSS,QSALTQPPSASGSPGQSVTISCTGTSSDVGGYNFVSWFQQHPGKAPKLMIYEVSKRPSGVPDRFSGSKSANTASLTVSGLQAEDEADYFCSSYAGSNNWVFGGGTKLTVL,IGHV1-8 (Human),IGHJ4 (Human),IGLV2-8 (Human),IGLJ3 (Human),ARGADMLNVAVGADFDY,SSYAGSNNWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C709_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C565,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLIQPGGSLRLSCAASGLIVSSNYMNWVRQAPGKGLEWVSLLYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRPEDTAVYYCARDLSVVGAFDIWGQGTMVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSLPSTYLAWYQQKRGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGTSPRVTFGPGTKVDIK,IGHV3-53 (Human),IGHJ3 (Human),IGKV3-20 (Human),IGKJ3 (Human),ARDLSVVGAFDI,QQYGTSPRVT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C565_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C566,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLQESGPGLVKSSQTLSLNCSVFGASISSGGYYWTWIRQHPGKGLEWIGYIHYRGTYYNPSLKSRVTMSVDTSKNQFSLKVRSVSAADTAIYYCARAIVVVTLNWFDLWGQGTLVTVSS,NFMLTQPHSVSESPGKTVTISCSGSGGSIASNYVQWYQQRPGSAPTAVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDTSNPVIFGGGTKLTV,IGHV4-31 (Human),IGHJ5 (Human),IGLV6-57 (Human),IGLJ2 (Human),ARAIVVVTLNWFDL,QSYDTSNPVI,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C566_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C567,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Patient,QVQLQESGPGLVKPSETLSLTCTVSGGSVINGSYYWSWIRQPPGKGLEWIGFVYYSGSTNYNPSLKSRVTISVDTSKNQFSLNLNSVTAADTAVYYCATGSKSSYYFDYWGQGTLVTVSS,QSVLTQPPSVSAAPGQKVTISCSGSSSNIGNNYVSWYQQLPGAAPKLLIYENNMRPSGIPDRFSGSKSGTSATLGITGLQTGDEADYYCGTWDSSLSVPYVFGTGTRVTVL,IGHV4-61 (Human),IGHJ4 (Human),IGLV1-51 (Human),IGLJ1 (Human),ATGSKSSYYFDY,GTWDSSLSVPYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C567_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C568,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVQSGAEVKKPGASVKVSCTASGYTFSSYYIHWVRQAPGQGLEWMGIINPGAGSTSYAQKFQGRVAMTTDTSTRTVYMELSSLRSDDTAVYYCARDEAFLPSAIFVGDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQGIRNDLGWYQQKPGKAPKRLIYAASNLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCLQHSTYPHTWTFGQGTKVEIK,IGHV1-46 (Human),IGHJ4 (Human),IGKV1-17 (Human),IGKJ1 (Human),ARDEAFLPSAIFVGDY,LQHSTYPHTWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C568_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C569,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVESGGNVVQPGRSLRLSCAASGFTFSNYGMHWIRQAPGKGLEWVAVISYDGSDKYYADSVKGRVTISRDNSKNTLYLQMNSLRAEDTAVYYCAKGGPYGDHVRSDYWGLGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKVPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQFHNLPLTFGQGTKLEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ2 (Human),AKGGPYGDHVRSDY,QQFHNLPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C569_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C570,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLQESGPGLVKPSETLSLTCTVSGASISSYYWSWIRQPPGKGLEWIGYIYYSGSTNYNPSLKSRVTISLDTSKNQFSLQLSSVTAADTAVYYCATYYFDNSGYSYGLDVWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTIACRASQSISSYLHWYQQQPGKAPKLLIYAVTNLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSLPQTFGQGTKVEIK,IGHV4-59 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ1 (Human),ATYYFDNSGYSYGLDV,QQSYSLPQT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C570_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C571,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLIQPGGSLKLSCVVSGFTVSRNYISWVRQAPGKGLEWVSVLFAGGSTFYADSVKGRFAISRDNSNNTLFLQMNSLRVEDTAIYYCARGDGELIFDQWGQGTLVTVSS,QSVLTQPPSVSGAPGQRVTIVCTGTSSNIGAGYDVHWYQQLPGRAPKVLVSGNNIRPSEVPDRFSGSRSGTSASLAITSLQPEDEAQYYCQSYDSNLYAVFGGGTKLTVL,IGHV3-53 (Human),IGHJ4 (Human),IGLV1-40 (Human),IGLJ3 (Human),ARGDGELIFDQ,QSYDSNLYAV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C571_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C572,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLIKPGRSLRLSCTASGFTFGDYAMTWFRQAPGKGLEWVGFIRSKAYGGTTGYAASVKYRFTISRDDSKSIAYLQMDSLKTEDTAVYYCTRWDGWSQHDYWGQGTLVTVSS,DIVMTQSPLSLSVTPGEPASISCRSSQSLLHSNGNNYFDWYLQKPGQSPQLLIYLASNRASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQVLQIPYTFGQGTKLEI,IGHV3-49 (Human),IGHJ4 (Human),IGKV2-28 (Human),IGKJ2 (Human),TRWDGWSQHDY,MQVLQIPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C572_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C573,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLQESGPGLVKPSGTLSLTCAVSGGSISTVNWWSWVRQPPGKGLEWIGEIHHSGNTNHNPSLRSRVTISVDKSKNQFSLKLRSVTAADTAVYYCARDGGRPGDAFDLWGQGTMVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKVPKVMIYDVSNRPSGISNRFSGSKSGNTASLTISGLQAEDEADYYCNSYRSNSTRVFGTGTKVTV,IGHV4-4 (Human),IGHJ3 (Human),IGLV2-14 (Human),IGLJ1 (Human),ARDGGRPGDAFDL,NSYRSNSTRV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C573_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C574,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYGFSWVRQAPGQGLEWLGWISAYNGNTNYAQKLQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARAIAVAGTSGEFDYWGQGTLVTVSS,QSVLTQPPSASGTPGQRVTISCSGSSSNIGSNTVNWYQQLPGTAPKLLIYSNNQRPSGVPDRFSGSKSGTSASLAISGLQSEDEADYYCAAWDDSLNGHVVFGGGTKLTVL,IGHV1-18 (Human),IGHJ4 (Human),IGLV1-44 (Human),IGLJ2 (Human),ARAIAVAGTSGEFDY,AAWDDSLNGHVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C574_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C575,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVQSGAEVKKPGASVMLSCKASGYTFTSYGISWVRQAPGQGLEWMGWISAYNGNTNYAQKLQGRVSMTTDTSTSTAYMELRSLRSDDTAVYYCARAMAVAGTSGDFDYWGQGTLVTVSS,QSVLTQPPSASGTPGQRVTISCSGSSSNIGSNTVNWYQQLPGTAPKLLIYSNNQRPSGVPDRFSGSKSGTSASLAISGLQSEDEADYYCAAWDDSLNGHVVFGGGTKLTVL,IGHV1-18 (Human),IGHJ4 (Human),IGLV1-44 (Human),IGLJ2 (Human),ARAMAVAGTSGDFDY,AAWDDSLNGHVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C575_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C576,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSIYAISWVRQAPGQGLEWMGGIIPILGTANYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYCASFHVAYGDYIPFDYWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEREDFAVYYCQQYGRSPTWTFGQGTKVEIK,IGHV1-69 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ1 (Human),ASFHVAYGDYIPFDY,QQYGRSPTWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C576_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C577,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVQSGAEVKKPGSSVKVSCKASGDTFSIYAFSWVRQAPGQGLQWMGAIIPLLGTTNYAQKFLGRVTITADESTSTTFMELSSLTSEDTAVYHCATFHVAYGDYIPFDSWGQGTLVIVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVTSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGRSPTWTFGQGTKVEIK,IGHV1-69 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ1 (Human),ATFHVAYGDYIPFDS,QQYGRSPTWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C577_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C578,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSSGMHWVRQAPGKGLEWVAIISYDGSNKYYADSVKGRFTISRDNSKNTLSLQMNSLRAEDTAVYYCAKDPLPFRDFFYYYMDVWGKGTTVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSTLGVFGTGTKVTVL,IGHV3-30 (Human),IGHJ6 (Human),IGLV2-14 (Human),IGLJ1 (Human),AKDPLPFRDFFYYYMDV,SSYTSSSTLGV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C578_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C579,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSNYGMHLVRQAPGKGLEWVAIISYDGSNKYYADSVKGRFTISRDSSKNTLYLQMNNLRAEDTAVYYCAKDPLPFRDYYYYYMDVWGKGTTVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSTLGVFGTGTKVTVL,IGHV3-30 (Human),IGHJ6 (Human),IGLV2-14 (Human),IGLJ1 (Human),AKDPLPFRDYYYYYMDV,SSYTSSSTLGV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C579_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C580,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVQSGAEVKKAGESLKISCNSSGYSFTNYWIAWVRQVPGKGLEWMGIIYLGDSDTRYSPSFQGRVTISADKSISAAYLHWSSLKASDTAIYYCARGGPPGGVKLELTDFWGQGTLVTVSS,QSVLTQPPSASGTPGQRVTISCSGSNSNIGDNTVHWYQQLPGTAPKLLIFNNNQRPSGVPDRFSGSKSGTSASLAISGLQSDDEADYYCAAWDDSLDGPVVFGGGTKLTVL,IGHV5-51 (Human),IGHJ4 (Human),IGLV1-44 (Human),IGLJ2 (Human),ARGGPPGGVKLELTDF,AAWDDSLDGPVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C580_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C581,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVQSGAEVKKPGESLKISCKGSGYRFTSYWIAWVRQMPGKGLEWMGIIYPGDSDTRYSPSFQGQVTISADQSISTAYLQWSSLKASDTAMYYCARGGPPGGVKLELTDYWGQGALVTVSS,QSVLTQPPSASGTPGQRVTISCSGSSSNIGSNTVNWYQQLPGTAPQLLIYNNYQRPSGVPDRFSGSKSGTSASLAISGLQSEDEADYYCAAWDDSLNGPVVFGGGTKLTVL,IGHV5-51 (Human),IGHJ4 (Human),IGLV1-44 (Human),IGLJ2 (Human),ARGGPPGGVKLELTDY,AAWDDSLNGPVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C581_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C582,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVESGGGVVQPGRSLRLSCVASGFTFSYFDMHWVRQAPGKGLEWVALISHDGSTTFYGDSARGRFTISRDNSRNTLDLQMNSLRPEDTAVYFCAKPVDAAMFDFWGQGTLVTVS,SYELTQPPSVSVAPGKTARITCGGNNIGSKSVHWYQQRPGQAPVLVIYYDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADFYCQVWDRSTNHLVVFGGGTQLTVL,IGHV3-30 (Human),IGHJ4 (Human),IGLV3-21 (Human),IGLJ2 (Human),AKPVDAAMFDF,QVWDRSTNHLVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C582_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C583,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLIQPGGSLRLSCAASILTVSRNYMSWVRQAPGKGLEWVSSIYSGGTTYYADSVKGRFTISRDDSKNTLYLQMNSLRAEDTAVYYCARPVVGGRAGMDVWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDINKYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIGTFYCLHNDNPPLTFGGGTKVEIK,IGHV3-53 (Human),IGHJ6 (Human),IGKV1-33 (Human),IGKJ4 (Human),ARPVVGGRAGMDV,LHNDNPPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C583_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C584,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFSTYDMHWVRQATGKGLEWVSAIGTAGDKYYPGSVKGRFTISRENAKNSLYLQMNSLRAGDTAVYYCVRAGYSSGWPLYWYFDLWGRGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKFLIYAASSLQSGVPSRFSGSGSGTDFTLTISNLQPEDFATYYCQQSYRTPPEFTFGPGTKVDIK,IGHV3-13 (Human),IGHJ2 (Human),IGKV1-39 (Human),IGKJ3 (Human),VRAGYSSGWPLYWYFDL,QQSYRTPPEFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C584_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C585,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLQESGPGLVKPSETLSLTCTVSGDSISSYFWSWIRQPPGRGLEWIGYIHDSVNTNYNPSLKSRVTISVDTSKSQFSLRLSSVTAADTAVYYCARCAWLRGSFDYWGQGTLVTVSS,NFMLTQPHSVSESPGKTVTISCTGSSGSIASNYVQWYQQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDFSSHYVFGTGTKVTVL,IGHV4-59 (Human),IGHJ4 (Human),IGLV6-57 (Human),IGLJ1 (Human),ARCAWLRGSFDY,QSYDFSSHYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C585_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C586,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLIQPGGSLRLSCTASGLIVSSNYMSWIRQAPGKGLEWVSLIYSGGSTFYADSVKGRFTISRDNSKNTLFLHMNSLRAEDTAVYYCARHPYGTDVWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDIVKYLNWYQQKSGKAPKLLIHDASNLETGVTSRFSGSGSGTHFTFTISSLQPEDLATYYCQQYDNLPITFGQGTRLEIK,IGHV3-53 (Human),IGHJ6 (Human),IGKV1-33 (Human),IGKJ5 (Human),ARHPYGTDV,QQYDNLPIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C586_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C587,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVQSGAEVKKSGSSVKVSCKASGGSFSSYAISWVRQAPGQGLEWMGGIIPIFGTAKYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYCASRWEQLNGGSWHYFDYWGQGTLVTVSS,QSALTQPASVSGSPGQSITISCTGTRSDVGRNNLVSWYQHHPGKAPKVMIYEGSKRPSGVSTRFSGSKSGNTASLTISGLQAEDEADYYCCSYAGSSTFEGVFGGGTKLTVL,IGHV1-69 (Human),IGHJ4 (Human),IGLV2-23 (Human),IGLJ3 (Human),ASRWEQLNGGSWHYFDY,CSYAGSSTFEGV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C587_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C588,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLVQPGGSLKLSCAASGFTFSGSAMHWVRQASGKGLEWVGRIRNKANSYATAYGASVRGRFTVSRDDSKNTAYLQMNSLKIEDTAVYYCTKDIAAGIPALNWFDSWGQGTLVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQHTNWPPRITFGGGTKVEIK,IGHV3-73 (Human),IGHJ5 (Human),IGKV3-11 (Human),IGKJ4 (Human),TKDIAAGIPALNWFDS,QQHTNWPPRIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C588_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C589,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLQESGPGLVKPSQTLSLTCTVSGGSISSGDYYWSWIRQPPGKGLEWIGYIYYSGSTNYNPSLRSRVTISVDTSKNQFSLRLRSVTAADTAVYYCARDAIGSASYGVEYFQHWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSRYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTEFTLTISRLEPEDFAVYYCQQYGSSPPYTFGQGTKLEIK,IGHV4-30 (Human),IGHJ1 (Human),IGKV3-20 (Human),IGKJ2 (Human),ARDAIGSASYGVEYFQH,QQYGSSPPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C589_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C590,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVQSGAEVKKPGASVKVSCKVSGYNLTELSMYWVRQAPGKGLEWMGGFDPEDGGPIHAQKFQGRVTMTEDPSTDTAYMELRSLRSEDTALYYCATGGLFMIRGLEIWGRGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSISYTSLAWYQQKPGQAPRLLIFGASRGATGTPDRFSGSWSGTDFTLTISRLEPEDFAVYYCQQYGNSPRLSFGGGTKVEIK,IGHV1-24 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ4 (Human),ATGGLFMIRGLEI,QQYGNSPRLS,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C590_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C591,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVQSGAEVKKPGASVKVSCKASGYILTDYFIHWVRQAPGQGLEWMGWINPNSGGTNYAQKFQGRVTMTRDTSISTAYMELSRLRSDDTAVYHCARYKGTTVNTNYYYGMDVWGQGTTVTVSS,SYELTQPPSVSVSPGQTASITCSGDKLGDKYACWYQQKAGQSPVLVIYQDSKRPSGIPERFSGSKSGNTATLTISGTQAMDEADYYCQAWDSSTVVFGGGTKLTVL,IGHV1-2 (Human),IGHJ6 (Human),IGLV3-1 (Human),IGLJ2 (Human),ARYKGTTVNTNYYYGMDV,QAWDSSTVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C591_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C592,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTDYFNHWVRQAPGQGLEWMGWINPNSGGTNSAQKFQGRVTMTRDTSITTVYMELSRLRSDDTAVYYCARYKGTTVNTNYYYGMDVWGQGTTVTVSS,SYELTQPPSVSVSPGQTASITCSGDKLRNKYACWYQQKAGQSPMLVIYQDTKRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCQAWDISTVVFGGGTKLTVL,IGHV1-2 (Human),IGHJ6 (Human),IGLV3-1 (Human),IGLJ2 (Human),ARYKGTTVNTNYYYGMDV,QAWDISTVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C592_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C593,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYDINWVRQAPGQGLEWMGWMNPNSGNTDYAQKFQGRFTMTRNTSISTAYMELSSLRSEDTAVYYCASRRWDPLTFYYYMVVWGKGTTVTVSS,DIVMTQSPLPLPVTPGEPASISCRSSQSLLYSNGYNYLDWYLQKPGQSPQLLIYLGSNRASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYFCMQALQTPPTFGGGTKVEIK,IGHV1-8 (Human),IGHJ6 (Human),IGKV2-28 (Human),IGKJ4 (Human),ASRRWDPLTFYYYMVV,MQALQTPPT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C593_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C594,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISDDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKSWWLSENWFDPWGQGTLVTVSS,EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGTGSGTEFTLTISSLQSEDFAVYYCQQYNNWPLTFGGGTKVEIK,IGHV3-30 (Human),IGHJ5 (Human),IGKV3-15 (Human),IGKJ4 (Human),AKSWWLSENWFDP,QQYNNWPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C594_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C595,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVESGGGVVQAGRSLRLSCAASGFTFSSFGLHWVRQAPGKGLEWVAVISDDGANKYYADSVKGRFTISRDNSKNTLYLQMNSLRADDTAKYYCAKSWWLSENWFDPWGQGTLVTVSS,EIVMTQSPATLSVSPGERATLSCRASQSVRSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTDFTLTISSLQSEDFAVYYCQQYNNWPLTFGGGTKVEIK,IGHV3-30 (Human),IGHJ5 (Human),IGKV3-15 (Human),IGKJ4 (Human),AKSWWLSENWFDP,QQYNNWPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C595_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
C596,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVESGGGVVQPGRSLRLSCAASGITFSHYGMHWVRQAPGKGLEWVALISSDGSKKYYADSVKGRFTISRDNSKSTLYLQMNSLRAEDTAIYYCAKDLGYYYGPPYGPDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDVSNSLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFSFTISSLQPEDIATYYCLQYDNFSMYTFGQGTKLEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ2 (Human),AKDLGYYYGPPYGPDY,LQYDNFSMYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C596_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w)","Aug 5, 2021","Aug 5, 2021",N/A,Memory B-cells. Complete
DL4,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QVQLQESGGGLVQPGGSLRLSCAASGSFFEFGTVGWFRQAPGKQRELVSRITGNDHRYYADSVKGRFTISRDNDETTVYLQMDSLKPEDTAIYHCNILEGQRWSNYWGQGTQVTVS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,NILEGQRWSNY,N/A,Expected (7F5G),Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DL4_rank1_imgt_scheme.pdb,"Dianfan Li et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.07.20.453054v1)","Jul 24, 2021","Jul 24, 2021",N/A,Mutation and variant binding data in paper. Awaiting release of structure in PDB
DL28,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QVQLQESGGGLVQAGGSLRLSCAASGSDFSSSTMGWYRQAPGKQREFVAISSEGSTSYAGSVKGRFTISRDNAKNTVYLQMNSLEPEDTAVYYCNVVDRWYDYWGQGTQVTVS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,NVVDRWYDY,N/A,Expected (7F5H),Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DL28_rank1_imgt_scheme.pdb,"Dianfan Li et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.07.20.453054v1)","Jul 24, 2021","Jul 24, 2021",N/A,Mutation and variant binding data in paper. Awaiting release of structure in PDB
Turner-07-1A11,Ab,SARS-CoV2,OC43;HKU1,,,S; RBD,B-cells; SARS-CoV2 Vaccinee (Lymph Nodes),EVQLVESGGGLVKPGGSLRLSCAASGFTFSYAWMTWVRQAPGKGLEWVGRIKSKTDGGTTDYAAPVKGRFTISRDDSKNTLFLQMNSLKTEDTAVYFCTTGWFTGTYGDYFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLQTGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPPTFGGGTKVEIK,IGHV3-15 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ4 (Human),TTGWFTGTYGDYFDY,QQYDNLPPT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Turner-07-1A11_rank1_imgt_scheme.pdb,"Jackson Turner et al., 2021 (https://www.nature.com/articles/s41586-021-03738-2)","Jul 24, 2021","Jul 24, 2021",N/A,Complete
Turner-07-1A12,Ab,SARS-CoV2,OC43;HKU1,,,S; RBD,B-cells; SARS-CoV2 Vaccinee (Lymph Nodes),EVQLVESGGGLVQPGRSLRLSCTASGFTFGDYAMNWVRQAPGKGLEWVGFIRSKPYGGTTQYAASVKGRFTISRDDSKSIAYLQMNSLKTEDTAVYYCTRVKYCSGGSCYGYHFDHWGQGTLVTVSS,EIVMTQSPATLSVSPGERAALSCGASQSVSSNVAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNWFTFGPGTKVDIK,IGHV3-49 (Human),IGHJ4 (Human),IGKV3-15 (Human),IGKJ3 (Human),TRVKYCSGGSCYGYHFDH,QQYNNWFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Turner-07-1A12_rank1_imgt_scheme.pdb,"Jackson Turner et al., 2021 (https://www.nature.com/articles/s41586-021-03738-2)","Jul 24, 2021","Jul 24, 2021",N/A,Complete
Turner-07-1E10,Ab,SARS-CoV2,OC43;HKU1,,,S; NTD,B-cells; SARS-CoV2 Vaccinee (Lymph Nodes),VQLQQWGSGLLKPSETLSLTCAVYGESFSDYYWSWIRQPPGKGLEWIGEINHSGSTNYHPSLKSRVTISVDTSKNQFSLRLSSVTAADTAVYYCARVVIAVAGTYPIQVYYYYGMDVWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQGISNYLAWYQQKPGKVPELLIYAASTLQSGVPSRFIGSGSGTDFTLTISSLQPEDVATYYCQKYNSAPRTFGQGTKVEIK,IGHV4-34 (Human),IGHJ6 (Human),IGKV1-27 (Human),IGKJ1 (Human),ARVVIAVAGTYPIQVYYYYGMDV,QKYNSAPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Turner-07-1E10_rank1_imgt_scheme.pdb,"Jackson Turner et al., 2021 (https://www.nature.com/articles/s41586-021-03738-2)","Jul 24, 2021","Jul 24, 2021",N/A,Complete
Turner-07-1E11,Ab,SARS-CoV2 (weak),OC43;HKU1,,,S; Unk,B-cells; SARS-CoV2 Vaccinee (Lymph Nodes),EVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKEEMIEDWGMDVWGQGSTVTVSS,SVTSYELTQPPSVSVSPGQTASITCSGDKLGDKYACWYQQKPGQSPVLVIYQDTKRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCQAWDRSTVVFGGGTKLTVL,IGHV3-30 (Human),IGHJ6 (Human),IGLV3-1 (Human),IGLJ2 (Human),AKEEMIEDWGMDV,QAWDRSTVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Turner-07-1E11_rank1_imgt_scheme.pdb,"Jackson Turner et al., 2021 (https://www.nature.com/articles/s41586-021-03738-2)","Jul 24, 2021","Jul 24, 2021",N/A,Complete
Turner-07-1H09,Ab,SARS-CoV2,OC43;HKU1,,,S; RBD,B-cells; SARS-CoV2 Vaccinee (Lymph Nodes),EVQLVESGGGLVQPGGSLRLSCAASGIIVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMSSLRAEDTAVYYCARDFREGAFDIWGQGTMVTVSS,DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPPTFGGGTKVEIK,IGHV3-66 (Human),IGHJ3 (Human),IGKV1-9 (Human),IGKJ4 (Human),ARDFREGAFDI,QQLNSYPPT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Turner-07-1H09_rank1_imgt_scheme.pdb,"Jackson Turner et al., 2021 (https://www.nature.com/articles/s41586-021-03738-2)","Jul 24, 2021","Jul 24, 2021",N/A,Complete
Turner-07-2A07,Ab,SARS-CoV2,OC43;HKU1,,,S; NTD,B-cells; SARS-CoV2 Vaccinee (Lymph Nodes),EVQLVESGGGLVKPGGSLRLSCAASGFTFSIYSMIWVRQAPGKGLEWVSSISSSNTFIYYADSVKGRFTISRDNSKNSLYLQMNSLRAEDTAVYYCARAGFVPKRAYCGGDCWYYFDYWGQGTLVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWLTFGGGTKVEIK,IGHV3-21 (Human),IGHJ4 (Human),IGKV3-11 (Human),IGKJ4 (Human),ARAGFVPKRAYCGGDCWYYFDY,QQRSNWLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Turner-07-2A07_rank1_imgt_scheme.pdb,"Jackson Turner et al., 2021 (https://www.nature.com/articles/s41586-021-03738-2)","Jul 24, 2021","Jul 24, 2021",N/A,Complete
Turner-07-2A08,Ab,SARS-CoV2,OC43;HKU1,,,S; Unk,B-cells; SARS-CoV2 Vaccinee (Lymph Nodes),QVQLQESGPGLVKPSETLSLTCTVSGGSISSYYWNWIRQPAGKGLEWIGRIYTSGSTNYNPSLKSRVTMSVDTSKNQFSLKLSSVTAADTAVYYCATDGGWYTFDHWGQGTLVTVSS,TSYELTQPPSVSVSPGQTASITCSGDKLGNKYACWYQQKPGQSPVLVIYQDNKRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCQAWGSSTVVFGGGTKLTVL,IGHV4-4 (Human),IGHJ4 (Human),IGLV3-1 (Human),IGLJ2 (Human),ATDGGWYTFDH,QAWGSSTVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Turner-07-2A08_rank1_imgt_scheme.pdb,"Jackson Turner et al., 2021 (https://www.nature.com/articles/s41586-021-03738-2)","Jul 24, 2021","Jul 24, 2021",N/A,Complete
Turner-07-2A10,Ab,SARS-CoV2,OC43;HKU1,,,S; RBD,B-cells; SARS-CoV2 Vaccinee (Lymph Nodes),QVQLQESGPGLAKPSQTLSLTCTVSGGSISSGGYYWSWIRQHPGKGLEWIGYIYYSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARYPVWGAFDIWGQGTMVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPNLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDFATYYCQHYDNLPPTFGPGTKVDIK,IGHV4-31 (Human),IGHJ3 (Human),IGKV1-33 (Human),IGKJ3 (Human),ARYPVWGAFDI,QHYDNLPPT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Turner-07-2A10_rank1_imgt_scheme.pdb,"Jackson Turner et al., 2021 (https://www.nature.com/articles/s41586-021-03738-2)","Jul 24, 2021","Jul 24, 2021",N/A,Complete
Turner-07-2C08,Ab,SARS-CoV2,OC43;HKU1,,,S; RBD,B-cells; SARS-CoV2 Vaccinee (Lymph Nodes),EVQLVQSGPEVKKPGTSVKVSCKASGFTFSSSAVQWVRQARGQRLEWIGWIVVGSGNTNYAQKFQERVTITRDMSTNTAYMELSSLRSEDTAVYYCAAAYCSGGSCSDGFDIWGQGTMVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLICATSSRATGIPDRFSGSGSGTDFTLTIRRLEPEDFALYYCQQYGSSPWTFGQGTKVEIK,IGHV1-58 (Human),IGHJ3 (Human),IGKV3-20 (Human),IGKJ1 (Human),AAAYCSGGSCSDGFDI,QQYGSSPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Turner-07-2C08_rank1_imgt_scheme.pdb,"Jackson Turner et al., 2021 (https://www.nature.com/articles/s41586-021-03738-2) and Aaron Schmitz et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.24.436864v1)","Jul 24, 2021","Jul 24, 2021",N/A,Complete
Turner-07-2C12,Ab,SARS-CoV2,OC43;HKU1,,,S; Unk,B-cells; SARS-CoV2 Vaccinee (Lymph Nodes),EVQLVESGGGVVQPGRSLRLSCAASGFTFNTYAMHWVRQAPGKGLEWVALISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARARGGSYSGAFDIWGQGTMVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSNYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPMYTFGQGTKVEIK,IGHV3-30-3 (Human),IGHJ3 (Human),IGKV3-20 (Human),IGKJ2 (Human),ARARGGSYSGAFDI,QQYGSSPMYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Turner-07-2C12_rank1_imgt_scheme.pdb,"Jackson Turner et al., 2021 (https://www.nature.com/articles/s41586-021-03738-2)","Jul 24, 2021","Jul 24, 2021",N/A,Complete
Turner-07-3D07,Ab,SARS-CoV2,OC43;HKU1,,,S; RBD,B-cells; SARS-CoV2 Vaccinee (Lymph Nodes),EVQLVESGGGVVQPGRSLRLSCAASGFTFSRYTMHWVRQAPGKGLEWVAFISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARVLWLRGMFDYWGQGTLVTVSS,NFMLTQPHSVSESPGKTVTISCTGSSGSIASNYVQWYQQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDISNHWVFGGGTKLTVL,IGHV3-30-3 (Human),IGHJ4 (Human),IGLV6-57 (Human),IGLJ3 (Human),ARVLWLRGMFDY,QSYDISNHWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Turner-07-3D07_rank1_imgt_scheme.pdb,"Jackson Turner et al., 2021 (https://www.nature.com/articles/s41586-021-03738-2)","Jul 24, 2021","Jul 24, 2021",N/A,Complete
Turner-07-4A07,Ab,SARS-CoV2,OC43;HKU1,,,S; RBD,B-cells; SARS-CoV2 Vaccinee (Lymph Nodes),EVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMFWVRQAPGKGLEWVAVISYDGSNEYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARGDYYGSGSYPGKTFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDITNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPLTFGGGTKVEIK,IGHV3-30-3 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ4 (Human),ARGDYYGSGSYPGKTFDY,QQYDNLPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Turner-07-4A07_rank1_imgt_scheme.pdb,"Jackson Turner et al., 2021 (https://www.nature.com/articles/s41586-021-03738-2)","Jul 24, 2021","Jul 24, 2021",N/A,Complete
Turner-07-4B05,Ab,SARS-CoV2,OC43;HKU1,,,S; RBD,B-cells; SARS-CoV2 Vaccinee (Lymph Nodes),EVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAINWVRQAPGQGLEWMGRIIPILGIANYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCARGRLDSYSGSYYSWFDPWGQGTLVTVSS,DIVMTQSPDSLAVSLGERATINCKSSQSVLYSSNNKDYLAWYQQKPGQPPNLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYSTPYTFGQGTKVEIK,IGHV1-69 (Human),IGHJ5 (Human),IGKV4-1 (Human),IGKJ2 (Human),ARGRLDSYSGSYYSWFDP,QQYYSTPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Turner-07-4B05_rank1_imgt_scheme.pdb,"Jackson Turner et al., 2021 (https://www.nature.com/articles/s41586-021-03738-2)","Jul 24, 2021","Jul 24, 2021",N/A,Complete
Turner-07-4C10,Ab,SARS-CoV2,OC43;HKU1,,,S; NTD,B-cells; SARS-CoV2 Vaccinee (Lymph Nodes),EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSTISGSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKNEMAMIVVVITLFDYWGQGTLVTVSS,QSVLTQPPSVSAAPGQKVTISCSGSSSNIGNNYVSWYQQLPGTAPKLLIYDNNKRPSGIPDRFSGSKSGTSATLGITGLQTGDEANYYCGTWDRSLSAWVFGGGTKVTVL,IGHV3-23 (Human),IGHJ4 (Human),IGLV1-51 (Human),IGLJ3 (Human),AKNEMAMIVVVITLFDY,GTWDRSLSAWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Turner-07-4C10_rank1_imgt_scheme.pdb,"Jackson Turner et al., 2021 (https://www.nature.com/articles/s41586-021-03738-2)","Jul 24, 2021","Jul 24, 2021",N/A,Complete
Turner-07-4D09,Ab,SARS-CoV2,OC43;HKU1,,,S; NTD,B-cells; SARS-CoV2 Vaccinee (Lymph Nodes),QVQLQESGPGLVKPSGTLSLTCAVSGGSISSSNWWSWVRQPPGKGLEWIGEIYHSGNTNYNPSLKSRVTISVDKSKNQFSLKLSSVTAADTAVYYCATKYCSGGSCSYFGYWGQGTLVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGSYNLVSWYQQHPGKAPKLMIYEVSKRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCCSYAGSSTWVFGGGTKLTVL,IGHV4-4 (Human),IGHJ4 (Human),IGLV2-23 (Human),IGLJ3 (Human),ATKYCSGGSCSYFGY,CSYAGSSTWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Turner-07-4D09_rank1_imgt_scheme.pdb,"Jackson Turner et al., 2021 (https://www.nature.com/articles/s41586-021-03738-2)","Jul 24, 2021","Jul 24, 2021",N/A,Complete
Turner-20-1A12,Ab,SARS-CoV2 (weak),OC43;HKU1,,,S; Unk,B-cells; SARS-CoV2 Vaccinee (Lymph Nodes),EVQLVESGGGVVQPGRSLRLSCAASGFTFSSCGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKGHSGSYRAPFDYWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSYTFGQGTKVEIK,IGHV3-49 (Human),IGHJ4 (Human),IGKV3-15 (Human),IGKJ3 (Human),AKGHSGSYRAPFDY,QQYGSSYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Turner-20-1A12_rank1_imgt_scheme.pdb,"Jackson Turner et al., 2021 (https://www.nature.com/articles/s41586-021-03738-2)","Jul 24, 2021","Jul 24, 2021",N/A,Complete
Turner-20-2A03,Ab,SARS-CoV2 (weak),OC43;HKU1,,,S; Unk,B-cells; SARS-CoV2 Vaccinee (Lymph Nodes),EVQLVESGGGVVQPGRSLRLSCAASGFTFSTYGMHWVRQAPGKGLEWVAVIWYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAREAYFGSGSSPDYWGQGTLVTVSS,SYELTQPPSVSVSPGQTARITCSGDALPKKYAYWYQQKSGQAPVLVIYEDSKRPSGIPERFSGSSSGTMATLTISGAQVGDEADYYCYSTDSSDNHRRVFGGGTKLTVL,IGHV3-33 (Human),IGHJ4 (Human),IGLV3-10 (Human),IGLJ2 (Human),AREAYFGSGSSPDY,YSTDSSDNHRRV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Turner-20-2A03_rank1_imgt_scheme.pdb,"Jackson Turner et al., 2021 (https://www.nature.com/articles/s41586-021-03738-2)","Jul 24, 2021","Jul 24, 2021",N/A,Complete
Turner-20-3C08,Ab,SARS-CoV2 (weak),OC43;HKU1,SARS-CoV2,,S; Unk,B-cells; SARS-CoV2 Vaccinee (Lymph Nodes),EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYWMSWVRQAPGKGLEWVANIKEDGSEKYYVDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCAREGTYYYDSSAYYNGGLDYWGQGTLVTVSS,SVTSYELTQPPSVSMSPGQTARITCSGDALPKKYAYWYQQKSGQAPVLVIYEDSKRPSGIPERFSGSSSGTMATLTISGAQVEDEADYYCYSTDSGGNPQGVFGGGTKLTVL,IGHV3-7 (Human),IGHJ4 (Human),IGLV3-10 (Human),IGLJ2 (Human),AREGTYYYDSSAYYNGGLDY,YSTDSGGNPQGV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Turner-20-3C08_rank1_imgt_scheme.pdb,"Jackson Turner et al., 2021 (https://www.nature.com/articles/s41586-021-03738-2)","Jul 24, 2021","Jul 24, 2021",N/A,Complete
Turner-20-3D12,Ab,SARS-CoV2 (weak),OC43;HKU1,,,S; Unk,B-cells; SARS-CoV2 Vaccinee (Lymph Nodes),EVQLVESGGGVVQPGGSLKLSCAASGFTFSRYGMHWVRQAPGKGLEWVALIWFDGSNKYYADSVKGRFTISRDNSKNTLSLQMNSLRAEDTAVYYCATEPVQLEPEVRLDYWGQGTLVTVSS,SYELTQPPSVSVSPGQTARITCSGDALPKKYAYWFQQKSGQAPVLVIYEDSKRPSGIPERFSGSSSGTMATLTISGAQVEDEADYYCYSTDSSGNHRRLFGTGTKVTVL,IGHV3-33 (Human),IGHJ4 (Human),IGLV3-10 (Human),IGLJ1 (Human),ATEPVQLEPEVRLDY,YSTDSSGNHRRL,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Turner-20-3D12_rank1_imgt_scheme.pdb,"Jackson Turner et al., 2021 (https://www.nature.com/articles/s41586-021-03738-2)","Jul 24, 2021","Jul 24, 2021",N/A,Complete
Turner-20-3F12,Ab,SARS-CoV2,OC43;HKU1,,,S; Unk,B-cells; SARS-CoV2 Vaccinee (Lymph Nodes),EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYWMSWVRQAPGKGLEWVANIKQDGSEKYYVDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARDQGVTTGPFDYWGQGTLVTVSS,SYELTQPPSVSVSPGQTASITCSGDKLGNKYACWYQQKPGQSPVLVIYQDSKRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCQAWDSSTVVFGGGTKLTVL,IGHV3-7 (Human),IGHJ4 (Human),IGLV3-1 (Human),IGLJ2 (Human),ARDQGVTTGPFDY,QAWDSSTVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Turner-20-3F12_rank1_imgt_scheme.pdb,"Jackson Turner et al., 2021 (https://www.nature.com/articles/s41586-021-03738-2)","Jul 24, 2021","Jul 24, 2021",N/A,Complete
Turner-22-1A11,Ab,SARS-CoV2 (weak),OC43;HKU1,,,S; Unk,B-cells; SARS-CoV2 Vaccinee (Lymph Nodes),EVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLVVWEELAGGYWGQGTLVTVSS,SYELTQPPSVSVSPGQTARITCSGDALPKKFAYWYQQKSGQAPVLVIYEDNKRPSGIPERFSGSSSGTMATLTISGAQVEDEADYYCYSTDSSGNHGVFGGGTKLTVL,IGHV3-30-3 (Human),IGHJ4 (Human),IGLV3-10 (Human),IGLJ3 (Human),ARDLVVWEELAGGY,YSTDSSGNHGV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Turner-22-1A11_rank1_imgt_scheme.pdb,"Jackson Turner et al., 2021 (https://www.nature.com/articles/s41586-021-03738-2)","Jul 24, 2021","Jul 24, 2021",N/A,Complete
Turner-22-1B04,Ab,SARS-CoV2,OC43;HKU1,,,S; RBD,B-cells; SARS-CoV2 Vaccinee (Lymph Nodes),EVQLVESGGVVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSDKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKQGGGTYCGGGSCYRGYFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPNLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPLTFGGGTKVEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ4 (Human),AKQGGGTYCGGGSCYRGYFDY,QQYDNLPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Turner-22-1B04_rank1_imgt_scheme.pdb,"Jackson Turner et al., 2021 (https://www.nature.com/articles/s41586-021-03738-2)","Jul 24, 2021","Jul 24, 2021",N/A,Complete
Turner-22-1B08,Ab,SARS-CoV2;OC43,HKU1,,,S; Unk,B-cells; SARS-CoV2 Vaccinee (Lymph Nodes),EVQLVQSGAEAKKPGASVNISCRTSGYTFSNYYIHWVRQAPGQGLEWMGIFNPSGGGTSYAQNFQGRLTMTSDTSTSTVFMELSSLGSEDTAVYYCARDPRVPAVTNVNDAFDLWGQGTMVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQHKPGQAPRLIIYNASNRATGIPARFSGSRSGTDFTLTISSLEPEDFAVYYCQQRSNRPPRWTFGQGTKVEIK,IGHV1-46 (Human),IGHJ3 (Human),IGKV3-11 (Human),IGKJ2 (Human),ARDPRVPAVTNVNDAFDL,QQRSNRPPRWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Turner-22-1B08_rank1_imgt_scheme.pdb,"Jackson Turner et al., 2021 (https://www.nature.com/articles/s41586-021-03738-2)","Jul 24, 2021","Jul 24, 2021",N/A,Complete
Turner-22-1B12,Ab,SARS-CoV2,OC43;HKU1,,,S; RBD,B-cells; SARS-CoV2 Vaccinee (Lymph Nodes),EVQLVETGGGLIQPGGSLRLSCAVSEFTVSSNYMSWVRQAPGEGLEWVSVIYLGGSTDYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARSHLEVRGVFDNWGQGTLVTVSS,DIVMTQSPDSLAVSLGERATVNCKSSQSVLYSSNNKNYLAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYSTPCSFGQGTKVEIK,IGHV3-53 (Human),IGHJ4 (Human),IGKV4-1 (Human),IGKJ2 (Human),ARSHLEVRGVFDN,QQYYSTPCS,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Turner-22-1B12_rank1_imgt_scheme.pdb,"Jackson Turner et al., 2021 (https://www.nature.com/articles/s41586-021-03738-2)","Jul 24, 2021","Jul 24, 2021",N/A,Complete
Turner-22-1C02,Ab,SARS-CoV2;OC43;HKU1,,,,S; Unk,B-cells; SARS-CoV2 Vaccinee (Lymph Nodes),EVQLVESGGGVVRPGGSLRLSCAASGFTFDDYGMSWVRQAPGRGLEWVSNINWNGGSTGYADSVKGRFTISRDNAKKSLYLQVNSLRAEDTALYYCARGTGAADYWGQGTLVTVSS,EIVLTQSPGTLSLSPGERVTLSCRASQSVRSSFLAWYQHKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDSAVYYCQQYGRSPYTFGQGTKVEIK,IGHV3-20 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ2 (Human),ARGTGAADY,QQYGRSPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Turner-22-1C02_rank1_imgt_scheme.pdb,"Jackson Turner et al., 2021 (https://www.nature.com/articles/s41586-021-03738-2)","Jul 24, 2021","Jul 24, 2021",N/A,Complete
Turner-22-1E07,Ab,SARS-CoV2,OC43;HKU1,,,S; Unk,B-cells; SARS-CoV2 Vaccinee (Lymph Nodes),EVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVIWYDGGNKHYADSVKGRFTISRDNSKNTLYLQMDSLRAEDTAVYYCAREGVYGDIGGAGLDYWGQGTLVTVSS,SYELTQPPSVSVSPGQTARITCSGDALPKKYAYWYQQKSGQAPVLVIYEDSKRPSGIPERFSGSSSGTMATLTISGAQVEDEADYYCYSTDSSVNGRVFGTGTKVTVL,IGHV3-33 (Human),IGHJ4 (Human),IGLV3-10 (Human),IGLJ1 (Human),AREGVYGDIGGAGLDY,YSTDSSVNGRV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Turner-22-1E07_rank1_imgt_scheme.pdb,"Jackson Turner et al., 2021 (https://www.nature.com/articles/s41586-021-03738-2)","Jul 24, 2021","Jul 24, 2021",N/A,Complete
Turner-22-1E11,Ab,SARS-CoV2,OC43;HKU1,,,S; RBD,B-cells; SARS-CoV2 Vaccinee (Lymph Nodes),EVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLFLQMSSLRAEDTAVYYCAKMGGVYCSAGNCYSGRLEYWGLGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLLTFGPGTKVDIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ3 (Human),AKMGGVYCSAGNCYSGRLEY,QQYDNLLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Turner-22-1E11_rank1_imgt_scheme.pdb,"Jackson Turner et al., 2021 (https://www.nature.com/articles/s41586-021-03738-2)","Jul 24, 2021","Jul 24, 2021",N/A,Complete
Turner-22-1G10,Ab,SARS-CoV2 (weak);OC43;HKU1,,,,S; Unk,B-cells; SARS-CoV2 Vaccinee (Lymph Nodes),QVQLQESGPRLVRPLETLSLTCTVSGGSMNSNYWSWIRQPPGKRLEWIGYIYYRGSTNYNPSLKSRVTISVDTSKNQFSLNLTSVTAADTAIYYCARETVNNWVDPWGQGTLVTVSS,DIVMTQSPDSLTVSLGERATINCKSSQSISYFSNNKNYLAWYQQKPGQPPKLLIYWASTRESGVPDRFGGSGSGADFTLTISSLQAEDVAVYYCQQYFTTPWTFGQGTKVEIK,IGHV4-59 (Human),IGHJ6 (Human),IGKV4-1 (Human),IGKJ1 (Human),ARETVNNWVDP,QQYFTTPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Turner-22-1G10_rank1_imgt_scheme.pdb,"Jackson Turner et al., 2021 (https://www.nature.com/articles/s41586-021-03738-2)","Jul 24, 2021","Jul 24, 2021",N/A,Complete
Turner-22-2A06,Ab,SARS-CoV2,OC43;HKU1,,,S; RBD,B-cells; SARS-CoV2 Vaccinee (Lymph Nodes),EVQLVQSGAEVKKPGESLKISCKGSGYSFTSYWIGWVRQMPGRGLEWMGIIYPGDSDTRYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARREWGGSLGHIDYWGQGTLVTVSS,NFMLTQPHSVSESPGKTVTISCTRSRGSIAGNYVQWYQQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEAEYYCQSFDSSNVVFGGGTKVTVL,IGHV5-51 (Human),IGHJ4 (Human),IGLV6-57 (Human),IGLJ2 (Human),ARREWGGSLGHIDY,QSFDSSNVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Turner-22-2A06_rank1_imgt_scheme.pdb,"Jackson Turner et al., 2021 (https://www.nature.com/articles/s41586-021-03738-2)","Jul 24, 2021","Jul 24, 2021",N/A,Complete
Turner-22-2A08,Ab,SARS-CoV2,OC43;HKU1,,,S; RBD,B-cells; SARS-CoV2 Vaccinee (Lymph Nodes),QVQLQESGPGLVKPSETLSLTCTVSGGSISSYFWSWIRQPPGKGLEWIAYIYFSGSTNYSPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARGQGVPAALYGMDVWGQGTTVTVSS,QSVLTQPPSVSGAPGQRVTISCTWSSSNIGAGYDVHWYRQLPGTAPKLLIYGNSNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDGSLSGSVFGGGTRLTVL,IGHV4-59 (Human),IGHJ6 (Human),IGLV1-40 (Human),IGLJ2 (Human),ARGQGVPAALYGMDV,QSYDGSLSGSV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Turner-22-2A08_rank1_imgt_scheme.pdb,"Jackson Turner et al., 2021 (https://www.nature.com/articles/s41586-021-03738-2)","Jul 24, 2021","Jul 24, 2021",N/A,Complete
Turner-22-2B06,Ab,SARS-CoV2,OC43;HKU1,,,S; RBD,B-cells; SARS-CoV2 Vaccinee (Lymph Nodes),EVQLVETGGGLIQPGGSLRLSCAASGFTVSSNYMTWVRQAPGKGLEWVSLIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLQLYGMDVWGQGTTVTVSS,SYELTQPPSVSVAPGQTARITCGGNNIGSNSVHWYQQKPGQAPVLVVYDDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYHCQVWDSSSDPVVFGGGTKLTVL,IGHV3-53 (Human),IGHJ6 (Human),IGLV3-21 (Human),IGLJ2 (Human),ARDLQLYGMDV,QVWDSSSDPVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Turner-22-2B06_rank1_imgt_scheme.pdb,"Jackson Turner et al., 2021 (https://www.nature.com/articles/s41586-021-03738-2)","Jul 24, 2021","Jul 24, 2021",N/A,Complete
Turner-22-2F03,Ab,SARS-CoV2,OC43;HKU1,,,S; NTD,B-cells; SARS-CoV2 Vaccinee (Lymph Nodes),EVQLVQSGAEVKKPGASVKVSCKASGYIFTSYGISWVRQAPGQGLEWMGWISAYNGNTNYAQKLQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARVPGLVGYSSSWYDNEKNYYYYYYGMDVWGQGTTVTVSS,SYELTQPPSVSVSPGQTARITCSGDALPKQYAYWYQQKPGQAPVLVIYKDSERPSGIPERFSGSSTGTTVTLTISGVQAEDEADYYCQSADSSGTYVFGTGTKVTVL,IGHV1-18 (Human),IGHJ6 (Human),IGLV3-25 (Human),IGLJ1 (Human),ARVPGLVGYSSSWYDNEKNYYYYYYGMDV,QSADSSGTYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Turner-22-2F03_rank1_imgt_scheme.pdb,"Jackson Turner et al., 2021 (https://www.nature.com/articles/s41586-021-03738-2)","Jul 24, 2021","Jul 24, 2021",N/A,Complete
Turner-22-3A06,Ab,SARS-CoV2,OC43;HKU1,,,S; NTD,B-cells; SARS-CoV2 Vaccinee (Lymph Nodes),EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSAISGSGGSTYYADSVKGRLTISRDNSKNTLYMQMNSLRAEDTAVYYCAKADTAMAWYNWFDPWGQGTLVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSTYLAWYQQKPGQALRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQHRSNWPLTFGGGTKVEIK,IGHV3-23 (Human),IGHJ5 (Human),IGKV3-11 (Human),IGKJ4 (Human),AKADTAMAWYNWFDP,QHRSNWPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Turner-22-3A06_rank1_imgt_scheme.pdb,"Jackson Turner et al., 2021 (https://www.nature.com/articles/s41586-021-03738-2)","Jul 24, 2021","Jul 24, 2021",N/A,Complete
Turner-22-3A11,Ab,SARS-CoV2,OC43;HKU1,,,S; RBD,B-cells; SARS-CoV2 Vaccinee (Lymph Nodes),QVQLQQWGAGLLKPSETLSLTCAVYGGSFSGYYWSWIRQPPGKGLEWLGEINHSGSTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARVWVRWWYFDLWGRGTLVTVSS,SYELTQPPSVSVAPGQTARITCGGNNIGRKSVHWYQQKPGQAPVLVVYDDSDRPSGIPERFSGSNSGNTATLTLSRVEAGDEADYYCQVWDNSSDQPNYVFGTGTKVTVL,IGHV4-34 (Human),IGHJ2 (Human),IGLV3-21 (Human),IGLJ1 (Human),ARVWVRWWYFDL,QVWDNSSDQPNYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Turner-22-3A11_rank1_imgt_scheme.pdb,"Jackson Turner et al., 2021 (https://www.nature.com/articles/s41586-021-03738-2)","Jul 24, 2021","Jul 24, 2021",N/A,Complete
Turner-22-3A12,Ab,SARS-CoV2,OC43;HKU1,,,S; RBD,B-cells; SARS-CoV2 Vaccinee (Lymph Nodes),EVQLVQSGAEVEKSGASVKVSCKASGYTFTSFYMHWVRQAPGQGLEWMGIINPSGGSTNYAQKFQGRVTMTRDTSTSTVYMELSSLRSEDTAVYYCASSLPARGGVPGRLNYWGQGALVTVSS,QSVLTQAPSVSAAPGQKVTISCSGSSSNIGNNYVSWYQQLPGTAPKLLIYDNNKRPSGIPDRFSGSKSGTSATLGITGLLTGDEADYYCGTWDSSLSVVVFGGGTKLTVL,IGHV1-46 (Human),IGHJ4 (Human),IGLV1-51 (Human),IGLJ2 (Human),ASSLPARGGVPGRLNY,GTWDSSLSVVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Turner-22-3A12_rank1_imgt_scheme.pdb,"Jackson Turner et al., 2021 (https://www.nature.com/articles/s41586-021-03738-2)","Jul 24, 2021","Jul 24, 2021",N/A,Complete
Turner-22-3D11,Ab,SARS-CoV2,OC43;HKU1,,,S; RBD,B-cells; SARS-CoV2 Vaccinee (Lymph Nodes),EVQLVQSGAEVKKPGESLKISCKGSGYSFTSYWIAWVRQMPGKGLEWMGIIYPGDSDTRYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARHHLDYDDYVGHWFDPWGQGTLVTVSS,QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWYQQLPGTAPKLLIYGNSNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSSLSGSGVFGGGTKLTVL,IGHV5-51 (Human),IGHJ5 (Human),IGLV1-40 (Human),IGLJ3 (Human),ARHHLDYDDYVGHWFDP,QSYDSSLSGSGV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Turner-22-3D11_rank1_imgt_scheme.pdb,"Jackson Turner et al., 2021 (https://www.nature.com/articles/s41586-021-03738-2)","Jul 24, 2021","Jul 24, 2021",N/A,Complete
Turner-22-3F08,Ab,SARS-CoV2 (weak),OC43;HKU1,,,S; Unk,B-cells; SARS-CoV2 Vaccinee (Lymph Nodes),EVQLVQSGAEVKKPGASVKVSCKASGYTFTSYGISWVRQAPGQGLEWMGWISVYNGNKNFAQKLQGRVTMTTDTPTSTAYMELRSLRSDDTAVYYCASCPRRPAAIGDYYGMDVWGQGTTVTVSS,SYELTQPPSVSVAPGQTARITCGGNNIGSKSVHWYQQKPGQAPVLVVYDDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDSSSYHAVFGGGTQLTVL,IGHV1-18 (Human),IGHJ6 (Human),IGLV3-21 (Human),IGLJ7 (Human),ASCPRRPAAIGDYYGMDV,QVWDSSSYHAV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Turner-22-3F08_rank1_imgt_scheme.pdb,"Jackson Turner et al., 2021 (https://www.nature.com/articles/s41586-021-03738-2)","Jul 24, 2021","Jul 24, 2021",N/A,Complete
MA4,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Mouse,ND,ND,ND,ND,ND,ND,ARDGYDVGAMDY,LQYASYPL,ND,,"Lina Jia et al., 2021 (https://onlinelibrary.wiley.com/doi/full/10.1002/mco2.79)","Jul 24, 2021","Jul 24, 2021",N/A,Complete
S2D106,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVQSGAEVKKPGSSVKVSCKASGGPFSSSAISWVRQAPGQGLEWMGGIIPMVGTANYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYCARDSRYCSGGSCYSVWFDPWGQGTLVTVSS,DIQLTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKVLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPRTFGQGTKVEMK,IGHV1-69 (Human),IGHJ5 (Human),IGKV1-39 (Human),IGKJ1 (Human),ARDSRYCSGGSCYSVWFDP,QQSYSTPRT,https://www.rcsb.org/structure/7R7N,,"Tyler Starr et al., 2021 (https://www.nature.com/articles/s41586-021-03807-6)","Jul 24, 2021","Jul 24, 2021",N/A,Complete
S2-L20,Ab,SARS-CoV2,,,SARS-CoV2,S; NTD,B-cells; SARS-CoV2 Patient,EVQLVESGGGVVQPGGSLRLSCAASGFTFNSYGMHWVRQAPGKGLEWVAFIRYDGGNKYYADSVKGRFTISRDNSKNTLYLQMKSLRAEDTAVYYCANLKDSRYSGSYYDYWGQGTLVTVS,VIWMTQSPSSLSASVGDRVTITCQASQDIRFYLNWYQQKPGKAPKLLISDASNMETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPFTFGPGTKVDF,IGHV3-30 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ3 (Human),ANLKDSRYSGSYYDY,QQYDNLPFT,https://www.rcsb.org/structure/7N8H; https://www.rcsb.org/structure/7N8I,,"Matthew McCallum et al., 2021 (https://science.sciencemag.org/content/early/2021/06/30/science.abi7994)","Jul 24, 2021","Jul 24, 2021",N/A,Variant binding data in McCallum et al. Complete
P003_001,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; non-S1,B-cells; SARS-CoV2 Patient,QVQLVESGPGLVKSSQTLPLTCTVSGASINSNNYYWNWIRQPAGKGLEWIGRIHSSGNTNYSPSLRSRLTISVDTSKNQFSLELTSVTAADTAVYYCARDDWTTALDCWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSNYLAWYQQKPGQAPRLLIYAASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYFCQQYGSSRNTFGQGTKVEIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV3-20 (Human),IGKJ1 (Human),ARDDWTTALDC,QQYGSSRNT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P003_001_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P003_002,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; NTD,B-cells; SARS-CoV2 Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGRIIPIFGTANYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYCARDRPPIVVVTTYYYYGMDVWGQGTTVTVSS,DIVLTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSMQSEDFAVYYCQQYNNWPPGDTFGQGTKVEIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV3D-15 (Human),IGKJ1 (Human),ARDRPPIVVVTTYYYYGMDV,QQYNNWPPGDT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P003_002_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P003_003,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; non-S1,B-cells; SARS-CoV2 Patient,EVQLLESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGINKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKAFKGNYYYGMDVWGQGTTVTVSS,DIQLTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQEPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPFTFGPGTKLEIK,IGHV3-30 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ3 (Human),AKAFKGNYYYGMDV,QQSYSTPFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P003_003_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P003_006,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; non-S1,B-cells; SARS-CoV2 Patient,QVQLVQSGAEVKNPGASVKVSCTASGYTFTSYGISWVRQAPGQGLEWMGWISAYNGNTNYAQKLQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCALVGATDYWGQGTLVTVSS,EIVMTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPTFGQGTKVEIK,IGHV1-18 (Human),IGHJ4 (Human),IGKV3-11 (Human),IGKJ1 (Human),ALVGATDY,QQRSNWPT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P003_006_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P003_007,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; non-S1,B-cells; SARS-CoV2 Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTGYYMHWVRQAPGQGLEWMGWINPNSGGTNYAQKFQGRVTMTRDTSISTAYMELSRLRSDDTAVYYCARGAASVLRFLEWLLDYWGQGALVTVSS,AIRMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPLTFGGGTKVEIK,IGHV1-2 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ4 (Human),ARGAASVLRFLEWLLDY,QQYDNLPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P003_007_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P003_014,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVESGGGLVQPGGSLRLSCAASGFTFSSYDMHWVRQATGKGLEWVSAIGTAGDTYYPGSVKGRFTISRENAKNSLYLQMNSLRAEDTAVYYCARAQYSSGWYLRFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSSQYTFGQGTKVEIK,IGHV3-13 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ4 (Human),ARAQYSSGWYLRFDY,QQSYSSQYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P003_014_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P003_015,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; non-S1,B-cells; SARS-CoV2 Patient,QLQLQESGPGLVKPSGTLSLTCAVSGGFISSSNWWSWVRQPPGKGLEWIGEIYHSGSTNYNPSLKSRVTISVDKSKNQFSLKLSSVTAADTAVYYCASRYCSGGSCGYFDYWGQGTLVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGSYNLVSWYQQHPGKAPKLMIYEVSKRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCCSYAGSSTWVFGGGTKLTVL,IGHV4-4 (Human),IGHJ4 (Human),IGLV2-23 (Human),IGLJ3 (Human),ASRYCSGGSCGYFDY,CSYAGSSTWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P003_015_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P003_016,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; NTD,B-cells; SARS-CoV2 Patient,QVQLVESGGGLVQPGGSLRLSCAASGFTFSSYWMHWVRQAPGKGLVWVSRINIYGSSTSYADSVKGRFTISRDNAKNTLYLQMNSLRAEDTAVYYCARDLHYDSSGWDYWGQGTLVTVSS,DIVMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPPWTFGQGTKLEIK,IGHV3-74 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ1 (Human),ARDLHYDSSGWDY,QQSYSTPPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P003_016_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P003_017,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTVSSNYMNWVRQAPGKGLEWVSVIYSGGSTYYGDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDFREGAFDIWGQGTMVTVSS,DIVMTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYTLTFGGGTKVDIK,IGHV3-66 (Human),IGHJ3 (Human),IGKV1-9 (Human),IGKJ4 (Human),ARDFREGAFDI,QQLNSYTLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P003_017_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P003_022,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; non-S1,B-cells; SARS-CoV2 Patient,EVQLVESGGGVVQPGRSLRLSCAASGFTFSTYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDPTIVVVAVNPTFDYWGQGTLVTVSS,QSALTQPRSVSGSPGQSVTISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSKRPSGVPDRFSGSKSGNTASLTISGLQAEDEADYYCCSYAGSYTFGYVFGTGTKVTVL,IGHV3-30 (Human),IGHJ4 (Human),IGLV2-11 (Human),IGLJ1 (Human),AKDPTIVVVAVNPTFDY,CSYAGSYTFGYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P003_022_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P003_026,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; non-S1,B-cells; SARS-CoV2 Patient,QVQLVESGGGLVKPGGSLRLSCAASGFTFSSYSMNWVRQAPGKGLEWVSSISSSSSYIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARDLDIVVVPAARSYYYYGMDVWGQGTTVTVSS,SYELTQPPSVSVSPGQTARITCSGDALPKQYAYWYQQKPGQAPVLVIYKDSERPSGIPERFSGSSSGTTVTLTISGVQAEDEADYYCQSADSSGTYHVVFGGGTKLTVL,IGHV3-21 (Human),IGHJ6 (Human),IGLV3-25 (Human),IGLJ3 (Human),ARDLDIVVVPAARSYYYYGMDV,QSADSSGTYHVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P003_026_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P003_027,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; NTD,B-cells; SARS-CoV2 Patient,EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYSMNWVRQAPGKGLEWVSYISSSSSTIYYADSVKGRFTISRDNAKNSLYLQMNRLRDEDTAVYYCARDRCGDCYGPYYYGMDVWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISTYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPYTFGQGTKVEIK,IGHV3-48 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ1 (Human),ARDRCGDCYGPYYYGMDV,QQSYSTPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P003_027_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P003_030,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; non-S1,B-cells; SARS-CoV2 Patient,QVQLQQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGRIIPIFGTANYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYCASHPYYDSSGYYPNYGMDAWGQGTTVTVSS,DIVMTQTPLSLSVTPGQPASISCKSSQSLLHSDGKTYLYWYLQKPGQPPQLLIYEVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQSIQLARFGQGTKLEIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV2-29 (Human),IGKJ2 (Human),ASHPYYDSSGYYPNYGMDA,MQSIQLAR,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P003_030_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P003_032,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; non-S1,B-cells; SARS-CoV2 Patient,EVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVIWYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDGQVGATSGIDYWGQGTLVTVSS,NFMLTQPPSVSVSPGQTARITCSGDALPKKYAYWYQQKSGQAPVLVIYEDSKRPSGIPERFSGSSSGTMATLTISGAQVEDEGDYYCYSTDSSGNKRVFGGGTKLTVL,IGHV3-33 (Human),IGHJ4 (Human),IGLV3-10 (Human),IGLJ3 (Human),ARDGQVGATSGIDY,YSTDSSGNKRV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P003_032_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P003_034,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; non-S1,B-cells; SARS-CoV2 Patient,EVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKSAFGSYYYGMDVWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQGISNYLAWYQQKPGKVPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDVATYYCQKYNSAPHTFGGGTKVEIK,IGHV3-30-3 (Human),IGHJ6 (Human),IGKV1-27 (Human),IGKJ4 (Human),AKSAFGSYYYGMDV,QKYNSAPHT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P003_034_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P003_038,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; non-S1,B-cells; SARS-CoV2 Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTIPRDNSKNTLYLQMNSLRAEDTAVYYCAKGGSGYRYYFDYWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSYTFGQGTKLEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ2 (Human),AKGGSGYRYYFDY,QQYGSSYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P003_038_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P003_043,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; non-S1,B-cells; SARS-CoV2 Patient,QVQLVQSGAEVKKPGASVKVSCKVSGYTLTELSMHWVRQAPGKGLEWMGGFDLADGETIYAQEFQGRVTMTEDTSTDTAYMALSSLRSEDTAVYYCATGPLTIAVAGQWFDPWGQGTLVTISS,DIVMTQSPLSLPVTPGEPASISCRSSQSLLHSNGYNYLDWYLQKPGQSPQLLIYMGSNRASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQALQSPYNLGQGTKLEIK,IGHV1-24 (Human),IGHJ5 (Human),IGKV2-28 (Human),IGKJ2 (Human),ATGPLTIAVAGQWFDP,MQALQSPYN,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P003_043_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P003_045,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; non-S1,B-cells; SARS-CoV2 Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSNYGTHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARPDSGSYWGAFDIWGQGTMVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSFTFGPGTKVDIK,IGHV3-30 (Human),IGHJ3 (Human),IGKV3-20 (Human),IGKJ3 (Human),ARPDSGSYWGAFDI,QQYGSSFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P003_045_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P003_051,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; S1,B-cells; SARS-CoV2 Patient,EVQLVQSGAEVKKPGASVKVSCKASGYTFTSYGISWVRQAPGQGLEWMGWISAYNGNTNYAQKLQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARDTRGRGGHDAFDIWGQGTMVTISS,SYELTQPPSVSVAPGQTARITCGGNNIGSKSVHWYQQKPGQAPVLVVYDDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,IGHV1-18 (Human),IGHJ3 (Human),IGLV3-21 (Human),IGLJ3 (Human),ARDTRGRGGHDAFDI,QVWDSSSDHVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P003_051_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P003_053,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; non-S1,B-cells; SARS-CoV2 Patient,EVQLLESGGGLVKPGGSLRLSCAASGFTFSNAWMTWVRQAPGKGLEWVGRIKSKTDGGTTDYAAPVKGRFTISRHDSKNTLYLQMNSLKTEDTAVYYCTTASNPDYWGQGTRVTVSS,DIVMTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVDIK,IGHV3-15 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ1 (Human),TTASNPDY,QQYGSSPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P003_053_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P003_055,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; NTD,B-cells; SARS-CoV2 Patient,EVQLVESGPGLVKPSETLSLTCTVSGGSISSYYWSWIRQPPGKGLEWIGYIYYSGSTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARENYDFWSGYFNGWFDPWGQGTLVTVSS,DIVMTQSPDSLAVSLGERATINCKSSQSVLYSSNNKNYLAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYSTPRTFGQGTKVEIK,IGHV4-59 (Human),IGHJ5 (Human),IGKV4-1 (Human),IGKJ1 (Human),ARENYDFWSGYFNGWFDP,QQYYSTPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P003_055_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P003_056,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; non-S1,B-cells; SARS-CoV2 Patient,EVQLLESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKSHSGSYFSSGDYWGQGTLVTVSS,NIVMTQSPDSLAVSLGERATINCKSSQSVLYSSNNKNYLAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYSTWTFGQGTKLEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV4-1 (Human),IGKJ1 (Human),AKSHSGSYFSSGDY,QQYYSTWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P003_056_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P003_058,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; non-S1,B-cells; SARS-CoV2 Patient,EVQLVQSGAEVKKPGESLKISCKGSGYSFTIYWIGWVRQMPGKGLEWMGIIYPGDSDTRYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARRTLTTTYGMDVWGQGTTVTVSS,DVVMTQSPSSVSASVGDRVTITCRASQGISSWLAWYQQKPGKAPELPIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQANSFPWTFGQGTKVDIK,IGHV5-51 (Human),IGHJ6 (Human),IGKV1-12 (Human),IGKJ1 (Human),ARRTLTTTYGMDV,QQANSFPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P003_058_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P003_064,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; non-S1,B-cells; SARS-CoV2 Patient,EVQLLESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKGWGGYNTHFDYWGQGTLVTVSS,EIVLTQSPDSLAVSLGERATINCKSSQSVLYSSNNKNYLAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYSPPPTFGPGTKVDIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV4-1 (Human),IGKJ3 (Human),AKGWGGYNTHFDY,QQYYSPPPT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P003_064_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P008_001,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; NTD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLVQPGRSLRLSCTGSGFTFGDYAMSWFRQAPGKGLEWVGFIRSEDHGGTTEYAASVKGRFTISRDDSKSIAYLQMNSLKTEDTAVYYCSRPLTYYYDSSGYYYPYYFDYWGQGTLVTISS,DIVMTQSPSFLSASVGDRVTITCRASQGISNYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNRYPLYTFGQGTKLEIK,IGHV3-49 (Human),IGHJ4 (Human),IGKV1-9 (Human),IGKJ2 (Human),SRPLTYYYDSSGYYYPYYFDY,QQLNRYPLYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P008_001_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P008_002,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; NTD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLVQPGRSLRLSCAASGFTFDDYAMHWVRQAPGKGLEWVSGISWNSGSIGYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTALYYCAKGNWNDVLSHYYYYYGMDVWGQGTTVTVSS,QSVLTQPPSVSVAPGQTARITCGGNNIGSKSVHWYQQKPGQAPVLVVYDDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDSSSDHWVFGGGTKLTVL,IGHV3-9 (Human),IGHJ6 (Human),IGLV3-21 (Human),IGLJ3 (Human),AKGNWNDVLSHYYYYYGMDV,QVWDSSSDHWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P008_002_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P008_003,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLQQWGAGLLKPSETLSLTCAAHGGSFSGYNWSWIRQPPGKGLEWIGEINHSGSTNYNPSLKSRVTISVDTSKNQLSLKLSSVTAADTAVYYCARGGTIGTTGIYDILTGYDPFFDYWGQGTLVTVSS,QSALTQPPSVSGAPGQRVTISCTGSSSNIGADYDVHWYQQLPGTAPKLLIYGNSNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSSDSSLSGSRVFGTGTKVTVL,IGHV4-34 (Human),IGHJ4 (Human),IGLV1-40 (Human),IGLJ1 (Human),ARGGTIGTTGIYDILTGYDPFFDY,QSSDSSLSGSRV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P008_003_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P008_004,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; non-S1,B-cells; SARS-CoV2 Patient,EVQLVESGGGLVHPGGSLRLSCAASGFTFSSYWMSWVRQAPGKGLEWVANIKEDGREKYYVDYVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARDSVHYYYDSSGYHYSYGMDVWGQGTTVTISS,AIRMTQSPSTLSASVGDRVTITCRASQSFSSWLAWYQQKPGKAPKLLIYKASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNSYLKTFGQGTKLEIK,IGHV3-7 (Human),IGHJ6 (Human),IGKV1-5 (Human),IGKJ2 (Human),ARDSVHYYYDSSGYHYSYGMDV,QQYNSYLKT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P008_004_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P008_005,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; non-S1,B-cells; SARS-CoV2 Patient,EVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGTNKYYADSVNGRFTISRDNSKNTLYLQMDSLRAGDTAVYYCARPNSGSYSSYLDYWGQGTLVTVSS,DIQMTQSPSTLSASVGDRVTITCRASQSFSSWLAWYQQKPGKAPKLLIYKASSLESGVPSRFSGSGSGTEFTLTTSSLQPDDFATYYCQQYSTYSPLTFGGGTKVDIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV1-5 (Human),IGKJ4 (Human),ARPNSGSYSSYLDY,QQYSTYSPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P008_005_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P008_006,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; non-S1,B-cells; SARS-CoV2 Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFNIYVMHWVRQAPGKGLEWVAVISYDGSNEYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKGRSGSYFNPLDYWGQGTLVTISS,AIRMTQSPSTVSASVGDRVTITCRASQSISTWLAWYQQKPGKAPKLLIYKASSLESGVPSRFSGSGSGTEFTLTISRLQPDDFATYYCQQYNSYLFGQGTKVEIK,IGHV3-30-3 (Human),IGHJ4 (Human),IGKV1-5 (Human),IGKJ1 (Human),AKGRSGSYFNPLDY,QQYNSYL,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P008_006_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P008_007,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; NTD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLVQPGGSLRLSCAASGFIFSNYRMNWVRQAPGKGLEWVSYISSSSSTIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARDSVPRYYYHYYGMDVWGQGTTVTVSS,SLSQLVLTQGRLGPGQTARITCEGNNIGGKSVLWYQQKPGQAPVLVVYDDSDRPSGIPERFSASNSGNTATLTISRVEAGDEADYYCQVWDTSSDHAGVFGGGTKLTVL,IGHV3-48 (Human),IGHJ6 (Human),IGLV3-21 (Human),IGLJ3 (Human),ARDSVPRYYYHYYGMDV,QVWDTSSDHAGV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P008_007_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P008_010,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; NTD,B-cells; SARS-CoV2 Patient,QVQLQESGPGLVKPSGTLSLTCAVSGDSISSSHWWSWVRQPPGKGLEWIGEIYHSGSTNYNPSLKSRVTISVEKSKNQFSLKLSSVTAADTAVYYCARRRLGPSSNNSGYFYWGQGTLVTVSS,EIVMTQSPATLSVSPGERATLSCRASQSISSNLAWHQQKPGQAPRLLISDASTRATGIPARFSGSGSGTEFTLTIDSLQSEDIAVYYCQQYNNWPPTITFGQGTRLEIK,IGHV4-4 (Human),IGHJ4 (Human),IGKV3-15 (Human),IGKJ5 (Human),ARRRLGPSSNNSGYFY,QQYNNWPPTIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P008_010_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P008_011,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; NTD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLVQPRGSLRLSCAASGFTFSTYWMTWVRQAPGKGLEWVANIGQDGSERYFVDSVKGRFTISRDNANNSLYLQMNSLRAEDSAVYYCARDYTDDYGDYGGYFDLWGRGTLVTVSS,DIQMTQSPSSLSASTGDRVTITCRASQGIRTYLVWYQQKPGQAPNLLIYAASSLQSGVPSRFSGSGSGTDFTLTISGLQSEDFATYYCQQYYSYPLTFGGGTKVEVK,IGHV3-7 (Human),IGHJ2 (Human),IGKV1-39 (Human),IGKJ4 (Human),ARDYTDDYGDYGGYFDL,QQYYSYPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P008_011_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P008_012,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; non-S1,B-cells; SARS-CoV2 Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTIYYMHWVRQAPGQGLEWMGIINPGGGSRSYAQRFQGRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARGRYCSSSSCYIGLDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDINNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISTLQPEDIATYYCQQYDNLLSLTFGGGTKVEIK,IGHV1-46 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ4 (Human),ARGRYCSSSSCYIGLDY,QQYDNLLSLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P008_012_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P008_014,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; NTD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLVKPGGSLRLSCAASGFTFSNAWMSWVRQAPGKGLEWVGRIKSKTDGGTTDYAAPVKGRFTISRDDSKNTLYLQMNSLKSEDTAVYYCATEEHPFAGRAKLHHLDYWGQGTLVTVSS,DIQLTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKFLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDFATYFCQQYDDLPYTFGQGTKLEIK,IGHV3-15 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ2 (Human),ATEEHPFAGRAKLHHLDY,QQYDDLPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P008_014_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P008_015,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLVQPGRSLRLSCAASGFTFDDYAMHWVRQAPGKGLEWVSGITWNSGTIGYADSVKGRFTISKDNAKNSLYLQMNRLRAEDTAFYYCAKDLTGWGLTFGGVITNWGQGTLVTISS,SYELTQPPSVSVAPGQTARITCGGNNIGGKSVHWYQQKPGQAPVLVVYDDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,IGHV3-9 (Human),IGHJ4 (Human),IGLV3-21 (Human),IGLJ3 (Human),AKDLTGWGLTFGGVITN,QVWDSSSDHVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P008_015_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P008_016,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; non-S1,B-cells; SARS-CoV2 Patient,QVQLQESGPGLVKPSETLSLSCTVSGGSISPYYWSWIRQLPGKGLEWIGYIYYTGSTNYNPSLKGRVTMSADMSKNQFSLNLSSVTAADTAMYYCARGYDFWSRGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSIYLAWYQQKPGQAPRLLIYAASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGTSPWTFGQGTKLEIK,IGHV4-59 (Human),IGHJ2 (Human),IGKV3-20 (Human),IGKJ1 (Human),ARGYDF,QQYGTSPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P008_016_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P008_018,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSFIYPGGSTYYVDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARSYGDYYFDYWGQGTLVTVSS,EIVLTQSPGTLSSSPGERATLSCRASQGVSSSYLAWYQQKLGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQHSRTFGQGTKLEIK,IGHV3-66 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ2 (Human),ARSYGDYYFDY,QHSRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P008_018_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P008_022,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKMMGQYCSGGDCYSGYFDYWGQGTLVTVSS,EIVMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSRTDFTFTISSLQPDDIATYYCQQYDKPPVTFGQGTKVDIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ3 (Human),AKMMGQYCSGGDCYSGYFDY,QQYDKPPVT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P008_022_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P008_023,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; non-S1,B-cells; SARS-CoV2 Patient,EVQLVESGGGLVKPGGSLRLSCAASGFTFSDYYMSWIRQAPGKGLEWVSYISSTTSYTNYADSAKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARDVAYYYDSGSYYYFDYWGQGTLVTVSS,EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNKWPRTFGQGTKLEIK,IGHV3-11 (Human),IGHJ4 (Human),IGKV3-15 (Human),IGKJ2 (Human),ARDVAYYYDSGSYYYFDY,QQYNKWPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P008_023_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P008_024,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSTYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKMVGQYCSGGNCYLGYFDYWGQGTLVTVSS,DIVMTQSPSSLSASEGDRVTITCQASQDINNYLNWYQQKPGKAPKLLIYDASNLEAGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPPAFGPGTKVDIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ3 (Human),AKMVGQYCSGGNCYLGYFDY,QQYDNLPPA,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P008_024_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P008_032,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; non-S1,B-cells; SARS-CoV2 Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSTNAMHWVRQAPGKGLEWVALISYDGSNKYYAVSAKGRFIISRDNSKNTLHLQMSSLRAEDTAVYYCVKGLGGNYYYFGFWGQGTLVTISS,EIVLTQSPGTLSLSPGEGATLSCRASQSVSSYLAWYQRKPGQAPRLLIYDSSNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQERSSWPPAFGQGTRLEIK,IGHV3-30-3 (Human),IGHJ4 (Human),IGKV3-11 (Human),IGKJ5 (Human),VKGLGGNYYYFGF,QERSSWPPA,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P008_032_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P008_035,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; NTD,B-cells; SARS-CoV2 Patient,QVQLVQSGAEVKKPGASVKVSCKVSGYTLTEISMHWVRQAPGKGLEWMGGFDPEEGETIYAQKFQGRVTMTEDTSTDTAYMELSSLRSEDTAVYYCATSEVVVPGAIRHKAAYYYNYMDVWGKGTTVTISS,DVVMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGQAPKLLIYAASNLQSGVPSRFSGSGSGTDFTLTISSLQPADFATYYCQQSYSIFRTSGQGTKVEIK,IGHV1-24 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ1 (Human),ATSEVVVPGAIRHKAAYYYNYMDV,QQSYSIFRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P008_035_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P008_036,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSNYGMHWVRQAPGKGLEWVAVISYDGSNEYYADSVKGRFTISRDNSKNTLYLQMNSLRVEDTAVYYCAKKGYSYGYFDYYFDYWGQGTLVTISS,DIVMTQTPLSLSVTPGQPASISCKSSQSLLHSDGKTYLYWYLQRPGQPPQLLIYEVSDRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQSIQLPVTFGQGTRLEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV2-29 (Human),IGKJ5 (Human),AKKGYSYGYFDYYFDY,MQSIQLPVT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P008_036_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P008_038,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYTISWVRQAPGQGLEWMGRIFPILGIANYAQKFQNRVTITADRSTSTAFMELSSLRSEDTAVYYCARDQDSGYIWWFDPWGQGTLVTVSS,QTVVTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWYQQLPGTAPKLLIFGNSNRPSGVPDRFSGSKSDTSASLAITGLQAEDEADYYCQSYDSSLIGSVFGTGTKVTVL,IGHV1-69 (Human),IGHJ5 (Human),IGLV1-40 (Human),IGLJ1 (Human),ARDQDSGYIWWFDP,QSYDSSLIGSV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P008_038_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P008_039,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; NTD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLVKPGGSLRLSCAASGFTFSSYSMNWVRQAPGKGLEWVSSISSSSSYIYYADSVRGRFTISRDNAKNSLFLQMNSLRAEDTALYYCARDPFSRWERPEGWFDPWGQGTLVTISS,DIVMTQSPSSVSASVGDRVTITCRASQGISSGLAWYRQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQANSFPYTFGQGTKVDIK,IGHV3-21 (Human),IGHJ5 (Human),IGKV1-12 (Human),IGKJ3 (Human),ARDPFSRWERPEGWFDP,QQANSFPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P008_039_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P008_040,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVESGGGLVQPGGSLRLSCAASGFIFDDYAIHWVRQGPGKGLEWVSGISWNSGSIGYGDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAFYYCAKGGRRAAMLLNYFDYWGQGTLVTVSA,DIVMTQSPATLSVSLGERATLSCRASQSVSSNLAWYQQKPGRAPRLLIYGASTRATGIPVRFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNWPPSITFGQGTRLEIK,IGHV3-9 (Human),IGHJ4 (Human),IGKV3-15 (Human),IGKJ5 (Human),AKGGRRAAMLLNYFDY,QQYNNWPPSIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P008_040_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P008_042,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLVQPGGSLRLSCAASGITVSSNYMNWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARESYGMDVWGQGTTITVSS,EIVLTQSPGTLSLSPGERATLSCRASQSISSTYLAWYQQKPGQAPRLLIHGASSRATGISDRISGSGSGTDFILTISRLEPEDFAVYYCQQYGSSPGTFGQGTKVEIK,IGHV3-66 (Human),IGHJ6 (Human),IGKV3-20 (Human),IGKJ1 (Human),ARESYGMDV,QQYGSSPGT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P008_042_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P008_044,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGVVQPGRSLRLSCAASGFTFSNYGMHWVRQAPGKGLEWVAVISYDGSNEYYADSVKGRFTISRDNSKNTLYLQMNSLRVEDTAVYYCAKKGYSYGYFDYYFDYWGQGTLVTVSS,DVVMTQTPLSLSVTPGQPASISCKSSQSLLHSDGKTYLYWYLQRPGQPPQLLIYEVSDRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQSIQLPVTFGQGTRLEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV2-29 (Human),IGKJ5 (Human),AKKGYSYGYFDYYFDY,MQSIQLPVT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P008_044_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P008_045,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; NTD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLVQPGRSLRLSCAASGFTFDDYAMHWVRQAPGKGLEWVSGISWNSGSIAYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTALYYCAKDIKSFGIFGVVTAFDYWGQGTLVTVSS,DIVMTQTPLSLSVTPGQPASISCKSSQSLLHSDGKTYLYWYLQKPGQPPQLLIYEVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQSIQPWRLTFGGGTKVEIK,IGHV3-9 (Human),IGHJ4 (Human),IGKV2-29 (Human),IGKJ4 (Human),AKDIKSFGIFGVVTAFDY,MQSIQPWRLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P008_045_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P008_047,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVETGGGLIQPGGSLRLSCATSGFTVSSNYMTWVRQAPGKGLEWVSTIYSGGSTYYADSVKGRFSISRDSSKNTLYLQMNSLRAEDTAVYYCARGPYPHFDYWGQGTLVTVSS,DVVMTQSPSSLSASVGDRVTITCQASQDIRNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQSEDIATYYCQQYDNLPITFGQGTRLEIK,IGHV3-53 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ5 (Human),ARGPYPHFDY,QQYDNLPIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P008_047_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P008_051,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; NTD,B-cells; SARS-CoV2 Patient,QVQLVESGPGLVKPSQTLSLTCTVSGGSISSGSYFWSWIRQPAGKGLEWIGRIFTSGSTNYNPSLKSRVTMSVDTSKNQFSLKLSSVTAADTAVYYCARGPDIVVVPAADPRNWFDPWGQGTLVTVSS,EIVLTQSPATLSLSPGEGATLSCRASQSVGRYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPPFTFGGGTKVDIK,IGHV4-61 (Human),IGHJ5 (Human),IGKV3-11 (Human),IGKJ3 (Human),ARGPDIVVVPAADPRNWFDP,QQRSNWPPFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P008_051_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P008_052,Ab,SARS-CoV2;SARS-CoV1,,SARS-CoV2,,S; NTD,B-cells; SARS-CoV2 Patient,QVQLQESGPGLVKPSETLSLTCTVSGGSVTSNNYYWGWIRQPPGEGLEWIGSIYYTGSTFYNPSLKSRVTISVDASKNQFSLKLSSVTAADTAVYYCTRQLVLVRGYFDYWGQGTLVTISS,QAVVTQPRSVSGSPGQSVTISCTGTSSDVGAYNFVSWYQQHPGKAPKLMTYDVTKRPSGVPDRFSGSKSGNTASLTISGLQAEDEADYYCCSYAGSFYVFGTGTKVTVL,IGHV4-59 (Human),IGHJ4 (Human),IGLV2-11 (Human),IGLJ1 (Human),TRQLVLVRGYFDY,CSYAGSFYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P008_052_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P008_055,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLIQPGRSLRLSCAASGFTFDDYAMHWVRQAPGKGLEWVSGISWNGGIIDYADSVKGRFTISRDNAKNSLYLHMRSLRAEDTAFYYCAKDIGPFEAARPGGNYYYYAMDVWGQGTTVTVSS,QTVVTQAPSASGTPGQRVTISCSGSSSNIGSNTVNWYQQLPGTAPKLLIYSDNQRPSGVPDRFSGSKSGTSASLAISGLQSEDEADYYCAAWDDSLNVVVFGGGTKLTVL,IGHV3-9 (Human),IGHJ6 (Human),IGLV1-44 (Human),IGLJ3 (Human),AKDIGPFEAARPGGNYYYYAMDV,AAWDDSLNVVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P008_055_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P008_057,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVETGGGLIQPGGSLRLSCAASGLTVSANYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRVEDTAVYYCARNIYDDAFDVWGQGTMVTVSS,DVVMTQSPSSLSASVGDRVTITCRASQGVSSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPPGTFGQGTKLEIK,IGHV3-53 (Human),IGHJ3 (Human),IGKV1-9 (Human),IGKJ2 (Human),ARNIYDDAFDV,QQLNSYPPGT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P008_057_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P008_060,Ab,SARS-CoV2;SARS-CoV1,,SARS-CoV2,,S; non-S1,B-cells; SARS-CoV2 Patient,EVQLVESGGGVVQPGRSLRLTCAASGFIFSSYGMHWVRQAPGKGLEWVAVISYDGSYKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCTKADYYDFWSGYQKTYYYYMDVWGKGTTVTISS,DIQLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGTSSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPQITFGQGTRLEIK,IGHV3-30 (Human),IGHJ6 (Human),IGKV3-20 (Human),IGKJ5 (Human),TKADYYDFWSGYQKTYYYYMDV,QQYGSSPQIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P008_060_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P008_062,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; NTD,B-cells; SARS-CoV2 Patient,QLQLQQSGAEVKKPGASVKDSCKASGYTFTSYGISWVRQAPGQGLEWVGWISAYNGNTNYGLKLQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARAHPFYDSGGYSDYWGQGSLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQGITNSLAWYQQQPGKAPKLLLYAASRLASGVPSRFSGSGSGTDYTLTISSLQPEDFATYYCQQYYSAPPTFGQGTKVEIK,IGHV1-18 (Human),IGHJ4 (Human),IGKV1-NL1 (Human),IGKJ1 (Human),ARAHPFYDSGGYSDY,QQYYSAPPT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P008_062_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P008_064,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; NTD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLVKPGGSLRLSCAASGFTFSSYSMNWVRQAPGKGLEWASSISSNSSCIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCASGEHNYYYYYGMDVWGQGTTVTISS,DIVMTQSPLSLAVTPGEPASISCRSSQSLLHSDGYNYLDWYLQKPGQSPQLLTYLGSNRASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQALQTSITFGQGTRLEIK,IGHV3-21 (Human),IGHJ6 (Human),IGKV2-28 (Human),IGKJ5 (Human),ASGEHNYYYYYGMDV,MQALQTSIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P008_064_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P008_065,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; NTD,B-cells; SARS-CoV2 Patient,EVQLLESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSNKYYTDSVKGRFTISRDNSKNTLYLQMNSLRPEDRAVYYCAKDAADSRITMFGVVIISHFDYWGQGTLVTVSS,DIQMTQSPSTLSAFVGDRVTIICRASQSISSWLAWYQQKPGKAPKLLIYKASSLESGVPSTFSGSGSGTEFTLTISSLQPDDFATYFCQQYNSYPYTFGQGTKVEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV1-5 (Human),IGKJ1 (Human),AKDAADSRITMFGVVIISHFDY,QQYNSYPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P008_065_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P008_067,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGALVQPGGSLRLSCEASEFIVSRNYMNWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFIISRDNSKNTLYLQMNSLRAEDTAVYYCARELVGYFDYWGQGTLVTVSS,DIVMTQSPSFLSASVGDRVTITCRASQGIRNDLGWYQQKPGKAPKRLIYAASSLQSGVPSRFSGYGSGTEFTLTISSLQPEDFATYYCQHLNSYPRYTFGQGTKLEIK,IGHV3-66 (Human),IGHJ4 (Human),IGKV1-17 (Human),IGKJ2 (Human),ARELVGYFDY,QHLNSYPRYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P008_067_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P008_068,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCASTPRGDSYGGGAYWGQGTLVTVSS,QLVLTQSPSASASLGASVKLTCTLSSGHSSNAIAWHQQQPEKGPRYLMKLNIDGSHRKGDGIPDRFSGSSSGAERYLTISSLQSEDEADYYCQTWGTGPNWVFGGGTKLTVL,IGHV3-66 (Human),IGHJ4 (Human),IGLV4-69 (Human),IGLJ3 (Human),ASTPRGDSYGGGAY,QTWGTGPNWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P008_068_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P008_070,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVESGGGVVQPGKSLRLSCAASGLTFSSYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKEGWGYSYGSYYFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYHQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPLTFGGGTKVDIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ4 (Human),AKEGWGYSYGSYYFDY,QQYDNLPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P008_070_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P008_071,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; NTD,B-cells; SARS-CoV2 Patient,EVQLVESGPGLVKPSETLSLTCTVSGGSISSTSYYWGWIRQPPGKGLEWIGSMYYSGNTYYNPPLQSRVTISVDTSKNQVSLSLSSVTAADTALYYCARHPDICDFWSGYPGWFDPWGQGTLVTVSS,QAVVTQPPSVSGAPGQRVTISCTGSSSNIGAGYDIHWYQQLPGTAPKLLIYNNSNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSSLSGYVFGTGTKVTVL,IGHV4-39 (Human),IGHJ5 (Human),IGLV1-40 (Human),IGLJ1 (Human),ARHPDICDFWSGYPGWFDP,QSYDSSLSGYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P008_071_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P008_072,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; non-S1,B-cells; SARS-CoV2 Patient,QVQLVQSGAEVKKPGSSVKVSCKTSGDTFRSYSISWVRQAPGQGLEWMGRIIPILGIPNYAQKFQGRVTITADKSTNTAYMELSSLRSEDTAVYYCARESPYCSSTTCLSDYWGQGTLVTISS,QSVLTQPPSVSGAPGQRVTISCTGSNSNIGAGYDVHWYQQFPGTAPKLLIYDNTNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSSRIDVVFGGGTKLTVL,IGHV1-69 (Human),IGHJ4 (Human),IGLV1-40 (Human),IGLJ3 (Human),ARESPYCSSTTCLSDY,QSYDSSRIDVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P008_072_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P008_073,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; NTD,B-cells; SARS-CoV2 Patient,QVQLVQSGAEVKKPGASVKVSCKASGYSFTSYGISWVRQAPGQGLEWMGWISAFNNNANYVQKFQGRVTMTTDTSTSTAYLELRSLRSDDAAVYYCARDDDNYDTTGYYLYWGQGTLVTISS,DIVMTQSPSTLSASVGDRVTITCRASQSISRWLAWYQQIPGKAPNLLIYQTSSLQSGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYYSYPLTFGGGTKVEIK,IGHV1-18 (Human),IGHJ4 (Human),IGKV1-5 (Human),IGKJ4 (Human),ARDDDNYDTTGYYLY,QQYYSYPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P008_073_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P008_076,Ab,SARS-CoV2;SARS-CoV1,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLVQPGGSLRLSCAASGFIFSSYDMHWVRQATGKGLEWVSGIGNAGDTHYPGAVKGRFTISRENAKNSLYLQMNSLRAGDTAVYYCARAHRGYYDRSGYYHNPDAFDIWGQGTTVTISS,NFMLTQPASVSGSPGQSITISCTGTSSDVGVYDYVSWYQQHPGKAPKLMIYEVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSTLVLYVFGTGTKVTVL,IGHV3-13 (Human),IGHJ3 (Human),IGLV2-14 (Human),IGLJ1 (Human),ARAHRGYYDRSGYYHNPDAFDI,SSYTSSSTLVLYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P008_076_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P008_077,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; NTD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLVKPGGSLRLSCAASGFMFSSYNMNWVRQAPGKGLEWVSSISSSSSYIYYEDSVKGRFTISRDNAKNSLYLQMISLSAEDTAVYYCARMAYFDSSGYYPNAFDIWGQGTMVTVSS,EIVLTQSPATLSVSPGERVTLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQHYYNWPPWTFGQGTKLEIK,IGHV3-21 (Human),IGHJ3 (Human),IGKV3-15 (Human),IGKJ1 (Human),ARMAYFDSSGYYPNAFDI,QHYYNWPPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P008_077_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P008_079,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; NTD,B-cells; SARS-CoV2 Patient,QVQLVQSGAEVKKPGASVKVSCKVSGYTLTELSMHWVRQAPGKGLEWMGGFVAEDGETIYAQKFQGRVSMTEDTSTDTAYMELSSLRSEDTAVYYCATDRARLDYFASGSYYGHFDYWGQGTLVTVSS,DIQLTQSPSFLSASVGDRVTITCRASQGIRSYLAWYQQKPGKAPNLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNTYALTFGGGTKLEIK,IGHV1-24 (Human),IGHJ4 (Human),IGKV1-9 (Human),IGKJ4 (Human),ATDRARLDYFASGSYYGHFDY,QQLNTYALT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P008_079_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P008_080,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; non-S1,B-cells; SARS-CoV2 Patient,QVQLVESGGGLVQPGGSLRLSCAASGFTFSIYWMHWVRQAPGKGLVWVSRINSDGSSTSNADSVKGRFTISRDNAKNTLYLQMNSLRAEDTAVYYCARDHVVAATPGMDVWGQGTTITVSS,SYELTQPPSVSVSPEQTASITCSGDKLGDKYACWYQQKAGQSPVLVIYEDGKRPSGIPERFSGSNSGNTATLTISGTQTMDEADYYCQAWDRTTAVFGGGTKLTVL,IGHV3-74 (Human),IGHJ6 (Human),IGLV3-1 (Human),IGLJ3 (Human),ARDHVVAATPGMDV,QAWDRTTAV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P008_080_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P008_081,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVQSGPEVKKPGTSVKVSCKASGFTFTSSAMQWVRQARGQRLEWIGWIVVGSGNTNYAQKFQERVTITRDMSTSTAYMELSSLRSEDTAVYYCAAPNCSRTSCQDGFDIWGQGTMVTVSS,DIQLTQSPGTLSLSPGERATLSCRASQSVSSSHLAWYQQKSGQAPRLFIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPPWTFGQGTKVEIK,IGHV1-58 (Human),IGHJ3 (Human),IGKV3-20 (Human),IGKJ1 (Human),AAPNCSRTSCQDGFDI,QQYGSSPPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P008_081_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P008_082,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVQSGAEVKKPGASVRVSCKAFGYSFTSFNLNWVRQAPGQGLEWMGWISAYNGNTSYAQKFQGRVTMTTDTSTTTVYMELRSLRSDDTAVYYCARALENYYDRNGNYYVGAFDYWGQGSLVTVSS,DVVMTQSPGTLSLSPGERATLSCRASHNISSTHLVWYQQKPGQAPRLLIYGASNRATGIPDRFSGGGSGTDFTLTISRLEPEDFAVYFCQQFGSSPQTFGQGTKVDIK,IGHV1-18 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ3 (Human),ARALENYYDRNGNYYVGAFDY,QQFGSSPQT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P008_082_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P008_083,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVESGGGLVQPGGSLRLSCAASGITVNSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMHSLRAEDTAVYYCARDRFGRINDYWGQGTLVTVSS,DIVMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGRAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDVATYYCQQYDNLPGTFGQGTKLEIK,IGHV3-66 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ2 (Human),ARDRFGRINDY,QQYDNLPGT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P008_083_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P008_085,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSDKYYADSVKGRLTIFRDNSKNTLYLQMNSLRAEDTAVYYCAREGADRSGWWGSFDYWGQGTLVTVSS,AIRMTQSPDSLAVSLGERATINCKSSQSVLHNSKNKSYLAWYQQKPGQPPNLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYGGRWTFGQGTKVDIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV4-1 (Human),IGKJ1 (Human),AREGADRSGWWGSFDY,QQYYGGRWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P008_085_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P008_086,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVQSGPEVKKPGTSVKVSCKASGFTFTSSAMQWVRQARGQRLEWIGWIVVGSGNTHYAQKFQERVTITRDMSTSTAYMELSSLRSEDTAVYYCAAPYCTTTRCHDGFDIWGQGTMVTVSS,DVVMTQSPGTLSLSPGERATLSCRASQSVSRSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSLLFTFGPGTKLEIK,IGHV1-58 (Human),IGHJ3 (Human),IGKV3-20 (Human),IGKJ3 (Human),AAPYCTTTRCHDGFDI,QQYGSLLFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P008_086_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P008_087,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLQESGPGLVKPSQTLSLTCTVSGGSISSYGKYWSWIRQHPGKGLEWIGYIYYSGSTQYNPSLKSRVTISVDTSKNQFSLKLNSVTAADTAVYYCARDSAAGHFDYWGQGTLVTVSS,EIVMTQSPSSLSASVGDRVTITCQASQDINNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGAGTYFTFTISSLQPEDIATYYCQQYDNLPPLFTFGPGTKVEIK,IGHV4-31 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ3 (Human),ARDSAAGHFDY,QQYDNLPPLFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P008_087_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P008_088,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; non-S1,B-cells; SARS-CoV2 Patient,EVQLVESGGGVVQPGRSLRLSCAASGFTFSGYGMHWVRQAPGRGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTVYLQMNSLRAEDTAVYYCAKPYSGSYWSYFDYWGQGTLVTVSS,DIVMTQSPDSLAVSLGERATINCKSSQSVLHSSNNKNYVAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYHCQQYYSTPLTFGGGTKVEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV4-1 (Human),IGKJ4 (Human),AKPYSGSYWSYFDY,QQYYSTPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P008_088_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P008_090,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVETGGGLIQPGGSLRLSCAASGFTVTANYMSWVRQAPGKGLEWVSTIYSGGSTFYADSVKGRFTISRDNSRNTLYLQMNSLRAEDTAVYYCARERGAKAFDPWGQGALVTVSS,EIVMTQSPSSLSASVGDRVTITCQASQDIRNYLNWYQQTPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCHQYDNLPQSFGGGTKVDIK,IGHV3-53 (Human),IGHJ5 (Human),IGKV1-33 (Human),IGKJ3 (Human),ARERGAKAFDP,HQYDNLPQS,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P008_090_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P008_091,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; NTD,B-cells; SARS-CoV2 Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSNAMHWVRQAPGKGLEWVAFISYDGSNQYSTDPVKGRFTFARDNSKDTLYLQMNSLRGDDTAVYYCAKSRGGNYFDAFDMWGQGTMVTVSS,DIQLTQSPSTLSASVGDRVTITCRASQSISSWLAWYQQKPGKAPKLLIYKASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNSYPWTFGQGTKVEIK,IGHV3-30-3 (Human),IGHJ3 (Human),IGKV1-5 (Human),IGKJ1 (Human),AKSRGGNYFDAFDM,QQYNSYPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P008_091_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P008_092,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLQESGPGLVKPSETLSLTCTVSGDSISNNYAYWGWIRQPPGKGLEWIGNLYYSGSTYYNPSLKSRVTISVDTSENQFSLRLSSVTAADTAVYYCARLPYGYDYVEAFDIWGQGTLVTISS,AIRMTQSPSSLSASVGDGVTITCRASQGIRNDLGWYQQKPGKAPKRLIYAASSLQSGVPSRFSGGGSGTEFTLTISSLQPEDFATYYCLQHNSYPLTFGGGTKVDIK,IGHV4-38-2 (Human),IGHJ4 (Human),IGKV1-17 (Human),IGKJ4 (Human),ARLPYGYDYVEAFDI,LQHNSYPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P008_092_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P008_093,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVQSGAEVKKPGASVKVSCKASGDTFTSYDVNWVRQATGQGLEWMGWMDPNSGNTGYAQNFQGRVTMTRSTSIGTAYMELSSLRSEDTAVYYCARSKERGYYNRTGYYYPGDWFDPWGQGTLVTVSS,DVVMTQSPATLSLSPGERATLSCRASQSVSSSLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLGPEDFAVYYCQQRSNWPPTWTFGQGTKLEIK,IGHV1-8 (Human),IGHJ5 (Human),IGKV3-11 (Human),IGKJ1 (Human),ARSKERGYYNRTGYYYPGDWFDP,QQRSNWPPTWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P008_093_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P008_095,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; non-S1,B-cells; SARS-CoV2 Patient,EVQLVESGGGVVQPGRSLRLSCAASGFTFISYAMHWVRQAPGKGLEWVAVISYDGNNKYYSDSVKGRFTISRDNSKNTLHLQMNSLRAEDTAVYYCAKDLSGGYSYWDYWGQGTLVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDTSNRATGIPARFSGGGSGTDFTLTISSLEPEDFAVYYCQQRSNWRTFGQGTKLEIK,IGHV3-30-3 (Human),IGHJ4 (Human),IGKV3-11 (Human),IGKJ2 (Human),AKDLSGGYSYWDY,QQRSNWRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P008_095_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P008_096,Ab,SARS-CoV2;SARS-CoV1,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLQESGPGLVKPSETLSLTCTVSGGSTSSSFHYWGWIRQPPGKGLEWIGNIYYSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARLGSGSYYTADYWGQGTRVTISS,DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTEFTFTITSLQPEDIATYYCQQYDTLPPTFGPGTKVDIK,IGHV4-39 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ3 (Human),ARLGSGSYYTADY,QQYDTLPPT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P008_096_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P008_099,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; NTD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSHAMNWVRQAPGKGLEWVSGISGSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKSMFGYDSSGYFYGEDFDYWGQGTLVTISS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQHKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSIPPTFGGGTKVDIK,IGHV3-23 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ3 (Human),AKSMFGYDSSGYFYGEDFDY,QQSYSIPPT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P008_099_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P008_100,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLLESGGGVVQPGGSLRLSCAASGLIFSHYGMHWVRQAPGKGLEWVAFIRNDGTNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDGGYYYESSGWFDYWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKSGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLQPEDFAVYYCQQYGSSPMYTFGQGTKLEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ2 (Human),AKDGGYYYESSGWFDY,QQYGSSPMYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P008_100_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P008_102,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; NTD,B-cells; SARS-CoV2 Patient,EVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGIHWVRQAPGKGLEWVAVISYDGSTKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYFCAKDRGTLIEGMDVWGKGTTVTVSS,QLVLTQPPSVSEAPRQRVTISCSGSSSNIGNNPVNWYQQLPGKAPKPLIYYDDLLPSGVSDRFSGSRSATSASLAISGLQSEDEADYYCTAWDGSLNGYVFGSGTKVTVL,IGHV3-30 (Human),IGHJ6 (Human),IGLV1-36 (Human),IGLJ6 (Human),AKDRGTLIEGMDV,TAWDGSLNGYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P008_102_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P008_103,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLVQPGGSLRLSCAASEFIVSRNYMNWVRQAPGKGLEWVSLIYSGGTTYYADAVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARGFGDRRLDYWGQGTLVTVSS,EIVLTQSPSSLSASVGDRVTITCQASQDINNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQFGEWFTFGQGTKLEIK,IGHV3-66 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ2 (Human),ARGFGDRRLDY,QQFGEWFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P008_103_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P008_108,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLVKPGGSLRLSCAASGFTFSDYYMSWIRQAPGKGLEWVSYITSPGSAIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTALYYCTRDGVIPPRFDYWGQGTMVTVSS,DIVMTQSPSSLSASVGDRVTITCQASQDISKYLNWYQRKPGTAPTLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIGTYYCQQYDNLPTFGGGTKVEIK,IGHV3-11 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ4 (Human),TRDGVIPPRFDY,QQYDNLPT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P008_108_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P054_002,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; NTD,B-cells; SARS-CoV2 Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTDYYMHWVRQAPGQGLEWMGWINPNSGGTDYVQKFQGRVTMTRDTSISTAYMELSRLRSDDTAVYYCASLSAAGPLNDVFDIWGQGTMVTVSS,QLVLTQPPTVSVSPGQTARITCSGDALPKKYAYWYQQKSGQAPVLVIYEDSKRPSGIPERISGSSSGTMATLTISGAQVEDGADYYCYSIDSSGNHYVFGTGTKVTVL,IGHV1-2 (Human),IGHJ3 (Human),IGLV3-10 (Human),IGLJ1 (Human),ASLSAAGPLNDVFDI,YSIDSSGNHYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P054_002_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P054_003,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVQSGTEVKKPGASVKVSCTASGYTFTVCYIHWVRQAPGQGLEWMGWINPNSGGTNYAQKFQGRVTMTRDTSISTAYMELSRLRSDDTAVYYCARVARHYYDRSGNLHSADYFQHWGQGTLVTISS,AIRMTQSPSSLSASVGDRVTITCQASQDISNFLNWYQEKPGKAPKLLISDASNLETGVPSRFSGSGSGTDFTFTITSLQPEDIATYYCQQYDNLLITFGQGTRLEIK,IGHV1-2 (Human),IGHJ1 (Human),IGKV1-33 (Human),IGKJ5 (Human),ARVARHYYDRSGNLHSADYFQH,QQYDNLLIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P054_003_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P054_004,Ab,SARS-CoV2;SARS-CoV1,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLQQWGAGLLKPSETLSLTCAVYGESFSGYYWSWIRQPPGKGLEWIGEIIHSGSTNYNPPLKSRVTISVDTSKSQFSLKLSSVTAADTAVYYCAREMSVAVVDHWGQGTLVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDIGGYNYVSWYQQHPGKAPKLMIYDVTNRPSGVSNRFSGSKSGNTASLTISGLQAEDEATYYCNSYTSSSTYVLFGGGTKLTVL,IGHV4-34 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ3 (Human),AREMSVAVVDH,NSYTSSSTYVL,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P054_004_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P054_005,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; NTD,B-cells; SARS-CoV2 Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTGFYIHWVRQAPGQGLEWMGWINPNSGGSNCAQKFQGRVTMTRDTSISTAYMEVSRLRSDDTAVYYCARYSNYYYYYGMDVWGQGTTVTVSS,DIQMTQTPLSLPVTPGEPASISCRSGQSLLDSDDGNTYLDWYLQKPGQSPQLLIYTLSYRASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQRIEFPWTFGQGTKLEIK,IGHV1-2 (Human),IGHJ6 (Human),IGKV2-40 (Human),IGKJ1 (Human),ARYSNYYYYYGMDV,MQRIEFPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P054_005_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P054_006,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; non-S1,B-cells; SARS-CoV2 Patient,QVQLVQSGAEVKKPGESLKISCKGSGYSFTNSWIAWVRQMPGKGLEWMGIIYPGDSDTRYSPSFQGQVTISADKSISTAYLQWSSLKASDSAMYYCARLGSWYVYYYYYALDVWGQGPLVTVSS,EIVLTQSPATLSVSPGERATLSCRASQSVSRNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNGRGTFGPGTKLEIK,IGHV5-51 (Human),IGHJ4 (Human),IGKV3-15 (Human),IGKJ2 (Human),ARLGSWYVYYYYYALDV,QQYNNGRGT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P054_006_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P054_009,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; non-S1,B-cells; SARS-CoV2 Patient,QVQLVESGGGLVQPGGSLRLSCAASGFTFSSYSMNWVRQAPGKGLEWVSYISSSGSTKYYGDSVKGRFTISRDNAKNSLYLQLNSLRDEDTAVYYCARTIYSYDSSGYYGTERYFDYWGQGTLVTVSS,DVVMTQSPATLSLSPGERATLSCRASQSVSSYLAWYQHKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPTFGQGTKLEIK,IGHV3-48 (Human),IGHJ4 (Human),IGKV3-11 (Human),IGKJ2 (Human),ARTIYSYDSSGYYGTERYFDY,,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P054_009_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P054_012,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; non-S1,B-cells; SARS-CoV2 Patient,EVQLLESGGGLVQPGRSLRLSCAASGFTFDDYAMHWVRQAPGKGLEWVSVISWHSGSIDYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTALYHCAKGTGYSYGYAVDGGFDYWGQGTLVTISS,QSALTQPPSASGTPGQRVTISCSGSSSNIGSYTVNWYQHLPGTAPKLLIYSNNQRPSGVPDRFSGSKSGTSASLAISGLQSEDEADYYCAAWDDSLNGYVFGTGTKVTVL,IGHV3-9 (Human),IGHJ4 (Human),IGLV1-44 (Human),IGLJ1 (Human),AKGTGYSYGYAVDGGFDY,AAWDDSLNGYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P054_012_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P054_015,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; NTD,B-cells; SARS-CoV2 Patient,EVQLVESGGGVVKPGGSLRLSCAASGFTFSTYSMNWVRQAPGKGLEWVSSISSSSTDIHYADSMKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARDFHRGWYDHSAYIFDFWGQGTLVTVSS,DVVMTQSPSTLSASVGDRVTITCRASQSISSWLAWYQQKPGKAPKLLIYDASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNSYSFTFGPGTKKDIK,IGHV3-21 (Human),IGHJ4 (Human),IGKV1-5 (Human),IGKJ3 (Human),ARDFHRGWYDHSAYIFDF,QQYNSYSFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P054_015_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P054_017,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; NTD,B-cells; SARS-CoV2 Patient,QVQLVASGGGVVQPGRSLRLSCAASGFIITSYGMHWVRQAPGKGLEWVAAIWYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSPRAEDTAVYYCARDDPTPDGDAFDIWGQGTMVTVSS,QLVLTQPPSVSVAPGQTARITCGGNSIGSKTVHWYQQKPGQAPVLVVYDDSDRPSGIPERFSGSKSGNTATLTISRVEAGDEADYYCQVWHISSDHLWVFGGGTKLTVL,IGHV3-33 (Human),IGHJ3 (Human),IGLV3-21 (Human),IGLJ3 (Human),ARDDPTPDGDAFDI,QVWHISSDHLWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P054_017_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P054_021,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; NTD,B-cells; SARS-CoV2 Patient,EVQLVQSGAEVKKPGASVKVSCKVSGYTLTELSMHWVRQAPGKGLEWLGGFDPEDAETIYAQKFQGRVTMTEDTSTDTAYMGLSSLTSEDTAVYYCATGVAVAGTQKNYSYYYGLDVWGQGTTVTVSS,DIQMTQTPLSSPVTLGQPASISCRSSQSLVHSDGNTYLSWLQQRPGQPPRLLIYKISNRFSGVPDRFSGSGAGTDFTLKISRVEAEDVGVYYCMQATQFPITFGQGTRLEIK,IGHV1-24 (Human),IGHJ6 (Human),IGKV2-24 (Human),IGKJ5 (Human),ATGVAVAGTQKNYSYYYGLDV,MQATQFPIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P054_021_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P054_022,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGSGLVKPSQTLSLTCAVSGGSIDSGGDSWSWIRQPPGKGLEWIGYIYHSGSTYYNPSLKSRVTISVDRSNNQFSLKLSSVTAADTAVYYCARHSGYDLGGAFDIWGQGTMVTISS,QSALTQPPSASGSPGQSVTISCTGTSSDVGGYNYVSWYQQHPGKAPKLMISEVSKRPSGVPDRFSGSKSGNTASLTVSGLQAEDEADYYCNSYAGSNNWVFGGGTKLTVL,IGHV4-30-2 (Human),IGHJ3 (Human),IGLV2-8 (Human),IGLJ3 (Human),ARHSGYDLGGAFDI,NSYAGSNNWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P054_022_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P054_026,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; NTD,B-cells; SARS-CoV2 Patient,QVQLVESGGGLVQPGRSLRLTCAASGFTFDDYAMHWVRQAPGKGLEWVSGISWNSGSIGYADSVKGRFTISRDNAKNSLYLQMNSLRPEDTALYYCAKDDSSSWYFYSRAKLGQYYYYGMDVWGQGTTVTVSS,EIVMTQSPATLSLSPGERATLSCRASQSVNNYLAWYQQEPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDLAVYYCQQCSNWPPSLTFGGGTKVEIK,IGHV3-9 (Human),IGHJ6 (Human),IGKV3-11 (Human),IGKJ4 (Human),AKDDSSSWYFYSRAKLGQYYYYGMDV,QQCSNWPPSLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P054_026_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P054_027,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLQESGPGLVKPSQTLSLTCTVSGGSISSGDYYWSWIRQPPGKGLTWIGHISYSGSTYYNPSLKSRLTISVDTSKNQFSLKLSSVTAADTAVYYCARQLWLRAPFDYWGQGALVTVSS,NFMLTQPHSVSESPGKTVTISCTGISGSIASNYVQWYQQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSSKYVVFGGGTKLTVL,IGHV4-30-4 (Human),IGHJ4 (Human),IGLV6-57 (Human),IGLJ3 (Human),ARQLWLRAPFDY,QSYDSSKYVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P054_027_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P054_031,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; NTD,B-cells; SARS-CoV2 Patient,QVQLVQSGAEVKEPGASVKVSCKASGYTFTSYGISWVRQAPGQGLEWMGWISAYDGNTNYAQKLQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCAREGSDYYDSSGFHDYWGQGTLVTVSS,EIVLTQSPSTLSASVGDRVTITCRASQSISSWLAWYQQKPGKAPKVLIYKASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNSYVTFGPGTKLEIK,IGHV1-18 (Human),IGHJ4 (Human),IGKV1-5 (Human),IGKJ2 (Human),AREGSDYYDSSGFHDY,QQYNSYVT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P054_031_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P054_044,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; NTD,B-cells; SARS-CoV2 Patient,QVQLVQSGAEMKEPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGIIPIFGTANYAQKFQDRVTITADESTSTAYLELSSLRSEDTAVYYCARESTTIFGVVILTSYGMDVWGQGTTITISS,DIQMTQSPSTLSASVGDRVTITCRASQSIRSWLAWYQQKPGKAPKVLIYDASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNYYSVTFGQGTKVEIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV1-5 (Human),IGKJ1 (Human),ARESTTIFGVVILTSYGMDV,QQYNYYSVT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P054_044_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P054_045,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; non-S1,B-cells; SARS-CoV2 Patient,EVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVALISYDGGNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARTRGGSYYYGMDVWGQGTTVTVSS,EIVLTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTPTISSLQPEDFATYYCQQSYSTPPYTFGQGTKVEIK,IGHV3-30 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ1 (Human),ARTRGGSYYYGMDV,QQSYSTPPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P054_045_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P054_048,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; NTD,B-cells; SARS-CoV2 Patient,QVQLQESGPGLVKPSETLSLTCTVSGGSISSSSYYWGWIRQPPGKGLEWIGTIYYSGSTYYNPSLKSRVTISVDTSNNQFSLKLSSVTAADTAVYYCARHVQWLVLYYFDYWGQGTLVTVSS,QSALTQPRSVSGSPGQSVTISCTGTSSDVGGYNSVSWYQHHPGKAPKLMIYDVSKRPSGVPDRFSGSKSGNTASLTISGLQAEDEADYYCCSYAGRYTLVFGGGTKLTVL,IGHV4-39 (Human),IGHJ4 (Human),IGLV2-11 (Human),IGLJ3 (Human),ARHVQWLVLYYFDY,CSYAGRYTLV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P054_048_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
P054_050,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYDMHWVRQPTGQDLEWVSAIGTAGDTYYPDSVKGRFTISRENAKNSSYLQMNSLRAGDTAVYYCARASFDSSGYLNYFDYWGQGTLVTVSS,AIRMTQSPSSLSASVGDRVTITCRASQSIRNYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYGIPDWTFGPGTKVEIK,IGHV3-13 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ1 (Human),ARASFDSSGYLNYFDY,QQSYGIPDWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P054_050_rank1_imgt_scheme.pdb,"Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","Jul 9, 2021","Jul 9, 2021",N/A,Complete
Cerutti_5-7,Ab,SARS-CoV2,,SARS-CoV2,,S; NTD,B-cells; SARS-CoV2 Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYYMHWVRQAPGQGLEWMGVINPSGGSTSYAEKFRGRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARDREPHSDSSGYWDSLKYYYYYALDVWGQGTTVTVSS,AIQLTQSPSSLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPELLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQLNTYPFTFGPGTKVDIK,IGHV1-46 (Human),IGHJ6 (Human),IGKV1-9 (Human),IGKJ3 (Human),ARDREPHSDSSGYWDSLKYYYYYALDV,,Expected,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Cerutti_5-7_rank1_imgt_scheme.pdb,"Gabriele Cerutti et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.06.29.450397v1)","Jul 9, 2021","Jul 9, 2021",N/A,Variant binding data in publication. Complete
PVI.V6-14,Ab,SARS-CoV2,,SARS-CoV2,,S: NTD,B-cells; SARS-CoV2 Patient,QLQLQESGPGLVKPSETLSLTCTVSGGSISSSSYYWGWIRQPPGKGLEWIGSIYYSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARCRPEYYFGSGSYLDFDYWGQGTLVTVSS,DIQMTQSPSSVSASVGDRVTITCRASQGISSWLAWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQANSFPLTFGGGTKVEIK,IGHV4-39 (Human),IGHJ4 (Human),IGKV1-12 (Human),IGKJ4 (Human),ARCRPEYYFGSGSYLDFDY,QQANSFPLT,Expected,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/PVI.V6-14_rank1_imgt_scheme.pdb,"Clara Altomare et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.07.08.451649v1)","Jul 9, 2021","Jul 9, 2021",N/A,Variant binding data in publication. Check sequence on publication.
OC24,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,Transgenic Mouse (PentaMice),QAYLQQSGAELVRPGASVKMSCKASGYTFTSYSMHWVKQTPRQGLEWIGAIYPGNDDTSYNQKFKGKATLTVDRSSSTAYMQLSSLTSEDSAVYFCTRDYSNYPFDYWGQGTTLTVSS,DIVLTQSPASLAVFLGQRATISCRASKSVSTSGYSYMHWYQQRPGQPPKLLIYLASNLESGVPARFSGSGSGTDFTLNIHPVEEEDAATYYCQHSRELPPTFGGGTKLEIK,IGHV1-12 (Mouse),IGHJ2 (Mouse),IGKV3-12 (Mouse),IGKJ1 (Mouse),TRDYSNYPFDY,QHSRELPPT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/OC24_rank1_imgt_scheme.pdb,"Larisa Troitskaya et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.07.05.451203v1)","Jul 9, 2021","Jul 9, 2021",N/A,Variant binding data in publication. Complete
B13,Ab,SARS-CoV2;SARS-CoV1,,SARS-CoV2,,S; RBD,Transgenic Mouse (PentaMice),QVQLQQSGAELVKPGASVKISCKASGYAFSNYWMNWVKQRPGKGLEWIGQIYPGDGDTNYNGNFKGKATLTADKSSSTAYIQLSSLTSEDSAVYFCGRGFIATVVEVFDHWGLGTTLTVSS,DIQMTQTTSSLSASLGDRVTISCRASQDISNYLNWYQQKPDGTVKLLIYYTSRLQSGVPSRFSGSGTGTDYSLTISNLEQEDIATYFCQQGNTLPWTFGGGTKLEIK,IGHV1-80 (Mouse),IGHJ2 (Mouse),IGKV10-96 (Mouse),IGKJ1 (Mouse),GRGFIATVVEVFDH,QQGNTLPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/B13_rank1_imgt_scheme.pdb,"Larisa Troitskaya et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.07.05.451203v1)","Jul 9, 2021","Jul 9, 2021",N/A,Variant binding data in publication. Complete
Ye_B6,Nb,SARS-CoV2,,,,N; RNA binding domain,ND,EVQLQASGGGLVQAGDSLRLSCVAVSGRTISTFAMGWFRQAPGKEREFVATINWSGSSARYADPVEGRFTISRDDAKNTVYLEMSSLKPGDSAVYYCASGRYLGGITSYSQGDFAPWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ6 (Alpaca),N/A,N/A,ASGRYLGGITSYSQGDFAP,N/A,https://www.rcsb.org/structure/7R98,,PDB (To be published),"Jul 9, 2021","Jul 9, 2021",N/A,Complete
COVOX-278,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVQSGAEVKKPGASVKVSCKASGYIFIRYGISWVRQAPGQGLEWMGWISANNGYTNYAQKLQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARDGGILTGYLDYFDHWGQGTLVTVSS,DIQMTQSPSSLSASVGDRLTITCRASQSIASYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYHCQQSYSTLGITFGPGTKVDIK,IGHV1-18 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ3 (Human),ARDGGILTGYLDYFDH,QQSYSTLGIT,https://www.rcsb.org/structure/7OR9,,"Chang Liu et al., 2021 (https://www.cell.com/cell/fulltext/S0092-8674(21)00755-8)","Jul 9, 2021","Jul 9, 2021",N/A,Variant binding and neutralisation data in paper. Complete
S24-1564,Ab,SARS-CoV2,,,,N; NTD,ND,QVQLQESGPGLVKPSETLSLTCTVSGGSISSYYWSWIRQPPGKGLEWIGYVYYSGNTKYNPSLKSRVTISVDTSKNQFSLKLGSVTAADTAVYYCARHSRIEVAGTLDFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSIRSYLNWYQQKRGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPPTFGQGTKVEIK,IGHV4-59 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ1 (Human),ARHSRIEVAGTLDFDY,QQSYSTPPT,https://www.rcsb.org/structure/7N3D,,PDB (To be published),"Jul 9, 2021","Jul 9, 2021",N/A,Awaiting publication for origin and reference
S24-202,Ab,SARS-CoV2,,,,N; NTD,ND,EVQLVQSGAEVKKPGESLRISCKGSGYSFSSYWISWVRQMPGKGLEWMGRIDPSDSNTNYSPSFQGHVTISADKSISTAYLQWSSLKASDTAMYYCARLSVRVWFGELPHYGMDVWGQGTTVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRASGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRRNWPLTFGGGTKVETK,IGHV5-10-1 (Human),IGHJ6 (Human),IGKV3-11 (Human),IGKJ4 (Human),ARLSVRVWFGELPHYGMDV,QQRRNWPLT,https://www.rcsb.org/structure/7N3C,,PDB (To be published),"Jul 9, 2021","Jul 9, 2021",N/A,Awaiting publication for origin and reference
RBD-chAb-45,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,ND,EVQLQQSGPELVKPGASVKISCKTSGYTFTEYTIYWVKQSLGKSLEWIGGNNPNNDDTTYKQFFKGKATLTVDKSSSTAYMELRSLTSEDSAVYYCARDGYPYYYALDFWGQGTSVTVSS,DIVMTQSQKFMSTSVGDRVSVTCKSSQNVGTNVAWYQQKPGQSPKALIYSASYRYSGVPDHFTGSGSGTDFTLTISNVQSADLAEYFCQQYNNYPWTFGGGTKLEIK,IGHV1-26 (Mouse),IGHJ4 (Mouse),IGKV6-15 (Mouse),IGKJ1 (Mouse),ARDGYPYYYALDF,QQYNNYPWT,https://www.rcsb.org/structure/7EJ5,,PDB (To be published),"Jul 9, 2021","Jul 9, 2021",N/A,Awaiting publication for origin and reference
RBD-chAb-25,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,ND,EVQLEESGGGLVKPGGSLKLSCAASGFTFSSYTMSWVRQSPEKRLEWVAEISSGGTYTNYPDTATGRFTISRDNAKNTLYLEMSSLRSEDTAMYYCANFGNYEEIAYWGQGTLVTVSA,QIVLTQSPAIMSVSLGERVTMTCTASSSVSSSYLHWYQQKPGSSPKLWIYSTSNLASGVPARFSGSGSGTSYSLTISSMEAEDAATYYCHQYHRSPYTFGGGTKLEIK,IGHV5-9-4 (Mouse),IGHJ3 (Mouse),IGKV4-74 (Mouse),IGKJ2 (Mouse),ANFGNYEEIAY,HQYHRSPYT,https://www.rcsb.org/structure/7EJ4,,PDB (To be published),"Jul 9, 2021","Jul 9, 2021",N/A,Awaiting publication for origin and reference
2B11,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,"Phage Display (antibody, human, immune [SARS-CoV2])",EVQLVESGGGLVQPGGSLRLSCAASEITVSSNYMNWVRQAPGKGLEWVSVIYSGGTTYYADSVKGRFTISRDNSENTLYLQMNSLRAEDTAVYYCARDLMEVGGMDVWGQGTTVTVSS,LPVLTQPPSASGTPGQRVTISCSGSSSNVENDNVNWFQQQVPGSTPKLVIYNDRLRPSGVPDRFSGSKSGTSAYLAISGLQSEDEADYYCVAWDASLQSYVFGTGTKVTVL,IGHV3-66 (Human),IGHJ6 (Human),IGLV1-44 (Human),IGLJ1 (Human),ARDLMEVGGMDV,VAWDASLQSYV,https://www.rcsb.org/structure/7E5Y,,"Yongbing Pan et al., 2021 (https://www.nature.com/articles/s41421-021-00295-w)","Jul 9, 2021","Aug 5, 2021",5th Aug '21: Updated reference,Complete
Shiakolas_5317-1,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV1-58 (Human),IGHJ4 (Human),IGLV1-44 (Human),IGLJ3 (Human),AADPFADY,ATWDDSLNAWV,ND,,"Andrea Shiakolas et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.06.02.446813v1)","Jun 16, 2021","Jun 16, 2021",N/A,Awaiting publication for full sequences
Shiakolas_5317-2,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV1-69 (Human),IGHJ5 (Human),IGKV1-39 (Human),IGKJ1 (Human),ARGLWFGDSETVWFDP,QQSYSTPPT,ND,,"Andrea Shiakolas et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.06.02.446813v1)","Jun 16, 2021","Jun 16, 2021",N/A,Awaiting publication for full sequences
Shiakolas_5317-3,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV3-64 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ1 (Human),VKGKIQLWLGADY,QQSYNTPWT,ND,,"Andrea Shiakolas et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.06.02.446813v1)","Jun 16, 2021","Jun 16, 2021",N/A,Awaiting publication for full sequences
Shiakolas_5317-4,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV4-34 (Human),IGHJ3 (Human),IGKV3-20 (Human),IGKJ2 (Human),ARKPLLHSSVNPGAFDI,QQYATSPRT,ND,,"Andrea Shiakolas et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.06.02.446813v1)","Jun 16, 2021","Jun 16, 2021",N/A,Awaiting publication for full sequences
Shiakolas_5317-7,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV3-7 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ2 (Human),ARGGLWGTFDY,QQFAYSLYT,ND,,"Andrea Shiakolas et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.06.02.446813v1)","Jun 16, 2021","Jun 16, 2021",N/A,Awaiting publication for full sequences
Shiakolas_5317-9,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; NTD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV1-69 (Human),IGHJ5 (Human),IGKV3-11 (Human),IGKJ4 (Human),ASLGGDSYISGTHYDRSGYDP,QRRSNWPPFT,ND,,"Andrea Shiakolas et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.06.02.446813v1)","Jun 16, 2021","Jun 16, 2021",N/A,Awaiting publication for full sequences
Shiakolas_5317-10,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD/non-RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV5-10-1 (Human),IGHJ4 (Human),IGKV2-28 (Human),IGKJ1 (Human),ARVNRVGDGPDF,MQALQTPWT,ND,,"Andrea Shiakolas et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.06.02.446813v1)","Jun 16, 2021","Jun 16, 2021",N/A,Awaiting publication for full sequences
Shiakolas_5317-5,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV1-69 (Human),IGHJ4 (Human),IGLV1-40 (Human),IGLJ2 (Human),AREKGYSSSSSATYYLDF,QSYDSSLTALV,ND,,"Andrea Shiakolas et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.06.02.446813v1)","Jun 16, 2021","Jun 16, 2021",N/A,Awaiting publication for full sequences
Shiakolas_5317-6,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV4-39 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ4 (Human),ARRVPGDYYCLDV,QQSFSARVPT,ND,,"Andrea Shiakolas et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.06.02.446813v1)","Jun 16, 2021","Jun 16, 2021",N/A,Awaiting publication for full sequences
Shiakolas_5317-8,Ab,SARS-CoV2,,,,S; S2,B-cells; SARS-CoV2 Patient,ND,ND,IGHV3-30-3 (Human),IGHJ6 (Human),IGKV3-1 (Human),IGLJ1 (Human),ARAYGGNYYYGMDV,QAWDSSTASFV,ND,,"Andrea Shiakolas et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.06.02.446813v1)","Jun 16, 2021","Jun 16, 2021",N/A,Awaiting publication for full sequences
Shiakolas_53181-1,Ab,SARS-CoV2,,SARS-CoV2,,S; NTD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV1-18 (Human),IGHJ6 (Human),IGKV3-20 (Human),IGKJ3 (Human),ARDPASYYDFWSGYVDYYYYGMDV,QQYGNSRLT,ND,,"Andrea Shiakolas et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.06.02.446813v1)","Jun 16, 2021","Jun 16, 2021",N/A,Awaiting publication for full sequences
Shiakolas_53181-2,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; NTD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV1-18 (Human),IGHJ6 (Human),IGKV3-20 (Human),IGKJ3 (Human),ARDPASYYDLWSGYVDYYYYGMDV,HHYGSSRLT,ND,,"Andrea Shiakolas et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.06.02.446813v1)","Jun 16, 2021","Jun 16, 2021",N/A,Awaiting publication for full sequences
Shiakolas_53181-4,Ab,SARS-CoV2,,,,S; S2,B-cells; SARS-CoV2 Patient,ND,ND,IGHV3-33 (Human),IGHJ4 (Human),IGLV3-10 (Human),IGLJ3 (Human),AREGAVGATSGLDY,YSRDSSGNPL,ND,,"Andrea Shiakolas et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.06.02.446813v1)","Jun 16, 2021","Jun 16, 2021",N/A,Awaiting publication for full sequences
Shiakolas_53181-5,Ab,SARS-CoV2,,,,S; S2,B-cells; SARS-CoV2 Patient,ND,ND,IGHV4-59 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ1 (Human),ARGFDY,QQYGSSPWT,ND,,"Andrea Shiakolas et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.06.02.446813v1)","Jun 16, 2021","Jun 16, 2021",N/A,Awaiting publication for full sequences
Shiakolas_53181-7,Ab,SARS-CoV2,,,,S; S2,B-cells; SARS-CoV2 Patient,ND,ND,IGHV3-23 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ2 (Human),AKSATIVLMVSAIY,SSYTSTSTLV,ND,,"Andrea Shiakolas et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.06.02.446813v1)","Jun 16, 2021","Jun 16, 2021",N/A,Awaiting publication for full sequences
Shiakolas_53181-8,Ab,SARS-CoV2,,,,S; S2,B-cells; SARS-CoV2 Patient,ND,ND,IGHV3-72 (Human),IGHJ4 (Human),IGKV2-28 (Human),IGKJ2 (Human),ARVRGGEWVGDLGWYYYYGMDV,MQALQTPRT,ND,,"Andrea Shiakolas et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.06.02.446813v1)","Jun 16, 2021","Jun 16, 2021",N/A,Awaiting publication for full sequences
Shiakolas_53181-9,Ab,SARS-CoV2,,,,S; S2,B-cells; SARS-CoV2 Patient,ND,ND,IGHV3-30 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ1 (Human),VKGATKIDY,FSYTSGGTRV,ND,,"Andrea Shiakolas et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.06.02.446813v1)","Jun 16, 2021","Jun 16, 2021",N/A,Awaiting publication for full sequences
Shiakolas_53182-1,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV3-53 (Human),IGHJ3 (Human),IGKV1-9 (Human),IGKJ3 (Human),TRGGWPSGDTFDI,QQLNSYPEIT,ND,,"Andrea Shiakolas et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.06.02.446813v1)","Jun 16, 2021","Jun 16, 2021",N/A,Awaiting publication for full sequences
Shiakolas_53182-3,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV3-66 (Human),IGHJ6 (Human),IGLV2-23 (Human),IGLJ3 (Human),ARDRRIIGYYFGMDV,CPYADTWV,ND,,"Andrea Shiakolas et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.06.02.446813v1)","Jun 16, 2021","Jun 16, 2021",N/A,Awaiting publication for full sequences
Shiakolas_53182-6,Ab,SARS-CoV2,,SARS-CoV2,,S: RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV3-66 (Human),IGHJ6 (Human),IGLV2-23 (Human),IGLJ3 (Human),VRDRRIVGYYFGLDV,CSYATTWV,ND,,"Andrea Shiakolas et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.06.02.446813v1)","Jun 16, 2021","Jun 16, 2021",N/A,Awaiting publication for full sequences
Shiakolas_53182-7,Ab,SARS-CoV2,,,,S; NTD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV3-23 (Human),IGHJ6 (Human),IGKV3-20 (Human),IGKJ5 (Human),AKDAFYYGSGSHFYYYYYMDV,QQYGSSPT,ND,,"Andrea Shiakolas et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.06.02.446813v1)","Jun 16, 2021","Jun 16, 2021",N/A,Awaiting publication for full sequences
Shiakolas_53182-9,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV3-53 (Human),IGHJ3 (Human),IGKV1-9 (Human),IGKJ3 (Human),ARGGWPSGDTFDI,QQLNSYPEIT,ND,,"Andrea Shiakolas et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.06.02.446813v1)","Jun 16, 2021","Jun 16, 2021",N/A,Awaiting publication for full sequences
Shiakolas_53182-11,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV3-9 (Human),IGHJ3 (Human),IGKV1-33 (Human),IGKJ3 (Human),AKDIGRYDHYNIFGRVGGAFDI,QHYDNLPR,ND,,"Andrea Shiakolas et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.06.02.446813v1)","Jun 16, 2021","Jun 16, 2021",N/A,Awaiting publication for full sequences
Shiakolas_53182-4,Ab,SARS-CoV2,,,,S; NTD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV2-5 (Human),IGHJ3 (Human),IGKV2-28 (Human),IGKJ2 (Human),ARLLIEHDAFDI,MQALHFPYT,ND,,"Andrea Shiakolas et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.06.02.446813v1)","Jun 16, 2021","Jun 16, 2021",N/A,Awaiting publication for full sequences
Shiakolas_53182-8,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV4-39 (Human),IGHJ4 (Human),IGKV4-1 (Human),IGKJ2 (Human),ARDRRGGGWTASFDF,QQHYSTPGYT,ND,,"Andrea Shiakolas et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.06.02.446813v1)","Jun 16, 2021","Jun 16, 2021",N/A,Awaiting publication for full sequences
Minenkova_76,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV3-53 (Human),ND,IGKV3-20 (Human),ND,ARDLSVAGAFDI,QQYGSSPYT,ND,,"Olga Minenkova et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.06.04.447066v1)","Jun 16, 2021","Jun 16, 2021",N/A,Variant binding data in preprint.Awaiting publication for full sequences.
Minenkova_76-46,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV3-53 (Human),ND,IGKV3-20 (Human),ND,ARDLSVAGAFDI,QQYGSSPIT,ND,,"Olga Minenkova et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.06.04.447066v1)","Jun 16, 2021","Jun 16, 2021",N/A,Variant binding data in preprint.Awaiting publication for full sequences.
Minenkova_76-55,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV3-53 (Human),ND,IGKV3-15 (Human),ND,ARDLSVAGAFDI,QQYVRSPPT,ND,,"Olga Minenkova et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.06.04.447066v1)","Jun 16, 2021","Jun 16, 2021",N/A,Variant binding data in preprint.Awaiting publication for full sequences.
Minenkova_76-57,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV3-53 (Human),ND,IGKV1-9 (Human),ND,ARDLSVAGAFDI,QHRDI,ND,,"Olga Minenkova et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.06.04.447066v1)","Jun 16, 2021","Jun 16, 2021",N/A,Variant binding data in preprint.Awaiting publication for full sequences.
Minenkova_76-58,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV3-53 (Human),ND,IGKV3-20 (Human),ND,ARDLSVAGAFDI,QQYGSSPRIT,ND,,"Olga Minenkova et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.06.04.447066v1)","Jun 16, 2021","Jun 16, 2021",N/A,Variant binding data in preprint.Awaiting publication for full sequences.
Minenkova_76-77,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV3-53 (Human),ND,IGKV3-20 (Human),ND,ARDLSVAGAFDI,QEYGSSPRVT,ND,,"Olga Minenkova et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.06.04.447066v1)","Jun 16, 2021","Jun 16, 2021",N/A,Variant binding data in preprint.Awaiting publication for full sequences.
Minenkova_5,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV1-46 (Human),ND,IGLV2-14 (Human),ND,ATGGAVPHVTGAFDI,NSYTRFSTGV,ND,,"Olga Minenkova et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.06.04.447066v1)","Jun 16, 2021","Jun 16, 2021",N/A,Variant binding data in preprint.Awaiting publication for full sequences.
Minenkova_86,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV1-46 (Human),ND,IGKV3-11 (Human),ND,ATGGAVPHVTGAFDI,QQRSNWPPGFT,ND,,"Olga Minenkova et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.06.04.447066v1)","Jun 16, 2021","Jun 16, 2021",N/A,Variant binding data in preprint.Awaiting publication for full sequences.
Mullen_15G11,Ab,SARS-CoV2,,,,S; Unk,Immunised Mouse (DivergiMab),QVQLQQSGAELVRPGVSVKISCKGSGYTFTDYAMHWVKQSHAKSLEWIGVISTYYGDASYNQKFKGKATMTVDKSSSTAYMELARLTSEDSAIYYCARWANWGYYYAMDYWGQGTSVTVSS,QAVVTQESALTTSPGETVTLTCRSSTGAVTTSNYANWVQEKPDHLFTGLIGGTNNRAPGVPARFSGSLIGDKAALTITGAQTEDEAIYFCALWYSNHWVFGGGTKLTVL,IGHV1-26 (Mouse),IGHJ4 (Mouse),IGLV1 (Mouse),IGLJ1 (Mouse),ARWANWGYYYAMDY,ALWYSNHWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Mullen_15G11_rank1_imgt_scheme.pdb,"Tracey Mullen et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.05.31.446421v1)","Jun 16, 2021","Jun 16, 2021",N/A,Complete
Mullen_18F4,Ab,SARS-CoV2,,,,S; RBD,Immunised Mouse (DivergiMab),QVQLKESGPGLVAPSQSLSITCTVSGFSLTSYAISWVRQPPGKGLEWLGVIWTGGGTNYNSALKSRLSISKDNSKSQVFLKMNSLQTDDTARYYCARKDYYGSSRNAMDYWGQGTSVTVSS,QAVVTQESALTTSPGETVTLTCRSSTGAVTTSNYANWVQEKPDHLFTGLIGGTNNRAPGVPARFSGSLIGDKAALTITGAQTEDEAIYFCALWYSNHWVFGGGTKLTVL,IGHV2-9-1 (Mouse),IGHJ4 (Mouse),IGLV1 (Mouse),IGLJ1 (Mouse),ARKDYYGSSRNAMDY,ALWYSNHWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Mullen_18F4_rank1_imgt_scheme.pdb,"Tracey Mullen et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.05.31.446421v1)","Jun 16, 2021","Jun 16, 2021",N/A,Complete
Mullen_1E5,Ab,SARS-CoV2,,,,S; RBD,Immunised Mouse (DiversiMab),QVQLQQPGAELVKPGASVKMSCKASGYTFTSYWITWVKQRPGQGLEWIGDIYPGSGSTNYNEKFKSKATLTVDTSSSTAYMQLSSLTSEDSAVYYCARSTVVATDAMDYWGQGTSVTVSS,DIVMTQAAFSNPVTLGTSASISCRSSKSLLHSNGITYLYWYLQKPGQSPQLLIYQMSNLASGVPDRFSSSGSGTDFTLRISRVEAEDVGVYYCAQNLELPWTFGGGTKLEIK,IGHV1-55 (Mouse),IGHJ4 (Mouse),IGKV2-109 (Mouse),IGKJ1 (Mouse),ARSTVVATDAMDY,AQNLELPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Mullen_1E5_rank1_imgt_scheme.pdb,"Tracey Mullen et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.05.31.446421v1)","Jun 16, 2021","Jun 16, 2021",N/A,Complete
Mullen_1G3,Ab,SARS-CoV2,,,,S; Unk,Immunised Mouse (DiversiMab),QVQLKESGPGLVAPSQSLSITCTVSGFSLTSYAISWVRQPPGKGLEWLGVIWTGGGTNYNSALKSRLSISKDNSKSQVFLKMNSLQTDDTARYYCARFHYYGSSYGYFDYWGQGTTLTVSS,QAVVTQESALTTSPGETVTLTCRSSTGAVTTSNYANWVQEKPDHLFTGLIGGTNNRAPGVPARFSGSLIGDKAALTITGAQTEDEAIYFCALWYSNHWVFGGGTKLTVL,IGHV2-9-1 (Mouse),IGHJ2 (Mouse),IGLV1 (Mouse),IGLJ1 (Mouse),ARFHYYGSSYGYFDY,ALWYSNHWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Mullen_1G3_rank1_imgt_scheme.pdb,"Tracey Mullen et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.05.31.446421v1)","Jun 16, 2021","Jun 16, 2021",N/A,Complete
Mullen_21C3,Ab,SARS-CoV2,,,,S; Unk,Immunised Mouse (DivergiMab),QVQLKESGPGLVAPSQSLSITCTVSGFSLTSYAISWVRQPPGKGLEWLGVIWTGGGTNYNSALKSRLSISKDNSKSQVFLKMNSLQTDDTARYYCARIYYYGSSYFDYWGQGTTLTVSS,QAVVTQESALTTSPGETVTLTCRSSTGAVTTSNYANWVQEKPDHLFTGLIGGTNNRAPGVPARFSGSLIGDKAALTITGAQTEDEAIYFCALWYSNQFIFGSGTKVTVL,IGHV2-9-1 (Mouse),IGHJ2 (Mouse),IGLV1 (Mouse),IGLJ3 (Mouse),ARIYYYGSSYFDY,ALWYSNQFI,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Mullen_21C3_rank1_imgt_scheme.pdb,"Tracey Mullen et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.05.31.446421v1)","Jun 16, 2021","Jun 16, 2021",N/A,Complete
Mullen_22D9,Ab,SARS-CoV2,,,,S; RBD,Immunised Mouse (DivergiMab),QVQLQQSGAELVRPGTSVKVSCKASGYAFTNYLIEWVKQRPGQGLEWIGVINPGSGGTNYNEKFKGKATLTADKSSSTAYMQLSSLTSEDSAVYFCARRHYYYGVDYWGQGTTLTVSS,DIKMTQSPSSMYASLGERVTITCKASQDINSYLSWFQQKPGKSPKTLIYRANRLVDGVPSRFSGSGSGQDYSLTISSLEYEDMGIYYCLQYDELYTFGGGTKLEIK,IGHV1-54 (Mouse),IGHJ2 (Mouse),IGKV14-111 (Mouse),IGKJ2 (Mouse),ARRHYYYGVDY,LQYDELYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Mullen_22D9_rank1_imgt_scheme.pdb,"Tracey Mullen et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.05.31.446421v1)","Jun 16, 2021","Jun 16, 2021",N/A,Complete
Mullen_23D11,Ab,SARS-CoV2,,,,S; RBD,Immunised Mouse (DivergiMab),EVQLQQSGPELVKPGASVKISCKTSGYTFTEYTMYWVKQSHGKSLEWIGGVNPNNGDTSYSQKFKGKATLTVDKSSSTAYMELRSLTSEDSAVYYCARDGYDLYYGMDYWGQGTSVTVSS,DIVMTQSQKFMSTSVGDRVSVTCKASQNVGTNVAWYQQKPGQSPKALIYSASYRYSGVPDRFTGSGSGTDFTLTISNVQSVDLAEYFCHQYNSYPWTFGGGTKLEIR,IGHV1-26 (Mouse),IGHJ4 (Mouse),IGKV6-15 (Mouse),IGKJ1 (Mouse),ARDGYDLYYGMDY,HQYNSYPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Mullen_23D11_rank1_imgt_scheme.pdb,"Tracey Mullen et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.05.31.446421v1)","Jun 16, 2021","Jun 16, 2021",N/A,Complete
Mullen_26E2,Ab,SARS-CoV2,,,,S; Unk,Immunised Mouse (DivergiMab),EVQLQQSGAELVRPGASVKLSCTASGFNIKDDYMHWVKQRPEQGLEWIGWIDPENGDTEYASKFQGKATITADTSSNTAYLQLSSLTSEDTAVYYCTKGYYGSSYDYFDYWGQGTTLTVSS,DIQMTQSPSSLSASLGGKVTITCKASQDINKYIAWYQHKPGKGPRLLIHYTSTLQPGIPSRFSGSGSGRDYSFSISNLEPEDIATYYCLQYDNLWTFGGGTKLEIK,IGHV14-4 (Mouse),IGHJ2 (Mouse),IGKV19-93 (Mouse),IGKJ1 (Mouse),TKGYYGSSYDYFDY,LQYDNLWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Mullen_26E2_rank1_imgt_scheme.pdb,"Tracey Mullen et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.05.31.446421v1)","Jun 16, 2021","Jun 16, 2021",N/A,Complete
Mullen_29F7,Ab,SARS-CoV2,,,,S; Unk,Immunised Mouse (DivergiMab),QVQLQQSGPELVKPGASVKISCKASGYAFSSSWMNWVKQRPGKGLEWIGRIYPGDGDTNYNGKFKGKATLTADKSSSTAYMQLSSLTSEDSAVYFCARDDYDEGDYWGQGTTLTVSS,DIVMTQSQKFMSTSVGDRVSVTCKASQNVGTNVAWYQQKPGQSPKALIYSASYRYSGVPDRFTGSGSGTDFTLTISNVQSEDLAEYFCQQYNSYPLYTFGGGTKLEIK,IGHV1-82 (Mouse),IGHJ2 (Mouse),IGKV6-15 (Mouse),IGKJ2 (Mouse),ARDDYDEGDY,QQYNSYPLYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Mullen_29F7_rank1_imgt_scheme.pdb,"Tracey Mullen et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.05.31.446421v1)","Jun 16, 2021","Jun 16, 2021",N/A,Complete
Mullen_3B3,Ab,SARS-CoV2,,,,S; Unk,Immunised Mouse (DiversiMab),DVKLVESGEGLVKPGGSLKLSCAASGFTFSSYAMSWVRQTPEKRLEWVAYISSGGDYIYYADTVKGRFTISRDNARNTLYLQMSSLKSEDTAMYYCTRVARLYDGYFDYWGQGTTLTVSS,NIVLTQSPASLAVSLGQRATISCRASESVDSYGNSFMHWYQQKPGQPPKLLIYLASNLESGVPARFSGSGSRTDFTLTIDPVEADDAATYYCQQNNEDPYTFGGGTKLEIK,IGHV5-9-1 (Mouse),IGHJ2 (Mouse),IGKV3-10 (Mouse),IGKJ2 (Mouse),TRVARLYDGYFDY,QQNNEDPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Mullen_3B3_rank1_imgt_scheme.pdb,"Tracey Mullen et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.05.31.446421v1)","Jun 16, 2021","Jun 16, 2021",N/A,Complete
Mullen_3F2,Ab,SARS-CoV2,,,,S; Unk,Immunised Mouse (DiversiMab),EVQLQQSGAELVRPGASVKLSCTASGFNIKDDYMHWVKQRPEQGLEWIGWIDPENGDTEYASKFQGKATITVDISSNTAYLQLNSLTSEDTAVYYCSTLIYYYGSSNDYWGQGTTLTVSS,QAVVTQESALTTSPGETVTLTCRSSTGAVTTSNYANWVQEKPDHLFTGLIGGTNNRAPGVPARFSGSLIGDKAALTITGAQTEDEAIYFCALWYSNHWVFGGGTKLTVL,IGHV14-4 (Mouse),IGHJ2 (Mouse),IGLV1 (Mouse),IGLJ1 (Mouse),STLIYYYGSSNDY,ALWYSNHWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Mullen_3F2_rank1_imgt_scheme.pdb,"Tracey Mullen et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.05.31.446421v1)","Jun 16, 2021","Jun 16, 2021",N/A,Complete
D59047-1195,Ab,SARS-CoV2,,,,S; Unk,Immunised Mouse (DivergiMab),QVQLKESGPGLVAPSQSLSITCTVSGFSLTSYAISWVRQPPGKGLEWLGVIWTGGGTNYNSALKSRLSISKDNSKSQVFLKMNSLQTDDTARYYCARIYYYGSSYFDYWGQGTTLTVSS,QAVVTQESALTTSPGETVTLTCRSSTGAVTTSNYANWVQEKPDHLFTGLIGGTNNRAPGVPARFSGSLIGDKAALTITGAQTEDEAIYFCALWYSNQFIFGSGTKVTVL,IGHV2-9-1 (Mouse),IGHJ2 (Mouse),IGLV1 (Mouse),IGLJ3 (Mouse),ARIYYYGSSYFDY,ALWYSNQFI,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/D59047-1195_rank1_imgt_scheme.pdb,"Tracey Mullen et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.05.31.446421v1)","Jun 16, 2021","Jun 16, 2021",N/A,Complete
D70678-12637-S1,Ab,SARS-CoV2,,,,S; Unk,Transgenic Mouse (Alloy GK),EVQLVESGGGLVKPGGSLRLSCATSGFTFSHYSMNWVRQAPGKGLEWVSSISSSSSNIYYADSVKGRFTVSRDNAKNSLYLQMNSLRAEDTAVYYCARRGSSWSFDYWGQGTLVTVSS,EIVLTQSPATLSLSPGERAILSCRASQSISSTYLAWNQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSWTFGQGTKVEIK,IGHV3-21 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ1 (Human),ARRGSSWSFDY,QQYGSSWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/D70678-12637-S1_rank1_imgt_scheme.pdb,"Tracey Mullen et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.05.31.446421v1)","Jun 16, 2021","Jun 16, 2021",N/A,Complete
D70678-12799-S1,Ab,SARS-CoV2,,,,S; Unk,Transgenic Mouse (Alloy GK),QVQLVQSGAEVKKPGASVKVSCKASGYTFTDYYMHWVRQAPGQGLEWMGWINPNSGGTNYAQKFQGRVTMTRDTSISTAYMELSRLRSDDTALYYCARLDYWSQGTLVTVSS,DIVMTQTPLSLPVTLGQPASISCRSSQSLVHSDGNTYLSWLQQRPGQPPRLLIYKISNRFSGVPDRFSGSGAGTDFTLKISRVEAEDVGVYYCMQETQFTWTFGQGTKVEIK,IGHV1-2 (Human),IGHJ4 (Human),IGKV2-24 (Human),IGKJ1 (Human),ARLDY,MQETQFTWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/D70678-12799-S1_rank1_imgt_scheme.pdb,"Tracey Mullen et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.05.31.446421v1)","Jun 16, 2021","Jun 16, 2021",N/A,Complete
D70678-13531-S1,Ab,SARS-CoV2,,,,S; Unk,Transgenic Mouse (Alloy GK),QVQLQESGPGLVKPSETLSLTCTVSGGSISSYYWTWIRQSPGKGLEWIGYIYYSGSTYTNPSLKSRVTFSVDTSENQFSLKLNSVTAADTAIYFCARDNMDVWGKGTTVTVSS,DVVMTQTPLSLPVTLGQPASISCRCSQSLVYSDGNTYLNWFQQRPGQSPRRLIYKVSIRDSGVPDRFSGSGSGTDFTLKISRVEAEDVGIYYCMQGTHRPITFGRGTRLEIK,IGHV4-59 (Human),IGHJ6 (Human),IGKV2-30 (Human),IGKJ5 (Human),ARDNMDV,MQGTHRPIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/D70678-13531-S1_rank1_imgt_scheme.pdb,"Tracey Mullen et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.05.31.446421v1)","Jun 16, 2021","Jun 16, 2021",N/A,Complete
D70678-13576-S1,Ab,SARS-CoV2,,,,S; Unk,Transgenic Mouse (Alloy GK),QVQLQESGPGLVKPSETLSLTCTVSGGSISNYYWTWIRQPPGKGLEWIGYIYYSGSTYTNPSLKSRVTISVDTSENQFSLKLNSVTAADTAIYYCARDNMDVWGKGTTVTVSS,DIVMTQSPDSLAVSLGERATINCKSSQSVLYSSNNKNYLAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYSTPYTFGQGTKLEIK,IGHV4-59 (Human),IGHJ6 (Human),IGKV4-1 (Human),IGKJ2 (Human),ARDNMDV,QQYYSTPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/D70678-13576-S1_rank1_imgt_scheme.pdb,"Tracey Mullen et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.05.31.446421v1)","Jun 16, 2021","Jun 16, 2021",N/A,Complete
D70678-14004-S2,Ab,SARS-CoV2,,,,S; Unk,Transgenic Mouse (Alloy GK),QVQLVQSGAEVKKPGASVKVSCKASGYTFSSYGIIWVRQAPGQGLEWMGWISAYNGNTNYAQKLQGRVTMTTDTSTSTAYMELRTLRSDDTAVYYCAREITLNWNYAGWFDPWGQGTLVTVSS,EIVMTQSPATLSVSPGERATLSCRASQSIRNNLAWYQQKPGQAPRLLIYGAISRATGVPARFSGSGSGTEFTLTISSLQSEDFAVYHCQQYNNWLPYTFGQGTKLEIK,IGHV1-18 (Human),IGHJ5 (Human),IGKV3-15 (Human),IGKJ2 (Human),AREITLNWNYAGWFDP,QQYNNWLPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/D70678-14004-S2_rank1_imgt_scheme.pdb,"Tracey Mullen et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.05.31.446421v1)","Jun 16, 2021","Jun 16, 2021",N/A,Complete
D70678-14027-S2,Ab,SARS-CoV2,,,,S; Unk,Transgenic Mouse (Alloy GK),EVQLVESGGGLVKPGGSLRLSCAASGFTFSYAWMTWVRQAPGKGLEWVGRIKTKSDGGTTDYASPVKGKFTISRDDSKNTLYLQMNSLQTEDTAVYYCTTHSSPDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDIRNYLNWYHQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPYTFGQGTKLEIK,IGHV3-15 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ2 (Human),TTHSSPDY,QQYDNLPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/D70678-14027-S2_rank1_imgt_scheme.pdb,"Tracey Mullen et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.05.31.446421v1)","Jun 16, 2021","Jun 16, 2021",N/A,Complete
D70678-2155-S1,Ab,SARS-CoV2,,,,S; Unk,Transgenic Mouse (Alloy GK),QVQLVESGGDLVKPGGSLRLSCAASGFTFSNAWMTWVRQAPGKELEWVGRIKTKSDGGTIEYGVSVKGRFTISRDDSKNTLFLQMNSLTTEDTAVYYCTTHSSPDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDIRNYLNWYQQKPGKAPKLLIYDASTLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCHQYGNLPLSFGGGTKVEIK,IGHV3-15 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ4 (Human),TTHSSPDY,HQYGNLPLS,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/D70678-2155-S1_rank1_imgt_scheme.pdb,"Tracey Mullen et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.05.31.446421v1)","Jun 16, 2021","Jun 16, 2021",N/A,Complete
D70678-2743-S1,Ab,SARS-CoV2,,,,S; Unk,Transgenic Mouse (Alloy GK),QVQLQESGPGLVKPSETLSLTCTVSGGSISSYYWTWIRQPPGKGLEWIGYIYSSGSTYTNPSLKSRVTISVDTSENQFSLKLNSVTAADTAVYYCARDNMDVWGKGTTVTVSS,DVVMTQTPLSLPVTLGQPASISCRSSQSLVYSDGNTYLNWFQQRPGQSPRRLIYKVSNRDSGVPDRFSGSGSGTDFTLKISRVEAEDVGIYYCMQGTHWPIIFGRGTRLEIK,IGHV4-4 (Human),IGHJ6 (Human),IGKV2-30 (Human),IGKJ5 (Human),ARDNMDV,MQGTHWPII,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/D70678-2743-S1_rank1_imgt_scheme.pdb,"Tracey Mullen et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.05.31.446421v1)","Jun 16, 2021","Jun 16, 2021",N/A,Complete
D70678-5521-S2,Ab,SARS-CoV2,,,,S; Unk,Transgenic Mouse (Alloy GK),EVQLVESGGGLVKPGGSLRLSCAASGFTFNYAWMTWVRQAPGKGLDWVGRIKTKTDSGTTDYAAPVKGRFTISRDDSKNTLYLQMNNLKTEDTAVYYCTTHSTPDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDINNHLNWYQQKPGKAPNLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDFATYYCQQYDNLPYTFGQGTKLEIK,IGHV3-15 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ2 (Human),TTHSTPDY,QQYDNLPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/D70678-5521-S2_rank1_imgt_scheme.pdb,"Tracey Mullen et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.05.31.446421v1)","Jun 16, 2021","Jun 16, 2021",N/A,Complete
NRL-N-E10,Nb,SARS-CoV2,,,,N,"Phage Display Library (Llama, immune)",DVQLQASGGGLVQAGGSLRLSCAASARTFYTMGWFRQVLGKDREFVGAIRWGVYATTRYADSVKGRFSISRDDATNTVALQMNSLKPEDTAVYYCAARAGPLGFELSATSSAEYDYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AARAGPLGFELSATSSAEYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/NRL-N-E10_rank1_imgt_scheme.pdb,"George Anderson et al., 2021 (https://pubs.acs.org/doi/10.1021/acs.analchem.1c00677)","Jun 16, 2021","Jun 16, 2021",N/A,Other clonal members available in the SI of Anderson et al. Complete
NRL-N-B6,Nb,SARS-CoV2,,,,N; RBD,"Phage Display Library (Llama, immune)",EVQLQASGGGLVQAGDSLRLSCVAVSGRTISTFAMGWFRQAPGKEREFVATINWSGSSARYADPVEGRFTISRDDAKNTVYLEMSSLKPGDSAVYYCASGRYLGGITSYSQGDFAPWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ6 (Alpaca),N/A,N/A,ASGRYLGGITSYSQGDFAP,N/A,Expected,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/NRL-N-B6_rank1_imgt_scheme.pdb,"George Anderson et al., 2021 (https://pubs.acs.org/doi/10.1021/acs.analchem.1c00677) and Qiaozhen Ye et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.06.01.446591v1)","Jun 16, 2021","Jun 16, 2021",N/A,Other clonal members available in the SI of Anderson et al. Awaiting release of structure in PDB.
NRL-N-C2,Nb,SARS-CoV2,,,,N; RBD,"Phage Display Library (Llama, immune)",EVQLQASGGGLVRPGGSLRLSCAASGFTFSSYAMMWVRQAPGKGLEWVSAINGGGGSTSYADSVKGRFTISRDNAKNTLYLQMNSLKPEDTAVYYCAKYQAAVHQEKEDYWGQGTQVTVSS,N/A,IGHV3S1 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AKYQAAVHQEKEDY,N/A,Expected,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/NRL-N-C2_rank1_imgt_scheme.pdb,"George Anderson et al., 2021 (https://pubs.acs.org/doi/10.1021/acs.analchem.1c00677) and Qiaozhen Ye et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.06.01.446591v1)","Jun 16, 2021","Jun 16, 2021",N/A,Other clonal members available in the SI of Anderson et al. Awaiting release of structure in PDB.
NRL-N-E2,Nb,SARS-CoV2,,,,N; CTD,"Phage Display Library (Llama, immune)",EVQLQASGGGLVQAGGSLRLSCAASGRTDSTQHMAWFRQAPGKEREFVTAIQWRGGGTSYTDSVKGRFTISRDNAKNTVYLEMNSLKPEDTAVYYCATNTRWTYFSPTVPDRYDYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,ATNTRWTYFSPTVPDRYDY,N/A,Expected,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/NRL-N-E2_rank1_imgt_scheme.pdb,"George Anderson et al., 2021 (https://pubs.acs.org/doi/10.1021/acs.analchem.1c00677) and Qiaozhen Ye et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.06.01.446591v1)","Jun 16, 2021","Jun 16, 2021",N/A,Other clonal members available in the SI of Anderson et al. Awaiting release of structure in PDB.
NRL-N-A9,Nb,SARS-CoV2,,,,N,"Phage Display Library (Llama, immune)",EVQLQASGGGLVQAGESLRLSCVVSGGAFRIMDMGWFRQVPGKQREVVGVISSGGYTNYADSVKGRFTISRDNAKRTVYLHMNSLKPEDTAVYYCNIIPKSDQGAVNTWGKGTLVSVSS,N/A,IGHV3S53 (Alpaca),IGHJ7 (Alpaca),N/A,N/A,NIIPKSDQGAVNT,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/NRL-N-A9_rank1_imgt_scheme.pdb,"George Anderson et al., 2021 (https://pubs.acs.org/doi/10.1021/acs.analchem.1c00677)","Jun 16, 2021","Jun 16, 2021",N/A,Other clonal members available in the SI of Anderson et al. Complete
eCR3022.1,Ab,SARS-CoV2;SARS-CoV1,,,,S; RBD,Engineered from CR3022,QMQLVQSGTEVKKPGESLKISCKGSGYGFIYYWIGWVRQMPGKGLEWMGIIYPGDGETRYSPSFQGQVTISADKSINTAYLQWSSLKASDTAIYYCAGGGGISTPMDVWGQGTTVTVSS,DIQLTQSPDSLAVSLGERATINCKSSQSVLWSSINKNYLAWYQQKPGQPPKLLIYWASRRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYRTPYTFGQGTKVEIK,IGHV5-51 (Human),IGHJ6 (Human),IGKV4-1 (Human),IGKJ1 (Human),AGGGGISTPMDV,QQYYRTPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/eCR3022.1_rank1_imgt_scheme.pdb,"Fangzhu Zhao et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.05.29.443900v1)","Jun 16, 2021","Jun 16, 2021",N/A,Complete
eCR3022.2,Ab,SARS-CoV2;SARS-CoV1,,SARS-CoV2,,S; RBD,Engineered from CR3023,QMQLVQSGTEVKKPGESLKISCKGSGYGFIWYWIGWVRQMPGKGLEWMGIIYPGDGETRYSPSFQGQVTISADKSINTAYLQWSSLKASDTAIYYCAGGGGISTPMDVWGQGTTVTVSS,DIQLTQSPDSLAVSLGERATINCKSSQSVLWSSINKNYLAWYQQKPGQPPKLLIYWASQRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYQSTPYTFGQGTKVEIK,IGHV5-51 (Human),IGHJ6 (Human),IGKV4-1 (Human),IGKJ1 (Human),AGGGGISTPMDV,QQYQSTPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/eCR3022.2_rank1_imgt_scheme.pdb,"Fangzhu Zhao et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.05.29.443900v1)","Jun 16, 2021","Jun 16, 2021",N/A,Complete
eCR3022.3,Ab,SARS-CoV2;SARS-CoV1,,,,S; RBD,Engineered from CR3024,QMQLVQSGTEVKKPGESLKISCKGSGYGFIYYWIGWVRQMPGKGLEWMGIIYPGDEETRYSPSFQGQVTISADKSINTAYLQWSSLKASDTAIYYCAGGGGISTPMDVWGQGTTVTVSS,DIQLTQSPDSLAVSLGERATINCKSSQSVLWSSINKNYLAWYQQKPGQPPKLLLYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYRTPYTFGQGTKVEIK,IGHV5-51 (Human),IGHJ6 (Human),IGKV4-1 (Human),IGKJ1 (Human),AGGGGISTPMDV,QQYYRTPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/eCR3022.3_rank1_imgt_scheme.pdb,"Fangzhu Zhao et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.05.29.443900v1)","Jun 16, 2021","Jun 16, 2021",N/A,Complete
eCR3022.4,Ab,SARS-CoV2;SARS-CoV1,,,,S; RBD,Engineered from CR3025,QMQLVQSGTEVKKPGESLKISCKGSGYGFIYYWIGWVRQMPGKGLEWMGIIYPGDSETRYSPSFQGQVTISADKSINTAYLQWSSLKASDTAIYYCAGGGGISTPMDVWGQGTTVTVSS,DIQLTQSPDSLAVSLGERATINCKSSQSVLWSSINKNYLAWYQQKPGQPPKLLIYWASYRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCEQYYSTPYTFGQGTKVEIK,IGHV5-51 (Human),IGHJ6 (Human),IGKV4-1 (Human),IGKJ1 (Human),AGGGGISTPMDV,EQYYSTPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/eCR3022.4_rank1_imgt_scheme.pdb,"Fangzhu Zhao et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.05.29.443900v1)","Jun 16, 2021","Jun 16, 2021",N/A,Complete
eCR3022.5,Ab,SARS-CoV2;SARS-CoV1,,,,S; RBD,Engineered from CR3026,QMQLVQSGTEVKKPGESLKISCKGSGYGFIFYWIGWVRQMPGKGLEWMGIIYPGDGETRYSPSFQGQVTISADKSINTAYLQWSSLKASDTAIYYCAGGGGISTPMDVWGQGTTVTVSS,DIQLTQSPDSLAVSLGERATINCKSSQSVLWSSINKNYLAWYQQKPGQPPKLLIYWGSTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCNQYYSTPYTFGQGTKVEIK,IGHV5-51 (Human),IGHJ6 (Human),IGKV4-1 (Human),IGKJ1 (Human),AGGGGISTPMDV,NQYYSTPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/eCR3022.5_rank1_imgt_scheme.pdb,"Fangzhu Zhao et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.05.29.443900v1)","Jun 16, 2021","Jun 16, 2021",N/A,Complete
eCR3022.6,Ab,SARS-CoV2;SARS-CoV1,,,,S; RBD,Engineered from CR3027,QMQLVQSGTEVKKPGESLKISCKGSGYGFIFYWIGWVRQMPGKGLEWMGIIYPGDGETRYSPSFQGQVTISADKSINTAYLQWSSLKASDTAIYYCAGGGGISTPMDVWGQGTTVTVSS,DIQLTQSPDSLAVSLGERATINCKSSQSVLWSSINKNYLAWYQQKPGQPPKLLEYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYSTPYTFGQGTKVEIK,IGHV5-51 (Human),IGHJ6 (Human),IGKV4-1 (Human),IGKJ1 (Human),AGGGGISTPMDV,QQYYSTPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/eCR3022.6_rank1_imgt_scheme.pdb,"Fangzhu Zhao et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.05.29.443900v1)","Jun 16, 2021","Jun 16, 2021",N/A,Complete
eCR3022.7,Ab,SARS-CoV2;SARS-CoV1,,SARS-CoV2,,S; RBD,Engineered from CR3028,QMQLVQSGTEVKKPGESLKISCKGSGYGFIWYWIGWVRQMPGKGLEWMGIIYPGDGETRYSPSFQGQVTISADKSINTAYLQWSSLKASDTAIYYCAGGGGISTPMDVWGQGTTVTVSS,DIQLTQSPDSLAVSLGERATINCKSSQSVLWSSINKNYLAWYQQKPGQPPKLLIYWASRRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCNQYYSTPYTFGQGTKVEIK,IGHV5-51 (Human),IGHJ6 (Human),IGKV4-1 (Human),IGKJ1 (Human),AGGGGISTPMDV,NQYYSTPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/eCR3022.7_rank1_imgt_scheme.pdb,"Fangzhu Zhao et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.05.29.443900v1)","Jun 16, 2021","Jun 16, 2021",N/A,Complete
eCR3022.8,Ab,SARS-CoV2;SARS-CoV1,,,,S; RBD,Engineered from CR3029,QMQLVQSGTEVKKPGESLKISCKGSGYGFIYYWIGWVRQMPGKGLEWMGIIYPGDGETRYSPSFQGQVTISADKSINTAYLQWSSLKASDTAIYYCAGGGGISTPMDVWGQGTTVTVSS,DIQLTQSPDSLAVSLGERATINCKSSQSVLWSSINKNYLAWYQQKPGQPPKLLIYWASHRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCEQYYSTPYTFGQGTKVEIK,IGHV5-51 (Human),IGHJ6 (Human),IGKV4-1 (Human),IGKJ1 (Human),AGGGGISTPMDV,EQYYSTPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/eCR3022.8_rank1_imgt_scheme.pdb,"Fangzhu Zhao et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.05.29.443900v1)","Jun 16, 2021","Jun 16, 2021",N/A,Complete
eCR3022.9,Ab,SARS-CoV2;SARS-CoV1,,,,S; RBD,Engineered from CR3030,QMQLVQSGTEVKKPGESLKISCKGSGYGFIYYWIGWVRQMPGKGLEWMGIIYPGDGETRYSPSFQGQVTISADKSINTAYLQWSSLKASDTAIYYCAGGGGISTPMDVWGQGTTVTVSS,DIQLTQSPDSLAVSLGERATINCKSSQSVLWSSINKNYLAWYQQKPGQPPKLLIYWASKRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYITPYTFGQGTKVEIK,IGHV5-51 (Human),IGHJ6 (Human),IGKV4-1 (Human),IGKJ1 (Human),AGGGGISTPMDV,QQYYITPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/eCR3022.9_rank1_imgt_scheme.pdb,"Fangzhu Zhao et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.05.29.443900v1)","Jun 16, 2021","Jun 16, 2021",N/A,Complete
eCR3022.10,Ab,SARS-CoV2;SARS-CoV1,,,,S; RBD,Engineered from CR3031,QMQLVQSGTEVKKPGESLKISCKGSGYGFIYYWIGWVRQMPGKGLEWMGIIYPGDGETRYSPSFQGQVTISADKSINTAYLQWSSLKASDTAIYYCAGGGGISTPMDVWGQGTTVTVSS,DIQLTQSPDSLAVSLGERATINCKSSQSVLWSSINKNYLAWYQQKPGQPPKLLIYWARTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQNYYSTPYTFGQGTKVEIK,IGHV5-51 (Human),IGHJ6 (Human),IGKV4-1 (Human),IGKJ1 (Human),AGGGGISTPMDV,QNYYSTPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/eCR3022.10_rank1_imgt_scheme.pdb,"Fangzhu Zhao et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.05.29.443900v1)","Jun 16, 2021","Jun 16, 2021",N/A,Complete
eCR3022.11,Ab,SARS-CoV2;SARS-CoV1,,,,S; RBD,Engineered from CR3032,QMQLVQSGTEVKKPGESLKISCKGSGYGFIFYWIGWVRQMPGKGLEWMGIIYPGDGETRYSPSFQGQVTISADKSINTAYLQWSSLKASDTAIYYCAGGGGISTPMDVWGQGTTVTVSS,DIQLTQSPDSLAVSLGERATINCKSSQSVLWSSINKNYLAWYQQKPGQPPKLLIYWAGTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCAQYYSTPYTFGQGTKVEIK,IGHV5-51 (Human),IGHJ6 (Human),IGKV4-1 (Human),IGKJ1 (Human),AGGGGISTPMDV,AQYYSTPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/eCR3022.11_rank1_imgt_scheme.pdb,"Fangzhu Zhao et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.05.29.443900v1)","Jun 16, 2021","Jun 16, 2021",N/A,Complete
eCR3022.12,Ab,SARS-CoV2;SARS-CoV1,,,,S; RBD,Engineered from CR3033,QMQLVQSGTEVKKPGESLKISCKGSGYGFIYYWIGWVRQMPGKGLEWMGIIYPGDGETRYSPSFQGQVTISADKSINTAYLQWSSLKASDTAIYYCAGGGGISTPMDVWGQGTTVTVSS,DIQLTQSPDSLAVSLGERATINCKSSQSVLYSSINKNYVAWYQQKPGQPPKLLIYWASYRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYSHPYTFGQGTKVEIK,IGHV5-51 (Human),IGHJ6 (Human),IGKV4-1 (Human),IGKJ1 (Human),AGGGGISTPMDV,QQYYSHPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/eCR3022.12_rank1_imgt_scheme.pdb,"Fangzhu Zhao et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.05.29.443900v1)","Jun 16, 2021","Jun 16, 2021",N/A,Complete
eCR3022.13,Ab,SARS-CoV2;SARS-CoV1,,,,S; RBD,Engineered from CR3034,QMQLVQSGTEVKKPGESLKISCKGSGYGFIFYWIGWVRQMPGKGLEWMGIIYPGDGETRYSPSFQGQVTISADKSINTAYLQWSSLKASDTAIYYCAGGGGISTPMDVWGQGTTVTVSS,DIQLTQSPDSLAVSLGERATINCKSSQSVLWSSINKNYLAWYQQKPGQPPKLLIYWESTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCGQYYSTPYTFGQGTKVEIK,IGHV5-51 (Human),IGHJ6 (Human),IGKV4-1 (Human),IGKJ1 (Human),AGGGGISTPMDV,GQYYSTPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/eCR3022.13_rank1_imgt_scheme.pdb,"Fangzhu Zhao et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.05.29.443900v1)","Jun 16, 2021","Jun 16, 2021",N/A,Complete
eCR3022.14,Ab,SARS-CoV2;SARS-CoV1,,,,S; RBD,Engineered from CR3035,QMQLVQSGTEVKKPGESLKISCKGSGYGFIYYWIGWVRQMPGKGLEWMGIIYPGDGETRYSPSFQGQVTISADKSINTAYLQWSSLKASDTAIYYCAGGGGISTPMDVWGQGTTVTVSS,DIQLTQSPDSLAVSLGERATINCKSSQSVLWSSINKNYLAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYKSTPYTFGQGTKVEIK,IGHV5-51 (Human),IGHJ6 (Human),IGKV4-1 (Human),IGKJ1 (Human),AGGGGISTPMDV,QQYKSTPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/eCR3022.14_rank1_imgt_scheme.pdb,"Fangzhu Zhao et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.05.29.443900v1)","Jun 16, 2021","Jun 16, 2021",N/A,Complete
eCR3022.15,Ab,SARS-CoV2;SARS-CoV1,,,,S; RBD,Engineered from CR3036,QMQLVQSGTEVKKPGESLKISCKGSGYGFIYYWIGWVRQMPGKGLEWMGIIYPGDGETRYSPSFQGQVTISADKSINTAYLQWSSLKASDTAIYYCAGGGGISTPMDVWGQGTTVTVSS,DIQLTQSPDSLAVSLGERATINCKSSQSVLWSSINKNYLAWYQQKPGQPPKLLIYWAQTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCNQYYSTPYTFGQGTKVEIK,IGHV5-51 (Human),IGHJ6 (Human),IGKV4-1 (Human),IGKJ1 (Human),AGGGGISTPMDV,NQYYSTPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/eCR3022.15_rank1_imgt_scheme.pdb,"Fangzhu Zhao et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.05.29.443900v1)","Jun 16, 2021","Jun 16, 2021",N/A,Complete
eCR3022.16,Ab,SARS-CoV2;SARS-CoV1,,,,S; RBD,Engineered from CR3037,QMQLVQSGTEVKKPGESLKISCKGSGYGFIFYWIGWVRQMPGKGLEWMGIIYPGDGETRYSPSFQGQVTISADKSINTAYLQWSSLKASDTAIYYCAGGGGISTPMDVWGQGTTVTVSS,DIQLTQSPDSLAVSLGERATINCKSSQSVLYSSWNKNYLAWYQQKPGQPPKLLIYWALTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYKSTPYTFGQGTKVEIK,IGHV5-51 (Human),IGHJ6 (Human),IGKV4-1 (Human),IGKJ1 (Human),AGGGGISTPMDV,QQYKSTPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/eCR3022.16_rank1_imgt_scheme.pdb,"Fangzhu Zhao et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.05.29.443900v1)","Jun 16, 2021","Jun 16, 2021",N/A,Complete
eCR3022.17,Ab,SARS-CoV2;SARS-CoV1,,,,S; RBD,Engineered from CR3038,QMQLVQSGTEVKKPGESLKISCKGSGYGFIWYWIGWVRQMPGKGLEWMGIIYPGDGETRYSPSFQGQVTISADKSINTAYLQWSSLKASDTAIYYCAGGGGISTPMDVWGQGTTVTVSS,DIQLTQSPDSLAVSLGERATINCKSSQSVLRSSINKNYLAWYQQKPGQPPKLLIYWASHRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYSWPYTFGQGTKVEIK,IGHV5-51 (Human),IGHJ6 (Human),IGKV4-1 (Human),IGKJ1 (Human),AGGGGISTPMDV,QQYYSWPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/eCR3022.17_rank1_imgt_scheme.pdb,"Fangzhu Zhao et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.05.29.443900v1)","Jun 16, 2021","Jun 16, 2021",N/A,Complete
eCR3022.18,Ab,SARS-CoV2;SARS-CoV1,,,,S; RBD,Engineered from CR3039,QMQLVQSGTEVKKPGESLKISCKGSGYGFIFYWIGWVRQMPGKGLEWMGIIYPGDGETRYSPSFQGQVTISADKSINTAYLQWSSLKASDTAIYYCAGGGGISTPMDVWGQGTTVTVSS,DIQLTQSPDSLAVSLGERATINCKSSQSVLKSSINKNYLAWYQQKPGQPPKLLIYWASARESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCLQYYSTPYTFGQGTKVEIK,IGHV5-51 (Human),IGHJ6 (Human),IGKV4-1 (Human),IGKJ1 (Human),AGGGGISTPMDV,LQYYSTPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/eCR3022.18_rank1_imgt_scheme.pdb,"Fangzhu Zhao et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.05.29.443900v1)","Jun 16, 2021","Jun 16, 2021",N/A,Complete
eCR3022.19,Ab,SARS-CoV2;SARS-CoV1,,,,S; RBD,Engineered from CR3040,QMQLVQSGTEVKKPGESLKISCKGSGYGFIYYWIGWVRQMPGKGLEWMGIIYPGDGETRYSPSFQGQVTISADKSINTAYLQWSSLKASDTAIYYCAGGGGISTPMDVWGQGTTVTVSS,DIQLTQSPDSLAVSLGERATINCKSSQSVLKSSINKNYLAWYQQKPGQPPKLLIYWHSTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCAQYYSTPYTFGQGTKVEIK,IGHV5-51 (Human),IGHJ6 (Human),IGKV4-1 (Human),IGKJ1 (Human),AGGGGISTPMDV,AQYYSTPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/eCR3022.19_rank1_imgt_scheme.pdb,"Fangzhu Zhao et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.05.29.443900v1)","Jun 16, 2021","Jun 16, 2021",N/A,Complete
eCR3022.20,Ab,SARS-CoV2;SARS-CoV1,,SARS-CoV2,,S; RBD,Engineered from CR3041,QMQLVQSGTEVKKPGESLKISCKGSGYGFIWYWIGWVRQMPGKGLEWMGIIYPGDGETRYSPSFQGQVTISADKSINTAYLQWSSLKASDTAIYYCAGGGGISTPMDVWGQGTTVTVSS,DIQLTQSPDSLAVSLGERATINCKSSQSVLWSSINKNYLAWYQQKPGQPPKLLIYWASTPESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYKTPYTFGQGTKVEIK,IGHV5-51 (Human),IGHJ6 (Human),IGKV4-1 (Human),IGKJ1 (Human),AGGGGISTPMDV,QQYYKTPYT,Expected,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/eCR3022.20_rank1_imgt_scheme.pdb,"Fangzhu Zhao et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.05.29.443900v1)","Jun 16, 2021","Jun 16, 2021",N/A,Complete
eCR3022.21,Ab,SARS-CoV2;SARS-CoV1,,,,S; RBD,Engineered from CR3042,QMQLVQSGTEVKKPGESLKISCKGSGYGFIYYWIGWVRQMPGKGLEWMGIIYPGDEETRYSPSFQGQVTISADKSINTAYLQWSSLKASDTAIYYCAGGGGISTPMDVWGQGTTVTVSS,DIQLTQSPDSLAVSLGERATINCKSSQSVLRSSINKNYLAWYQQKPGQPPKLLIYWASHRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCGQYYSTPYTFGQGTKVEIK,IGHV5-51 (Human),IGHJ6 (Human),IGKV4-1 (Human),IGKJ1 (Human),AGGGGISTPMDV,GQYYSTPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/eCR3022.21_rank1_imgt_scheme.pdb,"Fangzhu Zhao et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.05.29.443900v1)","Jun 16, 2021","Jun 16, 2021",N/A,Complete
eCR3022.22,Ab,SARS-CoV2;SARS-CoV1,,,,S; RBD,Engineered from CR3043,QMQLVQSGTEVKKPGESLKISCKGSGYGFIYYWIGWVRQMPGKGLEWMGIIYPGDGETRYSPSFQGQVTISADKSINTAYLQWSSLKASDTAIYYCAGGGGISTPMDVWGQGTTVTVSS,DIQLTQSPDSLAVSLGERATINCKSSQSVLWSSINKNYLAWYQQKPGQPPKLLIYWASHRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYKSTPYTFGQGTKVEIK,IGHV5-51 (Human),IGHJ6 (Human),IGKV4-1 (Human),IGKJ1 (Human),AGGGGISTPMDV,QQYKSTPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/eCR3022.22_rank1_imgt_scheme.pdb,"Fangzhu Zhao et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.05.29.443900v1)","Jun 16, 2021","Jun 16, 2021",N/A,Complete
eCR3022.23,Ab,SARS-CoV2;SARS-CoV1,,,,S; RBD,Engineered from CR3044,QMQLVQSGTEVKKPGESLKISCKGSGYGFIYYWIGWVRQMPGKGLEWMGIIYPGDGETRYSPSFQGQVTISADKSINTAYLQWSSLKASDTAIYYCAGGGGISTPMDVWGQGTTVTVSS,DIQLTQSPDSLAVSLGERATINCKSSQSVLYHSINKNYLAWYQQKPGQPPKLLIYWASHRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYHSTPYTFGQGTKVEIK,IGHV5-51 (Human),IGHJ6 (Human),IGKV4-1 (Human),IGKJ1 (Human),AGGGGISTPMDV,QQYHSTPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/eCR3022.23_rank1_imgt_scheme.pdb,"Fangzhu Zhao et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.05.29.443900v1)","Jun 16, 2021","Jun 16, 2021",N/A,Complete
eCR3022.24,Ab,SARS-CoV2;SARS-CoV1,,,,S; RBD,Engineered from CR3045,QMQLVQSGTEVKKPGESLKISCKGSGYGFIFYWIGWVRQMPGKGLEWMGIIYPGDGETRYSPSFQGQVTISADKSINTAYLQWSSLKASDTAIYYCAGGGGISTPMDVWGQGTTVTVSS,DIQLTQSPDSLAVSLGERATINCKSSQSVLWSSINKNYLAWYQQKPGQPPKLLIYWKSTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYHSTPYTFGQGTKVEIK,IGHV5-51 (Human),IGHJ6 (Human),IGKV4-1 (Human),IGKJ1 (Human),AGGGGISTPMDV,QQYHSTPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/eCR3022.24_rank1_imgt_scheme.pdb,"Fangzhu Zhao et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.05.29.443900v1)","Jun 16, 2021","Jun 16, 2021",N/A,Complete
eCR3022.25,Ab,SARS-CoV2;SARS-CoV1,,,,S; RBD,Engineered from CR3046,QMQLVQSGTEVKKPGESLKISCKGSGYGFIYYWIGWVRQMPGKGLEWMGIIYPGDSETRYSPSFQGQVTISADKSINTAYLQWSSLKASDTAIYYCAGGGGISTPMDVWGQGTTVTVSS,DIQLTQSPDSLAVSLGERATINCKSSQSVLWSSINKNYLAWYQQKPGQPPKLLIYWSSTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCEQYYSTPYTFGQGTKVEIK,IGHV5-51 (Human),IGHJ6 (Human),IGKV4-1 (Human),IGKJ1 (Human),AGGGGISTPMDV,EQYYSTPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/eCR3022.25_rank1_imgt_scheme.pdb,"Fangzhu Zhao et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.05.29.443900v1)","Jun 16, 2021","Jun 16, 2021",N/A,Complete
Nb_B6,Nb,SARS-CoV2,,,,N,ND,EVQLQASGGGLVQAGDSLRLSCVAVSGRTISTFAMGWFRQAPGKEREFVATINWSGSSARYADPVEGRFTISRDDAKNTVYLEMSSLKPGDSAVYYCASGRYLGGITSYSQGDFAPWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ6 (Alpaca),N/A,N/A,ASGRYLGGITSYSQGDFAP,N/A,https://www.rcsb.org/structure/7N0S,,PDB (To be published),"Jun 16, 2021","Jun 16, 2021",N/A,Awaiting publication for updated reference
E2,Nb,SARS-CoV2,,,,N,ND,EVQLQASGGGLVQAGGSLRLSCAASGRTDSTQHMAWFRQAPGKEREFVTAIQWRGGGTSYTDSVKGRFTISRDNAKNTVYLEMNSLKPEDTAVYYCATNTRWTYFSPTVPDRYDYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,ATNTRWTYFSPTVPDRYDY,N/A,https://www.rcsb.org/structure/7N0I,,PDB (To be published),"Jun 16, 2021","Jun 16, 2021",N/A,Awaiting publication for updated reference
N12-9,Ab,SARS-CoV2,,SARS-CoV2,,S; NTD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLVKPGGSLRLSCAASEFTFSSYSMNWVRQAPGKGLEWVSSISSSGSQIYYADSVKGRFTISRDNAKKSLYLQMNSLRVEDTAVYYCATNGGAHSSTWSFYGMDVWGQGTTVTVSS,SYELTQPPSVSVSPGQTATITCSGDKLGDKYACWYQQRPGQSPVLVIYQDSKRPSGIPERFSGSNSGNTATLTIGGTQAMDEAAYFCQAWDSNTGVFGGGTKLTVL,IGHV3-21 (Human),IGHJ6 (Human),IGLV3-1 (Human),IGLJ3 (Human),ATNGGAHSSTWSFYGMDV,QAWDSNTGV,https://www.rcsb.org/structure/7E8C;https://www.rcsb.org/structure/7E8F,,"Yunlong Cao et al., 2021 (vhttps://www.nature.com/articles/s41422-021-00514-9)","Jun 16, 2021","Jun 16, 2021",N/A,Variant binding data in publication. Complete
BD-623,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLVQPGGSLRLSCAASGVTVSSNYMSWVRQAPGKGLEWVSAVYSGGSTYYADSVKGRFTISRHNSKNTLYLQMKSLRPEDTAIYYCARLINHYYDSSGDGGAFDIWGQGTMVTVSS,LTQPASVSGSPGQSITISCTGTSSDVGSYNLVSWYQQRPGKAPKLILYEVTKRPSGVSNRFSGSKSGNTASLAISGLQAEDEADYYCCSYAGSSTWVFGGGTKLTVL,IGHV3-66 (Human),IGHJ3 (Human),IGLV2-23 (Human),IGLJ3 (Human),ARLINHYYDSSGDGGAFDI,CSYAGSSTWV,https://www.rcsb.org/structure/7E7Y,,"Yunlong Cao et al., 2021 (vhttps://www.nature.com/articles/s41422-021-00514-9)","Jun 16, 2021","Jun 16, 2021",N/A,Variant binding data in publication. Complete
N12-11,Ab,SARS-CoV2,,SARS-CoV2,,S; NTD,B-cells; SARS-CoV2 Patient,QVQVVQSGAEVKKPGASVKVSCKVSGYTLIEISIHWVRQAPGKGLEWMGGFDPEAGETIYAQKFQGRVTMTEDTSTDTAYMEVSSLRSEDTAVYYCATGPAIAAAETNWFDLWGQGTLVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGSYNYVSWYQQHPGKAPKLMIYDVTKRPSGVPDRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSTWVFGGGTKLTVL,IGHV1-24 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ3 (Human),ATGPAIAAAETNWFDL,SSYTSSSTWV,https://www.rcsb.org/structure/7E7X,,"Yunlong Cao et al., 2021 (vhttps://www.nature.com/articles/s41422-021-00514-9)","Jun 16, 2021","Jun 16, 2021",N/A,Complete
MW05,Ab,SARS-CoV2,,,,S; RBD,ND,EVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGRIIPIFGSSNYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYCAESPLGGGSGYSVSWFDPWGQGTLVTVSS,EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYSNWPPWTFGQGTKVEIK,IGHV1-69 (Human),IGHJ5 (Human),IGKV3-15 (Human),IGKJ1 (Human),AESPLGGGSGYSVSWFDP,QQYSNWPPWT,https://www.rcsb.org/structure/7DK0,,PDB (To be published),"Jun 16, 2021","Jun 16, 2021",N/A,Awaiting publication for updated reference
MW01,Ab,SARS-CoV2,,,,S; RBD,ND,EVQLVQSGAEVKKPGSSVKVSCKASGGTFSSFSISWVRQAPGQGLEWMGRIIPVLGIANYAQEVQGRVTITADKSTSTAYMELSSLRSEDTAVYFCTTDRFVEPATGPFFDYWGQGTLVTVSS,EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYSNWLTFGGGTKVEIK,IGHV1-69 (Human),IGHJ4 (Human),IGKV3-15 (Human),IGKJ4 (Human),TTDRFVEPATGPFFDY,QQYSNWLT,https://www.rcsb.org/structure/7DJZ,,PDB (To be published),"Jun 16, 2021","Jun 16, 2021",N/A,Awaiting publication for updated reference
C2,Nb,SARS-CoV2,,,,N,ND,EVQLQASGGGLVRPGGSLRLSCAASGFTFSSYAMMWVRQAPGKGLEWVSAINGGGGSTSYADSVKGRFTISRDNAKNTLYLQMNSLKPEDTAVYYCAKYQAAVHQEKEDYWGQGTQVTVSS,N/A,IGHV3S1 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AKYQAAVHQEKEDY,N/A,https://www.rcsb.org/structure/7N0R,,PDB (To be published),"Jun 6, 2021","Jun 6, 2021",N/A,Awaiting publication for updated reference
BLN1 ,Ab,SARS-CoV2,,SARS-CoV2,,S; NTD,"Phage Display (antibody, human, immune [SARS-CoV2])",EVQLVQSGAEVKKPGASVKVSCKVSGYTLTELSMHWVRQAPGKGLEWMGGFDPEDAETIYAQKFQGRVTMTEDTSTDTAYMELSSLRSEDTAVYYCVTAPAITGSPEAYSYYYGMDVWGQGTTVTVSS,DIVMTQTPLSSPVTLGQPASISCRSSQSLVHSDGNTYLSWLQQRPGQPPRLLIYKISNRFSGVPDRFSGSGAGTDFTLKISRVEAEDVGVYYCMQATQFPYTFGQGTKLEIK,IGHV1-24 (Human),IGHJ6 (Human),IGKV2-24 (Human),IGKJ2 (Human),VTAPAITGSPEAYSYYYGMDV,MQATQFPYT,,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/BLN1 _rank1_imgt_scheme.pdb,"Tal Noy-Porat et al., 2021 (https://www.sciencedirect.com/science/article/pii/S2589004221004478)","May 27, 2021","May 27, 2021",N/A,Complete
BLN2,Ab,SARS-CoV2,,SARS-CoV2,,S; NTD,"Phage Display (antibody, human, immune [SARS-CoV2])",EVQLVQSGAEVKKPGASVKVSCKVSGYTLTELSMHWVRQAPGKGLEWMGGFDPEDGETIYAQKFQGRVTMTEDTSTDTAYMELSSLRSEDTAVYYCAASPAVRGSPSNFYYYHGMDVWGQGTMVTVSS,QSVVTQPASVSGSPGQSITISCTGSSSDIGGYNYVSWYQQHPGKAPKLMIFEGSKRPSGVPDRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSTLVFGGGTELTVL,IGHV1-24 (Human),IGHJ6 (Human),IGLV2-14 (Human),IGLJ2 (Human),AASPAVRGSPSNFYYYHGMDV,SSYTSSSTLV,,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/BLN2_rank1_imgt_scheme.pdb,"Tal Noy-Porat et al., 2021 (https://www.sciencedirect.com/science/article/pii/S2589004221004478)","May 27, 2021","May 27, 2021",N/A,Complete
BLN3,Ab,SARS-CoV2,,SARS-CoV2,,S; NTD,"Phage Display (antibody, human, immune [SARS-CoV2])",QVQLQQSGAEVKKPGASVRVSCKVSGYTLTELSMHWVRQAPGKGLEWMGGFDPEDAETIYAQKFQGRVTMTEDTSTDRAYMELSSLRSEDTAVYYCVAAPVITGSPEAYSYYYGMDVWGQGTTVTVSS,SQSALTQPGSLSGSPGQSITISCTGTSSDVGSYNLVSWYQQHPGQTPKVIIYEVTNRASGVSNRCSGSQSGNTATLTISRLLADDQADDYCSSYTRTSTLDVVFGGRTELTVL,IGHV1-24 (Human),IGHJ6 (Human),IGLV2-14 (Human),IGLJ2 (Human),VAAPVITGSPEAYSYYYGMDV,SSYTRTSTLDVV,,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/BLN3_rank1_imgt_scheme.pdb,"Tal Noy-Porat et al., 2021 (https://www.sciencedirect.com/science/article/pii/S2589004221004478)","May 27, 2021","May 27, 2021",N/A,Complete
BLN4,Ab,SARS-CoV2,,SARS-CoV2,,S; NTD,"Phage Display (antibody, human, immune [SARS-CoV2])",QLQLQESGPGLVKPSQTLSLTCTVSGGSISSGSYYWSWIRQPAGKGLEWIGRIYTTGSTSYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARMAYQVYYYDSSGYYDAFDIWGQGTMVTVSS,NILTQPPSASGTPGQRVTISCSGSSSNIGSNTVN WYQQLPGTAPKLLIYSKNQRPSGVPDRFSGSKSGTSASLAISGLRSEDEADYYCSAWDDSLRGYVFGPGTKVTVL,IGHV4-30 (Human),IGHJ3 (Human),IGLV1-44 (Human),IGLJ1 (Human),ARMAYQVYYYDSSGYYDAFDI,SAWDDSLRGYV,,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/BLN4_rank1_imgt_scheme.pdb,"Tal Noy-Porat et al., 2021 (https://www.sciencedirect.com/science/article/pii/S2589004221004478)","May 27, 2021","May 27, 2021",N/A,Complete
BLN6,Ab,SARS-CoV2,,SARS-CoV2,,S; NTD,"Phage Display (antibody, human, immune [SARS-CoV2])",QVQLQESGPGLVKPSQTLSLTCTVSGGSISSGSYYWSWIRQPAGKGLEWIGRIYTTGSTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARMAYQVYYYDSSGYYDAFDIWGQGTMVTVSS,QSALTQPASASGSPGQSVTISCTGSSSDVGGYNFVSWYQQHPGKAPKLIIYEVSKRPSGVPNRFSGSKSGNTASLTVSGLQADDEALYYCSSYAGSNNYVFGPGTKVTVL ,IGHV4-61 (Human),IGHJ3 (Human),IGLV2-8 (Human),IGLJ1 (Human),ARMAYQVYYYDSSGYYDAFDI,SSYAGSNNYV,,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/BLN6_rank1_imgt_scheme.pdb,"Tal Noy-Porat et al., 2021 (https://www.sciencedirect.com/science/article/pii/S2589004221004478)","May 27, 2021","May 27, 2021",N/A,Complete
BLN7,Ab,SARS-CoV2,,SARS-CoV2,,S; NTD,"Phage Display (antibody, human, immune [SARS-CoV2])",EVQLVQSGAEVKKPGASVKVSCKVSGYTLPELSMHWVRQAPGKGLEWMGGFDPEDGGTIYAQKFQGRVTMTEDTSTDTAYMELSSLRSEDTAVYYCATSRVAGTPNWFHPWGQGTLVTVSS ,QSVLTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVPDRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSTLVFGTGTKVTVL,IGHV1-24 (Human),IGHJ5 (Human),IGLV2-14 (Human),IGLJ1 (Human),ATSRVAGTPNWFHP,SSYTSSSTLV,,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/BLN7_rank1_imgt_scheme.pdb,"Tal Noy-Porat et al., 2021 (https://www.sciencedirect.com/science/article/pii/S2589004221004478)","May 27, 2021","May 27, 2021",N/A,Complete
BLN8,Ab,SARS-CoV2,,SARS-CoV2,,S; NTD,"Phage Display (antibody, human, immune [SARS-CoV2])",EVQLLESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLQWVALISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLGSGWYPWGQGTLVTVSS ,NFMLTQPPSVSVSPGQTASITCSGDKLGDKYASWYQQKPGQSPVLVIYQDSKRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCQAWDSSTVVFGGGTELTVL,IGHV3-30 (Human),IGHJ5 (Human),IGLV3-1 (Human),IGLJ2 (Human),ARDLGSGWYP,QAWDSSTVV,,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/BLN8_rank1_imgt_scheme.pdb,"Tal Noy-Porat et al., 2021 (https://www.sciencedirect.com/science/article/pii/S2589004221004478)","May 27, 2021","May 27, 2021",N/A,Complete
BLN9,Ab,SARS-CoV2,,SARS-CoV2,,S; NTD,"Phage Display (antibody, human, immune [SARS-CoV2])",QVQLVQSGAGVKKPGASVKVSCKVSGYTLPELSMHWVRQAPGKGLEWMGGFDPEDGETIYAQKFQGRVTMTEDTSTDTAYMELSSLRSEDTAVYYCATSRVAGTPNWFHPWGQGTLVTVSS,QSALTQPVSVSGSPGQSITISCTGTSSDVGRYNYVSWYQQHPGKAPKLIIYDVKNRPSGVPDRFSGSKSGNTASLTISGLQAEDEADYYCSSYTRSSTLDVVFGGGTELTVL,IGHV1-24 (Human),IGHJ5 (Human),IGLV2-14 (Human),IGLJ2 (Human),ATSRVAGTPNWFHP,SSYTRSSTLDVV,,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/BLN9_rank1_imgt_scheme.pdb,"Tal Noy-Porat et al., 2021 (https://www.sciencedirect.com/science/article/pii/S2589004221004478)","May 27, 2021","May 27, 2021",N/A,Complete
BLN10,Ab,SARS-CoV2,,SARS-CoV2,,S; NTD,"Phage Display (antibody, human, immune [SARS-CoV2])",QVQLVQSGAEVKKPGASVKVSCKVSGYTLPELSMHWVRQAPGKGLEWMGGFDPEDGETIYAQKFQGRVTMTEDTSTDTAYMELSSLRSEDTAVYYCATGPAIAAAATGWFDPWGQGTLVTVSS,SYELIQEPSVSVSPGQTARITCQGDSLRSYYASWYQQKPGQAPVLVIYNRNKRPSGIPDRFSGSSSGNTASLTITGAQADDEADYYCNSRDNSGNHPFGGGTKVTVL ,IGHV1-24 (Human),IGHJ5 (Human),IGLV3-19 (Human),IGLJ2 (Human),ATGPAIAAAATGWFDP,NSRDNSGNHP,,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/BLN10_rank1_imgt_scheme.pdb,"Tal Noy-Porat et al., 2021 (https://www.sciencedirect.com/science/article/pii/S2589004221004478)","May 27, 2021","May 27, 2021",N/A,Complete
BLN12,Ab,SARS-CoV2,,SARS-CoV2,,S; NTD,"Phage Display (antibody, human, immune [SARS-CoV2])",QVQLQQSGAEVKKPGASVKVSCKVSGYTLTELSMHWVRQAPGKGLEWMGGFDPEDAETIYAQKFQGRVTMTEDTSTDTAYMELSSLRSEDTAVYYCVTAPVITGSPEAYSYYYGMDVWGQGTTVNVSS ,DIVMTQSPLSSPVTLGQPASISCRSSQSLVHSDGNTYLSWLQQRPGQPPRLLIYKISNRFSGVPDRFSGSGATDFTLKISRVEAEDVGVYYCMQATQFPITFGGGTKVEIK,IGHV1-24 (Human),IGHJ6 (Human),IGKV2-24 (Human),IGKJ4 (Human),VTAPVITGSPEAYSYYYGMDV,MQATQFPIT,,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/BLN12_rank1_imgt_scheme.pdb,"Tal Noy-Porat et al., 2021 (https://www.sciencedirect.com/science/article/pii/S2589004221004478)","May 27, 2021","May 27, 2021",N/A,Complete
BLN14,Ab,SARS-CoV2,,SARS-CoV2,,S; NTD,"Phage Display (antibody, human, immune [SARS-CoV2])",QMQLVQSWGRRGPAGRSLRLSCAASGSTFSSYGMHWVRQAPGKGLEWVAVISFDGSNKFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDHDDGYYFYYYMDVWGKGTTVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSRTFGGGTRLEIK,IGHV3-30 (Human),IGHJ6 (Human),IGKV3-20 (Human),IGKJ5 (Human),AKDHDDGYYFYYYMDV,QQYGSSRT,,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/BLN14_rank1_imgt_scheme.pdb,"Tal Noy-Porat et al., 2021 (https://www.sciencedirect.com/science/article/pii/S2589004221004478)","May 27, 2021","May 27, 2021",N/A,Complete
Asarnow_3D11,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,"Phage Display (antibody, human, non-immune)",QVQLQQWGAGLLKPSETLSLTCAVYGGSFSGYYWSWIRQPPGKGLEWIGEINHSGSTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARRWWLRGAFDIWGQGTTVTVSS,NFMLTQPHSVSASPGKTVTIPCTGSSGNIASNYVQWYQQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDNNIQVFGGGTKLTVL,IGHV4-34 (Human),IGHJ3 (Human),IGLV6-57 (Human),IGLJ3 (Human),ARRWWLRGAFDI,QSYDNNIQV,https://www.rcsb.org/structure/7M7B;https://www.rcsb.org/structure/7KQE,,"Daniel Asarnow et al., 2021 (https://www.cell.com/cell/fulltext/S0092-8674(21)00536-5)","May 27, 2021","May 27, 2021",N/A,Complete
Asarnow_5A6,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,"Phage Display (antibody, human, non-immune)",QVQLQESGGGLVQPGGSLRLSCAASGFTFSSYEMNWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARLITMVRGEDYWGQGTLVTVSS,DIQLTQSPSSLSASVGHRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYNLPRTFGGGTKLEVL,IGHV3-30 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ4 (Human),ARLITMVRGEDY,QQSYNLPRT,https://www.rcsb.org/structure/7KQB;https://www.rcsb.org/structure/7M71,,"Daniel Asarnow et al., 2021 (https://www.cell.com/cell/fulltext/S0092-8674(21)00536-5)","May 27, 2021","May 27, 2021",N/A,Complete
CM29,Ab,SARS-CoV2,,,SARS-CoV2,S; S2,B-cells; SARS-CoV2 Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTLSKYGMHWVRQAPDKGLEWVALMSYDGSIKYYGDSVKGRFTVSRDSSKNTLYLQMNNLRDDDTAVYFCARGAMAGNSSFDHWGQGTLVTVSS,DIVMTQSPLSLPVTLGQPASISCRSSQSLVYSDGNTYLNWFHQRPGQSPRRLIYKVSNRDSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQGTHWPPTFGGGTKVEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV2-30 (Human),IGKJ4 (Human),ARGAMAGNSSFDH,MQGTHWPPT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CM29_rank1_imgt_scheme.pdb,"William Voss et al., 2021 (https://science.sciencemag.org/content/early/2021/05/03/science.abg5268)","May 27, 2021","May 27, 2021",N/A,Complete
CM30,Ab,SARS-CoV2,,SARS-CoV2,,S; NTD,B-cells; SARS-CoV2 Patient,QVQLVESGGGLVKPGGSLRLSCAASGFTFSDYYMSWIRQAPGKGLEWVSSIDGSTSYTKYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARVGPAVAGSPFDSWGQGTLVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSTYLAWYQQKPGQAPRLLIFDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWLFSFGPGTKVDIK,IGHV3-11 (Human),IGHJ5 (Human),IGKV3-11 (Human),IGKJ3 (Human),ARVGPAVAGSPFDS,QQRSNWLFS,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CM30_rank1_imgt_scheme.pdb,"William Voss et al., 2021 (https://science.sciencemag.org/content/early/2021/05/03/science.abg5268)","May 27, 2021","May 27, 2021",N/A,Complete
CM31,Ab,SARS-CoV2,,,SARS-CoV2,S; NTD,B-cells; SARS-CoV2 Patient,QVTLKESGPTLVKPTQTLTLTCTVSGFSLSTNGVGVAWVRQPPGKALEWLGLIYWDDAQRYGPSLKSRLTITKDTSKNQVVLTLTNMDPVDTGTYYCSHVWVNSTHRQIDYWGQGTLVTVSS,QPVLTQPPSSSASPGESARLTCTLPSDFNVGSYNIYWYQKRPGSPPRYLLYYYSDSDKGQGSGVPSRFSGSKDASANTGILLISGLQSEDEADYYCMIWPINGVVFGGGTKLTVL,IGHV2-5 (Human),IGHJ4 (Human),IGLV5-37 (Human),IGLJ3 (Human),SHVWVNSTHRQIDY,MIWPINGVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CM31_rank1_imgt_scheme.pdb,"William Voss et al., 2021 (https://science.sciencemag.org/content/early/2021/05/03/science.abg5268)","May 27, 2021","May 27, 2021",N/A,Complete
CM32,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVQSGPEVKKPGASVKVSCQTSGYSFSDHYLHWVRQTPGQGFEWMGWIKPKSGATNSADNFQDRVTMTADASVNTAYMELSSLRPDDTAVYYCARGHRIPSAISDKYDFWGQGTLVTVSS,QSVLTQPASVSASPGQSITISCTGTSSDVGGYDYVSWYQHHPDNAPKLLIFEVSNRPSGVSNRFSGSKSGNAASLTISGLLAEDEADYFCTSYSSGRTPYVFGTGTKVTVL,IGHV1-2 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ1 (Human),ARGHRIPSAISDKYDF,TSYSSGRTPYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CM32_rank1_imgt_scheme.pdb,"William Voss et al., 2021 (https://science.sciencemag.org/content/early/2021/05/03/science.abg5268)","May 27, 2021","May 27, 2021",N/A,Complete
P22A-1D1,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDRDYYGMDVWGQGTTVTVSS,DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCLHLNSYRTFGLGTKVEIK,IGHV3-53 (Human),IGHJ6 (Human),IGKV1-9 (Human),IGKJ1 (Human),ARDRDYYGMDV,LHLNSYRT,https://www.rcsb.org/structure/7CHS,,"Qi Zhang et al., 2021 (https://www.nature.com/articles/s41467-021-24514-w)","May 27, 2021","Jul 24, 2021",24th July '21: Added reference,Complete
P5A-3C8,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSFIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLQEHGMDVWGQGTTVTVSS,DIQLTQSPSSLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQHLNSYPPGYTFGQGTKLEIK,IGHV3-53 (Human),IGHJ6 (Human),IGKV1-9 (Human),IGKJ2 (Human),ARDLQEHGMDV,QHLNSYPPGYT,https://www.rcsb.org/structure/7CHP,,"Qi Zhang et al., 2021 (https://www.nature.com/articles/s41467-021-24514-w)","May 27, 2021","Jul 24, 2021",24th July '21: Added reference,Complete
P5A-1D2,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLIQPGGSLRLSCAASGFIVSSNYMSWVRQAPGKGLEWVSIIYSGGSTYYADSVKGRFTISRDNSNNTLYLQMNSLRAEDTAVYYCARALQVGATSDYFDYWGQGTLVTVSS,QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWYQQLPGTAPKLLIYGNSNRPSGVPDRFSGSKSGTSASLAITGLQAEDETDYYCQSCDSSLSVVVFGGGTKLTVL,IGHV3-53 (Human),IGHJ4 (Human),IGLV1-40 (Human),IGLJ3 (Human),ARALQVGATSDYFDY,QSCDSSLSVVV,https://www.rcsb.org/structure/7CHO,,"Qi Zhang et al., 2021 (https://www.nature.com/articles/s41467-021-24514-w)","May 27, 2021","Jul 24, 2021",24th July '21: Added reference,Complete
54042-3,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; Unk,B-cells; SARS-CoV2 Patient,ND,ND,IGHV3-53 (Human),ND,IGLV1-40 (Human),ND,ARVHFRYYDDSGYYEANPWFFDL,QSYDSSLSAW,ND,,"Kevin Kramer et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.05.16.444004v1)","May 17, 2021","May 17, 2021",N/A,Awaiting publication for full sequences
54042-4,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV2-5 (Human),ND,IGKV1-39 (Human),ND,AHGLFSSSDWGGLDV,QQSHSTPFI,Expected,,"Kevin Kramer et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.05.16.444004v1)","May 17, 2021","May 17, 2021",N/A,Awaiting publication for full sequences
54042-5,Ab,SARS-CoV2,,SARS-CoV2,,S; Unk,B-cells; SARS-CoV2 Patient,ND,ND,IGHV2-70 (Human),ND,IGLV1-51 (Human),ND,ARVRLGGFDYYMDV,GTWDNNLNTGV,ND,,"Kevin Kramer et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.05.16.444004v1)","May 17, 2021","May 17, 2021",N/A,Awaiting publication for full sequences
54042-7,Ab,SARS-CoV2,,,,S; Unk,B-cells; SARS-CoV2 Patient,ND,ND,IGHV3-9 (Human),ND,IGLV1-51 (Human),ND,VRGFREFLKTSGPNDY,GTWDGSLSVYV,ND,,"Kevin Kramer et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.05.16.444004v1)","May 17, 2021","May 17, 2021",N/A,Awaiting publication for full sequences
54042-10,Ab,SARS-CoV2,,SARS-CoV2,,S; Unk,B-cells; SARS-CoV2 Patient,ND,ND,IGHV3-53 (Human),ND,IGKV1-9 (Human),ND,ARDLNVRGGLDV,QQLNSDPALT,ND,,"Kevin Kramer et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.05.16.444004v1)","May 17, 2021","May 17, 2021",N/A,Awaiting publication for full sequences
54042-11,Ab,SARS-CoV2,,SARS-CoV2,,S; Unk,B-cells; SARS-CoV2 Patient,ND,ND,IGHV3-53 (Human),ND,IGKV1-9 (Human),ND,ARDLVYYGMDV,QQVDSYSPFT,ND,,"Kevin Kramer et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.05.16.444004v1)","May 17, 2021","May 17, 2021",N/A,Awaiting publication for full sequences
54042-14,Ab,SARS-CoV2,,,,S; Unk,B-cells; SARS-CoV2 Patient,ND,ND,IGHV3-33 (Human),ND,IGKV3-11 (Human),ND,AKDTWDVPAANPPYSFYYMDV,QQRSTLIT,ND,,"Kevin Kramer et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.05.16.444004v1)","May 17, 2021","May 17, 2021",N/A,Awaiting publication for full sequences
54042-15,Ab,SARS-CoV2,,,,S; Unk,B-cells; SARS-CoV2 Patient,ND,ND,IGHV3-9 (Human),ND,IGKV3-11 (Human),ND,AKDRLKTGPGYFDL,QQRSDWLT,ND,,"Kevin Kramer et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.05.16.444004v1)","May 17, 2021","May 17, 2021",N/A,Awaiting publication for full sequences
J04,Ab,SARS-CoV2,SARS-CoV1;MERS-CoV,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYTISWVRQAPGQGLEWMGRIIPILDRVMYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCARRAIDSDTYVEQSHFDYWGQGTLVTVSS,EIVMTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPSLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQPLTFGGGTKVEIK,IGHV1-69 (Human),IGHJ4 (Human),IGKV3-11 (Human),IGKJ4 (Human),ARRAIDSDTYVEQSHFDY,QQPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/J04_rank1_imgt_scheme.pdb,"Emanuele Adreano et al., 2021 (https://www.sciencedirect.com/science/article/pii/S0092867421002245)","May 17, 2021","May 17, 2021",N/A,Complete
I14,Ab,SARS-CoV2,SARS-CoV1;MERS-CoV,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVQSGPEVKKPGTSVKVSCKASGFTFTSSAMQWVRQARGQRLEWIGWIVVGSGNTDYVQKFQGRVTITRDMSTSTAYMELSSLRSEDTAVYYCAAPYCSSTTCHDGFDIWGQGTMVTVSS,EIVMTQSPGTLSLAPGERATLSCRASQSVSSSYLGWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGRSPWTFGQGTKVEIK,IGHV1-58 (Human),IGHJ3 (Human),IGKV3-20 (Human),IGKJ1 (Human),AAPYCSSTTCHDGFDI,QQYGRSPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/I14_rank1_imgt_scheme.pdb,"Emanuele Adreano et al., 2021 (https://www.sciencedirect.com/science/article/pii/S0092867421002245)","May 17, 2021","May 17, 2021",N/A,Complete
F05,Ab,SARS-CoV2,SARS-CoV1;MERS-CoV,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTVSINYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAAPLLWADSYYMDVWGKGTTVTVSS,AIQMTQSPSSLSASVGDRVTITCRASQDIRNNLGWFQQKPGKAPKRLIYAASTLQRGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCLQHNSYLWTFGQGTKVEIK,IGHV3-66 (Human),IGHJ6 (Human),IGKV1-17 (Human),IGKJ1 (Human),AAPLLWADSYYMDV,LQHNSYLWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/F05_rank1_imgt_scheme.pdb,"Emanuele Adreano et al., 2021 (https://www.sciencedirect.com/science/article/pii/S0092867421002245)","May 17, 2021","May 17, 2021",N/A,Complete
G12,Ab,SARS-CoV2,SARS-CoV1;MERS-CoV,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVQSGAEVKKPGPSVKVSCKASGGTFSSYTINWVRQAPGQGLEWMGRIIPMLGIAKYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCARGIVGATPGYFDYWGQGTLVTVSS,DIVMTQSPAALSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSWSGTEFTLTISSLQSEDLAVYYCQQYNNWLTFGGGTKVEIK,IGHV1-69 (Human),IGHJ4 (Human),IGKV3-15 (Human),IGKJ4 (Human),ARGIVGATPGYFDY,QQYNNWLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/G12_rank1_imgt_scheme.pdb,"Emanuele Adreano et al., 2021 (https://www.sciencedirect.com/science/article/pii/S0092867421002245)","May 17, 2021","May 17, 2021",N/A,Complete
C14,Ab,SARS-CoV2,SARS-CoV1;MERS-CoV,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLVQPGGSLRLSCAASGLTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKDRFTISRDNSKNTLYLQMNSLRAEDTAVYYCVRDLYSYGMDVWGQGTTVTVSS,AIQMTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQVNSYPTFGQGTRLEIK,IGHV3-66 (Human),IGHJ6 (Human),IGKV1-9 (Human),IGKJ5 (Human),VRDLYSYGMDV,QQVNSYPT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C14_rank1_imgt_scheme.pdb,"Emanuele Adreano et al., 2021 (https://www.sciencedirect.com/science/article/pii/S0092867421002245)","May 17, 2021","May 17, 2021",N/A,Complete
B07,Ab,SARS-CoV2,SARS-CoV1;MERS-CoV,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVQSGAEVKKPGASVKVSCKASGFTFTNYYIHWVRQAPGQGLEWMGIINPSGGSTIYAQKFQGRVTMTRDTSTRTVYMELSSLRSEDTAVYYCADLLLDYWGQGTLVTVSS,AIQMTQSPSSLSASVGDRVTITCRASQGINNYLAWFQQKPGKAPKSLIYAASSLQSGVPSKFSGSGSGTDFTLTISSLQPEDFATYYCQQYNSYPFTFGQGTRLEIK,IGHV1-46 (Human),IGHJ4 (Human),IGKV1-16 (Human),IGKJ5 (Human),ADLLLDY,QQYNSYPFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/B07_rank1_imgt_scheme.pdb,"Emanuele Adreano et al., 2021 (https://www.sciencedirect.com/science/article/pii/S0092867421002245)","May 17, 2021","May 17, 2021",N/A,Complete
I21,Ab,SARS-CoV2,SARS-CoV1;MERS-CoV,,SARS-CoV2,S; S1 non-RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLSLQMNSLRAADTAVYYCATGTYDFWSDNHYLDYWGQGTLVTVSS,AIQMTQSPSFLSASVGDRVTITCRASQGISSSLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPSTTFGGGTKVEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV1-9 (Human),IGKJ4 (Human),ATGTYDFWSDNHYLDY,QQLNSYPSTT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/I21_rank1_imgt_scheme.pdb,"Emanuele Adreano et al., 2021 (https://www.sciencedirect.com/science/article/pii/S0092867421002245)","May 17, 2021","May 17, 2021",N/A,Complete
J13,Ab,SARS-CoV2,SARS-CoV1;MERS-CoV,SARS-CoV2,,S; S1 non-RBD,B-cells; SARS-CoV2 Patient,QVQLQESGAEVKKPGSSVKVSCKASGGTFSSYAINWVRQAPGQGLEWMGGLIPIFGTANYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYCANFIGDGYNYEEDYMDVWGKGTTVTVSS,EIVMTQSPATLSLSPGERATLSCRASQSVSSFLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPPFTFGPGTKVDIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV3-11 (Human),IGKJ3 (Human),ANFIGDGYNYEEDYMDV,QQRSNWPPFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/J13_rank1_imgt_scheme.pdb,"Emanuele Adreano et al., 2021 (https://www.sciencedirect.com/science/article/pii/S0092867421002245)","May 17, 2021","May 17, 2021",N/A,Complete
D14,Ab,SARS-CoV2,SARS-CoV1;MERS-CoV,SARS-CoV2,,S; S1 non-RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGVVQPGKSLRLSCADSGFTFSSYAMHWVRQAPGKGLEWVAVISFDGSKKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAREGQWLNWAFDYWGQGTLVTVSS,AIQMTQSPSSLSASVGDRVTITCRAGQSISSYLNWYQQKPGKAPKLLIYLASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPTWTFGQGTKVEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ1 (Human),AREGQWLNWAFDY,QQSYSTPTWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/D14_rank1_imgt_scheme.pdb,"Emanuele Adreano et al., 2021 (https://www.sciencedirect.com/science/article/pii/S0092867421002245)","May 17, 2021","May 17, 2021",N/A,Complete
H20,Ab,SARS-CoV2,SARS-CoV1;MERS-CoV,SARS-CoV2,,S; non-RBD,B-cells; SARS-CoV2 Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGITPIFHTANYAQKFQGRVTITADESTSTVYMELSSLSSEDTAVYYCARETGDQGVTAPFDLWGRGTLVTVSS,EIVMTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQLRGNWPPWTFGQGTKVEIK,IGHV1-69 (Human),IGHJ2 (Human),IGKV3-11 (Human),IGKJ1 (Human),ARETGDQGVTAPFDL,QLRGNWPPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H20_rank1_imgt_scheme.pdb,"Emanuele Adreano et al., 2021 (https://www.sciencedirect.com/science/article/pii/S0092867421002245)","May 17, 2021","May 17, 2021",N/A,Complete
I15,Ab,SARS-CoV2,SARS-CoV1;MERS-CoV,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Patient,QVQLVQSGAEVKKPGASAKVSCKVSGYTLTELSMHWVRQAPGKGLEWMGGFDPEDGETIYAQRFQGRVTMTEDASTDTAYMELSSLRSEDTAVYYCTTVGFPDYYDSSVYLRHFDYWGQGTLVTVSS,AIQMTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPRTFGQGTKLEIK,IGHV1-24 (Human),IGHJ4 (Human),IGKV1-9 (Human),IGKJ2 (Human),TTVGFPDYYDSSVYLRHFDY,QQLNSYPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/I15_rank1_imgt_scheme.pdb,"Emanuele Adreano et al., 2021 (https://www.sciencedirect.com/science/article/pii/S0092867421002245)","May 17, 2021","May 17, 2021",N/A,Complete
F10,Ab,SARS-CoV2,SARS-CoV1;MERS-CoV,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Patient,QVQLVQSGAEVKKPGASVKVSCKVSGYTLTELSMHWVRQTPGKGLEWMGGFDPADAETIYAQKLQGRVTMTEDTSTDTAYMELSSLRSEDTAVYYCATALPITMVRGVQYYYYGMDVWGPGTTVTVSS,DIVMTQTPLSSPVTLGQPASISCRSSQSLVHSDGNTYLSWLQQRPGQPPRLLIYKISNRFSGVPDRFSGSGAGTDFTLKISRVEAEDVGIYYCMQVTQFPYTFGQGTKLEIK,IGHV1-24 (Human),IGHJ6 (Human),IGKV2-24 (Human),IGKJ2 (Human),ATALPITMVRGVQYYYYGMDV,MQVTQFPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/F10_rank1_imgt_scheme.pdb,"Emanuele Adreano et al., 2021 (https://www.sciencedirect.com/science/article/pii/S0092867421002245)","May 17, 2021","May 17, 2021",N/A,Complete
F20,Ab,SARS-CoV2,SARS-CoV1;MERS-CoV,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Patient,QVQLVQSGAEVKKPGASVKVSCKVSGYSLIELSMHWVRQAPGKGLEWMGGFDPEDVETIYAQNLQGRVTMTEDTSTDTAYMELSSLRSEDTAVYYCATFFAVRGALNWFDSWGQGTLVTVSS,EIVLTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGLPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNWPPLTFGQGTKLEIK,IGHV1-24 (Human),IGHJ5 (Human),IGKV3-15 (Human),IGKJ2 (Human),ATFFAVRGALNWFDS,QQYNNWPPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/F20_rank1_imgt_scheme.pdb,"Emanuele Adreano et al., 2021 (https://www.sciencedirect.com/science/article/pii/S0092867421002245)","May 17, 2021","May 17, 2021",N/A,Complete
L19,Ab,SARS-CoV2,SARS-CoV1;MERS-CoV,SARS-CoV2 (weak),,S; S2,B-cells; SARS-CoV2 Patient,EVQLVESGGGLVKPGGSLRLFCAASGFTFSDYYMSWFRQAPGKGLEWVSYISSSGSNIYYADSVKGRFTVSRDNAKNSLYLQMNSLRAEDTAVYFCARGRLWGWFDPWGQGTLVTVSS,DIVMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLQTGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDHLLITFGQGTRLEIK,IGHV3-11 (Human),IGHJ5 (Human),IGKV1-33 (Human),IGKJ5 (Human),ARGRLWGWFDP,QQYDHLLIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/L19_rank1_imgt_scheme.pdb,"Emanuele Adreano et al., 2021 (https://www.sciencedirect.com/science/article/pii/S0092867421002245)","May 17, 2021","May 17, 2021",N/A,Complete
S2P6,Ab,SARS-CoV2;SARS-CoV1;MERS-CoV;OC43;HKU1,229E;NL63,SARS-CoV2,,S; S2 Stem Helix,B-cells; SARS-CoV2 Patient,EVQLVQSGAEVKKPGASVKVSCKASGYTFTSQYMHWVRQAPGQGLEWIGIINPSGVHTSYAQKFQGRVTLTRDTSTSTLYMELSSLRSEDTAVYYCARGSPKGAFDYWGQGTLVTVSS,EIVMMQSPGTLSLSPGERATLSCRASQSVRSNYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPPRFTFGPGTKVEIK,IGHV1-46 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ3 (Human),ARGSPKGAFDY,QQYGSSPPRFT,Expected,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/S2P6_rank1_imgt_scheme.pdb,"Dora Pinto et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.05.09.442808v1)","May 15, 2021","May 15, 2021",N/A,Antibody mutant data (e.g. germline reversion) in publication. Viral variant data also in publication. Complete
S2S43,Ab,SARS-CoV2;SARS-CoV1;MERS-CoV;OC43;HKU1,229E;NL63,,,S; S2 Stem Helix,B-cells; SARS-CoV2 Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYYMHWVRQAPGQGLEWMGIINPSGGSTSYAQKFQGRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARGGSHGMDVWGQGTTVTVSS,QSVLTQPPSVSAAPGQKVTISCSGSSSNIGNNYVSWYQQLPGTAPKLLIYENNKRPSGIPDRFSGSKSGTSATLGITGLQTGDEADYYCGTWDSSLSACVFGTGTKVTVL,IGHV1-46 (Human),IGHJ6 (Human),IGLV1-51 (Human),IGLJ1 (Human),ARGGSHGMDV,GTWDSSLSACV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/S2S43_rank1_imgt_scheme.pdb,"Dora Pinto et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.05.09.442808v1)","May 15, 2021","May 15, 2021",N/A,Viral variant data also in publication. Complete
P34D10,Ab,SARS-CoV2;SARS-CoV1;MERS-CoV;OC43;HKU1,229E;NL63,,,S; S2 Stem Helix,B-cells; SARS-CoV2 Patient,EVQLVQSGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAAISYHGTHPYYVDSVKGRFTISRDNSKNTLYLQMGSLGPDDTAVYYCAKDLVLRYFDSMDVWGQGTTVTVSS,QSALTQPASVSGSPGQSITISCTGTSSGVGSHDLVSWYQQHPGKAPKLMIYEVTRRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYHCCSYAGTGNSWVFGGGTKLTVL,IGHV3-30 (Human),IGHJ6 (Human),IGLV2-23 (Human),IGLJ3 (Human),AKDLVLRYFDSMDV,CSYAGTGNSWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P34D10_rank1_imgt_scheme.pdb,"Dora Pinto et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.05.09.442808v1)","May 15, 2021","May 15, 2021",N/A,Viral variant data also in publication. Complete
P34G12,Ab,SARS-CoV2;SARS-CoV1;MERS-CoV;OC43;HKU1,229E;NL63,,,S; S2 Stem Helix,B-cells; SARS-CoV2 Patient,EVQLVESGGGVVQPGRSLRLTCVASGFNFSSHGMHWVRQAPGKGLEWVAAISFHGTHPYYVDSVKGRFTISRDNSKNTLYLQMDSLGPDDTAIYYCAKDVVLRYFDAMDVWGQGTTVTISS,QAALTQPASVSGSPGQSITISCTGASGTGVGSHNLVSWYQQHPGKAPKLIIYEVTKRPSGVSTRFSGSKSGNTASLTISGLQADDEADYHCCSYAGTGNSWVFGGGTKLTVL,IGHV3-30 (Human),IGHJ6 (Human),IGLV2-23 (Human),IGLJ3 (Human),AKDVVLRYFDAMDV,CSYAGTGNSWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P34G12_rank1_imgt_scheme.pdb,"Dora Pinto et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.05.09.442808v1)","May 15, 2021","May 15, 2021",N/A,Viral variant data also in publication. Complete
P34E3,Ab,SARS-CoV2;SARS-CoV1;MERS-CoV;OC43;HKU1,229E;NL63,,,S; S2 Stem Helix,B-cells; SARS-CoV2 Patient,EVQLVESGGGVVQPGRSLRLSCVASGFSFSSYGMHWVRQAPGKGLEWVAAISFHGTHPFYGDSVKGRFTISRDNSKSTLFLDMGSLGTDDTAVYYCAKDVVLRYFDAMDVWGQGSTVTVSS,QAGQTQPASVSGSPGQSITISCTGASSGVGSHNLVSWYQQHPGKAPKLIIYEVTKRPSGVSDRFSGSKSGNTASLTISGLQAEDEADYHCCSYAGTGNSWVFGGGTKLTVL,IGHV3-30 (Human),IGHJ6 (Human),IGLV2-23 (Human),IGLJ3 (Human),AKDVVLRYFDAMDV,CSYAGTGNSWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P34E3_rank1_imgt_scheme.pdb,"Dora Pinto et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.05.09.442808v1)","May 15, 2021","May 15, 2021",N/A,Viral variant data also in publication. Complete
CV2-75,Ab,SARS-CoV2;SARS-CoV1,229E;NL63,SARS-CoV2;SARS-CoV1,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLQESGPGLVKPSETLSLTCTVSGGSISSYYWSWIRQPPGKGLEWIGYVYYSGSTNYNPSLKSRVTISVDTSKNEFSLKLSSVTAADTAVYYCASSQRPDGNLYYFDYWGQGTLVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNIGSKTVHWYQQKPGQAPVLVVYDDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDSSSDHYVFGTGTKVTVL,IGHV4-59 (Human),IGHJ4 (Human),IGLV3-21 (Human),IGLJ1 (Human),ASSQRPDGNLYYFDY,QVWDSSSDHYV,https://www.rcsb.org/structure/7M3I,,"Madeleine Jennewein et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.23.436684v1)","May 15, 2021","May 15, 2021",N/A,Variant binding data in publication. Complete
LY-CoV1404,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QITLKESGPTLVKPTQTLTLTCTFSGFSLSISGVGVGWLRQPPGKALEWLALIYWDDDKRYSPSLKSRLTISKDTSKNQVVLKMTNIDPVDTATYYCAHHSISTIFDHWGQGTLVTVSS,QSALTQPASVSGSPGQSITISCTATSSDVGDYNYVSWYQQHPGKAPKLMIFEVSDRPSGISNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTTSSAVFGGGTKLTVL,IGHV2-5 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ3 (Human),AHHSISTIFDH,SSYTTSSAV,https://www.rcsb.org/structure/7MMO,,"Kathryn Westendorf et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.04.30.442182v3)","May 15, 2021","May 15, 2021",N/A,Variant binding data in publication. Complete
SARS2-38,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Mouse,QVQLKESGPGLVAPSQSLSITCTVSGFSLTRYGVHWVRQPPGKGLEWLGVIWADGSTYYNSALMSRLSISKDNSKSQVFLNMNSLQTDDTAKYYCARDGRGYDDYWGQGTTLT,QIVLTQSPAIMSASPGEKVTMTCSASSTVSFIYWYQQKPGSSPRLLIYDTSNPASGVPVRFSGSGCGTSYYLTISRMEAEDAATYYCQQWNTYPLTFGAGTKLEL,IGHV2-9 (Mouse),IGHJ2 (Mouse),IGKV4-55 (Mouse),IGKJ5 (Mouse),ARDGRGYDDY,QQWNTYPLT,https://www.rcsb.org/structure/7MKL;https://www.rcsb.org/structure/7MKM,,"Laura VanBlargan et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.04.26.441501v1)","May 15, 2021","May 15, 2021",N/A,Variant binding data in publication. Complete
Zhou_28D5,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV4-59 (Human),ND,IGLV2-23 (Human),ND,ARYAKKTFDSESSDYHFDY,CSYAGSSTWV,ND,,"Xiaojuan Zhou et al., 2021 (https://www.sciencedirect.com/science/article/pii/S2211124721004435)","May 11, 2021","May 11, 2021",N/A,Contacting author for full sequences
Zhou_47F2,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV1-58 (Human),ND,IGKV3-20 (Human),ND,AAPSCDTSICYDAFNI,QHYGTSIFT,ND,,"Xiaojuan Zhou et al., 2021 (https://www.sciencedirect.com/science/article/pii/S2211124721004435)","May 11, 2021","May 11, 2021",N/A,Contacting author for full sequences
Zhou_34E5,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV1-58 (Human),ND,IGKV3-20 (Human),ND,AAPHCGGVCYDGFDV,QQYDRSPWT,ND,,"Xiaojuan Zhou et al., 2021 (https://www.sciencedirect.com/science/article/pii/S2211124721004435)","May 11, 2021","May 11, 2021",N/A,Contacting author for full sequences
Zhou_472C6,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV3-23 (Human),ND,IGKV1-12 (Human),ND,RGGYCSSTICYTRYYYMDV,QQANSFPLT,ND,,"Xiaojuan Zhou et al., 2021 (https://www.sciencedirect.com/science/article/pii/S2211124721004435)","May 11, 2021","May 11, 2021",N/A,Contacting author for full sequences
Zhou_282F4,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV3-30 (Human),ND,IGKV1-5 (Human),ND,ARGRTYYYDSSGYYPNWFDT,QHYNNYPIT,ND,,"Xiaojuan Zhou et al., 2021 (https://www.sciencedirect.com/science/article/pii/S2211124721004435)","May 11, 2021","May 11, 2021",N/A,Contacting author for full sequences
Zhou_282A1,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV3-11 (Human),ND,IGKV3-20 (Human),ND,ARDVDIVATIRYNYYGMDV,QQYDDSPPGT,ND,,"Xiaojuan Zhou et al., 2021 (https://www.sciencedirect.com/science/article/pii/S2211124721004435)","May 11, 2021","May 11, 2021",N/A,Contacting author for full sequences
Zhou_28G5,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV1-58 (Human),ND,IGKV3-20 (Human),ND,AAPSCRGVTCYDGFNI,QQYDNSPWT,ND,,"Xiaojuan Zhou et al., 2021 (https://www.sciencedirect.com/science/article/pii/S2211124721004435)","May 11, 2021","May 11, 2021",N/A,Contacting author for full sequences
Zhou_472D6,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV3-49 (Human),ND,IGKV3-15 (Human),ND,TRFQRHCSSTSCGYYMDV,QQYDNWLT,ND,,"Xiaojuan Zhou et al., 2021 (https://www.sciencedirect.com/science/article/pii/S2211124721004435)","May 11, 2021","May 11, 2021",N/A,Contacting author for full sequences
Zhou_282A2,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV4-59 (Human),ND,IGLV1-47 (Human),ND,ARGESWYKTSWFDP,TGWDDSLSGVV,ND,,"Xiaojuan Zhou et al., 2021 (https://www.sciencedirect.com/science/article/pii/S2211124721004435)","May 11, 2021","May 11, 2021",N/A,Contacting author for full sequences
Zhou_47F1,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV3-23 (Human),ND,IGKV1-12 (Human),ND,AKRGGYCSSATCFTRFYYLDV,QQANSFPLT,ND,,"Xiaojuan Zhou et al., 2021 (https://www.sciencedirect.com/science/article/pii/S2211124721004435)","May 11, 2021","May 11, 2021",N/A,Contacting author for full sequences
Zhou_47D1,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVQSGAEVKKPGSSVRVSCKASGGTFSTYPISWVRQAPGQGLEWMGGIIPIFGTAKSAQKFQGRVTITADEFTSTAYMEMSSLRSEDTAMYYCAREGRRYGSGWYISTGYFDYWGQGTLVTVSS,QLVLTQPASVSGSPGQSIIVSCTGTSSDVGGYKFVSWYQQHPGKAPRVMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQADDEADYYCSSYTNSSTVVFGGGTKVTVL,IGHV1-69 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ3 (Human),AREGRRYGSGWYISTGYFDY,SSYTNSSTVV,https://www.rcsb.org/structure/7MF1,,"Xiaojuan Zhou et al., 2021 (https://www.sciencedirect.com/science/article/pii/S2211124721004435)","May 11, 2021","May 11, 2021",N/A,Complete
Zhou_28F1,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV1-58 (Human),ND,IGKV3-20 (Human),ND,AAPYCSGGTCYDAFDI,QQFGTSPWT,ND,,"Xiaojuan Zhou et al., 2021 (https://www.sciencedirect.com/science/article/pii/S2211124721004435)","May 11, 2021","May 11, 2021",N/A,Contacting author for full sequences
Zhou_47A4,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV3-23 (Human),ND,IGKV1-12 (Human),ND,AKRGGYCTDTICYTRYYYMDV,QQANSFPLT,ND,,"Xiaojuan Zhou et al., 2021 (https://www.sciencedirect.com/science/article/pii/S2211124721004435)","May 11, 2021","May 11, 2021",N/A,Contacting author for full sequences
Zhou_47B2,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV1-69 (Human),ND,IGLV2-14 (Human),ND,ARREGTGWFGYGMDV,SSYASSSSLEV,ND,,"Xiaojuan Zhou et al., 2021 (https://www.sciencedirect.com/science/article/pii/S2211124721004435)","May 11, 2021","May 11, 2021",N/A,Contacting author for full sequences
Zhou_28C5,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV6-1 (Human),ND,IGKV3-20 (Human),ND,ARARGGTSHWDFDY,QQYGSSYT,ND,,"Xiaojuan Zhou et al., 2021 (https://www.sciencedirect.com/science/article/pii/S2211124721004435)","May 11, 2021","May 11, 2021",N/A,Contacting author for full sequences
Zhou_47B6,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV3-66 (Human),ND,IGKV1-9 (Human),ND,ARNLGDDAFDI,QQLNSYPPGT,ND,,"Xiaojuan Zhou et al., 2021 (https://www.sciencedirect.com/science/article/pii/S2211124721004435)","May 11, 2021","May 11, 2021",N/A,Contacting author for full sequences
Zhou_282C3,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV3-53 (Human),ND,IGKV1-9 (Human),ND,ARGRWEIDAFDI,QLLDSNPPGT,ND,,"Xiaojuan Zhou et al., 2021 (https://www.sciencedirect.com/science/article/pii/S2211124721004435)","May 11, 2021","May 11, 2021",N/A,Contacting author for full sequences
Zhou_282D1,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV3-21 (Human),ND,IGLV2-23 (Human),ND,ARELIRLGVLGDPAFYDYLYSYHYGMDV,CSYAGSSVV,ND,,"Xiaojuan Zhou et al., 2021 (https://www.sciencedirect.com/science/article/pii/S2211124721004435)","May 11, 2021","May 11, 2021",N/A,Contacting author for full sequences
Zhou_47F4,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV4-59 (Human),ND,IGLV6-57 (Human),ND,AKRGGYCTDTICYTRYYYMDV,QSYDSSNPVV,ND,,"Xiaojuan Zhou et al., 2021 (https://www.sciencedirect.com/science/article/pii/S2211124721004435)","May 11, 2021","May 11, 2021",N/A,Contacting author for full sequences
Zhou_28H5,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV3-11 (Human),ND,IGLV2-8 (Human),ND,ATRPYYYGSGSYY,SSYAGNNNFEL,ND,,"Xiaojuan Zhou et al., 2021 (https://www.sciencedirect.com/science/article/pii/S2211124721004435)","May 11, 2021","May 11, 2021",N/A,Contacting author for full sequences
Zhou_282B2,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV1-69 (Human),ND,IGKV1-5 (Human),ND,ARVRRPNEDALA,QQYHSYSPIT,ND,,"Xiaojuan Zhou et al., 2021 (https://www.sciencedirect.com/science/article/pii/S2211124721004435)","May 11, 2021","May 11, 2021",N/A,Contacting author for full sequences
Zhou_472G6,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV3-30 (Human),ND,IGKV1-39 (Human),ND,ATRVMVRGVIMGFDP,QQSYSTPIT,ND,,"Xiaojuan Zhou et al., 2021 (https://www.sciencedirect.com/science/article/pii/S2211124721004435)","May 11, 2021","May 11, 2021",N/A,Contacting author for full sequences
Zhou_28E1,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV1-69 (Human),ND,IGKV1-5 (Human),ND,ARGGDILANQDAFDF,QQYHSYSPLT,ND,,"Xiaojuan Zhou et al., 2021 (https://www.sciencedirect.com/science/article/pii/S2211124721004435)","May 11, 2021","May 11, 2021",N/A,Contacting author for full sequences
Zhou_282B3,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV3-53 (Human),ND,IGKV1-33 (Human),ND,ARDVPRAAGTL,QQYDNLPPT,ND,,"Xiaojuan Zhou et al., 2021 (https://www.sciencedirect.com/science/article/pii/S2211124721004435)","May 11, 2021","May 11, 2021",N/A,Contacting author for full sequences
Zhou_28B5,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV1-24 (Human),ND,IGKV3-11 (Human),ND,ATVDAGVIKDYFWGSYRRQGYYFDY,QQRSNWPWT,ND,,"Xiaojuan Zhou et al., 2021 (https://www.sciencedirect.com/science/article/pii/S2211124721004435)","May 11, 2021","May 11, 2021",N/A,Contacting author for full sequences
Zhou_28A5,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV7-4-1 (Human),ND,IGKV1-33 (Human),ND,AREGYYYDSGGLVLSDY,QQYDNFRS,ND,,"Xiaojuan Zhou et al., 2021 (https://www.sciencedirect.com/science/article/pii/S2211124721004435)","May 11, 2021","May 11, 2021",N/A,Contacting author for full sequences
Zhou_282H4,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV1-3 (Human),ND,IGKV1-5 (Human),ND,ARGGQQWLVDYFEK,QQYHGYPWT,ND,,"Xiaojuan Zhou et al., 2021 (https://www.sciencedirect.com/science/article/pii/S2211124721004435)","May 11, 2021","May 11, 2021",N/A,Contacting author for full sequences
Zhou_28B32,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV1-69 (Human),ND,IGKV1-5 (Human),ND,ATPGGILAGPAANKDAFDI,QQYNSYSPIT,ND,,"Xiaojuan Zhou et al., 2021 (https://www.sciencedirect.com/science/article/pii/S2211124721004435)","May 11, 2021","May 11, 2021",N/A,Contacting author for full sequences
Zhou_28F2,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV1-46 (Human),ND,IGKV1-39 (Human),ND,AGLTAAAEPSPFDY,QQSYSTPPT,ND,,"Xiaojuan Zhou et al., 2021 (https://www.sciencedirect.com/science/article/pii/S2211124721004435)","May 11, 2021","May 11, 2021",N/A,Contacting author for full sequences
Zhou_34H5,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV4-39 (Human),ND,IGLV2-14 (Human),ND,ARDNADPNGSRSYYYYYYYGVDV,SSYTSSSTYV,ND,,"Xiaojuan Zhou et al., 2021 (https://www.sciencedirect.com/science/article/pii/S2211124721004435)","May 11, 2021","May 11, 2021",N/A,Contacting author for full sequences
Zhou_282E1,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV4-38-2 (Human),ND,IGKV3-11 (Human),ND,ARAVGRGVAGE,QQRSNWPPIT,ND,,"Xiaojuan Zhou et al., 2021 (https://www.sciencedirect.com/science/article/pii/S2211124721004435)","May 11, 2021","May 11, 2021",N/A,Contacting author for full sequences
Zhou_282H2,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV3-11 (Human),ND,IGKV1-33 (Human),ND,AGARGVVAGYSLSY,QQYDNPSLT,ND,,"Xiaojuan Zhou et al., 2021 (https://www.sciencedirect.com/science/article/pii/S2211124721004435)","May 11, 2021","May 11, 2021",N/A,Contacting author for full sequences
Zhou_282E3,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV3-30-3 (Human),ND,IGKV1-33 (Human),ND,ARDGLLTTMVRGIMGPAYDY,QQYDNLPYT,ND,,"Xiaojuan Zhou et al., 2021 (https://www.sciencedirect.com/science/article/pii/S2211124721004435)","May 11, 2021","May 11, 2021",N/A,Contacting author for full sequences
Zhou_47G5,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV1-18 (Human),ND,IGLV1-51 (Human),ND,ATIFSGSSYELDH,GTWDSSLSVM,ND,,"Xiaojuan Zhou et al., 2021 (https://www.sciencedirect.com/science/article/pii/S2211124721004435)","May 11, 2021","May 11, 2021",N/A,Contacting author for full sequences
Zhou_282F3,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV1-69 (Human),ND,IGKV1-5 (Human),ND,ATPGDVTANKDAFDV,QQYHSYSPIT,ND,,"Xiaojuan Zhou et al., 2021 (https://www.sciencedirect.com/science/article/pii/S2211124721004435)","May 11, 2021","May 11, 2021",N/A,Contacting author for full sequences
Zhou_28B4,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV3-30-3 (Human),ND,IGKV1-33 (Human),ND,ARGRPRSGLY,QQYDEPTLT,ND,,"Xiaojuan Zhou et al., 2021 (https://www.sciencedirect.com/science/article/pii/S2211124721004435)","May 11, 2021","May 11, 2021",N/A,Contacting author for full sequences
Zhou_282G1,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV1-69 (Human),ND,IGKV1-5 (Human),ND,ARGDLTASGSGSDGMDV,QQYHSYSPIT,ND,,"Xiaojuan Zhou et al., 2021 (https://www.sciencedirect.com/science/article/pii/S2211124721004435)","May 11, 2021","May 11, 2021",N/A,Contacting author for full sequences
Zhou_282C4,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV1-69 (Human),ND,IGKV3-20 (Human),ND,ARSAYYSDSSGYHFDY,QQYHSSPRT,ND,,"Xiaojuan Zhou et al., 2021 (https://www.sciencedirect.com/science/article/pii/S2211124721004435)","May 11, 2021","May 11, 2021",N/A,Contacting author for full sequences
Zhou_282A3,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV1-69 (Human),ND,IGKV1-5 (Human),ND,ATPGSIVGMSTTNKDAFDI,QQYHSYSPIT,ND,,"Xiaojuan Zhou et al., 2021 (https://www.sciencedirect.com/science/article/pii/S2211124721004435)","May 11, 2021","May 11, 2021",N/A,Contacting author for full sequences
Zhou_282E2,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV3-30-3 (Human),ND,IGKV3-11 (Human),ND,ARDGESITMVRGLMSPAFDY,QQRYNWPRT,ND,,"Xiaojuan Zhou et al., 2021 (https://www.sciencedirect.com/science/article/pii/S2211124721004435)","May 11, 2021","May 11, 2021",N/A,Contacting author for full sequences
Zhou_282A5,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV1-69 (Human),ND,IGKV1-5 (Human),ND,ASPPGYTNSWYQFFQR,QQYNSYSYT,ND,,"Xiaojuan Zhou et al., 2021 (https://www.sciencedirect.com/science/article/pii/S2211124721004435)","May 11, 2021","May 11, 2021",N/A,Contacting author for full sequences
Zhou_47A5,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV1-58 (Human),ND,IGKV3-20 (Human),ND,AASVRITDFDWFEDGFDI,QQFGSSPYT,ND,,"Xiaojuan Zhou et al., 2021 (https://www.sciencedirect.com/science/article/pii/S2211124721004435)","May 11, 2021","May 11, 2021",N/A,Contacting author for full sequences
Zhou_282D4,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV1-69 (Human),ND,IGKV1-5 (Human),ND,ARVSNGGNDY,QAWDSSTALYV,ND,,"Xiaojuan Zhou et al., 2021 (https://www.sciencedirect.com/science/article/pii/S2211124721004435)","May 11, 2021","May 11, 2021",N/A,Contacting author for full sequences
Zhou_28C6,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV1-69 (Human),ND,IGKV1-5 (Human),ND,ATPADILAGSDAGPGKGTDTFDF,QQYKSYSPLT,ND,,"Xiaojuan Zhou et al., 2021 (https://www.sciencedirect.com/science/article/pii/S2211124721004435)","May 11, 2021","May 11, 2021",N/A,Contacting author for full sequences
Zhou_472F6,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV3-23 (Human),ND,IGKV1-12 (Human),ND,AKRGGYCTTTICYTRYYYMDV,QQANSFPLT,ND,,"Xiaojuan Zhou et al., 2021 (https://www.sciencedirect.com/science/article/pii/S2211124721004435)","May 11, 2021","May 11, 2021",N/A,Contacting author for full sequences
Zhou_28F3,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV3-30-3 (Human),ND,IGKV1-33 (Human),ND,ARGRPRSGLY,QQYDEPTLT,ND,,"Xiaojuan Zhou et al., 2021 (https://www.sciencedirect.com/science/article/pii/S2211124721004435)","May 11, 2021","May 11, 2021",N/A,Contacting author for full sequences
Zhou_282C1,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV3-66 (Human),ND,IGKV1-33 (Human),ND,ARFGYGTSRYDY,QQYDNLPVT,ND,,"Xiaojuan Zhou et al., 2021 (https://www.sciencedirect.com/science/article/pii/S2211124721004435)","May 11, 2021","May 11, 2021",N/A,Contacting author for full sequences
Zhou_34B6,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV1-46 (Human),ND,IGLV3-19 (Human),ND,ASGSLAPNFFYYAMGV,SSWDSSDNHPI,ND,,"Xiaojuan Zhou et al., 2021 (https://www.sciencedirect.com/science/article/pii/S2211124721004435)","May 11, 2021","May 11, 2021",N/A,Contacting author for full sequences
Zhou_28E5,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV3-66 (Human),ND,IGKV1-33 (Human),ND,ARDLRDWV,HQYDNLPRT,ND,,"Xiaojuan Zhou et al., 2021 (https://www.sciencedirect.com/science/article/pii/S2211124721004435)","May 11, 2021","May 11, 2021",N/A,Contacting author for full sequences
Zhou_34F5,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV3-66 (Human),ND,IGKV3-15 (Human),ND,ARDYYASGSYGWADSG,QQYITWPPMYT,ND,,"Xiaojuan Zhou et al., 2021 (https://www.sciencedirect.com/science/article/pii/S2211124721004435)","May 11, 2021","May 11, 2021",N/A,Contacting author for full sequences
Zhou_282H1,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV3-53 (Human),ND,IGKV1-39 (Human),ND,ARVARDLRVMYGDLNYYYYGMDV,QLTYTIPR,ND,,"Xiaojuan Zhou et al., 2021 (https://www.sciencedirect.com/science/article/pii/S2211124721004435)","May 11, 2021","May 11, 2021",N/A,Contacting author for full sequences
Zhou_282H3,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV1-69 (Human),ND,IGKV1-5 (Human),ND,ARATLGDCSGGPCGDAFDI,QQYHSYSPLT,ND,,"Xiaojuan Zhou et al., 2021 (https://www.sciencedirect.com/science/article/pii/S2211124721004435)","May 11, 2021","May 11, 2021",N/A,Contacting author for full sequences
Zhou_34H6,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV3-53 (Human),ND,IGKV1-9 (Human),ND,ARDLGPYGMDV,QQLNSYPPYT,ND,,"Xiaojuan Zhou et al., 2021 (https://www.sciencedirect.com/science/article/pii/S2211124721004435)","May 11, 2021","May 11, 2021",N/A,Contacting author for full sequences
Zhou_47D4,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV3-53 (Human),ND,IGKV1-33 (Human),ND,ARDPYCRGGGCHI,QQYDNLPIT,ND,,"Xiaojuan Zhou et al., 2021 (https://www.sciencedirect.com/science/article/pii/S2211124721004435)","May 11, 2021","May 11, 2021",N/A,Contacting author for full sequences
WuN1,Nb,SARS-CoV2; SARS-CoV1 (weak),229E;OC43;NL63;HKU;MERS-CoV,,,N,"Phage Display Library (Nanobody, non-immune, semisynthetic)",QVKLQQSGGGLVQAGGSLRLSCAPSGRTFSVNAMGWYRQAPGKQREPVALISTGGSTNYADSVKGRFTITRDNVKNTVYLQMNTLKPEDTAVYYCYTERWKPRGIERDWGQGTQVTVSS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,YTERWKPRGIERD,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/WuN1_rank1_imgt_scheme.pdb,"Laura Sherwood et al., 2021 (https://doi.org/10.1021/acssynbio.0c00566)","May 7, 2021","May 7, 2021",N/A,Complete
WuN3,Nb,SARS-CoV2; SARS-CoV1 (weak),229E;OC43;NL63;HKU;MERS-CoV,,,N,"Phage Display Library (Nanobody, non-immune, semisynthetic)",KVKLQQSGGGLVQTGGSLRLSCAPSGRTFSVNAMGWYRQAPGKQREPVALISTGGSTNYADSVKGRFTISRDNVKNTVYLQMNTLKPEDTAVYYCYTERWKPRGIERDWGQGTQVTVSS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,YTERWKPRGIERD,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/WuN3_rank1_imgt_scheme.pdb,"Laura Sherwood et al., 2021 (https://doi.org/10.1021/acssynbio.0c00566)","May 7, 2021","May 7, 2021",N/A,Complete
WNb-1,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QVQLQESGGGLVQAGGSLRLSCAASGRTFDRYAMGWFRQVPGKGLEWVSGIYSDGYTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAADRMDGSSWPERDFGSWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ6 (Alpaca),N/A,N/A,AADRMDGSSWPERDFGS,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/WNb-1_rank1_imgt_scheme.pdb,"Phillip Pymm et al., 2021 (https://www.pnas.org/content/118/19/e2101918118)","May 7, 2021","May 7, 2021",N/A,Complete
WNb-2,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QVQLQESGGGLVQPGGSLRLSCAVSGFTLDYYAIGWFRQAPGKEREGVSCISSSGGNTKYADSVKGRFTASRDNAKNTFYLQMNSLKPEDTAVYYCAAIAATYYSGSYYFQCPHDGMDYWGKGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ7 (Alpaca),N/A,N/A,AAIAATYYSGSYYFQCPHDGMDY,N/A,https://www.rcsb.org/structure/7LDJ;https://www.rcsb.org/structure/7LX5,,"Phillip Pymm et al., 2021 (https://www.pnas.org/content/118/19/e2101918118)","May 7, 2021","May 7, 2021",N/A,Complete
WNb-3,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QVQLQESGGGLVQPGGSLRLSCAASGFTLDYYAIGWFRQAPGKEREGVSCISSSGGSTNYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAAQMGSSRYCPIFIPGEGMDYWGKGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ7 (Alpaca),N/A,N/A,AAQMGSSRYCPIFIPGEGMDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/WNb-3_rank1_imgt_scheme.pdb,"Phillip Pymm et al., 2021 (https://www.pnas.org/content/118/19/e2101918118)","May 7, 2021","May 7, 2021",N/A,Complete
WNb-4,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QVQLQESGGGLVQPGGSLRLSCAASGFTLDYYAIGWFRQAPGKEREGVSCISSSGGSTNYADSVKGRFTISRDNAKNTVYLQMNSLQPEDTAVYYCAAQMGSSRYCPIFTPGEGMDYWGKGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ7 (Alpaca),N/A,N/A,AAQMGSSRYCPIFTPGEGMDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/WNb-4_rank1_imgt_scheme.pdb,"Phillip Pymm et al., 2021 (https://www.pnas.org/content/118/19/e2101918118)","May 7, 2021","May 7, 2021",N/A,Complete
WNb-5,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QVQLQESGGGLVQAGGSLRLSCAASGRTFSRYAIGWFRQAPGKEREGVSCISPSGGSTNYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAASTPSYHYCSGYVSEYDYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AASTPSYHYCSGYVSEYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/WNb-5_rank1_imgt_scheme.pdb,"Phillip Pymm et al., 2021 (https://www.pnas.org/content/118/19/e2101918118)","May 7, 2021","May 7, 2021",N/A,Complete
WNb-6,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QVQLQESGGGLVQPGGSLRLSCAASGFTFSSYAMGWFRQVPGKGLEWVSGIYSDGSTYYADSVKGRFTISRDNAKNTLYLQMNSLKPEDTAVYYCAKDRLEGSSRPERDFGSWGQGTQVTVSS,N/A,IGHV3S1 (Alpaca),IGHJ6 (Alpaca),N/A,N/A,AKDRLEGSSRPERDFGS,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/WNb-6_rank1_imgt_scheme.pdb,"Phillip Pymm et al., 2021 (https://www.pnas.org/content/118/19/e2101918118)","May 7, 2021","May 7, 2021",N/A,Complete
WNb-7,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QVQLQESGGGLVQPGGSLRLSCAAPGFTFSSYAMGWFRQVPGKGLEWVSGIYSDGSTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAKDRLEGSSWPERDFGSWGQGTQVTVSS,N/A,IGHV3S1 (Alpaca),IGHJ6 (Alpaca),N/A,N/A,AKDRLEGSSWPERDFGS,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/WNb-7_rank1_imgt_scheme.pdb,"Phillip Pymm et al., 2021 (https://www.pnas.org/content/118/19/e2101918118)","May 7, 2021","May 7, 2021",N/A,Complete
WNb-8,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QVQLQESGGGLVQPGGSLRLSCAASGFTFSSYAMGWARQVPGKGLEWVSGIYSDGSTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAKDRLESSSWPERDFGSWGQGTQVTVSS,N/A,IGHV3S1 (Alpaca),IGHJ6 (Alpaca),N/A,N/A,AKDRLESSSWPERDFGS,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/WNb-8_rank1_imgt_scheme.pdb,"Phillip Pymm et al., 2021 (https://www.pnas.org/content/118/19/e2101918118)","May 7, 2021","May 7, 2021",N/A,Complete
WNb-9,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QVQLQESGGGLVQPGGSLRLSCAASGFTFSSYAMGWARQVPGKGLEWVSGIYSDGSTYYGDSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAKDRMAGSSWPERDFGSWGQGTQVTVSS,N/A,IGHV3S1 (Alpaca),IGHJ6 (Alpaca),N/A,N/A,AKDRMAGSSWPERDFGS,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/WNb-9_rank1_imgt_scheme.pdb,"Phillip Pymm et al., 2021 (https://www.pnas.org/content/118/19/e2101918118)","May 7, 2021","May 7, 2021",N/A,Complete
WNb-10,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QVQLQESGGGLVQPGGSLRLSCAASGFTFRRYLMGWARQVPGKGLEWVSGIYSDGSTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAKDRMDGSTWPERDFGSWGQGTQVTVSS,N/A,IGHV3S1 (Alpaca),IGHJ6 (Alpaca),N/A,N/A,AKDRMDGSTWPERDFGS,N/A,https://www.rcsb.org/structure/7LX5,,"Phillip Pymm et al., 2021 (https://www.pnas.org/content/118/19/e2101918118)","May 7, 2021","May 7, 2021",N/A,Complete
WNb-11,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QVQLQESGGGLVQAGDSLRLSCAASGGTFSSYLMGWARQVPGKGLEWVAGIYSDGSTYYADSVKGRFIISRDNAKNTVYLQMNSLKPEDTAVYYCAKDRMEGSTWPERDFGSWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ6 (Alpaca),N/A,N/A,AKDRMEGSTWPERDFGS,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/WNb-11_rank1_imgt_scheme.pdb,"Phillip Pymm et al., 2021 (https://www.pnas.org/content/118/19/e2101918118)","May 7, 2021","May 7, 2021",N/A,Complete
WNb-13,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QVQLQESGGGLVQPGGSLRLSCAASGFTFSSYAMGWFRQVPGKGLEWVSGIYSDGSTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCATDRMAGSRWPERDFGSWGQGTQVTVSS,N/A,IGHV3S1 (Alpaca),IGHJ6 (Alpaca),N/A,N/A,ATDRMAGSRWPERDFGS,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/WNb-13_rank1_imgt_scheme.pdb,"Phillip Pymm et al., 2021 (https://www.pnas.org/content/118/19/e2101918118)","May 7, 2021","May 7, 2021",N/A,Complete
WNb-14,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QVQLQESGGGLVQPGGSLRLSCAASGFTFSSYAMGWARQVPGKGLEWVSGIYSDGSTYYADSVKGRFIISRDNAKNTVYLQMNSLKPEDTAVYYCAKDRMEGSSWPERDFGSWGQGTQVTVSS,N/A,IGHV3S1 (Alpaca),IGHJ6 (Alpaca),N/A,N/A,AKDRMEGSSWPERDFGS,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/WNb-14_rank1_imgt_scheme.pdb,"Phillip Pymm et al., 2021 (https://www.pnas.org/content/118/19/e2101918118)","May 7, 2021","May 7, 2021",N/A,Complete
WNb-15,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QVQLQESGGGLVQPGGSLRLSCAASGFTFSSYLMGWFRQVPGKGLEWVSGIYSDGGTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCATDRMEGSSWPERDFGSWGQGTQVTVSS,N/A,IGHV3S1 (Alpaca),IGHJ6 (Alpaca),N/A,N/A,ATDRMEGSSWPERDFGS,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/WNb-15_rank1_imgt_scheme.pdb,"Phillip Pymm et al., 2021 (https://www.pnas.org/content/118/19/e2101918118)","May 7, 2021","May 7, 2021",N/A,Complete
WNb-17,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QVQLQESGGGLVQPGGSLRLSCAASGSIFSINVMGWYRQAPGKQRELVAAITSVGSTNYADSVKGRFTISRDNAENTVYLQMNSLKPEDTAVYYCNAVSTFTQAMGGSPEHYWGQGTQVTVSS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,NAVSTFTQAMGGSPEHY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/WNb-17_rank1_imgt_scheme.pdb,"Phillip Pymm et al., 2021 (https://www.pnas.org/content/118/19/e2101918118)","May 7, 2021","May 7, 2021",N/A,Complete
WNb-19,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QVQLQESGGGLVQPGGSLRLSCAASGSMFSINVMGWYRQASGKQRELVAGITRDGATNYSDSVKGRFTISGDNAKNTVYLQMNSLKPEDTAVYYCNTNVDSVWGSRIDYFGQGTQVTVSS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,NTNVDSVWGSRIDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/WNb-19_rank1_imgt_scheme.pdb,"Phillip Pymm et al., 2021 (https://www.pnas.org/content/118/19/e2101918118)","May 7, 2021","May 7, 2021",N/A,Complete
WNb-20,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QVQLQESGGGLVQPGGSLRLSCAASGFTLEHYAIGWFRQAPGKEREGVSCISNSGGRTNYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAADLGVVERLCPAHPGSYEYDYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AADLGVVERLCPAHPGSYEYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/WNb-20_rank1_imgt_scheme.pdb,"Phillip Pymm et al., 2021 (https://www.pnas.org/content/118/19/e2101918118)","May 7, 2021","May 7, 2021",N/A,Complete
WNb-22,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QVQLQESGGGLVQPGGSLRLSCAASGFTFSSYAMGWARQVPGKGLEWLSGIYSDGSTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAKDRMDGSVWPERDFGSWGQGTQVTVSS,N/A,IGHV3S1 (Alpaca),IGHJ6 (Alpaca),N/A,N/A,AKDRMDGSVWPERDFGS,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/WNb-22_rank1_imgt_scheme.pdb,"Phillip Pymm et al., 2021 (https://www.pnas.org/content/118/19/e2101918118)","May 7, 2021","May 7, 2021",N/A,Complete
WNb-23,Nb,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,Immunised Alpaca,QVQLQESGGGLVQPGGSLRLSCAASGFTFKDYAMAWARQVPGKGLEWVSGIYSDGNTYYADSVKGRFTISRDNAKNTVYLRMNSLKPEDTAVYYCATERHPQGAADFGSWGQGTQVTVSS,N/A,IGHV3S1 (Alpaca),IGHJ6 (Alpaca),N/A,N/A,ATERHPQGAADFGS,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/WNb-23_rank1_imgt_scheme.pdb,"Phillip Pymm et al., 2021 (https://www.pnas.org/content/118/19/e2101918118)","May 7, 2021","May 7, 2021",N/A,Complete
WNb-24,Nb,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,Immunised Alpaca,QVQLQESGGGLVQAGESLRLSCAASGRTFSRYAMGWFRQAPGKEREFVAAVSWNGGNTYYADSVKGRFTISRDNAKNTLYLQMNSLKPEDTAVYYCAAGGEPVVVIKLRNADEYDFLGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAGGEPVVVIKLRNADEYDF,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/WNb-24_rank1_imgt_scheme.pdb,"Phillip Pymm et al., 2021 (https://www.pnas.org/content/118/19/e2101918118)","May 7, 2021","May 7, 2021",N/A,Complete
WNb-25,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QVQLQESGGGLVQAGGSLRLSCVTSGLTFSRAAMGWFRQAPEKEREFVASIHWRGLNIAYADSVKGRFTISRDDAKNTLYLQMNSLKTEDTAVYYCAAIPFYYFDHISPFSRAAAYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAIPFYYFDHISPFSRAAAY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/WNb-25_rank1_imgt_scheme.pdb,"Phillip Pymm et al., 2021 (https://www.pnas.org/content/118/19/e2101918118)","May 7, 2021","May 7, 2021",N/A,Complete
WNb-26,Nb,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,Immunised Alpaca,QVQLQESGGGLVQAGGSLRLSCVVSGRTFSPYAMGWFRQAPGKEREFVAGMSWSSGKYYADSVKGRFTISRDGAKNAVYLQMNSLKPEDTAVYYCGAGGEGYSRGRVNLQPDFWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,GAGGEGYSRGRVNLQPDF,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/WNb-26_rank1_imgt_scheme.pdb,"Phillip Pymm et al., 2021 (https://www.pnas.org/content/118/19/e2101918118)","May 7, 2021","May 7, 2021",N/A,Complete
WNb-27,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QVQLQESGGGLVEAGDSLRLSCAASGRTFSRYAMGWFRQAPGKEREFVAAVSWNGGNTYYADSVKGRFTISRDNAKNTLYLQMNSLKPEDTARYYCVADRGESYYYNRDSEYEWWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ7 (Alpaca),N/A,N/A,VADRGESYYYNRDSEYEW,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/WNb-27_rank1_imgt_scheme.pdb,"Phillip Pymm et al., 2021 (https://www.pnas.org/content/118/19/e2101918118)","May 7, 2021","May 7, 2021",N/A,Complete
WNb-29,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QVQLQESGGGLVQPGGSLRLSCAFSGRTFSMYAMGWFRQAPGKEREFVAVIDDGGGRTYYADSVKGRFTISRDNAKNTVYLQMNSLKTEDTAVYCCAADMGFGYTIWADSYDYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AADMGFGYTIWADSYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/WNb-29_rank1_imgt_scheme.pdb,"Phillip Pymm et al., 2021 (https://www.pnas.org/content/118/19/e2101918118)","May 7, 2021","May 7, 2021",N/A,Complete
WNb-30,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QVQLQESGGGLVQPGGSLRLSCVASGITLDYYAIGWFRQAPGKEREGVSCLSSSDGSTYYADSVKGRFTMSRDNVKNTVYLQMNSLKPEDTAVYYCATNPLTVVDGTFHLTCLDEYDYGGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,ATNPLTVVDGTFHLTCLDEYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/WNb-30_rank1_imgt_scheme.pdb,"Phillip Pymm et al., 2021 (https://www.pnas.org/content/118/19/e2101918118)","May 7, 2021","May 7, 2021",N/A,Complete
WNb-31,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QVQLQESGGGLVQAGDSLRLSCTASGRALNTYTVAWWRQAPGNEREFVASIIWSSGAAWYADAVKGRFTISRDNAKNTVDLQMTSLKPEETAIYFCAVGQWEGRDTWYTSYDYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AVGQWEGRDTWYTSYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/WNb-31_rank1_imgt_scheme.pdb,"Phillip Pymm et al., 2021 (https://www.pnas.org/content/118/19/e2101918118)","May 7, 2021","May 7, 2021",N/A,Complete
WNb-32,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QVQLQESGGGLVQAGGSLGLSCAASGRPLNSYSMAWFRQAPGKEREFVASIGRSDGLSKYNDFVKDRFTLSRGNAKTTLLLQMNNLKVEDTAVYYCSAALWDGWATDINEYDYRGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,SAALWDGWATDINEYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/WNb-32_rank1_imgt_scheme.pdb,"Phillip Pymm et al., 2021 (https://www.pnas.org/content/118/19/e2101918118)","May 7, 2021","May 7, 2021",N/A,Complete
WNb-33,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QVQLQESGGGLVQPGGSLRLSCAASGFTFSSYLMGWARQVPGKGLEWVAGIYSDGSTYYADSVKGRFIISRDNAKNTVYLQMNSLKPEDTAVYYCAKDRMEGSTWPERDLGSWGQGTQVTVSS,N/A,IGHV3S1 (Alpaca),IGHJ6 (Alpaca),N/A,N/A,AKDRMEGSTWPERDLGS,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/WNb-33_rank1_imgt_scheme.pdb,"Phillip Pymm et al., 2021 (https://www.pnas.org/content/118/19/e2101918118)","May 7, 2021","May 7, 2021",N/A,Complete
WNb-34,Nb,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,Immunised Alpaca,QVQLQESGGGLVEAGDSLRLSCAASGRTFSRYAMGWFRQAPGKEREFVAAVSWNGGNTYYADSVKGRFTISRDNAKNTLYLQMNSLKPEDTAVYYCAAGGEPVVVIKLRNANEYDFLGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAGGEPVVVIKLRNANEYDF,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/WNb-34_rank1_imgt_scheme.pdb,"Phillip Pymm et al., 2021 (https://www.pnas.org/content/118/19/e2101918118)","May 7, 2021","May 7, 2021",N/A,Complete
WNb-35,Nb,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,Immunised Alpaca,QVQLQESGGGLVQPGGSLRLSCAASGFTFSSYAMGWARQVPGKGLEWVSGIYSDGTTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAADRMEGSTWPERDFGSWGQGTQVTVSS,N/A,IGHV3S1 (Alpaca),IGHJ6 (Alpaca),N/A,N/A,AADRMEGSTWPERDFGS,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/WNb-35_rank1_imgt_scheme.pdb,"Phillip Pymm et al., 2021 (https://www.pnas.org/content/118/19/e2101918118)","May 7, 2021","May 7, 2021",N/A,Complete
WNb-36,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QVQLQESGGGLVQPGGSLRLSCAVSGFTLDYYAIGWFRQAPGKEREGVSCISNSGGNTKYADSVKGRFTTSVDNAQNTVYLLMNSLEPEDTAVYYCAAIAATYYSGTYYYQCPHYGMDYWGKGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ7 (Alpaca),N/A,N/A,AAIAATYYSGTYYYQCPHYGMDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/WNb-36_rank1_imgt_scheme.pdb,"Phillip Pymm et al., 2021 (https://www.pnas.org/content/118/19/e2101918118)","May 7, 2021","May 7, 2021",N/A,Complete
WNb-41,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QVQLQESGGGLVQPGGSLRLSCAVSGFTLDYYAIGWFRQAPGKEREGVSCISSSGGSTNYADSVKGRFTISRDNAKNTVYLQMNGLKPEDTAVYYCAAIAATYYSGSYYYQCPHDGMDYWGKGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ7 (Alpaca),N/A,N/A,AAIAATYYSGSYYYQCPHDGMDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/WNb-41_rank1_imgt_scheme.pdb,"Phillip Pymm et al., 2021 (https://www.pnas.org/content/118/19/e2101918118)","May 7, 2021","May 7, 2021",N/A,Complete
WNb-45,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QVQLQESGGGLVQPGGSLRLSCAASGFTFSSYAMGWFRQVPGKGLEWVSGIYSDGSTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAADRMEGSSWPERDFGSWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ6 (Alpaca),N/A,N/A,AADRMEGSSWPERDFGS,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/WNb-45_rank1_imgt_scheme.pdb,"Phillip Pymm et al., 2021 (https://www.pnas.org/content/118/19/e2101918118)","May 7, 2021","May 7, 2021",N/A,Complete
WNb-46,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QVKLQQSGGGLVQAGGSLRLSCAPSGRTFSVNAMGWYRQAPGKQREPVALISTGGSTNYADSVKGRFTITRDNVKNTVYLQMNTLKPEDTAVYYCYTERWKPRGIERDWGQGTQVTVSS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAISGSYYYTSLHPVEYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/WNb-46_rank1_imgt_scheme.pdb,"Phillip Pymm et al., 2021 (https://www.pnas.org/content/118/19/e2101918118)","May 7, 2021","May 7, 2021",N/A,Complete
WNb-49,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,KVKLQQSGGGLVQTGGSLRLSCAPSGRTFSVNAMGWYRQAPGKQREPVALISTGGSTNYADSVKGRFTISRDNVKNTVYLQMNTLKPEDTAVYYCYTERWKPRGIERDWGQGTQVTVSS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAISASYYYTSLHPVEYDS,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/WNb-49_rank1_imgt_scheme.pdb,"Phillip Pymm et al., 2021 (https://www.pnas.org/content/118/19/e2101918118)","May 7, 2021","May 7, 2021",N/A,Complete
WNb-50,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QVQLQESGGGLVQAGGSLRLSCAASGRTFDRYAMGWFRQVPGKGLEWVSGIYSDGYTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAADRMDGSSWPERDFGSWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ6 (Alpaca),N/A,N/A,AADRMAGSRWPERDFGS,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/WNb-50_rank1_imgt_scheme.pdb,"Phillip Pymm et al., 2021 (https://www.pnas.org/content/118/19/e2101918118)","May 7, 2021","May 7, 2021",N/A,Complete
WNb-52,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QVQLQESGGGLVQPGGSLRLSCAVSGFTLDYYAIGWFRQAPGKEREGVSCISSSGGNTKYADSVKGRFTASRDNAKNTFYLQMNSLKPEDTAVYYCAAIAATYYSGSYYFQCPHDGMDYWGKGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ7 (Alpaca),N/A,N/A,AKDRLEGSTWPERDFGS,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/WNb-52_rank1_imgt_scheme.pdb,"Phillip Pymm et al., 2021 (https://www.pnas.org/content/118/19/e2101918118)","May 7, 2021","May 7, 2021",N/A,Complete
WNb-53,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QVQLQESGGGLVQPGGSLRLSCAASGFTLDYYAIGWFRQAPGKEREGVSCISSSGGSTNYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAAQMGSSRYCPIFIPGEGMDYWGKGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ7 (Alpaca),N/A,N/A,AKDRMEDSTWPERDFGS,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/WNb-53_rank1_imgt_scheme.pdb,"Phillip Pymm et al., 2021 (https://www.pnas.org/content/118/19/e2101918118)","May 7, 2021","May 7, 2021",N/A,Complete
WNb-54,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QVQLQESGGGLVQPGGSLRLSCAASGFTLDYYAIGWFRQAPGKEREGVSCISSSGGSTNYADSVKGRFTISRDNAKNTVYLQMNSLQPEDTAVYYCAAQMGSSRYCPIFTPGEGMDYWGKGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ7 (Alpaca),N/A,N/A,AKDRMEGSVWPERDFGS,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/WNb-54_rank1_imgt_scheme.pdb,"Phillip Pymm et al., 2021 (https://www.pnas.org/content/118/19/e2101918118)","May 7, 2021","May 7, 2021",N/A,Complete
WNb-58,Nb,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,Immunised Alpaca,QVQLQESGGGLVQAGGSLRLSCAASGRTFSRYAIGWFRQAPGKEREGVSCISPSGGSTNYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAASTPSYHYCSGYVSEYDYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AADRMDGSRWPERDFGS,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/WNb-58_rank1_imgt_scheme.pdb,"Phillip Pymm et al., 2021 (https://www.pnas.org/content/118/19/e2101918118)","May 7, 2021","May 7, 2021",N/A,Complete
WNb-59,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QVQLQESGGGLVQPGGSLRLSCAASGFTFSSYAMGWFRQVPGKGLEWVSGIYSDGSTYYADSVKGRFTISRDNAKNTLYLQMNSLKPEDTAVYYCAKDRLEGSSRPERDFGSWGQGTQVTVSS,N/A,IGHV3S1 (Alpaca),IGHJ6 (Alpaca),N/A,N/A,AADPHGFDCSPSGGMDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/WNb-59_rank1_imgt_scheme.pdb,"Phillip Pymm et al., 2021 (https://www.pnas.org/content/118/19/e2101918118)","May 7, 2021","May 7, 2021",N/A,Complete
WNb-60,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QVQLQESGGGLVQPGGSLRLSCAAPGFTFSSYAMGWFRQVPGKGLEWVSGIYSDGSTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAKDRLEGSSWPERDFGSWGQGTQVTVSS,N/A,IGHV3S1 (Alpaca),IGHJ6 (Alpaca),N/A,N/A,ATDRMDGSSWPERDFGS,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/WNb-60_rank1_imgt_scheme.pdb,"Phillip Pymm et al., 2021 (https://www.pnas.org/content/118/19/e2101918118)","May 7, 2021","May 7, 2021",N/A,Complete
WNb-61,Nb,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,Immunised Alpaca,QVQLQESGGGLVQPGGSLRLSCAASGFTFSSYAMGWARQVPGKGLEWVSGIYSDGSTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAKDRLESSSWPERDFGSWGQGTQVTVSS,N/A,IGHV3S1 (Alpaca),IGHJ6 (Alpaca),N/A,N/A,AATPSGVATAQGPCDLTRWYDN,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/WNb-61_rank1_imgt_scheme.pdb,"Phillip Pymm et al., 2021 (https://www.pnas.org/content/118/19/e2101918118)","May 7, 2021","May 7, 2021",N/A,Complete
WNb-62,Nb,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,Immunised Alpaca,QVQLQESGGGLVQPGGSLRLSCAASGFTFSSYAMGWARQVPGKGLEWVSGIYSDGSTYYGDSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAKDRMAGSSWPERDFGSWGQGTQVTVSS,N/A,IGHV3S1 (Alpaca),IGHJ6 (Alpaca),N/A,N/A,NLDGRYENLEDDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/WNb-62_rank1_imgt_scheme.pdb,"Phillip Pymm et al., 2021 (https://www.pnas.org/content/118/19/e2101918118)","May 7, 2021","May 7, 2021",N/A,Complete
WNb-63,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QVQLQESGGGLVQPGGSLRLSCAASGFTFRRYLMGWARQVPGKGLEWVSGIYSDGSTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAKDRMDGSTWPERDFGSWGQGTQVTVSS,N/A,IGHV3S1 (Alpaca),IGHJ6 (Alpaca),N/A,N/A,AADRMDGSTWPERDFGS,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/WNb-63_rank1_imgt_scheme.pdb,"Phillip Pymm et al., 2021 (https://www.pnas.org/content/118/19/e2101918118)","May 7, 2021","May 7, 2021",N/A,Complete
WNb-67,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QVQLQESGGGLVQAGDSLRLSCAASGGTFSSYLMGWARQVPGKGLEWVAGIYSDGSTYYADSVKGRFIISRDNAKNTVYLQMNSLKPEDTAVYYCAKDRMEGSTWPERDFGSWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ6 (Alpaca),N/A,N/A,AAIAATYYGGSYYYQCPHYGMDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/WNb-67_rank1_imgt_scheme.pdb,"Phillip Pymm et al., 2021 (https://www.pnas.org/content/118/19/e2101918118)","May 7, 2021","May 7, 2021",N/A,Complete
WNb-68,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QVQLQESGGGLVQPGGSLRLSCAASGFTFSSYAMGWFRQVPGKGLEWVSGIYSDGSTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCATDRMAGSRWPERDFGSWGQGTQVTVSS,N/A,IGHV3S1 (Alpaca),IGHJ6 (Alpaca),N/A,N/A,AKDRMAGSRWPERDFGF,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/WNb-68_rank1_imgt_scheme.pdb,"Phillip Pymm et al., 2021 (https://www.pnas.org/content/118/19/e2101918118)","May 7, 2021","May 7, 2021",N/A,Complete
WNb-69,Nb,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,Immunised Alpaca,QVQLQESGGGLVQPGGSLRLSCAASGFTFSSYAMGWARQVPGKGLEWVSGIYSDGSTYYADSVKGRFIISRDNAKNTVYLQMNSLKPEDTAVYYCAKDRMEGSSWPERDFGSWGQGTQVTVSS,N/A,IGHV3S1 (Alpaca),IGHJ6 (Alpaca),N/A,N/A,AAISGSYYYTSLHPVEYDS,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/WNb-69_rank1_imgt_scheme.pdb,"Phillip Pymm et al., 2021 (https://www.pnas.org/content/118/19/e2101918118)","May 7, 2021","May 7, 2021",N/A,Complete
WNb-70,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QVQLQESGGGLVQPGGSLRLSCAASGFTFSSYLMGWFRQVPGKGLEWVSGIYSDGGTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCATDRMEGSSWPERDFGSWGQGTQVTVSS,N/A,IGHV3S1 (Alpaca),IGHJ6 (Alpaca),N/A,N/A,AAQMGSSEYCPIFIPGEGMDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/WNb-70_rank1_imgt_scheme.pdb,"Phillip Pymm et al., 2021 (https://www.pnas.org/content/118/19/e2101918118)","May 7, 2021","May 7, 2021",N/A,Complete
CA521,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,Transgenic Mouse,EVQLQQWGAGLLKPSETLSLTCAVYGGSFSGYYWSWIRQPPGKGLEWIGEVNHSGSTNYNPSLKSRVTISVDTSKNQLSLKLNSVTAADTAVYYCARGNTMVRGVIIPFEYWDKGTLVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPLTFGGGTKVEIK,IGHV4-34 (Human),IGHJ4 (Human),IGKV3-11 (Human),IGKJ4 (Human),ARGNTMVRGVIIPFEY,QQRSNWPLT,https://www.rcsb.org/structure/7E23,,"Deyong Song et al., 2021 (https://www.nature.com/articles/s42003-021-02029-w)","May 7, 2021","May 7, 2021",N/A,Complete
BG1-24,Ab,SARS-CoV2,SARS-CoV1;MERS-CoV,SARS-CoV2,SARS-CoV1;MERS-CoV,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGRIISMFGIANNAQKFQGRLTITADTSTSTAYMELSSLRSEDTAVYYCARGPYYYDSGGYYLDYWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVGSGYLAWYQQRPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYAGSPRTFGQGTRLEIK,IGHV1-69 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ5 (Human),ARGPYYYDSGGYYLDY,QQYAGSPRT,https://www.rcsb.org/structure/7M6I,,"Johannes Scheid et al., 2021 (https://www.sciencedirect.com/science/article/pii/S0092867421005353)","May 7, 2021","Jun 10, 2021",10th June '21: Corrected entry name,Variant binding data in publication. Complete
BG7-20,Ab,SARS-CoV2,SARS-CoV1;MERS-CoV,SARS-CoV2,SARS-CoV1;MERS-CoV,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVQSGAEVKKAGASVKVSCKASGYTFTSYDINWVRQASGQGLEWMGWMNPISGNTGYAQKFQGRVTMTRNTSITTAYMELSSLRSEDTAVYFCARGGRYCSSTTCYSGVGMDVWGQGTTVTVPSA,QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWYHQLPGTAPKFLIYGNSNRPSGVPDRFSGSKSGTSASLAITRLQAEDEADYYCQSYDSSLSGWVFGGGTKLTVL,IGHV1-8 (Human),IGHJ6 (Human),IGLV1-40 (Human),IGLJ3 (Human),ARGGRYCSSTTCYSGVGMDV,QSYDSSLSGWV,https://www.rcsb.org/structure/7M6H,,"Johannes Scheid et al., 2021 (https://www.sciencedirect.com/science/article/pii/S0092867421005353)","May 7, 2021","May 7, 2021",N/A,Variant binding data in publication. Complete
BG7-15,Ab,SARS-CoV2,SARS-CoV1;MERS-CoV,SARS-CoV2,SARS-CoV1;MERS-CoV,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYAISWVRQAPGQGLEWMGWVSAYNGNTNYAQKLQGRVTMTTDTSTNTAYMELRSLRSDDTAIYYCAIPYSSVTFDCWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSGTFLAWYQQKPGQAPRLLISGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSRPTFGQGTKLEIK,IGHV1-18 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ2 (Human),AIPYSSVTFDC,QQYGSSRPT,https://www.rcsb.org/structure/7M6G,,"Johannes Scheid et al., 2021 (https://www.sciencedirect.com/science/article/pii/S0092867421005353)","May 7, 2021","May 7, 2021",N/A,Variant binding data in publication. Complete
BG1-22,Ab,SARS-CoV2,SARS-CoV1;MERS-CoV,SARS-CoV2,SARS-CoV1;MERS-CoV,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLVQPGGSLRLSCSVSGFTVSSNYMNWVRQAPGKGLEWVSVIYPGGSTFYPDSVKGRFTISRDDSKNTLYLQMNSLRPEDTAAYYCASSRPPIGQLVPGLDLDWFDPWGQGTLVIVSS,QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYYVHWYQQHPGTAPKLLIYGNSNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSRLSGWVFGGGTKLTVL,IGHV3-66 (Human),IGHJ5 (Human),IGLV1-40 (Human),IGLJ3 (Human),ASSRPPIGQLVPGLDLDWFDP,QSYDSRLSGWV,https://www.rcsb.org/structure/7M6F,,"Johannes Scheid et al., 2021 (https://www.sciencedirect.com/science/article/pii/S0092867421005353)","May 7, 2021","May 7, 2021",N/A,Variant binding data in publication. Complete
BG10-19,Ab,SARS-CoV2;SARS-CoV1,MERS-CoV,SARS-CoV2;SARS-CoV1,MERS-CoV,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVQSGAEVKKPGESLKISCKGSGYSFTSYWIGWVRQMPGKGLEWMGVIYPGDSDTRYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARTQWGYNYGSHFFYMDVWGKGTTVTVSS,QSVLTQPPSASGTPGQRVTISCSGSSSNIGSDHVYWYQQLPGTAPKLFIYRNNQRPSGVPDRFSGSKSGTSASLAISGLRSEDEADYYCAAWDASLSGYVFGTGTKVTVL,IGHV5-51 (Human),IGHJ6 (Human),IGLV1-47 (Human),IGLJ1 (Human),ARTQWGYNYGSHFFYMDV,AAWDASLSGYV,https://www.rcsb.org/structure/7M6E,,"Johannes Scheid et al., 2021 (https://www.sciencedirect.com/science/article/pii/S0092867421005353)","May 7, 2021","May 7, 2021",N/A,Variant binding data in publication. Complete
BG4-25,Ab,SARS-CoV2,SARS-CoV1;MERS-CoV,SARS-CoV2,SARS-CoV1;MERS-CoV,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLIQPGGSLRLSCAASGITVVRNYMTWVRQAPGKGLEWVSVIYSGGTTYYADSVKGRFTISRDNSKNTMYLQMNSLRAEDTAIYYCARDLEVVGAMDVWGQGTTVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVPSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSPMYTFGQGTKLEIK,IGHV3-53 (Human),IGHJ6 (Human),IGKV3-20 (Human),IGKJ2 (Human),ARDLEVVGAMDV,QQYGSPMYT,https://www.rcsb.org/structure/7M6D,,"Johannes Scheid et al., 2021 (https://www.sciencedirect.com/science/article/pii/S0092867421005353)","May 7, 2021","May 7, 2021",N/A,Variant binding data in publication. Complete
S2H97,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVRLVQSGAEVKKSGESLKISCKGSGYSFTSYWIGWVRQMPGKGLEWMGIIYPGDSDTRYSPSFQGQVTISADKSISTVYLQWSSLKASDTAMYYCARQWSHYTYDYYYWGQGTLVTISS,QSVLTQPASVSGSPGQSITISCTGISSDVGGYNSVSWYQQHPGKAPKLMIYDVTNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSTPPYVFGTGTKVSVL,IGHV5-51 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ1 (Human),ARQWSHYTYDYYY,SSYTSSSTPPYV,https://www.rcsb.org/structure/7M7W,,"M Alejandra Tortorici et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.04.07.438818v1) and Tyler Starr et al., 2021 (https://www.nature.com/articles/s41586-021-03807-6)","Apr 21, 2021","Jul 24, 2021",24th July '21: Added new reference with expanded variant binding data.,Variant binding data in publication. Complete
COV2-2002,Ab,SARS-CoV2,,,SARS-CoV2,S; S2,B-cells; SARS-CoV2 Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFSFYWMSWVRQAPGKGLEWVANIKQDGSEKYYVDSVKGRSTISRDNAKNSLYLQMNSLRAEDTAVYYCARVGSSSWYFDYWGQGTLVTVSS,SYELTQPPSVSVSPGQTASITCSGDKLGDKYACWYQQKPGQSPVLVIYQDIKRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCQAWDSSTGVFGGGTKLTVL,IGHV3-7 (Human),IGHJ4 (Human),IGLV3-1 (Human),IGLJ3 (Human),ARVGSSSWYFDY,QAWDSSTGV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2002_rank1_imgt_scheme.pdb,"Elaine Chen et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.05.02.442326v1)","May 5, 2021","May 5, 2021",N/A,Complete
P008_056,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; NTD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLVKPGGSLRLSCAASGFSFSSYSMNWVRQAPGKGLEWVSSISSNSNYIYYADSMKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCASNRSPYDSSNYYFDYWGQGTRVTISS,AIRMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQHHDSLPLTFGGGTKVEIK,IGHV3-21 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ4 (Human),ASNRSPYDSSNYYFDY,QHHDSLPLT,https://www.rcsb.org/structure/7NTC,,"Annachiara Rosa et al., 2021 (https://advances.sciencemag.org/content/early/2021/04/22/sciadv.abg7607) and Carl Graham et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357)","May 5, 2021","Jul 9, 2021",9th July '21: Added new reference.,Complete
58G6,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV1-58 (Human),ND,IGKV3-20 (Human),ND,AAPNCNSTTCHDGFDI,QQYDNSPWT,Expected (7E3L),,"Tingting Li et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.04.19.440481v1)","Apr 21, 2021","Apr 21, 2021",N/A,Awaiting publication for full sequences
13G9,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV1-58 (Human),ND,IGKV3-20 (Human),ND,AAPYCSSTSCRDGFDI,QQYGRSPWT,Expected (7E3K),,"Tingting Li et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.04.19.440481v1)","Apr 21, 2021","Apr 21, 2021",N/A,Awaiting publication for full sequences
R15,Ab,SARS-CoV2,,,,S; RBD,Immunised Mouse,QIQLVQSGPELKKPGETVKISCKASGYTFTKYGINWVKQAPGKDLKWMGWINTYTGEPAYGDDFKGRFAFSLETSTNTAYLQINNFKNEDTATYFCARNGAMDYWGQGTSVTVSS,DVVMTQNPLTLSVTIGQPASISCKSSQSLLDSDGKTYLIWLLQRPGQSPKRLISLVSKLDSGVPDRFTGSGSGTDFTLKISRVEAEDLGVYYCWQGTHFPGTFGGGTKLEIK,IGHV9-3-1 (Mouse),IGHJ4 (Mouse),IGKV1-135 (Mouse),IGKJ1 (Mouse),ARNGAMDY,WQGTHFPGT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/R15_rank1_imgt_scheme.pdb,"Youjia Guo et al., 2021 (https://www.jbc.org/article/S0021-9258(21)00118-6/fulltext)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
R22,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,Immunised Mouse,EVQLQQSGPELVRPGASVKISCKTSGYTFTEYIIHWVKQSHGKSLEWIGGIDPNNGDTSYNQKFKGKASLTVDKSSSTAYMELRSLTSDDSAVYYCARLDFDYWGQGTTLTVSS,DIVMTQSHKFMSTSVGDRVSITCKASQDVRTAVAWYQQKPGQSPKLLIYWASTRYTGVPDRFTGSGSGTDYTLTISSVQAEDLALYYCQQHDSTPLTFGAGTKLELK,IGHV1-26 (Mouse),IGHJ2 (Mouse),IGKV6-25 (Mouse),IGKJ5 (Mouse),ARLDFDY,QQHDSTPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/R22_rank1_imgt_scheme.pdb,"Youjia Guo et al., 2021 (https://www.jbc.org/article/S0021-9258(21)00118-6/fulltext)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
R31,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,Immunised Mouse,QVQLQQSGAELVRPGTSVKISCKASYTFTNYWLAWVKQRPGHGLEWIGDIYPGGAYTNFNEKFKGKATLTADTSSSTAYMQLSSLTSEDSAVYFCARDGHYGYAMDYWGQGTSVTVSS,DIVMTQAAFSNPVTLGTSASISCRSSKSLLHSNGITYLYWYLQKPGQSPQLLIYQMSDLASGVPDRFSSSGSGTDFTLRISRVEAEDVGVYYCAQNLELPRTFGGGIKLEIK,IGHV1-63 (Mouse),IGHJ4 (Mouse),IGKV2-109 (Mouse),IGKJ1 (Mouse),ARDGHYGYAMDY,AQNLELPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/R31_rank1_imgt_scheme.pdb,"Youjia Guo et al., 2021 (https://www.jbc.org/article/S0021-9258(21)00118-6/fulltext)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
R52,Ab,SARS-CoV2,,,,S; RBD,Immunised Mouse,QIQLVQSGPELKKPGETVKISCKASGYTFTNYGMNWVKQAPGNGLRWMGWINTYTREPSYAADFKGRFAFSLETSARAAYLQINNLKNEDTATYFCARNGAMDYWGQGTSVTVSS,DVVMTQTPLTLSVTFGQPASISCKSSQSLLDSDGKTYLIWLLQRPGQSPKRLISLVSKLDSGVPDRFTGSGSGTDFTLKISRVEAEDLGVYYCWQGTHFPGTFGGGTKLEIK,IGHV9-3-1 (Mouse),IGHJ4 (Mouse),IGKV1-135 (Mouse),IGKJ1 (Mouse),ARNGAMDY,WQGTHFPGT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/R52_rank1_imgt_scheme.pdb,"Youjia Guo et al., 2021 (https://www.jbc.org/article/S0021-9258(21)00118-6/fulltext)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
S1D7,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Mouse,QVQLQQSGAELVKPGASVKLSCKASGYTFTSYYIYWMKQRPGQGLEWIGEINPNNGGTNFNEKFKSKATLTVDKSSSTAYMQLSSLTSEDSAVYYCTRGHSDYWGQGTTLTVSS,DIVLTQSPASLAVSLGQRATISCRASESVEYYGTGLMQWYQQKPGQPPKLLIYAASNVESGVPARFSGSGSGTDFSLNIHPVEEDDIAMYFCQQTRKVPYTFGGGTKLEIK,IGHV1-53 (Mouse),IGHJ2 (Mouse),IGKV3-1 (Mouse),IGKJ2 (Mouse),TRGHSDY,QQTRKVPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/S1D7_rank1_imgt_scheme.pdb,"Youjia Guo et al., 2021 (https://www.jbc.org/article/S0021-9258(21)00118-6/fulltext)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
S3D8,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Mouse,QVQLQQSGAELVKPGASVKLSCKASGYTFTSYYMYWMKQRPGQGLEWIGEINPSNGGTNFNEKFKSKATLTVDKSSSTAYMQLSSLTSEDSAVYYCTIFITRDAMDYWGQGTSVTVSS,QIVLTQSPAIMSASPGEKVTLTCSASSSVSSSYLFWYQQKPGSSPKLWIYTTSNLASGVPARFSGSGSGTSYSLTISSMEAEDAASYFCHQWSSYPPTFGAGTKLELK,IGHV1-53 (Mouse),IGHJ4 (Mouse),IGKV4-79 (Mouse),IGKJ5 (Mouse),TIFITRDAMDY,HQWSSYPPT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/S3D8_rank1_imgt_scheme.pdb,"Youjia Guo et al., 2021 (https://www.jbc.org/article/S0021-9258(21)00118-6/fulltext)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C158,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFISYYMHWVRQAPGQGLEWMGIINPSGGSTSYAQKFQGRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARANEGAAVSFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPPEGSFGQGTKLEIK,IGHV1-46 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ2 (Human),ARANEGAAVSFDY,QQSYSTPPEGS,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C158_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C159,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGDLVQPGGSLRLSCSASGFTFSSYAMHWVRQAPGKGLEYVSVISNTGGDTYYADSVKGRFTISRDNSKNTLYLQVSSLRPEDTAVYYCVKDQGGRGWPSYYYYHYMDVWGKGTTVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDIGDYNYVSWYQHHPGKAPKLMIYEVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDETDYYCISYTSSSTLPYVFGTGTKVTVL,IGHV3-64D (Human),IGHJ6 (Human),IGLV2-14 (Human),IGLJ1 (Human),VKDQGGRGWPSYYYYHYMDV,ISYTSSSTLPYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C159_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C160,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYGISWVRQAPGQGLEWMGWISAYNGNTNYAQKLQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARVPASYGDDDYYYYYGMDVWGQGTTVTVSS,SYELTQPPSVSVSPGQTARITCSGDALPKQYAYWYQQKPGQAPVLVIYKDSERPSGIPERFSGSSSGTTVTLTISGVQAEDEADYYCQSADSSGTLWVFGGGTKLTVL,IGHV1-18 (Human),IGHJ6 (Human),IGLV3-25 (Human),IGLJ3 (Human),ARVPASYGDDDYYYYYGMDV,QSADSSGTLWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C160_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C166,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLLESGGGLVQPGGSLRLSCAASGFTFSNYAMSWVRQAPGKGLEWVSGISNSGGSTYYEDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKVGEYCGDDCYRGLDYWGQGTLVTVSS,QTVVTQEPSLTVSPGGTVTLTCGSSTGAVTSGHYPYWFQQKSGQAPRTLIYETNIKHSWTPARFSGSLLGGKAALTLSGAQPDDEADYYCLLSYSGARPVFGGGTKLTVL,IGHV3-23 (Human),IGHJ4 (Human),IGLV7-46 (Human),IGLJ3 (Human),AKVGEYCGDDCYRGLDY,LLSYSGARPV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C166_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C167,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Patient,EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSAISNSGGSTYYEDSVKGRFTISRDNSKSTLYLQMNSLGADDTAVYYCAKVGEYCGGDCYRGLDYWGQGTLVTVSS,QAVVTQEPSLTVSPGGTVTLTCGSSTGAVTSGHYPYWFQQKSGQAPTTLIYETSIKHSWTPARFSGSLLGGKAALTLSGAQPEDEAEYYCLLSYSGARPVFGGGTKLTVL,IGHV3-23 (Human),IGHJ4 (Human),IGLV7-46 (Human),IGLJ3 (Human),AKVGEYCGGDCYRGLDY,LLSYSGARPV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C167_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C168,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLVQPGGSQRLSCAASGFTVSSNYMSWIRQAPGKGLEWVSVIYSGGSAYYVDSVKGRFTISRDNSKNTLYLQMNSLRPEDTAVYYCARIANYMDVWGKGTTVTVSS,EIVMTQSPATLSVSPGERATLSCRASQSVSSHLAWYQQKPGQAPRLLIYGASTRATGIPTRFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNWPPLTFGGGTKVEIK,IGHV3-66 (Human),IGHJ6 (Human),IGKV3-15 (Human),IGKJ4 (Human),ARIANYMDV,QQYNNWPPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C168_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C169,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLVQPGGSQRLSCAASGFTVSSNYMSWIRQAPGKGLEWVSVIYSGGSAYYVDSVKGRFTISRDNSKNTLYLQMNSLRPEDTAVYYCARIANYMDVWGKGTTVTVSS,EIVMTQSPATLSVSPGERATLSCRASQSVSSHLAWYQQKPGQAPRLLIYGASTRATGIPTRFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNWPPLTFGGGTKVEIK,IGHV3-66 (Human),IGHJ6 (Human),IGKV3-15 (Human),IGKJ4 (Human),ARIANYMDV,QQYNNWPPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C169_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C170,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Patient,QVQLQESGPGLVKPSETLSLTCTVSGGSISSYYWSWIRQPPGKGLEWIGYIYYSGSTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARYQLAPGSGSYYNWGGYPRESEYYFDYWGQGTLVTVSS,QSALTQPRSVSGSPGQSVTISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSKRPSGVPDRFSGSKSGNTASLTISGLQAEDEADYYCCSYAGSYTWVFGGGTKLTVL,IGHV4-59 (Human),IGHJ4 (Human),IGLV2-11 (Human),IGLJ3 (Human),ARYQLAPGSGSYYNWGGYPRESEYYFDY,CSYAGSYTWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C170_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C171,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Patient,QVQLQESGPGLVKPSETLSLTCTVSGGSISSYYWSWIRQPPGKGLEWIGYIYYSGSTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARYQLAPGSGSYYNWGGYPRESEYYFDYWGQGTLVTVSS,QSALTQPRSVSGSPGQSVTISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSKRPSGVPDRFSGSKSGNTASLTISGLQAEDEADYYCCSYAGSYTWVFGGGTKLTVL,IGHV4-59 (Human),IGHJ4 (Human),IGLV2-11 (Human),IGLJ3 (Human),ARYQLAPGSGSYYNWGGYPRESEYYFDY,CSYAGSYTWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C171_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C172,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGRDKYYVDSVKGRFIISRDNSKNTLYLQMNSLRGEDTAVYYCAKTYSGYGYYYYGMDVWGQGTTVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGDYNYVSWYQQHPGKAPKLMIYEVSNRPSGVSDRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSTWVFGGGTKLTVL,IGHV3-30 (Human),IGHJ6 (Human),IGLV2-14 (Human),IGLJ3 (Human),AKTYSGYGYYYYGMDV,SSYTSSSTWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C172_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C174,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFTRYAMNWVRQAPGKGLEWISYINIGSTNIEYGDSVKGRFTISRDNAKNSVYLQMNSLREEDTAVYYCSRGDCTSSSCYSIDFWGQGSLVIVSS,DIQMTQSPSSLSASVGDRVTITCRASQTITNYLNWYQQTPGKAPKLLIYAASNLQSGVPSRFSGSGSGTDFTLTISGLEAEDFAAYYCQQTYRAPLTFGGGTKVEIK,IGHV3-48 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ4 (Human),SRGDCTSSSCYSIDF,QQTYRAPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C174_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C175,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVETGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRVEDTAVYYCARGPYCGGDCDYWGQGTLVTVSS,DIQMTQSPSSLSAFVGDRVTITCQASQDISNYLNWFQQKPGKAPKLLIYDASNLKTGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPLTFGGGTKVEIK,IGHV3-53 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ4 (Human),ARGPYCGGDCDY,QQYDNLPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C175_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C445,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Patient,QVQLQQSGPGLVKPSQTLSLTCAISGDSVSSNSAAWNWIRQSPSRGLEWLGRTYYRSKWYNDYAVSVKSRITINPDTSKNQFSLQLNSVTPEDTAVYYCARDPSSHFDYWGQGTLVTVSS,SYELTQPPSVSVSPGQTASITCSGDKLGDKYACWYQQKPGQSPVLVIYQDNKRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCQAWDSSTARVFGGGTKLTVL,IGHV6-1 (Human),IGHJ4 (Human),IGLV3-1 (Human),IGLJ3 (Human),ARDPSSHFDY,QAWDSSTARV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C445_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C399,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYRGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARGGWYYDSSGYYSGRTDAFDIWGQGTMVTVSS,QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWYQQLPGTAPKLLIYGNSNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSSLSVFYVFGTGTKVTVL,IGHV3-53 (Human),IGHJ3 (Human),IGLV1-40 (Human),IGLJ1 (Human),ARGGWYYDSSGYYSGRTDAFDI,QSYDSSLSVFYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C399_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C447,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYRGGNTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARGGWYYDSSGYYSGRTDAFDIWGQGTMVTVSS,QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWYQQLPGTAPKLLIYGNSNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSSLSVFYVFGTGTKVTVL,IGHV3-53 (Human),IGHJ3 (Human),IGLV1-40 (Human),IGLJ1 (Human),ARGGWYYDSSGYYSGRTDAFDI,QSYDSSLSVFYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C447_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C394,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAREGDVEGYYDFWSGYSRDRYYFDYWGQGTLVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSTRVFGTGTKVTVL,IGHV3-53 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ1 (Human),AREGDVEGYYDFWSGYSRDRYYFDY,SSYTSSSTRV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C394_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C405,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLLESGGGLVKPGGSLRLSCAASGFTFSSYSMNWVRQAPGKGLEWVSSISSSSSYIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARERGYYGGKTPPFLGGQGTLVTVSS,NFMLTQPHSVSESPGKTVTISCTGSSGSIASNYVQWYQQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSSNYWVFGGGTKLTVL,IGHV3-21 (Human),IGHJ4 (Human),IGLV6-57 (Human),IGLJ3 (Human),ARERGYYGGKTPPFL,QSYDSSNYWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C405_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C449,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSAYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCHRGSYSTFSYYYYMDVWGKGTTVTVSS,DIQLTQSPSSLSASVGDRVTITCRASQGISSALAWYQQKPGKAPKLLIYDASSLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQFNSLFTFGPGTKVDIK,IGHV3-66 (Human),IGHJ6 (Human),IGKV1-13 (Human),IGKJ3 (Human),HRGSYSTFSYYYYMDV,QQFNSLFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C449_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C404,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Patient,QVQLQESGPGLVKPSGTLSLTCAVSGGSISSSNWWSWVRQPPGKGLEWIGEIYHSGSTNYNPSLKSRVTISVDKSKNQFSLKLSSVTAADTAVYYCATHLRLGELRGVDYWGQGTLVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFSLTISSLEPEDFAVYYCQQRSNWPPWTFGQGTKVEIK,IGHV4-4 (Human),IGHJ4 (Human),IGKV3-11 (Human),IGKJ1 (Human),ATHLRLGELRGVDY,QQRSNWPPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C404_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C403,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSAYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLRDQDGYSYGAFDYWGQGTLVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSSWVFGGGTKLTVL,IGHV3-66 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ3 (Human),ARDLRDQDGYSYGAFDY,SSYTSSSSWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C403_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C311,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Patient,EVQLLESGGGLVKPGGSLRLSCAASGFTFSSYNMNWVRQAPGKGLEWVSSISSSSSHIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARERGYHGGKTSPFLGGQGTLVTVSS,NFMLTQPHSVSESPGKTVTISCTGSSGSIASNYVQWYQQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSSNYWVFGGGTKLTVL,IGHV3-21 (Human),IGHJ5 (Human),IGLV6-57 (Human),IGLJ3 (Human),ARERGYHGGKTSPFL,QSYDSSNYWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C311_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C457,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Patient,QVQLQESGPGLVKPSETLSLTCTVSGGSISSYYWSWIRQPPGKGLEWIGYIYYSGSTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARYQLAPGSGSYYNWGGYPRESEYYFDYWGQGTLVTVSS,QSALTQPRSVSGSPGQSVTISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSKRPSGVPDRFSGSKSGNTASLTISGLQAEDEADYYCCSYAGSYTWVFGGGTKLTVL,IGHV4-59 (Human),IGHJ4 (Human),IGLV2-11 (Human),IGLJ3 (Human),ARYQLAPGSGSYYNWGGYPRESEYYFDY,CSYAGSYTWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C457_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C479,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYYMHWVRQAPGQGLEWMGIINPSGGSTTYAQKFQGRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARVGCGGDNCYFWRPLGNGMDVWGQGTTVTVSS,QTVVTQEPSLTVSPGGTVTLTCASSTGAVTSGYYPNWFQQKPGQAPRALIYSTSNKHSWTPARFSGSLLGGKAALTLSGVQPEDEAEYYCLLYYGGAQLGVFGGGTKLTVL,IGHV1-46 (Human),IGHJ6 (Human),IGLV7-43 (Human),IGLJ3 (Human),ARVGCGGDNCYFWRPLGNGMDV,LLYYGGAQLGV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C479_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C461,Ab,SARS-CoV2 (weak),,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Patient,EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSGISGSGTSTYYADSVKGRFTISRDNSKNTLYVQMNSLRAEDTAVYYCAKDLGLYGAPYWYFDLWGRGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSNLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPCSFGQGTKLEIK,IGHV3-23 (Human),IGHJ2 (Human),IGKV3-20 (Human),IGKJ2 (Human),AKDLGLYGAPYWYFDL,QQYGSSPCS,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C461_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C462,Ab,SARS-CoV2 (weak),,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Patient,EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSAISGSGGSTYYADSVKGRFTVSRDNSKNTLYLQMNSLRAEDTALYYCANPFTIFGVVPDWYFDLWGRGTLVTVSS,QSALTQPRSVSGSPGQSVTISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSKRPSGVPDRFSGSKSGNTASLTISGLQAEDEADYYCCSYAGSFWVFGGGTKLTVL,IGHV3-23 (Human),IGHJ2 (Human),IGLV2-11 (Human),IGLJ3 (Human),ANPFTIFGVVPDWYFDL,CSYAGSFWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C462_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C443,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVIRYDGSNKYYADSVKGRFTISRDNSKNKLYLQMNSLRAEDTAVYYCAREDYYDSSGSLDYWGQGTLVTVSS,QSALTQPRSVSGSPGQSVTISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSKRPSGVPDRFSGSKSGNTASLTISGLQAEDEADYYCCSYAGSPWVFGGGTKLTVL,IGHV3-33 (Human),IGHJ4 (Human),IGLV2-11 (Human),IGLJ3 (Human),AREDYYDSSGSLDY,CSYAGSPWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C443_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C482,Ab,SARS-CoV2 (weak),,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSAYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDGRAVAGTNWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPRTFGQGTKVEIK,IGHV3-66 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ1 (Human),ARDGRAVAGTN,QQYDNLPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C482_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C484,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSAYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCHRGSYSTFSYYYYMDVWGKGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQGISSALAWYQQKPGKAPKLLIYDASSLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQFNSLFTFGPGTKVDIK,IGHV3-66 (Human),IGHJ6 (Human),IGKV1-13 (Human),IGKJ3 (Human),HRGSYSTFSYYYYMDV,QQFNSLFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C484_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C348,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Patient,EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSATSDSGGTTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAIYYCARRGNSGSYPDPDYWGQGTLVTVSS,DIVMTQSPDSLAVSLGERATINCKSSQNVLYSSNNKNYLAWYQQKPRQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYTLRWTFGQGTKVEIK,IGHV3-23 (Human),IGHJ4 (Human),IGKV4-1 (Human),IGKJ1 (Human),ARRGNSGSYPDPDY,QQYYTLRWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C348_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C349,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVQSGAEVKKPGASVKVSCKTSGYIFTDYSMHWVRQAPGQGLEWMGWVNPNSGGTNYAQKFQGWVTMARDTSITTVYMELSRLRSDDTAVYYCARGPLPHRLVYDFWSGFHDAFDIWGQGTMVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGGYNFVSWYQQHPGKAPKLMIYEVSDRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSTWVFGGGTKLTVL,IGHV1-2 (Human),IGHJ3 (Human),IGLV2-14 (Human),IGLJ3 (Human),ARGPLPHRLVYDFWSGFHDAFDI,SSYTSSSTWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C349_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C350,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVESGGDLVKPGGSLRLSCAASGFIFSNAWMSWVRQAPGKGLEWVGRIKSKTDGGTTDYAAPVKGRFTISRDDSKNTLYLQMNSLKTEDTAVYYCYRFCSDGSCYRHFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISIYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPPETFGQGTKVEIK,IGHV3-15 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ1 (Human),YRFCSDGSCYRHFDY,QQSYSTPPET,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C350_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C351,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Patient,EVQLLESGGGLVKPGGSLRLSCAASGFTFSTYTMNWVRQAPGKGLEWVSSISSVSSYIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARECSDESFDYWGQGTLVTVSS,QSALTQPRSVSGSPGQSVTISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSKRPSGVPDRFSGSKSYNTASLTISGLQAEDEADYYCCSYAGSYTWVFGGGTKLTVL,IGHV3-21 (Human),IGHJ4 (Human),IGLV2-11 (Human),IGLJ3 (Human),ARECSDESFDY,CSYAGSYTWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C351_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C353,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSNYGMHWVRQAPGKGLEWVAVIRYNGNNIYYADFVKGRFTISRDNSKNTLYLQMNSLRGEDTAVYYCAREGDGPDAFDIWGQGTMV,DIQMTQSPSTLSASVGDRVTITCRASQSISSWLAWYQQKPGKAPKLLIYEASSLKSGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNNYGITFGQGTRLEIK,IGHV3-33 (Human),IGHJ3 (Human),IGKV1-5 (Human),IGKJ5 (Human),AREGDGPDAFDI,QQYNNYGIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C353_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C354,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLIQPGGSLRLSCAASGLTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVRGRFTISRDNSENTLYLQMNSLRAEDTAVYYCARVGDWYFSWGQGTLVTVSS,DIQLTQSPSFLSASVGDRVTITCRASQGVGSYLAWYQQKPGKAPNLLIYAASTLQSGVPSRFSGSGSGTEFTLKITSLQPEDIATYYCQQLNSYPPLTFGGGTKVEIK,IGHV3-53 (Human),IGHJ5 (Human),IGKV1-9 (Human),IGKJ4 (Human),ARVGDWYFS,QQLNSYPPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C354_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C355,Ab,SARS-CoV2 (weak),,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLIQPGGSLRLPCAASGFIVSSNYMSWVRQAPGKGLEWVSDIYSGGSTHYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARTTPHRGGEVWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQSDNLPLTFGGGTKVEI,IGHV3-53 (Human),IGHJ6 (Human),IGKV1-33 (Human),IGKJ4 (Human),ARTTPHRGGEV,QQSDNLPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C355_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C357,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Patient,QVQLQESGPGLVKPSETLSLTCTFSGGSISSYSWNWIRQPPGKGLEWIGYIYTSGSTNYNPSLKSRVTMSVDTSKNQFSLKLNSVTAADAAVYFCARGLFYNSGGYYSSNYYYYIDVWGKGTTVTVSS,EIVLTQSPGTLSLSPGERVTLSCRASQSITSTYLTWYQQKPGQAPRLLIYGASNRATGIPDRFSSSGSGTDFTLTISRLEPEDFAVYYCQHYDRSPLCSFGQGTKLEIK,IGHV4-4 (Human),IGHJ6 (Human),IGKV3-20 (Human),IGKJ2 (Human),ARGLFYNSGGYYSSNYYYYIDV,QHYDRSPLCS,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C357_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C358,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVQSAAEVKKPGESLRISCKGSGYSFTNYWINWVRQMPGKGLEWMGRIDPSDSYTNYSPSFQGHVTISADKSISTAYLQWSSLKASDTAMYYCARLNTDLRSRFGELYYYFDYWGQGTLV,EIVLTQSPGILSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRAAGIPDRFSGSGSGTDFTLTISRLEPEDSAVYYCQQYGSSLTWTFGQGTKVEIK,IGHV5-10-1 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ1 (Human),ARLNTDLRSRFGELYYYFDY,QQYGSSLTWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C358_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C379,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Patient,ESGGGLVQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSAYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLRDQDGYSYGAFDYWGQGTLVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSSWVFGGGTKLTVL,IGHV3-66 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ3 (Human),ARDLRDQDGYSYGAFDY,SSYTSSSSWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C379_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C380,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVQSGAEVKKPGASVKVSCKASGYIFTDYSMHWVRQAPGQGLEWIGWVNPNSGGTNYAQKFQGWVTMARDTSITTVYMELSRLKSDDTAVYFCARGPLFHRLVYDFWSGYHDGFDMWGQGTMVTVSS,QSVLTQPASVSGSPGQSITISCTGTSSDVGGYKFVSWYQQHPGKAPKLMIYEVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCNSYTSSSTWVFGGGTKLTVL,IGHV1-2 (Human),IGHJ3 (Human),IGLV2-14 (Human),IGLJ3 (Human),ARGPLFHRLVYDFWSGYHDGFDM,NSYTSSSTWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C380_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C381,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYGISWVRQAPGQGLEWMGWISAYNGNTNYAQKLQGRVTMTTDTSTSTAYMDLRSLRSDDTAVYYCARVPASYGDDDYYYYYGMDVWGQGTTVTVSS,SYELTQPPSVSVSPGQTARITCSGDALPKQYAYWYQQKPGQAPVLVIYKDSERPSGIPERFSGSSSGTTVTLTISGVQAEDEADYYCQSADSSGTLWVFGGGTKLTVL,IGHV1-18 (Human),IGHJ6 (Human),IGLV3-25 (Human),IGLJ3 (Human),ARVPASYGDDDYYYYYGMDV,QSADSSGTLWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C381_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C198,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLVKPGGSLRLSCAASGFTFSSYSMNWVRQAPGKGLEWVSSISRDSKYIYYAESVKGRFTISRDNAKNSLYLQMNSLIVEDTAVYYCARDDGIAAASDYWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASRRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPLLTFGGGTKVEIK,IGHV3-21 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ4 (Human),ARDDGIAAASDY,QQYGSSPLLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C198_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C199,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLVKPGGSLRLSCAASGFTFSSYSMNWVRQAPGKGLEWVSSISRDSKYIYYAESVKGRFTISRDNAKNSLYLQMNSLIVEDTAVYYCARDDGIAAASDYWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASRRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPLLTFGGGTKVEIK,IGHV3-21 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ4 (Human),ARDDGIAAASDY,QQYGSSPLLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C199_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C300,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLQQWGAGLLKPSETLSRTCAVYGGSFSGYYWSWIRQSPGKGLEWIGEINDSGSTNYNPSLKSRVTISVDTSKNQFSLRLSSVTAADTAVYYCARGHTQEKWELREGYYFDYWDQGTLVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGDYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYASGSTLYYVFGTGTKVTVL,IGHV4-34 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ1 (Human),ARGHTQEKWELREGYYFDY,SSYASGSTLYYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C300_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C387,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVQSGPEVKKPGTSVKVSCKASGFTFTSSAVQWVRQARGQRLEWIGWIVVGSGNTNYAQKFQERVTITRDMSTSTAYMELSSLRSEDTAVYYCAAPHCSGGSCYDAFDIWGQGTMVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK,IGHV1-58 (Human),IGHJ3 (Human),IGKV3-20 (Human),IGKJ1 (Human),AAPHCSGGSCYDAFDI,QQYGSSPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C387_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C388,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVQSGPEVKKPGTSVKVSCKASGFTFTSSAVQWVRQARGQRLEWIGWIVVGSGNTNYAQKFQERVTITRDMSTSTAYMELSSLRSEDTAVYYCAAPHCSGGSCYDAFDIWGQGTMVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK,IGHV1-58 (Human),IGHJ3 (Human),IGKV3-20 (Human),IGKJ1 (Human),AAPHCSGGSCYDAFDI,QQYGSSPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C388_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C450,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVQSGPEVKKPGTSVKVSCKASGFTFTSSAVQWVRQARGQRLEWIGWIVVGSGNTNYAQKFQERVTITRDMSTSTAYMELSSLRSEDTAVYYCAAPHCSGGSCYDAFDIWGQGTMVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPYTFGQGTKLEIK,IGHV1-58 (Human),IGHJ3 (Human),IGKV3-20 (Human),IGKJ2 (Human),AAPHCSGGSCYDAFDI,QQYGSSPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C450_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C402,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLQESGPGLVKPSGTLSLTCTVSSDSVSSYYWNWIRQTTGKGMEWIGRIDTGGRTNYNPSLSSRVAMSMATSKNQFSLKLSSVTAADTAVYFCARGLSYYPLYGSHINYIDYWGQGTLVTVSS,QSVLTQPPSASGTPGQRVTISCSGISSNLGSNTVNWFQQLPGTAPKLLIYNSNRRPSGVPDRFSGSKSGTSASLAISGLQSEDEGDYYCAEWDDSLSTWVFGGGTHLTVL,IGHV4-4 (Human),IGHJ4 (Human),IGLV1-44 (Human),IGKJ3 (Human),ARGLSYYPLYGSHINYIDY,AEWDDSLSTWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C402_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C398,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLQESGPGLVKPSGTLSLTCTVSSDSVSSYYWNWIRQTTGKGMEWIGRIDTGGRTNYNPSLSSRVAMSMATSKNQFSLKLSSVTAADTAVYFCARGLSYYPLYGSHINYIDYWGQGTLVTVSS,QSVLTQPPSASGTPGQRVTISCSGISSNLGSNTVNWFQQLPGTAPKLLIYNSNRRPSGVPDRFSGSKSGTSASLAISGLQSEDEGDYYCAEWDDSLSTWVFGGGTHLTVL,IGHV4-4 (Human),IGHJ4 (Human),IGLV1-44 (Human),IGLJ3 (Human),ARGLSYYPLYGSHINYIDY,AEWDDSLSTWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C398_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C431,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGIIPIFGTANYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYCARGNRLLYCSSTSCYLDAVRQGYYYYYYMDVWGKGTTVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPLTFGGGTKVEIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV3-11 (Human),IGKJ4 (Human),ARGNRLLYCSSTSCYLDAVRQGYYYYYYMDV,QQRSNWPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C431_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C395,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTGYYMHWVRQAPGQGLEWMGWINPNSGGTNYAQKFQGRVTMTRETSISTVYMELSRLRSDDTAVYYCARDLGWSRLHGAFDIWGQGTMVTVSS,QSALTQPPSASGSPGQSVTISCTGTSSDVGGYNYVSWYQQRPGKAPKLMIDEVTKRPSGVPDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYAGSNNWVFGGGTKLTVL,IGHV1-2 (Human),IGHJ3 (Human),IGLV2-8 (Human),IGLJ3 (Human),ARDLGWSRLHGAFDI,SSYAGSNNWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C395_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C386,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVESGGGVVQPGRSLRLSCAASGFPFSIYGMHWVRQAPGKGLEWVAVISYDGGNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKEGRPSDIVVVVAFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSVSGTDFTLTISSLLPEDFATYYCQQSYSTPRTFGQGTKVEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ1 (Human),AKEGRPSDIVVVVAFDY,QQSYSTPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C386_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C435,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTGYYMHWVRQAPGQGLEWMGWINPISGGTNYAQKFQGRVTMTRDTSISTAYMELSRLRSDDTAVYYCASPASRGYSGYDHGYYYYMDVWGKGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPITFGQGTRLEIK,IGHV1-2 (Human),IGHJ6 (Human),IGKV1-33 (Human),IGKJ5 (Human),ASPASRGYSGYDHGYYYYMDV,QQYDNLPIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C435_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C451,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTGYFLHWVRQAPGQGLEWVGWISPISGGTNYALKFQGRVTMTRDTSSTTAYMDLSRLRSDDTAVYYCAREALGYGDFPHDGFDLWGKGTMVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGYYNFVSWYQQHPGKAPKLMIFDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSARVFGGGTKVTVL,IGHV1-2 (Human),IGHJ3 (Human),IGLV2-14 (Human),IGLJ6 (Human),AREALGYGDFPHDGFDL,SSYTSSSARV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C451_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C432,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTGYYMHWVRQAPGQGLEWMGWINPNSGGTNYAQKFQGRVTMTRDTSIITAYMELSRLRSDDTAVYYCARAPPFYDFWSGIDYWGQGTLVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSTLVFGGGTKLTV,IGHV1-2 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ3 (Human),ARAPPFYDFWSGIDY,SSYTSSSTLV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C432_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C433,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSTYAISWVRQAPGQGLEWMGGIIPIFGTANYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYCARDLRNCSSTSCYYWFDPWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYVASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTRTFGQGTKVEIK,IGHV1-69 (Human),IGHJ5 (Human),IGKV1-39 (Human),IGKJ1 (Human),ARDLRNCSSTSCYYWFDP,QQSYSTRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C433_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C454,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYTMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARGPRGYYDFWSGYENEYYFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQGISNYLAWYQQKPGKVPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDVATYYCQKYNSAPLTFGQGTRLEIK,IGHV3-30-3 (Human),IGHJ4 (Human),IGKV1-27 (Human),IGKJ5 (Human),ARGPRGYYDFWSGYENEYYFDY,QKYNSAPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C454_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C474,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAREGAGPYYYDSSGYYTLFDDWGQGTLVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPTFGQGTRLEIK,IGHV3-30-3 (Human),IGHJ4 (Human),IGKV3-11 (Human),IGKJ5 (Human),AREGAGPYYYDSSGYYTLFDD,QQRSNWPT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C474_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C434,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGIIPIFGTANYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYCARGNRLLYCSSTSCYLDAVRQGYYYYYYMDVWGKGTTVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPLTFGGGTKVEIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV3-11 (Human),IGKJ4 (Human),ARGNRLLYCSSTSCYLDAVRQGYYYYYYMDV,QQRSNWPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C434_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C330,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVESGAEVKKPGASVKVSCKASGYTFTAYYMHWVRQAPGQGLEWMGWINPNSGGTNYAQKFQGRVTMTRDTSISTAYMELSRLRSDDTAVYYCARPPRDYYDSSGYQIRDDHFDYWGQGTLVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGPGTDFTLTISSLEPEDFAVYYCQQRSNCLFTFGPGTKVDIK,IGHV1-2 (Human),IGHJ4 (Human),IGKV3D-11 (Human),IGKJ3 (Human),ARPPRDYYDSSGYQIRDDHFDY,QQRSNCLFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C330_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C331,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVQSGAEVKKPGASVRVSCKASGYTFTSYDINWVRQATGQGLEWMGWMNPNSGNTGYAQKFQGRVTMTRNTSISTVYMELSSLRSEDTAVYYCARFPKVPAAIFPGDYYYGMDVWGQGTTVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGSYNLVSWYQQHPGKAPKLMIYEVSKRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCCSYAGSSTLVFGGGTKLTVL,IGHV1-8 (Human),IGHJ6 (Human),IGLV2-23 (Human),IGLJ3 (Human),ARFPKVPAAIFPGDYYYGMDV,CSYAGSSTLV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C331_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C332,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAMYYCARDEGSLTTTFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTISCRASQSISSYLNWFQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISTLQPEDFATYYCQQSYGTPPWTFGQGTKVEIK,IGHV3-33 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ1 (Human),ARDEGSLTTTFDY,QQSYGTPPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C332_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C333,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFSTYDMSWARQAPGKGLEWVANIKQDGSEKYYVDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARDTIPFWSGYYTSPDYYFDYWGQGTLVTVSS,QSALTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWYQQLPGTAPKLLIYGNSNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSSLSGVVFGGGTKLTVL,IGHV3-7 (Human),IGHJ4 (Human),IGLV1-40 (Human),IGLJ3 (Human),ARDTIPFWSGYYTSPDYYFDY,QSYDSSLSGVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C333_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C334,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLQESGPGLVKPSQTLSLTCTVSGGSISSGGYYWSWIRQHPGKGLEWIGYIYYSGTTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCASSRYDFWSGSFDYWGQGTLVTVSS,QSALTQPPSASGSPGQSVTISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYEVSKRPSGVPDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYAGSNNWVFGGGTKLTVL,IGHV4-31 (Human),IGHJ4 (Human),IGLV2-8 (Human),IGLJ3 (Human),ASSRYDFWSGSFDY,SSYAGSNNWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C334_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C384,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLQQWGAGLLKPSETLSRTCAVYGGSFSGYYWSWIRQSPGKGLEWIGEINDSGSTNYNPSLKSRVTISVDTSKNQFSLRLSSVTAADTAVYYCARGHTQEKWELREGYYFDYWDQGTLVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGDYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYASGSTLYYVFGTGTKVTVL,IGHV4-34 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ1 (Human),ARGHTQEKWELREGYYFDY,SSYASGSTLYYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C384_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C194,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVESGGGLIQPGGSLRLSCAASGLTVSSNYMTWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARETYGMDVWGQGTTVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSNYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK,IGHV3-53 (Human),IGHJ6 (Human),IGKV3-20 (Human),IGKJ1 (Human),ARETYGMDV,QQYGSSPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C194_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C195,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QLQLQESGPGLVKPSETLSLTCTVSGGSISRSDYYWGWIRQPPGKGLEWIGTIYYSGSTYYNPSLKSRVTISVDTSKNQFSLKLGSVTAADTAVYYCARQARTDASTYGHNFDSWGQGTLVT,QSALTQPASVSGSPGQSITISCTGTSSDVGSYNLVSWYQQHPGKAPKLMIYEGSKRPSGVSSRFSGSKSGNTASLTISGLQGEDEADYYCCSYAGSSTWVFAGGTKLTVL,IGHV4-39 (Human),IGHJ5 (Human),IGLV2-23 (Human),IGLJ3 (Human),ARQARTDASTYGHNFDS,CSYAGSSTWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C195_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C196,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QLQLQESGPGLVKPSETLSLTCTVSGGSISRSDFYWGWIRQPPGKGLEWIGTIYYSGSTYYNPSLKSRVTISVDTSKNQFSLKLDSVTAADTAVYYCARQARTDGSTYGHNFDYWGQGTLVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGSYNLVSWYQQHPGKAPKLMIYEGSKRPSGVSSRFSGSKFGNTASLTIYGLQGEDEADYYCCSYAGSITWVFGGGTKLTVL,IGHV4-39 (Human),IGHJ4 (Human),IGLV2-23 (Human),IGLJ3 (Human),ARQARTDGSTYGHNFDY,CSYAGSITWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C196_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C197,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTGYYMHWVRQAPGQGLEWMGWINPNSGGTNYAQKFQGWVTMTRDTSISTAYMELSRLRSDDTAVYYCARESHGGVWSAPGYYYGMDVWGQGT,QSVLTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTNSSAVVFGGGTKLTVL,IGHV1-2 (Human),IGHJ6 (Human),IGLV2-14 (Human),IGLJ3 (Human),ARESHGGVWSAPGYYYGMDV,SSYTNSSAVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C197_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C437,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTGYFMHWVRQAPGQGLEWMGWINPNSGGTNYAQKFQGRVTMTRDTSITTAYMELSRLRSDDTAVYYCARDDTLLRYSDWLPTTSFGGMDVWGQGTTVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKVMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSTNVFGTGTKVTVL,IGHV1-2 (Human),IGHJ6 (Human),IGLV2-14 (Human),IGLJ6 (Human),ARDDTLLRYSDWLPTTSFGGMDV,SSYTSSSTNV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C437_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C360,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTTYYLHWVRQAPGQGLEWMGIIDPSGGSTSYAQKFQGRVTMTKDTSTSTVYMELSSLRSEDTAVYYCARVGRGFSYGYFDYWGQGALVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDITNHLNWYQQKPGKAPKLLIYYASNLETGVPSRFSGIGSGTDFTFTISSLQPEDIATYYCQQYDNLPPLTFGGGTKVEIK,IGHV1-46 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ4 (Human),ARVGRGFSYGYFDY,QQYDNLPPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C360_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C362,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFNSYAISWVRQAPGQGLEWMGGIIPIFGTANYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYCARVGAEWPRDHKYYYYGMDVWGQGTTVTVSS,DIVMTQSPLSLPVTPGEPASISCRSSQSLLHSNGYNYLDWYLQKPGQSPQLLIYLGSNRASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQALQTPLTFGGGTKVEIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV2-28 (Human),IGKJ4 (Human),ARVGAEWPRDHKYYYYGMDV,MQALQTPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C362_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C363,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVESGGGLVQPGGSLRLSCAASGFTFSNYDMHWVRQATGRGLEWVSTIGTAGDTYYPGSVKGRFTISRENAKNSLYLQMNSLRAGDTAVYYCARVKYGGYVGYFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPELTFGGGTKVEIK,IGHV3-13 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ4 (Human),ARVKYGGYVGYFDY,QQSYSTPELT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C363_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C364,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVESGGVLVKPGGSLRLSCAASGFTFSNAWMSWVRQAPGKGLEWVGRIKSKTHGETTDYAAPVKGRFTISRDDSENTLYLQINSLKTEDTAVYFCATHRSEAGDLDYWGQGTLVTVSS,QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWYQQLPGTGPKLLIYVNNNRPSGVPERFSGSKSGTSASLAITGLQAEDEADYYCQSYDSSLSGSVFGGGTKLTVL,IGHV3-15 (Human),IGHJ4 (Human),IGLV1-40 (Human),IGLJ3 (Human),ATHRSEAGDLDY,QSYDSSLSGSV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C364_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C365,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSLIYSGGTTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARETLGRGGDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPRSFGQGTKLEIK,IGHV3-66 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ2 (Human),ARETLGRGGDY,QQYDNLPRS,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C365_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C366,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLVQPGRSLRLSCAASGFTFDDYAMHWVRQAPGKGLEWVSGVSWNSGTIGYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTALYYCAKIADIVRAYDFWSGQHFDAFDIWGQGTMVT,QSVLTQPPSASGTPGQRVTISCSGSSSNIGSNTVNWYQQLPGTAPKLLIYSNNQRPSGVPDRFSGSKSGTSASLAISGLQSEDEADYYCAAWDDSLVVFGGGTKLTVL,IGHV3-9 (Human),IGHJ3 (Human),IGLV1-44 (Human),IGLJ3 (Human),AKIADIVRAYDFWSGQHFDAFDI,AAWDDSLVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C366_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C367,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLVQPGRSLRLSCAASGFTFDDYAMHWVRQAPGKGLEWVSIISWNSDNIGYADSVKGRFTISRDNARNSLYLQMNSLRVEDTALYYCAKDKGSGSGYGMDVWGRGTTVTVSS,DIQMTQSPSTLSASVGDRVTITCRASQSISSWLAWYQQKPGKAPNLLIYTASNLESGVPSRYSGSGSGTEFTLSISSLQPEDSATYFCQRYNSYPYSFGQGTKLEIK,IGHV3-9 (Human),IGHJ6 (Human),IGKV1-5 (Human),IGKJ2 (Human),AKDKGSGSGYGMDV,QRYNSYPYS,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C367_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C368,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLVQPGRSLRLSCAASGFTFDDYAMHWVRQAPGKGLEWVSGTTWNSGTIGYADSVKGRFTISRDNAKNSLYLQMNSLRAEDMALYYCAKDQTKDGGGAYSYGLGGMDVWGQGTTVTVSS,SYELTQPPSVSVAPGKTARITCGGNNIGSKSVHWYQQKPGQAPVLVVYDDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDSSSDSWVFGGGTKLTVL,IGHV3-9 (Human),IGHJ6 (Human),IGLV3-21 (Human),IGLJ3 (Human),AKDQTKDGGGAYSYGLGGMDV,QVWDSSSDSWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C368_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C369,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Patient,QLQLQESGPGLVKPSETLSLTCTVSGGSISSSYYYWGWIRQPPGKGLEWIGSIYYSGSTYYNPSLKSRVTISVDTSKNQFSLTLSSVTAADTAVYYCATGGRFWGWFDPWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPPKLTFGGGTKVEIK,IGHV4-39 (Human),IGHJ5 (Human),IGKV1-33 (Human),IGKJ4 (Human),ATGGRFWGWFDP,QQYDNLPPKLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C369_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C370,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVQSGAEVKKPGESLKISCKGSGYSFISYWIGWVRQMPGKGLEWMGIIYPGDSDTRYSPSFQGQVTISADKSINTAYLQWSSLKASDTAMYYCARRVTIPNGWFDPWGQGTLVTVSS,QSVLTQPPSASGTPGQRVTISCSGSSSNIGSNTVNWYQQLPGTAPKLLIYSNNQRPSGVPDRFSGSKSGTSASLAISGLQSEDEADYYCAAWDDSLNGVVFGGGTKLTVL,IGHV5-51 (Human),IGHJ5 (Human),IGLV1-44 (Human),IGLJ3 (Human),ARRVTIPNGWFDP,AAWDDSLNGVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C370_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C371,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAINWVRQAPGQGLEWMGGIIPIFGTANYAQKFQGRVTITADESTSTAYMELSSLRSEDTALYYCARNRAVSEREDYYYGMDVWGQGTTVTVSS,DIQMTQSPSSVSASVGDRVTITCRASQGISRWLAWYQQKPGKAPKLLIYAAFSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQANSFPLTFGGGTKVEIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV1-12 (Human),IGKJ4 (Human),ARNRAVSEREDYYYGMDV,QQANSFPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C371_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Wang-C382,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLIQPGGSLRLSCAASGLTVSRNYMNWVRQAPGKGLEWVSVMYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARESYGMDVWGQGTTVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSFSSTYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYVTSPWTFGQGTKVEIK,IGHV3-53 (Human),IGHJ6 (Human),IGKV3-20 (Human),IGKJ1 (Human),ARESYGMDV,QQYVTSPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Wang-C382_rank1_imgt_scheme.pdb,"Zijun Wang et al., 2021 (https://stm.sciencemag.org/content/13/577/eabf1555)","Apr 21, 2021","Apr 21, 2021",N/A,Complete
Gai-Nb4-43,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Camels,ND,N/A,ND,ND,N/A,N/A,AKDPGPYGGSRYELFDY,N/A,ND,,"Junwei Gai et al., 2021 (https://onlinelibrary.wiley.com/doi/10.1002/mco2.60)","Apr 21, 2021","Apr 21, 2021",N/A,Following up for full VHH reads
Gai-Nb11-59,Nb,SARS-CoV2;SARS-CoV1;bat-SL-CoV-WIV1,,SARS-CoV2;SARS-CoV1;bat-SL-CoV-WIV1,,S; RBD,Immunised Camels,ND,N/A,ND,ND,N/A,N/A,APSQTYGGSWYWDPIGD,N/A,ND,,"Junwei Gai et al., 2021 (https://onlinelibrary.wiley.com/doi/10.1002/mco2.60)","Apr 21, 2021","Apr 21, 2021",N/A,Following up for full VHH reads
Gai-Nb14-33,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Camels,ND,N/A,ND,ND,N/A,N/A,AAAVLGRDVDQAVSWWGVADFNY,N/A,ND,,"Junwei Gai et al., 2021 (https://onlinelibrary.wiley.com/doi/10.1002/mco2.60)","Apr 21, 2021","Apr 21, 2021",N/A,Following up for full VHH reads
Gai-Nb15-61,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Camels,ND,N/A,ND,ND,N/A,N/A,AACSIPHKPSL,N/A,ND,,"Junwei Gai et al., 2021 (https://onlinelibrary.wiley.com/doi/10.1002/mco2.60)","Apr 21, 2021","Apr 21, 2021",N/A,Following up for full VHH reads
Gai-Nb16-52,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Camels,ND,N/A,ND,ND,N/A,N/A,ATGFQYGGSWYGGRI,N/A,ND,,"Junwei Gai et al., 2021 (https://onlinelibrary.wiley.com/doi/10.1002/mco2.60)","Apr 21, 2021","Apr 21, 2021",N/A,Following up for full VHH reads
Gai-Nb16-68,Nb,SARS-CoV2;SARS-CoV1;bat-SL-CoV-WIV1,,SARS-CoV2;SARS-CoV1;bat-SL-CoV-WIV1,,S; RBD,Immunised Camels,ND,N/A,ND,ND,N/A,N/A,AAPAGGTCSHSRAFGY,N/A,ND,,"Junwei Gai et al., 2021 (https://onlinelibrary.wiley.com/doi/10.1002/mco2.60)","Apr 21, 2021","Apr 21, 2021",N/A,Following up for full VHH reads
Gai-Nb16-75,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Camels,ND,N/A,ND,ND,N/A,N/A,YTVTSGSCPDGGMDY,N/A,ND,,"Junwei Gai et al., 2021 (https://onlinelibrary.wiley.com/doi/10.1002/mco2.60)","Apr 21, 2021","Apr 21, 2021",N/A,Following up for full VHH reads
CC40.8,Ab,SARS-CoV2,,SARS-CoV2,,S; S2,B-cells; SARS-CoV2 Patient,EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYVMTWARQAPGKGLEWVSAISGTGYTYYADSVKGRFTVSRDNSKNTLFLQMSSLRAEDTAVYYCAITMAPVVWGQGTTVTVSS,SYELTQPPSVSVSPGQTARITCSGDALPKRYAYWYQQKSGQAPILVIYEDKKRPSGIPERLSGSKSGTVATLTISGAQVEDEADYYCYSTDSSGNHAVFGGGTQLTVL,IGHV3-23 (Human),IGHJ6 (Human),IGLV3-10 (Human),IGLJ7 (Human),AITMAPVV,YSTDSSGNHAV,Expected,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CC40.8_rank1_imgt_scheme.pdb,"Panpan Zhou et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.30.437769v1)","Apr 21, 2021","Apr 21, 2021",N/A,Variant/Strain binding data in preprint. Awaiting release of PDB structure
S2X259,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGIFNTYTISWVRQAPGQGLEWMGRIILMSGMANYAQKIQGRVTITADKSTSTAYMELTSLRSDDTAVYYCARGFNGNYYGWGDDDAFDIWGQGTLVTVYS,QTVLTQPPSVSGAPGQRVTISCTGSNSNIGAGYDVHWYQQLPGTAPKLLICGNSNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSSLSGPNWVFGGGTKLTVL,IGHV1-69 (Human),IGHJ4 (Human),IGLV1-40 (Human),IGLJ3 (Human),ARGFNGNYYGWGDDDAFDI,QSYDSSLSGPNWV,https://www.rcsb.org/structure/7M7W,,"M Alejandra Tortorici et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.04.07.438818v1)","Apr 21, 2021","May 7, 2021",7th May 2021: Added sequence and structural data,Variant binding data in preprint. Complete
Goike-8-32,Ab,SARS-CoV2,,SARS-CoV2,,S; NTD,"Phage Display Library (antibody, patient-derived)",ND,ND,IGHV1-24 (Human),ND,IGLV2-8 (Human),ND,ATGSPFDRTQNWFDP,SSYAGSNNLA,ND,,"Jule Goike et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.04.07.438849v2)","Apr 21, 2021","Apr 21, 2021",N/A,Variant binding data in preprint.Awaiting publication for full sequences
Goike-N3-1,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,"Phage Display Library (antibody, patient-derived)",ND,ND,IGHV4-31 (Human),ND,IGKV1-5 (Human),ND,ARGTIYFDRSGYRRVDPFHI,QQYNSYSPWT,Expected,,"Jule Goike et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.04.07.438849v2)","Apr 21, 2021","Apr 21, 2021",N/A,Variant binding data in preprint.Awaiting publication for full sequences
Goike-8-131,Ab,SARS-CoV2,,SARS-CoV2,,S; NTD,"Phage Display Library (antibody, patient-derived)",ND,ND,IGHV1-24 (Human),ND,IGLV1-51 (Human),ND,ATGSPFDRTQNWFDP,GTWDNSLSAGV,ND,,"Jule Goike et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.04.07.438849v2)","Apr 21, 2021","Apr 21, 2021",N/A,Variant binding data in preprint.Awaiting publication for full sequences
Goike-8-114,Ab,SARS-CoV2,,SARS-CoV2,,S; NTD,"Phage Display Library (antibody, patient-derived)",ND,ND,IGHV1-24 (Human),ND,IGLV1-51 (Human),ND,ATGPAVRRGSWFDP,GTWDSSLSGYV,ND,,"Jule Goike et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.04.07.438849v2)","Apr 21, 2021","Apr 21, 2021",N/A,Variant binding data in preprint.Awaiting publication for full sequences
Goike-12C8,Ab,SARS-CoV2,,SARS-CoV2,,S; NTD,"Phage Display Library (antibody, patient-derived)",ND,ND,IGHV1-24 (Human),ND,IGLV1-51 (Human),ND,ATGPAVRRGSWFDP,GTWDSSLSAVV,ND,,"Jule Goike et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.04.07.438849v2)","Apr 21, 2021","Apr 21, 2021",N/A,Variant binding data in preprint.Awaiting publication for full sequences
Goike-A7V3,Ab,SARS-CoV2,,SARS-CoV2,,S; NTD,"Phage Display Library (antibody, patient-derived)",ND,ND,IGHV1-24 (Human),ND,IGLV1-51 (Human),ND,ATGSPFDRTQNWFDP,GTWDSSLSAVV,ND,,"Jule Goike et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.04.07.438849v2)","Apr 21, 2021","Apr 21, 2021",N/A,Variant binding data in preprint.Awaiting publication for full sequences
Goike-7-6,Ab,SARS-CoV2,,SARS-CoV2,,S; NTD,"Phage Display Library (antibody, patient-derived)",ND,ND,IGHV1-24 (Human),ND,IGLV3-19 (Human),ND,ATRFAVYGDYLIDY,NSRDSSGDLVV,ND,,"Jule Goike et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.04.07.438849v2)","Apr 21, 2021","Apr 21, 2021",N/A,Variant binding data in preprint.Awaiting publication for full sequences
Goike-8-132,Ab,SARS-CoV2,,SARS-CoV2,,S; NTD,"Phage Display Library (antibody, patient-derived)",ND,ND,IGHV1-24 (Human),ND,IGLV1-51 (Human),ND,ATGSPFDRTQNWFDP,GTWDSSLSAGV,ND,,"Jule Goike et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.04.07.438849v2)","Apr 21, 2021","Apr 21, 2021",N/A,Variant binding data in preprint.Awaiting publication for full sequences
Goike-4C7,Ab,SARS-CoV2,,SARS-CoV2,,S; NTD,"Phage Display Library (antibody, patient-derived)",ND,ND,IGHV1-24 (Human),ND,IGLV1-44 (Human),ND,ATAAAVRGRGTIDY,AAWDDSLNGPVV,ND,,"Jule Goike et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.04.07.438849v2)","Apr 21, 2021","Apr 21, 2021",N/A,Variant binding data in preprint.Awaiting publication for full sequences
Goike-4C8,Ab,SARS-CoV2,,SARS-CoV2,,S; NTD,"Phage Display Library (antibody, patient-derived)",ND,ND,IGHV1-24 (Human),ND,IGLV1-51 (Human),ND,ATAAAVRGRGTIDY,GTWDSSLSAVV,ND,,"Jule Goike et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.04.07.438849v2)","Apr 21, 2021","Apr 21, 2021",N/A,Variant binding data in preprint.Awaiting publication for full sequences
Goike-7A8,Ab,SARS-CoV2,,SARS-CoV2,,S; NTD,"Phage Display Library (antibody, patient-derived)",ND,ND,IGHV1-24 (Human),ND,IGLV1-51 (Human),ND,ATGSPFDRTQNWFDP,GTWDSSLSAVV,ND,,"Jule Goike et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.04.07.438849v2)","Apr 21, 2021","Apr 21, 2021",N/A,Variant binding data in preprint.Awaiting publication for full sequences
Goike-8-3,Ab,SARS-CoV2,,SARS-CoV2,,S; NTD,"Phage Display Library (antibody, patient-derived)",ND,ND,IGHV3-66 (Human),ND,IGLV7-46 (Human),ND,ARGGVVDTYYYYGMDV,LLSQSGAWV,ND,,"Jule Goike et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.04.07.438849v2)","Apr 21, 2021","Apr 21, 2021",N/A,Variant binding data in preprint.Awaiting publication for full sequences
Goike-3-26,Ab,SARS-CoV2,,SARS-CoV2,,S; S2,"Phage Display Library (antibody, patient-derived)",ND,ND,IGHV3-30-3 (Human),ND,IGLV1-47 (Human),ND,ARPYSGSYWGYFDY,AAWDDSLSGPV,ND,,"Jule Goike et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.04.07.438849v2)","Apr 21, 2021","Apr 21, 2021",N/A,Variant binding data in preprint.Awaiting publication for full sequences
Goike-N3-3,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,"Phage Display Library (antibody, patient-derived)",ND,ND,IGHV4-31 (Human),ND,IGKV3-11 (Human),ND,ARGTIYFDRSGYRRVDPFHI,QQRSNWPPLT,ND,,"Jule Goike et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.04.07.438849v2)","Apr 21, 2021","Apr 21, 2021",N/A,Variant binding data in preprint.Awaiting publication for full sequences
Goike-1D4,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,"Phage Display Library (antibody, patient-derived)",ND,ND,IGHV2-70 (Human),ND,IGKV3-15 (Human),ND,ARIPIATHLGSDY,QQYNNWPPWT,ND,,"Jule Goike et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.04.07.438849v2)","Apr 21, 2021","Apr 21, 2021",N/A,Variant binding data in preprint.Awaiting publication for full sequences
Goike-N3-7,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,"Phage Display Library (antibody, patient-derived)",ND,ND,IGHV4-31 (Human),ND,IGLV1-44 (Human),ND,ARGTIYFDRSGYRRVDPFHI,AAWDDSLNGPVV,ND,,"Jule Goike et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.04.07.438849v2)","Apr 21, 2021","Apr 21, 2021",N/A,Variant binding data in preprint.Awaiting publication for full sequences
Goike-6-3A,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,"Phage Display Library (antibody, patient-derived)",ND,ND,IGHV4-31 (Human),ND,IGLV8-61 (Human),ND,ARGTIYFDRSGYRRVDPFHI,TLYMGGGLLV,ND,,"Jule Goike et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.04.07.438849v2)","Apr 21, 2021","Apr 21, 2021",N/A,Variant binding data in preprint.Awaiting publication for full sequences
Goike-8-96,Ab,SARS-CoV2,,SARS-CoV2,,S; NTD,"Phage Display Library (antibody, patient-derived)",ND,ND,IGHV3-30 (Human),ND,IGLV1-40 (Human),ND,AKAPGQWLRFHYYGMDV,NSRDINSNHVL,ND,,"Jule Goike et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.04.07.438849v2)","Apr 21, 2021","Apr 21, 2021",N/A,Variant binding data in preprint.Awaiting publication for full sequences
Goike-8B5,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,"Phage Display Library (antibody, patient-derived)",ND,ND,IGHV1-2 (Human),ND,IGKV3-20 (Human),ND,ARELPPGRMVVPATYWHFDL,QQYGSSPPWT,ND,,"Jule Goike et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.04.07.438849v2)","Apr 21, 2021","Apr 21, 2021",N/A,Variant binding data in preprint.Awaiting publication for full sequences
Goike-3B9,Ab,SARS-CoV2,,SARS-CoV2,,S; NTD,"Phage Display Library (antibody, patient-derived)",ND,ND,IGHV3-30 (Human),ND,IGLV3-1 (Human),ND,ARDGGGYVSY,QAWDSSTVV,ND,,"Jule Goike et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.04.07.438849v2)","Apr 21, 2021","Apr 21, 2021",N/A,Variant binding data in preprint.Awaiting publication for full sequences
Goike-8-130,Ab,SARS-CoV2,,SARS-CoV2,,S; NTD,"Phage Display Library (antibody, patient-derived)",ND,ND,IGHV3-30 (Human),ND,IGKV1-39 (Human),ND,ATGPAVRRGSWFDP,QQSYSTPRT,ND,,"Jule Goike et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.04.07.438849v2)","Apr 21, 2021","Apr 21, 2021",N/A,Variant binding data in preprint.Awaiting publication for full sequences
Goike-4A5,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,"Phage Display Library (antibody, patient-derived)",ND,ND,IGHV3-30-3 (Human),ND,IGKV3-20 (Human),ND,AKASQLFWLGQFTRDGFDI,QQYGSSPPWT,ND,,"Jule Goike et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.04.07.438849v2)","Apr 21, 2021","Apr 21, 2021",N/A,Variant binding data in preprint.Awaiting publication for full sequences
Goike-6-3B,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,"Phage Display Library (antibody, patient-derived)",ND,ND,IGHV4-31 (Human),ND,IGLV1-40 (Human),ND,ARGTIYFDRSGYRRVDPFHI,QSYDGSLNDDVI,ND,,"Jule Goike et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.04.07.438849v2)","Apr 21, 2021","Apr 21, 2021",N/A,Variant binding data in preprint.Awaiting publication for full sequences
Goike-B3.1,Ab,SARS-CoV2,,SARS-CoV2,,S; S2,"Phage Display Library (antibody, patient-derived)",ND,ND,IGHV3-30 (Human),ND,IGKV1-5 (Human),ND,ARARGGSYYYGMDV,QQYNSYSPWT,ND,,"Jule Goike et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.04.07.438849v2)","Apr 21, 2021","Apr 21, 2021",N/A,Variant binding data in preprint.Awaiting publication for full sequences
Goike-8-42,Ab,SARS-CoV2,,SARS-CoV2,,S; NTD,"Phage Display Library (antibody, patient-derived)",ND,ND,IGHV3-30 (Human),ND,IGKV1-39 (Human),ND,ARDYGRGGV,QQSYSTRPLT,ND,,"Jule Goike et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.04.07.438849v2)","Apr 21, 2021","Apr 21, 2021",N/A,Variant binding data in preprint.Awaiting publication for full sequences
Goike-1D1,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,"Phage Display Library (antibody, patient-derived)",ND,ND,IGHV2-70 (Human),ND,IGKV1-5 (Human),ND,ARIPIATHLGSDY,QQYNSYSPWT,ND,,"Jule Goike et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.04.07.438849v2)","Apr 21, 2021","Apr 21, 2021",N/A,Variant binding data in preprint.Awaiting publication for full sequences
Goike-1D9,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,"Phage Display Library (antibody, patient-derived)",ND,ND,IGHV2-70 (Human),ND,IGLV3-1 (Human),ND,ARIPIATHLGSDY,QAWDSSTVV,ND,,"Jule Goike et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.04.07.438849v2)","Apr 21, 2021","Apr 21, 2021",N/A,Variant binding data in preprint.Awaiting publication for full sequences
Goike-N6-2,Ab,SARS-CoV2,,SARS-CoV2,,S; S2,"Phage Display Library (antibody, patient-derived)",ND,ND,IGHV3-30-3 (Human),ND,IGKV2-28 (Human),ND,ARPYSGSYWGYFDY,MQALQTPPYT,ND,,"Jule Goike et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.04.07.438849v2)","Apr 21, 2021","Apr 21, 2021",N/A,Variant binding data in preprint.Awaiting publication for full sequences
Goike-P4D3,Ab,SARS-CoV2,,SARS-CoV2,,S; S2,"Phage Display Library (antibody, patient-derived)",ND,ND,IGHV3-30 (Human),ND,IGLV1-40 (Human),ND,AKAPGQWLRFHYYGMDV,QSYGNNQGV,ND,,"Jule Goike et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.04.07.438849v2)","Apr 21, 2021","Apr 21, 2021",N/A,Variant binding data in preprint.Awaiting publication for full sequences
Goike-P4A3,Ab,SARS-CoV2,,SARS-CoV2,,S; S2,"Phage Display Library (antibody, patient-derived)",ND,ND,IGHV3-30 (Human),ND,IGKV1-39 (Human),ND,ARDDTGRVGSGWYCPLY,QQSYSTPLS,ND,,"Jule Goike et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.04.07.438849v2)","Apr 21, 2021","Apr 21, 2021",N/A,Variant binding data in preprint.Awaiting publication for full sequences
Goike-8-19,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,"Phage Display Library (antibody, patient-derived)",ND,ND,IGHV4-31 (Human),ND,IGKV1-39 (Human),ND,ARGTIYFDRSGYRRVDPFHI,QQSYSTRPLT,ND,,"Jule Goike et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.04.07.438849v2)","Apr 21, 2021","Apr 21, 2021",N/A,Variant binding data in preprint.Awaiting publication for full sequences
Goike-3-18,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,"Phage Display Library (antibody, patient-derived)",ND,ND,IGHV3-30 (Human),ND,IGLV1-40 (Human),ND,AKQAGAYCSGGSCYSSSEADY,QSYGNNQGV,ND,,"Jule Goike et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.04.07.438849v2)","Apr 21, 2021","Apr 21, 2021",N/A,Variant binding data in preprint.Awaiting publication for full sequences
Goike-P3B10,Ab,SARS-CoV2,,SARS-CoV2,,S; S2,"Phage Display Library (antibody, patient-derived)",ND,ND,IGHV3-30-3 (Human),ND,IGLV3-1 (Human),ND,ARPYSGSYWGYFDY,QAWDSSTF,ND,,"Jule Goike et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.04.07.438849v2)","Apr 21, 2021","Apr 21, 2021",N/A,Variant binding data in preprint.Awaiting publication for full sequences
Goike-6-3c,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,"Phage Display Library (antibody, patient-derived)",ND,ND,IGHV4-31 (Human),ND,IGLV3-1 (Human),ND,ARGTIYFDRSGYRRVDPFHI,QAWDSSTVV,ND,,"Jule Goike et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.04.07.438849v2)","Apr 21, 2021","Apr 21, 2021",N/A,Variant binding data in preprint.Awaiting publication for full sequences
Goike-4A7,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,"Phage Display Library (antibody, patient-derived)",ND,ND,IGHV3-30-3 (Human),ND,IGLV1-44 (Human),ND,AKASQLFWLGQFTRDGFDI,AAWDDSLNGPVV,ND,,"Jule Goike et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.04.07.438849v2)","Apr 21, 2021","Apr 21, 2021",N/A,Variant binding data in preprint.Awaiting publication for full sequences
Goike-1D5,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,"Phage Display Library (antibody, patient-derived)",ND,ND,IGHV2-70 (Human),ND,IGKV3-20 (Human),ND,ARIPIATHLGSDY,QQYGSSPPWT,ND,,"Jule Goike et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.04.07.438849v2)","Apr 21, 2021","Apr 21, 2021",N/A,Variant binding data in preprint.Awaiting publication for full sequences
Goike-P3C6,Ab,SARS-CoV2,,SARS-CoV2,,S; S2,"Phage Display Library (antibody, patient-derived)",ND,ND,IGHV3-23 (Human),ND,IGLV1-40 (Human),ND,APGRSLY,QSYDSGLSGSI,ND,,"Jule Goike et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.04.07.438849v2)","Apr 21, 2021","Apr 21, 2021",N/A,Variant binding data in preprint.Awaiting publication for full sequences
TRES6,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,Transgenic Mouse,QVQVVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVIWYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRVEDTAVYYCVRETVDGMDVWGQGTTVTVSS,NIQMTQSPSAMSASVGDSVTITCRARQDINNYLAWFQQKPGKVPKHLIYAASSLLSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCLQHNSYPYTFGQGTKLEIK,IGHV3-33 (Human),IGHJ6 (Human),IGKV1-17 (Human),IGKJ2 (Human),VRETVDGMDV,LQHNSYPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/TRES6_rank1_imgt_scheme.pdb,"Antonia Peter et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.04.16.440101v1)","Apr 21, 2021","Apr 21, 2021",N/A,Variant binding data in publication. Complete
TRES224,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,Transgenic Mouse,QVQVVESGGGVVQPGRSLRLSCAASGFTFSGYGMHWVRQAPGKGLEWVAVIWYDGSNQYYADSVKGRFTISRDNSKNTLYLQMNSLRVEDTAVYHCVRETVDGMDVWGQGTTVTVSS,NIQMTQSPSAMSASVGDSVTITCRARQDINNYLAWFQQKPGKVPKHLIYAASSLLSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCLQHNSYPYTFGQGTKLEIK,IGHV3-33 (Human),IGHJ6 (Human),IGKV1-17 (Human),IGKJ2 (Human),VRETVDGMDV,LQHNSYPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/TRES224_rank1_imgt_scheme.pdb,"Antonia Peter et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.04.16.440101v1)","Apr 21, 2021","Apr 21, 2021",N/A,Variant binding data in publication. Complete
TRES567,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,Transgenic Mouse,QVQVVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVIWYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRVEDTAVYYCVRETVDGMDVWGQGTTVTVSS,NIQMTQSPSAMSASVGDSVTITCRARQDINNYLAWFQQKPGKVPKHLIYAASSLLSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCLQHNSYPYTFGQGTKLEIK,IGHV3-33 (Human),IGHJ6 (Human),IGKV1-17 (Human),IGKJ2 (Human),VRETVDGMDV,LQHNSYPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/TRES567_rank1_imgt_scheme.pdb,"Antonia Peter et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.04.16.440101v1)","Apr 21, 2021","Apr 21, 2021",N/A,Variant binding data in publication. Complete
TRES49,Ab,SARS-CoV2,,SARS-CoV2,,S; NTD,Transgenic Mouse,QVQLVQSGAEVKKPGASVKVSCKVSGYTLTEVSVHWVRQAPGKGLEWMGGFDPEDAETIYAQKFQGRVTMTEDTSTDTAYMELSSLRYEDTAVYFCATAPAVAGPFYYYYYGMDVWGQGTTVTVSS,DIVMTQTPLSSPVTLGQPASISCRSSQSLVHSDGNTYLSWLQQRPGQPPRLLIYKVSNRFSGVPDRFSGSGAGTEFTLKISRVEAEDVGVYYCTQATQFPHTFGQGTKLEIK,IGHV1-24 (Human),IGHJ6 (Human),IGKV2-24 (Human),IGKJ2 (Human),ATAPAVAGPFYYYYYGMDV,TQATQFPHT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/TRES49_rank1_imgt_scheme.pdb,"Antonia Peter et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.04.16.440101v1)","Apr 21, 2021","Apr 21, 2021",N/A,Variant binding data in publication. Complete
TRES219,Ab,SARS-CoV2,,SARS-CoV2,,S; NTD,Transgenic Mouse,QVQLVQSGAEVKKPGASVKVSCKVSGYSLIEVSVHWVRQAPGKGLEWMGGFDPENAETIYARGFRGRVTMTEDTSTDTAYMELSSLKYEDTAVYFCATAPAVAGPFYYYYYGMDVWGQGTTVTVSS,DIVMTQTPLSSPVTLGQPASISCRSSQSLVHSDGNTYLSWLQQRPGQPPRLLIYKVSNRFSGVPDRFSGSGAGTEFTLKISRVEAEDVGVYYCTQATQFPHTFGQGTKLEIK,IGHV1-24 (Human),IGHJ6 (Human),IGKV2-24 (Human),IGKJ2 (Human),ATAPAVAGPFYYYYYGMDV,TQATQFPHT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/TRES219_rank1_imgt_scheme.pdb,"Antonia Peter et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.04.16.440101v1)","Apr 21, 2021","Apr 21, 2021",N/A,Variant binding data in publication. Complete
TRES328,Ab,SARS-CoV2,,SARS-CoV2,,S; NTD,Transgenic Mouse,QHQLVQSGAEVKKPGASVKVSCKVSGYTLVEVSVHWVRQAPGKGFEWMGGFDPENAATIYAQKFQGRVTMTEDTSTDTAYMELSSLRYEDTAVYFCATAPAVAGPLYYYYYGMDVWGQGTTVTVSS,DIVMTQTPLSSPVTLGQPASISCRSSQSLVHSDGNTYLSWLQQRPGQPPRLLIYKVSNRFSGVPDRFSGSGAGTEFTLKISRVEAEDVGVYYCTQATQFPHTFGQGTKLEIK,IGHV1-24 (Human),IGHJ6 (Human),IGKV2-24 (Human),IGKJ2 (Human),ATAPAVAGPLYYYYYGMDV,TQATQFPHT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/TRES328_rank1_imgt_scheme.pdb,"Antonia Peter et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.04.16.440101v1)","Apr 21, 2021","Apr 21, 2021",N/A,Variant binding data in publication. Complete
TRES618,Ab,SARS-CoV2,,SARS-CoV2,,S; NTD,Transgenic Mouse,QVQLVQSGAEVKKPGASVKVSCKVSGYTLTEVSVHWVRQAPGKGLEWMGGFDPEDAETIYAQKFQGRVTMTEDTSTDTAYMELSSLRSEDTAVYFCATAPAVAGPFYNFYYGIDVWGQGTTVTVSS,DIVMTQTPLSSPVTLGQPASISCRSSQSLVHSDGNTYLSWLQQRPGQPPRLLIYKVSNRFSGVPDRFSGSGAGTDFTLKISRVEAEDVGVYYCTQATQFPHTFGQGTKLEIK,IGHV1-24 (Human),IGHJ6 (Human),IGKV2-24 (Human),IGKJ2 (Human),ATAPAVAGPFYNFYYGIDV,TQATQFPHT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/TRES618_rank1_imgt_scheme.pdb,"Antonia Peter et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.04.16.440101v1)","Apr 21, 2021","Apr 21, 2021",N/A,Variant binding data in publication. Complete
TRES1209,Ab,SARS-CoV2,,SARS-CoV2,,S; NTD,Transgenic Mouse,QVQLVQSGAEVKKPGASVKVSCKVSGYTLTEVSVHWVRQAPEKGLEWMGGFDPEDAETIYAQKFQGRVTMTEDTSTDTAYMELSSLRSEDTAVYFCATAPAVAGPFYYYYYGMDVWGQGTTVTVSS,DIVMTQTPLSSPVTLGQPASISCRSSQSLVHSDGNTYLSWLQQRPGQPPRLIIYKVSNRFCGVPDRFSGSGAGTDFTLKISRVEAEDVGVYYCTQATQFPHTFGQGTKLEIK,IGHV1-24 (Human),IGHJ6 (Human),IGKV2-24 (Human),IGKJ2 (Human),ATAPAVAGPFYYYYYGMDV,TQATQFPHT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/TRES1209_rank1_imgt_scheme.pdb,"Antonia Peter et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.04.16.440101v1)","Apr 21, 2021","Apr 21, 2021",N/A,Variant binding data in publication. Complete
TRES1293,Ab,SARS-CoV2,,SARS-CoV2,,S; NTD,Transgenic Mouse,QVQLVQSGAEVKKPGASVKVSCKVSGYTLTEVSVHWVRQAPGKGLEWMGGFDPEDAKTIYAQKFQGRVTMTEDTSTDTAYMELSSLSSEDTAVYFCATAPAVAGPFYYYYYGMDVWGQGTTVTVSS,DIVMTQTPLSSPVTLGQPASISCRSSQSLVHSDGNTYLSWLQQRPGQPPRLLIYKVSNRFSGVPDRFSGSGAGTDFTLKISRVEAEDVGVYYCTQATQFPHTFGQGTKLEIK,IGHV1-24 (Human),IGHJ6 (Human),IGKV2-24 (Human),IGKJ2 (Human),ATAPAVAGPFYYYYYGMDV,TQATQFPHT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/TRES1293_rank1_imgt_scheme.pdb,"Antonia Peter et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.04.16.440101v1)","Apr 21, 2021","Apr 21, 2021",N/A,Variant binding data in publication. Complete
S2-L28,Ab,SARS-CoV2,,SARS-CoV2,,S; NTD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLVNPGGSLRLSCAASGFTFSDYTIHWVRQAPGKGLEWVSSISSSSNYIYYADSVKGRFTISRDNAKNSLSLQMNSLRAEDTAVYYCARDGNAYKWLLAENVRFDYWGQGTLVTVSS,VTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSDRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSTPNWVFGGGTKLT,IGHV3-21 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ3 (Human),ARDGNAYKWLLAENVRFDY,SSYTSSSTPNWV,https://www.rcsb.org/structure/7LXX;https://www.rcsb.org/structure/7LXZ,,"Matthew McCallum et al., 2021 (https://doi.org/10.1016/j.cell.2021.03.028)","Apr 21, 2021","Apr 21, 2021",N/A,Variant binding data in publication. Complete
S2-X333,Ab,SARS-CoV2,,SARS-CoV2,,S; NTD,B-cells; SARS-CoV2 Patient,VQLVESGGGVVQPGRSLRLSCAASGFTFSNYGMHWVRQAPGKGLEWVAVIWYDGSNKFYADSVKGRFTISRDNSKNSLYLQMNSLRAEDTAVYFCARAFPDSSSWSGFTIDYWGQGTLVTV,YELTQPPSVSTARITCGGNNIERKSVHWCQQKPGQAPALVVYDDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDSGSDQVIFGGGTKLT,IGHV3-33 (Human),IGHJ4 (Human),IGLV3-21 (Human),IGLJ3 (Human),ARAFPDSSSWSGFTIDY,QVWDSGSDQVI,https://www.rcsb.org/structure/7LXW;https://www.rcsb.org/structure/7LXY,,"Matthew McCallum et al., 2021 (https://doi.org/10.1016/j.cell.2021.03.028)","Apr 21, 2021","Apr 21, 2021",N/A,Variant binding data in publication. Complete
S2-M28,Ab,SARS-CoV2,,SARS-CoV2,,S; NTD,B-cells; SARS-CoV2 Patient,VQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVTVIWYDGSNRYYADSVKGRFTISRDNSKNTLYLQMDSLRAEDTAVYYCARAVAGEWYFDYWGQGTLVTVS,YELTQPPSVSVSPGQTARITCSGDALAKHYAYWYRQKPGQAPVLVIYKDSERPSGIPERFSGSSSGTTVTLTISGVQAEDEADYYCQSADSIGSSWVFGGGTKLTV,IGHV3-33 (Human),IGHJ4 (Human),IGLV3-25 (Human),IGLJ3 (Human),ARAVAGEWYFDY,QSADSIGSSWV,https://www.rcsb.org/structure/7LY0;https://www.rcsb.org/structure/7LY2;https://www.rcsb.org/structure/7LY3,,"Matthew McCallum et al., 2021 (https://doi.org/10.1016/j.cell.2021.03.028)","Apr 21, 2021","Apr 21, 2021",N/A,Variant binding data in publication. Complete
COVOX-222,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLIQPGGSLRLSCAASGLTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLGAEDTAVYYCARGEGSPGNWFDPWGQGTLVTVSS,DVVMTQSPGTLSLSPGERATLSCRASQSVPSSYLAWYQQKPGQAPRLLIYGASTRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQHYDTSPRFGGGTKVDIK,IGHV3-53 (Human),IGHJ5 (Human),IGKV3-20 (Human),IGKJ3 (Human),ARGEGSPGNWFDP,QHYDTSPR,https://www.rcsb.org/structure/7NX6; https://www.rcsb.org/structure/7NX7; https://www.rcsb.org/structure/7NX8; https://www.rcsb.org/structure/7NX9; https://www.rcsb.org/structure/7NXA; https://www.rcsb.org/structure/7NXB; https://www.rcsb.org/structure/7OR9,,"Wanwisa Dejnirattisai et al., 2021 (https://www.sciencedirect.com/science/article/pii/S0092867421004281)","Apr 21, 2021","Jul 9, 2021",N/A,Solved in complex with multiple variants. Complete
PR953,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Mouse (Balb/c),EVQLQQSGPELVKPGASVKISCKTSGYTFTEYTMHWVKQSHGKSLEWIGGINPNNGDNTYNQKLKGKATLTVHKSSSTAYMELRSLTSEDSAVYYCARDGYPYYYALDYWGQGTSVTVSS,DIVMTQSQKFMSTSVGDRVSVTCKASQNVGTNVAWYQQKPGQSPKPLIYSASSRYSGVPDRFTGSGSGTDFTLTISNVQSEDLAEYFCQQYNNYPWTFGGGTKLEIK,IGHV1-34 (Mouse),IGHJ4 (Mouse),IGKV6-15 (Mouse),IGKJ1 (Mouse),ARDGYPYYYALDY,QQYNNYPWT,https://www.rcsb.org/structure/7DEU,,"Dan Fu et al., 2021 (https://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.3001209)","Apr 21, 2021","May 11, 2021",11th May '21: Changed name of mAb and reference,scFv format. Complete
PR961,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Mouse (Balb/c),QVQLVQSGAEVKKPGASVKLSCKASGYSFTSYWVNWVRQAPGQGLEWIGMIHPSDSETRLNQKFKDRVTITVDKSTSTAYMELSSLRSEDTAVYYCARADGYEWYFDVWGRGTLVTVSS,DIVLTQSPASLAVSPGQRATITCRASESVDSYGNSFMHWYQQKPGQPPKLLIYRASNLESGIPARFSGSGSGTDFTLTINPVEANDVANYYCQQSNEDPWTFGQGTKVEIK,IGHV1-46 (Human),IGHJ2 (Human),IGKV3-11 (Human),IGKJ1 (Human),ARADGYEWYFDV,QQSNEDPWT,https://www.rcsb.org/structure/7DET,,"Dan Fu et al., 2021 (https://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.3001209)","Apr 21, 2021","May 11, 2021",11th May '21: Changed name of mAb and reference,scFv format. Complete
PR1077,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Mouse (H2L2),EVQLVESGGGVVQPGRSLRLSCAASGFTFSYYGMHWVRQAPGKGLEWVAVIWYDGSNRFYADSVKGRFTISRDNSKSTLYLQMNSLRAEDTAVYYCATDPPGLRFRFDYWGQGTLVTVSS,DIVMTQSPLSLPVTPGEPASISCRSSQSLLHSNGYNYLDWYLQKPGQSPQLLIYLGSNRASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQGLQTPLTFGGGTKVEIK,IGHV3-33 (Human),IGHJ4 (Human),IGKV2-28 (Human),IGKJ4 (Human),ATDPPGLRFRFDY,MQGLQTPLT,https://www.rcsb.org/structure/7DEO,,"Dan Fu et al., 2021 (https://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.3001209)","Apr 21, 2021","May 11, 2021",11th May '21: Changed name of mAb and reference,scFv format. Complete
6D6,Ab,SARS-CoV2;SARS-CoV1,,SARS-CoV2;SARS-CoV1,,S; RBD,ND,EVQLQQSGAELVKPGASVKLSCTTSGFNIIDTYMHWVKQRPEEGLEWIGGIDPVNGNSEYDPKFQDKATITADTSSNTAYLHLSRLTSEDTAVYYCASAHYYGSSSSFPYWGQGTDLVTVSA,DIVMTQSQKFMSTSVGDRVSVTCKASQNVGTHVAWYQQKPGQSPKALIYSASYRYSGVPDRFTGSGVGTDFTLTITNVQSEDLAEYFCQQYNSYFTFGSGTKLEIK,IGHV14-3 (Mouse),IGHJ3 (Mouse),IGKV6-15 (Mouse),IGKJ4 (Mouse),ASAHYYGSSSSFPY,QQYNSYFT,https://www.rcsb.org/structure/7EAN,,PDB (https://www.rcsb.org/structure/7EAN),"Apr 21, 2021","Apr 21, 2021",N/A,Awaiting publication for reference
7CR5,Ab,SARS-CoV2,,,,N; NTD,ND,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYIMHWVRQAPGKGLEWVAVISYDGSNEAYADSVKGRFTISRDNSKNTLYLQMSSLRAEDTGVYYCARETGDYSSSWYDSWGRGTLVTVSS,QLVLTQSPSASASLGASVKLTCTLSSGHSNYAIAWHQQQPEKGPRYLMKVNSDGSHTKGDGIPDRFSGSSSGAERYLTISSLQSEDEADYYCQTWGTGIQVFGGGTKLTVL,IGHV3-30 (Human),IGHJ5 (Human),IGLV4-59 (Human),IGLJ3 (Human),ARETGDYSSSWYDS,QTWGTGIQV,https://www.rcsb.org/structure/7CR5,,PDB (https://www.rcsb.org/structure/7CR5),"Mar 25, 2021","Mar 25, 2021",N/A,Awaiting publication for reference
7D6,Ab,SARS-CoV2,,,,S; RBD,ND,EVQLQQSGAELVRPGASVKLSCTASGFNIKDTYIHWVKQRPEQGLEWIGRIDPGDGDTEYDPSFQGKATITADTSSNTAYLELSSLTSEDTAVYYCTRFYDYVNYGMDYWGQGTSVTVSS,DIQMTQSPASLSASVGETVTITCRASGNIHNYLAWYQQKQGKSPQLLVYNAKTLADGVPSRFSGSGSGTQYSLKINSLQPEDFGSYYCQHFWSTPPWTFGGGTKLEVK,IGHV14-1 (Mouse),IGHJ4 (Mouse),IGKV12-41 (Mouse),IGKJ1 (Mouse),TRFYDYVNYGMDY,QHFWSTPPWT,https://www.rcsb.org/structure/7EAM,,PDB (https://www.rcsb.org/structure/7EAM),"Mar 19, 2021","Mar 19, 2021",N/A,Awaiting publication for reference
C051,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLIQAGGSLRLSCAASGFGVRNNYMSWVRQAPGKGLEWVSVIYSGGTTYYADSVKGRFTISRDNSKNTVFLQMNRLRAEDTAVYYCAREGDVEGFSDLWSGYSRDRYYFDYWGQGTLVTVSS,QSVLTQPASVSGSPGQSITFSCTGTSSDVGGYNYVSWYQQYPGKAPKLLIYDVTNRPSGVSDRFSGSKSGNTASLTISGLQAEDEADYYCSSFTSSNTRVFGTGTKVTVL,IGHV3-53 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ1 (Human),AREGDVEGFSDLWSGYSRDRYYFDY,SSFTSSNTRV,Expected (7R8N),Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C051_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321002946)","Mar 11, 2021","Mar 11, 2021",N/A,Variant binding data in paper. Awaiting PDB structure
C052,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLIRPGGSLRLSCAASGFSVSNNYMSWVRQAPGKGLEWVSVIYSGGTTYYADSVKGRFNISRDNSKNTVYLQMNSLRAEDTAVYYCAREGDVEGYYDFWSGYSRDRYYFDYWGQGALVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCNSYTSNNTRVFGTGTKVTVL,IGHV3-53 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ1 (Human),AREGDVEGYYDFWSGYSRDRYYFDY,NSYTSNNTRV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C052_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321002946)","Mar 11, 2021","Mar 11, 2021",N/A,Variant binding data in paper. Awaiting publication for sequences
C053,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLIQPGGSLRLSCAASGFIVSNNYMSWVRQAPGKGLDWVSVIYSGGTTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAREGDVEGYHDSWSGYSRDRYYFDYWGQGTLVTVSS,QSALTQPASVSGSPGQSITISCTGSSSDVGGYNFVSWYQQHPGRAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQVEDEADYYCSSYTNNNTRVFGTGTKVTVL,IGHV3-53 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ1 (Human),AREGDVEGYYDFWSGYSRDRYYFDY,SSYTSSSARV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C053_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321002946)","Mar 11, 2021","Mar 11, 2021",N/A,Variant binding data in paper. Awaiting publication for sequences
C054,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLIQPGGSLRLSCAASGFTVSNNYMSWVRQAPGKGLEWVSVIYSGGSTYDADSVKGRFTISRDNSKNTLYLQMNSLSAEDTAVYYCAREGDVEGYYDFWSGYSRDRYYFDYWGQGTLVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSARVFGTGTKVTVL,IGHV3-53 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ1 (Human),AREGDVEGYYDFWSGYSRDRYYFDY,SSYTSSSARV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C054_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321002946)","Mar 11, 2021","Mar 11, 2021",N/A,Variant binding data in paper. Awaiting publication for sequences
C548,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGIIPIFGTANYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYCARREAYGPRDYYYYYGMDVWGQGTTVTVSS,QSAVLTQPPSASASLGASVTLTCTLSSGYSNYKVDWYQQRPGKGPRFVMRVGTGGIVGSKGDGIPDRFSVLGSGLNRYLTIKNIQEEDESDYHCGADQGSGSNFVGVFGGGTKLTVL,IGHV1-69 (Human),IGHJ6 (Human),IGLV9-49 (Human),IGLJ3 (Human),ARREAYGPRDYYYYYGMDV,GADQGSGSNFVGV,Expected (7R8O),Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C548_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321002946)","Mar 11, 2021","Mar 11, 2021",N/A,Variant binding data in paper. Awaiting PDB structure
C549,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSTSAISWVRQAPGQGLEWMGGIIPFFGTPNYAQKFQGRVTIIADESTTTAYMELSGLRFEDSAVYYCARREPYGPRDYYYFFGMDVWGPGTTVTVSS,QSAVLTQPPFASASLGASVTLTCTLSSDYSYYKVDWYQQRPGKGPRFVIRVGPGGIVGSKGDGFPDRFSVLGSGLNRSLTINNIQEEDEGDYHCGADEGSGGTFVGVFGGGTKLTVL,IGHV1-69 (Human),IGHJ6 (Human),IGLV9-49 (Human),IGLJ3 (Human),ARREPYGPRDYYYFFGMDV,GADEGSGGTFVGV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C549_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321002946)","Mar 11, 2021","Mar 11, 2021",N/A,Variant binding data in paper. Complete
C032,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVQSGAEVKKPGESLKISCKGSGYSFTSYWIGWVRQMPGKGLEWMGIIYPGDSDTRYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARGVAVDWYFDLWGRGTLVTVSS,QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWYQQLPGTAPKLLIYGNSNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSSLSALYVFGTGTKVTVL,IGHV5-51 (Human),IGHJ2 (Human),IGLV1-40 (Human),IGLJ1 (Human),ARGVAVDWYFDL,QSYDSSLSALYV,Expected (7N3E;7R8M),Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C032_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321002946)","Mar 11, 2021","Mar 11, 2021",N/A,Variant binding data in paper. Awaiting PDB structure
C080,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVQSGAEVKKPGESLNISCKASGYSFTIYWIAWVRQLPGKGLEWMGIIYPGDSDTRYSPSFQGQVTISADKSISTAYLQWRSLKASDSAVYYCARGVAVDWYFDLWGRGTLVTVSS,QSVLTQPPSVSGAPGQRVTISCAGSSSNIGAGFDVYWYQQLPGTAPKLLIYGNNNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSSGSVLSDLYVFGTGTKVTVL,IGHV5-51 (Human),IGHJ2 (Human),IGLV1-40 (Human),IGLJ1 (Human),ARGVAVDWYFDL,QSSGSVLSDLYV,Expected (7N3F),Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C080_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321002946)","Mar 11, 2021","Mar 11, 2021",N/A,Variant binding data in paper. Awaiting PDB structure
C098,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLYSSGGTDIWGQGTMVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPGTFGQGTKVEIK,IGHV3-53 (Human),IGHJ3 (Human),IGKV3-20 (Human),IGKJ1 (Human),ARDLYSSGGTDI,QQYGSSPGT,Expected (7N3G;7N3I),Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C098_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321002946)","Mar 11, 2021","Mar 11, 2021",N/A,Variant binding data in paper. Awaiting PDB structure
C099,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLIQPGGSLRLSCAASGITVSSNYMSWVRQAPGKGLEWVSVMYAGGSTFYADSVKGRFTISRDDSKNTLFLQMNSLRAEDTAIYYCARDLYSSGGTDIWGQGTMVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSIGSSYLAWYQQKPGLAPRLLIYGASRRATGIPDKFSGSGSGADFTLTISRLEPEDFAVYYCQQYGSSPGTFGQGTKVEIK,IGHV3-53 (Human),IGHJ3 (Human),IGKV3-20 (Human),IGKJ1 (Human),ARDLYSSGGTDI,QQYGSSPGT,Expected (7N3H;7R8L),Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C099_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321002946)","Mar 11, 2021","Mar 11, 2021",N/A,Variant binding data in paper. Awaiting PDB structure
C055,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV3-66 (Human),IGHJ3 (Human),IGLV2-23 (Human),IGLJ3 (Human),ARDSSEVRDHPGHPGRSVGAFDI,CSYAGSHTFV,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321002946)","Mar 11, 2021","Mar 11, 2021",N/A,Variant binding data in paper. Awaiting publication for sequences
C512,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV4-4 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ3 (Human),AKGGDTAMGPEYFDY,SSFASSSTLL,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321002946)","Mar 11, 2021","Mar 11, 2021",N/A,Variant binding data in paper. Awaiting publication for sequences
G32Q3,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV1-18 (Human),IGHJ4 (Human),IGKV1-44 (Human),IGLJ2 (Human),ARSIAVAGTTAEFDY,AAWDDSLNGLVV,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321002946)","Mar 11, 2021","Mar 11, 2021",N/A,Memory B-cells. Awaiting publication for full sequence
G32B1,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV3-30 (Human),IGHJ6 (Human),IGLV2-14 (Human),IGLJ3 (Human),AKVVAPYYYYYYGMDV,SSYTSSSTSWV,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321002946)","Mar 11, 2021","Mar 11, 2021",N/A,Memory B-cells. Awaiting publication for full sequence
C63C8,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV3-7 (Human),IGHJ4 (Human),IGLV6-57 (Human),IGLJ1 (Human),ASLRWLQADFEY,QSYDSTNHV,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321002946)","Mar 11, 2021","Mar 11, 2021",N/A,Memory B-cells. Awaiting publication for full sequence
G32A4,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV1-58 (Human),IGHJ3 (Human),IGKV3-20 (Human),IGKJ1 (Human),AAPYCSSTSCHDAFDI,QQYGSSPWT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321002946)","Mar 11, 2021","Mar 11, 2021",N/A,Memory B-cells. Awaiting publication for full sequence
C83B6,Ab,SARS-CoV2,,,,S; NTD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV3-48 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ2 (Human),ARDRGGYGPYYYGMDV,QQSYSTPYT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321002946)","Mar 11, 2021","Mar 11, 2021",N/A,Memory B-cells. Awaiting publication for full sequence
C43N3,Ab,SARS-CoV2,,,,S; NTD,B-cells; SARS-CoV2 Patient,ND,ND,IGHV3-9 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ4 (Human),AKDPGYDSSGYYYDY,QQSYSTPLT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321002946)","Mar 11, 2021","Mar 11, 2021",N/A,Memory B-cells. Awaiting publication for full sequence
C7A9,Ab,SARS-CoV2,,,,S; S2,B-cells; SARS-CoV2 Patient,ND,ND,IGHV4-59 (Human),IGHJ4 (Human),IGKV4-1 (Human),IGKJ1 (Human),ARETRWNYVDY,QQYHGTPWT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321002946)","Mar 11, 2021","Mar 11, 2021",N/A,Memory B-cells. Awaiting publication for full sequence
C15C3,Ab,SARS-CoV2,,,,S; S2,B-cells; SARS-CoV2 Patient,ND,ND,IGHV4-59 (Human),IGHJ5 (Human),IGKV4-1 (Human),IGKJ1 (Human),ARETRYNWFDP,QQYFTTPWT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321002946)","Mar 11, 2021","Mar 11, 2021",N/A,Memory B-cells. Awaiting publication for full sequence
G32C5,Ab,SARS-CoV2,,,,S; S2,B-cells; SARS-CoV2 Patient,ND,ND,IGHV3-30-3 (Human),IGHJ4 (Human),IGKV3-15 (Human),IGKJ1 (Human),ARGKGGSYFGSFDY,QQYNNWPPT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321002946)","Mar 11, 2021","Mar 11, 2021",N/A,Memory B-cells. Awaiting publication for full sequence
C83B10,Ab,SARS-CoV2,,,,S; S2,B-cells; SARS-CoV2 Patient,ND,ND,IGHV3-30-3 (Human),IGHJ3 (Human),IGKV3-15 (Human),IGKJ2 (Human),ARARGGSYSDAFDI,QQYNNWPYT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321002946)","Mar 11, 2021","Mar 11, 2021",N/A,Memory B-cells. Awaiting publication for full sequence
COVOX-150,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVESGGGLIQPGGSLRLSCAASGVTVSSNYMSWVRQAPGKGLEWVSIIYSGGTTYYADSVKGRFTISRDSSMNTLYLQMNSLRAEDTAVYYCARDLMVYGIDVWGQGTTVTVSS,EIVMTQSPSSLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQLDSYPPGYTFGQGTKVDIK,IGHV3-53 (Human),IGHJ6 (Human),IGKV1-9 (Human),IGKJ1 (Human),ARDLMVYGIDV,QQLDSYPPGYT,https://www.rcsb.org/structure/7BEI;https://www.rcsb.org/structure/7ND5,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Mar 11, 2021","Mar 11, 2021",N/A,Complete
COVOX-158,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLLESGGDLIQPGGSLRLSCAASGVTVSSNYMSWVRQAPGKGLEWVSIIYPGGSTFYADSVKGRFTISRDNSKNTLYLQMHSLRAEDTAVYYCARDLGSGDMDVWGKGTTVTVSS,DIVMTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIQAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYRYTFGQGTKVEIK,IGHV3-53 (Human),IGHJ6 (Human),IGKV1-9 (Human),IGKJ1 (Human),ARDLGSGDMDV,QQLNSYRYT,https://www.rcsb.org/structure/7BEJ;https://www.rcsb.org/structure/7BEK,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Mar 11, 2021","Mar 11, 2021",N/A,Complete
COVOX-45,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSTYAMHWVRQAPGKGLEWVAVLSYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKGGSYAYYYYMDVWGKGTTVTVSS,DIQLTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGGGSGTDFTFTITSLQPEDIATYYCQQYDNLPLTFGGGTKVDIK,IGHV3-30-3 (Human),IGHJ6 (Human),IGKV1-33 (Human),IGKJ4 (Human),AKGGSYAYYYYMDV,QQYDNLPLT,https://www.rcsb.org/structure/7BEL;https://www.rcsb.org/structure/7ORA;https://www.rcsb.org/structure/7ORB,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Mar 11, 2021","Jul 9, 2021",9th July '21: Added new PDB structure and reference.,Variant binding and neutralisation data in Liu et al. Complete
COVOX-88,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Patient,QLQLQESGPGLVKPSQTLSLTCTVSGGSISSGSYNWTWIRQPAGKGLEWIGRIYNSGSTNYNPSLKSRVTISVDTSKNQLSLKVRSVTAADTAVYYCARHCSGGTCYPKYYYGMDVWGQGTTVTVSS,QSALTQPPSVSEAPRQRVTISCSGSSSNIGNNAVNWYQQFPGKAPKLLIYYDDLLPSGVSDRFSGSKSGTSASLAISGVQSEDEADYYCAAWDDSLNVVVFGGGTKLTVL,IGHV4-61 (Human),IGHJ6 (Human),IGLV1-36 (Human),IGLJ3 (Human),ARHCSGGTCYPKYYYGMDV,AAWDDSLNVVV,https://www.rcsb.org/structure/7BEL;https://www.rcsb.org/structure/7ND4,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Mar 11, 2021","Mar 11, 2021",N/A,Complete
COVOX-253H55L,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVQSGPEVKKPGTSVKVSCKASGFTFTTSAVQWVRQARGQRLEWIGWIVVGSGNTNYAQKFQERVTITRDMSTTTAYMELSSLRSEDTAVYFCAAPHCNSTSCYDAFDIWGQGTMVTVSS,DIQMTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFGVYYCQQYGSSPWTFGQGTKVEIK,IGHV1-58 (Human),IGHJ3 (Human),IGKV3-20 (Human),IGKJ1 (Human),AAPHCNSTSCYDAFDI,QQYGSSPWT,https://www.rcsb.org/structure/7BEO;https://www.rcsb.org/structure/7ND9;https://www.rcsb.org/structure/7NDA,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Mar 11, 2021","Mar 11, 2021",N/A,Complete
COVOX-75,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFNNYPLHWVRQAPGKGPEWVAVISQDGGNKYYVDSVKGRFTISRDNSKNTLYLQMNNLRAEDTALYYCARDVVVVVAARNHYYNGMDVWGQGTTVTVSS,DIQLTQSPSSVSASVGDRVTITCRASQGISSWLAWYQQKPGKAPKLLIYAVSSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQAKSFPFTFGPGTKVEIK,IGHV3-30 (Human),IGHJ6 (Human),IGKV1-12 (Human),IGKJ3 (Human),ARDVVVVVAARNHYYNGMDV,QQAKSFPFT,https://www.rcsb.org/structure/7BEO;https://www.rcsb.org/structure/7BEN;https://www.rcsb.org/structure/7ORB,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Mar 11, 2021","Jul 9, 2021",9th July '21: Added new PDB structure and reference.,Variant binding and neutralisation data in Liu et al. Complete
COVOX-384,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGLVKPGESLRLSCAASGFTFSDYYMTWIRQAPGKGLEWVSYIRSSGHTIYYADSVKGRFTISRDNAKNSLYLQMNSLRVEDTAVYYCARGGVLRFLEWPLNAFDIWGQGTMVTVSS,DIQLTQSPSSLSASVGDRVTITCRASQGISNYLAWYQQKPGKVPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDVATYYCQKYNNALGTFGQGTKVEIK,IGHV3-11 (Human),IGHJ3 (Human),IGKV1-27 (Human),IGKJ1 (Human),ARGGVLRFLEWPLNAFDI,QKYNNALGT,https://www.rcsb.org/structure/7BEP;https://www.rcsb.org/structure/7ND8,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Mar 11, 2021","Mar 11, 2021",N/A,Complete
COVOX-316,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTGYYMHWVRQAPGQGLEWMGWINPNSGGTNYTQKFQGRVTMTRDTSISTAYMELSRLRSDDTAVYSCARDMAFSMVRGSFDYWGQGTLVTVSS,QAVLTQPPSASGSPGQSVTISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYEVSKRPSGVPDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYAGSNHWVFGGGTKLTVL,IGHV1-2 (Human),IGHJ4 (Human),IGLV2-8 (Human),IGLJ3 (Human),ARDMAFSMVRGSFDY,SSYAGSNHWV,https://www.rcsb.org/structure/7BEH;https://www.rcsb.org/structure/7ND7,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Mar 11, 2021","Mar 11, 2021",N/A,Complete
COVOX-253,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVQSGPEVKKPGTSVKVSCKASGFTFTTSAVQWVRQARGQRLEWIGWIVVGSGNTNYAQKFQERVTITRDMSTTTAYMELSSLRSEDTAVYFCAAPHCNSTSCYDAFDIWGQGTMVTVSS,DIQMTQSPGTLSLSPGEGATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSGATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPYTFGQGTKVEIK,IGHV1-58 (Human),IGHJ3 (Human),IGKV3-20 (Human),IGKJ1 (Human),AAPHCNSTSCYDAFDI,QQYGSSPYT,https://www.rcsb.org/structure/7BEN;https://www.rcsb.org/structure/7ORA,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Mar 11, 2021","Jul 9, 2021",9th July '21: Added new PDB structure and reference.,Variant binding and neutralisation data in Liu et al. Complete
COVOX-269,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVESGGGLIQPGGSLRLSCAASGLTVNRNYMSWIRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLSLQMNSLRAEDTAIYYCARDFYEGSFDIWGQGTMVTVSS,AIQLTQSPSFLSASIGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFASYYCQQLNSYPAPVFGPGTKVDIK,IGHV3-53 (Human),IGHJ3 (Human),IGKV1-9 (Human),IGKJ3 (Human),ARDFYEGSFDI,QQLNSYPAPV,https://www.rcsb.org/structure/7BEM;https://www.rcsb.org/structure/7NEG;https://www.rcsb.org/structure/7NEH,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Mar 11, 2021","Mar 11, 2021",N/A,Complete
COVOX-40,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLLESGGDLIQPGGSLRLSCAASGVTVSSNYMSWVRQAPGKGLEWVSIIYPGGSTFYADSVKGRFTISRDNSKNTLYLQMHSLRAEDTAVYYCARDLGSGDMDVWGKGTTVTVSS,DIVMTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIQAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYRYTFGQGTKVEIK,IGHV3-53 (Human),IGHJ6 (Human),IGKV1-9 (Human),IGKJ1 (Human),ARDLGSGDMDV,QQLNSYRYT,https://www.rcsb.org/structure/7ND6,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Mar 11, 2021","Mar 11, 2021",N/A,Complete
COVOX-253H165L,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Patient,QVQLVQSGPEVKKPGTSVKVSCKASGFTFTTSAVQWVRQARGQRLEWIGWIVVGSGNTNYAQKFQERVTITRDMSTTTAYMELSSLRSEDTAVYFCAAPHCNSTSCYDAFDIWGQGTMVTVSS,DIVMTQSPGTLSLSPGERATLSCRASQSVRSSYLAWYQQKPGQAPRLLIYGASRRGTGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK,IGHV1-58 (Human),IGHJ3 (Human),IGKV3-20 (Human),IGKJ1 (Human),AAPHCNSTSCYDAFDI,QQYGSSPWT,https://www.rcsb.org/structure/7NDB,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Mar 11, 2021","Mar 11, 2021",N/A,Complete
COVOX-159,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Patient,EVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVALISYDGGNRYYADSVKGRFTISRDNSKNTLYLQMNRLRAEDTAMYYCAKDRDDGWDWYYFMDVWGKGTTVTVSS,DIQLTQSPGTLSLSPGERATLSCRASQSISGNYLAWYQHKPGQAPRLLIYGASTRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSYTFGQGTKVEIK,IGHV3-30 (Human),IGHJ6 (Human),IGKV3-20 (Human),IGKJ1 (Human),AKDRDDGWDWYYFMDV,QQYGSSYT,https://www.rcsb.org/structure/7NDC;https://www.rcsb.org/structure/7NDD,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Mar 11, 2021","Mar 11, 2021",N/A,Complete
DesAb-RBD-C1,Nb,SARS-CoV2,,,,S; RBD,Computational Engineering,EVQLEESGGGLVQPGGSLRLSCAASGFNIKDTYIGWVRQAPGKGEEWVASIYPTSGYTRYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCAAGSGSSATEVYEEFDYWGQGTLVTVSS,N/A,IGHV3-66 (Human),IGHJ4 (Human),N/A,N/A,AAGSGSSATEVYEEFDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DesAb-RBD-C1_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Mar 11, 2021","Mar 11, 2021",N/A,Complete
DesAb-RBD-C2,Nb,SARS-CoV2,,,,S; RBD,Computational Engineering,EVQLEESGGGLVQPGGSLRLSCAASGFNIKDTYIGWVRQAPGKGEEWVASIYPTSGYTRYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCAAGSVVADLSVEEFDYWGQGTLVTVSS,N/A,IGHV3-66 (Human),IGHJ4 (Human),N/A,N/A,AAGSVVADLSVEEFDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DesAb-RBD-C2_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Mar 11, 2021","Mar 11, 2021",N/A,Complete
Xu_Nb15,Nb,SARS-CoV2,,,,S; RBD,Immunised Llama,QVQLQESGGGLVQAGGSLRVSCAASGLPFSDYLMGWFRQAPGKEREYVAAISQNGGHTYADSVLGRFTISRDNAKNTVYLQMNMLTPGDTAVYSCAARRPGGGRWDAAHDYNYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AARRPGGGRWDAAHDYNY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Xu_Nb15_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Mar 11, 2021","Jun 17, 2021",17th June '21: Added new reference,Neutralised some VoC when mulitmerised. Complete
Xu_Nb17,Nb,SARS-CoV2,,,,S; RBD,Immunised Llama,QVQLQESGGGLVQTGGSLRLSCAASGRTFGIYRMGWFRQAPGKEREFVAAITSSADTAQYRDSVKGRFAISRDNAKNTLYLQMNSLKPEDTAIYYCAARDPTTLEYGNWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AARDPTTLEYGN,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Xu_Nb17_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Mar 11, 2021","Jun 17, 2021",17th June '21: Added new reference,Could not neutralise variants tested. Complete
Xu_Nb19,Nb,SARS-CoV2,,,,S; RBD,Immunised Llama,QVQLQESGGGLVQAGGSLRLSCAASGSGFSIHAMGWYRQAPGKQREFVAVVGHKTNYADSVKGRFTISRDVGKNTVELQMNSLKVEDTAVYYCYCNTIVTMTGVPDAVWGQGTQVTVSS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,YCNTIVTMTGVPDAV,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Xu_Nb19_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Mar 11, 2021","Jun 17, 2021",17th June '21: Added new reference,Neutralised some VoC when mulitmerised. Complete
Xu_Nb56,Nb,SARS-CoV2,,,,S; RBD,Immunised Llama,QVQLQESGGGLVQAGDSLRLSCVASERTFRRYGMGWFRQAPGKEREFVAAVDRSHTKTGYADFVKGRFTISTNYENMVYLQMNSLKPEDTAVYYCAAPSYEKGSDPTSWNTDRGYDYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAPSYEKGSDPTSWNTDRGYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Xu_Nb56_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Mar 11, 2021","Jun 17, 2021",17th June '21: Added new reference,Neutralised some VoC when mulitmerised. Complete
Xu_Nb12,Nb,SARS-CoV2,,,,S; RBD,"Transgenic Mouse (""nanomouse"")",QVKLEESGGGSVQAGGSLRLICTAPGLTHNNCGLDWYRRAPGKEREFVSSISADGTTSYADSVKGRFTISKDKVEDTVYLQMNSLKPEDTAIYSCKTAFPYFGNSCVLDYWGQGTSVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),QVKLEESGGGSVQAGGSLRLICTAPGLTHNNCGLDWYRRAPGKEREFVSSISADGTTSYADSVKGRFTISKDKVEDTVYLQMNSLKPEDTAIYSCKTAFPYFGNSCVLDYWGQGTSVTVSS,N/A,KTAFPYFGNSCVLDY,N/A,https://www.rcsb.org/structure/7MY3,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Mar 11, 2021","Jun 17, 2021",17th June '21: Added new reference and PDB structure,Neutralised all variants tested in monomeric form. Complete
Xu_Nb30,Nb,SARS-CoV2,,,,S; RBD,"Transgenic Mouse (""nanomouse"")",QVQLVESGGGLVQAGGSLRLSCAASGLTFSKYAMGWFRQAPGKERKFVATISWSGDSAFYADSVKGRFTISRDNARNTVYLQMNSLKPEDTAVYYCAADRGMGYGDFMDYWGQGTSVTASS,N/A,IGHV3-3 (Alpaca),IGHJ7 (Alpaca),QVQLVESGGGLVQAGGSLRLSCAASGLTFSKYAMGWFRQAPGKERKFVATISWSGDSAFYADSVKGRFTISRDNARNTVYLQMNSLKPEDTAVYYCAADRGMGYGDFMDYWGQGTSVTASS,N/A,AADRGMGYGDFMDY,N/A,https://www.rcsb.org/structure/7MY2,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Mar 11, 2021","Jun 17, 2021",17th June '21: Added new reference and PDB structure,Neutralised all variants tested in monomeric form. Complete
humVHH72,Nb,SARS-CoV2,,,,S; RBD,Engineered from VHH72,EVQLVESGGGLVQPGGSLRLSCAASGRTFSEYAMGWFRQAPGKEREFVATISWSGGSTYYTDSVKGRFTISRDNAKNTVYLQMNSLRPEDTAVYYCAAAGLGTVVSEWDYDYDYWGQGTLVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAAGLGTVVSEWDYDYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/humVHH72_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Mar 11, 2021","Mar 11, 2021",N/A,Complete
humVHH72_S56A,Nb,SARS-CoV2,,,,S; RBD,Engineered from VHH72,EVQLVESGGGLVQPGGSLRLSCAASGRTFSEYAMGWFRQAPGKEREFVATISWSGGATYYTDSVKGRFTISRDNAKNTVYLQMNSLRPEDTAVYYCAAAGLGTVVSEWDYDYDYWGQGTLVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAAGLGTVVSEWDYDYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/humVHH72_S56A_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Mar 11, 2021","Mar 11, 2021",N/A,Complete
A23-58-1,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV1-58 (Human),IGHJ6 (Human),IGKV3-20 (Human),IGKJ1 (Human),AAPNCSNVVCYDGFDI,QQYGTSPWT,https://www.rcsb.org/structure/7LRS;https://www.rcsb.org/structure/7LRT,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 28, 2021","Jul 24, 2021",24th July '21: Added PDB structure,Complete
B1-182-1,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV1-58 (Human),IGHJ3 (Human),IGKV3-20 (Human),IGKJ1 (Human),AAPYCSGGSCFDGFDI,QQYGNSPWT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 28, 2021","Feb 28, 2021",N/A,Complete
A19-61-1,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV3-30 (Human),IGHJ6 (Human),IGKV1-12 (Human),IGKJ5 (Human),ARDLAIAVAGTWHYYNGMDV,QQAKSFPIT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 28, 2021","Feb 28, 2021",N/A,Complete
A19-46-1,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV3-30 (Human),IGHJ6 (Human),IGLV8-61 (Human),IGLJ3 (Human),ARGWAYWELLPDYYYGMDV,VLYMGRGIVV,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 28, 2021","Feb 28, 2021",N/A,Complete
MW06,Ab,SARS-CoV2,,,,S; RBD,ND,EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMNWVRQAPGKGLEWVSVISGSGGSTYYADSVRGRFTISRDNSKNTLYLQMNSLRAEDTAVYCCAKGYYYDSSGYYFREDAFDIWGQGTLVTVSS,DIQMTQSPSAMSASVGDRVTITCRASQGISNYLAWFQQKPGKVPKRLIYAASSLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCLQHNSYPYTFGQGTKLEIK,IGHV3-23 (Human),IGHJ4 (Human),IGKV1-17 (Human),IGKJ2 (Human),AKGYYYDSSGYYFREDAFDI,LQHNSYPYT,https://www.rcsb.org/structure/7DPM,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 28, 2021","Feb 28, 2021",N/A,Awaiting publication for citation
Ehling_mAb-02,Ab,SARS-CoV2,,,,S; S2,B-cells; SARS-CoV2 Human Patient,QITLKESGPTLVKPTQTLTLTCTFSGFSLSTSGVGVGWIRQPPGKALEWLALIYWDDDKRYSPSLKSRLTITKDTSKNQVVLTMTNMDPVDTATYYCAHRPIAIAAAAFDYWGQGTLVTVSS,DIVMTQSPLSLPVTPGEPASISCRSSQSLLHSNGYNYLDWYLQKPGQSPQLLIYLGSNRASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQALQTPGTFGQGTKVEIK,IGHV2-5 (Human),IGHJ4 (Human),IGKV2-28 (Human),IGKJ1 (Human),AHRPIAIAAAAFDY,MQALQTPGT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Ehling_mAb-02_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 14, 2021","Feb 14, 2021",N/A,Plasma cells. Complete
Ehling_mAb-04,Ab,SARS-CoV2,,,,S; S2,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVKPGGSLRLSCAASGFTFSNAWMSWVRQAPGKGLEWVGRIKSKTDGGTTDYAAPVKGRFTISRDDSKNTLYLQMNSLKTEDTAVYYCTTATYVLRFLYYYYMDVWGKGTTVTVSS,EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNWWTFGQGTKVEIK,IGHV3-15 (Human),IGHJ6 (Human),IGKV3-15 (Human),IGKJ1 (Human),TTATYVLRFLYYYYMDV,QQYNNWWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Ehling_mAb-04_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 14, 2021","Feb 14, 2021",N/A,Plasma cells. Complete
Ehling_mAb-06,Ab,SARS-CoV2,,,,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVESGGRVVQPGRSLRLSCAASGFTFSTYGMHWVRQAPGKGLEWVAVISSDGSNKYYADSVKGRFTISRDNSKNTLYLQMNGLRAEDTAVYYCAKDDNRENYDVLTGYYGPFDYWGQGTLVTVSS,DIQMTQSPSTLSASVGDRVTISCRASQSISSWLAWYQQKPGKAPKLLIYKASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYMSYPWTFGQGTKVEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV1-5 (Human),IGKJ1 (Human),AKDDNRENYDVLTGYYGPFDY,QQYMSYPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Ehling_mAb-06_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 14, 2021","Feb 14, 2021",N/A,Plasma cells. Complete
Ehling_mAb-08,Ab,SARS-CoV2,,,,S; S2,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFNNYWMSWVRQAPGKGLEWVANIKQDGSEKYYVDSVKGRITISRDNAKNSLYLQMNSLRAEDTAVYYCASYRYGDYVFDYWGQGTLVTVSS,DIVMTQSPDSLAVSLGERATINCKSSQSVLYSSNNKNYLAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQCYSTPLTFGGGTKVEIK,IGHV3-7 (Human),IGHJ4 (Human),IGKV4-1 (Human),IGKJ4 (Human),ASYRYGDYVFDY,QQCYSTPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Ehling_mAb-08_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 14, 2021","Feb 14, 2021",N/A,Plasma cells. Complete
Ehling_mAb-12,Ab,SARS-CoV2,,,,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTGYYMHWVRQAPGQGLEWMGWINPNSGGTNYAQKFQGRVTMTRDTSISTAYMELSRLRSDDTAVYYCAVSGVAARLYYGMDVWGQGTTVTVSS,DIQMTQSPSSLSAYMGDRVTLTCRPSQGIGNDLSWYQQRPGKAPQRLIYAASRLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCLQHNSHPRTFGQGTKLEIK,IGHV1-2 (Human),IGHJ6 (Human),IGKV1-17 (Human),IGKJ2 (Human),AVSGVAARLYYGMDV,LQHNSHPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Ehling_mAb-12_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 14, 2021","Feb 14, 2021",N/A,Plasma cells. Complete
Ehling_mAb-14,Ab,SARS-CoV2,,,,S; S2,B-cells; SARS-CoV2 Human Patient,EVQLLQSGGGLIQPGGSLRLSCATSGFTFSTHAMSWVRQAPGKGLEWVSGIFGSGGNQYYAASVKGRFTISRDNSKNVLYLQMNSLRVDDTAVYYCAKDPVGCINGVCYGAWYYFDSWGQGVPVTVSS,EVVLTQSPGTLSLSPGERATLSCRASQSISNNLAWYQQKPGQAPRLLIYEASKRATGIPARFSGSGSGTDFTLTISSLEPEDFAIYHCQQRSSWPPRFTFGQGTKLEIK,IGHV3-23 (Human),IGHJ4 (Human),IGKV3-11 (Human),IGKJ2 (Human),AKDPVGCINGVCYGAWYYFDS,QQRSSWPPRFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Ehling_mAb-14_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 14, 2021","Feb 14, 2021",N/A,Plasma cells. Complete
Ehling_mAb-17,Ab,SARS-CoV2,,,,S; S1 non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKVSGYTLTELSMHWVRQAPGKGLEWMGGFDPEDGETIYAQKFQGRVTMTEDTSTDTAYMELSSLRSEDTAVYYCATGVAVAGTPINYYYYYGMDVWGQGTTVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGKAFGQGTKVEIK,IGHV1-24 (Human),IGHJ6 (Human),IGKV3-20 (Human),IGKJ1 (Human),ATGVAVAGTPINYYYYYGMDV,QQYGKA,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Ehling_mAb-17_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 14, 2021","Feb 14, 2021",N/A,Plasma cells. Complete
Ehling_mAb-18,Ab,SARS-CoV2,,,,S; S2,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVTVIYRGGSTYYADSVKGRFTISRDNSQNTLYLQMNSLRAEDTAVYYCVRCSNYGSWFDPWGQGTLVTVSS,EIVMTQYPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATDIAARFSGSGSGTEFTLTISSPQSEDSAVYYCQQYINWPRTFGQGTKVEIK,IGHV3-53 (Human),IGHJ5 (Human),IGKV3-15 (Human),IGKJ1 (Human),VRCSNYGSWFDP,QQYINWPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Ehling_mAb-18_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 14, 2021","Feb 14, 2021",N/A,Plasma cells. Complete
Ehling_mAb-19,Ab,SARS-CoV2,,,,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFNFNNYGMHWVRQAPGKGLEWLAVISYEGSKKYYADSLKGRFTISRDSSKNTLYLQMNSLSPDDTAVYYCAKASALFMITFGGVMGVDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDSVTITCRASQDIRNDLDWYQQKPGKAPQRLIYGASSLQSGVPSRFSGSGSGTEFTLTINSLQPEDFATYYCLQHNSYPLTFGGGTKVEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV1-17 (Human),IGKJ4 (Human),AKASALFMITFGGVMGVDY,LQHNSYPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Ehling_mAb-19_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 14, 2021","Feb 14, 2021",N/A,Plasma cells. Complete
Ehling_mAb-21,Ab,SARS-CoV2,,,,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGTSLRLSCAASGFNFNNFGMHWVRQAPGRGLEWVAGISYEGSIKKFADFVGGRFTVSRDFSKNTLYLQMNNLKTEDSAVYYCAKVKPILGFAQGWFLDYWGQGTLVTVS,QSALTQPRSVSGSPGQSVTISCTGTSSDVGGYDYVSWYQQHPGKVPKVIIYDVTQRPSGVPDRFSGSKSGNTASLTIAGLQAEDEADYYCSSYEGSNNIYVFGTGTKVTVL,IGHV3-30 (Human),IGHJ4 (Human),IGLV2-11 (Human),IGLJ1 (Human),AKVKPILGFAQGWFLDY,SSYEGSNNIYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Ehling_mAb-21_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 14, 2021","Feb 14, 2021",N/A,Plasma cells. Complete
Ehling_mAb-22,Ab,SARS-CoV2,,,,S; S1 non-RBD,B-cells; SARS-CoV2 Human Patient,EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSAISGSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKPNPTYDYVWGSYRYGWFDPWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPGTFGQGTKVEIK,IGHV3-23 (Human),IGHJ5 (Human),IGKV3-20 (Human),IGKJ1 (Human),AKPNPTYDYVWGSYRYGWFDP,QQYGSSPGT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Ehling_mAb-22_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 14, 2021","Feb 14, 2021",N/A,Plasma cells. Complete
Ehling_mAb-33,Ab,SARS-CoV2,,,,S; S1 non-RBD,B-cells; SARS-CoV2 Human Patient,EEQLVESGGGLVKPGESLRLSCTASGFTFNSYSIHWVRQAPGKGLEWVSSISSTGTYTFYADSVKGRFTVSRDNARNSLYLQMDSLRAEDTAMYYCVRNMFGQGTLATVSS,QSALTQPASVSGSPGQSITISCTGSSTDVGNHAYVNWYQQHPGKAPKLIIYEVTNRPSGVSSRFSASKSGNTASLTISGLQPDDEADYYCSSYSSTTNPRVFGTGTKVTVL,IGHV3-21 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ1 (Human),VRNM,SSYSSTTNPRV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Ehling_mAb-33_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 14, 2021","Feb 14, 2021",N/A,Plasma cells. Complete
Ehling_mAb-40,Ab,SARS-CoV2,,,,S; S2,B-cells; SARS-CoV2 Human Patient,EVQLAESGGGLVQPGGSLRLSCAVSGFSFTDNYISWVRQAPGKGLEWVSVIYSGGSTEYVDSVKGRFTISRDDSKKRVFLQMNGLRADDTAVYFCARSPEPGFGDLLQNRPYFYYAMDVWGQGTTVTVS,DIQLTQSPSSLSASVGDRITITCRASQSITTYLNWFQQKPGKAPRLLIFAASNLQGGVPSRFSGSGSGRDFTLTFSSLQPEDFATYYCQQTYTTPLTFGGGTKVEIK,IGHV3-66 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ4 (Human),ARSPEPGFGDLLQNRPYFYYAMDV,QQTYTTPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Ehling_mAb-40_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 14, 2021","Feb 14, 2021",N/A,Plasma cells. Complete
Ehling_mAb-42,Ab,SARS-CoV2,,,,S; S2,B-cells; SARS-CoV2 Human Patient,QLHLQESGPGLVKPSETLSLTCTVSGGSISTTKYNWGWIRQSPGKGLEWIASIYYSGTTYYNPSLKSRVTMSVDTSKNQFSLKLSSVTAADTAVYYCARDARGILTGFYWSAFDIWGQGTKVTASS,SSELTQDPAVSVALGQTVRITCQGDSLRGHYASWYQQKPGQAPVLVIYGRNSRPSGIPDRISGSSSGITASLTITGAQAEDEADYYCSSRDSSGNGLVFGTGTKVTVL,IGHV4-39 (Human),IGHJ3 (Human),IGLV3-19 (Human),IGLJ1 (Human),ARDARGILTGFYWSAFDI,SSRDSSGNGLV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Ehling_mAb-42_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 14, 2021","Feb 14, 2021",N/A,Plasma cells. Complete
Ehling_mAb-47,Ab,SARS-CoV2,,,,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSGTLTLTCAVSGGSITSNNWWSWVRQFPGKGLEWIGEIYHSGTTNYNPSLKSRVTISVDESKNQFSLNLRTVTAADTAVYYCARPMPGKGFDHWGPGTLVTVSS,QSVLTQPPSASGTPGQRVTISCSGGSSNIGSNTVYWYQQLPGTAPRVVIYGTNQRPSGVPDRFSGSKSGTSASLAISGLQSEDEADYHCAAWDDSLNGVVFGGGTKLTVL,IGHV4-4 (Human),IGHJ5 (Human),IGLV1-44 (Human),IGLJ3 (Human),ARPMPGKGFDH,AAWDDSLNGVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Ehling_mAb-47_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 14, 2021","Feb 14, 2021",N/A,Plasma cells. Complete
Ehling_mAb-49,Ab,SARS-CoV2,,,,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLRESGPGLVKPSGTLSLTCAVSGDSISNNNWWTWVRQPPGRGLEWIGEIYRSVTTNYNPSLKSRVTISGDKSKNQLSLTLNSVTAADTAVYYCATRMVYLDGMDVWGQGTTVTVSS,DIQMTQSPSSLSASIGDRVTITCRASQRISSYLNWYQQRPGKAPKLLIYTASNLQSGVPSRFTGGGSGTDFTLTISSLQPEDFATYYCQQSSTTPFTFGPGTKVDIK,IGHV4-4 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ3 (Human),ATRMVYLDGMDV,QQSSTTPFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Ehling_mAb-49_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 14, 2021","Feb 14, 2021",N/A,Plasma cells. Complete
Ehling_mAb-50,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVNPSETLSLTCGVSGYSISSGFYWGWIRQPPGKGLEWIGSIYHRGSTFYNPSLKSRVTISVDRSKNQFSLRLSSVTAADTAVYYCARGEVLTSGGYNARFDPWGQGTLVTVSS,DIQMTQSPSTLSASVGDSVTITCRASQSISLWLAWYQQKPGKAPKVLIYETSSLESGVPSRFSGSGAGTEFTLTISSLQPDDFATYYCQQYISYPLTFGGGTKVEIK,IGHV4-28 (Human),IGHJ5 (Human),IGKV1-5 (Human),IGKJ4 (Human),ARGEVLTSGGYNARFDP,QQYISYPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Ehling_mAb-50_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 14, 2021","Feb 14, 2021",N/A,Plasma cells. Complete
Ehling_mAb-51,Ab,SARS-CoV2,,,,S; S2,B-cells; SARS-CoV2 Human Patient,QVDLVESGGGVVQPGRSLRLSCAASGLALNPYGMHWVRQAPGKGLEWLAVIAYDGTNPNYADSVKGRFTISRDTSTRTLFLQIDNLRVEDTAIYYCAKDALASLRGATSGQLDYWGRGIPVTVSS,EIVLTQSPGTLSLSPGEGATLSCRASQSVSTNSLAWYQQKPGQAPRLLIYGASSRAPDIPHRFSGSGSETDFTLTITRLEPEDFAVYYCQHYASFSGTFGQGTRVEMK,IGHV3-30 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ1 (Human),AKDALASLRGATSGQLDY,QHYASFSGT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Ehling_mAb-51_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 14, 2021","Feb 14, 2021",N/A,Plasma cells. Complete
Ehling_mAb-52,Ab,SARS-CoV2,,,,S; S2,B-cells; SARS-CoV2 Human Patient,QLQLQESGSGLLEPSQTLSLTCAVSGGSIYNPYYTWSWIRQPPGGGLEWIGYVYHGPSTYYNPSLKSRVTISLDTSKNRFSLKLTAVTAADTAVYYCARGPKVLRLLEWLTPSFEDWGQGALVAVSS,QSALTQLASMSGSPGQSITVSCTGTSDDVGYYNYVSWYQQHPGKAPKLIIYDVTNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTTSSSLVFGTGTKVTVL,IGHV4-31 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ1 (Human),ARGPKVLRLLEWLTPSFED,SSYTTSSSLV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Ehling_mAb-52_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 14, 2021","Feb 14, 2021",N/A,Plasma cells. Complete
Ehling_mAb-55,Ab,SARS-CoV2,,,,S; S1/S2,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKVSGYTLTDLPIHWVRQVPGKGLEWMGNFDPEVGETTFAQEFQGRVTMTQDTSTHTGYMELSSLTSDDTALYYCATEGLVMVITYAFETWGQGTMVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQTINSNYLAWYQQRPGQAPRLLIYGASSRATGVPGRFSGSGSGTDFTLTITRLEPEDFAVYHCQQYGSSPRTFGQGTKVEIK,IGHV1-24 (Human),IGHJ3 (Human),IGKV3-20 (Human),IGKJ1 (Human),ATEGLVMVITYAFET,QQYGSSPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Ehling_mAb-55_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 14, 2021","Feb 14, 2021",N/A,Plasma cells. Complete
Ehling_mAb-57,Ab,SARS-CoV2,,,,S; S2,B-cells; SARS-CoV2 Human Patient,QVHLVQSGAEVKKPGASVRVSCRASGENFNSFALNWVRQAPGQRPEWMGGIMPILETATYSQKFQGRLTITADESTSTAYMELRRLTSEDTALYYCARGRDIVVEVSDSDPFDIWGQGTMVTVSS,EIVLTQSPGTLSLSAGQRATLSCGASHRVRSNYIAWYQQRPGQAPRLLIYGASSRPSGIPDRFRGSGSGTDFTLTISSLEPEDFAVYFCQQYGSSPYTFGQGTKLEIK,IGHV1-69 (Human),IGHJ3 (Human),IGKV3-20 (Human),IGKJ2 (Human),ARGRDIVVEVSDSDPFDI,QQYGSSPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Ehling_mAb-57_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 14, 2021","Feb 14, 2021",N/A,Plasma cells. Complete
Ehling_mAb-60,Ab,SARS-CoV2,,,,S; S2,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCSASGFTFSSYAMHWVRQAPGKGLEYVSAISSNGGSTYYADSVKGRFTISRDNSKNTLYLQMSSLRAEDTAVYYCVKDSGWFGELAEGLIYWFDPWGQGTLVTVSS,IQLTQSPSSLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQLNSYPWTFGQGTKVEIK,IGHV3-64 (Human),IGHJ5 (Human),IGKV1-9 (Human),IGKJ1 (Human),VKDSGWFGELAEGLIYWFDP,QQLNSYPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Ehling_mAb-60_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 14, 2021","Feb 14, 2021",N/A,Plasma cells. Complete
Ehling_mAb-62,Ab,SARS-CoV2,,,,S; S1/S2,B-cells; SARS-CoV2 Human Patient,QLQLQESGPGLVKPSETLSLTCSVSGGSISSSSYFWGWIRQPPGKGLEWIGSFYYSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARDRTPAYEILTGHHLLPKYYFDFWGQGTLVTVS,QSALTQPASVSGSPGQSITISCTGSSSDVGAYNYVSWYQHHPGKAPKLMIYEVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCNSYTYSSTLFGTGTKVTVL,IGHV4-39 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ1 (Human),ARDRTPAYEILTGHHLLPKYYFDF,NSYTYSSTL,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Ehling_mAb-62_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 14, 2021","Feb 14, 2021",N/A,Plasma cells. Complete
Ehling_mAb-64,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVETGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLHIYGMDVWGQGTTVTVSS,DIQMTQSPSSVSASVGDRVTITCRASQGISSWLAWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQANSFPNFGGGTKVEIK,IGHV3-53 (Human),IGHJ6 (Human),IGKV1-12 (Human),IGKJ4 (Human),ARDLHIYGMDV,QQANSFPN,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Ehling_mAb-64_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 14, 2021","Feb 14, 2021",N/A,Plasma cells. Complete
Ehling_mAb-71,Ab,SARS-CoV2,,,,S; S2,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVKPGESLRLSCAASGFTFTSYSMNWVRQAPGKGLEWVSSISSSSSYIKYADSVKGRFTISRDNAKKSLYLQMNSLRVEDTAVYYCARDFFGGDSGDYWYFDLWGRGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSIRRYLNWYQQKPGKAPKLLIHAASSLQSGAPSRFSGSGSGTDFTLTISSLQPEDFATYSCQQSYSTPWTFGQGTKVEIK,IGHV3-21 (Human),IGHJ2 (Human),IGKV1-39 (Human),IGKJ1 (Human),ARDFFGGDSGDYWYFDL,QQSYSTPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Ehling_mAb-71_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 14, 2021","Feb 14, 2021",N/A,Plasma cells. Complete
Ehling_mAb-77,Ab,SARS-CoV2,,,,S; S2,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVKPGGSLRVSCAASGFTFNSYSMNWVRQAPGKGLEWVSSMSSSSSHIYYADSVKGRFTISRDNAKNSVYLQMNSLRVEDTAVYYCARDGGVDIVDTSTDAFDIWGQGTMVTVSS,SYVLTQLSSVSVAPGQTARITCGGNNIESKSVHWYQQEPGQAPVLVVYDDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDSSIDHYVFGPGTKVTVL,IGHV3-21 (Human),IGHJ3 (Human),IGLV3-21 (Human),IGLJ1 (Human),ARDGGVDIVDTSTDAFDI,QVWDSSIDHYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Ehling_mAb-77_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 14, 2021","Feb 14, 2021",N/A,Plasma cells. Complete
Ehling_mAb-82,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGIIPIFGTANYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYCARGNDDSSGYYSHYYYGMDVWGQGTTVTVSS,QTVVTQEPSFSVSPGGTVTLTCGLSSGSVSTSYYPSWYQQTPGQAPRTLIYSTNTRSSGVPDRFSGSILGNKAALTITGAQADDESDYYCVLYMGSGAVFGGGTQLTVL,IGHV1-69 (Human),IGHJ6 (Human),IGLV8-61 (Human),IGLJ7 (Human),ARGNDDSSGYYSHYYYGMDV,VLYMGSGAV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Ehling_mAb-82_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 14, 2021","Feb 14, 2021",N/A,Plasma cells. Complete
Ehling_mAb-86,Ab,SARS-CoV2,,,,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLQQWGAGLLKPSETLSLTCAVYSGSFSGYFWSWVRQSPGKGLEWIGQINDRGSTDYNPSLESRVTMSVDTSKSQFSLKLTSVTAADTAVYYCARGVPGDWGQGTLVTVSS,IQMTQSPPTLSASVGDRVTITCRASQSIGTHLAWYQQKPGRTPKLLIYKTSTLENWVPSRFSGSGSATEFTLTISRLQPDDFATYYCQQYDGKPYTFGQGTNLEMK,IGHV4-34 (Human),IGHJ1 (Human),IGKV1-5 (Human),IGKJ2 (Human),CARGVPGDW,CQQYDGKPYTF,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Ehling_mAb-86_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 14, 2021","Feb 14, 2021",N/A,Plasma cells. Complete
Ehling_mAb-90,Ab,SARS-CoV2,,,,S; S2,B-cells; SARS-CoV2 Human Patient,QLQLQESGPGLVKPSETLTLTCTVSGGSISSSNYYWGWIRQPPGKGLEWIGSMYYSANTYYNPSLKSRVTISVDTSKNQFSLKVSSVTAADTAVYYCGRHPPYSNFDYWGQGTLVTVSS,EIVMTQSPATLSVSPGERATLSCRAGQSVSNNLGWYQQKPGQAPRLLIYDASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQCNSWPLTFGGGTKVEIK,IGHV4-39 (Human),IGHJ4 (Human),IGKV3-15 (Human),IGKJ4 (Human),GRHPPYSNFDY,QQCNSWPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Ehling_mAb-90_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 14, 2021","Feb 14, 2021",N/A,Plasma cells. Complete
Ehling_mAb-93,Ab,SARS-CoV2,,,,S; S1 non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDYGDYGGLDYWGQGTLVTVSS,DIVMTQSPDSLAVSLGERATINCKSSQSVLYSSNNKNYLAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYSTPLTFGQGTKVEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV4-1 (Human),IGKJ1 (Human),AKDYGDYGGLDY,QQYYSTPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Ehling_mAb-93_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 14, 2021","Feb 14, 2021",N/A,Plasma cells. Complete
Ehling_mAb-98,Ab,SARS-CoV2,,,,S; S2,B-cells; SARS-CoV2 Human Patient,QVTLRESGPALVKPTQTLTLTCTFSGFSLSTSGMCVSWIRQPPGKALEWLARIDWDDDKYYSTSLKTRLTISKDTSKNQVVLTMTNMDPVDTATYYCARTRATALMAFDIWGQGTMVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPRTFGQGTKLEIK,IGHV2-70 (Human),IGHJ3 (Human),IGKV1-39 (Human),IGKJ2 (Human),ARTRATALMAFDI,QQSYSTPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Ehling_mAb-98_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 14, 2021","Feb 14, 2021",N/A,Plasma cells. Complete
Ehling_mAb-100,Ab,SARS-CoV2,,,,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSQTLSLTCTVSGGSISSGGYYWSWIRQHPGKGLEWIGYIYYSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARALLVTHDAFDIWGQGTMVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPPMCSFGQGTKLEIK,IGHV4-61 (Human),IGHJ3 (Human),IGKV3-11 (Human),IGKJ2 (Human),ARALLVTHDAFDI,QQRSNWPPMCS,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Ehling_mAb-100_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 14, 2021","Feb 14, 2021",N/A,Plasma cells. Complete
Ehling_mAb-116,Ab,SARS-CoV2,,,,S; S2,B-cells; SARS-CoV2 Human Patient,QMQLVESGGGVVQAGRSLILSCAASGFNFNNYGMHWVRQAPGKGLEWVASIPYDGRSENYAESVKGRFTVSRDSSKSTLYLQMSSLRIEDTALYFCARGRYTYDYAEGFGFWGQGTLVTVST,EVVLTQSPGTLSLSPGETGTLSCRTSQSVSSDYLAWYQQKAGQAPRLLIYAAFSRAIGIPDRFTGSGSGTDFTLTITRLEPEDFAVYYCQHYGGSLWTFGRGTKVEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ1 (Human),ARGRYTYDYAEGFGF,QHYGGSLWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Ehling_mAb-116_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 14, 2021","Feb 14, 2021",N/A,Plasma cells. Complete
Ehling_mAb-124,Ab,SARS-CoV2,,,,S; S2,B-cells; SARS-CoV2 Human Patient,QVTLKESGPVLVKPTETLTLTCTVSGFSLRNDRMGVGWIRHPPGKALEWLAHIFSKDDKSYSASLRNRLTISKDPSRSQVVLTMTNMAPADTATYYCARIDDEMGATAGWFDPWGQGTLVTVSS,LPVLTQPPSASALLGASIQLTCTLSREHSDYTIEWYQQRPGRSPQFVMKIMDDGRHTRGDGIPDRFVGSSSGADRYLTISNLQSDDEGDFYCGETHTIDGQDGYVFGTGTKVTVL,IGHV2-26 (Human),IGHJ5 (Human),IGLV4-3 (Human),IGLJ1 (Human),ARIDDEMGATAGWFDP,GETHTIDGQDGYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Ehling_mAb-124_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 14, 2021","Feb 14, 2021",N/A,Plasma cells. Complete
Ehling_mAb-131,Ab,SARS-CoV2,,,,S; S2,B-cells; SARS-CoV2 Human Patient,QVLLVESGGGVVHPGRSLRLSCAASGFTFSNFGMHWVRQAPGKGLEWVAFISYEGSIKYYADSVKGRFTISKDNSRNTLYLQMNSLRAEDAAVYYCAKRGEFFQLMDYYGMDVWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQDIRNDLGWYQQKPGKAPKRLIYAASSLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCLQHNNYPLTFGGGTKVEIK,IGHV3-30 (Human),IGHJ6 (Human),IGKV1-17 (Human),IGKJ4 (Human),AKRGEFFQLMDYYGMDV,LQHNNYPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Ehling_mAb-131_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 14, 2021","Feb 14, 2021",N/A,Plasma cells. Complete
Ehling_mAb-132,Ab,SARS-CoV2,,,,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVQSGGGVVQPGKSLRLSCAASGFSFNNYGMHWVRQAPGKGLEWVAIMSYEGSKKYYADSVNGRFSISKDNSKKTLYLQMNSLKAEDTAVYYCAKSLDIFWFRSSYAMDVWGQGTTVIVSS,DVVMTQTPLSLSVTPGQPASISCKSSQSLLHSDGKTYLYWYLQKPGQPPQLLISEVSNRFSGVSDRFSGSGSETDFTLKISRVEADDVGIYYCMQTIQLPPITFGQGTRLEIK,IGHV3-30 (Human),IGHJ6 (Human),IGKV2D-29 (Human),IGKJ5 (Human),AKSLDIFWFRSSYAMDV,MQTIQLPPIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Ehling_mAb-132_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 14, 2021","Feb 14, 2021",N/A,Plasma cells. Complete
Ehling_mAb-133,Ab,SARS-CoV2,,,,S; S2,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLIHPGGSLRLSCAASGFSISSNFMNWVRQAPGKGLEWVSVIYSGDISGDIKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDSHGLVLPYYYGMDVWGQGTTVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGGYNSVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGKTASLTISGLQAEDEADYYCSSYTSSTTFYVFGTGTKVTVL,IGHV3-53 (Human),IGHJ6 (Human),IGLV2-14 (Human),IGLJ1 (Human),ARDSHGLVLPYYYGMDV,SSYTSSTTFYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Ehling_mAb-133_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 14, 2021","Feb 14, 2021",N/A,Plasma cells. Complete
ab008,Ab,SARS-CoV2 (weak),SARS-CoV1;WIV1,SARS-CoV2 (weak),,S; RBD,B-cells; Healthy Human,ND,ND,IGHV1-69 (Human),ND,IGKV3-20 (Human),ND,ARTSYASFAGLGWFDP,QQYGSSPGLT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 13, 2021","Feb 13, 2021",N/A,Naive B-cells. Tracking publication for full sequences
ab029,Ab,SARS-CoV2 (weak),,SARS-CoV2 (weak),,S; RBD,B-cells; Healthy Human,ND,ND,IGHV5-51 (Human),ND,IGLV2-14 (Human),ND,ARSDGYSYGYY,SSYTSSRTPWV,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 13, 2021","Feb 13, 2021",N/A,Naive B-cells. Tracking publication for full sequences
ab066,Ab,SARS-CoV2 (weak),,SARS-CoV2 (weak),,S; RBD,B-cells; Healthy Human,ND,ND,IGHV1-69 (Human),ND,IGKV4-1 (Human),ND,ARQGKRTYYDILTGSPAGAFDI,QQYYSTPLIT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 13, 2021","Feb 13, 2021",N/A,Naive B-cells. Tracking publication for full sequences
ab072,Ab,SARS-CoV2 (weak),,SARS-CoV2 (weak),,S; RBD,B-cells; Healthy Human,ND,ND,IGHV3-23 (Human),ND,IGLV2-14 (Human),ND,AKPPRGYYDSSGYYYEGWYFDL,SSYTSSSTLVV,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 13, 2021","Feb 13, 2021",N/A,Naive B-cells. Tracking publication for full sequences
ab090,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; Healthy Human,ND,ND,IGHV1-2 (Human),ND,IGKV3-15 (Human),ND,ARHYGDYGEDAFDI,QQYNNWPLT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 13, 2021","Feb 13, 2021",N/A,Naive B-cells. Tracking publication for full sequences
Wu_Nb1,Nb,SARS-CoV2,,,,S; Unk,Immunised Alpaca,ND,N/A,ND,ND,N/A,N/A,NARLFDPGY,N/A,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 13, 2021","Apr 6, 2021",6th April: Corrected Ab label to Nb,Tracking publication for full VH/VL sequences
Wu_Nb2,Nb,SARS-CoV2,,,,S; RBD,Immunised Alpaca,ND,N/A,ND,ND,N/A,N/A,AAHFVPPGSRLRDCLVNELYNY,N/A,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 13, 2021","Feb 13, 2021",6th April: Corrected Ab label to Nb,Tracking publication for full VH/VL sequences
Wu_Nb4,Nb,SARS-CoV2,,,,S; RBD,Immunised Alpaca,ND,N/A,ND,ND,N/A,N/A,AAHFVPPGSRLRGCLVNELYNY,N/A,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 13, 2021","Feb 13, 2021",6th April: Corrected Ab label to Nb,Tracking publication for full VH/VL sequences
Wu_Nb5,Nb,SARS-CoV2,,,,S; Unk,Immunised Alpaca,ND,N/A,ND,ND,N/A,N/A,AAPHSGSVCPRWAEYYGVDH,N/A,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 13, 2021","Feb 13, 2021",6th April: Corrected Ab label to Nb,Tracking publication for full VH/VL sequences
Wu_Nb7,Nb,SARS-CoV2,,,,S; Unk,Immunised Alpaca,ND,N/A,ND,ND,N/A,N/A,AAHFVPPGSRLRGCLVNEAYNY,N/A,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 13, 2021","Feb 13, 2021",6th April: Corrected Ab label to Nb,Tracking publication for full VH/VL sequences
Wu_Nb9,Nb,SARS-CoV2,,,,S; RBD,Immunised Alpaca,ND,N/A,ND,ND,N/A,N/A,AAHFVPPGGRLRGCLVNDLYNY,N/A,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 13, 2021","Feb 13, 2021",6th April: Corrected Ab label to Nb,Tracking publication for full VH/VL sequences
Wu_Nb12,Nb,SARS-CoV2,,,,S; RBD,Immunised Alpaca,ND,N/A,ND,ND,N/A,N/A,AAHFVPPGSRLRGCLVNDLYNY,N/A,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 13, 2021","Feb 13, 2021",6th April: Corrected Ab label to Nb,Tracking publication for full VH/VL sequences
Wu_Nb13,Nb,SARS-CoV2,,,,S; Unk,Immunised Alpaca,ND,N/A,ND,ND,N/A,N/A,NTFHY,N/A,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 13, 2021","Feb 13, 2021",6th April: Corrected Ab label to Nb,Tracking publication for full VH/VL sequences
Wu_Nb14,Nb,SARS-CoV2,,,,S; Unk,Immunised Alpaca,ND,N/A,ND,ND,N/A,N/A,TARPSLWAVVAGCPLDQNTYFS,N/A,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 13, 2021","Feb 13, 2021",6th April: Corrected Ab label to Nb,Tracking publication for full VH/VL sequences
Wu_Nb15,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,ND,N/A,ND,ND,N/A,N/A,AGVVHDVQAMCVMNPWGS,N/A,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 13, 2021","Feb 13, 2021",6th April: Corrected Ab label to Nb,Tracking publication for full VH/VL sequences
Wu_Nb19,Nb,SARS-CoV2,,,,S; RBD,Immunised Alpaca,ND,N/A,ND,ND,N/A,N/A,AAHFVPPGSRLRGCLVNDVYNY,N/A,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 13, 2021","Feb 13, 2021",6th April: Corrected Ab label to Nb,Tracking publication for full VH/VL sequences
Wu_Nb22,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,ND,N/A,ND,ND,N/A,N/A,AAHFVPPGSRLRGCLVNELYNY,N/A,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 13, 2021","Feb 13, 2021",6th April: Corrected Ab label to Nb,Tracking publication for full VH/VL sequences
Wu_Nb24,Nb,SARS-CoV2,,,,S; RBD,Immunised Alpaca,ND,N/A,ND,ND,N/A,N/A,AAHFVPPESRLRGCLVNELYNY,N/A,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 13, 2021","Feb 13, 2021",6th April: Corrected Ab label to Nb,Tracking publication for full VH/VL sequences
Wu_Nb25,Nb,SARS-CoV2,,,,S; Unk,Immunised Alpaca,ND,N/A,ND,ND,N/A,N/A,YGQDVLGQIY,N/A,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 13, 2021","Feb 13, 2021",6th April: Corrected Ab label to Nb,Tracking publication for full VH/VL sequences
Wu_Nb27,Nb,SARS-CoV2,,,,S; Unk,Immunised Alpaca,ND,N/A,ND,ND,N/A,N/A,TTAGSWQGDY,N/A,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 13, 2021","Feb 13, 2021",6th April: Corrected Ab label to Nb,Tracking publication for full VH/VL sequences
Wu_Nb28,Nb,SARS-CoV2,,,,S; Unk,Immunised Alpaca,ND,N/A,ND,ND,N/A,N/A,AAHFVPPESRLRGCLVNEAYNY,N/A,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 13, 2021","Feb 13, 2021",6th April: Corrected Ab label to Nb,Tracking publication for full VH/VL sequences
Wu_Nb29,Nb,SARS-CoV2,,,,S; Unk,Immunised Alpaca,ND,N/A,ND,ND,N/A,N/A,YGQDILGQIY,N/A,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 13, 2021","Feb 13, 2021",6th April: Corrected Ab label to Nb,Tracking publication for full VH/VL sequences
Wu_Nb30,Nb,SARS-CoV2,,,,S; RBD,Immunised Alpaca,ND,N/A,ND,ND,N/A,N/A,AAHFVPPGSRLRGCLVNELYNY,N/A,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 13, 2021","Feb 13, 2021",6th April: Corrected Ab label to Nb,Tracking publication for full VH/VL sequences
Wu_Nb31,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,ND,N/A,ND,ND,N/A,N/A,AAHFVPPGSRLGGCLVNELYNY,N/A,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 13, 2021","Feb 13, 2021",6th April: Corrected Ab label to Nb,Tracking publication for full VH/VL sequences
Wu_Nb33,Nb,SARS-CoV2,,,,S; RBD,Immunised Alpaca,ND,N/A,ND,ND,N/A,N/A,AAHFVPPGSRFRGCSVNELYNY,N/A,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 13, 2021","Feb 13, 2021",6th April: Corrected Ab label to Nb,Tracking publication for full VH/VL sequences
Wu_Nb34,Nb,SARS-CoV2,,,,S; Unk,Immunised Alpaca,ND,N/A,ND,ND,N/A,N/A,AAHFVPPGSRLGGCLVNELYNY,N/A,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 13, 2021","Feb 13, 2021",6th April: Corrected Ab label to Nb,Tracking publication for full VH/VL sequences
C601,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSETLSLTCTVSGGSINSYYWNWIRQPPGRGLEWIAYIFYSGGTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYFCARAAGVRSVLAAASSYYYYYGLDVWGQGTTVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGAKSGNTASLTISGLQAEDEADYYCSSYTSSGWVFGGGTKLTVL,IGHV4-59 (Human),IGHJ6 (Human),IGLV2-14 (Human),IGLJ3 (Human),ARAAGVRSVLAAASSYYYYYGLDV,SSYTSSGWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C601_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C602,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGLVEPGRSLRLSCTGSGFTFGDYVLSWVRQAPGKGLEWVGFIRSKAYGETTEHAASVKGRFTISRDDSKSIAYLQMSSLKTEDTAVYFCARGLRPTRKADYWGQGTLVTVSS,QSALTQPASVSGSPGQSITISCTGTRSDVGGYNSVSWYRQHPNKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCTSYTSSTTLDVFGTGTKVTVL,IGHV3-49 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ1 (Human),ARGLRPTRKADY,TSYTSSTTLDV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C602_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C603,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAINWVRQAPGQGLEWMGGIIPIFRTANYAQKFQGRVTITADESTRTVYMELSSLRSEDTAMYYCARGGEEGIAVAAKGWTEQNYENWFDPWGQGTLVTVSS,DIVMTQSPDSLAVSLGERATINCKSSQSVLYSSNNKNYLAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYHSTPLTFGGGTKVEIK,IGHV1-69 (Human),IGHJ5 (Human),IGKV4-1 (Human),IGKJ4 (Human),ARGGEEGIAVAAKGWTEQNYENWFDP,QQYHSTPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C603_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C604,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKRPGASVKVSCKASGYTFTSYYMHWVRQAPGQGLEWMGIINPSGSSTSYAQKFQGRVTLTRDTSTSTVYMELSSLRPEDTAVYYCASGYCSSGSCHAGDAFDIWGQGTMVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSMSNYLNWYQQKPGKAPKLLIYAASSLQSGVPARFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPPTFGGGTKVEIK,IGHV1-46 (Human),IGHJ3 (Human),IGKV1-39 (Human),IGKJ4 (Human),ASGYCSSGSCHAGDAFDI,QQSYSTPPT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C604_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C606,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Human Patient,QLQLQESGPGLVKPSETLSLTCTVSGASVSSSTYYWVWIRRPPGKGLEWIGTIYYSGSTYYSPSLKSRLTISVDTSKNQFSLRLSSVTAADTAIYYCAQSTWLRGSFDYWGQGTLVTVSS,NFMLTQPHSVSESPGKTVTISCTGSSGSIASNYVQWYQQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSTNHWVFGGGTKLTVL,IGHV4-39 (Human),IGHJ4 (Human),IGLV6-57 (Human),IGLJ3 (Human),AQSTWLRGSFDY,QSYDSTNHWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C606_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C607,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSGTLSLTCAVSGGSISSNDWWNWVRQPPGKGLEWIGEIYHSGSTNYNPSLKSRVIISVDKSKNQFALNLSSVTAADTAIYYCARNCAWGSCDWGQGTLVTVSS,QAVVTQEPAFSVSPGGTVTLTCGLSSGSVSTSHHPCWYQQTPGQAPRTLIYDTDARSSGVPDRFSGSILGDKAALTITGAQADDESDYYCALYMGSGSWVFGGGTKLTVL,IGHV4-4 (Human),IGHJ4 (Human),IGLV8-61 (Human),IGLJ3 (Human),ARNCAWGSCD,ALYMGSGSWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C607_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C608,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTTYGISWVRQAPGQGLEWMGWISAYNGNTKYAQKLQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARGIAALFGFDYWGQGTLVTVSS,NFMLTQPHSVSESPGKTVTISCTGSSGSIASNYVQWYQQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSSNEGVVFGGGTKLTVL,IGHV1-18 (Human),IGHJ4 (Human),IGLV6-57 (Human),IGLJ2 (Human),ARGIAALFGFDY,QSYDSSNEGVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C608_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C609,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTMYHMHWVRQAPGQGLEWMGIINPSGGSTRYAQQLQGRVSMTRDTSTSTVYMELSSLRSEDTAFYYCAREDVGGTGYFDYWGQGTLVTVSS,SYELTQPPSVSVAPGQTARITCGANNIGSKSVHWYQQKPGQAPVLVVYDDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDGSSDHFYVFGTGTTVTVL,IGHV1-46 (Human),IGHJ4 (Human),IGLV3-21 (Human),IGLJ1 (Human),AREDVGGTGYFDY,QVWDGSSDHFYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C609_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C610,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGRIIPILGIANYAQKFQGRVTITADKSTSTDYMELSSLRSEDTAVYYCAREGSAHYDSSGLNAEYFQHWGQGTTVTVSS,QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWYQQLPGTAPKLLIYGNTNRPSGVPDRISGSKSGTSASLAISGLQAEDEADYYCQSYDSSLIASLFGGGTKLTVL,IGHV1-69 (Human),IGHJ1 (Human),IGLV1-40 (Human),IGLJ3 (Human),AREGSAHYDSSGLNAEYFQH,QSYDSSLIASL,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C610_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C611,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGAEVKKPGASVKVSCKASGYSFTSYDINWVRQATGQGLEWMGWMNPNSGNRGYAQKFQGRVTMTRNTSISTAYMELSGLTSEDTAVYFCARGVGLTYYFDYWGQGTTVTVSS,SYELTQPPSVSVAPGQTARITCGGNSIGSKSVHWYHQKPGQAPVLVVYDDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDSSTDPVVFGGGTKLTVL,IGHV1-8 (Human),IGHJ4 (Human),IGLV3-21 (Human),IGLJ2 (Human),ARGVGLTYYFDY,QVWDSSTDPVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C611_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C612,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFNISRDNSKNTLYLQMNSLRAEDTAVYYCARDLEAAGGMDVWGQGTTVTVSS,HIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNGYPLTFGGGTKVEIK,IGHV3-53 (Human),IGHJ6 (Human),IGKV1-9 (Human),IGKJ4 (Human),ARDLEAAGGMDV,QQLNGYPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C612_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C613,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLIQPGGSLRLSCAASGLTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLFLEMNSLRAEDTAVYYCARDLDYYGMDVWGQGTTVTVSS,DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQLLNSYPRLTFGGGTKVEIK,IGHV3-53 (Human),IGHJ6 (Human),IGKV1-9 (Human),IGKJ4 (Human),ARDLDYYGMDV,QLLNSYPRLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C613_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C614,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLIQPGGSLRLSCAATGFIVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYAESVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDWGEYYFDYWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQIVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISGLEPEDFAVYYCQQYDSSPRTFGQGTKVEIK,IGHV3-53 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ1 (Human),ARDWGEYYFDY,QQYDSSPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C614_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C615,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSTIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDHVAAMVQGQGVWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDITNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPLTFGGGTKVEIK,IGHV3-53 (Human),IGHJ6 (Human),IGKV1-33 (Human),IGKJ4 (Human),ARDHVAAMVQGQGV,QQYDNLPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C615_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C616,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLIQPGGSLRLSCAASGILVSSNYMNWVRQAPGMGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAMYYCARDLGVSGMDVWGQGTTVTVSS,DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQNGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQHLNSYSLFGPGTKVDIK,IGHV3-53 (Human),IGHJ6 (Human),IGKV1-9 (Human),IGKJ3 (Human),ARDLGVSGMDV,QHLNSYSL,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C616_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C617,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDRGGALHDYWGQGTLVTVSS,DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPEGIFTFGPGTKVDIK,IGHV3-66 (Human),IGHJ4 (Human),IGKV1-9 (Human),IGKJ3 (Human),ARDRGGALHDY,QQLNSYPEGIFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C617_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C618,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSAISGSGGGTYYADSVKGRFTISRDNSKNTLYLQMNSLRADDTAVYYCAKDLNALQHVETFDPWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTLPYTFGQGTKLEIK,IGHV3-23 (Human),IGHJ5 (Human),IGKV1-39 (Human),IGKJ2 (Human),AKDLNALQHVETFDP,QQSYSTLPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C618_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C620,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAVSGFTFSIYGMHWVRQAPGKGLEWVAVISYDGDNKYSADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKGSYYDILTGYYGLDYWGQGTLVTVSS,DIVMTQSPLSLPVTPGEPASISCTSSQSLLYSNGYNYLDWYLQKPGQSPQLLIYLGSNRASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQALQTPYTFGQGTKLEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV2-28 (Human),IGKJ2 (Human),AKGSYYDILTGYYGLDY,MQALQTPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C620_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C621,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDSHYYYYDSSGYYGSIPDYWGQGTLVTVSS,DIVMTQSPLSLSVTPGQPASISCKSSQSLLHSDGKTYLYWYLQKPGQPPQLLIYEVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQSIQLPHSAFGPGTKVDIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV2D-29 (Human),IGKJ3 (Human),AKDSHYYYYDSSGYYGSIPDY,MQSIQLPHSA,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C621_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C688,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGRSLRLSCAASGFTFDDYAMHWVRQAPGKGLEWVSGISWNSGTIGYADSVKGRFIISRDNAKNSLYLQMNSLRAEDTALYYCAKDMSGPDYGGIEEYGMDVWGQGTTVTVSS,SYELTQPPSVSVAPGQTARITCGGNNIGSKSVHWYQQKPGQAPVLVVYDDSDRPSGIPDRFSGSDSGNTATLTISRVEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,IGHV3-9 (Human),IGHJ6 (Human),IGLV3-21 (Human),IGLJ3 (Human),AKDMSGPDYGGIEEYGMDV,QVWDSSSDHVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C688_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C622,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGLTFSSYSMNWVRQAPGKGLEWVSYISSSSSTIYYADSVKGRFTISRDNAKNSLYLQMNSLRDEDTAVYYCARVGARITGTSTYYFDYWGQGTLVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWFQHKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSTWPRGFTFGPGTKVDIK,IGHV3-48 (Human),IGHJ4 (Human),IGKV3-11 (Human),IGKJ3 (Human),ARVGARITGTSTYYFDY,QQRSTWPRGFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C622_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C623,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFSTYDMHWVRQATGKGLEWVSTIGTAGDTYYLGSVKGRFTISRENAKNSLYLQMNSLRAGDTAVYYCARARGGTAMAPYYFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTISCRASQSISNFLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYITPHLTFGGGTKVEIK,IGHV3-13 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ4 (Human),ARARGGTAMAPYYFDY,QQSYITPHLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C623_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C624,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGIIPIFGTANYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVFYCAIERYCTNGVCSAPGPSYYYYAMDVWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQHKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPLFGPGTKVDIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV1-33 (Human),IGKJ3 (Human),AIERYCTNGVCSAPGPSYYYYAMDV,QQYDNLPL,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C624_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C625,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAITWVRQAPGQGLECMGRIIPILGIAYYAQKFQGRVTITADQSTSTAYMELSSLRSEDTAVYYCAREFAVVPVASTWWFDPWGQGTLVTVSS,QSVLTQPPSVSGAPGQRVTISCTGTSSNIGAGYDVHWYQQLPGTAPKLLIYGNSNRPSGVPDRFSGSKSGTSASLAITGLQADDEADYYCQSYDSSLSGSVFGVGTKLTVL,IGHV1-69 (Human),IGHJ5 (Human),IGLV1-40 (Human),IGLJ2 (Human),AREFAVVPVASTWWFDP,QSYDSSLSGSV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C625_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C626,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYDINWVRQATGQGLEWMGWMNPNSGNTAYAQKFQGRVTMTRNTSVSTAYMELSSLRSEDTAVYYCARATRSGSYSFVMDVWGQGTTVTVSS,SYELTQPPSVSVAPGQTARITCGGNNIGSKNVHWYQQKPGQAPVLVVYDDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDSSSDHPLVVFGGGTKLTVL,IGHV1-8 (Human),IGHJ6 (Human),IGLV3-21 (Human),IGLJ2 (Human),ARATRSGSYSFVMDV,QVWDSSSDHPLVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C626_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C627,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGLVKPGGSLRLSCAASGFTFSDYYMTWIRQAPGKGLEWVSYITSTSSFTNYADSVRGRFTISRDYAKNSLYLQMTSLRAEDTAVYYCARVFLRSAYPSSRVVWAFDIWGQGTMVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFIISSLQPEDIATYYCQQYDLGVTFGPGTKVDIK,IGHV3-11 (Human),IGHJ3 (Human),IGKV1-33 (Human),IGKJ3 (Human),ARVFLRSAYPSSRVVWAFDI,QQYDLGVT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C627_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C628,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGLVKPGGSLRLSCAASGFTFSDYYMSWIRQAPGKGLEWVSYISVSSSYTNYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARGGYCTSTSCYKGFPNWFDPWGQGTLVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPITFGQGTRLEIK,IGHV3-11 (Human),IGHJ5 (Human),IGKV3-11 (Human),IGKJ5 (Human),ARGGYCTSTSCYKGFPNWFDP,QQRSNWPIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C628_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C629,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYDMHWVRQATGKGLEWVSAIGTAGDTYYPGSVKGRFIISRENAKNSLYLQMNSLRAGDTAVYYCARGGRWLQTVFDLWGRGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPNLLIFAASSLQSGVPSRFSGSGSGTDFTLTISRLQPEDFATYYCQQSYSMPPVTFGPGTKVDIK,IGHV3-13 (Human),IGHJ2 (Human),IGKV1-39 (Human),IGKJ3 (Human),ARGGRWLQTVFDL,QQSYSMPPVT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C629_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C630,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSAIVGSGGSTYYADSVKGRFTISRDNSKNTAYLQMNSLRAEDTAVYYCAKDVMVWSGSYLPEYFQHWGQGTLVTVSS,SYELTQPPSVSVSPGQTASITCSGHKLGDKYACWYQQKPGQSPVLVIYQDNKRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCQSWDSSVVFGGGTKLTVL,IGHV3-23 (Human),IGHJ1 (Human),IGLV3-1 (Human),IGLJ2 (Human),AKDVMVWSGSYLPEYFQH,QSWDSSVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C630_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C631,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLLESGGGLVQPGGSLRLSCAASGITFSRHAMSWVRQAPGKGLEWVSVISGSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDRYAGPYSSSSDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPVTFGGGTKVEIK,IGHV3-23 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ4 (Human),AKDRYAGPYSSSSDY,QQYDNLPVT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C631_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C633,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSNEYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKVNSQYSSDWYDRAFDYWGQGTLVTVSS,DIQMTQSPSTLSASVGDRVTITCRASQSISSWLAWYQQKPGKAPKLLIYKASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNSYWTFGQGTKVEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV1-5 (Human),IGKJ1 (Human),AKVNSQYSSDWYDRAFDY,QQYNSYWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C633_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C634,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSNYGMHWVRQAPGKGLEWVAIIWNDGSNKYYADSVKGRFTISRDISRNTLYLQMNSLRAEDTAVYYCARSQYYYDRSGYANHDAFDIWGQGTMVTVSS,DIQMTQSPSTLSASVGDRVTITCRASQSISSWLAWYQQKPGKAPKLLIYEASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNSYLTWTFGQGTKVEIK,IGHV3-33 (Human),IGHJ3 (Human),IGKV1-5 (Human),IGKJ1 (Human),ARSQYYYDRSGYANHDAFDI,QQYNSYLTWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C634_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C635,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFTTYNMNWVRQAPGKGLEWVSYISDSGGTIYYADSVKGRFTISRDNAKNSLYLQMNSLRDEDTAVYYCARVKGRSSYYYYGMDVWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQNIYIYLNWYQQKPGKAPKVLIYGASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDCATYYCQQSYSTPVTFGPGTKVDIK,IGHV3-48 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ3 (Human),ARVKGRSSYYYYGMDV,QQSYSTPVT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C635_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C636,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMNWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARVVPGNEDWGQGTLVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPEGTFGGGTKVEIK,IGHV3-53 (Human),IGHJ4 (Human),IGKV3-11 (Human),IGKJ4 (Human),ARVVPGNED,QQRSNWPEGT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C636_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C637,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLIQPGGSLRLSCAASGVTVRSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARGGGHYYGMDVWGQGTTVTVSS,DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPPYTFGQGTKLEIK,IGHV3-53 (Human),IGHJ6 (Human),IGKV1-9 (Human),IGKJ2 (Human),ARGGGHYYGMDV,QQLNSYPPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C637_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C638,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYAMHWVRQAPGKGLQYVSAISSNGGSTYYANSVKGRFTISRDNSKNTLYLQMGSLRAEDMAVYYCARDGCSSTSCPEINWFDPWGQGTLVTVSS,SYELTQPPSVSVAPGQTARITCGGNNIGSKSVHWYQQKPGQAPVLVVYDDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDGSSDHVVFGGGTKLTVL,IGHV3-64 (Human),IGHJ5 (Human),IGLV3-21 (Human),IGLJ2 (Human),ARDGCSSTSCPEINWFDP,QVWDGSSDHVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C638_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C639,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QLQLQESGPGLVKPSETLSLTCTVSGGSISSSSYYWGWIRQPPGKGLEWIGNIYYSGITYYNPSLKSRVTISVDTSKSQFSLNLSSVTAADTAVYYCARRGRVYGGNSGNAFDIWGQGTMVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGSYDLVSWYQQHPGKSPKLMIYEVIKRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCCSYAGSWVFGGGTKLTVL,IGHV4-39 (Human),IGHJ3 (Human),IGLV2-23 (Human),IGLJ3 (Human),ARRGRVYGGNSGNAFDI,CSYAGSWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C639_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C640,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSETLSLTCTVSGDSISRYYWSWIRQPPGKGLEWIGYSHYSGSTNYNPSLKSRVSLSLDTSKNHLSLKLSSVTAADTAVYYCARAHYYVTSDFDYWGQGTLVTVSS,QSVLTQPPSASGTPGQRVTIACSGSSSNIGSNSVNWFQQLPGTAPKLLIYSDNQRPSGVPDRFSGSKSGTSASLAISGLQSEDEADYYCAAWDDSLNGHVVFGGGTKLTVL,IGHV4-59 (Human),IGHJ4 (Human),IGLV1-44 (Human),IGLJ2 (Human),ARAHYYVTSDFDY,AAWDDSLNGHVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C640_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C641,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYYIHWVRQAPGQGLEWMGIIYPSGGSRRYAQKFQGRVTMTRDTSTSTVNMELNSLRSEDTAVYYCAREGSTGTTFLDYWGQGTLVTVSS,SYELTQPPSVSVAPGQTARITCGGNNIGSKSVHWYQQKPGQAPVLVVYDDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCHVWDGSSDHHVVFGGGTKLTVL,IGHV1-46 (Human),IGHJ4 (Human),IGLV3-21 (Human),IGLJ2 (Human),AREGSTGTTFLDY,HVWDGSSDHHVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C641_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C642,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGSFSNYAISWVRQAPGQGLEWMGGIIPFSGTANYAQKFQGRVTITADEATSTAYMELSSLRSEDTAVYYCARDDYGTLWAHYYYGMVVWGQGTTVTVSS,QAVVTQEPSFSVSPGGTVTLTCGLSSGSVSTSYYPSWFQQTPGQAPRTLIYSTNTRSSGVPDRFSGSVLGNKAALTITGAQSDDESDYYCVLYMGSGKVVFGGGTKLTV,IGHV1-69 (Human),IGHJ6 (Human),IGLV8-61 (Human),IGLJ2 (Human),ARDDYGTLWAHYYYGMVV,VLYMGSGKVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C642_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C643,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLLESGGGLVQPGGSLRLSCAASGFAFITYAMTWVRQAPGKGLEWVSIISASGGSTYYADSVKGRFTISRDNSENTLYLQMSSLRAEDTAVYFCAKVTFRTELTQVVPNYFDFWGQGTLVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVNTYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTGFTLTISSLEPEDFAVYYCQQRTNWPLTFGGGTKVEIK,IGHV3-23 (Human),IGHJ4 (Human),IGKV3-11 (Human),IGKJ4 (Human),AKVTFRTELTQVVPNYFDF,QQRTNWPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C643_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C644,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSTYAMHWVRQAPGKGLEWVAVILYDGSYKSYADSVKGRFTISRDNSKSTLYLHMNSLRAEDTAVYYCATDEGEATTYPGYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISRYLNWYQQKPGKAPNLLIYAASNLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPPWTFGQGTKVEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ1 (Human),ATDEGEATTYPGY,QQSYSTPPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C644_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C645,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISSDASNTYFADSVKGRLTISRDNSKNILFLQMNSLRTEDTAVYYCAKSHSTAYSPSTFYYYGLDVWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSIDSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYFCQQSYSTPPFTFGPGTKVDIK,IGHV3-30 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ3 (Human),AKSHSTAYSPSTFYYYGLDV,QQSYSTPPFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C645_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C646,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVKPGRSLRLSCTTSGFTFGDYTMSWFRQAPGKGLEWVGFIRTEAFGGTTEYAASVKGRFTISRDDSKSIAFLQMNSLKTEDTAVYYCTRRIMYYSDNSGSRTFDYWGQGTLVTVSS,EIVMTQSPATLSVSPGESVTLSCRASQSVSSNLAWYQQKPGQAPRLLIYGAAIRATGIPARFSGSGSGTEFTLTISSLQSEDFALYYCQQYNNWWTFGQGTKVEIK,IGHV3-49 (Human),IGHJ4 (Human),IGKV3-15 (Human),IGKJ1 (Human),TRRIMYYSDNSGSRTFDY,QQYNNWWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C646_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C647,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSHYGMYWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYVQMNSLRAEDTAVYYCAKNAGPYCSAHNCYSGPFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQHKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTITSLQPEDFATYYCQQYYNLPGFGPGTKVDIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ3 (Human),AKNAGPYCSAHNCYSGPFDY,QQYYNLPG,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C647_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C648,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGIIPIFGTANYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYCARVGDSGGYYPAGLDYFDYWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSDYLAWYQQKPGQAPRLLIYAASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPPFVAFGQGTKVEIK,IGHV1-69 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ1 (Human),ARVGDSGGYYPAGLDYFDY,QQYGSSPPFVA,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C648_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C649,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSNAINWVRQAPGQGLEWMGGIIPIFGTVNYAQNFQGRVTITADESTSTAHMELSSLRSQDTAVYYCARDTVVSPLYGLDVWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYGATSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPRIIFGPGTKVDIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ3 (Human),ARDTVVSPLYGLDV,QQSYSTPRII,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C649_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C650,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCTVSGFTFSRYGMHWVRQAPGRGLEWVAVISYDGDNRYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKKSGLYCGGSSCHSGTFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPLAFGQGTRLEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ5 (Human),AKKSGLYCGGSSCHSGTFDY,QQYDNLPLA,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C650_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C651,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSNYGMYWVRQAPGKGLEWVALISYDGSDKYYADSVKGRITISRDNSKNTLYLQMNSLRAEDTAVYNCAKCFYSYGYPCYYFDYWGQGTLVTVSS,NFMLTQPHSVSESPGKTVTISCTRSSGSIASNYVQWYQQRPGSAPTNVIYEDNQRPYGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSCDSNNLWVFGGGTKLTVL,IGHV3-30 (Human),IGHJ4 (Human),IGLV6-57 (Human),IGLJ3 (Human),AKCFYSYGYPCYYFDY,QSCDSNNLWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C651_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C652,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSNFAIHWVRQAPGKGLEWVAVLWYDGRNKDYADSVKGRFTISRDNSNNTLYLQMSSLRAEDTAVYYCARELYYYDRSGYYGPDDYAFDIWGQGTMVTVSS,DIQMTQSPSTLSASVGDRVTITCRASQSISSWLAWYQQKPGKAPKLLIYKASSLQSGVPSRFSGSGSGTEFSLTISSLQPDDFATYYCQHYNSYWRTFGQGTKVEIK,IGHV3-33 (Human),IGHJ3 (Human),IGKV1-5 (Human),IGKJ1 (Human),ARELYYYDRSGYYGPDDYAFDI,QHYNSYWRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C652_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C653,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSLIYSGGSTYYADSVKGRFTISRDNSKNTVHLQMNSLRAEDTAVYYCARPRYGSRSYYAGDYWGQGTLVTVSS,DIQMTQSPSSLSAFVGDRVTITCQASQDINNYLNWYQQKPGKAPKLLIYDTSNLEIGVPSRFSGSGSGTYFTFTISSLQPEDIATYYCQQYDNLPITFGQGTRLEIK,IGHV3-53 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ5 (Human),ARPRYGSRSYYAGDY,QQYDNLPIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C653_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C654,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLIQPGGSLRLSCAASGIIVSRNYMTWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLKMNNLRAEDTAVYYCARDLGAAGALDFWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSTFLAWYQQKPGQAPRLLIYGASSRATGIPDRFRGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPDTFGQGTKLEIK,IGHV3-53 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ2 (Human),ARDLGAAGALDF,QQYGSSPDT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C654_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C655,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCSASGFTFSSYAMHWVRQAPGKGLEYVSSITSDGVGTYYADSVKGRFTISRDNSKNTLYLQMRSLRAEDTAVYYCVSDSPTTMVTIFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYVASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSSLLTFGGGTKVEIK,IGHV3-64D (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ4 (Human),QQYGSSPDT,QQSYSSLLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C655_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C656,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYWMSWVRQAPGKGLEWVANIKQDGSEKYYVDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARGRLGVVLGVDYWGQGTLVTVSS,NFMLTQPHSVSESPGKTVTISCTRSSGSIASNYVQWYQQRPGSSPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSSNWVFGGGTKLTVL,IGHV3-7 (Human),IGHJ4 (Human),IGLV6-57 (Human),IGLJ3 (Human),ARGRLGVVLGVDY,QSYDSSNWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C656_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C657,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVQSGAEVKKPGESLKISCKGSGYSFTSYWIGWVRQMPGKGLEWMGIIYPGDSDTRYSPSFQGQVTISADKSISTAYLQWRSLKASDTAMYYCARHDSSYVPPGLWGQGTLVTVSS,QSVLTQPPSASGTPGQRVTISCSGSSSNIGSNSVNWYHQLPGTAPKVLICYNNQRPSGVPDRFSGSKSGTSASLAISGLQSEDEADYYCAAWDDSLNGYVFGTGTKVTVL,IGHV5-51 (Human),IGHJ4 (Human),IGLV1-44 (Human),IGLJ1 (Human),ARHDSSYVPPGL,AAWDDSLNGYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C657_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C658,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVQSGAEVKKPGESLKISCKGSGYSFISHWIGWVRQMPGKGLEWMGIIYPGDSDTKYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARIYSSSDNGMDVWGQGTTVTVSS,QSVLTQPPSASGTPGQRVTISCSGSSSNIGSNPVNWYQQLPGTAPKLLIYSNNQRPSGVPDRFSGSKSGTSASLAISGLQSEDEADYYCAAWDDSLNGWVFGGGTKLTVL,IGHV5-51 (Human),IGHJ6 (Human),IGLV1-44 (Human),IGLJ3 (Human),ARIYSSSDNGMDV,AAWDDSLNGWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C658_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C659,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLIQPGGSLRLSCAVSGFTVSRNYLNWVRQAPGKGLEGVSIIYPGGSTFYADSLKGRFTISRDNSKNTLYLQMNSLRAEDSAVYYCARSYGDYYLDFWGQGTLVTVSS,EIVLTQSPGTLSLTPGERATLSCRASQSVSSSYLSWYQQKPGQAPRLLFYGASGRATGIPDRFSGSGSGTDFTLTINRLEPEDFAVYYCQHYGRTWTFGQGTKVEIK,IGHV3-53 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ1 (Human),ARSYGDYYLDF,QHYGRTWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C659_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C660,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLIQPGGSLRLSCAASDFIVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRVEDTAVYYCARDWGDNYFDYWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSLSSRFLAWYQQKPGQAPRLLIYDASSRATGIPDRFRGSGSETDFTLTISRLEPEDFAVYYCQQYGSSPRTFGQGTKVEIK,IGHV3-53 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ1 (Human),ARDWGDNYFDY,QQYGSSPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C660_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C662,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSDKYYADSVKGRFTISRDNSKNTLFLQMNSLRAEDTAVYYCAKQISRYCGGGSCYSLTIDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPITFGQGTRLEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ5 (Human),AKQISRYCGGGSCYSLTIDY,QQYDNLPIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C662_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C663,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLIQPGGSLRLSCAASGLIVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSVRAEDTAVYYCAREVYGMDVWGQGTTVTVSS,DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNIYPPPFGPGTKVDIK,IGHV3-53 (Human),IGHJ6 (Human),IGKV1-9 (Human),IGKJ3 (Human),AREVYGMDV,QQLNIYPPP,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C663_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C664,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLIQPGGSLRLSCAASGVTVSSNYMTWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARSLEAYGMDVWGQGTTVTVSS,DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYGYTFGQGTKLEIK,IGHV3-53 (Human),IGHJ6 (Human),IGKV1-9 (Human),IGKJ2 (Human),ARSLEAYGMDV,QQLNSYGYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C664_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C665,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGPEVKKPGASVKVSCKASGYTFTSYGISWVRQAPGQGLEWMGWISTYNGNTNYAQKLQGRVTMTTDSSTSTAYMELRSLRSDDTAVFYCARVGTYYSDSSAYYFDYWGQGTLVTVSS,EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYDNWPPIFTFGPGTKVDIK,IGHV1-18 (Human),IGHJ4 (Human),IGKV3-15 (Human),IGKJ3 (Human),ARVGTYYSDSSAYYFDY,QQYDNWPPIFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C665_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C666,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLIQPGGSLRLSCAASGFTVRSGYMSWVRQAPGKGLEWVSAIYSGSSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAMYYCARFIPPDSRGYSSGAFDIWGQGTMVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGTYDLVSWYQQHPGKAPKLMIYEGSKRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCCSYAGSSTWVFGGGTKLTVL,IGHV3-53 (Human),IGHJ3 (Human),IGLV2-23 (Human),IGLJ3 (Human),ARFIPPDSRGYSSGAFDI,CSYAGSSTWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C666_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C667,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVQSGAEVKKPGESLKISCKGSGYSFTSYWIGWVRQMPGKGLEWMGIIYPGDSDTRYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARTLSYYDSSGTLLYEDYFDYWGQGTLVTVSS,QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWYQQLPGTAPKLLIYGNSNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSSLSGWVFGGGTKLTVL,IGHV5-51 (Human),IGHJ4 (Human),IGLV1-40 (Human),IGLJ3 (Human),ARTLSYYDSSGTLLYEDYFDY,QSYDSSLSGWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C667_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C668,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTNYYMHWVRQAPGQGLEWMGIINPSGGATTYAQKFQGRVTMTGDTSTRTVYMELSSLRSEDTAVYYCARGGSPIPAPGSDFDYWGQGTLVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGSYNLVSWYQQHPGKAPKLMIYEVSKRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCCSYAGRSTFVVFGGGTKLTVL,IGHV1-46 (Human),IGHJ4 (Human),IGLV2-23 (Human),IGLJ2 (Human),ARGGSPIPAPGSDFDY,CSYAGRSTFVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C668_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C669,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGIIPIFDTTNYAQKFQGRVSITADESTSTSYMQLSSLRSEDTAVYYCARVRGTAAAGPNEHIAAAGTFDYWGQGTLVTVSS,DIVMTQSPDSLAVSLGERATINCKSSQSVLYSSNNKNYLAWYQQKPGQPPKLLIYWASTRESGVPDRVSGSGSGTDFTLTISSLQAEDVAVYYCQQYYSTQITFGQGTRLEIK,IGHV1-69 (Human),IGHJ4 (Human),IGKV4-1 (Human),IGKJ5 (Human),ARVRGTAAAGPNEHIAAAGTFDY,QQYYSTQIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C669_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C670,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGVIPLFGTANYAQKFQGRVTITADKSTNTAYMELSSLRSEDTAVYYCARGGGSSGYNWFDPWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSINNFLNWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFASYYCQQSSSILYTFGQGTKLEIK,IGHV1-69 (Human),IGHJ5 (Human),IGKV1-39 (Human),IGKJ2 (Human),ARGGGSSGYNWFDP,QQSSSILYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C670_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C671,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYDINWVRQATGQGLEWMGWMNPISGNTGYAQKFQGRVTMTRNTSISTAYMELSSLRSEDTAVYYCARGGRYCSGDSCYSNIWFDPWGQGTLVTVSS,DIQLTQSPSFLSASVGDRVTITCRASQGISNYLAWYQQKPGKAPKVLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPGITFGQGTRLEIK,IGHV1-8 (Human),IGHJ5 (Human),IGKV1-9 (Human),IGKJ5 (Human),ARGGRYCSGDSCYSNIWFDP,QQLNSYPGIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C671_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C672,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFSRYDMHWVRQPTGKGLEWVSTLDTAGDPYYAGSVKGRFTISRENAKNTLYLQMNSLRAGDTAVYYCARERRYYDSSGYHRRDGMDVWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDITNFLNWYQQKPGKAPRLLIYDASNLEPGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPPLTFGGGTKVEI,IGHV3-13 (Human),IGHJ6 (Human),IGKV1-33 (Human),IGKJ4 (Human),ARERRYYDSSGYHRRDGMDV,QQYDNLPPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C672_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C673,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSNYGMHWVRQAPGKGLEWVAVISFDGSHKYYVDSVKGRFTISRDNSKKRLYLQMNSLRAEDTAVYYCAKQAELYCSAGSCYEGYIDYWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSNSYLAWYQQKPGQAPRLLISGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAIYYCQQYGSSPGTFGQGTKVEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ1 (Human),AKQAELYCSAGSCYEGYIDY,QQYGSSPGT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C673_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C674,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDYGDYVTYPDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPPWTFGQGTKVEIK,IGHV3-33 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ1 (Human),ARDYGDYVTYPDY,QQSYSTPPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C674_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C675,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMYWVRQAPGKGLEWVSVIFSGGSTFYADSVKGRFTISRDSSKNTLYLQMNSLRAEDTAVYYCARGPYPAADNYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPITFGQGTRLEIK,IGHV3-53 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ5 (Human),ARGPYPAADNY,QQYDNLPIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C675_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C676,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSQTLSLTCTVSGGSISSGDYYWSWIRQPPGKGLEWIGYIYYSGSTYYNPSLQSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARDGCSGGSCYSYWFDPWGQGTLVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSGYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSSWSTFGQGTRLEIK,IGHV4-30-4 (Human),IGHJ5 (Human),IGKV3-11 (Human),IGKJ5 (Human),ARDGCSGGSCYSYWFDP,QQRSSWST,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C676_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C677,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSFAISWVRQAPGQGLEWMGGIIPIFGTANYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYCARFGDYHDNRGYSYSDYWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSRTFGQGTKVEIK,IGHV1-69 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ1 (Human),ARFGDYHDNRGYSYSDY,QQYGSSRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C677_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C678,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTLSSHAISWVRQAPGQGFEWMGGIIPIFGTANYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYCARDHEMATIYGMDVWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSIGSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSAPLLTFGLGTKVDIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ3 (Human),ARDHEMATIYGMDV,QQSYSAPLLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C678_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C679,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAGISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKGGYYYYGSGSYNYGFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDISNYLSWYQQKPGKAPKLLIYDASYLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLIFTFGPGTKVDIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ3 (Human),AKGGYYYYGSGSYNYGFDY,QQYDNLIFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C679_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C680,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKERSWYYYDSSGSDYWGQGTLVTVSS,NFMLTQPHSVSESPGKTVTISCTRSSGSIASNYVQWYQQRPGSSPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSSISSWVFGGGTKLTVL,IGHV3-30 (Human),IGHJ4 (Human),IGLV6-57 (Human),IGLJ3 (Human),AKERSWYYYDSSGSDY,QSYDSSISSWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C680_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C681,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYNMNWVRQAPGKGLEWVSYIGSTSSTIYYADSVKGRFTISRDNAKNSLYLQMNSLRDEDTAVYYCARHQGSLSYYYHGMDVWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYTASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDLATYYCQQSYSTPSTFGPGTKVDIK,IGHV3-48 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ3 (Human),ARHQGSLSYYYHGMDV,QQSYSTPST,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C681_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C682,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLIQPGGSLRLSCAASGFIVSSNYMSWVRQAPGKGLEWVSVVYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDYGDYYFDYWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPRTFGQGTKLEIK,IGHV3-53 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ2 (Human),ARDYGDYYFDY,QQYGSSPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C682_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C683,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLECVSVLYSGGSSFYADSVKGRFTISRDNSKNTLYLQMNSLSAEDTAMYYCARWARGFDPWGQGTLVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQHRPGKAPKLMIYDVGTRPSGISNRFSGSKSDNTASLTISGLQAEDEADYYCSSYTSSIPVFGGGTKLTVL,IGHV3-53 (Human),IGHJ5 (Human),IGLV2-14 (Human),IGLJ3 (Human),ARWARGFDP,SSYTSSIPV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C683_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C684,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCSASGFTFSSYVMDWVRQAPGKGLEYVSGISTNGDITNYADSVKGRFTISRDNSKNTLYLQMSSLRAEDTAVYYCVKDLGLGTVDYFDYWGQGTLVTVSS,DIQMTQSPSSLSASVRDRVTITCRASQSISNYLSWFQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYTTVTFGGGTKVEIK,IGHV3-64D (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ4 (Human),VKDLGLGTVDYFDY,QQSYTTVT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C684_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C685,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYLMSWVRQAPGKGLEWVANIKQDGSEKYYVDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARARLGQLLGFDYWGQGTLVTVSS,NFMLTQPHSVSESPGKTVTISCTRSSGSIASNYVQWYQQRPGSSPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDTSNWVFGGGTKLTVL,IGHV3-7 (Human),IGHJ4 (Human),IGLV6-57 (Human),IGLJ3 (Human),ARARLGQLLGFDY,QSYDTSNWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C685_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C686,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVQSGAEVKKPGESLKISCKGSGYSFISHWIGWVRQMPGKGLEWMGIIYPGDSDTRYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARRGSAWELDYWGQGTLVTVSS,QSVLTQPPSASGTPGQRVTISCSGSSSNIGSNPVNWYRQLPGTAPKLLIYSNNQRPSGVPDRFSGSKSGTSASLAISGLQSEDEADYYCAAWDDSLNGYVFGTGTKVTVL,IGHV5-51 (Human),IGHJ4 (Human),IGLV1-44 (Human),IGLJ1 (Human),ARRGSAWELDY,AAWDDSLNGYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C686_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C687,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVQSGAEVKKPGESLKISCKGSGYSFTSQWIGWVRQMPGKGLEWMGIIYPGDSDTRYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCGRQVADAASGMDVWGQGTTVTVSS,QSVLTQPPSASGTPGQRVTISCSGSSSNIGSNPVNWYQQLPGTAPKLLIYNNNQRPSGVPDRFSGSKSGTSASLAISGLQSEDEADYYCAAWDDSLNGQVFGGGTKLTVL,IGHV5-51 (Human),IGHJ6 (Human),IGLV1-44 (Human),IGLJ3 (Human),GRQVADAASGMDV,AAWDDSLNGQV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C687_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C837,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCEASRFTFRSHAMHWVRQAPGKGLEWVAVIWYDGKNEYYADSVKGRFTISRDNSKKMVYLQMNNLRAEDTAVYYCAREGIAAPDSKADAFDIWGQGTMVTVSS,DIQMTQSPSSLSASVGDRVTITCRATETISSFLNWYQHKPGKAPKLVIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTLYSFGQGTKLEIK,IGHV3-33 (Human),IGHJ3 (Human),IGKV1-39 (Human),IGKJ2 (Human),AREGIAAPDSKADAFDI,QQSYSTLYS,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C837_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C689,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QLQLQESGPGLVRPSETLSLTCTVSGGSISSSSYYWGWIRQPPGKGLEWIGSIYDSGTTYYNPSLKSRVTIFVDTSKNQFSLRLKSVTAADTAIYYCARLLGLIDYWGQGALVTVSS,DIQMTQSPSSLSASVGDRVTITCRATQGISNSLAWYQQEPGKAPKLLLYAASTLESGVPSRFSGSGSGTDFTLTISTLQPEDFATYYCQQYYSAPPHTFGQGTKLEIK,IGHV4-39 (Human),IGHJ4 (Human),IGKV1-NL1 (Human),IGKJ2 (Human),ARLLGLIDY,QQYYSAPPHT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C689_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C690,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFRTYGMHWVRQAPGKGLEWVAVISYDGSKKYYGDSVRGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKQGGPYCSGGNCNVGYFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKFLIYDASNLETGVSSRFSGSGSGTDFTFTISSLQPEDIGTYYCQQYDNLPLTFGGGTKVEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ4 (Human),AKQGGPYCSGGNCNVGYFDY,QQYDNLPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C690_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Mar 16, 2021",16th March: Corrected CDRH3 seq,RBD variant binding data in SI Table 5. Complete
C691,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSQTLSLSCTVSGGSISSGGYYWSWIRQHPEKGLEWIGNIYYTGTTYYNPSLKSRVSISVDTSKNHFSLRLSSVTAADTAVYYCARALGLIDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQVISNSLAWYQQKPGKAPKLLLYAASTLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYYSDPPHTFGQGTKLEIK,IGHV4-31 (Human),IGHJ4 (Human),IGKV1-NL1 (Human),IGKJ2 (Human),ARALGLIDY,QQYYSDPPHT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C691_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C692,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSQTLSLTCTVSGDSVSSGDYYWSWIRQHPGKGLEWIGYIYYSGNTYYNPSLKSRVTLSIDRSKNQFSLRLSSVTAADTAVYYCARAFTPYNSSPFDYWGQGTLVTVSS,EIVMTQSPVTLSVSPGERATLSCRASQSISSNLAWYQQKPGQAPRLLIYDASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNWPLAFGQGTKVEIK,IGHV4-31 (Human),IGHJ4 (Human),IGKV3-15 (Human),IGKJ1 (Human),ARAFTPYNSSPFDY,QQYNNWPLA,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C692_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C693,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKASETLSLTCAVSGYSISGGYYWGWIRQPPGKGLEWIGNIFHSGSTYYNPSLKSRVTISIDTPQNKFSLNLSSVTAADTAVYYCVRALGAFDIWGQGTMVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQVISNSLSWYQQRPGKAPKLLLYAASTLESGVPSRFSGSGSGTIYTLTISSLQPEDFATYYCQQYYSDPPITFGPGTKVDIK,IGHV4-38-2 (Human),IGHJ3 (Human),IGKV1-NL1 (Human),IGKJ3 (Human),VRALGAFDI,QQYYSDPPIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C693_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C694,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSETLSLTCTVSGGSISNYYWSWIRQSPGERLEWIGYIFHSGSTNYSPSLRGRVTVSVDTSKKQFSLKLRSVTAADTAVYYCARDRGYDSSGPDAFDIWGQGTMVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSRYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCHQRSNWPGTFGQGTRLEIK,IGHV4-59 (Human),IGHJ3 (Human),IGKV3-11 (Human),IGKJ5 (Human),ARDRGYDSSGPDAFDI,HQRSNWPGT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C694_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C695,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYSFSSDGISWVRQAPGQGLEWMGWISAYNGDTKYAQKFQGRLTMTTDTSTSTAYMELRSLRSDDTAVYYCARDLGWFGELSVGRDFDYWGQGTLVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQPPRLLIYDASKRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCHQRSNSYTFGQGTKLEIK,IGHV1-18 (Human),IGHJ4 (Human),IGKV3-11 (Human),IGKJ2 (Human),ARDLGWFGELSVGRDFDY,HQRSNSYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C695_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C696,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQPGAEVKKPGASVKVSCKASGYTFTTHGISWVRQAPGQGLEWMGWISAYNGYTKYAQKFQGRVTMTTATSTDTAYMELRSLRSDDTAVYYCARHLIAVAGTLILSPPGWGYDYWGQGTLVTVSS,SYELTQPPSVSVSPGQTARITCSGDALSKEYVYWYQQKPGQAPVLVIYKDSERPSGIPERFSGSSSGTTVSLTISGVQAEDEADYYCQSADSSGTYSFGEGTKLTVL,IGHV1-18 (Human),IGHJ4 (Human),IGLV3-25 (Human),IGLJ3 (Human),ARHLIAVAGTLILSPPGWGYDY,QSADSSGTYS,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C696_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C698,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASADTFTNNYIHWVRQAPGQGLEWMGIINPSGGSTTYAQKFQGRVTMTGDTSTGTVYMELSSLKSEDTAVYYCARGGHIPYVRGAFDYWGQGTLVTVSS,EIVLTQSPGTLFLSPGERATLSCRASQSVSSTYFAWYQQKLGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQHYGSSPAFGQGTKVEIK,IGHV1-46 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ1 (Human),ARGGHIPYVRGAFDY,QHYGSSPA,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C698_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C699,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSEGEVKKPGSSVKVSCRASGGTFSSYTFSWMRQAPGQGLEWMGRIIPALGVPNYAEKFQARVTLTADKSTTTAYMELSSLRYDDTAVYYCARDRVESSGWGYWFDPWGQGTLVTVSS,QSVLTQPPSVSGAPGQRVTISCTGSNSNIGAGYDVHWYQQLPGTAPKILIYGNNNRPSGVPDRFSGSQSDTSASLAITGLQAEDEADYYCQSYDSSLSEVFGGGTKLTVL,IGHV1-69 (Human),IGHJ5 (Human),IGLV1-40 (Human),IGLJ2 (Human),ARDRVESSGWGYWFDP,QSYDSSLSEV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C699_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C801,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLLESGGGLVQPGGSLRLSCAASGFTFSSFPMNWVRQAPGKGLEWVAGISGSGDITNYADSVKGRFSISRDNSKNTLYLQMNSLRVEDTALYYCAKDASDYNDYVEWFDPWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSIGRYLNWYQQRPGKAPRLLIYAASTLQSGVPSRFSGSGSATDFTLTISSLQPEDFATYYCQQSYSSSPYTFGQGTKLEIK,IGHV3-23 (Human),IGHJ5 (Human),IGKV1-39 (Human),IGKJ2 (Human),AKDASDYNDYVEWFDP,QQSYSSSPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C801_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C803,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLIQPGGSLRLSCAASGFTVSLNYMTWVRQAPGKGLEWVSLIYSGGSTSYADSVKGRFTVSRDNSKNTLYLQMNSLRAEDTAVYHCARVAYHMGVTHFDSWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTISCRASQNINNYLNWYQQKPGKAPKLLIYAASSLQSGVPSKFRGSGSGTDFTLTISSLQPEDFATYFCQQTYSTPQGTFGQGTKVEIK,IGHV3-53 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ1 (Human),ARVAYHMGVTHFDS,QQTYSTPQGT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C803_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C804,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGVIQPGGSLRLSCAASGFTVSSNYMGWVRQAPGKGLEWVSFIYTGDATYYADSVKGRFTISTDNSKNTLYLQMNSLRAEDTAVYYCASLYTSGWNFRGAPQVWGRGTMVTVSS,EIVMTQSPATLSVSPGERATLSCRASQSVSSHLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNWPPRSYTFGQGTKLEIK,IGHV3-53 (Human),IGHJ3 (Human),IGKV3-15 (Human),IGKJ2 (Human),ASLYTSGWNFRGAPQV,QQYNNWPPRSYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C804_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C806,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLLESGGALIQPGGSLRLSCAASGFSFSSYAMTWVRQAPGKGLEWVSVISATGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRVEDTAVYYCAKDGMEWVLVDYYDYYGMDVWGRGTTVTVSS,DIVMTQTPLSSPVTLGQPASISCRSSQSLVHSDGYTYLSWLQQRPGQPPRLLIYKVSNRFSGVPDRFSGSGAGTDFTLKISRVEAEDVGVYYCMQATQFPPTFGQGTKVEIK,IGHV3-23 (Human),IGHJ6 (Human),IGKV2-24 (Human),IGKJ1 (Human),AKDGMEWVLVDYYDYYGMDV,MQATQFPPT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C806_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C807,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEAKKPGSSVKVSCKASGGTFKSYIINWVRQAPGQGLEWMGEIIPIFGTANYAQKFQGRVTSTADESTSTAYMELSSLKSEDTAVYYCARGRGYSGYGASYYFDYWGQGTLVTVSS,QSVLTQPPSVSGAPGQRVTISCTGSNSNIGAGYDVHWYQQLPGTAPKLLIYANSNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSGLSGSVFGGGTKLTVL,IGHV1-69 (Human),IGHJ4 (Human),IGLV1-40 (Human),IGLJ2 (Human),ARGRGYSGYGASYYFDY,QSYDSGLSGSV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C807_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C808,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QLQLQESGPGLVKPSETLSLTCTVSGGSISSSRYYWGWIRQPPGKGLEWIGSIYYSGSTHHNPSLMSRVTMSVDASKNQFSLKLTSVTAADTAVYYCARLLSPNHYYDSGSYYLVGQGTLVTVSS,DIVMTQSPDSLAVSLGERATINCKSSQSVLYSSNNKNYLAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSETDFTLTISSLQAEDVAIYYCQQYYSTPLTFGGGTKVEIK,IGHV4-39 (Human),IGHJ4 (Human),IGKV4-1 (Human),IGKJ4 (Human),ARLLSPNHYYDSGSYYL,QQYYSTPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C808_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C810,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASEYTFTNYYMHWVRQAPGQGLEWMGIINPSGGSTTYAQKFQGRLTMTGDTSTSTVYMELSSLTSDDTAVYYCARGGVVPAASGEFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISRYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDSATYHCQQTYSAPPVTFGQGTKLEIK,IGHV1-46 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ2 (Human),ARGGVVPAASGEFDY,QQTYSAPPVT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C810_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C812,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSTYAMHWVRQSPGKGLVWVALVSYDGSNKSYSDSVKGRFTISRDNSKNTLFLQMNSLRAEDTALYYCAKNIYSYGSTSYFDYWGQGTLVTVSS,DIQMTQSPSSLSASVRDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLEAGVPSRFSGSGSGTDFKFTISSLQPEDIATYYCLQYDNFPLTFGGGTKVEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ4 (Human),AKNIYSYGSTSYFDY,LQYDNFPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C812_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C814,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Human Patient,QLQLQESGPGLVKPSETLSLTCTVSGGSISSSRYYWGWIRQPPGKGLEWIGIIYYSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARLMWLRGPFDYWGQGTLVTVSS,NFMLTQPHSVSESPGKTVTISCTGSSGSIASNYVQWYQQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSSTHVVFGGGTKLTVL,IGHV4-39 (Human),IGHJ4 (Human),IGLV6-57 (Human),IGLJ2 (Human),ARLMWLRGPFDY,QSYDSSTHVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C814_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C815,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLLQPGGSLRLSCAASGFTFSNYDMHWVRQATGKGLEWVSTIGTAGDTYYPGSVKGRFTISRENAKNSLYLQMTSLTAGDTAVYYCARVEYSSGIYWYFDLWGRGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISGYLNWYQQKPGKSPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYTNPHYTFGQGTKLEI,IGHV3-13 (Human),IGHJ2 (Human),IGKV1-39 (Human),IGKJ2 (Human),ARVEYSSGIYWYFDL,QQSYTNPHYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C815_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C816,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGRSLRLSCAASGFTFDDYAMHWVRQSPGRGLEWVSGLSWNGGTLGYADSVKGRFIISRDNAKNSLYLQMNSLRPEDTALYYCAKDLRFLDNGGDYYMDVWGKGTTVTVSS,DIQMTQSPSSVSASVGDRVTITCRASQGISGWLAWYQQKPGKAPKLLMYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQANSFPLTFGQGTRLEIK,IGHV3-9 (Human),IGHJ6 (Human),IGKV1-12 (Human),IGKJ5 (Human),AKDLRFLDNGGDYYMDV,QQANSFPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C816_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C817,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSRYAMHWVRQAPGKGLEWVAVIWYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRTEDTAVYYCAKTLYSYAYDQYYFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQGISSALAWYQQKPGKAPKLLISDASSLESGVPSRFSGSGSGTDFSLTISSLQPEDFATYYCQQFNSYPPLTFGGGTKVEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV1-13 (Human),IGKJ4 (Human),AKTLYSYAYDQYYFDY,QQFNSYPPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C817_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C818,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSGTLSLTCAVSGGSITSSNWWSWVRQPPGKGLEWIGEIYHRGYTNYNPSLKTRVTLSIDKSKNQFSLKLNTVTAADTAVYYCARAFQDGTSGPYYFDSWGQGTLVTVSS,EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNWPGTFGQGTKVEIK,IGHV4-4 (Human),IGHJ4 (Human),IGKV3-15 (Human),IGKJ1 (Human),ARAFQDGTSGPYYFDS,QQYNNWPGT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C818_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C819,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSETLSLTCTVSGGSISSYYWNWIRQPPGKGLEWIGYIYYSGSTNFNPSLESRVTISVDTSKNQFSLNLSSVTAADTAVYYCARETSYYDSSGSFSGSHPYYFDSWGQGTLVTVSS,QSVLTQPPSVSGAPGQRVTISCTGRSSNIGAGYDVHWYQQLPGTAPKLLIYANNNRPSGVPDRFSGSNSGTSASLAITGLQAEDEADYYCQSYDSSLTGWVFGGGTKLTVL,IGHV4-59 (Human),IGHJ4 (Human),IGLV1-40 (Human),IGLJ2 (Human),ARETSYYDSSGSFSGSHPYYFDS,QSYDSSLTGWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C819_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C820,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Human Patient,QLQLQESGPGLVKPSETLSLTCTVSGGSIRSNPYYWGWIRQPPGKGLEWIGIIYYSGTTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARLRWLRGDFEYWGQGTLVTVSS,NFMLTQPLSVSESPGKTVTISCTGSSGSIASNYVQWYQQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSTNHVFGTGTKVTVL,IGHV4-39 (Human),IGHJ4 (Human),IGLV6-57 (Human),IGLJ1 (Human),ARLRWLRGDFEY,QSYDSTNHV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C820_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C821,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGLIVSSNYMNWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRLTISRHNSKNTLYLQMNSLRPEDTAVYYCARDLDYYGMDVWGQGTTVTVSS,DIQLTQSPSFLSASVGDTVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPPAVTFGGGTKVEIK,IGHV3-53 (Human),IGHJ6 (Human),IGKV1-9 (Human),IGKJ4 (Human),ARDLDYYGMDV,QQLNSYPPAVT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C821_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C822,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTLTSYGISWVRQAPGQGLEWMGWISAYNGNTNYAQKLQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARDLRTYIGESYYYYGMDVWGRGTTVTVSS,SYELTQPPSVSVAPGQTARITCGGNNVGSKSVHWYQQRPGQAPVLVIFYDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYFCQVWDSTSDHYVFGTGTKVTVL,IGHV1-18 (Human),IGHJ6 (Human),IGLV3-21 (Human),IGLJ1 (Human),ARDLRTYIGESYYYYGMDV,QVWDSTSDHYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C822_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C823,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVRVSCKASGYTFTSYGISWVRQAPGQGLEWMGWVSPYNGNTYYAQEFQGRVTMTTDTSTSTAYMELGSLRSDDTAVYYCARVKSNSGPQLRFLEWLLFDYYMDVWGKGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSFSTPRTFGPGTKVDIK,IGHV1-18 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ3 (Human),ARVKSNSGPQLRFLEWLLFDYYMDV,QQSFSTPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C823_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C824,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTTYAMHWVRQAPGQRLEWMGWIYAGDGNTKYSQKFQGRVTITRDTSASTAYMELSSLRSEDTAVYYCARDTSVLYDFWSAYFQNAFDIWGQGTMVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSMYTFGQGTKLEIK,IGHV1-3 (Human),IGHJ3 (Human),IGKV3-20 (Human),IGKJ2 (Human),ARDTSVLYDFWSAYFQNAFDI,QQYGSMYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C824_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C825,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYYMHWVRQAPGQGLEWMGIINPSGGSTSYAQKFQGRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARVGSVTYYDILTGHPPYYYYGMDVWGQGTTVTVSS,QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWYQQLPGTAPKLLIYGNSNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSSLSGSVFGTGTKVTVL,IGHV1-46 (Human),IGHJ6 (Human),IGLV1-40 (Human),IGLJ1 (Human),ARVGSVTYYDILTGHPPYYYYGMDV,QSYDSSLSGSV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C825_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C826,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSDAISWVRQAPGQGLEWMGGIIPIFGTTNYAQNFQARVTITADESTNTAYMELRSLRSEDTAVYYCAKDVTTSPLYGMDVWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISRYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYRTPLVTFGGGTKVEIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ4 (Human),AKDVTTSPLYGMDV,QQSYRTPLVT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C826_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C827,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGPEMKKPGTSVKVSCKASGFTFASSAVQWVRQARAQGLEWIGWIVVGSGNTNYAQKFQERVTISRDMSTNTAYMELSSLGSEDTAVYYCAAPHCNRTSCFDGFDIWGQGTMVTVSS,EIVLTQSPGTLSLSPGEGATLSCRASQTVRSSYLGWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK,IGHV1-58 (Human),IGHJ3 (Human),IGKV3-20 (Human),IGKJ1 (Human),AAPHCNRTSCFDGFDI,QQYGSSPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C827_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C828,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFMFSSYWMSWVRQAPGKGLEWVANIKQDGSETYYVDSVKGRFTISRDNAKHSLYLQMNSVGVEDTAVYYCARDLGLLWFGEDPRARDVWDRGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQDISNSLAWYQQTPGKAPKLLLYTASTLESGVPSRFSGSGSGTDFTLTISSLQPQDFATYYCQHYYSAPRTFGQGTKLEIK,IGHV3-7 (Human),IGHJ6 (Human),IGKV1-NL1 (Human),IGKJ2 (Human),ARDLGLLWFGEDPRARDV,QHYYSAPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C828_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C829,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQQWGAGLLKPSETLSLTCAVYGGSFSGYYWNWIRQPPGKGLEWIGEINHSGSTNYNPSLKSRVTISVDTSKKQFSLKLSSVTAADTAVYYCARATYYYDSSGYGINWFDPWGQGTLVTVSS,QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWYQQLPGTAPKLLIYGNSNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSSLSAYVFGGGTKLTVL,IGHV4-34 (Human),IGHJ5 (Human),IGLV1-40 (Human),IGLJ2 (Human),ARATYYYDSSGYGINWFDP,QSYDSSLSAYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C829_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C830,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGSSVKVSCTASGGTFSSYSITWVRQAPGQGLEWMGRIIPSFGTASYAQKFQGRVTITADESTSTASMELSSLRSEDTAVYYCATGGVHIVVVPTYHNYYGLDVWGQGTTVTVSS,QSALTQPRSVSGSPGQSVTISCTGTSSDVGGYDYVSWYQQHPGKAPKLMIYDVTKRPSGVPDRFSGSKSGNTASLTISGLQAEDEADYYCCSYAGSYTHVFGTGTKVTVL,IGHV1-69 (Human),IGHJ6 (Human),IGLV2-11 (Human),IGLJ1 (Human),ATGGVHIVVVPTYHNYYGLDV,CSYAGSYTHV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C830_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C831,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYTISWVRQAPGQGLEWMGRIIPTLGIASYAQKFQGRVTITADKSTTTAYMALSSLRSEDTAVYYCARDRWLADVVVPAAIYPLGYWGQGTLVTVSS,DIQMTQSPSTLSASVGDRVTITCRASQSISSWLAWYQQKPGKAPKLLIYKASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNSSPGTFGQGTKLEIK,IGHV1-69 (Human),IGHJ4 (Human),IGKV1-5 (Human),IGKJ2 (Human),ARDRWLADVVVPAAIYPLGY,QQYNSSPGT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C831_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C832,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYSISWVRQAPGQGLEWMGRIIPILGIASYAQKFQGRVTITADKSTSTVYMELTGLRSDDTAVYYCARDRGYSDYGSHYYMDVWGKGTTVTVSS,QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWYQQLPGTAPKLLIYINSNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSSLSDSVFGGGTKLTVL,IGHV1-69 (Human),IGHJ6 (Human),IGLV1-40 (Human),IGLJ3 (Human),ARDRGYSDYGSHYYMDV,QSYDSSLSDSV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C832_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C835,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGFTLTSYGISWVRQAPGQGLEWMGWISGDSGKKNYAQQLQGRVTLTTETSMSTAYLELRSLRSDDTAVYYCARSTGILDCWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQGISNSLAWYQQKPGKAPKLLLYGASTLESGVPSRFSGSGSGTDYTLTISSLQPEDFATYYCQQYYSSRGFTFGPGTKVDIK,IGHV1-18 (Human),IGHJ4 (Human),IGKV1-NL1 (Human),IGKJ3 (Human),ARSTGILDC,QQYYSSRGFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C835_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
C836,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLIQPGGSLRLSCAASGLTVSSNYMTWVRQAPGKGLEWVSLIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAIYYCARDLYYYGMDVWGQGTTVTVSS,DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISRLQPEDFATYYCQQINDYPFFGGGTKVEIK,IGHV3-53 (Human),IGHJ6 (Human),IGKV1-9 (Human),IGKJ4 (Human),ARDLYYYGMDV,QQINDYPF,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C836_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,RBD variant binding data in SI Table 5. Complete
COV107-23,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLGTGLFDYWGQGTLVTVSS,DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLDSYPPGTFGPGTKVDIK,IGHV3-53 (Human),IGHJ4 (Human),IGKV1-9 (Human),IGKJ3 (Human),ARDLGTGLFDY,QQLDSYPPGT,https://www.rcsb.org/structure/7LKA,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 11, 2021","Feb 11, 2021",N/A,Complete
COV107-23+COVD21-C8,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLGTGLFDYWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPRTFGQGTKVEIK,IGHV3-53 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ1 (Human),ARDLGTGLFDY,QQYGSSPRT,https://www.rcsb.org/structure/7LK9,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 28, 2021","Feb 28, 2021",N/A,Complete
Fab_15033-7,Ab,SARS-CoV2,,,,S; RBD,ND,EVQLVESGGGLVQPGGSLRLSCAASGFDLGGYSMHWVRQAPGKGLEWVAGIYASGGATAYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARSYYYGGFGMDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSVSSAVAWYQQKPGKAPKLLIYSASDLYSGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQSHTYPITFGQGTKVEIK,IGHV3-23 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ1 (Human),ARSYYYGGFGMDY,QQSHTYPIT,https://www.rcsb.org/structure/7KXJ; https://www.rcsb.org/structure/7KXK;https://www.rcsb.org/structure/7KML; https://www.rcsb.org/structure/7KLG; https://www.rcsb.org/structure/7KMK; https://www.rcsb.org/structure/7KLH,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 5, 2021","Feb 5, 2021",N/A,Complete
Sb68,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGSVQAGGSLRLSCAASGSISSITYLGWFRQAPGKEREGVAALITVNGHTYYADSVKGRFTVSLDNAKNTVYLQMNSLKPEDTALYYCAAAAWGYAWPLHQDDYWYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAAAWGYAWPLHQDDYWY,N/A,https://www.rcsb.org/structure/7KLW,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Awaiting publication for data
LY-CoV481,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYPGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAREVAGTYDYWGQGTLVTVSS,DIQMTQSPSSVSASVGDRVTITCRASQGISSWLAWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQANSFPGGTFGPGTKVDIK,IGHV3-53 (Human),IGHJ4 (Human),IGKV1-12 (Human),IGKJ3 (Human),AREVAGTYDY,QQANSFPGGT,https://www.rcsb.org/structure/7KMI,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
LY-CoV488,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLIQPGGSLRLSCAASGLTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARSPYGGNSWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPITFGQGTRLEIK,IGHV3-53 (Human),IGHJ5 (Human),IGKV1-33 (Human),IGKJ5 (Human),ARSPYGGNS,QQYDNLPIT,https://www.rcsb.org/structure/7KMH,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
VHH_E,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Llama,QVQLVETGGGFVQPGGSLRLSCAASGVTLDYYAIGWFRQAPGKEREGVSCIGSSDGRTYYSDSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCALTVGTYYSGNYHYTCSDDMDYWGKGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ7 (Alpaca),N/A,N/A,ALTVGTYYSGNYHYTCSDDMDY,N/A,https://www.rcsb.org/structure/7KN5;https://www.rcsb.org/structure/7KSG;https://www.rcsb.org/structure/7B14;https://www.rcsb.org/structure/7B18;https://www.rcsb.org/structure/7B17,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
VHH_U,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Llama,QVQLVESGGGLVQPGGSLRLSCAASGFTLDYYAIGWFRQAPGKEREGVSCISSSGGSTHFADSVKGRFTISRDNAKNTVYLQMNSLIPEDTAVYYCAAQSGSYYWCGSDWHEYEYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAQSGSYYWCGSDWHEYEY,N/A,https://www.rcsb.org/structure/7KN5,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 12, 2021","Feb 12, 2021",N/A,Complete
VHH_V,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QVQLVETGGGLVQPGGSLRLSCAASGFTFSSYAMGWARQVPGKGLEWVSYIYSDGSTEYQDSVKGRFTISRDNAKSTVYLQMNSLKPEDTAVYYCATEGSLGGWGRDFGSWGQGTQVTVSS,N/A,IGHV3S1 (Alpaca),IGHJ6 (Alpaca),N/A,N/A,ATEGSLGGWGRDFGS,N/A,https://www.rcsb.org/structure/7KN6;https://www.rcsb.org/structure/7B11,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Feb 11, 2021","Feb 11, 2021",N/A,Complete
VHH_W,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QVQLVESGGGLVQPGGSLRLSCAASGFTLDYYAIGWFRQAPGKEREGVSCISSSGDSTHYVDSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAAQSGSYYWCGSDWHEYDYRGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAQSGSYYWCGSDWHEYDY,N/A,https://www.rcsb.org/structure/7KN7,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS001,Ab,SARS-CoV2 (weak),,,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQQWGAGLLKPSETLSLTCAVYGGSFSGYYWYWSWIRQPPGKGLEWIGEIDHSGSTDYDPSLKSRVTISVDTSKDQFSLKLSSVTAADTAVYYCGVPYCSSSSCYRYYGMDVWGQGTTVTVSS,EMVMTQSPATLSVSPGERGTLFCRASQSVSSDLAWYQQKPGQAPRLLIYGASTRAIGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYDDWPRTFGQGTKVEIK,IGHV4-34 (Human),IGHJ6 (Human),IGKV3-15 (Human),IGKJ1 (Human),GVPYCSSSSCYRYYGMDV,QQYDDWPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS001_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS002,Ab,SARS-CoV2 (weak),,,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSETLSLTCTVSGGFIRYYYWTWIRQPPGKGLEWIGYIYYSGSTDYDPSLKSRVTISVDTSKDQFSLDLSSVTAADTAVYYCARRGKYGSGSPDDAFDVWGQGTMVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISTYLDWYQHKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPRTFGQGTKLEIR,IGHV4-59 (Human),IGHJ3 (Human),IGKV1-39 (Human),IGKJ2 (Human),ARRGKYGSGSPDDAFDV,QQSYSTPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS002_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS003,Ab,SARS-CoV2 (weak),,,,S; RBD,B-cells; SARS-CoV2 Human Patient,QITLKESGPTLVKPTQTLTLTCTFSGFSLSTSGVGVGWIRQPPGKALEWLALIYWDDDKRYSPSLKTRLTITKDTSKDQVVLTLTDMDPVDTATYYCAHRPAGFWSAHFDYWGQGTLVTVSS,DIVMTQSPLSLPVTPGEPASISCRSSQSLLHSIGYDYLDWYLQKPGQSPQLLIYLGSDRASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQALQSPYTFGQGTKLEIK,IGHV2-5 (Human),IGHJ4 (Human),IGKV2-28 (Human),IGKJ2 (Human),AHRPAGFWSAHFDY,MQALQSPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS003_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS004,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,QMQLVQSGPEVKKPGTSVKVSCKASGFTFSGSAVQWVRQARGQRLEWIGWIVVGSGDTDYAQRFQERVTITRDMSTSTAYMELSSLRSEDTAVYYCAAPYCSSTSCRDGFDIWGQGTMVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVRSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGRSPWTFGQGTKVEIK,IGHV1-58 (Human),IGHJ3 (Human),IGKV3-20 (Human),IGKJ1 (Human),AAPYCSSTSCRDGFDI,QQYGRSPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS004_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS005,Ab,SARS-CoV2 (weak),,,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVKPGGSLRLSCAASGFTLSDAWMSWVRQAPGKGLEWVGRIKSKTDGGTTDYAAPVKGRFTISRDDSKTAVYYCTTDKGPLFFWSGYYTDYWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQHYGSSPRTFGQGTKLEIK,IGHV3-15 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ2 (Human),TTDKGPLFFWSGYYTDY,QHYGSSPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS005_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS006,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYYIHWVRQAPGQGLEWMGIFDPGAGTTDYPQKFQGRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARDGSPWGDDYDIYGMDVWGQGTTVTVSS,DIVMTQSPDSLAVSLGERATVDCKSSQSVLYSSDDKDYLAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLDISSLQAEDVAVYYCQQYYSTPYTFGQGTKLEIK,IGHV1-46 (Human),IGHJ6 (Human),IGKV4-1 (Human),IGKJ2 (Human),ARDGSPWGDDYDIYGMDV,QQYYSTPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS006_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS007,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,VQLVESGGGLIQPGGSLRLSCAASGFTVSSDYMSWVRQAPGKGLEWVSGIYSGGSTYYADSVKGRFTISRDKSKDTLYLQMDSLRAEDTAVYYCARDGGYSAYTLFYSDFAFDIWGQGTMVTVSS,DIQMTQSPSSLSASVGDRVTITCRAGQDISSYLDWYQQKPGKAPKLLIYATSSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSSPPRTFGQGTKVEIK,IGHV3-53 (Human),IGHJ3 (Human),IGKV1-39 (Human),IGKJ1 (Human),ARDGGYSAYTLFYSDFAFDI,QQSYSSPPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS007_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS008,Ab,SARS-CoV2 (weak),,,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKDPGASVKVSCKASGYSFIDYGISWVRQAPGQGLEWMGWISAYDGDTDYAQKLQGRVTMTTDTSTSTAYMELRSLRFDDTAVYYCARVQWLRLDYWGQGTLVTVSS,DIVMTQTPLSLSVTPGQPASISCKSRQSLLHSDGKTYLYWYLQKPGQSPQLLIYDVSSRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYFCMQGIHLPTFGQGTRLDIK,IGHV1-18 (Human),IGHJ4 (Human),IGKV2-29 (Human),IGKJ5 (Human),ARVQWLRLDY,MQGIHLPT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS008_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS009,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGRSLRLSCAASGFTFDDYAMHWVRQAPGKGLEWVSGISWDSGSIGYADSVKGRFTISRDDAKDSLYLQMDSLRAEDTALYYCAKDRSGDYGDYEAGFDPWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISDYLDWYQQKPGKAPKLLIYATSSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATHYCQQSYSTPYTFGQGTKLEIK,IGHV3-9 (Human),IGHJ5 (Human),IGKV1-39 (Human),IGKJ2 (Human),AKDRSGDYGDYEAGFDP,QQSYSTPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS009_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS010,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGTEVKKPGASVKVSCKASTYTFTDFGLSWVRQAPGQGLEWMGWISAYDGDTDYAQKLQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARVQEFWLDPWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDISDYLDWYQQKPGKAPKLLIYDASDLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDDLPITFGQGTRLEIK,IGHV1-18 (Human),IGHJ5 (Human),IGKV1-33 (Human),IGKJ5 (Human),ARVQEFWLDP,QQYDDLPIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS010_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS011,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASEVTVSSDYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDDSKDTLYLQMDSLRAEDTAVYYCARDGLVGATLAFDFWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLDWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPPYTFGQGTKLEIK,IGHV3-66 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ2 (Human),ARDGLVGATLAFDF,QQSYSTPPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS011_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS012,Ab,SARS-CoV2 (weak),,,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVQSGAEVKKPGESLKISCKGSGYSFDIYWIGWVRQMPGKGLEWMGIIYPGDSDTRYSPSFEGQVTVSADKSISTAYLQWSSLKASDTGIYYCVRGCSSDSCEWAMDVWGQGTTVTVSS,VLTQPPSVSGAPGQRVTISCTGSSSDIGAGAGYDVHWYQQFPGTAPKLLIYGDDDRPSGVPDRFSGSKSGTSASLTITGLQAEDEADYYCQSYDRSLSVLYVFGTGTKVTVL,IGHV5-51 (Human),IGHJ6 (Human),IGLV1-40 (Human),IGLJ1 (Human),VRGCSSDSCEWAMDV,QSYDRSLSVLYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS012_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS013,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTGYYIHWVRQAPGQGLEWMGWIDPDSGGTDFVQKFQGRVTMTRDTSISTAYMELSRLKSDDTAVYYCARGTPPDSVVVPAAIHPYDWFDPWGQGTLVTVSS,QSVLTQPPSVSGAPGQRVTLSCTGSSSDIGAGYDVHWYQQLPGTAPKVLIYGDSDRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSSLSGDFVFGTGTKVTVL,IGHV1-2 (Human),IGHJ5 (Human),IGLV1-40 (Human),IGLJ1 (Human),ARGTPPDSVVVPAAIHPYDWFDP,QSYDSSLSGDFV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS013_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS014,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,QLQLQESGPGLVRPSETLSLTCTVSGGSISSSSYFWGWIRQPPGKGLEWIGSIYYSGTTHYDPSLKSRITISVDTSKDQFSLKLTSVTAADTAVYYCATLEWLRAPFDDWGQGTLVTVSS,DFMLTQPHSVSESPGKTVTISCTGSSGSIASDYVQWYQQRPGSAPTTVIYEDDQRPSGVPDRFSGSIDSSSDSASLTISGLKTEDEADYYCQSYDSSDVVFGGGTKLTVL,IGHV4-39 (Human),IGHJ4 (Human),IGLV6-57 (Human),IGLJ3 (Human),ATLEWLRAPFDD,QSYDSSDVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS014_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS015,Ab,SARS-CoV2 (weak),,,,S; RBD,B-cells; SARS-CoV2 Human Patient,QITLKESGPTLVKPTQTLTLTCTFSGFSLSTSGVGVGWIRQPPGKALEWLALIYWDDDKRYSPSLKSRLTITKDTSKDQVVLTMTTMDPVDTATYYCAHRPLFSGPFDYWGQGTLVTVSS,SFMLTQPHSVSESPGKTVTISCTGSSGSIASDYVQWYQQRPGSAPTTLIYEDDQRPSGVPDRFSGSIDSSSDSASLTISGLKTEDEADYYCQSYDSSTIIFGGGTKLTVL,IGHV2-5 (Human),IGHJ4 (Human),IGLV6-57 (Human),IGLJ3 (Human),AHRPLFSGPFDY,QSYDSSTII,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS015_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS016,Ab,SARS-CoV2 (weak),,,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYSITWVRQAPGQGLEWMGRIIPILGVADYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCAREGTTITEYFQQWGQGTLVTVSS,QSVLTQPPSVSGAPGQRVTISCTGSDSDIGAGYDVHWYQQLPGTAPKLLIYGDSDRPSGVPDRFSGSKSDTSASLAITGLQAEDEADYYCQSYDSSLTGSVFGGGTKVTVL,IGHV1-69 (Human),IGHJ1 (Human),IGLV1-40 (Human),IGLJ6 (Human),AREGTTITEYFQQ,QSYDSSLTGSV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS016_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS018,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,QITLKESGPTLVKPTQTLTLTCTFSGFSLSTSGVGVGWIRQPPGKALEWLALIYWDDDKRYSPSLKTRLTITKDTSKDQVVLTLTDMDPVDTATYYCAHRPAGFWSAHFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLDWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPAWTFGQGTKVEIK,IGHV2-5 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ1 (Human),AHRPAGFWSAHFDY,QQSYSTPAWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS018_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS019,Ab,SARS-CoV2 (weak),,,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLIQPGGSLRLSCAASEIIVSSDYMDWVRQAPGKGLEWVSLLYSGGTTYYADSVKGRFTISRDDSKDTLYLQMDSLRAEDTAVYYCARDLGPYGMDVWGQGTTVTVSS,DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLDSYPQATFGQGTRLEIK,IGHV3-53 (Human),IGHJ6 (Human),IGKV1-9 (Human),IGKJ5 (Human),ARDLGPYGMDV,QQLDSYPQAT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS019_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS020,Ab,SARS-CoV2 (weak),,,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVGSGGGLVQPGGSLRLSCAASGFTVSSDYMSWVRQAPGKGLEWVSLIYSGGSTYYADSVKGRFTISRDDSKDTLFLQMDSLRPEDTAVYYCARDGRAVAGTDWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDIDDYLDWYQQKPGKAPKLLIYDASDLETGVPSRFSGSGSGTDFTFTISSLQPVDIATYYCHQYDDLPRTFGQGTKVEIK,IGHV3-66 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ1 (Human),ARDGRAVAGTD,HQYDDLPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS020_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS021,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVMLVESGGGLIQPGGSLRLSCAASGFIVSSNYMSWVRQAPGKGLEWVSLIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLGAEDTAVYYCARFRYGDYPDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDISIYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIAIYYCQQYDNLPSFTFGPGTKVDIK,IGHV3-53 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ3 (Human),ARFRYGDYPDY,QQYDNLPSFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS021_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS022,Ab,SARS-CoV2 (weak),,,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGRSLRLSCAASGFTFDDYAMNWVRQAPGKGLEWVSGISWNSGSFGYADSVKGRFTISRDNAKNSLYLQMNSLRPEDTALYYCAKDIGCSSTSCSYYHYYGMDVWGLGTTVTVSS,DIVMTQSPLSLPVTPGEPASISCRSSQSLLHSNGYNYLDWYLQKPGQSPQLLIYLGSNRASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQALQTPTFGQGTKLEIK,IGHV3-9 (Human),IGHJ6 (Human),IGKV2-28 (Human),IGKJ2 (Human),AKDIGCSSTSCSYYHYYGMDV,MQALQTPT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS022_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS023,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVRVSCKASGYTFTTYGLSWVRQAPGQGLEWMGWVSAYNGNTNYAQKLQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARDYGWFGELSTEGQFDYWGQGTLVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSRYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFALYYCQQRRDFTFGPGTRVDIK,IGHV1-18 (Human),IGHJ4 (Human),IGKV3-11 (Human),IGKJ3 (Human),ARDYGWFGELSTEGQFDY,QQRRDFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS023_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS026,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVTLRESGPALVKPTQTLTLTCTFSGFSLSTSGMCVSWIRQPPGKALQWLARIDWDDDKYYSTSLKTRLTISKDTSKNQVVLTVTNVDPVDTGTYYCARVQVAAAGSPYDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISRYLNWYQQKPGKAPNLLIYAAASLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQTYSTPRTFGQGTKVEIK,IGHV2-70 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ1 (Human),ARVQVAAAGSPYDY,QQTYSTPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS026_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS028,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,QMQLVQSGPEVKKPGTSVKVSCKASGFTFTTSAVQWVRQARGQRLEWIGWIVVGSDNTNYAQKFQERVTITRDMSTRTAYMELSSLRSEDTAVYYCAADRMRIVGGKGYYYGMDVWGQGTTVTVSS,DIQMTQSPSTLSASVGDRVTITCRASQSITSWLAWYQQKPGKAPKLLIYKASTLERGVPSRFSGSGSGPEFTLTISSLQPDDFATYYCQQYNSYSPGDTFGQGTKLEIK,IGHV1-58 (Human),IGHJ6 (Human),IGKV1-5 (Human),IGKJ2 (Human),AADRMRIVGGKGYYYGMDV,QQYNSYSPGDT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS028_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS029,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKNPGASVKVSCKASGYSFINYGISWVRQAPGQGLEWMGWISAYNGNTNYAQKLQGRVTMTTDTSTSTAYMELRSLRFDDTAVYYCARVQWLRLDYWGQGTLVTVSS,DIQMTQSPSSVSASVGDRVTITCRASQHISSWLAWYQQKPGKAPKLLIYDASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYFCQQAKGFPLTFGGGTKVEIK,IGHV1-18 (Human),IGHJ4 (Human),IGKV1-12 (Human),IGKJ4 (Human),ARVQWLRLDY,QQAKGFPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS029_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS030,Ab,SARS-CoV2 (weak),,,,S; RBD,B-cells; SARS-CoV2 Human Patient,QLQLQESGPGLVKPSETLSLTCTVSGGSISSTSHYWGWIRQPPGKGLEWIGSIHYSGSTYYNPSLKSRVTISVDTSKKQFSLKLRSVTAADTAVYYCARFITDGSSGSDSWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSVSSYLNWYQQNPGKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISTLQPEDFATYFCQQSYSTPRLTFGGGTKVEIK,IGHV4-39 (Human),IGHJ5 (Human),IGKV1-39 (Human),IGKJ4 (Human),ARFITDGSSGSDS,QQSYSTPRLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS030_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS034,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVRVSCKASGYTFTTYGLSWVRQAPGQGLEWMGWVSAYNGNTNYAQKLQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARDYGWFGELSTEGQFDYWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYAASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCHQYASSPRTFGQGTKVEIK,IGHV1-18 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ1 (Human),ARDYGWFGELSTEGQFDY,HQYASSPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS034_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS035,Ab,SARS-CoV2 (weak),,,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSETLSLTCRVSGGFISSYYWSWIRQPPGKGLEWIGYIYYSGTTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARRSMGYCSGGNCYSGFDPWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPELLIYAASSLQSGVPSRFSGSESGTDFTLTISSLQPEDFATYYCQQSYSTPLTFGGGTKVEIK,IGHV4-59 (Human),IGHJ5 (Human),IGKV1-39 (Human),IGKJ4 (Human),ARRSMGYCSGGNCYSGFDP,QQSYSTPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS035_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS036,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSETLSLTCTVSGGSISSYYWTWIRQAPGKGLEWIGYIYNSGSTNYNPSLRGRVTISVDTSKNQFSLNLSSVTAADTAVYYCARDQGYSSGWNDAFDIWGQGTMVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGSYNLVSWYQQHPGKAPKLMIYEGSKRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYHCCSYAGSRFWVFGGGTKLTVL,IGHV4-4 (Human),IGHJ3 (Human),IGLV2-23 (Human),IGLJ3 (Human),ARDQGYSSGWNDAFDI,CSYAGSRFWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS036_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS038,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFNNYWMTWVRQAPGKGLEWVANIKLDGSEKYYVDSVKGRFTISRDNAKNSLYLQVNSLRAEDTAVYYCARSPHYYGGFDYWGQGTLVTVSS,NFMLTQPHSVSESPGKTVTISCTGSSGSVASNYVQWYQQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYHNSVWVFGGGTKLTVL,IGHV3-7 (Human),IGHJ4 (Human),IGLV6-57 (Human),IGLJ3 (Human),ARSPHYYGGFDY,QSYHNSVWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS038_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS041,Ab,SARS-CoV2 (weak),,,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVQSGAEVKKPGESLKISCKGSGYSFTSYWIGWVRQMPGKGLEWMGIIYPGDSDTRYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARRWDGVGFDIWGQGTMVTVSS,SSELTQDPAVSVALGQTVRITCQGDSLRSYYASWYQQKPGQAPVLVIYDKNNRPSDIPDRFSGSSSGNTASLTITGAQAEDEADYYCNSRDSSINHYVFGTGTKVTVL,IGHV5-51 (Human),IGHJ3 (Human),IGLV3-19 (Human),IGLJ1 (Human),ARRWDGVGFDI,NSRDSSINHYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS041_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS052,Ab,SARS-CoV2 (weak),,,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVQSGAEVKKPGESLRISCKGSGYSFTSYWITWVRQMPGKGLECMGRIDPSDSYSKYSPSFQGHVTISADKSISTAFLQWSSLKASDTAMYYCARLPFCDSASCGRAHYYYGMDVWGQGTTVTVSS,EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYAASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNWPETFGQGTKLEIK,IGHV5-10-1 (Human),IGHJ6 (Human),IGKV3-15 (Human),IGKJ2 (Human),ARLPFCDSASCGRAHYYYGMDV,QQYNNWPET,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS052_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS057,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVTLRESGPALVKPTQTLTLTCTFSGFSLSTSGMCVSWIRQPPGKALEWLARIDWDDDKYYSTSLRTRLTISKDTSKNLVVLTMTNMDPVDTATYYCALGRAGTMDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSIRSYLNWYQQKPGKAPKVLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPGDFATYYCQQSYSPPYTFGQGTKLEIK,IGHV2-70 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ2 (Human),ALGRAGTMDY,QQSYSPPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS057_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS058,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGRSLRLSCAASGFTFDDYAMHWVRQAPGKGLEWVSGISWSSGSIVYADSVKGRFTVSRDNAKNSLYLQMNSLRVEDTAFYYCAKDMVAGPHYYGMDVWGQGTTVTVSS,RSVLTQPPSASGTPGQRVTISCSGSSSNIGSNTVNWYQQLPGTAPKLLIYNNNQRPSGVPDRFSGSKSGTSASLAISGLQSEDEADYSCAAWDDSLNGWVFGGGTKLTVL,IGHV3-9 (Human),IGHJ6 (Human),IGLV1-44 (Human),IGLJ3 (Human),AKDMVAGPHYYGMDV,AAWDDSLNGWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS058_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS059,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVQSGAEVKKPGESLKISCKASGYRFTNYWTVWVRQMPGKGLEWMGIIYPGDSEIRYSPPFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARHPSNFYDSGGDYYAMDVWGQGTPVTVSS,QSALTQPASVSGSPGQSITISCTGTSSNVGNYDLVSWYQQHPGKAPKLMIYEVNKRPSGVSDRFSGSKSGNTASLTISGLQAEDEADFYCCSYAGSSSWVFGGGTKVTVL,IGHV5-51 (Human),IGHJ6 (Human),IGLV2-23 (Human),IGLJ3 (Human),ARHPSNFYDSGGDYYAMDV,CSYAGSSSWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS059_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS062,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGRSLRLSCAASGFTFDDYAMHWVRQAPGKGLEWVSGISWNSDSIGYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTALYYCAKDLSSGWDLFDYWGQGTLVTVSS,SYVLTQPPSVSVAPGKTARITCGGNNIGSKSVHWYQQKPGQAPVLVIYYDSDRPSGIPERFSGSNSGNTATLSISRVEAGDEAGYYCQVWDTSGDPLVFGGGTKLTVL,IGHV3-9 (Human),IGHJ4 (Human),IGLV3-21 (Human),IGLJ3 (Human),AKDLSSGWDLFDY,QVWDTSGDPLV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS062_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS064,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVQSGAEVKKPGESLKISCEGSGYSFISYWIGWVRQMPGKGLEWMGIIYPGDSDTRYSPSFQGQVTISADRSISTAYLQWSSLKASDTAMYYCVRSDGDYVIGHDYWGQGTLVTVSS,QSVLTQPPSASGTPGQRVTISCSGSSSNIGGNTVNWYQQLPGTAPKLLIYNNNQRPSGVPDRFSGSKSGTSASLAISGLQSEDEADYYCATWDDSLNGRVFGGGTKLTVL,IGHV5-51 (Human),IGHJ4 (Human),IGLV1-44 (Human),IGLJ3 (Human),VRSDGDYVIGHDY,ATWDDSLNGRV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS064_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS065,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,EMQLVESGGGLVQPGGSLRLSCAASGFTFSTYEMNWVRQAPGKGLEWVSYISSSTNSIYYAGSVQGRFTISRGNAKNSLYLQMNSLRAEDTAVYYCARGRDDYGDYRGGDFDYWGQGTLVTVSS,QIVLTQSPATLSLSPGERATLSCRASQSVTTYLAWYQQKPGQAPRLLIYDASHRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPPITFGPGTKVEIK,IGHV3-48 (Human),IGHJ4 (Human),IGKV3-11 (Human),IGKJ3 (Human),ARGRDDYGDYRGGDFDY,QQRSNWPPIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS065_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS067,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFTSYAFSWVRQAPGQGLEWMGGIIPIFGTSNYAQKFQGRVTISADESSSTAYMELSSLRSEDTAVYYCARGPAYVSGTYYWNAFDIWGQGTMVTVSS,EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQHYNNWPLYTFGQGTKLEIK,IGHV1-69 (Human),IGHJ3 (Human),IGKV3-15 (Human),IGKJ2 (Human),ARGPAYVSGTYYWNAFDI,QHYNNWPLYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS067_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS068,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYTLHWVRQAPGKGLEWVAVISSDGSSKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDPPPGNMGSMAQHLVLLVVFDIWGQGTMVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAATSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYTTLALTFGGGTKVEIK,IGHV3-30 (Human),IGHJ3 (Human),IGKV1-39 (Human),IGKJ4 (Human),ARDPPPGNMGSMAQHLVLLVVFDI,QQSYTTLALT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS068_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS070,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGITVSSNYMNWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRHNSKNTLYLQMNSLRAEDTAVYYCAREGLGMDVWGQGTTVTVSS,EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQHYNNWPLYTFGQGTKLEIK,IGHV3-66 (Human),IGHJ6 (Human),IGKV3-15 (Human),IGKJ2 (Human),AREGLGMDV,QHYNNWPLYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS070_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS074,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSTYAMHWVRQAPGKGLEWVAVIWYDGSDKYYADSVKGRFTISRDNSKNTLYLQMSSLGVEDTAVYYCAKGGFGYASGWYYLDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDISNSLNWYQQKPGKAPKLLIYDASDLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYGNLPPIAFGQGTRLEIK,IGHV3-33 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ5 (Human),AKGGFGYASGWYYLDY,QQYGNLPPIA,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS074_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS075,Ab,SARS-CoV2 (weak),,,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMNWVRQAPGKGLEWVSVIYSGDNTHYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARGYGSGSYGWFDPWGQGTLVTVSS,EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQHYNNWPLYTFGQGTKLEIK,IGHV3-53 (Human),IGHJ5 (Human),IGKV3-15 (Human),IGKJ2 (Human),ARGYGSGSYGWFDP,QHYNNWPLYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS075_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS076,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAAAGFTFSNYDMHWVRQATGKGLEWVSVIGTAGDTYYPDSVKGRFTISRENAKNSLYLQMNSLRAGDTAVYYCARAYYDTSGYYNYFDHWGQGTLVTVSS,EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQHYNNWPLYTFGQGTKLEIK,IGHV3-13 (Human),IGHJ4 (Human),IGKV3-15 (Human),IGKJ2 (Human),ARAYYDTSGYYNYFDH,QHYNNWPLYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS076_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS078,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVRVSCKASGDTFSSHYIHWVRQAPGQGLEWMGIINPSGGSTSYAQKFQGRVTMTSDTSTSTVYLELSSLRSEDTAVYYCARDQAFIVATLGPDYWGQGILVTVSS,QTVVTQEPSFSVSPGGTVTLTCGLSSGSVSTSYYASWYQQTPGQAPRTLIYSTNTRSSGVPDRFSGSILGNKAALTITGAQADDESDYYCVLYMGSGIWVFGGGTKLTVL,IGHV1-46 (Human),IGHJ4 (Human),IGLV8-61 (Human),IGLJ3 (Human),ARDQAFIVATLGPDY,VLYMGSGIWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS078_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS079,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGDNTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKMLWLRGWFDPWGQGTLVTVSS,NFMLTQPHSVSESPGKTVTISCTRSSGSIASNYVQWYQQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDSSSDSASLTISGLKTEDEADYYCQSYDTSNHWVFGGGTKLTVL,IGHV3-53 (Human),IGHJ5 (Human),IGLV6-57 (Human),IGLJ3 (Human),AKMLWLRGWFDP,QSYDTSNHWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS079_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS080,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVTLRESGPALVRPTQTLTLTCTFAGFSLRTHGMCVSWIRQPPGKALEWLARIDWDGDKYYSTSLKTRLTISKDTSKDQVVLTMTNMDPVDTATYYCARFLVGGFKAWFDPWGQGTLVTVSS,QSVLTQPPSVSAAPGQKVTISCSGSSSNIGNNYVSWYQQLPGIAPELLIYDNNKRPSGIPGRFSGSRSGTSATLDITGLQTGDEADYYCGTWDTSLNVWVFGGGTKLTVL,IGHV2-70 (Human),IGHJ5 (Human),IGLV1-51 (Human),IGLJ3 (Human),ARFLVGGFKAWFDP,GTWDTSLNVWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS080_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS082,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVQSGAEVKKPGESLKISCKGSGYSFSTYWIGWVRQMPGKGLEWMGIIYPYDSDTRYSPSFQGQVTISADKSISTAYLQWSSLKASDTAIYYCARQESGWSFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQNINKYLNWYQQKPGKAPKLLIYVASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPRTFGQGTKVEIK,IGHV5-51 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ1 (Human),ARQESGWSFDY,QQSYSTPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS082_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS083,Ab,SARS-CoV2 (weak),,,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGLTVSSNYMSWVRQAPGKGLEWVSLIYSGGSTYYADSVKGRFTISRHNSKNTLYLQMNSLRAEDTAVYYCARDLEERGAMDVWGQGTTVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSTYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRVEPEDFAVYYCQQYGSSLWTFGQGTKVEIK,IGHV3-66 (Human),IGHJ6 (Human),IGKV3-20 (Human),IGKJ1 (Human),ARDLEERGAMDV,QQYGSSLWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS083_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS086,Ab,SARS-CoV2 (weak),,,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGITVNSNYMSWVRQAPGKGLEWVSVIYNGVTTYYADSVKGRFTISRDISKNTVYLQMNSLRAEDTAVYYCARAGWLRGRFDPWGQGTLVIVSS,SYVLTQPPSVSVAPGQTASITCGGSNIGSKNVHWYQQKSGQAPVLVVYDDSDRPSGIPERFSGSNSGNTATLIINRVEAGDEADYYCQVWDSTTDLPHWVFGGGTKLTVL,IGHV3-66 (Human),IGHJ5 (Human),IGLV3-21 (Human),IGLJ3 (Human),ARAGWLRGRFDP,QVWDSTTDLPHWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS086_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS090,Ab,SARS-CoV2 (weak),,,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVTLRESGPALVKPTQTLTLTCTFSGFSLSTSGMCVNWIRQPPGKALEWLARIDWDDDKYYSTSLETRLTISKDTSKNQVVLTMTNMDPVDTATYYCARTRLGITAFDIWGQGTMVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQNIKTYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYTTPRTFGQGTKVEIK,IGHV2-70 (Human),IGHJ3 (Human),IGKV1-39 (Human),IGKJ1 (Human),ARTRLGITAFDI,QQSYTTPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS090_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS091,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGALVQPGGSLRLSCAASGFTFSSYDMHWVRQATAKGLEWVSTIGTAGDTYYPGSVKGRFTISRENAKNSLYLQMNNLRAGDTAVYYCARVGYDSSGYYWYLDLWGRGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASLSIGRYLNWYQQKPGKAPKLLISAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFAAYYCQQSYTTPLFTFGPGTKVDIK,IGHV3-13 (Human),IGHJ2 (Human),IGKV1-39 (Human),IGKJ3 (Human),ARVGYDSSGYYWYLDL,QQSYTTPLFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS091_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS094,Ab,SARS-CoV2 (weak),,,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAGSGFTFSHYGMHWVRQAPGKGLEWVAVILYDGSNNYYADSVKGRFTVSRDNSKNTLYLQMNSLRTEDTAVYYCGKGAGPYCGGGSCYPTKVDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDISNCLNWYQQKPGKAPTLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLLWTFGPGTKVEIK,IGHV3-33 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ1 (Human),GKGAGPYCGGGSCYPTKVDY,QQYDNLLWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS094_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS097,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVALIWYDGSNKYYADSVKGRFTISRDNSKNTMYLQMNSLRAEDTAVYYCAKDGSGSYYNSGALDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDISNSLNWYQQKTGKAPKPLIYDASILEAGVPSRFSGSGSGTDFTFTITSLQPEDIATYYCQQYDNLPPYTFGQGTNLEIK,IGHV3-33 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ2 (Human),AKDGSGSYYNSGALDY,QQYDNLPPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS097_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS098,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSNNTLYLQMNSLRAEDTAVYYCARDYGDYYFDYWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSTYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPRTFGQGTKVEIK,IGHV3-66 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ1 (Human),ARDYGDYYFDY,QQYGSSPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS098_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS099,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFNSYGISWVRQAPGQGLEWMGWISSYNGNTNYAQKLQGRVTMTTDTSTSTAYMELRSLTSDDTAVYYCATDDPDIVLVPAAMSLDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDISNSLNWYQQKTGKAPKPLIYDASILEAGVPSRFSGSGSGTDFTFTITSLQPEDIATYYCQQYDNLPPYTFGQGTNLEIK,IGHV1-18 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ2 (Human),ATDDPDIVLVPAAMSLDY,QQYDNLPPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS099_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS101,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFNSYGISWVRQAPGQGLEWMGWISSYNGNTNYAQKLQGRVTMTTDTSTSTAYMELRSLTSDDTAVYYCATDDPDIVLVPAAMSLDYWGQGTLVTVSS,DIQMTQSPSSLPASVGDRVTITCRASQSISIYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISNLQHEDFATYYCQQSYNTLALSFGGGTKVEIK,IGHV1-18 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ4 (Human),ATDDPDIVLVPAAMSLDY,QQSYNTLALS,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS101_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS103,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSETLSLICTVSGGSITSYYWTWIRQPPGKGLEWIGYIYYNGSSNYNPSLESRVTISVDASKNQFSLKLSSVTAADTAVYYCATDYYDSSGYRYGMDVWGQGTTVTVSS,DIQMTQSPSSVSASLGDRVTITCRASQGISGWLAWYQQKPGKAPMLLIYAASSLQSGVPSRFSGSGSGTDFTLSISSLQPEDFATYYCQQANSFPLTFGGGTKVEIK,IGHV4-59 (Human),IGHJ6 (Human),IGKV1-12 (Human),IGKJ4 (Human),ATDYYDSSGYRYGMDV,QQANSFPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS103_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS104,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,RGPGNGVWAEVKKPGSSVKVSCKTSGGTFSSYAISWVRQAPGQGLEWMGGIIPIFGTANYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYCASFGSLWDLRDYWGQGTLVTVSS,ESVLTQSPGTLSLSPGERATLSCRASQSVSSNYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGTSRTFGGGTKVEIK,IGHV1-69 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ4 (Human),ASFGSLWDLRDY,QQYGTSRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS104_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS105,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLLESGGGLVQPGGSLRLSCAASGFTFSSFAMSWVRQAPGKGLEWVSVISSSGDYTSYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDVGSRLIYDVFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSIRSYLNWYQQKPGKAPKLLMYAASSLQSGVPSRFSGSGSGTDFTLTINSLQPEDFATYYCQQSYSTPPYSFGQGTKLEIK,IGHV3-23 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ2 (Human),AKDVGSRLIYDVFDY,QQSYSTPPYS,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS105_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS106,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVTLRESGPALVKPTQTLTLTCTFSGFSLNTSGMSVSWIRQPPGKALEWLARIDWDDDKYYSTSLKTRLSISKDTSKNQVVLTMTNVDPVDTATYYCTRTATVVKDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQTISRYLNWYQQRPGKAPKLLIYIASNLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPRTFGQGTKVEIK,IGHV2-70 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ1 (Human),TRTATVVKDY,QQSYSTPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS106_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS107,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVTLRESGPALVKPTQTLTLTCTFSGFSLNTSGMCVSWIRQPPGKALEWLARIDWDDEKYYSTSLQTRLTISKDTSKNQVVLTMTNMDPVDTATYYCARMIPIPALDYWGQGTLVTVSS,DIQMTQSPSSLSTSVGDRVTITCRASQSISRYLNWYQQKPGKAPKLLIYTASSLQSGVPSRFSGSGSGTNFTLTISSLQPEDFATFYCQQSYSTPHTFGQGTKLEIK,IGHV2-70 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ2 (Human),ARMIPIPALDY,QQSYSTPHT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS107_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS108,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVTLRESGPALVKPTQTLTLTCTFSGFSLSTSGMCVSWIRQPPGKALEWLARIDWDDDKYYSTSLKTRLTISKDTSKNQVVLTMTNMDPVDTATYYCAREEAAGTKLDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRTSQSIRVYLNWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPRTFGQGTKVEIK,IGHV2-70 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ1 (Human),AREEAAGTKLDY,QQSYSTPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS108_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS110,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,RSQLVESGGGVVQPGRSLRLSCAASGFTFSSYVMHWVRQAPGKGLEWVAVISYDGSSKYYADSVKGRSTISRDNSKNTLYLQMNSLRAEDTAVYYCAKRGGTYCSGGICYGGYFDYWGQGMLVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVTERPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSFTSSSTPYVFGTGTKVTVL,IGHV3-30-3 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ1 (Human),AKRGGTYCSGGICYGGYFDY,SSFTSSSTPYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS110_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS113,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFSFSTYAMHWVRQAPGKGLVWVAFISYDESNKYYTDSVKGRFTVSRDNSKNTLYLQMNSLRAEDTAVYYCAGGGVLVTSDPDAFDIWGQGTMVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKSGKAPKLLIYDASNLETGVPSRFSGSGSGADFTFTISSLQPEDIGTYYCQQSDNVPVTFGPGTKVDIK,IGHV3-30 (Human),IGHJ3 (Human),IGKV1-33 (Human),IGKJ3 (Human),AGGGVLVTSDPDAFDI,QQSDNVPVT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS113_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS115,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVQSGAEVKKPGESLKISCKGSGYSFTRYWIGWVRQMPGKGLEWMGIIYPGDSDTRYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARIEYYNDSSGYYQFWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSWTFGQGTKVEIK,IGHV5-51 (Human),IGHJ1 (Human),IGKV3-20 (Human),IGKJ1 (Human),ARIEYYNDSSGYYQF,QQYGSSWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS115_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS116,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYDINWVRQATGQGLEWMGWMNPKSVYTGYAQKFQGRVTMTRNTSIRTAYMELSSLRSEDTAVYYCARGLWFGDLTRTKYNWFDPWGQGTLVTVSS,AIQLTQSPSSLSASVGDRVTITCRASQGISSALAWYQQKPGKAPKLLIYDASSLESGVPSRFNGSGSGTDFTLTISSLQPEDFATYYCQQFNNFLLTFGGGTKVEIK,IGHV1-8 (Human),IGHJ5 (Human),IGKV1-13 (Human),IGKJ4 (Human),ARGLWFGDLTRTKYNWFDP,QQFNNFLLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS116_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS121,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVQSGAEVKKPGESLKISCKGSGYSFSTYWIGWVRQMPGKGLEWMGIIYPYDSDTRYSPSFQGQVTISADKSISTAYLQWSSLKASDTAIYYCARQESGWSFDYWGQGTLVTVSS,SSELTQDPAVSVALGQTVRITCQGDSLRSYYASWYQQKPGQAPVLVIYGKNNRPSGIPDRFSGSSSGNTASLTITGAQAEDEADYSCNSRDSSGNHWVFGGGTKLTVL,IGHV5-51 (Human),IGHJ4 (Human),IGLV3-19 (Human),IGLJ3 (Human),ARQESGWSFDY,NSRDSSGNHWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS121_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS123,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,QITLKESGPTLVKPTQTLTLTCTFSGFSLSTSGVGVGWIRQPPGKALEWLAVIYWDDDKRYSPSLKSRLTITKDTSKNQVVLTMTNMDPVDTATYYCAHTTWYYYGSGWFDPWGQGTLVTVSS,QSVLTQPPSASGTPGQRVTISCSGSSSNIGSNNVNWYQQLPGTAPKVLIYSNNQRPSGVPDRFSGSKSGTSASLAISGLQSEDEADYYCAAWDDSLNGHVFGGGTKLTVL,IGHV2-5 (Human),IGHJ5 (Human),IGLV1-44 (Human),IGLJ3 (Human),AHTTWYYYGSGWFDP,AAWDDSLNGHV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS123_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS124,Ab,SARS-CoV2 (weak),,,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGTEVKKPGASVKVSCKASTYTFTNFGLSWVRQAPGQGLEWMGWISAYNGNTNYAQKLQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARVQEFWLDPWGQGTLVTVSS,SYVLTQPPSVSVAPGKTASITCGGNNIGSKSVHWYQQRPGQAPVLVIYYDTDRPSGIPERFSGSNSVNTATLTISRVEAGDEADYYCQVWDSSSDHPLFGGGTKLTVL,IGHV1-18 (Human),IGHJ5 (Human),IGLV3-21 (Human),IGLJ3 (Human),ARVQEFWLDP,QVWDSSSDHPL,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS124_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS127,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSTISASGDSTYYADFVKGRFTISRDNSKNTVYLQMNSLRAEDTAIYYCAKEPSFGLWFGELSGWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSLSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSLPYTFGQGTKLEIK,IGHV3-23 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ2 (Human),AKEPSFGLWFGELSG,QQYGSSLPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS127_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS130,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGFLQPGGSLRLSCAASGFTFSSDDMHWVRQVTGKGLEWVSAIGTSGDTYYSGSVKGRFTISRENAKNSLYLQMNSLRVGDTAVYYCARGSLRGGILSGYAFDIWGQGTMVTVSS,DIQMTQSPSSLSASVGDTVTITCRASQIINSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSSPPWTFGQGTKVEIK,IGHV3-13 (Human),IGHJ3 (Human),IGKV1-39 (Human),IGKJ1 (Human),ARGSLRGGILSGYAFDI,QQSYSSPPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS130_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS132,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVQSGAEVKKPGESLKISCKGSGDSFPSYWIEWVRQMPGKGLEWMGLIYPGDSDTRYSPSFQGQVTISADKSISTAYLQLSSLKASDTAMYFCARHPVLRGNIDYWGQGTLVIVSS,QSVLTQPPSVSGAPGQRVTISCTASSSNIGADYDVHWYQQLPGTVPKLLIYGNTNRPSGVPDRFSGSKSGTSASLAITFLQAEDEADYYCQSYDSSLRGSVFGGGTKLTVL,IGHV5-51 (Human),IGHJ4 (Human),IGLV1-40 (Human),IGLJ3 (Human),ARHPVLRGNIDY,QSYDSSLRGSV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS132_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS133,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSFYSIHWVRQAPGKGLEWVAVISYDGSYKFYADSVKGRFTISRDNSKDTVYLQMNSLRAEDTAVYYCARDWVHYGSGSYPPDYWGQGTLVTVSS,QSALTQPPSVSGSPGQSVTISCAGTSSDVGSYNRVSWYQQPPGTAPRLMIYEVGNRPSGVPDRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSTWVFGGGTKLTVL,IGHV3-30 (Human),IGHJ4 (Human),IGLV2-18 (Human),IGLJ3 (Human),ARDWVHYGSGSYPPDY,SSYTSSSTWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS133_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS134,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,QLQLQESGPGLVKASETLSLTCTVSGGSISSSSYYWGWIRQPPGKGLEWIGSIHDSGSTYYNPSLKSRVTISVDTSKNQFSLRLSSVTAADTAVYYCARYYGPGTYYDAFDIWGQGTMVTVSS,QSALTQPASMSGSPGQSITISCTGTTSDVGAYNYVSWYQQHPGKAPKLMISNVSKRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSTWVFGGGTKLTVL,IGHV4-39 (Human),IGHJ3 (Human),IGLV2-14 (Human),IGLJ3 (Human),ARYYGPGTYYDAFDI,SSYTSSSTWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS134_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS135,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGLTVSSNYMSWVRQAPGKGLDWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARELGPVGGTDQWGQGTLVSVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKQGKAPNLLIYAASSLQSGVPSRFSGSGSGTDFTLTITSLQVEDFATYYCQQSHSTPYTFGQGTKVEIK,IGHV3-66 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ1 (Human),ARELGPVGGTDQ,QQSHSTPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS135_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS138,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVHLVESGGGVVQPGRSLRLSCAASGFTFSTYGMHWVRQAPGKGLEWVATISYDGSDKFYADSVKGRFTISRDNSRNTLYVQMNSLRPEDTALYYCAKGGWYGDIRVDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTTFTFTISSLQPADIATYYCQHYNNLPLTFGGGTKVEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ4 (Human),AKGGWYGDIRVDY,QHYNNLPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS138_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS148,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,QITLKESGPTLVKPTQTLTLTCTFSGFSLSTSGVGVGWIRQPPGKALEWLALIYWDDDDRYSPSLKSRLTITKDTSKNQVVLTMTNMDPVDTATYYCAHSLPSKYSYSYGSFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSINYYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSAPYTFGQGTKLEIK,IGHV2-5 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ2 (Human),AHSLPSKYSYSYGSFDY,QQSYSAPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS148_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS151,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLLESGGGLVQPGGSLRLSCAASKFTFSNYAMNWVRQAPGKGLEWVSAISGSGGNTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKGELLWFGELLENWFDPWGQGTRVTVSS,DIQMTQSPSSVSASVGDRVTITCRASQGISSWLAWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQADSFPWTFGQGTRVEIK,IGHV3-23 (Human),IGHJ5 (Human),IGKV1-12 (Human),IGKJ1 (Human),AKGELLWFGELLENWFDP,QQADSFPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS151_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS154,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVQSGAEVKKPGESLKISCKASGYSFTTYWIGWVRQMPGKGLEWMGIIYPGDSDTRYSPSFQGQVTISADKSITTAYLQWSSLKASDTAIYYCARLPPHFGSGSYYGNAFDIWGLGTMVTVSS,QSVLTQPPSASGTPGQRVTISCSGSSSNIGSNYVYWYQQLPGTAPKLLIYRSNQRPSGVPDRFSGSKSGTSASLAISGLRSEDEADYYCATWDDSLTGPVFGGGTKLTVL,IGHV5-51 (Human),IGHJ3 (Human),IGLV1-47 (Human),IGLJ3 (Human),ARLPPHFGSGSYYGNAFDI,ATWDDSLTGPV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS154_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS155,Ab,SARS-CoV2 (weak),,,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVQSGSGLKKPGASVKVSCKASGYSFTDYAMNWVRQAPGQGLEWMGWINTNTGNPTYAQGFTGRFVFSLDTSVSTAYLQISTLKAEDTAVYYCASTVGRGSGTYYYGNYYSYSMDVWGQGTTVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGTYNYVSWYQQHPGKAPKLMIYDVSKRPSGVSNRFSGSKSGNTASLTISGLQAEDEADFYCTSYTGSSTSVVFGGGTKLTVL,IGHV7-4-1 (Human),IGHJ6 (Human),IGLV2-14 (Human),IGLJ3 (Human),ASTVGRGSGTYYYGNYYSYSMDV,TSYTGSSTSVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS155_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS157,Ab,SARS-CoV2 (weak),,,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVRKPGASVKVSCKASGYTFTSYYMHWVRQAPGQGLEWMGIINPEANSTTYAQKFQGRVTMTSDTSTSTVYLDLSSLRSEDTAVYYCARTGFLIPSKGGGMDVWGQGTTVTVSS,QSALTQPASVSGSPEQSITISCTGTSSDVGVYNYVSWYQQHPGKAPKLMIYDVSKRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSSLQIFGGGTKLTVL,IGHV1-46 (Human),IGHJ6 (Human),IGLV2-14 (Human),IGLJ3 (Human),ARTGFLIPSKGGGMDV,SSYTSSSSLQI,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS157_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS163,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGPEVKKPGASVKVSCKASGYTFTSYYVHWVRQAPGHGLEWMAIINPDAGSTSFAQRFQGRLTMTTDTSTSTVYMGLNSLRSEDTAVYYCARGGLVPAVMPALDYWGQGALVTVSS,QSVLTQPPSASGTPGQRVTISCSGSSSNIGSNYVYWYQQLPGTAPKLLIYRNNQRPSGVSDRFSGSKSGTSASLAISGLRSEDEADYYCAAWDDSLSGPVFGGGTKLTVL,IGHV1-46 (Human),IGHJ4 (Human),IGLV1-47 (Human),IGLJ3 (Human),ARGGLVPAVMPALDY,AAWDDSLSGPV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS163_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS172,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAAAGFTFSTYDMHWVRQVTGKGLEWVSALGTSGDTYYADSVKGRFTISRENAKNSLYLQMNSLRAGDTAVYYCVRSDHSSGWYGTYYYYMDVWGKGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSIRSYLNWYQQKPGKAPKLLIYGASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDIATYYCQQSYSSPPWTFGQGAKVEIK,IGHV3-13 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ1 (Human),VRSDHSSGWYGTYYYYMDV,QQSYSSPPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS172_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS173,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGDLVQPGGSLRLSCAASGITVSSNYMNWVRQAPGKGLEWISVIYSGGSTYYADSVKGRFTISRDNSKNTLFLQMNSLRAEDTAVYYCARDLDIAGAFDIWGQGTMTVSS,DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQLLNSFPITFGQGTRLEIK,IGHV3-66 (Human),IGHJ3 (Human),IGKV1-9 (Human),IGKJ5 (Human),ARDLDIAGAFDI,QLLNSFPIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS173_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS174,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRVSCAASGFAVSNNYMTWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMKSLRAEDTAVYYCARDLVVAGIDYWGQGTLVTVSS,AIQLTQSPSSLSASVGDRVTITCRASQGISNYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQLLNSDSPTFGQGTKLEIK,IGHV3-66 (Human),IGHJ4 (Human),IGKV1-9 (Human),IGKJ2 (Human),ARDLVVAGIDY,QLLNSDSPT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS174_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Mar 16, 2021",16th March: Corrected CDRL3 seq,Complete
CQTS175,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRVSCAASGFAVSNNYMTWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMKSLRAEDTAVYYCARDLVVAGIDYWGQGTLVTVSS,EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPASFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNDWPPMYTFGQGTKLEIR,IGHV3-66 (Human),IGHJ4 (Human),IGKV3-15 (Human),IGKJ2 (Human),ARDLVVAGIDY,QQYNDWPPMYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS175_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS177,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGVTVSSNYMNWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRHNSKNTLYLQMNSLRAEDTAVYYCARDLGPLGMDVWGQGTTVTVSS,DIVLTQSPGTLSLSPGERATLSCRASQSVSSSSLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFGVYYCQQYGSSPLFGQGTRLEIK,IGHV3-66 (Human),IGHJ6 (Human),IGKV3-20 (Human),IGKJ5 (Human),ARDLGPLGMDV,QQYGSSPL,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS177_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS178,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSGTLSLTCAVSGGSISSSNWWSWVRQPPGKGLEWIGEIYHSGSTYYNPSLKSRVTISVDKSKNQFSLKLSSVTAADTAVYYCARVQGLIDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQGIGNSLAWYQQKPGKAPKLLLYAASTLESGVPSRFSGSGSGTDYTLTISSLQPEDFATYYCQQYYSTPPRTFGQGTKLEIK,IGHV4-4 (Human),IGHJ4 (Human),IGKV1-NL1 (Human),IGKJ2 (Human),ARVQGLIDY,QQYYSTPPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS178_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS179,Ab,SARS-CoV2 (weak),,,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVQSGAEVKKPGESLKISCKRSGYSFTSYWIGWVRQMPGKGLEWMGIIYPGDSDTRYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCASQAAAGYYYYMDVWGKGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFAAYYCQQSYNILWTFGQGTKVEIK,IGHV5-51 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ1 (Human),ASQAAAGYYYYMDV,ASQAAAGYYYYMDV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS179_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS180,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLLESGGGLVQPGGSLRLSCAASGFTFSIFAMSWVRQAPGKGLEWVSGINGSGDNTYYADSVKGRFTISRDNSRNTLYLQMNSLRPEDTAVYYCAKQTDYGVGWFDPWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDIRNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNFSLTFGGGTKVEIK,IGHV3-23 (Human),IGHJ5 (Human),IGKV1-33 (Human),IGKJ4 (Human),AKQTDYGVGWFDP,QQYDNFSLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS180_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS185,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASRGTFSSYAISWVRQAPGQGLEWMGGIIPIFTTPNYAQNFQGRVTITADKSTSTAYMELNSLTSEDTAVYYCAVLPLHSSYNWYYFDYWGQGTLVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEAEDFAVYYCQQRSNWPPGMYTFGQGTKLEIK,IGHV1-69 (Human),IGHJ4 (Human),IGKV3-11 (Human),IGKJ2 (Human),AVLPLHSSYNWYYFDY,QQRSNWPPGMYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS185_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS186,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFSRYDMHWVRQTTGKSLEWVSAIGTAGDTYYPDSVKGRFIISRENANSSLYLQMNSLRAGDTAVYYCARGSDTVTTAFDIWGQGTMVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSFLNWYQQKPGKAPKFLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYTTPGLTFGGGTKVEIK,IGHV3-13 (Human),IGHJ3 (Human),IGKV1-39 (Human),IGKJ4 (Human),ARGSDTVTTAFDI,QQSYTTPGLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS186_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS187,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASEIIVSSNYMSWVRQAPGMGLEWVSVVYSGGSTFYADSVKGRFTISRHNSKNTLYLQMNSLRTEDTAVYYCAREAPNSRGSGTNFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSFLNWYQQKPGKAPKFLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYTTPGLTFGGGTKVEIK,IGHV3-66 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ4 (Human),AREAPNSRGSGTNFDY,QQSYTTPGLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS187_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQTS188,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLMESGGGVVQPGRSLRLSCAASGFTFSNYGMHWVRQAPGKGLEWVAVIWYDGTNEKYADSVKGRFTISRDNSKNTLYLQVNSLRAEDTAVYYCAKNGYSYAYPRQYFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSINNYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYFCQQSYSTPPYTFGQGTKLEIK,IGHV3-33 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ2 (Human),AKNGYSYAYPRQYFDY,QQSYSTPPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQTS188_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQT190,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSQTLSLTCTVSGGSISSGDYYWSWIRQHPGKGLEWIGYIFYSGSTYYNPSLKSRVIISVDTSKNQFSLKLSSVTAADTAVYYCARVSRYTMVRGVIFDYWGQGTLVTVSS,QSALTQPASVSGSPGQSITLSCTGTSSDVGSYDLVSWYQHHPGKAPKLMIYEVTKRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCCLYAGHSTYVVFGGGTKLTVL,IGHV4-31 (Human),IGHJ4 (Human),IGLV2-23 (Human),IGLJ3 (Human),ARVSRYTMVRGVIFDY,CLYAGHSTYVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQT190_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQT191,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSETLSLTCTVSGYSISSGYYWGWIRQPPGKGLEWIGSIYQSGSTYYNLSLKSRVTILVDTSKNQLSLKLSSVTAADTAVYYCARVGVATILGVDYWGQGTLVTVSS,NFMLTQPHSVSESPGKTVIISCTRSSGSIASNYVQWYQQRPGSAPTTVIYEDSLRPSGVPHRFSGSIDSSSNSASLTISGLMTEDEADYYCQSYDSSWVFGGGTKLTVL,IGHV4-38-2 (Human),IGHJ4 (Human),IGLV6-57 (Human),IGLJ3 (Human),ARVGVATILGVDY,QSYDSSWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQT191_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQT195,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVRLVESGGGVVQPGRSLRLSCAASGFTFSSFGMHWVRQAPGKGLEWVALLSYDGTNKYYADSVKGRFTISRDNSKSTLFLQMHSLRAEDTAVYFCAKGGGYISAWSTRYYAMDVWGQGTTVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGNAPKLMIYDVNNRPSGVSDRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSTWVFGGGTKLTVL,IGHV3-30 (Human),IGHJ6 (Human),IGLV2-14 (Human),IGLJ3 (Human),AKGGGYISAWSTRYYAMDV,SSYTSSSTWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQT195_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQT197,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSGISDSGGSPYYADSVKGRFTISRDNSKNTLYLQMNSLRVEDTAVYYCAESSSLTGNFNYWGQGTLVTVSS,SYVLTQPPSVSVAPGKTARITCGGNNIGSKSVHWYQQRPGQAPVLVVYDDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDTAWVFGGGTKLTVL,IGHV3-23 (Human),IGHJ4 (Human),IGLV3-21 (Human),IGLJ3 (Human),AESSSLTGNFNY,QVWDTAWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQT197_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQT198,Ab,SARS-CoV2 (weak),,,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSETLSLTCTVSGGSVSSGSYYWSWIRQPPGKGLEWIGYIYYSGSTNYNPSLTSRVTLSVDTSKNQFSLKLSSVTAADTAVYYCAREYFVSLPAAQTLYYYGIDVWGQWTTVTVSS,EIVMTQSPVTVSVSPGERATLSCRASQSVSSNLAWYQQKPGQGPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYFCQQYKNWPPWTFGQGTKVEIK,IGHV4-61 (Human),IGHJ6 (Human),IGKV3-15 (Human),IGKJ1 (Human),AREYFVSLPAAQTLYYYGIDV,QQYKNWPPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQT198_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQT199,Ab,SARS-CoV2 (weak),,,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVQSGAEVKKPGASVKVSCKASGYTFTSYDINWVRQATGQGLEWMGWMNPKSVYTGYAQKFQGRVTMTRNTSIRTAYMELSSLRSEDTAVYYCARGLWFGDLTRTKYNWFDPWGQGTLVTVSS,EIVLTQSPGTLSLSPGERAALSCRASQGVTSTYLAWYQQKPGQAPRLLIYGVSTRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCHQYDSSPLTFGGGTKVEIK,IGHV1-8 (Human),IGHJ5 (Human),IGKV3-20 (Human),IGKJ4 (Human),ARGLWFGDLTRTKYN,HQYDSSPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQT199_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQT200,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGHTFTSYLIHWVRQAPGQGLEWMGIINPSGGSTSYAQKFQGRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARDPPSGNYDNIDEWTRSENHYNYGMDAWGQGTTVTVLT,EIVLTQSPATLSLSPGERATLSCRASQSVRSFLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPYLTFGGGTKVEIK,IGHV1-46 (Human),IGHJ6 (Human),IGKV3-11 (Human),IGKJ4 (Human),ARDPPSGNYDNIDEWTRSENHYNYGMDA,QQRSNWPYLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQT200_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQT201A,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGLVKPGGSLRLSCAASGFTFSDYYMSWIRQAPGKGLEWVSYISSSSSYTNYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYFCARDGSAVAGPMSYFDYWGQGTPVTVSS,DIQMTQPPSSLSASVGDRVTITCRASQDISNSLAWYQQKPGKAPKLLLYAASRLESGVPSRFSGSGSGTDYTLTISSLQPEDFATYYCQQYYSIPRTFGQGTKVEIK,IGHV3-11 (Human),IGHJ4 (Human),IGKV1-NL1 (Human),IGKJ1 (Human),ARDGSAVAGPMSYFDY,QQYYSIPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQT201A_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQT201B,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVTLRESGPALVKPTQTLTLTCTFSGFSLSTSGMCVSWIRQPPGKALEWLARIDWDDAKYYSTSLETRLTISKDTSNNQVVLTLTNMDPVDTATYYCAREVAGAVHLDYWGQGTLVTVSS,DIQMTQSPSSLPASVGDRVTITCRASQSIRRYINWYQQKPGKAPKLLIYVASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDSAIYYCQQSFSTPRTFGQGTKVEIK,IGHV2-70 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ1 (Human),AREVAGAVHLDY,QQSFSTPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQT201B_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQT202,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYWMSWVRQAPGKGLEWVANIKQDGSEKYYVDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARDLGVLWFGDLLFSSQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQGISNSLAWYQQKPGTAPKLLLYAASTLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYYSDPPRTFGQGTKVEIK,IGHV3-7 (Human),IGHJ4 (Human),IGKV1-NL1 (Human),IGKJ1 (Human),ARDLGVLWFGDLLF,QQYYSDPPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQT202_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQT203,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSETLSLTCTVSGGSFSTYYWSWIRQPPGKGLEWIGHISYSGSTHYNPSLKGRVTISLDTSKNQFSLNLSSVTAADTAVYYCARGGYYYGPPRDFDYWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQGVSSNYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQHYGSSPQYTFGQGTKLEIR,IGHV4-59 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ2 (Human),ARGGYYYGPPRDFDY,QHYGSSPQYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQT203_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQT206,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,QITLKESGPTLVKPTQTLTLTCTFSGFSLSTSGVGVGWIRQPPGKPLEWLALIYWDDDKRYSPSLKSRLTITKDTSKNQVVLRMTNMDPVDTATYYCAHSPDHRYFDVLTGYFNSERFYFDYWGQGTLVTVSS,RSVLTQPPSVSAAPGQKVTISCSGSSSNIGNNYVSWYQQLPGTAPKVLIYDNNKRPSGIPDRFSGSKSGTSATLGITGLQTGDEADYYCGTWDSSLSAGVFGGGTKLTVL,IGHV2-5 (Human),IGHJ4 (Human),IGLV1-51 (Human),IGLJ3 (Human),AHSPDHRYFDVLTGYFNSERFYFDY,GTWDSSLSAGV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQT206_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQT209,Ab,SARS-CoV2 (weak),,,,S; RBD,B-cells; SARS-CoV2 Human Patient,QLQLQESGPGLVKPSETLSLTCTVSGGSISSSNYYWGWIRQPPGRGLEWIGSIYYSGSTYYNPSLKSRVTISVDTSKNQFSLNLSSVTAADTAVYYCARIPRHLGQDHYYYVMDVWGQGTTVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGSYNLVSWYQQHPGKAPKLMIYEGSKRPSGVSDRFSGSKSGNTASLTISGLQAEDEADYYCCSYAGIFVFGTGTKVTVL,IGHV4-39 (Human),IGHJ6 (Human),IGLV2-23 (Human),IGLJ1 (Human),ARIPRHLGQDHYYYVMDV,CSYAGIFV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQT209_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQT210,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVALISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKAAGGGYSYIYWGGDYWGQGTLVTSPH,NFMLTQPHSVSESPGKTVTISCTRSSGSIASNYVQWYQQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSSNLWVFGGGTKLTVL,IGHV3-30 (Human),IGHJ4 (Human),IGLV6-57 (Human),IGLJ3 (Human),AKAAGGGYSYIYWGGDY,QSYDSSNLWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQT210_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQT212,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYDMHWVRQATGKGLEWVSAVGTAGDTYYPGSVKGRFTISRENAKNSLYLQMNSLRAGDTAVYYCARGFDTTTGFYFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQGITNSLAWYQQKPGKAPKLLLYAASRLQSGVPSRFSGSGSGTDYTLTISSLQPEDFAVYYCQQDYNFPWTFGQGTKVEIK,IGHV3-13 (Human),IGHJ4 (Human),IGKV1-NL1 (Human),IGKJ1 (Human),ARGFDTTTGFYFDY,QQDYNFPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQT212_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQT215,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVHLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGRIIPIFDIANYAQKFQGRVTMTADKSTTTAYMELTSLRSEDTAMYYCARTEYSYDSGSSRAYSMDVWGKGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQTISNYLNWYQQKPGKAPELLIYAASNLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQTHSTPRTFGQGTKVEIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ1 (Human),ARTEYSYDSGSSRAYSMDV,QQTHSTPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQT215_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQT216,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVIWYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKGGWYSSKWYYFDYWGQGTLVTVSS,DIVMTQSPVSLPVTPGEPASMSCRSSQSLLHSNGYIYLDWYVQKPGQSPQLLFYLGSNRAPGVPVRFSASGSGTDFTLKISRVEAEDVGVYYCMQALQMGTFGQGTKVEIK,IGHV3-33 (Human),IGHJ4 (Human),IGKV2-28 (Human),IGKJ1 (Human),AKGGWYSSKWYYFDY,MQALQMGT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQT216_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQT217,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGSELKKPGASVKVSCKASGYTFTSYAMNWVRQAPGQGLEWMGWINTNTGNPTYAQGFTGRFVFSLDTSISTAYLQISSLKAEDTAVYYCARVGPSSSWPSWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISTYLNWYQQKPGKAPKLLIYVASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPRTFGQGTKVEIK,IGHV7-4-1 (Human),IGHJ5 (Human),IGKV1-39 (Human),IGKJ1 (Human),ARVGPSSSWPS,QQSYSTPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQT217_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CQT218,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFSFSSYWMSWVRQAPGKGLEWVGNIKQDGSEKYYVDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARDLGVLWFGDPYWGQGTLVTVSS,DIQMTQSPSSLSASVGDGVTITCRASQQISNSLAWYQQKPGKAPKLLLYAASTVESGVPSRFSGRGSGTDYTLTISSLLPEDFATYYCQQYYSAPRTFGQGTKVEIK,IGHV3-7 (Human),IGHJ4 (Human),IGKV1-NL1 (Human),IGKJ1 (Human),ARDLGVLWFGDPY,QQYYSAPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CQT218_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
CN111875701A,Ab,SARS-CoV2,,,,S; RBD,"Phage Display (antibody, human, non-immune)",EVQLVESGAEVKKPGESLKISCKGSGYSFTSYWIGWVRQMPGKGLEWMGIIYPGDSDTRYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARQGSHYGMDVWGQGTTVTVSS,QPVLTQPPSVSGTPGQRVTISCSGSSSNIGGNAVSWYQQLPGTAPKLLIYSNKERPSGVPDRFSGSKSGTSASLAISGLQSEDEADYYCAAWDDSLNGWVFGGGTKLTVL,IGHV5-51 (Human),IGHJ6 (Human),IGLV1-44 (Human),IGLJ3 (Human),ARQGSHYGMDV,AAWDDSLNGWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CN111875701A_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
D2,Ab,SARS-CoV2,,,,S; RBD,"Phage Display (antibody, mouse, non-immune)",EVKLQQSGGGLLKPGASVKISCKASGYAFSSYWMNWVKQRPGKGLEWIGQIYPGDGDTNYNGKFKGKATLTADKSSNTAYMQLSSLTTEDSAIYYCFTATFAMDYWGQGTSVTVST,DVVMTQSHKFMSTSVGDRVSITCKASQDVGTAVAWYQQKPGQSPKLLIYWASTRHTGVPDRFTGSGSGTDFTLTISNVQSEDLADYFCQQYSIYPYTFGGGTKLEIK,IGHV1-80 (Mouse),IGHJ4 (Mouse),IGKV6-23 (Mouse),IGKJ2 (Mouse),FTATFAMDY,QQYSIYPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/D2_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
H6,Ab,SARS-CoV2,,,,S; RBD,"Phage Display (antibody, mouse, non-immune)",EVKLLESGAELVKPGASVKLSCTASGFNIKDTYMHWVKQRPEQGLEWIGWIDPENGNTIYDPKFQGKASITADTSSNTAYMELARLTSEDSAIYYCARGGGYDPWFAYWGQGTLVTVSS,TVMTQSQKFMSTSVGDRVSVTCKASQNVGTNVAWYQQKPGQSPKLLIYWASTRHTGVPDRFTGSGSGTDFTLTISNVQSEDLAEYFCQQYNSYPYMYTFGGGTKLEIK,IGHV1-14-1 (Mouse),IGHJ3 (Mouse),IGKV6-15 (Mouse),IGKJ2 (Mouse),ARGGGYDPWFAY,QQYNSYPYMYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H6_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jan 30, 2021",N/A,Complete
DK1,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Mouse,EVQLQQSGPELVKPGASVKISCKTSGYTFTEYTMHWVKQSHGKSLEWIGGINPYNDDTNYIQKFKGKATLTVDKSSSTAYMELRSLTSEDSAVYYCARDDYDYAGAYWGQGTLVTVSA,DIVMSQSPSSLAVSVGEKVTVSCKSSQSLLYSSNQKNYLAWYQQKPGQSPKLLIYWASTRESGVPDRFTGSGSGTDFTLTISSVKAEDLAVYYCQQYYSYPLTFGAGTKLELK,IGHV1-26 (Mouse),IGHJ3 (Mouse),IGKV8-30 (Mouse),IGKJ5 (Mouse),ARDDYDYAGAY,QQYYSYPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DK1_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jul 24, 2021",22nd July: Added publication reference and corrected CDRH3 sequence,Also known as MA8 in paper. Complete
DK2,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Mouse,QVQLQQPGAELVKPGASVKMSCKASGYTFISYSMHWVKQTPGQGLEWIGAIYPGNGDTSYTQKFKGKATLTADKSSTTAYMQLSSLTSEDSAVYYCARDHGNYVLDYWGQGTTLTVSS,DIVMTQSHKFMSTSVGDRVSITCKASQDVGTAVAWYQQKPGQSPKLLIYWASTRHTGVPDRFTGSGSGTDFTLTISNVQSEDLADYFCQQYSSYPWTFGGGTKLEIK,IGHV1-12 (Mouse),IGHJ2 (Mouse),IGKV6-23 (Mouse),IGKJ1 (Mouse),ARDHGNYVLDY,QQYSSYPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DK2_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jul 24, 2021",22nd July: Added publication reference,Also known as MA7 in paper. Complete
DK4,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Mouse,EVQLQQSGPELVKPGASVKISCKTSGYTFTEYTMHWVKQRHGKSLEWIGGINPNIGDTTYNQNFKGKATLTVDKSSSTAYMELRSLTSEDSAVYYCARGATTAPFAYWGQGTLVTVSA,DIVMSQSPSSLAVSVGEKVTMSCKSSQSLLYSSNQKNYLAWYQQKPGQSPKLLIYWASTRESGVPDRFTGSGSGTDFTLTIRSVKAEDLAVYYCQQYYSYPLTFGAGTKLELK,IGHV1-26 (Mouse),IGHJ3 (Mouse),IGKV8-30 (Mouse),IGKJ5 (Mouse),ARGATTAPFAY,QQYYSYPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DK4_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jul 24, 2021",22nd July: Added publication reference,Also known as MA10 in paper. Complete
DK5,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Mouse,QVQLQQPGAELVKPGASVKMSCKASGYTFTSYSMHWVEKQTPGQGLEWIGAIYPGNGDTSYNQKFKGKATLTADKSSSTAYMQLSSLTSEDSAVYYCARDYHYDGYYVTLDYWGQGTTLTVSS,DIQMTQSPSSLSASLGERVSLTCRASQEISGYLSWLQQKPDGTIKRLIYAASTLDSGVPKRFESGSRSGSDYSLTISSLESEDFADYYCLQYASYPWTFGGGTKLEIK,IGHV1-12 (Mouse),IGHJ2 (Mouse),IGKV9-124 (Mouse),IGKJ1 (Mouse),ARDYHYDGYYVTLDY,LQYASYPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DK5_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jul 24, 2021",22nd July: Added publication reference,Could be MA2/MA11/MA13/MA14 in paper. Complete
DK6,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Mouse,QVQLQQPGTELVKPGASVKMSCKASGYTFTSYSIHWVKQTPGQGLEWIGALYPGNGDTSYNQKFKGKATLTADKSSSTAYMQLSSLTSEDSAVYYCARDYHYDGYYVTILDYWGQGTTLTVSS,DIQMTQSPSSLSASLGERVSLTCRASQEISGYLSWLQQKPDGTIKRLIYAASTLDSGVPKRFSGSRSGSDYSLTISSLESEDFADYYCLQYASYPWTFGGGTKLEIK,IGHV1-12 (Mouse),IGHJ2 (Mouse),IGKV9-124 (Mouse),IGKJ1 (Mouse),ARDYHYDGYYVTILDY,LQYASYPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DK6_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jul 24, 2021",22nd July: Added publication reference,Complete
DK7,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Mouse,QVQLQQPGAELVKPGASVKMSCKASGYTFTSYSMHWVKQTPGQGLEWIGAIYPGNGDTSYNQKFKGKATLTADKSSSTAYMQLSSLTSEDSAVYYCARDYHYDGYYVILDYWGQGTTLTVSS,DIQMTQSPSSLSASLGERVSLTCRASQEISGYLSWLQQKPDGTIKRLIYAASTLDSGVPKRFSGSRSGSDYSLTISSLESEDFADYYCLQYASYPWTFGGGTKLEIK,IGHV1-12 (Mouse),IGHJ2 (Mouse),IGKV9-124 (Mouse),IGKJ1 (Mouse),ARDYHYDGYYVILDY,LQYASYPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DK7_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jul 24, 2021",22nd July: Added publication reference,Complete
DK8,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,Immunised Mouse,EVMLVESGGDLVKPGGSLKLSCAASGETESGYAMSWVRQTPEKRLEWVATISSGGSYTYYPDSVKGRETISRDNAKNILYLQMSSLRSEDTAMYYCARHDGNYVDYAMDYWGQGTSVTVSS,QLVLTQSPAIMSASLGEEITLTCSASSSVSYMHWYQQKSGTSPKLLIYTTSNLASGVPSRFSGSGSGTFYSLTISSVEAEDAADYYCHQWSCWTFGGGTKLEIK,IGHV5-9-1 (Mouse),IGHJ4 (Mouse),IGKV4-80 (Mouse),IGKJ1 (Mouse),ARHDGNYVDYAMDY,HQWSCWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DK8_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jul 24, 2021",22nd July: Added publication reference,Also known as MA16 in paper. Complete
DK9,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Mouse,EVQLQQSGPELVKPGASVKISCKTSGYTETEYTMHWVKQSHGKSLEWIGGINPNNGDTIYNQKFKGKATLTVDKSSSTAYMELRSLTSEDSAVYCCAREDYGSSYAYWGQGTLVTVSA,DIVMSQSPSSLAVSVGEKVTMSCKSSQSLLYNSNQKKYLAWYQQKPGQSPKLLTYWASTRESGVPDRFTGSGSGTDFTLTISSVKAEDLAIYYCQQYYSYPLTFGAGTKLELK,IGHV1-26 (Mouse),IGHJ3 (Mouse),IGKV8-30 (Mouse),IGKJ5 (Mouse),AREDYGSSYAY,QQYYSYPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DK9_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jul 24, 2021",22nd July: Added publication reference,Also known as MA3 in paper. Complete
DK10,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Mouse,QVQLQQPGAELVKPGASVKMSCKASGYTFTSYSMHWVKQTPGQGLEWIGAIYPGNGDTSYTQKEKGKATLTADKSSSTAYMQLNSLTSEDSAVYYCARDYHYDGYYVILDYWGQGTTLTVSS,DIQMTQSPSSLSASLGERVSLTCRASQEISGYLSWLQQKPDGTIKRLIYAASTLDSGVPKRFSGSRSGSDYSLTISSLESEDFADYYCLQYASYPWTFGGGTKLEIK,IGHV1-12 (Mouse),IGHJ2 (Mouse),IGKV9-124 (Mouse),IGKJ1 (Mouse),ARDYHYDGYYVILDY,LQYASYPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DK10_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jul 24, 2021",22nd July: Added publication reference,Complete
DK11,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Mouse,EVQLQQSGPELVKPGASVKISCKASGYSFTGYFMNWVKQSHGKSLEWIGRINPYNGDTFYNQKFKGKATLTVDKSSSTAHMELLSLTSEDSAVYYCGRGYLDYWGQGTTLTVSS,DIVMTQSHKFMSTSVGDRVSITCKASQDVSTAVAWYQQKPGQSPKLLIFSASYRYTGVPDRFTGSGSGTDFTFTISSVQAEDLAVYYCQEHYSNPYTFGGGTKLEIK,IGHV1-37 (Mouse),IGHJ2 (Mouse),IGKV6-17 (Mouse),IGKJ2 (Mouse),GRGYLDY,QEHYSNPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DK11_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jul 24, 2021",22nd July: Added publication reference,Also known as MA9 in paper. Complete
DK12,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,Immunised Mouse,EVMLVESGGGLVKPGGSLKLSCAASGFMFSRYAMSWVRQTPEKRLEWVATISSGGSYTYYPDSVKGRFTMSRDNAKNTLYLQMSSLRSEDTAMYNCARHDGNYVDYAMDYWGQGTSVTVSS,QIVLTQSPAIMSASLGEEITLTCSASSSVSHMHWYQQKSGTSPKLLIYSTFNLASGVPSRFSGSGSGTFYSLTISSVEAEDAADYYCHQWSSWTFGGGTKLEIK,IGHV5-9-1 (Mouse),IGHJ4 (Mouse),IGKV4-80 (Mouse),IGKJ1 (Mouse),ARHDGNYVDYAMDY,HQWSSWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DK12_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jul 24, 2021",22nd July: Added publication reference,Also known as MA5 in paper. Complete
DK13,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,Immunised Mouse,QVQLKQSGPGLVQPSQSLSITCTVSGFSLTSYGVHWVRQSPGKGLEWLGVIWSGGNTDYNAAFISRLSISKDNSKSQVFFKMNSLQANDTAIYYCARNRYGSAMDYWGQGTSVTVSS,DVVLTQTPLSLPVNIGDQASISCKSTKRLLNSDGFTFLDWYLQKPGQSPQLLIYLVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDLGVYYCFQSHYLPLTFGAGTKLELK,IGHV2-2 (Mouse),IGHJ4 (Mouse),IGKV1-99 (Mouse),IGKJ5 (Mouse),ARNRYGSAMDY,FQSHYLPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DK13_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jul 24, 2021",22nd July: Added publication reference,Also known as MA6 in paper. Complete
DK14,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Mouse,QVQLQQPGAELVKPGASVKLSCKASGYTFISYWMHWVKQRPGQGLEWIGEIDPSDSYTNSNQKFKGKATLTVDKSSSTAYMQLSSLTSEDSAVYYCARSELWAMDYWGQGTSVTVSS,DIVMTQAAFSNPVTLGTSASISCRSSKSLLHSHGITYLYWYLQKPGQSPQLLIYQMSNLASGVPDRFSSSGSGTDFTLRISRVEAEDVGVYYCAQNLELPWTFGGGTKLEIR,IGHV1-69 (Mouse),IGHJ4 (Mouse),IGKV2-109 (Mouse),IGKJ1 (Mouse),ARSELWAMDY,AQNLELPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DK14_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jul 24, 2021",22nd July: Added publication reference,Either MA12 or MA15 in paper. Complete
DK15,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Mouse,QVQLQQPGAEFVMPGASVKMSCKASGYTFTDYWMHWVKQRPGQGLEWIGAIDTSDTYTRYNQKFKDKATLTVDESSSTAYMQLSSLTSEDSAVYYCARFLYYYGNPTFDYWGQGTTLTVSS,DVQITQSPSYLAASPGETITINCRASKSISKYLAWYQEKPGKTNKLLIYSGSTLQSGIPSRFSGSGSGTDFTLTISSLEPEDFAMYYCQQHNEYPLTFGAGTKLELK,IGHV1-69 (Mouse),IGHJ2 (Mouse),IGKV16-104 (Mouse),IGKJ5 (Mouse),ARFLYYYGNPTFDY,QQHNEYPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DK15_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jul 24, 2021",22nd July: Added publication reference,Also known as MA17 in paper. Complete
DK16,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,Immunised Mouse,QVQLKESGPGLVAPSQSLSITCTVSGFSLSDYSISWIRQPPGKGLEWLGVIWGGGSTYYNSALKSRLSISKDNSKSQVELKMNSLQTDDTAMYYCAKHPLYYGSNSDGYYAMDYWGQGTSVTVSS,DIVMTQSHKFMSTSVGDRVSITCKASQDVGIVVAWYQQKPGQSPKLLIYWASTRHTGVPDRFTGSGSGTDFTLTISNVQSEDLADYFCQQYSSYPLTFGGGTKLEIK,IGHV2-6-5 (Mouse),IGHJ4 (Mouse),IGKV6-23 (Mouse),IGKJ1 (Mouse),AKHPLYYGSNSDGYYAMDY,QQYSSYPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DK16_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jul 24, 2021",22nd July: Added publication reference,Also known as MA1 in paper. Complete
DK17,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,Immunised Mouse,QVQLQQPGAELVRPGASVKLSCKASGYTFISYWIHWVKQRPGQGLEWIGEIDPSDSYSNYNQNFKGKATLTVDKSSSTAYMQLSSLTSEDSAVYYCARSELWAMDYWGQGTSVTVSS,DIVMTQAAFSNPVTLGTSASISCRSSKSLLHSHGITYLYWYLQKPGQSPQLLIYQMSNLASGVPDRFSSSGSGTDFTLRISRVEAEDVGVYYCAQNLELPWTFGGGTKLEI,IGHV1-69 (Mouse),IGHJ4 (Mouse),IGKV2-109 (Mouse),IGKJ1 (Mouse),ARSELWAMDY,AQNLELPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DK17_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 30, 2021","Jul 24, 2021",22nd July: Added publication reference,Either MA12 or MA15 in paper. Complete
XG001,Ab,SARS-CoV2,,,SARS-CoV2,S; S2,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV4-59 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ1 (Human),ARGFDY,QQFGSSPWT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 19, 2021","Jan 19, 2021",N/A,Mutation data in Table S1. MTA required for full sequence. Complete
XG002,Ab,SARS-CoV2,,,SARS-CoV2,S; S2,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV4-59 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ1 (Human),ARGFDF,QQHSSSPWT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 19, 2021","Jan 19, 2021",N/A,Mutation data in Table S1. MTA required for full sequence. Complete
XG003,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV2-70 (Human),IGHJ4 (Human),IGLV2-11 (Human),IGLJ2 (Human),ARMIVTTSTYFDY,CSYAGSYSVL,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 19, 2021","Jan 19, 2021",N/A,Mutation data in Table S1. May be associated with ADE. MTA required for full sequence. Complete
XG004,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV2-70 (Human),IGHJ4 (Human),IGLV2-11 (Human),IGLJ2 (Human),ARMIVTTSTYFDY,CSYAGSYTVV,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 19, 2021","Jan 19, 2021",N/A,Mutation data in Table S1. May be associated with ADE. MTA required for full sequence. Complete
XG005,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV2-5 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ2 (Human),ARLTAADTIFDC,SSYTTTSVV,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 19, 2021","Jan 19, 2021",N/A,Mutation data in Table S1. May be associated with ADE. MTA required for full sequence. Complete
XG006,Ab,SARS-CoV2,,SARS-CoV2,,S1; non-RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV1-24 (Human),IGHJ5 (Human),IGLV1-51 (Human),IGLJ2 (Human),ATTTVHCSGGSCSSYWFDP,GTWDSSLSVVV,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 19, 2021","Jan 19, 2021",N/A,Mutation data in Table S1. May be associated with ADE. MTA required for full sequence. Complete
XG007,Ab,SARS-CoV2,,,SARS-CoV2,S1; non-RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV3-11 (Human),IGHJ4 (Human),IGKV3-15 (Human),IGKJ1 (Human),VRGALLLWFGELSAEPFDY,VQYNAWPPV,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 19, 2021","Jan 19, 2021",N/A,Mutation data in Table S1. MTA required for full sequence. Complete
XG008,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV1-69 (Human),IGHJ4 (Human),IGLV2-23 (Human),IGLJ2 (Human),ARDAPDYDFWSGRPRYFDS,CSYAGSTTVV,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 19, 2021","Jan 19, 2021",N/A,Mutation data in Table S1. MTA required for full sequence. Complete
XG009,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV1-8 (Human),IGHJ5 (Human),IGKV1-9 (Human),IGKJ4 (Human),ARGGRYCSGGSCFSGIWFDP,QQLNSYPSS,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 19, 2021","Jan 19, 2021",N/A,Mutation data in Table S1. May be associated with ADE. MTA required for full sequence. Complete
XG010,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV4-59 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ1 (Human),ASDYSDSTGYYYGFDH,QQYGNSPDRT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 19, 2021","Jan 19, 2021",N/A,Mutation data in Table S1. MTA required for full sequence. Complete
XG011,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV3-13 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ2 (Human),ARVKFRFLEWFLDV,QQSYSNPQYT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 19, 2021","Jan 19, 2021",N/A,Mutation data in Table S1. MTA required for full sequence. Complete
XG012,Ab,SARS-CoV2,,SARS-CoV2,,S; S2,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV4-34 (Human),IGHJ2 (Human),IGKV3-20 (Human),IGKJ2 (Human),ARGVGWFYYWYFDL,QQYGSSPPNT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 19, 2021","Jan 19, 2021",N/A,Mutation data in Table S1. MTA required for full sequence. Complete
XG013,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV2-70 (Human),IGHJ4 (Human),IGLV1-44 (Human),IGLJ1 (Human),ARMRVGGYDSYFDY,AAWDDSLNGYV,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 19, 2021","Jan 19, 2021",N/A,Mutation data in Table S1. May be associated with ADE. MTA required for full sequence. Complete
XG014,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV5-51 (Human),IGHJ6 (Human),IGLV1-51 (Human),IGLJ3 (Human),TRHQYGYNYGYFYYYIDV,GTWHTSLSSGV,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 19, 2021","Jan 19, 2021",N/A,Mutation data in Table S1. MTA required for full sequence. Complete
XG015,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV4-4 (Human),IGHJ4 (Human),IGLV2-23 (Human),IGLJ3 (Human),ARRTGYCGSTSCYNFDH,CSYVGSVL,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 19, 2021","Jan 19, 2021",N/A,Mutation data in Table S1. MTA required for full sequence. Complete
XG016,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV2-5 (Human),IGHJ4 (Human),IGKV1-5 (Human),IGKJ3 (Human),AHYSSSSLYFAY,QQYNSYFT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 19, 2021","Jan 19, 2021",N/A,Mutation data in Table S1. May be associated with ADE. MTA required for full sequence. Complete
XG017,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV3-66 (Human),IGHJ4 (Human),IGLV2-8 (Human),IGLJ3 (Human),ARGEGWDLPFDF,SSYAGSNNLM,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 19, 2021","Jan 19, 2021",N/A,Mutation data in Table S1. MTA required for full sequence. Complete
XG018,Ab,SARS-CoV2,,,SARS-CoV2,S1; non-RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV3-11 (Human),IGHJ4 (Human),IGKV3-15 (Human),IGKJ1 (Human),ARDVSSDWRRGYFDY,HQYNNWPRT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 19, 2021","Jan 19, 2021",N/A,Mutation data in Table S1. MTA required for full sequence. Complete
XG019,Ab,SARS-CoV2,,,SARS-CoV2,S1; non-RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV4-59 (Human),IGHJ6 (Human),IGKV3-15 (Human),IGKJ3 (Human),ARALDPHSRSYYMDV,QQYNNWPPSFT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 19, 2021","Jan 19, 2021",N/A,Mutation data in Table S1. MTA required for full sequence. Complete
XG020,Ab,SARS-CoV2,,,SARS-CoV2,S; Unk,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV3-30 (Human),IGHJ3 (Human),IGLV1-40 (Human),IGLJ2 (Human),ARVYGGNYFNGFDI,QSFDSSLSGVV,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 19, 2021","Jan 19, 2021",N/A,Mutation data in Table S1. MTA required for full sequence. Complete
XG021,Ab,SARS-CoV2,,,,S; Unk,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV1-69 (Human),IGHJ6 (Human),IGKV3-11 (Human),IGKJ1 (Human),ARDGSNSRENRVSYMDV,HQRSDWPWT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 19, 2021","Jan 19, 2021",N/A,Mutation data in Table S1. MTA required for full sequence. Complete
XG022,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV3-43 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ4 (Human),GRDLYRRISGYFGTTFDY,QQSYSTPPFA,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 19, 2021","Jan 19, 2021",N/A,Mutation data in Table S1. MTA required for full sequence. Complete
XG023,Ab,SARS-CoV2,,,SARS-CoV2,S; Unk,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV1-69 (Human),IGHJ1 (Human),IGLV2-11 (Human),IGLJ1 (Human),ATHYYDSSVYYDEFQADYFHY,CSYAGRYVYV,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 19, 2021","Jan 19, 2021",N/A,Mutation data in Table S1. MTA required for full sequence. Complete
XG024,Ab,SARS-CoV2,,,SARS-CoV2,S1; non-RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV4-39 (Human),IGHJ2 (Human),IGLV3-19 (Human),IGLJ2 (Human),ARPVGEVYNSGLDVDYWYFDL,GSRDNSGNPV,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 19, 2021","Jan 19, 2021",N/A,Mutation data in Table S1. MTA required for full sequence. Complete
XG025,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV3-33 (Human),IGHJ3 (Human),IGKV1-33 (Human),IGKJ4 (Human),ARGRIGNSMIVDVTGEDAFDI,QQNDNLPLT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 19, 2021","Jan 19, 2021",N/A,Mutation data in Table S1. MTA required for full sequence. Complete
XG026,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV4-39 (Human),IGHJ4 (Human),IGLV2-23 (Human),IGLJ2 (Human),ARLCRFVVIATASFDY,CSYAGSNVL,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 19, 2021","Jan 19, 2021",N/A,Mutation data in Table S1. MTA required for full sequence. Complete
XG027,Ab,SARS-CoV2,,,,S1; non-RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV3-15 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ1 (Human),TTESEGYSYGYEDFDY,QLYGSSLRT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 19, 2021","Jan 19, 2021",N/A,Mutation data in Table S1. MTA required for full sequence. Complete
XG028,Ab,SARS-CoV2,,SARS-CoV2,,S1; non-RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV3-21 (Human),IGHJ3 (Human),IGKV3-15 (Human),IGKJ1 (Human),VRARMNYYDSKGYYPDAFDI,QQYYNWPPWT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 19, 2021","Jan 19, 2021",N/A,Mutation data in Table S1. MTA required for full sequence. Complete
XG029,Ab,SARS-CoV2,,,SARS-CoV2,S1; non-RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV1-24 (Human),IGHJ4 (Human),IGLV1-40 (Human),IGLJ3 (Human),ATDYAAVQLGLAF,QSYDSGLRGWV,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 19, 2021","Jan 19, 2021",N/A,Mutation data in Table S1. MTA required for full sequence. Complete
XG030,Ab,SARS-CoV2,,SARS-CoV2,,S1; non-RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV1-24 (Human),IGHJ5 (Human),IGLV1-51 (Human),IGLJ2 (Human),ATSSPFTSYNWFDP,GTWDSSLSTVV,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 19, 2021","Jan 19, 2021",N/A,Mutation data in Table S1. MTA required for full sequence. Complete
XG031,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV2-5 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ2 (Human),AHRCVDTAVLAFDY,SSFTSSSAYVL,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 19, 2021","Jan 19, 2021",N/A,Mutation data in Table S1. May be associated with ADE. MTA required for full sequence. Complete
XG032,Ab,SARS-CoV2,,,SARS-CoV2,S; Unk,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV1-69 (Human),IGHJ6 (Human),IGLV2-11 (Human),IGLJ2 (Human),ARGLGSLDYYYMDV,CSYAGTYTFL,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 19, 2021","Jan 19, 2021",N/A,Mutation data in Table S1. MTA required for full sequence. Complete
XG033,Ab,SARS-CoV2,,,SARS-CoV2,S1; non-RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV3-33 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ1 (Human),ARDGGFTGYPYFEN,QQYGSSPQWT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 19, 2021","Jan 19, 2021",N/A,Mutation data in Table S1. MTA required for full sequence. Complete
XG034,Ab,SARS-CoV2,,,,S; Unk,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV4-39 (Human),IGHJ4 (Human),IGKV2-28 (Human),IGKJ5 (Human),ARSGIVAVPAAIWPVDY,MQALQTPIT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 19, 2021","Jan 19, 2021",N/A,Mutation data in Table S1. MTA required for full sequence. Complete
XG035,Ab,SARS-CoV2,,SARS-CoV2,,S1; non-RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV4-39 (Human),IGHJ5 (Human),IGLV1-40 (Human),IGLJ3 (Human),ARPIAVYQVLKQHNNWFDP,QSYDSSLSAPE,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 19, 2021","Jan 19, 2021",N/A,Mutation data in Table S1. MTA required for full sequence. Complete
XG036,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV1-69 (Human),IGHJ5 (Human),IGLV1-40 (Human),IGLJ3 (Human),ARERVYSGSGAAYWFDP,QSYDSSVSGSV,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 19, 2021","Jan 19, 2021",N/A,Mutation data in Table S1. MTA required for full sequence. Complete
XG037,Ab,SARS-CoV2,,,SARS-CoV2,S; Unk,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV3-30 (Human),IGHJ4 (Human),IGLV2-11 (Human),IGLJ2 (Human),ARDHHRRPDND,RSYAGTYTLGV,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 19, 2021","Jan 19, 2021",N/A,Mutation data in Table S1. MTA required for full sequence. Complete
XG038,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV1-18 (Human),IGHJ4 (Human),IGLV2-23 (Human),IGLJ3 (Human),ARDLELGGAFDY,CAYAGSSTWV,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 19, 2021","Jan 19, 2021",N/A,Mutation data in Table S1. MTA required for full sequence. Complete
XG039,Ab,SARS-CoV2,,,,S; Unk,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV4-39 (Human),IGHJ4 (Human),IGLV2-23 (Human),IGLJ3 (Human),ARMSGSGNYNLADYHFDS,CSYAGSRTWV,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 19, 2021","Jan 19, 2021",N/A,Mutation data in Table S1. MTA required for full sequence. Complete
XG040,Ab,SARS-CoV2,,,SARS-CoV2,S; Unk,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV3-7 (Human),IGHJ6 (Human),IGLV3-19 (Human),IGLJ3 (Human),ARIKIVVEPPGGGVFQGYYYNYYMDV,NSRDSSGKELNWV,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 19, 2021","Jan 19, 2021",N/A,Mutation data in Table S1. MTA required for full sequence. Complete
XG041,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV1-46 (Human),IGHJ5 (Human),IGLV3-21 (Human),IGLJ3 (Human),ARSRVAPSEDWFDP,QVWESSSGHYWV,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 19, 2021","Jan 19, 2021",N/A,Mutation data in Table S1. MTA required for full sequence. Complete
XG042,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV1-69 (Human),IGHJ4 (Human),IGLV2-11 (Human),IGLJ2 (Human),ARGGGTLTGTTAFDY,CSYAGRYTVI,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 19, 2021","Jan 19, 2021",N/A,Mutation data in Table S1. MTA required for full sequence. Complete
XG043,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV3-20 (Human),IGHJ6 (Human),IGLV2-14 (Human),IGLJ2 (Human),ARVGSTIFGVVRRNYYYYMDV,SSYTRSSTLV,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 19, 2021","Jan 19, 2021",N/A,Mutation data in Table S1. May be associated with ADE. MTA required for full sequence. Complete
XG044,Ab,SARS-CoV2,,,SARS-CoV2,S; Unk,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV3-30 (Human),IGHJ3 (Human),IGLV1-40 (Human),IGLJ2 (Human),ARVYGGNYFNGFDI,QSFDTSLSGVI,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 19, 2021","Jan 19, 2021",N/A,Mutation data in Table S1. MTA required for full sequence. Complete
XG045,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV3-30 (Human),IGHJ4 (Human),IGKV4-1 (Human),IGKJ1 (Human),ARPHTGNYYDYFDF,QQYFSPPWT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 19, 2021","Jan 19, 2021",N/A,Mutation data in Table S1. MTA required for full sequence. Complete
XG046,Ab,SARS-CoV2,,,SARS-CoV2,S; S2,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV4-59 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ4 (Human),ALGPLGYYYYYMDV,QQSSSTLT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 19, 2021","Jan 19, 2021",N/A,Mutation data in Table S1. MTA required for full sequence. Complete
XG047,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV4-59 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ2 (Human),ARLPLFSAFDY,QQYGSSPYT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 19, 2021","Jan 19, 2021",N/A,Mutation data in Table S1. MTA required for full sequence. Complete
Fab1-17,Ab,SARS-CoV2,,SARS-CoV2,,S; NTD,B-cells; SARS-CoV2 Human Patient,ND,SYELTQPPSVSVSPGQTARITCSGDALPKEYAYWYQQKPGQAPVLVIYKDSERPSGIPERFSGSSSGTTVTLTISGVQAEDEADYYCQSTDSSNTYVIFGGGTKLTVL,ND,ND,IGLV3-25 (Human),ND,ND,QSTDSSNTYVI,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 12, 2021","Jan 12, 2021",N/A,Awaiting release of sequence data in GenBank
46472-1,Ab,SARS-CoV2;SARS-CoV1,HKU1;OC43,,SARS-CoV2,S; S2,B-cells; SARS-CoV1 Human Patient,ND,ND,IGHV1-69 (Human),ND,IGKV3-15 (Human),ND,AREVNYYSAFDD,QQYNFWWT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 11, 2021","May 27, 2021",27th May '21: Added new publication,Awaiting release of sequence data in GenBank
46472-2,Ab,SARS-CoV2;SARS-CoV1;HKU1 (weak),OC43,,SARS-CoV2,S; S2,B-cells; SARS-CoV1 Human Patient,ND,ND,IGHV5-10 (Human),ND,IGLV6-57 (Human),ND,AAGPTGYDLLTGQYFPYFNY,QSYHGSDVV,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 11, 2021","May 27, 2021",27th May '21: Added new publication,Awaiting release of sequence data in GenBank
46472-3,Ab,SARS-CoV2;SARS-CoV1;HKU1 (weak),OC43,,SARS-CoV2,S; S2,B-cells; SARS-CoV1 Human Patient,ND,ND,IGHV3-30 (Human),ND,IGLV3-19 (Human),ND,ARDRSATYYGPFDY,NSRDNSGNHPVI,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 11, 2021","May 27, 2021",27th May '21: Added new publication,Awaiting release of sequence data in GenBank
46472-4,Ab,SARS-CoV2;SARS-CoV1;HKU1 (weak),OC43,,SARS-CoV2,S; S2,B-cells; SARS-CoV1 Human Patient,ND,ND,IGHV3-23 (Human),ND,IGKV1-39 (Human),ND,AKDLLSHSGTYSAGSTFDY,QESYSTNT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 11, 2021","May 27, 2021",27th May '21: Added new publication,Awaiting release of sequence data in GenBank
46472-6,Ab,SARS-CoV2;SARS-CoV1;OC43;HKU1,,,SARS-CoV2,S; NTD,B-cells; SARS-CoV1 Human Patient,ND,ND,IGHV4-39 (Human),ND,IGKV4-1 (Human),ND,ARRPQYLLLSMTTGRRHHDFVMDV,QQYYNTPRT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 11, 2021","May 27, 2021",27th May '21: Added new publication,Awaiting release of sequence data in GenBank
46472-12,Ab,SARS-CoV2;SARS-CoV1;OC43;HKU1,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV1 Human Patient,ND,ND,IGHV1-8 (Human),ND,IGKV1-39 (Human),ND,ARDRVERTGNVGFGYYAMDV,QQTYSSPSYT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 11, 2021","May 27, 2021",27th May '21: Added new publication,Awaiting release of sequence data in GenBank
CM17,Ab,SARS-CoV2,,SARS-CoV2,,S; NTD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVQKPGASVKVSCKVSGYTLPELSMHWVRQAPGKGLEWMGGFDPEDGETFYAQKFQGRVTMTEDSSTDTAYMELSSLGSEDTAVYYCATAAAVRGRGTIDYWGQGTLVTVSS,QSVVTQPPSVSAAPGQKVTISCSGSSSNIGSNYVSWYRQLPGTVPRLLIYDNNKRPSGIPNRFSGSNSGTSATLAIAGLQTGDEADYYCATWDSSLNSGVFGGGTKVTVL,IGHV1-24 (Human),IGHJ4 (Human),IGLV1-51 (Human),IGLJ6 (Human),ATAAAVRGRGTIDY,ATWDSSLNSGV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CM17_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 11, 2021","May 27, 2021",27th May '21: Added new publication and data,Complete
CM25,Ab,SARS-CoV2,,SARS-CoV2,,S; NTD,B-cells; SARS-CoV2 Human Patient,VQLVQSGAEVKKPGASVKVSCKVSGYTLTELSMHWVRQAPGKGLEWMGGFDPEDGETIYAQKFQGRVTMTEDTSTDTAYMELSSLRSEDTAVYYCATGPAVRRGSWFDPWGQGTLVTVSS,VVTQPPSVSAAPGQKVTISCSGSSSNIGNNYVSWYQQLPGTAPKLLIYDNNKRPSGIPDRFSGSKSGTSATLGITGLQTGDEADYYCGTWDSSLSAHWVFGGGTKLTVL,IGHV1-24 (Human),IGHJ5 (Human),IGLV1-51 (Human),IGLJ3 (Human),ATGPAVRRGSWFDP,GTWDSSLSAHWV,https://www.rcsb.org/structure/7M8J,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 11, 2021","May 27, 2021",27th May '21: Added new publication and data,Complete
CM58,Ab,SARS-CoV2,,SARS-CoV2,,S; NTD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKVSGYTLTELSMHWVRQAPGKGLEWMGGFDPEDGETIYAQKFQGRVTMTEDTSTDTAYMELSSLRSEDTAVYYCATGPVRGVIGWFDPWGQGTLVTVSS,QSVLTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSTLVVFGGGTKLTVL,IGHV1-24 (Human),IGHJ5 (Human),IGLV2-14 (Human),IGLJ3 (Human),ATGPVRGVIGWFDP,SSYTSSSTLVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CM58_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 11, 2021","May 27, 2021",27th May '21: Added new publication and data,Complete
CN111825762A-B4,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLQASGGGLVQTGGSLRLSCASSGRAFTLNEVGWYRQAPGKQRELVATITRGGDINYADSVKDRFTITRDNARNTLYLQMTNLKSEDTAVYYCAPRNGSPSVFEILLVSVYWGKGTQVTVSS,N/A,IGHV3S53 (Alpaca),IGHJ7 (Alpaca),N/A,N/A,APRNGSPSVFEILLVSVY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CN111825762A-B4_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 11, 2021","Jan 11, 2021",N/A,Complete
CN111825762A-B6,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",DVQLQASGGGLVQGGGSLRVSCTYSGRTFSRNIMGWFRQSPGKTREFVAAIGWSRVTTLYADSVKGRFTISRDNAKNTMYLQMNSLKPEDTAVYYCASGAVPAHQIGFRSTTLYWGKGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ7 (Alpaca),N/A,N/A,ASGAVPAHQIGFRSTTLY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CN111825762A-B6_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 11, 2021","Jan 11, 2021",N/A,Complete
CN111825762A-B9,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLQASGGGLVQAGGSLRLSCAASGVIFSLNYMGWYRQAAGKGRELVATINRSGGASYGDSVKGRFTISRDNAKNTVDLQMNSLKPEDTAVYYCANVIGTVNAYGAASKPAYWGKGTQVTVSS,N/A,IGHV3S53 (Alpaca),IGHJ7 (Alpaca),N/A,N/A,ANVIGTVNAYGAASKPAY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CN111825762A-B9_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 11, 2021","Jan 11, 2021",N/A,Complete
CN111825762A-E3,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLQASGGGWVQPGGSLRLSCAASGFTFSSYAMTWVRQALGKGLEWVSDINYGGHTSYADSVKGRFTISRDNAKNTLYLQMNSLKPEDTAVYYCAAVAMLPFLTAVTPRPGYWGKGTQVTVSS,N/A,IGHV3S1 (Alpaca),IGHJ7 (Alpaca),N/A,N/A,AAVAMLPFLTAVTPRPGY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CN111825762A-E3_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 11, 2021","Jan 11, 2021",N/A,Complete
CN111825762A-E6,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",DVQLVESGGGLVQPGGSLPLSCAASGFIFDNYAMSWVRQAPGKGLEWVSKLHTGVLNTYYANSVKGRFTISTDNAKNTLYLQMNSLQSEDTAVYYCAFGPAPKPQNVLTTALPYWGKGTQVTVSS,N/A,IGHV3S1 (Alpaca),IGHJ7 (Alpaca),N/A,N/A,AFGPAPKPQNVLTTALPY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CN111825762A-E6_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 11, 2021","Jan 11, 2021",N/A,Complete
CN111825762A-E7,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",DVQLQASGGGLVQPGGSLRLSCAASRFTFSTYWMYWVRQAPGKGLEWVSGFNIGGGSTYYADSVKGRFTIFGDNAKNTLYLQMNNLKPEDTAVYYCAPLLASAFVLMYGSRHLYWGKGTQVTVSS,N/A,IGHV3S1 (Alpaca),IGHJ7 (Alpaca),N/A,N/A,APLLASAFVLMYGSRHLY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CN111825762A-E7_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 11, 2021","Jan 11, 2021",N/A,Complete
CN111825762A-F4,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQPGGSLRLSCAASGFTFSAYAMSWVRQAPGKGLEWVSAIHSGGDNTNYAESVKGRFTISRDNAKNTLYLQMNSLKPEDTAVYYCAPGPGFTTMDRSQARIAYWGKGTQVTVSS,N/A,IGHV3S1 (Alpaca),IGHJ7 (Alpaca),N/A,N/A,APGPGFTTMDRSQARIAY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CN111825762A-F4_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 11, 2021","Jan 11, 2021",N/A,Complete
CN111825762A-F5,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQPGGSLRLSCAASGFTFDDYGMSWVRQAPGKGLEWVSSIYSYISNSYYADSVKGRFTGSTDNAKNTLYLQMNSLKSEDTAVYYCAHRFQTRVRTTNPIESEYWGKGTQVTVSS,N/A,IGHV3S1 (Alpaca),IGHJ7 (Alpaca),N/A,N/A,AHRFQTRVRTTNPIESEY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CN111825762A-F5_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 11, 2021","Jan 11, 2021",N/A,Complete
CN111825762A-F8,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLQASGGGLVQAGGSLRLSCASTGSIFSGDVDGVGWFRRAPGKERELLARIRDGGTTYYADSVKGRFTISGDDAMNTVYLQMNSLKPEDTAVYYCAFGHTHMVRPGSTVMIMYWDKGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ7 (Alpaca),N/A,N/A,AFGHTHMVRPGSTVMIMY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CN111825762A-F8_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 11, 2021","Jan 11, 2021",N/A,Complete
CN111825762A-G2,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQPGGSLRLSCAASGFTFSSADMSWVRQAPGKGPEWVSVIESSGSTYYAESVKGRFTISRDNAKNTVYLQMNNLKPEDTAVYYCAYVVPYAIAAGAPDQIGYWGKGTQVTVSS,N/A,IGHV3S1 (Alpaca),IGHJ7 (Alpaca),N/A,N/A,AYVVPYAIAAGAPDQIGY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CN111825762A-G2_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 11, 2021","Jan 11, 2021",N/A,Complete
CN111825762A-G5,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLAESGGGLVQPGGSLRLSCAASGFALSSNWMYWVRQAPGKGLEWVTLIRPTNGNKDYVDSVKGRFTISRDDAKNTLYLQMNSLKSEDTAVYYCAPRVRLKVRFQDRVMVTYWGKGTQVTVSS,N/A,IGHV3S1 (Alpaca),IGHJ7 (Alpaca),N/A,N/A,APRVRLKVRFQDRVMVTY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CN111825762A-G5_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 11, 2021","Jan 11, 2021",N/A,Complete
CN111825762A-A1,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",EVQLLESGGGLVQPGGSLRLSCAASGSTSSSYAMSWVRQAPGKGLEWVSAISSGGSRTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAALASSGYSRDYGAYDYWGQGTLVTVSS,N/A,IGHV3S1 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AALASSGYSRDYGAYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CN111825762A-A1_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 11, 2021","Jan 11, 2021",N/A,Complete
CN111825762A-F1,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",EVQLLESGGGLVQPGGSLRLSCAASGSTFSSNAMSWVRQAPGKGLEWVSAINWGSSSTNYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAAYLSSSRSGDYYWGQGTLVTVSS,N/A,IGHV3S1 (Alpaca),IGHJ5 (Alpaca),N/A,N/A,AAYLSSSRSGDYY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CN111825762A-F1_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 11, 2021","Jan 11, 2021",N/A,Complete
CN111825762A-G3,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLQESGGGLVQAGGSLRLSCAASGYTNSRYYMGWFRQAPGKEREFVAAISAIGRTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAASDRLSGLRSYGYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AASDRLSGLRSYGY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CN111825762A-G3_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 11, 2021","Jan 11, 2021",N/A,Also sequence of C7 and D4 from the patent. Complete
CN111825762A-H3,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",HVQLVESGGGLVQPGGSLRLSCAASGFTFNSYDFTWVRQAPGKGLEWVSAITANGGSTFYAGSVKGRFTVSRDNAKNVVSLQMSSLTLEDTAVYYCARTSEARYRGYPRFRVMFYWGKGTQVTVSS,N/A,IGHV3S1 (Alpaca),IGHJ7 (Alpaca),N/A,N/A,ARTSEARYRGYPRFRVMFY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CN111825762A-H3_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 11, 2021","Jan 11, 2021",N/A,Complete
CN111825762A-H4,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",HVQLQESGPGLVKSSQTVSLTCSDSGGSITTTHYYWSWIRQPPGKGLEWIGYIAYIGDTFYNSSLKSRTAISWDTSKNQFTLHLNSVTPEDTAVYYCADRNRVRGYDPCLHGYWGKGTQVTVSS,N/A,IGHV2S1 (Alpaca),IGHJ7 (Alpaca),N/A,N/A,ADRNRVRGYDPCLHGY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CN111825762A-H4_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 11, 2021","Jan 11, 2021",N/A,Complete
CN111825762A-H6,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",HVQLLESGPGLVKPSQTLSLTCTVSGGSITTDVAYWSWLRQPPGKGLEWMGAIASSGSTYNSPFFGSRTFISRDTSKSQFTLQLSSVTPEDTAVYYCAAIAVRDPHYVGVGGYWGKGTQVTVSS,N/A,IGHV2S1 (Alpaca),IGHJ7 (Alpaca),N/A,N/A,AAIAVRDPHYVGVGGY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CN111825762A-H6_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 11, 2021","Jan 11, 2021",N/A,Complete
US10822379B1-#9,Nb,SARS-CoV2,,,,S; RBD,"Phage Display (antibody, human, non-immune)",EVQLVESGGGLVQPGGSLRLSCKGSGFTLSDYYIGWVRQAPGKGLEWIGSMYHSGRTYINPSLKSRVTISRDNSKNTLYLQMNSLRAEDTAVYYCARGGITGTTPIDYWGQGTLVTVSS,N/A,IGHV3-66 (Human),IGHJ4 (Human),N/A,N/A,ARGGITGTTPIDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/US10822379B1-#9_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 11, 2021","Jan 11, 2021",N/A,Patent only supplies VH domain. Complete
US10822379B1-#8,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,"Phage Display (antibody, human, non-immune)",EVQLVESGGGLVQPGGSLRLSCAASGFTFDDYAMSWVRQAPGKGLEWIGRMYNNGRTSYNPSLKSLVTISRDNSKNTLYLQMNSLRAEDTATYYCARDNLGYRPSENLYGMDVWGQGTTVTVSS,N/A,IGHV3-23 (Human),IGHJ6 (Human),N/A,N/A,ARDNLGYRPSENLYGMDV,https://www.rcsb.org/structure/7MJH;https://www.rcsb.org/structure/7MJI,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 11, 2021","May 15, 2021",13th Jan 2021: Added new reference. 30th March 2021: Added new reference. 15th May 2021: Added PDB structures,Single domain Ab. Alternative name is ab8. Variant binding data in Zehua Sun et al. Complete.
US10822379B1-#7,Nb,SARS-CoV2,,,,S; RBD,"Phage Display (antibody, human, non-immune)",EVQLVESGGGLVQPGGSLRLSCAASAFDFYDYEMSWVRQAPGKALEWIGEIHHSGSTYYNPPSLKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDVSYHADVWGQGTTVTVSS,N/A,IGHV3-23 (Human),IGHJ6 (Human),N/A,N/A,AKDVSYHADV,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/US10822379B1-#7_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 11, 2021","Jan 11, 2021",N/A,Patent only supplies VH domain. Complete
US10822379B1-#6,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,"Phage Display (antibody, human, non-immune)",EVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWIGNIYHDGSTFYNPSLKSLVTISRDDSTNTLYLQMNSLRAEDTAIYYCARVWLYGSGYMDVWGKGTLVTVSS,N/A,IGHV3-30 (Human),IGHJ6 (Human),N/A,N/A,ARVWLYGSGYMDV,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/US10822379B1-#6_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 11, 2021","Mar 30, 2021",30th Mar: Added new reference,Patent only supplies VH domain. Alternative name may be ab6. Variant binding data in Zehua Sun et al. Complete.
US10822379B1-#5,Nb,SARS-CoV2,,,,S; RBD,"Phage Display (antibody, human, non-immune)",KVQLQQWGAGLLKPSETLSLTCAVYGGSFSGYYWSWIRQPPGKGLEWIGEINHSGSTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCVRLPMIKKSFDIWGPGTLVTVSS,N/A,IGHV4-34 (Human),IGHJ4 (Human),N/A,N/A,VRLPMIKKSFDI,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/US10822379B1-#5_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 11, 2021","Jan 11, 2021",N/A,Patent only supplies VH domain. May be the VH used in ab5 in https://www.pnas.org/content/117/47/29832. Complete
US10822379B1-#4,Ab,SARS-CoV2,,,,S; RBD,"Phage Display (antibody, human, non-immune)",EVQLVQSGGGLVQPGGSLRLSCAASGFTFSNYAMTWVRQAPGKGLEWVSTIAGSGDNTYYADSVKGRFTISRDNDKNTLYLQMNSLRADDTAVYYCARDRYYTMDVWGQGTLVTVSS,QSVVTQPPSASGSPGQSVTISCTGTSSDVGGYNHVSWYQQHPGKAPKLLIYEVSERPSGVPDRFSGSKSDNKASLTIIGLQTEDEADYYCQSTDSSLSGSLFGTGTKLTVL,IGHV3-23 (Human),IGHJ6 (Human),IGLV2-8 (Human),IGLJ3 (Human),ARDRYYTMDV,QSTDSSLSGSL,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/US10822379B1-#4_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 11, 2021","Jan 11, 2021",N/A,Complete
US10822379B1-#3,Ab,SARS-CoV2,,,,S; RBD,"Phage Display (antibody, human, non-immune)",EVQLVQSGGGLVQPGGSLRLSCSASGFTFSSYAMHWVRQAPGKGLEYVSAISTDGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKTYYDFWRTYYGMDVWGQGTMVTVSS,EATLTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGRAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPYTFGQGTRLEIK,IGHV3-64 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ5 (Human),AKTYYDFWRTYYGMDV,QQSYSTPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/US10822379B1-#3_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 11, 2021","Jan 11, 2021",N/A,Complete
US10822379B1-#2,Ab,SARS-CoV2,,,,S; RBD,"Phage Display (antibody, human, non-immune)",QVQLQQSGPGLVKPSQTLSLTCAISGDSVSSNSAAWNWIRQSPSRGLEWLGRTYYRSKWYNDYAVSVKSRITINPDTSKNQFSLQLNSVTPEDTAVYYCAREQQQLVPHYYYYGMDVWGQGTTVTVSS,DVVMTQSPSVSGSPGQSVTISCTGTTSDVGGYNYVSWYQQRPGKAPKLMIYEVSKRPSGVPDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYTSSSTLFGTGTKLTVL,IGHV6-1 (Human),IGHJ6 (Human),IGLV2-8 (Human),IGLJ3 (Human),AREQQQLVPHYYYYGMDV,SSYTSSSTL,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/US10822379B1-#2_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 11, 2021","Jan 11, 2021",N/A,Complete
aRBD-2,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QVQLVESGGGLVQAGGSLRLSCAASGRTYTMGWFRQAPGKEREFVAAMRWSDTDYADSLKGRFTISRDNANNAMYLQMNSLGPEDTAVYYCAAGEAWLARSTHHYDYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAGEAWLARSTHHYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/aRBD-2_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 11, 2021","Feb 4, 2021",4th February: Added new publication with neutralisation evidence,Complete
aRBD-3,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QVQLVESGGGLVQPGGSLRLSCAASGLTLDYYAIGWFRQAPGKEREGVSCISHPGGSTNYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAASPLALFRLCVLPSPLPYDYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AASPLALFRLCVLPSPLPYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/aRBD-3_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 11, 2021","Feb 4, 2021",4th February: Added new publication with neutralisation evidence,Complete
aRBD-5,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QVQLVESGGGLVQPGGTLRLSCAASGFTLDYYAIGWFRQAPGKEREGVSCISGSGGITNYTDSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAPVSHTVVAGCAFEAWTDFGSWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ6 (Alpaca),N/A,N/A,APVSHTVVAGCAFEAWTDFGS,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/aRBD-5_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 11, 2021","Feb 4, 2021",4th February: Added new publication with neutralisation evidence,Complete
aRBD-7,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QLQLVESGGGLVQAGGSLRLSCAASERTFSGGVMGWFRQRPGKEREFVAAIRWNGASTFYADSVKGRFTCSRDNAKNTGYLQMNSLTPEDTAVYYCARAVRTYASSDYYFQERTYDYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,ARAVRTYASSDYYFQERTYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/aRBD-7_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 11, 2021","Feb 4, 2021",4th February: Added new publication with neutralisation evidence,Complete
aRBD-41,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QVQLVESGGGLVQPGGSLRLSCAASGFTSGHYAIGWFRQAPGKEREGVSCIGSSDGSTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAAGLWYGRSLNSFDYDYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAGLWYGRSLNSFDYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/aRBD-41_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 11, 2021","Feb 4, 2021",4th February: Added new publication with neutralisation evidence,Complete
aRBD-42,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QLQLVESGGGLVQAGGSLRLSCAASGRTFSSATMGWFRQAPGKEREFVAAISWSGLSRYYADSVKGRFTISRDNAENTVYLQMNSLKTEDTAVYYCAADSWGCSGLGCYDARQYDVWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AADSWGCSGLGCYDARQYDV,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/aRBD-42_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 11, 2021","Feb 4, 2021",4th February: Added new publication with neutralisation evidence,Complete
aRBD-54,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QLQLVESGGGLVQPGGSLRLSCAASGRTFGSFMGWFRQAPGQERDFVAAITWSGGSTYYADSVKGRFTISRDNAENTVYLQMNSLKPEDTAVYYCAARISSAYYTRSSSYAYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AARISSAYYTRSSSYAY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/aRBD-54_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 11, 2021","Feb 4, 2021",4th February: Added new publication with neutralisation evidence,Complete
CN111875700A-1A6,Nb,SARS-CoV2,,,,N,"Phage Display (antibody, mouse, non-immune)",EVKLKESGAELVKPGASVKLSCTASGFNIKDTYMHWVKQRPGQGLEWIGYINPSTGYTEYNQKFKDKATLTADKSSSTAYMQLSSLTSEDSAVYYCARDALGWYFDVWGAGTLVTVST,DVVMTQSHKFMSTSVGDRVSVTCKASQNVGTNVAWYQQKPGQFPKALIYSASYRYSGVPDRFTGSGSGTDFTLTISNVQSEDLAEYFCQQYNSYPLTFGAGTKLEIK,IGHV1-7 (Mouse),IGHJ1 (Mouse),IGKV6-15 (Mouse),IGKJ5 (Mouse),ARDALGWYFDV,QQYNSYPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CN111875700A-1A6_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 11, 2021","Jan 11, 2021",N/A,Complete
CN112062840A,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLQESGGGLVQAGGSLRLSCAASGRTFSSNAMGWFRQAPGKEREFVAAISSGSGSTNYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAAAYRYNGRDYYDRYDYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAAYRYNGRDYYDRYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CN112062840A_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 11, 2021","Jan 11, 2021",N/A,Complete
CN112062838A-sdAb,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,"Phage Display (antibody, human, non-immune)",QVQLVQSGGGLVQPGGSLRLSCAASDFDFYDYEMSWVRQAPGKALEWIGEIHHSGSTYYNPSLKSRVTISRDNSKNTLYLQMNTLRAEDTAIYYCVKDFVGADGPFVFDYWGQGTLVTVSS,N/A,IGHV3-23 (Human),IGHJ4 (Human),N/A,N/A,VKDFVGADGPFVFDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CN112062838A-sdAb_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 11, 2021","Jan 11, 2021",N/A,Complete
CN111995674A-mhC3b,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,Humanised from Immunised Mouse,EVQLVESGGGLVKPGGSLKLSCAASGFTFNTYAMNWVRESPGKGLEWVARIRSKSNNYATYYADSVKDRFTISRDNSTSSLYLQMNNLKSEDTAMYYCVTPYYGNYADWFTYWGQGTTVTVSS,DIVMTQSPLSLSVSLGDSASISCRSSQSLVHSNGNTYLHWYQQKPGQSPKLLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYFCSQSTHVPYTFGGGTKLEIK,IGHV10-1 (Mouse),IGHJ2 (Mouse),IGKV1-110 (Mouse),IGKJ2 (Mouse),VTPYYGNYADWFTY,SQSTHVPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CN111995674A-mhC3b_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 11, 2021","Jan 11, 2021",N/A,Complete
CN111995674A-mhC3,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,Humanised from Immunised Mouse,EVQLVESGGDLVKPGGSLKLSCAASGFTFNTYAMNWVRQTPGKGLEWVARIRSKSNNYATYYADSVKDRFTISRDDSQSMLYLQMNNLKTEDTAMYYCVTPYYGNYADWFTYWGQGTSVTVSS,DVVMTQTPLSLPVSLGDQASISCRSSQSLVHSNGNTYLHWYLQKPGQSPKLLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDLGVYFCSQSTHVPYTFGGGTKLEIK,IGHV10-1 (Mouse),IGHJ2 (Mouse),IGKV1-110 (Mouse),IGKJ2 (Mouse),VTPYYGNYADWFTY,SQSTHVPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CN111995674A-mhC3_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 11, 2021","Jan 11, 2021",N/A,Complete
ab1,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,"Phage Display (antibody, human, non-immune)",EVQLVESGGGLVQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRHNSKNTLYLQMNSLRAEDTAVYYCARGYGDYYFDYWGQGTLVTVSS,DVVMTQSPATLSLSPGEKATLSCRASQSVSSYLAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYGSSPLTFGGGTKVEIK,IGHV3-66 (Human),IGHJ4 (Human),IGKV3-15 (Human),IGKJ4 (Human),ARGYGDYYFDY,QQYGSSPLT,https://www.rcsb.org/structure/7MJJ;https://www.rcsb.org/structure/7MJK;https://www.rcsb.org/structure/7MJL,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/ab1_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 11, 2021","May 15, 2021",30th Mar 2021: Added new reference. 15th May 2021: Added new PDB structures,Variant binding data in Zehua Sun et al. Complete
H712375+L711691,Ab,SARS-CoV2 (weak),"SARS-CoV1,MERS-CoV",,,S; RBD,B-cells; SARS-CoV1 Human Patient,QVQLQQSGPGLVKPSQTLSLTCGISGDSVSSSYAVWNWIRQSPSRGLEWLGRSYYRSKWYIDYAESVKGRITINPDTSKNQFSLQLKSLTPEDTAVYYCARSPVDVLPGYFTYWGQGTLVTVSS,QSALTQPRSVSGSPGQSVTISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSKRPSGVPDRFSGSKSGNTASLTISGLQAEDEADYYCCSYARTYTYVLFGGGTKLTVL,IGHV6-1 (Human),IGHJ4 (Human),IGLV2-11 (Human),IGLJ3 (Human),ARSPVDVLPGYFTY,CSYARTYTYVL,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712375+L711691_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712320+K711861,Ab,"SARS-CoV1 (weak),SARS-CoV2",MERS-CoV,,,S; RBD,B-cells; SARS-CoV1 Human Patient,QLQLQESGPGLVKPSETLSLTCTVSGGSINNNIYYWGWIRQPPGKGLEWIGSIYYSGSTYYNPSLRSRVSISVDTSKNEFSLRLSSVTAADTAVYYCARPGVYCSGASCYYYLNMDVWGQGTTVTVSS,AIQLTQSPSSLSASVGDRVTITCRASQGISSALAWYQQKPGKVPKLLIYDASSLESGVPSRFSGSGSGTDFTLTINSLQPEDFATYYCQQFNNYPALTFGGGTKVEIK,IGHV4-39 (Human),IGHJ6 (Human),IGKV1D-13 (Human),IGKJ4 (Human),ARPGVYCSGASCYYYLNMDV,QQFNNYPALT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712320+K711861_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712328+L711666,Ab,"SARS-CoV1,SARS-CoV2",MERS-CoV,,,S; NTD,B-cells; SARS-CoV1 Human Patient,QVQLQQWGAGLLKPSETLSLTCAVYGGSFSGYFWVRSSTGDEVQLVESGEINHSGSTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARIEYSYGRRGLDYWGQGTLVTVSS,SSELTQDPAVSVALGQTVTITCRGDSLRTSYASWCQQKPGQAPVLAIYGKNNRPSGIPDRFSGSYSGSIASLTTTGAQAEDEADYYCNSRDSSGDHVPFGGGTRLTVL,IGHV4-34 (Human),IGHJ4 (Human),IGLV3-19 (Human),IGLJ3 (Human),ARIEYSYGRRGLDY,NSRDSSGDHVP,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712328+L711666_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712427+K711927,Ab,"SARS-CoV1,SARS-CoV2",MERS-CoV,,,S; S2,B-cells; SARS-CoV1 Human Patient,QVQLQESGPGLVKPSETLSLTCTVSGGSISNYYWSWLRQSPGKGLEWIGYIYDSGTTNYNPSLKSRVTISIDTSKNHFSLKLNSVTAADTAVYYCARGFDYWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSNYLAWFQQKPGQAPRLLIYATFSRSIGIADRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK,IGHV4-59 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ1 (Human),ARGFDY,QQYGSSPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712427+K711927_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712412+K711916,Ab,SARS-CoV2 (weak),"SARS-CoV1,MERS-CoV",,,S; S2,B-cells; SARS-CoV1 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSTYGMHWVRQAPGKGLEWVAVIWYDGSNDYYADSVRGRFTIFRDNSMNTLYLQMNSLRAEDTAVYYCAREGKGMVRGVLDYWGQGTLVTVSS,AIQMTQSPSSLSASVGDTVTITCRASQGIRNDLGWYQQKPGKAPALLIFAASSLYSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCLQDYNYPLTFGGGTKVEIK,IGHV3-33 (Human),IGHJ4 (Human),IGKV1-6 (Human),IGKJ4 (Human),AREGKGMVRGVLDY,LQDYNYPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712412+K711916_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H026129+L024057,Ab,SARS-CoV1 (weak),"SARS-CoV2,MERS-CoV",,,S; non-RBD,B-cells; SARS-CoV1 Human Patient,QVQLVQSGAEVRKTGASVKISCKASGYSFTSYYLHWVRQAPGQGLVWMGTIDPIGGATNYAQRFQGRVSMTRDTSTSTAYMEVSSLRFEDTAVYYCARMDRSQVYWGQGALVTVSA,QSALTQPPSVSGSPGQSVTISCTGTSSDVGGYNYVSWYQHHPGKAPKLMIYDVTKRPSGVPDRFSGSKSGNTASLTISGLQAEDEADYYCCSYAGSNTWVFGGGTKLTVL,IGHV1-46 (Human),IGHJ4 (Human),IGLV2-11 (Human),IGLJ3 (Human),ARMDRSQVY,CSYAGSNTWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H026129+L024057_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H026129+L024058,Ab,SARS-CoV1,"SARS-CoV2,MERS-CoV",,,S; non-RBD,B-cells; SARS-CoV1 Human Patient,QVQLVQSGAEVRKTGASVKISCKASGYSFTSYYLHWVRQAPGQGLVWMGTIDPIGGATNYAQRFQGRVSMTRDTSTSTAYMEVSSLRFEDTAVYYCARMDRSQVYWGQGALVTVSA,SYELTQPPSVSVSPGQTATITCSGDAWPKQYAYWHQQKAGQAPVLVIYEDNKRPSGIPGRFSGSTSGTTVALTISGVQPEDEADYYCQSADSRGTVVFGGGTKLTVL,IGHV1-46 (Human),IGHJ4 (Human),IGLV3-25 (Human),IGLJ3 (Human),ARMDRSQVY,QSADSRGTVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H026129+L024058_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712327+L711665,Ab,SARS-CoV1,"SARS-CoV2,MERS-CoV",,,S; non-RBD,B-cells; SARS-CoV1 Human Patient,QVQLVQSGARLISCVQTTSLGARGHKPKFFWGHRGQNPKNPRLRLEWMGWLNPIIEITGYSHNFQGIITMTTDTSINTAFMELSALKSEDTAIYYCARGPSGYYYASGDFWGQGTLVTVSS,SYELTQPLSVAVAPGETARITCSGDALSEEYTHWYQQRPGQAPVLIIYKDTERPSGIPERFSGSTSGTTVTLTISGVQAEDEADYYCQSPDTTSTYRVFGGGTKLTVL,IGHV1-8 (Human),IGHJ4 (Human),IGLV3-25 (Human),IGLJ3 (Human),ARGPSGYYYASGDF,QSPDTTSTYRV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712327+L711665_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H026164+K023917,Ab,SARS-CoV1,"SARS-CoV2,MERS-CoV",,,S; non-RBD,B-cells; SARS-CoV1 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFRTYAINWVRQAPGQGLEWMGGIIPLFGTPSYPRSYQGRVTITADESTSTAFLTLNSLRSDDTAVYYCARDDGKMNFGSAPWDFFHSWGQGTLVTVSS,EIVLTQSPGTLSLSPGQRATLSCRASQSVSSNYLAWFQQKPGQAPRLLIYGASSRATGIPARFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPGITFGQGTRLEIK,IGHV1-69 (Human),IGHJ5 (Human),IGKV3-20 (Human),IGKJ5 (Human),ARDDGKMNFGSAPWDFFHS,QQYGSSPGIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H026164+K023917_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712327+L711664,Ab,SARS-CoV1,"SARS-CoV2,MERS-CoV",,,S; non-RBD,B-cells; SARS-CoV1 Human Patient,QVQLVQSGARLISCVQTTSLGARGHKPKFFWGHRGQNPKNPRLRLEWMGWLNPIIEITGYSHNFQGIITMTTDTSINTAFMELSALKSEDTAIYYCARGPSGYYYASGDFWGQGTLVTVSS,QSALTQPASVSGSPGQSITISCTETSSDIGGYNYASWYQQHPGKAPKLIIYDVSDRPSGVSNRFSGSKSDNTASLTISGLQAEDEADYYCSSYMSSNVIFGGGTKLTVL,IGHV1-8 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ3 (Human),ARGPSGYYYASGDF,SSYMSSNVI,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712327+L711664_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712357+K711882,Ab,SARS-CoV1,"SARS-CoV2,MERS-CoV",,,S; non-RBD,B-cells; SARS-CoV1 Human Patient,QVQLVQSGAEVKKPGASVNVACKASGYTFTTYYVHWVRQAPGQGLEWLGVINPSDGSTRYAPKLEGRVTMTSDTPTNTVYLELSSLKSGDTAVYYCARVYMGATVMRAFDVWGQGTMVSVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSNYLAWYQQKPGQAPRLVIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAIYYCQQYGGSPMYTFGQGTKLEMK,IGHV1-46 (Human),IGHJ3 (Human),IGKV3-20 (Human),IGKJ2 (Human),ARVYMGATVMRAFDV,QQYGGSPMYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712357+K711882_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H026207+K023944,Ab,SARS-CoV1,"SARS-CoV2,MERS-CoV",,,S; non-RBD,B-cells; SARS-CoV1 Human Patient,EVQLVESGGGLVKPGGSLRLSCAASGFTFSSNSMTWVRQAPGKGLEWVSSISPDSGYIYYVDSVKGRFTISRDNAKNSLFLQMNSLRAEDSAVYYCARCGGGGCNQVGGMDVWGQGTTVTVSS,DIQMTQSPSTLSASVGDGVTITCRASQSISNWLAWYQQKPGKAPKLLINEASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQHYNGYPFTFGQGTRLEIK,IGHV3-21 (Human),IGHJ6 (Human),IGKV1-5 (Human),IGKJ5 (Human),ARCGGGGCNQVGGMDV,QHYNGYPFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H026207+K023944_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H026259+K023977,Ab,SARS-CoV1,"SARS-CoV2,MERS-CoV",,,S; non-RBD,B-cells; SARS-CoV1 Human Patient,EVQLVESGGGLVKPGGSLRLSCAASGFPFSSYSLSWVRQAPGKGLEWVSSISSSSTYRYYTDSVKGRFTISRDNAKNSLELQMNSLRAEDTALYYCARAEAGYCRGGACYFFDYWGQGTLVAVSS,DIVMTQSPDSLAVSLGERATINCKSSQTVFSTSNNKNYLVWYQQKLGQPPKLLIYWASTRGSGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYSSPLTFGGGTKVEIK,IGHV3-21 (Human),IGHJ4 (Human),IGKV4-1 (Human),IGKJ4 (Human),ARAEAGYCRGGACYFFDY,QQYYSSPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H026259+K023977_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712328+K711865,Ab,SARS-CoV1,"SARS-CoV2,MERS-CoV",,,S; non-RBD,B-cells; SARS-CoV1 Human Patient,QVQLQQWGAGLLKPSETLSLTCAVYGGSFSGYFWVRSSTGDEVQLVESGEINHSGSTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARIEYSYGRRGLDYWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPKTFGQGTKVEIK,IGHV4-34 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ1 (Human),ARIEYSYGRRGLDY,QQYGSSPKT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712328+K711865_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712346+L711676,Ab,SARS-CoV1,"SARS-CoV2,MERS-CoV",,,S; non-RBD,B-cells; SARS-CoV1 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFVSGRFWMTWFRQAPGKGLEWVANIKQDSSEKNYADFAKGRFSISRDNPGNSLFLQMSSLRVEDTAVYFCARDAGGLWGQGTLVTVSS,SYELTQPSSMSVSPGETAEITCSGDVLERKYGRWFQQKPGQAPVLVIYKDTERPSGISERFSGSSSGTTVTLTISGAQVEDEADYYCYTAADNNVLFGGGTKLTVL,IGHV3-7 (Human),IGHJ4 (Human),IGLV3-27 (Human),IGLJ3 (Human),ARDAGGL,YTAADNNVL,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712346+L711676_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712368+K711887,Ab,SARS-CoV1,"SARS-CoV2,MERS-CoV",,,S; non-RBD,B-cells; SARS-CoV1 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKTSGGTFVNFNSYAISWVRQAPGQGLEWMGRIIPILGVTNYAQKFQGRVTITADKATRTVYMELSNLGSEDTAMYYCARVQDIVIVPAVYGMDVWGQGTTVTVSS,DIVMTQSPDSLAVSLGERATINCKSSQNLLYNSNNYNYLAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVALYYCQQYYHNPFTFGPGTKVDIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV4-1 (Human),IGKJ3 (Human),ARVQDIVIVPAVYGMDV,QQYYHNPFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712368+K711887_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712365+L711685,Ab,SARS-CoV1,"SARS-CoV2,MERS-CoV",,,S; non-RBD,B-cells; SARS-CoV1 Human Patient,QVQLQESGPGLVKPSETLSLTCTVSDGSISPYFWSWIRQPPGEGLEWIGYIYYDGNTNYSPSLKSRATISLDTSKNQFSLILTSVTAADTAVYYCARIPLRLRSGGRVAFDIWGQGTMVTVSS,QSALTQPASVSGSPGQSITISCTGSNSDVVSWYQHHPGKAPKFMIYEGTKRPSGVSDRFSGSKSGNTASLTISGLQAEDEADYYCCSYVGSSAHVVFGGGTKLTVL,IGHV4-59 (Human),IGHJ3 (Human),IGLV2-23 (Human),IGLJ3 (Human),ARIPLRLRSGGRVAFDI,CSYVGSSAHVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712365+L711685_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H025898+K023767,Ab,"SARS-CoV1,SARS-CoV2",MERS-CoV,,,N,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCVASGLAFSNYAMHWVRQAPGKGLEWVAVISYDGNNQNYADSVRGRFTISRDNSKNTLYLQINSLRAEDTAIYYCVRFYSPLHDLVIHYGNYWGQGALVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDIRNYLNWWQQKPGKAPNLLIYDESNLEAGVPSRFSGTGSGTDFTLTISSLQPEDIATYYCQQYDDLWTFGQGTKVEIK,IGHV3-30-3 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ1 (Human),VRFYSPLHDLVIHYGNY,QQYDDLWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H025898+K023767_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H025853+K023746,Ab,"SARS-CoV1,SARS-CoV2",MERS-CoV,,,N,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKVSGHTLTQLSMHWVRQAPGQGLEWMGTFDPKDDEAIYAQEFQGRVTITEDASTDTAYMEVTSLRSEDTAVYYCATDSIFGVVIYAFAFWGQGTMVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVYSGSLAWYQQRPGQAPRLLIYGASSRTTGIPDRFSGSGSGTDFTLTITRLEPEDFAVYYCQHYGTSPYTFGQGTKLEIK,IGHV1-24 (Human),IGHJ3 (Human),IGKV3-20 (Human),IGKJ2 (Human),ATDSIFGVVIYAFAF,QHYGTSPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H025853+K023746_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H025816+L023919,Ab,"SARS-CoV1,SARS-CoV2",MERS-CoV,,,N,B-cells; SARS-CoV2 Human Patient,EVQLVQSGAEVKKPGESLYISCKASGYDFTSYWIGWVRQMPGKGLEWMGIIYPADSDARYSPSFQGQVTISVDKSITTAYLQWTSLKPSDTAMYYCAREAIVEGARGPFDFWGQGTMVAVSS,SYELTQPPSVSVYPGQTARITCSGDELPTEYASWYQQKPGQAPVLVIYKDIERPSGIPERFSGSTSGTTVTLTISGVQAEDEADYYCLSPDNSGTYRVFGGGTKLTVL,IGHV5-51 (Human),IGHJ3 (Human),IGLV3-25 (Human),IGLJ3 (Human),AREAIVEGARGPFDF,LSPDNSGTYRV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H025816+L023919_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H025771+K023698,Ab,"SARS-CoV1,SARS-CoV2",MERS-CoV,,,N,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCSASGFTFSSYAMHWVRQAPGKGLEYVSAISSNGGSTYYADSVKGRFTISRDNSKNTLYLQMSSLRAEDTAVYYCVKDLAVQDYDSSGYFDPGDIWGQGTMVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPLTFGGGTKVEIK,IGHV3-64D (Human),IGHJ3 (Human),IGKV1-33 (Human),IGKJ4 (Human),VKDLAVQDYDSSGYFDPGDI,QQYDNLPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H025771+K023698_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H025924+K023782,Ab,"SARS-CoV1,SARS-CoV2",MERS-CoV,,,N,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCRASGYSLTALPMYWVRQAPGEGLEWVGTFDPEDGETVYSQKFQGRVTLTEDTSTDTAYMELSSLRSEDTAVYYCTTESIFGVVIYAFAIWGQGTLVTVSP,EIVLTQSPGTLSLSPGERATLSCRASQSVSNSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPDDFAVYYCQQYDSSPYAFGQGTTLEIK,IGHV1-24 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ2 (Human),TTESIFGVVIYAFAI,QQYDSSPYA,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H025924+K023782_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H025871+L023939,Ab,"SARS-CoV1,SARS-CoV2",MERS-CoV,,,N,B-cells; SARS-CoV2 Human Patient,EVQLVQSGAEVKKPGESLKISCKASGYNFNNHWIGWVRQMPGKGLEWMGIIYPDDFDTRYSPSFQGQVTISVDKSITTAYLQWSSLKPSDTAMYYCAREEVLEAARGPFDVWGQGTMVAVSS,DIQMTQSPSSLSASVGDRVTITCRASQYISSSLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQLEDLATYFCQQSSITPRTFGQGTKVEIK,IGHV5-51 (Human),IGHJ3 (Human),IGKV1-39 (Human),IGKJ1 (Human),AREEVLEAARGPFDV,QQSSITPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H025871+L023939_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H025804+K023716,Ab,"SARS-CoV1,SARS-CoV2",MERS-CoV,,,N,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCVASGLAFSNYAMHWVRQAPGKGLEWVAVISYDGNNKNYADSVRGRFTISRDNSKNTLYLQINSLRAEDTAVYYCVRFYSPLHDLVIHYGNYWGQGALVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDIRNYLNWWQQKPGKAPNLLIYDESNLEAGVPSRFSGTGSGTDFTLTISSLQPEDIATYYCQQYDDLWTFGQGTKVEIK,IGHV3-30-3 (Human),IGHJ3 (Human),IGKV1-33 (Human),IGKJ1 (Human),VRFYSPLHDLVIHYGNY,QQYDDLWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H025804+K023716_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H025797+L023911,Ab,"SARS-CoV1,SARS-CoV2",MERS-CoV,,,N,B-cells; SARS-CoV2 Human Patient,EVQLVQSGAEVKEPGESLKISCKASGYTFTNNWIGWVRQMPGKGLEWMGIIYPGDSDTRYSPSFQGQVTIAADNSIDTAYLQWSSLKASDTAMYYCARHETQHDSSGTYYLGMDVWGQGTTVIVSS,SYELTQPPSVSVSPGQTARITCSGDALPEEYAYWYQQKPGQAPVLLIYKDSERPSGIPERFSGSSSGTTVTLTISGVEAQDEADYYCQSVDSSGPYRVFGGGTKLTVL,IGHV5-51 (Human),IGHJ6 (Human),IGLV3-25 (Human),IGLJ3 (Human),ARHETQHDSSGTYYLGMDV,QSVDSSGPYRV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H025797+L023911_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H025764+L023895,Ab,"SARS-CoV1,SARS-CoV2",MERS-CoV,,,N,B-cells; SARS-CoV2 Human Patient,EVQLVQSGPEIKEPGESVMISCWASGYIFTNYWIGWVRQMPGKGLEWMGIVYPGDSDTRYNPSFQGQVSISVDKSINTAYLQWKNLKPSDTAMYYCVREEIVGGARGPIDTWGQGTMLTVSS,DIQMTQSPSTLSASVGDRVTITCRASPSISPWLAWYQQKPGKAPKLLIYKASTLETGVPSRFSGSGSGTDFTLTITSLQPDDSATYYCQHYDSLSRTFGQGTRVEIK,IGHV5-51 (Human),IGHJ3 (Human),IGKV1-5 (Human),IGKJ5 (Human),VREEIVGGARGPIDT,QHYDSLSRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H025764+L023895_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H025825+L023924,Ab,"SARS-CoV1,SARS-CoV2",MERS-CoV,,,N,B-cells; SARS-CoV2 Human Patient,EVQLVQSGAEVKKPGESLKISCKASGYNFNNHWIGWVRQMPGKGLEWMGIIYPDDFDTRYSPSFQGQVTISVDKSITTAYLQWSSLKPSDSAMYYCAREEIVEAARGPFDVWGQGTMVAVSS,SYELTQPLSVSVSPGQTARITCSGDALSEEYIHWYQQRPGQAPVLVIYKDTERPSGIPERFSGSSSGTTVTLTISGVQAEDEADYYCQSPDSTSTYRVFGGGTKLTVL,IGHV5-51 (Human),IGHJ3 (Human),IGLV3-25 (Human),IGLJ3 (Human),AREEIVEAARGPFDV,QSPDSTSTYRV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H025825+L023924_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H025891+L023952,Ab,"SARS-CoV1,SARS-CoV2",MERS-CoV,,,N,B-cells; SARS-CoV2 Human Patient,EVQLVQSGAEVKKPGESLKISCKASGYSFTNNWIGWVRQMPGKGLEWMGIIYPGDSDTRYSPSFQGQVTIAADNSISTAYLQWSSLKASDTAMYYCARHETQHDSSGTYYLGMDVWGQGTTVTVSS,SYELTQPPSVSVSPGQTARITCSGDALPEEYAYWYKQKPGQAPVLLIYKDSERPSGIPERFSGSSSGTTVTLTISGVEAEDEADYYCQSVETSGPYRVFGGGTKLTVL,IGHV5-51 (Human),IGHJ3 (Human),IGLV3-25 (Human),IGLJ3 (Human),ARHETQHDSSGTYYLGMDV,QSVETSGPYRV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H025891+L023952_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H025815+L023918,Ab,"SARS-CoV1,SARS-CoV2",MERS-CoV,,,N,B-cells; SARS-CoV2 Human Patient,EVQLVQSGAEVKKPGEAVKISCRASGYDFANYWIGWVRQMPGKGLEWMGIIYPSDSDTRYSPSFQGQVTISVDKSITTAYLQWSSLKASDTAMYYCTREAIVAGARGPIDFWGQGTMVTVSS,SYELTQPPSMSVSPGQSASITCSGDALANEYTHWYQQKPGQAPVLVIYKDTERPSGIPERFSGSSSGTTVTLTISGVQAEDEADYYCQSPDSSGTYRVFGGGTKLTVL,IGHV5-51 (Human),IGHJ3 (Human),IGLV3-25 (Human),IGLJ3 (Human),TREAIVAGARGPIDF,QSPDSSGTYRV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H025815+L023918_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H025845+L023930,Ab,"SARS-CoV1,SARS-CoV2",MERS-CoV,,,N,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCVASGLAFSNYAMHWVRQAPGKGLEWVAVISYDGNNQNYADSVRGRFTISRDNSKNTLYLQINSLRAEDTAIYYCVRFYSPLHDLVIHYGNYWGQGALVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDIRNYLNWWQQKPGKAPNLLIYDESNLEAGVPSRFSGTGSGTDFTLTISSLQPEDIATYYCQQYDDLWTFGQGTKVEIK,IGHV3-30-3 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ1 (Human),VRFYSPLHDLVIHYGNY,QQYDDLWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H025845+L023930_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H025791+L023908,Ab,"SARS-CoV1,SARS-CoV2",MERS-CoV,,,N,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYGISWVRQAPGQGLEWMGWISVYNGNTYNAQQFQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARVNYSYYSSSFFDYFYYYGMDVWGQGTTVTVSS,SYELTQPPSVSVSPGQTARVTCSGDALPKQFAYWYQQKPGQAPVVVIYKDSERPSGIPERFSGSSSGTTVTLTISGVQAEDEADYYCQSADSSGTYVFGSGTKVTVL,IGHV1-18 (Human),IGHJ6 (Human),IGLV3-25 (Human),IGLJ6 (Human),ARVNYSYYSSSFFDYFYYYGMDV,QSADSSGTYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H025791+L023908_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H511580+K511307,Ab,"SARS-CoV1,SARS-CoV2",MERS-CoV,,,N,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKVSGHTLTQLSMHWVRQAPGQGLEWMGTFDPKDDEAIYAQEFQGRVTITEDASTDTAYMEVTSLRSEDTAVYYCATDSIFGVVIYAFAFWGQGTMVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVYSGSLAWYQQRPGQAPRLLIYGASSRTTGIPDRFSGSGSGTDFTLTITRLEPEDFAVYYCQHYGTSPYTFGQGTKLEIK,IGHV1-24 (Human),IGHJ6 (Human),IGKV3-20 (Human),IGLJ6 (Human),ATDSIFGVVIYAFAF,QHYGTSPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H511580+K511307_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H025888+L023950,Ab,"SARS-CoV1,SARS-CoV2",MERS-CoV,,,N,B-cells; SARS-CoV2 Human Patient,EVQLVQSGAEVKKPGESLKISCKASGYSFTNNWIGWVRQMPGKGLEWMGIIYPGDSDIRYSPSFRGQVTIAADNSISTAYLQWSSLKASDTAMYYCARHETQHDSSGTYYLGMDVWGQGTTVTVSS,SYELTQPPSVSVSPGQTARITCSGDALPEEYAYWYQQKPGQAPVLLIYKDSERPSGIPERFSGSSSGTTVTLTISGVEAEDEADYYCQSVDSSGPYRVFGGGTKLTVL,IGHV5-51 (Human),IGHJ6 (Human),IGLV3-25 (Human),IGLJ3 (Human),ARHETQHDSSGTYYLGMDV,QSVDSSGPYRV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H025888+L023950_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H025948+L023978,Ab,"SARS-CoV1,SARS-CoV2",MERS-CoV,,,N,B-cells; SARS-CoV2 Human Patient,EVQLVQSGAEVKKPGESVKISCRASGYDFANYWIAWVRQMPGKGLEWMGVIYPADSDTRYSPSFQGQVTISVDKSTTTAYLQWSSLKSSDTAMYYCTREAILGGARGPIDLWGRGTMVTVSS,SYELTQPPSMSVSPGQSARITCSGDELAIEYTHWYQQKPGQAPVLVIFKDTERPSGIPERFSGSSSGTIATLTISGVQAEDEADYYCQSPDSSGTYRVFGGGTKLTVL,IGHV5-51 (Human),IGHJ2 (Human),IGLV3-25 (Human),IGLJ3 (Human),TREAILGGARGPIDL,QSPDSSGTYRV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H025948+L023978_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H025759+K023691,Ab,"SARS-CoV1,SARS-CoV2",MERS-CoV,,,N,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSQTLSLTCTVSGGSISSGGYYWNWIRQHPGKGLEWIGYIFYSGSTYYNPSLKSRVIISVDTSKNQFSLKLSSVTAADTAVYYCARRGTDWYFDLWGRGTLVTVSP,DIVMTQSPDSLAVSLGERATINCKSSQSILYRSNNKNYLAWYHQKPGQPPKLLISWAFTRESGVPDRFSGSGSGTDFTLTISGLQAEDVAVYYCQQYYSSPYTFGQGTKLEIK,IGHV4-31 (Human),IGHJ2 (Human),IGKV4-1 (Human),IGKJ2 (Human),ARRGTDWYFDL,QQYYSSPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H025759+K023691_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H511649+L510363,Ab,"SARS-CoV1,SARS-CoV2",MERS-CoV,,,N,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLKLSCATSGFVFSDSAVHWVRQAPGKGLEWVGRIRSKANSHATSVPPSVEGRFIISRDDSKHTAYLQMNRLKTEDTAIYYCTVRLVPVDKFDYWGQGTLVSVSS,SYELTQPPSVSVSPGQTARITCSGDALPKKYAYWYQQRPGQAPVLVIHEDTKRPSGTPERFSGSSSGTVATLTITGAQVEDEADYYCYSTDISGDQYVFGTGTKVTVL,IGHV3-73 (Human),IGHJ4 (Human),IGLV3-10 (Human),IGLJ1 (Human),TVRLVPVDKFDY,YSTDISGDQYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H511649+L510363_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H711711+K711403,Ab,"SARS-CoV1,SARS-CoV2",MERS-CoV,,,N,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGDSVKVSCRLSGYSLSDSPMYWVRQAPGGGLEWVGTSDPEDGETVYSQKFQDRLTLTEDTSTETAYMELSSLTSDDTAVYYCTTESIFGVVIYAFAIWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSHNYLAWYQQKPGQAPRLVIYGVSNRAAGIPDRFSGSGSGADFTLTIGRLEPEDFAVYYCQQYGVSPYTFGQGTTLEIK,IGHV1-24 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ2 (Human),TTESIFGVVIYAFAI,QQYGVSPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H711711+K711403_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H711658+L711114,Ab,"SARS-CoV1,SARS-CoV2",MERS-CoV,,,N,B-cells; SARS-CoV2 Human Patient,EVQLVQSGAEVKKPGESLRISCKASGYTFTNNWIGWVRQMPGKGLEWMGIIYPGDSDIRYSPSFQGQVTIAADNSISTAYLQWSSLKASDTAMYYCARHETQHDSSGTYYLGMDVWGQGTTVTVSS,SYELTQPPSVSVSPGQTARITCSGDALPEEYAYWYQQKPGQAPVLLIYKDSERPSGIPERFSGSSSGTTVTLTISGVEAEDEADYYCQSVDSSGPYRVFGGGTKLTVL,IGHV5-51 (Human),IGHJ6 (Human),IGLV3-25 (Human),IGLJ3 (Human),ARHETQHDSSGTYYLGMDV,QSVDSSGPYRV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H711658+L711114_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H711935+K711600,Ab,"SARS-CoV1,SARS-CoV2",MERS-CoV,,,N,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCVASGLAFSNYAMHWVRQAPGKGLEWVAVISYDGNNQNYADSVRGRFTISRDNSKNTLYLQINSLRAEDTAIYYCVRFYSPLHDLVIHYGNYWGQGALVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDIRNYLNWWQQKPGKAPNLLIYDESNLEAGVPSRFSGTGSGTDFTLTISSLQPEDIATYYCQQYDDLWTFGQGTKVEIK,IGHV3-30-3 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ1 (Human),VRFYSPLHDLVIHYGNY,QQYDDLWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H711935+K711600_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H711967+K711635,Ab,"SARS-CoV1,SARS-CoV2",MERS-CoV,,,N,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCVASGLAFSNYAMHWVRQAPGKGLEWVAVISYDGNNKNYADSVRGRFTISRDNSKNTLYLQINSLRAEDTAVYYCVRFYSPLHDLVIHYGNYWGQGALVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDIRNYLNWWQQKPGKAPNLLIYEESNLEAGVPSRFSGTGSGTDFTLTISSLQPEDIATYYCQQYDDLWTFGQGTKVEIK,IGHV3-30-3 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ1 (Human),VRFYSPLHDLVIHYGNY,QQYDDLWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H711967+K711635_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H711748+K711431,Ab,"SARS-CoV1,SARS-CoV2",MERS-CoV,,,N,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVIWYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCASDYYDSSGYPWDYYFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTRWTFGQGTKVEIK,IGHV3-33 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ1 (Human),ASDYYDSSGYPWDYYFDY,QQSYSTRWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H711748+K711431_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H711963+L711351,Ab,"SARS-CoV1,SARS-CoV2",MERS-CoV,,,N,B-cells; SARS-CoV2 Human Patient,EVQLVQSGAEVKKPGESLKISCKTSGYTFNNYWIGWVRQMPGKGLEWMGIIYPEDFDTRYSPSFQGQVTISVDKSSTTAYLHWTNLKPSDTAMYYCAREEIVEGARGPFDVWGQGTMVVVSS,SYELTQPLSVSVSPGQTARITCSGDTLSEEYTHWYQQKPGQAPILVIYKDTERPSGIPERFSGSSSGTTVTLTISGVQAEDEADYYCQSPDTTSTYRVFGGGTKLTVL,IGHV5-51 (Human),IGHJ3 (Human),IGLV3-25 (Human),IGLJ3 (Human),AREEIVEGARGPFDV,QSPDTTSTYRV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H711963+L711351_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H711622+L711096,Ab,"SARS-CoV1,SARS-CoV2",MERS-CoV,,,N,B-cells; SARS-CoV2 Human Patient,EVQLVQSGTEVKKPGESLKISCKASGYNFNNHWIGWVRQMPGKGLEWMGIIYPDDYDTRYSPSFQGQVTISVDKSITTAYLHWGSLEPSDTAMYYCAREEIVEAARGPFDVWGQGTMVAVSP,SYELTQPLSVAVAPGETARITCSGDALSEEYTHWYQQRPGQAPVLIIYKDTERPSGIPERFSGSTSGTTVTLTISGVQAEDEADYYCQSPDTTSTYRVFGGGTKLTVL,IGHV5-51 (Human),IGHJ3 (Human),IGLV3-25 (Human),IGLJ3 (Human),AREEIVEAARGPFDV,QSPDTTSTYRV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H711622+L711096_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H711950+L711337,Ab,"SARS-CoV1,SARS-CoV2",MERS-CoV,,,N,B-cells; SARS-CoV2 Human Patient,EVQLVQSGTEVKKPGESLKISCKTSGYNFNNYWIGWVRQMPGKGLEWMGIIYPEDFDTRYSPSFQGQVTISVDKSITTAYLQWTNLKPSDTAMYYCAREEIVEAARGPFDVWGQGTMVVVSS,SYELTQPLSVSVSPGQTARITCSGDALSEEYTHWYQQRPGQAPILVIYKDTERPSGIPERFSGSSSGTTVTLTISGVQAEDEADYYCQSPDSTSTYRVFGGGTRLTVL,IGHV5-51 (Human),IGHJ3 (Human),IGLV3-25 (Human),IGLJ3 (Human),AREEIVEAARGPFDV,QSPDSTSTYRV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H711950+L711337_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H711886+K711560,Ab,"SARS-CoV1,SARS-CoV2",MERS-CoV,,,N,B-cells; SARS-CoV2 Human Patient,QLQLQESGPGPVKPSETLSLTCTVSGDSISNDNYYWGWIRQPPGKGLEWIGTFYYSGNTYYNPSLKSRVTISVDTSSNQFSLKLRSVTAADTAIYYCAGASDLDYFDYWGQGTLVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSRYLAWYQQKPGQAPRLLIYDASKRATGIPARFSGSGSGTDFTLSISSLEPEDFAVYYCQQRDNWPSFGGGTKVEIK,IGHV4-39 (Human),IGHJ4 (Human),IGKV3-11 (Human),IGKJ4 (Human),AGASDLDYFDY,QQRDNWPS,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H711886+K711560_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H711935+L711318,Ab,"SARS-CoV1,SARS-CoV2",MERS-CoV,,,N,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCVASGLAFSNYAMHWVRQAPGKGLEWVAVISYDGNNQNYADSVRGRFTISRDNSKNTLYLQINSLRAEDTAIYYCVRFYSPLHDLVIHYGNYWGQGALVTVSS,SSELTQDPTVSVALGQTVTITCQGDSLRHYYASWYRQKPGQAPLLVLYDKIRRPSGIPDRFSGSSSGDTGSLTITGVQAEDEADYYCNSRDTNGNRVFGGGTKLTVL,IGHV3-30-3 (Human),IGHJ4 (Human),IGLV3-19 (Human),IGLJ3 (Human),VRFYSPLHDLVIHYGNY,NSRDTNGNRV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H711935+L711318_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H025966+K023804,Ab,SARS-CoV2,"SARS-CoV1,MERS-CoV",,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSGTLSLTCAVSGGSISSSNWWSWVRQPPGKGLEWIGEIYHSGSTNYNPSLKSRVTISVDKSKNQFSLKLSSVTAADTAVYYCAMVQGVMVYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQGISNSLAWYQQKPGKAPKLLLYAASRLESGVPSRFSGSGSGTDYTLTISSLQPEDFATYYCQQYYSTLGRTFGQGTKVEIK,IGHV4-4 (Human),IGHJ4 (Human),IGKV1-NL1 (Human),IGKJ1 (Human),AMVQGVMVY,QQYYSTLGRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H025966+K023804_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712007+K711670,Ab,SARS-CoV2,"SARS-CoV1,MERS-CoV",,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARAYGDYFFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISCLQSEDFATYYCQQYYSFPPTFGQGTKVEIK,IGHV3-53 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ1 (Human),ARAYGDYFFDY,QQYYSFPPT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712007+K711670_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H711851+K711528,Ab,SARS-CoV2,"SARS-CoV1,MERS-CoV",,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVKPGGSLRLSCAASGFTFSSYSMNWVRQAPGKGLEWVSSISSSSSYIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARPHNPAAYCSGGSCYSAYYYYYGMDVWGQGTTVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLQSEDFALYYCQQYNNWLTFGGGTKVAIK,IGHV3-21 (Human),IGHJ6 (Human),IGKV3-11 (Human),IGKJ4 (Human),ARPHNPAAYCSGGSCYSAYYYYYGMDV,QQYNNWLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H711851+K711528_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H711899+L711281,Ab,SARS-CoV2,"SARS-CoV1,MERS-CoV",,,S; RBD,B-cells; SARS-CoV2 Human Patient,QLQLQESGPGLVKPSETLSLTCTVSGGSISSSSYYWGWIRQPPGKGLEWIGSIYYSGSTYYNPSLKSRVTISVDTSKNQFSLKMSSVTAADTAVYYCARRGYYDFWSGPIFDYWGLGTPCSCSS,SYVLTQPPSVSVAPGKTARITCGGNNIGSKSVHWYQQKPGQAPVLVIYYDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDSSSDHPNYVFGTGTKVTVL,IGHV4-39 (Human),IGHJ4 (Human),IGLV3-21 (Human),IGLJ1 (Human),ARRGYYDFWSGPIFDY,QVWDSSSDHPNYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H711899+L711281_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H025956+L023982,Ab,"SARS-CoV-1,SARS-CoV2",MERS-CoV,,,S; S2,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVKPGGSLRLSCAASGFTFSAYFINWVRQAPGKGLEWVASVESSGRQKSYADSVKGRFTISRDNAKNSVFLHMASLRAEDTAIYYCAREGITSFGIVTHYYALDVWGQGTTVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDIGIYQYVSWYQQHTVKAPVLVIYEVTKRPSGVSDRFSGSKSGNTASLTISGLQSEDEADYYCSSYTASNTLVFGTGTKVTVL,IGHV3-21 (Human),IGHJ6 (Human),IGLV2-14 (Human),IGLJ1 (Human),AREGITSFGIVTHYYALDV,SSYTASNTLV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H025956+L023982_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H025946+K023794,Ab,SARS-CoV2,"SARS-CoV1,MERS-CoV",,,S; S2,B-cells; SARS-CoV2 Human Patient,QITLKESGPTLVKPTQTLTLTCTFSGFSLSTSGVGVGWIRQPPGKALEWLALIYWDDDKRYSPSLKSRLTITKDTSKNQVVLTMTNMDPVDTATYYCAHIVIAVARYYFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPYSFGQGTKLEIK,IGHV2-5 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ2 (Human),AHIVIAVARYYFDY,QQSYSTPYS,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H025946+K023794_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H511697+L510393,Ab,SARS-CoV2,"SARS-CoV1,MERS-CoV",,,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASEFTFSSYGMHWVRQAPGKGLEWVAVIWFDGSNKYYADPVKGRFTISRDNSKNALYLQMNNLRAEDTAVYYCARDQDFWSGYYLPWFDPWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSSLAWYQQKPGQAPRLLIFGASTRATGIPERFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGTSPFTFGPGTSVDIK,IGHV3-33 (Human),IGHJ5 (Human),IGKV3-20 (Human),IGKJ3 (Human),ARDQDFWSGYYLP,QQYGTSPFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H511697+L510393_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H511699+L510395,Ab,SARS-CoV2,"SARS-CoV1,MERS-CoV",,,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVIWYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCASEPIVAARTSFETDYWGQGTLVTVSS,DIVMTQSPESLNVSLGERATINCKSSQSVLSSSTHKNYLAWYQQKPGQPPKVVIYWASSRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYSTPHSFGQGTKVGIK,IGHV3-33 (Human),IGHJ4 (Human),IGKV4-1 (Human),IGKJ1 (Human),ASEPIVAARTSFETDY,QQYYSTPHS,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H511699+L510395_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H511685+L510388,Ab,SARS-CoV2,"SARS-CoV1,MERS-CoV",,,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSETLSLTCSVSGDSIQTGTHWWTWVRQPPGKGLEWIGEVHHSGNTNYNPSLKSRVTMSVDKSQNRFFLEVNSMTGADTPVYYCARLFADRGGYFWFDPWGQGALVTVTS,SYELTQPPSVSVSPGQTARITCSGDALPKKYAYWYQQMSGQAPVVVIYEDKKRPSGIPERFSGSSSGTMATLTISGAQVEDEGDYYCASTDSSGNHRVFGGGTKLTVL,IGHV4-4 (Human),IGHJ5 (Human),IGLV3-10 (Human),IGLJ3 (Human),ARLFADRGGYFWFDP,ASTDSSGNHRV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H511685+L510388_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H025837+K023736,Ab,SARS-CoV2,"SARS-CoV1,MERS-CoV",,,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARTYSGSYWDAFDIWGQGTMVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSYSFGQGTKLEIK,IGHV3-30-3 (Human),IGHJ3 (Human),IGKV3-20 (Human),IGKJ2 (Human),ARTYSGSYWDAFDI,QQYGSSYS,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H025837+K023736_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H511576+L510332,Ab,SARS-CoV2,"SARS-CoV1,MERS-CoV",,,S; S2,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVKPGGSLRLSCAASGFTFSAYFINWVRQAPGKGLEWVASVESSGRQKSYADSVKGRFTISRDNAKNSVFLHMASLRAEDTAIYYCAREGITSFGIVTHYYALDVWGQGTTVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDIGIYQYVSWYQQHTVKAPVLVIYEVTKRPSGVSDRFSGSKSGNTASLTISGLQSEDEADYYCSSYTASNTLVFGTGTKVTVL,IGHV3-21 (Human),IGHJ6 (Human),IGLV2-14 (Human),IGLJ1 (Human),AREGITSFGIVTHYYALDV,SSYTASNTLV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H511576+L510332_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H511698+L510393,Ab,SARS-CoV2,"SARS-CoV1,MERS-CoV",,,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSGTLSLTCAVSGGSISSSNWWSWVRQPPGKGLEWIGEIYHSGSTNYNPSLKSRVTISVDKSKNQFSLKLSSVTAADTAVYYCARWGSGWSNDAFDIWGQGTMVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSSLAWYQQKPGQAPRLLIFGASTRATGIPERFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGTSPFTFGPGTSVDIK,IGHV4-4 (Human),IGHJ3 (Human),IGKV3-20 (Human),IGKJ3 (Human),ARWGSGWSNDAFDI,QQYGTSPFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H511698+L510393_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H025886+L023949,Ab,SARS-CoV2,"SARS-CoV1,MERS-CoV",,,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPWGTLSLTCAVSGGSISSSHWWTWVRQPPGKGLEWIGEVHHSGNTNYNPSLRTRVTIAVDKSKNHFSLRLTSVTAADTAVYYCARLFSDSGNYFWFDPWGQGTLVPVSS,DIQMTQSPSSLSASVGDRVTITCRASQYISSSLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQLEDLATYFCQQSSITPRTFGQGTKVEIK,IGHV4-4 (Human),IGHJ5 (Human),IGKV1-39 (Human),IGKJ1 (Human),ARLFSDSGNYFWFDP,QQSSITPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H025886+L023949_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H025794+K023710,Ab,SARS-CoV2,"SARS-CoV1,MERS-CoV",,,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARPHGGSYYSYFDYWGQGTLVTVSS,DIVMTQSPDSLAVSLGERATINCKSSQSVLYSSNNKNYLAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYSTLYTFGQGTKLEIK,IGHV3-30-3 (Human),IGHJ4 (Human),IGKV4-1 (Human),IGKJ2 (Human),ARPHGGSYYSYFDY,QQYYSTLYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H025794+K023710_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H025783+L023904,Ab,"SARS-CoV-1 (weak), SARS-CoV2",MERS-CoV,,,S; S2,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVKPGGSLRLSCAASGFTFSAYFMNWVRQAPGKGLEWVASVESSGRQKSYADSVKGRFTISRDNAKNSVFLHMASLRAEDTAIYYCAREGITSFGVVTHYYALDVWGQGTTVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGFYQYVSWYQQHPVKAPVLVIYEVTKRPSGVSDRFSGSKSGNTASLTISGLQSEDEADYYCSSYTASSTLVFGTGTKVTVL,IGHV3-21 (Human),IGHJ6 (Human),IGLV2-14 (Human),IGLJ1 (Human),AREGITSFGVVTHYYALDV,SSYTASSTLV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H025783+L023904_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H025895+L023955,Ab,SARS-CoV2,"SARS-CoV1,MERS-CoV",,,S; S2,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVKPGGSLRLSCAASGFTFSAYFMNWVRQAPGKGLEWVASVESSGRQKSYADSVKGRFTISRDNAKNSVFLHMAPLRAEDTAIYYCAREGITNFGVVTHYYALDVWGQGTTVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGIYQYVSWYQQHPVKAPVLVIYEVTKRPSGVSDRFSGSKSGNTASLTISGLQSEDEADYYCSSYTASSTLVFGTGTKVTVL,IGHV3-21 (Human),IGHJ6 (Human),IGLV2-14 (Human),IGLJ1 (Human),AREGITNFGVVTHYYALDV,SSYTASSTLV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H025895+L023955_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H511606+L510344,Ab,SARS-CoV2 (weak),"SARS-CoV1,MERS-CoV",,,S; S2,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVKPGGSLRLSCAASGFTFSAYFMNWVRQAPGKGLEWVASVESGGRQKSYADSVKGRFTISRDNAKNSVFLHMASLRAEDTAIYYCAREGITSFGIVTHYYALDVWGQGTTVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDIGIYQYVSWYQQHTVKAPVLVIYEVTKRPSGVSDRFSGSKSGNTASLTISGLQSEDEADYYCSSYTATNTLVFGTGTKVTVL,IGHV3-21 (Human),IGHJ6 (Human),IGLV2-14 (Human),IGLJ1 (Human),AREGITSFGIVTHYYALDV,SSYTATNTLV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H511606+L510344_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H025789+L023907,Ab,"SARS-CoV1 (weak), SARS-CoV2 (weak)",MERS-CoV,,,S; S2,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVKPGGSLRLSCAASGFTFSAYFMNWVRQAPGKGLEWVASVESSGRQKSYADSVKGRFTISRDNAKNSVFLHMASLRAEDTAIYYCAREGITSFGVVTHYYALDVWGQGTTVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGIYQYVSWYQQHPVKAPVLVIYEVTKRPSGVSDRFSGSKSGNTASLTISGLQSEDEADYYCSSYTASSTLVFGTGTKVTVL,IGHV3-21 (Human),IGHJ6 (Human),IGLV2-14 (Human),IGLJ1 (Human),AREGITSFGVVTHYYALDV,SSYTASSTLV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H025789+L023907_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H511600+K511320,Ab,SARS-CoV2 (weak),"SARS-CoV1,MERS-CoV",,,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARSSSGSYLYYFDYWGQGTLVTVSS,EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNWPGTFGPGTKVDIK,IGHV3-30-3 (Human),IGHJ4 (Human),IGKV3-15 (Human),IGKJ3 (Human),ARSSSGSYLYYFDY,QQYNNWPGT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H511600+K511320_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H511686+K511377,Ab,SARS-CoV2 (weak),"SARS-CoV1,MERS-CoV",,,S; S2,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVEPGGSLRLSCAPSGFTFNNAWMNWVRQAPGKGLEWVGRIKSETDGGTTDYAAPVRGRFTISRNDSINTLYMVIHSLKIEDTALYFCTTVHSDYVWGSYRKGYFDYWGQGALVTVSS,DIQMTQSPSSLSASVGDRVTITCRTSQSIRTYLHWYQQKPGKAPKLLIYTASSLQGGVPSRFSGSGSGTDFTLTISSLQPEDFASYYCQQGYTTPYTFGQGTKLEIK,IGHV3-15 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ2 (Human),TTVHSDYVWGSYRKGYFDY,QQGYTTPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H511686+K511377_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H711917+K711586,Ab,"SARS-CoV1,SARS-CoV2",MERS-CoV,,,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLCCAASGFTFSDYGMHWVRQAPGKGLEWVAVITYDGRNKKHADSVEGRFTISRDNPTNTLYLQMNSLRAEDTAVYYCAKENRDRNYDSWSGSYSDYYYGMDVWGQGTTVTVSS,DIQLTQSPSFLSASVGDRVTITCRASQGIDSFLAWYQQKPGSAPNLLIYGASTLQGGVPSRFSGSGSGTEFTLTISSLQPDDFAIYYCQQLYSYPTITFGQGTRLEIR,IGHV3-30 (Human),IGHJ6 (Human),IGKV1-9 (Human),IGKJ5 (Human),AKENRDRNYDSWSGSYSDYYYGMDV,QQLYSYPTIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H711917+K711586_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H711725+K711414,Ab,"SARS-CoV1,SARS-CoV2",MERS-CoV,,,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFNFGDFGMHWVRQAPGKGLEWVAVISYEGRNKNHADSVRGRFTISRDNSRNMLYLQMNSLRRGDTAVYYCAKENRDRNYDSWSASYSDYYYGMDVWGQGTTVTVSS,DIQLTQSPSFLSASVGDRVTITCRASQGIDRYLAWYQQKPGSAPKLLIYAASTLQSGVPSRFSGSGSETDFTLTISSLQPDDFATYYCQQLSTYPTITFGQGTRLEIK,IGHV3-30 (Human),IGHJ6 (Human),IGKV1-9 (Human),IGKJ5 (Human),AKENRDRNYDSWSASYSDYYYGMDV,QQLSTYPTIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H711725+K711414_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H711920+L711295,Ab,SARS-CoV2,"SARS-CoV1,MERS-CoV",,,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVIWYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDFMWKDQLLFGYQWGQGTLVTVSS,SYELTQPPSVSVSPGQTARITCSGDALPKKYAYWYQQKSGQAPVLVIYEDSKRPSGIPERFSGSSSGTMATLTISGAQVEDEADYYCYSTDSSGNHWVFGGGTKLTVL,IGHV3-33 (Human),IGHJ4 (Human),IGLV3-10 (Human),IGLJ3 (Human),ARDFMWKDQLLFGYQ,YSTDSSGNHWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H711920+L711295_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H711827+K711491,Ab,SARS-CoV2,"SARS-CoV1,MERS-CoV",,,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSGTLSLSCTVSGDSINSDNWWSWVRQPPGKGLEWIGEIFHTGGTNYNPSLKSRVTISVDNSENRFSLTLTSVTAADTAVYYCVRLTYVNSGYNYFDPWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRVSQSVSGAFLGWYQQRPGQAPRLLIYGASRRATGVPDRFSGSGSGTDFTLTITRLEPEDFAVYYCQQYGRAPPITFGPGTKVDIK,IGHV4-4 (Human),IGHJ5 (Human),IGKV3-20 (Human),IGKJ3 (Human),VRLTYVNSGYNYFDP,QQYGRAPPIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H711827+K711491_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H711853+L711214,Ab,SARS-CoV2,"SARS-CoV1,MERS-CoV",,,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCRPSGFTLTDYSVHWVRQAPGQGLEWMGRINSNGGDTQSAQKFQGRVAMTRDTSIRTAYMELHNLKSDDTAVYYCARSGGLGILAFDLWGQGTMVTVFS,QSALTQPPSASGSPGQSVTISCTGTSNDVGGYNFVSWYQQHPGKAPKLMIYEVSKRPSGVPDRFSGSKSGNTASLTVSGLQAEDEASYYCISYADINHVVFGGGTKLTVL,IGHV1-2 (Human),IGHJ3 (Human),IGLV2-8 (Human),IGLJ3 (Human),ARSGGLGILAFDL,ISYADINHVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H711853+L711214_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H711743+K711428,Ab,SARS-CoV2,"SARS-CoV1,MERS-CoV",,,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSNYGMHWVRQAPGKGLEWVAVIWYDGSNKYYADSVRGRFTISRDNSKNTLFLQMNSLRAEDTAVYYCARAPGGGDLGFYWGQGTLVTVSS,DIVMTQSPDSLTVSLGERATINCKSRQSVLNSSNNKNWLVWYQQKPGQPPKALISWASTRESGVPDRFSGSGSGTEFTLTISSLQAEDVAIYYCQQYYSTPWTFGQGTKVEIK,IGHV3-33 (Human),IGHJ4 (Human),IGKV4-1 (Human),IGKJ1 (Human),ARAPGGGDLGFY,QQYYSTPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H711743+K711428_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H711665+L711117,Ab,SARS-CoV2,"SARS-CoV1,MERS-CoV",,,S; S2,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVKSGGSLRLSCTGSGFTFSAYFMIWVRQAPGKGLEWVASIDSAGRSINYAESVTGRFTISRDNAKGSSHLQMNRLRAEDTALYYCAAEGISVFGVVTHFYALAAWGQGTTVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDIAAYNYVSWYQQHPGEVPKLLVYDVSNRPSGVSDRFAGSRSGNTAYLTISGLQAEDDADYYCSSYTSSGGLVFGGGTKATVL,IGHV3-21 (Human),IGHJ6 (Human),IGLV2-14 (Human),IGLJ3 (Human),AAEGISVFGVVTHFYALAA,SSYTSSGGLV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H711665+L711117_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H711695+K711388,Ab,SARS-CoV2,"SARS-CoV1,MERS-CoV",,,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASEDTFSDYYMHWVRQAPGQGLEWMGRINPATGDTNCAQKFQGRVTMTRDSSISTAYMELSRLTFDDTAVYYCASPKTDSTGSTLPLFDWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLFCRVSQSISSSQLAWYQRKPGQAPRLIIYDASSRASGIPDRFSGSESGTDFTLTINRLEPEDLAVYYCQQYGSAPYTFGQGTKLEIK,IGHV1-2 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ2 (Human),ASPKTDSTGSTLPLFD,QQYGSAPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H711695+K711388_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H711653+L711110,Ab,SARS-CoV2,"SARS-CoV1,MERS-CoV",,,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVIWYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDRPFPSSWFGEDFDYWGQGTLVTVSS,SYELTQPPSVSVSPGQTARITCSGDALPKKYAYWYQQKSGQAPVLVIYEDSKRPSGIPERFSGSSSGTMATLTISGAQVEDEADYYCYSTDSSGNHWVFGGGTKLTVL,IGHV3-33 (Human),IGHJ4 (Human),IGLV3-10 (Human),IGLJ3 (Human),ARDRPFPSSWFGEDFDY,YSTDSSGNHWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H711653+L711110_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H026058+L024028,Ab,SARS-CoV2,"SARS-CoV1,MERS-CoV,OC43,HKU1,NL63",,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGALLRVSCKGSGDTSTNHAIAWVRQAPGQGLEWMGWINVYNGRTNYAQKFQGRVTLTTDTATSTAYMELSSLRSDDTAVYYCARWIHRDFDWLPYGMFMDVWGQGTTVTVSS,QSALTQPPSASGSPGQSVTISCTGTSSDVGVYKYVSWYQHHPGKTPKVIIYEVSKRPSGVPDRFSGSKSGNTASLTVSGLQAEDEADYYCTSYEADNTLVLGGGTKLTVL,IGHV1-18 (Human),IGHJ6 (Human),IGLV2-18 (Human),IGLJ3 (Human),ARWIHRDFDWLPYGMFMDV,TSYEADNTLV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H026058+L024028_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712070+L711478,Ab,SARS-CoV2,"SARS-CoV1,MERS-CoV,OC43,HKU1,NL63",,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGGEVKKPGALLRVSCKASGDTSTNHAISWVRQAPGQGLEWMAWINVYNGRTNYAPHLQGRVTLTTDTATSTAYMQLSSLRSDDTAVYYCARWIHRDFDWLPYGMFMDVWGQGTTVTVSS,QSALTQPPSASGSPGQSVTISCTGTSIDLGVYKYVSWYQHHPGKAPKLIIYEVSKRPSGVPDRFSGSKSGNTASLTVSGLQAEDEADYYCTSYEGDNTLVFGGGTKLTVL,IGHV1-18 (Human),IGHJ6 (Human),IGLV2-18 (Human),IGLJ3 (Human),ARWIHRDFDWLPYGMFMDV,TSYEGDNTLV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712070+L711478_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712228+L711607,Ab,SARS-CoV2,"SARS-CoV1,MERS-CoV,OC43,HKU1,NL63",,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYYMHWVRQAPGQGLEWMGIINPSGGSTSYAQKFQGRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARDTSNAEDFWSAPILGYYYGMDVWGQGTTVTVSS,QSVLTQPPSASGTPGQRVTISCSGSSSNIGSNYVYWYQQLPGTAPKLLIYRNNQRPSGVPDRFSGSKSGTSASLAISGLRSEDEADYYCAAWDDSLSGVVFGGGTKLTVL,IGHV1-46 (Human),IGHJ6 (Human),IGLV1-47 (Human),IGLJ3 (Human),ARDTSNAEDFWSAPILGYYYGMDV,AAWDDSLSGVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712228+L711607_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H026027+L024013,Ab,SARS-CoV2,"SARS-CoV1,MERS-CoV,OC43,HKU1,NL63",,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVQSGAEVKKPGATVKISCKVSGYTFTDSYIHWVQQAPGKGLEWMGLLDPEDGETINAAKFQGRVTITADTSTDTAYMELRSLRSEDTAVYYCGSGSEAHYGIDYWGQGTLVTVSS,QSVLTQPPSVSGTPGQRVTISCSGSSSNIGGNFVYWYQQFPGTAPKLLIYLNNRRPSGVPDRFSGSNSGTSASLAISGLRSEDEAEYYCAAWDDSLSGQKVFGTGTKVTVL,IGHV1-69-2 (Human),IGHJ4 (Human),IGLV1-47 (Human),IGLJ1 (Human),GSGSEAHYGIDY,AAWDDSLSGQKV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H026027+L024013_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712183+L711576,Ab,SARS-CoV2,"SARS-CoV1,MERS-CoV,OC43,HKU1,NL63",,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVIWDDGSNRYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARATPHRRDQGPFHYWGQGTLVTVSS,SYVLTQPPSVSVAPGKTARITCGGNSIGSKNVHWYQQKPGQAPVLVIYYDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDIGVVFGGGTKLTVL,IGHV3-33 (Human),IGHJ4 (Human),IGLV3-21 (Human),IGLJ3 (Human),ARATPHRRDQGPFHY,QVWDIGVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712183+L711576_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712076+L711485,Ab,SARS-CoV2,"SARS-CoV1,MERS-CoV,OC43,HKU1,NL63",,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGALLRVSCKASGDTSTNHGITWVRQAPGQGLEWMGWITVYNGRTNYAQKVQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARWIHRDFDWLPYGMFMDVWGQGTTVTVSS,QSALTQPPSASGSPGQSVTISCTGTSSDLGVYKYVSWYQHHPGKAPKLMVYEVSKRPSGVPDRFSGSKSGNAASLTVSGLQAEDEADYYCTSYEGDNTLVFGGGTKLTVL,IGHV1-18 (Human),IGHJ6 (Human),IGLV2-8 (Human),IGLJ3 (Human),ARWIHRDFDWLPYGMFMDV,TSYEGDNTLV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712076+L711485_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712229+K711818,Ab,SARS-CoV2,"SARS-CoV1,MERS-CoV,OC43,HKU1,NL63",,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSQTLSLTCTVSGGSIRSGGYYWSWIRQHPGKGLEWIGNIYYSGSTYHNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAIYYCARGGPEITMIAIDAFDIWGQGTIVTVSS,DIQMTQSPSSLSASVGDRVTITCRTSQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTLLFTFGPGTKVDIK,IGHV4-31 (Human),IGHJ3 (Human),IGKV1-39 (Human),IGKJ3 (Human),ARGGPEITMIAIDAFDI,QQSYSTLLFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712229+K711818_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H026089+K023870,Ab,SARS-CoV2,"SARS-CoV1,MERS-CoV,OC43,HKU1,NL63",,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSQTLSLTCTVSGGSISSGSYYWSWIRQPAGKGLEWIGRIYSSGSTNYNPSLKSRVTISIDTSKNQLSLKLSSVTAADTAVYYCARADRERVPYFGYDFWSGYPDAFDIWGQGTMLTVSS,DIVMTQSPDSLAVPLGERATINCKSSQSVLYSSNNKNYLAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYSTRTFGQGTKVEIK,IGHV4-61 (Human),IGHJ3 (Human),IGKV4-1 (Human),IGKJ1 (Human),ARADRERVPYFGYDFWSGYPDAFDI,QQYYSTRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H026089+K023870_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H026085+L024042,Ab,SARS-CoV2,"SARS-CoV1,MERS-CoV,OC43,HKU1,NL63",,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSNYAINWVRQAPGQGLEWMGRIIPIFGIANYAQEFQGRVTITADKSTSTVYMELSSLRSEDTAVYYCARANYYYESSGYYFDYWGQGTLVTVSS,NFMLTQPHSVSESPGKTVTISCTGSSGSIASNYVQWYQQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSSTYWVFGGGTKLTVL,IGHV1-69 (Human),IGHJ4 (Human),IGLV6-57 (Human),IGLJ3 (Human),ARANYYYESSGYYFDY,QSYDSSTYWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H026085+L024042_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H026076+K023864,Ab,SARS-CoV2,"SARS-CoV1,MERS-CoV,OC43,HKU1,NL63",,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSETLSLTCTVSGGSISSYYWSWIRQPPGKGLEWIGYIYYSGSTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARGPEYYDFWSGYPGGMDVWGQGTTVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK,IGHV4-59 (Human),IGHJ6 (Human),IGKV3-20 (Human),IGKJ1 (Human),ARGPEYYDFWSGYPGGMDV,QQYGSSPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H026076+K023864_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712140+L711541,Ab,SARS-CoV2,"SARS-CoV1,MERS-CoV,OC43,HKU1,NL63",,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSGTLSLTCAVSGGSISSPNWWSWVRQPPEKGLEWIGEIFHIGSTNYNPSLKSRVTISLDKSKNQFSLRLSSVTAADTAVYYCARGFTNWYFDLWGRGTLVTVSS,SYELTQPPSVSVSPGQTATITCSGDKLGDKYACWYQQKPGQSPVLVIYQDNKRPSGIPERFSGSNSGNTATLTISETQALDEADYYCQAWDSSTDGVFGTGTKVTVL,IGHV4-4 (Human),IGHJ2 (Human),IGLV3-1 (Human),IGLJ1 (Human),ARGFTNWYFDL,QAWDSSTDGV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712140+L711541_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712103+L711508,Ab,SARS-CoV2 (weak),"SARS-CoV1,MERS-CoV,OC43,HKU1,NL63",,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSGISGSGITYNADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKLAVAGGRGANYWGQGTLVTVSS,SYELTQPPSVSVSPGQTAAITCSGDKLGDKYACWYQQKPGQSPVLVIYQDNKRPSGILERFSGSNSGNTATLTISETQALDEADYYCQAWDSSTDGVFGTGTKVTVL,IGHV3-23 (Human),IGHJ4 (Human),IGLV3-1 (Human),IGLJ1 (Human),AKLAVAGGRGANY,QAWDSSTDGV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712103+L711508_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H026078+K023865,Ab,SARS-CoV2 (weak),"SARS-CoV1,MERS-CoV,OC43,HKU1,NL63",,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCATNRQPIAVAGTLDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPYTFGQGTKLEIK,IGHV3-30-5 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ2 (Human),ATNRQPIAVAGTLDY,QQYDNLPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H026078+K023865_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712075+L711484,Ab,SARS-CoV2 (weak),"SARS-CoV1,MERS-CoV,OC43,HKU1,NL63",,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLKLSCAASGFTFSGSAMHWVRQASGKGLEWVGRIRSKANSYATAYAASVKGRFTISRDDSKNTAYLQMNSLKTEDTAVYYCTTVLRFLEWLWVRDYWGQGTLVTVSS,QSVLTQPPSVSAALGQKVTISCSGSSSNIESNYVSWYQQFPGTVPTLLIYENNKRPSGIPDRFSASKFGTSATLGISGLQTGDEADYYCGTWDRSLSAWVFGGGTKVTVL,IGHV3-73 (Human),IGHJ4 (Human),IGLV1-51 (Human),IGLJ3 (Human),TTVLRFLEWLWVRDY,GTWDRSLSAWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712075+L711484_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H026059+K023856,Ab,SARS-CoV2 (weak),"SARS-CoV1,MERS-CoV,OC43,HKU1,NL63",,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQTGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLESVAIISYDGSSTYYAESVQDRFTISRDNSKNTLYLQMNSLRTEDTAMYYCAKDMAFSGTFPFLEYWGQGTLVTVSS,DIQMTQSPSSVSASVGDRVTLTCRASQGISSWLAWYQQKPGKAPKLLIYIASSLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQARTFPYTFGQGTKLEIR,IGHV3-30-3 (Human),IGHJ4 (Human),IGKV1-12 (Human),IGKJ2 (Human),AKDMAFSGTFPFLEY,QQARTFPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H026059+K023856_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712148+K711777,Ab,SARS-CoV2 (weak),"SARS-CoV1,MERS-CoV,OC43,HKU1,NL63",,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQQWGAGLLKPSETLSRTCAVYGASFSGSYWSWIRQSPGKGLEWIGDINHRGNTNYNPSLESRLTMSVDTSKKQFSLELSSVTAADTAVYYCARSTPFRLTAAGPDYYGLDVWGQGATVIVSS,AIQMTQSPSSLSASVGDRVTITCRASQVIRNDLGWYQQKPGKAPKLLMFAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDSATYYCLQDYNYPRTFGQGTKVEIK,IGHV4-34 (Human),IGHJ6 (Human),IGKV1-6 (Human),IGKJ1 (Human),ARSTPFRLTAAGPDYYGLDV,LQDYNYPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712148+K711777_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H026089+L024044,Ab,SARS-CoV2 (weak),"SARS-CoV1,MERS-CoV,OC43,HKU1,NL63",,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSQTLSLTCTVSGGSISSGSYYWSWIRQPAGKGLEWIGRIYSSGSTNYNPSLKSRVTISIDTSKNQLSLKLSSVTAADTAVYYCARADRERVPYFGYDFWSGYPDAFDIWGQGTMLTVSS,QSALTQPRSVSGSPGQSVTISCTGTSSDVGGYNYVSWYQQHPGKAPQLMIYDVIKRPSGVPDRFSGSKSGNTASLTISGLQAEDEADYYCCSYAGSYIFYVFGTGTKVTVL,IGHV4-61 (Human),IGHJ3 (Human),IGLV2-11 (Human),IGLJ1 (Human),ARADRERVPYFGYDFWSGYPDAFDI,CSYAGSYIFYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H026089+L024044_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712154+K711779,Ab,SARS-CoV2 (weak),"SARS-CoV1,MERS-CoV,OC43,HKU1,NL63",,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCASERSRSIAVAGTLDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLLLTFGGGTKVEIK,IGHV3-30-3 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ4 (Human),ASERSRSIAVAGTLDY,QQYDNLLLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712154+K711779_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712167+K711783,Ab,SARS-CoV2,"SARS-CoV1,MERS-CoV,OC43,HKU1,NL63",,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVTLKESGPVLVKPTETLTLTCTVSGFSLSNARMGVSWIRQPPGKALEWLAHIFSGDEKSYSTSLTSRLTISKDTSKSQVVLTMTNMDPVDTATYYCARIQLWLDGGGMDVWGQGTTVTVSS,AIQMTQSPSSLSASVGDRVTITCRASQDIKNDLAWYQQRPGKAPNLLIYAASSLQTGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCLQDYDFPPYTFGQGTKLEIK,IGHV2-26 (Human),IGHJ6 (Human),IGKV1-6 (Human),IGKJ2 (Human),ARIQLWLDGGGMDV,LQDYDFPPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712167+K711783_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712149+L711549,Ab,SARS-CoV2,"SARS-CoV1,MERS-CoV,OC43,HKU1,NL63",,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYFCATDPASDSLYYYYGMDVWGQGTTVTVSS,SYELTQPPSVSVSPGQTASITCSGDKLGDKYACWYQQKPGQSPVLVIYQDSKRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCQAWDSRIVVFGGGTQLTVL,IGHV3-30 (Human),IGHJ6 (Human),IGLV3-1 (Human),IGLJ3 (Human),ATDPASDSLYYYYGMDV,QAWDSRIVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712149+L711549_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H172145+K711775,Ab,SARS-CoV2,"SARS-CoV1,MERS-CoV,OC43,HKU1,NL63",,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKTGASVKVSCKTSGYTFTGFHIHWVRQAPGQGLEWMGRINPNTGGTTYAQEFQGWVTMTRDSSISTAYMDLSRLKLDDTAVYYCATARCSGDLCPFDYWGQGTLVTVSS,DIQMTQSPSNLSASVGDRVIITCRASQTISSWLAWYQQKPGKAPNLLIYEASSLESGVPARFSGSGSGTEFTLTINGLQPDDFATYYCQQYDTYWTFGQGTKVEIK,IGHV1-2 (Human),IGHJ4 (Human),IGKV1-5 (Human),IGKJ1 (Human),ATARCSGDLCPFDY,QQYDTYWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H172145+K711775_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712475+K711960,Ab,SARS-CoV2,"SARS-CoV1,MERS-CoV,OC43,HKU1,NL63",,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYGISWVRQAPGQGLEWMGWISVYNGYTNYAQKLQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCAREGYCSSTSCYGGNYYYYGMDVWGQGTTVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRRNRGTFGQGTKLVIK,IGHV1-18 (Human),IGHJ6 (Human),IGKV3-11 (Human),IGKJ2 (Human),SSTSCYGGNYYYYGMDV,QQRRNRGT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712475+K711960_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712488+L711741,Ab,SARS-CoV2,"SARS-CoV1,MERS-CoV,OC43,HKU1,NL63",,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVQSGAEVKKPGATVKISCKVSGYTFTDSYIHWVQQAPGKGLEWMGLLDPEDGETINAARLQGRVTITADTSTDTAYMELRSLRSEDTAVYYCGSGSEAHYGIDYWGQGTLVTVSS,QSVLTQPPSVSGTPGQRVTISCSGSSSNIGGNFVYWYQQFPGTAPKLLIYLNYRRPSGVPDRFSGSNSGTSASLAISGLRSEDEAEYYCATWDDSLSGQKVFGTGTKVTVL,IGHV1-69-2 (Human),IGHJ4 (Human),IGLV1-47 (Human),IGLJ1 (Human),GSGSEAHYGIDY,ATWDDSLSGQKV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712488+L711741_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712463+K711953,Ab,SARS-CoV2,"SARS-CoV1,MERS-CoV,OC43,HKU1,NL63",,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSGTLSLTCAVSGGSISSPNWWSWVRQPPEKGLEWIGEIFHIGSTNYNPSLKSRVTISLDKSKNQFSLRLSSVTAADTAVYYCARGFTNWYFDLWGRGTLVTVSS,DIQMTQSPSTLSASVGDRVTITCRASQSISSWLAWYQQKPGKAPKVLIYKASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNSYSPLTFGGGTKVEIK,IGHV4-4 (Human),IGHJ2 (Human),IGKV1-5 (Human),IGKJ4 (Human),ARGFTNWYFDL,QQYNSYSPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712463+K711953_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712467+L711731,Ab,SARS-CoV2,"SARS-CoV1,MERS-CoV,OC43,HKU1,NL63",,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLKLSCAASGFTFSSYNMNWVRQAPGKGLEWVSYISSSSSAIYYADSVKGRFTISRDNAKNSLYLQMNSLRHEDTAVYYCARMGSRHTRPYSSGWYPDPDDYWGQGTLVTVSS,SYVLTQPPSVSVAPGKTARITCGENNIGSKSVHWYQQKPGQAPVLVIYYDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCHVWDSSSGHPRVFGTGTKVTVL,IGHV3-48 (Human),IGHJ4 (Human),IGLV3-21 (Human),IGLJ1 (Human),ARMGSRHTRPYSSGWYPDPDDY,HVWDSSSGHPRV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712467+L711731_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712442+K711940,Ab,SARS-CoV2,"SARS-CoV1,MERS-CoV,OC43,HKU1,NL63",,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDYGDFYFDYWGQGTLVTVSS,EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQHYYNWPRTFGQGTKVEVK,IGHV3-53 (Human),IGHJ4 (Human),IGKV3-15 (Human),IGKJ1 (Human),ARDYGDFYFDY,QHYYNWPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712442+K711940_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712492+L711744,Ab,SARS-CoV2,"SARS-CoV1,MERS-CoV,OC43,HKU1,NL63",,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPRLVKPSETLSLTCTVSGGSISSYYWSWIRQPPGKGLEWIGYIYYSGNTKYNPSLKSRVAISVDTSKNQFSLRLSSVTAADTAVYYCARVLVPISGVDVWGQGTTVTVSS,NFMLTQPHSVSESPGKTVTISCTGSSGSIASNYVQWYQQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDNSFWVFGGGTKLTVL,IGHV4-59 (Human),IGHJ6 (Human),IGLV6-57 (Human),IGLJ3 (Human),ARVLVPISGVDV,QSYDNSFWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712492+L711744_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712494+K711975,Ab,SARS-CoV2,"SARS-CoV1,MERS-CoV,OC43,HKU1,NL63",,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASELTVSSNYMTWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLNYYGMDVWGQGTTVTVSS,DIQLTQSPSFLSASVGDRVTITCRASQGINSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPADFATYYCQQLDSYPPFTFGPGTKVDIK,IGHV3-66 (Human),IGHJ6 (Human),IGKV1-9 (Human),IGKJ3 (Human),ARDLNYYGMDV,QQLDSYPPFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712494+K711975_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712495+K711745,Ab,SARS-CoV2,"SARS-CoV1,MERS-CoV,OC43,HKU1,NL63",,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVQSGAEVTKPGTTLKISCKVSGYNSSAYYVHWVRQTPEKGLQWMGLIDREGRGAIYAETFKGRVTMIVDTSTATAYLEVTRLRSDDTAVYYCATGPGATRATIYGFAHWGQGTLVTVSS,QAVVTQEPSLTVSPGGTVTLTCGSSTGAVTSGHYPYWFQQKPGQAPRTLIYDTSNKHSWTPARFSGSLLGGKAALTLSGAQPEDEAEYYCLLSYSGARYVVFGGGTKLTVL,IGHV1-69-2 (Human),IGHJ1 (Human),IGLV7-46 (Human),IGLJ3 (Human),ATGPGATRATIYGFAH,LLSYSGARYVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712495+K711745_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712483+K711968,Ab,SARS-CoV2,"SARS-CoV1,MERS-CoV,OC43,HKU1,NL63",,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCLASGFPFKNYAMTWVRQAPGKGLEWISVLSGPGTSINYAASVKGRFTVSRDNSKSTLYLQMNRLTVEDTAIYYCARNRTDLSGAAWFDSWGQGVLVTVSS,DIQMTQSPSAVSASVGDRVTITCRASQGIRGGLAWYQQIPGKAPKLLIYGASTLQSGVPSRFSGRGSGTEFTLTISSLQPEDFAVYHCQQGDSFPYSFGQGTKLEIK,IGHV3-23 (Human),IGHJ5 (Human),IGKV1D-12 (Human),IGKJ2 (Human),ARNRTDLSGAAWFDS,QQGDSFPYS,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712483+K711968_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H026331+L024145,Ab,SARS-CoV2,"SARS-CoV1,MERS-CoV,OC43,HKU1,NL63",,,S; RBD,B-cells; SARS-CoV2 Human Patient,QLQLQESGPGLVKPSETLSLTCTVSGGSISSSSYYWGWIRQPPGKGLEWIGSIYYSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARRMNYDSSGYYYVHFDYWGQGTLVTVSS,QSALTQPRSVSGSPGQSVTISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSKRPSGVPDRFSGSKSGNTASLTISGLQAEDEADYYCCSYAGSYTYYVFGTGTKVTVL,IGHV4-39 (Human),IGHJ4 (Human),IGLV2-11 (Human),IGLJ1 (Human),ARRMNYDSSGYYYVHFDY,CSYAGSYTYYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H026331+L024145_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H026335+L024147,Ab,SARS-CoV2,"SARS-CoV1,MERS-CoV,OC43,HKU1,NL63",,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVTLKESGPVLVKATETLTLTCTVSGFSHSNVRMGVSWIRQPPGKALEWLAHISPNDEKSYSTSLKSRLTISEDTSKSQVVLTMTNMDPVDTATYYCARPLSPGFPDVFDIWGQGSMVTVSS,SYVLTQPPSVSVAPGKTARITCGGDNIRTKSVQWYQQKPGQAPMLVIYYDSDRPSGIPERFSGSNSGNTATLTISRVEGGDEADYYCQVWDSSGDQAVFGGGTKLTVL,IGHV2-26 (Human),IGHJ3 (Human),IGLV3-21 (Human),IGLJ3 (Human),ARPLSPGFPDVFDI,QVWDSSGDQAV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H026335+L024147_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712574+L711805,Ab,"SARS-CoV1,SARS-CoV2,MERS-CoV,OC43","HKU1,NL63",,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAINWVRQAPGQGLEWMGRIIPLFGIANYAQKFQGRVTITADNSTTTAYMELSSLRSEDTAVYYCARAGYYYDSSPYPFDYWGQGTLVTVSS,SYELTQPLSVAVAPGETARITCSGDALSEEYTHWYQQRPGQAPVLIIYKDTERPSGIPERFSGSTSGTTVTLTISGVQAEDEADYYCQSPDTTSTYRVFGGGTKLAVL,IGHV1-69 (Human),IGHJ4 (Human),IGLV3-25 (Human),IGLJ3 (Human),ARAGYYYDSSPYPFDY,QSPDTTSTYRV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712574+L711805_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H026336+L024148,Ab,"SARS-CoV1,SARS-CoV2,MERS-CoV,OC43","HKU1,NL63",,,S; RBD,B-cells; SARS-CoV2 Human Patient,QITLKESGPTLVKPTQTLTLTCTFSGFSLSTSGVGVGWIRQPPGKALEWLALIYWDDDKRYSPSLKSRLTITKDTSKNQVVLTMTNMDPVDTATYYCTHRPIPAAGTLVFLNWFDPWGQGTLVTVSS,QSVLTQPPSVSEAPRQRVTISCSGSSSNIGNNVVNWYQQLPGKAPKLLIYYDDLLPSGVSDRFSGSKSGTSASLAISGLQSEDEADYYCASWDDSLNGPVFGGGTKLTVL,IGHV2-5 (Human),IGHJ5 (Human),IGLV1-36 (Human),IGLJ3 (Human),THRPIPAAGTLVFLNWFDP,ASWDDSLNGPV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H026336+L024148_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712568+L711801,Ab,SARS-CoV2,"SARS-CoV1,MERS-CoV,OC43,HKU1,NL63",,,S; RBD,B-cells; SARS-CoV2 Human Patient,QLQLQESGPGLVKPSETLSLTCTVSGGSISSSSYYWGWIRQPPGKGLEWIGSIYYSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCASQQWLRGNFDYWGQGTLVTVSS,NFMLTQPHSVSESPGKTVTISCTGSSGSIASNYVQWYQQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSSTYWVFGGGTKLTVL,IGHV4-39 (Human),IGHJ4 (Human),IGLV6-57 (Human),IGLJ3 (Human),ASQQWLRGNFDY,QSYDSSTYWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712568+L711801_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H026367+K024035,Ab,SARS-CoV2,"SARS-CoV1,MERS-CoV,OC43,HKU1,NL63",,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSNYAINWVRQAPGQGLEWMGRIIPMFDIANYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCARAGYYYDSSGYPFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQNISNYLNWYQQKPRKAPNLLIYAASSLQSGVPSRFSGSGSGTDFTLTINSLQPEDFATYYCQQSYNAPRTFGQGTKVEIT,IGHV1-69 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ1 (Human),ARAGYYYDSSGYPFDY,QQSYNAPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H026367+K024035_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H026368+K024036,Ab,SARS-CoV2,"SARS-CoV1,MERS-CoV,OC43,HKU1,NL63",,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKHLWGSVKAPCKASGGTFSSYAINWVRQAPGQGLEWMGRIIPMFGIANYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCARAGYYYESSGYHFDYWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSRTFGQGTKVEIK,IGHV1-69 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ1 (Human),ARAGYYYESSGYHFDY,QQYGSSRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H026368+K024036_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H026337+L024149,Ab,SARS-CoV2,"SARS-CoV1,MERS-CoV,OC43,HKU1,NL63",,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGALLRVSCKASGDTSTNHGISWVRQAPGQGLEWMGWINVYNGRTNYAQKVQGRVTMTTDTSTRTAYMELRSLRSDDTAVYYCARWIHRDFDWLPYGMFMDVWGQGTTVTVSS,QSALTQPPSASGSPGQSVTISCTGTSSDVGVYKYVSWYQHHPGKAPKLMLYEVSKRPSGVPDRFSGSKSGNTASLTVSGLQAEDEADYYCTSYEGDNTLVFGGGTKLTVL,IGHV1-18 (Human),IGHJ6 (Human),IGLV2-8 (Human),IGLJ3 (Human),ARWIHRDFDWLPYGMFMDV,TSYEGDNTLV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H026337+L024149_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H026350+K024024,Ab,SARS-CoV2,"SARS-CoV1,MERS-CoV,OC43,HKU1,NL63",,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLIQPGGSLRLSCAASEFIVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARQLGDYVDYWGQGTLVTVSS,DIQLTQSPSFLSASVGDRVTITCRASQGIGSYLAWYQQKPGKAPKLLIYASSTLQGGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQHLNTYPPSLTFGGGTKVEIK,IGHV3-53 (Human),IGHJ4 (Human),IGKV1-9 (Human),IGKJ4 (Human),ARQLGDYVDY,QHLNTYPPSLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H026350+K024024_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712556+K712020,Ab,SARS-CoV2,"SARS-CoV1,MERS-CoV,OC43,HKU1,NL63",,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLIQPGGSLRLSCAASGVTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRVEDTAVYYCARDLAERGGMDVWGQGTTVTVSS,DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPITFGQGTRLEIK,IGHV3-53 (Human),IGHJ6 (Human),IGKV1-9 (Human),IGKJ5 (Human),ARDLAERGGMDV,QQLNSYPIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712556+K712020_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H026349+K024023,Ab,SARS-CoV2,"SARS-CoV1,MERS-CoV,OC43,HKU1,NL63",,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPKKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAREGAAANTHGWFDPWGQGTLVTVSS,DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPPITFGQGTRLEIK,IGHV3-53 (Human),IGHJ5 (Human),IGKV1-9 (Human),IGKJ5 (Human),AREGAAANTHGWFDP,QQLNSYPPIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H026349+K024023_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H026346+K024021,Ab,SARS-CoV2,"SARS-CoV1,MERS-CoV,OC43,HKU1,NL63",,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQQSGPGLVKPSQTLSLTCAISGDSVSYNSAAWNWIRQSPSRGLEWLGRTYYRSNWYNDYAVSVKSRITINPDTSKNQFSLQLNSVTPEDTAVYYCARAPGIAARLGLYGMDVWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSIPRTFGGGTKVEIK,IGHV6-1 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ4 (Human),ARAPGIAARLGLYGMDV,QQSYSIPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H026346+K024021_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H026371+L024159,Ab,"SARS-CoV1,SARS-CoV2,MERS-CoV (weak),OC43","HKU1,NL63",,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSETLSLTCTVSGGSISSYYWSWIRQPPGKGLEWIGYIYYSGSTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARGTFTLGYYYGMDVWGQGTTVTVSS,SYVLTQPPSVSVAPGKTARITCGGNNIGSKSVHWYQQKPGQAPVLVIYYDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDSSSDPVFGGGTKLTVL,IGHV4-59 (Human),IGHJ6 (Human),IGLV3-21 (Human),IGLJ3 (Human),ARGTFTLGYYYGMDV,QVWDSSSDPV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H026371+L024159_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H026348+L024151,Ab,SARS-CoV2,"SARS-CoV1,MERS-CoV,OC43,HKU1,NL63",,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSNYGMHWVRQAPGKGLEWVALIWYDGSNKYYVDSVKGRLTISRDNSKNTLYLQMNSLRAEDTAVYYCARGADILTGYYNYYYYGMDVWGQGTTVTVSS,QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWYQQLPGTAPKLLIYGNNNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSFDSSLSDHVVFGGGTKLTVL,IGHV3-33 (Human),IGHJ6 (Human),IGLV1-40 (Human),IGLJ3 (Human),ARGADILTGYYNYYYYGMDV,QSFDSSLSDHVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H026348+L024151_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H026364+K024033,Ab,SARS-CoV2,"SARS-CoV1,MERS-CoV,OC43,HKU1,NL63",,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSGTLSLTCAVSGGSISSPNWWSWVRQPPEKGLEWIGEIFHIGSTNYNPSLKSRVTISLDKSKNQFSLRLSSVTAADTAVYYCARGFTNWYFDLWGRGTLVTVSS,DIQMTQSPSTLSASVGDRVTITCRASQSISSWLAWYQQKPGKAPKVLIYKASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNSYSPLTFGGGTKVEIK,IGHV4-4 (Human),IGHJ2 (Human),IGKV1-5 (Human),IGKJ4 (Human),ARGFTNWYFDL,QQYNSYSPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H026364+K024033_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712561+L711795,Ab,"SARS-CoV1,SARS-CoV2,MERS-CoV,OC43","HKU1,NL63",,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQQSGPGLVKPSQTLSLTCAISGDSVSSDSATWNWIRQSPSRGLEWLGRTYYRSKWYNDYVVSVKSRISINPDTSKNQFSLQLNSVTPEDTAVYYCARDWGPQYCSGGSCYSTSRWFDPWGQGTPVTVSS,QSVLTQPPSASGTPGQRVTISCSGSSSNIGSNTVNWYQQLPGTAPKLLIYSNNQRPSGVPDRFSGSKSGTSASLAISGLQSEDEADYYCAAWDDSLNGYVFGTGTKVTVL,IGHV6-1 (Human),IGHJ5 (Human),IGLV1-44 (Human),IGLJ1 (Human),ARDWGPQYCSGGSCYSTSRWFDP,AAWDDSLNGYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712561+L711795_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712562+L711796,Ab,SARS-CoV2,"SARS-CoV1,MERS-CoV,OC43,HKU1,NL63",,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQQSGPGLVKPSQTLSLTCAISGDSVSSDSATWNWIRQSPSRGLEWLGRTYYRSKWYNDYVVSVKSRISINPDTSKNQFSLQLNSVTPEDTAVYYCARDWGPQYCSGGSCYSTSRWFDPWGQGTPVTVSS,SYELTQPLSVAVAPGETARITCSGDALSEEYTHWYQQRPGQAPVLIIYKDTERPSGIPERFSGSTSGTTVTLTISGVQAEDEADYYCQSPDTTSTYRVFGGGTKLTVL,IGHV6-1 (Human),IGHJ5 (Human),IGLV3-25 (Human),IGLJ3 (Human),ARDWGPQYCSGGSCYSTSRWFDP,QSPDTTSTYRV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712562+L711796_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712564+K712022,Ab,SARS-CoV2,"SARS-CoV1,MERS-CoV,OC43,HKU1,NL63",,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSQTLSLTCTVSGGSISRAGYYWSWIRQHPGKGLEWIGYIFYSGSTYYNPSLKSRVTISEDTSKNQFSLKLSSVTAADTAVYYCASSGRLTIYYWGQGTLVTVSS,DIVMTQTPLSSPVTLGQPASISCRSSQSLVHSDGNTYLSWLQQRPGQPPRLLIYKISNRFSGVPDRFSGSGAGTDFTLKISRVEAEDVGVYYCMQGTQFPQVTFGQGTRLEIK,IGHV4-31 (Human),IGHJ4 (Human),IGKV2-24 (Human),IGKJ5 (Human),ASSGRLTIYY,MQGTQFPQVT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712564+K712022_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712574+K712026,Ab,SARS-CoV2,"SARS-CoV1,MERS-CoV,OC43,HKU1,NL63",,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAINWVRQAPGQGLEWMGRIIPLFGIANYAQKFQGRVTITADNSTTTAYMELSSLRSEDTAVYYCARAGYYYDSSPYPFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTFTCRASQNISSYLNWYQHKPGKAPKLLIYGASSLQSGVPSRVSGSGSGTDFTLTISSLQPEDFATYYCQQSYSSPRTFGQGTKVEIK,IGHV1-69 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ1 (Human),ARAGYYYDSSPYPFDY,QQSYSSPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712574+K712026_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712572+L711804,Ab,"SARS-CoV1,SARS-CoV2,MERS-CoV,OC43","HKU1,NL63",,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVIWYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAREFGSTPIYDIMTGPFDYWGQGTLVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQGEDEADYYCSSYTSSSTRVFGGGTKLTVL,IGHV3-33 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ3 (Human),AREFGSTPIYDIMTGPFDY,SSYTSSSTRV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712572+L711804_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712571+K712024,Ab,SARS-CoV2,"SARS-CoV1,MERS-CoV,OC43,HKU1,NL63",,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSNYAISWVRQAPGQGLEWMGGIIPIFDTTNYSQKFQGRVTFTADESTGTAYMELSSLRSEDTAIYYCARLQNDRLFLSWFDPWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQGISNYLAWYQQKPGKVPKLLIYGASTLQSGVPSRFSGSGSGTDFALTISGLQTEDVATYYCQKYNSALFTFGPGTKVNIK,IGHV1-69 (Human),IGHJ5 (Human),IGKV1-27 (Human),IGKJ3 (Human),ARLQNDRLFLSWFDP,QKYNSALFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712571+K712024_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712110+L711513,Ab,SARS-CoV2,SARS-CoV1,,,S; NTD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGLVKPGGSLRLSCAASGFTFSDYYMSWIRQAPGKGLEWVSYISGTGSTIYYADSVKGRFTISRDNAKNSLYLQMNSLRAADTAVYYCARDAVAGPRRELYYYYGMDIWGQGTTVTVSS,SYELTQPPSVSVSPGQTARITCSGDALPKQYGYWYQQKPGQALVLVIYKDSERPSGISERFSGSSSGTTVTLTISGVQAEDEADYYCQSADSSATYPVFGGGTKLTVL,IGHV3-11 (Human),IGHJ6 (Human),IGLV3-25 (Human),IGLJ3 (Human),ARDAVAGPRRELYYYYGMDI,QSADSSATYPV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712110+L711513_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H026054+K023853,Ab,SARS-CoV2,SARS-CoV1,,,S; NTD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSQTLSLTCTVSGGSISSGDYYWSWIRQPPGKGLEWIGYIYYSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARGQSHVLLWFGELLGWFDPWGQGTLVTVSS,EIVLTQSPGTLSLSPGERASLSCRASQSVTSSYLTWYQQKPGQAPRLLIFGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAEYYCQHYGNPLFTFGQGTKIDIE,IGHV4-30-4 (Human),IGHJ5 (Human),IGKV3-20 (Human),IGKJ3 (Human),ARGQSHVLLWFGELLGWFDP,QHYGNPLFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H026054+K023853_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712057+L711468,Ab,SARS-CoV2,SARS-CoV1,,,S; NTD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSGTLSLTCAVSGGSISSGHWWTWVRQPPGKGLEWIGEIYHSGNTNYNTSLKSRVTISVDKSNNQFSLKLTSVTAADTAVFYCARRYCSGGTCSPFDYWGQGTLVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGSYNLVSWYQQHPGKAPKLMIYEVNKRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCCSYGGSSTWVFGGGTKLTVL,IGHV4-4 (Human),IGHJ4 (Human),IGLV2-23 (Human),IGLJ3 (Human),ARRYCSGGTCSPFDY,CSYGGSSTWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712057+L711468_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H026054+K023854,Ab,SARS-CoV2,SARS-CoV1,,,S; NTD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSQTLSLTCTVSGGSISSGDYYWSWIRQPPGKGLEWIGYIYYSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARGQSHVLLWFGELLGWFDPWGQGTLVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTNFTLTISSLEPEDYAVYYCQHRSNSFGQGTRLEIK,IGHV4-30-4 (Human),IGHJ5 (Human),IGKV3-11 (Human),IGKJ5 (Human),ARGQSHVLLWFGELLGWFDP,QHRSNS,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H026054+K023854_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712101+L711506,Ab,SARS-CoV2,SARS-CoV1,,,S; NTD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSTYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKSDSELLPHFDYWGQGTLVTVSS,SYVLTQPPSVSVAPGKTARITCGGDNIRSKSVHWYQQKPGQAPMLVIYYDSDRPSGIPERFSGSNSGNTATLTISRVEGGDEADYYCQVWDSSGDQAVFGGGTKLTVL,IGHV3-30 (Human),IGHJ4 (Human),IGLV3-21 (Human),IGLJ3 (Human),AKSDSELLPHFDY,QVWDSSGDQAV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712101+L711506_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H026014+L024006,Ab,SARS-CoV2,SARS-CoV1,,,S; NTD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSTYGMHWVRQAPGKGLEWVAVISYGGSNKDYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAQLEGDSNSYGYDYYYYYGMDVWGQGTTVTVSS,QSVLTQPPSASGTPGQRVTISCSGSSSNIGSNSVNWYQKLPGTAPKLLIYSNNQRPSGVPDRFSGSKSGTSASLAISGLQSEDEADYYCAAWDDSLNWVFGGGTKLTVL,IGHV3-30 (Human),IGHJ6 (Human),IGLV1-44 (Human),IGLJ3 (Human),AQLEGDSNSYGYDYYYYYGMDV,AAWDDSLNWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H026014+L024006_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712056+L711468,Ab,SARS-CoV2,SARS-CoV1,,,S; NTD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFAGYYMHWVRQAPGQGLEWMGRINPNSGGTNYAQKFQGRVTMTRDMSISTAYMELSRLRSDDTVVYYCARENRGSGRGWFDPWGQGTLVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGSYNLVSWYQQHPGKAPKLMIYEVNKRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCCSYGGSSTWVFGGGTKLTVL,IGHV1-2 (Human),IGHJ5 (Human),IGLV2-23 (Human),IGLJ3 (Human),ARENRGSGRGWFDP,CSYGGSSTWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712056+L711468_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712222+K711812,Ab,SARS-CoV2,SARS-CoV1,,,S; NTD,B-cells; SARS-CoV2 Human Patient,EVQLVQSGAEVKKPGVTVKISCKVSGYTFTDYYMHWVQQAPGKGLEWMGLVDPEDGETIYAEKFQGRVTITADTSTDTAYMELSSLRSEDTAVYYCATSAVGATLGYWGQGTLVTVSS,DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYLTFGGGTKVEIK,IGHV3-48 (Human),IGHJ4 (Human),IGLV1-40 (Human),IGKJ4 (Human),ATSAVGATLGY,QQLNSYLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712222+K711812_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712087+L711494,Ab,SARS-CoV2,SARS-CoV1,,,S; NTD,B-cells; SARS-CoV2 Human Patient,QVQLQQWGAGLLKPSETLSLTCAVYGGSLSGYYWSWIRQPPGRGLEWIGEISHDGNTKYNPSLKSRLTISVDMSNNHFSLKLSSVTAADTAVYYCARMVVQGHLQPYYYGMDVWGQGTTVTVSS,QSVLTQPPSVSGTPGQRVIISCSGSSSNIGSNYVYWYQQFSGTAPKLLIYRNTQRPSGVPDRISGSKSGTSASLAISGLRSEDEADYYCATWDDRVRGYWVFGGGTKLTVL,IGHV4-34 (Human),IGHJ6 (Human),IGLV1-47 (Human),IGLJ3 (Human),ARMVVQGHLQPYYYGMDV,ATWDDRVRGYWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712087+L711494_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712135+K711770,Ab,SARS-CoV2,SARS-CoV1,,,S; NTD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVKPGGSLRLSCAASGFTFSNAWMSWVRQAPGKGLEWVGRIKSKTDGGTTDYAAPVKGRFTISRDDSKNTLYLQMNSLKTEDTAVYYCTTDRDYDYIWGSYRYRDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSPLFGPGTKVDIK,IGHV3-15 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ3 (Human),TTDRDYDYIWGSYRYRDY,QQSYSPL,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712135+K711770_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712227+K711816,Ab,SARS-CoV2,SARS-CoV1,,,S; NTD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGTGLEWVAVIWYDVSNNYNADSLKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDDSSGWYRPLYYYYYGMDVWGQGTTVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPRTFGGGTKVEIK,IGHV3-33 (Human),IGHJ6 (Human),IGKV3-20 (Human),IGKJ4 (Human),ARDDSSGWYRPLYYYYYGMDV,QQYGSSPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712227+K711816_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712205+K711804,Ab,SARS-CoV2,SARS-CoV1,,,S; NTD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSQTLSLTCTVSGGSITSGNYYWTWIRQPAGKGLEWIGRIDTSGSTNYNPSLKSRVTTSLDTSKNQFSLKLSSVTAADTAVYYCAREVAFFDWLLQSDYYHGMDVWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSITRSLNWYQQKPGKAPNVLIYGASSLQTGVPSRFSGSGSGTDFTLTISALQPEDFATYYCQQSYTTPITFGQGTRLEIK,IGHV4-61 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ5 (Human),AREVAFFDWLLQSDYYHGMDV,QQSYTTPIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712205+K711804_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712214+L711598,Ab,SARS-CoV2 (weak),SARS-CoV1,,,S; NTD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSQTLSLTCTVSGGSISSGGYYWSWIRQHPGKGLEWIGYIYYSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARADIVVVPAAAFDYWGQGTLVTVSS,QSALTQPPSASGSPGQSVTISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYEVTKRPSRVPDRFSASKSGNTASLTVSGLQAEDEADYYCSSYAGSNNPYVFGPGTKVTVL,IGHV4-31 (Human),IGHJ4 (Human),IGLV2-8 (Human),IGLJ1 (Human),ARADIVVVPAAAFDY,SSYAGSNNPYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712214+L711598_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712061+K711727,Ab,SARS-CoV2 (weak),SARS-CoV1,,,S; NTD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKVSHDFGDYGDYEFDYWGQGTLVTVSS,DIQMTQSPSPPCAYVGDRVTITCRGSQGIRKGLDWYQQKPQKAPKSLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCLQYNSYPHFFGKETSVDQH,IGHV3-30 (Human),IGHJ4 (Human),IGKV1D-16 (Human),IGKJ3 (Human),AKVSHDFGDYGDYEFDY,LQYNSYPHF,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712061+K711727_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712170+K711785,Ab,SARS-CoV2 (weak),SARS-CoV1,,,S; NTD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYTISWVRQAPGQGLEWMGRIIPILGIANYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCARAEWDCSGGSCPWGQGTLVTVSS,EIVLTQSPATLSLSPGERATLSCGASQSVSSSYLAWYQQKPGLAPRLLIYDASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK,IGHV1-69 (Human),IGHJ5 (Human),IGKV3D-20 (Human),IGKJ1 (Human),ARAEWDCSGGSCP,QQYGSSPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712170+K711785_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H026109+K023883,Ab,SARS-CoV2 (weak),SARS-CoV1,,,S; NTD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYWMSWVRQAPGKGLEWVANIKQDGSEKYYVDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARDGGGEYSGYDYAFDIWGQGTMVTVSS,DIQMTQSPSSVSASVGDRVTITCRASQGISSWLAWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQANSFPPTFGGGTKVEIK,IGHV3-7 (Human),IGHJ3 (Human),IGKV1-12 (Human),IGKJ4 (Human),ARDGGGEYSGYDYAFDI,QQANSFPPT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H026109+K023883_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712219+K711810,Ab,SARS-CoV2 (weak),SARS-CoV1,,,S; NTD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVRVPCKVSGYRITELSMHWVRQAPGKGLEWMGGFNPEDGETIYAQQFQGRVSMTEDTAADTAYMELTRLRSDDTAVYYCATSLAVVGDRGHYHYYFGMDVWGQGTTVTVSS,DIVMTQTPLSSPVTLGQPASISCRSSQSLVHSDGNTYLSWLQQRPGQPPRLLIYKISERFSGVPDRFSGSGAETDFTLKISRVEAEDVGVYYCMQATHFAYTFGQGTKLEIK,IGHV1-24 (Human),IGHJ6 (Human),IGKV2-24 (Human),IGKJ2 (Human),ATSLAVVGDRGHYHYYFGMDV,MQATHFAYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712219+K711810_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712051+K711722,Ab,SARS-CoV2 (weak),SARS-CoV1,,,S; NTD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSTYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSMKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKGDYDVWSGYHRVYYYHGMDVWGQGTTVTVSS,DIVMTQSPLSLPVTPGELASISCRSSQSLLYSNGNNYLDWYLQKPGQSPQLLIYLGSNRASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQALQTPYTFGQGTKLEIK,IGHV3-30 (Human),IGHJ6 (Human),IGKV2-28 (Human),IGKJ2 (Human),AKGDYDVWSGYHRVYYYHGMDV,,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712051+K711722_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712450+L711722,Ab,SARS-CoV2,SARS-CoV1,,,S; NTD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYYMHWVRQAPGQGLEWMGIINPSGGSTSYAQKFQGRVTMTRDTSTSTVYMELSSLRSEETAVYYCARDHRKRGGDYGGNIFPGFDYWGQGTLVTVSS,SYELTQPPSVSVSPGQTARITCSGDALPKQYAYWYQQKPGQAPVLVIYKDSERPSGIPERFSGSSSGTTVTLTISGVQAEDEADYYCQSADSSGNSVVFGGGTKLTVL,IGHV1-46 (Human),IGHJ4 (Human),IGLV3-25 (Human),IGLJ3 (Human),ARDHRKRGGDYGGNIFPGFDY,QSADSSGNSVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712450+L711722_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712470+L711734,Ab,SARS-CoV2,SARS-CoV1,,,S; NTD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVTVSCKASGYTFTSFGISWVRQAPGQGLEWMGWIRPYSGNTNYAQKVQGRVTMTTDTSTTTAYMELRSLRSDDTAVYYCARDGYYDSSGYRFYWRDDAFDIWGQGTMVTVSS,QLVLTQSPSASASLGASVKVTCTLSSGHSSYAIAWHQQQPEKGPRYLMKLNSDGSHTKGDGIPDRFSGSSSGAERYLTISSLQSEDEADYYCQTWGTGIRVFGGGTKLTVL,IGHV1-18 (Human),IGHJ3 (Human),IGLV4-69 (Human),IGLJ3 (Human),ARDGYYDSSGYRFYWRDDAFDI,QTWGTGIRV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712470+L711734_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712436+K711936,Ab,SARS-CoV2,SARS-CoV1,,,S; NTD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGFIPIFGTANYAQKFQGRVTITADESTSTVYMELSSLRSEDTAVYYCARIHTDLAVADPDLGFYSMDVWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYTASSLQSGVPSRFSGGGSGTDFTLTISSLQPEDFATYYCQQSYSTPYTFGQGTKLEIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ2 (Human),ARIHTDLAVADPDLGFYSMDV,QQSYSTPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712436+K711936_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712524+L711767,Ab,SARS-CoV2,SARS-CoV1,,,S; NTD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFINYAMHWVRQAPGKGLEWVAVISYDGSNKYYEDSVKGRFTISRDNSKNTLYLQMNSLRPEDTAVYYCARDLAYWDTDYGMDVWGLGTTVTVSS,QSALTQPRSVSGSPGQSVTISCTETSSDVGGYKYVSWYQQHPGKAPKLMIYDVNKRPSGVPDRFSGSKSGNTASLTISGLQAEDEADYYCCSYAGSYTRVFGGGTKLTVL,IGHV3-30-3 (Human),IGHJ6 (Human),IGLV2-11 (Human),IGLJ3 (Human),ARDLAYWDTDYGMDV,CSYAGSYTRV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712524+L711767_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712444+L711718,Ab,SARS-CoV2,SARS-CoV1,,,S; NTD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAFISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLGAKDTAVYYCASLIAAAGGRDYWGQGTLVTVSS,SYELTQPPSVSVSPGQTARITCSGDALPKRYAYWYQQKSGQAPVLVIYEDTKRPSGIPERFSGSSSGTMATLTISGAQVEDEADYYCYSTDSSGNHVVFGGGTKLTVL,IGHV3-30-3 (Human),IGHJ4 (Human),IGLV3-10 (Human),IGLJ3 (Human),ASLIAAAGGRDY,YSTDSSGNHVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712444+L711718_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712507+L711753,Ab,SARS-CoV2,SARS-CoV1,,,S; NTD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYTMNWVRQAPGKGLEWVSYISSSAGTIHYADSVKGRFTISRDNAKNSLYLQMNSLRVEDTAVYYCARDSGAIFDSWGQGTLVTVSS,SYELTQPPSVSVSPGQTVSITCSGDKLGEKYVCWYQQKPGQSPVLVIYQDKKRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCQASDSSTNYVFGTGTKVTVL,IGHV3-48 (Human),IGHJ5 (Human),IGLV3-1 (Human),IGLJ1 (Human),ARDSGAIFDS,QASDSSTNYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712507+L711753_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712533+K712003,Ab,SARS-CoV2,SARS-CoV1,,,S; NTD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVRVPCKVSGYSITELSIHWVRQAPGKGLEWMGGFNPEEAETIYAQQFQGRVTMTEDTSADTAYMELTRLRSEDTAVYYCATALAVAGDRGHYHYYFGMDVWGQGTTVTVSS,DIVMTQTPLSSPVTLGQPASISCRSSQSLVHSDGNTYLSWLQQRPGQPPRLLIYKISERVSGVPDRFSGSGAETDFTLKISRVEAEDVGVYYCMQATQFAYSFGQGTKLEIK,IGHV1-24 (Human),IGHJ6 (Human),IGKV2-24 (Human),IGKJ2 (Human),ATALAVAGDRGHYHYYFGMDV,MQATQFAYS,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712533+K712003_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Mar 16, 2021",16th March: Corrected CDRH3 seq,Complete
H712455+K711947,Ab,SARS-CoV2,SARS-CoV1,,,S; NTD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAGSGFTFSRYGMHWVRQAPGKGLEWVAVISYDGSNTYYGDSVKGRFTISRDNSKNTLYLQMNSLRVEDTAVYYCAKEVGYSDYDGWDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPLTFGGGTKVEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ4 (Human),AKEVGYSDYDGWDY,QQYDNLPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712455+K711947_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712518+L711760,Ab,SARS-CoV2,SARS-CoV1,,,S; NTD,B-cells; SARS-CoV2 Human Patient,QITLKESGPTLVKPTQTLTLTCTFSGFSLSTSGVGVGWIRQPPGKALEWLALIYWDDDKRYSPSLKSRLTITKDTSKNQVVLTMTNMDPVDTATYYCAHRSGELLWFRGEDWFDPWGQGTLVTVSS,SYELTQPPSVSVSPGQTARITCSGDALPKKYAYWYQQKSGQAPVLVIYEDSKRPSGIPERFSGSSSGTMATLTISGAQVEDEADYYCYSTDSSGNHRVFGGGTKLTVL,IGHV2-5 (Human),IGHJ5 (Human),IGLV3-10 (Human),IGLJ3 (Human),AHRSGELLWFRGEDWFDP,YSTDSSGNHRV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712518+L711760_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712538+L711778,Ab,SARS-CoV2 (weak),SARS-CoV1,,,S; NTD,B-cells; SARS-CoV2 Human Patient,EVQLVQSGAEVKKPGESLRISCKGSGYSFTSYWISWVRQMPGKGLEWMGRIDPSDSYTNYSPSFQGHVTISADKSISTAYLQWSSLKASDTAMYYCARLVRGCSGGSCYSVDDYWGQGTLVTVSS,SYELTQPPSVSVSPGQTASITCSGDKLGDKYACWYQQKPGQSPVLVIYQDSKRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCQAWDSSTVVFGGGTKLTVL,IGHV5-10-1 (Human),IGHJ4 (Human),IGLV3-1 (Human),IGLJ3 (Human),ARLVRGCSGGSCYSVDDY,QAWDSSTVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712538+L711778_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712174+K711788,Ab,"SARS-CoV1 (weak), SARS-CoV2",,,,S; S2,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGEGLEWVSIIYSGGPTYYADSVKGRFTISRDNSKNTLYLQMSSLRAEDTAMYYCATGRYDSIHWGQGTLVTVSS,DIQMTQSPSTLSAFLGDRVSITCRASQDLSSSLAWYQQKPGKAPKLLIYEASTLESGVPSRFSGSGSGTEFTLTISGLQPDDFATYYCQQYKNYSPVTFGPGSKVEIK,IGHV3-53 (Human),IGHJ1 (Human),IGKV1-5 (Human),IGKJ3 (Human),ATGRYDSIH,QQYKNYSPVT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712174+K711788_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H026068+K023860,Ab,SARS-CoV2,SARS-CoV1,,,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSTYAMHWVRQAPGKGLYWVAVISYDGINKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARSGSGSYFNWFDPWGQGTLVTVSS,DIVMTQSPDSLAVSLGERATINCKSSQSVLYSSNNKNYLAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYVSPLTFGGGTKVEIK,IGHV3-30-3 (Human),IGHJ5 (Human),IGKV4-1 (Human),IGKJ4 (Human),ARSGSGSYFNWFDP,QQYYVSPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H026068+K023860_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H025979+K023813,Ab,"SARS-CoV1,SARS-CoV2",,,,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFSSFYMNWVRQAPGQGLEWMGIINPDGGGTVYSQKIQDRLTMTRDTSTSTFYLELSGLGSEDTAVYYCARGRSDFLLQNFDYWGQGTPVTVSS,DIQMTQSPSTLSASLGDRVSITCRASQDISSCLAWYQQKPGKAPKLLIYEASTLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYKNYSPVTFGPGTKVEIK,IGHV1-46 (Human),IGHJ4 (Human),IGKV1-5 (Human),IGKJ3 (Human),ARGRSDFLLQNFDY,QQYKNYSPVT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H025979+K023813_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712083+K711741,Ab,SARS-CoV2,SARS-CoV1,,,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVESGGDVVQPRRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGINKYYADSVRGQFAISRDNSKSTLYLQMNSLRAEDTAVYYCARPRLGNYFDAFDIWGLGTMVTVSS,DIQMTQSPSTLSASVGDRVTITCRASQSISTWLAWYQQKPGKAPKLLIYKASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQHYNTYAWTFGQGTKVEIK,IGHV3-30-3 (Human),IGHJ3 (Human),IGKV1-5 (Human),IGKJ1 (Human),ARPRLGNYFDAFDI,QHYNTYAWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712083+K711741_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712168+K711784,Ab,SARS-CoV2,SARS-CoV1,,,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSTYAIHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLTTEDTAVYYCARDREGAYWGPIDYWGQGTLVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRNNWPPITFGQGTRLEIK,IGHV3-30-3 (Human),IGHJ4 (Human),IGKV3-11 (Human),IGKJ5 (Human),ARDREGAYWGPIDY,QQRNNWPPIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712168+K711784_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712073+H712073,Ab,SARS-CoV2,SARS-CoV1,,,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAIISYDGTNKYYPDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARANGGNYYYGMDVWGQGTTVTVSS,QSALTQSASVSGSPGQSITISCTGTSSDIAAYNYVSWYQQHPGEVPKLLVYDVSNRPSGVSDRFAGSRSGNTAYLTISGLQAEDDADYYCSSYTSSGGLVFGGGTKATVL,IGHV3-30-3 (Human),IGHJ6 (Human),IGLV2-14 (Human),IGLJ3 (Human),ARANGGNYYYGMDV,SSYTSSGGLV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712073+H712073_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712068+L711476,Ab,SARS-CoV2,SARS-CoV1,,,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVHPGRSLRLSCAASGFTFSSYAMYWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSENTLYLQMNSLRAEDTAVYYCARPESGSYLGHFDSWGQGTLVTVSS,QLVLTQSPSASASLGASVKLTCTLSSGHSSYAIAWHQQQPEKGPRYLMKLNSDGSHTKGDGIPDRFSGSSSGAERYLTISSLQSEDEADYYCQTWGTGIQVFGGGTKLTVL,IGHV3-30-3 (Human),IGHJ5 (Human),IGLV4-69 (Human),IGLJ3 (Human),ARPESGSYLGHFDS,QTWGTGIQV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712068+L711476_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712065+L711472,Ab,SARS-CoV2,SARS-CoV1,,,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARSGSGNYYHWFDPWGQGTLVTVSS,QSVLTQPPSVSAALGQKVTISCSGSSSNIESNYVSWYQQFPGTVPTLLIYENNKRPSGIPDRFSASKFGTSATLGISGLQTGDEADYYCGTWDRSLSAWVFGGGTKVTVL,IGHV3-30-3 (Human),IGHJ5 (Human),IGLV1-51 (Human),IGLJ3 (Human),ARSGSGNYYHWFDP,GTWDRSLSAWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712065+L711472_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712116+L711519,Ab,SARS-CoV2,SARS-CoV1,,,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSTYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKSPPASYYTWFHPWGHGSLVTVST,SYELTQPPSVSVSPGQTARITCSGDALPKKYAYWYQQKSGQAPVLVIYEDSKRPSGIPERFSGSSSGTMATLTISGAQVEDEADYYCYSTDNSGNRWVFGGGTKLTVL,IGHV3-30-3 (Human),IGHJ5 (Human),IGLV3-10 (Human),IGLJ3 (Human),AKSPPASYYTWFHP,YSTDNSGNRWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712116+L711519_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H026062+K023859,Ab,SARS-CoV2,SARS-CoV1,,,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCRTSGYTFSTYYLHWVRQAPGQGFEWMGIINPSGGGTSYAPNFEGRVTMTMDTFTSTVFLELSSLTSEDTAVYYCARDGPVLDWLFVFDYWGQGTLVTVSS,EIVLTQSPDTLSLSPGERATLSCGASQRIRSNYLAWYQQKPGQAPRLLIYATSTRATGIPDRFSGSGSGTDFTLIISRLEPEDFAVYYCQQYGSSQWTFGQGTKVEIK,IGHV1-46 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ1 (Human),ARDGPVLDWLFVFDY,QQYGSSQWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H026062+K023859_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712081+K711740,Ab,SARS-CoV2,SARS-CoV1,,,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASAKISCKASGFSFTTYTIQWVRQAPGQSLEWMGWIDTGNGNTEYSQKFQGRITITRDASARAAYMELSSLTSEDTAVYYCARDLSPKDFLGSSLGGRDVWGQGTTVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQTLRNNYLAWYQQKPGQAPWLLIYGAYNRATGIPDRFSGSGSGTDFTLTVSRLEPEDFAVYYCQQYGSSPTFGQGTRLEIR,IGHV1-3 (Human),IGHJ6 (Human),IGKV3-20 (Human),IGKJ5 (Human),ARDLSPKDFLGSSLGGRDV,QQYGSSPT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712081+K711740_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712116+K711753,Ab,SARS-CoV2,SARS-CoV1,,,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFNTYAIHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDSRGYGHFDYWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFALYYCQQYGSSPMYTFGQGTKLEIK,IGHV3-30-3 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ2 (Human),ARDSRGYGHFDY,QQYGSSPMYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712116+K711753_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H026037+L024018,Ab,SARS-CoV2,SARS-CoV1,,,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFNTYAIHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDSRGYGHFDYWGQGTLVTVSS,QSALTQPRSVSGSPGQSVTISCTGTSSDVGGYNYVSWYQHHPGKAPKLLIYDVSKRPSGVPDRFSGSKSGNTASLTISGLQAEDEADYYCCSYAGFYTFGGGTKLTVL,IGHV3-30-3 (Human),IGHJ4 (Human),IGLV2-11 (Human),IGLJ3 (Human),ARDSRGYGHFDY,CSYAGFYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H026037+L024018_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H026070+L024034,Ab,SARS-CoV2,SARS-CoV1,,,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVIWYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARGPQEQYDILTGYYFPANWYFDLWGRGTLVTVSS,NFMLTQPHSVSESPGKTVTISCTGSSGSIASNYVQWYQQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSSTYWVFGGGTKLTVL,IGHV3-33 (Human),IGHJ2 (Human),IGLV6-57 (Human),IGLJ3 (Human),ARGPQEQYDILTGYYFPANWYFDL,QSYDSSTYWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H026070+L024034_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H026118+K023890,Ab,SARS-CoV2,SARS-CoV1,,,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSTYAMHWVRQAPGKGLECVAFISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARSLAAYWYFDYWGQGTLVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQHKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPGFGPGTKVDIK,IGHV3-30-3 (Human),IGHJ4 (Human),IGKV3-11 (Human),IGKJ3 (Human),ARSLAAYWYFDY,QQRSNWPG,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H026118+K023890_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H026080+L024040,Ab,SARS-CoV2,SARS-CoV1,,,S; S2,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFSFYWMSWVRQAPGKGLEWVANIKQDGGEKYYVDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYFCARLGGSSWYWDYWGQGTLVTVSS,SYELTQPPSVSVSPGQTASITCSGDKLGDKYVCWYQQKPGQSPVLVIYQDTKRPSGIPERFSGANSGNTATLTISGTQAMDEADYYCQAWDSSTGVIGGGTKLTVL,IGHV3-7 (Human),IGHJ4 (Human),IGLV3-1 (Human),IGLJ3 (Human),ARLGGSSWYWDY,QAWDSSTGV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H026080+L024040_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712132+L711532,Ab,SARS-CoV2,SARS-CoV1,,,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARSGSGNYYHWFDPWGQGTLVTVSS,QSVLTQPPSVSAALGQKVTISCSGSSSNIESNYVSWYQQFPGTVPTLLIYENNKRPSGIPDRFSASKFGTSATLGISGLQTGDEADYYCGTWDRSLSAWVFGGGTKVTVL,IGHV3-30-3 (Human),IGHJ5 (Human),IGLV1-51 (Human),IGLJ3 (Human),ARSGSGNYYHWFDP,GTWDRSLSAWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712132+L711532_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H026063+L024029,Ab,SARS-CoV2,SARS-CoV1,,,S; S2,B-cells; SARS-CoV2 Human Patient,EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSAISGSGGSTYFADSVKGRFTISRDNSKNTLYLQMNSLRAEDTALYYCAKGVHGTSGWYPPRAFDYWGQGTLVTVSS,QSALTQPASVSGSPGQSITISCTGTISDVGVYNYVSWYQQHPVKAPKLMIYDVINRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSTTLVFGGGTKLTVL,IGHV3-23 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ3 (Human),AKGVHGTSGWYPPRAFDY,SSYTSSTTLV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H026063+L024029_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712185+L711578,Ab,SARS-CoV2,SARS-CoV1,,,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSQTLSLTCTVSGGSIRTGGSYWTWMRQRPGKGLEWLGYVFYSGSTYYNPSLKSRVIMSVDTSNNQFSLRLTSVTAADTAVYFWSKDQGPVFGVDNWFDPWGQGTLVTVSS,SYELTQPPSVSVSPGQTASITCSGDKLGHTSVCWYQQKSGRSPVLVICQDTKRPSGIPERFSGSNSGNTATLTISGTQAIDEAEYYCQAWDSKTVIFGGGTKLTVL,IGHV4-31 (Human),IGHJ5 (Human),IGLV3-1 (Human),IGLJ3 (Human),SKDQGPVFGVDNWFDP,QAWDSKTVI,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712185+L711578_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712165+L711559,Ab,SARS-CoV2,SARS-CoV1,,,S; S2,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFSTYNMNWVRQAPGKGLEWVSYISSSSSSIYYADSVKGRFTISRDNAKNSLYLQMNSLRDEDTAVYYCARDGPTVTHYFDYWGQGTLVTVSS,SYELTQPPSVSVSPGQTASITCSGDKLGDKYACWYQQRPGQSPVLVIYQDTKRPSGIPERFSGSNSGNTATLTISGTQTMDEADYYCQAWDSSTAGVFGTGTKVTVL,IGHV3-48 (Human),IGHJ4 (Human),IGLV3-1 (Human),IGLJ1 (Human),ARDGPTVTHYFDY,QAWDSSTAGV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712165+L711559_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H026049+K023851,Ab,SARS-CoV2,SARS-CoV1,,,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSFGIHWVRQAPGKGLEWVALISYDGINKYYADSVKGRFTLSRDNSKNTLYLQMNSLRPEDTAVYYCAKTIWGTYRSPFDYWGQGTLVTVSS,DIQMTQSPSTLSASVGDRVTITCRASQSISSWLAWYQQKPGKAPNLLIYQASTLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNSYYTFGQGTKLEIK,IGHV3-30-5 (Human),IGHJ4 (Human),IGKV1-5 (Human),IGKJ2 (Human),AKTIWGTYRSPFDY,QQYNSYYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H026049+K023851_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712133+L711533,Ab,SARS-CoV2,SARS-CoV1,,,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARSGSGNYYHWFDPWGQGTLVTVSS,QSVLTQPPSVSAALGQKVTISCSGSSSNIESNYVSWYQQFPGTVPTLLIYENNKRPSGIPDRFSASKFGTSATLGISGLQTGDEADYYCGTWDRSLSAWVFGGGTKVTVL,IGHV3-30-3 (Human),IGHJ5 (Human),IGLV1-51 (Human),IGLJ3 (Human),ARSGSGNYYHWFDP,GTWDRSLSAWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712133+L711533_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712210+K711807,Ab,SARS-CoV2,SARS-CoV1,,,S; S2,B-cells; SARS-CoV2 Human Patient,EVQLVQSGLELKKPGESLKISCKTSGYSFTTHWIGWVRQMPGKGLEWMGIIFPGDSETRYGPSVQGQVTISVDNSITTTYVQWTTLKPSDTAMYFCARRGNGGYDAFDVWGQGTMLIVSS,DIQMTQSPSALSASIGDRVTISCRASQTVSGYLNWYQQKPGKAPKLLIYATFTLQSGVPPRFSGGGSETDFTLTISSLQHEDSAIYYCQQSYAVPWTFGQGTKVEIK,IGHV5-51 (Human),IGHJ3 (Human),IGKV1-39 (Human),IGKJ1 (Human),ARRGNGGYDAFDV,QQSYAVPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712210+K711807_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712115+K711752,Ab,SARS-CoV2,SARS-CoV1,,,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCRTSGYTFSTYYLHWVRQAPGQGFEWMGIINPSGGGTSYAPNFEGRVTMTMDTFTSTVFLELSSLTSEDTAVYYCARDGPVLDWLFVFDYWGQGTLVTVSS,EIVLTQSPDTLSLSPGERATLSCGASQRIRSNYLAWYQQKPGQAPRLLIYATSTRATGIPDRFSGSGSGTDFTLIISRLEPEDFAVYYCQQYGSSQWTFGQGTKVEIK,IGHV1-46 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ1 (Human),ARDGPVLDWLFVFDY,QQYGSSQWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712115+K711752_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712188+L711580,Ab,SARS-CoV2,SARS-CoV1,,,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFIFSTYGMHWVRQAPGKGLEWVAVIWYDGSNKYYADSVKGRFSISRDNSKNTLFLQMNSLRAEDTAVYYCARDYQVGGDYRSDFWGQGTLVTVSS,SYELTQPPSVSVSPGQTARITCSGDALPKKYAYWYQQKSGQAPVLVIYEDNKRPSGIPERLSGSSSGTMATLTISGAQVEDEADYYCHSADTSGHHWVFGGGTKLTVL,IGHV3-33 (Human),IGHJ4 (Human),IGLV3-10 (Human),IGLJ3 (Human),ARDYQVGGDYRSDF,HSADTSGHHWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712188+L711580_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712142+L711543,Ab,SARS-CoV2,SARS-CoV1,,,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCVASGFTFRSYAMHWVRQAPGKGLEWVTVISYDGNNQYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARPRGGNYVGPFDYWGQGTLVTVSS,SYELTQPLSVAVAPGETARITCSGDALSEEYTHWYQQRPGQAPVLIIYKDTERPSGIPERFSGSTSGTTVTLTISGVQAEDEADYYCQSPDTTSTYRVFGGGTKLTVL,IGHV3-30-3 (Human),IGHJ4 (Human),IGLV3-25 (Human),IGLJ3 (Human),ARPRGGNYVGPFDY,QSPDTTSTYRV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712142+L711543_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H026098+K023876,Ab,SARS-CoV2,SARS-CoV1,,,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLQESGAGLVKPSETLSLTCTVSGGSISGNFWSWVRQSPGRGLEWIGYVYYTGVTNYSPSLKSRVTISVDTSRKQFSLNLTSVTAADTAVYYCAREVRWNWFDTWGQGTRVTVSS,DIVMTQSPDSLAVSLGERATINCKSSQPIFYSTNNKNYLAWYQQRPGQPPKLLIYWASSRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYHDTPWTFGQGTKVEIK,IGHV4-59 (Human),IGHJ4 (Human),IGKV4-1 (Human),IGKJ1 (Human),AREVRWNWFDT,QQYHDTPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H026098+K023876_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712072+L711480,Ab,SARS-CoV2,SARS-CoV1,,,S; S2,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLIQPGGSLRLSCVASGFTVSSNYMSWVRQAPGKGLEWISVIYSGGTTFYADSVKGRFTISRDNSKNTLYLQMNSLRADDTAVYYCARDRRITMVRGVIYYYYGMDVWGQGTTVTVSS,QSVLTQPPSASGTPGQRVTISCSGSSSNIGSNTVNWYQLLPGTAPKLLIYSNNQRPSGVPDRFSGSKSGTSASLAISGLQSEDEADYYCAAWDDSLNGPVFGGGTKLTVL,IGHV3-53 (Human),IGHJ6 (Human),IGLV1-44 (Human),IGLJ3 (Human),ARDRRITMVRGVIYYYYGMDV,AAWDDSLNGPV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712072+L711480_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712098+L711504,Ab,SARS-CoV2,SARS-CoV1,,,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSNYGMHWVRQAPGKGLEWVAVIWYDGSNKYYADSVKGRFTISRDNSENTVYLQMNSLRAEDTAVYYCARDGMVGATTGIDYWGQGTLITVSS,SYELTQPPSVSVSPGQTARITCSGDALPKKYAYWYQQRSGQAPVLVIYEDSKRPSGIPERFSGSSSGTMATLTISGAQVEDEADYYCYSTDSSGNHNYVFGTGTKVTVL,IGHV3-33 (Human),IGHJ4 (Human),IGLV3-10 (Human),IGLJ1 (Human),ARDGMVGATTGIDY,YSTDSSGNHNYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712098+L711504_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712058+L711469,Ab,SARS-CoV2,SARS-CoV1,,,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFIFSSYGMHWVRQAPGKGLEWVAVISYDGSNTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDTSVVVIPIFLFDYWGQGTLVTVSS,QSALTQPPSASGSPGQSVTISCTGTSSDVGGYNYVSWYQQHPGKAPKLIISEVSQRPSGVPDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYAGTNNFGVFGGGTKLTVL,IGHV3-30 (Human),IGHJ4 (Human),IGLV2-8 (Human),IGLJ3 (Human),AKDTSVVVIPIFLFDY,SSYAGTNNFGV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712058+L711469_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712218+K711809,Ab,SARS-CoV2,SARS-CoV1,,,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSGTLSLTCAVSGGSISSGHWWTWVRQPPGKGLEWIGEIYHSGNTNYNTSLKSRVTISVDKSNNQFSLKLTSVTAADTAVFYCARRYCSGGTCSPFDYWGQGTLVTVSS,EIVLTQSPDTLSLSPGERATLSCGASQRIRSNYLAWYQQKPGQAPRLLIYATSTRATGIPDRFSGSGSGTDFTLIISRLEPEDFAVYYCQQYGSSQWTFGQGTKVEIK,IGHV4-4 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ1 (Human),ARRYCSGGTCSPFDY,QQYGSSQWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712218+K711809_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H026064+L024030,Ab,SARS-CoV2,SARS-CoV1,,,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTRYFIHWVRQAPGQGLEWMGIINPSGGSTSYAQKFQGRVTMTRDTSTSTVYMELNSLRSEDTAVYYCAILVVYGMRDYWGQGSLVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGSYNLVSWYQQHPGKAPKLMIYEGIKRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCCSYAGSHVVFGGGTNLTVL,IGHV1-46 (Human),IGHJ4 (Human),IGLV2-23 (Human),IGLJ3 (Human),AILVVYGMRDY,CSYAGSHVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H026064+L024030_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712176+K711789,Ab,SARS-CoV2,SARS-CoV1,,,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLQESGAGLVKPSETLSLTCTVSGGSISGNFWSWVRQSPGRGLEWIGYVYYTGVTNYSPSLKSRVTISVDTSRNQFSLNLTSVTAADTAVYYCAREVRWNWFDTWGQGTRVTVSS,DIVMTQSPDSLAVSLGERATINCKSSQPIFYSTNNKNYLAWYQQRPGQPPKLLIYWASSRESGVPARFSGSGSGTDFTLTINSLQAEDVAVYYCQQYHDTPWTFGQGTKVEIK,IGHV4-59 (Human),IGHJ4 (Human),IGKV4-1 (Human),IGKJ1 (Human),AREVRWNWFDT,QQYHDTPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712176+K711789_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712120+L711521,Ab,SARS-CoV2,SARS-CoV1,,,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEMKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGRIIPFFGIANSAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCARVPPSTGYDFYFDYWGQGTLVTVSS,SYELTQPPSVSVSPGQTASITCSGDELGDKYACWYQQKPGQSPVLVIYRDSKRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCQAWDSNTFYVFGTGTKVTVL,IGHV1-69 (Human),IGHJ4 (Human),IGLV3-1 (Human),IGLJ1 (Human),ARVPPSTGYDFYFDY,QAWDSNTFYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712120+L711521_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712090+K711743,Ab,SARS-CoV2,SARS-CoV1,,,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVRPGRSLRISCVASGFTFSSYAMHWVRQAPVKGLEWVAIISYDGGNTYYADSVKGRFTISRDNSKNTLYLQMNSLTAEDTAVYYCAKDLAFSGSFPFLDYWGQGTLVTVSA,DIQMTQSPSSVSASVGDRVTLACRASQGISSWLAWYQQKPGKAPKFLIYIASSLQSGVPSRFSGSGSGTNFTLTISSLQPEDFGTYYCQQARDFPYTFGQGTKVEIR,IGHV3-30-3 (Human),IGHJ4 (Human),IGKV1-12 (Human),IGKJ1 (Human),AKDLAFSGSFPFLDY,QQARDFPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712090+K711743_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H026019+K023836,Ab,SARS-CoV2,SARS-CoV1,,,S; S2,B-cells; SARS-CoV2 Human Patient,QLQLQESGSGLVKPSQTLSLTCAVSGGSISSGGYSWSWIRQPPGKGLEWIGYIYHGGNTYYNPSLKNRVTISEDRSKNQFSLRLSSVTAADTAVYYCARVQGYCTGGVCYSVPYYFDFWGQGTLVTVSS,DIVMTQSPDSLAVSLGERATINCKSSQSVLYSSNNKNYLAWYQQRPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYSCQQYYSTPLTFGGGTKVEIK,IGHV4-30-2 (Human),IGHJ4 (Human),IGKV4-1 (Human),IGKJ4 (Human),ARVQGYCTGGVCYSVPYYFDF,QQYYSTPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H026019+K023836_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712169+L711563,Ab,SARS-CoV2,SARS-CoV1,,,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSETLSLTCTVSGGSISSYYWSWIRQPPGKGLEWIGSIYYSGSTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCAGSYSYGYSWFDPWGQGTLVTVSS,QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWYQQLPGTAPKLLIYGNTNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYSCQSFDSSLSGSVFGGGTKLTVL,IGHV4-59 (Human),IGHJ5 (Human),IGLV1-40 (Human),IGLJ3 (Human),AGSYSYGYSWFDP,QSFDSSLSGSV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712169+L711563_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712123+K711759,Ab,SARS-CoV2,SARS-CoV1,,,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKAQWVGFSPLDYWGQGTLVTVSS,DIQMTQSPSTLSASVGDRVTITCRASQSISSWLAWYQQKPGKAPKLLIYKASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNSYYYSFGQGTKLEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV1-5 (Human),IGKJ2 (Human),AKAQWVGFSPLDY,QQYNSYYYS,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712123+K711759_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712196+L711585,Ab,SARS-CoV2 (weak),SARS-CoV1,,,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASRFTFSSYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRENSKNTLYLQMDSLRAEDTAVYYCAKAQRHFDYLLRSDAFDIWGQGTMVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSITLYVFGTGTKVTVL,IGHV3-30 (Human),IGHJ3 (Human),IGLV2-14 (Human),IGLJ1 (Human),AKAQRHFDYLLRSDAFDI,SSYTSSITLYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712196+L711585_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H026009+K023830,Ab,SARS-CoV2 (weak),SARS-CoV1,,,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARSSGGSYWGYFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQGISSWLAWYQQKPEKAPKSLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYNSYPFTFGPGTKVDIK,IGHV3-30-3 (Human),IGHJ4 (Human),IGKV1D-16 (Human),IGKJ3 (Human),ARSSGGSYWGYFDY,QQYNSYPFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H026009+K023830_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712073+L711482,Ab,SARS-CoV2,SARS-CoV1,,,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAIISYDGTNKYYPDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARANGGNYYYGMDVWGQGTTVTVSS,SYELTQPLSVAVAPGETARITCSGDALSEEYTHWYQQRPGQASVLIIYKDTERPSGIPERFSGSTSGTTVTLTISGVQAEDEADYYCQSPDTTSTYRVFGGGTKLTVL,IGHV3-30-3 (Human),IGHJ6 (Human),IGLV3-25 (Human),IGLJ3 (Human),ARANGGNYYYGMDV,QSPDTTSTYRV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712073+L711482_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712485+K711969,Ab,SARS-CoV2,SARS-CoV1,,,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASEFTFSSYAMHWVRQAPGKGLEWVALISYDGSNEYYADSVKGRFTVSRDNSKTTLYLQMNSLRAEDTAVYYCARARSGSYYYGMDVWGQGTTVTVSS,DIQMTQSPASLSASVGDRLTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSAPRLTFGGGTKVEIK,IGHV3-30-3 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ4 (Human),ARARSGSYYYGMDV,QQSYSAPRLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712485+K711969_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712441+K711939,Ab,SARS-CoV2,SARS-CoV1,,,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAIHWVRQAPGKGLEWVTLISYDGSNKYYADSVKGRITISRDNSKNTLYLQMNSLRAEDTAVYYCARSTGGSYYYGMDVWGQGTTVTVSS,DIQMTQSPASLSASVGDRLTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSAPRLTFGGGTKVEIK,IGHV3-30-3 (Human),IGHJ6 (Human),IGKV1-5 (Human),IGKJ4 (Human),ARSTGGSYYYGMDV,QQSYSAPRLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712441+K711939_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712511+L711756,Ab,"SARS-CoV1,SARS-CoV2,MERS-CoV,NL63",,,,S; S2,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVKPGGSLRLSCAASGFTFSHYNMNWVRQAPGKGLEWVSSITSTGSYIYYADSLKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCAREGRIAGIPTGGLFDYWGQGTLVTVSS,QAVLTQPSSLSASPGASARLTCTLRSGINLGSYRIFWHQQKPESPPRYLLSYYSDSSNHQGSGVPSRFSGSKDASGNAGILVISGLQSEDEADYYCMIWHSSTYVFGTGTKVTVL,IGHV3-21 (Human),IGHJ4 (Human),IGLV5-45 (Human),IGLJ6 (Human),AREGRIAGIPTGGLFDY,MIWHSSTYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712511+L711756_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712443+K711941,Ab,"SARS-CoV2,MERS-CoV",SARS-CoV1,,,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSETLSLTCTVSGGSISSYYWSWIRQPPGKGLEWIGYIYYSGSTNYNPSLKSRITISVDTSKNQFSLKLSSVTAADTAMYYCARGFDYWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRAIGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQFGSSPWTFGQGTKVEIK,IGHV4-59 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ1 (Human),ARGFDY,QQFGSSPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712443+K711941_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712493+K711974,Ab,"SARS-CoV2,MERS-CoV",SARS-CoV1,,,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVQSGTEVKKPGASVKVSCKTSGYRFTNYYIHWVRQAPGQGLEWMGIFNPNGGGTSYAQRFQGRVTLTSDTSANIGYMELRSLTSEDTAVYYCARDPRSSGDNDGFDMWGQGTMVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSLSNYLAWYQQKPGQAPRLLIYDASKRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYFCQQRSNRPPAWTFGQGTKVEIK,IGHV1-46 (Human),IGHJ3 (Human),IGKV3-11 (Human),IGKJ1 (Human),ARDPRSSGDNDGFDM,QQRSNRPPAWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712493+K711974_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712447+K711943,Ab,SARS-CoV2,SARS-CoV1,,,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAIHWVRQAPGKGLEWVTLISYDGSNKYYADSVKGRITISRDNSKNTLYLQMNSLRAEDTAVYYCARSTGGSYYYGMDVWGQGTTVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQFGGSPLFTFGPGTKVDIK,IGHV3-30-3 (Human),IGHJ6 (Human),IGKV3-20 (Human),IGKJ3 (Human),ARSTGGSYYYGMDV,QQFGGSPLFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712447+K711943_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712460+L711729,Ab,SARS-CoV2,SARS-CoV1,,,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSNYGMHWVRQAPGKGLEWVAVIWYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRVEDTAVYYCVRDRPPDYFDSSATPDAFDIWGQGTMVTVSS,SYELTQPPSVSVSPGQTARITCSGDALPKKYAYWYQQKSGQAPVLVIYEDNKRPSGIPERFSGSSSGTMATLTISGAQVEDEADYYCYSTDSSGNHWVFGGGTKLTVL,IGHV3-33 (Human),IGHJ3 (Human),IGLV3-10 (Human),IGLJ3 (Human),VRDRPPDYFDSSATPDAFDI,YSTDSSGNHWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712460+L711729_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712500+K711978,Ab,"SARS-CoV2,MERS-CoV",SARS-CoV1,,,S; S2,B-cells; SARS-CoV2 Human Patient,EVQLVQSGAEVKKPGESLKISCKGSGYSFTSYRIGWVRQMPGKGLEWMGIIYPGDSDTKYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARLWHCGGDCYPKLNWLDPWGQGTLVTVSS,DIVMTQTPLSLPVTPGEPASISCRSSQSLLDSDDGNTYLDWYLQKPGQSPQLLIYTLSYRASGVPDRFSGSGSGTDFTLTISRVEAEDVGVYYCMQRIEFPFTFGGGTKVEIK,IGHV5-51 (Human),IGHJ5 (Human),IGKV2-40 (Human),IGKJ4 (Human),ARLWHCGGDCYPKLNWLDP,MQRIEFPFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712500+K711978_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712459+L711728,Ab,SARS-CoV2,SARS-CoV1,,,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSTYAMYWVRQAPGKGLEWVAVISYDGNNKYYADSVKGRFTISRDNSKNTLYLQMNSLRVEDTAVYYCARGGGGNYFFFDSWGQGTLVTVSS,QSVLTQPPSVSGAPGQRVSISCTGSSSNIGAGYDVHWYQQLPGTAPKLLIYANNNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDTSLSGLVFGGGTKLTVL,IGHV3-30-3 (Human),IGHJ5 (Human),IGLV1-40 (Human),IGLJ3 (Human),ARGGGGNYFFFDS,QSYDTSLSGLV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712459+L711728_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712484+L711739,Ab,SARS-CoV2,SARS-CoV1,,,S; S2,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYWMSWVRQAPGKGLEWVANIKQDGSEKYYVDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCAGLSSSSWNLDYWGQGTLVTVSS,SYELTQPPSVSVSPGQTASITCSGDKLGDKYACWYQQKPGQSPVLVIYQDSKRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCQAWDSSTGVFGTGTKVTVL,IGHV3-7 (Human),IGHJ4 (Human),IGLV3-1 (Human),IGLJ1 (Human),AGLSSSSWNLDY,QAWDSSTGV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712484+L711739_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712552+K712018,Ab,SARS-CoV2,SARS-CoV1,,,S; S2,B-cells; SARS-CoV2 Human Patient,QITLKESGPTLVKPTQTLTLTCTFSGFSLSTSGVGVGWIRQPPGKTLEWLALIYWDDDKRYSPSLKSRLTITKDTSKNQVVLTMTNMDPVDTATYYCAHRRGLLMYNCFDPWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASGLQSGVPSRFSGSGSGTDFILTISRLQPEDFATYYCQQSYSTPFTFGPGTKVDIK,IGHV2-5 (Human),IGHJ5 (Human),IGKV1-39 (Human),IGKJ3 (Human),AHRRGLLMYNCFDP,QQSYSTPFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712552+K712018_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712482+L711738,Ab,SARS-CoV2,SARS-CoV1,,,S; S2,B-cells; SARS-CoV2 Human Patient,QLQLQESGPGLVKPSETLSLTCTVSGGSISSSSYYWGWIRQPPGKGLEWIGSMYYSGSTYDNPSLKSRVIISVDTSKNQFSLKLSSVTAADTAVYYCVRQNHNMLQGPHHVFDIWGQGTMVTVSS,QSALTQPRSVSGSPGQSVTISCTGTSSDVGAYNYVSWYQQHPGKAPNLIIYDVNKRPSGVPDRFSGSKSGNTASLTISGLQAEDEADYYCCSFAGSYTFWVFGGGTKLTVL,IGHV4-39 (Human),IGHJ3 (Human),IGLV2-11 (Human),IGLJ3 (Human),VRQNHNMLQGPHHVFDI,CSFAGSYTFWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712482+L711738_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712461+K711951,Ab,SARS-CoV2,SARS-CoV1,,,S; S2,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVKPGGSLRLSCAASGFTFNNAWMNWVRQAPGKGLEWVGRVKSENDGGTTDYAAPVRGRFTISRNDSLNTLFLVIHDPRIEDTALYYCTTVHSDYVWGSYRKGYFDYWGQGALVTVSS,DIQMTQSPSSLSASVGDRVTLTCRTSQSIRTFLNWYQQKPGKAPKLLISESSSLQSGVPSRFSGSGSGTDFTLTINSLQPEDFATYYCQQGYTVPYTFGQGTRLEIT,IGHV3-15 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ5 (Human),TTVHSDYVWGSYRKGYFDY,QQGYTVPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712461+K711951_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712477+L711736,Ab,SARS-CoV2,SARS-CoV1,,,S; S2,B-cells; SARS-CoV2 Human Patient,QITLKESGPTLVKPTQTLTLTCTFSGFSLSTTGVGVGWIRQPPGKALEWLALIYWDDDKRYSPSLKSRLTITKDTSKNQVVLTMTNMDPVDTATYYCAHYIAIRPFDYWGQGTLVTVSS,NFMLTQPHSVSESPGKTVTISCTRSSGSIASNYVQWYQQRPGSVPTIVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSSNLWVFGGGTKLTVL,IGHV2-5 (Human),IGHJ4 (Human),IGLV6-57 (Human),IGLJ3 (Human),AHYIAIRPFDY,QSYDSSNLWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712477+L711736_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712499+L711750,Ab,SARS-CoV2,SARS-CoV1,,,S; S2,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGRSLRLSCAASGFTFSTYWMSWVRQAPGKGLEWVANIKQDGSEKYYVDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARLSVLGWYFDLWGRGTLVTVSS,SYELTQPPSVSVSPGQTASITCSGDKLGDKYVCWYQQKPGQSPVLVIYQDSKRPTGIPERFSGSNSGNTATLTISGTQAMDEADYYCQAWGSSTGVFGTGTKVTVL,IGHV3-7 (Human),IGHJ2 (Human),IGLV3-1 (Human),IGLJ1 (Human),ARLSVLGWYFDL,QAWGSSTGV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712499+L711750_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712512+L711757,Ab,SARS-CoV2,SARS-CoV1,,,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKRPGASVRVSCKASGYTFSSYDINWVRQAPGQGLEWMGWMSPNGGNTGYAQRFQGRVTMTRDNSISTAYMELSGLGPEDSAVYYCARGELDDDIWGTYSMRWFDPWGQGTLVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGGYNFVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCNSYTSSTSYVFGTGTKVTVL,IGHV1-8 (Human),IGHJ5 (Human),IGLV2-14 (Human),IGLJ1 (Human),ARGELDDDIWGTYSMRWFDP,NSYTSSTSYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712512+L711757_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712448+K711944,Ab,SARS-CoV2 (weak),SARS-CoV1,,,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSQTLSLTCTVSGGSITSGNYYWTWIRQPAGKGLEWIGRIDTSGSTNYNPSLKSRVTTSLDTSKNQFSLKLSSVTAADTAVYYCAREVAFFDWLLQSDYYHGMDVWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSITRSLNWYQQKPGKAPNVLIYGASSLQTGVPSRFSGSGSGTDFTLTISALQPEDFATYYCQQSYTTPITFGQGTRLEIK,IGHV4-61 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ5 (Human),AREVAFFDWLLQSDYYHGMDV,QQSYTTPIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712448+K711944_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H712499+L711749,Ab,SARS-CoV2 (weak),SARS-CoV1,,,S; S2,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGRSLRLSCAASGFTFSTYWMSWVRQAPGKGLEWVANIKQDGSEKYYVDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARLSVLGWYFDLWGRGTLVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDIAAYNYVSWYQQHPGEVPKLLVYDVSNRPSGVSDRFAGSRSGNTAYLTISGLQAEDDADYYCSSYTSSGGLVFGGGTKATVL,IGHV3-7 (Human),IGHJ2 (Human),IGLV2-14 (Human),IGLJ3 (Human),ARLSVLGWYFDL,SSYTSSGGLV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H712499+L711749_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
H026341+K024016,Ab,"SARS-CoV2,MERS-CoV",SARS-CoV1,,,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGRIIPIFGIANYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCARAPQATVTTFNYYYGLDVWGQGTTVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQHYGTSPWTFGQGTKVEIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV3-20 (Human),IGKJ1 (Human),ARAPQATVTTFNYYYGLDV,QHYGTSPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H026341+K024016_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Complete
ABP18,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,"Phage Display (antibody, human, non-immune)",ND,ND,IGHV1-69 (Human),ND,IGLV2-23 (Human),ND,GAHIAAEYFQH,CSYAGSSTFV,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Awaiting publication for full sequences
NBP10,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,"Phage Display (antibody, human, non-immune)",ND,ND,IGHV5-51 (Human),ND,IGLV1-40 (Human),ND,YYAGGGFDV,QSYDSSLSGYV,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Awaiting publication for full sequences
NBP11,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,"Phage Display (antibody, human, non-immune)",ND,ND,IGHV5-51 (Human),ND,IGKV1-5 (Human),ND,FSVGPGGPFDS,QQYNSYSYT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 9, 2021","Jan 9, 2021",N/A,Awaiting publication for full sequences
PGT-126,Ab,"SARS-CoV2,HIV-1",,,SARS-CoV2,S2 (quaternary glycan epitope),HIV-1 induced Ab,QPQLQESGPGLVEASETLSLTCTVSGDSTAACDYFWGWVRQPPGKGLEWIGGLSHCAGYYNTGWTYHNPSLKSRLTISLDTPKNQVFLKLNSVTAADTAIYYCARFDGEVLVYHDWPKPAWVDLWGRGTLVTVTVSS,QSALTQPPSASGSPGQSISISCTGTSNRFVSWYQQHPGKAPKLVIYGVNKRPSGVPDRFSGSKSGNTASLTVSGLQTDDEAVYYCSSLVGNWDVIFGGGTKLTVL,IGHV4-38-2 (Human),IGHJ2 (Human),IGLV2-8 (Human),IGLJ3 (Human),ARFDGEVLVYHDWPKPAWVDL,SSLVGNWDVI,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/PGT-126_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Mar 16, 2021",16th March: Corrected CDRH3 seq,Complete
PGT-128,Ab,"SARS-CoV2,HIV-1",,,SARS-CoV2,S2 (quaternary glycan epitope),HIV-1 induced Ab,QPQLQESGPTLVEASETLSLTCAVSGDSTAACNSFWGWVRQPPGKGLEWVGSLSHCASYWNRGWTYHNPSLKSRLTLALDTPKNLVFLKLNSVTAADTATYYCARFGGEVLRYTDWPKPAWVDLWGRGTLVTVSS,QSALTQPPSASGSPGQSITISCTGTSNNFVSWYQQHAGKAPKLVIYDVNKRPSGVPDRFSGSKSGNTASLTVSGLQTDDEAVYYCGSLVGNWDVIFGGGTKLTVL,IGHV4-38-2 (Human),IGHJ2 (Human),IGLV2-8 (Human),IGLJ3 (Human),ARFGGEVLRYTDWPKPAWVDL,GSLVGNWDVI,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/PGT-128_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
910-30,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSLIYSGGSTYYADSVKGRFTISRHNSKNTLYLQMNSLRAEDTAVYYCARIYGDYAWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSRSGTDFTFTISSLQPEDIATYYCHQYDNLPLTFGGGTKVEIK,IGHV3-53 (Human),IGHJ5 (Human),IGKV1-33 (Human),IGKJ4 (Human),ARIYGDYA,HQYDNLPLT,https://www.rcsb.org/structure/7KS9,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Feb 11, 2021",11th Feb: Added PDB structure and full seq,Complete
DH1043,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSRYAINWVRQAPGQGLEWMGRIIPIFGIANYAQKFQGKVTITADKSTSTAYMELSSLRSEDTAVYYCARADYYYDSSGYFFDYWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQTPRLLIYGASSRATGIPARFSGSGSGTNFTLTISRLEPEDFAVYYCQQYSSSRTFGQGTKVEIK,IGHV1-69 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ1 (Human),ARADYYYDSSGYFFDY,QQYSSSRT,https://www.rcsb.org/structure/7LJR,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Apr 6, 2021",6th April: Added structure 7ljr,Complete
DH1125,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLIQPGGSLRLSCAASGFIVSYNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDYGDYYFDYWGQGTLVTVSS,EIVLTQSPATLSLSPGERATLSCGASQSVTSRYLAWYQQKPGLAPRLLIYDASSRATGIPDRFSGSGSGTEFTLTISRLEPEDFAVYYCQQYGSSPRTFGQGTKVEIK,IGHV3-53 (Human),IGHJ4 (Human),IGKV3D-20 (Human),IGKJ1 (Human),ARDYGDYYFDY,QQYGSSPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1125_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1042,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGRIIPMFGIANYAQKFQGRVTITADKSTSTAYLELSSLRSEDTAVYYCARYMVTRDQYYYDMDVWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISNYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSPPPTFGQGTKLEIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ2 (Human),ARYMVTRDQYYYDMDV,QQSYSPPPT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1042_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1179,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFTNNAMHWVRQAPGKGLEWVAVISYDGSNRYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAREDYYDSSGSFDHWGQGILVTVSS,QSALTQPASVSESPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMTYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYSSSSTWVFGGGTKLTVL,IGHV3-30-3 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ3 (Human),AREDYYDSSGSFDH,SSYSSSSTWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1179_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1184,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSRYGISWVRQAPGQGLEWMGRIIPMFGIANYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCATKPYYYDSSGYYGGFDYWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK,IGHV1-69 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ1 (Human),ATKPYYYDSSGYYGGFDY,QQYGSSPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1184_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1041,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGVTFSSYWMSWVRQAPGKGLEWVANIRQDGSEKYSVDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARARRADNSGYYGFHFDCWGQGTLVTVSS,QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWYQQLPGTAPKLLIYGNNNRPSGVPDRFSDSKSGTSASLAITRLQAEDEADYYCQSYDSSLSGWVFGGGTKLTVL,IGHV3-7 (Human),IGHJ4 (Human),IGLV1-40 (Human),IGLJ3 (Human),ARARRADNSGYYGFHFDC,QSYDSSLSGWV,https://www.rcsb.org/structure/7LAA,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Mar 19, 2021",19th March: Added structure,Complete
DH1186,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSNYAINWVRQAPGQGLEWMGRIIPIFGIANYAQEFQGRVTITADKSTSTVYMELSSLRSEDTAVYYCARANYYYESSGYYFDYWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSFLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCLQYGSSRTFGQGTKVEIK,IGHV1-69 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ1 (Human),ARANYYYESSGYYFDY,LQYGSSRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1186_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1044,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISFDGSNKYYVDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDMHNDYGDYVSYYFYYGMDVWGQGTTVTVSS,QSVLTQPPSVSAAPGQKVIISCSGSSSNIGNNYVSWYQQLPGTAPKLLIYENNKRPSGIPDRFSGSKSGTSATLGITGLQTGDEADYYCGTWDSSLRTDVFGGGTKLIVL,IGHV3-30 (Human),IGHJ6 (Human),IGLV1-51 (Human),IGLJ2 (Human),AKDMHNDYGDYVSYYFYYGMDV,GTWDSSLRTDV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1044_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Mar 16, 2021",16th March: Corrected CDRH3 seq,Complete
DH1213,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFRSYAISWVRQAPGQGLEWMGRIIPMFGIANYAQKFQDRVTITADKSTSTAYMELSSLRSEDTAVYYCAENLQDDSGTLYSGGWGQGTLVTVSS,QSVLTQPPSVSAALGQKVTISCSGSSSNIESNYVSWYQQFPGTVPTLLIYENNKRPSGIPDRFSASKFGTSATLGISGLQTGDEADYYCGTWDRSLSAWVFGGGTKVTVL,IGHV1-69 (Human),IGHJ4 (Human),IGLV1-51 (Human),IGLJ3 (Human),AENLQDDSGTLYSGG,GTWDRSLSAWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1213_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1126,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLIQPGGSLRLSCAASGFIVSSNYMSWVRQAPGKGLEWVSLIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLQQLGIDYWGQGTLVTVSS,DIQMTQSPSSVSASVGDRVTITCRASQGISSWLAWYQQKPGKAPKLLIYSASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQTNSFPYFGQGTRLDIK,IGHV3-53 (Human),IGHJ4 (Human),IGKV1-12 (Human),IGKJ5 (Human),ARDLQQLGIDY,QQTNSFPY,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1126_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1161-1,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGALLRVSCKASGDTSTNHGISWVRQAPGQGLEWMGWINVYNGRTNYAQKVQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARWIHRDFDWLPYGMFMDVWGQGTTVTVSS,QSALTQPPSASGSPGQSVTISCTGTSSDVGVYKYVSWYQHHPGKAPKLMVYEVSKRPSGVPDRFSGSKSGNTASLTVSGLQAEDEADYYCTSYEGDNTLVFGGGTKLTVL,IGHV1-18 (Human),IGHJ6 (Human),IGLV2-8 (Human),IGLJ3 (Human),ARWIHRDFDWLPYGMFMDV,TSYEGDNTLV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1161-1_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1173,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTGYYMHWVRQAPGQGLEWMGWINPNSGATNYAQKFQGWVTMTRDTSINTAYMELRRLKSDDTAVFYCARETSFAIFGGGGMDVWGQGTTVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDIGSYNLVSWYQQHPGKAPKLMIYEGSKRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCCSYAGSSTYVFGTGTKVTVL,IGHV1-2 (Human),IGHJ6 (Human),IGLV2-23 (Human),IGLJ1 (Human),ARETSFAIFGGGGMDV,CSYAGSSTYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1173_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1143,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYYMHWVRQAPGQGLEWMGIITPSGGSTSYAQKFQGRVTMTRDTSTSTVYMELSSLRSEDTALYYCARERVGVGIYSRSSESDFPTFDPWGQGTLVTVSS,DIQMTQSPSSLSASVGDTVTITCRASQNINNYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSETDFTLTISSLQPEDFATYYCQQSYSTPQYSFGQGTKLEIK,IGHV1-46 (Human),IGHJ5 (Human),IGKV1-39 (Human),IGKJ2 (Human),ARERVGVGIYSRSSESDFPTFDP,QQSYSTPQYS,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1143_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1154,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLGAEDTAVYYCARDLGSRGAFDIWGQGTMVTVSS,DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSDPVPFGGGTKVEIK,IGHV3-53 (Human),IGHJ3 (Human),IGKV1-9 (Human),IGKJ4 (Human),ARDLGSRGAFDI,QQLNSDPVP,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1154_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1047,Ab,"SARS-CoV1,SARS-CoV2",,SARS-CoV2,,S; RBD,B-cells; SARS-CoV1 Human Patient,QVQLVQSGAEVKKPGASVQVSCQASANTFTNHYIHWVRQAPGQGLEWMGIIYPTGGNTIYAQGFQGRVTMTRDTSLNTIYLELSSLRSEDTAVYYCARDVRVDDSWSGYDLLSGGTYFDYWGQGTLVTVSS,DIVMTQSPDSLAVSLGERATINCRSSQSVLYSSNNENYLAWYQQKPGQPPKLLIYWASTRESGIPDRFSGSGSGTDFTLTISRLQAEDVAVYYCQQYYSLPRTFGQGTKVEIK,IGHV1-46 (Human),IGHJ4 (Human),IGKV4-1 (Human),IGKJ1 (Human),ARDVRVDDSWSGYDLLSGGTYFDY,QQYYSLPRT,https://www.rcsb.org/structure/7LD1,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 30, 2021",30th Jan: Added PDB structure,Complete
DH1151,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTDYYMHWVRQAPGQGLEWMGRINPSSGGTNYVQKFQGRVTMTRDTSISTSYMELSRLRSDDTAVYYCARDLEDFWSGYPPLGYALDVWGQGTTVTVSS,NFMLTQPHSVSESPGKTVTISCTRSSGSIASNYVQWYQQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDISNVIFGGGTQLTVL,IGHV1-2 (Human),IGHJ6 (Human),IGLV6-57 (Human),IGLJ2 (Human),ARDLEDFWSGYPPLGYALDV,QSYDISNVI,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1151_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1197,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTVSSSYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDPSSRGYYGMDVWGQGTTVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDAFNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPSLTFGGGTKVEIK,IGHV3-66 (Human),IGHJ6 (Human),IGKV3-11 (Human),IGKJ4 (Human),ARDPSSRGYYGMDV,QQRSNWPSLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1197_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1160,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGGEVKKPGALLRVSCKASGDTSTNHAISWVRQAPGQGLEWMAWINVYNGRTNYAPHLQGRVTLTTDTATSTAYMQLSSLRSDDTAVYYCARWIHRDFDWLPYGMFMDVWGQGTTVTVSS,QSALTQPPSASGSPGQSVTISCTGTSIDLGVYKYVSWYQHHPGKAPKLIIYEVSKRPSGVPDRFSGSKSGNTASLTVSGLQAEDEADYYCTSYEGDNTLVFGGGTKLTVL,IGHV1-18 (Human),IGHJ6 (Human),IGLV2-8 (Human),IGLJ3 (Human),ARWIHRDFDWLPYGMFMDV,TSYEGDNTLV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1160_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1140,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSGTLSLTCAVSGGSISSPNWWSWVRQPPEKGLEWIGEIFHIGSTNYNPSLKSRVTISLDKSKNQFSLRLSSVTAADTAVYYCARGFTNWYFDLWGRGTLVTVSS,DIQMTQSPSTLSASVGDRVTITCRASQSISSWLAWYQQKPGKAPKVLIYKASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNSYSPLTFGGGTKVEIK,IGHV4-4 (Human),IGHJ2 (Human),IGKV1-5 (Human),IGKJ4 (Human),ARGFTNWYFDL,QQYNSYSPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1140_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1210,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVQSGAEVKKPGATVKISCKVSGYTFTDSYIHWVQQAPGKGLEWMGLLDPEDGETINAAKFQGRVTITADTSTDTAYMELRSLRSEDTAVYYCGSGSEAHYGIDYWGQGTLVTVSS,QSVLTQPPSVSGTPGQRVTISCSGSSSNIGGNFVYWYQQFPGTAPKLLIYLNNRRPSGVPDRFSGSNSGTSASLAISGLRSEDEAEYYCAAWDDSLSGQKVFGTGTKVTVL,IGHV1-69-2 (Human),IGHJ4 (Human),IGLV1-47 (Human),IGLJ1 (Human),GSGSEAHYGIDY,AAWDDSLSGQKV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1210_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1150,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGRSLRLSCAASGFTFDDYAMHWVRQAPGKGLEWVSGITWNSGIIGYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTALYYCAKDILSRVHYYDSSGSYGMDVWGQGTTVTVSS,SYELTQPPSVSVSPGQTASITCSGDKLGDKYACWYQQKPGQSPVLVIYQDSKRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCQAWDSSTASVIFGGGTKLTVL,IGHV3-9 (Human),IGHJ6 (Human),IGLV3-1 (Human),IGLJ2 (Human),AKDILSRVHYYDSSGSYGMDV,QAWDSSTASVI,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1150_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1045,Ab,"SARS-CoV1,SARS-CoV2",,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QLQLQESGPGLVKPSETLSLTCTVSGGSISSSGYYWGWIRQPPGKGLEWIGTIYYGGSTYYSPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCASQQWLRGNFDYWGQGTLVTVSS,NFMLTQPHSVSESPGKTVTISCTGSSGSIASNYVQWYQQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSSTYWVFGGGTKLTVL,IGHV4-39 (Human),IGHJ4 (Human),IGLV6-57 (Human),IGLJ3 (Human),ASQQWLRGNFDY,QSYDSSTYWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1045_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1046,Ab,"SARS-CoV1,SARS-CoV2",,SARS-CoV2,,S; RBD,B-cells; SARS-CoV1 Human Patient,EVQLVESGGGMVQPGGSLRLSCAASGFTFNNYAMNWVRQAPGKGLEWVSAISGSGIRTYYAESVKGRVTISRDNSKSTLYLQMNSLRAEDTAVYYCAKDLFYDFWSGFDFGPGESFGMDVWGQGTTVTVSS,DIQMTQSPSTLSASVGDRVNITCRVSQRITSWLAWYQQKPGKAPKVLISKTSSLEGGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYSEFSYTFGQGTKLEIK,IGHV3-23 (Human),IGHJ6 (Human),IGKV1-5 (Human),IGKJ2 (Human),AKDLFYDFWSGFDFGPGESFGMDV,QQYSEFSYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1046_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1180,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPDKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQLNSLRTEDTAVYYCAREDYYDSSGSLDYWGQGTLVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYFCSSYTSSSTWVFGGGTKLTVL,IGHV3-30-3 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ3 (Human),AREDYYDSSGSLDY,SSYTSSSTWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1180_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1183,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAREDYYDSSGSLDYWGQGTLVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSTWVFGGGTKLTVL,IGHV3-30-3 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ3 (Human),AREDYYDSSGSLDY,SSYTSSSTWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1183_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1128,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGDLVQPGGSLRLSCAASGFTFSTYAMTWVRQAPGKGLEWVSTISTTGGDTYYADSVKGRFTISRDNSKNTLNLHMNSLRAEDTAVYSCARHNELDYWGQGTLVTVSS,EIVLTQSPDFQSVTPNEKVTITCRASQSIGSSLHWYQQKPDQSPKLLIKYASQSLSGVPSRFSGSGSGTDFTLTINSLEVEDGATYYCHQSSSFPRTFGQGTKVEIK,IGHV3-23 (Human),IGHJ4 (Human),IGKV6-21 (Human),IGKJ1 (Human),ARHNELDY,HQSSSFPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1128_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1129,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGDLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSTISTTGGDTYYADSVKGRFTISRDNSKNKLNLQMNSLRAEDTAVYSCARHNELDYWGQGTLVTVSS,EIVLTQSPDFQSVTPNEKVTITCRASQSIGSSLHWYQQKPDQSPKLLIKYASQSFSGVPSRFSGSGSGTDFTLTINSLEAEDGATYYCHQSSSFPRTFGQGTKVEIK,IGHV3-23 (Human),IGHJ4 (Human),IGKV6-21 (Human),IGKJ1 (Human),ARHNELDY,HQSSSFPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1129_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1155,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSGTLSLTCAVSGGSISSSNWWSWVRQPPGKGLEWIGEIYHSGSTNYNPSLKSRVTISVDKSKNQFSLKLSSVTAADTAVYYCAMVQGVMVYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQGISNSLAWYQQKPGKAPKLLLYAASRLESGVPSRFSGSGSGTDYTLTISSLQPEDFATYYCQQYYSTLGRTFGQGTKVEIK,IGHV4-4 (Human),IGHJ4 (Human),IGKV1-NL1 (Human),IGKJ1 (Human),AMVQGVMVY,QQYYSTLGRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1155_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1193,Ab,"SARS-CoV1,SARS-CoV2",,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSNYGMHWVRQAPGKGLEWVTVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKVLTWSIHPEDYYYGMDVWGQGTTVTVSS,QSALTQPPSASGSPGQSVTISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYEVSQRPSGVPDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYAGSNIGVFGGGTTLTVL,IGHV3-30 (Human),IGHJ6 (Human),IGLV2-8 (Human),IGLJ3 (Human),AKVLTWSIHPEDYYYGMDV,SSYAGSNIGV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1193_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1111,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSGISGSGITYNADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKLAVAGGRGANYWGQGTLVTVSS,DIQMTQSPSTLSASVGDRVTITCRASQSISSWLAWYQQKPGKAPKLLIYKASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYHSWWTFGQGTKVEIK,IGHV3-23 (Human),IGHJ4 (Human),IGKV1-5 (Human),IGKJ1 (Human),AKLAVAGGRGANY,QQYHSWWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1111_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1161-2,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV1 Human Patient,QVQLVQSGAEVKKPGALLRVSCKGSGDTSTNHAIAWVRQAPGQGLEWMGWINVYNGRTNYAQKFQGRVTLTTDTATSTAYMELSSLRSDDTAVYYCARWIHRDFDWLPYGMFMDVWGQGTTVTVSS,QSALTQPPSASGSPGQSVTISCTGTSSDVGVYKYVSWYQHHPGKTPKVIIYEVSKRPSGVPDRFSGSKSGNTASLTVSGLQAEDEADYYCTSYEADNTLVLGGGTKLTVL,IGHV1-18 (Human),IGHJ6 (Human),IGLV2-8 (Human),IGLJ2 (Human),ARWIHRDFDWLPYGMFMDV,TSYEADNTLV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1161-2_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1064,Ab,"SARS-CoV1,SARS-CoV2",,SARS-CoV2,,S; RBD,B-cells; SARS-CoV1 Human Patient,QVQLVESGGGVVQPGRSLRLSCTASGFTFSQYGMHWVRQAPGKGLEWVAGMSYDGNDKNYLDSVKGRFSISRDDSKSTQYLQMNSLRAEDTAVYYCAKKGSPYCGVDCYKGYFDYWGQGILVIVSS,DIQMTQSPSSLSASVGDRVTITCQASHDINKYLSWYQHKPGKAPKIMTSDASNLEAGVPSRFSGGGSGTDFTLTINGLQPEDFATYYCQQYDRLPITFGQGTRLDIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ5 (Human),AKKGSPYCGVDCYKGYFDY,QQYDRLPIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1064_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1073,Ab,"SARS-CoV1,SARS-CoV2",,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVRKPGASVKVSCKASGYTFTDYYIHWVRQAPGQGLEWMGIINPEAGSTTSAQRFQGRLIMTTDTSASTVYMELNSLTSADTAVYYCARDYFLIPAANTMEVWGQGTTVTVSS,EIVLTQSPDTLSLSPGERATLSCRASQSVGTYLAWFQQKPGQPPRLLIYDASNRATGIPARFGGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPRTWTFGQGTKVEIK,IGHV1-46 (Human),IGHJ6 (Human),IGKV3-11 (Human),IGKJ1 (Human),ARDYFLIPAANTMEV,QQRSNWPRTWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1073_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1130,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGDLVQPGGSLRLSCAASGFTFTTYAMTWVRQAPGKGLEWVSTISTTGGDTYYADSVKGRFTISRDNSRNTLNLQMNSLRAEDTAVYSCARHNELDHWGQGTLVIVSS,EIVLTQSPDFQSVSPKEKVTITCRASQSIGSSLHWYQQKPDQSPKLLIKYASQSLSGVPSRFSGSGSGTDFTLTINSLEVEDGATYYCHQSSSFPRTFGQGTKVEIK,IGHV3-23 (Human),IGHJ4 (Human),IGKV6-21 (Human),IGKJ1 (Human),ARHNELDH,HQSSSFPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1130_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1063,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFSFNNYGFHWVRQAPGKGLEWLTSIWHDGSREFYADSVKGRFTISRDNPQNTMYLQMNSLRAEDTALYFCARDVAHCTTVGCHGNWFDTWGQGTLVTVSS,EIVLTQSPATLSLSPGDRATLSCRSSQTVDIYVGWYQQKPGQPPRLLIYDASNRAPGVPARFSGSGSGTDFTLTISSLEPEDFAVYFCQQRKSWPPLTFGGGTKVEMK,IGHV3-33 (Human),IGHJ5 (Human),IGKV3-11 (Human),IGKJ4 (Human),ARDVAHCTTVGCHGNWFDT,QQRKSWPPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1063_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1082,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLIQPGGSLRLSCAASGLFFGAYSMNWVRQAPGKGLEWVAYISSSSKTIYYADSVKGRFTISRDNAKNELFLQMTSLRDEDTAVYFCACMVGPTAPFDFWGQGTRVTVSS,DIQMTQSPSSLSASVGDRVTITCRAGQIIGTYLNWYQQRPGKAPMLLIYAASNLHSGVPSRFSGSGSGTDFTLTIDSLQPEDFATYYCQQTYSTPRTFGPGTKLEIK,IGHV3-48 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ2 (Human),ACMVGPTAPFDF,QQTYSTPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1082_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1072,Ab,"SARS-CoV1,SARS-CoV2",,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSHYGMHWVRQAPGKGLEWVALISYDGNNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKAPYSYAYSVYFFDYWGQGTLVTVSS,NFMLTQPHSVSESPGKTVTISCTRSSGSIASNNVQWYQQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSSNHVVFGGGTKLTVL,IGHV3-30 (Human),IGHJ4 (Human),IGLV6-57 (Human),IGLJ2 (Human),AKAPYSYAYSVYFFDY,QSYDSSNHVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1072_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1159-2,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSQTLSLTCTVSGGSISSATYYWSWIRQPAGKGLEWIGHIYTSGTTNYNPSLKSRVTISVDTSKSQFSLKLNSVTAADTAVYYCARGLRFCSDTRCYPYFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISNYLNWYQQTPGKAPKLLVYATSGLQSGVPSRFTGSGSGTDFTLTISSLQPGDFAIYYCQQTYSAPWTFGQGTKVEIK,IGHV4-61 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ1 (Human),ARGLRFCSDTRCYPYFDY,QQTYSAPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1159-2_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1088,Ab,"SARS-CoV1,SARS-CoV2",,SARS-CoV2,,S; RBD,B-cells; SARS-CoV1 Human Patient,EVQLVESGGGLVQPGRSLRLSCVASGFSPGDYAMHWVRQAPGKGLEWVSGISWNSVSIDYADSVKGRFTISRDNAKNSLYLQMNSLRPEDTALYYCARGGFKSGFYIHGMDVWGQGTTVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDIGDYDYVSWYQQHPGKAPKLLIYDVTYRPSGVSNLFSGSKSGNTASLTISGLQAEDEAVYYCSSYTTSNTLVFGGGTKLTVL,IGHV3-9 (Human),IGHJ6 (Human),IGLV2-14 (Human),IGLJ3 (Human),ARGGFKSGFYIHGMDV,SSYTTSNTLV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1088_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1196,Ab,"SARS-CoV2,HKU",,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGSELKKPGASVKVSCKASGYTFTSYAMNWVRQAPGQGLEWMGWINTNTGNPTYAQGFTGRFVFSLDTSVSTAYLQISSLKAEDTAVYYCAGGYDFWSGYPNPTDYWGQGTLVTVSS,QSVLTQPPSASGTPGQRVTISCSGSSSNIGSNYVYWYQQLPGTAPKLLIYRNNQRPSGVPDRFSGSKSGTSASLAISGLRSEDEADYYCAAWDDSLSGHVFGGGTKLTVL,IGHV7-4-1 (Human),IGHJ4 (Human),IGLV1-47 (Human),IGLJ3 (Human),AGGYDFWSGYPNPTDY,AAWDDSLSGHV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1196_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1117,Ab,"SARS-CoV1,SARS-CoV2",,SARS-CoV2,,S; RBD,B-cells; SARS-CoV1 Human Patient,EVQLVESGGGLVQPGGFLRLSCSASGFSFRTYSMHWVRQAPGKGLEHVSAISRNGDITYYADSMEGRFTISRDNSKNTLYLQMSSLRPEDTAVYYCVKDKVTTIFDVFDLWGQGTMVTVSS,DIQMTQSPASLSASVGDRVTITCRASQSVNIYLNWYQQKPGKAPTLLIHGASSLQTGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSPPRTFGQGTKVEIR,IGHV3-64D (Human),IGHJ3 (Human),IGKV1-39 (Human),IGKJ1 (Human),VKDKVTTIFDVFDL,QQSYSPPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1117_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1156,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGALVQPGGSLRLSCVVSGFSLMKYDMHWVRQVTGRGLEWVSGITVTGDTNYVGSVKGRFTVSRENAKDLLYLQMNSLRVDDTAVYYCARSRYYDFWSGYYSVDDYGMDVWGQGTTVTVSS,QSVLTQPPSVSGAPGQRVTISCTGSGSNIGAGYGVHWYQQFPGTAPKFLIYANTNRPSGVPDRFTGSKSGTSASLAITGLQAEDEADYYCQSYDSSISGWVFGGGTKVTVL,IGHV3-13 (Human),IGHJ6 (Human),IGLV1-40 (Human),IGLJ3 (Human),ARSRYYDFWSGYYSVDDYGMDV,QSYDSSISGWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1156_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1214,Ab,"SARS-CoV1,SARS-CoV2",,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFRSYAISWVRQAPGQGLEWMGRIIPMFGIANYAQKFQDRVTITADKSTSTAYMELSSLRSEDTAVYYCAENLQDDSGTLYSGGWGQGTLVTVSS,QTVVTQEPSLTVSPGGTVTLTCASSTGAVTSGYYPNWFQQKPGQAPRALIYSTSNKHSWTPARFSGSLLGGKAALTLSGVQPEDEAEYYCLLYYGGASGWVFGGGTKLTVL,IGHV1-69 (Human),IGHJ4 (Human),IGLV1-51 (Human),IGLJ3 (Human),AENLQDDSGTLYSGG,LLYYGGASGWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1214_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1091,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKEGNNYDFWSGYSYYFDYWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPFPAFGGGTKVEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ4 (Human),AKEGNNYDFWSGYSYYFDY,QQYGSSPFPA,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1091_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1102,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDYGDYGAFDYWGQGTLVTVSS,DIVMTQSPDSLAVSLGERATINCKSSQSVLYSSNNKNYLAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYSTPLTFGGGTKVEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV4-1 (Human),IGKJ4 (Human),AKDYGDYGAFDY,QQYYSTPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1102_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1139,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYSMNWVRQAPGKGLEWVSYISSSSSTIYYADSVKGRFTISRDNAKNSLYLQMNSLRDEDTAVYYCARDRNRGYNKLGDAFDIWGQGTMVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPPWTFGQGTKVEIK,IGHV3-48 (Human),IGHJ3 (Human),IGKV3-11 (Human),IGKJ1 (Human),ARDRNRGYNKLGDAFDI,QQRSNWPPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1139_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1169,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QVTLKESGPVLVKATETLTLTCTVSGFSHSNVRMGVSWIRQPPGKALEWLAHISPNDEKSYSTSLKSRLTISEDTSKSQVVLTMTNVDPVDTAAYYCARPLNPGFPDVFDIWGQGTMVTVSS,SYVLTQPPSVSVAPGKTARITCGGDNIRSKSVQWYQQKPGQAPMLVIYYDSDRPSGIPERFSGSNSGNTATLTISRVEGGDEADYYCQVWDSSGDQAVFGGGTKLTVL,IGHV2-26 (Human),IGHJ3 (Human),IGLV3-21 (Human),IGLJ2 (Human),ARPLNPGFPDVFDI,QVWDSSGDQAV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1169_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1172,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSQTLSLTCTVSGGSISSNGYYWSWIRQHPGKGLEWIGYIYYSGSTYYNPSLKSRVSISVDTSKNQFSLKLSSVTAADTAVYYCARSYLSGYEGHSFDYWGQGTLVSVSS,DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQHKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYENLPLTFGGGTKVEIK,IGHV4-31 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ4 (Human),ARSYLSGYEGHSFDY,QQYENLPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1172_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1152,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFSRYWMSWVRQAPGKGLEWVANIKQDGSEKDYVDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARATYYYDSSDYGINWFDPWGQGTLVTVSS,QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWYQQLPGTAPKLLIYGNSNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSSLSVYVFGTGTKVTVL,IGHV3-7 (Human),IGHJ5 (Human),IGLV1-40 (Human),IGLJ1 (Human),ARATYYYDSSDYGIN,QSYDSSLSVYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1152_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1096,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSETLSLTCTVSGGSISSYYWSWIRQPPGKGLEWIGYIYYSGSTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCASYYYDSSGYYYGFDIWGQGTMVTVSS,DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYLTFGGGTKVEIK,IGHV4-59 (Human),IGHJ3 (Human),IGKV1-9 (Human),IGKJ4 (Human),ASYYYDSSGYYYGFDI,QQLNSYLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1096_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1104-2,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSRKLSCAASGFTFRNSAMHWVRQAPGKGLEWVAVISYDGNLKYSADSVKGRFTISRDNSKNTLFLQMNSLRLDDTAVYYCARQGAHCSGGVCYGMDVWGQGTTVTVSS,AIQMTQSPSSLSASVGDRVTITCRSSQDIKNDLAWYQQRPGKAPNLLIYAASSLQTGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCLQDYDFPPYTFGQGTKLEIK,IGHV3-30-3 (Human),IGHJ6 (Human),IGKV1-6 (Human),IGKJ2 (Human),ARQGAHCSGGVCYGMDV,LQDYDFPPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1104-2_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1105-1,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSRRLSCAASGFTFRNSAMHWVRQAPGKGLEWVAVISYDGNLKYSADSVKGRFTISRDNSKNTLFLQMNSLRLDDTAVYYCARQGAHCSGGVCYGMDVWGQGTTVTVSS,AIQMTQSPSSLSASVGDRVTITCRASQDIKNDLAWYQQRPGKAPNLLIYAASSLQTGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCLQDYDFPPYTFGQGTKLEIK,IGHV3-30-3 (Human),IGHJ6 (Human),IGKV1-6 (Human),IGKJ2 (Human),ARQGAHCSGGVCYGMDV,LQDYDFPPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1105-1_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1109,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGKSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVIWYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNRLRAEDTAVYYCARGDGGGYWSGYGEVKWGQGTLVTVSS,NFMLTQPHSVSESPGKTVTISCTRSSGSIASNYVQWYQQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSTNLWVFGGGTKLTVL,IGHV3-33 (Human),IGHJ4 (Human),IGLV6-57 (Human),IGLJ3 (Human),ARGDGGGYWSGYGEVK,QSYDSTNLWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1109_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1127,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSNKYYTDSVKGRFTISRDNSKNTLFLQMNSLRAEDTAVYYCAKQGGGPYYFGSGYFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPRRVTFGPGTKVDIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ3 (Human),AKQGGGPYYFGSGYFDY,QQYDNLPRRVT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1127_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1185,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSRYGISWVRQAPGQGLEWMGRIIPMFGIANYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCATKPYYYDSSGYYGGFDYWGQGTLVTVSS,EIVLTQSPDTLSLSPGERATLSCGASQRIRSNYLAWYQQKPGQAPRLLIYATSTRATGIPDRFSGSGSGTDFTLIISRLEPEDFAVYYCQQYGSSQWTFGQGTKVEIK,IGHV1-69 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ1 (Human),ATKPYYYDSSGYYGGFDY,QQYGSSQWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1185_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1191,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFSFSRYGMDWVRQAPGKGLEWVAIIWYDGSNNHYADSVKGRFTISRDNSKNTLFLQMNSLRAEDTAVYYCARSFNEGQLGDAYHGMDVWGQGTTVTVSS,DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPLTFGQGTKVEIK,IGHV3-33 (Human),IGHJ6 (Human),IGKV1-9 (Human),IGKJ1 (Human),ARSFNEGQLGDAYHGMDV,QQLNSYPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1191_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1166,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYDMHWVRQVTGKGLEWVSLIGTAGDTYYPGSVKGRFTISRENAKNSLYLQMNSLRAGDTAVYYCARVGYTYGFRYWYFDLWGRGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSIPGLTFGGGTKVEIK,IGHV3-13 (Human),IGHJ2 (Human),IGKV1-39 (Human),IGKJ4 (Human),ARVGYTYGFRYWYFDL,QQSYSIPGLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1166_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1203,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVKPGGSLRLSCAASGFTLSNAWMNWVRQAPGKGLQWVGRINSETDGGTTDYAAPVKGRFTISRDDSKNTLYLQMNSLKTEDTAVYYCTTSDYLRYYYYGIDVWGQGTTVTVSS,DIQMTQSPSTLSASVGDRVTITCRASQSISSWLAWYQQKPGKAPKLLIYKASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYDSYSWTFGQGTKVEIK,IGHV3-15 (Human),IGHJ6 (Human),IGKV1-5 (Human),IGKJ1 (Human),TTSDYLRYYYYGIDV,QQYDSYSWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1203_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1170,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QVTLKESGPVLVKATETLTLTCTVSGFSHSNVRMGVSWIRQPPGKALEWLAHISSNDEKSYSTSLKSRLTISGDTSKSQVVLTMTNVDPVDTAAYYCARPLNPGFPDVFDIWGQGTMVTVSS,SYVLTQPPSVSVAPGKTARITCGGDNIRSKSVHWYQQKPGQAPMLVIYYDSDRPSGIPERFSGSNSGNTATLTISRVEGGDEADYYCQVWDSSGDQAVFGGGTKLTVL,IGHV2-26 (Human),IGHJ3 (Human),IGLV3-21 (Human),IGLJ2 (Human),ARPLNPGFPDVFDI,QVWDSSGDQAV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1170_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1201,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSGTLSLTCAVSGGSISSSNWWSWVRQPPGKGLEWIGEIYHSGSTNYNPSLKSRVTISVDKSKNQFSLKLSSVTAADTAVYYCAREPSYSSGCLDYWGQGTLVTVSS,EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNWPLTWTFGQGTKVEIK,IGHV4-4 (Human),IGHJ4 (Human),IGKV3-15 (Human),IGKJ1 (Human),AREPSYSSGCLDY,QQYNNWPLTWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1201_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1209,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFSNYWLSWVRQAPGKGLEWVANINQDGSEKYYVDSVKGRFTISRDNTKNSLYLQMNSLRAEDTAVYYCARARRAGSSGYYGFHFDYWGQGTLVTVSS,QSVLTQPPSVSGAPGQRVTISCTGNSSNIGTGYDVHWYQQLPGTAPKLLIYGNSNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSSLSGWVFGGGTKLTVL,IGHV3-7 (Human),IGHJ4 (Human),IGLV1-40 (Human),IGLJ3 (Human),ARARRAGSSGYYGFHFDY,QSYDSSLSGWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1209_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1208,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSTYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKSDSELLPHFDYWGQGTLVTVSS,SYVLTQPPSVSVAPGKTARITCGGNNIGSKNVHWYQQKPGQAPVLVIYYDNDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDGTSDPVVFGGGTKLTVL,IGHV3-30 (Human),IGHJ4 (Human),IGLV3-21 (Human),IGLJ2 (Human),AKSDSELLPHFDY,QVWDGTSDPVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1208_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1085,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; RBD,B-cells; SARS-CoV1 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTYSTYAMSWVRQAPGKGLEWVSAISGDGGRTYYADSVKGRFTISRDNSKTILYLQVNSLRVEDTAVYYCAKLEGGHYYGSGSYYISTPLAMDVWGQGTTVTVSS,SYVLTQPPSVSVAPGKTARINCEGNSIGSKNVHWYQQKPGQAPVLVIFYDNDRPSGIPERFSGSNSGNTATLTISRVEAGDEADFYCQVWDSSTDQCVFGTGTKVTVL,IGHV3-23 (Human),IGHJ6 (Human),IGLV3-21 (Human),IGLJ1 (Human),AKLEGGHYYGSGSYYISTPLAMDV,QVWDSSTDQCV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1085_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1075,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV1 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSNYPMHWVRQAPGKGLEWVAVISFDGSATYYADSVKGRFTISRDNFKNTLFLQMSSLRPQDTALYYCARDQLLDYWGQGTLVTVSS,DIVMTQTPLSLSVTPGQPASISCKSSQSLLHSDGKTYLYWYLQKPGQSPQLLIYEVSSRFSGVPNRFSGSGSVTDFTLKISRVEAEDVGVYYCMQGIHLPSFTFGPGTKVDIK,IGHV3-30-3 (Human),IGHJ4 (Human),IGKV2-29 (Human),IGKJ3 (Human),ARDQLLDY,MQGIHLPSFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1075_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1080,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; RBD,B-cells; SARS-CoV1 Human Patient,QVQLVQSGGEVKKPGASVNVSCKASGYSFRTYGVGWVRQAPGQGLEWMGWIGANNDITDYAQKFQGRLTLTTDPSTSTAYMDLRSLTSDDTGVYYCARAGPEVPFDHWGQGTLVTVSS,DIVMTQSPDSLAVSLGERATINCKSSESVLFATNNKKYLAWYQQKPGQPPKLLIYWASTRASGVPDRFSGSGSRTDFTLTISSLQAEDVAVYYCQQYYSAPLYAFGQGTKLEVK,IGHV1-18 (Human),IGHJ4 (Human),IGKV4-1 (Human),IGKJ2 (Human),ARAGPEVPFDH,QQYYSAPLYA,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1080_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1107,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV1 Human Patient,QVQLQESGPGLVKPSQTLSLTCSVSGGSLSNAGYYWSWIRQHPGKGLEWIGYIYYTGDTYYNASLKGRASMSLDMSENRFSLSLTSVTDADTAVYYCTRAIRYCLGGYCHHPWFDPWGQGVLVVVSS,DIQMTQSPSSLSASVGDTVTITCQASQDINKFLNWYQQKPGKAPKLLIFDSSDLDTGVPTRFSGSGSGTDFKFTISSLQPEDFATYYCQQYENLPVTFGGGTKVETN,IGHV4-31 (Human),IGHJ5 (Human),IGKV1-33 (Human),IGKJ4 (Human),TRAIRYCLGGYCHHPWFDP,QQYENLPVT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1107_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1120,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; RBD,B-cells; SARS-CoV1 Human Patient,QVQLVQSGAEVRKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGIIPIFGTTNYAQRFQDRVTITADESTRTAYMELRSLRSEDTAVYYCGHMAATGRISFYYHGLDVWGQGTTVTVSS,DIVMTQTPLSLSVTPGQPASISCKSSQSLSHSDGKTYLYWYLQRPGQSPRLLIYEVSSRFSGVPDRFSGSGSGTDFTLKIGRVEAEDVGVYYCMQGIHRIFTFGPGTKVDIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV2-29 (Human),IGKJ3 (Human),GHMAATGRISFYYHGLDV,MQGIHRIFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1120_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1092,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV1 Human Patient,EVQLVESGGGLVQPGRSLRLSCTASGFTFDDYAIHWVRQAPGKGLEWVSGVDWNGGTIDYADSVKGRFTISRDNAKNSLYLQMNSLRPEDTAFYYCAKGDCSSTSCDDPYFDYWGQGTLVTVSS,SYELTQPPSVSVSPGQTARITCAGDALPKKYAYWYQQKSGQAPVLVIYEDSKRPSGIPERFSGSSSGTMATLTISGAQVEDEADYYCYSTDSSGNHRVFGGGTKLTVL,IGHV3-9 (Human),IGHJ4 (Human),IGLV3-10 (Human),IGLJ3 (Human),AKGDCSSTSCDDPYFDY,YSTDSSGNHRV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1092_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1112,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; RBD,B-cells; SARS-CoV1 Human Patient,QVQLVQSGAEVQKPGASVKVSCQASGSTFSNSDINWVRQAIGQGLEWMGWVNPNSGNTGYAHKFQGRVTMTRDTSRNTVYMELSSLTSEDTAVYYCAKGPDDYWSGYGRFDPWGQGTLVTVSS,DIQMTQSPSPLSASVGDRVTITCRASQSISTYLDWYQQKPGKAPKLLIYAASTLQNGVPSRFSGSGSGTDFTLTISSLQPEDFATYHCQQSYSTPYTFGQGTKLEIK,IGHV1-8 (Human),IGHJ5 (Human),IGKV1-39 (Human),IGKJ2 (Human),AKGPDDYWSGYGRFDP,QQSYSTPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1112_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1115,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; RBD,B-cells; SARS-CoV1 Human Patient,QVQLVQSGGEAKKPGASVKVSCKASGYTFNTHDINWVRQTTGQGLEWMGWVNPSSGNTGYSHKFQGRVTMTTDTSINTAFMELSGLRSEDTAIYYCARGPSGYYYGSGDFWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSIGFYLNWYQQKPGKAPKFLIYAASTLHSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPFNFGPGTKVDIK,IGHV1-8 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ3 (Human),ARGPSGYYYGSGDF,QQSYSTPFN,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1115_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1095,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; RBD,B-cells; SARS-CoV1 Human Patient,QVQLQESGPGLVKPSQTLSLTCTVSGGSVISDDYYWNWIRQSPGKGLEWIGYISHNGDKYYNPSLMSRVSISVDTSKNQFSLKLTSVTAADTAVYYCARDQRTGSYFGYYFDYWGQGTLVIVSS,DIQMTQSPSSLPASVGDRVTVTCRASQSISNYLNWYQHKPGKAPKFLIYGASSLQSGVPSRFSGSGSGTNFTLTITGLQPEDFATYYCQQSYTTVYTFGQGTKLEMK,IGHV4-30-4 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ2 (Human),ARDQRTGSYFGYYFDY,QQSYTTVYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1095_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1113,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; RBD,B-cells; SARS-CoV1 Human Patient,QVQLVQSGPEVKKPGSSVKVSCEASGDGLSNYGISWVRQAPGQGLEWMGRIIPILGITNYAQRFQGRVTITVELTSTVYMELSSLRSEDTAVYFCARERYNTRNFDYWGQGTQVTVSS,DIVMTQSPLSLPVTPGEPASISCRSSQSLLHSNGYNYLDWYLQKPGQSPQLLIYLGSKRASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQGLQGYTFGQGTKLEIK,IGHV1-69 (Human),IGHJ4 (Human),IGKV2-28 (Human),IGKJ2 (Human),ARERYNTRNFDY,MQGLQGYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1113_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1098,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; RBD,B-cells; SARS-CoV1 Human Patient,EVQLVESGGGLVQPGGSLRVSCAASGFTFSNYAMAWVRQAPGKGLEWVSTISGSGYTTSSADSVKGRFTISRDNSKSTLYLQMNSLSAEDTAVYYCARDWPTNVRYCSSDICPLFDYWGQGTLVTVSS,AIQMTQSPSSLSASVGDRVTITCRASQGISTDLGWYQQKPGKAPKLLIYAASSLQDGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCLQNYNYPFTFGGGTKVEIK,IGHV3-23 (Human),IGHJ4 (Human),IGKV1-6 (Human),IGKJ4 (Human),ARDWPTNVRYCSSDICPLFDY,LQNYNYPFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1098_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1101,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; RBD,B-cells; SARS-CoV1 Human Patient,EVQLVESGGGLIHPGGSLRLSCAASGVIVSDNYMAWVRQAPGKGLEWVSFLSSGGATYYAASVEGRFTISGDGSQNTVYLQMDSLKAEDTAVYYCVRVGGSSGWVSDYYFDSWGQGTLVTVSS,EIVMTQSPATLSVSPGKRATLSCRASQSVSDNLAWYQQKPGQAPRLLIYASSTRATGIPARISGSGSGTEFTLTISSLQSEDFAVYYCQQYNSWPLTFGGGTKVEIK,IGHV3-53 (Human),IGHJ4 (Human),IGKV3-15 (Human),IGKJ4 (Human),VRVGGSSGWVSDYYFDS,QQYNSWPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1101_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1049,Ab,SARS-CoV2,,SARS-CoV2,,S; NTD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKVSGYTLIELSMHWVRQAPGKGLEWMGGFDPEDGETIYAQKFQGRVTMTEDTSTDTAYMELSSLTSEDTAVYYCATTTPFGVVNAIWFDPWGQGTLVTVSS,QSVLTQPPSVSAAPGQKVTISCSGSSSNIGNNYVSWYQQLPGTAPKLLIYENNKRPSGIPDRFSGSKSGTSATLAITGLQTGDEADYCCGTWDSSLSAGVFGGGTKLTVL,IGHV1-24 (Human),IGHJ5 (Human),IGLV1-51 (Human),IGLJ3 (Human),ATTTPFGVVNAIWFDP,GTWDSSLSAGV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1049_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1050-1,Ab,SARS-CoV2,,SARS-CoV2,,S; NTD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKVSGYTLPELSMHWVRQAPGKGLEWMGGFHPEDGETIYAQKFQGRVTMTEDTSTDTAYMELSSLRSEDTAVYYCATGSPFGVVTDWFDPWGRGTLVTVSS,QSALTQPPSASGSPGQSVTISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYEVSKRPSGVPDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYAGSNNPYVFGTGTKVTVL,IGHV1-24 (Human),IGHJ5 (Human),IGLV2-8 (Human),IGLJ1 (Human),ATGSPFGVVTDWFDP,SSYAGSNNPYV,https://www.rcsb.org/structure/7LCN,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 30, 2021",30th Jan: Added PDB structure,Complete
DH1051,Ab,SARS-CoV2,,SARS-CoV2,,S; NTD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAFIWYDGSNIYYTDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDRVDSSSWGFYFDYWGQGTLVTVSS,SYELTQPPSVSVSPGQTARITCSGDALPKKYAYWYQQKSGQAPVLVIYEDSKRPSRIPERFSGSSSGTMATLTISGAQVEDEADYYCYSTDSSINHSGVFGGGTKLTVL,IGHV3-33 (Human),IGHJ4 (Human),IGLV3-10 (Human),IGLJ2 (Human),ARDRVDSSSWGFYFDY,YSTDSSINHSGV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1051_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1167,Ab,SARS-CoV2,,SARS-CoV2,,S; NTD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYGISWVRQAPGQGLEWMGGTIPIFGTANYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYCSGFGGDDGMDVWGPGTTVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSSFLAWYQQKPGQPPRLLIYGASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQRRSNWPPWTFGQGTKVEIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV3-11 (Human),IGKJ1 (Human),SGFGGDDGMDV,QRRSNWPPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1167_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1190,Ab,SARS-CoV2,,SARS-CoV2,,S; NTD,B-cells; SARS-CoV2 Human Patient,EVQLVQSGAEVKKPGESLRISCKGSGYSFTSYWISWVRQMPGKGLEWMGRIDPSDSYTNYSPSFQGHVTISADKSISTAYLQWSSLKASDTAMYYCARLVPGQWHFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLLALTFGGGTKVEIK,IGHV5-10-1 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ4 (Human),ARLVPGQWHFDY,QQYDNLLALT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1190_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1050-2,Ab,SARS-CoV2,,SARS-CoV2,,S; NTD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKVSGYTLIELSMHWVRQAPGKGLEWMGGFDPEDGETIYAQKFQGRVTMTEDTSTDTAYMELSSLRSEDTAVYYCATGSPFGVVTSWFDPWGQGTLVTVSS,QSALTQPPSASGSPGQSVTISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYEVTKRPSRVPDRFSASKSGNTASLTVSGLQAEDEADYYCSSYAGSNNPYVFGPGTKVTVL,IGHV1-24 (Human),IGHJ5 (Human),IGLV2-8 (Human),IGLJ1 (Human),ATGSPFGVVTSWFDP,SSYAGSNNPYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1050-2_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1138,Ab,SARS-CoV2,,SARS-CoV2,,S; NTD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSQTLSLTCTVSGDSISSGSYYWSWIRQPAGKGLEWIGRIYTDGSTNYNPSLKSRVTISVDTSKNQFSLKLSSLTAADTAVYYCARDVDIVGVFDYWGQGTLVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSTYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSKWVTFGGGTKVEIK,IGHV4-61 (Human),IGHJ4 (Human),IGKV3-11 (Human),IGKJ4 (Human),ARDVDIVGVFDY,QQRSKWVT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1138_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1048,Ab,SARS-CoV2,,SARS-CoV2,,S; NTD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYSMNWVRQAPGKGLEWVSYISSSSSTIYYADSVKGRFTISRDNAKNSLYLQMNSLRDEDTAVYYCARMAIVGAYANWGFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNPLITFGQGTRLEIK,IGHV3-48 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ5 (Human),ARMAIVGAYANWGFDY,QQYDNPLIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1048_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1205,Ab,SARS-CoV2,,SARS-CoV2,,S; NTD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARGEYNWNDEDYYYGMDVWGQGTTVTVSS,QLVLTQSPSASASLGASVKLTCTLSSGHSSYAIAWHQQQPEKGPRYLMKLNSDGSHSKGDGIPDRFSGSSSGAERYLTISSLQSEDEADYYCQTWGTGIHVVFGGGTKLTVL,IGHV3-53 (Human),IGHJ6 (Human),IGLV4-69 (Human),IGLJ2 (Human),ARGEYNWNDEDYYYGMDV,QTWGTGIHVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1205_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1171,Ab,"SARS-CoV1,SARS-CoV2",,SARS-CoV2,,S; NTD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSQTLSLTCTVSGGSISSGGYYWSWIRQHPGKGLEWIGYIYYSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARADIVVVPAAAFDYWGQGTLVTVSS,SSELTQDPAVSVALGQTVRITCQGDSLRNYYASWYQQKPGQAPVLVIYGNINRPSGIPDRFSGSSSGNTASLTITGAQAEDEADYYCNSRDSSGNQLGVFGGGTKLTVL,IGHV4-31 (Human),IGHJ4 (Human),IGLV3-19 (Human),IGLJ2 (Human),ARADIVVVPAAAFDY,NSRDSSGNQLGV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1171_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1198,Ab,SARS-CoV2,,,SARS-CoV2,S; NTD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSQTLSLTCTVSGGSISSGSYYWSWIRQPAGKGLEWIGRIYTSGSTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARDLGLRYFDWLLRSDYYYYGMDVWGQGTTVTVSS,QSVLTQPPSASGTPGQRVTISCSGSSSNIGSNTVNWYQQLPGTAPKLLIYSNNQRPSGVPDRFSGSKSGTSASLAISGLQSEDEADYYCAAWDDSLNGWVFGGGTKLTVL,IGHV4-61 (Human),IGHJ6 (Human),IGLV1-44 (Human),IGLJ3 (Human),ARDLGLRYFDWLLRSDYYYYGMDV,AAWDDSLNGWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1198_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1204,Ab,SARS-CoV2,,,SARS-CoV2,S; NTD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEMKKPGASVKVSCKASGYIFTTYYMHWVRQAPGQGLEWMGIINPSDGSTSNAQNFQGRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARDITVTTRDVYDYYYGMDVWGQGTTVTVSS,SYELTQPPSVSVSPGQTARITCSGDALPKQFAYWYQQKPGQAPVVLIYKDSERPSGIPERISGSSSGTTVTLTISGVEAEDEADYYCQSADSSGTYVVFGGGTKLTVL,IGHV1-46 (Human),IGHJ6 (Human),IGLV3-25 (Human),IGLJ3 (Human),ARDITVTTRDVYDYYYGMDV,QSADSSGTYVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1204_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1162,Ab,SARS-CoV2,,,SARS-CoV2,S; NTD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLHEWELLAAGLDYWGQGTLVTVSS,SYELTQPPSVSVSPGQTASITCSGDKLGDKYACWYQQKPGQSPVLVIYQDSKRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCQAWDSSTARYVFGTGTKVTVL,IGHV3-30-3 (Human),IGHJ4 (Human),IGLV3-1 (Human),IGLJ1 (Human),ARDLHEWELLAAGLDY,QAWDSSTARYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1162_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1199,Ab,SARS-CoV2,,,SARS-CoV2,S; NTD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSGTLSLTCAVSGGSISSSNWWSWVRQPPGKGLEWIGEIYHSGSTNYNPSLKSRVTISVDKSKNQFSLKLSSVTAADTAVYYCARAATILGLYYYYGMDVWGQGTTVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPTWTFGQGTKVEIK,IGHV4-4 (Human),IGHJ6 (Human),IGKV3-20 (Human),IGKJ1 (Human),ARAATILGLYYYYGMDV,QQYGSSPTWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1199_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1090,Ab,SARS-CoV2,,,SARS-CoV2,S; NTD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYWMSWVRQAPGKGLEWVANIKQDGSEKYYVDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARDESTYYYDSSGYYYEGYFDYWGQGTLVTVSS,SYELTQPPSVSVSPGQTARITCSGDALPKKYAYWYQQKSGQAPVLVIYEDSKRPSGIPERFSGSSSGTMATLTISGAQVEDEADYYCYSTDSSGNHRVFGGGTKLTVL,IGHV3-7 (Human),IGHJ4 (Human),IGLV3-10 (Human),IGLJ3 (Human),ARDESTYYYDSSGYYYEGYFDY,YSTDSSGNHRV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1090_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1118,Ab,SARS-CoV2,,,SARS-CoV2,S; NTD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVKPGGSLRLSCAASGFTFSNAWMNWVRQAPGKGLEWVGRIKSKTDGGTTDYAAPVKGRFTISRDDSKNTLYLQMNSLKTEDTAVYYCTTDRIYDYVWGSYRYKDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQGISNSLAWYQQKPGKAPKLLLYAASRLESGVPSRFSGSGSGTDYTLTISSLQPEDFATYYCQQYYSTPMYTFGQGTKLEIK,IGHV3-15 (Human),IGHJ4 (Human),IGKV1-NL1 (Human),IGKJ2 (Human),TTDRIYDYVWGSYRYKDY,QQYYSTPMYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1118_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1119,Ab,SARS-CoV2,,,SARS-CoV2,S; NTD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVKPGGSLRLSCAASGFTFSNAWMSWVRQAPGKGLEWVGRIKSKTDGGTTDYAAPVKGRFTISRDDSKNTLYLQMNSLKTEDTAVYYCTTDRDYDYIWGSYRYRDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSPLFGPGTKVDIK,IGHV3-15 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ3 (Human),TTDRDYDYIWGSYRYRDY,QQSYSPL,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1119_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1200,Ab,SARS-CoV2,,,SARS-CoV2,S; NTD,B-cells; SARS-CoV2 Human Patient,QITLKESGPTLVKPTQTLTLTCTFSGFSLSTSGVGVGWIRQPPGKALEWLALTYWDDHKRYSPSLKSRLTITKDTSKNQVVLTMTNMDPMDTATYYCAHRNPYGGEAGYYYYGLDVWGQGTTVTVSS,SYELTQPPSVSVSPGQTARITCSGDALPRQYAYWYQQKPGQAPVMIIYKDTERPSGIPERFSGFSSGTTVTLTISGVQAEDESDYYCQSADSSNTYVVFGGGTKLTVL,IGHV2-5 (Human),IGHJ6 (Human),IGLV3-25 (Human),IGLJ2 (Human),AHRNPYGGEAGYYYYGLDV,QSADSSNTYVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1200_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1144,Ab,SARS-CoV2,,,SARS-CoV2,S; NTD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAITWVRQAPGQGLEWMGGIIPIFGRANYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYCARVVITGLDYYYGMDVWGQGTTVTVSS,SYVLTQPPSVSVAPGKTARITCGGNNIGYKSVHWYQQKPGQAPVLVIYYDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDSSSDHWVFGGGTKLTVL,IGHV1-69 (Human),IGHJ6 (Human),IGLV3-21 (Human),IGLJ3 (Human),ARVVITGLDYYYGMDV,QVWDSSSDHWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1144_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1153,Ab,SARS-CoV2,,,SARS-CoV2,S; NTD,B-cells; SARS-CoV2 Human Patient,QVTLKESGPVLVKPTETLTLTCTVSGFSLSNARMGVSWIRQPPGKALEWLAHIFSGDEKSYSTSLTSRLTISKDTSKSQVVLTMTNMDPVDTATYYCARIQLWLDGGGMDVWGQGTTVTVSS,QSALTQPPSASGSPGQSVTISCTGSSSDVGGFYYVSWYQQHPGKAPKLLIYEVTKRPSGVPDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYAGSYVFGTGTKVTVL,IGHV2-26 (Human),IGHJ6 (Human),IGLV2-8 (Human),IGLJ1 (Human),ARIQLWLDGGGMDV,SSYAGSYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1153_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1206,Ab,SARS-CoV2,,,SARS-CoV2,S; NTD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVKPGGSLRLSCAASGFTFSSYSMNWVRQAPGKGLEWVSSISFRSSYIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARVRNHYYDSSGYYPDAFDIWGQGTMVTVSS,EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTITSLQSEDFAVYYCQQYYNWPPWSFGQGTKLEIK,IGHV3-21 (Human),IGHJ3 (Human),IGKV3-15 (Human),IGKJ2 (Human),ARVRNHYYDSSGYYPDAFDI,QQYYNWPPWS,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1206_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1052,Ab,SARS-CoV2,,,SARS-CoV2,S; NTD,B-cells; SARS-CoV2 Human Patient,EVQLVQSGAEVKKPGATVKISCKVSGYTFTDYYMHWVQQAPGKGLEWMGLVDPEDGETIYAEKFQGRVTITADTSTDTAYMELSSLRSEDTAVYYCATSSGPSRLCGGGSCYHSFDYWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPTWTFGQGTKVEIK,IGHV1-69-2 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ1 (Human),ATSSGPSRLCGGGSCYHSFDY,QQYGSSPTWT,https://www.rcsb.org/structure/7LAB,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Mar 11, 2021",11th March: Added PDB structure,Complete
DH1053,Ab,SARS-CoV2,,,SARS-CoV2,S; NTD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGAVVQPGGSLRLSCAASGFTFDAYTMHWVRQTPGRGLEWLSLISWDGSTFYAESLKGRFTVSRDNSKNSLYLQMSSLRADDTALYYCAKAKDPYTEYFDYWGQGTLVTVSS,DIQMTQSPSTLSASVGDRVTITCRASQTINSWLAWYQMKPGKAPKVLIYKASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYYIYSLSFGGGTKVEIK,IGHV3-43 (Human),IGHJ4 (Human),IGKV1-5 (Human),IGKJ4 (Human),AKAKDPYTEYFDY,QQYYIYSLS,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1053_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1054,Ab,SARS-CoV2,,,SARS-CoV2,S; NTD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFIISRDNSKNTLYLQMDSLRAEDTAVYYCARGDIVGATWDPAFDIWGQGTLVTVSS,SYVLTQPPSVSVAPGKTARITCGGNNIGSKSVHWYQQKPGQAPVLVIYYASARPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDTSSDHSVVFGGGTKLTVL,IGHV3-53 (Human),IGHJ3 (Human),IGLV3-21 (Human),IGLJ2 (Human),ARGDIVGATWDPAFDI,QVWDTSSDHSVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1054_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1055,Ab,SARS-CoV2,,,SARS-CoV2,S; NTD,B-cells; SARS-CoV2 Human Patient,QVTLRESGPALVKPTQTLTLTCTFSGFSLSTSGMCVSWIRQPPGKALEWLALIDWDDDKYYSTSLKTRLTISKDTSKNQVVLTMTNMDPVDTATYYCARINAYSSSWPTFDYWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSSWTFGQGTKVEIK,IGHV2-70 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ1 (Human),ARINAYSSSWPTFDY,QQYGSSSWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1055_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1056,Ab,SARS-CoV2,,,SARS-CoV2,S; NTD,B-cells; SARS-CoV2 Human Patient,QLQLQESGPGLVKPSETLSLTCTVSGGSISSSSYYWGWIRQPPGKGPEWIGSIYYGGTTYYNPSLRSRVTISLDMSKNQISLKLSSVTATDTAVYYCARSSSGFSYDTPLDPWGQGTLVIVSS,DIQMTQSPSSLSASVGDRVTITCRASQGIRNDLGWFQQKPGKAPKRLIYAASSLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCLQHNSYPITFGQGTRLEIK,IGHV4-39 (Human),IGHJ5 (Human),IGKV1-17 (Human),IGKJ5 (Human),ARSSSGFSYDTPLDP,LQHNSYPIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1056_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1065,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; NTD,B-cells; SARS-CoV1 Human Patient,QVQLQQWGAGLLKPSETLSLTCAVYGGSFSGYHWNWIRQSPGKGLEWIGEINHDGSTNYNPSLKSRVSISADTSKSQFSLKLNSVTAADTAVYYCARDLSRTYRFQYYDSGVTEAFDIWGQGTMVTVSS,QSVLTQPPSVSAAPGQRVTISCSGSSSNIGNNYVSWYQQVPGTAPKLLIYDNDKRPSGIPDRFSGSKSGTSATLGITGLQTGDEADYYCGTWDSSLSAGVFGGGTKLTVL,IGHV4-34 (Human),IGHJ3 (Human),IGLV1-51 (Human),IGLJ3 (Human),ARDLSRTYRFQYYDSGVTEAFDI,GTWDSSLSAGV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1065_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1069,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; NTD,B-cells; SARS-CoV1 Human Patient,QVQLQESGAGLVKPSETLSLMCGVYGGSFSGFYWSWIRQPPGKGLQWIGEIYHSGSTNYNPSLKSRVTMSIDTSKKQFSLKLSSVTAADTALYYCARGRRGIVVGIDDPNYDYWGQGTLVTVSS,QSVLTQPPSVSAAPGQKVTISCSGSSSNIGNHYVSWYQQLPGTAPKLLIYDNNKRPSDMPDRFSASKSGTSATLGITGLQTGDEADYYCGTWDSSLSAVVFGGGTKLTVL,IGHV4-34 (Human),IGHJ4 (Human),IGLV1-51 (Human),IGLJ2 (Human),ARGRRGIVVGIDDPNYDY,GTWDSSLSAVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1069_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1110,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; NTD,B-cells; SARS-CoV1 Human Patient,QVQLQQWGAGLLKPSETLSLTCAVYGGSFSGFYWSWIRQPPGKGLEWIGEITHSGGTSYSGGTNYNPSLKSRVTISIDTSKKQFSLNLTSVTAADTAVYFCARGTTIGLYTNTWNFPRLGFDPWGQGTLVTVSA,QSALTQPASVSGSPGQSITISCTGTSSDVGGYNFVSWYKQDPGKAPKLMIYEVSKRPSVVSDRFSGSKSGNTASLTISGLQAEDEADYYCCSYAGSYTLFGSGTKVTVL,IGHV4-34 (Human),IGHJ5 (Human),IGLV2-23 (Human),IGLJ1 (Human),ARGTTIGLYTNTWNFPRLGFDP,CSYAGSYTL,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1110_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1106,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; NTD,B-cells; SARS-CoV1 Human Patient,QVQLQQWGAGLLRPSETLSLTCAVYGGSFSGFSWSWVRQPPGKGLEWIGEISHDGTTNFDSSLKSRVTMSLDTSKNHFSLNLNSVTAADTAVYYCARVPTVTVYGVDVINVSWFDPWGQGTLVTVSS,QSALTQPASVSGSPGQSITISCTGAGNDVGSYNLVSWYQHHPGKAPKLIIYEGTKRPSVVSDRFSGSKSATTASLTISGLQAEDEADYYCCLYGRTRTFYVFGTGTKVTVL,IGHV4-34 (Human),IGHJ5 (Human),IGLV2-23 (Human),IGLJ1 (Human),ARVPTVTVYGVDVINVSWFDP,CLYGRTRTFYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1106_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1093,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; NTD,B-cells; SARS-CoV1 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGIFTSHIISWVRQAPGQGLEWMGRIIPSLDRANYAQKFQDRVTITADKSTSTAYMELSSLRSEDTAMYYCAREEFVVVPGNWFDPWGQGTLVTVSS,SSELTQDPVVSVALGQTVRITCQGDSLRSYFASWYQQKPGQAPVLVIYGKNNRPSGIPDRFSASNSGNTASLTITGAQAEDEAGYFCCSRDSSGNHHVVFGGGTKLTVL,IGHV1-69 (Human),IGHJ5 (Human),IGLV3-19 (Human),IGLJ2 (Human),AREEFVVVPGNWFDP,CSRDSSGNHHVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1093_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1114,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; NTD,B-cells; SARS-CoV1 Human Patient,QVQLQQWGAGLLKPSETLSLTCDVYGGSFNGFYWSWIRQPPGKGLEWIGEINHSGSVNYIPSLKSRVTISIDTSKKQFSLKVTSMTAADTGVYYCARGVTTPVVHLYSSGRPSRWFDSWGQGTLVTVSS,QSALTQPASVSGSPGQSSTILCSGTSSDVGSGDLVSWYQQHPGEAPNLIIYEGTKRPSAVSDRFSGSKSGDTASLTISGLQAEDEADYYCCSYAGSGTWMFGGGTKLTVL,IGHV4-34 (Human),IGHJ5 (Human),IGLV2-23 (Human),IGLJ3 (Human),ARGVTTPVVHLYSSGRPSRWFDS,CSYAGSGTWM,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1114_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1081,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; NTD,B-cells; SARS-CoV1 Human Patient,QVQLVESGGDLVKPGGSLRLSCEASGFIFSEYYMSWIRQAPGKGLEWVSYITGSGRTIHYADSVKGRFTVSRDNAKNSVYLQLNNLRVEDTAVYYCARGHRFLEFPLNYLDPWGQGTLVAVSS,QSALTQPASVSGSPGQSITISCTVSGSDRGSQNLVSWHQQYPGKAPKLMIYEVNKRPSGVSDRFSGSKSGNTASLTISGLQAEDEGVYYCSSYGGRSTSVVFGGGTRLTVL,IGHV3-11 (Human),IGHJ5 (Human),IGLV2-23 (Human),IGLJ2 (Human),ARGHRFLEFPLNYLDP,SSYGGRSTSVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1081_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1061-1,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; NTD,B-cells; SARS-CoV1 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFRTYAINWVRQAPGQGLEWMGGIIPLFGTPSYPRSYQGRVTITADESTSTAFLTLNSLRSDDTAVYYCARDDGKMNFGSAPWDFFHSWGQGTLVTVSS,EIVLTQSPGTLSLSPGQRATLSCRASQSVSSNYLAWFQQKPGQAPRLLIYGASSRATGIPARFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPGITFGQGTRLEIK,IGHV1-69 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ5 (Human),ARDDGKMNFGSAPWDFFHS,QQYGSSPGIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1061-1_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1066,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; NTD,B-cells; SARS-CoV1 Human Patient,QVQLQESGPGLVRPSGTLTLTCAVSGDSISSGHWCTWVRQPPGKGLEWIGKISHSGSINYNPSLKSRITMSVDKSKNQFSLKLSSVTAADTAMYYCARVRIGASYYDFWSGYYSDAFDIWGQGTMVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVGNDYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGTSPVYTFGQGTKLEIK,IGHV4-4 (Human),IGHJ3 (Human),IGKV3-20 (Human),IGKJ2 (Human),ARVRIGASYYDFWSGYYSDAFDI,QQYGTSPVYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1066_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1067,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; NTD,B-cells; SARS-CoV1 Human Patient,QVQLQESGPGLVKPSETLSLICTVSGGSISNNYWNWIRQSPGKGLEWIGYIYYRGSTNYNPSLKSRVSISVDTSKNQFSLKLTSVTAADTAVYYCARGLVIRYSDSFPSGPIIAAFDIWGQGTMVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSSFLAWYQQKPGQAPRLLIYDAFNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRTSTLTFGGGTKVEIK,IGHV4-59 (Human),IGHJ3 (Human),IGKV3-11 (Human),IGKJ4 (Human),ARGLVIRYSDSFPSGPIIAAFDI,QQRTSTLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1067_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1068,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; NTD,B-cells; SARS-CoV1 Human Patient,EVQLVESGGGLVQPGGSLRLSCEASGFTFSNYAMSWVRQAPGKGLQWVSAISFSGGSTYYAASVRGRFTISRDNSKNTLYLQMNNVRAEDTAVYFCAKDAGSDSLWGNLRYTDVGRYFDYWGQGTVVSVSS,EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYRRKPGQAPRLLIYGASTRATGIPASFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNTWPFTFGPGTKVDVK,IGHV3-23 (Human),IGHJ4 (Human),IGKV3-15 (Human),IGKJ3 (Human),AKDAGSDSLWGNLRYTDVGRYFDY,QQYNTWPFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1068_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1086,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; NTD,B-cells; SARS-CoV1 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFSGFAMGWVRQAPGKGLEWVSSISGSAGGGKTYYADSVKGRFTISRDNLKNTLSLQMNSLRAEDTAIYYCARDFHVRFLNYYTPVGGAFDIWGQGTMVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVDNYLAWYQQKPGQAPRLLIFDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPPWTFGQGTKVEIK,IGHV3-23 (Human),IGHJ3 (Human),IGKV3-11 (Human),IGKJ1 (Human),ARDFHVRFLNYYTPVGGAFDI,QQRSNWPPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1086_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1071,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; NTD,B-cells; SARS-CoV1 Human Patient,QVQLQESGPGLVRPSGTLSLTCAVSGASISSSSWWSWVRQPPGGVLEWIGEISPSGSTSYRPSFRSRITMSADKSRNHLSLKLSSVTAADTAVYYCARAQPNDFWSGYYTAAFDMWGQGTVVIVSS,EIVLTQSPGTLSLSPGERASLSCRASQSVSSSYLAWYQQRPGQAPRLLIYDASSRATGIPDRFSGSGSGTDFTLTISRLESEDFAVYYCQQYGNSPRTFGQGTKVEIK,IGHV4-4 (Human),IGHJ3 (Human),IGKV3-20 (Human),IGKJ1 (Human),ARAQPNDFWSGYYTAAFDM,QQYGNSPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1071_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1057-1,Ab,"SARS-CoV1,SARS-CoV2,OC43,PCoV GXP4L,BCoV RsSHC014,BCoV RaTG13",,,SARS-CoV2,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVQSGTEVKKPGASVKVSCKTSGYIFTNYYIHWVRQAPGQGLEWMGIFNPNGGGTSYAQKFQGRITLTGNTSANTGYMVLRSLTSEDTAVYYCARDPRTSGDNDGFDMWGQGTKVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSLSSYNYLAWYQQKPGQAPRLLIYAASKRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYFCQQRSNRPPAWTFGQGTKVEIK,IGHV1-46 (Human),IGHJ3 (Human),IGKV3-11 (Human),IGKJ1 (Human),ARDPRTSGDNDGFDM,QQRSNRPPAWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1057-1_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1175,Ab,SARS-CoV2,,,SARS-CoV2,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARSSSGSYLYYFDYWGQGTLVTVSS,EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNWPGTFGPGTKVDIK,IGHV3-30-3 (Human),IGHJ4 (Human),IGKV3-15 (Human),IGKJ3 (Human),ARSSSGSYLYYFDY,QQYNNWPGT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1175_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1103,Ab,SARS-CoV2,,,SARS-CoV2,S; S2,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLMQPGGSLRLSCAVSGFTFRSYAMTWVRQAPGKGLEWVSSISGSSNSTYYAESLKGRVTIYRDNSKNTLYLQISSLRAEDTAAYYCARGPQCTSAGCYVVGAMDVWGQGTTVTVPS,SYELTQPPSLSVSPGQTARITCSGHALPTQYAYWYQQRTGQAPVLLIYKDSERPSGVPERFSGSSSGTTVTLTISGVQAEDEADYYCQSQDGSGIVVFGGGTKVTVL,IGHV3-23 (Human),IGHJ6 (Human),IGLV3-25 (Human),IGLJ2 (Human),ARGPQCTSAGCYVVGAMDV,QSQDGSGIVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1103_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1121,Ab,SARS-CoV2,,,SARS-CoV2,S; S2,B-cells; SARS-CoV2 Human Patient,EVQLVQSGAEVKKPGESLRISCKGSGYSFTSYWISWVRQMPGKGLEWMGRIDPSDSYTNYSPSFQGHVTISADKSISTGYLQWSSLKASDTAMYYCARHFPRTQWLPWGFDPWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYFCQQFGSSPWAFGQGTKVEIK,IGHV5-10-1 (Human),IGHJ5 (Human),IGKV3-20 (Human),IGKJ1 (Human),ARHFPRTQWLPWGFDP,QQFGSSPWA,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1121_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1058-3,Ab,"SARS-CoV1,SARS-CoV2,MERS-CoV,229E,NL63,HKU1,OC43",,,SARS-CoV2,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFNFNDYGMHWVRQAPGKGLEWVAVISFEGRNKNHADSVRGRFTISRDNPKNMLYLQMNSLRAEDTAVYYCAKENRDRNYGSWSGSNSDYYYGMDVWGQGTTVTVSS,DIQLTQSPSFLSASIGDRVTITCRASQGIDSFLAWYQQKPGSAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISGLQPDDFATYYCQQLNSYPTITFGQGTRLEIK,IGHV3-30 (Human),IGHJ6 (Human),IGKV1-9 (Human),IGKJ5 (Human),AKENRDRNYGSWSGSNSDYYYGMDV,QQLNSYPTIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1058-3_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1078,Ab,"SARS-CoV1,SARS-CoV2,HKU1,OC43",,,SARS-CoV2,S; S2,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVKPGGSLRLSCAASGFTFSAYFINWVRQAPGKGLEWVASVESSGRQKSYADSVKGRFTISRDNAKNSVFLHMASLRAEDTAIYYCAREGITSFGIVTHYYALDVWGQGTTVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDIGIYQYVSWYQQHTVKAPVLVIYEVTKRPSGVSDRFSGSKSGNTASLTISGLQSEDEADYYCSSYTASNTLVFGTGTKVTVL,IGHV3-21 (Human),IGHJ6 (Human),IGLV2-14 (Human),IGLJ1 (Human),AREGITSFGIVTHYYALDV,SSYTASNTLV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1078_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1137-3,Ab,"SARS-CoV1,SARS-CoV2,OC43",,,SARS-CoV2,S; S2,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVEPGGSLRLSCAPSGFTFNNAWMNWVRQAPGKGLEWVGRIKSETDGGTTDYAAPVRGRFTISRNDSINTLYMVIHSLKIEDTALYFCTTVHSDYVWGSYRKGYFDYWGQGALVTVSS,DIQMTQSPSSLSASVGDRVTITCRTSQSIRTYLHWYQQKPGKAPKLLIYTASSLQGGVPSRFSGSGSGTDFTLTISSLQPEDFASYYCQQGYTTPYTFGQGTKLEIK,IGHV3-15 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ2 (Human),TTVHSDYVWGSYRKGYFDY,QQGYTTPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1137-3_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1077,Ab,SARS-CoV2,,,SARS-CoV2,S; S2,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVKSGGSLRLSCTGSGFTFSAYFMIWVRQAPGKGLEWVASIDSAGRSINYAESVTGRFTISRDNAKGSSHLQMNRLRAEDTALYYCAAEGISVFGVVTHFYALAAWGQGTTVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDIAAYNYVSWYQQHPGEVPKLLVYDVSNRPSGVSDRFAGSRSGNTAYLTISGLQAEDDADYYCSSYTSSGGLVFGGGTKATVL,IGHV3-21 (Human),IGHJ6 (Human),IGLV2-14 (Human),IGLJ1 (Human),AAEGISVFGVVTHFYALAA,SSYTSSGGLV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1077_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1099,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARGRGSYNTYFDYWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPYTFGQGTKLEIK,IGHV3-30-3 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ2 (Human),ARGRGSYNTYFDY,QQYGSSPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1099_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1132,Ab,SARS-CoV2,,,SARS-CoV2,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARARGGSYAGGFDIWGQGTMVTVSS,DIQMTQSPSTLSASVGDRVTITCRASQSISSWLAWYQQKPGKAPKLLIYKASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNSYWTFGQGTKVEIK,IGHV3-30-3 (Human),IGHJ3 (Human),IGKV1-5 (Human),IGKJ1 (Human),ARARGGSYAGGFDI,QQYNSYWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1132_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1089,Ab,SARS-CoV2,,,SARS-CoV2,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPWGTLSLTCAVSGGSISSSHWWTWVRQPPGKGLEWIGEVHHSGNTNYNPSLRTRVTIAVDKSKNHFSLRLTSVTAADTAVYYCARLFSDSGNYFWFDPWGQGTLVPVSS,DIQMTQSPSSLSASVGDRVTITCRASQYISSSLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQLEDLATYFCQQSSITPRTFGQGTKVEIK,IGHV4-4 (Human),IGHJ5 (Human),IGKV1-39 (Human),IGKJ1 (Human),ARLFSDSGNYFWFDP,QQSSITPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1089_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1174,Ab,SARS-CoV2,,,SARS-CoV2,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARTYSGSYYSYFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDIRNYLNWWQQKPGKAPNLLIYDESNLEAGVPSRFSGTGSGTDFTLTISSLQPEDIATYYCQQYDDLWTFGQGTKVEIK,IGHV3-30-3 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ1 (Human),ARTYSGSYYSYFDY,QQYDDLWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1174_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1058-1,Ab,"SARS-CoV1,SARS-CoV2,MERS-CoV,229E,NL63,HKU1,OC43",,,SARS-CoV2,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFNFGDFGMHWVRQAPGKGLEWVAVISYEGRNKNHADSVRGRFTISRDNSRNMLYLQMNSLRGGDTAVYYCAKENRDRNYDSWSASYSDYYYGMDVWGQGTTVTVSS,DIQLTQSPSFLSASVGDRVTITCRASQGIDRYLAWYQQKPGSAPKLLIYAASTLQSGVPSRFSGSGSETDFTLTISSLQPDDFATYYCQQLSTYPTITFGQGTRLEIK,IGHV3-30 (Human),IGHJ6 (Human),IGKV1-9 (Human),IGKJ5 (Human),AKENRDRNYDSWSASYSDYYYGMDV,QQLSTYPTIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1058-1_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1137-2,Ab,"SARS-CoV2,OC43",,,SARS-CoV2,S; S2,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVEPGGSLRLSCAASGFTFNNAWMNWVRQAPGKGLEWVGRIKSKTDGGTTDYAAPVRGRITISRNDSTNTLFLVMDSLKSEDAALYYCTTVHSDYLWGSYRKGYFDYWGQGALVTVSS,DIQMTQSPSSLSASVGDRVTITCRTSQSIRTFLNWYQQIPGKAPKLLIYTASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFASYYCQQGYTTPYTFGQGTKLEMK,IGHV3-15 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ2 (Human),TTVHSDYLWGSYRKGYFDY,QQGYTTPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1137-2_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1058-2,Ab,"SARS-CoV1,SARS-CoV2,MERS-CoV,229E,NL63,HKU1,OC43",,,SARS-CoV2,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCVASGFNFSDYGMHWVRQAPGKGLEWVAVISYEGRNKNHADSVKGRFTISRDNPKNTLYFEMNSLRADDTAVYYCAKENRDRNYDSWSGSYSDYYYGMDVWGRGTTVTVSS,DIQLTQSPSFLSASVGDRVTITCRASQGIGSFLAWYQQKPGSAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQLNSYPTITFGQGTRLEIK,IGHV3-30 (Human),IGHJ6 (Human),IGKV1-9 (Human),IGKJ5 (Human),AKENRDRNYDSWSGSYSDYYYGMDV,QQLNSYPTIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1058-2_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1195,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; S2,B-cells; SARS-CoV2 Human Patient,QLQLQESGPGLVKPSETLSLTCTVSGGSISSSSYYWGWIRQPPGKGLEWIGSIYYSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCAGEGLRWYQLAHWYFDLWGRGTLVTVSS,QSALTQPPSVSGSPGQSVTISCTGTSSDVGSYNRVSWYQQPPGTAPKLMIYEVSNRPSGVPDRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSTYVFGTGTKVTVL,IGHV4-39 (Human),IGHJ2 (Human),IGLV2-18 (Human),IGLJ1 (Human),AGEGLRWYQLAHWYFDL,SSYTSSSTYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1195_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1142-1,Ab,SARS-CoV2,,,SARS-CoV2,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARSGSGNYYHWFDPWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPRTFGGGTKVEIK,IGHV3-30-3 (Human),IGHJ5 (Human),IGKV3-20 (Human),IGKJ4 (Human),ARSGSGNYYHWFDP,QQYGSSPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1142-1_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1057-2,Ab,"SARS-CoV1,SARS-CoV2,HKU1,OC43",,,SARS-CoV2,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVQSGTEVKKPGASVKVSCKTSGYIFTNYYIHWVRQAPGQGLEWMGIFNPNGGGTSYAQKFQGRITLTGYTSANIGYMELRSLTSEDTAVYYCARDPRSSGDNDGFDMWGQGTKVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSLSSYNYLAWYQQKPGQAPRLLIYAASKRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYFCQQRSIRPPAWTFGPGTKVEIK,IGHV1-46 (Human),IGHJ3 (Human),IGKV3-11 (Human),IGKJ1 (Human),ARDPRSSGDNDGFDM,QQRSIRPPAWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1057-2_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1188,Ab,SARS-CoV2,,,SARS-CoV2,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSFAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLFLQMNSLRDEDTDVYYCARGFGGNYYGMDVWGQGTTVTVSS,DIQMTQSPSSVSASVGDRVTITCRASQGISSRLAWYQQKPGKAPKLLIYGASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQANSFPLTFGGGTKVEIK,IGHV3-30-3 (Human),IGHJ6 (Human),IGKV1D-12 (Human),IGKJ4 (Human),ARGFGGNYYGMDV,QQANSFPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1188_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1211,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSQTLSLTCTVSGGSISSGGYYWSWIRQHPGKGLEWIGYIYYSGSTYYNPSLKSRVTISVDTSKNQFSLRLSSVTAADTAIYYCATESLHYDILTGYSPTNYGMDVWGQGTTVTVSS,QSALTQAASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEAAYYCSSYTRSSTLVFGGGTKLTVL,IGHV4-31 (Human),IGHJ6 (Human),IGLV2-14 (Human),IGLJ2 (Human),ATESLHYDILTGYSPTNYGMDV,SSYTRSSTLV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1211_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1136,Ab,SARS-CoV2,,,SARS-CoV2,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSFGIHWVRQAPGKGLEWVALISYDGINKYYADSVKGRFTLSRDNSKNTLYLQMNSLRPEDTAVYYCAKTIWGTYRSPFDYWGQGTLVTVSS,DIQMTQSPSTLSASVGDRVTITCRASQSISSWLAWYQQKPGKAPNLLIYQASTLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNSYYTFGQGTKLEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV1-5 (Human),IGKJ2 (Human),AKTIWGTYRSPFDY,QQYNSYYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1136_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1083,Ab,SARS-CoV2,,,SARS-CoV2,S; S2,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYWMHWVRQAPGKGLVWVSRINSDGSSTTYADSVKGRFTISRDNAKNTLYLQMNSLRAEDMAVYYCVREGIVATIYFDYWGQGTLVTVSS,SYELTQPPSVSVSPGQTASITCSGDKLGDRYACWYQQKPGQSPVLVIYQDTKRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCQAWDSSTAGGVFGGGTKLTVL,IGHV3-74 (Human),IGHJ4 (Human),IGLV3-1 (Human),IGLJ2 (Human),VREGIVATIYFDY,QAWDSSTAGGV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1083_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1094,Ab,SARS-CoV2,,,SARS-CoV2,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSNYGMHWVRQAPGKGLEWVAVIWYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRVEDTAMYFCTTDIPALTENPFDYWGQGTLVTVSS,SYELTQPPSVSVSPGQTARITCSGDALPKKYAYWYQQKSGQAPVLVISEDSKRPSGIPERFSGSSSGTMATLTISGAQVEDEADYYCYSTDSSGNHRVFGGGTKLTVL,IGHV3-33 (Human),IGHJ4 (Human),IGLV3-10 (Human),IGLJ3 (Human),TTDIPALTENPFDY,YSTDSSGNHRV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1094_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1100,Ab,SARS-CoV2,,,SARS-CoV2,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFIFSTYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLSAEDTAVYYCARGGGNYREPFDYWGQGTLVTVSS,SYVLTQPPSVSVAPGKTARIPCGGNNIGSKSVHWYQQKPGQAPVLVIYYDSDRPSGIPERFSASNSGNTATLTISRVEAGDEADYYCQVWDSSSDHPVVFGGGTKLTVL,IGHV3-30-3 (Human),IGHJ4 (Human),IGLV3-21 (Human),IGLJ2 (Human),ARGGGNYREPFDY,QVWDSSSDHPVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1100_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1131,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFNRNAINWVRQAPGQGLEWMGRIIPIFGITHYAQKFQGRVAITADKSTNTAYMELSSLRSEDTAVYYCARSFCSSGACYFDYWGQGTLVTVSS,SYELTQPPSVSVSPGQTASITCSGNKLGDKDTCWYQQRPGQSPVVVIYQDTKRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCQAWDSSTLVFGGGTKLTVL,IGHV1-69 (Human),IGHJ4 (Human),IGLV3-1 (Human),IGLJ2 (Human),ARSFCSSGACYFDY,QAWDSSTLV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1131_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1133,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSFALHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKSRGGNYFDAFDIWGQGTMVTVSS,DIVMTQSPDSLAVPLGERATINCKSSQSVLYSSNNKNYLAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYSTRTFGQGTKVEIK,IGHV3-30-3 (Human),IGHJ3 (Human),IGKV4-1 (Human),IGKJ1 (Human),AKSRGGNYFDAFDI,QQYYSTRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1133_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1134,Ab,SARS-CoV2,,,SARS-CoV2,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGINKYYADSVKGRFTISRDNSKNTLYLRMNSLRAEDTAVYYCARVFGGSYLGAFDVWGQGTKVTVSS,DIQLTQSPSFLSASVGDRVTITCRASQGISNYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPLFTFGPGTKVDIK,IGHV3-30-3 (Human),IGHJ3 (Human),IGKV1-9 (Human),IGKJ3 (Human),ARVFGGSYLGAFDV,QQLNSYPLFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1134_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1165,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVESGGDVVQPRRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGINKYYADSVRGQFAISRDNSKSTLYLQMNSLRAEDTAVYYCARPRLGNYFDAFDIWGLGTMVTVSS,DIQMTQSPSTLSASVGDRVTITCRASQSISTWLAWYQQKPGKAPKLLIYKASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQHYNTYAWTFGQGTKVEIK,IGHV3-30 (Human),IGHJ3 (Human),IGKV1-5 (Human),IGKJ1 (Human),ARPRLGNYFDAFDI,QHYNTYAWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1165_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1141,Ab,SARS-CoV2,,,SARS-CoV2,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSTYSMHWVRQAPGKGLQWVTLISYDGINTYYADSVKGRFTISRDNSKNTLYLHMNSLRAEDTAVYYCARTDGYNQAFDIWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSRYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSLYSFGQGTKLEIK,IGHV3-30-3 (Human),IGHJ3 (Human),IGKV3-20 (Human),IGKJ2 (Human),ARTDGYNQAFDI,QQYGSLYS,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1141_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1157,Ab,"SARS-CoV1,SARS-CoV2,229E,NL63,HKU1,OC43",,,SARS-CoV2,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFSSFYMNWVRQAPGQGLEWMGIINPDGGGTVYSQKIQDRLTMTRDTSTSTFYLELSGLGSEDTAVYYCARGRSDFLLQNFDYWGQGTPVTVSS,DIQMTQSPSTLSASLGDRVSITCRASQDISSCLAWYQQKPGKAPKLLIYEASTLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYKNYSPVTFGPGTKVEIK,IGHV1-46 (Human),IGHJ4 (Human),IGKV1-5 (Human),IGKJ3 (Human),ARGRSDFLLQNFDY,QQYKNYSPVT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1157_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1168,Ab,SARS-CoV2,,,SARS-CoV2,S; S2,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGEGLEWVSIIYSGGPTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAMYYCATGRYDSIHWGQGTLVTVSS,DIQMTQSPSTLSASVGDRVTITCRASQSISSWLAWYQQKPGKAPKLLIYKASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNTYSWTFGQGTKVEIK,IGHV3-53 (Human),IGHJ4 (Human),IGKV1-5 (Human),IGKJ1 (Human),ATGRYDSIH,QQYNTYSWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1168_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1097,Ab,SARS-CoV2,,,SARS-CoV2,S; S2,B-cells; SARS-CoV1 Human Patient,QVQLVQSGAELKKPGASVRVSCKASGYTFPSYGITWVRQAPGQGLEWLGWISTYNDNTIYAQNLQGRVTMTTDTSTSTAFMELRSLISDDTAVYYCAICWGPYNWNEGWGQGTLVTVSS,QSVVTQPPSVSGAPGQRVTMSCTGSRSNIGAGYDVHWYQQLPGTAPKLLIYGNNNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDNSLSAAVVFGGGTKLTVL,IGHV1-18 (Human),IGHJ5 (Human),IGLV1-40 (Human),IGLJ2 (Human),AICWGPYNWNEG,QSYDNSLSAAVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1097_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1159-2B,Ab,"SARS-CoV1,SARS-CoV2,229E,NL63,HKU1,OC43",,,SARS-CoV2,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFSSFYMNWVRQAPGQGLEWMGIINPDGGGTVYSQKIQDRLTMTRDTSTSTFYLEVSGLRSEDTAVYYCARGRSDFLLQNFDYWGQGTPVTVSS,DIQMTQSPSTLSAFLGDRVSITCRASQDLSSSLAWYQQKPGKAPKLLIYEASTLESGVPSRFSGSGSGTEFTLTISGLQPDDFATYYCQQYKNYSPVTFGPGSKVEIK,IGHV1-46 (Human),IGHJ4 (Human),IGKV1-5 (Human),IGKJ3 (Human),ARGRSDFLLQNFDY,QQYKNYSPVT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1159-2B_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1159-1,Ab,"SARS-CoV1,SARS-CoV2,229E,NL63,HKU1,OC43",,,SARS-CoV2,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFSSFYMNWVRQAPGQGLEWMGIINPDGGGTVYSQKIQDRLTMTRDTSTSTFYLEVSGLRSEDTAVYYCARGRSDFLLQNFDYWGQGTPVTVSS,DIQMTQSPSTLSASLGDRVSITCRASQDLSSSLAWYQQKPGKAPKLLIYEASTLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYKNYSPVTFGPGSKVEIK,IGHV1-46 (Human),IGHJ4 (Human),IGKV1-5 (Human),IGKJ3 (Human),ARGRSDFLLQNFDY,QQYKNYSPVT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1159-1_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1163,Ab,"SARS-CoV1,SARS-CoV2,MERS-CoV",,,SARS-CoV2,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSQTLSLTCTVSGGSISNGGYYWSWIRQHPGKGLEWIGFIYYSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCATSLYGSSYYGTFNIWGQGTMVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK,IGHV4-31 (Human),IGHJ3 (Human),IGKV3-20 (Human),IGKJ1 (Human),ATSLYGSSYYGTFNI,QQYGSSPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1163_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1187,Ab,"SARS-CoV1,SARS-CoV2,229E,NL63,HKU1,OC43",,,SARS-CoV2,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCRTSGYTFSTYYLHWVRQAPGQGFEWMGIINPSGGGTSYAPNFEGRVTMTMDTFTSTVFLELSSLTSEDTAVYYCARDGPVLDWLFVFDYWGQGTLVTVSS,EIVLTQSPDTLSLSPGERATLSCGASQRIRSNYLAWYQQKPGQAPRLLIYATSTRATGIPDRFSGSGSGTDFTLIISRLEPEDFAVYYCQQYGSSQWTFGQGTKVEIK,IGHV1-46 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ1 (Human),ARDGPVLDWLFVFDY,QQYGSSQWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1187_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1194,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVMVSCKASGYTFTDYYMHWVRQAPGQGLEWMGRINPSSGGTNYAQKFQGRVTMTRDTSISTAYMELSRLRSDDTAVYYCARDSSSWRYNWFDPWGQGTLVTVSS,DIQMTQSPSTLSASVGDRVTITCRASQSISSWLAWYQQKPGKAPKLLIYKASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNSYSITFGQGTRLEIK,IGHV1-2 (Human),IGHJ5 (Human),IGKV1-5 (Human),IGKJ5 (Human),ARDSSSWRYNWFDP,QQYNSYSIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1194_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1164,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSETLSLTCTVSGGSISSYYWSWIRQPPGKGLEWIGYIYYSGSTNYNPSLKSRVTISVDTSKNQFSLKVRSVTAADTAVYYCARVVRWFDPWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSDSTLLTFGGGTKVEIK,IGHV4-59 (Human),IGHJ5 (Human),IGKV1-39 (Human),IGKJ4 (Human),ARVVRWFDP,QQSDSTLLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1164_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1145,Ab,SARS-CoV2,,,SARS-CoV2,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAIISYDGTNKYYPDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARANGGNYYYGMDVWGQGTTVTVSS,EIVLTQSPSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPPGFALGPGSKSNNL,IGHV3-30-3 (Human),IGHJ6 (Human),IGKV3-20 (Human),IGKJ3 (Human),ARANGGNYYYGMDV,QQYGSSPPGFA,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1145_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1212,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAITWVRQAPGQGLEWMGGIIPIFGTANYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYCARVESYDNSGYYFDYWGQGTLVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSSFLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPPKLTFGGGTKVEIK,IGHV1-69 (Human),IGHJ4 (Human),IGKV3-11 (Human),IGKJ4 (Human),ARVESYDNSGYYFDY,QQRSNWPPKLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1212_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1147,Ab,SARS-CoV2,,,SARS-CoV2,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYPDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARARGGNYYYGMDVWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPNTFGQGTKLEIK,IGHV3-30-3 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ2 (Human),ARARGGNYYYGMDV,QQSYSTPNT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1147_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1148,Ab,SARS-CoV2,,,SARS-CoV2,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLSLSCAASGFTFSSYAMHWVRQAPGKGLEWVALISYDGNNKYYADSMKGRFTISRDNSKKTLYLQLNSLRAEDTAVYYCASTFGGAYSYGMDVWGQGTTVTVSS,DIQLTQSPSFLSASVGDRVTITCRASQVISNYLAWYHQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPLFTFGPGTKVDIK,IGHV3-30-3 (Human),IGHJ6 (Human),IGKV1-9 (Human),IGKJ3 (Human),ASTFGGAYSYGMDV,QQLNSYPLFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1148_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1149,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSTYAMHWVRQAPGKGLEWVALISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRADDTALYYCARATRGSYYYGMDVWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSFLNWYQQKPGKAPKLLIYAASTLQSGVPSRFSGGGSGTDFTLTISSLQPEDFATYFCQQSYSTEFTFGPGTKVDIK,IGHV3-30-3 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ3 (Human),ARATRGSYYYGMDV,QQSYSTEFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1149_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1176,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVHPGRSLRLSCAASGFTFSSYAMYWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSENTLYLQMNSLRAEDTAVYYCARPESGSYLGHFDSWGQGTLVTVSS,QSVLTQPPSASGTPGQRVTISCSGSSSNIGSNAVNWYQQLPGTAPKLLIYSNNQRPSGVPDRFSGSKSGTSASLAISGLQSEDEADYYCAAWDDSLNGPGFGGGTKVTVL,IGHV3-30-3 (Human),IGHJ4 (Human),IGLV1-44 (Human),IGLJ2 (Human),ARPESGSYLGHFDS,AAWDDSLNGPG,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1176_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1177,Ab,SARS-CoV2,,,SARS-CoV2,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFNNYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLSLQVNSLRAEDTALYYCARDRSGSYFGPFDYWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATDIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQCGSSPRTFGQGTKVEIK,IGHV3-30-3 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ1 (Human),ARDRSGSYFGPFDY,QQCGSSPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1177_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1178,Ab,SARS-CoV2,,,SARS-CoV2,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCVASGFTFRSYAMHWVRQAPGKGLEWVTVISYDGNNQYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARPRGGNYVGPFDYWGQGTLVTVSS,EIVLTQSPGTLSLSPGEGATLSCRASQSVSSSYLAWYQQKPGRAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQLYGSSPYTFGQGTKLEIK,IGHV3-30-3 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ2 (Human),ARPRGGNYVGPFDY,QLYGSSPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1178_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1181,Ab,SARS-CoV2,,,SARS-CoV2,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSTYAMHWVRQAPGKGLEWVAVISYDGSNKYYAVSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARTHGGNYGRYFDYWGQGTLVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYFCSSYTTSSTPPYVFGTGTKVTVL,IGHV3-30-3 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ1 (Human),ARTHGGNYGRYFDY,SSYTTSSTPPYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1181_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1182,Ab,SARS-CoV2,,,SARS-CoV2,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGNNKYYADSVKGRFTFSRDNSKNTLYLQMSSLRAEDTAVYYCARARGGGYNRLFDYWGQGTLVTVSS,DIQMTQSPSTLSASVGDRVTITCRASQSISSWLAWYQQKPGKAPKLLIYKASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFASYYCQHYNSYSQTFGQGTKVEIK,IGHV3-30-3 (Human),IGHJ4 (Human),IGKV1-5 (Human),IGKJ1 (Human),ARARGGGYNRLFDY,QHYNSYSQT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1182_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1202,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAIISYDGSNKYYADSVKGRFAISRENSKNTLYLQMNSLRAEDTAVYYCARAYSGGYYYGMDVWGQGTTVAVSS,DIQMTQSPSSLSASVGDRVTITCRASQTIISYLNWYQQKPGKAPNLLIYAASSLQSGVPSRFSGSGSGTAFTLTISSLQPEDFATYYCQQSYSLHSFGQGTKLEIK,IGHV3-30 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ2 (Human),ARAYSGGYYYGMDV,QQSYSLHS,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1202_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1207,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; S2,B-cells; SARS-CoV2 Human Patient,QLQLQESGPGLVKPSETLSLTCTVSGGSISSSSYYWGWIRQPPGKGLEWIGSIYYSGSTYYNPSLKSRVTISVDTSKNQFSLKLTSVTAADTALYYCAGESTDNNYYYYYAMDVWGQGTTVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLLIYDVNNRPSGVSNRFSGSKSGNTASLTISGLQADDEADYYCSSFTSISTWVFGGGTKLTVL,IGHV4-39 (Human),IGHJ6 (Human),IGLV2-14 (Human),IGLJ2 (Human),AGESTDNNYYYYYAMDV,SSFTSISTWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1207_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1142-2,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARSGSGNYYHWFDPWGQGTLVTVSS,EIVMTQSPATLSVSPGERATLSCRASQSLSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNWPQTFGQGTKVEIK,IGHV3-30-3 (Human),IGHJ5 (Human),IGKV3-15 (Human),IGKJ1 (Human),ARSGSGNYYHWFDP,QQYNNWPQT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1142-2_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1142-4,Ab,SARS-CoV2,,,SARS-CoV2,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTALYYCASHDGVTETTWKYYAMDVWGQGTTVTVSS,QSVLTQPPSVSGTPGQRVIISCSGSSSNIGSNYVYWYQQFSGTAPKLLIYRNTQRPSGVPDRISGSKSGTSASLAISGLRSEDEADYYCATWDDRVRGYWVFGGGTKLTVL,IGHV3-30-3 (Human),IGHJ5 (Human),IGLV1-47 (Human),IGLJ3 (Human),ASHDGVTETTWKYYAMDV,ATWDDRVRGYWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1142-4_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1079,Ab,SARS-CoV2,,,SARS-CoV2,S; S2,B-cells; SARS-CoV1 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFIFSTYAMHWVRQAPGKGLEWVALISYDGNNQYYADSTKGRFTISRDNSKNTLFLQMNSLRPEDTAVYYCARGGGGTYSYFDFWGQGTLVTVSS,QSALTQPRSVSGSPGQSVTISCTGTSSDVGDYNSVSWYQQHPGKAPKLVIYAVTRRPSGVPDRFSGSKSGNTASLTISGLQAEDEADYYCYSYAGSNTFGTGTKVTVL,IGHV3-30-3 (Human),IGHJ4 (Human),IGLV2-11 (Human),IGLJ1 (Human),ARGGGGTYSYFDF,YSYAGSNT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1079_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1084,Ab,SARS-CoV2,,,SARS-CoV2,S; S2,B-cells; SARS-CoV1 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFIFSSYPMHWVRQAPGKGLEWLTVISYDGNNKYYADSVKGRFTISRDNSKNTLFLQITSLRAEDTALYYCARDRAANYGRGGFDYWGQGTLVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVTDSLAWYQHKPGQAPRLLIYDVSNRATGIPVRFSGSGSGTDFTLTISSLEAEDFAVYYCQQRVTFGPGTKVDIK,IGHV3-30-3 (Human),IGHJ4 (Human),IGKV3-11 (Human),IGKJ3 (Human),ARDRAANYGRGGFDY,QQRVT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1084_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1108,Ab,SARS-CoV2,,,SARS-CoV2,S; S2,B-cells; SARS-CoV1 Human Patient,QVQLVESGGGVVQPGRSVRLSCAASGFTFSIYPMHWVRQAPGKGLEWVALISYDGHNAYYADSVRGRFTISRDNSKNTLYLQMNSLRAEDTAVYFCARAYSGSYFNAFNIWGQGTMVTVSS,DIVMTQSPDSLAVSLGERATINCKSSQSILYSSDNKNYLAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTINSLQAEDVAVYYCQQYSRTPPYTFGQGTKLEIN,IGHV3-30 (Human),IGHJ3 (Human),IGKV4-1 (Human),IGKJ2 (Human),ARAYSGSYFNAFNI,QQYSRTPPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1108_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
DH1087,Ab,SARS-CoV2,,,SARS-CoV2,S; S2,B-cells; SARS-CoV1 Human Patient,EVQLVQSGAEVKKPGTTVKVSCKVSGYTFTDYYMHWVQQAPGKGLEWVGLVDPQDGETEYAEKFQGRVTIIADTSTDTAYMELSSLRSEDTAFYYCATETIFGVSPRVEGNWGQGTLVIVSS,QLVLTQSPSASASLGASVKLTCILSGGHSGYAIAIAWHQQRPEKGPRFLMQLNSDGSHTKGDGIPHRFSGSSSGAERYLTISGLQSEDEADYYCQTWGTGIRGIFGGGTKLTVL,IGHV1-69-2 (Human),IGHJ4 (Human),IGLV4-69 (Human),IGLJ3 (Human),ATETIFGVSPRVEGN,QTWGTGIRGI,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DH1087_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
2G12,Ab,"SARS-CoV2,HIV-1",,HIV-1,,S; S2 (quaternary glycan epitope),HIV-1 induced Ab,EVQLVESGGGLVKAGGSLILSCGVSNFRISAHTMNWVRRVPGGGLEWVASISTSSTYRDYADAVKGRFTVSRDDLEDFVYLQMHKMRVEDTAIYYCARKGSDRLSDNDPFDAWGPGTVVTVSP,DVVMTQSPSTLSASVGDTITITCRASQSIETWLAWYQQKPGKAPKLLIYKASTLKTGVPSRFSGSGSGTEFTLTISGLQFDDFATYHCQHYAGYSATFGQGTRVEIK,IGHV3-21 (Human),IGHJ4 (Human),IGKV1-5 (Human),IGKJ5 (Human),ARKGSDRLSDNDPFDA,QHYAGYSAT,https://www.rcsb.org/structure/7L02; https://www.rcsb.org/structure/7L06; https://www.rcsb.org/structure/7L09,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete
ION-300,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,ND,ND,ND,ND,ND,ND,Expected,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Awaiting release of PDB structure
ION-312,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV1-58 (Human),IGHJ3 (Human),ND,ND,AAPDCSSTSCYDAFDI,ND,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete (sequence of this and all other Abs in study available under MTA)
ION-336,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV3-66 (Human),IGHJ6 (Human),ND,ND,ARDLVAYGMDV,ND,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete (sequence of this and all other Abs in study available under MTA)
ION-360,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,ND,ND,ND,ND,ND,ND,Expected,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Awaiting release of PDB structure
ION-1000,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV1-58 (Human),IGHJ3 (Human),ND,ND,AAPHCSSTSCNDAFDI,ND,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","Jan 5, 2021",N/A,Complete (sequence of this and all other Abs in study available under MTA)
B6,Ab,"SARS-CoV2,MERS-CoV,HKU4,OC43",,"SARS-CoV2,MERS-CoV,HKU4,OC43",,S; RBD,Mouse Hybridoma,EVQLQQSGPVLVKPGASVRMSCKASGYTITDYYLNWVKQSHGKSLEWLGVLNPYSGGSLYSQTFKGKATLTVDRSSSTAYLELNSLTSEDSAVYYCARQLGRGNGLDYWGQGTSVTVSS,NIMMTQSPSSLAVSAGEKVTMSCKSSQSVLHSSDQKNYLAWYQQKPGQSPKLLIYWASTRESGVPDRFTGSGSGTDFTLTISSVQAEDLAVYFCHQYLSSYTFGGGTKLEIK,IGHV1-19 (Mouse),IGHJ4 (Mouse),IGKV8-27 (Mouse),IGKJ2 (Mouse),ARQLGRGNGLDY,HQYLSSYT,https://www.rcsb.org/structure/7M51;https://www.rcsb.org/structure/7M52;https://www.rcsb.org/structure/7M53;https://www.rcsb.org/structure/7M55,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jan 5, 2021","May 27, 2021",27th May '21: Added sequence and structure,Complete
m396-B10,Ab,"SARS-CoV1,SARS-CoV2",,"SARS-CoV1,SARS-CoV2",,S; RBD,Phage Library Engineered from SARS-CoV-1 binder,QVQLQQSGAEVKKPGSSVKVSCKASGGTFSTYSISWVRQAPGQGLEWMGGIAPSHGFANYAQKFQGRVTITTDESTSTAYMELSSLRSEDTAVYYCARDTATGGMDVWGQGTTVTVSS,SYELTQPPSVSVAPGKTARITCGGNNIGSKSVHWYQQKPGQAPVLVVYDDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDTYSDYVFGTGTKVTVL,IGHV1-69 (Human),IGHJ6 (Human),IGLV3-21 (Human),IGLJ1 (Human),ARDTATGGMDV,QVWDTYSDYV,https://www.rcsb.org/structure/7KZC,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Dec 21, 2020","Feb 28, 2021",28th Feb: Added 7KZC,Complete
CR3014-C8,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,Phage Library Engineered from SARS-CoV-1 binder,EVQLVESGGGLVQPGGSLRLSCAASGFTFSDHYMDWVRQAPGKGLEWVGRTRNKANSYTTEYAASVKGRFTISRDDSKNSLYLQMNSLKTEDTAVYYCARGISPFYFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQYIYDSLNWYQQKPGKAPKLLIYDSSYLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSWDTPVTFGQGTKVEIK,IGHV3-72 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ1 (Human),ARGISPFYFDY,QQSWDTPVT,https://www.rcsb.org/structure/7KZB,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Dec 21, 2020","Dec 21, 2020",N/A,Complete
CR3014-D1,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,Phage Library Engineered from SARS-CoV-1 binder,EVQLVESGGGLVQPGGSLRLSCAASGFTFSDHYMDWVRQAPGKGLEWVGRTRNKANSYTTEYAASVKGRFTISRDDSKNSLYLQMNSLKTEDTAVYYCARGISPFYFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQDIAYALNWYQQKPGKAPKLLIYASSSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQMGREPTTFGQGTKVEIK,IGHV3-72 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ1 (Human),ARGISPFYFDY,QQMGREPTT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Dec 21, 2020","Dec 21, 2020",N/A,Complete
CR3022-B6,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,Phage Library Engineered from SARS-CoV-1 binder,QMQLVQSGTEVKKPGESLKISCKGSGYGFITYWIGWVRQMPGKGLEWMGIIYPGDSETRYSPSFQGQVTISADKSINTAYLQWSSLKASDTAIYYCAGGSGISTPMDVWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSIYSALNWYQQKPGKAPKLLIYAASALQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQTDIHPYTFGQGTKVEIK,IGHV5-51 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ1 (Human),AGGSGISTPMDV,QQTDIHPYT,https://www.rcsb.org/structure/7KZA;https://www.rcsb.org/structure/7KZB,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Dec 21, 2020","Feb 28, 2021",28th Feb: Added 7KZA,Complete
CR3022-B11,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,Phage Library Engineered from SARS-CoV-1 binder,QMQLVQSGTEVKKPGESLKISCKGSGYGFITYWIGWVRQMPGKGLEWMGIIYPGDSETRYSPSFQGQVTISADKSINTAYLQWSSLKASDTAIYYCAGGSGISTPMDVWGQGTTVTVSS,DIQLTQSPDSLAVSLGERATINCKSSQSVLSDSIAKNYLAWYQQKPGQPPKLLIYWASSRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYSTPYTFGQGTKVEIK,IGHV5-51 (Human),IGHJ6 (Human),IGKV4-1 (Human),IGKJ1 (Human),AGGSGISTPMDV,QQYYSTPYT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Dec 21, 2020","Dec 21, 2020",N/A,Complete
CR3022-G11,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,Phage Library Engineered from SARS-CoV-1 binder,QMQLVQSGTEVKKPGESLKISCKGSGYGFNYYWIGWVRQMPGKGLEWMGIIYPGDSETRYSPSFQGQVTISADKSINTAYLQWSSLKASDTAIYYCAGGDGVSTPMDVWGQGTTVTVSS,DIQLTQSPDSLAVSLGERATINCKSSQSVLSYAVHKNYLAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYSTPYTFGQGTKVEIK,IGHV5-51 (Human),IGHJ6 (Human),IGKV4-1 (Human),IGKJ1 (Human),AGGDGVSTPMDV,QQYYSTPYT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Dec 21, 2020","Dec 21, 2020",N/A,Complete
STE90-C11,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,"Phage Display Library (Antibody, human, immune - CoV2)",QVQLVESGGGLVQPGGSLRLSCAASGLTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDDSKNTLYLQMNSLRAEDTAVYYCARDVADAFDIWGQGTMVTVSS,DIVMTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPPFTFGPGTKVDIK,IGHV3-66 (Human),IGHJ3 (Human),IGKV1-9 (Human),IGKJ3 (Human),ARDVADAFDI,QQLNSYPPFT,https://www.rcsb.org/structure/7B3O,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Dec 21, 2020","Dec 21, 2020",N/A,Complete
FC05,Ab,SARS-CoV2,,SARS-CoV2,,S; NTD,"Phage Display Library (Antibody, human, immune - CoV2)",EVQLLEQSGAEVKKPGASVRVSCKVSGYTLPEVAMHWVRQAPGKGLEWMGGFDPEDGETMYAQKFQGRVTMTEDTSTDTAYMELSSLRSEDTAVYYCATTTPFSSSYWFDPWGQGTLVTVSS,SVLTQAPSVSAAPGQKVTISCSGSSSNIGNNYVSWYQQLPGTAPKLLIYDNNKRPSGIPDRFSGSKSGTSATLGITGLQTGDEADYYCGTWDSSLSAVVFGGGTKLTVL,IGHV1-24 (Human),IGHJ5 (Human),IGLV1-51 (Human),IGLJ3 (Human),ATTTPFSSSYWFDP,GTWDSSLSAVV,https://www.rcsb.org/structure/7CWS;https://www.rcsb.org/structure/7CWU;https://www.rcsb.org/structure/7D4G;https://www.rcsb.org/structure/7CWT,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Dec 21, 2020","Jul 9, 2021",7th July: Added extra PDB structure,Complete
P17,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,"Phage Display (antibody, human, non-immune)",QQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARHATLMNNKDIWGQGTLVTVSS,DIQLTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPRTFGQGTKVEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ1 (Human),ARHATLMNNKDI,QQSYSTPRT,https://www.rcsb.org/structure/7CWM; https://www.rcsb.org/structure/7CWN; https://www.rcsb.org/structure/7CWO; https://www.rcsb.org/structure/7CWL,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Dec 21, 2020","Jan 30, 2021",30th Jan: Added PDB structure,May be a double-up or derivative of P17-A11. Complete
NbSL17,Nb,SARS-CoV2,,,,Nsp3; PLpro,"Yeast Display (Nb, Synthetic)",QVQLQESGGGLVQAGGSLRLSCAASGSISDSTRMGWYRQAPGKERELVATITYGSTTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAAFDENVYVYRPYHYYWGQGTQVTVSS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAFDENVYVYRPYHYY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/NbSL17_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Dec 14, 2020","Dec 14, 2020",N/A,Inhibitory against enzymatic function of PLpro. Complete
NbSL18,Nb,SARS-CoV2,,,,Nsp3; PLpro,"Yeast Display (Nb, Synthetic)",QVQLQESGGGLVQAGGSLRLSCAASGSIFLPGFMGWYRQAPGKERELVASITPGTTTNYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAAYVFVYRNYWGQGTQVTVSS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAYVFVYRNY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/NbSL18_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Dec 14, 2020","Dec 14, 2020",N/A,Inhibitory against enzymatic function of PLpro. Complete
NbSL19,Nb,SARS-CoV2,,,,Nsp3; PLpro,"Yeast Display (Nb, Synthetic)",QVQLQESGGGLVQAGGSLRLSCAASGSIFFQAYMGWYRQAPGKERELVAGIDAGTTTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAAEYFWNYNPYRGTNSTHPYWGQGTQVTVSS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAEYFWNYNPYRGTNSTHPY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/NbSL19_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Dec 14, 2020","Dec 14, 2020",N/A,Inhibitory against enzymatic function of PLpro. Complete
3C1,Ab,SARS-CoV2,,,,S; RBD,ND,EVQLQESGPSLVKPSQTLSLTCSVTGDSITNGYWNWIRKFPGNKLEYMGYISYSGSTYYSPSLKSRISITRDTSKNQHYLQLNSVTSEDTATYYCASDYHGSKYYFDYWGQGTTLTVSS,DIVMTQSHKFMSTSVGHRVSITCKASQDVGNDVAWYQQKPGQSPKLLIYWASTRHTGVPDRFTGSGSGTDFTLTISNVQSEDLADYFCQQYNRYPYTFGGGTKLEIK,IGHV3S1 (Mouse),IGHJ2 (Mouse),IGKV6-23 (Mouse),IGKJ2 (Mouse),ASDYHGSKYYFDY,QQYNRYPYT,https://www.rcsb.org/structure/7DD2; https://www.rcsb.org/structure/7DCC; https://www.rcsb.org/structure/7DD8; https://www.rcsb.org/structure/7DCX,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Dec 14, 2020","Dec 14, 2020",N/A,Awaiting publication in Nature Communications
2H2,Ab,SARS-CoV2,,,,S; RBD,ND,QVQLKQSGPSLVQPSQSLSITCTVSGFSLTSYGVHWVRQSPGKGLEWLGVMWRGGNTDYNAAFMSRLSITKDNSKSQVFFKMNSLQTDDTAIYYCAKNGGAHAMDFWGQGTSVTVSS,NIVLTQSPASLAVSLGQRATISCRASESVDSYGNSFLHWYQQKPGQPPKLLIYLASNLESGVPARFSGSGSRTDFTLTIDPVEADDAATYYCQQNNEDPFTFGSGTKLEIK,IGHV2-5-1 (Mouse),IGHJ4 (Mouse),IGKV3-10 (Mouse),IGKJ4 (Mouse),AKNGGAHAMDF,QQNNEDPFT,https://www.rcsb.org/structure/7DK5; https://www.rcsb.org/structure/7DK6; https://www.rcsb.org/structure/7DK7; https://www.rcsb.org/structure/7DK4,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Dec 14, 2020","Dec 14, 2020",N/A,Awaiting publication in Nature Communications
HB27,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,Humanised from Immunised Mouse,VKLVESGGGLVKPGGSLRLSCAASGFTFTNYGMSWVRQAPGKRLEWVAEISSGGSYTYYPDTVTGRFTISRDNAKNTLYLQMNSLRAEDTAVYYCARFRYGGGGTVDYWGQGTLVTVSS,IVLTQSPTLSLSPGERATLSCRASESVDNYGISFMNWFQQKPGQAPRLLIYAASNQGSGIPSRFSGSGSGTDFSLTISSLEPEDFAVYFCQQSKEVPRIFGQGTKVEIL,IGHV9-5-4 (Mouse),IGHJ4 (Mouse),IGKV3-11 (Human),IGKJ1 (Human),ARFRYGGGGTVDY,QQSKEVPRI,https://www.rcsb.org/structure/7CYP;https://www.rcsb.org/structure/7CYH;https://www.rcsb.org/structure/7CWT,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 26, 2020","Jul 9, 2021",16th June '21: Added PDB structure and sequence data. 9th July '21: Added new PDB entry.,Complete
6D3,Ab,SARS-CoV2,,SARS-CoV2,,S; S1/S2 Cleavage Site,Mouse Hybridoma,QVQLQQSGAELVKPGASVKLSCKASGYTFTSHWMHWVKQRPGQGLEWIGEIDPSDSYINYNQIFEGKATLTVDKSSTTAYLQLSSLTSEDSAVYYCARTAGLLAPMDYWGQGTSVTVSS,DIVMTQSPSSLTVTAGEKVTMTCKSSQSLFNSGNQKNFLTWYQQIPGQPPKLLIYWASTRDSGVPDRFTGSGSGTDFTLTISSVQAEDLAVYYCQNDYTYPLTFGVGTKLELK,IGHV1-69 (Mouse),IGHJ4 (Human),IGKV8-19 (Human),IGKJ5 (Mouse),ARTAGLLAPMDY,QNDYTYPLT,http://www.rcsb.org/structure/4RGN,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 26, 2020","Nov 26, 2020",N/A,Complete
P2C-1A3,Ab,SARS-CoV2,,,,S; RBD,ND,QVQLVESGGGLVKPGGSLRLSCAASGFTFSDYYMSWIRQAPGKGLEWVSYISSSGSTIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARDFSHQQLVPSWGQGTLVTVSS,DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPLTFGGGTKVEIK,IGHV3-11 (Human),IGHJ5 (Human),IGKV1-9 (Human),IGKJ4 (Human),ARDFSHQQLVPS,QQLNSYPLT,http://www.rcsb.org/structure/7CDJ,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 22, 2020","Nov 22, 2020",N/A,Awaiting publication for full reference and neutralisation data (X. Wang et al.)
P2C-1F11,Ab,SARS-CoV2,,,,S; RBD,ND,EVQLVESGGGLVQPGGSLRLSCAASGITVSSNYMNWVRQAPGKGLEWVSLIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYHCARDLVVYGMDVWGQGTTVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPTFGQGTKLEIK,IGHV3-11 (Human),IGHJ5 (Human),IGKV1-9 (Human),IGKJ4 (Human),ARDLVVYGMDV,QQYGSSPT,http://www.rcsb.org/structure/7CDI;https://www.rcsb.org/structure/7E8M,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 22, 2020","Nov 22, 2020",27th May '21: Added extra structure (7e8m),Awaiting publication for full reference and neutralisation data (X. Wang et al.)
CN111778218A-A9,Ab,SARS-CoV2,,,,S; RBD,"Phage Display Library (Antibody, human, non-immune)",EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSGITNSGSSTSYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKGTDAFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSNCSPATFGQGTKVEIK,IGHV3-23 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ1 (Human),AKGTDAFDY,QQSNCSPAT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CN111778218A-A9_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
CN111778218A-E11,Ab,SARS-CoV2,,,,S; RBD,"Phage Display Library (Antibody, human, non-immune)",EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSSIDSSGYYTSYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKNSDSFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYSASYLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYDDGPNTFGQGTKVEIK,IGHV3-23 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ1 (Human),AKNSDSFDY,QQYDDGPNT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CN111778218A-E11_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
CN111778218A-F5,Ab,SARS-CoV2,,,,S; RBD/non-RBD,"Phage Display Library (Antibody, human, non-immune)",EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSTIDSAGNSTTYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKNDSSFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYSASWLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYSDGPDTFGQGTKVEIK,IGHV3-23 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ1 (Human),AKNDSSFDY,QQYSDGPDT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CN111778218A-F5_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
CN111778218A-F10,Ab,SARS-CoV2,,,,S; RBD/non-RBD,"Phage Display Library (Antibody, human, non-immune)",EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSGIDSAGYYTTYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDSDTFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASYLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQAYSTPATFGQGTKVEIK,IGHV3-23 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ1 (Human),AKDSDTFDY,QQAYSTPAT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CN111778218A-F10_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
CN111778218A-H9,Ab,SARS-CoV2,,,,S; RBD/non-RBD,"Phage Display Library (Antibody, human, non-immune)",EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSDITDNGASTGYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKSTNTFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYINWYQQKPGKAPKLLIYDASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQNSNSPSTFGQGTKVEIK,IGHV3-23 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ1 (Human),AKSTNTFDY,QQNSNSPST,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CN111778218A-H9_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
CN111690059A-1D7,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,ND,EVQLVESGGGWIQPGGSLRLSCAASGLTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLVVYGMDVWGQGTTVTVSS,AIRMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTLGMYTFGQGTKLEIK,IGHV3-53 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ2 (Human),ARDLVVYGMDV,QQSYSTLGMYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CN111690059A-1D7_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
CN111732654A-1E10,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,ND,EVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGRIIPILGIANYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCAREVSDFDWLYRSHYGMDVWGQGTTVTVSS,EIVLTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPQTFGGGTKVEIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ4 (Human),AREVSDFDWLYRSHYGMDV,QQSYSTPQT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CN111732654A-1E10_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
CN111718411A-1F2,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,ND,EVQLLESGGGLVQPGGSLRLSCAASGFTVSSNYMNWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLDILGGMDVWGQGTTVTVSS,EIVMTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPPTFGQGTKVEIK,IGHV3-66 (Human),IGHJ6 (Human),IGKV3-20 (Human),IGKJ1 (Human),ARDLDILGGMDV,QQYGSSPPT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CN111718411A-1F2_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
4B7,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFPFSSYAMSWVRQAPGKGLEWVSAITGSGGSTYYADSVKGRFTISRDNSKNTLYLHMNSLRAEDTAVYYCAKDDYGDYVLGAFDIWGQGTTVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGTYKFVSWYQQHPGKAPKLMIYEGSKRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCCSYAGSSTLVFGGGTKLTVL,IGHV3-23 (Human),IGHJ3 (Human),IGLV2-23 (Human),IGLJ3 (Human),AKDDYGDYVLGAFDI,CSYAGSSTLV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/4B7_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Jan 11, 2021",11th Jan 2021: Added additional patent reference,Complete
B8,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,"Phage Display Library (Humanised sdAbs, immune - CoV2)",EVKLLESGGGLVQPGGSLRLSCTASGLNFGTSVMHWVRQVQGTGLLWVSRIDSGGTSITYADSVRGRFTVSRDNAKNTLYLQMNSLRVEDTGVYYCSTDSGSIGEFWGQGTLVTVSS,ELQMTQSPSPLSASVGDRVTITCRAGQNIRGYVNWYQHKAGEAPKLLIYHASNLQSGLPLRFSGSGSGTDFTLTITSLQPEDFAIYYCQQSHDTLTWTFGQGTKVEIK,IGHV3-74 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ1 (Human),STDSGSIGEF,QQSHDTLTWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/B8_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
B10,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,"Phage Display Library (Humanised sdAbs, immune - CoV2)",QVQLQESGGGLVQPGESLKLSCAASGFTFSSSAMHWVRQASGKGLEWIGRIRSKPNSYATAYAASVTGRFTISRDDSKNTAYLQMNSLKTEDTAVYYCTSVCSGGSCYQWGQGTLVTVSS,ELVMTQSPDSLAVSLGERATINCKSSRNVLYSPNNKNYLGWYQQKPGQPPKLLIYWASSRESGVPDRFSGSGSETDFTLTISSLQAEDVAVYYCHQYFSTLWTFGQGTKVEIK,IGHV3-73 (Human),IGHJ4 (Human),IGKV4-1 (Human),IGKJ1 (Human),TSVCSGGSCYQ,HQYFSTLWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/B10_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
C7,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,"Phage Display Library (Humanised sdAbs, immune - CoV2)",EVQLVESGGGLVMPGRSLRLSCRHSGFTFADYTMNWFRQVPGKGLEWIGFIRSKTYGGTAEYAASVKGRFTISRDDSKSIAYLEMNSLNTENTGVYRCTRISGYYGAGSGGAMDVWGQGTTVTVSS,ELVLTQSPGTLSLSPGERATLSYRASQSVSSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPLTFGPGTKVDIK,IGHV3-49 (Human),IGHJ6 (Human),IGKV3-11 (Human),IGKJ3 (Human),TRISGYYGAGSGGAMDV,QQRSNWPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C7_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
G10,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,"Phage Display Library (Humanised sdAbs, immune - CoV2)",EVQLVQSGGGLVQPGGSLRLSCAASGFNFSSYAMHWVRQAPGKGPEWVALISSDGSVTYFTDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARSGWDDAFDIWGQGTMVTVSS,SQSVLTQPPSMSLAPGQTATITCAGTNIGRKYVHWYQQRPGQAPVLVMSDNDDRPSGIPERFSASNSGHTATLIINRVEVDDEADYYCQVWDTTYSRPVIFGGGTKLTVL,IGHV3-30 (Human),IGHJ3 (Human),IGLV3-21 (Human),IGLJ3 (Human),ARSGWDDAFDI,QVWDTTYSRPVI,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/G10_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
FC08,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,"Phage Display Library (Antibody, human, immune - CoV2)",EVQLLQQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGIIPILGIANYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCVRERGYSGYGAAYYFDYWGQGTLVTVSS,QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWYQQLPGTAPKLLIYGNSNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSSLSGSVFGGGTKLTVL,IGHV1-69 (Human),IGHJ4 (Human),IGLV1-40 (Human),IGLJ3 (Human),VRERGYSGYGAAYYFDY,QSYDSSLSGSV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/FC08_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
FC11,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,"Phage Display Library (Antibody, human, immune - CoV2)",EVQLLESGGGVVQPGRSLRLSCAASGFTFSYYGMHWVRQAPGTGLEWVAVISYDGSNEYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKAMFLGDSSGLTGLDMDVWGQGTTVTVSS,DIELTQSPGTLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFALYYCQQRGNWPPTFGGGTKLEIK,IGHV3-30 (Human),IGHJ6 (Human),IGKV3-11 (Human),IGKJ4 (Human),AKAMFLGDSSGLTGLDMDV,QQRGNWPPT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/FC11_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
P16-A3,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,"Phage Display Library (Fab, human, non-immune)",QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARAYSSSWLLQSFYYYGMDVWGQGTTVTVSS,NIQLTQSPVSLSASVGDRVTLTCRASQGIGYSLVWYQKKPGTAPKLLIFDASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDSATYYCQQVIHYPLTFGGGTKVEIK,IGHV3-30 (Human),IGHJ6 (Human),IGKV1-13 (Human),IGKJ4 (Human),ARAYSSSWLLQSFYYYGMDV,QQVIHYPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P16-A3_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
P17-A11,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,"Phage Display Library (Fab, human, non-immune)",QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARHATLMNNKDIWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPRTFGQGTKVEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ1 (Human),ARHATLMNNKDI,QQSYSTPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/P17-A11_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
Fab20,Ab,SARS-CoV2,,SARS-CoV2,,N,"Phage Display Library (Antibody, human, immune - CoV2)",QVQLLEQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGTIPIFGTANYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYCARGGWSSSAGGYYGMDVWGQGTTVTVSS,EIELTQSPLSLPVTPGEPASISCRSSQSLLHSNGYNYLDWYLQKPGQSPQLLIYLGSNRASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQALQTPTTFGQGTRLEIK,IGHV3-9 (Human),IGHJ6 (Human),IGLV3-21 (Human),IGLJ3 (Human),ARGGWSSSAGGYYGMDV,MQALQTPTT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Fab20_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
B2,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,"Phage Display Library (Humanised sdAbs, immune - CoV2)",QVQLVQSGGGLVQPGRSLRLSCAASGFTFDDYAMHWVRQAPGKGLEWVSGISWNGGIIGYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTALYYCAKVGEVGSREWSAFDVWGQGTTVTVSS,LPVLTQPPSVSVTPGQTARITCGGSNIGSKSVHWYQQKPGQAPVLVVYDDSDRPSGIPERFSGSNSGNTATLTISGVEAGDEADYYCQLWDGSSDRAIFGGGTKLAVL,IGHV3-9 (Human),IGHJ6 (Human),IGLV3-21 (Human),IGLJ3 (Human),AKVGEVGSREWSAFDV,QLWDGSSDRAI,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/B2_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
A10,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,"Phage Display Library (Humanised sdAbs, immune - CoV2)",QVQLVQSGAGVKKPGASVKVSCKTSGYSFNKYGISWVRQAPGQGLEWMGWMNPNSGNTGYAQKFQGRVTMTRNTSISTAYMELSSLRSEDTAVYYCARGGNGGMDVWGQGTLVTVSS,SYELTQPPSVSGAPGQRVTISCSGSSSNIGNNLVNWYQQLPGKTPRLLIYYDDIVASGVSDRFSGSKSGTSASLAISGLQSEDEADYYCAAWDDILSAYVFGPGTKVTVL,IGHV1-8 (Human),IGHJ6 (Human),IGLV1-36 (Human),IGLJ1 (Human),ARGGNGGMDV,AAWDDILSAYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/A10_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
E3,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,"Phage Display Library (Humanised sdAbs, immune - CoV2)",QVQLQESGPGLVKPSGTLSLTCAVSGDSISSSNWWSWVRQPPGKGLEWIGEIYHSGSTNYNPSLKSRVTISVDMSKDQFSLKLSSVTAADTAVYYCARHNAQFGELLVPQDAFDMWGQGTMVTVSS,ELQMTQSPSTLSASVGDRVTITCRASQQISNWLAWYQQKPGKAPNLLIYDASSLEYGVPSRFSGSGSGTEFTLTISSLQADDFATYYCQQYSNYPPWTFGQGTKLEIK,IGHV4-4 (Human),IGHJ3 (Human),IGKV1-5 (Human),IGKJ1 (Human),ARHNAQFGELLVPQDAFDM,QQYSNYPPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/E3_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
GW01,Ab,"SARS-CoV1,SARS-CoV2",,"SARS-CoV1,SARS-CoV2",,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGVVQPGGSLRLSCAASGFRFDDHAMHWVRQAPGKGLEWVSVISGDGGSTYYADSVKGRFSISRDDSKNSLYLQMNSLRTEDTALYYCAKDRSYGPPDVFNYEYGMDVWGQGTTVTVSS,QSVLTQPPSASGTPGQRVTISCSGSSSNIGSNTVNWYQQLPGTAPKLLIYSNNQRPSGVPDRFSGSKSGTSASLAISGLQSEDEADYYCAAWDDSLNWVFGGGTKLTVL,IGHV3-43 (Human),IGHJ6 (Human),IGLV1-44 (Human),IGLJ3 (Human),AKDRSYGPPDVFNYEYGMDV,AAWDDSLNWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/GW01_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
4A3,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,SARS-CoV1,S; RBD,"Phage Display Library (Antibody, human, non-immune)",EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSSIASSGYYTDYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDADSFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASYLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQAYSAPSTFGQGTKVEIK,IGHV3-23 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ1 (Human),AKDADSFDY,QQAYSAPST,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/4A3_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Jan 11, 2021",11th Jan 2021: Updated references,Complete
C1A-A1,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD/non-RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV1-69 (Human),ND,IGKV3-11 (Human),ND,ND,ND,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 14, 2020","Nov 14, 2020",N/A,Awaiting publication for full sequences
C1A-A6,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV3-11 (Human),ND,IGKV1-13 (Human),ND,ND,ND,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 14, 2020","Nov 14, 2020",N/A,Awaiting publication for full sequences
C1A-A11,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV3-30 (Human),ND,IGKV1-33 (Human),ND,ND,ND,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 14, 2020","Nov 14, 2020",N/A,Awaiting publication for full sequences
C1A-B1,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; non-RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV1-2 (Human),ND,IGKV3-20 (Human),ND,ND,ND,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 14, 2020","Nov 14, 2020",N/A,Awaiting publication for full sequences
C1A-B3,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGATYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARGDVSGYRYGLDYWGQGTLVTVSG,DIQLTQSPSSLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQLISYPGTFGQGTKLEIK,IGHV3-53 (Human),IGHJ4 (Human),IGKV1-9 (Human),IGKJ2 (Human),ARGDVSGYRYGLDY,QQLISYPGT,https://www.rcsb.org/structure/7KFV,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 14, 2020","Mar 23, 2021",14th Dec: Added PDB structure; 23rd Mar: Added PDB structure caveat,Complete
C1A-B5,Ab,SARS-CoV2,,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV4-59 (Human),ND,IGKV4-1 (Human),ND,ND,ND,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 14, 2020","Nov 14, 2020",N/A,Awaiting publication for full sequences
C1A-B6,Ab,SARS-CoV2,,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV1-24 (Human),ND,IGLV2-8 (Human),ND,ND,ND,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 14, 2020","Nov 14, 2020",N/A,Awaiting publication for full sequences
C1A-B12,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGATYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARGDVSGYRYGLDYWGQGTLVTVSG,DIQLTQSPSSLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQLISYPGTFGQGTKLEIK,IGHV3-53 (Human),IGHJ4 (Human),IGKV1-9 (Human),IGKJ2 (Human),ARGDVSGYRYGLDY,QQLNSYPGT,https://www.rcsb.org/structure/7KFW,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 14, 2020","Mar 23, 2021",14th Dec: Added PDB structure. 23 Mar: corrected two point mutations in Fv sequence,Complete
C1A-C1,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV3-23 (Human),ND,IGKV1-39 (Human),ND,ND,ND,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 14, 2020","Nov 14, 2020",N/A,Awaiting publication for full sequences
C1A-C2,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLIQPGGSLRLSCAVSGFTVSNNYMSWVRQAPGKGLEWVSVIYSGGTTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARGDVSGYRYGLDYWGQGTLVTVSG,DIQLTQSPSSLSAFVGDRVTITCRASEGISSYLAWYQQKPGNAPKLLIYAASTLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQLNSYPGTFGQGTKLEIK,IGHV3-53 (Human),IGHJ4 (Human),IGKV1-9 (Human),IGKJ2 (Human),ARGDVSGYRYGLDY,QQLNSYPGT,https://www.rcsb.org/structure/7KFX,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 14, 2020","Dec 14, 2020",14th Dec: Added PDB structure,Complete
C1A-C4,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV3-53 (Human),ND,IGKV1-9 (Human),ND,ND,ND,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 14, 2020","Nov 14, 2020",N/A,Awaiting publication for full sequences
C1A-C6,Ab,SARS-CoV2,,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV1-69 (Human),ND,IGKV3-11 (Human),ND,ND,ND,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 14, 2020","Nov 14, 2020",N/A,Awaiting publication for full sequences
C1A-C8,Ab,SARS-CoV2,,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV1-24 (Human),ND,IGLV3-21 (Human),ND,ND,ND,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 14, 2020","Nov 14, 2020",N/A,Awaiting publication for full sequences
C1A-C9,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV1-69 (Human),ND,IGKV1-39 (Human),ND,ND,ND,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 14, 2020","Nov 14, 2020",N/A,Awaiting publication for full sequences
C1A-C10,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; non-RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV3-23 (Human),ND,IGLV2-23 (Human),ND,ND,ND,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 14, 2020","Nov 14, 2020",N/A,Awaiting publication for full sequences
C1A-D1,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD/non-RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV4-39 (Human),ND,IGKV1-33 (Human),ND,ND,ND,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 14, 2020","Nov 14, 2020",N/A,Awaiting publication for full sequences
C1A-D9,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV3-30 (Human),ND,IGKV2-30 (Human),ND,ND,ND,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 14, 2020","Nov 14, 2020",N/A,Awaiting publication for full sequences
C1A-D11,Ab,SARS-CoV2,,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV1-69 (Human),ND,IGKV3-11 (Human),ND,ND,ND,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 14, 2020","Nov 14, 2020",N/A,Awaiting publication for full sequences
C1A-E1,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV3-9 (Human),ND,IGKV1-39 (Human),ND,ND,ND,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 14, 2020","Nov 14, 2020",N/A,Awaiting publication for full sequences
C1A-E3,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV1-18 (Human),ND,IGKV1-39 (Human),ND,ND,ND,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 14, 2020","Nov 14, 2020",N/A,Awaiting publication for full sequences
C1A-E4,Ab,SARS-CoV2,,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV3-30 (Human),ND,IGKV3-20 (Human),ND,ND,ND,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 14, 2020","Nov 14, 2020",N/A,Awaiting publication for full sequences
C1A-E8,Ab,SARS-CoV2,,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV3-48 (Human),ND,IGKV2-28 (Human),ND,ND,ND,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 14, 2020","Nov 14, 2020",N/A,Awaiting publication for full sequences
C1A-E9,Ab,SARS-CoV2,,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV3-30 (Human),ND,IGKV3-20 (Human),ND,ND,ND,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 14, 2020","Nov 14, 2020",N/A,Awaiting publication for full sequences
C1A-F2,Ab,SARS-CoV2,,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV3-30-3 (Human),ND,IGKV2-28 (Human),ND,ND,ND,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 14, 2020","Nov 14, 2020",N/A,Awaiting publication for full sequences
C1A-F3,Ab,SARS-CoV2,,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV4-61 (Human),ND,IGKV1-39 (Human),ND,ND,ND,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 14, 2020","Nov 14, 2020",N/A,Awaiting publication for full sequences
C1A-F4,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV3-30-3 (Human),ND,IGKV1-5 (Human),ND,ND,ND,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 14, 2020","Nov 14, 2020",N/A,Awaiting publication for full sequences
C1A-F7,Ab,SARS-CoV2,,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV3-15 (Human),ND,IGKV4-1 (Human),ND,ND,ND,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 14, 2020","Nov 14, 2020",N/A,Awaiting publication for full sequences
C1A-F10,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGTTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARGDVSGYRYGLDYWGQGTLVTVSG,DIQLTQSPSSLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLENGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQLNSYPGTFGQGTKLEIK,IGHV3-53 (Human),IGHJ4 (Human),IGKV1-9 (Human),IGKJ2 (Human),ARGDVSGYRYGLDY,QQLNSYPGT,https://www.rcsb.org/structure/7KFY,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 14, 2020","Dec 14, 2020",14th Dec: Added PDB structure,Complete
C1A-F11,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV1-69 (Human),ND,IGKV1-33 (Human),ND,ND,ND,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 14, 2020","Nov 14, 2020",N/A,Awaiting publication for full sequences
C1A-F12,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV4-39 (Human),ND,IGLV1-40 (Human),ND,ND,ND,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 14, 2020","Nov 14, 2020",N/A,Awaiting publication for full sequences
C1A-G4,Ab,SARS-CoV2,,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV3-23 (Human),ND,IGLV2-23 (Human),ND,ND,ND,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 14, 2020","Nov 14, 2020",N/A,Awaiting publication for full sequences
C1A-G9,Ab,SARS-CoV2,,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV3-30-3 (Human),ND,IGKV3-20 (Human),ND,ND,ND,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 14, 2020","Nov 14, 2020",N/A,Awaiting publication for full sequences
C1A-G11,Ab,SARS-CoV2,,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV1-69 (Human),ND,IGKV1-5 (Human),ND,ND,ND,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 14, 2020","Nov 14, 2020",N/A,Awaiting publication for full sequences
C1A-G12,Ab,SARS-CoV2,,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV3-30-3 (Human),ND,IGKV3-15 (Human),ND,ND,ND,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 14, 2020","Nov 14, 2020",N/A,Awaiting publication for full sequences
C1A-H5,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV3-53 (Human),ND,IGKV1-9 (Human),ND,ND,ND,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 14, 2020","Nov 14, 2020",N/A,Awaiting publication for full sequences
C1A-H6,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV3-53 (Human),ND,IGKV1-9 (Human),ND,ND,ND,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 14, 2020","Nov 14, 2020",N/A,Awaiting publication for full sequences
C1A-H10,Ab,SARS-CoV2,,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV3-21 (Human),ND,IGKV3-15 (Human),ND,ND,ND,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 14, 2020","Nov 14, 2020",N/A,Awaiting publication for full sequences
C1A-H11,Ab,SARS-CoV2,,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV3-30 (Human),ND,IGLV2-14 (Human),ND,ND,ND,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 14, 2020","Nov 14, 2020",N/A,Awaiting publication for full sequences
C1A-H12,Ab,SARS-CoV2,,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV4-39 (Human),ND,IGKV3-15 (Human),ND,ND,ND,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 14, 2020","Nov 14, 2020",N/A,Awaiting publication for full sequences
C1B-A3,Ab,SARS-CoV2,,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV3-30-3 (Human),ND,IGKV3-11 (Human),ND,ND,ND,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 14, 2020","Nov 14, 2020",N/A,Awaiting publication for full sequences
C1B-A5,Ab,SARS-CoV2,,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV3-30-3 (Human),ND,IGKV3-20 (Human),ND,ND,ND,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 14, 2020","Nov 14, 2020",N/A,Awaiting publication for full sequences
C1B-A11,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD/non-RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV3-30-3 (Human),ND,IGKV3-20 (Human),ND,ND,ND,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 14, 2020","Nov 14, 2020",N/A,Awaiting publication for full sequences
P4A1,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLIQPGGSLRLSCAASGFIVSSNYMSWVRQAPGKGLEWVSIIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRVEDTAVYYCARDLQELGSLDYWGQGTLVTVSS,DIQMTQSPSSVSASVGDRVTITCRASQGISSWLAWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQEANSFPYTFGQGTKLEIK,IGHV3-53 (Human),IGHJ4 (Human),IGKV1-12 (Human),IGKJ2 (Human),ARDLQELGSLDY,QEANSFPYT,https://www.rcsb.org/structure/7CJF,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 12, 2020","May 27, 2021",26th Nov: Changed name of entry from 7cjf; 27th May '21: Changed publication reference and origin,Complete
S2-E12,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGPEVKKPGTSVRVSCKASGFTFTSSAVQWVRQARGQRLEWVGWIVVGSGNTNYAQKFHERVTITRDMSTSTAYMELSSLRSEDTAVYYCASPYCSGGSCSDGFDIWGQGTMVTVSS,DIVLTQTPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYVGLTGWTFGQGTKVEIK,IGHV1-58 (Human),IGHJ3 (Human),IGKV3-20 (Human),IGKJ1 (Human),ASPYCSGGSCSDGFDI,QQYVGLTGWT,https://www.rcsb.org/structure/7K4N;https://www.rcsb.org/structure/7K45;https://www.rcsb.org/structure/7K3Q;https://www.rcsb.org/structure/7R6X,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 11, 2020","Jul 24, 2021",26th Nov: Added PDB structure and sequence information; 24th July '21: Added new PDB structure and reference with variant binding data.,Variant binding data in Starr et al. Complete
S2-M11,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVQSGAEVKKPGASVKVSCKASGYTFTGYYMHWVRQAPGQGLEWMGWINPISSGTSYAQTFQGRVTMTSDTSITTAYMELSRLRSDDTAVYYCARAAPFYDFWSGYSYFDYWGQGTLVTVSS,EIVMMQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSAWTFGQGTKVEIK,IGHV1-2 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ1 (Human),ARAAPFYDFWSGYSYFDY,QQYGSSAWT,https://www.rcsb.org/structure/7K43;https://www.rcsb.org/structure/7LY2;https://www.rcsb.org/structure/7N8H;https://www.rcsb.org/structure/7N8I,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 11, 2020","Apr 21, 2021",26th Nov: Added PDB structure and sequence information; 21st April: Added new structure,Complete
Bamlanivimab,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSNYAISWVRQAPGQGLEWMGRIIPILGIANYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCARGYYEARHYYYYYAMDVWGQGTAVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLSWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTITSLQPEDFATYYCQQSYSTPRTFGQGTKVEIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ1 (Human),ARGYYEARHYYYYYAMDV,QQSYSTPRT,https://www.rcsb.org/structure/7KMG;https://www.rcsb.org/structure/7L3N,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 11, 2020","Jan 30, 2021",14th Nov: Corrected CDRL3 sequence; 30th Jan: Added PDB structure and publication,Therapeutic mAb. Also known as LY-CoV555. Complete
Regdanvimab,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,ND,QITLKESGPTLVKPTQTLTLTCSFSGFSLSTSGVGVGWIRQPPGKALEWLALIDWDDNKYHTTSLKTRLTISKDTSKNQVVLTMTNMDPVDTATYYCARIPGFLRYRNRYYYYGMDVWGQGTTVTVSS,ELVLTQPPSVSAAPGQKVTISCSGSSSNIGNNYVSWYQQLPGTAPKLLIYDNNKRPSGIPDRFSGSKSGTSATLGITGLQTGDEADYYCGTWDSSLSAGVFGGGTELTVL,IGHV2-70 (Human),IGHJ6 (Human),IGLV1-51 (Human),IGLJ3 (Human),ARIPGFLRYRNRYYYYGMDV,GTWDSSLSAGV,https://www.rcsb.org/structure/7CM4,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 11, 2020","Jul 24, 2021",30th Jan: Added PDB structure; 24th July '21: Added new publication with variant binding data,Therapeutic mAb. Also known as CT-P59. Variant binding data in Ryu et al. Complete
Sotrovimab,Ab,SARS-CoV2,,,,S; RBD,ND,QVQLVQSGAEVKKPGASVKVSCKASGYPFTSYGISWVRQAPGQGLEWMGWISTYQGNTNYAQKFQGRVTMTTDTSTTTGYMELRRLRSDDTAVYYCARDYTRGAWFGESLIGGFDNWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQTVSSTSLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQHDTSLTFGGGTKVEIK,IGHV1-18 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ4 (Human),ARDYTRGAWFGESLIGGFDN,QQHDTSLT,See S309,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 11, 2020","Nov 11, 2020",N/A,Therapeutic mAb. One mutation away from S309. See S309 for structures of near-identical sequence. Complete
S-B8,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,"Phage Display Library (Antibody, human, non-immune)",VQLVQSGGGLIQPGGSLLRLSCAASGFTVSLSHMNWVRQAPGKGLEWVSITYGDGNSDYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAREYYYGMDVWGQGTTVTVSS,DIVMTQSPDSLAVSLGERATINCKSSQSVLYSSNNKNYLAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYSLPLTFGGGTKLEIK,IGHV3-66 (Human),IGHJ6 (Human),IGKV4-1 (Human),IGKJ4 (Human),AREYYYGMDV,QQYYSLPLT,Expected (7KN3),Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/S-B8_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 11, 2020","Nov 11, 2020",N/A,Awaiting release of structure in PDB
S-D4,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,"Phage Display Library (Antibody, human, non-immune)",ND,ND,IGHV3-33 (Human),ND,ND,ND,ND,ND,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 11, 2020","Nov 11, 2020",N/A,Contacting authors for sequence
S-E6,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,"Phage Display Library (Antibody, human, non-immune)",ESGPGLVKPSETLSLTCAVSGGSLSSVNYYWSWIRQHPGKGLEWIGYIYYSGSTNYNPSLKSRVTMSLDTSKNQFSLKLSSVTAADTAVYYCATPGAIMGALHIWGQGTLVTVSS,QAVLTQPSSASSTPGQRVIISCSGSSSNIGSNTVSWYQQVPGAAPKLLIYFDYRRPSGVPDRFSGTRSGTSASLGISGLQSEDEADYYCAAWDDSLSAWVFGRGTKLTVL,IGHV4-31 (Human),IGHJ4 (Human),IGLV1-44 (Human),IGLJ3 (Human),ATPGAIMGALHI,AAWDDSLSAWV,Expected (7NK4),Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/S-E6_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 11, 2020","Nov 11, 2020",N/A,Awaiting release of structure in PDB
Fab-52,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,"Phage Display Library (Antibody, human, non-immune)",QVQLVQSGAEVKKPGSSVKVSCKASGYTFTSYGISWVRQAPGQGLEWMGGIIPMFGTTNYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCARDRGDTIDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQGISNNLNWYQQKPGKAPKLLIYAASSLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQGNGFPLTFGPGTKVDIK,IGHV1-69 (Human),IGHJ4 (Human),IGKV1-12 (Human),IGKJ3 (Human),ARDRGDTIDY,QQGNGFPLT,https://www.rcsb.org/structure/7K9Z,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 2, 2020","Nov 2, 2020",N/A,Complete
Fab-298,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,"Phage Display Library (Antibody, human, non-immune)",QVQLVQSGAEVKKPGASVKVSCKASGGTFSTYGISWVRQAPGQGLEWMGWISPNSGGTDLAQKFQGRVTMTRDTSTSTVYMELSSLRSEDTAVYYCASDPRDDIAGGYWGQGTLVTVSS,DIVMTQSPDSLAVSLGERATINCKSSQSVLYSSNNKNYLAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYSTPPTFGQGTKLEIK,IGHV1-2 (Human),IGHJ4 (Human),IGKV4-1 (Human),IGKJ2 (Human),ASDPRDDIAGGY,QQYYSTPPT,https://www.rcsb.org/structure/7K9Z,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 2, 2020","Nov 2, 2020",N/A,Complete
P2B-1A1,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSETLSLTCTVSGGSISSYYWSWIRQPPGKGLEWIGYIYYSGSTNYNPSLKSRVTISVDTSKKQFSLKLSSVTAADTAVYYCARLERDWPLDAFDIWGQGTMVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKFMIYDVSKRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSNNTFAFGGGTKLTVL,IGHV4-59 (Human),IGHJ3 (Human),IGLV2-14 (Human),IGLJ3 (Human),ARLERDWPLDAFDI,SSYTSNNTFA,https://www.rcsb.org/structure/7CZP,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 16, 2020","Mar 11, 2021",N/A,Complete
P2B-1A10,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAREGPKSITGTAFDIWGQGTIVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDISNYFNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPMYTFGQGTKLEIK,IGHV3-53 (Human),IGHJ3 (Human),IGKV1-33 (Human),IGKJ2 (Human),AREGPKSITGTAFDI,QQYDNLPMYT,https://www.rcsb.org/structure/7CZQ,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 16, 2020","Mar 11, 2021",N/A,Complete
P5A-3A1,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDYGDFYFDYWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPRTFGQGTKLEIK,IGHV3-53 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ2 (Human),ARDYGDFYFDY,QQYGSSPRT,https://www.rcsb.org/structure/7D0C,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 16, 2020","Mar 11, 2021",N/A,Complete
P5A-1B8,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYPGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARETLAFDYWGQGTLVTVSS,DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPPAFGGGTKVEIK,IGHV3-53 (Human),IGHJ4 (Human),IGKV1-9 (Human),IGKJ4 (Human),ARETLAFDY,QQLNSYPPA,https://www.rcsb.org/structure/7CZR;https://www.rcsb.org/structure/7CZS;https://www.rcsb.org/structure/7D00,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 16, 2020","Mar 11, 2021",N/A,Complete
P5A-2G9,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVIWYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARWFHTGGYFDYWGQGTLVTVSS,QPVLTQPPSSSASPGESARLTCTLPSDINVSSYNIYWYQQKPGSPPRYLLYYYSDSDKGQGSGVPSRFSGSKDASANTGILLISGLQSEDEADYYCMIWPSNALYVFGTGTKVTVL,IGHV3-33 (Human),IGHJ4 (Human),IGLV5-37 (Human),IGLJ1 (Human),ARWFHTGGYFDY,MIWPSNALYV,https://www.rcsb.org/structure/7CZT,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 16, 2020","Mar 11, 2021",N/A,Complete
P5A-1B6,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDGQAITMVQGVIGPPFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPYTFGQGTKLEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ2 (Human),ARDGQAITMVQGVIGPPFDY,QQYDNLPYT,https://www.rcsb.org/structure/7CZU;https://www.rcsb.org/structure/7CZV,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 16, 2020","Mar 11, 2021",N/A,Complete
P5A-2G7,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSETLSLTCTVSGDSVSSGSYYWSWIRQPPGKGLEWIGYIYYSGSTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARERCYYGSGRAPRCVWFDPWGQGTLVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSTLVVFGGGTKLTVL,IGHV4-61 (Human),IGHJ5 (Human),IGLV2-14 (Human),IGLJ3 (Human),ARERCYYGSGRAPRCVWFDP,SSYTSSSTLVV,https://www.rcsb.org/structure/7CZW;https://www.rcsb.org/structure/7D03,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 16, 2020","Mar 11, 2021",N/A,Complete
P5A-1B9,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSETLSLTCTVSGGSISSYYWSWIRQPPGKGLEWIGYISYSGSTNYNPSLKSRVTISLDTSKNQFSLKLSSVTAADTAVYYCASNGQYYDILTGQPPDYWYFDLWGRGTLVTVSS,DIVMTQSPDSLAVSLGERATINCKSSQSVLYSSNNKNYLAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYSTPLTFGGGTKVEIK,IGHV4-59 (Human),IGHJ2 (Human),IGKV4-1 (Human),IGKJ4 (Human),ASNGQYYDILTGQPPDYWYFDL,QQYYSTPLT,https://www.rcsb.org/structure/7CZX,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 16, 2020","Mar 11, 2021",N/A,Complete
P5A-2F11,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYDINWVRQATGQGLEWMGWMNPNSGNTGYAQKFQGRVTMTRNTSISTAYMELSSLRSEDTAVYYCARYIVVVPAAKGFDPWGQGTLVTVSS,DIVMTQSPDSLAVSLGERATINCKSSQSVLYSSNNKNYLAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYSTPLTFGGGTKVEIK,IGHV1-8 (Human),IGHJ5 (Human),IGKV4-1 (Human),IGKJ4 (Human),ARYIVVVPAAKGFDP,QQYYSTPLT,https://www.rcsb.org/structure/7CZY;https://www.rcsb.org/structure/7CZZ,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 16, 2020","Mar 11, 2021",N/A,Complete
P5A-3C12,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QITLKESGPTLVKPTQTLTLTCTFSGFSLSTSGVGVGWIRQPPGKALEWLALIYWDDDKRYSPSLKSRLTITKDTSKNQVVLTMTNMDPVDTATYYCAHSLFLTVGYSSSWSPFDYWGQGTLVTVSS,DIVMTQSPDSLAVSLGERATINCKSSQSVLYSSNNKNYLAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYSTPHTFGQGTKLEIK,IGHV2-5 (Human),IGHJ4 (Human),IGKV4-1 (Human),IGKJ2 (Human),AHSLFLTVGYSSSWSPFDY,QQYYSTPHT,https://www.rcsb.org/structure/7D0B;https://www.rcsb.org/structure/7D0D,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 16, 2020","Mar 11, 2021",N/A,Complete
mAb-3A2,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Mouse,ND,ND,IGHV8-6 (Mouse),ND,IGKV6-23 (Mouse),ND,ARRGPLITTDGTFDV,QQYSSYPYT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 16, 2020","Oct 16, 2020",N/A,Awaiting publication for full sequences
mAb-3A7,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Mouse,ND,ND,IGHV8-6 (Mouse),ND,IGKV6-23 (Mouse),ND,ARRGPLITTDGTFDV,QQYSSYPYT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 16, 2020","Oct 16, 2020",N/A,Awaiting publication for full sequences
mAb-3F5,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Mouse,ND,ND,IGHV8-6 (Mouse),ND,IGKV6-23 (Mouse),ND,ARRGPLITTDGTFDV,QQYSSYPYT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 16, 2020","Oct 16, 2020",N/A,Awaiting publication for full sequences
mAb-3C6,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Mouse,ND,ND,IGHV8-12 (Mouse),ND,IGKV6-13 (Mouse),ND,ARRGPLITTDGTFDV,QQYSSYPYT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 16, 2020","Oct 16, 2020",N/A,Awaiting publication for full sequences
mAb-3B3,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Mouse,ND,ND,IGHV3-1 (Mouse),ND,IGKV4-55 (Mouse),ND,AGRRGAYYGNYEEDY,QQWSSYPYT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 16, 2020","Oct 16, 2020",N/A,Awaiting publication for full sequences
mAb-3G7,Ab,SARS-CoV2,,SARS-CoV2,,S; S1,Immunised Mouse,ND,ND,IGHV1-61 (Mouse),ND,IGKV3-5 (Mouse),ND,ARSSGYDWYFDV,QQSNEDPWT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 16, 2020","Oct 16, 2020",N/A,Awaiting publication for full sequences
mAb-3C2,Ab,SARS-CoV2,,SARS-CoV2,,S; S1,Immunised Mouse,ND,ND,IGHV1-5 (Mouse),ND,IGKV3-5 (Mouse),ND,ARSGGYDWYFDV,QQSNEDPWT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 16, 2020","Oct 16, 2020",N/A,Awaiting publication for full sequences
mAb-3H6,Ab,SARS-CoV2,,SARS-CoV2,,S; S1,Immunised Mouse,ND,ND,IGHV10-1 (Mouse),ND,IGKV1-117 (Mouse),ND,ASYDGYRAWFAY,SQSTHVPWT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 16, 2020","Oct 16, 2020",N/A,Awaiting publication for full sequences
mAb-3H2,Ab,SARS-CoV2,,SARS-CoV2,,S; S1,Immunised Mouse,ND,ND,IGHV1-9 (Mouse),ND,IGKV1-117 (Mouse),ND,ARNGYFAMDY,SQSTHVPWT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 16, 2020","Oct 16, 2020",N/A,Awaiting publication for full sequences
mAb-3F2,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; S1,Immunised Mouse,ND,ND,IGHV1-12 (Mouse),ND,IGKV8-30 (Mouse),ND,ARDGYFAMDYW,HQYYSYPWT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 16, 2020","Oct 16, 2020",N/A,Awaiting publication for full sequences
mAb-3E5,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; S1,Immunised Mouse,ND,ND,IGHV1-20 (Mouse),ND,IGKV14-100 (Mouse),ND,GLRTY,VQSVQFPYT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 16, 2020","Oct 16, 2020",N/A,Awaiting publication for full sequences
mAb-3G1,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; S1,Immunised Mouse,ND,ND,IGHV2-2 (Mouse),ND,IGKV3-12 (Mouse),ND,AKYRYDSFAY,QHSRELPYT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 16, 2020","Oct 16, 2020",N/A,Awaiting publication for full sequences
mAb-3E1,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; S1,Immunised Mouse,ND,ND,IGHV14-1 (Mouse),ND,IGKV6-32 (Mouse),ND,ARTYYYGSSYEAMDY,QQDYSSPT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 16, 2020","Oct 16, 2020",N/A,Awaiting publication for full sequences
mAb-3D3,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; S1,Immunised Mouse,ND,ND,IGHV14-1 (Mouse),ND,IGKV6-32 (Mouse),ND,ARTYYYGSSYEAMDY,QQDYSSPT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 16, 2020","Oct 16, 2020",N/A,Awaiting publication for full sequences
mAb-9F2,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; S1,Immunised Mouse,ND,ND,IGHV14-1 (Mouse),ND,IGKV6-32 (Mouse),ND,ARTYYYGSSYEAMDY,QQDYSSPT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 16, 2020","Oct 16, 2020",N/A,Awaiting publication for full sequences
mAb-3H4,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; S1,Immunised Mouse,ND,ND,IGHV14-1 (Mouse),ND,IGKV6-32 (Mouse),ND,ARSYYDYDGGGCFDY,QQGYSSPLT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 16, 2020","Oct 16, 2020",N/A,Awaiting publication for full sequences
mAb-3D7,Ab,SARS-CoV2,,,SARS-CoV2,S; S1,Immunised Mouse,ND,ND,IGHV14-1 (Mouse),ND,IGKV6-32 (Mouse),ND,ARSYYDYDGGGCFDY,QQGYSSPLT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 16, 2020","Oct 16, 2020",N/A,Awaiting publication for full sequences
mAb-3B6,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; S1,Immunised Mouse,ND,ND,IGHV14-1 (Mouse),ND,IGKV6-32 (Mouse),ND,ARSYYTYDGFFDV,QQDYSSPPT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 16, 2020","Oct 16, 2020",N/A,Awaiting publication for full sequences
mAb-3F6,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; S1,Immunised Mouse,ND,ND,IGHV14-1 (Mouse),ND,IGKV6-32 (Mouse),ND,ARSYYTYDGFFDV,QQDYSSPPT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 16, 2020","Oct 16, 2020",N/A,Awaiting publication for full sequences
mAb-3F1,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; S1,Immunised Mouse,ND,ND,IGHV14-1 (Mouse),ND,IGKV4-54 (Mouse),ND,TRYYYGSSGFFDV,QQDYSSPT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 16, 2020","Oct 16, 2020",N/A,Awaiting publication for full sequences
mAb-3D5,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; S1,Immunised Mouse,ND,ND,IGHV14-1 (Mouse),ND,IGKV3-5 (Mouse),ND,TRYYYGSSGFFDV,QQDYSSPT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 16, 2020","Oct 16, 2020",N/A,Awaiting publication for full sequences
mAb-3B4,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; S1,Immunised Mouse,ND,ND,IGHV14-1 (Mouse),ND,IGKV13-85 (Mouse),ND,ARSYYYGTTSWFAS,QQYWSTPYT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 16, 2020","Oct 16, 2020",N/A,Awaiting publication for full sequences
mAb-3C4,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; S1,Immunised Mouse,ND,ND,IGHV14-1 (Mouse),ND,IGKV15-103 (Mouse),ND,ASGYDVNYELDY,QQGQSYPYT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 16, 2020","Oct 16, 2020",N/A,Awaiting publication for full sequences
mAb-3E4,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; S1,Immunised Mouse,ND,ND,IGHV14-1 (Mouse),ND,IGKV15-103 (Mouse),ND,ASGYDVNYELDY,QQGQSYPYT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 16, 2020","Oct 16, 2020",N/A,Awaiting publication for full sequences
mAb-3F4,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; S1,Immunised Mouse,ND,ND,IGHV14-1 (Mouse),ND,IGKV12-98 (Mouse),ND,TRYYDYVYAMDY,QQLYSTPLT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 16, 2020","Oct 16, 2020",N/A,Awaiting publication for full sequences
mAb-3D1,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; S1,Immunised Mouse,ND,ND,IGHV14-1 (Mouse),ND,IGKV14-111 (Mouse),ND,VSGYYYYGSPYGAMDY,QQYHGYPLT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 16, 2020","Oct 16, 2020",N/A,Awaiting publication for full sequences
mAb-3G2,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; S1,Immunised Mouse,ND,ND,IGHV14-1 (Mouse),ND,IGKV6-32 (Mouse),ND,ARWDFGNYVDYAMDY,LQYDAFPWT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 16, 2020","Oct 16, 2020",N/A,Awaiting publication for full sequences
mAb-3G6,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; S1,Immunised Mouse,ND,ND,IGHV14-1 (Mouse),ND,IGKV14-111 (Mouse),ND,ARLNYDGYYDYAMDY,LQYDEFPFT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 16, 2020","Oct 16, 2020",N/A,Awaiting publication for full sequences
mAb-3D2,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; S1,Immunised Mouse,ND,ND,IGHV1-4 (Mouse),ND,IGKV6-23 (Mouse),ND,ARRYGNYDAWFTY,QQYRT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 16, 2020","Oct 16, 2020",N/A,Awaiting publication for full sequences
mAb-3A1,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; S1,Immunised Mouse,ND,ND,IGHV3-1 (Mouse),ND,IGKV12-44 (Mouse),ND,ARWGNGKNAMDY,QHHYGSPPT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 16, 2020","Oct 16, 2020",N/A,Awaiting publication for full sequences
mAb-3A6,Ab,SARS-CoV2 (weak),,SARS-CoV2 (weak),,S; S1,Immunised Mouse,ND,ND,IGHV2-9 (Mouse),ND,IGKV4-63 (Mouse),ND,GRDYGILLIDY,FQGSGYPFT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 16, 2020","Oct 16, 2020",N/A,Awaiting publication for full sequences
mAb-3B1,Ab,SARS-CoV2 (weak),,SARS-CoV2 (weak),,S; S1,Immunised Mouse,ND,ND,IGHV3-6 (Mouse),ND,IGKV4-50 (Mouse),ND,ARVDYDVGHWFAY,HQFTTSPWT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 16, 2020","Oct 16, 2020",N/A,Awaiting publication for full sequences
S2H14,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVKPGGSLRLSCAASGFTFSNAWMSWVRQAPGKGLEWVGRIKSKTDGGTTDYAAPVKGRFTISRDDSKNTLYLQMNSLKTEDTAVYYCTTGSETYYYDSSGPFDYWGQGTLVTVSS,NFMLTQPHSVSESPGKTVTISCTRSSGSIASNYVQWYQQRPGSSPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSSNQVFGGGTKLTVL,IGHV3-15 (Human),IGHJ4 (Human),IGLV6-57 (Human),IGLJ3 (Human),TTGSETYYYDSSGPFDY,QSYDSSNQV,https://www.rcsb.org/structure/7JX3,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 16, 2020","Oct 16, 2020",N/A,Complete
S2H13,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGDSVQPGGSLRLSCAAAGFTFSSYWMNWVRQAPGKGLEWVANIKQDGSEKYYVDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCALSSGYSGYAGNYWGQGTLVTVSS,QAVVTQEPSLTVSPGGTVTLTCGSSTGAVTSGHYPYWFQQKPGQAPRTLIYDTSNKHSWTPARFSGSLLGGKAALTLSGARPEDEAEYYCLLSYSGARGVFGGGTKLTVL,IGHV3-7 (Human),IGHJ4 (Human),IGLV7-46 (Human),IGLJ3 (Human),ALSSGYSGYAGNY,LLSYSGARGV,https://www.rcsb.org/structure/7JV2; https://www.rcsb.org/structure/7JV4; https://www.rcsb.org/structure/7JV6,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 16, 2020","Oct 16, 2020",N/A,Complete
S2X35,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTNYGISWVRQAPGQGLEWMGWISAYKGNTNYAQKLQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARPDYQVLGYDFWIGYYGMDVWGQGTTVIVSS,QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWYQQLPGTAPKLLIYGNTNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSSLSGSEVVFGGGTKLTVL,IGHV1-18 (Human),IGHJ6 (Human),IGLV1-40 (Human),IGLJ3 (Human),ARPDYQVLGYDFWIGYYGMDV,QSYDSSLSGSEVV,https://www.rcsb.org/structure/7JXE;https://www.rcsb.org/structure/7R6W,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 16, 2020","Jul 24, 2021",24th July '21: Added new PDB structure and reference,Variant binding data in Starr et al. Complete
S2A4,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYWMNWVRQAPGKGLEWVANIKQDGSEKYYVDSVKGRFTISRDNAKNSLFLQMNSLRAEDTAVYYCARVWWLRGSFDYWGQGTLVTVSS,NFMLTQPHSVSESPGKTVTISCTGSSGSIASNYVQWYQQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSSNHVVFGGGTKLTVL,IGHV3-7 (Human),IGHJ4 (Human),IGLV6-57 (Human),IGLJ3 (Human),ARVWWLRGSFDY,QSYDSSNHVV,https://www.rcsb.org/structure/7JVA; https://www.rcsb.org/structure/7JVC; https://www.rcsb.org/structure/7JXD,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 16, 2020","Oct 16, 2020",N/A,Complete
TAU-1109,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGPEVKKPGASVKVSCKASGYTFTSYSINWVRQAPGQGLEWMGWISTYNGNTNYAQRLQGRVTMTTDTSTGTAHMELRSLRSDDTAIYYCAREEPLYCSGGSCYEFQHWGQGTLVTVSS,EIVLTQSPARLSLSPGERATLSCRASQSVSSDLAWYQQKPGQAPRLLIYDASHRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRINWPPIFTFGPGTKVDIK,IGHV1-18 (Human),ND,IGKV3-11 (Human),ND,AREEPLYCSGGSCYEFQH,QQRINWPPIFT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 8, 2020","Feb 16, 2021",16th Feb: Added new publication and Fv sequence,Complete
TAU-1110,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV3-15 (Human),ND,IGLV1-47 (Human),ND,TIDEGRGYGYGYGMDV,ND,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 8, 2020","Oct 8, 2020",16th Feb: Added new publication,Contacting authors for sequence
TAU-1115,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFSNYVMSWVRQAPGKGLEWVSGISGSGGSTYYADSMKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDLTRDYYDSSGYQTGAFDIWGQGTMVTVSS,SYELNQPPSVSVAPGQTARITCGGNNIGSKSVHWYQQKPGQAPVLVVYDDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWGGVFGGGTKLTVL,IGHV3-23 (Human),ND,IGLV3-21 (Human),ND,AKDLTRDYYDSSGYQTGAFDI,QVWGGV,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 8, 2020","Oct 8, 2020",16th Feb: Added new publication and Fv sequence,Complete
TAU-1145,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Human Patient,QLQLQESGPGLVKPSETLSLTCTLSGGAIRSGSYYWGWIRQTPGKGLEWIGSIFHIGNAFYNPSLKSRVTISADKAKNQISLNVRSVTAADTAVYYCVRPNNEHGGFFFDYWGQGILVTVSS,SYELTQPPSLSVAPGKTARISCGGNNIGSRSVHWYQQKPGQAPVVVISYDTDRPSEIPERFSGSKSGNTATLTISRVEAGDEADYYCQVWVSTFDHVVFGGGTKLTVL,IGHV4-39 (Human),ND,IGLV3-21 (Human),ND,VRPNNEHGGFFFDY,QVWVSTFDHVV,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 8, 2020","Oct 8, 2020",16th Feb: Added new publication and Fv sequence,Complete
TAU-1148,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV3-23 (Human),ND,IGKV3-15 (Human),ND,ARAGGSGTYPYYFDW,ND,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 8, 2020","Oct 8, 2020",16th Feb: Added new publication,Contacting authors for sequence
TAU-1225,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV3-23 (Human),ND,IGKV2-30 (Human),ND,ARKISTGNQYYYYGMDV,ND,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 8, 2020","Oct 8, 2020",16th Feb: Added new publication,Contacting authors for sequence
TAU-1236,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV1-18 (Human),ND,IGKV1-39 (Human),ND,ARVASILGATTRGFDS,ND,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 8, 2020","Oct 8, 2020",16th Feb: Added new publication,Contacting authors for sequence
TAU-1242,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV3-11 (Human),ND,IGLV1-44 (Human),ND,ARSTTVFAVRDYYYYMDV,ND,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 8, 2020","Oct 8, 2020",16th Feb: Added new publication,Contacting authors for sequence
TAU-1245,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV4-4 (Human),ND,IGLV1-44 (Human),ND,ARESSGVTMPGTSSAFFDP,ND,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 8, 2020","Oct 8, 2020",16th Feb: Added new publication,Contacting authors for sequence
TAU-2173,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV4-39 (Human),ND,IGLV1-51 (Human),ND,ARHRNRTPLDALDF,ND,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 8, 2020","Oct 8, 2020",16th Feb: Added new publication,Contacting authors for sequence
TAU-2189,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLLESGGGLVQPGGSLRLFCAASGFTFSSFAMSWVRQAPGKGLEWVSTISGSGGRTYYADSVKGRFTIFRDNSKNTLYLQMNSLRAEDTALYYCAKDMDIVVVITGDAFDIWGQGTMVTVSS,SYELTQPPSVSVSPGQTARITCSGDALPKQYAYWYQQKPGQAPVLVIYKDSERPSGIPERFSGSSSGTTVTLTISGVQAEDEADYYCQSADSSGTYRVFGTGTKVTVL,IGHV3-23 (Human),ND,IGLV3-25 (Human),ND,AKDMDIVVVITGDAFDI,QSADSSGTYRV,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 8, 2020","Oct 8, 2020",16th Feb: Added new publication and Fv sequence,Complete
TAU-2230,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMNWVRQAPGKGLEWVSVISGSGGRTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDLDIVVVITGDAFDIWGQGTMVTVSS,SYELTQPPSVSVSPGQTARITCSGDALPRHYSYWYQQKPGQAPVLLIYKDSERPSGIPERFSGSSSGTTVTLTISGVQAEDEADYYCQSADSSGTYRVFGIGTKVTVL,IGHV3-23 (Human),ND,IGLV3-25 (Human),ND,AKDLDIVVVITGDAFDI,QSADSSGTYRV,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 8, 2020","Oct 8, 2020",16th Feb: Added new publication and Fv sequence,Complete
TAU-2212,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTGYYMHWVRQAPGQGLEWMGWINPNSGGTNYAQKFQGWVTMTRDTSISTAYMELSRLRSDDTAVYYCARGWATYYDILTGYSLFDYWGQGTLVTVSS,QSVLTQPASVSGSPGQSITISCTGTSSDVGSYNLVSWYQQHPGKAPKLMIYEVSKRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCCSYAGSSTPHVVFGGGTKLTVL,IGHV1-2 (Human),ND,IGLV3-23 (Human),ND,ARGWATYYDILTGYSLFDY,CSYAGSSTPHVV,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 8, 2020","Oct 8, 2020",16th Feb: Added new publication and Fv sequence,Complete
TAU-2218,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV3-49 (Human),ND,IGKV3-20 (Human),ND,TGPRPYYDSSGYYPYYFDY,ND,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 8, 2020","Oct 8, 2020",16th Feb: Added new publication,Contacting authors for sequence
TAU-2220,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTNYFIHWVRQAPGQGLEWMGMINPSVGSTTYAQNFQGRVTMTRDTSTSTVYMELSSLRSEDTAIYYCARTHVAQLWEIWYFDIWGRGTLVTVSS,QSVLTQPPSASGTPGQRVTISCSGSTSNIGSNAVNWYQQLPGTAPKLLIYSDNHRPSGVPDRFSGSRSGTSASLAISRLQSEDEADYYCAAWDDSLKGVFGGGTKLTVL,IGHV1-46 (Human),ND,IGLV1-44 (Human),ND,ARTHVAQLWEIWYFDI,AAWDDSLKGV,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 8, 2020","Oct 8, 2020",16th Feb: Added new publication and Fv sequence,Complete
TAU-2247,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV3-9 (Human),ND,IGLV3-21 (Human),ND,AKDRGAALSRLRGMDA,ND,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 8, 2020","Oct 8, 2020",16th Feb: Added new publication,Contacting authors for sequence
TAU-2255,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV3-9 (Human),ND,IGLV3-21 (Human),ND,AKDRGAALSRLRGMDA,ND,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 8, 2020","Oct 8, 2020",16th Feb: Added new publication,Contacting authors for sequence
TAU-2303,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTVRSNYMSWVRQAPGKGLEWVSLIYSGGSTYYADSVKGRFIISRDNSKNTLYLQMNSLRAEDTAVYYCARDLAVYGMDVWGQGTTVTVSS,DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYGASTLQSGVPSRFSGSGSGTEFKLTISSLQPEDFATYYCQQLNNYPPVTFGQGTRLEIK,IGHV3-66 (Human),ND,IGKV1-9 (Human),ND,ARDLAVYGMDV,QQLNNYPPVT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 8, 2020","Oct 8, 2020",16th Feb: Added new publication and Fv sequence,Complete
TAU-2310,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLLESGGGLVQPGGSLRLSCAASGFTFSNYVMSWVRQAPGKGLEWVSGIGGSGDSTYYADSVKGRFTISRDNSKNTLYLQINSLRAEDTAVYYCAKGAAPYYYYYYGMDVWGQGTTVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGGYDYVSWYQQHPGKAPKLMIYEVSDRPSGVSNRFSGSKSGSTASLTISGLQAEDEADYYCSSYTSSSALYVFGTGTKVTVL,IGHV3-23 (Human),ND,IGLV2-14 (Human),ND,AKGAAPYYYYYYGMDV,SSYTSSSALYV,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 8, 2020","Oct 8, 2020",16th Feb: Added new publication and Fv sequence,Complete
TAU-2312,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV4-34 (Human),ND,IGLV1-36 (Human),ND,ARPLGYCSGRKCERKEMYY,ND,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 8, 2020","Oct 8, 2020",16th Feb: Added new publication,Contacting authors for sequence
TAU-2381,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV3-21 (Human),ND,IGLV4-60 (Human),ND,AREGTRYDYVWGSYRPWELDY,ND,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 8, 2020","Oct 8, 2020",16th Feb: Added new publication,Contacting authors for sequence
TAU-2383,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV3-66 (Human),ND,IGKV1-39 (Human),ND,ARTRVGSGWDAFDV,ND,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 8, 2020","Oct 8, 2020",16th Feb: Added new publication,Contacting authors for sequence
Ab_57B8,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Human Patient,EVLLVESGGGLIQPGGSLRLSCAASGLTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLVTWGLDYWGQGTLVTVSS,AIQLTQSPSSLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQLLNTDPITFGQGTRLEIK,IGHV3-53 (Human),IGHJ4 (Human),IGKV1-9 (Human),IGKJ5 (Human),ARDLVTWGLDY,QLLNTDPIT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Sep 7, 2020","Jan 30, 2021",30th Jan: Added sequence from patent,CQTS118 from patent. Complete
Ab_58D2,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGLVKPGGSLRLSCAASGFTFSDYYMIWIRQAPGKGLEWVSYISSSGATIYYADSVKGRFTISRDNAKNSLYLQMTSLRAEDTAVYYCASPLLSHNYGSGSYYNVYWYFELWGRGTLVSVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIFDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQLGTFGQGTKLEIK,IGHV3-11 (Human),IGHJ2 (Human),IGKV3-11 (Human),IGKJ2 (Human),ASPLLSHNYGSGSYYNVYWYFEL,QQLGT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Sep 7, 2020","Jan 30, 2021",30th Jan: Added sequence from patent,CQTS129 from patent. Complete
Ab_511E7,Ab,SARS-CoV2 (weak),,,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVQSGAEVKKPGESLKISCKGSGYSFTSYWIGWVRQMPGKGLEWMGIIYPGDSDTRYRPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCALAVGRGIPTSYFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITKQASQDISNYLNWYQQKPGKAPKLLIYDASNLQTGVPSRFSGSGSGTDFTFTISSLQPEDIATFYCQQYHNLPITFGPGTKVDIK,IGHV5-51 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ3 (Human),ALAVGRGIPTSYFDY,QQYHNLPIT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Sep 7, 2020","Jan 30, 2021",30th Jan: Added sequence from patent,CQTS168 from patent. Complete
Ab_57C4,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVKPGGSLRLSCAASGFSFSNAWMSWVRQAPGKGLEWVGRIKFTTDGGTSDYAAPVRGRFTISRDDSKNTLYLQMNSLRTEDTAVYYCSTTNDYGDYSANYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISRYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPLTFGGGTKVEIK,IGHV3-15 (Human),IGHJ5 (Human),IGKV1-39 (Human),IGKJ4 (Human),STTNDYGDYSANY,QQSYSTPLT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Sep 7, 2020","Jan 30, 2021",30th Jan: Added sequence from patent,CQTS114 from patent. Complete
Ab_51D3,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGITVSSNYMNWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTIARDNSKNTLYLQMNSLRAEDTAVYYCAREGLLVGPTGRGLGMDVWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDINNYLNWYQQKPGKAPKLLIYDASNLQTGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYADLPYTFGQGTKLQIK,IGHV3-66 (Human),IGHJ6 (Human),IGKV1-33 (Human),IGKJ2 (Human),AREGLLVGPTGRGLGMDV,QQYADLPYT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Sep 7, 2020","Jan 30, 2021",30th Jan: Added sequence from patent,CQTS047 from patent. Complete
Ab_57F7,Ab,SARS-CoV2 (weak),,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQQWGAGLLKPSETLSLTCAVHGGSFSGYLWTWIRLPPGKGLEWLGEINQSGNTNYNSSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARDDSSSSGVGTGMDVWGQGTTVTVSS,QSVLTQPPSASGTPGQRVTISCSGSSSNIGINTVNWYQQFPGTAPKLLIYSNNQRPSGVPDRFSGSKSGTSASLAISGLQSEDEADYYCAVWDDSLNGWVFGGGTKLTVL,IGHV4-34 (Human),IGHJ6 (Human),IGLV1-44 (Human),IGLJ3 (Human),ARDDSSSSGVGTGMDV,AVWDDSLNGWV,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Sep 7, 2020","Jan 30, 2021",30th Jan: Added sequence from patent,CQTS122 from patent. Complete
Ab_58G6,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QMQLVQSGPEVKKPGTSVKVSCKASGFTFSSSAVQWVRQARGQHLEWIGWIVVGSGNTNYAQKFQERVTLTRDMSTRTAYMELSSLRSEDTAVYYCAAPNCNSTTCHDGFDIWGQGTVVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVRSSYLGWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLESEDFAVYYCQQYDNSPWTFGQGTKVEIK,IGHV1-58 (Human),IGHJ3 (Human),IGKV3-20 (Human),IGKJ1 (Human),AAPNCNSTTCHDGFDI,QQYDNSPWT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Sep 7, 2020","Jan 30, 2021",30th Jan: Added sequence from patent,CQTS126 from patent. Complete
Ab_57A8,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLLESGGGLVQPGGSLRLSCAASRFTFSNYAMTWVRQAPGKGLEWVSAISGSAGSIYYADSVKGRFTISRDNSKNTLYLQMNSLRADDTAVYFCAKGQRGSPDFFDYWGQGTLVTVSS,DIQMTQSPSTLSASVGDRVTITCRASQSISSWLAWYQQKPGKAPKLLIYDSSSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNSYSPLTFGGGTKVEIK,IGHV3-23 (Human),IGHJ4 (Human),IGKV1-5 (Human),IGKJ4 (Human),AKGQRGSPDFFDY,QQYNSYSPLT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Sep 7, 2020","Jan 30, 2021",30th Jan: Added sequence from patent,CQTS117 from patent. Complete
Ab_511E9,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYGISWVRQAPGQGLEWMGWISAYNGNTNYAQNLQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCAREGAGLIIAYDYWGQGTLVTVSS,EIVLTQSPDFQSVTPKEKVTITCRASQSIASSLHWYQQKPDQSPKLLIKYASQSFSGVPSRFSGSGSGTDFTLTINSLEPEDAATYYCHQSSSLPYTFGQGTKLEIK,IGHV1-18 (Human),IGHJ4 (Human),IGKV6-21 (Human),IGKJ2 (Human),AREGAGLIIAYDY,HQSSSLPYT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Sep 7, 2020","Jan 30, 2021",30th Jan: Added sequence from patent,CQTS170 from patent. Complete
Ab_511H7,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSAISGSGSSTYYADSVKGRFTISRDTSKNTLYLQMNSLRAEDTAVYYCARGLQYYYDTSGYYKDSYYYGVDVWGQGTTVTVSS,QSVLTQPPSASGTPGQRVTISCSGSSSNIGSNYVYWYQQLPGTAPKLLIYRNNQRPSGVSDRFSGSKSGTSASLAISGLRSEDEADYYCAAWDDSLSGPVFGGGTKLTVL,IGHV3-23 (Human),IGHJ6 (Human),IGLV1-47 (Human),IGLJ3 (Human),ARGLQYYYDTSGYYKDSYYYGVDV,AAWDDSLSGPV,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Sep 7, 2020","Jan 30, 2021",30th Jan: Added sequence from patent,CQTS164 from patent. Complet.e
Ab_55A8,Ab,SARS-CoV2 (weak),,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYDFIWVRQAPGQGLEWMGRIIPILGIANYAQKFQGRVTITADKSTTTAYMELSSLRSEDTAVYYCARGTEYGDYDVSHDWGQGTLVTVSS,DIQMTQSPSTLSASVGDRVTITCRASQSISSWLAWYQQKPGKAPKLLIYKASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNSYSHTFGQGTKLEIK,IGHV1-69 (Human),IGHJ4 (Human),IGKV1-5 (Human),IGKJ2 (Human),ARGTEYGDYDVSHD,QQYNSYSHT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Sep 7, 2020","Jan 30, 2021",30th Jan: Added sequence from patent,CQTS093 from patent. Complete
Ab_82B6,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSETLSLTCTVSGGSVSSGIYYWSWIRQPPGKGLEWIGYVFYSGSTNYNPSLKSRVTISVDTSKNQFSLKLRSVTAADTAVYYCAMTYYDYIWGRVDPQFDPWGQGTLVTVSS,DVVMTQSPLSLPVTLGQPASISCRSSQSLVYSDGNTYLNWFQQRPGQSPRRLIYKVSNRDSGVPDRFSGSGSGTDFTLKISRVEAEDVGGVYYCMQGTHWPPTFGQGTKVEIK,IGHV4-61 (Human),IGHJ5 (Human),IGKV2-30 (Human),IGKJ1 (Human),AMTYYDYIWGRVDPQFDP,CMQGTHWPPT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Sep 7, 2020","Jan 30, 2021",30th Jan: Added sequence from patent,CQTS031 from patent. Complete
Ab_82F6,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSRYGLHWVRQAPGKGLEWVGVILYDGSDEHYADSVKGRFTISRDNSKNTLDLQMNSLRPEDTAVYYCAKQASPYCSGGSCYSGNFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQANQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQHDNVPLTFGGGTKVEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ4 (Human),AKQASPYCSGGSCYSGNFDY,QQHDNVPLT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Sep 7, 2020","Jan 30, 2021",30th Jan: Added sequence from patent,CQTS033 from patent. Complete
Ab_52C6,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGIIPIFGTANYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYCATDGGGGSYYYAHYYYGMDVWGQGTTVTVSS,QTVVTQEPSFSVSPGGTVTLTCGLSSGSVPTSYFPSWYQQTPGQAPRTLIYGTNTRSSGVPDRFSGSILGNKAALTITGAQADDESDYYCVLYMGSGIVVFGGGTKLTVL,IGHV1-69 (Human),IGHJ6 (Human),IGLV8-61 (Human),IGLJ2 (Human),ATDGGGGSYYYAHYYYGMDV,VLYMGSGIVV,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Sep 7, 2020","Jan 30, 2021",30th Jan: Added sequence from patent,CQTS063 from patent. Complete
Ab_52F7,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGRSLRLSCAASGFTFDVYAMHWVRQAPGKGLEWVSGISWHSGNIGYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAFYFCAKDIGVMVPGVTPYGMDVWGQGTTVTVSS,DVVMTQSPLSLPVTLGQPASISCRSSQSLVYSDGDSYLNWFQQRPGQSPRRLIYKVSNWDSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQGTHWPPGTFGQGTKLEIK,IGHV3-9 (Human),IGHJ6 (Human),IGKV2D-30 (Human),IGKJ2 (Human),AKDIGVMVPGVTPYGMDV,MQGTHWPPGT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Sep 7, 2020","Jan 30, 2021",30th Jan: Added sequence from patent,CQTS066 from patent. Complete
Ab_511H11,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV3-33 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ1 (Human),VRGDHSSGWYGTYYYYMDV,QQSYSSPPWT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Sep 7, 2020","Sep 7, 2020",N/A,Tracking for full VH/VL sequences
Ab_53H3,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGITVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARYYGPQGRAFDIWGQGTMVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDISNFLNWYQQKPGKAPKLLIYAASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPLTFGPGTKVDIK,IGHV3-66 (Human),IGHJ3 (Human),IGKV1-33 (Human),IGKJ3 (Human),ARYYGPQGRAFDI,QQYDNLPLT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Sep 7, 2020","Jan 30, 2021",30th Jan: Added sequence from patent,CQTS073 from patent. Complete
Ab_51A1,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGLIVSRNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLNIAGGFDIWGQGTMVTVSS,DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQHLNIDPITFGQGTRLEIK,IGHV3-66 (Human),IGHJ3 (Human),IGKV1-9 (Human),IGKJ5 (Human),ARDLNIAGGFDI,QHLNIDPIT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Sep 7, 2020","Jan 30, 2021",30th Jan: Added sequence from patent,CQTS050 from patent. Complete
Ab_81C7,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,QITLKESGPTLVKPTQTLTLTCYFSGFSLSTSGVSVGWIRQPPGKALEWLALIYWDDDKRYNPSLKSRLTITKDTSKNQVVLTMTNMDPVDTATYYCAHSMVRGVLFGADFDYWGQGTLVAVSS,QSVLTQPPSVSEAPRQRVTISCSGSSSNIGHNAVNWYQQIPGKAPKLLIYYDDLVPSGVSDRFSGSKSGTSASLAISGLQSEDEAEYYCAAWDDSLNGPVFGGGTKLTVL,IGHV2-5 (Human),IGHJ4 (Human),IGLV1-36 (Human),IGLJ3 (Human),AHSMVRGVLFGADFDY,AAWDDSLNGPV,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Sep 7, 2020","Jan 30, 2021",30th Jan: Added sequence from patent,CQTS045 from patent. Complete
Ab_51E10,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYIFSSYGISWVRQAPGQGLEWMGWISADNGNTNYAQKLQGRVTMTTDTSSSTAYMDLRSLRSDDTAVYYCARARQLVLNWYFDLWGRGTLVTVSS,DIVMTQSPDSLAVSLGERATINCKSSQSVLNSSNNKNYLAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYITPQLTFGGGTKVEIK,IGHV1-18 (Human),IGHJ2 (Human),IGKV4-1 (Human),IGKJ4 (Human),ARARQLVLNWYFDL,QQYYITPQLT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Sep 7, 2020","Jan 30, 2021",30th Jan: Added sequence from patent,CQTS054 from patent. Complete
Ab_51D2,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QITLKESGPTLVKPTQTLTLTCTFSGFSLSTSAVGVGWIRQPPGKALEWLALIYWNDDKRYSPSLKNRLTITKDPSKNQVVLTMTNMDPVDTATYYCAHRLAPDYDFLTGYYNGDDAFDVWGPGTMVTISS,DIQMTQSPSSLPASVGDRVTITCRASQSISIYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISNLQPEDFATYYCQQSYNTLALSFGGGTKVEIK,IGHV2-5 (Human),IGHJ3 (Human),IGKV1-39 (Human),IGKJ4 (Human),AHRLAPDYDFLTGYYNGDDAFDV,QQSYNTLALS,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Sep 7, 2020","Jan 30, 2021",30th Jan: Added sequence from patent,CQTS049 from patent. Complete
Ab_53F9,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGIIVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRHNSKNTLYLQMNSLRAEDTAVYYCAREGLVGTTLTFDYWGQGSLVTVSS,DVVMTQSPLSLPVTLGQPASISCRSSQSLVYSDGDSYLNWFQQRPGQSPRRLIYKVSNWDSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQGTHWPPGTFGQGTKLEIK,IGHV3-53 (Human),IGHJ4 (Human),IGKV2D-30 (Human),IGKJ2 (Human),AREGLVGTTLTFDY,MQGTHWPPGT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Sep 7, 2020","Jan 30, 2021",30th Jan: Added sequence from patent,CQTS072 from patent. Complete
Ab_51D4,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Human Patient,QVTLRESGPALVKPTQTLTLTCTFSGFSLSTSGMCVTWIRQPPGKALEWLARVDWDDDKYYSTSLQTRLTISKDTSKNQVVLTMTNMDPVDTATYYCARMVVRGVMLDYWGQGILVTVSS,DIQMTQSPSSLSASVGDRVTITCRTSQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSPPHSFGQGTKVEIK,IGHV2-70 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ2 (Human),ARMVVRGVMLDY,QQSYSPPHS,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Sep 7, 2020","Jan 30, 2021",30th Jan: Added sequence from patent,CQTS046 from patent. Complete
Ab_57E11,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYDINWVRQATGQGLEWMGWMNPKSVYTGYAQKFQGRVTMTRNTSIRTAYMELSSLRSEDTAVYYCARGLWFGDLTRTKYNWFDPWGQGTLVTVSS,RSVLTQPPSASGTPGQRVTISCSGSSSNIGSNTVNWYQQLPGTAPKLLIYNNNQRPSGVPDRFSGSKSGTSASLAISGLQSEDEADYSCAAWDDSLNGWVGFFFTKLTVL,IGHV1-8 (Human),IGHJ5 (Human),IGLV1-44 (Human),IGLJ3 (Human),ARGLWFGDLTRTKYNWFDP,AAWDDSLNGWV,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Sep 7, 2020","Jan 30, 2021",30th Jan: Added sequence from patent,CQTS125 from patent. Complete
Ab_511A1,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSQTLSLTCTVSGGSISSGGYYWSWIRQHPGKGLEWIGYIYYSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCAREKIRSIAAAGTVYYYGMDVWGQGTTVTVSS,EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTHTISSLQSEDFAVYYCQQYNNWPPWTFGQGTKVEIK,IGHV4-31 (Human),IGHJ6 (Human),IGKV3-15 (Human),IGKJ1 (Human),AREKIRSIAAAGTVYYYGMDV,QQYNNWPPWT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Sep 7, 2020","Jan 30, 2021",30th Jan: Added sequence from patent,CQTS166 from patent. Complete
Ab_53F12,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRISCAASGFTVSSNYMSWVRQAPGKGLEWVSLIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNTLRVEDTAVYYCARDAVGSYYYGMEVWGQGTTVTVSS,EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQHYNNWPLYTFGQGTKLEIK,IGHV3-66 (Human),IGHJ6 (Human),IGKV3-15 (Human),IGKJ2 (Human),ARDAVGSYYYGMEV,QHYNNWPLYT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Sep 7, 2020","Jan 30, 2021",30th Jan: Added sequence from patent,CQTS081 from patent. Complete
Ab_51E7,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFSNYDMHWVRQGTGKGLEWVSAIGTAGDTYYPGSVKGRFTISRENAKNSLYLQMNSLRAGDTALYYCARVGYYGSGSYPLYWYFDLWGRGTLVTVSS,DIQMTPSPSSLSASVGDRVTITCRASQSISIYLNWYQQKPGKAPKLLIYAASNLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYFCQQSYSAPPWYFGQGTRVEIR,IGHV3-13 (Human),IGHJ2 (Human),IGKV1-39 (Human),IGKJ1 (Human),ARVGYYGSGSYPLYWYFDL,QQSYSAPPWT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Sep 7, 2020","Jan 30, 2021",30th Jan: Added sequence from patent,CQTS055 from patent. Complete
Ab_59A2,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,DVQLVESGGGLVQPGGSLRLSCAASEFIVSSNYMSWVRQAPGRGLEWISVIYSGGSTFYADSVKGRFTISRDSSKNTLYLQMNSLRAEDTAVYYCARDLPLHGDYFDYWGQGTLVTVSS,QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWYQQLPGTAPKVLIYGNSNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSSLSVVVFGGGTKLTVL,IGHV3-66 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ3 (Human),ARDLPLHGDYFDY,QQSDNVPVT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Sep 7, 2020","Jan 30, 2021",30th Jan: Added sequence from patent,CQTS136 from patent. Complete
Ab_511B4,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSETLSLTCTVSGASISSYFWSWIRQPPGKGLDWIGYIYYNGSTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYFCASTYWDSSGYYYGVDYWGHGTLVTVSS,DIQMTQSPSSVSASVGDRVTITCRASQGISSWLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTHFTLTISSLQPEDFATYYCQQANSFRLTFGGGTKVEIK,IGHV4-59 (Human),IGHJ5 (Human),IGKV1D-12 (Human),IGKJ4 (Human),ASTYWDSSGYYYGVDY,QQANSFRLT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Sep 7, 2020","Jan 30, 2021",30th Jan: Added sequence from patent,CQTS167 from patent. Complete
Ab_81C8,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVIWYDGSGKHYADSVKGQFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDGVDFGMVTLFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSITSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYNTPPWTFGQGTKVEIK,IGHV3-33 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ1 (Human),ARDGVDFGMVTLFDY,QQSYNTPPWT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Sep 7, 2020","Jan 30, 2021",30th Jan: Added sequence from patent,CQTS025 from patent. Complete
Ab_81E1,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Human Patient,RVQLTQSGAEVKKPGASVRVSCRVSGYSLAESPMHWVRQAPGKGLEWVGGLDPEDGEIINAQKFEGRVTMTEDRSSDTAYMELTSLTSEDTAVYFCAITSVARGLRGYFDTWGQGTLVIVSS,QSVLTQPPSASGTLGQRVNFSCSGSSSNLGNNFVYWYQQLPGTAPKLLSYLNSRRPSGVPDRFSGSKSGTSASLDISGLRSEDEAEYYCAAWDDSLSRVVFGGGTKLTVL,IGHV1-24 (Human),IGHJ4 (Human),IGLV1-47 (Human),IGLJ2 (Human),AITSVARGLRGYFDT,AAWDDSLSRVV,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Sep 7, 2020","Jan 30, 2021",30th Jan: Added sequence from patent,CQTS040 from patent. Complete
Ab_81C3,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Human Patient,QLHLQESGPGLVKPSETLSLTCTVSGGSVSSSSYYWGWIRQPPGKGLEWIGSIYYTGSTSYNPSLKSRITISVDTSKNQFSLKLSSVTAADTAVFYCARHPRFSWRGNDSGYFDYWGQGTLVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVTERPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSFTSSSTPYVFGTGTKVTVL,IGHV4-39 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ1 (Human),ARHPRFSWRGNDSGYFDY,SSFTSSSTPYV,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Sep 7, 2020","Jan 30, 2021",30th Jan: Added sequence from patent,CQTS044 from patent. Complete
Ab_59D6,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV4-34 (Human),IGHJ4 (Human),IGLV1-40 (Human),IGLJ2 (Human),ARHRRDYITMIVRPTRLWAFDY,QSYDSALVV,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Sep 7, 2020","Sep 7, 2020",N/A,Tracking for full VH/VL sequences
Ab_51D7,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVQSGAEVKKPGESLKISCQGSGFSFSNYWIGWVRQMPGKGLEWMGIIYPDDSDTRYSPSFQGQVTISADKSISTAFLQWSSLKASDTAMYYCATRTGWTNDAFDIWGQGTMVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSSLNWYHQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPCTFGQGTKLEIK,IGHV5-51 (Human),IGHJ3 (Human),IGKV1-39 (Human),IGKJ2 (Human),ATRTGWTNDAFDI,QQSYSTPCT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Sep 7, 2020","Jan 30, 2021",30th Jan: Added sequence from patent,CQTS056 from patent. Complete
Ab_81E10,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,RILLTQSGAEVKKPGASAKVSCKVSGYSLSESPMHWVRQAPGKGLEWMGGFDPEDGEIINVQKFKGRVTMTEDTSSDTAYMELTSLTSEDTAVYFCAITSLARGLKGYFDSWGQGTLLIVSS,QSVLTQPPSASGTPGQRVNISCSGSSSNLGNNFVYWYQQLPGTAPKLLSYLDSRRPSGVPDRFSGSKSGTSASLDISGLRSEDEADYYCAAWDDSLSGVIFGGGTKLTVL,IGHV1-24 (Human),IGHJ4 (Human),IGLV1-47 (Human),IGLJ2 (Human),AITSLARGLKGYFDS,AAWDDSLSGVI,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Sep 7, 2020","Jan 30, 2021",30th Jan: Added sequence from patent,CQTS042 from patent. Complete
Ab_56H3,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSNNTLYLQMNSLRAEDTAVYYCARDYGDYYFDYWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSTYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPRTFGQGTKVEIK,IGHV3-66 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ1 (Human),ARDYGDYYFDY,QQYGSSPRT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Sep 7, 2020","Jan 30, 2021",30th Jan: Added sequence from patent,CQTS100 from patent. Complete
Ab_51A3,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYGIIWVRQAPGQGLEWMGWISAYNGNTNYAQKLQGRVTMTIDTSTSTAYMELRSLRSDDTAVYYCARDLAWFGELSESPIEYWGQGTLVTVSS,EIVLTQSPATLSLSPGDRATLSCRASQSVSRYLGWYQQKPGQAPRVLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRGNSITFGQGTRLEIK,IGHV1-18 (Human),IGHJ4 (Human),IGKV3-11 (Human),IGKJ5 (Human),ARDLAWFGELSESPIEY,QQRGNSIT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Sep 7, 2020","Jan 30, 2021",30th Jan: Added sequence from patent,CQTS048 from patent. Complete
Ab_52C1,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTVISNYMSWVRQAPGKGLEWVSVIYRGGSTYFADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARLASDGSGSYLDYFDYWGQGTLVTVSS,QSVLTQPPSVSGAPGQRVTISCTGSSSNIGADYDVHWYQQFPGTAPKLLIYGNSNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSSLSGSWVFGGGTKLTVL,IGHV3-66 (Human),IGHJ4 (Human),IGLV1-40 (Human),IGLJ3 (Human),ARLASDGSGSYLDYFDY,QSYDSSLSGSWV,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Sep 7, 2020","Jan 30, 2021",30th Jan: Added sequence from patent,CQTS061 from patent. Complete
Ab_52G9,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSNNTLYLQMNSLRAEDTAVYYCARDPMRPGMDVWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFIFTISSLQPEDIATYYCQQYDNLPRTFGQGTKVEIK,IGHV3-66 (Human),IGHJ6 (Human),IGKV1-33 (Human),IGKJ1 (Human),ARDPMRPGMDV,QQYDNLPRT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Sep 7, 2020","Jan 30, 2021",30th Jan: Added sequence from patent,CQTS069 from patent. Complete
Ab_81A11,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYSISWVRQAPGQGLEWMGRIIPILGVADDAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCAREAGTTDWYFDLWGRGTLVTVSS,QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWYQQLPGTAPKLLIYDNTNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSSLSVVVFGGGTKLTVL,IGHV1-69 (Human),IGHJ2 (Human),IGLV1-40 (Human),IGLJ2 (Human),AREAGTTDWYFDL,QSYDSSLSVVV,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Sep 7, 2020","Jan 30, 2021",30th Jan: Added sequence from patent,CQTS043 from patent. Complete
Ab_82C6,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,QLQLQESGPGLVKPSETLSLTCTVSGGSISSNTFYWGWIRQPPGKGLEWIGSIHYTGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARFITDGYSSGSDSWGQGTLVTVSS,DVVMTQSPVSLPVTLGQPASISCRSSQSLVHSDGNTYLNWFQQRPGQSPRRLIYKVSYRHSGVPDRFSGSGSGTDFTLEISRVEAEDVGVYYCMQGTHWPMYTFGQGTKVEIK,IGHV4-39 (Human),IGHJ4 (Human),IGKV2-30 (Human),IGKJ2 (Human),ARFITDGYSSGSDS,MQGTHWPMYT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Sep 7, 2020","Jan 30, 2021",30th Jan: Added sequence from patent,CQTS032 from patent. Complete
Ab_58G1,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLIQPGGSLRLSCAASGLIVSRNYMNWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLENGGLDVWGQGTTVTVFS,DIQMTQSPSSVSASVGDRVTITCRASQQISKWVAWYQQKPGKAPKILIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQTNSFPTFGGGTKVEIK,IGHV3-53 (Human),IGHJ6 (Human),IGKV1D-12 (Human),IGKJ4 (Human),ARDLENGGLDV,QQTNSFPT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Sep 7, 2020","Jan 30, 2021",30th Jan: Added sequence from patent,CQTS131 from patent. Complete
Ab_510D7,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV1-69 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ2 (Human),ATGRYTYGYGYYFDY,QQYGSSRT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Sep 7, 2020","Jan 30, 2021",30th Jan: Amalgamated with Ab_51F11,CQTS053 from patent. Complete
Ab_510H2,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGDLVQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDKWEGTFDYWGQGTLVTVSS,DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPRMTFGGGTKVEIK,IGHV3-66 (Human),IGHJ4 (Human),IGKV1-9 (Human),IGKJ4 (Human),ARDKWEGTFDY,QQLNSYPRMT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Sep 7, 2020","Jan 30, 2021",30th Jan: Added sequence from patent,CQTS143 from patent. Complete
Ab_510A4,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Human Patient,QVTLRESGPALVKPTQTLTLTCTFSGFSLSTSGMCVSWIRQPPGKALQWLARIDWDDDKYYSTSLKTRLTISKDTSKNQVVLTVTNVDPVDTGTYYCARVQVAAAGSPYDYWGQGTLVTVSS,DIVMTQSPLSLPVTPGEPASISCRSSQSLLHSNGHNYLDWYLQKPGQSPQLLIYLGSNRAPGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQALQMGTFGQGTKVEIK,IGHV2-70 (Human),IGHJ4 (Human),IGKV2-28 (Human),IGKJ1 (Human),ARVQVAAAGSPYDY,MQALQMGT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Sep 7, 2020","Jan 30, 2021",30th Jan: Added sequence from patent,CQTS144 from patent. Complete
Ab_510H4,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSIIFSGGTTYYADSVKGRFTISRDNSRNTLYLQMSSLRAEDTAVYYCAETGWDGMDVWGQGTTVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPGTFGQGTKVEIK,IGHV3-66 (Human),IGHJ6 (Human),IGKV3-11 (Human),IGKJ1 (Human),AETGWDGMDV,QQRSNWPGT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Sep 7, 2020","Jan 30, 2021",30th Jan: Added sequence from patent,CQTS146 from patent. Complete
Ab_510G4,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSQTLSLTCTVSGGSISSGGYYWSWIRQHPGKGLDWIGYIYYSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARDYGGNSNYFHYWGQGTLVTVSP,DIQMTQSPSSLSASVGDRVTITCQASQDISKYLSWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGADFTFTISSLQPEDIATYYCQQYDTLPLTFGGGTKVEIK,IGHV4-31 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ4 (Human),ARDYGGNSNYFHY,QQYDTLPLT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Sep 7, 2020","Jan 30, 2021",30th Jan: Added sequence from patent,CQTS145 from patent. Complete
Ab_58A4,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSETLSLTCTVSGGSIITYYWSWIRQPPGKGLEWIGYIDYSGSTNYNPSLKSRVTISVDTSKNQFSLELSSVTAADTAVYYCARTLGAYYDILTGFRTPGGWFAPWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRAGQSVSSSYLAWYQQKPGQAPRVLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK,IGHV4-59 (Human),IGHJ5 (Human),IGKV3-20 (Human),IGKJ1 (Human),ARTLGAYYDILTGFRTPGGWFAP,QQYGSSPWT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Sep 7, 2020","Jan 30, 2021",30th Jan: Added sequence from patent,CQTS128 from patent. Complete
Ab_510A5,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGRSLRLSCAASGFTFDDYAMHWVRQAPGKGLEWVSGISWNSDSIDYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTALYYCAKDRGYEILTPASFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWFQHKPGKAPKLLIYGASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPPYTFGQGTKLEIK,IGHV3-9 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ2 (Human),AKDRGYEILTPASFDY,QQSYSTPPYT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Sep 7, 2020","Jan 30, 2021",30th Jan: Added sequence from patent,CQTS147 from patent. Complete
Ab_57A9,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQIVQSGAEVKKPGASVKVSCKASGYTFTSYAIHWVRQAPGQRLEWMGWINTGNGNTKYSQNFQDRVTITRDTSATTAYMELSSLTPEDTAVYYCARAGWELNYWGQGTLVTVSS,DIVMTQSPDSLAVSLGERATINCKSSQSVLYSSNNKNYLAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYSFWAFGQGTKVEIK,IGHV1-3 (Human),IGHJ4 (Human),IGKV4-1 (Human),IGKJ1 (Human),ARAGWELNY,QQYYSFWA,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Sep 7, 2020","Jan 30, 2021",30th Jan: Added sequence from patent,CQTS119 from patent. Complete
Ab_55C9,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGITVSSNYMNWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTVSRHNSKNTLYLQMNSLRVEDTAVYYCAREGLVGTALAFDYWGQGNLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSINNYLNWYQQKPGKAPNLLIYAASSLQSGVPSRFSGSGSGTDFTLTINSLQPEDFATYYCQQSYSTPPYTFGQGTKLEIK,IGHV3-53 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ2 (Human),AREGLVGTALAFDY,QQSYSTPPYT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Sep 7, 2020","Jan 30, 2021",30th Jan: Added sequence from patent,CQTS092 from patent. Complete
Ab_510H7,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV4-59 (Human),IGHJ5 (Human),IGKV1D-13 (Human),IGKJ4 (Human),ARHCPWQQLVSNWFDP,QQFNNFLLT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Sep 7, 2020","Sep 7, 2020",N/A,Tracking for full VH/VL sequences
Ab_56E1,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFSFSTYAMHWVRQAPGKGLVWVAFISYDESNKYYTDSVKGRFTVSRDNSKNAVYYCAGGGVLVTSDPDAFDIWGQGTMVTVSS,QSVLTQPPSASGTPGQRVTISCSGSSSNIGSNSVNWYQQLPGTAPKFFMYSNNQRPSGVPDRFSGSKSGTSASLAISGLQSEDEADYYCAAWDDSLNGWVFGGGTKLTVL,IGHV3-30 (Human),IGHJ3 (Human),IGLV1-44 (Human),IGLJ3 (Human),AGGGVLVTSDPDAFDI,AAWDDSLNGWV,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Sep 7, 2020","Jan 30, 2021",30th Jan: Added sequence from patent,CQTS109 from patent. Complete
Ab_56H11,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSETLSLTCTVSGGSISSFYWSWIRQPAGKGLEWIGRMSASGSTNYNPSLKSRVTMSVDTSENQISLKLGSVTAADTAVYYCAGEQHIVTTIIDYWGQGTLVTVSS,QSVLTQPLSASGTPGQRVTISCSGKSSNIGSNTVNWYQQLPGTAPKLLIYSNNQRPSGVPDRFSGSKSGTSASLAISGLQSEDEADYYCATWDDSLNGRVFGGGTKLTVL,IGHV4-4 (Human),IGHJ4 (Human),IGLV1-44 (Human),IGLJ3 (Human),AGEQHIVTTIIDY,ATWDDSLNGRV,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Sep 7, 2020","Jan 30, 2021",30th Jan: Added sequence from patent,CQTS112 from patent. Complete
Ab_56D7,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGVTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMSSLRAEDTAVYYCARDLDYYGMDVWGQGTTVTVSS,DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPPITFGQGTRLEIK,IGHV3-66 (Human),IGHJ6 (Human),IGKV1-9 (Human),IGKJ5 (Human),ARDLDYYGMDV,QQLNSYPPIT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Sep 7, 2020","Jan 30, 2021",30th Jan: Added sequence from patent,CQTS102 from patent. Complete
Ab_57A6,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVQSGAEVKKPGESLKISCKGSGYSFSTYWIGWVRQMPGKGLEWMGIIYPYDSDTRYSPSFQGQVTISADKSISTAYLQWSSLKASDTAIYYCARQESGWSFDYWGQGTLVTVSS,SSELTQDPAVSVALGQTVRITCQGDSLRSYYASWYQQKPGQAPVLVIYGKNNRPSGIPDRFSGSSSGNTASLTITGAQAEDEADYSCNSRDSSGNHWVFGGGTKLTVL,IGHV5-51 (Human),IGHJ4 (Human),IGLV3-19 (Human),IGLJ3 (Human),ARQESGWSFDY,NSRDSSGNHWV,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Sep 7, 2020","Jan 30, 2021",30th Jan: Added sequence from patent,CQTS121 from patent. Complete
Ab_57G9,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVTLRESGPALVKPTQTLTLTCTFSGFSLSTSGMCVSWIRQPPGKALEWLARIDWDDDKYYSTSLETRLTISKDTSKNQVVLTMTNMDPVDTATYYCARITPHLVYDYWSQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISRYLNWYQQKPGKAPKSLIYVASSLQSGVPSRFSGSGSGTNFTLTISSLQPEDFATYYCQQSYSIPRTFGQGTKLEIK,IGHV2-70 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ2 (Human),ARITPHLVYDY,QQSYSIPRT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Sep 7, 2020","Jan 30, 2021",30th Jan: Added sequence from patent,CQTS120 from patent. Complete
Ab_56C12,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGDVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRVEDTAVYYCAKDPTSLYCSGGSCYNNWFDPWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISRYLNWYQQKPGKAPNLLIYAAASLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQTYSTPRTFGQGTKVEIK,IGHV3-30 (Human),IGHJ5 (Human),IGKV1-39 (Human),IGKJ1 (Human),AKDPTSLYCSGGSCYNNWFDP,QQTYSTPRT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Sep 7, 2020","Jan 30, 2021",30th Jan: Added sequence from patent,CQTS111 from patent. Complete
Ab_511D11,Ab,SARS-CoV2(weak),,,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYGITWVRQAPGQGLEWMGWISVYNGNTHYAQKLQGRVTMTTGTSTSTAYMELRSLRSDDTAVYYCAVLDYCSGGSSSSGYYNYGMDVWGQGTTVTVSS,EIVLTQSPGTLSLSPGERTTLSCRASQSVRGSYLAWYQQKPGQAPRLLIYGASTRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGRSPYTFGQGTKLEIK,IGHV1-18 (Human),IGHJ6 (Human),IGKV3-20 (Human),IGKJ2 (Human),AVLDYCSGGSSSSGYYNYGMDV,QQYGRSPYT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Sep 7, 2020","Jan 30, 2021",30th Jan: Added sequence from patent,CQTS171 from patent. Complete
Ab_511A5,Ab,SARS-CoV2 (weak),,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVLLQESGPGLVKPSQTLSLTCTVSGGSISNGSYYWSWIRQHPGKGLEWIGYIYYSGSTYYNPSLRSRVTISLDTSMNQFSLKLSSVTAADTAVYYCARIYRGTMVVVFSDLHWYFDLWGRGTLVTVSS,SYVVTQPPSVSVAPGKTARITCGGNNIGSKSVHWYQQKPGQAPVLVMYYDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDSSADHYVFGTGTKVTVL,IGHV4-31 (Human),IGHJ2 (Human),IGLV3-21 (Human),IGLJ1 (Human),ARIYRGTMVVVFSDLHWYFDL,QVWDSSADHYV,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Sep 7, 2020","Jan 30, 2021",30th Jan: Added sequence from patent,CQTS159 from patent. Complete
Ab_53C10,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGVVQPGGSLRLSCAASGFTFDDYAMNWVRQAPGKGLEWVSLISGDGDSPSYSGSVKGRFTISRDNSKNSLYLQMISLRTEDTALYYCARESPKLTGYFDYWGQGTLVTVSS,SYVLTQPPSVSVAPGQTAGITCGGDDIGSKNVHWYQQKPGQAPVLVVYDDHDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDSSSDPYVFGTGTKVTVL,IGHV3-43 (Human),IGHJ4 (Human),IGLV3-21 (Human),IGLJ1 (Human),ARESPKLTGYFDY,QVWDSSSDPYV,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Sep 7, 2020","Jan 30, 2021",30th Jan: Added sequence from patent,CQTS077 from patent. Complete
Ab_511E5,Ab,SARS-CoV2 (weak),,,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYIFTGYYMHWVRQAPGQGLEWMGWINPNSGGTNYAQKFQGRVTMTRDTSINTAYMELSRLTSDDTAVYYCARDSLFSRVDWYFDLWGRGTLVTVSS,QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWYQQLPGTAPKLLIYDNTNRPSGIPDRFSGSSSGNTASLTITGAQAEDEADYYCNSRDSSGNTVVFGGGTKLTVL,IGHV1-2 (Human),IGHJ2 (Human),IGLV1-40 (Human),IGLJ2 (Human),ARDSLFSRVDWYFDL,NSRDSSGNTVV,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Sep 7, 2020","Jan 30, 2021",30th Jan: Added sequence from patent,CQTS160 from patent. Complete
Ab_53C5,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASAGTFSSYAVSWVRQAPGQGLEWMGRIIPIVSITKYAQKFQGRVTMTADKSTSTAYMELSSLRSEDTAVYYCARGRYTYGTEGYFDNWGQGTLVTVSS,DIQMTQSPSTLSASVGDRVTITCRASQSISTWLAWYQQKPGKAPKLLIYDASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYHCQQYNNLYTFGQGTKLEIK,IGHV1-69 (Human),IGHJ4 (Human),IGKV1-5 (Human),IGKJ2 (Human),ARGRYTYGTEGYFDN,QQYNNLYT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Sep 7, 2020","Jan 30, 2021",30th Jan: Added sequence from patent,CQTS071 from patent. Complete
Ab_81F2,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQQWGAGLLKPSETLSLTCAVYGRSFSGDSWSWIRQPPGKGLEWIGEIDHSGSTDYDPSLKSRVTISVDTSKDQFSLKLDSVTAADTAVYYCARGWTVPPLWVLNWFDPWGQGTLVTVSS,DIVMTQSPLSLPVTPGEPASISCRSSQSLLHSDGYDYLDWYLQKPGQSPQLVIYLGSDRASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQALQTPRTFGGGTKVEIK,IGHV4-34 (Human),IGHJ5 (Human),IGKV2-28 (Human),IGKJ4 (Human),ARGWTVPPLWVLNWFDP,MQALQTPRT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Sep 7, 2020","Jan 30, 2021",30th Jan: Added sequence from patent,"CQTS017 from patent. ""LNWFDP"" CDRH3 from paper SI. Complete"
Ab_510H10,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVTLRESGPALVKPTQTLTLTCTFSGFSLSTSGMCVSWIRQPPGKALEWLARIDWDDDKYYSTSLMTRLTISKDTSKNQVVLTMTNMDPVDTATYYCARIQRGIAADYWGQGILVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQTISSYLNWFQQKPGKAPKLLIYVASNLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPRTFGQGTKLEIK,IGHV2-70 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ2 (Human),ARIQRGIAADY,QQSYSTPRT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Sep 7, 2020","Jan 30, 2021",30th Jan: Added sequence from patent,CQTS152 from patent. Complete
Ab_511B11,Ab,SARS-CoV2 (weak),,,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYWMSWVRQAPGKGLEWVANIKQDASEKYYVDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCAGLFWYGGYFDYWGQGTLVTVSS,VLTQPPSVSGAPGQRVTISCYGSSSNIGAGAGYDVHWYQQFPGTAPKLLIYGNNNRPSGVPDRFSGSKSGTSASLTITGLQAEDEADYYCQSYDRSLSVLYVFGTGTKVTVL,IGHV3-7 (Human),IGHJ4 (Human),IGLV1-40 (Human),IGLJ1 (Human),AGLFWYGGYFDY,QSYDRSLSVLYV,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Sep 7, 2020","Jan 30, 2021",30th Jan: Added sequence from patent,CQTS165 from patent. Complete
Ab_511G7,Ab,SARS-CoV2 (weak),,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSTYGMHWVRQAPGKGLEWVTVIWYDGSNKYYADSVKGRFTISRDNSKNTVYLQMNSLRAEDTAVYYCAKGGNYGDYLRGFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKVLIYDASNLETGVPSRFSGSGSGTDFTFAISSLQPEDIATYYCQQYHNVPPAFGGGTKVEIK,IGHV3-33 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ4 (Human),AKGGNYGDYLRGFDY,QQYHNVPPA,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Sep 7, 2020","Jan 30, 2021",30th Jan: Added sequence from patent,CQTS169 from patent. Complete
Ab_511G5,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLIQSGAEVKKPGASVKVSCTTSGYTFTSYFLHWVRQAPGQGLEWMGIINPSDGTTTYAQKFQGRVTMTRDTSTGTVSMELSSLRYEDTAVYYCARDGALYSNSPTEFDYWGQGTLVTVSS,QSVLTQPPSASGTPGQRVTISCSGSNSNIGSNYVYWYQQLPGTAPKLLIYRNNQRPSGVPDRFSGSKSGTSASLAISGLRSEDEADYYCTTWDASRGGWVFGGGTKLTVL,IGHV1-46 (Human),IGHJ4 (Human),IGLV1-47 (Human),IGLJ3 (Human),ARDGALYSNSPTEFDY,TTWDASRGGWV,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Sep 7, 2020","Jan 30, 2021",30th Jan: Added sequence from patent,CQTS161 from patent. Complete
Ab_51E12,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTLSRYWMSWVRQAPGKGLEWVANIKQDGSEKKYVDSVKGRFTISRDNTKNSLYLQMNSLRAEDTAVYYCARLMYYYGNFDYWGQGTLVTVSS,AIRITQSPSSLSASTGDRVTITCRASQGISSYLAWYQQKPGKAPNLLIYAASTLQSGVPSRFSGSGSGTDFTLTISRLHSEDFATYYCQQYYGYPTFGQGTKLEIK,IGHV3-7 (Human),IGHJ4 (Human),IGKV1-8 (Human),IGKJ2 (Human),ARLMYYYGNFDY,QQYYGYPT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Sep 7, 2020","Jan 30, 2021",30th Jan: Added sequence from patent,CQTS051 from patent. Complete
CV05-163,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTGYYMHWVRQAPGQGLEWMGWINPNSGGTNYAQKFQGRVTMTRDTSISTAYMELSRLRSDDTAVYYCAREVMVRGALPPYGMDVWGQGTTVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPPVTFGGGTKVEIK,IGHV1-2 (Human),IGHJ6 (Human),IGKV3-11 (Human),IGKJ4 (Human),AREVMVRGALPPYGMDV,QQRSNWPPVT,https://www.rcsb.org/structure/7LOP,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Aug 27, 2020","Mar 11, 2021",11th Mar: Added 7LOP crystal structure,Complete
CV07-200,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGTEMKKPGASVKVSCKASGYTFTGYYMHWVRQAPGQGLEWMGWINPNSGGTNYAQKFQGRVTMTRDTSIRTVYMELSRLRSDDTAVYYCARGPFYYDNSGTLGGLDVWGQGTTVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYEVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSTYVFGTGTKVTVLGQPKANPTVTL,IGHV1-2 (Human),IGHJ6 (Human),IGLV2-14 (Human),IGLJ1 (Human),ARGPFYYDNSGTLGGLDV,SSYTSSSTYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CV07-200_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Aug 27, 2020","Aug 27, 2020",N/A,Complete
CV07-209,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGLVKPGGSLRLSCAASGFTFSDYYMSWIRQAPGKGLEWVSYISSSVSTIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARDGVIPPRFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPLTFGGGTKVEIK,IGHV3-11 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ4 (Human),ARDGVIPPRFDY,QQYDNLPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CV07-209_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Aug 27, 2020","Aug 27, 2020",N/A,Complete
CV07-222,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTDYYVHWVRQAPGQGLEWMGWINPISGGTNYAQKFQGRVTMTRDTSISTAYMELSRLRSDDTAVYYCARGPYYYDSSGSLGAFDIWGQGTMVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGSYNLVSWYQQHPGKAPKLMIYEGSKRPSGVSNRFSGSKSGNTASLTISGLQAEDEAHYYCCSYAGGSTSYVFGTGTKVTVL,IGHV1-2 (Human),IGHJ3 (Human),IGLV2-23 (Human),IGLJ1 (Human),ARGPYYYDSSGSLGAFDI,CSYAGGSTSYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CV07-222_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Aug 27, 2020","Aug 27, 2020",N/A,Complete
CV07-250,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSEAEVKEPGASVEVSCKASGYNFTNFAISWVRQAPGQGLEWMGWISGYNGDTNSAQKFLGRVTMTTDTSTTTAYMELRSLRSDDTAVYYCAGSDNYGFPYNGMDVWGQGTTVTVFN,QSALTQPPSASGSPGQSVTISCTGTSSDLGAYHFVTWYQHYPGKAPKVMIYGVRKRPSGVPDRFSGSKSGNTASLTVSGLQDEDEADYYCSSYAGNNDFVFGGGTKLTVL,IGHV1-18 (Human),IGHJ6 (Human),IGLV2-8 (Human),IGLJ3 (Human),AGSDNYGFPYNGMDV,SSYAGNNDFV,https://www.rcsb.org/structure/6XKQ,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Aug 27, 2020","Aug 27, 2020",N/A,Complete
CV07-255,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPEASVKVSCKASGYTFTGYYMHWVRQAPGQGLEWMGWINPNSGGTNYAQKFQGRVTMTRDTSISTVYMELSRLRSDDTAVYYCARDSRFSYVNGEFDYWGQGILVTVSS,QSALTQPASVSGSPGQSITISCTRTSSDVESYNLVSWYQQHPGKAPKLMIYEVSKRPSGISNRFSGSKSGNTASLTISGLQAEDEADYYCCSYAGHSTWVFGGGTELTVLGQPKAAPSVTL,IGHV1-2 (Human),IGHJ4 (Human),IGLV2-23 (Human),IGLJ3 (Human),ARDSRFSYVNGEFDY,CSYAGHSTWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CV07-255_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Aug 27, 2020","Aug 27, 2020",N/A,Complete
CV07-262,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTGYYMHWVRQAPGQGLEWMGWINPNSGGTNYAQTFQGRVTMTRDTSITTTYMELSRLRSDDTAVYYCARVGWYDFGTPGDYYYYYGMDVWGQGTTVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGSYNLVSWYQQHPGKAPKLMIYEGSKRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYFCCSYAGTSTFVFGTGTKVTVLGQPKANPTVTL,IGHV1-2 (Human),IGHJ6 (Human),IGLV2-23 (Human),IGLJ1 (Human),ARVGWYDFGTPGDYYYYYGMDV,CSYAGTSTFV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CV07-262_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Aug 27, 2020","Aug 27, 2020",N/A,Complete
CV07-270,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGLVKPGGSLRLSCAASGFTFSDYYMTWIRQAPGKGLEWVSYISSSGSTIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARARGSSGWYRIGTRWGNWFDPWGQGTLVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYEVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSNVVFGGGTMLTVL,IGHV1-2 (Human),IGHJ6 (Human),IGLV2-14 (Human),IGLJ3 (Human),ARARGSSGWYRIGTRWGNWFDP,CSYAGSSSWV,https://www.rcsb.org/structure/6XKP,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Aug 27, 2020","Feb 18, 2021",18th Feb: Fixed CDRH3 annotation,Complete
CV07-283,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASAKVSCKASGYTFTGYYIHWVRQAPGQGLEWMGLINPISGGTNYAQKFQDRVTMTRDTSISTAYMELSRLRSDDTAVYYCVRGPFYYDSSGPLGGMDVWGQGTTVTVSS,QSALTQPASVSGSPGQSITISCTGTSGDVGGYNYVSWYQQHPGKAPKLMIYEVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSTYVFGTGTKVTVLGQPKANPTVTL,IGHV1-2 (Human),IGHJ6 (Human),IGLV2-14 (Human),IGLJ1 (Human),VRGPFYYDSSGPLGGMDV,SSYTSSSTYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CV07-283_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Aug 27, 2020","Aug 27, 2020",N/A,Complete
CV07-287,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGPEVKKPGTSVKVSCKASGFTFTSSAMQWVRQARGQRLEWIGWIVVGSGNTNYAQKFQERVTITRDMSTSTAYMELSSLRSEDTAVYYCAAPYCSSTNCYDAFDIWGQGTMVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK,IGHV1-58 (Human),IGHJ3 (Human),IGKV3-20 (Human),IGKJ1 (Human),AAPYCSSTNCYDAFDI,QQYGSSPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CV07-287_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Aug 27, 2020","Feb 2, 2021",2nd Feb: Corrected CDRL3 annotation,Complete
CV07-315,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGRSLRLSCAASGFTFDDYAMHWVRQAPGKGLEWVSGISWNSGSIGYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTALYYCAKDFLWDLHPPRYYGMDVWGQGTTVTVSS,QSVLTRPPSVSAAPGQKVTISCSGSSSNIGNNYVSWYQQLPGTAPKLLIYENNKRPSGIPDRFSGSKSGTSATLGITGLQTGDEADYYCGTWDSSLNGVFGGGTKLTVLGQPKAAPSVTL,IGHV3-9 (Human),IGHJ6 (Human),IGLV1-51 (Human),IGLJ3 (Human),AKDFLWDLHPPRYYGMDV,QQSYSTHA,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CV07-315_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Aug 27, 2020","Aug 27, 2020",N/A,Complete
CV38-113,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRHNSKNTLYLQMNSLRAEDTAVYFCARGGRLADAAGDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPSWTFGQGTKLEIK,IGHV3-53 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ1 (Human),ARGGRLADAAGDY,QQYDNLPSWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CV38-113_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Aug 27, 2020","Aug 27, 2020",N/A,Complete
CV38-139,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVFYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARGHYDLFDYWGQGTLVTVSS,DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPPGTFGPGTKVDIK,IGHV3-53 (Human),IGHJ4 (Human),IGKV1-9 (Human),IGKJ3 (Human),ARGHYDLFDY,QQLNSYPPGT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CV38-139_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Aug 27, 2020","Aug 27, 2020",N/A,Complete
CV38-142,Ab,"SARS-CoV1,SARS-CoV2",,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVQSGAEVKKPGESLKISCQGSGYSFTSYWIGWVRQMPGKGLEWMGIIYPGESDTRYSSSFQGHVTISADKSISTAYLQWSSLKASDTAMYYCARIRGVYSSGWIGGDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPRQWTFGQGTKVEIK,IGHV5-51 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ1 (Human),ARIRGVYSSGWIGGDY,QQSYSTPRQWT,https://www.rcsb.org/structure/7LM8;https://www.rcsb.org/structure/7LM9,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Aug 27, 2020","Apr 6, 2021","12th Feb: Added expected structures from new preprint. 6th April: Added structures 7lm8,7lm9.",Complete
CV38-183,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARGDGWDNYYYGMDVWGQGTTVTVSS,QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWYQHLPGTAPKLLIYANSNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSSLSGSVFGGGTKLTVLGQPKAAPSVTL,IGHV3-53 (Human),IGHJ6 (Human),IGLV1-40 (Human),IGLJ3 (Human),ARGDGWDNYYYGMDV,QSYDSSLSGSV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CV38-183_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Aug 27, 2020","Aug 27, 2020",N/A,Complete
CV38-221,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGITVSSNYMIWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARGFGDYYFDYWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYFAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQLYTFGQGTKLEIK,IGHV3-66 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ2 (Human),ARGFGDYYFDY,QQLYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CV38-221_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Aug 27, 2020","Aug 27, 2020",N/A,Complete
CV-X1-126,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGLTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRHNSKNTLYLQMNSVRAEDTAVYYCARDLSEGGMDVWGQGTTVTVSS,DIQMTQSPSSVSASVGDRVTITCRASQGISSWLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQANGFPPLFGGGTKVEIK,IGHV3-53 (Human),IGHJ6 (Human),IGKV1-12 (Human),IGKJ4 (Human),ARDLSEGGMDV,QQANGFPPL,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CV-X1-126_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Aug 27, 2020","Aug 27, 2020",N/A,Complete
CV-X2-106,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGIIPIFGTANYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYCATRKETTVTTSLVYGMDVWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSFLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSVTDFTLTISSLQPEDFATYYCQQSYSTPYTFGQGTKLEIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ2 (Human),ATRKETTVTTSLVYGMDV,QQSYSTPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CV-X2-106_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Aug 27, 2020","Aug 27, 2020",N/A,Complete
H014,Ab,"SARS-CoV1,SARS-CoV2",,"SARS-CoV1,SARS-CoV2",,S; RBD,Immunised Humanised (hACE2) Mouse,EVQLVQSGAEVKKPGATVKISCKVSGYSFSNYYIHWVKQAPGKSLEWIGYIDPFNGGTSDNLKFKGAATLTADTSTDTAYMELSSLRSEDTAVYYCARSEYDPYYVMDYWGQGTTVTVSS,IVLTQSPFQSVSPKEKVTITCRASQSISSNLHWYQQKPDQSPKLLIKYASQSISGIPSRFSGSGSGTDFTLTINSLEAEDFGIYFCQQTNFWPYIFGQGTKLEIL,IGHV1-69-2 (Mouse),IGHJ6 (Mouse),IGKV6-21 (Mouse),IGKJ2 (Mouse),ARSEYDPYYVMDY,QQTNFWPYI,"https://www.rcsb.org/structure/7CAI; https://www.rcsb.org/structure/7CAK; https://www.rcsb.org/structure/7CWN; https://www.rcsb.org/structure/7CAC; Expected (7cab, 7cah)",,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 27, 2020","Feb 28, 2021","1st Oct: Added PDB structures and Sequence info, 21st Dec: Added new structure (7cwn), 28th Feb: Added 7CAC",Complete
BD-236,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLIQPGGSLRLSCAASGITVSSNYMSWVRQAPGKGLEWVSVIYSGGSTDYADSVKGRFTISRDKSKNTLYLQMNSLRAEDTAVYYCARDLGEAGGMDVWGQGTTVTVSS,AIQLTQSPSSLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQLNSYPPAFGGGTKVEIK,IGHV3-53 (Human),IGHJ6 (Human),IGKV1-9 (Human),IGKJ4 (Human),ARDLGEAGGMDV,QQLNSYPPA,https://www.rcsb.org/structure/7CHB; https://www.rcsb.org/structure/7CHE,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Aug 2, 2020","Oct 1, 2020",Added PDB structures and LC info,Complete
BD-368-2,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLLESGGGVVQPGGSLRLSCAASGFAFTTYAMNWVRQAPGRGLEWVSAISDGGGSAYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKTRGRGLYDYVWGSKDYWGQGTLVTVSS,DIVMTQSPLSLPVTPGEPASISCRSSQSLLHSNGYNYLDWYLQKPGQSPQLLIYLGSNRASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQALQTPGTFGQGTRLEIK,IGHV3-23 (Human),IGHJ4 (Human),IGKV2-28 (Human),IGKJ5 (Human),AKTRGRGLYDYVWGSKDY,MQALQTPGT,https://www.rcsb.org/structure/7CHC;https://www.rcsb.org/structure/7CHF;https://www.rcsb.org/structure/7CHE;https://www.rcsb.org/structure/7CHH;https://www.rcsb.org/structure/7E8C;https://www.rcsb.org/structure/7E8F,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Aug 2, 2020","Jun 16, 2021",1st October '20: Added PDB structures and LC info; 16th June '21: Added new structures,Complete
BD-604,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLIQPGGSLRLSCAASGIIVSSNYMTWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMSSLRAEDTAVYYCARDLGPYGMDVWGQGTTVTVSS,DIQLTQSPSFLSASVGDRVTITCRASQGISSDLAWYQQKPGKAPNLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSDLYTFGQGTKLEIK,IGHV3-53 (Human),IGHJ6 (Human),IGKV1-9 (Human),IGKJ2 (Human),ARDLGPYGMDV,QQLNSDLYT,https://www.rcsb.org/structure/7CH4; https://www.rcsb.org/structure/7CHF; https://www.rcsb.org/structure/7E8C; https://www.rcsb.org/structure/7E8F,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Aug 2, 2020","Jun 16, 2021",1st October '20: Added PDB structures and LC info; 16th June '21: Added new structures,Complete
BD-629,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLIQPGGSLRLSCAASEFIVSRNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLNLQMNSLRAEDTAVYYCARDYGDYYFDYWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQGVSSFLAWYQQKPGQAPRLLIHGASSRATGIPDRFSGSGSGTDFTLTITRLEPEDFAVYYCQQYGSSPRTFGQGTKVEIK,IGHV3-53 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ1 (Human),ARDYGDYYFDY,QQYGSSPRT,https://www.rcsb.org/structure/7CH5; https://www.rcsb.org/structure/7CHC,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Aug 2, 2020","Oct 1, 2020",Added PDB structures and LC info,Complete
COV2-2997,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYYMHWVRQAPGQGLEWMGIINPGGGSTTYAQKFQGRVTMTSDTSTSTVYMELSSLRSEDTAMYYCARGAIPPNSRAEIDYWGQGTLVTVSS,EIVMTQSPATLSVSPGERVTLSCRASQSVSSNLAWCQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYYNWPLTFGGGTKVEIK,IGHV1-46 (Human),IGHJ4 (Human),IGKV3-15 (Human),IGKJ4 (Human),ARGAIPPNSRAEIDY,QQYYNWPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2997_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-3012,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYDLHWVRQGTGKRLEWVSAIGTAGDTYYLGSVKGRFTISRENAKNSLYLQMNSLRAGDTAVYYCARVLYDSSGFYNWFDPWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYEIPPWTFGQGTKVEIK,IGHV3-13 (Human),IGHJ5 (Human),IGKV1-39 (Human),IGKJ1 (Human),ARVLYDSSGFYNWFDP,QQSYEIPPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-3012_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2961,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QMQLVQSGPEVKKPGTSVKVSCKASGFTFMSSAVQWVRQARGQRLEWIGWIVIGSGNTNYAQKFQERVTITRDMSTSTAYMELSSLRSEDTAVYYCAAPYCSSISCNDGFDIWGQGTMVTVSS,ETVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQHYGSSRGWTFGQGTKVEIK,IGHV1-58 (Human),IGHJ3 (Human),IGKV3-20 (Human),IGKJ1 (Human),AAPYCSSISCNDGFDI,QHYGSSRGWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2961_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-3025,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVQSGPEVKKPGTSVKVSCKASGFTFMSSAVQWVRQARGQRLEWIGWIVIGSGNTNYAQKFQERVTITRDMSTSTAYMELSSLRSEDTAVYYCAAPYCSSISCNDGFDIWGQGTMVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQHYGSSRGWTFGQGTKVEIK,IGHV1-58 (Human),IGHJ3 (Human),IGKV3-20 (Human),IGKJ1 (Human),AAPYCSSISCNDGFDI,QHYGSSRGWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-3025_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2046,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGRSLRLSCAASGFTFDDYAMHWVRQAPGKGLEWVSGISWNSGSIAYTDSVKGRFTISRDNAKNSLYLQMNSLRAEDTALYYCAKAHSTGHQYYYGMDVWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSFLNWYQQKPGKAPKLLIYAAFNLQSGVPSRFSGSGSGTDFTLTISSLQSEDFATYYCQQSYNTPYTFGQGTKLEIK,IGHV3-9 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ2 (Human),AKAHSTGHQYYYGMDV,QQSYNTPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2046_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2196,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QMQLVQSGPEVKKPGTSVKVSCKASGFTFMSSAVQWVRQARGQRLEWIGWIVIGSGNTNYAQKFQERVTITRDMSTSTAYMELSSLRSEDTAVYYCAAPYCSSISCNDGFDIWGQGTMVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQHYGSSRGWTFGQGTKVEIK,IGHV1-58 (Human),IGHJ3 (Human),IGKV3-20 (Human),IGKJ1 (Human),AAPYCSSISCNDGFDI,QHYGSSRGWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2196_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Nov 11, 2020",Added therapeutic relevance,Therapeutic mAb Tixagevimab. Complete
COV2-2901,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYPGGSAFYADSVKGRFTISRHNSNNTLCLQMNSLRTEDTAVYYCARSYDILTGYRDAFDIWGQGTMVTVSS,QSVLTQPPSVSGAPGQRVTISCTGSSSNIGSGSDVHWYQQLPGTAPKLLIYGNTNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCVAWDDSRNGLVFGGGAKLTVL,IGHV3-53 (Human),IGHJ3 (Human),IGLV1-40 (Human),IGLJ2 (Human),ARSYDILTGYRDAFDI,VAWDDSRNGLV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2901_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2070,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQQWGAGLLKPSETLSLTCAVSGGSFSAYYWSWIRQPPGKGLEWIGEINHSGSTNYNPSLRSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARVGYSQGYYYYYMDVWGKGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISNYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFSLTISSLQPEDFATYSCQQSYTTLLTFGGGTKVEIK,IGHV4-34 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ4 (Human),ARVGYSQGYYYYYMDV,QQSYTTLLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2070_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2132,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLIQPGGSLRLSCAASEVTVSSNYMSWVRQAPGKGLEWVSLIYSGGTTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDFLRWHDLWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDINNYLNWYQQKPGKAPKLLIYDASNLETGVPLRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPPVFGGGTKVEIK,IGHV3-53 (Human),IGHJ5 (Human),IGKV1-33 (Human),IGKJ4 (Human),ARDFLRWHDL,QQYDNLPPV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2132_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2911,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,QLQLRESGPGLVKPSETLSLTCTVSGGSISSSSYYWGWIRQPPGKGLEWIGSIYYSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVFYCARMSRGYNYAYTFDIWGQGTMVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGSYNLVSWYQQHPGKAPKLKIYEGSKRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCCSYAGSVLFGGGTKLTVL,IGHV4-39 (Human),IGHJ3 (Human),IGLV2-23 (Human),IGLJ2 (Human),ARMSRGYNYAYTFDI,CSYAGSVL,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2911_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2098,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLLESGGGLIQPGGSLRLSCAASGFTFSNYAMSWVRQAPGKGLEWVSGIISTSGGATYNADSVRGRFTTSRDNSKNILYLQMNSLRGEDTAVYYCVKGLFDWFPLWGQGTMVTVSS,DIVMTQSPATLSVSPGERAILSCRASQSVRSNLAWYQQKPGQAPRLLISGASTRATAIPARFSGSGSGTEFTLTITSLQSEDCAVYYCHQYNNWPQTFGQGTKVEIK,IGHV3-23 (Human),IGHJ3 (Human),IGKV3-15 (Human),IGKJ1 (Human),VKGLFDWFPL,HQYNNWPQT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2098_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2108,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,NVQLVESGGGLVQPGGSLRLSCAASGFTFHHYAMHWVRQAPGKGLEWVSGISGSSDYRAYADSLKGRFTISRDYAKNSLWLQMNSLTSEDTAFYYCAKGVDYGGKLAYFDSWGQGTLVTVSS,DIVMTQSPLSLPVTPGEPASISCRSSQSLLHSLGYNSLSWYLQKPGQSPHLLIYLGSNRASGVPDRFSGSGSATDFTLKISRLEAEDVGVYYCMQALQTPLTFGQGTRLEIK,IGHV3-9 (Human),IGHJ4 (Human),IGKV2-28 (Human),IGKJ5 (Human),AKGVDYGGKLAYFDS,MQALQTPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2108_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2114,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGDTFSSYTINWVRQAPGQGLEWMGRIIPILGIPNYAQKFQGRVTITADKSTSTAFMELSSLRSEDTAVYYCARGRGYSNYGASYYMDVWGKGTTVTVSS,QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWYQQLPETAPKLLIYANSNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSSLSGSVFGGGTKLTVL,IGHV1-69 (Human),IGHJ6 (Human),IGLV1-40 (Human),IGLJ2 (Human),ARGRGYSNYGASYYMDV,QSYDSSLSGSV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2114_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2304,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVKPGGSLRLSCAASGFTFSSYSMNWVRQAPGKGLEWVSCISSSSSFIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARDPVWVDGELLSGGIPFDYWGQGTLVTVSS,QSVLTQPPSASGTPGQRVTISCSGSSSNIESNSVNWYQQLPGTAPKLLIYSNNQRPSGVPDRFSGSKSGTSASLAISGLQSEDEADYYCAAWDDSLNGVVFGGGTKLTVL,IGHV3-21 (Human),IGHJ4 (Human),IGLV1-44 (Human),IGLJ2 (Human),ARDPVWVDGELLSGGIPFDY,AAWDDSLNGVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2304_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2078,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYSITWVRQAPGQGLEWMGRIIPVLGIANYAQKFQDRVTITADKSTSTAYMELSSLRSEDTAVYYCARVGVSGFKSGSNWYFDLWGRGTLVTVSS,QSVLTQPPSVSGAPGQRVTLSCTGSNSNIGAGYDVHWYQQLPGTAPKLLIYGNSNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSSLSDSVFGGGTKVTVL,IGHV1-69 (Human),IGHJ2 (Human),IGLV1-40 (Human),IGLJ3 (Human),ARVGVSGFKSGSNWYFDL,QSYDSSLSDSV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2078_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2299,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFSFSSYVMNWVRQAPGKGLEWVAVISYDGSSKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDIDSGYDPTPVFDYWGQGTLVTVSS,DIQMTQSPSSLSACVGDRVTITCRASQSISSYLNWYQQKPGKGPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPWTFGQGTKVEIK,IGHV3-30-3 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ1 (Human),ARDIDSGYDPTPVFDY,QQSYSTPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2299_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2351,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVQSGAEVKKPGESLKISCKGSGYSFTSYWIGWVRQMPGKGLEWMGIIYPGDSDTTYNPSFQGQVTISADKSLTTAFLHWSSLKASDTAIYYCARRFYGPSSFDYWGQGTLVIVSS,SSELTQDPAVSVALGQTVTITCQGDSLRSHYASWYKVKPGQAPLLVIYGRNNRPSGIPDRFSGSRSGNTASLTITGAQVDDEADYYCSSGDSSTDHHVVFAGGTKLAVV,IGHV5-51 (Human),IGHJ4 (Human),IGLV3-19 (Human),IGLJ2 (Human),ARRFYGPSSFDY,SSGDSSTDHHVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2351_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2318,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,QVTLRESGPALVKPTQTLSLTCTFSGFSLGTSGMCVSWIRQPPGKALEWLARIDWDDDKYYSTSLKTRLTISKDTSKNQVVLTMTNMDPVDTATYYCARGVVTYDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSIAGYLNWYQQKPGKAPKLLIYGTTSLQSGVPVRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPGTFGQGTRLEIK,IGHV2-70 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ5 (Human),ARGVVTYDY,QQSYSTPGT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2318_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2703,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYDMHWVRQATGKGLEWVSAIGTAGDTYYPGSVKGRFTISRENAKNSLYLQMNSLRAGDTAVYYCARARGGYNWNFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYDASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPPITFGQGTRLEIK,IGHV3-13 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ5 (Human),ARARGGYNWNFDY,QQSYSTPPIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2703_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2277,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVALISSDGGNKFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDVPTTVTAFTVFTYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISTYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDYATYYCQQSYSTPGLTFGGGTKVEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ4 (Human),ARDVPTTVTAFTVFTY,QQSYSTPGLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2277_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2068,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYPGGSAFYADSVKGRFTISRHNSNNTLCLQMNSLRTEDTAVYYCARSYDILTGYRDAFDIWGQGTMVTVSS,QSVLTQPPSVSGAPGQRVTISCTGSSSNIGSGSDVHWYQQLPGTAPKLLIYGNTNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSRLSGFVVFGGGTKLTVL,IGHV3-53 (Human),IGHJ3 (Human),IGLV1-40 (Human),IGLJ2 (Human),ARSYDILTGYRDAFDI,QSYDSRLSGFVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2068_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2504,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTDYYMHWVRQAPGQGLEWMGWINPNSRGTNYAQKFQGRVTMTRDTSISTVYMELSRLTSDDTAVYYCARVVVLGYGRPNNYYDGRNVWDYWGQGTLVTVSS,QSVLTQPPSASGTPGQRVIISCSGSSSNIGSNTVKWYHQLPGTAPKLLICSNNQRPSGVPDRFSGSKSDTSASLAISGLQSEDEADYYCAAWDDSLNALVFGGGTKLTVL,IGHV1-2 (Human),IGHJ4 (Human),IGLV1-44 (Human),IGLJ2 (Human),ARVVVLGYGRPNNYYDGRNVWDY,AAWDDSLNALV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2504_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2510,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGSELKKPGASVKVSCKASGYTFTSHTMNWVRQAPGQGLEWMGWINTNTGNPMYAQGFTGRFVFSLDTSGSTAYLQISSLKAEDTAVYYCARWGPDYGDYASNDYWGQGTLVTVSS,SYELTQPSSVSVSPGQTARITCSGDVLAKNYARWFQQKPGQAPVLVIYKDSERPSGIPKRFSGSSSGTTVTLTISGAQVEDEADYYCYSAADNNRVFGGGTKLTVL,IGHV7-4-1 (Human),IGHJ4 (Human),IGLV3-27 (Human),IGLJ2 (Human),ARWGPDYGDYASNDY,YSAADNNRV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2510_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2308,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLLESGGGLIQPGGSLRLSCAASGFTFSNYAMSWVRQAPGKGLEWVSGIISSSGGATYNADSVRGRFTTSRDNSKNILYLQMNSLRGEDTAVYYCVKGLFDWFPLWGQGTMVTVSS,DIVMTQSPATLSVSPGERAILSCRASQSVRSNLAWYQQKPGQAPRLLISGASTRATAIPARFSGSGSGTEFTLTITSLQSEDCAVYYCHQYNNWPQTFGQGTKVEIK,IGHV3-23 (Human),IGHJ3 (Human),IGKV3-15 (Human),IGKJ1 (Human),VKGLFDWFPL,HQYNNWPQT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2308_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2391,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFGSFDINWVRQATGQGLEWMGRMNSNSGNTAYAQKFQGRVTMTRDTSTNTAYMELSSLRSEDTAMYYCARMRSGWPTHGRPDDFWGRGTLVTVSS,QSVLTQAPSASGTPGQRVTISCSGSNSNIGSYTINWYQQLPGTAPKLLIYGNDQRTSGVPDRFSGSKFGTSASLAISGLQSEDENNYYCAVWDDSLNGLVFGGGTKLTVL,IGHV1-8 (Human),IGHJ4 (Human),IGLV1-44 (Human),IGLJ2 (Human),ARMRSGWPTHGRPDDF,AVWDDSLNGLV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2391_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2767,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYPGGSAFYADSVKGRFTISRHNSNNTLCLQMNSLRTEDTAVYYCARSYDILTGYRDAFDIWGQGTMVTVSS,QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWYQQLPETAPKLLIYANSNRPSGVPDRFSGSKSGTSASLAISGLQSEAEADYYCVAWDDSRNGLVFGGGAKLTVL,IGHV3-53 (Human),IGHJ3 (Human),IGLV1-40 (Human),IGLJ2 (Human),ARSYDILTGYRDAFDI,VAWDDSRNGLV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2767_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2113,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLIQPGGSLRLSCAASEVTVSSNYMSWVRQAPGKGLEWVSLIYSGGTTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDFLRWHDLWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDINNYLNWYQQKPGKAPKLLIYDASNLETGVPLRFSGSGSGTDFIFTISSLQPEDIATYYCQQYDNLPPVFGGGTKVEIK,IGHV3-53 (Human),IGHJ5 (Human),IGKV1-33 (Human),IGKJ4 (Human),ARDFLRWHDL,QQYDNLPPV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2113_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2290,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLAQSGAEVKKPGASVKVSCKAAGYTFTSYDINWVRQATGQGLEWMGWMNPNSGNAGYAQKFQGRVTMTRDTSISTAYMELSSLRSEDTAVYYCARMRSGWPTHGRPDDFWGRGTLVTVSS,QSVLTQPPSASGTPGQRVTISCSGSNSNIGSYTVNWYQQFPGTAPKLLIYDNNQRTSGVPDRFSGSKSGTSASLAISGLQSEDEANYYCLVWDDSLNGLVFGGGTKLTVL,IGHV1-8 (Human),IGHJ4 (Human),IGLV1-44 (Human),IGLJ2 (Human),ARMRSGWPTHGRPDDF,LVWDDSLNGLV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2290_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2130,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVKPGGSLRLSCAASGFTFRDVWMSWVRQAPGKGLEWVGRIKSKIDGGTTDYAAPVKGRFTISRDDSKNTLYLQMNSLKTEDTAVYYCTTAGSYYYDTVGPGLPEGKFDYWGQGTLVTVSS,DIVMTQSPDSLAVSLGERATINCKSSQSVLYSSNNKNYLAWYQQKPGQPPKLLMYWASTRESGVPDRFSGSGSGAEFTLTISSLQAEDVAIYYCQQYYSTLTFGGGTKVEIK,IGHV3-15 (Human),IGHJ4 (Human),IGKV4-1 (Human),IGKJ4 (Human),TTAGSYYYDTVGPGLPEGKFDY,QQYYSTLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2130_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Nov 11, 2020",Added therapeutic relevance,Therapeutic mAb Cilgavimab. Complete
COV2-2050,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTDYYMHWVRQAPGQGLEWMGWINPNSRGTNYAQKFQGRVTMTRDTSISTVYMELSRLTSDDTAVYYCARVVVLGYGRPNNYYDGRNVWDYWGQGTLVTVSS,QSVLTQPPSASGTPGQRVIISCSGSSSNIGSNTVKWYHQLPGTAPKLLICSNNQRPSGVPDRFSGSKSDTSASLAISGLQSEDEADYYCAAWDDSLNALVFGGGTKLTVL,IGHV1-2 (Human),IGHJ4 (Human),IGLV1-44 (Human),IGLJ2 (Human),ARVVVLGYGRPNNYYDGRNVWDY,AAWDDSLNALV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2050_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2064,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLAQSGAEVKKPGASVKVSCKAAGYTFTSYDINWVRQATGQGLEWMGWMNSNSGNAGYAQKFQGRVTMTRDTSTSTAYMELSSLTSDDTAVYYCARMRTGWPTHGRPDDFWGRGTLVTVSS,QSVLTQPPSASGTPGQRVTISCSGSNSNIGSYTVNWYQQFPGTAPKLLIYDNNQRTSGVPDRFSGSKSGTSASLAISGLQSEDEANYYCLVWDDSLNGLVFGGGTKLTVL,IGHV1-8 (Human),IGHJ4 (Human),IGLV1-44 (Human),IGLJ2 (Human),ARMRTGWPTHGRPDDF,LVWDDSLNGLV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2064_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2684,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Human Patient,QMQLVQSGPEVKKPGTSVKVSCKTSGFTFTSSAIQWVRQARGQRLEWIGWIVVGSGNTNYAQKFQERVTITRDMSTSTAYMELSSLRSEDTAVYYCAAPHCNRTSCYDAFDLWGQGTMVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLGWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLESEDFALYYCQQYNNWWRTFGQGTKVEIK,IGHV1-58 (Human),IGHJ3 (Human),IGKV3-20 (Human),IGKJ1 (Human),AAPHCNRTSCYDAFDL,QQYNNWWRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2684_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2072,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QMQLVQSGPEVKKPGTSVKVSCKTSGFTFTSSAIQWVRQARGQRLEWIGWIVVGSGNTNYAQKFQERVTITRDMSTSTAYMELSSLRSEDTAVYYCAAPHCNRTSCYDAFDLWGQGTMVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLGWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK,IGHV1-58 (Human),IGHJ3 (Human),IGKV3-20 (Human),IGKJ1 (Human),AAPHCNRTSCYDAFDL,QQYGSSPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2072_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2539,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLAQSGAEVKKPGASVKVSCKAGGYTFTSYDINWVRQATGQGLEWMGWMNSNSGNAGYAQKFQGRVTMTRDTSISTAYMELSSLRSEDTAVYYCARMRTGWPTHGRPDDFWGRGTLVTVSS,QSVLTQPPSASGTPGQRVTISCSGSNSNIGSYTVNWYQQFPGTAPKLLIYDNNQRTSGVPDRFSGSKSGTSASLAISGLQSEDEASYYCLAWDDSLNGLVFGGGTKLTVL,IGHV1-8 (Human),IGHJ4 (Human),IGLV1-44 (Human),IGLJ3 (Human),ARMRTGWPTHGRPDDF,LAWDDSLNGLV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2539_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2389,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGRSLRLSCAASGFTFDDYAMHWVRQAPGKGLEWVSGISWNSGTIGYADSVKGRFIISRDNAKNSLYLQMNSLRPEDTALYYCAKDIIRQGEDGMDVWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQNIASYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEEFATYYCQQSYSTPWTFGQGTKVEIK,IGHV3-9 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ1 (Human),AKDIIRQGEDGMDV,QQSYSTPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2389_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2532,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVRVSCKAPGYTFTTYYIHWVRQAPGQGLEWMGIINPSAGSTTYAQKFQGRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARGFHVPAALRNWFDPWGQGTLVTVSS,QSVLTQPPSASGTPGQRVTISCSGSSSNIGSNTVNWYQQLPGTAPKLLIYNNNQRPSGVPDRLSGSKSGTSASLAISGLQSEDEADYYCVAWDDSRNGLVFGGGTKLTVL,IGHV1-46 (Human),IGHJ5 (Human),IGLV1-44 (Human),IGLJ2 (Human),ARGFHVPAALRNWFDP,VAWDDSRNGLV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2532_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2096,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFGSFDINWVRQATGQGLEWMGRMNSNSGNTAYAQKFQGRVTMTRDTSTNTAYMELSSLRSEDTAMYYCARMRSGWPTHGRPDDFWGRGTLVTVSS,QSVLTQAPSASGTPGQRVTISCSGSNSNIGSYTINWYQQLPGTAPKLLIYGNDQRTSGVPDRFSGSKFGTSASLAISGLQSEDENNYYCAVWDDSLNGLVFGGGTKLTVL,IGHV1-8 (Human),IGHJ4 (Human),IGLV1-44 (Human),IGLJ2 (Human),ARMRSGWPTHGRPDDF,AVWDDSLNGLV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2096_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2051,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,QVTLRESGPALVKPTQTLSLTCTFSGFSLGTSGMCVSWIRQPPGKALEWLARIDWDDDKYYSTSLKTRLTISKDTSKNQVVLTMTNMDPVDTATYYCARGVVTYDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSIAGYLNWYQQKPGKAPKLLIYGTTSLQSGVPVRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPGTFGQGTRLEIK,IGHV2-70 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ5 (Human),ARGVVTYDY,QQSYSTPGT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2051_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2759,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVQSGAEVKKPGESLKISCKGSGYSFTNYWIGWVRQMPGKGLEWMGIIYPGDSDTRYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARTPTLYNWFHPWGQGTPVTVSS,QSVLTQPPSASGTPGQRVTISCSGSSSNIGSNSLNWYQQLPGTAPKLLIYSNNQRPSGVPDRFSGSKSGTSASLAISGLQSEDEADYYCAAWDDSLNGSWVFGGGTKLTVL,IGHV5-51 (Human),IGHJ5 (Human),IGLV1-44 (Human),IGLJ3 (Human),ARTPTLYNWFHP,AAWDDSLNGSWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2759_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2240,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGRSLRLSCAASGFTFDDYAMHWVRQAPGKGLEWVSGISWNSGSIGYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTALYYCAKVGYTISRQWLVGEFDYWGQGTLVTVSS,QSALTQPPSASGSPGQSVTISCTGTSSDVGTYNYVSWYQQHPGKAPKLMIYEVSKRPSGVPDRFSGSKSGNTASLTVSGLQAEDEAEYYCSAYAGSNNLVFGGGTKLTVL,IGHV3-9 (Human),IGHJ4 (Human),IGLV2-8 (Human),IGLJ2 (Human),AKVGYTISRQWLVGEFDY,SAYAGSNNLV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2240_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2413,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYDINWVRQATGQGLEWMGWMNPNSGNAGYGQKFQGRVTMTRNTSISTAYMELSSLRSEDTAVYYCARMRSGWPTHGRPDDYWGRGTLVTVSS,QSVLTQPPSASGTPGQRVTFSCSGSNSNIGSYTVNWYQQLPGTAPKLLIYDNNQRPSGVPDRFSGSKSGTSASLAISGLQSEDEADYYCAVWDDSLNGLVFGGGTKLTVL,IGHV1-8 (Human),IGHJ4 (Human),IGLV1-44 (Human),IGLJ3 (Human),ARMRSGWPTHGRPDDY,AVWDDSLNGLV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2413_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2416,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSQTLSLTCTVSGGSISSGGYYWSWIRQHPGKGLEWIGYIYYSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCASAKLVATISYFDYWGQGTLVTVSS,QSVLTQPPSVSEAPRQRVTISCSGSSSNIGNNAVNWYQQLPGKAPKLLIYYDDLLPSGVSDRFSGSKSGTSASLAISGLQSEDEADYYCAAWDDSLNGVVFGGGTKLTVL,IGHV4-31 (Human),IGHJ4 (Human),IGLV1-36 (Human),IGLJ2 (Human),ASAKLVATISYFDY,AAWDDSLNGVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2416_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2399,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFSVSTNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDYRDWIWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDISKYLNWYQQKPGKAPKLLIYDASNLERGVPSRFSGSGSGTDFTFTISSLQAEDIATYYCQQYHNLPRTFGQGTKVEIK,IGHV3-66 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ1 (Human),ARDYRDWI,QQYHNLPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2399_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2756,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,EAQLLESGGALVQPGGSLRLSCAASGFTFSCCAMGWVRQAPGRGLEWVSSIHDDGVGTFYAVSVKGRFSISRDNSKNTVYLQMNGLRAEDTGVYYCAKWAGPIVMKYYLQYWGQGALVTVSS,QSLLTQPPSVSGAPGQRVTLSCAGATSNIGAGSDVHWYQQLPGTAPKLLIYYNTNRPSGVPDRFSGSKSATSASLVITGLQTEDEADYYCQSYDISLGGWVFGGGTKLTVL,IGHV3-23 (Human),IGHJ4 (Human),IGLV1-40 (Human),IGLJ3 (Human),AKWAGPIVMKYYLQY,QSYDISLGGWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2756_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2819,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSQTLSLTCTVSGDSISSAGYYWSWIRQHPGKGLEWIGYIYYSGRTYYNPSLKSRVTMSVDTSKNQFSLRLRSVTAADTAVYYCARVVPTRGPVAWFDPWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQRPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISTLQPEDFATYYCQQSYSTLLYTFGQGTKLEIK,IGHV4-31 (Human),IGHJ5 (Human),IGKV1-39 (Human),IGKJ2 (Human),ARVVPTRGPVAWFDP,QQSYSTLLYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2819_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2381,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QMQLVQSGPEVKKPGTSVKVSCKASGFTFTSSAVQWVRQARGQRLEWIGWIAVGSGNTNYAQKFQERVSITRDMSTSTAYMELSSLRSEDTAVYYCAAPYCSRTSCHDAFDIWGQGTKVTVSS,EVVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYHCQHFGSSSQWTFGQGTKVEIK,IGHV1-58 (Human),IGHJ3 (Human),IGKV3-20 (Human),IGKJ1 (Human),AAPYCSRTSCHDAFDI,QHFGSSSQWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2381_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2628,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGRSLRLSCAASGFTFDDYAMHWVRQAPGKGLEWVSGISWNSGTIGYADSVKGRFIISRDNAKNSLYLQMNSLRPEDTALYYCAKDIIRQGEDGMDVWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQNIASYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEEFATYYCHQSYFTPQTFGQGTKLEIK,IGHV3-9 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ2 (Human),AKDIIRQGEDGMDV,HQSYFTPQT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2628_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2909,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGDTFSSYTINWVRQAPGQGLEWMGRIIPILGIPNYAQKFQGRVTITADKSTSTAFMELSSLRSEDTAVYYCARGRGYSNYGASYYMDVWGKGTTVTVSS,QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWYQQLPETAPKLLIYANSNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSSLSGSVFGGGTKLTVL,IGHV1-69 (Human),IGHJ6 (Human),IGLV1-40 (Human),IGLJ2 (Human),ARGRGYSNYGASYYMDV,QSYDSSLSGSV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2909_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2353,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVQSGAEVKKPGESLKISCKGFGYNFTNYWIGWVRQMPGKGLEWMGIIYPGDSETRNSPSFQGQVTISADKSMSTAYLQWSSLKASDTAMYYCARLGVSKYCSGGRCLSGGSNWFDPWGQGTLVTVSS,EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNWPPMYTFGQGTKLEIK,IGHV5-51 (Human),IGHJ5 (Human),IGKV3-15 (Human),IGKJ2 (Human),ARLGVSKYCSGGRCLSGGSNWFDP,QQYNNWPPMYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2353_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2589,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Human Patient,QVTLRESGPALVKPTQTLTLTCTFSGFSLSTSGMCVSWIRQPPGKALEWLARIDWDDDKYYSTSLETRLTISKDTSKNQVVLTMTNMDPVDTATYYCARIQYQLNGMDVWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLHSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPYTFGQGTKLEIK,IGHV2-70 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ2 (Human),ARIQYQLNGMDV,QQSYSTPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2589_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2485,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYSITWVRQAPGQGLEWMGRIIPVLGIANYAQKFQDRVTITADKSTSTAYMELSSLRSEDTAVYYCARVGVSGFKSGSNWYFDLWGRGTLVTVSS,QSVLTQPPSVSGAPGQRVTLSCTGSNSNIGAGYDVHWYQQLPGTAPKLLIYGNSNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSSLSDSVFGGGTKVTVL,IGHV1-69 (Human),IGHJ2 (Human),IGLV1-40 (Human),IGLJ3 (Human),ARVGVSGFKSGSNWYFDL,QSYDSSLSDSV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2485_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2693,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCQASGYTFTSYDINWVRQATGQGLEWMGWMKSNSGNTGYAQKFQGRVTMTRNTSISTAYMELTSLRSEDTAVYYCARMRSGWPTHGRPDDLWGRGTLVTVSS,QSVLTQPPSASGTPGQRVTISCSGSNSNIGSYTVNWYQQLPGTAPKLLIYDNNQRTSGVPDRLSGSKSGTSASLAISGLQSEDEANYYCAVWDDSLNGLVFGGGTKLTVL,IGHV1-8 (Human),IGHJ5 (Human),IGLV1-44 (Human),IGLJ2 (Human),ARMRSGWPTHGRPDDL,AVWDDSLNGLV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2693_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2762,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,QLQLQESGPGLVKPSETLSLTCTVSGGSISSSSYYWGWIRQPPGKGLEWIGSIYYSGITYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARHQRYCSSSSCHVWDYWGQGTLVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGSYNLVSWYQQHPGKAPKLMIYEGSKRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCCSYAGSSTWLFGGGTKLTVL,IGHV4-39 (Human),IGHJ4 (Human),IGLV2-23 (Human),IGLJ3 (Human),ARHQRYCSSSSCHVWDY,CSYAGSSTWL,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2762_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2080,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGLTVRSNYMTWVRQTPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTVYLQMNSLRAEDTAVYYCARDLVTYGLDVWGQGTTVTVSS,DIQLTQSPSFLSASVGDRVTITCRASQGISNYLAWYQQKPGTAPNLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQLLNSHPLTFGQGTRLEIK,IGHV3-66 (Human),IGHJ6 (Human),IGKV1-9 (Human),IGKJ5 (Human),ARDLVTYGLDV,QLLNSHPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2080_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2527,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSQTLSLTCTVSGGSISSGDYYWSWIRQPPGKGLEWIGYIYYSGSTYYNPSLKSRVTISVDTSKNQVSLKLSSVTAADTAVYYCARFRRSYGSGSYYNISFDYWGQGTLVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGSYNLVSWYQQHPGKAPKLMIYEVSKRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCCSYVGSSTYVVFGGGTKLTVL,IGHV4-30-4 (Human),IGHJ4 (Human),IGLV2-23 (Human),IGLJ2 (Human),ARFRRSYGSGSYYNISFDY,CSYVGSSTYVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2527_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2618,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCVASEFTFSSYWMSWFRQAPGKGLEWVSGINWNGGSTGYADSVKGRFTISRDNAKNSLYLQMNSLKTEDTAVYYCASVITFGGVIVRSYWGQGTLVTVSS,QSVLTQPPSASGTPGQRVTISCSGSSSNIGSNTVNWYQQLPGTAPKLLIYSNNQRPSGVPDRFSGSKSGTSASLAISGLQSEDENNYYCAVWDDSLNGVVFGGGTKLTVL,IGHV3-20 (Human),IGHJ4 (Human),IGLV1-44 (Human),IGLJ2 (Human),ASVITFGGVIVRSY,AVWDDSLNGVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2618_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2531,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSETLSLTCSVSGGSIRSYFWNWVRQPPGKGLEWIGYIYYSGSTNYKPSFKSRVTISLDTSKNQISLKLSSVTAADTAVYYCARATWLRDAFGIWGQGTMVTVSS,NFMLTQPHSVSESPGKTVTISCTGNSGSIASNYVQWYQQRPGSAPTTVIYEDSQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSFDSGNVVFGGGTKLTVL,IGHV4-59 (Human),IGHJ3 (Human),IGLV6-57 (Human),IGLJ2 (Human),ARATWLRDAFGI,QSFDSGNVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2531_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2919,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVTLRESGPALVKPTQTLTLTCTFSGFSLSTSGMCLSWIRQPPGKALEWLARIDWDDDKYYSTSLETRLTISKDTSKNQVVLTMTNMDPVDTGTYYCARTMATINAFDIWGQGTMVTVSS,DIQMTQSPSSLSASAGDRVTITCRASQSIRYYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFAAYYCQQSFSTPRTFGQGTKLEIK,IGHV2-70 (Human),IGHJ3 (Human),IGKV1-39 (Human),IGKJ2 (Human),ARTMATINAFDI,QQSFSTPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2919_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2037,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGESLRLSCAASGITVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFIISRHNSKNTLYLQMNSLRAEDTAVYYCARDLNEHGLDVWGQGTTVSVSS,DIQMTQSPSSVSASVGDRVTITCRASQGISSWLAWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQTNSFPTFGQGTRLEIR,IGHV3-53 (Human),IGHJ6 (Human),IGKV1-12 (Human),IGKJ5 (Human),ARDLNEHGLDV,QQTNSFPT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2037_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2780,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQQWGAGLLKPSETLSRTCAVYGASFSNYYWSWIRQPPGKGLEWIGEINHSENTNYNPSLKSRVTISVDTSKNQFSLRLSSVTAADTAVYYCARLRYSSSGGHIFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDINNYLNWYQQKSGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTINSLQPEDIATYYCQQYDNLPYTFGQGTKLEIK,IGHV4-34 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ2 (Human),ARLRYSSSGGHIFDY,QQYDNLPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2780_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2710,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYDINWVRQATGQGLEWMGWMSPNSGNTGYAQKFQGRVTMTRDTSISTAYMELNSLRSEDTAVYYCARMRSGWPTHGRPDDHWGQGTLVTVSS,QSVLTQPPSASGTPGQRVTISCSGSNSNIGSYTVNWYQQLPGTAPKLLIFGNNQRPSGVPDRFSGSKSGTSASLAISGLQSEDEADYYCVAWDDSRNGLVFGGGAKLTVL,IGHV1-8 (Human),IGHJ4 (Human),IGLV1-44 (Human),IGLJ2 (Human),ARMRSGWPTHGRPDDH,VAWDDSRNGLV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2710_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2097,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGRSLRLSCAASGFTFDDYAMHWVRQAPGKGLEWVSGISWNSGTIGYADSVKGRFIISRDNAKNSLYLQMNSLRPEDTALYYCAKDIIRQGEDGMDVWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQNIASYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEEFATYYCQQSYSTPWTFGQGTKVEIK,IGHV3-9 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ1 (Human),AKDIIRQGEDGMDV,QQSYSTPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2097_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2243,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,QLQLQESGPGLVKPSETLPLTCTVSGGSISSSSYYWGWIRQPPGKGLQWIGNIYYSGSTYYNSSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARQSRGYSYAWSFDYWGQGTLVTVSS,QSALTQPASVSGSHGQSITISCTGTSSDVGSYNLVSWYQQHPGKAPKLMIYEVSKRPSGVSNRFSGSTSGNTASLTISGLQAEDEADYYCCSYAGIVLFGGGTKVTVL,IGHV4-39 (Human),IGHJ4 (Human),IGLV2-23 (Human),IGLJ2 (Human),ARQSRGYSYAWSFDY,CSYAGIVL,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2243_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2694,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKRPGSSVKVSCKASGGTFSSYTISWVRQAPGQGLEWMGRIIPILAVANYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCARDHSGYYDSTSLMSPFFDYWGQGTLVTVSS,QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWYQQLPGTAPKLLIFGNTNRPSGVPDRFSGSKSGTSTSLAITGLQAEDEADYYCQSYDSSLNGDVFGGGTKLTVL,IGHV1-69 (Human),IGHJ4 (Human),IGLV1-40 (Human),IGLJ3 (Human),ARDHSGYYDSTSLMSPFFDY,QSYDSSLNGDV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2694_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2826,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGDTFTTYYIHWVRQAPGQGLEWMGIINPSGGSRSYAQKFQGRISMTSDTSTSTVYMELSSLRSEDTAVYYCARGYGFVPNVLYYFDYWGQGTLVTVST,QSALTQPASVSGSPGQSITISCTGTSSDVGSYNLVSWYQQHPGKAPKLMIYEGSKRPSGVSNRFSGSKSGITASLTISGLQAEDEADYYCCSYAGSSTWLFGGGTKLTVL,IGHV1-46 (Human),IGHJ4 (Human),IGLV2-23 (Human),IGLJ3 (Human),ARGYGFVPNVLYYFDY,CSYAGSSTWL,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2826_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2813,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLIQPGGSLRLSCAASGITVSSNYMSWVRQAPGKGLEWVSVIYAGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDALYYNGPGRDGMDVWGQGTTVTVSS,VIQMTQSPSSLSASVGDRVTITCQASQDINKYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPRTFGQGTKLEIK,IGHV3-53 (Human),IGHJ6 (Human),IGKV1-33 (Human),IGKJ2 (Human),ARDALYYNGPGRDGMDV,QQYDNLPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2813_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2796,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSQTLSLTCTVSGDSISSGRYYWSWIRQHPGKGLEWIGFVYYSGSTYYNPSLKSRVTISVDTSKNQFSLRLSSVTAADTAVYYCARETYSAYEMPPYFDYWGQGTLVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGSYNLVSWYQQHPGKAPKLMIYEGSKRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCCSYARSSTRVFGGGTKLTVL,IGHV4-31 (Human),IGHJ4 (Human),IGLV2-23 (Human),IGLJ3 (Human),ARETYSAYEMPPYFDY,CSYARSSTRV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2796_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2812,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLIQPGGSLRLSCAASGITVSSNYMSWVRQAPGKGLEWVSVIYAGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDALYYNGPGRDGMDVWGQGTTVTVSS,VIQMTQSPSSLSASVGDRVTITCQASQDINKYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYANLPFTFGPGTKVDIK,IGHV3-53 (Human),IGHJ6 (Human),IGKV1-33 (Human),IGKJ3 (Human),ARDALYYNGPGRDGMDV,QQYANLPFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2812_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2941,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Human Patient,QMQLVQSGPEVKKPGTSVKVSCKASGFTFMSSAVQWVRQARGQRLEWIGWIVIGSGNTNYAQKFQERVTITRDMSTSTAYMELSSLRSEDTAVYYCAAPYCSSISCNDGFDIWGQGTMVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPPRYTFGQGTKLEIK,IGHV1-58 (Human),IGHJ3 (Human),IGKV3-20 (Human),IGKJ2 (Human),AAPYCSSISCNDGFDI,QQYGSSPPRYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2941_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2479,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKTSGDTSSSYTVGWVRQAPGQGLEWMGRIIPILGIAYSAQKFQGRLTITADKSTSTSYMELSSLRSEDTAVYYCARGVVAATPGWFDPWGQGTLVTVSS,EIVMTQSPATLSVSPGERVTLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGGGSGTEFTLTISSLQSEDFAVYYCQQYNNFLTFGGGTKVEIK,IGHV1-69 (Human),IGHJ5 (Human),IGKV3-15 (Human),IGKJ4 (Human),ARGVVAATPGWFDP,QQYNNFLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2479_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2790,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYPGGSAFYADSVKGRFTISRHNSNNTLCLQMNSLRTEDTAVYYCARSYDILTGYRDAFDIWGQGTMVTVSS,QSVLTQPPSVSGAPGQRVTISCTGSSSNIGSGSDVHWYQQLPGTAPKLLIYGNTNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSRLSGFVVFGGGTKLTVL,IGHV3-53 (Human),IGHJ3 (Human),IGLV1-40 (Human),IGLJ2 (Human),ARSYDILTGYRDAFDI,QSYDSRLSGFVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2790_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2809,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKVSGYTFTGYVVHWVRQAPGQDLEWMGWINTGYGNTKYSQKFQGRVTISWDTSATTAYMELSNLKSEDKAVYYCASMTRMSEQTYYGMDVWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISNYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFSLTISSLQPEDFATYSCQQSYTTLLTFGGGTKVEIK,IGHV1-3 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ4 (Human),ASMTRMSEQTYYGMDV,QQSYTTLLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2809_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2891,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQAGAEVKKPGASVKVSCKASGYTFTSYYMHWVRQAPGQGLEWMGIINPSGGSTSYAQKFQGRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARGAAVPAAGEFDYWGQGTLVTVSS,DIQMTQSPSTLSASVGDRVTITCRASQSISSWLAWYQQKPGKAPKLLIYKASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNSYSYTFGQGTKLEIK,IGHV1-46 (Human),IGHJ4 (Human),IGKV1-5 (Human),IGKJ2 (Human),ARGAAVPAAGEFDY,QQYNSYSYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2891_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2370,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSETLSLTCTVSGGSVSSGSYYWSWIRQPPGKGLECIGYIYYSGSSNYNPSLKSRVTISVDTSKNQFSLKMSSVTAADTAVYYCAGSPVPPTIVGASYWGQGTLVTDSS,NFMLTQPHSVSESPGKTVTFSCTGSSGSIASNYVQWYQQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDGINRWLVFGGGTKLTVL,IGHV4-61 (Human),IGHJ4 (Human),IGLV6-57 (Human),IGLJ2 (Human),AGSPVPPTIVGASY,QSYDGINRWLV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2370_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2952,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGLTVRSNYMTWVRQTPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTVYLQMNSLRAEDTAVYYCARDLVTYGLDVWGQGTTVTVSS,DIQLTQSPSFLSASVGDRVTITCRASQGISNYLAWYQQKPGTAPNLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQLLNSHPLTFGQGTRLEIK,IGHV3-66 (Human),IGHJ6 (Human),IGKV1-9 (Human),IGKJ5 (Human),ARDLVTYGLDV,QLLNSHPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2952_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2562,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLAQSGAEVKKPGASVKVSCKAAGYTFTSYDINWVRQATGQGLEWMGWMNSNSGNAGYAQKFQGRVTMTRDTSTSTAYMELSSLTSDDTAVYYCARMRTGWPTHGRPDDFWGRGTLVTVSS,QSVLTQPPSASGTPGQRVTISCSGSNSNIGSYTVNWYQQFPGTAPKLLIYDNNQRTSGVPDRFSGSKSGTSASLAISGLQSEDEANYYCLVWDDSLNGLVFGGGTKLTVL,IGHV1-8 (Human),IGHJ4 (Human),IGLV1-44 (Human),IGLJ2 (Human),ARMRTGWPTHGRPDDF,LVWDDSLNGLV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2562_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2137,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSETLSLTCTVSGGSVSSGSYYWSWIRQPPGKGLECIGYIYYSGSSNYNPSLKSRVTISVDTSKNQFSLKMSSVTAADTAVYYCAGSPVPPTIVGASYWGQGTLVTVSS,NFMLTQPHSVSESPGKTVTFSCTGSSGSIASNYVQWYQQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDGINRWLVFGGGTKLTVL,IGHV4-61 (Human),IGHJ4 (Human),IGLV6-57 (Human),IGLJ2 (Human),AGSPVPPTIVGASY,QSYDGINRWLV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2137_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2631,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,QLQVVQSGPGLVKPSETLSLTCTVSGDPVINTNYYWGWIRQPPGKGLEWIGTLSYSGGTHYNPSLSSRVTIAVDSSKKRFSLTLRSVTAADTAIYYCARHPVDGYNYGYSDLWGQGTLVTVSS,EIVLTQSPATLALSVGERATLSCVASQRVSSDYIAWYQKKPGLAPRLLVYHGSAWATGSSARFSGSGSGTAFTLTISSLEPEDFAVYYCQQYGNSPFTFGPGTKVEFK,IGHV4-39 (Human),IGHJ5 (Human),IGKV3D-20 (Human),IGKJ3 (Human),ARHPVDGYNYGYSDL,QQYGNSPFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2631_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2768,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDDNSPQGSGWYFYYYYAMDVWGQGTTVTVSS,QSVLTQPPSVSAAPGQKVTISCSGSSSNIGNNYVSWYQQLPGTAPKLLIYDNNERPSGIPDRFSGSKSGTSATLGITGLQTGDEADYYCGTWDSSLSAYVFGTGTKVTVL,IGHV3-30-3 (Human),IGHJ6 (Human),IGLV1-51 (Human),IGLJ1 (Human),ARDDNSPQGSGWYFYYYYAMDV,GTWDSSLSAYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2768_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2434,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGDLIQPGGSLRLSCAASGLTVSSNYMSWVRQAPGKGLEWVSIIYSGGSTYYADSVKGRFSISRDNSNNTLYLQMNSLRAEDTAVYFCARHIPAWGYKWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDIRNYLNWYQQKPGKAPELLIYDASNLETGVPSRFSGSGSGTDFIFTISSLQPEDIATYYCHQYDYLPYTFGQGTKLDIK,IGHV3-53 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ2 (Human),ARHIPAWGYK,HQYDYLPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2434_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2752,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLIQPGGSLRLSCAASEVTVSSNYMSWVRQAPGKGLEWVSLIYSGGTTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDFLRWHDLWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDINNYLNWYQQKPGKAPKLLIYDASNLETGVPLRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPPVFGGGTKVEIK,IGHV3-53 (Human),IGHJ5 (Human),IGKV1-33 (Human),IGKJ4 (Human),ARDFLRWHDL,QQYDNLPPV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2752_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2832,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGLTVSSNYMSWVRQAPGKGLECVSVIYAGGNTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARGDGGYYSPFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKVLIYAASTMQSGVPSRFRGSGSGTDFTLTISSLQLEDFATYYCQQSYSTPQTFGQGTKVEIK,IGHV3-66 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ1 (Human),ARGDGGYYSPFDY,QQSYSTPQT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2832_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2165,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGLTVRSNYMTWVRQTPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTVYLQMNSLRAEDTAVYYCARDLVTYGLDVWGQGTTVTVSS,DIQLTQSPSFLSASVGDRVTITCRASQGISNYLAWYQQKPGTAPNLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQLLNSHPLTFGQGTRLEIK,IGHV3-66 (Human),IGHJ6 (Human),IGKV1-9 (Human),IGKJ5 (Human),ARDLVTYGLDV,QLLNSHPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2165_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2955,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFVTSGIHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKGGPNKEVLYFGELLDYGMDVWGQGTTVTVSS,DIVMTQTPLSLSVTPGQPASFSCKSSQSLLHSDGKTYLYWYLQKPGQSPQLLIYAVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQSIQLPYTFGQGTKLEIK,IGHV3-30 (Human),IGHJ6 (Human),IGKV2D-29 (Human),IGKJ2 (Human),AKGGPNKEVLYFGELLDYGMDV,MQSIQLPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2955_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2499,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QLQLQESGPGLVKPSETLSLTCTVSGGSVSSRSYYWGWIRQPPGKGLEWIGSIYYSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARHTVDCGGDCFPNDAFDIWGQGTMVTVSS,SSELTQDPAVSVALGQTVRITCQGDSLRSYYASWYQQKPGQAPLLVIYGKNNRPSGIPDRFSGSSSGNTPSLTITGAQAEDEADYYCNFRDSSGHHPVFGEGTKLTVL,IGHV4-39 (Human),IGHJ3 (Human),IGLV3-19 (Human),IGLJ2 (Human),ARHTVDCGGDCFPNDAFDI,NFRDSSGHHPV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2499_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2751,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,EVQVVESGGGLVQPGRSLRLSCVSSGFIFDDYVMHWVRQRPGKGLEWVAGITYNGGILGYGDSVKGRFIIARDNVRGFLSLQMGDLRTEDTALYYCARDYCSSTTCPAETYYYMDVWGKGTAVTVSS,SYELAQPPSVSVAPGETATIFCRATYIGRKNVQWYQQKPGQAPVLVVYDDSDRPSGIPGRFSGSNSGDTATLTISRIEAGDEAAYYCQVWDGINDRVVFGGGTKLTVL,IGHV3-9 (Human),IGHJ6 (Human),IGLV3-21 (Human),IGLJ2 (Human),ARDYCSSTTCPAETYYYMDV,QVWDGINDRVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2751_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2835,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGLTVGSNYMNWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQLNSLRAEDTAVYYCAREVVGYFDCWGQGTLVTVSS,DIQLTQSPSFLSASVGDRVTITCRASQGISTYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPGYTFGQGTKLEIK,IGHV3-66 (Human),IGHJ4 (Human),IGKV1-9 (Human),IGKJ2 (Human),AREVVGYFDC,QQLNSYPGYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2835_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2268,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QITLKESGPTLVKPTQTLTLTCTFSGFSLSTSGVGVGWIRQPPGKALEWLALIYWDDDKRYSPSLKSRLSITKDTSKNQVVLTMTNMDPVDTGTYYCARHQIVVLFDMWGQGTRVTVSS,QSALTQPASVSGSPGQSITISCTGTGSDVGGSNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSTLVLFGGGTKLSVL,IGHV2-5 (Human),IGHJ3 (Human),IGLV2-14 (Human),IGLJ2 (Human),ARHQIVVLFDM,SSYTSSSTLVL,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2268_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2760,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Human Patient,QVTLRESGPALVKPTQTLTLTCTFSGFSLSTSGLCVSWIRQPPGKALEWLARIDWDDDKYYNTSLRTRLTISKDTSKNQVVLTMTNMDPVDTATYYCARATTFFYGMDVWGQGTTVTVSS,QSVLTQPPSASGTPGQRVTISCSGSRYNIGSNYVYWYQQLPGTAPRLLIYSNNQRPSGVPDRFSGSKSGTSASLAISGLRSEDEADYYCAAWDDSLSGLIFGGGTKLTVQ,IGHV2-70 (Human),IGHJ6 (Human),IGLV1-47 (Human),IGLJ2 (Human),ARATTFFYGMDV,AAWDDSLSGLI,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2760_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2632,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTDYYMHWVRQAPGQGLEWMGWINPNSRGTNYAQKFQGRVTMTRDTSISTVYMELSRLTSDDTAVYYCARVVVLGYGRPNNYYDGRNVWDYWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQEKPGQAPRLLMYSASSRATGIPDRFSGSGSATDFTLTINRLEPEDFAVYYCQQYVEPPFTFGQGTKLEIK,IGHV1-2 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ2 (Human),ARVVVLGYGRPNNYYDGRNVWDY,QQYVEPPFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2632_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2730,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGRSLTLSCAASGFTFDDYTMHWVRQAPGKGLEWVSGIDWNGGTIGYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTALYYCAKAGYYAYVWGSYRFEYFDNWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLLYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPPWTFGQGTKVEIK,IGHV3-9 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ1 (Human),AKAGYYAYVWGSYRFEYFDN,QQSYSTPPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2730_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2039,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYYMHWVRQAPGQGLEWMGIINPSAGSTSYAQKFQGRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARGTLIPAHRGAFDIWGQGTMVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSFLAWYQQKPGQAPRLLIYGASNRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGNSPQFGPGTKVDIK,IGHV1-46 (Human),IGHJ3 (Human),IGKV3-20 (Human),IGKJ3 (Human),ARGTLIPAHRGAFDI,QQYGNSPQ,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2039_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2518,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGRSLRLSCAASGFTFDDYAMHWVRQAPGKGLEWVSGISWNSGTIGYADSVKGRFIISRDNAKNSLYLQMNSLRPEDTALYYCAKDIIRQGEDGMDVWGQGTTVTVSS,SSELTQDPAVSVALGQTVRITCQGDSLRSYYASWYQQKPGQVPILVIYDKNNRPSGIPDRFSGSSSGNTASLTITGAQAEDEADYYCNSRDSSGNAVVFGGGTKLTVA,IGHV3-9 (Human),IGHJ6 (Human),IGLV3-19 (Human),IGLJ2 (Human),AKDIIRQGEDGMDV,NSRDSSGNAVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2518_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2939,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVIWYDGSNKYYAESVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLHQDWVVVVAANVYGMDVWGQGTTVTVSS,SSELTQDPAVSVALGQTVRITCQGDSLRRYYASWYQQKPGQAPVLVIYGKNNRPSGIPDRFSGSSSGNTASLTITGAQAEDEADYYCNSRDSSGNPRWFGGGTKLTVL,IGHV3-33 (Human),IGHJ6 (Human),IGLV3-19 (Human),IGLJ3 (Human),ARDLHQDWVVVVAANVYGMDV,NSRDSSGNPRW,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2939_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2807,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVTLRESGPALVKPTQTLTLTCTFSGFSLTTSGMCVSWIRQPPGKALEWLARIDWDDDKYYSTSLQTRLTISKDTSKNQVVLTMTNMDPVDTATYYCARETPVTAIDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISRYLNWYQQKPGKAPKLLIYTASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPRTFGQGTKVEIK,IGHV2-70 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ1 (Human),ARETPVTAIDY,QQSYSTPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2807_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2585,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYSMNWVRQAPGKGLEWVSYISSRSSTIKYADSVKGRFTISRDNAKNSLYLQMNSLRDEDTAVYYCARVDYYGSGSVYWYFDLWGRGTLVTVSS,QSALTQPRSVSGSPGQSVTISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSKRPSGVPDRFSGSKSGNTASLTISGLQAEDEADYYCCSYAGIWVFGGGTKLTVL,IGHV3-48 (Human),IGHJ2 (Human),IGLV2-11 (Human),IGLJ2 (Human),ARVDYYGSGSVYWYFDL,CSYAGIWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2585_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2110,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFSFSSYVMNWVRQAPGKGQLEWVAVISYDGSSKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDIDSGYDPTPVFDYWGQGTLVTVSS,DIQMTQSPSSLSACVGDRVTITCRASQSISSYLNWYQQKPGKGPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSSLSITFGQGTRLEIK,IGHV3-30-3 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ5 (Human),ARDIDSGYDPTPVFDY,QQSYSSLSIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2110_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2355,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QMQLVQSGPEVKKPGTSVKVSCKTSGFTFTSSAIQWVRQARGQRLEWIGWIVVGSGNTNYAQKFQERVTITRDMSTSTAYMELSSLRSEDTAVYYCAAPHCNRTSCYDAFDLWGQGTMVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLGWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK,IGHV1-58 (Human),IGHJ3 (Human),IGKV3-20 (Human),IGKJ1 (Human),AAPHCNRTSCYDAFDL,QQYGSSPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2355_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2822,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGVTVSSNYMSWVRQAPGKGLEWVSLIYSGGSTFYADSVKGRFTISRHNSKNTLYLQMNSLRPEDTAVYYCARGPEPDAFDIWGQGTMVTVSS,DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSNPSYTFGQGTKLEIK,IGHV3-53 (Human),IGHJ3 (Human),IGKV1-9 (Human),IGKJ2 (Human),ARGPEPDAFDI,QQSYSNPSYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2822_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2733,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGVTVSSNYMSWVRQAPGKGLEWVSLIYSGGSTFYADSVKGRFTISRHNSKNTLYLQMNSLRPEDTAVYYCARGPEPDAFDIWGQGTMVTVSS,DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYSFETFGPGTKVAIK,IGHV3-53 (Human),IGHJ3 (Human),IGKV1-9 (Human),IGKJ3 (Human),ARGPEPDAFDI,QQLNSYSFET,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2733_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2841,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSETLSLTCTVSGGSISSYYWSWIRQPPGKGLEWIGHIYYTGSSYYNPSLKSRVTISLDTSKNQFSLKLNSVTAADTAVYYCARLRWLRGGIDFWGQGTLVIVSS,NLMLTQPHSVSESPGKTVTISCTGSSGSIASNYVQWYQQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSNNQVFGGGTKLTVL,IGHV4-59 (Human),IGHJ4 (Human),IGLV6-57 (Human),IGLJ3 (Human),ARLRWLRGGIDF,QSYDSNNQV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2841_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2789,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVRVSCKAPGYTFTTYYIHWVRQAPGQGLEWMGIINPSAGSTTYAQKFQGRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARGFHVPAALRNWFDPWGQGTLVTVSS,QSVLTQPPSASGTPGQRVTISCSGSSSNIGSNTVNWYQQLPGTAPKLLIYNNNQRPSGVPDRLSGSKSGTSASLAISGLQSEDEADYYCATWDDSLNGPVFGGGTKLTVL,IGHV1-46 (Human),IGHJ5 (Human),IGLV1-44 (Human),IGLJ2 (Human),ARGFHVPAALRNWFDP,ATWDDSLNGPV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2789_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2786,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYDLHWVRQGTGKRLEWVSAIGTAGDTYYLGSVKGRFTISRENAKNSLYLQMNSLRAGDTAVYYCARVLYDSSGFYNWFDPWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYEIPPWTFGQGTKVEIK,IGHV3-13 (Human),IGHJ5 (Human),IGKV1-39 (Human),IGKJ1 (Human),ARVLYDSSGFYNWFDP,QQSYEIPPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2786_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2853,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYYMHWVRQAPGQGLEWMGIINPGGGSTTYAQKFQGRVTMTSDTSTSTVYMELSSLRSEDTAMYYCARGAIPPNSRAEIDYWGQGTLVTVSS,EIVMTQSPATLSVSPGERVTLSCRASQSVSSNLAWCQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYYNWPLTFGGGTKVEIK,IGHV1-46 (Human),IGHJ4 (Human),IGKV3-15 (Human),IGKJ4 (Human),ARGAIPPNSRAEIDY,QQYYNWPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2853_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2352,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKRPGASMNISCKASGYNFNNNYIYWVRQAPGQGLEWMGVVNPTGGGTAYAQGFQDRVTITSDTPRNTVYLGVTGLHSEDTAVYFCARGGEWRIVPGGRDYFDYWGQGTLVTVSA,DMEVTQFPSSLSASIGDRVTITCRATQSISTYLNWYQQKPGKAPNLLIYSASHLQRGVPARFSGSGSGTEFTLTITTLQPEDVGTYYCHQSYGVPITFGGGTKVDIK,IGHV1-46 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ4 (Human),ARGGEWRIVPGGRDYFDY,HQSYGVPIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2352_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2801,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,QVHLVQSGAEVKKPGASVKLSCKASGYTFTNYLLHWVRQAPGQGLEWMGNVNPSRGTATYPQKLDDRVTMTSDKSASTIYMELSGLRSEDTAIYYCARERSGTYFFDYWGQGTLLTVSS,QSVLTQPPSASGTPGQSVTISCSGSSSNIGNNKVNWYQQLPGTAPKVLIYNSNQRPSGVPDRFSGSKSGTSASLAISGLQSEDEADYYCAVWDDSLHSYVFGTETKVTVL,IGHV1-46 (Human),IGHJ4 (Human),IGLV1-44 (Human),IGLJ1 (Human),ARERSGTYFFDY,AVWDDSLHSYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2801_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2253,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYWMHWVRQVPGKGLVWVSRINSDGSSTSYADSVKGRFTISRDNAKNTLYLEMNSLRAQDTAVYYCAGSPWLRGDIDYWGQGTLVTVSS,NFMLTQPHSVSESPGKTVTISCTGSSGSIASNYVQWYQQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLMTEDEADYYCQSYDGSNHAVVFGGGTKLTVL,IGHV3-74 (Human),IGHJ4 (Human),IGLV6-57 (Human),IGLJ2 (Human),AGSPWLRGDIDY,QSYDGSNHAVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2253_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-3010,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSDYAMHWVRQAPGKGLEWVADISFDGSNKYYADSVKGRFTISRDSSENTLYLQMDSLRADDTAVYYCARDLSTTWYLEMWGPDAFDIWGQGTVVTVSS,DIQMTQSPSTLSASIGDRVTITCRASQSISSWLAWYQQIPGKAPKLLIYKASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNSYPYTFGQGTKLEIK,IGHV3-30-3 (Human),IGHJ3 (Human),IGKV1-5 (Human),IGKJ2 (Human),ARDLSTTWYLEMWGPDAFDI,QQYNSYPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-3010_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-3013,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSNYGMHWVRQAPGKGLEWVAVMSYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKNLGPYCSGGTCYSLVGDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYANLPFTFGPGTKVDIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ3 (Human),AKNLGPYCSGGTCYSLVGDY,QQYANLPFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-3013_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2945,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQVVESGGGLVQPGRSLRLSCAASGFTFEDYAMHWVRQAPGKGLEWVSGVSWNSGIIGYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTALYYCAKLDVGGYDFVSGHYYAFDIWGQGTMVTVSS,DVVMTQSPLSLPVTLGQPASISCRSSQSLVYSDGNTYLNWFQQRPGQSPRRLIYKVSSRDSGVPDRFSGSGSGTAFTLKISRVEAEDVGVYYCMQGTHWPYTFGQGTKLEIK,IGHV3-9 (Human),IGHJ3 (Human),IGKV2-30 (Human),IGKJ2 (Human),AKLDVGGYDFVSGHYYAFDI,MQGTHWPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2945_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2103,Ab,"SARS-CoV1,SARS-CoV2",,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFSRHWMTWVRQAPGKGLEWVANIKQDGSEKYYVDSVKGRLTISRDNAKNSLYLQMNSLRAEDTAVYYCARLGFYYGGADYWGQGTLVTVSS,NFMLTQPHSVSESPGKTVTISCTGSSGSIASNYVQWYQQRPGSAPTTVISEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDGINRAWVFGGGTKLTVL,IGHV3-7 (Human),IGHJ4 (Human),IGLV6-57 (Human),IGLJ3 (Human),ARLGFYYGGADY,QSYDGINRAWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2103_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2111,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYDLHWVRQGTGKRLEWVSAIGTAGDTYYLGSVKGRFTISRENAKNSLYLQMNSLRAGDTAVYYCARVLYDSSGFYNWFDPWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYEIPPWTFGQGTKVEIK,IGHV3-13 (Human),IGHJ5 (Human),IGKV1-39 (Human),IGKJ1 (Human),ARVLYDSSGFYNWFDP,QQSYEIPPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2111_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2677,Ab,"SARS-CoV1,SARS-CoV2",,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QLQLQESGPGLVKPSETLSLTCTVSGGSISSSSYYWGWIRQPPGKGLEWIGSMYYSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARLLWLRGHFDYWGQGTLVTVSS,NFMLTQPHSVSESPGKTVTISCTGSSGSIASNYVQWYQQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSSNYWVFGGGTKLTVL,IGHV4-39 (Human),IGHJ4 (Human),IGLV6-57 (Human),IGLJ3 (Human),ARLLWLRGHFDY,QSYDSSNYWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2677_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2354,Ab,"SARS-CoV1,SARS-CoV2",,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVHLVGSGGGLIQPGGSLRLSCAASGFTVSSNFMSWVRQAPGKGLEWVSIIHNGGDSYYTDSVKGRFTISRDNSKNTLYLQMNNLRAEDTAVYYCASSSWLRGAFDIWGQGTMVTVSS,NFMLTQPHSVSESPGKTVTISCTGSSGSIASNYVQWYQQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSSKYVVFGGGTKLTVL,IGHV3-53 (Human),IGHJ3 (Human),IGLV6-57 (Human),IGLJ2 (Human),ASSSWLRGAFDI,QSYDSSKYVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2354_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2842,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGDTFTTYYIHWVRQAPGQGLEWMGIINPSGGSRSYAQKFQGRISMTSDTSTSTVYMELSSLRSEDTAVYYCARGYGFVPNVLYYFDYWGQGILVTVSS,NFMLTQPHSVSESPGKTVTISCTRSSGSIASSYVQWYQQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSSDVVFGGGTKLTVL,IGHV1-46 (Human),IGHJ4 (Human),IGLV6-57 (Human),IGLJ2 (Human),ARGYGFVPNVLYYFDY,QSYDSSDVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2842_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2734,Ab,"SARS-CoV1,SARS-CoV2",,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSETLSLTCTVSGGSVSSGSYYWSWIRQPPGKGLECIGYIYYSGSSNYNPSLKSRVTISVDTSKNQFSLKMSSVTAADTAVYYCAGSPVPPTIVGASYWGQGTLVTVSS,NFMLTQPHSVSESPGKTVTFSCTGSSGSIASNYVQWYQQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDGINRWLVFGGGTKLTVL,IGHV4-61 (Human),IGHJ4 (Human),IGLV6-57 (Human),IGLJ2 (Human),AGSPVPPTIVGASY,QSYDGINRWLV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2734_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2821,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKTAGGTSSSYAISWVRQAPGQGLEWMGRIIPILGVAIYAQKFQGRVTITADKSTSTAYMELNSLRSEDTAVYYCTTTQGGDYGDNLYYLDYWGQGTLVTVSS,SYVLTQPPSVSVAPGKTASITCEGNNIGSKSVHWYQQKPGQAPVLVIYYDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDSSSDRLYVFGTGTKVTVL,IGHV1-69 (Human),IGHJ4 (Human),IGLV3-21 (Human),IGLJ1 (Human),TTTQGGDYGDNLYYLDY,QVWDSSSDRLYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2821_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2358,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFSFSSYVMNWVRQAPGKGLEWVAVISYDGSSKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDIDSGYDPTPVFDYWGQGTLVTVSS,DIQMTQSPSSLSACVGDRVTITCRASQSISSYLNWYQQKPGKGPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSSLSITFGQGTRLEIK,IGHV3-30-3 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ5 (Human),ARDIDSGYDPTPVFDY,QQSYSSLSIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2358_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2357,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGDLVKPGRSLRLSCSASGFTFGDYTMSWFRQAPGKGLEWVAFIRSKAYGGTTEYAASVIGRFTISRDDSKSIAYLQMNSLKSEDTAVYYCSRVRGSFYGSVGKNYGMDVWGQGTTVTVSS,DIVMTQSPLSLPVTPGEPASISCRSSQSLLHSNGYNYLDWYLQKPGQSPQLLIYLGSTRASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQALQTPLYTFGQGTKLEIK,IGHV3-49 (Human),IGHJ6 (Human),IGKV2-28 (Human),IGKJ2 (Human),SRVRGSFYGSVGKNYGMDV,MQALQTPLYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2357_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2878,Ab,"SARS-CoV1,SARS-CoV2",,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFSRHWMTWVRQAPGKGLEWVANIKQDGSEKYYVDSVKGRLTISRDNAKNSLYLQMNSLRAEDTAVYYCARLGFYYGGADYWGQGTLVTVSS,NFMLTQPHSVSESPGKTVTISCTGSSGSIASNYVQWYQQRPGSAPTTVISEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDGINRAWVFGGGTKLTVL,IGHV3-7 (Human),IGHJ4 (Human),IGLV6-57 (Human),IGLJ3 (Human),ARLGFYYGGADY,QSYDGINRAWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2878_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2464,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSQTLSLTCTVSGGSISSGGYYWSWIRQHPGKGLEWIGYISYSGSTYYNPSLKSRLTISVDTSKNQFSLKLSSVTAADTAVYYCARDLGDGYNLRVPAYFDLWGRGTLVTVSS,SYELTQPPSVSVSPGQTARITCSGDALPNQYAYWYHQKPGQAPVVVIYKDSERPSGIPQRFSGSSSGTTVTLTISGVQAEDEADYYCQSADSSGYVFGTGTKVTVL,IGHV4-31 (Human),IGHJ2 (Human),IGLV3-25 (Human),IGLJ1 (Human),ARDLGDGYNLRVPAYFDL,QSADSSGYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2464_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2808,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGFTFMSSAVQWVRQARGQRLEWIGWIVIGSGNTNYAQKFQERVTITRDMSTSTAYMELSSLRSEDTAVYYCAAPYCSSISCNDGFDIWGQGTMVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPDDIATYYCQQYDNLPLAFGPGTKVDIK,IGHV1-58 (Human),IGHJ3 (Human),IGKV1-33 (Human),IGKJ3 (Human),AAPYCSSISCNDGFDI,QQYDNLPLA,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2808_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2863,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYYLHWVRQAPGQGLEWMGIINPSGGSTTYAQKFQGRVTMTRDTSTSAVYMELRSLRSEDTAVYYCARENDYGDYVEPRDYYYGMDVWGQGTTVTVSS,SYELTQPPSVSVSPGQTARITCSGDALPKQYAYWYQQKPGQAPVLVIYKDSERPSGIPERFSGSSSGTTVTLTISGVQAEDEADYYCQSADSSAAYVVFGGGTKLTVL,IGHV1-46 (Human),IGHJ6 (Human),IGLV3-25 (Human),IGLJ2 (Human),ARENDYGDYVEPRDYYYGMDV,QSADSSAAYVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2863_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-3029,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGVVQPGGSLRLSCAASGFTFDDYAMHWVRQAPGKGLEWVSLISGDGGNTYYADSVKGRFTISRDNSKNSLYLQMNSLRTEDTALYYCAKDEMAYPPSHHYYYYYMDVWGKGTTVTVSS,SYELTQPPSVSVSPGQTARITCSTDALPNEYIYWYQQKPGQAPVLVIYKDSERPSGIPERFSGSSSGTTVTLTISGVQAEDEADYYCQSVDSSGTYPHVIFGGGTKLTVL,IGHV3-43 (Human),IGHJ6 (Human),IGLV3-25 (Human),IGLJ2 (Human),AKDEMAYPPSHHYYYYYMDV,QSVDSSGTYPHVI,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-3029_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2462,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSSDLHWVRQATGKGLEWVSAIGTAGDTYYLGSVKGRFTISRENGKNSLYLQMNSLRAGDTAVYYCARVLYDSSGFYNWFDPWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLKSGVPSRFGGSGSGTDFTLTISSLQPEDFATYYCQQSYEMPPWTFGQGTKVEIE,IGHV3-13 (Human),IGHJ5 (Human),IGKV1-39 (Human),IGKJ1 (Human),ARVLYDSSGFYNWFDP,QQSYEMPPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2462_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2083,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSNYGMHWVRQAPGKGLEWVAVMSYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKNLGPYCSGGTCYSLVGDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYANLPFTFGPGTKVDIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ3 (Human),AKNLGPYCSGGTCYSLVGDY,QQYANLPFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2083_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2313,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGRSLRLSCAASGFTFDDYAMHWVRQAPGKGLEWVSGISWNSGSIGYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTALYYCAKVSSITSLLGYYFDSWGQGTLVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQHRSNWPPRLTFGGGTKVEIK,IGHV3-9 (Human),IGHJ4 (Human),IGKV3-11 (Human),IGKJ4 (Human),AKVSSITSLLGYYFDS,QHRSNWPPRLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2313_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2231,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGRSLRLSCAASGFTFDDYAMNWVRQPPGKGLEWVSGISWNSDSIGYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAMYYCAKGRGAGYTSYMDVWGKGTTVTVSS,SYVLTQPPSVSVAPGKTARITCEGNNIGSKSVHWYQQKPGQAPVLVVYDDSGRPSGIPERFSGSNSGNTATLTISRVEAGDEADYFCQVWDSSSDHHVVFGGGTKLTVL,IGHV3-9 (Human),IGHJ6 (Human),IGLV3-21 (Human),IGLJ2 (Human),AKGRGAGYTSYMDV,QVWDSSSDHHVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2231_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2516,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTNYYMHWVRQAPGQGLEWMGILNPGAGSTSYAQKFQGRVTMTSDTSTNTVYMQLSSLKSEDTAVYYCARDQQIVPHADGFDIWGQGTMVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPPRTWTFGQGTKVEIK,IGHV1-46 (Human),IGHJ3 (Human),IGKV3-11 (Human),IGKJ1 (Human),ARDQQIVPHADGFDI,QQRSNWPPRTWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2516_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2817,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFRSYDMHWVRQVTGKGLEWVSTIGTAGDTYYPGSVKGRFTISRENAKNSLYLQMNSLRAGDTAVYYCARVFETKVIRGGRYYYYYYMDVWGKGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSNPSYTFGQGTKLEIK,IGHV3-13 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ2 (Human),ARVFETKVIRGGRYYYYYYMDV,QQSYSNPSYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2817_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2331,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QLQLQESGPGLVKPSETLSLTCTVSGGSISSSSYYWGWIRQPPGNGLEWIGSIYYSGSTYYNPSLKGRVSISVDTSKNQFSLKLSSVTAADTAVYYCARILVIFTLNWFDPWGQGTLVTVSS,NFMLTQPHSVSESPGKTVTISCTGSSGSIASNYVQWYQQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSGNPIFGGGTKLTVL,IGHV4-39 (Human),IGHJ5 (Human),IGLV6-57 (Human),IGLJ2 (Human),ARILVIFTLNWFDP,QSYDSGNPI,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2331_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2765,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGRSLRLSCAASGFTFDDYAMNWVRQPPGKGLEWVSGISWNSDSIGYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAMYYCAKGRGAGYTSYMDVWGKGTTVTVSS,SYVLTQPPSVSVAPGKTARITCEGNNIGSKSVHWYQQKPGQAPVLVVYDDSGRPSGIPERFSGSNSGNTATLTISRVEAGDEADYFCQVWDSSSDHHVVFGGGTKLTVL,IGHV3-9 (Human),IGHJ6 (Human),IGLV3-21 (Human),IGLJ2 (Human),AKGRGAGYTSYMDV,QVWDSSSDHHVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2765_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2758,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYDMHWVRQATGKGLEWVSAIGTAGDTYYPDSVKGRFTISRENAKNSLYLQMNSLRAGDTAVYYCARGGDSGYDLGAWYFDLWGRGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSVSIYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTVSSLQPEDFATYYCQQSYSMPPITFGQGTRLEIK,IGHV3-13 (Human),IGHJ2 (Human),IGKV1-39 (Human),IGKJ5 (Human),ARGGDSGYDLGAWYFDL,QQSYSMPPIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2758_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2944,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFRRYGMYWVRQAPGKGLEWVAVISYDGTDKYYTDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKKGGPYCGGGNCYAGYFDYWGQGILVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKAGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPDDIATYYCQQYDNLPLAFGPGT KVDVK,IGHV3-30 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ3 (Human),AKKGGPYCGGGNCYAGYFDY,QQYDNLPLA,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2944_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2031,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QVTLKESGPVLVKPTETLTLTCTVSGFSLSNARMGVSWIRQPPGKALEWLAHIFWNDENSYSTSLKTRLTISKDTSKSQVVLNMTNMDPVDTATYYCARTEWLLSDNWFDSWGQGTLVTVSS,SYELTQPPSVSVSPGQTARITCSGDAWPNQYAYWYQQKPGQAPVLVIYKDTERPSGIPERFSGSSSGTTVTLTISGVQAEDEADYFCQSSDSSGVVFGGGTKLTVL,IGHV2-26 (Human),IGHJ5 (Human),IGLV3-25 (Human),IGLJ3 (Human),ARTEWLLSDNWFDS,QSSDSSGVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2031_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2329,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLLESGGGLVQPGGSLRLSCAASGFTFNNYAMSWVRQAPGKGLEWVSAIGGSGGSTYYADSVKGRFTVSRDNSENTLYLQMSSLRAEDTAVYYCARVEGDWLLGGPYYHYYGMDVWGQGTTVTVSS,QSVLTQPPSASGTPGQRVTISCSGSSSNIGSNYVYWYQQLPGTAPKLLISRNNQRPSGVPDRFSGSKSGTSASLAISGLRSEDEADYYCAAWDDSLSSWVFGGGTKLTVL,IGHV3-23 (Human),IGHJ6 (Human),IGLV1-47 (Human),IGLJ3 (Human),ARVEGDWLLGGPYYHYYGMDV,AAWDDSLSSWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2329_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2783,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGIIPIFGTANYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYCARGLTGSSAYKDEIYFDYWGQGTLVTVSS,SYELTQPPSVSVSPGQTARITCSGDALPKQYAYWYQQKPGQAPVLVIYKDTERPSGIPERFSGSSSGTTVTLTISGVQAEDEADYYCQSADSSGSRFGGGTKLTVL,IGHV1-69 (Human),IGHJ4 (Human),IGLV3-25 (Human),IGLJ2 (Human),ARGLTGSSAYKDEIYFDY,QSADSSGSR,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2783_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2894,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQSGGSLRLSCAASGFTFSTYGMHWVRQAPGKGLEWVAIISYDGINKYYADSVKGRFTISRDNSKNTVYLQMNSLRTEDTAMYYCAKGDGSYLMDYFDYWGQGTLVTVSS,EIVMTQSPATLSVSPGERATLSCRASQSVSNNLAWYQQKPGQAPRLLIYGASTRATGIPVRFSGSGSGTEFTLTISSLQSEDFAVYYCQQYDDWPPEVTFGG GTKVEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV3-15 (Human),IGKJ4 (Human),AKGDGSYLMDYFDY,QQYDDWPPEVT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2894_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2794,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,EAQLVESGGGLVQPGGSLRLSCEASGFIFSSYWMSWVRQAPGKGLEWVANIKQDGSEKYYVDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARVNDGRPNPLEYYFDYWGQGTLVTVSS,SYELTQPPSVSVSPGQTARITCSGDALPKQYAYWYHQKPGQAPVLVIYKDSERPSGIPERFSGSSSGTTVTLTISGVQAEDEADYYCQSADSSGTSVLFGGGTKLTVL,IGHV3-7 (Human),IGHJ4 (Human),IGLV3-25 (Human),IGLJ2 (Human),ARVNDGRPNPLEYYFDY,QSADSSGTSVL,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2794_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2749,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQQWGAGLLKPSETLSLTCAVSGGSFSAYYWSWIRQPPGKGLEWIGEINHSGSTNYNPSLRSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARVGYSQGYYYYYMDVWGKGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISNYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFSLTISSLQPEDFATYSCQQSYTTLLTFGGGTKVEIK,IGHV4-34 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ4 (Human),ARVGYSQGYYYYYMDV,QQSYTTLLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2749_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2709,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSNYGMHWVRQAPGKGLEWVAVMSYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKNLGPYCSGGTCYSLVGDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYANLPFTFGPGTKVDIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ3 (Human),AKNLGPYCSGGTCYSLVGDY,QQYANLPFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2709_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2736,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSDYAMHWVRQAPGKGLEWVADISFDGSNKYYADSVKGRFTISRDSSENTLYLQMDSLRADDTAVYYCARDLSTTWYLEMWGPDAFDIWGQGTVVTVSS,DIQMTQSPSTLSASIGDRVTITCRASQSISSWLAWYQQIPGKAPKLLIYKASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNSYPYTFGQGTKLEIK,IGHV3-30-3 (Human),IGHJ3 (Human),IGKV1-5 (Human),IGKJ2 (Human),ARDLSTTWYLEMWGPDAFDI,QQYNSYPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2736_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2382,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCVASGFTFSSYGMHWVRQAPGKGLEWVAVISFDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVFYCAKDLPPYASGWYEGGFDYWGRGTQVTVSS,QTVVTQEPSLTVSPGGTVTLTCASSTGAVTSGYFPNWFQQKPGQAPRALIFSTNNRHSWTPARFSGSLLGDKAALTLSGVQPEDEAEYYCLLYYGGPWVFGGGTKLTVL,IGHV3-30 (Human),IGHJ4 (Human),IGLV7-43 (Human),IGLJ3 (Human),AKDLPPYASGWYEGGFDY,LLYYGGPWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2382_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2465,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSGTLSLTCAVSGGSISSSNWWSWVRQPPGKGLEWIGEIYHGGSTDYNPSLKSRVTISVDKSKNQFSLKLTSVTAADTAVYYCARVDHVNVRDYWGPGTLVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSKRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSIPYVFGTGTKVTVL,IGHV4-4 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ1 (Human),ARVDHVNVRDY,SSYTSSSIPYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2465_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2705,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSYKYFADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDQGTVVTHFDYWGQGTLVTVSS,DIQMTQSPSSLSTSVGDRVTITCRASQSIRSYLNWYQQKPGKAPKLLIYVASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPPWTFGQGTKVEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ1 (Human),ARDQGTVVTHFDY,QQSYSTPPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2705_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2713,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGVVQPGGSLRLSCAASGFTFDDYAMHWVRQAPGKGLEWVSLISGDGGNTYYADSVKGRFTISRDNSKNSLYLQMNSLRTEDTALYYCAKDEMAYPPSHHYYYYYMDVWGKGTTVTVSS,SYELTQPPSVSVSPGQTARITCSTDALPNEYIYWYQQKPGQAPVLVIYKDSERPSGIPERFSGSSSGTTVTLTISGVQAEDEADYYCQSVDSSGTYPHVIFGGGTKLTVL,IGHV3-43 (Human),IGHJ6 (Human),IGLV3-25 (Human),IGLJ2 (Human),AKDEMAYPPSHHYYYYYMDV,QSVDSSGTYPHVI,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2713_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2848,Ab,"SARS-CoV1,SARS-CoV2",,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSRYAMYWVRQAPGKGLEWVALISYDGRNEYYADSVKGRFTISRDNSKNTLYLQMNSLRAGDSAVYYCARDLAYHPYRDYGDDDYYYYYGMDVWGQGTTVTVSS,SYELTQPPSVSVSPGQTARITCFGDALPKQYAYWYQQKPGQGPVLVIYKDSERPSGIPERFSGSTSGTTVTLTISGVQAEDEADYYCQSADSSGTYRVFGGGTKLTVL,IGHV3-30 (Human),IGHJ6 (Human),IGLV3-25 (Human),IGLJ3 (Human),ARDLAYHPYRDYGDDDYYYYYGMDV,QSADSSGTYRV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2848_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2678,Ab,"SARS-CoV1,SARS-CoV2",,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGVVRPGGSLRLSCAASGFIFDDYDMTWVRQAPGKGLEWVSGISWNGGNTGYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTALYHCAVIMSPIPRYSGYDWAGGAFDIWGQGTMVTVSS,SSELTQDPAVSVALGQTVRITCQGDSLRSYYASWYQQKPGQVPILVIYDKNNRPSGIPDRFSGSSSGNTASLTITGAQAEDEADYYCNSRDSSGNAVVFGGGTKLTVL,IGHV3-20 (Human),IGHJ3 (Human),IGLV3-19 (Human),IGLJ3 (Human),AVIMSPIPRYSGYDWAGGAFDI,NSRDSSGNAVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2678_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2722,Ab,"SARS-CoV1,SARS-CoV2",,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVRLVQSGAEVKKPGSSVKVSCKASGGTFSDYAISWVRQAPGQGLEWMGGIIPIFGTANYAQKFQGRVTITADEFTITAYMELSSLRSEDTAVYYCARLSGSGWLGYAMDVWGQGTTVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGGYNFVSWYQQHPGKAPKLIIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCTSYTSSSTLNVVFGGGTKLTVL,IGHV1-69 (Human),IGHJ6 (Human),IGLV2-14 (Human),IGLJ2 (Human),ARLSGSGWLGYAMDV,TSYTSSSTLNVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2722_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2258,Ab,"SARS-CoV1,SARS-CoV2",,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGVVRPGGSLRLSCAASGFTLDDYGLSWVRHAPGKGLEWVSGINWNGGRTAYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTALYHCARARGPSEQYYDLLTGYYDAFDIWGQGTMVTVSS,EIVLTQSPGTLSLSPGERATLSCGASQSISSSYLAWYQQKPGQAPRLLIYGASSRAAGIPDRFSGSGSGTDFTLTISRLEPEDFAVYFCQQYGGSLTFGGGTKVEIK,IGHV3-20 (Human),IGHJ3 (Human),IGKV3-20 (Human),IGKJ4 (Human),ARARGPSEQYYDLLTGYYDAFDI,QQYGGSLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2258_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2753,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYDMHWVRQATGKGLEWVSTIGTAGDTYYPDSVKGRFTISRENAKNSLFLQMNSLRAGDTAVYYCARVDFDILTGYYSNWGQGTLVTVSS,DFQMTQSPSSLSASVGDRVTITCRASQSISTYLNWYQQKPGKAPNLLIFAASSLHSGVPSRFSGSGSGTDFTLSISSLQPEDFATYYCQQSYSSEWTFGQGTKVEIK,IGHV3-13 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ1 (Human),ARVDFDILTGYYSN,QQSYSSEWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2753_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2797,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVQSGAEVKKPGESLKISCKGSGYSFTSYWIGWVRQMPGKGLEWMGIIQPGDSDTRYSPSFQGQVTMSADKSTSTAYLQWSSLKASDTAMYYCARDLIIESTIAARPGYYGMDVWGQGTTVTVSS,SYELTQPPSVSVSPGQTARITCSGDAFPKQYGYWYQQKPGQAPVLVIYKDSERPSGIPERFSGSSSGTTVTLTISGVQAEDEADYYCQSADSRGAVFGSGTKVTVL,IGHV5-51 (Human),IGHJ6 (Human),IGLV3-25 (Human),IGLJ1 (Human),ARDLIIESTIAARPGYYGMDV,QSADSRGAV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2797_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2032,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGDTFSSYYLHWVRQAPGQGLQWMGISNPSGGSTTYAQKFQGRVTMTGDTSTSTVYMELSSLRSEDTAVYYCARGGLVPAARNAFDIWGQGTMVTVSS,DIQMTQSPSTLSASVGDRVTITCRASQSISSWLAWYQQKPGKAPKLLIYKASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNSYSWTFGQGTKVEIK,IGHV1-46 (Human),IGHJ3 (Human),IGKV1-5 (Human),IGKJ1 (Human),ARGGLVPAARNAFDI,QQYNSYSWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2032_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2740,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFRRYGMYWVRQAPGKGLEWVAVISYDGTDKYYTDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKKGGPYCGGGNCYAGYFDYWGQGTLVTVSS,DIQMTQSPSSLSASIGDRVTITCRASQNIRSYLNWYQHKPGKAPKLLIYAASTLQSGVPSRFSGSESGTDFTLTISSLQPEDFATYYCQQSSSSPITFGQGTKLEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ2 (Human),AKKGGPYCGGGNCYAGYFDY,QQSSSSPIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2740_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2287,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKVSGYTFTSYDINWVRQATGQGLEWMGWMNPNSGHTGYAQKFQGRVTMTRNTSISTAYMELSSLRYEDTAVYYCARGYGLTYYMDVWGKGTTVTVSS,SYVLTQPPSVSVAPGKTARITCGGNNIGSKNVHWYQQKPGQAPVLVVYDDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDSSYYHPVVFGGGTKLTVL,IGHV1-8 (Human),IGHJ6 (Human),IGLV3-21 (Human),IGLJ2 (Human),ARGYGLTYYMDV,QVWDSSYYHPVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2287_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2514,Ab,"SARS-CoV1,SARS-CoV2",,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGVVRPGGSLRLSCAASGFIFDDYDMTWVRQAPGKGLEWVSGINWNGGSTGYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTALYHCAVIMSPIPRYSGYDWAGDAFDIWGQGTMVTVSS,SSELTQDPAVSVALGQTVRITCQGDSLRSYYASWYQQKPGQVPILVIYDKNNRPSGIPDRFSGSSSGNTASLTITGAQAEDEADYYCNSRDSSGNAVVFGGGTKLTVL,IGHV3-20 (Human),IGHJ3 (Human),IGLV3-19 (Human),IGLJ2 (Human),AVIMSPIPRYSGYDWAGDAFDI,NSRDSSGNAVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2514_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2717,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKTPGASVKVSCKASGYTFTSYDINWVRQATGQGPEWMGWMNPNSGNTGYAHKFQGRVTMTRNTSISTAYMELSSLRSEDTAVYYCARGPSILTGFYNPLDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSIISYLNWYHQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPYTFGQGTKLEIK,IGHV1-8 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ2 (Human),ARGPSILTGFYNPLDY,QQSYSTPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2717_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2417,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQQWGAGLLKPSETLSLTCAVYGGSFSGYYWNWLRQPPGKGLEWIGEINHSGSTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARVGGYYYYYMDVWGKGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSITSYLNWYQQRPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLSISSLQPEDFATYYCQQSYTTLLTFGGGTKVEIK,IGHV4-34 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ4 (Human),ARVGGYYYYYMDV,QQSYTTLLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2417_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2015,Ab,"SARS-CoV1,SARS-CoV2",,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGRSLRLSCAASGFTFDDYAMHWVRQAPGKGLEWVSGISWNSGSIGYADSVKGRFTISRDNAKNSLYLQMNSLRTEDTALYYCAMGPFGELLPYYFDYWGQGTLVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDTSNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPPYTFGQGTKLEIK,IGHV3-9 (Human),IGHJ4 (Human),IGKV3-11 (Human),IGKJ2 (Human),AMGPFGELLPYYFDY,QQRSNWPPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2015_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2461,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSQTLSLTCTVSGGSISSGGYFWSWIRQHPGKGLEWIGSIYYSGSTYYNPSLRSRITISVDTSKNQFSLKLSSVTAADTAVYYCARGGSGSYSLFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDITNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDFATYYCQQYDNLYSVHFGQGTKLEIK,IGHV4-31 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ2 (Human),ARGGSGSYSLFDY,QQYDNLYSVH,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2461_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2873,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGLVKPGGSLRLSCAASGFTFSDYYMSWIRQAPGKGLEWVSYISSSGITIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCTGVVAAPAEYFQHWGQGTLVTVSS,SYVLTQPPSVSVAPGKTARITCGGNNIGSKSVHWYQQKPGQAPVLVVYDDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDSSSDPFYVFGTGTKVTVL,IGHV3-11 (Human),IGHJ1 (Human),IGLV3-21 (Human),IGLJ1 (Human),TGVVAAPAEYFQH,QVWDSSSDPFYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2873_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2953,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QITLKESGPTLVKPTQTLTLTCTFSGFSLSTKRVGVGWIRQPPGKALEWLALIYWDDDQRYSPSLKSRLTITKDTSKNQVVLTMTNMDPVDTATYYCAHSGPPDLSPVLSQGWFDPWGQGTLVTVSS,SYELTQPPSVSVSPGQTARITCSGDALPKQYAYWYQQKPGQAPVLVIYRDSERPSGIPERFSGSTSGTTVTLTISGVQAEDEADYYCQSADSTGWVFGGGTKLTVL,IGHV2-5 (Human),IGHJ5 (Human),IGLV3-25 (Human),IGLJ3 (Human),AHSGPPDLSPVLSQGWFDP,QSADSTGWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2953_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2828,Ab,"SARS-CoV1,SARS-CoV2",,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVKPGGSLRLSCAASGFTFRDYSMNWVRQAPGKGLEWVSSISSGGSYIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARGGSILWWLIDYWGQGTLVTVSS,NFMLTQPHSVSESPGKTVTISCTGSSGSIASNYVQWYQQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSTSRVVFGGGTKLTVL,IGHV3-21 (Human),IGHJ4 (Human),IGLV6-57 (Human),IGLJ2 (Human),ARGGSILWWLIDY,QSYDSTSRVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2828_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2554,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSHYMHWVRQAPGQGLEWMGIINPSGGSTSYAQKFQGRVTMTSDTSTSTVYMELSSLRSEDTAMYYCARDVFWVPAASSFDYWGQGTLVTVSS,DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYLGTFGQGTKVEIK,IGHV1-46 (Human),IGHJ4 (Human),IGKV1-9 (Human),IGKJ1 (Human),ARDVFWVPAASSFDY,QQLNSYLGT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2554_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2552,Ab,"SARS-CoV1,SARS-CoV2",,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGLVKPGGSLRLSCAASGFTFSDYYMSWIRQAPGKGLECVSYISSSGSTIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARDPIRDGVWGLNENDYWGQGTLVTVSS,QPVLTQSSSASASLGSSVKLTCTLSSGHSSYIIAWHQQQPGKAPRYLMKLEGSGSYNKGSGVPDRFSGSSSGADCYLTISNLQSEDEADYYCETWDSNTRVFAGGTKLTVL,IGHV3-11 (Human),IGHJ4 (Human),IGLV4-60 (Human),IGLJ3 (Human),ARDPIRDGVWGLNENDY,ETWDSNTRV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2552_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2906,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVQSGAEVKKPGESLKISCKGSGYSFTSYWVGWVRQMPGKGLEWMGIIYPGDSDTRDSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARLGSESKIDYYYYGMDVWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRPSQSITTYLNWYQQKPGKAPRLLIYAVSSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPPTFGQGTRLEIK,IGHV5-51 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ5 (Human),ARLGSESKIDYYYYGMDV,QQSYSTPPT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2906_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2007,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSRYGMHWVRQAPGKGLEWVGIISYDASDKTYAESVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKVSATYYYYYYGMDVWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDISTYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLLFTFGPGTKVDVK,IGHV3-30 (Human),IGHJ6 (Human),IGKV1-33 (Human),IGKJ3 (Human),AKVSATYYYYYYGMDV,QQYDNLLFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2007_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2450,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSTYGMHWVRQAPGKGLEWVAVILYDGSNRYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKQGGLYCSGTNCWGGYLDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDISNYLHWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYHNLPPITFGQGTRLEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ5 (Human),AKQGGLYCSGTNCWGGYLDY,QQYHNLPPIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2450_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2342,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QITLKESGPTLVKPTQTLTLTCTFSGFSLNTSGVGVGWIRQPPGKALEWLALIYWDDDKRYNPSLKSRLTITKDTSKNQVVLTMTNMDPVDTATYYCAHRPPSYHGWCYFDYWGQGNLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISIYLNWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTHMSTFGQGTKLEIK,IGHV2-5 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ2 (Human),AHRPPSYHGWCYFDY,QQSYSTHMST,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2342_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2256,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGSELTKPGASVKVSCKASGYTFTSYAMNWVRQAPGQGLEWMGWINTDTGNPTYAQGFTGRFVFSLDTSVSTAYLQISSLKAEDTAVYYCARDPSYCSSTRCYTVGWFDPWGQGTLVTVSS,SYVLTQPPSVSVAPGKTARITCGGNNIGSKNVHWYQQKPGQAPVVVVYDDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDSSSDPVVFGGGTKLTVL,IGHV7-4-1 (Human),IGHJ5 (Human),IGLV3-21 (Human),IGLJ2 (Human),ARDPSYCSSTRCYTVGWFDP,QVWDSSSDPVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2256_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2834,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QITLKESGPTLVKPTQTLTLTCTFSGFSLSTSGVGVAWIRQPPGKALEWLALIYWDDDKRYSPSLKSRLTITKDTSKNQVVLTMTNMDPVDTATYYCAHRLPTPQLLPSFENWFDPWGQGTLVTVSS,QSVLTQPPSVSEAPRQRVTISCSGGSSNIGNNAVNWYQQLPGKAPKLLIYYDDLLPSGVSDRFSGSKSGTSASLAISGLQSEDEADYYCASWDDSLIGPVFGGGTKLTVL,IGHV2-5 (Human),IGHJ5 (Human),IGLV1-36 (Human),IGLJ2 (Human),AHRLPTPQLLPSFENWFDP,ASWDDSLIGPV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2834_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2082,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGVVRPGGSLRLSCAASGFIFDDYDMTWVRQAPGKGLEWVSGISWNGGNTGYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTALYHCAVIMSPIPRYSGYDWAGGAFDIWGQGTMVTVSS,SSELTQDPAVSVALGQTVRITCQGDSLRSYYASWYQQKPGQVPILVIYDKNNRPSGIPDRFSGSSSGNTASLTITGAQAEDEADYYCNSRDSSGNAVVFGGGTKLTVL,IGHV3-20 (Human),IGHJ3 (Human),IGLV3-19 (Human),IGLJ3 (Human),AVIMSPIPRYSGYDWAGGAFDI,NSRDSSGNAVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2082_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2128,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QLQLQESGPGLVKPSETLSLTCTVSGGSISSSSYYWGWIRQPPGNGLEWIGSIYYSGSTYYNPSLKGRVSISVDTSKNQFSLKLSSVTAADTAVYYCARILVIFTLNWFDPWGQGTLVTVSS,NFMLTQPHSVSESPGKTVTISCTGSSGSIASNYVQWYQQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSGNPIFGGGTKLTVL,IGHV4-39 (Human),IGHJ5 (Human),IGLV6-57 (Human),IGLJ2 (Human),ARILVIFTLNWFDP,QSYDSGNPI,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2128_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2094,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGVVRPGGSLRLSCAASGFIFDDYDMTWVRQAPGKGLEWVSGINWNGGSTGYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTALYHCAVIMSPIPRYSGYDWAGDAFDIWGQGTMVTVSS,SSELTQDPAVSVALGQTVRITCQGDSLRSYYASWYQQKPGQVPILVIYDKNNRPSGIPDRFSGSSSGNTASLTITGAQAEDEADYYCNSRDSSGNAVVFGGGTKLTVL,IGHV3-20 (Human),IGHJ3 (Human),IGLV3-19 (Human),IGLJ2 (Human),AVIMSPIPRYSGYDWAGDAFDI,NSRDSSGNAVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2094_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2055,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGRSLRLSCAASGFTFDDYAMNWVRQPPGKGLEWVSGISWNSDSIGYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAMYYCAKGRGAGYTSYMDVWGKGTTVTVSS,SYVLTQPPSVSVAPGKTARITCEGNNIGSKSVHWYQQKPGQAPVLVVYDDSGRPSGIPERFSGSNSGNTATLTISRVEAGDEADYFCQVWDSSSDHHVVFGGGTKLTVL,IGHV3-9 (Human),IGHJ6 (Human),IGLV3-21 (Human),IGLJ2 (Human),AKGRGAGYTSYMDV,QVWDSSSDHHVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2055_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2158,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSQTLSLTCTVSGGSISSGGYFWSWIRQHPGKGLEWIGSIYYSGSTYYNPSLRSRITISVDTSKNQFSLKLSSVTAADTAVYYCARGGSGSYSLFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDITNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDFATYYCQQYDNLYSVHFGQGTKLEIK,IGHV4-31 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ2 (Human),ARGGSGSYSLFDY,QQYDNLYSVH,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2158_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2016,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKVSGYTLTELSIHWVRQAPGKGLEWMGGFDPEDAETIYAQNFQGRVTMTEDTSTDTAYMELSSLRSEDTALYYCAAAPAVMTAGWFDPWGQGTLVSVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGGYHYVSWYQHHPGKAPKLIIYDVIKRPSGVSNRFSGSKSGNTASLTISGLQAEDEAYYYCSSYTSSTTWVFGGGTRLTVL,IGHV1-24 (Human),IGHJ5 (Human),IGLV2-14 (Human),IGLJ3 (Human),AAAPAVMTAGWFDP,SSYTSSTTWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2016_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2021,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; NTD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKVSGYTLIELSIHWVRQAPGKGLEWMGGFDPEDVETIYAQKFQGRVTMTEDTSTDTAYMELSSLTSEDRAVYYCATQPAAIGGTPPYYWGQGTLVTVSS,QSVLTQPPSASGTPGQRVTISCSGSSSNIGSNYVYWYQQLPGTAPKLLIYRNNQRPSGVPDRFSGSKSGTSASLAISGLRSEDEADYYCAAWDASLSGHVVFGGGTKLTVL,IGHV1-24 (Human),IGHJ4 (Human),IGLV1-47 (Human),IGLJ2 (Human),ATQPAAIGGTPPYY,AAWDASLSGHVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2021_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2026,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; NTD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKVSGYTLTELSIHWVRQAPGKGLEWMGGFDPEDGETVYAQKFQGRVTMTEDTSSDTAYMELSSLRSEDTAVYYCATSFPIRGDPSYYYYYYGMDVWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQGITNYLAWFQQKPGKAPKSLIYAVSSLQSGVPSKFSGSGSGTDFTLTISSLQPEDFATYYCQQYNSYPWTFGQGTKVEIK,IGHV1-24 (Human),IGHJ6 (Human),IGKV1-16 (Human),IGKJ1 (Human),ATSFPIRGDPSYYYYYYGMDV,QQYNSYPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2026_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2146,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; NTD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCEASGFTFSSSEINWVRQAPGKGLEWVSHISSSGSIIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARRSYRSSWYYYYGMDVWGQGTTVTVSS,DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPVTFGQGTKVEIK,IGHV3-48 (Human),IGHJ6 (Human),IGKV1-9 (Human),IGKJ1 (Human),ARRSYRSSWYYYYGMDV,QQLNSYPVT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2146_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2150,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; NTD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSTYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMIGLRAEDTAVYYCARDWAPTYYDMPSAFDIWGQGTMVTVSS,SYVLTQPPSVSVAPGKTARITCGGNNIGNKGVHWYQQKPGQAPVLVVDDDSDRPSGIPERFSGSNSGNTATLIISSVEVGDEADFYCQVWDSSSDHPGVFGGGTKLTVL,IGHV3-30-3 (Human),IGHJ3 (Human),IGLV3-21 (Human),IGLJ3 (Human),ARDWAPTYYDMPSAFDI,QVWDSSSDHPGV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2150_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2190,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; NTD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYEMNWVRQAPGKGLEWVSYISSSGSAIYYADSVKGRFTISRDNAKNSLYLQMNSLRVEDTAVYYCAREARSRYFDWLPSYYFDYWGQGTLVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDIGGYNYVSWYQQHPGKAPKLLIYDVSNRPSGVSTRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSTHVVFGGGTKLTVL,IGHV3-48 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ2 (Human),AREARSRYFDWLPSYYFDY,SSYTSSSTHVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2190_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2199,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; NTD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKVSGYTLTELSIHWVRQAPGKGLEWMGGFDPEDAETIYAQQFQGRVTMTEDTSTDTAYMELSSLKSEDTALYYCATGFAVFGRAAVPYWGQGTLVTVSS,SYELTQPPSVSVSPGQTASITCFGDKLGDKYACWFQQKPGQSPVLIIYQGAKRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCQAWDSSTVVFGGGTKLTVL,IGHV1-24 (Human),IGHJ4 (Human),IGLV3-1 (Human),IGLJ2 (Human),ATGFAVFGRAAVPY,QAWDSSTVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2199_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2210,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; NTD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRVEDTAVYYCARDQEWFRELFLFDYWGQGTLVTVSS,DIQMTQSPSSVSASVGDRVTITCRASQGISSWLAWYQQKPGKAPKLLIYDASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQANSFPPTFGPGTKVDIK,IGHV3-30-3 (Human),IGHJ4 (Human),IGKV1-12 (Human),IGKJ3 (Human),ARDQEWFRELFLFDY,QQANSFPPT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2210_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jun 6, 2021",21st Dec: Added new reference. 6th June: Confirmed association with increased infectivity,Associated with increased infectivity (Y. Liu et al). Complete.
COV2-2212,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; NTD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVKPGGSLRLSCAASGFTFSSYSMNWVRQAPGKGLEWVSSISNSNSFIYYADSMKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARVNGNSNWNFGSYYYYYMDVWGKGTTVTVSS,EIVLTQSPAILSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDTSNRATGIPARFSGSGSGTDFTLTISSLEPEDFAFYYCQQRGNWWTFAQGTKVEIK,IGHV3-21 (Human),IGHJ6 (Human),IGKV3-11 (Human),IGKJ1 (Human),ARVNGNSNWNFGSYYYYYMDV,QQRGNWWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2212_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2215,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; NTD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVKPGGSLRLSCAASGFTFSGYSMNWVRQAPGKGLEWVSSISSSSSYIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARWLQLRSDYYYFGMDVWGQGTTVTVSS,EIVMTQSPATLSVSPGERATLSCRASQSVSNNLAWYQHKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYFCQQCYNWPPWTFGQGTKVEIK,IGHV3-21 (Human),IGHJ6 (Human),IGKV3-15 (Human),IGKJ1 (Human),ARWLQLRSDYYYFGMDV,QQCYNWPPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2215_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2222,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; NTD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSETLSLTCTVSGGSISSYYWSWIRQPPGKGLEWIGYIYYSGSTNYNPSLKSRVTISVDMSKNQFSLKLRSVTAADTAVYYCARAPRERLQWGEYYFDYWGQGTLVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGSYNLVSWYQQHAGKAPKLMIYEVIKRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCCSYAVSTTYVIFGGGTKLTVL,IGHV4-59 (Human),IGHJ4 (Human),IGLV2-23 (Human),IGLJ2 (Human),ARAPRERLQWGEYYFDY,CSYAVSTTYVI,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2222_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2228,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; NTD,B-cells; SARS-CoV2 Human Patient,QVQLQQWGAGLLKPSETLSLTCAVYGGSFSGHYWSWIRQPPGKGLEWIGEINHSGSTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARPPQAARIHYYYYMDVWGKGTTVTVSS,EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNYWPPLTFGGGTKVEIK,IGHV4-34 (Human),IGHJ6 (Human),IGKV3-15 (Human),IGKJ4 (Human),ARPPQAARIHYYYYMDV,QQYNYWPPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2228_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2251,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; NTD,B-cells; SARS-CoV2 Human Patient,QVTLKESGPVLVKPTETLTLTCAVSGFSLSNAKMGVSWIRQPPGKALEWLAHIFSNDEKAYSTSLKTRLTISKDTSKSQVVLTVTNMDPVDTATYYCARIVLGASGTYPSPGFDPWGQGTLVTVSS,QTVVTQEPSLTVSPGGTVTLTCASSAGAVTSGYYPNWFQQKPGQAPRALIYSTANKHSWTLARFSGSLLGGKAALTLSGVQPEDEAEYYCLLYYGGAWVFGGGTKLTVL,IGHV2-26 (Human),IGHJ5 (Human),IGLV7-43 (Human),IGLJ3 (Human),ARIVLGASGTYPSPGFDP,LLYYGGAWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2251_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2257,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; NTD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSQTLSLTCTVSGDSINSGNYYWSWIRQPAGKGLEWIGRMFTSGSTNYNPSLTSRVTMSIDTSKNQFSLNLNSVTAADTAMYYCARGHVAAWESCYYWGQGILVTVSS,NIVMTQSPLSLPVTPGEPASISCRSSQSLLNSNGLTYLDWYLQKPGQSPQLLIYFVSNRASGVSDRFSGSGSGADFTLTISRVEAEDVGVYYCMQALQTPQTFGQGTKVEIK,IGHV4-61 (Human),IGHJ4 (Human),IGKV2-28 (Human),IGKJ1 (Human),ARGHVAAWESCYY,MQALQTPQT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2257_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2260,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; NTD,B-cells; SARS-CoV2 Human Patient,EVQLLESGGGLVHPGGSLRLSCAASGFTFSSYALSWVRQAPGKGLEWVSAISGSGGSTYYADSVKGRFTISRDNSKNTLYLQMNRLRAEDTAVYYCAQMGPLGSTSSAADYWGQGTLVTVSS,SYELTQPPSVSVSPGQTASITCSGDKMGDKYACWYQQKPGQSPVVVIYEDNKRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCQAWDSSLVVFGGGTKLTVL,IGHV3-23 (Human),IGHJ4 (Human),IGLV3-1 (Human),IGLJ2 (Human),AQMGPLGSTSSAADY,QAWDSSLVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2260_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2263,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; NTD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCEASGFTFSSSEINWVRQAPGKGLEWVSHISSSGSIIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARRSYRSSWYYYYGMDVWGQGTTVTVSS,DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPVTFGQGTKVEIK,IGHV3-48 (Human),IGHJ6 (Human),IGKV1-9 (Human),IGKJ1 (Human),ARRSYRSSWYYYYGMDV,QQLNSYPVT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2263_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2293,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; NTD,B-cells; SARS-CoV2 Human Patient,EVQLLQSGGGLVQPGGSLRLSCAASGFTFRNYAMSWVRQAPGKGLEWVSAISGSGGTTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKNERITMLVVVTLFDYWGQGTLVTVSS,QSVLTQPPSVSAAPGQKVTISCSGSSSNIGNNYISWYQQLPGTAPKLLIYDNNKRPSGIPDRFSGSKSGTSATLGITGLQTGDEADYYCGTWDSSLSAVVFGGGTKLTVL,IGHV3-23 (Human),IGHJ4 (Human),IGLV1-51 (Human),IGLJ2 (Human),AKNERITMLVVVTLFDY,GTWDSSLSAVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2293_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2305,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; NTD,B-cells; SARS-CoV2 Human Patient,QLQLQESGPGLVKPSETLSLTCTVSGGSIRSSSYYWGWIRQPPGKGLEWIASIYYSGSTYYNSSLKSRVTISVDTSKNQFSLKVNSMTAADTAVYYCAILWRGSSWADRHYYYYSMDVWGQGTTVTVSS,QSVLTQPPSASGTPGQRVTISCSGSTSNIGSNTVNWYQQLPGTAPKLLIYSNNQRPSGVPDRFSGSKSGPSASLAISGLQSVDEADYYCAAWDDSLNGWVFGGGTKLTVL,IGHV4-39 (Human),IGHJ6 (Human),IGLV1-44 (Human),IGLJ3 (Human),AILWRGSSWADRHYYYYSMDV,AAWDDSLNGWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2305_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2307,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; NTD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCTASGFTFSSYAMHWVRQAPGKGLEWVALISYDGNNKYYADSAKGRFTISRDNSKNTLYLQMNSLRSEDTAVYYCARDLGRGLDPWGQGTLVTVSS,SYELTQSPSVSVSPGQTASITCSGDKLGDKYACWYQQRPGQSPVLVIYQDSQRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCQAWDSSTAVFGGGTKLTVL,IGHV3-30-3 (Human),IGHJ5 (Human),IGLV3-1 (Human),IGLJ3 (Human),ARDLGRGLDP,QAWDSSTAV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2307_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2335,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; NTD,B-cells; SARS-CoV2 Human Patient,QLQLQESGPGLVKPSETLSLTCTVSGGPISSSRYYWGWIRQPPGKGLEWIGSIYYSGSTYYNPSLKSRVTISVDTSKNQFSLKLNSVTAADTAVYYCARHDGSGEMDTITWGPIYYYMDVWGKGTTVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYYVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSTLNVLFGGGTKLTVL,IGHV4-39 (Human),IGHJ6 (Human),IGLV2-14 (Human),IGLJ2 (Human),ARHDGSGEMDTITWGPIYYYMDV,SSYTSSTLNVL,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2335_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2346,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; NTD,B-cells; SARS-CoV2 Human Patient,QVQLQQWGAGLLKPSETLSLTCAVYGGSFSGHYWSWIRQPPGKGLEWIGEINHSGSTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARPPQAARIHYYYYMDVWGKGTTVTVSS,EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNYWPPLTFGGGTKVEIK,IGHV4-34 (Human),IGHJ6 (Human),IGKV3-15 (Human),IGKJ4 (Human),ARPPQAARIHYYYYMDV,QQYNYWPPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2346_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2384,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; NTD,B-cells; SARS-CoV2 Human Patient,QVTLKESGPVLVKPTETLTLTCTVSGFSLSNARMGVSWIRQPPGKALEWLAHIFSGDEKSYSTSLKSRLTISKDTSKSQVVLTMTNMDPLDTATYYCARTTWGTWIQAWYFDIWGRGTLVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDIGSYNLVSWYQQYPGKAPKLMIYEVSKRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCCSYAGGNTFVVFGGGTKLTVL,IGHV2-26 (Human),IGHJ2 (Human),IGLV2-23 (Human),IGLJ2 (Human),ARTTWGTWIQAWYFDI,CSYAGGNTFVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2384_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2394,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; NTD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVKPGGSLRLSCAASGFTFSGYSMNWVRQAPGKGLEWVSSISSSSSYIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARWLQLRSDYYYFGMDVWGQGTTVTVSS,EIVMTQSPATLSVSPGERATLSCRASQSVSNNLAWYQHKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYFCQQCYNWPPWTFGQGTKVEIK,IGHV3-21 (Human),IGHJ6 (Human),IGKV3-15 (Human),IGKJ1 (Human),ARWLQLRSDYYYFGMDV,QQCYNWPPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2394_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2405,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; NTD,B-cells; SARS-CoV2 Human Patient,QLQLQESGPGLVKPSETLSLTCTVSGGSISSSSYYWGWIRQPPGKGLEWIGSFYYSGSTYYNPSLKSRVTISVDTSKNQFSLNLSSVTAADTAVYSCASLWFGDLYSFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTFTCRASQGISNYLAWYQQKPGKVPKLLIYAASTLQSGVPSRFSGIGSGTDFTLTISSLQPEDVATYYCQKYNSAPWTFGQGTKVEIK,IGHV4-39 (Human),IGHJ4 (Human),IGKV1-27 (Human),IGKJ1 (Human),ASLWFGDLYSFDY,QKYNSAPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2405_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2438,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; NTD,B-cells; SARS-CoV2 Human Patient,EVQLLESGGGLVQPGGSLRLSCAASGFTFTSYGMSWVRQAPGKGLEWVSAISISGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKLLGSGITLDNDAFDIWGQGTMVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAATSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQTYSTPLYTFGQGTKLEIK,IGHV3-23 (Human),IGHJ3 (Human),IGKV1-39 (Human),IGKJ2 (Human),AKLLGSGITLDNDAFDI,QQTYSTPLYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2438_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2444,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; NTD,B-cells; SARS-CoV2 Human Patient,EVQLLESGGGLVQPGGSLRLSCAASGFTFTSYAMNWVRQAPGKGLEWVSAISVSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDFGSGIVGATGFDFWGQGTLVTVSS,SYELTQPPSVSVSPGQTARITCSGDALPNQYAYWYQQKPGQAPVLVMCKDSERPSGIPERFSGSSSGTTVTLTISGVQAEDEADYYCQSADSSGTYVVFGGGTKLTVL,IGHV3-23 (Human),IGHJ4 (Human),IGLV3-25 (Human),IGLJ2 (Human),AKDFGSGIVGATGFDF,QSADSSGTYVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2444_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2455,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; NTD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYEMNWVRQAPGKGLEWVSYISSSGSAIYYADSVKGRFTISRDNAKNSLYLQMNSLRVEDTAVYYCAREARSRYFDWLPSYYFDYWGQGTLVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDIGGYNYVSWYQQHPGKAPKLLIYDVSNRPSGVSTRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSTHVVFGGGTKLTVL,IGHV3-48 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ2 (Human),AREARSRYFDWLPSYYFDY,SSYTSSSTHVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2455_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2459,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; NTD,B-cells; SARS-CoV2 Human Patient,QLQLQESGPGLVKPSETLSLTCTVSGGSISSGTYYCGWIRQPPGKGLEWIGSTYYGGSTLYNPSLRGRVTISVDTSKNQFSLKLSSVTAADTAVYYCARRGNYYDSKNWFDPWGQGTLVTVSS,EIVMTQSPATVSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSASGSGTEFTLTISSLQSEDFAVYYCQQYNNWPPMYTFGQGTKVEIK,IGHV4-39 (Human),IGHJ5 (Human),IGKV3-15 (Human),IGKJ2 (Human),ARRGNYYDSKNWFDP,QQYNNWPPMYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2459_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2466,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; NTD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVKPGGSLRLSCAASGFTFSSYSMNWVRQAPGKGLEWVSSISNSNSFIYYADSMKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARVNGNSNWNFGSYYYYYMDVWGKGTTVTVSS,EIVLTQSPAILSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDTSNRATGIPARFSGSGSGTDFTLTISSLEPEDFAFYYCQQRGNWWTFAQGTKVEIK,IGHV3-21 (Human),IGHJ6 (Human),IGKV3-11 (Human),IGKJ1 (Human),ARVNGNSNWNFGSYYYYYMDV,QQRGNWWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2466_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2489,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2 (weak),,S; NTD,B-cells; SARS-CoV2 Human Patient,QLQLQESGPGLVKPSETLSLTCTVSGGSISSTTYYWGWIRQPPGKGLEWIASIYYSGSTYYNPSLKSRLTVSVDTSKNQFSLKLSSVTAADTAVYYCARQWKWFGEAWYFDLWGRGTLVTVSS,EIVLTQSPGTLSLSPGERASLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPFTFGGGTKVEIK,IGHV4-39 (Human),IGHJ2 (Human),IGKV3-20 (Human),IGKJ4 (Human),ARQWKWFGEAWYFDL,QQYGSSPFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2489_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jan 30, 2021",30th Jan 2021: Added new reference,Complete
COV2-2490,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; NTD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYWMNWVRQAPGKGLEWVANINQDGGEKYYVDSVRGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARDPYDLYGDYGGTFDYWGQGTLVTVSS,DIQMTQSPSTLSASVGDRVTITCRASQSISSWLAWYQQKPRKAPKLLIYKASTLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNSYSLTFGGGTKVEIK,IGHV3-7 (Human),IGHJ4 (Human),IGKV1-5 (Human),IGKJ4 (Human),ARDPYDLYGDYGGTFDY,QQYNSYSLT,https://www.rcsb.org/structure/7DZY,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jun 6, 2021",21st Dec: Added new reference. 6th June: Confirmed association with increased infectivity and added PDB structure,Associated with increased infectivity (Y. Liu et al). Complete.
COV2-2495,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; NTD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAAVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGIVPIFGTANYAQKFQGRVTITADESTTTAYMELNSLRSEDTAVYYCAREDYYGSGSLVDPYYYYRMDVWGQGTTVTVSS,EIVLTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTDFTLTISSLQSEDFALYYCQQYNNWWRTFGQGTKVEIN,IGHV1-69 (Human),IGHJ6 (Human),IGKV3-15 (Human),IGKJ1 (Human),AREDYYGSGSLVDPYYYYRMDV,QQYNNWWRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2495_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2525,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; NTD,B-cells; SARS-CoV2 Human Patient,EVRLLESGGGLVQPGGSLRLSCAASGFTFTSYAMSWVRQAPGKGLQWVSTISVSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDPASGIVGPTHFDYWGQGTLVTVSS,QLVLTQSPSASASLGASVKLTCTLSSGHTTYAIAWHQQQPEKGPRYLMKLNSDGSHTRGDGIPDRFSGSSSGAERYLTISSLQSEDEADYYCQSWDTGIGVFGGGTKLTVL,IGHV3-23 (Human),IGHJ4 (Human),IGLV4-69 (Human),IGLJ3 (Human),AKDPASGIVGPTHFDY,QSWDTGIGV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2525_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2526,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; NTD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKVSGYTLTELSIHWVRQAPGKGLEWMGGFDPEDAETIYAQQFQGRVTMTEDTSTDTAYMELSSLKSEDTALYYCATGFAVFGRAAVPYWGQGTLVTVSS,SYELTQPPSVSVSPGQTASITCFGDKLGDKYACWFQQKPGQSPVLIIYQGAKRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCQAWDSSTVVFGGGTKLTVL,IGHV1-24 (Human),IGHJ4 (Human),IGLV3-1 (Human),IGLJ2 (Human),ATGFAVFGRAAVPY,QAWDSSTVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2526_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2533,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; NTD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSQTLSLTCTVSGGSISSGGYYWSWIRQHPGKGLEWIGYIYYSGSTYYNPSLKSRVTISVDTSKNQFSLKLTSVTAADTAVYYCAREANDSGSFYNGPFDYWGQGTLVTVSS,DIVMTQSPDSLAVSLGERATINCKSSQSVLYSSNNKNYLAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYSTRTFGQGTKLEIK,IGHV4-31 (Human),IGHJ4 (Human),IGKV4-1 (Human),IGKJ2 (Human),AREANDSGSFYNGPFDY,QQYYSTRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2533_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2558,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; NTD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRVEDTAVYYCARDQEWFRELFLFDYWGQGTLVTVSS,DIQMTQSPSSVSASVGDRVTITCRASQGISSWLAWYQQKPGKAPKLLIYDASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQANSFPPTFGPGTKVDIK,IGHV3-30-3 (Human),IGHJ4 (Human),IGKV1-12 (Human),IGKJ3 (Human),ARDQEWFRELFLFDY,QQANSFPPT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2558_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2563,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; NTD,B-cells; SARS-CoV2 Human Patient,QVQLQQWGAGLLKPSETLSLTCAVYGGSFSGYYWSWIRQPPGKGLEWIGEINHSGSSNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARGWGWGAVAGRAEYYFDYWGQGTLVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGSYNLVSWYQQHPGKAPKLMIYEVSKRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCCSYAGSSTWGFGTGTKVTVL,IGHV4-34 (Human),IGHJ4 (Human),IGLV2-23 (Human),IGLJ1 (Human),ARGWGWGAVAGRAEYYFDY,CSYAGSSTWG,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2563_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2571,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; NTD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSETLSLTCTVSGGSLSSYYWSWIRQPPGKGLEWIGYIYDSGGASRSTNYNPSLKSRVTISVDTSRNQLSLKLSSVTAADTAVYYCARDQRQFQLLGRFGWFDPWGQGTLVTVSS,EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNWPRTFGQGTKVEIK,IGHV4-59 (Human),IGHJ5 (Human),IGKV3-15 (Human),IGKJ1 (Human),ARDQRQFQLLGRFGWFDP,QQYNNWPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2571_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2622,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; NTD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSGTLSLTCAVSGGSISSSNWWSWVRQPPGKGLEWIGEIYHSGSTNYNPSLKSRVTISVDKSKNQFSLKLSSVTAADTAVYYCARGWYFDYWGQGTLVTVSA,QSALTQPASVSGSPGQSITISCTGTSSDVGSYNLVSWYQQHPGKAPKLMIYEVSKRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCYSYAGSSTWVFGGGTKLTVL,IGHV4-4 (Human),IGHJ4 (Human),IGLV2-23 (Human),IGLJ3 (Human),ARGWYFDY,YSYAGSSTWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2622_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2673,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; NTD,B-cells; SARS-CoV2 Human Patient,QVTLKESGPVLVKPTETLTLTCAVSGFSLSNAKMGVSWIRQPPGKALEWLAHIFSNDEKAYSTSLKTRLTISKDTSKSQVVLTVTNMDPVDTATYYCARIVLGASGTYPSPGFDPWGQGTLVTVSS,QTVVTQEPSLTVSPGGTVTLTCASSAGAVTSGYYPNWFQQKPGQAPRALIYSTANKHSWTPARFSGSLLGGKAALTLSGVQPEDEAEYYCLLYYGGAWVFGGGTKLTVL,IGHV2-26 (Human),IGHJ5 (Human),IGLV7-43 (Human),IGLJ3 (Human),ARIVLGASGTYPSPGFDP,LLYYGGAWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2673_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2769,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; NTD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSTYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMIGLRAEDTAVYYCARDWAPTYYDMPSAFDIWGQGTMVTVSS,SYVLTQPPSVSVAPGKTARITCGGNNIGNKGVHWYQQKPGQAPVLVVDDDSDRPSGIPERFSGSNSGNTATLIISSVEVGDEADFYCQVWDSSSDHPGVFGGGTKLTVL,IGHV3-30-3 (Human),IGHJ3 (Human),IGLV3-21 (Human),IGLJ3 (Human),ARDWAPTYYDMPSAFDI,QVWDSSSDHPGV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2769_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2816,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; NTD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSETLSLTCTVSGGSISSYYWSWIRQPPGKGLEWIGYIYYSGSTNYNPSLKSRVTISVDMSKNQFSLKLRSVTAADTAVYYCARAPRERLQWGEYYFDYWGQGTLVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGSYNLVSWYQQHAGKAPKLMIYEVIKRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCCSYAVSTTYVIFGGGTKLTVL,IGHV4-59 (Human),IGHJ4 (Human),IGLV2-23 (Human),IGLJ2 (Human),ARAPRERLQWGEYYFDY,CSYAVSTTYVI,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2816_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2830,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; NTD,B-cells; SARS-CoV2 Human Patient,EVQLLESGGGLVQPGGSLRLSCAASGFTFTSYAMSWVRQAPGKGLEWVSGISISGGSTYYAASVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDSRSGIAGVDAFDIWGQGTMVTVSS,SYVLTQPPSVSVAPGRTARITCGGNNIGSKSVHWYQQKPGQAPVLVVYDDSDRPSGIPERFSGSKFGNTATLIISRVEAGDEADYSCQVWDSGSDHVVFGGGTKVTVL,IGHV3-23 (Human),IGHJ3 (Human),IGLV3-21 (Human),IGLJ2 (Human),AKDSRSGIAGVDAFDI,QVWDSGSDHVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2830_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2582,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; NTD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGSELKKPGASVKVSCKASGYTFTTYAMNWVRQAPGQGLEWMGWINTNTGNPTYAQGFTGRFVFSLDTSVNTAFLHIGSLKAEDTAVYYCARDQDSGYPTYYYYYMDVWGKGTTVTVSS,DIVMTQTPLSLSVTPGQPASISCKSSQSLLHSDGKTYLYWYLQKPGQSPQLLIYEVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQSIQPPLTFGGGTKVEIK,IGHV7-4-1 (Human),IGHJ6 (Human),IGKV2D-29 (Human),IGKJ4 (Human),ARDQDSGYPTYYYYYMDV,MQSIQPPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2582_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jun 6, 2021",21st Dec: Added new reference. 6th June: Confirmed association with increased infectivity and refined epitope to NTD,Associated with increased infectivity (Y. Liu et al). Complete.
COV2-2248,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFDSYGVHWVRQAPGKGLEWVAVISYDGSNKHYADSVKGRFTISRDNSKNTLYVQMNSLRTEDTAVYYCARDSGGNYGDSYFDYWGQGTLVTVSS,SYELTQPPSVSVSPGQTARITCSGDALSKQYAYWYQQKPGQAPVLVIYKDSERPSGIPERFSGSSSGTTVTLTISGVQAEDEADYYCQSVDRSGTYFNWVFGGGTKLTVL,IGHV3-30 (Human),IGHJ4 (Human),IGLV3-25 (Human),IGLJ3 (Human),ARDSGGNYGDSYFDY,QSVDRSGTYFNWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2248_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2245,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSNYGIHWVRQAPGQGLEWVAGIWYDGSNKYYVDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAGSSGEGGLYYYYGMDVWGQGTTVTVSS,SYELTQPPSVSVSPGQTTRITCSGDALPKQYGYWYQQKAGQAPILVIYKDSERPSGIPERFSGSSSGTTVTLTISGVQAEDEAHYYCQSGDSSGTYVVFGGGTKLTVL,IGHV3-33 (Human),IGHJ6 (Human),IGLV3-25 (Human),IGLJ3 (Human),AGSSGEGGLYYYYGMDV,QSGDSSGTYVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2245_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2418,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,EVRLLESGGGLVQPGGSLRLSCAASGFTFSDYAMNWVRQAPGKGLEWVSAISATGGSTFYADSVKGRFSISRDNSKNSLVLQMNSLRAEDTAVYYCAKPYGMDVWGQGTTVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGGYNFVSWHQQHPGKAPKNMIYDVSKRPSGVSNRFSGSKSGNTASLTISGLHTEDEADYYCSSYTSTSTPWVFGGGTKLTVL,IGHV3-23 (Human),IGHJ6 (Human),IGLV2-14 (Human),IGLJ3 (Human),AKPYGMDV,SSYTSTSTPWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2418_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2378,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,EVQLVQSGAEVKKPGESLKISCKGSGYSFPTYWIGWVRQMPGKGLEWMGIIYPGDSDTRYGPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARRDTDFDYWGQGTLVTVSS,QPVLTQPPSASASLGASVTLTCTLSSGYSNYKVDWFQQRPGKGPRFVMRVGTGGIVGSKGDGIPDRFSVLGSGLNRYLTIKNIQEEDESDYHCGADHGSGSNFVYVVFGGGTKLTVL,IGHV5-51 (Human),IGHJ4 (Human),IGLV9-49 (Human),IGLJ2 (Human),ARRDTDFDY,GADHGSGSNFVYVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2378_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2574,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,QLQLQESGPGLVKPSETLSLTCTVSGGSISSTTYYWGWIRQPPGKGLEWIASIYYSGSTYYNPSLKSRLTVSVDTSKNQFSLKLSSVTAADTAVYYCARQWKWFGEAWYFDLWGRGTLVTVSS,QPVVTQSPSASASLGASVKLTCTLDSGHRSYAIAWHQQRPEKGPRFLMRITTDGRHTKGDGIPDRFSGSGSGTERYLTISSLQSEDEADYYCQTWGTFGGGTRLTVL,IGHV4-39 (Human),IGHJ2 (Human),IGLV4-69 (Human),IGLJ2 (Human),ARQWKWFGEAWYFDL,QTWGT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2574_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2697,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSHYMHWVRQAPGQGLEWMGIINPSGGSTSYAQKFQGRVTMTGDTSTSTVYMELSSLRSEDTAVYYCARDLAGVPAALGCWFDPWGQGTLVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDAYKRDTGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPLIFTFGPGTKVDIK,IGHV1-46 (Human),IGHJ5 (Human),IGKV3-11 (Human),IGKJ3 (Human),ARDLAGVPAALGCWFDP,QQRSNWPLIFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2697_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2488,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAVSGFTFSSYWMHWVRQAPGKGLVWVSRINSDGSSTSYADSVKGRFTISRDNAKNTLYLQMNSLRAEDTAVYYCAREVEQLAHMVDYWGQGTLVTVSS,SYELTQPPSVSVSPGQTARITCSGDALPNQYAYWYQQKPGQAPVLVIYKDSERPSGIPERFSGSSSGTTVTLTISGVQAEDEADYYCQSADSSGTSWVFGGGTKLTVL,IGHV3-74 (Human),IGHJ4 (Human),IGLV3-25 (Human),IGLJ3 (Human),AREVEQLAHMVDY,QSADSSGTSWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2488_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2368,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,EVQLVQSGAEVKKPGESLKISCKGSGYSFTTYWIGWVRQMPGKGLEWMGIIYPGDSDTRYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARRRGGIGIEYGMDVWGQGTTVTVSS,SNELTQPPSVSVSPGQTARITCSGDALPKQYAYWYQQKPGQAPVLVIYKDTERPSGIPERFSGSSSGTTVTLTISGVQAEDEADYYCQSTASSGTYVVFGGGTKLTVL,IGHV5-51 (Human),IGHJ6 (Human),IGLV3-25 (Human),IGLJ2 (Human),ARRRGGIGIEYGMDV,QSTASSGTYVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2368_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2496,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSNYGMHWVRQAPGKGLEWVAVIWYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCVRDLALFEVVIQQGVWGQGTLVTVSS,SYELTQPPSVSVSPGQTARITCSGDALPKKYAYWYQQKSGQAPVLVIYEDSKRPSGIPERFSGSSSGTMATLTISGAQVEDEADYYCYSTDSSGNHWVFGGGTKLTVL,IGHV3-33 (Human),IGHJ4 (Human),IGLV3-10 (Human),IGLJ3 (Human),VRDLALFEVVIQQGV,YSTDSSGNHWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2496_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2400,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,QITLKESGPTLVKPTQTLTLTCTFSGFSLSTSGVGVGWIRQPPGKALEWLALIYWDDDKRYSPSLKSRLTITKDTSKNQVVLTMTNMDPVDTATYYCAHNRFQYCSSTTCYTLLPFDYWGQGTLVTVSS,DIQLTQSPSFLSASVRDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPFTFGPGTKVDIK,IGHV2-5 (Human),IGHJ4 (Human),IGKV1-9 (Human),IGKJ3 (Human),AHNRFQYCSSTTCYTLLPFDY,QQLNSYPFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2400_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2445,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGVVRPGGSLRLSCAASGFTFDDYGMSWVRQAPGKGLEWVSAINWNGGSTGYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTALYHCARRRSSSRYSSGWYMYYYYMDVWGKGTTVTVSS,DIQMTQSPSTLSASVGDRVTITCRASQSVSTWLAWYQQKPGKAPNLLIYEASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNTYSGTFGQGTKVEIK,IGHV3-20 (Human),IGHJ6 (Human),IGKV1-5 (Human),IGKJ1 (Human),ARRRSSSRYSSGWYMYYYYMDV,QQYNTYSGT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2445_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2147,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLAESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARSTSGSYYYGMDVWGQGTTVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGDYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEAEYYCSSYTSSSTLLYVFGTGTKVTVL,IGHV3-30-3 (Human),IGHJ6 (Human),IGLV2-14 (Human),IGLJ1 (Human),ARSTSGSYYYGMDV,SSYTSSSTLLYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2147_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2584,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,EVALVESGGGLVKPGGSLRLSCAASGFIFSNAWMTWVRQAPGKGLEWVGRIKSKSEGGTPEYAAPVKGRFIISRDDSTNSLHLQMNYLRIEDTAVYYCTTGGYSSYAASDYWGQGTLVTVSS,QSALTQPASVSGSPGQLITIFCNGSISDVGGWNYVSWYQQHPDKAPKMMIYDVRHRPSGVSSRFSGSKSGNTASLTISGLQAEDEGDYYCSSFTSRGALVLFGGGTKLTVL,IGHV3-15 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ2 (Human),TTGGYSSYAASDY,SSFTSRGALVL,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2584_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2195,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVHLVESGGGVVQPGRSLRLSCAASGFTFSNYGMHWVRQAPGKGLEWVAVISNDEFNKFYANSVKGRFTISRDNSKNTVYLQLNSLRTEDTARYYCAKGGDGSGWAWDGDNPPTDYWGQGTLVIVSS,DIVMTQSPDFLAVSLGERATISCKSSQSVLYTPKNKNYLAWYKQKPGQPPKVLIYWASTRESGVPDRFSGSGSGTDFTLIISSLQAEDAAVYYCQQYYTAPLTFGGGTRVEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV4-1 (Human),IGKJ4 (Human),AKGGDGSGWAWDGDNPPTDY,QQYYTAPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2195_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2473,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSNYGMHWVRQAPGKGLEWVAVIYYDGSNKYYADSVKGRFTISRDNSKNTLYLQIHSLRAEDTAVYYCAREGQMAATTGIDYWGQGTLVTVSS,SYELTQPPSVSVSPRQTARITCSGDALPKKYAYWYQQKSGQAPVLVIYEDSKRPSGIPERFSGSSSGTMATLTISGAQVEDEADYYCYSTDTSGNHWVFGGGTKLTVL,IGHV3-33 (Human),IGHJ4 (Human),IGLV3-10 (Human),IGLJ3 (Human),AREGQMAATTGIDY,YSTDTSGNHWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2473_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2586,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGRSLRLSCAASGFTFDDYAMHWVRQAPGKGLEWVSGISWNSGSIAYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTALYFCAKVGWELSIDAFDLWGQGTMVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLGWYHQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQHYGSSRSTFGQGTKLEIK,IGHV3-9 (Human),IGHJ3 (Human),IGKV3-20 (Human),IGKJ2 (Human),AKVGWELSIDAFDL,QHYGSSRST,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2586_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2173,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGVVRPGGSLRLSCAASGFTFDDYGMSWVRQAPGKGLEWVSAINWNGGSTGYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTALYHCARRRSSSRYSSGWYMYYYYMDVWGKGTTVTVSS,DIQMTQSPSTLSASVGDRVTITCRASQSVSTWLAWYQQKPGKAPNLLIYEASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNTYSGTFGQGTKVEIK,IGHV3-20 (Human),IGHJ6 (Human),IGKV1-5 (Human),IGKJ1 (Human),ARRRSSSRYSSGWYMYYYYMDV,QQYNTYSGT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2173_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2369,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; NTD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVADISYDGSEKYYADSVKGRFTIYRDNSKNTLYLQMNSLRAEDTAVYYCAKDFGGDNTAMVEYFFDFWGQGTLVTVSS,DIQMTQSPSTLSASVGDRVTITCRASQSISSWLAWYQQKPGKAPKLLIYKASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNSYSPTFGQGTKVEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV1-5 (Human),IGKJ1 (Human),AKDFGGDNTAMVEYFFDF,QQYNSYSPT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2369_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jun 6, 2021",21st Dec: Added new reference. 6th June: Confirmed association with increased infectivity and refined epitope to NTD,Associated with increased infectivity (Y. Liu et al). Complete.
COV2-2427,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSGTLSLTCAVSGGSISSSNWWSWVRQPPGKGLEWIGEIYHSGSTNYNPSLKSRVTISVDKSKNQFSLKLNSVTAADTAVYYCASRWGDYFDSSGAYDSWGQGTLLTVSS,DIQMTQSPSSVSASVGDRVTITCRASQGISSWLAWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTITSLQPEDFATYYCQQGNSFPLTFGGGTKVEIK,IGHV4-4 (Human),IGHJ4 (Human),IGKV1-12 (Human),IGKJ4 (Human),ASRWGDYFDSSGAYDS,QQGNSFPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2427_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2191,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGVVRPGGSLRLSCAASGFTFDDYGMSWVRQAPGKGLEWVSAINWNGGSTGYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTALYHCARRRSSSRYSSGWYMYYYYMDVWGKGTTVTVSS,DIQMTQSPSTLSASVGDRVTITCRASQSVSTWLAWYQQKPGKAPNLLIYEASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNTYSGTFGQGTKVEIK,IGHV3-20 (Human),IGHJ6 (Human),IGKV1-5 (Human),IGKJ1 (Human),ARRRSSSRYSSGWYMYYYYMDV,QQYNTYSGT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2191_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2262,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2 (weak),,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYDINWVRQATGQGLEWMGWMNPNSGNTGYAQKFQGRVTMTRNTSISTAYMELSSLRSEDTALYYCAREARYFDWIFEGSDYYYYGMDVWGQGTTVTVSS,QSALTQPPSVSGSPGQSVTISCTGTSSDVGSYNRVSWYQQPPGTAPKLMIYEVSNRPSGVPDRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSLRVFGGGTKLTVL,IGHV1-8 (Human),IGHJ6 (Human),IGLV2-18 (Human),IGLJ3 (Human),AREARYFDWIFEGSDYYYYGMDV,SSYTSSSLRV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2262_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2660,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; NTD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYDMHWVRQATGKGLEWVSAIGTAGDTYYPGSVKGRFTISRENAKNSLYLQMNSLRAGDTAVYYCARADPYQLLGQHYYYGMDVWGQGTTVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPLITFGQGTRLEIK,IGHV3-13 (Human),IGHJ6 (Human),IGKV3-20 (Human),IGKJ5 (Human),ARADPYQLLGQHYYYGMDV,QQYGSSPLIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2660_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jun 6, 2021",21st Dec: Added new reference. 6th June: Confirmed association with increased infectivity and refined epitope to NTD,Associated with increased infectivity (Y. Liu et al). Complete.
COV2-2054,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGDTFSSYTINWVRQAPGQGLEWMGRIIPILGIPNYAQKFQGRVTITADKSTSTAFMELSSLRSEDTAVYYCARGRGYSNYGASYYMDVWGKGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDINHYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTITSLQPEDVATYYCQQSDNLPMYTFGQGTKLEIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV1-33 (Human),IGKJ2 (Human),ARGRGYSNYGASYYMDV,QQSDNLPMYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2054_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2226,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,EVQLVQSGAEVKKPGESLKISCKGSGYSFTNSWIGWVRQMPGKGLEWMGIIYPGDSDTRYSPSFQGQVTISADKSISTAYLQWSSLKASDTAIYYCATHRCSGGFCYLAYWGQGTLVTVSS,QPVLTQPPSASASLGASVTLTCTLSSGYSNYKVDWYQQRPGKGPRFVMRVGTGGIVGSKGDGIPDRFSVLGSGLNRYLTIKNIQEEDESDYHCGADHGSGSNFVFVVFGGGTKLTVL,IGHV5-51 (Human),IGHJ4 (Human),IGLV9-49 (Human),IGLJ2 (Human),ATHRCSGGFCYLAY,GADHGSGSNFVFVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2226_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2700,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSTYAMHWVRQAPGKGLEWVAVISYDGGNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKNLGPYCSGGTCYSLVGDYWGQGTLVTVSS,QSVLTQPPSVSGVPGQRVTVSCTGSSSNIGAGFDVYWYQQFLGTAPKLLIYGNNNRPSGVPDRFSASKSGTSASLAITGLQAEDEADYYCQSYDSSLSGYVFGTGTKVTVL,IGHV3-30-3 (Human),IGHJ4 (Human),IGLV1-40 (Human),IGLJ1 (Human),AKNLGPYCSGGTCYSLVGDY,QSYDSSLSGYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2700_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2386,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVIWFDGSNKHYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAREGDFWSGYYTGWFDPWGQGTLVTVSS,EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNWPRTFGQGNRVEIN,IGHV3-33 (Human),IGHJ5 (Human),IGKV3-15 (Human),IGKJ1 (Human),AREGDFWSGYYTGWFDP,QQYNNWPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2386_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2521,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLACAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGNNKYYADSLKGRFTISRDDSKNTLYLQMNSLRAEDTAVYYCAKDRTAVFLFFGLGDAFDIWGQGTMVTVSS,SYVLTQPPSVSVAPGKTARITCGGNNIGSKSVHWYQQKPGQAPVVVVYDDSDRPSGLPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDSSSDHWVFGGGTKLTVL,IGHV3-30 (Human),IGHJ3 (Human),IGLV3-21 (Human),IGLJ3 (Human),AKDRTAVFLFFGLGDAFDI,QVWDSSSDHWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2521_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2675,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSIYGMHWVRQAPGKGLEWVAVISFDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDGSGSYYGWFDPWGQGTLVTVSS,EIVLTQSPDFQSVTPKEKVTITCRASQNIGSSLHWYQQKPDQSPKVIIKYASQSFSGVPSRFSGSGSGTDFTLTINSLEAEDAATYYCHQSSSLPPTFGGGTKVEIK,IGHV3-30 (Human),IGHJ5 (Human),IGKV6-21 (Human),IGKJ4 (Human),AKDGSGSYYGWFDP,HQSSSLPPT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2675_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2942,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVTLRESGPALVKPTQTLTLTCTFSGFSLSTSGLCVSWIRQPPGKALEWLARIDWDDDKYYNTSLRTRLTISKDTSKNQVVLTMTNMDPVDTATYYCARATTFFYGMDVWGQGTTATVSS,SYELTQPPSVSVSPGQTARITCSTDALPNEYIYWYQQKPGQAPVLVIYKDSERPSGIPERFSGSSSGTTVTLTISGVQAEDEADYYCQSVDSSGTYRVFGGGTKLTVL,IGHV2-70 (Human),IGHJ6 (Human),IGLV3-25 (Human),IGLJ3 (Human),ARATTFFYGMDV,QSVDSSGTYRV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2942_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2621,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYLMHWVRQAPGKGLEWVAVIWANGNRYYADSVKGRFTISRDISKNTLYLQMNSLRAEDTAMYYCARDYCNGVTCNSNYWGQGTLVTVSS,DFVMTQSPGSLAVSLGERATINCRSSQSVLDNSSNKNHLAWHQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYSSHWTFGQGTKVEIK,IGHV3-33 (Human),IGHJ4 (Human),IGKV4-1 (Human),IGKJ1 (Human),ARDYCNGVTCNSNY,QQYYSSHWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2621_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2300,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSGTLSLTCAVSGGSISSSNWWTWVRQPPGKGLEWIGEIYHSGSTNYNPSLKSRVTISVDKSKNQFSLKLSSVTAADTAVYYCASRWGDYFDSSGAYDSWGQGTLVTVSS,DIQMTQSPSSVSASVGDRVTITCRASQGISSWLAWYQQKPGKAPKLLIYAASSLQRGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQANSLPLTFGGGTKVEVK,IGHV4-4 (Human),IGHJ4 (Human),IGKV1-12 (Human),IGKJ4 (Human),ASRWGDYFDSSGAYDS,QQANSLPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2300_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2570,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,QLQLQESGPGLVKPSETLSLTCTVSGGSISSSSNYWGWIRQPPGKGLEWIGSIYYSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARDPRVVVTARMYNWFDPWGQGTLVTVSS,EIVMTQSPGTLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGVPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNWPPMYTFGQGTKLEIK,IGHV4-39 (Human),IGHJ5 (Human),IGKV3-15 (Human),IGKJ2 (Human),ARDPRVVVTARMYNWFDP,QQYNNWPPMYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2570_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2373,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGLTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISGDNSKNTLYLQMNSLRVDDTAVYYCARDPGSRYSGGWYDYYYAMDVWGQGTTVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPPYTFGQGTKLEIK,IGHV3-66 (Human),IGHJ6 (Human),IGKV3-20 (Human),IGKJ2 (Human),ARDPGSRYSGGWYDYYYAMDV,QQYGSSPPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2373_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2872,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSTYGMHWVRQAPGKGLEWVAVIWYDGNKKYCADSVKGRCTISRDNSKNTLYLQMNSLRAEDTAVYYCAREGPFGDREASGAFDVWGQGTMVTVSS,SYELTQPPSVSVSPGQTARITCSGDALPKKYTYWYQQKSGQAPVVVIYEDSKRPSGIPERFSGSSSGTMATLTISGAQVEDEADYYCYSTDSSGKGVFGGGTKLTVL,IGHV3-33 (Human),IGHJ3 (Human),IGLV3-10 (Human),IGLJ3 (Human),AREGPFGDREASGAFDV,YSTDSSGKGV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2872_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2035,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,QITLKESGPTLVKPTQTLTLTCTFSGFSLNTNGVAVGWIRQPPGKALEWLALIYWDDDKRYSPSLKSRLTITKDTSKNQVVLTMTNMDPVDTATYYCAHRRGILTEDAFDIWGQGTMVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQRPGKAPKLLIYAASSLQSGVPSRFSGSGYGTDFTLTISSLQPEDFATYYCQQSYNTPRTFGQGTKVEIK,IGHV2-5 (Human),IGHJ3 (Human),IGKV1-39 (Human),IGKJ1 (Human),AHRRGILTEDAFDI,QQSYNTPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2035_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2383,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVVSYDGSNKYYTDSVKGRFTISRDNSKNTLFLQMIGLREEDTAVYYCAQGRGGYYSPFDDWGQGTLVTVSS,EIVMTQSPGTLSVSPGERATLSCRASQTLSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYHCQQYNNWPLAFGQGTKVEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV3-15 (Human),IGKJ1 (Human),AQGRGGYYSPFDD,QQYNNWPLA,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2383_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2454,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVIWYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAREGQGTYLDYWGQGTLVTVSS,SYELTQPPSVSVSPGQTARITCSGDALPKKYAHWYQQKSGQAPVLVIYEDSKRPSGIPERFSGSSSGTMATLTISGAQVEDEADYYCCSTDSSGNQRVFGGGTKLTVL,IGHV3-33 (Human),IGHJ4 (Human),IGLV3-10 (Human),IGLJ3 (Human),AREGQGTYLDY,CSTDSSGNQRV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2454_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2676,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2 (weak),,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAINWVRQAPGQGLEWMGGIIPIFGTANYAQKFQGRVTFTADESTSTAYMEVSSLRSEDTAVYYCARSCGDCYSADLDFWGQGTLVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSISSFLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQRRSNWPPFTFGPGTKVDIK,IGHV1-69 (Human),IGHJ4 (Human),IGKV3-11 (Human),IGKJ3 (Human),ARSCGDCYSADLDF,QRRSNWPPFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2676_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jan 30, 2021",30th Jan 2021: Added new reference,Complete
COV2-2934,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGSELKKPGASVKVSCKASEYTFTSYAMNWVRQAPGQGLEWMGWINTNTGNPTYAQGFTGRFVFSLDTSVSTAYLQISSLKAEDTAVYYCARPGKAAAFDYWGQGTLVTVSS,DIVMTQSPLSLPVTPGEPASISCRSSQSLLHSNGYNFLDWYLQKPGQSPQLLIYLGSNRASGVPDRFSGSGSGTDFTLKISRVQAEDVGVYYCMQALQTPWTFGQGTKVEIK,IGHV7-4-1 (Human),IGHJ4 (Human),IGKV2-28 (Human),IGKJ1 (Human),ARPGKAAAFDY,MQALQTPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2934_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2241,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,EVQLVQSGAEVKKPGESLKISCKGSGYSFTSYWIDWVRQMPGKGLEWMGIIYPGDSDTRYSPSFQGQVTISADKSTSTAYLQWSSLKASDTAMYYCARRGEAAGIWYFDLWGRGTLVTVSS,QPVLTQPPSASASLGASVTLTCTLSSGYSNYKVDWYQQRPGKGPRFVMRVGTGGIVGSKGDGIPDRFSVLGSGLNRYLTIKNIQEEDESDYHCGADHGSGSNFEYVVFGGGTKLTVL,IGHV5-51 (Human),IGHJ2 (Human),IGLV9-49 (Human),IGLJ2 (Human),ARRGEAAGIWYFDL,GADHGSGSNFEYVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2241_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2549,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPDKGLEWVAVIWYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAREGQWPNQAFDIWGQGTMVTVSS,SYELTQPPSVSVSPGQTASITCSGDKLGDKYACWYQQKPGQSPVLVIHQDSQRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCQAWDSSTHVVFGGGTKLTVL,IGHV3-33 (Human),IGHJ3 (Human),IGLV3-1 (Human),IGLJ2 (Human),AREGQWPNQAFDI,QAWDSSTHVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2549_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2428,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGKSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVIWYDGNNKFYVDSVKGRFTISRDNSKNTLYMEMNSLRAEDTAVYYCARKGPLWRFDYWGQGTLVTVSS,QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWYQQIPGTAPKLLFYGNNNRPSGVPDRFSDSKSGTSASLAITGLQAEDEADYYCQSYDSSLSAWVFGGGTKLTVL,IGHV3-33 (Human),IGHJ4 (Human),IGLV1-40 (Human),IGLJ3 (Human),ARKGPLWRFDY,QSYDSSLSAWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2428_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2545,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQIQQWGAGVLKPSETLSLTCAVYGGSFSGHYWSWIRQPPGKGLEWIGEINHSGSTKYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARGPPVTTFFVFSLLFDPWGQGTLVTVSS,QSVLTQPPSASGTPGQRVTISCSGSSSNIGSNYVYWYQQLPGTAPKLLIYSSNQRPSGVPDRFSGSKSGTSASLAISGLRSEDEADYYCAAWDASLSGWVFGGGTKLTVL,IGHV4-34 (Human),IGHJ5 (Human),IGLV1-47 (Human),IGLJ3 (Human),ARGPPVTTFFVFSLLFDP,AAWDASLSGWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2545_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2624,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFHNYAISWVRQAPGQGLEWMGGFIPILGTTNYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYCARVEGEGVDSYYYGMDVWGQGTTVTVSS,SYELTQPPSVSVSPGQTARITCSADALPKQYAYWYQQKPGQAPVLVIYKDSERPSGIPERFSGSSSGTTVTLTISGVQAEDEADYYCQSTDSSGSYVVFGGGTKLTVL,IGHV1-69 (Human),IGHJ6 (Human),IGLV3-25 (Human),IGLJ2 (Human),ARVEGEGVDSYYYGMDV,QSTDSSGSYVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2624_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2784,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSETLSLTCTVSGGSISSYYWSWIRQPPGKGLEWIGYIYYSGSTKYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARDGGNAYSSGWYRYYYHMDVWGKGTTVTVSS,EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATVIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNWPYTFGQGTKLEIK,IGHV4-59 (Human),IGHJ6 (Human),IGKV3-15 (Human),IGKJ2 (Human),ARDGGNAYSSGWYRYYYHMDV,QQYNNWPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2784_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2726,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISNDGRNKYYADSVKGRLTISRDNSKNTLYLQMNSLRAEDTAVYYCARPSNWYFDLWGRGTLVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGSYNLVSWYQQHPGKAPKLMIYEVSKRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCCSYASSSIVVFGGGTKLTVL,IGHV3-30 (Human),IGHJ2 (Human),IGLV2-23 (Human),IGLJ2 (Human),ARPSNWYFDL,CSYASSSIVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2726_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2718,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,QLQLQESGPGLVKPSETLSLTCTVSGGSISSSNYYWGWIRQPPGKGLEWIGTIHYSGISYYNPSLKSRVTISVDTSNNKFSLELSSVTAADTAVYFCARRTYYDLWSAYSSTAYYCMDVWGKGTTVTVSS,DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPLTFGGGTKVEIK,IGHV4-39 (Human),IGHJ6 (Human),IGKV1-9 (Human),IGKJ4 (Human),ARRTYYDLWSAYSSTAYYCMDV,QQLNSYPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2718_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2474,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVKPGGSLRLSCAASGFTFSNAWMSWVRQAPGKGLEWVGRIKGKTDGGTTDYAAPVKGRFTISKDDSKNTLYLQMSSLNTEDTAVYWCTTLTYYYDSSAYLNDAFDIWGQGTMVTVSS,SYELTQPPSVSVSPGQTARITCSGDALPKKYAYWYQQKSGQAPVLVISEDSKRPSGIPERFSGSSSGTVATLTISGAQVEDEADYYCYSTDSSGNHRVFGGGTKLTVL,IGHV3-15 (Human),IGHJ3 (Human),IGLV3-10 (Human),IGLJ3 (Human),TTLTYYYDSSAYLNDAFDI,YSTDSSGNHRV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2474_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2947,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGSELKKPGASVKVSCKASGYTFSDYAMNWVRQAPGQGLEWMGWINTNTGNPTYAQGFTGRFVFSLDTSVSTAYLQISSLKAEDTAVYYCARGLISLFRGAIFHYYYGMDVWGQGTTVTVSS,QSALTQPRSVSGSPGQSVTISCTGTSSDVGGYTYVSWYQQHPGKAPKLMIYDVNKRPSGVPDRFSGSKSGITASLTISGLQAEDEADYYCCSYAGRYTWVFGGGTTLTVL,IGHV7-4-1 (Human),IGHJ6 (Human),IGLV2-11 (Human),IGLJ3 (Human),ARGLISLFRGAIFHYYYGMDV,CSYAGRYTWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2947_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2177,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,QITFKESGPTLVKPTETLTLTCTFSGFSVSTSGEGVGWIRQPPGKALEWLAVIYWDDDKRYSPSLKSRLTITRDTSKNQVVLTMTNMDPVDTATYYCAHRLWFRDAFDIWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRARQSISNYLNWYQQKPGKAPKLLIYAASSLHSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQTYSTFWTFGQGTNVEIK,IGHV2-5 (Human),IGHJ3 (Human),IGKV1-39 (Human),IGKJ1 (Human),AHRLWFRDAFDI,QQTYSTFWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2177_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2420,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,QGQLVQSGGDVVQPGKSLRLSCAASGFTFTNYAMHWVRQAPGKGLEWVAVISNDGSNEKYVDSVKGRFSLSRDNSKNTVYLDMHSLRPEDTAIYYCARDRSNLERLVMTFGGIIAGAFDIWGQGARVTVSS,EIVMTQSPGTLSVSPGERATLSCRASQSLSSHLAWYQQKPGQAPRLLIYGVSTRATGIPARFSGSGSGTEFTLAISSLQSEDSAVYYCQQYHVWPPITFGQGTRLEIK,IGHV3-30 (Human),IGHJ3 (Human),IGKV3-15 (Human),IGKJ5 (Human),ARDRSNLERLVMTFGGIIAGAFDI,QQYHVWPPIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2420_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2818,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLQQWGAGLLKPSETLSLTCAVYGGSFSGYYWSWIRQPPGKGLEWIGEINHSGSTNYNPSLKSRVTISVDTSKNHFSLKMNSVTAADTAVYYCARCRQMGNFYYYYMDVWGKGTTVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVASSYLAWYQQKPGQAPRLLIYGASGRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPPRYTFGQGTKLEIK,IGHV4-34 (Human),IGHJ6 (Human),IGKV3-20 (Human),IGKJ2 (Human),ARCRQMGNFYYYYMDV,QQYGSSPPRYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2818_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2027,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFIFSTYGMHWVRQAPGKGLEWVAVISYDGSNKYNADSVKGRFTISRDNSKNTLYLQMNSLRVEDTAVYYCAIYGYYYYGLDVWGQGTTVTVSS,SYELTQPPSVSVSPGQTARITCSGDALPKQYAYWYQQKPGQAPVLVIYKDSERPSGIPERFSGSSSGTTVTLTISGVQAEDEADYYCQSADSSGTYFWVFGGGTKLTVL,IGHV3-30 (Human),IGHJ6 (Human),IGLV3-25 (Human),IGLJ3 (Human),AIYGYYYYGLDV,QSADSSGTYFWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2027_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2451,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,QITLKESGPTLVKPTQTLTLTCTVSGFSLSTSGVGVGCIRQPPGKALEWLALIYWDDDKRYSPSLKSRLTITRDTSKNQVVLTMTNMDPVDTGTYFCVHRHVSGAFDYWGQGTLVTVSS,SYELTQPPSVSVSPGQTASITCSGDKLGETYVSWYQQKPGQSPVLVIYEDSKRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCQAWDSSTGGVFGTGTKVTVL,IGHV2-5 (Human),IGHJ4 (Human),IGLV3-1 (Human),IGLJ1 (Human),VHRHVSGAFDY,QAWDSSTGGV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2451_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2546,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGRNKYYADSVKGRFTISRDNSKNTLYLQMSSLRAEDTAVYYCAKEGEWELRGNALDIWGQGTMVTVSS,SYELTQPPSVSVSPGQTARITCSADALPKHYAYWYQQRPGQAPVLVIYKDIERPSGIPERFSGSSSGTTVTLTITGAQAEDEADYYCQSVDGSGSSVVFGGGTKLAVL,IGHV3-30 (Human),IGHJ3 (Human),IGLV3-25 (Human),IGLJ3 (Human),AKEGEWELRGNALDI,QSVDGSGSSVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2546_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2643,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARGSAGNYYYGMDVWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDYATYYCQQSYSTPGTFGQGTRLEIK,IGHV3-30 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ5 (Human),ARGSAGNYYYGMDV,QQSYSTPGT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2643_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2022,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYVISWVRQAPGQGLEWMGWISAYNGNTNYAQKLQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARDQGPTYYYGSGSPHYGMDVWGQGTTVTVSS,DIVMAQTPLSLPVTPGEPASISCRSSQSLLDSDDGNTYFDWYLQKPGQSPQLLIYTLSYRASGVPDRFSGSGSGTDFTLKINRVEAEDVGVYYCMQRIEFPWTFGQGTKLEIK,IGHV1-18 (Human),IGHJ6 (Human),IGKV2-40 (Human),IGKJ2 (Human),ARDQGPTYYYGSGSPHYGMDV,MQRIEFPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2022_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2656,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,EVQLVQSGAEVKKPGESLKISCKGSGYSFSDYWIGWVRQMPGKGLEWMGIIYPGDSDTRYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARLTFGGSGSYYFYYNGMDVWGQGTTVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGRSSGTFGQGTKVEIK,IGHV5-51 (Human),IGHJ6 (Human),IGKV3-20 (Human),IGKJ1 (Human),ARLTFGGSGSYYFYYNGMDV,QQYGRSSGT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2656_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2529,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGSELKKPGASVKVSCKASGYTFTRHAMNWVRQAPGQGLEWMGWINTNTGNPTYAQGFTGRFVFSLDTSVSTAYLQISSLKAEDTAVYYCVREYGSGHPLPIWGQGTLVTVSS,SYELTQPPSVSVSPGQTARITCSADALSKQYAYWYQQKPGQAPVVVIYKDSERPSGIPERFSGSSSGTTVTLTISGVQAEDEADYYCQSADSSSHWVFGGGTKLTVL,IGHV7-4-1 (Human),IGHJ4 (Human),IGLV3-25 (Human),IGLJ3 (Human),VREYGSGHPLPI,QSADSSSHWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2529_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2553,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFIFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARSPPASYYNPSTGYFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATFYCQQSYSTPMHTFGQGTKLEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ2 (Human),ARSPPASYYNPSTGYFDY,QQSYSTPMHT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2553_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2611,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRVSCAASGFTFSSHGMHWVRQAPGKGLEWVSVIWYDGSNKYYADSVKGRFTISRDNSKNTLSLQMNSLRAEDTAVYYCARESADISSRLDYWGRGTLVTVSS,SYELTQPPSVSVSPGQTARITCSGDALPTKYAYWYQQKSGQAPVLVIYDDSKRPSGIPERFSGSSSGTMATLTISGAQVEDEADYYCYSTDSSGNVFGTGTKVTVL,IGHV3-33 (Human),IGHJ4 (Human),IGLV3-10 (Human),IGLJ1 (Human),ARESADISSRLDY,YSTDSSGNV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2611_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2238,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,QITLKESGPPLVEPKQTLTLTCTFSGFSLTTSGEAVGWIRQPPGKALEWLALIYWDDDKHYSPSLRNRLTITRDTSKNQVVLTLTNVDPADTGTYYCAHRAVILNFDHWGQGFLVTVSS,FYELTQPPSVSVSPGQTAGITCSGDKLGHKYAYWYQQKPGQSPILLIYQDDKRPSGIPERFSGSNSGTIATLTISGTQPVDEADYYCQAWDNDAGVVFGGGTKLTVL,IGHV2-5 (Human),IGHJ4 (Human),IGLV3-1 (Human),IGLJ3 (Human),AHRAVILNFDH,QAWDNDAGVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2238_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2207,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,EVQLVQSGAEVKKPGESLKISCKGSGYSFTSHWIGWVRQMPGKGLEWMGIIYPGDSDTRYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCASALRERGVQLWSVWGQGTLVTVSS,QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWYQQLPGTAPKLLIFINSNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSSLGALFGGGTKLTVL,IGHV5-51 (Human),IGHJ4 (Human),IGLV1-40 (Human),IGLJ3 (Human),ASALRERGVQLWSV,QSYDSSLGAL,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2207_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2143,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSAGSTYYADSVKGRFSISRDKSKNTLYLQMNSLRAEDTAVYYCAKEGGSGSLRYYYYGMDVWGQGTTVTVSS,QSVVTQPPSASGTPGQRVTISCSGSSSNIGYNIVNWYQQLPGTAPKLLIYSNNQRPSGVPDRFSGSKSGTSASLSISGLQSEDEADYYCAAWDDSLNGYVFGTGTKVTVL,IGHV3-66 (Human),IGHJ6 (Human),IGLV1-44 (Human),IGLJ1 (Human),AKEGGSGSLRYYYYGMDV,AAWDDSLNGYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2143_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2296,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTVSGNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSPRAEDTAVYYCARDPSAYYDILTGYSGDVWGKGTTVTVSS,DIQMTQSPSTLSASVGDRVTITCRASQSINSWLAWYQQKPGKAPKLLIYKASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYSIYSWTFGQGTKVEIK,IGHV3-66 (Human),IGHJ6 (Human),IGKV1-5 (Human),IGKJ1 (Human),ARDPSAYYDILTGYSGDV,QQYSIYSWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2296_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2446,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,EVQLVQSGAEVKKPGESLKISCKGSGYSFTNSWIGWVRQMPGKGLEWMGIIYPGDSDTRYSPSFQGQVTISADKSISTAYLQWSSLKASDTAIYYCATHRCSGGFCYLAYWGQGTLVTVSS,QPVLTQPPSASASLGASVTLTCTLSSGYSNYKVDWYQQRPGKGPRFVMRVGTGGIVGSKGDGIPDRFSVLGSGLNRYLTIKNIQEEDESDYHCGADHGSGSNFVFVVFGGGTKLTVL,IGHV5-51 (Human),IGHJ4 (Human),IGLV9-49 (Human),IGLJ2 (Human),ATHRCSGGFCYLAY,GADHGSGSNFVFVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2446_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2197,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,EVQLVQSGAEVKKPGESLKISCKGSGYSFTSYWIGWVRQMPGKGLEWMGIIYPGDSDTRYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARPDYSSGWFSYWYFDLWGRGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSNFLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGRSPITFGQGTRLEIK,IGHV5-51 (Human),IGHJ2 (Human),IGKV3-20 (Human),IGKJ5 (Human),ARPDYSSGWFSYWYFDL,QQYGRSPIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2197_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2142,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,EVQLVQSGAEVKKPGESLKISCKGSGYSFTSYWIDWVRQMPGKGLEWMGIIYPGDSDTRYSPSFQGQVTISADKSTSTAYLQWSSLKASDTAMYYCARRGEAAGIWYFDLWGRGTLVTVSS,QPVLTQPPSASASLGASVTLTCTLSSGYSNYKVDWYQQRPGKGPRFVMRVGTGGIVGSKGDGIPDRFSVLGSGLNRYLTIKNIQEEDESDYHCGADHGSGSNFEYVVFGGGTKLTVL,IGHV5-51 (Human),IGHJ2 (Human),IGLV9-49 (Human),IGLJ2 (Human),ARRGEAAGIWYFDL,GADHGSGSNFEYVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2142_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2274,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGRLVLPGGSLRLSCAASGFTFSVYEMNWVRQAPGKGLEWLSYIGTSGSPIYYADSVKGRFTVSRDNAKNSLYLQMNSLRVEDTALYYCARDRGWNYGLDYWGQGTLVTVSS,SYELTQPSSVSVSPGQTARITCSGDALPKRYAYWYRQKSGQAPVLVIHEDSKRPSGIPERFSGSTSGTMATLTITGAQLEDEADYYCFSMDSSGDLRVFGGGTKLTVL,IGHV3-48 (Human),IGHJ4 (Human),IGLV3-10 (Human),IGLJ2 (Human),ARDRGWNYGLDY,FSMDSSGDLRV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2274_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2614,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QITFKESGPTLVKPTETLTLTCTFSGFSVSTSGEGVGWIRQPPGKALEWLAVIYWDDDKRYSPSLKSRLTITRDTSKNQVVLTMTNMDPVDTATYYCAHRLWFRDAFDIWGQGTTVTVSS,EIVMTQSPATLSVSAGERATLSCRASQSISSNLAWYHQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNSYSLTFGGGTKVEIK,IGHV2-5 (Human),IGHJ3 (Human),IGKV3-15 (Human),IGKJ4 (Human),AHRLWFRDAFDI,QQYNSYSLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2614_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2904,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLQQWGAGLLKPSETLSLTCAVYGGSFSGYYWSWIRQPPGKGLEWIGEINHSGSTNYNPSLKSRVTISVDTSKNHFSLKMNSVTAADTAVYYCARCRQMGNFYYYYMDVWGKGTTVTVSP,QSVLTQPPSVSGVPGQRVTVSCTGSSSNIGAGFDVYWYQQFLGTAPKLLIYGNNNRPSGVPDRFSASKSGTSASLAITGLQAEDEADYYCQSFDIGRGGWIFGGGTKLTVL,IGHV4-34 (Human),IGHJ6 (Human),IGLV1-40 (Human),IGLJ2 (Human),ARCRQMGNFYYYYMDV,QSFDIGRGGWI,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2904_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2681,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSFYAIHWVRQAPGQGLEWAAAISSDGTYKYYADSVKGRFTISRDNSKNTSYLQMNSLRAEDTAVYYCARALNKGFDPWGQGTLLTVSS,DIVMTQSPDSLAVSLGERATINCKSSQSVLYSSNNKNYLAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYSSPYTFGQGTKLEIK,IGHV3-30 (Human),IGHJ5 (Human),IGKV4-1 (Human),IGKJ2 (Human),ARALNKGFDP,QQYYSSPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2681_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2371,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSNYGMHWVRQAPGKGLEWVAVISYDGTNKYYADSVKGRFTISRDNSKNTLYLQMNSLRADDTAVYYCAKGRGNYLTFFDSWGQGTLVTVSS,EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNWPGTFGQGTKVEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV3-15 (Human),IGKJ1 (Human),AKGRGNYLTFFDS,QQYNNWPGT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2371_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2639,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDEINKYYADSVKGRFTISRDNSKTTLDLQMNSLRAEDTAVYYCARAGGGSYRGPFDYWGQGTLVTVSS,QSALTQPRSVSGSPGQSVTISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSKRPSGVPDRFSGSKSGNTASLTVSGLQAEDEAEYYCSAYAGSNNLVFGGGTKLTVL,IGHV3-30 (Human),IGHJ4 (Human),IGLV2-11 (Human),IGLJ2 (Human),ARAGGGSYRGPFDY,SAYAGSNNLV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2639_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2524,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,EVQLVQSGAEVKKPGESLKISCKGSGYSFTSHWIGWVRQMPGKGLEWMGIIYPGDSDTRYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCASALRERGVQLWSVWGQGTLVTVSS,QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWYQQLPGTAPKLLIFINSNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSSLGALFGGGTKLTVL,IGHV5-51 (Human),IGHJ4 (Human),IGLV1-40 (Human),IGLJ3 (Human),ASALRERGVQLWSV,QSYDSSLGAL,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2524_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2430,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QLQLQESGPGLVKPSETLSLTCTVSGGSISSSSYYWGWIRQPPGKGLEWIGSVYYIGSTYYNPSLKSRVTMSVDTSKNQFSLKLSSVTAADTAVYYCARAPFQLLDKYYFFYYMDVWGKGTTVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPPGVTFGQGTRLEIK,IGHV4-39 (Human),IGHJ6 (Human),IGKV3-11 (Human),IGKJ5 (Human),ARAPFQLLDKYYFFYYMDV,QQRSNWPPGVT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2430_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-3058,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGAVQPGRSLRLSCAASGFTFSTYAMYWVRQAPGKGLEWVAVISYDGSNRYYADSVKGRFTISRDNSKNTLYLQMNSLRPEDTAVYYCARDRSGNYRDAFDIWGQGTMVTVSS,DIVMTQSPDSLAVSLGERATINCKSSQSVLYSSNNENYLAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYSSYTFGQGTKVEIK,IGHV3-30 (Human),IGHJ3 (Human),IGKV4-1 (Human),IGKJ2 (Human),ARDRSGNYRDAFDI,QQYYSSYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-3058_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2602,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,EVQLVQSGAEVKKPGESLKISCKGSGYSFTSYWIGWVRQMPGKGLEWMGIIYPGDSDTRYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARPDYSSGWFSYWYFDLWGRGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSNFLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGRSPITFGQGTRLEIK,IGHV5-51 (Human),IGHJ2 (Human),IGKV3-20 (Human),IGKJ5 (Human),ARPDYSSGWFSYWYFDL,QQYGRSPIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2602_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2685,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVQVSCEASGYTFTTYYMHWVRQAPGQGLEWMGIINPSGGSTTYAQKFQGRVTMTRDTSTSTVYMDLSSLRSEDTAVYYCARDRLGDGSYLGGGYYGMDVWGQGTTVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKRGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPRLTFGGGTKVEIK,IGHV1-46 (Human),IGHJ6 (Human),IGKV3-20 (Human),IGKJ4 (Human),ARDRLGDGSYLGGGYYGMDV,QQYGSSPRLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2685_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2041,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSQTLSLTCTVSGGSISSGTYYWSWIRQPAGKGLEWIGRFYTSGSTNYNPSLKSRVTISVDASKNQFSLKLSSVTAADTAVYYCARARPDYYYYYAMDVWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISNWLAWYQQKPGKAPKLLIYKASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNSYSTWTFGQGTKVEIK,IGHV4-61 (Human),IGHJ6 (Human),IGKV1-5 (Human),IGKJ1 (Human),ARARPDYYYYYAMDV,QQYNSYSTWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2041_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2814,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISSDGSNKYYAGSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDMVEPLFSHYYYYGMDVWGQGTTVTVSS,QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWYQQLPGTAPKLLIYGNSNRPSGVPDRFSGSKSGTSASLAISGLQAEDEADYSCQSYDSSLSGYVFGTGTKVTVL,IGHV3-30 (Human),IGHJ6 (Human),IGLV1-40 (Human),IGLJ1 (Human),AKDMVEPLFSHYYYYGMDV,QSYDSSLSGYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2814_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2266,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGRSLRLSCTASGFIFGDYAMGWVRQAPGKGLEWVGFIRGKAYDGTTEYAASVKGRFTISRDDSKYIAHLQMNSLKTEDTAVYYCIRDYDFWGGYYYHPLRAFDIWGRGTMVTVSS,QSALTQPRSVSGSPGQSVTISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVTKRPSGVPERFSGSKSGNTASLTISGLQAEDEADYSCCSYAGSYTYVFGTGTKVTVL,IGHV3-49 (Human),IGHJ3 (Human),IGLV2-11 (Human),IGLJ1 (Human),IRDYDFWGGYYYHPLRAFDI,CSYAGSYTYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2266_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2387,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDLTIVVIPAAPNFDYWGQGTLVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSRSGNTASLTISGLQAEDEADYYCSSYTSSSTPVVFGGGTKLTVL,IGHV3-30 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ2 (Human),AKDLTIVVIPAAPNFDY,SSYTSSSTPVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2387_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2281,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFAFSNYAIHWVRQAPGKGLEWVAVISYDGNNKDYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARVPVMVRGVYFDYWGQGTLVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVVGYNYVSWYQQHPGKAPKLMIYDVRNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYFCISYTSSRTLVFGGGTKLTVL,IGHV3-30-3 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ2 (Human),ARVPVMVRGVYFDY,ISYTSSRTLV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2281_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2235,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLIQPGGSLRLSCAASGFIVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARESTQWGQGTLVTVSS,DIQMTQSPSTLSASVGDRVTITCRASHSISSWLAWYQQKPGKAPKLLIYKASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNTYSQTFGQGTKVEIK,IGHV3-53 (Human),IGHJ4 (Human),IGKV1-5 (Human),IGKJ1 (Human),ARESTQ,QQYNTYSQT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2235_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-3057,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYWMSWVRQAPGKGLEWVANIKQDGSEKYFVDSVKGRFTISRDNAKNSLYLQMNSLRAEDAAVYYCARLVTTVTTANGLYYYSYYYMDVWGKGTTVTVSS,QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWYQQLPGTAPKLLIYGNTNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYASSLSAHVVFGGGTKLTVL,IGHV3-7 (Human),IGHJ6 (Human),IGLV1-40 (Human),IGLJ2 (Human),ARLVTTVTTANGLYYYSYYYMDV,QSYASSLSAHVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-3057_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2025,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVHLVESGGGVVQPGRSLRLSCAASGFTFSNYGMHWVRQAPGKGLEWVAVISGDENNKFYANSVKGRFTISRDNSKNTLSLQMNSLRPEDTARYYCAKGGDSSGWAWDGDNPPTDYWGQGTLVIVSS,DIVMTQSPDFLAVSLGERATINCKSSQSVLHTPKNKNYLAWYKQKPGQPPKVLIYWASTRESGVPERFSGSGSGTDFTLIISSLQAEDAAVYYCQQYYTAPLTFGGGTKVEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV4-1 (Human),IGKJ4 (Human),AKGGDSSGWAWDGDNPPTDY,QQYYTAPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2025_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2203,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSTYAMHWVRQAPGKGLAWVALISYDGYNKYYADSVRGRFTISRINSKNTLSLQMNSLRAEDTAVYYCARGSAGNYYYGMDVWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQTITNYLNWYQLKSGRAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPYTFGQGTKLEIK,IGHV3-30 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ2 (Human),ARGSAGNYYYGMDV,QQSYSTPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2203_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2453,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGSELKKPGASVKVSCKASGYTFTSYAMNWVRQAPGQGLEWMGWINTNTGNPTYAQGFTGRFVFSLDTSVNTAYLQISSLKAEDTAVYYCARARLLGYCSSTSCYTIGWGAFDIWGQGTMVTVSS,DIQMTQSPSSLSASVGDRVTITCQASLDISKYLNWYQHKPGKAPNLLIYDAFNLERGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPPGVSTTFGQGTRLEIK,IGHV7-4-1 (Human),IGHJ3 (Human),IGKV1-33 (Human),IGKJ5 (Human),ARARLLGYCSSTSCYTIGWGAFDI,QQYDNLPPGVSTT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2453_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2189,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,EAQLVESGGGLVQPGRSLRLSCAASGFTFDDSAMHWVRQAPGKGLEWVSGISWNSGNVGYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTALYYCTKASRYCSSTICYWNWFDPWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYGASSLQTGVPSRFSGSGSGTDFTLTIRSLQPEDFASYYCQQSYSTPTFGGGTKVEIK,IGHV3-9 (Human),IGHJ5 (Human),IGKV1-39 (Human),IGKJ4 (Human),TKASRYCSSTICYWNWFDP,QQSYSTPT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2189_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2401,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYALFWVRQAPGKGLEWVAVISYDGNNKYYADSVRGRFTISRDNSKNTLYLQMNSLRPEDTAVYYCARPYTGSYKSYMDVWGKGTTVTVSS,DIVMTQSPDSLAVSLGERATINCKSSQSVLYSSNNKNSLAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYSISWTFGQGTKVEIK,IGHV3-30 (Human),IGHJ6 (Human),IGKV4-1 (Human),IGKJ1 (Human),ARPYTGSYKSYMDV,QQYYSISWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2401_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2034,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTTYGISWVRQAPGQGLEWMGWISAYNGNSNYGKKFQGRVTMTADTSTSTAYMELRSLRSDDTAVYYCARDLPIKVVVPAADYNWFDPWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPPTFGGGTKVQIK,IGHV1-18 (Human),IGHJ5 (Human),IGKV1-39 (Human),IGKJ4 (Human),ARDLPIKVVVPAADYNWFDP,QQSYSTPPT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2034_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2322,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSNYAMHWVRQAPGKGLDWVAVISYDGSNRYYAASVKGRFTISRDNSKNTLYLQMNSLRTEDTAVYFCARGDGYRSQFDPWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSYTFGQGTKLEIK,IGHV3-30 (Human),IGHJ5 (Human),IGKV3-20 (Human),IGKJ2 (Human),ARGDGYRSQFDP,QQYGSSYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2322_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2933,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSYYPMHWLWVRQAPGKGLEWVAVTSYDGTNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARGGATNFDYWGQGTLVTVSS,SYVLTQPPSVSVAPGKTANITCGGNNIGRKSVHWYQQKSGQAPVLVVYDDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDSSSDHPEWVFGGGTKLTVL,IGHV3-30-3 (Human),IGHJ4 (Human),IGLV3-21 (Human),IGLJ3 (Human),ARGGATNFDY,QVWDSSSDHPEWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2933_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2388,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSFISGTGDSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDQARVQDYIWGSYRSYGMDVWGLGTTVTVSS,DIVMTQSPLSLPVTPGEPASISCRSSQSLLHSNGYNYLDWYLQKPGQSPHLLIYLGSNRASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQALQTPRTFGQGTKVEIK,IGHV3-23 (Human),IGHJ6 (Human),IGKV2-28 (Human),IGKJ1 (Human),AKDQARVQDYIWGSYRSYGMDV,MQALQTPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2388_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2151,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVRKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGIIPVFGTANYAQKFQGRVTITADKSTSTAFMELNSLRSEDTAVYYCARIGSYPEYFQHWGQGTLVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSSFLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCHYRSNWPPVLTFGGGTKVEIE,IGHV1-69 (Human),IGHJ1 (Human),IGKV3-11 (Human),IGKJ4 (Human),ARIGSYPEYFQH,HYRSNWPPVLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2151_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2403,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMSSLRAEDTAVFYCARGDGDVYNFLLVRNWFDPWGQGTLVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVGNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSTLYVFGTGTKVTVL,IGHV3-30 (Human),IGHJ5 (Human),IGLV2-14 (Human),IGLJ1 (Human),ARGDGDVYNFLLVRNWFDP,SSYTSSSTLYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2403_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2013,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVHLVESGGGVVQPGRSLRLSCAASGFTFSNYGMHWVRQAPGKGLEWVAVISGDENNKFYANSVKGRFTISRDNSKNTLSLQMNSLRPEDTARYYCAKGGDSSGWAWDGDNPPTDYWGQGTLVIVSS,DIVMTQSPDFLAVSLGERATINCKSSQSVLHTPKNKNYLAWYKQKPGQPPKVLIYWASTRESGVPERFSGSGSGTDFTLIISSLQAEDAAVYYCQQYYTAPLTFGGGTKVEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV4-1 (Human),IGKJ4 (Human),AKGGDSSGWAWDGDNPPTDY,QQYYTAPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2013_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2617,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGIIPVFGTTNYAQKLQGRVTISADESTSTAYMEVSSLRSEDTAVYYCARVSGYGDYGAYSDYWGQGTLVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSRFLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPPRLTFGGGTKVEIK,IGHV1-69 (Human),IGHJ4 (Human),IGKV3-11 (Human),IGKJ4 (Human),ARVSGYGDYGAYSDY,QQRSNWPPRLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2617_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2341,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLAESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARSTSGSYYYGMDVWGQGTTVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGDYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEAEYYCSSYTSSSTLLYVFGTGTKVTVL,IGHV3-30-3 (Human),IGHJ6 (Human),IGLV2-14 (Human),IGLJ1 (Human),ARSTSGSYYYGMDV,SSYTSSSTLLYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2341_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2273,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QLQLQESGPGLVKPSETLSLTCTVSGGSISSSSYYWGWIRQPPGKGLEWIGTIYYSGSTYYNPSLKSRVTISVDTSKKQFSLKLSSVTAADTAVYYCAGEEVRGVKLYYYYAMDVWGQGTTVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDIGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSISTWVFGGGTKVTVL,IGHV4-39 (Human),IGHJ6 (Human),IGLV2-14 (Human),IGLJ3 (Human),AGEEVRGVKLYYYYAMDV,SSYTSISTWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2273_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2337,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QITFKESGPTLVKPTETLTLTCTFSGFSVSTSGEGVGWIRQPPGKALEWLAVIYWDDDKRYSPSLKSRLTITRDTSKNQVVLTMTNMDPVDTATYYCAHRLWFRDAFDIWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRARQSISNYLNWYQQKPGKAPKLLIYAASSLHSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPGTFGQGTRLEIK,IGHV2-5 (Human),IGHJ3 (Human),IGKV1-39 (Human),IGKJ5 (Human),AHRLWFRDAFDI,QQSYSTPGT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2337_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2515,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGSELKKPGASVKVSCKASGYTFTTYAMNWVRQAPGQGLEWMGWINTNTGNPTYAQDFTGRFVFSLDTSVSTAYLQISSLKAEDTAVYYCARGLVGRIDPWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDISNSLSWYQQKPGKAPKLLIYDASNLKTGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLLLFTFGPGTKVDIK,IGHV7-4-1 (Human),IGHJ5 (Human),IGKV1-33 (Human),IGKJ3 (Human),ARGLVGRIDP,QQYDNLLLFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2515_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2610,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGSALKKPGASVKVSCKASGYTFTSYAMNWVRQAPGQGLEWMGWINTNTGNPTYAQGFTGRFVFSLDTSVSTAYLQISSLKAEDTAVYYCARGRSYGLSLGYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYAASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLLQFTFGPGTKVDIK,IGHV7-4-1 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ3 (Human),ARGRSYGLSLGY,QQYDNLLQFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2610_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2422,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMYWVRQAPGKGLEWVAVISYDGINKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARVNSGSYYSYFDYWGQGTLVTVSS,DIVMTQSPDSLAVSLGERATINCKSSQSVLYSSNNKNYLAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYSTPLTFGQGTKVEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV4-1 (Human),IGKJ1 (Human),ARVNSGSYYSYFDY,QQYYSTPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2422_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2250,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSTYAMHWVRQAPGKGLAWVALISYDGYNKYYADSVRGRFTISRINSKNTLSLQMNSLRAEDTAVYYCARGSAGNYYYGMDVWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQTITNYLNWYQLKSGRAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPYTFGQGTKLEIK,IGHV3-30 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ2 (Human),ARGSAGNYYYGMDV,QQSYSTPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2250_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2844,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVELVESGGGVVQPGRSLRLSCAASGFIFSSYAMHWVRQAPGKGLEWVAVISYDGGNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARAQGGNYYYGMDVWGQGTTVTVSS,SYVLTQPPSVSVAPGKTARITCGGNNIGSKNVHWYQQKPGQAPVKVVYHDGDRPSGIPERFSGSNSGNTATLTINRVEAGDEADYSCQVWDSSSDHHVVFGGGTKLTVL,IGHV3-30-3 (Human),IGHJ6 (Human),IGLV3-21 (Human),IGLJ2 (Human),ARAQGGNYYYGMDV,QVWDSSSDHHVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2844_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2520,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYWMSWVRQAPGKGLEWVANIKEDGSEKYYVDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARDVGGYSGYDLGFDYYYYMDVWGKGTTVTVSS,SSELTQDPAVSVALGQTVRITCQGDSLRSYYANWYQQKPGQAPVVVIFGKNNRPSGIPDRFSGSNSGNTASLTITGAQAEDEADYYCNSRDSSGYIWGWMFGGGTKLTVL,IGHV3-7 (Human),IGHJ6 (Human),IGLV3-19 (Human),IGLJ3 (Human),ARDVGGYSGYDLGFDYYYYMDV,NSRDSSGYIWGWM,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2520_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2960,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQVVQSGAEVKKPGASVKVSCKASGYTFKNYGISWVRQAPGQGLEWMGWISAYTGNTNYAQKFQGRMTMTTDTSTGTGYMELRSLRSDDTAVYYCARVQRRRLDYWGQGTLVIVSS,DIVVTQTPLSLSVTPGQPASISCKSSETLLHSDGKTYLSWYLQKPGQPPQLLIYEVSNRFSGVPDRFSGSGSGTDFTLKIGRVEAEDVGLYYCMQSIQLAFGQGTRLEIE,IGHV1-18 (Human),IGHJ4 (Human),IGKV2D-29 (Human),IGKJ5 (Human),ARVQRRRLDY,MQSIQLA,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2960_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2006,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSYYAILWFRQAPGKGLEWVAIISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRPEDTAVYYCARPQSGGYYAPLDYWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK,IGHV3-30-3 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ1 (Human),ARPQSGGYYAPLDY,QQYGSSPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2006_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2333,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; S2,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFSIYWMSWVRQAPGKGLQWVANIKQDASEKYYVDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARLGGSSWHFDYWGQGTLVTVSS,SYELTQPPSVSVSPGQTASITCSGDKLGDKYSSWYQQKPGQSPVLVIYEDTKRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCQAWSSSTAVFGGGTKLTVL,IGHV3-7 (Human),IGHJ4 (Human),IGLV3-1 (Human),IGLJ3 (Human),ARLGGSSWHFDY,QAWSSSTAV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2333_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","May 5, 2021",5th May: Updated binding domain based on Chen et al,Complete
COV2-2458,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSRHAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFAISRDNSKNTLYLQMNSLRPEDTAVYYCARDPSPLVLITSIDYWGQGTLVTVSS,SYELTQPPSVSVSPGQTARITCSGDALPRQYTYWYQQKPGQAPVLVIYKDSERPSGIPERFSGSSSGTTVTLTISGVQAEDEADYYCQSADTIGTYWVFGGGTKLTVL,IGHV3-30 (Human),IGHJ4 (Human),IGLV3-25 (Human),IGLJ2 (Human),ARDPSPLVLITSIDY,QSADTIGTYWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2458_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2009,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSTYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNPKNTLYLQMNSLRAEDTAVYYCARDTATYVLLWSGDFNLDYWGQGTLVTVSS,QSALTQPASVSGSPGQSITISCTGTSGDVGAYNYVSWYQQHPVKAPKLMIYDVSKRPSGVSNRFSGSKSGNTASLTISGLQTEDEADYYCSSYTSSSTLWVFGGGTKLTVL,IGHV3-30 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ3 (Human),ARDTATYVLLWSGDFNLDY,SSYTSSSTLWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2009_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2616,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFILSDHYMDWVRQAPGKGLEWVGRTRNKANSYTTEYAASVKGRFTISRDDSKNSLYLQMNSLKTEDTAVYYCASVITFGGVIVRSYWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQYYGSSPFGFGPGTKVDIK,IGHV3-72 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ3 (Human),ASVITFGGVIVRSY,QYYGSSPFG,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2616_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2517,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVRKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGIIPVFGTANYAQKFQGRVTITADKSTSTAFMELNSLRSEDTAVYYCARIGSYPEYFQHWGQGTLVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSSFLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCHYRSNWPPVLTFGGGTKVEIE,IGHV1-69 (Human),IGHJ1 (Human),IGKV3-11 (Human),IGKJ4 (Human),ARIGSYPEYFQH,HYRSNWPPVLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2517_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2397,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCVASGFTFSFYWMSWVRQAPGKGLEWVANIKQDGGEKYYVDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARLSGSSWDFDYWGQGTLVTVSS,SYELTQPPSVSVSPGQTASITCSGDKLGDKYACWYQQRPGQSPVLVIYQDSKRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCQAWDSSTGVFGTGTKVTVL,IGHV3-7 (Human),IGHJ4 (Human),IGLV3-1 (Human),IGLJ1 (Human),ARLSGSSWDFDY,QAWDSSTGV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2397_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2325,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QITFKESGPTLVKPTETLTLTCTFSGFSVSTSGEGVGWIRQPPGKALEWLAVIYWDDDKRYSPSLKSRLTITRDTSKNQVVLTMTNMDPVDTATYYCAHRLWFRDAFDIWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRARQSISNYLNWYQQKPGKAPKLLIYAASSLHSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQTYSTFWTFGQGTNVEIK,IGHV2-5 (Human),IGHJ3 (Human),IGKV1-39 (Human),IGKJ1 (Human),AHRLWFRDAFDI,QQTYSTFWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2325_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2033,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSGTLSLTCVVSGGSISSSNWGWVRQPPGKGLEWIGEIYHSGTTNYNPSLRSRVTISVDKSKNQLSLKLNSVTAADTAIYYCARPTAGAGGAFDTWGQGTMVTVSA,QSVLTQPPSASGTPGQRVTISCSGSNSKIGSYSVNWYQQLPGTAPKLLIYRNNQRPSGVPDRFSGSKSGTSASLAISGLQSEDEADYYCSVWDDSLNGPLFGGGTKLTFL,IGHV4-4 (Human),IGHJ3 (Human),IGLV1-44 (Human),IGLJ3 (Human),ARPTAGAGGAFDT,SVWDDSLNGPL,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2033_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2310,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSQTLSLTCAVSGASISSGSYYWSWIRQPAGKGLEWIGRIYTSGNTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCATGYIGTYYYYMDVWGKGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISTYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYHCQQSYSTLTFGGGTKVEIK,IGHV4-61 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ4 (Human),ATGYIGTYYYYMDV,QQSYSTLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2310_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2669,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVHLVESGGGVVQPGRSLRLSCAASGFTFSNYGMHWVRQAPGKGLEWVAVISNDEFNKFYANSVKGRFTISRDNSKNTVYLQLNSLRTEDTARYYCAKGGDGSGWAWDGDNPPTDYWGQGTLVIVSS,DIVMTQSPDFLAVSLGERATISCKSSQSVLYTPKNKNYLAWYKQKPGQPPKVLIYWASTRESGVPDRFSGSGSGTDFTLIISSLQAEDAAVYYCQQYYTAPLTFGGGTRVEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV4-1 (Human),IGKJ4 (Human),AKGGDGSGWAWDGDNPPTDY,QQYYTAPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2669_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2774,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYWMTWVRQAPGKGLEWVANIKQDGSEKYYVDSVKGRFTISRDNAKNSLSLQMNSLRVEDTAVYYCVRLGVSSWYFDYWGQGTLVTVSS,SYELTQPPSVSVSPGQTASITCSGDKLGDKYACWYQQKPGQSPVLVIYQDTKRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCQAWGSSRGVFGGGTKLTVL,IGHV3-7 (Human),IGHJ4 (Human),IGLV3-1 (Human),IGLJ3 (Human),VRLGVSSWYFDY,QAWGSSRGV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2774_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2340,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYGMHWVRQAPGQRLEWMGWINVGNGNTKYSQRFQGRVTITRDTSASTAYMELSSLRSEDTAVYYCAMGPSAFSWLDPWGQGTLVTVSS,QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWYQHLPGTAPKLLIYGNSNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSSLSGWSVFGTGTKVTVL,IGHV1-3 (Human),IGHJ5 (Human),IGLV1-40 (Human),IGLJ1 (Human),AMGPSAFSWLDP,QSYDSSLSGWSV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2340_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2811,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSFAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAAYYCARELMSVGWGQGTLVTVSS,QSVLTQPPSVSGAPGQRVTISCTGSSSNIGARYDVHWYQQLPGTAPKLLMYGNNNRPSGVPDRFSGSKSGTSVSLAITGLQAEDEADYYCQSYDSSLSGWVFGGGTKLTVL,IGHV3-30 (Human),IGHJ4 (Human),IGLV1-40 (Human),IGLJ3 (Human),ARELMSVG,QSYDSSLSGWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2811_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2239,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGINKYYADAVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARPRSGSYYAYFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQGISNYLAWFQQKPGKAPKSLIYAASSLQSGVPSKFSGSGSGTDFTLTISSLQPEDVATYYCQQYNSHPPTFGGGTKVEIK,IGHV3-30-3 (Human),IGHJ4 (Human),IGKV1-16 (Human),IGKJ4 (Human),ARPRSGSYYAYFDY,QQYNSHPPT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2239_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2429,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLIQPGGSLRLSCAASGFIVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARESTQWGQGTLVTVSS,DIQMTQSPSTLSASVGDRVTITCRASHSISSWLAWYQQKPGKAPKLLIYKASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNTYSQTFGQGTKVEIK,IGHV3-53 (Human),IGHJ4 (Human),IGKV1-5 (Human),IGKJ1 (Human),ARESTQ,QQYNTYSQT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2429_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2883,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSTYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAMYYCAKDGSIAAADYWGQGTLVTVSS,DIVMTQSPDSLAVSLGERATINCKSSQSVLHSSNNKDSLVWYQQKPGQPPKLLIYWASSRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYSTPWTFGQGTKVEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV4-1 (Human),IGKJ1 (Human),AKDGSIAAADY,QQYYSTPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2883_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2536,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSQTLSLTCTVSGGSISSGSYYWSWIRQPAGKGLEWIGRIFTSGSTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARGGLLWFGGAGNYMDVWGKGTTVTVSS,DIVMTQSPDSLAVSLGERATINCKSSQSVLYSSNNKNYLAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYSTPPYTFGQGTKVEIK,IGHV4-61 (Human),IGHJ6 (Human),IGKV4-1 (Human),IGKJ2 (Human),ARGGLLWFGGAGNYMDV,QQYYSTPPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2536_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2028,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVHLVESGGGVVQPGRSLRLSCAASGFSFRNYGMHWVRQAPGKGLEWVAVISGDENNKFYANSVKGRFTISRDNSKNTLSLQMNSLRPEDTARYYCAKGGDSSGWAWDGDNPPTDYWGQGTLVIVSS,DIVMTQSPDFLAVSLGERATINCKSSQSVLHTPKNKNYLAWYKQKPGQPPKVLIYWASTRESGVPERFSGSGSGTDFTLIISSLQAEDAAVYYCQQYYTAPLTFGGGTKVEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV4-1 (Human),IGKJ4 (Human),AKGGDSSGWAWDGDNPPTDY,QQYYTAPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2028_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2017,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLEESGPGLVKPSETLSLTCTVSGGSISSHYWSWIRQPPGKGLEWIGYIQDSGSTNYNPSLKSRVTISVDTSKNQFSLRLSSVTTADTAVYYCVRGAMAWFDPWGQGTLVTVSS,QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYNVHWYQQLPGTAPKLLIYGNNNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSFDSSLSGSDVFGTGTKVSVL,IGHV4-59 (Human),IGHJ5 (Human),IGLV1-40 (Human),IGLJ1 (Human),VRGAMAWFDP,QSFDSSLSGSDV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2017_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2011,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSTYAMHWVRQAPGKGLEWVTLISYDGGNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDAAVYFCARGHTGNYYYGMDVWGQGTTVTVSS,ITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFGGSASGTDFTLTISSLQPEDFATYYCQQSYSTFTFGPGTKVDIK,IGHV3-30-3 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ3 (Human),ARGHTGNYYYGMDV,QQSYSTFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2011_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2509,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFIFSTYAMHWVRQAPGKGLEWVAVISYDGDNKYYADSVKGRFTISRDNSKNTLYLEMNSLRAEDTAVYYCARPRGGSYQTCFDYWGQGTLVTVSS,EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNWPGTFGQGTKVEIK,IGHV3-30-3 (Human),IGHJ4 (Human),IGKV3-15 (Human),IGKJ1 (Human),ARPRGGSYQTCFDY,QQYNNWPGT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2509_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2406,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCADSAFTFSSFWMSWVRQAPGKGLEWVANIKQDGSEKFYLDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARLGRSSWNFDYWGQGTLVTVSS,SYELTQPPSVSVSPGQTASITCSGDKLGDKFVCWYQQKPGQSPVLVIYQDNKRPSGIPERFSGSNSGNTATLTISGTQALDEADYYCQAWDSSTGVFGGGTKLTVL,IGHV3-7 (Human),IGHJ4 (Human),IGLV3-1 (Human),IGLJ2 (Human),ARLGRSSWNFDY,QAWDSSTGV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2406_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2441,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAIIWVRQAPGQGLEWMGGIIPIFGTTNYAQKFQGRVTITADESTSTAYVELSSLRSEDTAVYYCARIGHFDSSGYYLDYWGQGTLVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSSFLAWYQQKPGQAPRLLIYDASNRPTGIPARFTGSGSGTDFTLTISSLEPEDFAVYYCQHRTNWPPLFTFGPGTKVDIK,IGHV1-69 (Human),IGHJ4 (Human),IGKV3-11 (Human),IGKJ3 (Human),ARIGHFDSSGYYLDY,QHRTNWPPLFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2441_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2564,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGYNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARAQGGNYYYGMDVWGQGTTVTVSS,SYVLTQPPSVSVAPGKTARITCGGNNIGTKGVHWYQQKPGQAPVLVVYDDSDRPSGIPGRFSGSNSGNTATLTISRVEAGDEADYFCQVWDSSSDHHVVFGGGTKLTVL,IGHV3-30-3 (Human),IGHJ6 (Human),IGLV3-21 (Human),IGLJ2 (Human),ARAQGGNYYYGMDV,QVWDSSSDHHVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2564_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2776,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGDLVQPGGSLRLTCAASGFTFSSHWMTWVRQAPGKGLEWVANIKEDGREKYYVDSVKGRLTISRDNAKNSLYLQMNSLRAEDTAVYYCARVVVEVATNKGIHGVDYYYYYYMDVWGKGTTVTVSS,SSELTQDPAVSVALGQTVRITCQGDSLRSYYASWYQQKPGQAPVVVIYGKNNRPSGIPDRFSGSSSGNKASLTITGAQAGDEADYYCNSRDNSGNLNWVFGGGTKLTVL,IGHV3-7 (Human),IGHJ6 (Human),IGLV3-19 (Human),IGLJ3 (Human),ARVVVEVATNKGIHGVDYYYYYYMDV,NSRDNSGNLNWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2776_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2587,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QITFKESGPTLVKPTETLTLTCTFSGFSVSTSGEGVGWIRQPPGKALEWLAVIYWDDDKRYSPSLKSRLTITRDTSKNQVVLTMTNMDPVDTATYYCAHRLWFRDAFDIWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRARQSISNYLNWYQQKPGKAPKLLIYAASSLHSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPTFGGGTKVEIK,IGHV2-5 (Human),IGHJ3 (Human),IGKV1-39 (Human),IGKJ4 (Human),AHRLWFRDAFDI,QQSYSTPT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2587_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2551,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSETLSLTCTVSGGSISSSSYYWGWIRQPPGKGLEWIGSIYYSGSSYYSPSLKSRVTISADTSKNQFSLNLRSVTAADTAVYYCASGPPYMATFSYYFDYWGQGTLVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWFQHHPDKAPRLMIYDVSKRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSTPFVFGTGTKVTVL,IGHV4-39 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ1 (Human),ASGPPYMATFSYYFDY,SSYTSSSTPFV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2551_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2481,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFGSYVISWVRQAPGQGLQWMGGIIPIFGKPNYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYCARGWFGELLKGTYWFDPWGQGTLVTVSS,DIVMTQSPDSLAVSLGERATINCKSSQSVLYSSNNKNYLAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYSTPGFGQGTKLEIK,IGHV1-69 (Human),IGHJ5 (Human),IGKV4-1 (Human),IGKJ2 (Human),ARGWFGELLKGTYWFDP,QQYYSTPG,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2481_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2029,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSGTLSLTCVVSGGSISSSNWGWVRQPPGKGLEWIGEIYLSGTTNYNPSLTSRVTISVDKSKNQFSLKLNSVTAADTAIYYCARPTAGAGGAFDIWGQGTVVTVSS,QSVLTQPPSVSGTPGQRVTISCSGSNSKIGSYSVNWYQQLPGTAPKLLIYRNNQRPSGVPDRFFGSKSGTSASLAISGLQSEDEADYYCSVWDDSLNGPLFGGGTKLTFV,IGHV4-4 (Human),IGHJ3 (Human),IGLV1-44 (Human),IGLJ3 (Human),ARPTAGAGGAFDI,SVWDDSLNGPL,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2029_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2590,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFSSYDINWVRQATGQGLEWMGWVNPNSGHTGYAQKFQGRVTMTRNTSVSTAYMELSSLRSEDTAVFYCARGRVGYVGSGSRGYYYYYDMDVWGQGTTVTVSS,SSELTQDPAVSVALGQTVRITCQGDSLRSYYASWYQQKPRQAPVLIISGNNNRPSGIPDRFSGSSSGNTASLTITGAQAEDEADYYCNSRDSSGNHLRVFGGGTKLTVL,IGHV1-8 (Human),IGHJ6 (Human),IGLV3-19 (Human),IGLJ2 (Human),ARGRVGYVGSGSRGYYYYYDMDV,NSRDSSGNHLRV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2590_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2408,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSQTLSLTCTVSGDSISSGSYYWSWIRQPAGKGLEWIGRIYTSGSTTYNPSLKSRVTISVNTSKNQFSLNLSSVTAADTAVYYCARVGGISPYYYYYYMDVWGKGTTVTVSS,DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLMYAASTLQSGVPSRFSGSGSGTEFTLTINTLQPEDFATYYCQQLNSYPITFGQGTRLEIK,IGHV4-61 (Human),IGHJ6 (Human),IGKV1-9 (Human),IGKJ5 (Human),ARVGGISPYYYYYYMDV,QQLNSYPIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2408_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2565,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSQTLSLTCTVSGGSISSGSYYWSWIRQPAGKGLEWIGRVYIYSSGSTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARGAASFDYWGQGTLVTVSS,DIVMTQSPLSLPVTPGEPASISCRSSQSLLHSDGYTYLDWYLQKPGQSPQLLIYLGSKRASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQALQTPLTFGGGTKVEIK,IGHV4-61 (Human),IGHJ4 (Human),IGKV2-28 (Human),IGKJ4 (Human),ARGAASFDY,MQALQTPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2565_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2641,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSTYAMHWVRQAPGKGLEWVTVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKSYNGNYYDAFDIWGQGTMVTVSS,EIVLTQSPGTLSLSPGERATLSCRAGQTVSSSYLAWYQHKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSYTFGQGTKLEIK,IGHV3-30 (Human),IGHJ3 (Human),IGKV3-20 (Human),IGKJ2 (Human),AKSYNGNYYDAFDI,QQYGSSYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2641_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2449,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCATSGFTFSSFALHWVRQAPGKGLEWVTVISDDGNNKYYVDSVKGRFTISRDNSKNTLFLQMNSLRVEDTAIYYCARASYNSNWSIGEYFRDWGQGTLVTVSS,DIVMTQSPDSLAVSLGERATINCKSSQSLLYTSNNKNYLAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYSPPWTFGQGTKVEIK,IGHV3-30 (Human),IGHJ1 (Human),IGKV4-1 (Human),IGKJ1 (Human),ARASYNSNWSIGEYFRD,QQYYSPPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2449_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2619,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,EVQLLESGGGLVQPGGSLRLSCAASGFTFNNYAMSWVRQAPGKGLEWVSAIGGSGGSTYYADSVKGRFTVSRDNSENTLYLQMSSLRAEDTAVYYCARVEGDWLLGGPYYHYYGMDVWGQGTTVTVSS,QSVLTQPPSASGTPGQRVTISCSGSSSNIGSNYVYWYQQLPGTAPKLLISRNNQRPSGVPDRFSGSKSGTSASLAISGLQSEDEANYYCLVWDDSLNGLVFGGGTKLTVL,IGHV3-23 (Human),IGHJ6 (Human),IGLV1-47 (Human),IGLJ2 (Human),ARVEGDWLLGGPYYHYYGMDV,LVWDDSLNGLV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2619_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2367,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGIIPIFGAANYAQNFQGRVTITADESTSTGYMQLSSLRFEDTAVYYCARTSHYDSSGSYFEYWGQGTLVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLDPEDFAVYYCHKRSNWPPSLTFGGGTKVEIK,IGHV1-69 (Human),IGHJ4 (Human),IGKV3-11 (Human),IGKJ4 (Human),ARTSHYDSSGSYFEY,HKRSNWPPSLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2367_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2343,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQVVQSGAEVKKPGASVKVSCKASGYTFKNYGISWVRQAPGQGLEWMGWISAYTGNTNYAQKFQGRMTMTTDTSTGTGYMELRSLRSDDTAVYYCARVQRRRLDYWGQGTLVIVSS,DIVVTQTPLSLSVTPGQPASISCKSSETLLHSDGKTYLSWYLQKPGQPPQLLIYEVSNRFSGVPDRFSGSGSGTDFTLKIGRVEAEDVGLYYCMQSIQLAFGQGTRLEIE,IGHV1-18 (Human),IGHJ4 (Human),IGKV2D-29 (Human),IGKJ5 (Human),ARVQRRRLDY,MQSIQLA,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2343_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2270,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGIIPIFGTANYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYCAITYYYDSSGYWWDDWGQGTLVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSSFLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPPSYTFGQGTKLEIK,IGHV1-69 (Human),IGHJ4 (Human),IGKV3-11 (Human),IGKJ2 (Human),AITYYYDSSGYWWDD,QQRSNWPPSYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2270_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2187,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSYYPMHWLWVRQAPGKGLEWVAVTSYDGTNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARGGATNFDYWGQGTLVTVSS,SYVLTQPPSVSVAPGKTANITCGGNNIGRKSVHWYQQKSGQAPVLVVYDDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDSSSDHPEWVFGGGTKLTVL,IGHV3-30-3 (Human),IGHJ4 (Human),IGLV3-21 (Human),IGLJ3 (Human),ARGGATNFDY,QVWDSSSDHPEWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2187_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2478,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGRSLRLSCAASGFTFDDYAMHWVRQAPGKGLEWVSGISWNSDNIGYADSVKGRFTISRDIAKNSLYLQMNSLRAEDTALYYCAKGIYYDIFMPLLDWGRGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSTFLAWYQQKPGQAPRLLIFGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCHQYGTSPYTFGQGTKLEIK,IGHV3-9 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ2 (Human),AKGIYYDIFMPLLD,HQYGTSPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2478_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2820,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVIWYDGSKKDYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDQSQGAYILTGYRGYGMDVWGQGTTVTVSS,DIVMTQSPLSLPVTPGEPASISCRSSQSLLHSNGYNYLDWYLQKPGQSPQFLIYLGSNRASGVPDRFSGSGSGTDFILKISRVEAEDVGVYYCMQALQTPFTFGPGTKVDIK,IGHV3-33 (Human),IGHJ6 (Human),IGKV2-28 (Human),IGKJ3 (Human),ARDQSQGAYILTGYRGYGMDV,MQALQTPFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2820_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2620,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAGISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARADTMVRGTYFEYWGQGTLVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYCCSSYTSSRAVLFGGGTKLTVL,IGHV3-30-3 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ2 (Human),ARADTMVRGTYFEY,SSYTSSRAVL,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2620_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2171,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCVASGFTFSFYWMSWVRQAPGKGLEWVANIKQDGGEKYYVDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARLSGSSWDFDYWGQGTLVTVSS,SYELTQPPSVSVSPGQTASITCSGDKLGDKYACWYQQRPGQSPVLVIYQDSKRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCQAWDSSTGVFGTGTKVTVL,IGHV3-7 (Human),IGHJ4 (Human),IGLV3-1 (Human),IGLJ1 (Human),ARLSGSSWDFDY,QAWDSSTGV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2171_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2583,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYDMNWVRQATGQGLEWMGWMNPNSGNTGYAQKFQGRVTMTRNTSISTAYMELSSLRSEDTAVYYCARGGIYYLVRGFIIGYYGMDVWGQGTTVTVSS,DIVMTQSPDSLAVSLGERATINCKSSQSVLYSSNNKNYLAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYSTPLTFGGGTKVEIK,IGHV1-8 (Human),IGHJ6 (Human),IGKV4-1 (Human),IGKJ4 (Human),ARGGIYYLVRGFIIGYYGMDV,QQYYSTPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2583_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2227,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVIWYDGSKKDYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDQSQGAYILTGYRGYGMDVWGQGTTVTVSS,DIVMTQSPLSLPVTPGEPASISCRSSQSLLHSNGYNYLDWYLQKPGQSPQFLIYLGSNRASGVPDRFSGSGSGTDFILKISRVEAEDVGVYYCMQALQTPFTFGPGTKVDIK,IGHV3-33 (Human),IGHJ6 (Human),IGKV2-28 (Human),IGKJ3 (Human),ARDQSQGAYILTGYRGYGMDV,MQALQTPFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2227_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2160,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLAESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARSTSGSYYYGMDVWGQGTTVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGDYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEAEYYCSSYTSSSTLLYVFGTGTKVTVL,IGHV3-30-3 (Human),IGHJ6 (Human),IGLV2-14 (Human),IGLJ1 (Human),ARSTSGSYYYGMDV,SSYTSSSTLLYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2160_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2178,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFSTYWMTWVRQAPGKGLEWVANIKQDGSEKYYVDSVKYRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARVGSSSWYFDYWGQGTLVTVSS,SYELTQPPSVSVSPGQTASITCSGDKLGDKYACWYQQKPGQSPVVVIYQDSKRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCQAWDSSTAVFGGGTKLTVL,IGHV3-7 (Human),IGHJ4 (Human),IGLV3-1 (Human),IGLJ2 (Human),ARVGSSSWYFDY,QAWDSSTAV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2178_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2159,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLAESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARSTSGSYYYGMDVWGQGTTVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGDYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEAEYYCSSYTSSSTLLYVFGTGTKVTVL,IGHV3-30-3 (Human),IGHJ6 (Human),IGLV2-14 (Human),IGLJ1 (Human),ARSTSGSYYYGMDV,SSYTSSSTLLYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2159_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2166,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAIIWVRQAPGQGLEWMGGIIPIFGTTNYAQKFQGRVTITADESTSTAYVELSSLRSEDTAVYYCARIGHFDSSGYYLDYWGQGTLVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSSFLAWYQQKPGQAPRLLIYDASNRPTGIPARFTGSGSGTDFTLTISSLEPEDFAVYYCQHRTNWPPLFTFGPGTKVDIK,IGHV1-69 (Human),IGHJ4 (Human),IGKV3-11 (Human),IGKJ3 (Human),ARIGHFDSSGYYLDY,QHRTNWPPLFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2166_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2224,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSTYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAMYYCAKDGSIAAADYWGQGTLVTVSS,DIVMTQSPDSLAVSLGERATINCKSSQSVLHSSNNKDSLVWYQQKPGQPPKLLIYWASSRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYSTPWTFGQGTKVEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV4-1 (Human),IGKJ1 (Human),AKDGSIAAADY,QQYYSTPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2224_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2214,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAIIWVRQAPGQGLEWMGGIIPIFGTTNYAQKFQGRVTITADESTSTAYVELSSLRSEDTAVYYCARIGHFDSSGYYLDYWGQGTLVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSSFLAWYQQKPGQAPRLLIYDASNRPTGIPARFTGSGSGTDFTLTISSLEPEDFAVYYCQHRTNWPPLFTFGPGTKVDIK,IGHV1-69 (Human),IGHJ4 (Human),IGKV3-11 (Human),IGKJ3 (Human),ARIGHFDSSGYYLDY,QHRTNWPPLFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2214_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2218,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYALFWVRQAPGKGLEWVAVISYDGNNKYYADSVRGRFTISRDNSKNTLYLQMNSLRPEDTAVYYCARPYTGSYKSYMDVWGKGTTVTVSS,DIVMTQSPDSLAVSLGERATINCKSSQSVLYSSNNKNSLAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYSISWTFGQGTKVEIK,IGHV3-30 (Human),IGHJ6 (Human),IGKV4-1 (Human),IGKJ1 (Human),ARPYTGSYKSYMDV,QQYYSISWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2218_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2216,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGIIPIFGAANYAQNFQGRVTITADESTSTGYMQLSSLRFEDTAVYYCARTSHYDSSGSYFEYWGQGTLVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLDPEDFAVYYCHKRSNWPPSLTFGGGTKVEIK,IGHV1-69 (Human),IGHJ4 (Human),IGKV3-11 (Human),IGKJ4 (Human),ARTSHYDSSGSYFEY,HKRSNWPPSLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2216_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2175,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCVASGFTFSFYWMSWVRQAPGKGLEWVANIKQDGGEKYYVDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARLSGSSWDFDYWGQGTLVTVSS,SYELTQPPSVSVSPGQTASITCSGDKLGDKYACWYQQRPGQSPVLVIYQDSKRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCQAWDSSTGVFGTGTKVTVL,IGHV3-7 (Human),IGHJ4 (Human),IGLV3-1 (Human),IGLJ1 (Human),ARLSGSSWDFDY,QAWDSSTGV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2175_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
COV2-2183,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAGISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARADTMVRGTYFEYWGQGTLVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYCCSSYTSSRAVLFGGGTKLTVL,IGHV3-30-3 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ2 (Human),ARADTMVRGTYFEY,SSYTSSRAVL,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COV2-2183_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 12, 2020","Jul 12, 2020",N/A,Complete
mAb-1,Ab,"SARS-CoV1,SARS-CoV2","229E, HKU1, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,EVQLVESGGGLVKPGGSLRLSCAASGFTFSSYYMNWVRQAPGKGLEWVSSISSDGYNTYYPDSLKGRFTISRDSAKNSLYLQMNSLRADDTAVYYCARDFSGHTAVAGTGFEYWGQGTLVTVSS,QPVLTQPPSVSGAPGQRITISCTGSSSNIGAGYDVHWYQQLPGTAPKLLIYGSSSRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSSLSVLYVFGTGTKVTVL,IGHV3-21 (Human),IGHJ4 (Human),IGLV1-40 (Human),IGLJ1 (Human),ARDFSGHTAVAGTGFEY,QSYDSSLSVLYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-1_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-2,Ab,"SARS-CoV1,SARS-CoV2","229E, HKU1, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVESGGGLVQPGGSLRLSCSASGFTFSRFAMHWVRQAPGKGLEYVSAINLNGDSTYYTDSVRGRFTISRDNSKNTLYLQMSSVRPDDTAFYYCVKDGGYYDSSGPGHWGQGTLVTVSS,EIVLTQSPATLSLSPGERATLSCRASENIAHYLAWYQQKPGQAPRLVIYDASSRATGIPGRFSGSGAGTDFTLTINSLEPEDFAVYYCQQRSNWPQNFGGGTKVEIK,IGHV3-64D (Human),IGHJ1 (Human),IGKV3-11 (Human),IGKJ4 (Human),VKDGGYYDSSGPGH,QQRSNWPQN,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-2_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-3,Ab,"SARS-CoV1,SARS-CoV2","229E, HKU1, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLQESGPGLVRPSETLSLTCTVSGDSVSSSDYHWGWIRQPPGKGLEWIGSIYYGGRSHFNPSLKSRVAIFVDTSNNQFSLRLNSVTASDTAVYFCAGRHQELLPMGSFDMWAQGTTVTVSS,EIVMTQSPSSLSASIGDRVTISCRASQNIGSYLNWYQQRPGKAPNLLIFVASSLQSGVPSRFSGSGSGTDFTLTISSLQAEDFATYYCQQSYTTPITFGQGTRLEIK,IGHV4-38-2 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ5 (Human),AGRHQELLPMGSFDM,QQSYTTPIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-3_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-4,Ab,"SARS-CoV1,SARS-CoV2","229E, HKU1, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,EVQLVESGGGLVKPGGSLRLSCAASGFTFSDYYMNWVRQAPGKGLEWVSSISSSSYMYYADSMKGRFTISRDNAQNSLYLQMSSLRAEDTAVYYCARDFPGDTAVAGTGFNYWGQGTLVTVSS,QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWYQQVPGTAPKLLIYGNSNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSSLSVLYVFGTGTKVTVL,IGHV3-21 (Human),IGHJ4 (Human),IGLV1-40 (Human),IGLJ1 (Human),ARDFPGDTAVAGTGFNY,QSYDSSLSVLYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-4_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-5,Ab,"SARS-CoV1,SARS-CoV2","229E, HKU1, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,EVQLVESGGGLVQPGRSLRLSCSASGFSFGDYAMSWFRQAPGKGLQWVGLIKTRAYGAATDYAASVQGRFIISRDDSKSIAYLQMNSLKTEDTAVYFCAREGTSLGYYYYYAMDVWGHGTTVTVSS,DIVLTQTPSSLSASVGDRVTITCRASQTISYYLNWYQQKVGKAPQLLVYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSVPLTLGQGTKVDIK,IGHV3-49 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ3 (Human),AREGTSLGYYYYYAMDV,QQSYSVPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-5_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-6,Ab,"SARS-CoV1,SARS-CoV2","229E, HKU1, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVQSGAEVKKPGASVKVSCRASGYTFSGYDINWVRQATGQGLEWMGWMNPNSGDTGYAHKFQGRVTMTRNSSISTAYMELSSLTSEDTAVYFCAREKKSFGPQYYYGSGEDWGQGTLVTVSS,EIVMTQSPSSLSASVGDRVTITCRASQSISNYLYWYQQKPGKAPKLLIYVASNLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPYNFGQGTKVDIK,IGHV1-8 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ3 (Human),AREKKSFGPQYYYGSGED,QQSYSTPYN,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-6_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-7,Ab,"SARS-CoV1,SARS-CoV2","229E, HKU1, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,EVQLLESGGGLSRPGGSLRLSCAASGFIASRNCMQWVRQAPGKGLEWVSIICGDEITYIRDSVKGRFTISRDDSKNTLHLEMNSLRADDTAVYYCARATPPGGTTGWPYIDLWGQGTLVTVSS,EIVLTQSPATLSVSPGDGASLSCRASQSVGSNLAWYQQKPGQAPRLLISDASARATGVPARFTGSGSGTDFTLTISSLQSEDFAVYYCHQYNTWPPLTFGGGTKLEIK,IGHV3-66 (Human),IGHJ4 (Human),IGKV3-15 (Human),IGKJ4 (Human),ARATPPGGTTGWPYIDL,HQYNTWPPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-7_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-8,Ab,"SARS-CoV1,SARS-CoV2","229E, HKU1, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVQSGAEVKKPGSSMKLSCKASGINFRSYSFSWVRQAPGQGLEWMGGVIPYFPTANYAEKFRGRVTATADESTGTVYLEMSSLRSEDTAVYYCASEYFDGRSYHSFCGLDVWGQGTLVTVSS,ETTLTQSPLSLPVTLGQPASISCRSSQGLAHSNGNTYLNWFHQRPGQSPRRLIYQVSNRDSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQGTEWPRTFGQGTKVEIK,IGHV1-69 (Human),IGHJ4 (Human),IGKV2-30 (Human),IGKJ1 (Human),ASEYFDGRSYHSFCGLDV,MQGTEWPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-8_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-9,Ab,"SARS-CoV1,SARS-CoV2","229E, HKU1, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFSSYDINWVRQATGQGLEWMGWMSPNTGDTGYAHKFQGRVRMTSNTSISTAYMELNSLTSEDTAVYYCARRGNNFGYYYYYTVDVWGQGTTVTVSS,DIRLTQSPSSLSASVGDRVTIACRASQSVSNYLNWYQQKPGKAPKLLIYAASSLQNGVPSRFGGSGSGTDFTLTISSLQPEDFATYYCQQCYSYPPTFGHGTKVEIK,IGHV1-8 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ1 (Human),ARRGNNFGYYYYYTVDV,QQCYSYPPT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-9_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-10,Ab,"SARS-CoV1,SARS-CoV2","229E, HKU1, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,EVQLVESGGGLSQPGGSLRLSCAASGFVVKNNCMNWVRQAPGKGLEWVALICADGITYHSDSVTGRFTIYRDESDNTLHLQMDSLRIEDTAVYYCVRASPPGGNTGWPFFEDWGQGTLVTVSS,DIVLTQTPATLSVSPGEGATLSCRASQSVRSNLAWFQQRPGQVPRLLIYDASTRATGVPARFTGSGSGTYFTLTISSLQSEDFAVYYCQQYNSWPPLTFGGGTKLEIK,IGHV3-66 (Human),IGHJ4 (Human),IGKV3-15 (Human),IGKJ4 (Human),VRASPPGGNTGWPFFED,QQYNSWPPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-10_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-11,Ab,"SARS-CoV1,SARS-CoV2","229E, HKU1, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVQSGGGVVQPGRSLKLSCVVSGFSFSHYGMNWVRQAPGKGLEWVAVMSYDGSDKYYADSVKGRFTISRDISKNTLYLEMNSLRTEDTAVYYCAKKGSPYCGVDCYKGYFDYWGQGTLVTVSS,EIVLTQSPSSLSASVGDRVTITCQASQDIRKCLNWYQHIPGKAPKLLIHDASSLESGVPSRFSGSGSGTDFSFTINSLHPEDIATYYCQQFEDLPITFGQGTRLEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ5 (Human),AKKGSPYCGVDCYKGYFDY,QQFEDLPIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-11_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-12,Ab,"SARS-CoV1,SARS-CoV2","229E, HKU1, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVQSGAEVRKPGSSVKLSCKASGGTFSTHAISWVRQAPGQRPEWMGGIMPIFGESKDTQKFQGRVTFTADESTTTAYMELRSLRSDDTAIYYCVRDSDPYTATVTSNHYWYAMDVWGQGTTVTVSS,ETTLTQSPLSLPVTLGQPASISCRSSQGLVHSNGNTYVNWFHQRPGQSPRRLIYEVSNRDSGVPDRFSGSGSGTDFTLKISRVEAEDIGVYYCMQGTEWPRTFGQGTKVDIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV2-30 (Human),IGKJ3 (Human),VRDSDPYTATVTSNHYWYAMDV,MQGTEWPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-12_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-13,Ab,"SARS-CoV1,SARS-CoV2","229E, HKU1, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKISGGTFKNSAFSWARQVPGQGFQWMGGIIPMFGVPHSVQMFQGRVTLTADESTSAVYMELSGLTSDDTAVYYCAREEYSGTVHNFFGMDVWGQGTTVTVSS,DIRMTQSPLSLPVTRGQPASISCRSSHNVVHSDGKTYLNWFHQRPGQAPRRLIYQVSKRDSGVPDRFSGSGSGSDFTLTISRVEAEDVGVYYCMQGTDWPRSFGGGTKVEIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV2-30 (Human),IGKJ4 (Human),AREEYSGTVHNFFGMDV,MQGTDWPRS,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-13_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-14,Ab,"SARS-CoV1,SARS-CoV2","229E, HKU1, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,EVQLVESGGGVVQPGRSLRLSCAASGFTFSGYPMHWVRQAPGKGLEWVALISFDGDSKYYTDSVKARFAISRDNSKNTLFLQMNSLRVADTALYYCARAKGGSYSNAFDYWGQGTLVTVSS,EIVLTQSPDSLAVSLGERATINCKSSQSVLYSSNNENCLAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYCSTPPYTFGQGTKVDIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV4-1 (Human),IGKJ3 (Human),ARAKGGSYSNAFDY,QQYCSTPPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-14_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-15,Ab,"SARS-CoV1,SARS-CoV2","229E, HKU1, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVQSGAELKKPGSSVRVSCKAAGGTLTNYAISWVRQAPGQGFEWMGGIMPVSHTAGYAQKFQGRVTFTADESATTAYMDLTSLRPEDTAIYYCARDPSIHYTGNHHWYDLDIWGQGTMVTVSS,DIRLTQSPLSLPVTLGQPASISCRSSQRIVHTDGNTYLNWFLQRPGQSPRRLIYKVSNRDSGVPDRFSGSGSGTDFTLKISRVEAEDVGIYYCMQGTEWPRTFGQGTKVDIK,IGHV1-69 (Human),IGHJ3 (Human),IGKV2-30 (Human),IGKJ3 (Human),ARDPSIHYTGNHHWYDLDI,MQGTEWPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-15_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-16,Ab,"SARS-CoV1,SARS-CoV2","229E, HKU1, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,EVQLVESGAEVRTPGSSVKLSCKASGGTFSTHAFSWVRQAPGQRPEWMGGIIPIFGESKDTQKFQGRVTFTADESTTTVYMELRSLKSDDTAIYYCVRDSDPYTATYRNNHYWYAMDVWGQGTTVTVSS,EIVLTQSPLSLPVTLGQPASISCRSSLRLVHTDGNTYLNWFQQRPGQSPRRLIYKVSNRDSGVPDRFSGSGSGTDFTLKISRVEAEDIGVYYCMQGTEWPRTFGQGTKVDIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV2-30 (Human),IGKJ3 (Human),VRDSDPYTATYRNNHYWYAMDV,MQGTEWPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-16_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-17,Ab,"SARS-CoV1,SARS-CoV2","229E, HKU1, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVQSGAELKKPGSSVRVSCKAAGGTLTNYAISWVRQAPGQGFEWMGGIMPVSHTAGYAQKFQGRVTFTADESATTAYMDLTSLRPEDTAIYYCARDPSIHYTGNHHWYDLDIWGQGTMVTVSS,ETGLTQIPFSLPVTFGQPASISCRFSQRLVHTDGNTNLNWFLQRPGQFPRGLIYKVFNRDSGVPDRFRGSGSGIDFTLKISRVEVEDVGIYYGMQGTEWLGTFGQGTKVEIK,IGHV1-69 (Human),IGHJ3 (Human),IGKV2-30 (Human),IGKJ1 (Human),ARDPSIHYTGNHHWYDLDI,MQGTEWLGT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-17_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-18,Ab,"SARS-CoV1,SARS-CoV2","229E, HKU1, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLQQWGAGLLKPSETLSLSCAVYGGSFSGFYWSWIRQPPGKGLEWIGEINHSGSANYNPSLMSRVTISMDTSKKQFSLQLRSVTAADTAVYYCARGQESPIVGVTGRWFDPWGQGTLVTVSS,QPVLTQPASVSGSPGQSVTISCTGTSSDVGSYSDVGNYVSWYQHHPGKAPKLMIYEVRTRPSWVSTRFSGSKSGTTASLTISGLQAEDEADYYCCSYAGASPFVVFGGGTKLTVL,IGHV4-34 (Human),IGHJ5 (Human),IGLV2-23 (Human),IGLJ3 (Human),ARGQESPIVGVTGRWFDP,CSYAGASPFVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-18_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-19,Ab,"OC43, SARS-CoV1,SARS-CoV2","229E, HKU1, NL63",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLQQWGAGLLKPSETLSLTCAVYGGSFSGFHWSWIRQPPGKGLEWIGEVNHSGSTKYNPSLKSRVTVSVDTSKNQFSLRLSSVTAADTAIYYCARGSLSREYDFLTAPQNGPWFDSWGQGALVTVSS,QSVLTQPPSVSAAPGQKVTISCSGSSSNLGNNYVSWYQQLPGTAPKLLIYDNHKRPSGIPDRFSGSKSGTSATLGITGLQTGDEADYYCETWDSSLSVVVFGGGTKVTVL,IGHV4-34 (Human),IGHJ5 (Human),IGLV1-51 (Human),IGLJ3 (Human),ARGSLSREYDFLTAPQNGPWFDS,ETWDSSLSVVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-19_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-20,Ab,"OC43, SARS-CoV1,SARS-CoV2","229E, HKU1, NL63",,,S; Unk,B-cells; SARS-CoV1 Human Patient,EVQLVESGPGLVKPSETLSLTCTVSGASVTAGSSYWGWIRQPPGKGLEWIGYMFSSGNTKYNPSLKSRVTISADTSKNQFSLRLSSVTAADTAVYFCARVGWVRYFDWSKPYYYFDLWGRGTLVTVSS,QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYYVHWYQQLPGTAPKLLIYDNNNRPSGVPDRFSGSRSGTSASLAITGLQAEDEGDYFCQSYDSSLSASFGGGTKVTVL,IGHV4-59 (Human),IGHJ2 (Human),IGLV1-40 (Human),IGLJ6 (Human),ARVGWVRYFDWSKPYYYFDL,QSYDSSLSAS,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-20_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-21,Ab,"SARS-CoV1,SARS-CoV2","229E, HKU1, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFSTSAMSWVRQAPGKGLEWVSRIGGGGGRTKYADSVKGRFTISRDNSKNTLYLQMNSLRADDTAVYYCAKCDLVRYFDWLGEENNWFDPWGQGTLVTVSS,QSVLTQPPSVSGAPGQRVTISCTGSNSNIGAGYDVHWYQQLPETAPKLLIYANGNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSSLSGVLFGGGTKLTVL,IGHV3-23 (Human),IGHJ5 (Human),IGLV1-40 (Human),IGLJ3 (Human),AKCDLVRYFDWLGEENNWFDP,QSYDSSLSGVL,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-21_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-22,Ab,"SARS-CoV1,SARS-CoV2","229E, HKU1, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVQSGAEVRKPGSSVKLSCKASGGTFSTHAISWVRQAPGQRPEWMGGIMPIFGESKDTQKFQGRVTFTADESTTTAYMELRSLKSDDTAIYYCVRDSDPYTATVRNNHYWYALDVWGPGTMVTVSS,DIQLTQSPLSLPVTLGQPASISCRSSQHLVHSDGNTYLNWFQQRPGQSPRRLIYKVSNRDSGVPDRFSGSGSGIDFTLKISRVEAEDIGVYYCMQGTEWPRTFGQGTKVEIK,IGHV1-69 (Human),IGHJ3 (Human),IGKV2-30 (Human),IGKJ1 (Human),VRDSDPYTATVRNNHYWYALDV,MQGTEWPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-22_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-23,Ab,"SARS-CoV1,SARS-CoV2","229E, HKU1, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,EVQLVESGGGLSQPGGSLRLSCAASGFTVRTYCMNWVRQAPGKGLEWVSLVCGDNIDYYPDSVKGRFSISRDDSKNTLLLHMDSLRVEDTAVYYCARATPPGGGTGWPYFDFWGQGTLVTVSS,DIQVTQSPATVSVSPGEGASLSCRASQSVRSNLAWFQQKPGQAPRLLISDASTRASGVPARFTGSGFGTEFTLTISSLQSEDFAIYYCQQYNTWPPLTFGGGTKVEIK,IGHV3-66 (Human),IGHJ4 (Human),IGKV3-15 (Human),IGKJ4 (Human),ARATPPGGGTGWPYFDF,QQYNTWPPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-23_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-24,Ab,"SARS-CoV1 (weak), SARS-CoV2","229E, HKU1, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVQSGAEMRKPGSSVKVSCKASGGTFSRYCFSWVRQAPGQRLEWMGGIMSILGAHYAQKFQGRVTFTADESTNTAYMELISLTSEDTAVYYCAREEPSGTYHNYYGLDVWGQGTTVTVSS,DIRLTQSPLSLPVTLGQPASISCRSSQSLVHSNGNTYLNWFQQRPGQSPRRLIYEVSNRDSGVPDRFTGSGSGTDFTLKISRVEAEDVGVYYCMQGTHWPRSFGGGTKVEIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV2-30 (Human),IGKJ4 (Human),AREEPSGTYHNYYGLDV,MQGTHWPRS,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-24_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-25,Ab,"SARS-CoV1,SARS-CoV2","229E, HKU1, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLQESGPGLVKPSGTLSLTCAVSGGSISSSDWCSWVRQPPGKGPEWIAEISHSGSTNYNPSLKSRVTMSVDRSKNQFSLNLNSVTAADTAVYYCAARIRGATHYDFWSGFWAGPFDIWGQGTTVTVSS,ETTLTQSPGTLSLSPGERATLSCRASQSIGSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSAPLYTFGQGTKVEIK,IGHV4-4 (Human),IGHJ3 (Human),IGKV3-20 (Human),IGKJ1 (Human),AARIRGATHYDFWSGFWAGPFDI,QQYGSAPLYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-25_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-26,Ab,"SARS-CoV1,SARS-CoV2","229E, HKU1, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,EVQLQESGPGLVKPSGTLSLTCGVSGVSISSSSWWSWVRQPPGRGLEWIGEISPSGSTSYNPSFRSRLTMSVDKSRNQLSLKLSSVTAADTAVYYCARTQSNDFWSGYYTAAFDLWGQGTMVTVSS,EIVLTQSPGTLSLSPGERASLSCRASQSVSSSYLAWYQHRPGQAPRLLIYDASSRATGIPDRFSGSGSGTDFTLTISRLESEDFAVYYCQQYGNSPRTFGQGTKVDIK,IGHV4-4 (Human),IGHJ3 (Human),IGKV3-20 (Human),IGKJ3 (Human),ARTQSNDFWSGYYTAAFDL,QQYGNSPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-26_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-27,Ab,"SARS-CoV1,SARS-CoV2","229E, HKU1, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVQWGAGLLKPSETLSLTCAVYGGSFSGFHWSWIRQPPGKGLEWIGEINHSGSTKYNPSLKSRVTISVDTSKNQFSLRLRSVTAADTAIYYCARGSLSREYDFLTAPQNGPWFDSWGQGALVTVSS,QPVLTQPPSVSAAPGQKVTISCSGSSSNIGDNYVSWYQQLPGTAPKLLIYDNNKRPSGIPDRFSGSKSGTSATLGITGLQTGDEADYYCETWDTSLSVVVFGGGTKLTVL,IGHV4-34 (Human),IGHJ5 (Human),IGLV1-51 (Human),IGLJ3 (Human),ARGSLSREYDFLTAPQNGPWFDS,ETWDTSLSVVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-27_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-28,Ab,"SARS-CoV1,SARS-CoV2","229E, HKU1, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,EVQLVESGPELKKPGSSVRVSCKASGGSFSNFAVSWVRQAPGQRLEWMGGVIPRFGRSEYVQKFQGRVTITVDEAASTAYMELSSLRSEDTAIYYCVLDTTSANPHNWYGMDVWGQGTTVTVSS,DIVMTQTPLSLAVTLGQPASISCRSSHGLVHTNGNTYLNWFHQRPGQPPRRLIYKISNRDSGVPDRFSGSGSGTDFTLKISRVEADDVGVYYCMQGTDWPRTFGQGTKVEIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV2-30 (Human),IGKJ1 (Human),VLDTTSANPHNWYGMDV,MQGTDWPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-28_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-29,Ab,"SARS-CoV1,SARS-CoV2","229E, HKU1, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVQSGGGVVNPGGSLRLSCVGSGFTFSDYYMGWIRQAPGKGLEVISYISSTGSYIRDADSVKGRFTISRDNAENSVYLQMNSLRGEDTAVYYCARMGPYGSGSFDYWGLGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQTVTRSQLAWYQHKPGQPPRLLIYDSSKRATGSPDRFSASGSGTDFTLTISGLEPEDTGIYYCLQYSDATTFGPGTKLEIK,IGHV3-11 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ2 (Human),ARMGPYGSGSFDY,LQYSDATT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-29_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-30,Ab,SARS-CoV2,"229E, HKU1, NL63, OC43, SARS-CoV1",,,S; Unk,B-cells; SARS-CoV1 Human Patient,PGPACTVWAEVKKPGSSVKVSCKASGGMFSDYAISWVRQAPGQRLEWMGGIMPGLGSPGYAQIFRGRATISADVSTSTAYLELTSLKPEDTAVYYCARDPSILNTGNHHWYDLDIWGQGTQVTVSS,DIVMTQSPLSLPVGLGQSASISCRSSQRVVHTDGNTYLNWFHQRPGQSPRRLIYKVSNRDSGVPDRFSGSGSGTDFTLRISRVEAEDVGVYYCMQATEWPRTFGQGTKVEIK,IGHV1-69 (Human),IGHJ3 (Human),IGKV2-30 (Human),IGKJ1 (Human),ARDPSILNTGNHHWYDLDI,MQATEWPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-30_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-31,Ab,SARS-CoV2,"229E, HKU1, NL63, OC43, SARS-CoV1",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTSSTHAISWVRQAPGQGLEWMGGIIPIFGTTNYAQKFQDRVTITADESTSTAYMELSSLRSEDTAVYFCVRDGAYDSSGYYSTQWGQGTLVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSNFLAWYQQKPGQPPRLLIYDASNRASGIAARFSGRGSGTDFTLTISSLEPEDFAVYYCQQRRNWPPMYTFGQGTKLEIK,IGHV1-69 (Human),IGHJ4 (Human),IGKV3-11 (Human),IGKJ2 (Human),VRDGAYDSSGYYSTQ,QQRRNWPPMYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-31_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-32,Ab,"SARS-CoV1,SARS-CoV2","229E, HKU1, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,EVQLVQSGAEVKKPGSSVKVSCKVSGGRFSDYAISWLRQAPVKGLEWMGGIIPRLNRKGYSQDFQGRLTFTADESTSTAYMELSGLTSEDTAVYYCARDPTFLNSGNHFWYAVDIWGQGTTVTVSS,EIVLTQSPLSLSVTLGQAASISCTCSQTAVHSDGNTYLNWFHQRPGQSPRRLIYKVSNRDSGVPDRFSGSGSGTDFTLKISRVEAEDVGIYYCMQTTDWPRTFGQGTKLEIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV2-30 (Human),IGKJ2 (Human),ARDPTFLNSGNHFWYAVDI,MQTTDWPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-32_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-33,Ab,"SARS-CoV1,SARS-CoV2","229E, HKU1, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVQSGAEVKKPGSSVTVSCKVSGGRFSDYAISWLRQAPVEGLEWMGGIIPHLNKKGYSQKFQDRITFTADESTSTAYMELSGLTSEDTAIYYCARDPTFLNTGNHFWYAVDIWGQGTTVTVSS,ETTLTQSPLSLSVTLGQAASISCTCSQSAVHSDGNTYFNWFHQRPGQSPRRLIYKVSNRDSGVPERFSGSGSGTHFTLIISRVEAEDVGVYYCMQTTDWPRTFGQGTKVDIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV2-30 (Human),IGKJ3 (Human),ARDPTFLNTGNHFWYAVDI,MQTTDWPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-33_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-34,Ab,"SARS-CoV1,SARS-CoV2","229E, HKU1, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFSLFHVHWVRQAPGQGLEWMGWINPHNGDTTFAERFQGRVALTRDTSINTAYMELSRLTSDDTAVYFCARDFGVRYDDSRQLMKYCDSWGQGTLVTVSS,NFMLTQPHSVSESPGKAVIISCTRSSGNIASNFVQWYQQRPGSSPTPVIYEDKLRPSGVPDRFSGSIDRSSNSASLTISGLKTEDEADYYCQSYDSGNLVVFGGGTKLTVL,IGHV1-2 (Human),IGHJ5 (Human),IGLV6-57 (Human),IGLJ3 (Human),ARDFGVRYDDSRQLMKYCDS,QSYDSGNLVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-34_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-35,Ab,"SARS-CoV1,SARS-CoV2","229E, HKU1, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTLADYAISWVRQAPGQGLEWMGGIKPLHGAAGYSQLFRGRLSITADESASTAYMELTGLTSDDTAMYYCARDPSILNTGNHHWYDLDLWGQGTTVTVSS,DIQMTQSPLSLPVTLGQAASISCRSSQPIPHTDGNTYLNWFHQRPGQSPRRLIHKVSNRDSGVPDRFSGSGSGLDFTLEISGVEAEDVGIYYCMQGTEWPRTFGQGTKVEIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV2-30 (Human),IGKJ1 (Human),ARDPSILNTGNHHWYDLDL,MQGTEWPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-35_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-36,Ab,"SARS-CoV1,SARS-CoV2","229E, HKU1, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVQSGPELKKPGSSVRVSCKASGGSISSYAISWVRQAPGQRLEWMGGVLPMMGRESPVQKFKDRVTIAADESTSTAYMELRSLSAEDTAVYYCVVDTTMADPHNWYGLDVWGQGTTVTVSS,EIVMTQTPLSLPVTLGQPASISCRSSHGLVHTNGNTYLNWFHQRPGQPPRRLIYQVSHRDSGVPDRFSGSGSGTDFTLKISRVEADDVGVYYCMQGTDWPRTFGQGTKVDIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV2-30 (Human),IGKJ3 (Human),VVDTTMADPHNWYGLDV,MQGTDWPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-36_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-37,Ab,"SARS-CoV1,SARS-CoV2","229E, HKU1, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVQSGPGLVRPSGTLSLTCAVSGDSISGDYWCTWVRQTPGKGLEWIGKISHSGSINYNPSLKSRITMSVDKSKNQFSLKLNSVTAADTAMYYCARVRVGASHHNFWSGYYTDAFDIWGQGTTVTVSS,ETTLTQSPGTLSLSPGERATLSCRASQSVGNNYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGTSPVYTFGQGTKVEIK,IGHV4-4 (Human),IGHJ3 (Human),IGKV3-20 (Human),IGKJ1 (Human),ARVRVGASHHNFWSGYYTDAFDI,QQYGTSPVYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-37_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-38,Ab,"SARS-CoV1,SARS-CoV2","229E, HKU1, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKVSGGTFSNYAISWLRQAPGQGPEWMGGIIPALSRVGYARKFQARLTISADELTTTAYMDLSSLTSEDTAVYYCARDPSFLNTGNHFWYDFDMWGQGTTVTVSS,DIQLTQSPLSLPVTLGQPASISCTSSQNVVHTDGNTYLNWFHQRPGQSPRRLIYKVSNRDSGVPDRFSGSGSGSHFTLKISRVEAEDVGIYYCMQGTDWPRTFGQGTKVEIK,IGHV1-69 (Human),IGHJ4 (Human),IGKV2-30 (Human),IGKJ1 (Human),ARDPSFLNTGNHFWYDFDM,MQGTDWPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-38_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-39,Ab,SARS-CoV2,"229E, HKU1, NL63, OC43, SARS-CoV1",,,S; Unk,B-cells; SARS-CoV1 Human Patient,EVQLQQSGAEVKKPGSSVKVSCKASGGTSSTHAISWVRQAPGQGLEWMGGIIPIFGTTNYAQKFQDRVTITADESTSTAYMELSSLRSEDTAVYFCVRDGAYDSSGYYSTQWGQGTLVTVSS,DIVLTQTPATLSLSPGERATLSCRASQSVSNFLAWYQQKPGQPPRLLIYDASNRASGIAARFSGRGSGTDFTLTISSLEPEDFAVYYCQQRRNWPPMYTFGQGTKVEIK,IGHV1-69 (Human),IGHJ4 (Human),IGKV3-11 (Human),IGKJ1 (Human),VRDGAYDSSGYYSTQ,QQRRNWPPMYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-39_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-40,Ab,SARS-CoV2,"229E, HKU1, NL63, OC43, SARS-CoV1",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVESGGDLVKPGRSLRLSCTASGFTIGDYAMTWFRQAPGKGLECVAVIRSRAFGGTTEYAASVKGRFIVSRDDSNSVAFLQMNSLKTEDTAVYYCSRDLRRGYYDSNGHQQFDLWGQGTLVTVSS,DIRLTQSPATLSLSPGERATLSCRASQSIGYYLAWFQQKPGQAPRLLIYDASKRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQHRTNWPYTFGQGTKVEIK,IGHV3-49 (Human),IGHJ4 (Human),IGKV3-11 (Human),IGKJ1 (Human),SRDLRRGYYDSNGHQQFDL,QHRTNWPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-40_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-41,Ab,SARS-CoV2,"229E, HKU1, NL63, OC43, SARS-CoV1",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSRYGMHWVRQAPGKGLEWVAVIYSDGRNEYYADSVKGRFTISRDNSKNTLHLQMNSLGAADTAVYYCARDPGPITFFDWSPDKSRKSYYDYNGMDVWGQGTTVTVSS,QPGLTQEPSLTVSPGGTVTLTCGSSAGAVTSGHYPYWFQQKPGQAPRTLIYDTNNKYSWTPARFSGSLLGGKAALTLSGAQPEDEAEYFCFLSYRGAPPVFGGGTHLTVL,IGHV3-30 (Human),IGHJ6 (Human),IGLV7-46 (Human),IGLJ3 (Human),ARDPGPITFFDWSPDKSRKSYYDYNGMDV,FLSYRGAPPV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-41_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-42,Ab,SARS-CoV2,"229E, HKU1, NL63, OC43, SARS-CoV1",,,S; Unk,B-cells; SARS-CoV1 Human Patient,EVQLLESGGGVVQPGTSLRLSCVASGFTFSTFAMHWVRQAPGKGLEWVALISFDSTNIRYANSVRGRFTISRDNSKNTLYLEVDSLRIEDTGVYYCARDLPPLDYWGQGTLVTVSS,DIRMTQSPFSLSASVGDRVTITCRASQGFGNRLAWYQQKPGRAPKLLIYDASTLQSGVPSRFSGSGSETDFALTISSLQPEDVATYYCQKHDRDPWTFGQGTKVEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV1-27 (Human),IGKJ1 (Human),ARDLPPLDY,QKHDRDPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-42_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-43,Ab,"SARS-CoV1,SARS-CoV2","229E, HKU1, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVQSGAEVRKPGSSVKLSCKASGGTFSTHAISWVRQAPGQRPEWMGGIIPIFGESKDTQKFQGRVTFTADESTTTAYMELRSLRSDDTAIYYCVRDSDPYTTTFSHNHYWYAMDVWGQGTTVTVSS,DIVMTQSPLSLPVTLGQPASISCRSSQRLVHSDGNTYLNWFQQRPGQSPRRLIYKVSNRDSGVPDRFSGSGSGTDFTLKISRVEAEDIGVYYCMQGTEWPRTFGQGTKVEIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV2-30 (Human),IGKJ1 (Human),VRDSDPYTTTFSHNHYWYAMDV,MQGTEWPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-43_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-44,Ab,"SARS-CoV1,SARS-CoV2","229E, HKU1, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVQSGGGLVQPGGSLRVSCSASGFTFSSFAMHWVRQAPGKGLEYVAGISDNGHTTMYADSVKGRFTISRDNSKNTLYLQLSSLRPEDTAVYFCVKDNVILPGAIVRPQFDYWGQGTLVTVSS,ETTLTQSPASVSASVGDRVTISCRASQGIGRWLAWYQQKPGRAPKLLIFSASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQAESFPFTFGGGTKVEIK,IGHV3-64D (Human),IGHJ4 (Human),IGKV1-12 (Human),IGKJ4 (Human),VKDNVILPGAIVRPQFDY,QQAESFPFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-44_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-45,Ab,SARS-CoV2,"229E, HKU1, NL63, OC43, SARS-CoV1",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKVSGGMFSDYAISWVRQAPGQRLEWMGGIMPGLGSPAYAQIFRGRVTISADISTSTAYLEVTSLRPEDTAVYYCARDPSILNTGNHHWYDLDMWGQGTTVTVSS,ETTLTQSPLSLPVDLGQSASISCRSSQRVVHTNGNTYLHWFHQRPGQAPRRLIYKVSNRESGVPDRFSGSGSGTDFTLRISRVEAEDVGVYYCMQATDWPRTFGQGTKVEIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV2-30 (Human),IGKJ1 (Human),ARDPSILNTGNHHWYDLDM,MQATDWPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-45_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-46,Ab,"SARS-CoV1,SARS-CoV2","229E, HKU1, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,EVQLVESGGGVVQPGRSLRLSCVASGFTLAPYGMQWVRQAPGKGLEWVAFLSHDGSHLGYVDSVKGRFTISRDNSKNTLYLEMNSLRAEDTATYYCARDNVVQQNADNVGYFDFWGQGSLVTVSS,CIRLTQSPATLSLSPGERATLSCRASQSVTSYLAWYQQRPGQAPRLLIYDTSNRVTGVPVRFSGSGYGTDFTLTISSLEPEDFAVYYCQQRGNGYTFGPGTKVEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV3-11 (Human),IGKJ3 (Human),ARDNVVQQNADNVGYFDF,QQRGNGYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-46_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-47,Ab,"SARS-CoV1,SARS-CoV2","229E, HKU1, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGMFRDYAISWLRQAPGQRLEWMGGIMPAFGAPGYAQIFRGRATISADVSTTTAYLELTSLMPDDTAVYYCARDPSILNTGNHHWYDLDLWGQGTTVTVSS,ETTLTQSPLSLPVGLGQSASISCRSSQRVVHTDGNTYLNWFHQRPGQSPRRLIYKVSNRDSGVPDRFSGSGSGTDFTLRISRVEAEDVGVYYCMQATEWPRTFGQGTKVDIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV2-30 (Human),IGKJ3 (Human),ARDPSILNTGNHHWYDLDL,MQATEWPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-47_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-48,Ab,"SARS-CoV1,SARS-CoV2","229E, HKU1, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVTLKESGAEVKKPGSSVKVSCKTSGGTFSTHAISWVRQAPGQGPEWMGGIIPLFGTSQHAQRFQARVKFTADESTNTAYMELSSLTPEDTAVYYCVRDSDPYTATSRNNHYWYGMDVWGHGTTVTVSS,EIVMTQSPLSLPVTLGQPASISCRSSQSVVHSDGNTYLNWFHQRPGQSPRRLIYKVSNRDSGVPDRFSGSGSGTDFTLKISRVEAEDIGVYYCMQGTDWPRTFGQGTKLEIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV2-30 (Human),IGKJ2 (Human),VRDSDPYTATSRNNHYWYGMDV,MQGTDWPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-48_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-49,Ab,"SARS-CoV1,SARS-CoV2","229E, HKU1, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGMFSDYAISWVRQAPGQRLEWMGGIMPGLGSPAYAQSFGGRVTISADISTSTAYLEVTSLRPEDTAVYYCARDPSILNTGNHHWYDLDMWGQGTMVTVSS,DIVMTQSPLSLPVDLGQSASISCRSSQTAVHTNGNTYLHWFHQRPGQAPRRLIYKVSNRESGVPDRFSGSGSGTDFTLRINRVEAEDVGVYYCMQATDWPRTFGQGTKLEIK,IGHV1-69 (Human),IGHJ3 (Human),IGKV2-30 (Human),IGKJ2 (Human),ARDPSILNTGNHHWYDLDM,MQATDWPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-49_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-50,Ab,"SARS-CoV1,SARS-CoV2","229E, HKU1, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGMFSDYAISWVRQAPGQRLEWMGGIMPGLGSPAYAQIFRGRVTISADISTSTAYLEVTSLRPEDTAVYYCARDPSILNTGNHHWYDLDMWGQGTTVTVSS,DIQMTQSPLSLPVDLGQSASISCRSSQRVVHTNGNTYLHWFHQRPGQAPRRLIYKVSNRESGVPDRFSGSGSGTDFTLRISRVEAEDVGVYYCMQATDWPRTFGQGTKVEIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV2-30 (Human),IGKJ1 (Human),ARDPSILNTGNHHWYDLDM,MQATDWPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-50_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-51,Ab,"SARS-CoV1,SARS-CoV2","229E, HKU1, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,EVQLVESGGGLVQPGGSLRLSCLTSGFSFSSYWMIWVRQAPGKGLEWVANIEPDGNEEYYVDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARGPIRHFGLDAFDIWGQGTTVTVSS,QPGLTQPASVSGSPGQSITISCTRTSGDVGDYNSVSWYVSWYQQHPGRAPKLMLYDVSNRPSGVSNRFSGSKLGDTASLTISELQAEDEADYYCSTYTSTSTIFGGGTKLTVL,IGHV3-7 (Human),IGHJ3 (Human),IGLV2-14 (Human),IGLJ3 (Human),ARGPIRHFGLDAFDI,STYTSTSTI,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-51_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-52,Ab,SARS-CoV2,"229E, HKU1, NL63, OC43, SARS-CoV1",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVQSGDEMKKPGSSVKVSCKASGDTFSTHAISWVRQAPGQGPEWMGGIIPLFGTASYAQTSQSRVKITADESTSTAYMELSSLTSEDTAVYYCVRDSDPYTATSRNNHYWYGMDVWGQGTTVTVSS,DIQMTQSPLSLPVTLGQPASISCRASQTVVHTNGNTYLNWFHQRPGQSPRRLIYEVSNRDSGVPDRFSGSGSGTDFTLSISRVEAEDIGVYYCMQGTDWPRTFGPGTKVEIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV2-30 (Human),IGKJ3 (Human),VRDSDPYTATSRNNHYWYGMDV,MQGTDWPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-52_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-53,Ab,"SARS-CoV1,SARS-CoV2","229E, HKU1, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGMFSDYAISWVRQAPGQRLEWMGGIMPGLGSPAYAQSFGGRVTISADISTSTAYLEVTSLRPEDTAVYYCARDPSILNTGNHHWYDLDMWGQGTMVTVSS,DIRLTQSPLSLPVDLGQSASISCRSSQTVVHTNGNTYLHWFHQRPGQAPRRLIYKVSNRESGVPDRFSGSGSGTDFTLRISRVEAEDVGVYYCMQATDWPRTFGQGTKVDIK,IGHV1-69 (Human),IGHJ3 (Human),IGKV2-30 (Human),IGKJ3 (Human),ARDPSILNTGNHHWYDLDM,MQATDWPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-53_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-54,Ab,"SARS-CoV1,SARS-CoV2","229E, HKU1, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,EVQLVESGGGLVQPGGSLRLSCSASGFTFSNYAMYWVRQAPGKRPEYVSGISSNGGITYYADSVEGRFTVSRDNSKKSLYLQMSSLRPEDTAVYYCVKDLGATVTYDVFDVWGQGTMVTVSS,DIRVTQSPSSLSATVGDRVTITCRASQTITKYLNWYQQKPGKAPKLLLYGASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQTYITPGTFGQGTRLEIK,IGHV3-64D (Human),IGHJ3 (Human),IGKV1-39 (Human),IGKJ5 (Human),VKDLGATVTYDVFDV,QQTYITPGT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-54_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-55,Ab,SARS-CoV2,"229E, HKU1, NL63, OC43, SARS-CoV1",,,S; Unk,B-cells; SARS-CoV1 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYSMSWVRQAPGKGLEWVSGHDGGTTHYADSVKGRFTISRDDSMNTLSLQMNSLRAEDTAVYYCAKERDLPGRGGYFDHWGQGTLVTVSS,DIRLTQSPDSLALSLGERATINCKSSQSVLFSSNNNNYLGWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYLTPWTFGQGTKVDIK,IGHV3-23 (Human),IGHJ4 (Human),IGKV4-1 (Human),IGKJ1 (Human),AKERDLPGRGGYFDH,QQYYLTPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-55_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-56,Ab,SARS-CoV2,"229E, HKU1, NL63, OC43, SARS-CoV1",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLQQWGAGLLKPSETLSLTCAVYGGSFRGFYWTWIRQPPGKGLEWIGEVSHSGETNYNPSLKSRVTISVDTSKNQFSLNLISVTAADTSVYYCARGYTAPIIREVPITFRPRWFDPWGQGTPVTVSS,QPVLTQPASVSGSPGQSITISCTGTSSDVGNYNVVSWYQQHPGKAPQLFIYEDTKRPSGVSDRFSGSKSGITASLTISRLQPEDEADYYCCSYAVSGTVLFGGGTKVTVL,IGHV4-34 (Human),IGHJ5 (Human),IGLV2-23 (Human),IGLJ3 (Human),ARGYTAPIIREVPITFRPRWFDP,CSYAVSGTVL,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-56_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-57,Ab,"SARS-CoV1,SARS-CoV2","229E, HKU1, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVQSGGGVVNPGGSMRLSCAGSGFTFSDHYMGWIRQAPGKGLEVISYISSSGSFIRDADSVKGRFTISRDNAKNSVYLQMNSLRAEDTAVYYCARMGPYGSGTFDYWGQGTLVTVSS,EIVLTQSPGTLSVSPGERATLSCRASQIINRSQLGWYQHKPGQAPRLLIFDSSKRATGTPDRFSASGSETDFTLTISGVEPEDSGVYYCLQYSLATTFGPGTKVDIK,IGHV3-11 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ3 (Human),ARMGPYGSGTFDY,LQYSLATT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-57_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-58,Ab,"SARS-CoV1,SARS-CoV2","229E, HKU1, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVQSGGNVVQPGGSLRLSCVGSEFSITFFAMQWVRRTPGKGLEWVALVSHDGSNIRYSDSVKGRFIISRDNAKNTLYLQLDSLTPEDTGIYYCARDHALQNGRPGYFDSWGQGSQVTVSS,DIQLTQSPATLSLSPGERATLSCRASPSVFTFLAWYQQRPGQPPRLLIHDVSNRAPGIPARFSGSGSGTDFTLIISSLEPDDSAVYFCQQRSDGYNFGPGTKVDIK,IGHV3-30 (Human),IGHJ5 (Human),IGKV3-11 (Human),IGKJ3 (Human),ARDHALQNGRPGYFDS,QQRSDGYN,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-58_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-59,Ab,"SARS-CoV1,SARS-CoV2","229E, HKU1, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVQSGGGLVQPGGSLRLSCSASGFTFNTYAMHWVRQAPGKRLEYVSSITRDGAGKFYADSVKGRFTISRDNSKNTLYQQMSSLRPEDTAVYYCVREGQQWLGLYFDHWGQGALVTVSS,DIRVTQSPSSLSASVGDRVTITCRASQTINNYLNWYQQKPGKAPNLLIYAASTLQNGVPSRFSGSGSGTDFTLTISSVQPEDFATYYCQQTYITPTWTFGQGTKVEIK,IGHV3-64 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ1 (Human),VREGQQWLGLYFDH,QQTYITPTWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-59_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-60,Ab,"SARS-CoV1,SARS-CoV2","229E, HKU1, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,EVQLVQSGAEMKKPGESLKISCKGSGYSFPNYWIGWVRQMPGKGLEWMAIMWPSDSDTRYSPSFQGQVTISADTSTSTVYLQWGSLKASDTAMYYCVRQRYCSGGSCFLFEDAFEIWGQGTMVTVSS,EIVLTQSPSTLSASVGDRVTITCRASQNVNNWLAWYQQKPGKAPKLLIYEASTLKSGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNSQYTFGQGTKVDIK,IGHV5-51 (Human),IGHJ3 (Human),IGKV1-5 (Human),IGKJ3 (Human),VRQRYCSGGSCFLFEDAFEI,QQYNSQYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-60_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-61,Ab,SARS-CoV2,"229E, HKU1, NL63, OC43, SARS-CoV1",,,S; Unk,B-cells; SARS-CoV1 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFIFKNEPMNWIRQFPGKGLEWISNIRDNGNDVYYADSVKGRFTVSRDNAKNSLYLQMNSLRDDDTALYYCVRDTDWAFDSWGQGTLVTVSS,QPVLTQPRSVSGSPGQSVTISCTGSSSTFGTDNHISWYQQLPGKVPKLIIHAVSQRPSVVPDRFSGSRSGNTASLTISGLQAEDEADYYCCSSPGTITWVFGGGTKVTVL,IGHV3-48 (Human),IGHJ5 (Human),IGLV2-11 (Human),IGLJ3 (Human),VRDTDWAFDS,CSSPGTITWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-61_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-62,Ab,SARS-CoV2,"229E, HKU1, NL63, OC43, SARS-CoV1",,,S; Unk,B-cells; SARS-CoV1 Human Patient,EVQLVESGPTLVKPTQTLTLTCTFSGFSLTTRRQGVGWLRRPPGKALEWLALIYWDDDKRYSPSLKSRLTITKDTSKNHVVLSLTNVGPADTATYYCAHTSELPPRRPYAAFDFWGQGTLVTVSS,QSVLTQPPSVSGVPRQKVTISCSGSTANIASNGVNWYQLVPGKAPRLLISYDDLVPSGVSARFSGSKSGTSASLAISGLQAEDEADYYCATWDDILNGPVFGGGTKLTVL,IGHV2-5 (Human),IGHJ4 (Human),IGLV1-36 (Human),IGLJ3 (Human),AHTSELPPRRPYAAFDF,ATWDDILNGPV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-62_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-63,Ab,SARS-CoV2,"229E, HKU1, NL63, OC43, SARS-CoV1",,,S; Unk,B-cells; SARS-CoV1 Human Patient,EVQLLESGGGLVQPGGSLRLSCAASGFPFSTDAMNWVRQAPGEGLEWVSTISDSGRDTYYAASVRGRFTISRDNSKNTVYLQMNSLRVEDTAVYYCANTNFLDYWGQGTLVTVSS,DIVLTQSPLSLPVTLGQSASISCRSSQGLVHSDGNIYLNWFQQRPGQSPRRLIYKVSNRDSGVPDRFSGSGSGTDFTLKISRVEAEDVGLYYCMQATHWPRAFGQGTKLEIK,IGHV3-23 (Human),IGHJ4 (Human),IGKV2-30 (Human),IGKJ2 (Human),ANTNFLDY,MQATHWPRA,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-63_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-64,Ab,"SARS-CoV1,SARS-CoV2","229E, HKU1, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,EVQLQESGPGLLKPSETLSLTCTVSGSPIASNYWSWVRQPAGKGLEWIGRIDTSPTTDYNPSLKSRVIMSVDTSTSQFSLKMSSVTAADTAVYYCTRSFISFDSSGHPYYYYAMDVWGQGTTVTVSS,EIVMTQSPGTLSLSPGERVTLSCRATQSVSNNHLAWYQQKPGQAPRLLIYGASTTATDIPDRFSGRVAGTDFTLTISRLDPEDFAVYYCHQYGSSPWTFGQGTKVEIK,IGHV4-4 (Human),IGHJ6 (Human),IGKV3-20 (Human),IGKJ1 (Human),TRSFISFDSSGHPYYYYAMDV,HQYGSSPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-64_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-65,Ab,"SARS-CoV1,SARS-CoV2","229E, HKU1, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVQSGAEVRKPGSSVKLSCRASGGTFHTYTVNWVRQAPGQGLEWLGGIIPIFGTPTYAQRFQGKVSITADSSTNTVFMELTSLTSEDTAVYYCTRETGTDEFDFWGQGALVTVSS,DIRLTQSPATLSLSPGERATLSCRASQSVSSSLAWYQQKPGQAPRLLIYEASNRATGVPARFSGSGSGTDFTLAISSLEPEDFAVYYCQHRSNWPPRYTFGQGTKVEIK,IGHV1-69 (Human),IGHJ4 (Human),IGKV3-11 (Human),IGKJ1 (Human),TRETGTDEFDF,QHRSNWPPRYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-65_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-66,Ab,SARS-CoV2,"229E, HKU1, NL63, OC43, SARS-CoV1",,,S; Unk,B-cells; SARS-CoV1 Human Patient,EVQLVESGPGLVKPSGTLSLTCAVSGASVSSDHWWSWVRQSPGKGLEWIGEVYHSGSTNYNPSLKSRVTISLDQSNNQFSLKLTSVTAADTAIYYCATMWGGLCTASNCYGNPMDVWGQGTTVTVSS,SYELTQPPSVSVSPGQTARITCSGDALPRRYAYWYQQRSGQAPVLVIYEDNKRPSGIPERFSAFSSGTRATLTISGAQVEDEADYYCYSTDSTANYKVFGGGTKVTVL,IGHV4-4 (Human),IGHJ6 (Human),IGLV3-10 (Human),IGLJ6 (Human),ATMWGGLCTASNCYGNPMDV,YSTDSTANYKV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-66_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-67,Ab,SARS-CoV2,"229E, HKU1, NL63, OC43, SARS-CoV1",,,S; Unk,B-cells; SARS-CoV1 Human Patient,EVQLVESGPGLVKPSGTLSLTCAVTGASVSSDHWWSWVRQSPGKGLEWIGEVYHSGSTNYNPSLKSRVTISLDQSNNQFSLKLTSVTAADTAIYYCATMWGGLCTASNCYGNPMDVWGQGTTVTVSS,SYELTQPPSVSVSPGQTARITCSGDALPRRYAYWYQQRSGQAPVLVIYEDNKRPSGIPERFSAFSSGTRATLTISGAQVEDEADYYCYSTDSTANYKVFGGGTKLTVL,IGHV4-4 (Human),IGHJ6 (Human),IGLV3-10 (Human),IGLJ3 (Human),ATMWGGLCTASNCYGNPMDV,YSTDSTANYKV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-67_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-68,Ab,"SARS-CoV1,SARS-CoV2","229E, HKU1, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLQESGPGLVKPSGTLSLTCAVSGASVSSDHWWSWVRQSPGKGLEWIGEVYHSGSTNYNPSLKSRVTISLDQSNNQFSLKLTSVTAADTAIYYCATMWGGLCTASNCYGNPMDVWGQGTTVTVSS,SYELTQPPSVSVSPGQTARITCSGDALPRRYAYWYQQRSGQAPVLVIYEDNKRPSGIPERFSAFSSGTRATLTISGAQVEDEADYYCYSTDSTANYKVFGGGTKLTVL,IGHV4-4 (Human),IGHJ6 (Human),IGLV3-10 (Human),IGLJ3 (Human),ATMWGGLCTASNCYGNPMDV,YSTDSTANYKV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-68_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-69,Ab,"SARS-CoV1,SARS-CoV2","229E, HKU1, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLQESGGGLVQPGGSLRLSCEASGFSFSDFVMHWVRQVPGKGLEWVSRISHDGSITSYVDSVKGRFTVSRDNGKKTLYLQMNSPRTEDTAVYYCARDLAWTFFDYWGHGTLVTVSS,QSVLTQPSSLSASPGASASLTCTLHSGFNVGDHTINWYQQRPGSPPRYLLKYKSDSDKEQGSGVPIRFSGSKDASANAGFLLISGLRSEDEADYYCMIWHDNAVVFGGGTKLTVL,IGHV3-74 (Human),IGHJ4 (Human),IGLV5-45 (Human),IGLJ3 (Human),ARDLAWTFFDY,MIWHDNAVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-69_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-70,Ab,"229E, HKU1 (weak), NL63, SARS-CoV1 (weak), SARS-CoV2",OC43,,,S; Unk,B-cells; SARS-CoV1 Human Patient,EVQLLESGGGLVQPGGSLRLSCAASGFPFSTDAMNWVRQAPGEGLEWVSTISDTGRDTYYAASVKGRFTISRDNSKNTVYLQMNSLRAEDTAVYYCANTNFLDYWGQGTLVTVSS,EIVMTQSPLSLPVTLGQSASISCRSSQGLVHSDGNIYLNWFQQRPGQSPRRLIYKVSNRDSGVPDRFSGSGSGTDFTLKISRVEAEDVGLYYCMQATHWPRAFGQGTKVDIK,IGHV3-23 (Human),IGHJ4 (Human),IGKV2-30 (Human),IGKJ3 (Human),ANTNFLDY,MQATHWPRA,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-70_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-71,Ab,SARS-CoV2,"229E, HKU1, NL63, OC43, SARS-CoV1",,,S; Unk,B-cells; SARS-CoV1 Human Patient,EVQLVESGGGLVQPGRSLRLSCAASGFILDDYAVHWVRLAPGKGLEWVSGITWNSGYLGYADSVKGRFTISRDNAKNSLYLQMNSLRPEDTALYYCAKLGTDHPIGVDVWGQGTTVTVSS,DIVMTQSPLALSVTPGQPASISCKSSQSLLHSDGKTYFYWYLQKPGQSPHLLIYEVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQSIQVPITFGGGTKLEIK,IGHV3-9 (Human),IGHJ6 (Human),IGKV2D-29 (Human),IGKJ5 (Human),AKLGTDHPIGVDV,MQSIQVPIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-71_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-72,Ab,SARS-CoV2,"229E, HKU1, NL63, OC43, SARS-CoV1",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVQSGGGLVQPGGSLRLSCSASGFTFNTYTMHWVRQAPGKGLEYVSAISSNGVVTYYADSVKGRFTISRDNSKNTLYLQMSSLRAEDTAVYYCVKALYSSSWCPFDYWGQGALVTVSS,DIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATNIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNLWPYTFGQGTKVDIK,IGHV3-64D (Human),IGHJ4 (Human),IGKV3-15 (Human),IGKJ3 (Human),VKALYSSSWCPFDY,QQYNLWPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-72_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-73,Ab,SARS-CoV2,"229E, HKU1, NL63, OC43, SARS-CoV1",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLQQSGGGLVQPGGSLRLSCEASGFNFNSYSMSWVRQAPGKGLEWLSYISSRSSTIKYASSVQGRFTVSRDNAKKSVFLQMNSLRDEDTAVYYCARELDSETYYNYNSLDVWGQGTTVTVSS,EIVLTQSPSSLSASVGDRVTISCRASQGISTFLAWFQQRPGKAPKSLIYAASKLQSGVPSRFSGSDSGPDFTLTIDNLQPEDSATYYCKQYNSYPYTFGQGTKLEIK,IGHV3-48 (Human),IGHJ6 (Human),IGKV1-16 (Human),IGKJ2 (Human),ARELDSETYYNYNSLDV,KQYNSYPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-73_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-74,Ab,SARS-CoV2,"229E, HKU1, NL63, OC43, SARS-CoV1",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLQESGPGLVRPSETLSLTCTVSRGSISSSYWSWIRQPPGKGLEWIGFMYYSGSTNYNPSLKSRVTISLDTSKNQFSLKLSSVTAADTAVYYCAKAQGIYYRGWSYWFDPWGQGTLVTVSS,QSVVTQPPSVSAAPGQKVTISCSGSSSNIGNNYVSWYQQLPGTAPKLLIYDSDKRPSGIPERFSGSKSATSATLGITGLQTGDEADYYCETWDDSLSAVVFGGGTKLTVL,IGHV4-59 (Human),IGHJ5 (Human),IGLV1-51 (Human),IGLJ3 (Human),AKAQGIYYRGWSYWFDP,ETWDDSLSAVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-74_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-75,Ab,"229E, HKU1 (weak), NL63, SARS-CoV1 (weak), SARS-CoV2",OC43,,,S; Unk,B-cells; SARS-CoV1 Human Patient,EVQLVQSGAEVKKPGASVKISCKASGYAFRNNYINWIRQAPGQGLEWMGIINPSAGTSTYAQKFQGRVTMTRDTSTNTVYMEITSLRSEDTATYFCAREARRQVTQWFGEFWGPYNWFDPWGQGTLVTVSS,DIVLTQSPLSLSVTPGQPASISCRSSQSLQHTDGKTYLYWYLQKPGQSPQLLIYELFNRFSGVPERFSGSGSGTDFTLKISRVEAEDVGIYYCMQSIQTPITFGQGTRLEIK,IGHV1-46 (Human),IGHJ5 (Human),IGKV2D-29 (Human),IGKJ5 (Human),AREARRQVTQWFGEFWGPYNWFDP,MQSIQTPIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-75_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-76,Ab,"SARS-CoV1,SARS-CoV2","229E, HKU1, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLQQWGAGLLKPSETLSLTCGVYGVSFSDYYWSWIRQPPGKGLEWIGEINHSGITNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARGLISYTLWLRESYFDYWGQGTLVTVSS,DIRVTQSPDSLAVSLGERATINCKSSQSVLYSSNNKNYLAWYQQKIGQPPKLLIYWASIRESGVPDRFTGSGSGTDFTLTISSLQAEDVAVYYCQQYYSTPPTFGGGTKLEIK,IGHV4-34 (Human),IGHJ4 (Human),IGKV4-1 (Human),IGKJ4 (Human),ARGLISYTLWLRESYFDY,QQYYSTPPT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-76_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-77,Ab,"SARS-CoV1,SARS-CoV2","229E, HKU1, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGSLRDYAISWVRQAPGQGPEWMGGIMPIFGTAGYAQKFQGRVKFTADESATTAYMELTGLRSEDSAVYFCARDPSILNTGNHHWYDLDIWGQGTTVTVSS,EIVMTQTPLSLPVTLGQPASISCRSSQFVSHTDGNTYLNWFQQRPGQSPRRLIYKVSKRDSGVPDRFSGSGSGTDFTLTISRVEAEDVGVYYCMQATEWPRTFGQGTKVEYQ,IGHV1-69 (Human),IGHJ6 (Human),IGKV2-30 (Human),IGKJ1 (Human),ARDPSILNTGNHHWYDLDI,MQATEWPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-77_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-78,Ab,SARS-CoV2,"229E, HKU1, NL63, OC43, SARS-CoV1",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTNDGFVWVRQAPGQVPEWMGWISVHTGDTIYAQRFQGRVTMTTDTSTRTSYMELMSLRSDDTAVYYCARDYGDGPPDHWGQGTLVTVSS,DIVMTQSPDSLAVSLGERATINCKSSQSVLFSSNNKNYLAWYQQKPGLPPKLLIYWASTRKSGVSDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYTTPLFTFGPGTKVDIK,IGHV1-18 (Human),IGHJ4 (Human),IGKV4-1 (Human),IGKJ3 (Human),ARDYGDGPPDH,QQYYTTPLFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-78_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-79,Ab,"SARS-CoV1,SARS-CoV2","229E, HKU1, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVQSGPEVKKPGSSVRVSCKVSGGPFSSYGVSWARQAPEKGLEWMGGVLPIFGTVGYVHKFQGRVTITADESTSTVYMALSSLRSEDTAVYYCVLDTTMSHPHNWYGMDVWGHGTTVTVSS,DIVMTQSPLSLPVTLGQPASISCRSSHSLVHTNGNTYLNWFQQRPGQPPRRLIYQVSNRDSGVPDRFSGSGSGTDFTLKISRVEADDVGIYYCMQGTDWPRTFGQGTKVDIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV2-30 (Human),IGKJ3 (Human),VLDTTMSHPHNWYGMDV,MQGTDWPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-79_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-80,Ab,"229E, HKU1 (weak), NL63, SARS-CoV1 (weak), SARS-CoV2",OC43,,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTLSDYAISWVRQAPGQGLEWMGGIMPVFGSPGYAEIFQGRLTITADESRSTAYMELTSLRSEDTAVYYCARDPSILNTGPHHWYDLDIWGPGTTVTVSS,DIVMTQSPLSLPVSLGQPASISCRSSQSVVHTDGNTYLNWYQQRPGQSPRRLIYKVSNRDSGVPDRFSGSGSVTDFTLKISRVEAEDVAVYYCMQGTEWPRTFGQGTKVDIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV2-30 (Human),IGKJ3 (Human),ARDPSILNTGPHHWYDLDI,MQGTEWPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-80_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-81,Ab,SARS-CoV2,"229E, HKU1, NL63, OC43, SARS-CoV1",,,S; Unk,B-cells; SARS-CoV1 Human Patient,EVQLVQSGAEVKKPGSSMRVSCRVSGGTFITHAMSWVRQAPGQGPEWMGGIVPLFGRASYAQPSQTRVQITADESTSTVYLEVPSLTSEDTAVYYCVRDSEPYTATRSQNHYWYDMDVWGQGTTVTVSS,DIQMTQSPLSLSVTLGQSASISCRASQTVVHSVDGNTYLNWFHQRPGQSPRRLIYKVSNRDSGVPDRFSGSGSGTDFTLRISRVEAEDIGIYYCMQGTDWPRTFGQGTKVEIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV2-30 (Human),IGKJ1 (Human),VRDSEPYTATRSQNHYWYDMDV,MQGTDWPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-81_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-82,Ab,"HKU1, SARS-CoV1,SARS-CoV2","229E, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,EVQLVESGPGLVKPSATLSLTCTVSGGSINNYYWTWVRQSAGKGLEWIGRINTSGSTNYNASLKSRVTMSIDTSKNEFSLRLSSVTAADTAVYYCAREFGVRFLDRSLFGAMDVWGHGATVTVSS,QPVLTQPASVSGSPGQSITISCTGTSSDVGSFNYVSWYQQHPGKAPKLVIYDVYNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSTLYVFGTGTKVTVL,IGHV4-4 (Human),IGHJ6 (Human),IGLV2-14 (Human),IGLJ1 (Human),AREFGVRFLDRSLFGAMDV,SSYTSSSTLYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-82_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-83,Ab,SARS-CoV2,"229E, HKU1, NL63, OC43, SARS-CoV1",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSAFAMHWVRQAPGKGLEWVTIISYDGSNEYYADSVQGRFSISRDNSKNTLFLQMSSLRTEDTAIYYCARAGGYLSAFDIWGQGTTVTVSS,DIRLTQSPSTLSASVGDRVTITCRASQSISSWLAWYQQKPGKAPNLLIYKASTLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNSGWTFGQGTKVEIK,IGHV3-30 (Human),IGHJ3 (Human),IGKV1-5 (Human),IGKJ1 (Human),ARAGGYLSAFDI,QQYNSGWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-83_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-84,Ab,"SARS-CoV1,SARS-CoV2","229E, HKU1, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,EVQLVQSGAEVKKPGSSVKVSCKVSGGTFSNYAISWLRQAPGQGPEWMGGIIPALSKVGYAGKFQARLTFSADELKTTVYMDLSSLTSEDTAVYYCARDPSFLNAGNHFYYDFDVWGQGTMVTVSS,DIRLTQSPLSLPVTLGQPASISCTSSQDVVHTDGNTYLNWFHQRPGQSPRRLIYKVSNRDSGVPDRFSGSGSGSHFTLKISRVEAEDAGIYYCMQGTDWPRTFGQGTKVDIK,IGHV1-69 (Human),IGHJ3 (Human),IGKV2-30 (Human),IGKJ3 (Human),ARDPSFLNAGNHFYYDFDV,MQGTDWPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-84_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-85,Ab,SARS-CoV2,"229E, HKU1, NL63, OC43, SARS-CoV1",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLQESGPGLVKPSGTLSLTCAVSGGSITSRDWWSWVRQPPGKGLEWIGEVYHSGSTSYNPSLKSRVTISVDKSKNEFSLKLSSVTAADTAVYYCARAGNIVVMPAAQYYFDYWGQGTLVTVSS,EIVLTQSPSSLSASVGDRVTITCRASQDISNYLAWYQQKPGKAPKLLIYAASTLQSGVPLRFSGSGSGTDFTLTISSLQPEDFATYYCLQLHNYSSFGGGTKVDIK,IGHV4-4 (Human),IGHJ4 (Human),IGKV1-9 (Human),IGKJ3 (Human),ARAGNIVVMPAAQYYFDY,LQLHNYSS,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-85_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-86,Ab,"SARS-CoV1,SARS-CoV2","229E, HKU1, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,EVQLVESGGSVVQPGTSLKLSCAGSAGLTITRYAMHWVRQAPGKGLEWVALVSHDGIHIGYSDSVRGRFTISRDNSRNTLYLQMDGLRPEDTAVYYCVRDDVLQHSRPSGPGYFVSWGQGTLVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSTFLGWYQQRPGQPPRLLIYDASYRAPDIPVRFSGSGSGTDFTLTINSLEPEDSAVYYCQQRSDGYNFGPGTKLEIK,IGHV3-30 (Human),IGHJ5 (Human),IGKV3-11 (Human),IGKJ2 (Human),VRDDVLQHSRPSGPGYFVS,QQRSDGYN,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-86_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-87,Ab,SARS-CoV2,"229E, HKU1, NL63, OC43, SARS-CoV1",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLQESGPGLVKPSETLSLTCTVSGGSMNHYYWSWIRQPPGKGLEGIGYTYYSGSTNYNPSLKSRVTISVDASKNQFSLRLSSVTAADTAVYYCARGSQIDLRGGLGATFFDYWGQGTLVTVSS,QSVLTQPASVSGSPGQSITISCTGTSSDVGAYNYVSWYQQHPGKAPKLTVYDVRNRPSGVSNRFSGSKSGNTASLTISGLQAEDEAHYYCSSYTSTNTVFGGGTKLTVL,IGHV4-59 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ3 (Human),ARGSQIDLRGGLGATFFDY,SSYTSTNTV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-87_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-88,Ab,SARS-CoV2,"229E, HKU1, NL63, OC43, SARS-CoV1",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVESGAEVKKPGSSVKISCKISGDTFSTNAISWLRQAPGREPEWMGGIVPLVGPASYAQRPQGRLTITADEFTNTAYLELNSLRSEDTATYYCARDSDPYTATRRHNHYWYAMDVWGQGTTVTVSS,DIRLTQTPLSLPVTLGQPASISCRSSQIAMHSDGNTYLSWFHQRPGQPPRRLIYKISNRDSGVPDRFSGSGSGTDFTLKISRVEAEDIGTFYCMQGTDWPRTFGQGTKVDIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV2-24 (Human),IGKJ3 (Human),ARDSDPYTATRRHNHYWYAMDV,MQGTDWPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-88_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-89,Ab,"SARS-CoV1,SARS-CoV2","229E, HKU1, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,EVQLLESGGGLVQPGGSLRLSCAASGFIFKNEPMNWIRQFPGKGLEWISNIRDNGNDVYYADSVKGRFTVSRDNAKNSLYLQMNSLRDDDTALYYCVRDTDWAFDSWGQGTLVTVSS,QSALIQPRSVSGSPGQSVTISCTGSSSTFGTDNHISWYQQLPGKVPKLIIHAVSQRPSVVPDRFSGSRSGNTASLTISGLQAEDEADYYCCSSPGTITWVFGGGTKVTVL,IGHV3-48 (Human),IGHJ5 (Human),IGLV2-11 (Human),IGLJ3 (Human),VRDTDWAFDS,CSSPGTITWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-89_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-90,Ab,"HKU1, SARS-CoV1,SARS-CoV2","229E, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVQSGADVKKPGASVKVSCKASGYTFTSYYMHWVRQAPGQGLEWLGVIHPSGGSTTFAQKFQGRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARVLAGSSHEWQLTHDAFDIWGQGTTVTVSS,DIRMTQSPDSLAVSLGERATINCRTSQSVLYSSNNKNYLGWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYSTPYTFGQGTKVDIK,IGHV1-46 (Human),IGHJ3 (Human),IGKV4-1 (Human),IGKJ3 (Human),ARVLAGSSHEWQLTHDAFDI,QQYYSTPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-90_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-91,Ab,"HKU1 (weak), SARS-CoV1 (weak), SARS-CoV2","229E, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSGIDGGGGSSYYADSVRGRFTVSRDNSKNMLHLQMNSLRADDTAVYFCAKGDWIRYFDWSLPISFFDYWGQGALVTVSS,QSALTQPASVSGSPGQSITISCTGTNSDISNSYSVSWYQQYPGKAPKLVIFDVINRPSGVSNRFSGSKSGNTASLTISGLQADDEADYYCCSYTRTNTPVLFGGGTKLTVL,IGHV3-23 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ3 (Human),AKGDWIRYFDWSLPISFFDY,CSYTRTNTPVL,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-91_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-92,Ab,"SARS-CoV1,SARS-CoV2","229E, HKU1, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,EVQLLESGPGLLKPSETLSLTCTVSGDSVSSGNFYWSWVRRPPGKALEWIAYSHYTGGTNSDPSFMGRVTMSIDPSRNQFSLRLTSVAAADTAVYYCARTTSPLTYSGHWPLFDYWGQGSLVTVSS,DIQLTQSPATLSVSPGERATLSCRASQSVTKHLAWYQQKPGQAPRLLIYGASTRATGVPARFSGSGSDTEFSLTISSLQSEDFAVYYCQQYYSWPPLTFGGGTKLEIK,IGHV4-61 (Human),IGHJ4 (Human),IGKV3-15 (Human),IGKJ4 (Human),ARTTSPLTYSGHWPLFDY,QQYYSWPPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-92_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-93,Ab,"SARS-CoV1,SARS-CoV2","229E, HKU1, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVQSGDEMKKPGSSVKVSCKASGDTFSTHAISWVRQAPGQGPEWMGGIIPLFGTASYAQTSQSRVKITADESTSTAYMELSSLTSEDTAVYYCVRDSDPYTATSRNNHYWYGMDVWGQGTTVTVSS,DIVMTQTPLSLPVTLGQPASISCRASQTVVHTNGNTYLNWFHQRPGQSPRRLIYEVSNRDSGVPDRFSGSGSGTDFTLSISRVEAEDIGVYYCMQGTDWPRTFGPGTKVEIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV2-30 (Human),IGKJ3 (Human),VRDSDPYTATSRNNHYWYGMDV,MQGTDWPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-93_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-94,Ab,SARS-CoV2,"229E, HKU1, NL63, OC43, SARS-CoV1",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGMFTDYAISWVRQAPGQRLEWMGGIMPGLGSPAYAQIFRDRATISADVSTSTAYLELTSLKPEDTAVYYCARDPSILNTGNHHWYDLDIWGQGTTVTVSS,DIQLTQSPLSLPVGLGQSASISCRSSQRVVHTDGNTYLNWYHQRPGQSPRRLIYKVSNRDSGVPDRFSGSGSGTDFTLRISRVEAEDVGVYYCMQSTDWPRTFGQGTKLEIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV2-30 (Human),IGKJ2 (Human),ARDPSILNTGNHHWYDLDI,MQSTDWPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-94_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-95,Ab,"SARS-CoV1,SARS-CoV2","229E, HKU1, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGMFTDYAISWVRQAPGQRPEWMGGIMPGLGSPAYAQIFRGRATISADLSTSTAYLELTSLKPEDTAVYYCARDPSILNTGNHHWYDLDIWGQGTMVTVSS,DIVLTQSPLSLPVGLGQSASISCRSSQRVVHTDGNTYLHWFHQRPGQSPRRLIYKVSNRDSGVPDRFSGSGSGTDFTLRISRVEAEDVGVYYCMQGTEWPRTFGQGTKLEIK,IGHV1-69 (Human),IGHJ3 (Human),IGKV2-30 (Human),IGKJ2 (Human),ARDPSILNTGNHHWYDLDI,MQGTEWPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-95_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-96,Ab,SARS-CoV2,"229E, HKU1, NL63, OC43, SARS-CoV1",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVTLKESGGGLVQPGGSLRLSCAASGFTVNSYGMSWVRQAPGKGLEWVSGFKSRSDRPDYAESVKGRFTISRDTSKNTVYLEMIGLRAEDTATYYCVRMDWMEWMKYYFDSWGQGALVTVSS,ETTLTQSPVTLSVSPGERATLSCRASQSVISNLAWYQQKPGQAPRLLIFGASTRATGVPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNWPSLTFGGGTKLEIK,IGHV3-66 (Human),IGHJ5 (Human),IGKV3-15 (Human),IGKJ4 (Human),VRMDWMEWMKYYFDS,QQYNNWPSLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-96_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-97,Ab,"SARS-CoV1 (weak), SARS-CoV2","229E, HKU1, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGMISDYAISWVRQAPGQRLEWMGGIMPAFGSPGYAQIFRGRATISADVSTNTAYLELTSLNPDDTAVYYCARDPSILNTGNHHWYDLDMWGQGTMVTVSS,DIQVTQSPLSLPVGLGQSASISCRSSQRVVHTDGNTYLNWFHQRPGQSPRRLIYKVSNRDSGVPDRFSGSGSGTDFTLRISRVEAEDVGVYYCMQATEWPRTFGQGTKVDIK,IGHV1-69 (Human),IGHJ3 (Human),IGKV2-30 (Human),IGKJ3 (Human),ARDPSILNTGNHHWYDLDM,MQATEWPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-97_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-98,Ab,"SARS-CoV1,SARS-CoV2 (weak)","229E, HKU1, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVESGGSVVQPGTSLKLSCAGSAGLTITRYAMHWVRQAPGKGLEWVALVSHDGIHIGYSDSVRGRFTISRDNSRNTLYLQMDGLRPEDTAVYYCVRDDVLQHSRPSGPGYFVSWGQGTLVTVSS,EIVMTQSPATLSLSPGERATLSCRASQSVSTFLGWYQQRPGQPPRLLIYDASYRAPDIPVRFSGSGSGTDFTLTINSLEPEDSAVYYCQQRSDGYNFGPGTKLEIK,IGHV3-30 (Human),IGHJ5 (Human),IGKV3-11 (Human),IGKJ2 (Human),VRDDVLQHSRPSGPGYFVS,QQRSDGYN,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-98_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-99,Ab,SARS-CoV2 (weak),"229E, HKU1, NL63, OC43, SARS-CoV1",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLQESGPGLVKPSGTLSLTCAVSGASVSSDHWWSWVRQSPGKGLEWIGEVYHSGSTNYNPSLKSRVTISLDQSNNQFSLKLTSVTAADTAIYYCATMWGGLCTASNCYGNPMDVWGQGTTVTVSS,QPVLTQPPSVSVSPGQTARITCSGDALPRRYAYWYQQRSGQAPVLVIYEDNKRPSGIPERFSAFSSGTRATLTISGAQVEDQADYYCYSTDSTANYKVFGGGTKLTVL,IGHV4-4 (Human),IGHJ6 (Human),IGLV3-10 (Human),IGLJ3 (Human),ATMWGGLCTASNCYGNPMDV,YSTDSTANYKV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-99_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-100,Ab,SARS-CoV2 (weak),"229E, HKU1, NL63, OC43, SARS-CoV1",,,S; Unk,B-cells; SARS-CoV1 Human Patient,EVQLVESGGGVVQPGRSLRLSCVTSGFDFRPYAMQWVRQAPGKGLEWVAVISHDGVHTGYADSLKGRFTISRDNSKNTLYLQVDSLRPDDSALYYCARDNALQNAQIGYLDYWGQGTLVTVSS,EIVMTQSPATLSVSPGETATLSCRASQSVGRFMGWYQQKPGQAPRLLIFDASNRVTGVPDRFRGSGSGTDFILTINSLEPEDSASYYCQRRGDGYNFGQGTKVEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV3-11 (Human),IGKJ1 (Human),ARDNALQNAQIGYLDY,QRRGDGYN,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-100_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-101,Ab,SARS-CoV2 (weak),"229E, HKU1, NL63, OC43, SARS-CoV1",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVQSGAEVRKPGSSVKLSCKASGGIFSTHAISWVRQAPGQRPEWMGGIIPIFGESKDTRKFQGRVTFTADESTTTAYMELRSLKSDDTAIYYCVLDSDPYTATFSHNHYWYAMDVWGQGTTVTVSS,ETTLTQSPLSLPVTLGQPASISCRSSQGLVHSDGNTYLNWFQQRPGQSPRRLIYKVSNRDSGVPDRFSGSGSGTDFTLKISRVEAEDIGVYYCMQGTEWPRTFGQGTKVEIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV2-30 (Human),IGKJ1 (Human),VLDSDPYTATFSHNHYWYAMDV,MQGTEWPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-101_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-102,Ab,SARS-CoV2 (weak),"229E, HKU1, NL63, OC43, SARS-CoV1",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVQSGAELKKPGSSVRVSCKAAGGTLTNYAISWVRQAPGQGFEWMGGIMPVSHTAGYAQKFQGRVTFTADESATTAYMDLTSLRPEDTAIYYCARDPSIHYTGNHHWYDLDIWGQGTTVTVSS,DIRVTQSPLSLPVTLGQPASISCRSSQRIVHTDGNTYLNWFLQRPGQSPRRLIYKVSNRDSGVPDRFSGSGSGTDFTLKISRVEAEDVGIYYCMQGTEWPRTFGQGTKVDIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV2-30 (Human),IGKJ3 (Human),ARDPSIHYTGNHHWYDLDI,MQGTEWPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-102_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-103,Ab,SARS-CoV2 (weak),"229E, HKU1, NL63, OC43, SARS-CoV1",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVQSGSELKKPGASVKVSCKASGYTFSNYAMNWVRQAPGQGPEWMGWIDTNTGNPTYAQGFIGRFVFSLDTSVNTAYLLIGSLEAEDTAVYYCAREEHYDFSSGYFRPAYWGQGTLVTVSS,EIVMTQSPSSLSASVGDRVTITCRAGHTISTYLNWYQQKPGKAPKILISGASSLQSGVPSRFSGSGSGTDFTLTIGSLQPEDFATYYCQQSYSTPYTFGQGTKVDIK,IGHV7-4-1 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ3 (Human),AREEHYDFSSGYFRPAY,QQSYSTPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-103_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-104,Ab,SARS-CoV2 (weak),"229E, HKU1, NL63, OC43, SARS-CoV1",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLQQWGAGLLKPSETLSLICDVYGGSFNGFYWSWIRQPPGKGLEWIGEISHDGSTNYSPSLKSRVSISIDTSKKQFSLKLRSVTAADTAMYYCARGMTSPVVHLYSSGRPSRWFDFWGQGTLVTVSS,QPVLTQPASVSGSPGQSSTLSCSGTSSDVGSYDLVSWYQQHPGKAPKLMIYEGTKRPSGVSDRFSGSTSGNTASLTISGLQAEDEANYYCCSYAGSGTWIFGGGTKLTVL,IGHV4-34 (Human),IGHJ4 (Human),IGLV2-23 (Human),IGLJ3 (Human),ARGMTSPVVHLYSSGRPSRWFDF,CSYAGSGTWI,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-104_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-105,Ab,SARS-CoV2 (weak),"229E, HKU1, NL63, OC43, SARS-CoV1",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLQESGPGLLKPSETLSLTCTVSNSPISSNYWSWIRQPAGKGLEWIGRIDITGNTNYNPSLKSRVIMSVDTSKSQFSLKMTSVTAADTAVYYCARSFISFDSSGHPYYYYAMDVWGQGTTVTVSS,EIVLTQSPGTLSLSPGDRVTLFCRASQNIANNHLAWYQQKPGQAPRVLIYGASTTATDIPDRFSGRVSGTDFTLTISRLDPEDFAVYYCHQYGSSPWTFGQGTKLEIK,IGHV4-4 (Human),IGHJ6 (Human),IGKV3-20 (Human),IGKJ1 (Human),ARSFISFDSSGHPYYYYAMDV,HQYGSSPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-105_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-106,Ab,SARS-CoV2 (weak),"229E, HKU1, NL63, OC43, SARS-CoV1",,,S; Unk,B-cells; SARS-CoV1 Human Patient,EVQLLESGGGVVQPGRSLRLSCVTSGFDFRPYAMQWVRQAPGKGLEWVAVISHDGVHTGYADSLKGRFTISRDNSKNTLYLQVDSLRPDDSALYYCARDNALQNAQIGYLDYWGQGTLVTVSS,ETTLTQSPATLSVSPGETATLSCRASQSVGRFMGWYQQKPGQAPRLLIFDASNRVTGVPDRFRGSGSGTDFILTINSLEPEDSASYYCQRRGDGYNFGQGTKVEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV3-11 (Human),IGKJ1 (Human),ARDNALQNAQIGYLDY,QRRGDGYN,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-106_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-107,Ab,"SARS-CoV1,SARS-CoV2 (weak)","229E, HKU1, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVQSGAEVKKPGSSVEVSCKVSGGTFRDYAISWVRQAPGQRLEWMGGIMPGLGSPAYAQIFGDRVTISADTSTSTAYLQVTNLRPEDTAVYYCARDPSILNTGNHHWYDLDMWGQGTTVTVSS,DIRMTQSPLSLPVDLGQSASISCRSSQRVVHTNGNTYLHWFHQRPGQAPRRLIYKVSNRESGVPDRFSGSGSGTDFTLRISRVEAEDVGVYYCMQATDWPRTFGQGTKLEIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV2-30 (Human),IGKJ2 (Human),ARDPSILNTGNHHWYDLDM,MQATDWPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-107_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-108,Ab,SARS-CoV2 (weak),"229E, HKU1, NL63, OC43, SARS-CoV1",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVQSGAEVKKPGSSVKVSCRVSGGRFSDYAFSWLRQAPVKGLEWMGGIIPRLDRKGYSHIFQDRLTFTADESTSTTYMELSGLTSDDTAVYYCARDPTFLNSGNHFWYDVDIWGQGTTVTVSS,DIVMTQSPLSLSVTLGQAASISCTCSQTAVHSDGNTYLNWFHQRPGQSPRRLIYKVSNRDSGVPDRFSGSGSGTDFTLKINRVEAEDVGIYYCMQTTDWPRTFGQGTKVEIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV2-30 (Human),IGKJ1 (Human),ARDPTFLNSGNHFWYDVDI,MQTTDWPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-108_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-109,Ab,"SARS-CoV1,SARS-CoV2 (weak)","229E, HKU1, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVESGAEVKKPGSSVRVSCKASGGTFRKSAISWVRQAPGQGFEWMGGIIPTLDRRGFAQKFQDRLTMTADEFTSTAYMDLSDLRSDDTAVYYCARDASFPNTGNHFWYDFDLWGQGTTVTVSS,ETTLTQSPVTLPVTLGQPASISCTSSRWLVHTNGNTYLNWFHQRPGQSPRRLIYQVSNRDSGVPDRFSGSGSGTDFTLQISRVEAEDVGVYYCMQGTEWPRTFGQGTKLEIK,IGHV1-69 (Human),IGHJ4 (Human),IGKV2-30 (Human),IGKJ2 (Human),ARDASFPNTGNHFWYDFDL,MQGTEWPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-109_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-110,Ab,"SARS-CoV1,SARS-CoV2 (weak)","229E, HKU1, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,EVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVIWYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARVGSGRVYWGQGTLVTVSS,DIVMTQSPDSLAVSLGERATINCKSSQSVLYSSNNKNYLAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYSTPYTFGQGTKVEIK,IGHV3-33 (Human),IGHJ4 (Human),IGKV4-1 (Human),IGKJ1 (Human),ARVGSGRVY,QQYYSTPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-110_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-111,Ab,"229E (weak), SARS-CoV1,SARS-CoV2 (weak)","HKU1, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVESGPGLVRPSGTLSVTCAVSGDSISSDYWCTWVRQSPGKGLEWIGKISHSGSLNYNPSLKSRVTMSVDKSKNHFSLKLASVTAADTAVYYCARVRIGASHHNFWSGYYTDAFDIWGQGTTVTVSS,DIVVTQSPGTLSLSPGERAALSCRASQSVGNNYLAWYQQKPGQAPRLLIYGATSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGTSPVYTFGQGTKVEIK,IGHV4-4 (Human),IGHJ3 (Human),IGKV3-20 (Human),IGKJ1 (Human),ARVRIGASHHNFWSGYYTDAFDI,QQYGTSPVYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-111_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-112,Ab,"229E (weak), HKU1 (weak), NL63, SARS-CoV1,SARS-CoV2 (weak)",OC43,,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVQSGAEVKKPGESLKISCKASGYSFTNYWVGWVRQMPAKGLEWMGIIWPDDSDTRYRPSFQGQVTISVDKSISTAYLHWNSLKASDNGMYFCARAPLASCSGGRCPTYNRFDLWGQGTLVTVSS,QPVLTQPPSVSAAPGQKVTISCSGSSSNIENNYVSWYQQLPGAAPKLLIYDNNKRPSGIPDRFSGSKSGTSATLGITGLQTGDEADYYCGTWDFSLSAGVFGGGTKLTVL,IGHV5-51 (Human),IGHJ4 (Human),IGLV1-51 (Human),IGLJ3 (Human),ARAPLASCSGGRCPTYNRFDL,GTWDFSLSAGV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-112_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-113,Ab,"229E, HKU1 (weak), NL63, SARS-CoV1,SARS-CoV2 (weak)",OC43,,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVQSGAEVKKPGSSMKVSCKASGVNFRSYSFSWVRQAPGQGLEWMGGVIPYFPTANYADKFRDRVTITADESTGTVYLDMSSLRSEDTAVYFCASEYFDGRSYHSFCGLDVWGQGTTVTVSS,ETTLTQSPLSLPVTLGQPASISCRSSQGLVHTNGNLYLNWFHQRPGQSPRRLIYQVSNRDSGVPDRFSGSGSGTDFTLRISRVEAEDVGIYYCMQGTEWPRTFGQGTKVEIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV2-30 (Human),IGKJ1 (Human),ASEYFDGRSYHSFCGLDV,MQGTEWPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-113_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-114,Ab,"229E, HKU1, NL63, SARS-CoV1,SARS-CoV2 (weak)",OC43,,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVESGGGLVQPGGSLRLSCAASGFTFSNYAMTWVRQAPGKGLKWVSGINPSGDATFYTDSVKGQFTISRDNSKNILYLQMNRLRADDTAIYYCAKGLSFYGSGSDAFDVWGQGTTVTVSS,DIQLTQSPSTLSASVGDSVTITCRASQSISSWLAWYQQKPGKAPKLLIYKASSLETGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYKSPLSFGGGTKVEIK,IGHV3-23 (Human),IGHJ6 (Human),IGKV1-5 (Human),IGKJ4 (Human),AKGLSFYGSGSDAFDV,QQYKSPLS,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-114_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-115,Ab,"229E, HKU1 (weak), NL63, SARS-CoV1,SARS-CoV2 (weak)",OC43,,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTDYYVHWVRQVPGQGLEWMGWISPDSGDTIRAQNFQGRVTMTRDTSMNTAYMEVNRLRTDDTAIYYCARDLISVIRGLGGGMDVWGQGTTVTVSS,DIQVTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASKRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSDWHPITFGQGTRLEIK,IGHV1-2 (Human),IGHJ6 (Human),IGKV3-11 (Human),IGKJ5 (Human),ARDLISVIRGLGGGMDV,QQRSDWHPIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-115_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-116,Ab,"229E (weak), HKU1 (weak), NL63 (weak), SARS-CoV1,SARS-CoV2 (weak)",OC43,,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVQSGAEVKKPGASVKVSCKTSGYTFTGHYIHWVRQAPGQGLEWMGWINPASGDTNYAQKFQGRVTKTRDTSITTAYMELNRLRSDDTAVYYCARGGPLPWSDLDIVGTFDYWGQGTLVTVSS,DIQVTQSPSSLSASVGDRVTITCRASQSISSSLNWYQQKPGKAPTLLIYTASNLQSGVPSRFSGSGSGTDFTLTITSLQPEDFATYYCQQSYSTPGFGPGTKVDIK,IGHV1-2 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ3 (Human),ARGGPLPWSDLDIVGTFDY,QQSYSTPG,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-116_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-117,Ab,"229E, HKU1, NL63, SARS-CoV1,SARS-CoV2 (weak)",OC43,,,S; Unk,B-cells; SARS-CoV1 Human Patient,EVQLVESGGGVVQPGKSLRLSCVPSGFSFGTYGMHWVRQAPGKGPEWLAVMWYDGITQYYADSVKGRFTISRDNSKETLYLQMNSLTADDTGIYYCVKDQSSGDRLLYLGYFDLWGPGALVTVSS,EIVMTQSPATLSLSPGERATLSCRASQSVSIYLAWYQQKPGQAPRLLIYDASNRATGVPARFSGSGSGTDFTLTINNLEPEDFAIYYCQQRAKWPPRVTFGPGTKVDIK,IGHV3-33 (Human),IGHJ2 (Human),IGKV3-11 (Human),IGKJ3 (Human),VKDQSSGDRLLYLGYFDL,QQRAKWPPRVT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-117_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-118,Ab,"229E, HKU1 (weak), NL63 (weak), SARS-CoV1,SARS-CoV2 (weak)",OC43,,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVQSGGGVVQPGKSLRLSCVASGFSFGTYGMHWVRQAPGKGPEWLAVMWYDGITQYYADSVKGRFTISRDNSKETLYLQMNSLTADDTGVYYCVKDQSSGDRLLYLGYFDLWGPGTLVTVSS,DIVLTQSPATLSLSPGERATLSCRASQSVSIYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTINNLEPEDFAIYYCQQRAKWPPRVIFGPGTKVEIK,IGHV3-33 (Human),IGHJ2 (Human),IGKV3-11 (Human),IGKJ3 (Human),VKDQSSGDRLLYLGYFDL,QQRAKWPPRVI,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-118_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-119,Ab,"229E, HKU1 (weak), NL63 (weak), SARS-CoV1,SARS-CoV2 (weak)",OC43,,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLQESGPGLVKPSGTLSLTCAVSGASVSSDHWWSWVRQSPGKGLEWIGEVYHSGSTNYNPSLKSRVTISLDQSNNQFSLKLTSVTAADTAIYYCATMWGGLCTASNCYGNPMDVWGQGTTVTVSS,SYELTQPPSVSVSPGQTARITCSGDALPRRYAYWYQQRSGQAPVLVIYEDNKRPSGIPERFSAFSSGTMATLTISGAQVEDEADYYCYSTDSTANYKVFGGGTKLTVL,IGHV4-4 (Human),IGHJ6 (Human),IGLV3-10 (Human),IGLJ3 (Human),ATMWGGLCTASNCYGNPMDV,YSTDSTANYKV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-119_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-120,Ab,"229E (weak), HKU1 (weak), NL63 (weak), SARS-CoV1,SARS-CoV2 (weak)",OC43,,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLQQWGAGVLKPSETLSLTCAVYGGSFRGFFWSWIRQPPGKGLEWIGQITHSGSTNYNSSLKSRLTISVDTSKNQFSLNLSSVTAADTAIYYCARGQGGYDLRRVGYGLTSWFDPWGQGILVTVSS,QSVLIQPASVSGSPGQSITISCTGSSSDVGSYNLVSWYQQHPGKAPKLMIYEGYKRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCCSYAGSSAVVVVFGGGTKLTVL,IGHV4-34 (Human),IGHJ5 (Human),IGLV2-23 (Human),IGLJ3 (Human),ARGQGGYDLRRVGYGLTSWFDP,CSYAGSSAVVVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-120_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-121,Ab,"229E, HKU1 (weak), NL63 (weak), SARS-CoV1,SARS-CoV2 (weak)",OC43,,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYYIHWVRQAPGQGLEWLGVIHPSGGSTTFAQKFQGRVTMTRDTSTSTVYMELGSLRSDDTAVYYCARVLAGSSHEWQLTHDAFDIWGQGTTVTVSS,DIRVTQSPDSLAVSLGERATINCRTSQSVLYSSNNKNYLGWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYSTPYTFGQGTKVDIK,IGHV1-46 (Human),IGHJ3 (Human),IGKV4-1 (Human),IGKJ3 (Human),ARVLAGSSHEWQLTHDAFDI,QQYYSTPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-121_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-122,Ab,"229E (weak), HKU1 (weak), NL63 (weak), SARS-CoV1,SARS-CoV2 (weak)",OC43,,,S; Unk,B-cells; SARS-CoV1 Human Patient,EVQLVESGAEVKKPGASVILSCKASGYTVTNYYIHWVRQAPGQGLEWMGWIDPDSGVTNFAEKFQGRVTMTRDTSISTAYMELRWLESDDTAVYYCAKDLITVIRGLGGGMDVWGQGTTVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSTYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFALYYCLQRSDWHPITFGQGTRLEIK,IGHV1-2 (Human),IGHJ6 (Human),IGKV3-11 (Human),IGKJ5 (Human),AKDLITVIRGLGGGMDV,LQRSDWHPIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-122_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-123,Ab,"229E (weak), HKU1 (weak), SARS-CoV1,SARS-CoV2 (weak)","NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,EVQLLESGAEVKKPGSSVKVSCKASGGTFSSDAISWVRQAPGQGLEWMGGIIPIFGTTNYAQKFQGRVTITADESTNTAYMELSSLRSEDTAVYYCARDGPYDSGGYHLNHWGQGTLVTVSS,DIQLTQSPATLSLSPGERATLSCRANQSVSNFLAWYQQKPGQAPRHLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPPRLTFGGGTKVEIK,IGHV1-69 (Human),IGHJ1 (Human),IGKV3-11 (Human),IGKJ4 (Human),ARDGPYDSGGYHLNH,QQRSNWPPRLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-123_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-124,Ab,"HKU1 (weak), SARS-CoV1,SARS-CoV2 (weak)","229E, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,EVQLLESGGGVVNPGGSMRLSCAGSGFTFSDHYMGWIRQAPGKGLEVISYISSSGSFIRDADSVKGRFTISRDNAKNSVYLQMNSLRAEDTAVYYCARMGPYGSGTFDYWGQGTLVTVSS,DIVMTQTPGTLSVSPGERATLSCRASQIINRSQLGWYQHKPGQPPRLLIFDSSKRATGTPDRFSASGSETDFTLTISGVEPEDSGVYYCLQYSLATTFGPGTKVEIK,IGHV3-11 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ3 (Human),ARMGPYGSGTFDY,LQYSLATT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-124_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-125,Ab,"229E, HKU1 (weak), NL63 (weak), SARS-CoV1,SARS-CoV2 (weak)",OC43,,,S; Unk,B-cells; SARS-CoV1 Human Patient,EVQLVESGAEVRKPGSSVKVSCKATGGTFSSYGITWVRQAPGQGLEWMGRIIPTLGRTNYAQKFQGRVTITADKSTSTAHMELSSLRSEDTAVYYCARDLSTLQPDAIVNFDYWGQGTLVTVSS,QPVLTQSSSASASLGSSVKLTCTLSSGHSSYILAWHQQQPGKAPRFLMKFEVGGRYNKGSGVPDRFSGSSSGADRYLTISNLQSEDEADYYCETWDSNLKGVFGGGTKVTVL,IGHV1-69 (Human),IGHJ4 (Human),IGLV4-60 (Human),IGLJ6 (Human),ARDLSTLQPDAIVNFDY,ETWDSNLKGV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-125_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-126,Ab,"HKU1 (weak), SARS-CoV1,SARS-CoV2 (weak)","229E, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKTSGGSFTSYVLSWVRQAPGQGLEWMGRIVPNLGVANYAQKFQDRVTITADKSTTTAYLELRSLRSEDTAVYYCARDLYYDNGGYNYLDYWGPGTLVTVSS,QPVLTQSSSASASLGSSVKLTCTLRSGHSSYIIAWHQQQPGKAPRFLMKVGHSGSYNKGSGVPDRFSGSRSGADHYLTISNLQPDDEADYYCEAWDNNNLGVFSGGTKVTVL,IGHV1-69 (Human),IGHJ4 (Human),IGLV4-60 (Human),IGLJ6 (Human),ARDLYYDNGGYNYLDY,EAWDNNNLGV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-126_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-127,Ab,"229E (weak), HKU1 (weak), SARS-CoV1,SARS-CoV2 (weak)","NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVESGGGLVQPGGSLRLSCAASGFTFSNYNMVWVRQAPGKGLEWISYISSSSSTIYYADSVKGRFIISRDNAKNSLHLQMNSLRDEDTAVYYCVRDYCNSVSCYTYYYIGMDVWGQGTTVTVSS,DIQLTQSPSAMSASVGDRVTITCRASQGINDNLAWFQQKPGKVPKRLIYAASNLQNGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCLQHNSYPLTFGGGTKLEIK,IGHV3-48 (Human),IGHJ6 (Human),IGKV1-17 (Human),IGKJ4 (Human),VRDYCNSVSCYTYYYIGMDV,LQHNSYPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-127_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-128,Ab,"229E (weak), HKU1, NL63 (weak), SARS-CoV1,SARS-CoV2 (weak)",OC43,,,S; Unk,B-cells; SARS-CoV1 Human Patient,EVQLVQSGAEVKKPGASVKVSCKASGYSSTNYGFSWVRQAPGQGLEWMGWISVHSGNANFAQKFQGRITMTTDTSTTTAYMELRNLRSDDTATYYCATSASSYSRYYFGLDVWGQGTTVTVSS,DIRMTQSPLSLPVTPGEPASISCRSSQSLLHSNGYNYLDWYLQKPGQSPQLLIYLGSNRASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQALQTPGVTFGGGTKVDIK,IGHV1-18 (Human),IGHJ6 (Human),IGKV2-28 (Human),IGKJ3 (Human),ATSASSYSRYYFGLDV,MQALQTPGVT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-128_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-129,Ab,"HKU1, SARS-CoV1 (weak), SARS-CoV2 (weak)","229E, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,EVQLLESGPGLVKPSQTLSLTCTVSNGFISSGEYYWSWIRQSPGKGLEWIGYISHSGSTYYNRSLKSRVTISLDTSRNQFSLNLSSVTAADTAVYYCARDLAKWSYGYYYSGMDVWGQGTTVTVSS,QPVLTQPPSASGTPGQRVTISCSGSYSNIGTNPANWYQQLPGTAPKLLIYNNDQRPSGVPDRFSGSKSGTSASLAISGLQSEDETDYYCATWDDSLNGVVFGGGTKLTVL,IGHV4-31 (Human),IGHJ6 (Human),IGLV1-44 (Human),IGLJ3 (Human),ARDLAKWSYGYYYSGMDV,ATWDDSLNGVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-129_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-130,Ab,"HKU1 (weak), NL63 (weak), SARS-CoV1 (weak), SARS-CoV2 (weak)","229E, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,EVQLVESGGGLVQPGRSLRLSCAASGFTFDDYAMHWVRQVPGRGLEWVSGISWNSGTINYADSVMGRFTISRDNAKNSLYLQMNSLRAEDTALYYCAKDGRYCSGISCRTGMDVWGQGTTVTVSS,EIVLTQSPSSLSASVGDRVTITCRASRSISSYLNWYQQKPGKAPNLLIYDASTLQSGVPSRFSGSGSGTDFSLTISSLQPEDFATYYCLHTYTTPRTFGQGTKVEIK,IGHV3-9 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ1 (Human),AKDGRYCSGISCRTGMDV,LHTYTTPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-130_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-131,Ab,"229E (weak), HKU1 (weak), SARS-CoV1 (weak), SARS-CoV2 (weak)","NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,EVQLVESGGGLVQPGESLRLSCAASGFNFSPYGMNWVRQAPGKGLEWIAYIISGSGTIYYADSVKGRFTISRDNAQSSLYLQMNSLRAEDTAVYYCARGLLDYLHDAFDIWGQGTMVTVSS,EIVLTQSPATLSVSPGERITLSCRASHSVSSNLAWYQQKPGQVPRLLIYGASARATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNYWPPLTFGGGTKVEIK,IGHV3-48 (Human),IGHJ3 (Human),IGKV3-15 (Human),IGKJ4 (Human),ARGLLDYLHDAFDI,QQYNYWPPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-131_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-132,Ab,"229E, HKU1 (weak), NL63 (weak), SARS-CoV1 (weak), SARS-CoV2 (weak)",OC43,,,S; Unk,B-cells; SARS-CoV1 Human Patient,EVQLQESGPGLVKPSETLSLTCAVSGGSVSSDTDYWGWIRQPPGKGLEWIGSIHDSERTYYDPSLKSRVTISVDTSKNQFSLRLSSVTAADTALYFCASRHLDLLPIGSFDVWGRGTMVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISTYLNWYQQKTGKAPELLIYVASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYRFPITFGQGTRLEIK,IGHV4-38-2 (Human),IGHJ3 (Human),IGKV1-39 (Human),IGKJ5 (Human),ASRHLDLLPIGSFDV,QQSYRFPIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-132_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-133,Ab,"HKU1 (weak), SARS-CoV1 (weak), SARS-CoV2 (weak)","229E, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLLESGGGLVQPGRSLRLSCTASGFRFGDYTMTWFRQAPGKGLEWVGFIRSIAYGGTTEHAASVEGRFIISRDDSKSIAYLQMNSLKAEDTGVYFCTRGSGMFYGSSSGMDVWGQGTTVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVGTYLAWYQQKHGQAPRLLISDVSKRATGIPARFSGSGSGTDFTLTITSLEPEDFAVYYCQQRTNWPGATFGPGTKVDIK,IGHV3-49 (Human),IGHJ6 (Human),IGKV3-11 (Human),IGKJ3 (Human),TRGSGMFYGSSSGMDV,QQRTNWPGAT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-133_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-134,Ab,"229E (weak), HKU1 (weak), SARS-CoV1 (weak), SARS-CoV2 (weak)","NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,EVQLLESGAEVKKPGSSVKVSCKTSGGTFNSYTISWVRQAPGQGLEWMGGIIPILDTPHYAQKFRGRVTITADKSTSTAFMDLSSLTSEDTAVYYCAIRRDYSDYRDFDYWGQGTLVTVSS,QPVLTQSPSASASLGGSVKLTCTLTSGHSTYAIAWHQQQPEKGPRFLMKLNSDGSHNKGDGIPDRFSGSSSGAERYLTISSLQSEDEADYYCHTWGTDIQVFGGGTKLTVL,IGHV1-69 (Human),IGHJ4 (Human),IGLV4-69 (Human),IGLJ3 (Human),AIRRDYSDYRDFDY,HTWGTDIQV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-134_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-135,Ab,"HKU1 (weak), SARS-CoV1 (weak), SARS-CoV2 (weak)","229E, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,EVQLVESGPGLVKPSETLSLACTVSGGSISNYYWNWVRQPPGKGLEWIGNIYYSGSTTFNPSLKSRVTISVDTSRNQFSLKLSSVTAADTAVYYCARQSSSWYNPYYFDQWGQGTLVTVSS,NFMLTQPHSVSESPGKTVTISCTRSSGSIANNYVQWLQQRPGSSPTTIIYEDNQRPSGVPDRFSGSIDASSNSASLTISGLKTEDEADYYCQSYDSSSQVFGGGTKVTVL,IGHV4-59 (Human),IGHJ4 (Human),IGLV6-57 (Human),IGLJ6 (Human),ARQSSSWYNPYYFDQ,QSYDSSSQV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-135_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-136,Ab,"HKU1, SARS-CoV1 (weak), SARS-CoV2 (weak)","229E, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVQSGGGLVQPGESLRLSCAASGFNFSPYGMNWVRQAPGKGLEWIAYIISGSGTIYYADSVKGRFTISRDNAQSSLYLQMNSLRAEDTAVYYCARGLLDYLHDAFDIWGQGTMVTVSS,DIVLTQSPATLSVSPGERITLSCRASHSVSSNLAWYQQKPGQVPRLLIYGASARATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNYWPPLTFGGGTKVEIK,IGHV3-48 (Human),IGHJ3 (Human),IGKV3-15 (Human),IGKJ4 (Human),ARGLLDYLHDAFDI,QQYNYWPPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-136_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-137,Ab,"HKU1, SARS-CoV1 (weak), SARS-CoV2 (weak)","229E, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,EVQLVESGAEVKNPGSSVKISCKSSGGTLGDYAISWVRQAPGLGLEWLGGIMPLHGTTGYSQRFRPRLTITADESARTAYMELTALSSEDSAIYYCARDPSILNTGNHHWYDLDLWGQGTEVTVSS,ETTLTQSPLSLSVTLGQAASISCRPNLGLMHTDGNTYLNWFHQRPGQSPRRLIYKVSNRDSGVPDRFAGSGSGTHFTLEISGVEADDVGVYYCMQGTEWPRTFGQGTKLEIK,IGHV1-69 (Human),IGHJ4 (Human),IGKV2-30 (Human),IGKJ2 (Human),ARDPSILNTGNHHWYDLDL,MQGTEWPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-137_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-138,Ab,"HKU1 (weak), SARS-CoV1 (weak), SARS-CoV2 (weak)","229E, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,EVQLLESGGGVVQPGRSLRLSCAASGFTFNSYALFWVRQAPGKGLEWVAVVSYDGNNKYYADSVKGRFTISRDNSKNTLYLQMNSLKTEDTSVYYCARPRSGSYRQAIDYWGLGTLVTVSS,DIRMTQSPSTLSASVGDRVTITCRASQTIGSWLAWYQQKPGKAPNLLIYKASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNSLYTFGQGTKLEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV1-5 (Human),IGKJ2 (Human),ARPRSGSYRQAIDY,QQYNSLYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-138_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-139,Ab,"229E, HKU1 (weak), NL63, SARS-CoV1 (weak), SARS-CoV2 (weak)",OC43,,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVQSGGGLVQPGGSLRLSCAASGFIFSGHWMSWVRQAPGKGLEWVANIKQDGREKHYVDSVKGRFTISRDNAKNSVSLQMNSLRAEDTAVYYCVRQNVAIQYYYYAMDVWGQGTTVTVSS,ETTLTQSPGTLSVSPGERATLSCRASQSVISNLAWYQQKPGQAPRLLIYGASTRATGVPARFSGSGSGTEFTLTIASLQSEDFAVYYCQQYHHWPPYTFGQGTKVDIK,IGHV3-7 (Human),IGHJ6 (Human),IGKV3-15 (Human),IGKJ3 (Human),VRQNVAIQYYYYAMDV,QQYHHWPPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-139_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-140,Ab,"229E, HKU1 (weak), NL63, SARS-CoV1 (weak), SARS-CoV2 (weak)",OC43,,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVESGAEVKKPGSSVKVSCKASGGTLSDYAISWVRQAPGQGLEWMGGIMPIFGSPGYAEIFQGRVTITADESKSTVYMELTSLRSEDTAVYYCARDPSILDTGNHHWYDLDIWGQGTMVTVSS,EIVMTQSPLSLPVSLGQPASISCRSSQSVIHTDGNTYLNWYHQRPGQSPRRLIYKVSNRDSGVPDRFSGSGSVTDFTLKISRVEAEDVGVYYCMQGTEWPRTFGQGTKVEIK,IGHV1-69 (Human),IGHJ3 (Human),IGKV2-30 (Human),IGKJ1 (Human),ARDPSILDTGNHHWYDLDI,MQGTEWPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-140_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-141,Ab,"229E, HKU1 (weak), NL63, SARS-CoV1 (weak), SARS-CoV2 (weak)",OC43,,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKTSGATYKNSAFSWARQAPGQGFQWMGGIIPLFGVPHYVQMFQGRVTITADESTSAVYMELSGLTSDDTAVYYCAREEYSGTVHNFFGMDVWGQGTTVTVSS,DIVMTQSPLSLPVSRGQSASISCRSSHSVVHSDGKTYVNWFHQRPGQAPRRLIYQVSKRDSGVPDRFSGSGSGFDFTLKISRVEAEDVGVYFCMQGTDWPRSFGGGTKVDIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV2-30 (Human),IGKJ3 (Human),AREEYSGTVHNFFGMDV,MQGTDWPRS,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-141_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-142,Ab,"229E, HKU1 (weak), NL63, SARS-CoV1 (weak), SARS-CoV2 (weak)",OC43,,,S; Unk,B-cells; SARS-CoV1 Human Patient,EVQLVESGGGLVQPGGSLRLSCSASEFTLRSHAMHWVRQAPGKGLEYVSGISTDGSGRFYADSVKGRFTISRDNSKNKLFLQMSSLRPEDTAVYYCVRDWGSSTHYDVFDLWGQGTMVTVSS,DIVMTQSPSSLSASVGDRVTITCRASQSINIYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPLITFGQGTRLEIK,IGHV3-64D (Human),IGHJ3 (Human),IGKV1-39 (Human),IGKJ5 (Human),VRDWGSSTHYDVFDL,QQSYSTPLIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-142_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-143,Ab,"229E, 229E (weak), HKU1 (weak), NL63 (weak), OC43 (weak), SARS-CoV1 (weak), SARS-CoV2 (weak)",,,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTLADYAISWVRQAPGQGLEWMGGIKPLHGAAGYSQHFRGRLSITADESASTAYMELTGLRSEDTAMYYCARDPSILNTGNHHWYDLDLWGQGTMVTVSS,DIRLTQSPLSLPVTLGQAASISCKSSHFIVHTDGNTYLNWFHQRPGQSPRRLIYKVSNRDSGVPDRFSGSGSGTDFTLEISGVEAEDVGVYYCMQGTEWPRTFGQGTKVDIK,IGHV1-69 (Human),IGHJ3 (Human),IGKV2-30 (Human),IGKJ3 (Human),ARDPSILNTGNHHWYDLDL,MQGTEWPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-143_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-144,Ab,"229E, HKU1, NL63, SARS-CoV1 (weak), SARS-CoV2 (weak)",OC43,,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVQSGAELKKPGSSVKVSCKASGGTFYNSAFSWLRHAPGQGPEWMGGITPSLGRVGYSERFLARLTITADESTSTVYMELTSLASEDTAVYYCARDASIVGTGNHLWYGLDFWGHGTTVTVSS,ETTLTQSPLFLPVTLGQPASISCTSSVHVVHSDGNTYLNWFQQRPGQSPRRLIYKVSNRDSGVPDRFSGSGSGTYFTLKISRVEAEDVGVYYCMQGTDWPRTFGQGTKVDIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV2-30 (Human),IGKJ3 (Human),ARDASIVGTGNHLWYGLDF,MQGTDWPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-144_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-145,Ab,"229E, HKU1 (weak), NL63, SARS-CoV1 (weak), SARS-CoV2 (weak)",OC43,,,S; Unk,B-cells; SARS-CoV1 Human Patient,EVQLVESGGHVVLPGKSLRLSCAGSGFGFPLYAMQWVRRAPGKGLEWVALVSYDSSNIRYADSVKGRFTISRDNSQNTLYLQMDSLRPEDTAMYYCARDNALQDGRPGYFDSWGQGTLVTVSS,ETTLTQSPATLSLSPGERATLSCRASQSINDYLGWYQHRPGQAPRLLIHDASTRAPGIPVRFSGSGSGTDFTLTISSLEPEDSAVYYCQQRFSWYNFGPGTKVEIK,IGHV3-30 (Human),IGHJ5 (Human),IGKV3-11 (Human),IGKJ3 (Human),ARDNALQDGRPGYFDS,QQRFSWYN,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-145_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-146,Ab,"229E, HKU1 (weak), NL63, SARS-CoV1 (weak), SARS-CoV2 (weak)",OC43,,,S; Unk,B-cells; SARS-CoV1 Human Patient,EVQLVESGGGLVKPGGSLRLSCAASGFIFSDYYMSWIRQAPGKGLEWVSYITGSGRTIHYADSVKGRFTISRDNAKNSVYLQMNSLRAEDTAVYYCARGHRFLEFPLNYFDPWGQGTLVTVSS,QSVLTQPASVSGSPGQSITISCAVTSSDVGSYNLVSWHQQHPGKAPKLMIYEVNKRPSGVSNRFSGSKSGNTASLTISGLQAEDEAVYYCCSYGGRSTSVVFGGGTKLTVL,IGHV3-11 (Human),IGHJ5 (Human),IGLV2-23 (Human),IGLJ3 (Human),ARGHRFLEFPLNYFDP,CSYGGRSTSVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-146_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-147,Ab,"229E, HKU1 (weak), NL63 (weak), SARS-CoV1 (weak), SARS-CoV2 (weak)",OC43,,,S; Unk,B-cells; SARS-CoV1 Human Patient,EVQLLESGGHVVLPGKSLRLSCAGSGFGFPLYAMQWVRRAPGKGLEWVALVSYDSSNIRYADSVKGRFTISRDNSQNTLYLQMDSLRPEDTAMYYCARDNALQDGRPGYFDSWGQGTLVTVSS,DIRLTQSPATLSLSPGERATLSCRASQSINDYLGWYQHRPGQAPRLLIHDASTRAPGIPVRFSGSGSGTDFTLTISSLEPEDSAVYYCQQRFSWYNFGPGTKLEIK,IGHV3-30 (Human),IGHJ5 (Human),IGKV3-11 (Human),IGKJ2 (Human),ARDNALQDGRPGYFDS,QQRFSWYN,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-147_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-148,Ab,"229E, HKU1 (weak), NL63 (weak), SARS-CoV1 (weak), SARS-CoV2 (weak)",OC43,,,S; Unk,B-cells; SARS-CoV1 Human Patient,EVQLVESGGGVVQPGRSLRLSCAASGFTFSKFAMHWVRQAPGKGLEWVAIISYDGSHKNYADSVKGRFTISRDNSKNTVYLQVDSLRAEDTAVYYCALLYGSGSYYNFVFFGWKDGSDAWGPGTTVTVSS,QPVLTQPASVSGSPGQSITISCTGTTSDVGGYDYVSWYQQRPGKAPKLIIYDVINRPSGVSNRFSGSKSGNTASLTISGLQADDETDYYCSSYTSGGTLVFGTGTKLTVL,IGHV3-30 (Human),IGHJ6 (Human),IGLV2-14 (Human),IGLJ3 (Human),ALLYGSGSYYNFVFFGWKDGSDA,SSYTSGGTLV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-148_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-149,Ab,"229E (weak), HKU1, NL63 (weak), SARS-CoV1 (weak), SARS-CoV2 (weak)",OC43,,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGMFTDYAISWVRQAPGQRLEWMGGILPAFAASGSPGYAPIFRGRATFSADVSTSTAYLELTNLKPEDTAVYYCARDPSILNTGNHHWYDLDLWGQGTEVTVSS,DIQMTQSPLSLPVGLGQSASISCRSSQWVVHTDGNTYLNWFHQRPGQSPRRLIYKVSNRDSGVPDRFSGSGSGTDFTLRISRVEAEDVGVYYCMQATEWPRTFGQGTKVEIK,IGHV1-69 (Human),IGHJ4 (Human),IGKV2-30 (Human),IGKJ1 (Human),ARDPSILNTGNHHWYDLDL,MQATEWPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-149_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-150,Ab,"229E (weak), HKU1 (weak), NL63, SARS-CoV1 (weak), SARS-CoV2 (weak)",OC43,,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVQSGAELKKPGSSVRVSCKAAGGTLTNYAISWVRQAPGQGFEWMGGIMPVSHTAGYAQKFQGRVTFTADESATTAYMDLTSLRPEDTAIYYCARDPSIHYTGNHHWYDLDIWGQGTMVTVSS,DIQLTQSPLSLPVTLGQPASISCRSSQRIVHTDGNTYLNWFLQRPGQSPRRLIYKVSNRDSGVPDRFSGSGSGTDFTLKISRVEAEDVGIYYCMQGTEWPRTFGQGTKVEIK,IGHV1-69 (Human),IGHJ3 (Human),IGKV2-30 (Human),IGKJ1 (Human),ARDPSIHYTGNHHWYDLDI,MQGTEWPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-150_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-151,Ab,"229E (weak), HKU1 (weak), NL63 (weak), SARS-CoV1 (weak), SARS-CoV2 (weak)",OC43,,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVQSGAEVKKPGSSMRVSCRVSGGTFITHAMSWVRQAPGQGPEWMGGIVPLFGRASYAQPSQTRVQITADESTSTVYLEVPSLTSEDTAVYYCVRDSEPYTATRSQNHYWYDMDVWGQGTTVTVSS,ETTLTQSPLSLSVTLGQSASISCRASQTVVHSVDGNTYLNWFHQRPGQSPRRLIYKVSNRDSGVPDRFSGSGSGTDFTLRISRVEAEDIGIYYCMQGTDWPRTFGQGTKVEIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV2-30 (Human),IGKJ1 (Human),VRDSEPYTATRSQNHYWYDMDV,MQGTDWPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-151_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-152,Ab,"229E (weak), HKU1 (weak), NL63 (weak), SARS-CoV1 (weak), SARS-CoV2 (weak)",OC43,,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVQSGAELKKPGSSVRVSCKAAGGTLTNYAISWVRQAPGQGFEWMGGIMPVSHTAGYAQKFQGRVTFTADESATTAYMDLTSLRPEDTAIYYCARDPSIHYTGNHHWYDLDIWGQGTTVTVSS,DIVMTQSPLSLPVTLGQPASISCRSSQRIVHTDGNTYLNWFLQRPGQSPRRLIYKVSNRDSGVPDRFSGSGSGTDFTLKISRVEAEDVGIYYCMQGTEWPRTFGQGTKVEIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV2-30 (Human),IGKJ1 (Human),ARDPSIHYTGNHHWYDLDI,MQGTEWPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-152_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-153,Ab,"229E (weak), HKU1 (weak), NL63 (weak), SARS-CoV1 (weak), SARS-CoV2 (weak)",OC43,,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTLSHYAISWVRQAPGQGLEWMGGIMPVSGTVGYAQKFQGRVKFTADEYASTAYMELTNLRSEDSAVYFCARDPSIVDSGPHHWYDLDIWGQGTMVTVSS,DIRMTQSPLSLPVTLGQPASISCRSSQFVVHTDGNTYLNWFQQRPGQSPRRLIYKVSNRDSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQATEWPRTFGQGTKVDIK,IGHV1-69 (Human),IGHJ3 (Human),IGKV2-30 (Human),IGKJ3 (Human),ARDPSIVDSGPHHWYDLDI,MQATEWPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-153_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-154,Ab,"229E (weak), HKU1 (weak), NL63 (weak), SARS-CoV1 (weak), SARS-CoV2 (weak)",OC43,,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVESGAEVKRPGASVKVSCKASGYAFSDYYMHWVRQAPGQGPEWMGWINPNSGDTGYPQKFRGWVTMTRDTSVSTAYMELKRLKSDDTAVYYCASGPNYFDYWGQGTLVTVSS,SYVLTQPPSVSVSPGQTARITCSADGLPKQYSYWYQQKPGQAPVMVIYKDTERPSGIPERFSGSSSGTTATLTISGVQAEDEADYYCQSADSNDSSPVFGGGTQLTVL,IGHV1-2 (Human),IGHJ4 (Human),IGLV3-25 (Human),IGLJ7 (Human),ASGPNYFDY,QSADSNDSSPV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-154_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-155,Ab,"229E (weak), HKU1 (weak), NL63 (weak), SARS-CoV1 (weak), SARS-CoV2 (weak)",OC43,,,S; Unk,B-cells; SARS-CoV1 Human Patient,EVQLLESGGGLVKPGGSLRLSCEASGFTFSNYNMNWVRQAPGKGLEWVSSISGSSSYISYADSVKGRFTISRDNAKNSLYLQMNSLRVEDTAVYYCARADRDYDFWSDPPLIDHWGQGTLVTVSS,ETTLTQSPATLSLSPGEGATLSCRASQSVSSSLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDYTLTISSLEPEDFAVYYCHQRSNWPYTFGQGTKVEIK,IGHV3-21 (Human),IGHJ4 (Human),IGKV3-11 (Human),IGKJ1 (Human),ARADRDYDFWSDPPLIDH,HQRSNWPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-155_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-156,Ab,"229E (weak), HKU1 (weak), SARS-CoV1 (weak), SARS-CoV2 (weak)","NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,EVQLVESGGGLIQPGGSLRLSCAASGFTVTDNYMSWVRQAPGKGLEWVSVLYSGGSTYYADAVQGRFSISRDNSKNALYLQMNSLRAEDTAVYYCARGFGNGWSYYFDYWGQGTLVTVSS,DIVLTQTPSSLSASVGDRVTITCRASQTIATYLSWYQQKPGKAPKLLIYAVSSLQSGVPSRFSGSGSGTDFTLTIGSLQPEDFATYYCQQSYSIPWTFGQGTKVDIK,IGHV3-53 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ1 (Human),ARGFGNGWSYYFDY,QQSYSIPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-156_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-157,Ab,"HKU1, SARS-CoV1 (weak), SARS-CoV2 (weak)","229E, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,EVQLVQSGGGLVQPGGSLRLSCAASGFTFSSYSMSWVRQAPGKGLEWVSYITRSSDNIYYAESVKGRFTISRDSAKNSLYLHMNSLRDEDTAVYYCARDPGLEYSGNYFSYYYYAMDVWGQGTTVTVSS,EIVMTQSPSSLSASVGDRVTITCRASQSISYYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFILTISSLQPEDIATYYCQHSYSSPPLTFGGGTKVEIK,IGHV3-48 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ4 (Human),ARDPGLEYSGNYFSYYYYAMDV,QHSYSSPPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-157_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-158,Ab,"HKU1, SARS-CoV1 (weak), SARS-CoV2 (weak)","229E, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSTHAISWVRQAPGHGPEWMGGIIPLFGTSESAQRFQARVRFTADESTSTAYMELSSLTSEDTAVYYCVRDSDPYTATSRNNHYWYDMDVWGQGTTVTVSS,ETTLTQSPLSLPVTLGQPASISCRSSQIVVHSDGNTYLNWFHQRPGQSPRRLIYKVSNRDSGVPDRFSGSGSGTDFTLKISRVEAEDIGVYYCMQGTDWPRTFGQGTKVDIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV2-30 (Human),IGKJ3 (Human),VRDSDPYTATSRNNHYWYDMDV,MQGTDWPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-158_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-159,Ab,"HKU1, SARS-CoV1 (weak), SARS-CoV2 (weak)","229E, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKVSGGRFSDYAISWLRQAPVKGLEWMGGIIPRLNRKGYSQDFQGRLTFTADESTSTAYMELSGLTSEDTAVYYCARDPTFLNSGNHFWYAVDIWGQGTTVTVSS,DIRLTQSPLSLSVTLGQAASISCTCSQTAVHSDGNTYLNWFHQRPGQSPRRLIYKVSNRDSGVPDRFSGSGSGTDFTLKISRVEAEDVGIYYCMQTTDWPRTFGQGTKVEIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV2-30 (Human),IGKJ1 (Human),ARDPTFLNSGNHFWYAVDI,MQTTDWPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-159_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-160,Ab,"HKU1, SARS-CoV1 (weak), SARS-CoV2 (weak)","229E, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,EVQLVESGGGVVKPGGSLRVSCVGSGFTFSDHYMSWIRQAPGKGLEIISYISTDGSYINDADSVKGRFINSRDNAKNSVYLQLNSLRAEDTAVYYCARMGPSGSGSLDYWGQGSLVTVSS,DIVMTQSPGTLSLSPGERAALSCRASQIVTRSQLAWYQHKPGQPPRLLIYDSSSRATGTPDRFSGSGSGTDFTLTISRLEPEDSAVYYCHQYSGSATFGPGTKVEIK,IGHV3-11 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ3 (Human),ARMGPSGSGSLDY,HQYSGSAT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-160_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-161,Ab,"HKU1, SARS-CoV1 (weak), SARS-CoV2 (weak)","229E, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,EVQLVESGPTLVKPTQTLTLTCTFSGFSLNTRELGVGWIRQPPGKALEWLALIYWDDDKRYSPSLKSRLSITKDTSKNQVVLTLTNMDPGDTATYYCAHTSELPPRRPYAAFDFWGQGTLVTVSS,SYELTQPPSVSGAPRQKVTISCSGSSANIASNGVNWYQQLPGKAPKLLIYYDDLVSSGVSDRFSGSKSGTSASLAISGLQSEDEADYYCATWDDILNGPVFGGGTKLTVL,IGHV2-5 (Human),IGHJ4 (Human),IGLV1-36 (Human),IGLJ3 (Human),AHTSELPPRRPYAAFDF,ATWDDILNGPV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-161_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-162,Ab,"HKU1 (weak), SARS-CoV1 (weak), SARS-CoV2 (weak)","229E, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,EVQLVESGGGVVQPGGSLRLSCVASGFPFGRYAMHWVRQAPGQGLEWLTLISFDSSNIEYSDSVQGRFTISRDNSRNTLFLQMTSLRPEDTAVYFCARDLPPLDYWGQGTLVTVSS,DIRMTQSPSSLSASVGDRVTITCRASQGFGNKVAWYQQKPGTAPKLLIYETSTLQSGVPSRFSGSGSGTEFAFTISSLQPEDGATYYCQKYNRAPWTFGQGTKVEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV1-27 (Human),IGKJ1 (Human),ARDLPPLDY,QKYNRAPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-162_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-163,Ab,"HKU1 (weak), NL63 (weak), SARS-CoV1 (weak), SARS-CoV2 (weak)","229E, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLQQWGAGLLKPSETLSLTCAVNGGSFNNYYWSWIRQPPGKGPEWIGEVVHSGSTTYNPSLKSRVTISIDMSKNQFALKLNSVTAADTAVYYCARGFTFTYSDFLTGQRTFEYWGQGTLVTVSS,QSALIQPASVSGSPGQSITISCTGTSSDVGRYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEAAYYCSSYISDIKLVVFGGGTKLTVL,IGHV4-34 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ3 (Human),ARGFTFTYSDFLTGQRTFEY,SSYISDIKLVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-163_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-164,Ab,"HKU1 (weak), NL63 (weak), SARS-CoV1 (weak), SARS-CoV2 (weak)","229E, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,EVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVALISYDGDKKYYPDSVRGRFTISRDNSKNTLHLQMNSLRLEDTAVYYCARSYGGSYSTVGYWGQGALVTVSS,QSALIQPRSVSGSPGQSVTISCTGTSSDVGGSNYVSWYQQHPGKAPKLLVYDVTKRPSGVPDRFSGSKSGNTASLTISGLQAEDEADYYCCSYAGTYIFGTGTKLTVL,IGHV3-30 (Human),IGHJ4 (Human),IGLV2-11 (Human),IGLJ1 (Human),ARSYGGSYSTVGY,CSYAGTYI,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-164_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-165,Ab,"HKU1 (weak), NL63 (weak), SARS-CoV1 (weak), SARS-CoV2 (weak)","229E, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVQSGGDSVNPGGSLRLSCAGSGFSVRDVWMSWVRQAPGKGLEWIGRIKSEADGGSSDYRASLKDRFSIWRDASKNTLYLQVNGLQTEDTAIYFCSWNDVGWAFTFWGQGTLVTVSS,QSVLTQPPSVSGSPGQSVSISCSGTSSDFGNYNRISWYQQTPGTAPKVIIYEVNSRPSGVPDRFSGSKSGNTASLTITGLQAEDEADYYCCSYRSDNTYIFGGGTKVTVL,IGHV3-15 (Human),IGHJ4 (Human),IGLV2-18 (Human),IGLJ1 (Human),SWNDVGWAFTF,CSYRSDNTYI,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-165_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-166,Ab,"HKU1 (weak), SARS-CoV1 (weak), SARS-CoV2 (weak)","229E, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVQSGAEVKKAGSSVKVSCKASGGPFSSFAISWVRQAPGQGLEWLGGIMTVFGPAHYAQKSRDRISITADESTSTSYLELSSLTSDDTAVYYCAAEERSGTNHNYYGLDVWGQGTTVTVSS,ETTLTQSPLFLPVTLGQPASISCRSSQRLVHTNGNTYLNWFQQRPGHSPRRLIYQVSNRDSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQGTEWPRTFGGGTKLEIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV2-30 (Human),IGKJ4 (Human),AAEERSGTNHNYYGLDV,MQGTEWPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-166_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-167,Ab,"HKU1 (weak), SARS-CoV1 (weak), SARS-CoV2 (weak)","229E, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,EVQLVESGGGLIQPGGSLRLSCAASGFPFSGTYMTWVRQAPGKGLEWVSIIYSGGDTYYADSVKGRFTISRDNSKNTLFLQMNSLRVEDTAMYYCARDREMAIITERSYGLDVWGQGTMVTVSS,QPVLTQPPSASGTPGQRVTISCSGGSSNIGSNSVNWYQQLPGTAPKLLIYSNSQRPSGVPDRFSGSKSGTSASLAISGLQSEDEADYYCAAWDDSLNTFRYVFGTGTKVTVL,IGHV3-53 (Human),IGHJ3 (Human),IGLV1-44 (Human),IGLJ1 (Human),ARDREMAIITERSYGLDV,AAWDDSLNTFRYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-167_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-168,Ab,"HKU1 (weak), SARS-CoV1 (weak), SARS-CoV2 (weak)","229E, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,EVQLVESGGGLVQPGGSLRLSCGASGFTFSDYAMSWVRQAPGKGLEWVSTISGSGDKTYYADSLKGRFTNSRDNSKSTLYLQMTSLRAEDTAVYFCAKDRYCSGGSCFYDAFDIWGQGTTVTVSS,ETTLTQSPSSLSASVGDRVNITCRASQSISTYLTWYQQKPGKAPKLLIYGASSLHSGVPSRFTGVGSGTEFTLSISSLQPEDFATYYCQQSYNTFFTFGGGTKVDIK,IGHV3-23 (Human),IGHJ3 (Human),IGKV1-39 (Human),IGKJ3 (Human),AKDRYCSGGSCFYDAFDI,QQSYNTFFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-168_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-169,Ab,"HKU1 (weak), SARS-CoV1 (weak), SARS-CoV2 (weak)","229E, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,EVQLVESGGGVVQPGRSLRLSCEASGFTFADYPMHWVRQAPGKGLEWVAVISSHGRSQGYAASVKGRFTFSRDNSQSSLFLQLNSLRVEDTAVYFCAREAQSSGRAGCLDAWGQGTLVTVSS,DIRLTQSPSSLSASVGDRVTITCRASQAIAGWLAWYQQKPGRAPKSLIYRASSLQSGVPSRFSGSGSGTDFSLTISNLQPEDSATYYCQHYDSYPTAFGQGTRLEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV1D-16 (Human),IGKJ5 (Human),AREAQSSGRAGCLDA,QHYDSYPTA,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-169_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-170,Ab,"HKU1 (weak), SARS-CoV1 (weak), SARS-CoV2 (weak)","229E, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVQSGAEVREPGSSVKLSCKTSGGTFSTHAISWVRQAPGQRPEWMGGIMPIFGESKDTQKFQGRVTFTADESTTTAYMELRSLKSDDTAIYYCVRDSDPYTATVRSNHYWYAMDVWGQGTTVTVSS,ETTLTQSPLSLAVTLGQPASISCRSSLGLVHTNGNTYLNWFQQRPGQSPRRLIYRVSNRDSGVPDRFSGSGSVTDFTLTISRVEAEDIGVYYCMQGTEWPRTFGQGTKVEIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV2-30 (Human),IGKJ1 (Human),VRDSDPYTATVRSNHYWYAMDV,MQGTEWPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-170_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-171,Ab,"HKU1 (weak), SARS-CoV1 (weak), SARS-CoV2 (weak)","229E, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,EVQLVQSGAEVKKPGSSVKVSCKVSGGRFSDYAISWLRQAPVKGLEWMGGIIPRLNRKGYSQDFQGRLTFTADESTSTAYMELSGLTSEDTAVYYCARDPTFLNSGNHFWYAVDIWGQGTTVTVSS,ETTLTQSPLSLSVTLGQAASISCTCSQTAVHSDGNTYLNWFHQRPGQSPRRLIYKVSNRDSGVPDRFSGSGSGTDFTLKISRVEAEDVGIYYCMQTTDWPRTFGQGTKVDIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV2-30 (Human),IGKJ3 (Human),ARDPTFLNSGNHFWYAVDI,MQTTDWPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-171_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-172,Ab,"HKU1 (weak), SARS-CoV1 (weak), SARS-CoV2 (weak)","229E, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLQESGRGLVKPSETLSLTCTVSGGSITSSRYYWGWIRQPPGRNLEWIGSIHYSGTTSYNPSLWSRVAISVDTAQNQFSLRLNSVTAADTAVYYCAAPAPSNHESWSGTDWFDPWGQGILVTVSS,EIVMTQSPASLSASVGDRVTITCRAGQSISTNLCWYQQRQGKAPKLLIYAASSLRSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPPTFGGGTKVDIK,IGHV4-39 (Human),IGHJ5 (Human),IGKV1-39 (Human),IGKJ3 (Human),AAPAPSNHESWSGTDWFDP,QQSYSTPPT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-172_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-173,Ab,"HKU1 (weak), SARS-CoV1 (weak), SARS-CoV2 (weak)","229E, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVQSGAEVKGPGASVKVSCKVSGYSFITYDITWVRQAPGQGLEWMGWISTKSGDTRYAQNVQGRVTMTTDTSTNTAYMELRNLKSDDTALYYCARTTPRGWEQWPVLEYWGQGTLVTVSS,DIQVTQSPATLSVSPGERVTLSCRASQSISNTLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCHQYNKWPPITFGGGTKVEIK,IGHV1-18 (Human),IGHJ4 (Human),IGKV3-15 (Human),IGKJ4 (Human),ARTTPRGWEQWPVLEY,HQYNKWPPIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-173_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-174,Ab,"HKU1 (weak), SARS-CoV1 (weak), SARS-CoV2 (weak)","229E, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,EVQLVESGGGLVQPGGSLRLSCEASGFNFNSYSMSWVRQAPGKGLEWLSYISSRSSTIKYASSVQGRFTVSRDNAKKSVYLQMNSLRDEDTAVYFCARELDSETYYNYNSLDVWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTISCRASQGISTFLAWFQQRPGKAPKSLIYAASKLQSGVPSRFSGSDSGPDFTLTIDNLRPEDSATYYCKQYNSYPYTFGQGTKLEIK,IGHV3-48 (Human),IGHJ6 (Human),IGKV1-16 (Human),IGKJ2 (Human),ARELDSETYYNYNSLDV,KQYNSYPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-174_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-175,Ab,"HKU1 (weak), SARS-CoV1 (weak), SARS-CoV2 (weak)","229E, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVESGGEVKKPGASVKVSCKASGYTLSSYPISWVRQAPGHGLEWMGWINTYNGRTNYEQMLQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARVVFRHGQYDDSSGRLAFDIWGQGTMVTVSS,EIVMTQSPSSLSASVGDSVTITCRASQSISNYLNWYQDKPGKAPELLIYAASNLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSDSWTFGQGTKVDIK,IGHV1-18 (Human),IGHJ3 (Human),IGKV1-39 (Human),IGKJ1 (Human),ARVVFRHGQYDDSSGRLAFDI,QQSYSDSWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-175_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-176,Ab,"HKU1 (weak), SARS-CoV1 (weak), SARS-CoV2 (weak)","229E, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVQSGAELKKPGSSVRVSCKAAGGTLTNYAISWVRQAPGQGFEWMGGIMPVSHTAGYAQKFQGRVTFTADESATTAYMDLTSLRPEDTAIYYCARDPSIHYTGNHHWYDLDIWGQGTMVTVSS,ETTLTQSPLSLPVTLGQPASISCRSSQRIVHTDGNTYLNWFLQRPGQSPRRLIYKVSNRDSGVPDRFSGSGSGTDFTLKISRVEAEDVGIYYCMQGTEWPRTFGQGTKVEIK,IGHV1-69 (Human),IGHJ3 (Human),IGKV2-30 (Human),IGKJ1 (Human),ARDPSIHYTGNHHWYDLDI,MQGTEWPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-176_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-177,Ab,"HKU1 (weak), SARS-CoV1 (weak), SARS-CoV2 (weak)","229E, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,EVQLLESGAEVKKPGSSVKVSCKTSGGTFSTHAISWVRQAPGQGPEWMGGIIPLFGTSEHAQRFQARVKFTADESTSTAYMELSSLTPEDTAVYYCVRDSDPYTATSRNNHYWYGMDVWGQGTTVTVSS,DIQMTQSPLSLPVTLGQPASISCRSSQSVVHSDGNTYLNWFHQRPGQSPRRLIYKVSNRDSGVPDRFSGSGSGTDFTLKISRVEAEDIGVYYCMQGTDWPRTFGQGTKVDIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV2-30 (Human),IGKJ3 (Human),VRDSDPYTATSRNNHYWYGMDV,MQGTDWPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-177_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-178,Ab,"SARS-CoV1 (weak), SARS-CoV2 (weak)","229E, HKU1, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,EVQLLESGGGVVQPGTSLRLSCAVSGFMFKNYAIHWVRQAPGKGLEWVAVISFDGSDISYTESVQGRFTISRDNSENMLYLQMNSLRAEDTAMYYCAREPDGIGAAGISGYWGQGTLVTVSS,GIVLTQSPDSLAVSVGERATINCKSSQTVLYSSKNKHYLAWYQQKPGQPPKLLTSSPSTREPGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYTTPYTFGQGTKVDIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV4-1 (Human),IGKJ3 (Human),AREPDGIGAAGISGY,QQYYTTPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-178_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-179,Ab,"SARS-CoV1 (weak), SARS-CoV2 (weak)","229E, HKU1, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,EVQLVESGGGLVKPGGSLRLSCVASGFTFSDFYMSWIRQAPGKGLEWVSYISGSGDTIYYADSVKGRFTVSRDNAKNSLFLQMSSLGAEDTAMYYCAREMATSFGYYFVLDVWGQGTTVTVSS,EIVMTQTPSSLSASVGDRVTITCRASQSISNYVNWYQQKPGRAPNLLIYAASSLQSGVSSRFSGSGSGTDFTLTISSLQPEDFATYYCQQTYSTPPEGPTFGPGTKVEIK,IGHV3-11 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ3 (Human),AREMATSFGYYFVLDV,QQTYSTPPEGPT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-179_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-180,Ab,"SARS-CoV1 (weak), SARS-CoV2 (weak)","229E, HKU1, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,EVQLVESGGGVVQPGRSLRLSCAASEFTFSTYAMHWVRQAPGKGLEWVALISYDGINKYYADSVKGRFAISRDNSKNTLYLQVNSLRADDTAVYYCVRPYSGSYTNWFDLWGQGTLVTVSS,EIVMTQSPGTLSSSPGERATLSCRASQSVSSRYLAWYQQKPGQAPRLLIYGTSNRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSYTFGPGTKLEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ2 (Human),VRPYSGSYTNWFDL,QQYGSSYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-180_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-181,Ab,"SARS-CoV1 (weak), SARS-CoV2 (weak)","229E, HKU1, NL63, OC43",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGMLSDYAISWVRQAPGQRLEWMGGIMPAFGSPGYAQIFRGRATISADVSTSTAYLELTSLKPEDTAVYYCARDPSILNTGNHHWYDLDIWGQGTMVTVSS,DIVMTQSPLSLPVGLGQSASISCRSSQRVVHTDGNTYLNWFHQRPGQSPRRLIYKVSNRDSGVPDRFSGSGSGTDFTLRISRVEAEDVGVYYCMQATEWPRTFGQGTKVEIK,IGHV1-69 (Human),IGHJ3 (Human),IGKV2-30 (Human),IGKJ1 (Human),ARDPSILNTGNHHWYDLDI,MQATEWPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-181_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-182,Ab,"229E (weak), HKU1 (weak), SARS-CoV2 (weak)","NL63, OC43, SARS-CoV1",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVQSGAEVKMPGSSVKVSCKVSGGRFSDYAISWLRQAPLEGLEWMGGIVPHLNRKGYSQKFQDRLTFTADDSTSTAYMELSGLTSEDTAVYYCARDPTFLNTGNHFWYAVDIWGQGTTVTVSS,DIRLTQSPLSLSVTLGQAASISCTCSQSAVHSDGTTYFNWFHQRPGQSPRRLIYKVSNRDSGVPDRFIGSGSGTHFTLKISRVEAEDVGVYYCMQTTDWPRTFGQGTKVEIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV2-30 (Human),IGKJ1 (Human),ARDPTFLNTGNHFWYAVDI,MQTTDWPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-182_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-183,Ab,"HKU1, SARS-CoV2 (weak)","229E, NL63, OC43, SARS-CoV1",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSTHAISWVRQAPGHGPEWLGGILPLFGTSESAQRFQARVKITADESTSTAYMELSSLTSEDTAVYYCVRDSDPYTATSRNNHYWYAMDVWGQGTTVTVSS,ETTLTQSPLSLPVTLGQPASISCRSSQSVVHSDGNTYLNWFHQRPGQSPRRLIYKVSNRDSGVPDRFSGSGSGTDFTLKISRVEAEDIGVYYCMQGTDWPRTFGQGTKVEIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV2-30 (Human),IGKJ1 (Human),VRDSDPYTATSRNNHYWYAMDV,MQGTDWPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-183_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-184,Ab,"HKU1 (weak), SARS-CoV2 (weak)","229E, NL63, OC43, SARS-CoV1",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKVSGGTFSNYAISWLRQAPGQGPEWMGGIIPALSRVGYVRKFQARLTISADELTTTAYMDLSSLTSEDTAVYYCARDPSFLNTGNHFWYDFDLWGQGTTVTVSS,ETTLTQSPLSLPVTLGQPASISCTSSQTVVHTDRNTYLNWYHQRPGQSPRRLIYKVSNRDSGVPDRFSGSGSGSHFTLKISRVEAEDVGVYYCMQGTEWPRTFGQGTKLEIK,IGHV1-69 (Human),IGHJ4 (Human),IGKV2-30 (Human),IGKJ2 (Human),ARDPSFLNTGNHFWYDFDL,MQGTEWPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-184_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-185,Ab,SARS-CoV2 (weak),"229E, HKU1, NL63, OC43, SARS-CoV1",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLQQWGAGLLKPSETLSLTCAVYGGSFSGFYWTWIRQPPGKGLEWIGEINHSGSSNYDLSLKSRVTMSVDTSKNQFSLKLSSVTAADTAVYYCARGMISPRIPRTTRQRWFDTWGQGTLVTVSS,QPGLTQPASVSGSPGQSITISCTGTSGDVGSDNLVSWYQRHPGKAPKLMIYEGSKRPSGVSHRFSGSNSGNTASLTISGLQAEDDADYYCCSYAGDDTVVFGGGTKLTVL,IGHV4-34 (Human),IGHJ4 (Human),IGLV2-23 (Human),IGLJ3 (Human),ARGMISPRIPRTTRQRWFDT,CSYAGDDTVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-185_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-186,Ab,SARS-CoV2 (weak),"229E, HKU1, NL63, OC43, SARS-CoV1",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLQQWGAGLLKPSETLSLTCGVYGGSFSGYFWSWIRQSPGKGLEWIGEINHSRSMSYNPSLKSRITMSVDTSKNQFSLNLNSVTAADTAVYFCARGKAHRNDFWSGYYPHWFDPWGQGILVTVSS,DIVLTQSPGTLSLSPGERVTLSCRASQSISSNYLAWYQQKPGQAPRLLISDASSRATGIPDRFSGSGSGADFTLIISRLEPEDFAVYFCHQYGGSPTTFGQGTKVEIK,IGHV4-34 (Human),IGHJ5 (Human),IGKV3-20 (Human),IGKJ1 (Human),ARGKAHRNDFWSGYYPHWFDP,HQYGGSPTT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-186_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-187,Ab,SARS-CoV2 (weak),"229E, HKU1, NL63, OC43, SARS-CoV1",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVQSGAEVKKPGSSVKISCKISGDTFSTNAISWLRQAPGREPEWMGGIVPLVGPASYAQRPQGRLTITADEFTNTAYLELNSLRSEDTATYYCARDSDPYTATRRHNHYWYAMDVWGQGTTVTVSS,ETTLTQSPLSLPVTLGQPASISCRSSQIAMHSDGNTYLSWFHQRPGQPPRRLIYKISNRDSGVPDRFSGSGSGTDFTLKISRVEAEDIGTFYCMQGTDWPRTFGQGTKVEIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV2-30 (Human),IGKJ1 (Human),ARDSDPYTATRRHNHYWYAMDV,MQGTDWPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-187_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-188,Ab,SARS-CoV2 (weak),"229E, HKU1, NL63, OC43, SARS-CoV1",,,S; Unk,B-cells; SARS-CoV1 Human Patient,EVQLLESGPGLVKPSETLSLTCTVSGGSINSQYWNWIRQSPGKGLEWIGYVYYSGSTNYNPSLKSRVTMSVDTSKNHFSLNLRSVTAADTAVYYCARGLVVRYFDGFPSGPIIGAFDIWNQGTTVTVSS,ETTLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDAFNRATGVPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRTSTLTFGGGTKVDIK,IGHV4-59 (Human),IGHJ3 (Human),IGKV3-11 (Human),IGKJ4 (Human),ARGLVVRYFDGFPSGPIIGAFDI,QQRTSTLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-188_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-189,Ab,SARS-CoV2 (weak),"229E, HKU1, NL63, OC43, SARS-CoV1",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKVSGGTFSSHAISWVRQAPGQRPEWMGGIMPIFGESKDTQKFQGRVTFTVDESTNTAYMELTSLKSEDTAIYYCVRDPDPYTATVRHNHYWHGMDVWGQGTTVTVSS,ETTLTQSPLSLPVTLGQAASISCRSSQAVVHSDGNTYLNWFQQRPGQPPRRLIYKVSNRDSGVPDRFSGSGSGTVFTLKISRVEAEDIGVYYCMQGTEWPRTFGQGTKVEIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV2-30 (Human),IGKJ1 (Human),VRDPDPYTATVRHNHYWHGMDV,MQGTEWPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-189_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-190,Ab,SARS-CoV2 (weak),"229E, HKU1, NL63, OC43, SARS-CoV1",,,S; Unk,B-cells; SARS-CoV1 Human Patient,EVQLLESGPGLVKPSETLSLTCTVSGGSISSNNLYWGWIRQPPGKGLEWIGSIYYSGSTYYNPSLKSRVIIPVDTSKDQFSLRLSSVTAADTAVYYCARHSQKDIVLIPAAQSPIFDYWGQGTLVTVSS,QSVLTQPPSVSATPGQKVTISCSGSSSNIGNNYVSWYQQLPGTAPKLLIYDNNKRPSGIPDRFSGSKSGTSATLGITGLQTGDEADYYCGTWDSRLSAVVFGGGTKLTVL,IGHV4-39 (Human),IGHJ4 (Human),IGLV1-51 (Human),IGLJ3 (Human),ARHSQKDIVLIPAAQSPIFDY,GTWDSRLSAVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-190_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-191,Ab,SARS-CoV2 (weak),"229E, HKU1, NL63, OC43, SARS-CoV1",,,S; Unk,B-cells; SARS-CoV1 Human Patient,EVQLVESGGGLVQPGGSLRLSCSASGFTFSRYAMHWVRQAPGKGLEYVSAINLNGDSTYYTDSVRGRFTISRDNSKNTLFLQMSNVRPEDTAFYYCVKDGGYYDSSGPGHWGQGTLVTVSS,DIRVTQSPATLSLSPGERATLSCRASENIAHYLAWYQQKPGQAPRLVIYDASSRATGIPGRFSGSGAGTDFTLTINSLEPEDFAVYYCQQRSNWPQNFGGGTKVDIK,IGHV3-64D (Human),IGHJ1 (Human),IGKV3-11 (Human),IGKJ3 (Human),VKDGGYYDSSGPGH,QQRSNWPQN,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-191_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-192,Ab,SARS-CoV2 (weak),"229E, HKU1, NL63, OC43, SARS-CoV1",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVQSGGGVVQPGGSLRLSCADSGNAFIANPMHWVRQAPGKGLEWLALISTDGNNRHYADSVKGRFTFSRDNSKNSLYLQMDSLRPEDTGVYYCARESRSSGRAGCFDSWGQGTLVTVSS,DIRLTQSPSSLSASVGDRVTITCRASQDISSWLAWYQQKSGKAPKSLIYAASSLQNGVPSRFSGSRSGTDFTLTISSLQPEDLGTYYCQQYDSYPVTFGQGTRLEIK,IGHV3-30 (Human),IGHJ5 (Human),IGKV1D-16 (Human),IGKJ5 (Human),ARESRSSGRAGCFDS,QQYDSYPVT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-192_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-193,Ab,SARS-CoV2 (weak),"229E, HKU1, NL63, OC43, SARS-CoV1",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVESGGGVVQPGTSLRLSCAATGFTFTTYPMHWVRQAPGKGLEWVAVISYDGMNQYYADFLKGRFTISRDNSKNTLYLQMNSLRADDTAVYYCARAYGGNYQNHFDHWGQGTLVTVSS,DIVLTQTPDSLAVSLGERATINCKSSQSVLYSSNNKNYLAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYTMWTFGQGTKVEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV4-1 (Human),IGKJ1 (Human),ARAYGGNYQNHFDH,QQYYTMWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-193_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-194,Ab,SARS-CoV2 (weak),"229E, HKU1, NL63, OC43, SARS-CoV1",,,S; Unk,B-cells; SARS-CoV1 Human Patient,EVQLVQWGAGLLKPSETLSLRCAVYGGSFNGFYWTWIRQAPGQGLEWIAEINHSGTTNYNPSLKSRVTISIDTSKKQFSLSLKSVTAADTAMYFCARGTISPIVGVPTPVVPRRGRSWFDPWGQGTLVTVSS,QSVLTQPPSVSAAPGQKVTISCSGSSSNIGNDYVSWYQQLPGTAPKLLIYENYKRPSGIPDRFSGSKSGTSATLDITGLQTGDEADYYCGTWDSSLSVDNYVFGTGTKLTVL,IGHV4-34 (Human),IGHJ5 (Human),IGLV1-51 (Human),IGLJ1 (Human),ARGTISPIVGVPTPVVPRRGRSWFDP,GTWDSSLSVDNYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-194_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-195,Ab,SARS-CoV2 (weak),"229E, HKU1, NL63, OC43, SARS-CoV1",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSTHAISWVRQAPGHGPEWLGGIIPLFGTSESAQRFQARVKITADESTSTAYMELSSLTSEDTAVYYCVRDSDPYTATSRNNHYWYAMDVWGQGTTVTVSS,DIVLTQSPLSLPVTLGQPASISCRSSQSVVHSDGNTYLNWFHQRPGQSPRRLIYKVSNRDSGVPDRFSGSGSGTDFTLKISRVEAEDIGVYYCMQGTDWPRTFGQGTKVDIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV2-30 (Human),IGKJ3 (Human),VRDSDPYTATSRNNHYWYAMDV,MQGTDWPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-195_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-196,Ab,SARS-CoV2 (weak),"229E, HKU1, NL63, OC43, SARS-CoV1",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVQSGAEVREPGSSVKLSCKTSGGPFSTHAFSWVRQAPGQRPEWMGGIMPVFGESKDTQKFKGRVTFTADASTTTTYMELRSLKSDDTAIYYCVRDSDPYTATSSHNHYWYAMDVWGQGTTVTVSS,ETTLTQSPLSLPVTLGQPASISCRSSQVLVHSDGNTYLNWFQQRPGQSPRRLIYKVSNRDSGVPDRFSGSGSGIDFTLKISRVEAEDIGVYYCMQGTEWPRTFGQGTKVDIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV2-30 (Human),IGKJ3 (Human),VRDSDPYTATSSHNHYWYAMDV,MQGTEWPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-196_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-197,Ab,SARS-CoV2 (weak),"229E, HKU1, NL63, OC43, SARS-CoV1",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLVESGGGLVKPGGSLRLSCAASGFTFSDYYMIWIRQAPGKGLEWLSYISHTASTIYYADSVKGRFTISRDNAKNSLFLQMNSLTAEDTAVYYCARDRGSGVIDPWGQGTLVTVSS,DIQLTQSPSSLSASVGDRVTITCRASQSISHYLNWYQQKPGKAPKLLIYAASNLQSGVPSRFSGNGSGTDFTLTISSLQPEDFATYFCQQSYSTPLTFGGGTKVDIK,IGHV3-11 (Human),IGHJ5 (Human),IGKV1-39 (Human),IGKJ4 (Human),ARDRGSGVIDP,QQSYSTPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-197_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-199,Ab,SARS-CoV1 (weak),"229E, HKU1, NL63, OC43, SARS-CoV2",,,S; Unk,B-cells; SARS-CoV1 Human Patient,EVQLVESGGGVVNPGGSLRLSCAGSGFTFSDYYMGWIRQAPGKGLEVVSYISTTGSYIKDADSVKGRFTISRDNAKNSVYLQMNSLRAEDTAVYYCARMGPYGSGSFDYWGQGTLVTVSS,EIVMTQSPGTLSLSPGERATLSCRASQTVTRSQLAWYQHKPGQPPRLLIYDSSNRATGTPDRFSASGSGTEFTLTITRLEPEDSAVYYCLQYSSATTFGPGTKVDIK,IGHV3-11 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ3 (Human),ARMGPYGSGSFDY,LQYSSATT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-199_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
mAb-200,Ab,SARS-CoV1 (weak),"229E, HKU1, NL63, OC43, SARS-CoV2",,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLQESGPGLVKPSETLSLTCTVSGGSVSDTPFYWGWIRQPPGKGLEWIGSMYYTGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARHPSSIFRGTVFTPYYFDYWGQGTLVTVSS,ETTLTQSPGTLSLSPGERATLSCRASQSVTSNYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGRAPLYTFGLGTKVDIK,IGHV4-59 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ3 (Human),ARHPSSIFRGTVFTPYYFDY,QQYGRAPLYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mAb-200_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 11, 2020","Jul 11, 2020",N/A,Complete
CnC2t1p1_B10,Ab,SARS-CoV2,,,SARS-CoV2,S; Unk,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGIIPIFGTANYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCARVSGYDSSGYWGDYWGQGTLVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPPALTFGGGTKVEIK,IGHV1-69 (Human),IGHJ4 (Human),IGKV3-11 (Human),IGKJ4 (Human),ARVSGYDSSGYWGDY,QQRSNWPPALT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CnC2t1p1_B10_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 9, 2020","Jul 9, 2020",N/A,Complete
CnC2t1p1_B4,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYGISWVRQAPGQGLEWMGWISAYNGNTNYAQKLQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARDGELLGWFDPWGQGTLVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGSYNLVSWYQQHPGKAPKLMIYEGSKRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCCSYAGSSTWVFGGGTKLTVL,IGHV1-18 (Human),IGHJ5 (Human),IGLV2-23 (Human),IGLJ3 (Human),ARDGELLGWFDP,CSYAGSSTWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CnC2t1p1_B4_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 9, 2020","Jul 9, 2020",N/A,Complete
CnC2t1p1_D6,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGRSLRLSCTASGFTFGDYAMSWFRQAPGKGLEWVGFIRSKAYGGTTEYAASVKGRFTISRDDSKSIAYLQMNSLKTEDTAVYYCTRVRRLWFGSYYYGMDVWGQGTTVTVSS,DIVMTQSPLSLPVTPGEPASISCRSSQSLLHSNGYNYLDWYLQKPGQSPQLLIYLGSNRASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQALQTPGTFGPGTKVDIK,IGHV3-49 (Human),IGHJ6 (Human),IGKV2-28 (Human),IGKJ3 (Human),TRVRRLWFGSYYYGMDV,MQALQTPGT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CnC2t1p1_D6_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 9, 2020","Jul 9, 2020",N/A,Complete
CnC2t1p1_E12,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGRSLRLSCTASGFTFGDYAMSWFRQAPGKGLEWVGFIRSKAYGGTTEYAASVKGRFTISRDDSKSIVYLQMNSLKTEDTAVYYCTRVRRLWFGSYYYGMDVWGQGTTVTVSS,DIVMTQSPLSLPVTPGEPASISCRSSQSLLHSNGYNYLDWYLQKPGQSPQLLIYLGSNRASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQALQTPGTFGPGTKVDIK,IGHV3-49 (Human),IGHJ6 (Human),IGKV2-28 (Human),IGKJ3 (Human),TRVRRLWFGSYYYGMDV,MQALQTPGT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CnC2t1p1_E12_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 9, 2020","Jul 9, 2020",N/A,Complete
CnC2t1p1_E8,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKNPGASVKVSCKASGYIFTNYYIHWVRQAPGQGLEWVGWIHSLSGGTSYAQKFQGRVTLTRDASIRTAYMELSRLGSDDTALYYCARASVSTITDFDYWGQGTLVAVSS,QSALTQPASVSGSPGQSITISCTGTSGDVGSYNLVSWYQQHPGKAPKLVIYEATKRPSGVSNRFFASKSGNTASLTISGLQAEDEADYYCCSYAGVRTVVFGGGTKLTVL,IGHV1-2 (Human),IGHJ4 (Human),IGLV2-23 (Human),IGLJ3 (Human),ARASVSTITDFDY,CSYAGVRTVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CnC2t1p1_E8_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 9, 2020","Jul 9, 2020",N/A,Complete
CnC2t1p1_G6,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYIFTNYYIHWVRQAPGQGLEWVGWIHSLSGGTSYAQKFQGRVTLTRDAPIRTAYMELSGLGSDDTAVYYCARASVATITDFDYWGQGTLVAVSS,QSALTQPASVSGSPGQSITISCTGTSGDIGSYNLVSWYQQYPGKAPKLIIYEASKRPSGVSNRFFASKSGNTASLTISGLQAEDEADYYCCSYAGVRTVVFGGGTKLTVL,IGHV1-2 (Human),IGHJ4 (Human),IGLV2-23 (Human),IGLJ3 (Human),ARASVATITDFDY,CSYAGVRTVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CnC2t1p1_G6_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 9, 2020","Jul 9, 2020",N/A,Complete
FnC1t1p2_A5,Ab,SARS-CoV2,,SARS-CoV2,,S; S1 non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYDINWVRQATGQGLEWMGWMNPNSGNTGYAQKFQGRVTMTRNTSISTAYMELSSLRSEDTAVYYCARATTDCSSTSCWSLDFWSGYYTGGREKIFDWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPGTFGQGTKVEIK,IGHV1-8 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ1 (Human),ARATTDCSSTSCWSLDFWSGYYTGGREKIFD,QQYGSSPGT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 9, 2020","Jul 9, 2020",N/A,Complete. Homology modelling failed as no suitable length 31 CDRH3 templates.
FnC1t2p1_D4,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGSELKKPGASVKVSCKASGYTFLRFAMNWLRQAPGQGLEWMGWIDTNTGTPTYAQGFTGRFVFSLDTSVSTAYLQISSLKAEDTAVYYCARSLRGANLVPWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDVSNYLNWYQQQPGKAPKLLIYDAFNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPLTFGGGTKVEIK,IGHV7-4-1 (Human),IGHJ5 (Human),IGKV1-33 (Human),IGKJ4 (Human),ARSLRGANLVP,QQYDNLPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/FnC1t2p1_D4_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 9, 2020","Jul 9, 2020",N/A,Complete
FnC1t2p1_G5,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGSELKKPGASVKVSCKASGYTFLRFAMNWLRQAPGQGLEWMGWIDTNTGTPTYAQGFTGRFVFSLDTSVSTAYLQISSLKAEDTAVYYCARSLRGANLVPWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDVSNYLNWYQQQPGKAPKLLIYDAFNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPLTFGGGTKVEIK,IGHV7-4-1 (Human),IGHJ5 (Human),IGKV1-33 (Human),IGKJ4 (Human),ARSLRGANLVP,QQYDNLPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/FnC1t2p1_G5_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 9, 2020","Jul 9, 2020",N/A,Complete
HbnC2t1p2_D9,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVIWYDGRNKYYVDSVKGRFTISRDNSKNTLYLQISSLRAEDTAVYYCARAARRPVVTDTMAYYMDVWGKGTTVTVSS,EIVLTQSPATLSLSPGERATLSCRASLSLSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPPTWTFGQGTKAEIK,IGHV3-33 (Human),IGHJ6 (Human),IGKV3-11 (Human),IGKJ1 (Human),ARAARRPVVTDTMAYYMDV,QQRSNWPPTWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/HbnC2t1p2_D9_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 9, 2020","Jul 9, 2020",N/A,Complete
HbnC3t1p1_C6,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QMQLVQSGPEVKKPGTSVKVSCKASGFTFTSSAVQWVRQARGQRLEWIGWIVVGSGNTNYAQKFQERVTITRDMSTSTAYMELSSLRSEDTAVYYCAAPHCSSTICYDGFDIWGQGTMVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRVEPEDFAVYYCQQYGSSPWTFGQGTKVEIK,IGHV1-58 (Human),IGHJ3 (Human),IGKV3-20 (Human),IGKJ1 (Human),AAPHCSSTICYDGFDI,QQYGSSPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/HbnC3t1p1_C6_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 9, 2020","Jul 9, 2020",N/A,Complete
HbnC3t1p1_F4,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAATGFTFRRYGMHWVRQAPGKGLEWVAGILFDGSNKYYVDSVKGRFTISRDSSRNTLYLQLNSLRREDTAVYYCAKGGDYEWELLESWGQGTLVTVSS,DIQMTQSPSTVSASVGDRVTITCRASQSIDNWLAWYQEKPGKAPKVLIYKASSLESGVPSRFSGRGSGTEFTLTISSLQPGDFATYYCQHYHSFPLTFGGGTKVDIK,IGHV3-30 (Human),IGHJ5 (Human),IGKV1-5 (Human),IGKJ4 (Human),AKGGDYEWELLES,QHYHSFPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/HbnC3t1p1_F4_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 9, 2020","Jul 9, 2020",N/A,Complete
HbnC3t1p1_G4,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDFGDFFFDYWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYGVSSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPRTFGQGTKVEIK,IGHV3-66 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ1 (Human),ARDFGDFFFDY,QQYGSSPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/HbnC3t1p1_G4_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 9, 2020","Jul 9, 2020",N/A,Complete
HbnC3t1p2_B10,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFIVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDYGDYFFDYWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLISGASSRAAGIPDRFSGSGSGTDFTLTINRLEPEDFAVYYCQQYGSSPRTFGQGTKLEIK,IGHV3-66 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ2 (Human),ARDYGDYFFDY,QQYGSSPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/HbnC3t1p2_B10_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 9, 2020","Jul 9, 2020",N/A,Complete
HbnC3t1p2_C6,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QMQLVQSGPEVKKPGTSVKVSCKASGFTFSSSAVQWVRQARGQRLEWIGWIVVGSGNTNYAQKFQGRVTITRDMSTRTAYMELSSLRSEDTAMYYCAAPYCSSTRCYDAFDIWGQGTMVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGRSPWTFGQGTKVEI,IGHV1-58 (Human),IGHJ3 (Human),IGKV3-20 (Human),IGKJ1 (Human),AAPYCSSTRCYDAFDI,QQYGRSPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/HbnC3t1p2_C6_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 9, 2020","Jul 9, 2020",N/A,Complete
HbnC4t1p1_D5,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGRSLRLSCAASGFTFDDYAMHWVRQAPGKGLEWVSGISWNSGSIGYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTGLYYCAKDINYDSGGYHKNYFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRATITCRASQSISSYLNWYQEKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSNPLTFGGGTKVEIK,IGHV3-9 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ4 (Human),AKDINYDSGGYHKNYFDY,QQSYSNPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/HbnC4t1p1_D5_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 9, 2020","Jul 9, 2020",N/A,Complete
MnC1t3p1_G9,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLLESGGGLVQPGGSLRLSCAASGFTFRNYAMTWVRQAPGKGLEWVSGISDSGDRTYNADSVKGRFSISRDNSKNTLHLQMNSLRAEDTAVYYCALASGSYFGGANYWGQGTLVTVSS,QAVVTQEPSLTVSPGGTVTLTCGSSTGPVTSDHYPYWFQQKPGQAPTTLIYDTNNKHSWTPARFSGSLLGGKAALTLSGAQPEDEAEYYCLLSYTGARVFGGGTKLTVL,IGHV3-23 (Human),IGHJ4 (Human),IGLV7-46 (Human),IGLJ3 (Human),ALASGSYFGGANY,LLSYTGARV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/MnC1t3p1_G9_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 9, 2020","Jul 9, 2020",N/A,Complete
MnC2t1p1_A3,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTVSSNYMSWVRQAPGRGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRPEDTAVYYCATGARFGESPFDYWGQGTLVTVSS,DIQMTQSPSSVSASVGDRVTITCRASQGISSWLAWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQANSFPGTFGQGTKVEIK,IGHV3-66 (Human),IGHJ4 (Human),IGKV1D-12 (Human),IGKJ1 (Human),ATGARFGESPFDY,QQANSFPGT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/MnC2t1p1_A3_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 9, 2020","Jul 9, 2020",N/A,Complete
MnC2t1p1_C5,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCATGARFGESPFDYWGQGTLVTVSS,DIQMTQSPSSVSASVGDRVTITCRASQGISSWLAWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQANSFPGTFGQGTKVEIK,IGHV3-66 (Human),IGHJ4 (Human),IGKV1D-12 (Human),IGKJ1 (Human),ATGARFGESPFDY,QQANSFPGT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/MnC2t1p1_C5_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 9, 2020","Jul 9, 2020",N/A,Complete
MnC2t2p1_C11,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSRYTIIWVRQAPGQGLEWMGRIIPILDIANYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCAREGGLDYFGSRNSGWTYTWFDPWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQNISSYLNWYQQKPGKAPNLLIYAASSLQSGVPPRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTLYSFGQGTKLEIK,IGHV1-69 (Human),IGHJ5 (Human),IGKV1-39 (Human),IGKJ2 (Human),AREGGLDYFGSRNSGWTYTWFDP,QQSYSTLYS,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/MnC2t2p1_C11_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 9, 2020","Jul 9, 2020",N/A,Complete
MnC4t1p1_A10,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QLQVQESGPGLVKPSETLSLTCTVSGASISSNHYFWGWIRQPPGKGLAWIGSMHYSGSTYYNPSLKSRVTISVDTSKNQLSLKLSSVTAADTAVYYCARGVNYYDRNGYYRNDGFDIRGQGTMVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQGIRNDLGWYEQKPGKAPKRLIYAASSLESGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCLQHNTYPFTFGPGTRVDIK,IGHV4-39 (Human),IGHJ3 (Human),IGKV1-17 (Human),IGKJ3 (Human),ARGVNYYDRNGYYRNDGFDI,LQHNTYPFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/MnC4t1p1_A10_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 9, 2020","Jul 9, 2020",N/A,Complete
MnC4t1p1_A11,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYSMNWVRQAPGKGLEWVSYISSSSNTRYYTDSVMGRFTISRDNAKNSLFLQMNSLRAEDTAVYYCASSKGFCSGGSCSDYWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGVSSRATGIPDRFSGSGSGTDFTLTISRLEPEDFVVYYCHQYGSSPWTFGQGTKVEIK,IGHV3-48 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ1 (Human),ASSKGFCSGGSCSDY,HQYGSSPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/MnC4t1p1_A11_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 9, 2020","Jul 9, 2020",N/A,Complete
MnC4t2p1_B3,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGHLVQPGRSLRLSCAASGFTFDDYAMHWVRQVPGKGLEWVSGISWNGGILDYADSVKGRFTISRDNAKNSLYLHMRSLRTDDTALYYCAKDLRRQDYYADWYFDLWGRGTLVTVSS,DIQMIQSPSSVSASVGDRVTITCRASQGISSWLAWYQQKPGKAPKLLIYAASTLLSAVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQGNSFPFTFGPGTIVDV,IGHV3-9 (Human),IGHJ2 (Human),IGKV1-12 (Human),IGKJ3 (Human),AKDLRRQDYYADWYFDL,QQGNSFPFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/MnC4t2p1_B3_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 9, 2020","Jul 9, 2020",N/A,Complete
MnC4t2p1_D10,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QLQVQESGPGLVKPSETLSLTCTVSGASISSNHYFWGWIRQPPGKGLAWIGSMHYSGSTYYNPSLKSRVTISVDTSKNQLSLKLSSVTAADTAVYYCARGVNYYDRNGYYRNDGFDIRGQGTMVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQGIRNDLGWYEQKPGKAPKRLIYAASSLESGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCLQHNTYPFTFGPGTRVDIK,IGHV4-39 (Human),IGHJ3 (Human),IGKV1-17 (Human),IGKJ3 (Human),ARGVNYYDRNGYYRNDGFDI,LQHNTYPFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/MnC4t2p1_D10_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 9, 2020","Jul 9, 2020",N/A,Complete
MnC4t2p1_E6,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGHLVQPGRSLRLSCAASGFTFDDYAMHWVRQVPGKGLEWVSGISWNGGILGYADSVKGRFTISRDNAKNSLYLQMRSLRTDDTALYYCAKDLRRQDYYADWYFDLWGRGTLVTVSS,DIQMTQSPSSVSASVGDRVTITCRASQGISSWLAWYQQKPGKAPKLLIYAASTLLSAVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQGNSFPFTFGPGTKVDV,IGHV3-9 (Human),IGHJ2 (Human),IGKV1-12 (Human),IGKJ3 (Human),AKDLRRQDYYADWYFDL,QQGNSFPFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/MnC4t2p1_E6_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 9, 2020","Jul 9, 2020",N/A,Complete
MnC4t2p1_F5,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QLQVQESGPGLVKPSETLSLTCTVSGASISSNHYFWGWIRQPPGKGLAWIGSMHYSGSTYYNPSLKSRVTISVDTSKNQLSLKLSSVTAADTAVYYCARGVNYYDRNGYYRNDGFDIRGQGTMVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQGIRNDLGWYEQKPGKAPKRLIYAASSLESGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCLQHNTYPFTFGPGTRVDIK,IGHV4-39 (Human),IGHJ3 (Human),IGKV1-17 (Human),IGKJ3 (Human),ARGVNYYDRNGYYRNDGFDI,LQHNTYPFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/MnC4t2p1_F5_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 9, 2020","Jul 9, 2020",N/A,Complete
MnC4t2p2_A4,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGSELKKPGASVKISCKASGYIFINYAMNWVRQAPGQGLEWMGWINTNTGNPTYAQDFTGRFVFSLDTSLSTAYLQISSLEAEDTAVYYCAKIGSRNSLGVWGQGTLVTVSA,EIVLTQSPGTLSLSPGERATLSCRASHSVDRSYLAWYQQKPGLAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFALYYCQHFGTSSVTFGRGTRLEIK,IGHV7-4-1 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ5 (Human),AKIGSRNSLGV,QHFGTSSVT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/MnC4t2p2_A4_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 9, 2020","Jul 9, 2020",N/A,Complete
MnC5t2p1_G1,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QMQLVQSGPEVKKPGTSVKVSCKASGFTFTSSAVQWVRQARGQRLEWIGWIVVGSGNTDYAQKFQERVTITRDVSTSTAYMELSSLRSEDTAVYYCAAPRCSGGSCYDGFDIWGQGTMVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQHKPGQAPRLLICGASSRATGIPDRFSGSGSGTGFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK,IGHV1-58 (Human),IGHJ3 (Human),IGKV3-20 (Human),IGKJ1 (Human),AAPRCSGGSCYDGFDI,QQYGSSPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/MnC5t2p1_G1_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 9, 2020","Jul 9, 2020",N/A,Complete
II62,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,"Phage Display Library (Antibody, human, non-immune)",ND,ND,IGHV3-23 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ1 (Human),AKAAGSFDY,QQTTNAPNT ,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 1, 2020","Oct 1, 2020",N/A,Complete
413-2,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,SARS-CoV1,S; non-RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,ND,ND,ND,ND,ARDNNYRNYYYYMDV,QQYGSSPPLT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 8, 2020","Jul 8, 2020",N/A,Following up for VH/VL reads
414-1,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,SARS-CoV1,S; RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,ND,ND,ND,ND,ARGALGCSSTSCYPNNFDY,AAWDDSLNGVV,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 8, 2020","Jul 8, 2020",N/A,Following up for VH/VL reads
505-3,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,SARS-CoV1,S; RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,ND,ND,ND,ND,ARDFISRPRGYR,MQGTHWPPT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 8, 2020","Jul 8, 2020",N/A,Following up for VH/VL reads
505-5,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,SARS-CoV1,S; RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,ND,ND,ND,ND,ARDFISRPRGYR,MQGTHWPPT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 8, 2020","Jul 8, 2020",N/A,Following up for VH/VL reads
505-8,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,SARS-CoV1,S; non-RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,ND,ND,ND,ND,ARGQDDFWSMNWFDP,SSYTSSSIVV,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 8, 2020","Jul 8, 2020",N/A,Following up for VH/VL reads
515-1,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,SARS-CoV1,S; RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,ND,ND,ND,ND,ARDFISRPRGYR,MQGTHWPPT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 8, 2020","Jul 8, 2020",N/A,Following up for VH/VL reads
515-5,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,SARS-CoV1,S; non-RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,ND,ND,ND,ND,TRGSQWATINDARFDY,LQHNSYPIT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 8, 2020","Jul 8, 2020",N/A,Following up for VH/VL reads
553-15,Ab,"SARS-CoV1,SARS-CoV2",,"SARS-CoV1,SARS-CoV2",,S; RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,ND,ND,ND,ND,ARVWYYYGPRDY,QSYDGSNHNVV,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 8, 2020","Jul 8, 2020",N/A,Following up for VH/VL reads
553-49,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,SARS-CoV1,S; RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,ND,ND,ND,ND,AKDSSSWYNYYGMDV,QSYDSSNHVV,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 8, 2020","Jul 8, 2020",N/A,Following up for VH/VL reads
553-60,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,SARS-CoV1,S; RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,ND,ND,ND,ND,ARVFRGSQYWFDP,QQYGSSPPT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 8, 2020","Jul 8, 2020",N/A,Following up for VH/VL reads
553-63,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,SARS-CoV1,S; RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,ND,ND,ND,ND,ARMEAPKLTLDP,QQSYSIPRT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 8, 2020","Jul 8, 2020",N/A,Following up for VH/VL reads
4A8,Ab,SARS-CoV2,,SARS-CoV2,,S; S1 non-RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGAEVKKPGASVKVSCKVSGYTLTELSMHWVRQAPGKGLEWMGGFDPEDGETMYAQKFQGRVTMTEDTSTDTAYMELSSLRSEDTAVYYCATSTAVAGTPDLFDYYYGMDVWGQGTTVTVSS,EIVMTQSPLSSPVTLGQPASISCRSSQSLVHSDGNTYLSWLQQRPGQPPRLLIYKISNRFSGVPDRFSGSGAGTDFTLKISRVEAEDVGVYYCTQATQFPYTFGQGTKVDIK,IGHV1-24 (Human),IGHJ6 (Human),IGKV2-24 (Human),IGKJ3 (Human),ATSTAVAGTPDLFDYYYGMDV,TQATQFPYT,http://www.rcsb.org/structure/7C2L,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 23, 2020","Jul 5, 2020",5th July 2020: Added PDB structure; 11th Jan 2021: Added new patent reference,Complete
9A1,Ab,SARS-CoV2,,,SARS-CoV2,S; S2,B-cells; SARS-CoV2 Human Patient,EVQLLESGGGVVQPGRSLRLSCVVSGFTFNNYGMHWVRQAPGKGLEWVAVISYEGSVKYYGDHVDGRFTISRDPFKNTLYLHMNNLRPDDTAVYYCAKVSAIFWLGQGLSPIDVWGQGTTVTVSS,DIVMTQSPATLSASPGERVTLSCRASQNIRNNLAWYQQKPGQAPRLLIHGASTRAAGAPARFSGSGSDTQFTLTVSSLQSEDFAVYYCHQYSKWPVTFGGGTKVDIK,IGHV3-30 (Human),IGHJ6 (Human),IGKV3-15 (Human),IGKJ3 (Human),AKVSAIFWLGQGLSPIDV,HQYSKWPVT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/9A1_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 23, 2020","Jun 23, 2020",N/A,Complete
8D9,Ab,SARS-CoV2,,,SARS-CoV2,S; S2,B-cells; SARS-CoV2 Human Patient,EVQLLESGGGLVQPGGSLRLSCTASGFTFSSYWMSWVRQAPGKGLEWVANIQQDGSEKYYVDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARPTIGYSYGSDYWGQGTTVTVSS,SYELTQPPSVSVSPGQTASITCSGDKLGDKYACWYRQKPGQSPVLVIYQDSKRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCQAWDSSTGVFGGGTKLTVL,IGHV3-7 (Human),IGHJ4 (Human),IGLV3-1 (Human),IGLJ3 (Human),ARPTIGYSYGSDY,QAWDSSTGV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/8D9_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 23, 2020","Jun 23, 2020",N/A,Complete
8D2,Ab,SARS-CoV2,,,SARS-CoV2,S; NTD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYWMSWVRQAPGKGLEWVANINQDGSEKYYVDSVKGRFTISRDNAKNSLYLQVNSLRAEDTAVYYCARDWDYDILTGSWFGAFDIWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQGIRNDLGWYQQKPGKAPKRLIYAASSLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCLQHNSYPLTFGGGTKVEIK,IGHV3-7 (Human),IGHJ3 (Human),IGKV1-17 (Human),IGKJ4 (Human),ARDWDYDILTGSWFGAFDI,LQHNSYPLT,https://www.rcsb.org/structure/7DZX,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 23, 2020","Jun 6, 2021","21st Dec: Added new reference. 6th June '21: Confirmed association with infectivity (Y. Liu et al), corrected epitope to within NTD and added PDB structure",Associated with enhancement of SARS-CoV2 infectivity. Complete
10C10,Ab,SARS-CoV2,,,SARS-CoV2,S; Unk,B-cells; SARS-CoV2 Human Patient,QVQLVQSGGGLVQPGGSLRLSCAASGFTFSSYWMSWVRQAPGKGLEWVANINQDGSEKYYVDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARDWDYDILTGSWFGAFDIWGQGTMVTVSS,DIQLTQSPSSLSASVRNRVTITCRASQGIKNDLCWYQQKPGKAPKRLIYAASSLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCLQHNNYPLTFGGGTNEEIK,IGHV3-7 (Human),IGHJ3 (Human),IGKV1-17 (Human),IGKJ4 (Human),ARDWDYDILTGSWFGAFDI,LQHNNYPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/10C10_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 23, 2020","Jun 23, 2020",N/A,Complete
0304-3H3,Ab,SARS-CoV2,,SARS-CoV2,,S; S2,B-cells; SARS-CoV2 Human Patient,EVQLVESGPGLVKPSETLSLTCTASGGSISTYYWSWIRQPPGKGLEWIGYIYYSGSTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARDRIAPVGKFFGWYFDLWGRGTLVTVSS,DIVMTQSPATLSVSPEERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNKWPPWTFGQGTKVDIK,IGHV4-59 (Human),IGHJ2 (Human),IGKV3-15 (Human),IGKJ1 (Human),ARDRIAPVGKFFGWYFDL,QQYNKWPPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/0304-3H3_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 23, 2020","Jun 23, 2020",N/A,Complete
0304-2F8,Ab,SARS-CoV2 (weak),,,SARS-CoV2,S; Unk,B-cells; SARS-CoV2 Human Patient,EVQLVQSGAEVSQPGESLKISCKGSGYSFTGYWISWVRQMPGKGLEWMGIIYPGDSDTKYTPSFQGQVTISTDKSINTAYLQWSSLKASDTAMYYCARRGDGLYYYGMDVWGQGTTVTVSS,EIVMTQSHTLLPVTPGEPASITCRSSQSLLHSNGYNYLDWYLQKPGQSPQLLIYLGSNRASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQALQTPQTFGQGTKVDIK,IGHV5-51 (Human),IGHJ6 (Human),IGKV2-28 (Human),IGKJ3 (Human),ARRGDGLYYYGMDV,MQALQTPQT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/0304-2F8_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 23, 2020","Jun 23, 2020",N/A,Complete
0304-4A2,Ab,SARS-CoV2,,,SARS-CoV2,S; S1 non-RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGPGLVKPSETLSLTCAVSGDSTSSSSSYWDWIRQPPGKGLEWIGNIYYTGTTYYNPSLKSRVTISVDTSKDQFSLKLSSVTAADTAVYYCARELFTAVAGKGGIDYWGQGTLVTVSS,EIVLTQSPDSLAVSLGERATINCKSSQSVLYSSNNKNYLAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCHQYYNTPRTFGQGTKVEIK,IGHV4-39 (Human),IGHJ4 (Human),IGKV4-1 (Human),IGKJ1 (Human),ARELFTAVAGKGGIDY,HQYYNTPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/0304-4A2_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 23, 2020","Jun 23, 2020",N/A,Complete
0304-4A10,Ab,SARS-CoV2,,,SARS-CoV2,S; S2,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFSTYAMHWVRQAPGKGLEYVSGISSNGGSTYYANSVKGRFTISRDNSKNTLYIQMGSLRAEDMAVYYCARSSSRGFDYWGQGTLVTVSS,EIVLTQSPDSLAVSLGERATINCRSSQSVLYSSNNKNYLAWYQQKPGQPPKVLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYSSPYAFGPGTKVDIK,IGHV3-64 (Human),IGHJ4 (Human),IGKV4-1 (Human),IGKJ3 (Human),ARSSSRGFDY,QQYYSSPYA,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/0304-4A10_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 23, 2020","Jun 23, 2020",N/A,Complete
1M-1D2,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGLVQPGGSLRLSCAASGFTFSSYAMHWVRQAPGKGLEYVSAISGNGGSTYYAKSVKGRFTISRDNSKNTLYLQMGSLRAEDMAVYYCARGAEYYDFWSGYYSAYFDYWGQGTLVTVSS,QAVVTQPPSASGTPGQRVTISCSGSSSNIGSNYVYWYQQLPGTAPKLLIYNNNQRPSGVPDRFSGSKSGTSASLAISGLRSEDEADYYCAAWDDSLIYVLFGGGTKLTVL,IGHV3-64 (Human),IGHJ4 (Human),IGLV1-47 (Human),IGLJ3 (Human),ARGAEYYDFWSGYYSAYFDY,AAWDDSLIYVL,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/1M-1D2_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 23, 2020","Jun 23, 2020",N/A,Complete
2M-2D1,Ab,SARS-CoV2,,,SARS-CoV2,S; S2,B-cells; SARS-CoV2 Human Patient,EVQLVESGPGLVKPSETLSLTCTVSGGSISSSSYYWGWIRQPPGKGLEWIGSIYYSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYSARGDRIQLWLLDAFDIWGQGTMVTVSS,QSVLTQLPSASGTPGQTVTISCSGNVFKEKSNYVYWYQQLPGTAPKLLIYRNNHRPSGVPDRFSGSKSGTSPSLAISGLRSEDEADYYCAARDDSLSGWVFSGRTKLTVL,IGHV4-39 (Human),IGHJ3 (Human),IGLV1-47 (Human),IGLJ3 (Human),ARGDRIQLWLLDAFDI,AARDDSLSGWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/2M-2D1_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 23, 2020","Jun 23, 2020",N/A,Complete
2M-2D4,Ab,SARS-CoV2,,,SARS-CoV2,S; S2,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSAISGSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKIGLGLGGLLRRYFDYWGQGTLVTVSS,EIVMTQSPATLSLSPGERATLSCRASQSVSTSLAWYQQKPGQAPRLLIYDASNRATGVPARFSGSGSGTDFTLTISSLEPDDFAVYYCQQRTNWPLFGPGTKVEIK,IGHV3-23 (Human),IGHJ4 (Human),IGKV3-11 (Human),IGKJ3 (Human),AKIGLGLGGLLRRYFDY,QQRTNWPL,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/2M-2D4_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 23, 2020","Jun 23, 2020",N/A,Complete
2M-2G12,Ab,SARS-CoV2,,,SARS-CoV2,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGLLKPGETLSLSCAASGFTFSDYYWSWIRQAPGKGLEWIAVINHSGSTIYYPYPVKGVFIFSRDTANNFSLKLMNMMTSDTAVYYCGTRIMITWYSRRGMDGWGKGVTVTVSS,DIQMTQSPSSLSVSAGERATLSCRASQSVSSYLIWCHQKPGKAPKLLIYDASTLQTGVPSRFIGGGSGTNFTLTIISLQPEDFAAYYCQQNYSTWTIGQGSRVEMK,IGHV3-11 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ1 (Human),GTRIMITWYSRRGMDG,QQNYSTWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/2M-2G12_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 23, 2020","Jun 23, 2020",N/A,Complete
2M-4G4,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGAEVKKPGASVKVSCKASGYTFTSYYIHWVRQAPGQGLEWMGVINPSGGSTTYAQKFQGRVTVTRDTSTSTVYMELSSLRSEDTAVYYCARERGDSSGYYEIITTANRRFGMDVWGQGTTVTVSS,QSVLTQPASVSGSPGQSITISCTGTSSDVGMYNLVSWYQQHPGQAPKLMIYEGSKRPSGVSNRFSGSKSGNTASLTISGLQAEDEAYYYCCSYAVSSTWVFGGGTKLTVL,IGHV1-46 (Human),IGHJ6 (Human),IGLV2-23 (Human),IGLJ3 (Human),ARERGDSSGYYEIITTANRRFGMDV,CSYAVSSTWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/2M-4G4_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 23, 2020","Jun 23, 2020",N/A,Complete
2M-7E9,Ab,SARS-CoV2,,,SARS-CoV2,S; S2,B-cells; SARS-CoV2 Human Patient,EVQLVESGAEVKKPGSSVKVSCKASGGTFSSFAISWVRQAPGQGLEWMGGIIPIFDTTNYAQKFQGRVTITADESTRTAYMELSSLRSEDTAVYYCARIPGWDRGTDRNWNDDWGQGTTVTVSS,DIVMTQSPATLSLSPGERATLSCRASQSVSNFLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPPAFTFGPGTKVEIK,IGHV1-69 (Human),IGHJ6 (Human), IGKV3-11 (Human),IGKJ3 (Human),ARIPGWDRGTDRNWNDD,QQRSNWPPAFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/2M-7E9_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 23, 2020","Jun 23, 2020",N/A,Complete
2M-8E7,Ab,SARS-CoV2,,,SARS-CoV2,S; S2,B-cells; SARS-CoV2 Human Patient,EVQLVESGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGIIPIFGTANYAQKFQGRVTVTADESTSTAYMELSSLRSEDTAVYYCARTYSFDSSGYYYDYWGQGTMVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPPKITFGQGTRLEIK,IGHV1-69 (Human),IGHJ4 (Human),IGKV3-11 (Human),IGKJ5 (Human),ARTYSFDSSGYYYDY,QQRSNWPPKIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/2M-8E7_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 23, 2020","Jun 23, 2020",N/A,Complete
2M-8H10,Ab,SARS-CoV2,,,SARS-CoV2,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVLPGRSLRLSCAASGFTFSTFAMHWVRQAPGKGLEWVAVISDEGSNKYYADSVKGRFTISRDNSRNTLYLQMNSLRAEDTAVYYCARAFYDSNWSVGSYFDSWGQGTPVTVSS,DIQMTQSPDSLAVSLGERATIKCKSSQSVLHSSNNKNYLAWYQQKAGQPPSLLLYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYNNQWTFGQGTKVDIK,IGHV3-30 (Human),IGHJ5 (Human),IGKV4-1 (Human),IGKJ1 (Human),ARAFYDSNWSVGSYFDS,QQYYNNQWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/2M-8H10_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 23, 2020","Jun 23, 2020",N/A,Complete
2M-9F10,Ab,SARS-CoV2,,,SARS-CoV2,S; S2,B-cells; SARS-CoV2 Human Patient,EVQLLQSGGDLIQPGRSLRLSCAASGFSFEDYAMHWVRQAPGQGLEWVSGISYNGGSIDYVDSVKGRFTISRDNAKNALYLEMNSLRPEDTAFYYCAKDSVRREYTHARVPFDNWGLGTLVTVSS,AIRMTQSPSSLSASVGDRVTISCRATQNINYFLNWYQQKPGRAPKLLIYAASGLQSGVPSRFSGSGTGRVFTLTINSLQPDDFATYYCQQSFVSPRTFGQGTKVDIK,IGHV3-9 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ3 (Human),AKDSVRREYTHARVPFDN,QQSFVSPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/2M-9F10_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 23, 2020","Jun 23, 2020",N/A,Complete
2M-9H1,Ab,SARS-CoV2,,,SARS-CoV2,S; S2,B-cells; SARS-CoV2 Human Patient,EVQLLESGGGVVQPGRSLRLSCVASGFNFNNYGMHWVRQAPGKGLEWLAALSYEGSKEHYADSLKGRFTVSRDYSRATLHLHMNSLEPEDTAVYFCAKSSKIFYLGESREVDYWGRGTLVTVSS,DIVMTQSPSSLSAFVGDRVTITCRASRDIGGDLSWFQQKPGKAPERLIYAASSLESGVPSRFSGSGSATEFALTITSLQPEDFATYYCLQHKSYPLTFGGGTKVDIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV1-17 (Human),IGKJ4 (Human),AKSSKIFYLGESREVDY,LQHKSYPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/2M-9H1_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 23, 2020","Jun 23, 2020",N/A,Complete
2M-10B11,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARATWLRGVMDVWGQGTTVTVSS,QSALTQPHSVSESPGKTVTISCTGSSGSIASNYVQWYQQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSSNHWVFGGGTKLTVL,IGHV3-66 (Human),IGHJ6 (Human),IGLV6-57 (Human),IGLJ3 (Human),ARATWLRGVMDVW,QSYDSSNHWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/2M-10B11_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 23, 2020","Jun 23, 2020",N/A,Complete
2M-12D7,Ab,SARS-CoV2,,,SARS-CoV2,S; S2,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGRSLRLSCAASGFTFDDYVMHWVRQAPGKGLEWVSGINWNSGSIGYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTALYYCAKDVRYCSSTSCYFSAFDIWGQGTMVTVSS,AIRMTQSPSSLSASVGDRVTITCRASQSITGYLNWYQQKPGKAPKLLISAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPRTFGPGTKVEIK,IGHV3-9 (Human),IGHJ3 (Human),IGKV1-39 (Human),IGKJ3 (Human),AKDVRYCSSTSCYFSAFDI,QQSYSTPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/2M-12D7_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 23, 2020","Jun 23, 2020",N/A,Complete
2M-13A3,Ab,SARS-CoV2,,,SARS-CoV2,S; S2,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGVVQPGRSLRLSCAASGFTFSGYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARGGGSYYYWFDPWGQGTMVTVSS,AIRMTQSPDSLAVSLGERATINCKSSQSVLYSPNNKNYLAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYSTPFTFGQGTRLEIK,IGHV3-30 (Human),IGHJ3 (Human),IGKV4-1 (Human),IGKJ5 (Human),ARGGGSYYYWFDP,QQYYSTPFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/2M-13A3_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 23, 2020","Jun 23, 2020",N/A,Complete
2M-13D11,Ab,SARS-CoV2,,,SARS-CoV2,S; S2,B-cells; SARS-CoV2 Human Patient,EVQLVQWGAGLLKPSETLSLTCAVYGGSFSGYYWSWIRQPPGKGLEWIGEINHSGSTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARAGYSSSWYGVRGVDPWGQGTMVTVSS,EIVMTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSRSWTFGQGTKVEIK,IGHV4-34 (Human),IGHJ3 (Human),IGKV3-20 (Human),IGKJ1 (Human),ARAGYSSSWYGVRGVDP,QQYGSSRSWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/2M-13D11_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 23, 2020","Jun 23, 2020",N/A,Complete
2M-14B2,Ab,SARS-CoV2,,,SARS-CoV2,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLLQSGGGVVQPGRSLRLSCAASGFTFSTYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKGSDIVVVPVGNWFDPWGQGTLVTVSS,AIRMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTFTLYTFGQGTKVDIK,IGHV3-30 (Human),IGHJ5 (Human),IGKV1-39 (Human),IGKJ3 (Human),AKGSDIVVVPVGNWFDP,QQSYSTFTLYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/2M-14B2_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 23, 2020","Jun 23, 2020",N/A,Complete
2M-14E4,Ab,SARS-CoV2,,,SARS-CoV2,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSETLSLACTVSGGSVSSDNSYWSWIRQPPGKGLEWIGYTFHSGSANYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARVQRYYPDSSGFYGRRFDIWGQGTLVTVSS,DIVMTQSPSSLSASVGDRVSITCRASQNISNYLNWYQQKPGEAPKLLISAASSLQSGVPSRFGGSGSGTGFTLTINSLQPEDFATYYCQQSHSFPFTFGPGTKVDIK,IGHV4-61 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ3 (Human),ARVQRYYPDSSGFYGRRFDI,QQSHSFPFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/2M-14E4_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 23, 2020","Jun 23, 2020",N/A,Complete
2M-14E5,Ab,SARS-CoV2,,,SARS-CoV2,S; S2,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGVVQPGRSLRLSCAASGFTFSTYSMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQVNSLRAEDTAVYYCARSGGGSYRGPFDYWGQGTLVTVSS,AIRMTQSPSFLSVSVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYVTFGGGTKVEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV1-9 (Human),IGKJ4 (Human),ARSGGGSYRGPFDY,QQLNSYVT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/2M-14E5_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 23, 2020","Jun 23, 2020",N/A,Complete
0317-A1,Ab,SARS-CoV2,,,SARS-CoV2,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVQSGGGVVQPGRSLRLSCAAPGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDFKGGSSSWYTPEIEYGMDVWGQGTTVTVSS,DIVMTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGADFTLTISSLEPEDFAVYYCRQRSNWPPTFGGGTKVDIK,IGHV3-30 (Human),IGHJ6 (Human),IGKV3-11 (Human),IGKJ3 (Human),AKDFKGGSSSWYTPEIEYGMDV,RQRSNWPPT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/0317-A1_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 23, 2020","Jun 23, 2020",N/A,Complete
0317-A2,Ab,SARS-CoV2,,,SARS-CoV2,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVQSGSELKKPGASVKVSCKASGYTFTSYAMNWVRQAPGQGLEWMGWINTNTGNPTYAQGFTGRFVFSLDTSVSTAYLQISSLKAEDTAVYYCARLIRHEAHTYCSGGSCYSPDYYYGMDVWGQGTMVTVSS,DIVMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQEPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPPTFGQGTKVDIK,IGHV7-4-1 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ3 (Human),ARLIRHEAHTYCSGGSCYSPDYYYGMDV,QQSYSTPPT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/0317-A2_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 23, 2020","Jun 23, 2020",N/A,Complete
0317-A3,Ab,SARS-CoV2 (weak),,,SARS-CoV2,S; Unk,B-cells; SARS-CoV2 Human Patient,EVQLLQSGGGLVQPGGSLRLSCVASGFTFSSYEMNWVRQAPGKGLEWVSYISTSGSTINYADSVKGRFSISRDNAKKSLYLQMNSLRAEDTAVYYCASNPPLGEPYFDIWGQGTMVTVSS,DIQMTHSLILLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGADFTLTISSLQPEDFATYYCQQTYRPPWTFGQGTKVDIK,IGHV3-48 (Human),IGHJ3 (Human),IGKV1-39 (Human),IGKJ1 (Human),ASNPPLGEPYFDI,QQTYRPPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/0317-A3_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 23, 2020","Jun 23, 2020",N/A,Complete
0317-A7,Ab,SARS-CoV2,,,SARS-CoV2,S; S1 non-RBD,B-cells; SARS-CoV2 Human Patient,EVQLLESGGGVVQPGRSLRLSCAASGFTFSNYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARWGGGMQYLDVWGQGTTVTVSS,EIVVTQSLLSLPVTPGEPASISCRSSQSLLHSNGYNYLDWYLQKPGQSPQVLIYLGSNRASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQTLQTPYTFGQGTKVEIK,IGHV3-30-3 (Human),IGHJ6 (Human),IGKV2-28 (Human),IGKJ1 (Human),ARWGGGMQYLDV,MQTLQTPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/0317-A7_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 23, 2020","Jun 23, 2020",N/A,Complete
0317-A8,Ab,SARS-CoV2 (weak),,,SARS-CoV2,S; S1 non-RBD,B-cells; SARS-CoV2 Human Patient,EVQLVQSGSELKKPGASVKVSCKASGYTFTSYAMNWVRQAPGQGLEWMGWINTNTGNPTYAQGFTGRFVFSLDTSVSTAYLQISSLKAEDTAVYYCARAGPNYDFWSGYYQTFDYWGQGTMVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPLTFGGGTKVEIK, IGHV7-4-1 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ4 (Human),ARAGPNYDFWSGYYQTFDY,QQYDNLPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/0317-A8_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 23, 2020","Jun 23, 2020",N/A,Complete
0317-A9,Ab,SARS-CoV2 (weak),,,SARS-CoV2,S; Unk,B-cells; SARS-CoV2 Human Patient,EVQLVQSGAEVKKPGASVKVSCKVSGYTLTELSMHWVRQAPGKGLEWMGGFDPEDGETIYAQKFQGRVTMTEDTSTDTAYMELSSLRSEDTAVYYCATATAMDGYYYYYGMDVWGQGTTVTVSS,EIVMTQSPLSSPVTLGQPASISCRSSQSLVHSDGNTYLSWLQQRPGQPPRLLIYKISNRFSGVPDRFSGSGAGTDFTLKISRVEAEDVGVYYCMQATQFPYTFGQGTKVDIK,IGHV1-24 (Human),IGHJ6 (Human),IGKV2-24 (Human),IGKJ3 (Human),ATATAMDGYYYYYGMDV,MQATQFPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/0317-A9_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 23, 2020","Jun 23, 2020",N/A,Complete
0317-B1,Ab,SARS-CoV2 (weak),,,SARS-CoV2,S; Unk,B-cells; SARS-CoV2 Human Patient,EVQLVESGAEVKKPGESLKISCKGSGYSFTSYWIGWVRQMPGEGLEWMGIIYPGDSDTRYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCASAGSSWYGDAFDIWGQGTMVTVSS,DIVMTHSLRLLAVSLGERATINCKSSQSVLYSSNNKNYLAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYSTYGSFGGGTKVDIK,IGHV5-51 (Human),IGHJ3 (Human),IGKV4-1 (Human),IGKJ3 (Human),ASAGSSWYGDAFDI,QQYYSTYGS,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/0317-B1_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 23, 2020","Jun 23, 2020",N/A,Complete
0317-C4,Ab,SARS-CoV2 (weak),,,SARS-CoV2,S; Unk,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKVSGCTLTELSMHWVRQAPGKGLEWMGGFDPEDGETIYAQKFQGRVTMTEDTSTDTAYMELSSLRSEDTAVYYCATATIFGVANNWFDPWGQGTTVTVSS,QAVVTQPPSVSAAPGQKVTISCSGSSSNIGNNYVSWYQQLPGTAPKLLIYDNNKRPSGIPDRFSGSKSGTSATLGITGLQTGDEADYYCGTWDSSLSVVVFGGGTKLTVL,IGHV1-24 (Human),IGHJ5 (Human),IGLV1-51 (Human),IGLJ3 (Human),ATATIFGVANNWFDP,GTWDSSLSVVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/0317-C4_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 23, 2020","Jun 23, 2020",N/A,Complete
0317-C9,Ab,SARS-CoV2,,,SARS-CoV2,S; S2,B-cells; SARS-CoV2 Human Patient,QVQLVQSGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDLGYYDILTGQLGGYYYYYGMDVWGQGTTVTVSS,QAVVTQPPSASGTPGQRVTISCSGSSSNIGSNTVNWYQQLPGTAPKLLIYSNNQRPSGVPDRFSGSKSGTSASLAISGLQSEDEADYYCAAWDDSLNGVVFGGGTKLTVL,IGHV3-30 (Human),IGHJ6 (Human),IGLV1-44 (Human),IGLJ3 (Human),AKDLGYYDILTGQLGGYYYYYGMDV,AAWDDSLNGVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/0317-C9_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 23, 2020","Jun 23, 2020",N/A,Complete
1A09,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; RBD,Immunised Mouse,QVQLKESGPGLVAPSQSLSITCTVSGFSLTSYAISWVRQPPGKGLEWLGVIWTGGGTNYNSALKSRLSISKDNSKSQVFLKMNSLQTDDTARYYCARKDYYYGSSYAMDYWGQGTSVTVSS,QAVVTQESALTTSPGETVTLTCRSSTGAVTTSNYANWVQEKPDHLFTGLIGGTNNRAPGVPARFSGSLIGDKAALTITGAQTEDEAIYFCALWYSNHWVFGGGTKLTVL,IGHV2-9-1 (Mouse),IGHJ4 (Mouse),IGLV1 (Mouse),IGLJ1 (Mouse),ARKDYYYGSSYAMDY,ALWYSNHWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/1A09_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 27, 2020","Jun 27, 2020",N/A,Complete
1A10,Ab,SARS-CoV2,"MERS-CoV, SARS-CoV1",,SARS-CoV2,S; RBD,Immunised Mouse,EVQLQQSGAELVRPGASVKLSCKASGYTFSDYYINWVKQRPGQGLEWIARIYPGSGNTYYNEKFTGKATLTAEKSSSTAYMQLSSLTSEDSAVYFCARDYGSSYVDYFDYWGQGTTLTVSS,DIQMTQSPSSLSASLGDRVTISCRASQDISNYLNWYQQKPDGTVKLLIFYTSRLHSGVPSRFSGSGSGTDYSLTISNLEQEDIATYFCQQGNTLPYTFGGGTKLEIK,IGHV1-76 (Mouse),IGHJ2 (Mouse),IGKV10-96 (Mouse),IGKJ2 (Mouse),ARDYGSSYVDYFDY,QQGNTLPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/1A10_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 27, 2020","Jun 27, 2020",N/A,Complete
1A12,Ab,SARS-CoV2,"MERS-CoV, SARS-CoV1",SARS-CoV2 (weak),,S; RBD,Immunised Mouse,EVQLQQSGAELVRPGASVKLSCTASGFNIKDDYMHWVKQRPEQGLEWIGWINPENGDTEYASKFQGKAAITADTSSNTACLQLSSLTSEDTAVYYCSTGGYGNYVDAMDYWGQGTSVTVSS,DIKMTQSPSSMYASLGERVTITCKASQDINSFLSWFQQKPGKSPKTLIYRANRLVDGVPSRFSGSGSGQDYSLTISSLDYEDMGIYYCLQYDEFRTFGGGTKLEIK,IGHV14-4 (Mouse),IGHJ4 (Mouse),IGKV14-111 (Mouse),IGKJ1 (Mouse),STGGYGNYVDAMDY,LQYDEFRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/1A12_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 27, 2020","Jun 27, 2020",N/A,Complete
1B07,Ab,SARS-CoV2,"MERS-CoV, SARS-CoV1",SARS-CoV2,,S; RBD,Immunised Mouse,QVQLKESGPGLVAPSQSLSITCTVSGFSLTSYAISWVRQPPGKGLEWLGVIWTGGGTNYNSALKSRLSISKDNSKSQVFLKMNSLQTDDTARYYCARKDYYGSSSNVMDYWGQGTSVTVSS,QAVVTQESALTTSPGETVTLTCRSSTGAVTTSNYANWVQEKPDHLITGLIGGTNNRVPGVPARFSGSLIGDKAALTITGAQTEDEAIYFCALWYSNQFIFGSGTKVTVL,IGHV2-9-1 (Mouse),IGHJ4 (Mouse),IGLV1 (Mouse),IGLJ3 (Mouse),ARKDYYGSSSNVMDY,ALWYSNQFI,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/1B07_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 27, 2020","Jun 27, 2020",N/A,Complete
1B10,Ab,SARS-CoV2,"MERS-CoV, SARS-CoV1",SARS-CoV2,,S; RBD,Immunised Mouse,QVQLKESGPGLVAPSQSLSITCTVSGFSLTNYAINWVRQPPGKGLEWLGVIWTGGGTNYNSALRSRLSISKDNSKSQVFLKMNSLHTDDTARYYCARKDYYGSSLAMDYWGQGTSVTVSS,QAVVTQESALTTSPGETVTLTCRSSTGAVTTSNYANWVQEKPDHLFTGLIGGTNNRAPGVPARFSGSLIGDKAALTITGAQTEDEAIYFCALWYSNHWVFGGGTKLTVL,IGHV2-9-1 (Mouse),IGHJ4 (Mouse),IGLV1 (Mouse),IGLJ1 (Mouse),ARKDYYGSSLAMDY,ALWYSNHWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/1B10_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 27, 2020","Jun 27, 2020",N/A,Complete
1C05,Ab,"SARS-CoV1,SARS-CoV2",MERS-CoV,SARS-CoV2 (weak),,S; RBD,Immunised Mouse,EVQLQQSGPELVKPGASVKISCKASGYSFTDYYMNWVKQSPEKSLEWIGEINPSTGGPTYNQKFKAKATVTVDKSSSTAYMQLKSLTSEDSAVYYCARRNYDLYYYAMDYWGQGTSVTVSS,DIVLTQSPASLAVSLGQRATISCRASESVDSYGTSFMHWYQQKPGQPPKLLIYLASNLESGVPARFSGSGSRTDFTLTIDPVEADDAATYYCQQNNEDPLTFGAGTKLELK,IGHV1-42 (Mouse),IGHJ4 (Mouse),IGKV3-10 (Mouse),IGKJ5 (Mouse),ARRNYDLYYYAMDY,QQNNEDPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/1C05_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 27, 2020","Jun 27, 2020",N/A,Complete
1C06,Ab,SARS-CoV2,"MERS-CoV, SARS-CoV1",,SARS-CoV2,S; RBD,Immunised Mouse,EVQLQQSGAELAKPGASVKLSCKASGYTFTNYWMHWVKQRPGQGLEWIGYINPSSGYTKFNQKFNDKATLTADKSSTTAYMQLSSPTYEDSAVYYCARSDYYGSSYVGYAMDYWGQGTSVTVSS,DVVMTQTPLSLPVSLGDQASISCRSSQSIVHSNGNTYLEWYLQKPGQSPKLLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDLGVYYCFQGSHVPPTFGGGTKLEIK,IGHV1-7 (Mouse),IGHJ4 (Mouse),IGKV1-117 (Mouse),IGKJ1 (Mouse),ARSDYYGSSYVGYAMDY,FQGSHVPPT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/1C06_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 27, 2020","Jun 27, 2020",N/A,Complete
1C07,Ab,"SARS-CoV1,SARS-CoV2",MERS-CoV,,SARS-CoV2,S; RBD,Immunised Mouse,EVQLQQPGPELVKPGASVKISCKASGYSFTDYYMNWVKQSPEKSLEWIGEINPSTGGTSYNQKFKGKATLTVDKSSSTAYMQLKSLTSEDSAVYYCARRNYDLYYYAMDYWGQGTSVTVSS,DIVLTQSPASLAVSLGQRATISCRASEGVDSYGSSFMHWYQQKPGQPPKLLIYLASNLESGVPARFSGSGSGTDFTLTIDPVEADDAATYYCQQNNEDPLTFGAGTKLELK,IGHV1-42 (Mouse),IGHJ4 (Mouse),IGKV3-10 (Mouse),IGKJ5 (Mouse),ARRNYDLYYYAMDY,QQNNEDPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/1C07_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 27, 2020","Jun 27, 2020",N/A,Complete
1D04,Ab,SARS-CoV2,"MERS-CoV, SARS-CoV1",,SARS-CoV2,S; RBD,Immunised Mouse,EVQLQQSGAELVRPGASVKLSCTASGFNIKDDYMHWVKQRPEQGLEWIGWINPENGDTEYASKFQGKAAITADTSSNTACLQLSSLTSEDTAVYYCSTGGYGNYVDAMDYWGQGTSVTVSS,DIKMTQSPSSMYASLGERVTITCKASQDINSFLSWFQQKPGKSPKTLIYRANRLVDGVPSRFSGSGSGQDYSLTISSLEYEDMGIYYCLQYDEFRTFGGGTKLEIK,IGHV14-4 (Mouse),IGHJ4 (Mouse),IGKV14-111 (Mouse),IGKJ1 (Mouse),STGGYGNYVDAMDY,LQYDEFRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/1D04_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 27, 2020","Jun 27, 2020",N/A,Complete
1D05,Ab,SARS-CoV2,"MERS-CoV, SARS-CoV1",,SARS-CoV2,S; RBD,Immunised Mouse,QVQLKESGPGLVAPSQSLSITCTVSGFSLTSYAISWVRQPPGKGLEWLGVIWTGGGTNYNSALKSRLSISKDNSKSQVFLKMNSLQTDDTARYYCARKDYYGSSSNVMDYWGQGTSVTVSS,QAVVTQESALTTSPGETVTLTCRSSTGAVTTSNYANWVQEKPDHLITGLIGGTNNRVPGVPARFSGSLIGDKAALTITGAQTEDKAIYFCALWYSNQFIFGSGTKVTVL,IGHV2-9-1 (Mouse),IGHJ4 (Mouse),IGLV1 (Mouse),IGLJ3 (Mouse),ARKDYYGSSSNVMDY,ALWYSNQFI,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/1D05_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 27, 2020","Jun 27, 2020",N/A,Complete
100,Ab,SARS-CoV2,"MERS-CoV, SARS-CoV1",,SARS-CoV2,S; RBD,Immunised Mouse,EVQLQQPGPELVKPGASVKISCKASGYSFTDYYMNWVKQSPEKSLEWIGEINPSTGGTSYNQKFKGKATLTVDKSSSTAYMQLKSLTSEDSAVYYCSRRNYDLYYYAMDYWGQGTSVTVSS,DIVLTQSPASLAVSLGQRATISCRASEGVDSYGSSFMHWYQQKPGQAPKLLIYLASNLESGVPARFSGSGSRTDFTLTIDPVEADDAAIYYCQQNNEDPLTFGAGTKLEIK,IGHV1-42 (Mouse),IGHJ4 (Mouse),IGKV3-10 (Mouse),IGKJ5 (Mouse),SRRNYDLYYYAMDY,QQNNEDPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/1E02_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 27, 2020","Jun 27, 2020",N/A,Complete
1E07,Ab,SARS-CoV2,"MERS-CoV, SARS-CoV1",SARS-CoV2,,S; RBD,Immunised Mouse,EVQLQQSGPELVKPGASVKISCKASGYSFTGYSMNWVKKSPEKSLEWIGEINPSTGGTTYNQKFKAKATLTVDKSSSTAYIQLKSLTSEDSAVYYCARGAGAYWGQGTLVTVSA,DIVLTQSPASLAVSLGQRATISCRASESVEYYGTSLMQWFQQKPGQPPKLLIFAASNVESGVPARFGGSGSGTDFSLNIHPVEEDDIAMYFCQQSRKVPWTFGGGTKLEIK,IGHV1-42 (Mouse),IGHJ3 (Mouse),IGKV3-1 (Mouse),IGKJ1 (Mouse),ARGAGAY,QQSRKVPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/1E07_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 27, 2020","Jun 27, 2020",N/A,Complete
1E10,Ab,SARS-CoV2,"MERS-CoV, SARS-CoV1",,SARS-CoV2,S; RBD,Immunised Mouse,EVQLQQSGPELVKPGASVKISCKASGYAFSSSWMNWVKQRPGKGLEWIGRIYPGDGDTNYNGKFKGKATLTADKSSSTAYMQLSSLTSEDSAVYFCARDHGPAWFAYRGQGTLVTVSA,QIVLTQSPAIMSASPGEKVTMTCSASSSVSYMHWYQQKSGTSPKRWIYDTSKLASGVPARFSGSGSGTSYSLTISSMEAEDAATYYCQQWSSNPPTFGSGTKLEIK,IGHV1-82 (Mouse),IGHJ3 (Mouse),IGKV4-59 (Mouse),IGKJ2 (Mouse),ARDHGPA,QQWSSNPPT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/1E10_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 27, 2020","Jun 27, 2020",N/A,Complete
1H06,Ab,SARS-CoV2,"MERS-CoV, SARS-CoV1",,SARS-CoV2,S; RBD,Immunised Mouse,EVQLQQSGPELVKPGASVKISCKASGYSFTGYSMNWVKKSPEKSLEWIGEINPSTGGTTYNQKFKAKATLTVDKSSSTAYIQLKSLTSEDSAVYYCARGAGAYWGQGTLVTVSA,DIVLTQSPASLAVSLGQRATISCRASESVEYYGTSLMQWFQQKPGQPPKLLIFAASNVESGVPARFGGSGSGTDFSLNIHPVEEDDIATYFCQQSRKVPWTFGGGTKLEIK,IGHV1-42 (Mouse),IGHJ3 (Mouse),IGKV3-1 (Mouse),IGKJ1 (Mouse),ARGAGAY,QQSRKVPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/1H06_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 27, 2020","Jun 27, 2020",N/A,Complete
1H10,Ab,SARS-CoV2,"MERS-CoV, SARS-CoV1",SARS-CoV2 (weak),,S; RBD,Immunised Mouse,QVQLKESGPGLVAPSQSLSITCTVSGFSLTNYAISWVRQPPGKGLEWLGVIWTGGGTNYNSALKSRLSISKDNSKSQVFLKMNSLQTDDTARYYCARISYYDYEGVDYWGQGTTLTVSS,QAVVTQESALTTSPGETVTLTCRSSTGAVTTSNYANWVQEKPDHLFTGLIGGTNNRAPGVPARFSGSLIGDKAALTITGAQTEDEAIYFCALWYSNHWVFGGGTKLTVL,IGHV2-9-1 (Mouse),IGHJ2 (Mouse),IGLV1 (Mouse),IGLJ1 (Mouse),ARISYYDYEGVDY,ALWYSNHWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/1H10_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 27, 2020","Jun 27, 2020",N/A,Complete
2B04,Ab,SARS-CoV2,"MERS-CoV, SARS-CoV1",SARS-CoV2,,S; RBD,Immunised Mouse,QVQLKQSGPGLVAPSQSLSITCTVSGFSLINYAISWVRQPPGKGLEWLGVIWTGGGTNYNSALKSRLSISKDNSKSQVFLKMNSLQTDDTARYYCARKDYYGRYYGMDYWGQGTSVTVSS,QAVVTQESALTTSPGETVTLTCRSSTGAVTTSNYANWVQEKPDHLFTGLIGGTNNRAPGVPARFSGSLIGDKAALTITGAQTEDEAIYFCALWYNNHWVFGGGTKLTVL,IGHV2-9-1 (Mouse),IGHJ4 (Mouse),IGLV1 (Mouse),IGLJ1 (Mouse),ARKDYYGRYYGMDY,ALWYNNHWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/2B04_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 27, 2020","Jun 27, 2020",N/A,Complete
2C02,Ab,"SARS-CoV1,SARS-CoV2",MERS-CoV,,SARS-CoV2,S; RBD,Immunised Mouse,EVQLQQPGAELVKPGASVKVSCKASGYIFTNYWMHWVKQRPGQGLEWIGRIHPSDSDTKYNQKFKGKATLTVDKSSSTAYMQLSSLTSEDSAVYYCAILDSYWYFDVWGTGTTVTVSS,QIVLTQSPAIMSASPGEKVTMTCSASSSVSYMYWYQQKPGSSPRLLIYDTSNLASGVPIRFSGSGSGTSYSLTISRMEAEDAATYYCQQWSSYPLTFGAGTKLELK,IGHV1-74 (Mouse),IGHJ1 (Mouse),IGKV4-55 (Mouse),IGKJ5 (Mouse),AILDSYWYFDV,QQWSSYPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/2C02_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 27, 2020","Jun 27, 2020",N/A,Complete
2C03,Ab,SARS-CoV2,"MERS-CoV, SARS-CoV1",SARS-CoV2 (weak),,S; RBD,Immunised Mouse,EVQLQQSGPELVKPGASVKISCKASGYAFSSSWMNWVKQRPGKGLEWIGRIYPGDGDTNYNGKLKGKATLTADKSSSTAYMQLSSLTSEDSAVYFCARKSYGYWHFDVWGTGTTVTVSS,DVVMTQTPLSLPVSLGDQASISCRSSQSIVYSNGNTYLEWYLQKPGQSPKLLIYKVSNRFSGVPDRFSGSGSGTDFTLKISGVEAEDLGVYYCFQGSHVPYTFGGGTKLEIK,IGHV1-82 (Mouse),IGHJ1 (Mouse),IGKV1-117 (Mouse),IGKJ2 (Mouse),ARKSYGYWHFDV,FQGSHVPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/2C03_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 27, 2020","Jun 27, 2020",N/A,Complete
2C04,Ab,SARS-CoV2,"MERS-CoV, SARS-CoV1",,SARS-CoV2,S; RBD,Immunised Mouse,EVQLQQPGPELVKPGTSVKISCKASGYTFTDYYMNWVKQSHGKSLEWIGDINPNNGGTNYNQKFKGKATLTVDKSSSTAYMELRSLTSEDSAVCYCAAGKGDYWGQGTTLTVSS,DIVLTQSQASLAVSLGQRATISCRASESVEYYGTSLMQWYQQKPGQPPKLLIYAASNVESGVPARFSGSGSGTDFSLNIHPVEEDDIAMYFCQQSRKVPWTFGGGTKLEIK,IGHV1-26 (Mouse),IGHJ2 (Mouse),IGKV3-1 (Mouse),IGKJ1 (Mouse),AAGKGDY,QQSRKVPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/2C04_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 27, 2020","Jun 27, 2020",N/A,Complete
2D01,Ab,SARS-CoV2,"MERS-CoV, SARS-CoV1",,SARS-CoV2,S; RBD,Immunised Mouse,EVQLQQPGAELVKPGASVKVSCKASGYIFTNYWMHWVKQRPGQGLEWIGRIHPSDSDTKYNQKFKGKATLTVDKSSSTAYMQLSSLTSEDSAVYYCAILDSYWYFDVWGTGTTVTVSS,QIVLTQSPAIMSASPGEKVTMTCSASSSVSYMYWYQQKPGSSPRLLIYDTSNLASGVPIRFSGSGSGTSYSLTISRMEAEDAATYYCQQWSSYPLTFGAGTKLELK,IGHV1-74 (Mouse),IGHJ1 (Mouse),IGKV4-55 (Mouse),IGKJ5 (Mouse),AILDSYWYFDV,QQWSSYPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/2D01_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 27, 2020","Jun 27, 2020",N/A,Complete
2D08,Ab,SARS-CoV2,"MERS-CoV, SARS-CoV1",SARS-CoV2 (weak),,S; RBD,Immunised Mouse,EVQLQQSGPELVKPGTSVKISCKASGYTFTDYYMNWVKQSHGKSLEWIGDINPNNGGTNYNQKFKGKATLTVDKSSSTAYMELRSLTSEDSAVYYCAAGKGDYWGQGTTLTVSS,DIVLTQSQASLAVSLGQRATISCRASESVEYYGTSLMQWYQQKPGQPPKLLIYAASNVESGVPARFSGSGSGTDFSLNIHPVEEDDIAMYFCQQSRKVPWTFGGGTKLEIK,IGHV1-26 (Mouse),IGHJ2 (Mouse),IGKV3-1 (Mouse),IGKJ1 (Mouse),AAGKGDY,QQSRKVPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/2D08_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 27, 2020","Jun 27, 2020",N/A,Complete
2D11,Ab,SARS-CoV2,"MERS-CoV, SARS-CoV1",,SARS-CoV2,S; RBD,Immunised Mouse,EVQLQQSGPELVKPGASVKISCKASGYTFTDYYMNWVKQSHGKSLEWIGDINPNNGGTSYNQKFKGKATLTVDKSSSTAYMELRSLTSEDSAVYYCARKGDGYYGGFAYWGQGTLVTVSA,DIVLTQSPASLAVSLGQRATISCRASESVDNYGISFMNWFQQKPGQPPKLLIYAASNQGSGVPARFSGSGSGTDFSLNIHPMEEDDTAMYFFQQSKEVPWTFGGGTKLEIK,IGHV1-26 (Mouse),IGHJ3 (Mouse),IGKV3-2 (Mouse),IGKJ1 (Mouse),ARKGDGYYGGFAY,QQSKEVPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/2D11_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 27, 2020","Jun 27, 2020",N/A,Complete
2E06,Ab,"SARS-CoV1,SARS-CoV2",MERS-CoV,SARS-CoV2 (weak),,S; RBD,Immunised Mouse,EVQLQQSVADLVRPGASVKLSCTASGFNIKNTYMHWVKQRPEQGLEWIGRIDPTNGDTKYVSKFQGKATITADTSSNTAYLQLSSLTSEDTAIYYCATYGSYYLYYYAMNYWGQGTSVTVSS,DIVLTQSPASLTVSLGQRATISCKASQSVDYGGDRYMNWYQQKPGQPPKLLIFAASNLESGIPARFSGSGSGTDFTLNIHPVEEEDAATYYCQQSNEDPYTFGGGTKLEIK,IGHV14-3 (Mouse),IGHJ4 (Mouse),IGKV3-4 (Mouse),IGKJ2 (Mouse),ATYGSYYLYYYAMNY,QQSNEDPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/2E06_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 27, 2020","Jun 27, 2020",N/A,Complete
2E10,Ab,"SARS-CoV1,SARS-CoV2",MERS-CoV,,SARS-CoV2,S; RBD,Immunised Mouse,EVQLQQPGAELVRPGASVKLSCKASGYTFTDYYINWVKQRPGQGLEWIARIYPGTGTTYYNEKFKGKATLTAEKSSSTAYMQLSSLTSEDSAVYFCARYDGNLYYYAMDYWGQGTSVTVSS,DIVLTQSPASLAVSLGQRATMSCRASESVDSYGNGFMHWYQQKPGQPPKLLIYLASNLESGVPARFSGSGSRTDFSLTIDPVEADDAAIYYCQQNNEDPLTFGAGTKLELK,IGHV1-76 (Mouse),IGHJ4 (Mouse),IGKV3-4 (Mouse),IGKJ5 (Mouse),ARYDGNLYYYAMDY,QQNNEDPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/2E10_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 27, 2020","Jun 27, 2020",N/A,Complete
2F04,Ab,SARS-CoV2,"MERS-CoV, SARS-CoV1",,SARS-CoV2,S; RBD,Immunised Mouse,EVQLQQPGAELVKPGASVKMSCKASGYTFTSYWITWVKQRPGQGLEWIGDIYPGSGSTKYNEKFRSEATLTVDTSSTTAYMQLSSLTSEDSAVYYCARWDFYGSRTFDYWGQGTTLTVSS,DIVLTQSPAILSVSPGERVSFSCRASQNIGTIIHWYQQRTNGSPRLLIKYASESVSGIPSRFSGSGSGTDFTLSINSVESEDIADYYCQQSSSWPLTFGAGTKLELK,IGHV1-55 (Mouse),IGHJ2 (Mouse),IGKV5-48 (Mouse),IGKJ5 (Mouse),ARWDFYGSRTFDY,QQSSSWPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/2F04_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 27, 2020","Jun 27, 2020",N/A,Complete
2H04,Ab,SARS-CoV2,"MERS-CoV, SARS-CoV1",SARS-CoV2,,S; RBD,Immunised Mouse,EVQLQQSGAELVKPGASVKMSCKASGYTFTSYWITWVKQRPGQGLEWIGDIYPGSGSTKYNEKFRSEATLTVDTSSTTAYMQLSSLTSEDSAVYYCARWDFYGSRTFDYWGQGTTLTVSS,DIVLTQSPAILSVSPGERVSFSCRASQNIGTIIHWYQQRTNGSPRLLIKYASESVSGIPSRFSGSGSGTDFTLSINSVESEDIADYYCQQSSSWPLTFGAGTKLELK,IGHV1-55 (Mouse),IGHJ2 (Mouse),IGKV5-48 (Mouse),IGKJ5 (Mouse),ARWDFYGSRTFDY,QQSSSWPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/2H04_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 27, 2020","Jun 27, 2020",N/A,Complete
REGN10913,Ab,SARS-CoV2,,,,S; RBD,B-cells; Transgenic Mouse (VelocImmune),EVQLVESGGGLVQPGGSLRLSCAASGFTFRNYEMNWVRQAPGKGLEWVSYITSSGSTMYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARDGFYYYYAMDVWGQGTTVTVSS,QSVLTQPPSVSAAPGQKVTISCSGSSSNIGNNYVSWYQQLPGTAPKLLIYDNNKRPSGIPDRFSGSKSGTSATLGITGLQTGDEADYYCGTWDSSLSVGRVFGTGTKVTVL,IGHV3-48 (Human),IGHJ6 (Human),IGLV1-51 (Human),IGLJ1 (Human),ARDGFYYYYAMDV,GTWDSSLSVGRV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/REGN10913_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
REGN10915,Ab,SARS-CoV2,,,,S; RBD,B-cells; Transgenic Mouse (VelocImmune),EVQLVESGGGLVQPGGSLRLSCAASGFTVSSNYMNWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRHNSKNTLYLQMNSLRPEDTAVYYCARDLGGYFDYWGQGTLVTVSS,DIQMTQSPSTLSASVGDRVTITCRASQSFSSWLAWYQQKPGKAPKLLIYKASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNSYYTFGQGTKLEIK,IGHV3-66 (Human),IGHJ4 (Human),IGKV1-5 (Human),IGKJ2 (Human),ARDLGGYFDY,QQYNSYYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/REGN10915_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
REGN10921,Ab,SARS-CoV2,,,,S; RBD,B-cells; Transgenic Mouse (VelocImmune),EVQLVESGGGLVQPGGSLRLSCAASGITVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRHNSKNTLYLQMNSLRAEDTAVYYCARERNFDAFDIWGQGTMVTVSS,DIQMTQSPSSVSASVGDRVTITCRASQGISSWLAWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQANSFPLFTFGPGTKVDIK,IGHV3-66 (Human),IGHJ3 (Human),IGKV1-12 (Human),IGKJ3 (Human),ARERNFDAFDI,QQANSFPLFTF,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/REGN10921_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
REGN10922,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; Transgenic Mouse (VelocImmune),EVQLVESGGGLVQPGGSLRLSCAASGFTFSIYEMNWVRQAPGKGLEWVSYITSSGTTIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCASSSSSGYYFDYWGQGTLVTVSS,DIVMTQSPDSLAVSLGERATINCKSSQSVLYSSNNKNYLAWYQQKPGQPPNLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYSTPPTFGQGTKLEIK,IGHV3-48 (Human),IGHJ4 (Human),IGKV4-1 (Human),IGKJ2 (Human),ASSSSSGYYFDY,QQYYSTPPT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/REGN10922_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
REGN10923,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; Transgenic Mouse (VelocImmune),QVQLVQSGAEVKKPGASVKVSCKASGYTFINYYIHWVRQAPGQGLEWMGWINPNSGGTNYAQKFQGRVTMTRDTSISTAYMELSRLRSDDTAVYYCAIITIFGVVTWFDPWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPLTFGGGTKVEIK,IGHV1-2 (Human),IGHJ5 (Human),IGKV1-39 (Human),IGKJ4 (Human),AIITIFGVVTWFDP,QQSYSTPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/REGN10923_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
REGN10924,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; Transgenic Mouse (VelocImmune),QVQLQESGPGLVKPSETLSLTCTVSGGSISSYYWSWIRQPPGKGLEWIGYIYYSGSTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARDPLLIDYWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSRSYLAWYQQKPGQAPRLLIYGVSSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPQTFGQGTKLEIK,IGHV4-59 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ2 (Human),ARDPLLIDY,QQYGSSPQT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/REGN10924_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
REGN10930,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; Transgenic Mouse (VelocImmune),EVQLVESGGGLVQPGRSLRLSCAASGFTFDDYAMYWVRQAPGKGLEWVSGISWNSGSIGYADSVKGRFTISRDNAKNSLYLQMNSLRAADTALYYCAKDKDWNSRGYYYYGMDVWGQGTTVTVSS,DVVMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYITPYTFGQGTKVEIK,IGHV3-9 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ1 (Human),AKDKDWNSRGYYYYGMDV,QQSYITPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/REGN10930_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
REGN10932,Ab,SARS-CoV2,,,,S; RBD,B-cells; Transgenic Mouse (VelocImmune),EVQLVESGGGLVQSGGSLRLSCAASGLTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYSDSVKGRFTISRHNSKNTLYLQMNSLRAEDTAVYYCARARGDAFDIWGQGTMVTVSS,DRVTITCQASQGISNYLNWYQQKPGKAPKLLISDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLRFFTFGPGTKVDIK,IGHV3-66 (Human),IGHJ3 (Human),IGKV1-33 (Human),IGKJ3 (Human),ARARGDAFDI,QQYDNLRFFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/REGN10932_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
REGN10933,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; Transgenic Mouse (VelocImmune),QVQLVESGGGLVKPGGSLRLSCAASGFTFSDYYMSWIRQAPGKGLEWVSYITYSGSTIYYADSVKGRFTISRDNAKSSLYLQMNSLRAEDTAVYYCARDRGTTMVPFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDITNYLNWYQQKPGKAPKLLIYAASNLETGVPSRFSGSGSGTDFTFTISGLQPEDIATYYCQQYDNLPLTFGGGTKVEIK,IGHV3-11 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ4 (Human),ARDRGTTMVPFDY,QQYDNLPLT,https://www.rcsb.org/structure/6XDG,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 21, 2020","Nov 18, 2020",11th Nov: Added therapeutic relevance; 16th Nov: Clarified sequence origin by cross-referencing patent,Therapeutic mAb Casirivimab. Complete
REGN10934,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; Transgenic Mouse (VelocImmune),EVQLVESGGGLVKPGGSLRLSCAASGITFSNAWMSWVRQAPGKGLEWVGRIKSKTDGGTTDYAAPVKGRFTISRDDSKNTLYLQMNSLKTEDTAVYYCTTARWDWYFDLWGRGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDIWNYINWYQQKPGKAPKLLIYDASNLKTGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQHDDLPPTFGQGTKVEIK,IGHV3-15 (Human),IGHJ2 (Human),IGKV1-33 (Human),IGKJ1 (Human),TTARWDWYFDL,QQHDDLPPT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/REGN10934_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 21, 2020","Nov 18, 2020",16th Nov: Clarified sequence origin by cross-referencing patent,Complete
REGN10935,Ab,SARS-CoV2,,,,S; RBD,B-cells; Transgenic Mouse (VelocImmune),EVQLVESGGGLVQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSLIYSGGSTYYADSVKGRFTISRHNSKNTLYLQMNSLRSEDTAVYYCARVPLGDYYYGMDVWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDINKYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQSDNLPLTFGGGTKVEIK,IGHV3-66 (Human),IGHJ6 (Human),IGKV1-33 (Human),IGKJ4 (Human),ARVPLGDYYYGMDV,QQSDNLPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/REGN10935_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
REGN10936,Ab,SARS-CoV2,,,,S; RBD,B-cells; Transgenic Mouse (VelocImmune),QVQLVESGGGVVQPGRSLRLSCAASGFTFRNYGMHWVRQAPGKGLEWVSVIWYDGSNRYYADSVKGRFTISRDTSKNTLYLQMNSLRAEDTAVYYCARDPPITGTTGGDAFDIWGQGTMVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPHLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPYTFGQGTKLEIK,IGHV3-33 (Human),IGHJ3 (Human),IGKV1-39 (Human),IGKJ2 (Human),ARDPPITGTTGGDAFDI,QQSYSTPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/REGN10936_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
REGN10937,Ab,SARS-CoV2,,,,S; RBD,B-cells; Transgenic Mouse (VelocImmune),QITLKESGPTLVKPTQTLTLTCTFSGFSLSTNVVGVGWIRQPPGKALEWLALIYWNDDKRYSPSLKSRLTITKDTSKNQVVLTMTNMDPVDTATYYCAHGPTGDYFDYWGQGTLVTVSS,DRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQTYSTLMYTFGQGTKLEIK,IGHV2-5 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ2 (Human),AHGPTGDYFDY,QQTYSTLMYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/REGN10937_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
REGN10938,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; Transgenic Mouse (VelocImmune),EVQLVESGGGLVQPGGSLRLSCAVSGFTVSSNYMSWVRQAPGKGLEWVSLIYSGGSTFYADSVKGRFTISRHNSKNTLYLQMNSLRAEDTAVYYCAREGGYSYDYNYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDIRNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGIGSGTDFTFTISSLQPEDIATYYCQQYDNLPITFGQGTRLEIK,IGHV3-66 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ5 (Human),AREGGYSYDYN,QQYDNLPIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/REGN10938_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
REGN10939,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; Transgenic Mouse (VelocImmune),EVQLVESGGGLVQPGGSLRLSCAASGLTVSSNYMNWVRQVPGKGLEWVSVIYSGGSKFYVDSVKGRFTISRHNSKNTLYLQMNSLRPEDTAVYYCTRDAQYYGMDVWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISTYLHWYQQKPGEAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPPEIFGQGTKLEIK,IGHV3-66 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ2 (Human),TRDAQYYGMDV,QQSYSTPPEI,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/REGN10939_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
REGN10940,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; Transgenic Mouse (VelocImmune),EVQLVESGGGLVQPGRSLRLSCAASGFTFDDYAMHWVRQAPGKGLEWVSGVSWNSGTIDYADSVKGRFTIIRDNAKNSLYLQMNSLRAEDTALYYCSKDMGRLDYYSGLDVWGQGTTVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSDFAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK,IGHV3-9 (Human),IGHJ6 (Human),IGKV3-20 (Human),IGKJ1 (Human),SKDMGRLDYYSGLDV,QQYGSSPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/REGN10940_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
REGN10941,Ab,SARS-CoV2,,SARS-CoV2,,S; Unk,B-cells; Transgenic Mouse (VelocImmune),EVQLVESGGGLVQPGGSLRLSCAASGITVSSNYMTWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRHNSKNTLYLQMNNLRAEDTAVYYCVRDLEVRGGMDVWGQGTTVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSFSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK,IGHV3-66 (Human),IGHJ6 (Human),IGKV3-20 (Human),IGKJ1 (Human),VRDLEVRGGMDV,QQYGSSPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/REGN10941_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
REGN10954,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGITVSSNYMSWVRQAPGKGLEWVSLIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRVEDTAVYYCARDHGMAAAGYNYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDINKYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTINSLQPEDFATYFCQQYDNLPPAFGQGTKVEIK,IGHV3-66 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ1 (Human),ARDHGMAAAGYNY,QQYDNLPPA,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/REGN10954_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 21, 2020","Nov 18, 2020",16th Nov: Clarified sequence origin by cross-referencing patent,Complete
REGN10955,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRVSCAASGFTVSRNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAIYYCARYIPRFDPWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWFQQKPGRAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPITFGQGTRLEIK,IGHV3-66 (Human),IGHJ5 (Human),IGKV1-33 (Human),IGKJ5 (Human),ARYIPRFDP,QQYDNLPIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/REGN10955_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
REGN10956,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGLTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLIKYGMDVWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPPHFGPGTKVDIK,IGHV3-66 (Human),IGHJ6 (Human),IGKV1-33 (Human),IGKJ3 (Human),ARDLIKYGMDV,QQYDNLPPH,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/REGN10956_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
REGN10957,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGVTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLFLQMNSLRIEDTAVYYCARDLGPYGMDVWGQGTTVTVSS,DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTQFILTISSLQPEDFATYYCQQLNSYPGFTFGPGTKVDIK,IGHV3-66 (Human),IGHJ6 (Human),IGKV1-9 (Human),IGKJ3 (Human),ARDLGPYGMDV,QQLNSYPGFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/REGN10957_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
REGN10964,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSETLSLTCTVSGGSINNYYWIWIRQPPGKGLEWIGYIYHSGSTNYNPSLKSRVTISVDTSKNQFSLKVSSVTAADTAVYYCANMVRGVYEDDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISNYLNWYQQKPGKAPKLLIFAASSLRSGVPSRFSGSGSGTDFTLTISSLHPEDFATYYCQQNYNTPLTFGPGTKVDIK,IGHV4-4 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ3 (Human),ANMVRGVYEDDY,QQNYNTPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/REGN10964_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 21, 2020","Nov 18, 2020",16th Nov: Clarified sequence origin by cross-referencing patent,Complete
REGN10965,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLIQPGGSLRLSCAASVFTVSYNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARALPGWGGSFEYFDYWGQGTLVTVSS,DIQMTQSPSTLSASVGDRVTITCRASQSISSWLAWYQQKPGKAPKLLIYKASSLESGVSSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNSYSVTFGQGTKVEIK,IGHV3-53 (Human),IGHJ4 (Human),IGKV1-5 (Human),IGKJ1 (Human),ARALPGWGGSFEYFDY,QQYNSYSVT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/REGN10965_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
REGN10966,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD/non-RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGLTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRPEDTAVYYCAREGRIAATGYGMDVWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLGTGVPSRFSGSRSGTDFTFTISSLQPEDIATYYCHQYDNLPQTFGPGTKVDIK,IGHV3-66 (Human),IGHJ6 (Human),IGKV1-33 (Human),IGKJ3 (Human),AREGRIAATGYGMDV,HQYDNLPQT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/REGN10966_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
REGN10967,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYPGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDQRDFAWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISGLQPEDIATYYCQQYDNLPPTFGQGTRLEIK,IGHV3-66 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ5 (Human),ARDQRDFA,QQYDNLPPT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/REGN10967_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
REGN10970,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNRLRADDTAVYYCVRDPVGRYYYGMDVWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDINNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPRTFGGGTKVEIK,IGHV3-66 (Human),IGHJ6 (Human),IGKV1-33 (Human),IGKJ4 (Human),VRDPVGRYYYGMDV,QQYDNLPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/REGN10970_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
REGN10971,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLIQPGGSLRLSCAASGVTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYSDSVKGRFSISRDNSKNTLYLQMNSLRAEDTAVYYCARDLYYYGMDVWGQGTTVTVSS,DIQLTQSPSFLSASVGDRVTITCRASQGISTYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLDSYPGLTFGGGTKVEIK,IGHV3-53 (Human),IGHJ6 (Human),IGKV1-9 (Human),IGKJ4 (Human),ARDLYYYGMDV,QQLDSYPGLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/REGN10971_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
REGN10977,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAITWVRQAPGQGLEWMGRIIPMFGIANYAQKFQGRVTITADKSTSTAYMEVSSLRSEDTAVYYCARTPFYYDSSGYYLDYWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSNYLAWYQQSPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYVRSPRTFGQGTKVEIK,IGHV1-69 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ1 (Human),ARTPFYYDSSGYYLDY,QQYVRSPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/REGN10977_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 21, 2020","Nov 18, 2020",16th Nov: Clarified sequence origin by cross-referencing patent,Complete
REGN10982,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGLTVSSNYMSWVRQAPGKGLEWVSVIYSGGTTYYADSVKGRFTISRHNSKNTLSLQMNSLRAEDTAVYYCARGEGANYYGMDVWGQGTTVTVSS,QSVLTQPPSVSGAPGQRVTISCTGSSSNIGTGYDVHWYQQLPGTAPKLLIYGNSNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSSLSGYVVFGGGTKLTVL,IGHV3-66 (Human),IGHJ6 (Human),IGLV1-40 (Human),IGLJ3 (Human),ARGEGANYYGMDV,QSYDSSLSGYVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/REGN10982_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
REGN10984,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGLTVNRNYMSWVRQAPGKGLEWVSLIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRLEDTAVYYCARGELGIPYGMDVWGQGTTVTVSS,QSVLTQPPSVSAAPGQKVTISCSGSSSNIGNNYVSWYQQLPGTAPKLLIYDNNKRPSGIPDRFSGSKSGTSATLGITGLQTGDEADYYCGTWDSSLSAGVFGGGTKLTVL,IGHV3-66 (Human),IGHJ6 (Human),IGLV1-51 (Human),IGLJ3 (Human),ARGELGIPYGMDV,GTWDSSLSAGV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/REGN10984_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 21, 2020","Nov 18, 2020",16th Nov: Clarified sequence origin by cross-referencing patent,Complete
REGN10985,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGRSLRLSCAASGFTFDDYAMHWVRQAPGKGLEWVSGISWNRGSIGYADSVKGRFTISRDNAKNSLYLQMSSLRAEDTALYYCAKDGERWDSVVVPSARNGMDVWGQGTTVTVSS,QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWYQQLPGTAPKLLIYGNSNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSSLSGSYVFGTGTKVTVL,IGHV3-9 (Human),IGHJ6 (Human),IGLV1-40 (Human),IGLJ1 (Human),AKDGERWDSVVVPSARNGMDV,QSYDSSLSGSYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/REGN10985_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
REGN10986,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASEFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARALPYGDLHFDYWGQGTLVTVSS,QSVLTQPPSVSGAPGQRVTISCTGSSSNIGTGYDVHWYQQLPGTAPKLLIYGNTNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSSLSDSYVFGTGTKVTVL,IGHV3-66 (Human),IGHJ4 (Human),IGLV1-40 (Human),IGLJ1 (Human),ARALPYGDLHFDY,QSYDSSLSDSYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/REGN10986_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 21, 2020","Nov 18, 2020",16th Nov: Clarified sequence origin by cross-referencing patent,Complete
REGN10987,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSNYAMYWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRTEDTAVYYCASGSDYGDYLLVYWGQGTLVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSKRPSGVSNRFSGSKSGNTASLTISGLQSEDEADYYCNSLTSISTWVFGGGTKLTVL,IGHV3-30 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ3 (Human),ASGSDYGDYLLVY,NSLTSISTWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/REGN10987_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
REGN10988,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCTASGFTFSNYEMNWVRQAPGKGLEWVSYISSRSGSTLHYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARRGDGTSSLIHHYYYMDVWGKGTTVTVSS,QSVLTQPPSASGTPGQRVTISCSGSSSNIGSNTVNWYQQLPGTAPKLLIYSNNQRPSGVPDRFSGSKSGTSASLAISGLQSEDEADYYCAAWDDSLNGPVFGGGTKLTVL,IGHV3-48 (Human),IGHJ6 (Human),IGLV1-44 (Human),IGLJ3 (Human),ARRGDGTSSLIHHYYYMDV,AAWDDSLNGPV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/REGN10988_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
REGN10989,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYIFTGYYMHWVRQAPGQGLEWMGWINPNSGGANYAQKFQGRVTLTRDTSITTVYMELSRLRFDDTAVYYCARGSRYDWNQNNWFDPWGQGTLVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGTYNYVSWYQQHPGKAPKLMIFDVSNRPSGVSDRFSGSKSGNTASLTISGLQAEDEADYYCSSFTTSSTVVFGGGTKLTVL,IGHV1-2 (Human),IGHJ5 (Human),IGLV2-14 (Human),IGLJ3 (Human),ARGSRYDWNQNNWFDP,SSFTTSSTVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/REGN10989_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 21, 2020","Nov 18, 2020",16th Nov: Clarified sequence origin by cross-referencing patent,Complete
REGN10996,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,Hybridoma from Transgenic Mouse (VelocImmune),EVQMVESGGGLVQPGGSLRLSCAASGFTVSSNYMTWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRHNSKNTLYLQMNSLRAEDTAVYYCARDGVSYGMDVWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPPITFGQGTRLEIK,IGHV3-66 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ5 (Human),ARDGVSYGMDV,QQSYSTPPIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/REGN10996_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
REGN10998,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,Hybridoma from Transgenic Mouse (VelocImmune),EVQLVESGGGLVHPGGSLRLSCAASGLTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRHNSKNTLFLQMNSLRAEDTAVYYCARDRPITGTTLDVWGQGTTVTVSS,DIQMTQSPSSLFASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFAFYYCQQTYSTPPITFGQGTRLEIK,IGHV3-66 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ5 (Human),ARDRPITGTTLDV,QQTYSTPPIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/REGN10998_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
REGN11000,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,Hybridoma from Transgenic Mouse (VelocImmune),EVQLVESGGGLVQPGGSLRLSCAASGFTVSSNYMNWVRQAPGKGLEWVSVIYSGGSTFYADSVRGRFTISRHNSKNTLYLQMNSLRAEDTAVYYCARDGSAYGMDVWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSFLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSSPPITFGQGTRLEIK,IGHV3-66 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ5 (Human),ARDGSAYGMDV,QQSYSSPPIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/REGN11000_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
REGN11004,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,Hybridoma from Transgenic Mouse (VelocImmune),EVQLVESGGGLVQPGGSLRLSCAASGLIVSRNYMIWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRHNSKNTLYLQMNSLRAEDTAVYYCARDLGTGGMDVWGQGTTVTVSS,DIQLTQSPSFLSASVGDRVTITCWASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPLTFGGGTKVEIK,IGHV3-66 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ4 (Human),ARDLGTGGMDV,QQLNSYPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/REGN11004_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
REGN11006,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,Hybridoma from Transgenic Mouse (VelocImmune),QVQLVESGGGVVQPGRSLRLSCVASGFTFSIYGMDWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRPEDTAVYYCAKDREAAADAFDIWGQGTMVTVSS,DIQMTQSPSSVSASVGDRVTITCRASQGISSWLAWYQQKPGKAPKLLIYAASSLHSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQANSFRLTFGGGTKVEIK,IGHV3-30 (Human),IGHJ3 (Human),IGKV1-12 (Human),IGKJ4 (Human),AKDREAAADAFDI,QQANSFRLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/REGN11006_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
REGN11008,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,Hybridoma from Transgenic Mouse (VelocImmune),EVQLVESGGGLVQPGGSLRLSCAASGFIVSRNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRHNSKNTLYLQMNSLKAEDTAVYYCARELRGYFDYWGQGTLVTVSS,DIQLTQSPSFLSASVGDRVTITCWASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQLLNSYPYTFGQGTKLEIK,IGHV3-66 (Human),IGHJ4 (Human),IGKV1-9 (Human),IGKJ2 (Human),ARELRGYFDY,QLLNSYPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/REGN11008_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
REGN11010,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,Hybridoma from Transgenic Mouse (VelocImmune),EVQLVESGGGLVQPGGSLRLSCAASGFTVSSNYMTWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRHNSENTLYLQMNSLRAEDTAVYYCARDLAAAGTDYWGQGALVTVSS,DIQLTQSPSFLSASVGDRVTITCWASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQHLNSYLYTFGQGTKLEIK,IGHV3-66 (Human),IGHJ4 (Human),IGKV1-9 (Human),IGKJ2 (Human),ARDLAAAGTDY,QHLNSYLYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/REGN11010_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
CA1,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVQSGAEVKKPGASVKVSCKASGYTFTSYGISWVRQAPGQGLEWMGWISAYNGNTNYAQKLQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCAREGYCSGGSCYSGYYYYYGMDVWGQGTTVTVSS,DIVMTQTPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRRNWGTFGPGTKVDIK,IGHV1-18 (Human),IGHJ6 (Human),IGKV3-11 (Human),IGKJ3 (Human),AREGYCSGGSCYSGYYYYYGMDV,QQRRNWGT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CA1_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 28, 2020","Mar 16, 2021",16th Nov: Clarified sequence origin by cross-referencing patent. 16th March: Corrected entire entry,Complete
CB6,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSMNTLFLQMNSLRAEDTAVYYCARVLPMYGDYLDYWGQGTLVTVSS,DIVMTQSPSSLSASVGDRVTITCRASQSISRYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPPEYTFGQGTKLEIK,IGHV3-66 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ2 (Human),ARVLPMYGDYLDY,QQSYSTPPEYT,https://www.rcsb.org/structure/7C01,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 28, 2020","Nov 11, 2020",Added therapeutic relevance,Therapeutic mAb Etsevimab. Complete
EY6A,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGVVQPGRSLRLSCAASAFTFSSYDMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDGGKLWVYYFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTLALTFGGGTKVEIK,IGHV3-30-3 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ4 (Human),AKDGGKLWVYYFDY,QQSYSTLALT,https://www.rcsb.org/structure/6ZCZ; https://www.rcsb.org/structure/6ZDG; https://www.rcsb.org/structure/6ZDH; https://www.rcsb.org/structure/6ZER; https://www.rcsb.org/structure/6ZFO; https://www.rcsb.org/structure/7NX6; https://www.rcsb.org/structure/7NX7; https://www.rcsb.org/structure/7NX8; https://www.rcsb.org/structure/7NX9; https://www.rcsb.org/structure/7NXA; https://www.rcsb.org/structure/7NXB,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 14, 2020","Jul 31, 2020",26th June: Added sequence & structure data from PDB. 5th July: Added extra structure 6zdh. 8th July: Added extra structure 6zfo. 31st July: Added extra structure 6zdg,Complete
Fab1-20,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLIQPGGSLRLSCAASGLTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLFYYGMDVWGQGTTVTVSS,DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPCFGPGTKVDIK,IGHV3-53 (Human),IGHJ6 (Human),IGKV1-9 (Human),IGKJ3 (Human),ARDLFYYGMDV,QQLNSYPC,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Fab1-20_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 1, 2020","Oct 1, 2020",N/A,Complete
Fab1-57,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVHLVESGGGLVQPGGSLRLSCAASGFTFSDHYMDWVRQAPGKGLEWVGRTRNKANSYTTEYAASVKGRFTISRDDAKNSLYLQMNSLKTEDTAVYYCARVHRWAYCINGVCFGAYSDYWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPSTFGQGTKLEIK,IGHV3-72 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ2 (Human),ARVHRWAYCINGVCFGAYSDY,QQYGSSPST,https://www.rcsb.org/structure/7LS9,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Fab1-57_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 1, 2020","Mar 19, 2021",28th Feb: Added new reference and expected structure. 19th March: Added structure,Complete
Fab1-68,Ab,SARS-CoV2,,SARS-CoV2,,S; NTD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKVSGYTLIELSMHWVRQAPGKGLEWMGGFDPEDAETIYAQKFQGRVTMTEDTSTDTAYMELSSLRSEDTAVYYCATGWAVAGSSDVWYYYYGMDVWGQGTTVTVSS,QSALTQPPSVSGSPGQSVTISCTGTSSDVGSYNRVSWYQQPPGTAPKLMIYEVSNRPSGVPDRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSTYVFGTGTKVTVL,IGHV1-24 (Human),IGHJ6 (Human),IGLV2-18 (Human),IGLJ1 (Human),ATGWAVAGSSDVWYYYYGMDV,SSYTSSSTYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Fab1-68_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 1, 2020","Jan 12, 2021",12th Jan 2021: Corrected to NTD binder,Complete
Fab1-87,Ab,SARS-CoV2,,SARS-CoV2,,S; NTD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKVSGYTLIELSMHWVRQAPGKGLEWMGGFDPEDAETIYAQKFQGRVTMTEDTSTDTAYMELSSLRSEDTAVYYCATGIAVIGPPPSTYYYYGMDVWGQGTTVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSKRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSTYVFGTGTKVTVL,IGHV1-24 (Human),IGHJ6 (Human),IGLV2-14 (Human),IGLJ1 (Human),ATGIAVIGPPPSTYYYYGMDV,SSYTSSSTYV,https://www.rcsb.org/structure/7L2D,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 1, 2020","Mar 25, 2021",12th Jan 2021: Corrected to NTD binder and added expected structure. 25th Mar 2021: Added structure,Awaiting PDB structure
Fab2-4,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTGYYMHWVRQAPGQGLEWMGWINPNSGGTNYTQMFQGRVTMTRDTSISTAYMEVSRLRSDDTAVYYCARDRSWAVVYYYMDVWGKGTTVTVSS,QSALTQPPSASGSPGQSVTISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYEVSKRPSGVPDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYAGSNNLVFGGGTKLTVL,IGHV1-2 (Human),IGHJ6 (Human),IGLV2-8 (Human),IGLJ3 (Human),ARDRSWAVVYYYMDV,SSYAGSNNLV,https://www.rcsb.org/structure/6XEY,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 19, 2020","Jul 26, 2020",Jul 26th: Added PBD structure and corresponding sequence information; Oct 1st: Updated publication information,Complete
Fab2-7,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QITLKESGPTLVKPTQTLTLTCTFSGFSLSTSGVGVGWIRQPPGKALEWLALIYWDDDKRYSPSLKSRLTITKDTSKNQVVLTMTNMDPVDTATYYCAHHKIERIFDYWGQGTLVTVSS,QSALAQPASVSGSPGQSITISCTGTSSDVGAYNYVSWYQQHPGKAPKLMIYDVSKRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTTSSTVFGGGTKLTVL,IGHV2-5 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ3 (Human),AHHKIERIFDY,SSYTTSSTV,https://www.rcsb.org/structure/7LSS,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Fab2-7_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 1, 2020","Mar 19, 2021",28th Feb: Added new reference and expected structure. 19th March: Added structure,Complete
Fab2-15,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVRVSCKASGYTFTGYYMHWVRQAPGQGLEWMGWINPISDGTNYAQKFQGWVTMTRDTSISTVYMELSRLRSDDTAVYYCARGGSRCSGGNCYGWAYDAFDIWGQGTMITVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGGYNFVSWYQQHPGKAPKLMIYDVSKRPSGVSNRFSGSKSGNTASLTISGLQAEDEADCYCSSYTSSSTFVFGTGTKVTVL,IGHV1-2 (Human),IGHJ3 (Human),IGLV2-14 (Human),IGLJ1 (Human),ARGGSRCSGGNCYGWAYDAFDI,SSYTSSSTFV,https://www.rcsb.org/structure/7L5B;https://www.rcsb.org/structure/7L57,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 1, 2020","Apr 21, 2021",12th Jan 2021: Added expected structure; 11th Feb: Added PDB structure; 21st Apr: Added new PDB structure,Complete
Fab2-17,Ab,SARS-CoV2,,SARS-CoV2,,S; NTD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGNIPIFGTANYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYCARGVGYRGVIPLNWFDPWGQGTVVTVSS,EIVMTQSPATLSVSPGERATLSCRASQSVSSDLAWYQHKPGQAPRLLIYGASTRATGIPVRFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNWPPFTFGGGTKVEIK,IGHV1-69 (Human),IGHJ5 (Human),IGKV3-15 (Human),IGKJ4 (Human),ARGVGYRGVIPLNWFDP,QQYNNWPPFT,https://www.rcsb.org/structure/7LQW,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 1, 2020","Jan 12, 2021",12th Jan 2021: Corrected to NTD binder and added expected structure,Awaiting PDB structure
Fab2-30,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYTMHWVRQAPGKGLEWVAAISYDGNNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARSILYGGGMDVWGQGTTVTVSS,AIQLTQSPSSLSASVGDRVTITCRASQGISSYLAWYQQKPGQAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQLNSYPLTFGGGTKVEIK,IGHV3-30 (Human),IGHJ6 (Human),IGKV1-9 (Human),IGKJ4 (Human),ARSILYGGGMDV,QQLNSYPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Fab2-30_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 1, 2020","Oct 1, 2020",N/A,Complete
Fab2-36,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSETLSLTCTVSGGSVSSSNYYWSWIRQPPGKGLEWIGYMYYSGSTKYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCAREVYYYDRSGYYASDGFDIWGQGTMVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPQTFGQGTKVEIK,IGHV4-59 (Human),IGHJ3 (Human),IGKV3-20 (Human),IGKJ1 (Human),AREVYYYDRSGYYASDGFDI,QQYGSSPQT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Fab2-36_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 1, 2020","Oct 1, 2020",N/A,Complete
Fab2-38,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVKPGGSLRLSCAASGFTFSSYSMNWVRQAPGKGLEWVSSISSSSSYIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCTRAGWELRLDAFDIWGQGTMVTVSS,SSELTQDPAVSVALGQTVRITCQGDSLRSSYASWYQQKPGQAPILVIYDKNNRPSGIPDRFSGSSSGNTASLTITGAQAEDEADYYCNSRDSSGILFGGGTKLTVL,IGHV3-21 (Human),IGHJ3 (Human),IGLV3-19 (Human),IGLJ3 (Human),TRAGWELRLDAFDI,NSRDSSGIL,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Fab2-38_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 1, 2020","Oct 1, 2020",N/A,Complete
Fab2-43,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTGYYMHWVRQAPGQGLEWMGWINPNSGGTNYAQKFQGRVTMTRDTSITTAYMELRRLRSDDTAVYYCARGLGVGCSGGNCYLDYYYMDVWGKGTTVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSKRPSGVSNRFSGSKSGNTASLTISGLQAEDEGDYYCSSYTSSSTWVFGGGTKLTVL,IGHV1-2 (Human),IGHJ6 (Human),IGLV2-14 (Human),IGLJ3 (Human),ARGLGVGCSGGNCYLDYYYMDV,SSYTSSSTWV,https://www.rcsb.org/structure/7L56,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Fab2-43_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 1, 2020","Apr 19, 2021",12th Jan 2021: Added expected structure; 19th Apr 2021: Added link to structure,Complete
Fab2-51,Ab,SARS-CoV2,,SARS-CoV2,,S; NTD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKVSGYTLIELSMHWVRQAPGKGLEWMGGFDPEDVETIYAQQFQGRVTMTEDTSTDTAYMELSSLRSEDTAVYYCATGWAYKSTWYFGYWGQGTLVTVSS,QSALTQPPSASGSPGQSVTISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYEVSKRPSGVPDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYAGSRMGFGGGTKLTVL,IGHV1-24 (Human),IGHJ4 (Human),IGLV2-8 (Human),IGLJ3 (Human),ATGWAYKSTWYFGY,SSYAGSRMG,https://www.rcsb.org/structure/7L2C,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 1, 2020","Jan 12, 2021",12th Jan 2021: Corrected to NTD binder and added expected structure,Awaiting PDB structure
Fab4-8,Ab,SARS-CoV2,,SARS-CoV2,,S; NTD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKAGSSVKVSCKASGGTFSSHTITWVRQAPGQGLEWMGRIIPILGIANYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCASLQTVDTAIEKYYGMDVWGQGTTVTVSS,SYELTQPPSVSVSPGQTASITCSGDKLGDKYACWYQQKPGQSPVLVIYQDNKRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCQAWDSSTAVFGGGTKLTVL,IGHV1-69 (Human),IGHJ6 (Human),IGLV3-1 (Human),IGLJ3 (Human),ASLQTVDTAIEKYYGMDV,QAWDSSTAV,https://www.rcsb.org/structure/7LQV,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 1, 2020","Jan 12, 2021",12th Jan 2021: Corrected to NTD binder and added expected structure,Awaiting PDB structure
Fab4-18,Ab,SARS-CoV2,,SARS-CoV2,,S; NTD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSNKHYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDSGYNYGYSWFDPWGQGTLVTVSS,SYELTQPPSVSVSPGQTARITCSADALAKQYAYWYQQKPGQAPVLVIYKDSERPSGIPERFSGSSSGTTVTLTISGVQAEDEADYYCQSTDNSGTYPNWVFGGGTKLTVL,IGHV3-30 (Human),IGHJ5 (Human),IGLV3-25 (Human),IGLJ3 (Human),AKDSGYNYGYSWFDP,QSTDNSGTYPNWV,https://www.rcsb.org/structure/7L2E,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 1, 2020","Mar 25, 2021",12th Jan 2021: Corrected to NTD binder and added expected structure. 25th Mar 2021: Added structure,Awaiting PDB structure
Fab4-19,Ab,SARS-CoV2,,SARS-CoV2,,S; NTD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSETLSLTCTVSGGSISNYYWSWIRQSPGKGLEWIGYIYYSGSTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARSAKHWLAPPGDYYYYMDVWGKGTTVTVSS,DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYLTFGGGTKVEIK,IGHV4-59 (Human),IGHJ6 (Human),IGKV1-9 (Human),IGKJ4 (Human),ARSAKHWLAPPGDYYYYMDV,QQLNSYLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Fab4-19_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 1, 2020","Jan 12, 2021",12th Jan 2021: Corrected to NTD binder,Complete
Fab4-20,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLLQSGAEVKKPGASVKVSCKASGYSFTSYYMHWVRQAPGQGLEWMGIINPSGGGTTYAQKFQGRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARPGGGSYQEFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLISAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYNTLQVTFGGGTKVEIK,IGHV1-46 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ4 (Human),ARPGGGSYQEFDY,QQSYNTLQVT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Fab4-20_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 1, 2020","Jan 12, 2021",12th Jan 2021: Corrected to NTD binder,Complete
Fab5-7,Ab,SARS-CoV2,,SARS-CoV2,,S; NTD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYYMHWVRQAPGQGLEWMGVINPSGGSTSYAEKFRGRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARDREPHSDSSGYWDSLKYYYYYALDVWGQGTTVTVSS,AIQLTQSPSSLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPELLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQLNTYPFTFGPGTKVDIK,IGHV1-46 (Human),IGHJ6 (Human),IGKV1-9 (Human),IGKJ3 (Human),ARDREPHSDSSGYWDSLKYYYYYALDV,QQLNTYPFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Fab5-7_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 1, 2020","Oct 1, 2020",N/A,Complete
Fab5-24,Ab,SARS-CoV2,,SARS-CoV2,,S; NTD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGLTFSSYVMHWVRQAPGKGLDWVGVIWYDGSKKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDPRDYYDFWSGYDYYYGLDVWGQGTTVTVSS,EIVLTQSPGILSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSGALTFGGGTKVEIK,IGHV3-33 (Human),IGHJ6 (Human),IGKV3-20 (Human),IGKJ4 (Human),ARDPRDYYDFWSGYDYYYGLDV,QQYGSSGALT,https://www.rcsb.org/structure/7L2F,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 1, 2020","Mar 25, 2021",12th Jan 2021: Corrected to NTD binder and added expected structure. 25th Mar 2021: Added structure,Awaiting PDB structure
MD17,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,"Phage Display Library (Antibody, human, immune - CoV2)",ND,ND,IGHV3-64 (Human),ND,IGKV1-39 (Human),ND,VKDQDSSSWYDAFDI,QQSYTTPLT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 21, 2020","Oct 1, 2020",Added first two residues of CDRH3 sequence,Available under an MTA (see reference)
MD29,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,"Phage Display Library (Antibody, human, immune - CoV2)",ND,ND,IGHV3-64 (Human),ND,IGKV1-39 (Human),ND,VKDQDSSSWYDAFDI,HQTYTSPYT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 21, 2020","Oct 1, 2020",Added first two residues of CDRH3 sequence,Available under an MTA (see reference)
MD45,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,"Phage Display Library (Antibody, human, immune - CoV2)",ND,ND,IGHV3-53 (Human),ND,IGKV3-20 (Human),ND,ARDLSVRGGMDV,QQYGVSPEII,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 21, 2020","Oct 1, 2020",Added first two residues of CDRH3 sequence,Available under an MTA (see reference)
MD47,Ab,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,"Phage Display Library (Antibody, human, immune - CoV2)",ND,ND,IGHV3-23 (Human),ND,IGLV3-21 (Human),ND,AKDLVTAPSYEAFDI,QVWDSSSHHHVV,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 21, 2020","Oct 1, 2020",Added first two residues of CDRH3 sequence,Available under an MTA (see reference)
MD62,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,"Phage Display Library (Antibody, human, immune - CoV2)",ND,ND,IGHV3-53 (Human),ND,IGKV1-12 (Human),ND,ARDLQYYGMDV,QQANSFPLT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 21, 2020","Oct 1, 2020",Added first two residues of CDRH3 sequence,Available under an MTA (see reference)
MD63,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,"Phage Display Library (Antibody, human, immune - CoV2)",ND,ND,IGHV3-64 (Human),ND,IGKV1-39 (Human),ND,VKDQDSNSWYDAFDI,QQSYSTPYT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 21, 2020","Oct 1, 2020",Added first two residues of CDRH3 sequence,Available under an MTA (see reference)
MD65,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,"Phage Display Library (Antibody, human, immune - CoV2)",ND,ND,IGHV3-66 (Human),ND,IGKV3-20 (Human),ND,ARDLAVAGAFDI,QQYGSSPLT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 21, 2020","Oct 1, 2020",Added first two residues of CDRH3 sequence,Available under an MTA (see reference)
MD67,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,"Phage Display Library (Antibody, human, immune - CoV2)",ND,ND,IGHV3-53 (Human),ND,IGKV3-20 (Human),ND,ARDLSVRGGMDV,QQFGSSPLT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 21, 2020","Oct 1, 2020",Added first two residues of CDRH3 sequence,Available under an MTA (see reference)
BD23,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGSELKKPGASVKVSCKASGYTFTSYAMNWVRQAPGQGLEWMGWINTNTGNPTYAQGFTGRFVFSLDTSVSTAYLQISSLKAEDTAVYYCARPQGGSSWYRDYYYGMDVWGQGTTVTVSS,DIQMTQSPSTLSASVGDRVTITCRASQSISSWLAWYQQKPGKAPKLLIYKASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNSYPYTFGQGTKLEIK,IGHV7-4-1 (Human),IGHJ6 (Human),IGKV1-5 (Human),IGKJ2 (Human),ARPQGGSSWYRDYYYGMDV,QQYNSYPYT,https://www.rcsb.org/structure/7BYR,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 10, 2020","Jun 10, 2020",N/A,Complete
BD-494,Ab,SARS-CoV2,,SARS-CoV2,,S; probably RBD (implied by clustering),"Phage Display Library (Antibody, human, immune - CoV2)",ND,ND,IGHV3-53 (Human),IGHJ6 (Human),IGKV1-9 (Human),IGKJ3 (Human),ARDLVVYGMDV,QQLNSYPFT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 19, 2020","May 20, 2020",Added MTA information.,Tracking public release of patent application to obtain full sequences. MTA available for non-commercial use (see paper).
BD-498,Ab,SARS-CoV2,,SARS-CoV2,,S; probably RBD (implied by clustering),"Phage Display Library (Antibody, human, immune - CoV2)",ND,ND,IGHV3-66 (Human),IGHJ6 (Human),IGKV1-9 (Human),IGKJ5 (Human),ARDLVVYGMDV,QQLNSYPLT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 19, 2020","May 20, 2020",Added MTA information.,Tracking public release of patent application to obtain full sequences. MTA available for non-commercial use (see paper).
BD-500,Ab,SARS-CoV2,,SARS-CoV2,,S; probably RBD (implied by clustering),B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV3-53 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ5 (Human),ARDAMSYGMDV,QQSYSTPPDT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 19, 2020","May 20, 2020",Added MTA information.,Tracking public release of patent application to obtain full sequences. MTA available for non-commercial use (see paper).
BD-503,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV3-53 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ3 (Human),ARDAAVYGIDV,QQSYTTPLFT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 19, 2020","May 20, 2020",Added MTA information.,Tracking public release of patent application to obtain full sequences. MTA available for non-commercial use (see paper).
BD-504,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV3-66 (Human),IGHJ6 (Human),IGKV1-9 (Human),IGKJ3 (Human),ARDLISRGMDV,QQSYTTPLFT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 19, 2020","May 20, 2020",Added MTA information.,Tracking public release of patent application to obtain full sequences. MTA available for non-commercial use (see paper).
BD-505,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV3-53 (Human),IGHJ6 (Human),IGKV1-33 (Human),IGKJ5 (Human),ARDRVVYGMDV,HQYDNLPPT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 19, 2020","May 20, 2020",Added MTA information.,Tracking public release of patent application to obtain full sequences. MTA available for non-commercial use (see paper).
BD-506,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV3-53 (Human),IGHJ6 (Human),IGKV1-9 (Human),IGKJ4 (Human),ARDLVSYGMDV,QQLNSYPLT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 19, 2020","May 20, 2020",Added MTA information.,Tracking public release of patent application to obtain full sequences. MTA available for non-commercial use (see paper).
BD-507,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,IGHV3-53 (Human),IGHJ6 (Human),IGKV1-9 (Human),IGKJ3 (Human),ARDLVVYGMDV,QQLNSNPPIT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 19, 2020","May 20, 2020",Added MTA information.,Tracking public release of patent application to obtain full sequences. MTA available for non-commercial use (see paper).
BD-508,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFIVSSNYMTWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRHNSKNTLFLQMNSLRAEDTAVYYCARDAQNYGMDVWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIFAASSLQTGAPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPPYTFGQGTKLEIK,IGHV3-53 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ2 (Human),ARDAQNYGMDV,QQSYSTPPYT,https://www.rcsb.org/structure/7E86,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 19, 2020","Jun 16, 2021",20th May '20: Added MTA information. 16th June '21: Added full sequence and structure,Variant binding data available in 2021 paper. Complete
BD-515,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,VQLVESGGGLVQPGGSLRLSCAASEFIVSRNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTGVYYCARDRGLVSDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDINKYLNWYQQKPGKAPKLLIFDASHLETGVPSRFSASGSGTDFTFTISSLQPEDIATYYCHQYDNLPRTFGQGTRLEIK,IGHV3-66 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ5 (Human),ARDRGLVSDY,HQYDNLPRT,https://www.rcsb.org/structure/7E88,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 19, 2020","Jun 16, 2021",20th May '20: Added MTA information. 16th June '21: Added full sequence and structure,Variant binding data available in 2021 paper. Complete
P2B-2F6,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSETLSLTCTVSGYSISSGYYWGWIRQPPGKGLEWIGSIYHSGSTYYNPSLKTRVTISVDTSKNQFSLKLSSVTAADTAVYYCARAVVGIVVVPAAGRRAFDIWGQGTMVTVSS,QSALTQPPSASGSPGQSVTISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYEVSKRPSGVPDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYAGSNNLVFGGGTKLTVL,IGHV4-38-2 (Human),IGHJ3 (Human),IGLV2-8 (Human),IGLJ3 (Human),ARAVVGIVVVPAAGRRAFDI,SSYAGSNNLV,https://www.rcsb.org/structure/7BWJ,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 4, 2020","Jun 4, 2020",N/A,Complete
COVA1-01,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,HQHQVEQGPGGVEQSETLFLTCCVSGGFTISSCYKRGGIRQPPRKGEEWAVSSYYSSSTYYTPSLKSRVTISVDKSKNQFSLKMSSVTAADTAVYYCARVSSGYYFTPFDYWGQGTRGHRLF,EIVMTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPPPFTFGPGTKVDIK,IGHV4-39 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ3 (Human),ARVSSGYYFTPFDY,QQYGSSPPPFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COVA1-01_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 17, 2020","Jun 17, 2020",N/A,Complete
COVA1-02,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGVVQPGRSLRLSCAASGFTFSIYAMHWVRQAPGKGLEWVAVISYDGSNQYYADSVRGRFTISRGNSKNTLYLQMNSLRPEDTAVYYCARARGGSYNDAFDIWGQGTMVTVSS,NFMLTQPASVSGSPGQSITISCTGASSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSTPVVFGGGTELTVL,IGHV3-30 (Human),IGHJ3 (Human),IGLV2-14 (Human),IGLJ3 (Human),ARARGGSYNDAFDI,SSYTSSSTPVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COVA1-02_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 17, 2020","Jun 17, 2020",N/A,Complete
COVA1-03,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,SARS-CoV1,Unk,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDGQYYDFWSGYLGARTNPHYYYYMDVWGKGTMVTVSS,DIVMTQSPSSLSASVGDRVTITCRASQGISNYLAWYQQKPGKVPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDVATYYCQKYNSAPPAFGQGTKVDIK,IGHV3-30 (Human),IGHJ6 (Human),IGKV1-27 (Human),IGKJ3 (Human),AKDGQYYDFWSGYLGARTNPHYYYYMDV,QKYNSAPPA,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COVA1-03_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 17, 2020","Jun 17, 2020",N/A,Complete
COVA1-06,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,EVQLVQSGGGLVQPGRSLRLSCAASGFTFGEYAMHWVRQAPGKGLEWVSGISWNSGSIDYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTALYYCAKDMGEAVAGTHYGMDVWGQGTMVTASS,QSALTQPPSVSVSPGQTASIPCSGDKLGDIYACWYQQKPGQSPVLVIYQDTKRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCQAWGSTTAKVFGGGTKLTVP,IGHV3-9 (Human),IGHJ6 (Human),IGLV3-1 (Human),IGLJ3 (Human),AKDMGEAVAGTHYGMDV,QAWGSTTAKV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COVA1-06_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 17, 2020","Jun 17, 2020",N/A,Complete
COVA1-07,Ab,"SARS-CoV1,SARS-CoV2",,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGAEVKKPGSSVKVSCKASGGTLSSYAITWVRQAPGQGLEWVGGIIPIFGTANYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYCARVGAYDSSGYSNDYWGQGTLVTVSS,DIQLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPPRVTFGGGTKVEIK,IGHV1-69 (Human),IGHJ4 (Human),IGKV3-11 (Human),IGKJ4 (Human),ARVGAYDSSGYSNDY,QQRSNWPPRVT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COVA1-07_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 17, 2020","Jun 17, 2020",N/A,Complete
COVA1-08,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGVVQPGGSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAREDYYDSSGSFDYWGQGTLVTVSS,QSVLTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSTRHWVFGGGTKLTVL,IGHV3-30 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ3 (Human),AREDYYDSSGSFDY,SSYTSSSTRHWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COVA1-08_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 17, 2020","Jun 17, 2020",N/A,Complete
COVA1-09,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,QLQLVESGPGLVKPSETLSLTCTVSGGSISSYFWSWIRQPPGKGLEWIGYIYYSGSTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARHSQGWLQQAVAFDIWGQGTMVTVSS,DIQMTQSPSSLSASVRDRVTITCRASQSITSSLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPYTFGQGTKVEIK,IGHV4-59 (Human),IGHJ3 (Human),IGKV1-39 (Human),IGKJ1 (Human),ARHSQGWLQQAVAFDI,QQSYSTPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COVA1-09_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 17, 2020","Jun 17, 2020",N/A,Complete
COVA1-10,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTVTSTYMTWVRRAPGKGLEWVSIIYNDDTTYYADSVKDRVTVSRDDSKNTLYLQMNSLRAEDTAIYYCARGGYYYDPSGYYSRSFSFDYWGQGTLVTVSS,NFMLTQPASVSGSPGQSITISCTGSSSDIAPYTFVSWYQQHSGTAPKLIIYDVRNRPSGISDRFSGSRSGNTASLSISGLQAEDEADYYCSAYTTTSTSWVFGGGTKLTVL,IGHV3-66 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ3 (Human),ARGGYYYDPSGYYSRSFSFDY,SAYTTTSTSWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COVA1-10_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 17, 2020","Jun 17, 2020",N/A,Complete
COVA1-12,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,SARS-CoV1,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVQSGTEVKKPGASVKVSCKASGYTFPGYYIHWVRQAPGQGLEWMGWINPNSGVAKSAQKFQGRVTMTRDSSISTVYLDVTSDDTAVYYCARDLVWATVSGTMDVWGQGTTVTVSS,QSALTQPPSASGSPGQSVTISCTGTSSDIGTYNYVSWYQQHPGKAPKLMIYEVTKRPSGVPDRFSGSKSGNTASLTVSGLQADDEGDYYCSSYVGNNNWVFGGGTKLTVL,IGHV1-2 (Human),IGHJ6 (Human),IGLV2-8 (Human),IGLJ3 (Human),ARDLVWATVSGTMDV,SSYVGNNNWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COVA1-12_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 17, 2020","Jun 17, 2020",N/A,Complete
COVA1-16,Ab,"SARS-CoV1,SARS-CoV2",,"SARS-CoV1,SARS-CoV2",,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYYMHWVRQAPGQGLEWMGIINSSGGSTSYAQKFQGRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARPPRNYYDRSGYYQRAEYFQHWGQGTLVTVSS,DIQLTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQRPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNPPLTFGGGTKLEIK,IGHV1-46 (Human),IGHJ1 (Human),IGKV1-33 (Human),IGKJ4 (Human),ARPPRNYYDRSGYYQRAEYFQH,QQYDNPPLT,https://www.rcsb.org/structure/7JMW; https://www.rcsb.org/structure/7JMX; https://www.rcsb.org/structure/7LM8,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 17, 2020","Apr 6, 2021",6th April: Added 7lm8,Complete
COVA1-18,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,SARS-CoV1,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARVEWAAAGTFYWGQGTLVTVSS,QSALTQEPSLTVSPGGTVTLTCGSSTGAVTSGHYPYWFQQKPGQAPRTLIYDTSNKRSWTPARFSGSLLGGKAALTLSGAQPEDEAEYYCLLSYSGVWVFGGGTKLTVL,IGHV3-66 (Human),IGHJ4 (Human),IGLV7-46 (Human),IGLJ3 (Human),ARVEWAAAGTFY,LLSYSGVWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COVA1-18_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 17, 2020","Jun 17, 2020",N/A,Complete
COVA1-19,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGLVKPGGSLRLSCAASGFTFSSYSMNWVRQAPGKGLEWVSSISSSSSFIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARWKSDYYDSSGYYPAAFDIWGQRDKWSPSS,EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNWPPWTFGQGTKVEIK,IGHV3-21 (Human),IGHJ3 (Human),IGKV3-15 (Human),IGKJ1 (Human),ARWKSDYYDSSGYYPAAFDI,QQYNNWPPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COVA1-19_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 17, 2020","Jun 17, 2020",N/A,Complete
COVA1-20,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGLVKPGGSLRLSCAASGFTFSSYSMNWVRQAPGKGLEWVSSISSSSSYIYYADSVKGRFTISRDDAKNSLFLQMNSLRAEDTAVYYCAGDQNLYCSGDSCYYHYYGMDVWGQGTVVTVSS,NFMLTQPPSVSVAPGKTARITCGGNNIGSKSVHWYQQKPGQAPVLVIYYDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDSSSDHWVFGGGTKLTVL,IGHV3-21 (Human),IGHJ6 (Human),IGLV3-21 (Human),IGLJ3 (Human),AGDQNLYCSGDSCYYHYYGMDV,QVWDSSSDHWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COVA1-20_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 17, 2020","Jun 17, 2020",N/A,Complete
COVA1-21,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,SARS-CoV1,S; non-RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNTKNTLYLQMNSLRAEDTAVYYCARDSEYYDILTGYLAPTHYYYYYMDVWGKGTTVTVSS,EIVMTQSPATLSVSPGERATLSYRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNWPPGTFGQGTKLEIK,IGHV3-30 (Human),IGHJ6 (Human),IGKV3-15 (Human),IGKJ2 (Human),ARDSEYYDILTGYLAPTHYYYYYMDV,QQYNNWPPGT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COVA1-21_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 17, 2020","Jun 17, 2020",N/A,Complete
COVA1-22,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGAEVKKPGASVKVSCKASGYTFTSYGISWVRQAPGQGLEWMGWISAYNGYTNSAQKLQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARDLVDTAMVQTLDDYGMDVWGQGTMVTVSS,SYELTQPPSVSVSPGQTASITCSGDKLGDKYACWYQQKPGQSPVLVTYQDNKRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCQAWDSSTAVFGGGTKLTVL,IGHV1-18 (Human),IGHJ6 (Human),IGLV3-1 (Human),IGLJ3 (Human),ARDLVDTAMVQTLDDYGMDV,QAWDSSTAV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COVA1-22_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 17, 2020","Jun 17, 2020",N/A,Complete
COVA1-23,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGESLKISCKGSGYRFTTYWIGWVRQMPGKGLEWMGIIYPGDSDTRYSPSFQGQVTISADKSISTAYLQWSSLTASDTAIYYCARYYYDSRGYTSIDFWGQGTLVTVSS,SYELTQPPSVSVSPGQTARITCSGDALPKQYAYWYQQKPGQAPVLVIYKDSERPSGIPERFSGSSSGTTVTLTISGVQAEDEADYYCQSADSSGTYSVVFGGGTKLTVL,IGHV5-51 (Human),IGHJ4 (Human),IGLV3-25 (Human),IGLJ3 (Human),ARYYYDSRGYTSIDF,QSADSSGTYSVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COVA1-23_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 17, 2020","Jun 17, 2020",N/A,Complete
COVA1-25,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGPGLVKPSETLSLTCTVSGGSISSTSYYWGWIRQPPGKGLECIGSIYYSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARLNYDFWSGYYSYALYYMDVWGKGTMVTVSS,DIQLTQSPSTLSASVGDRVTITCRASQSISSWLAWYQQKPGKAPKLLIYKASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNSYSITFGPGTKVDIK,IGHV4-39 (Human),IGHJ6 (Human),IGKV1-5 (Human),IGKJ3 (Human),ARLNYDFWSGYYSYALYYMDV,QQYNSYSIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COVA1-25_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 17, 2020","Jun 17, 2020",N/A,Complete
COVA1-26,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,QLQLQESGPGLVKPSQTLSLTCTVSGGSISSGGYYWSWIRQLPGKGLEWIGYIYYSGSTYYNPSLKSRVTISVDTSKNQFSLNLSSVTAADTAVYYCARQQLDYYDSSGCFDYWGQGTLVTVSS,DIVMTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLHSYPLTFGGGTKVDIK,IGHV4-31 (Human),IGHJ4 (Human),IGKV1-9 (Human),IGKJ4 (Human),ARQQLDYYDSSGCFDY,QQLHSYPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COVA1-26_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 17, 2020","Jun 17, 2020",N/A,Complete
COVA1-27,Ab,"SARS-CoV1,SARS-CoV2",,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGPGLVKPSETLSLTCTVSGGSISSYYWSWIRQPPGKRLEWIGYIYYSGSTNYNPSLKSRVTISVDTSKNQFSLKLNSVTAADTAAYYCARGFDYWGQGTRVTVSS,DVVMTQSPGTLSLSPGERATLSCRASQNVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPLFTFGPGTKVEIK,IGHV4-59 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ3 (Human),ARGFDY,QQYGSSPLFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COVA1-27_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 17, 2020","Sep 10, 2020",CDRH3 Entry Corrected,Complete
COVA2-01,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYDMHWVRQTTGKGLQWVSAIGTAGDTYYPGSVKGRFTISRENAKNSLYLQMNSLRAGDTAVYYCARGGDRYPVGYFDLWGRGTLVTVSS,DIVMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPPVTFGGGTKVEIK,IGHV3-13 (Human),IGHJ2 (Human),IGKV1-39 (Human),IGKJ4 (Human),ARGGDRYPVGYFDL,QQSYSTPPVT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COVA2-01_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 17, 2020","Jun 17, 2020",N/A,Complete
COVA2-02,Ab,"SARS-CoV1,SARS-CoV2",,"SARS-CoV1,SARS-CoV2 (weak)",,S; RBD,B-cells; SARS-CoV2 Human Patient,VQLQQESGPGLVKPSETLSLTCTVSGGSISSSSYYWGWIRQPPGKGLEWIGSIYYSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARRSTSRWGYYYMDVWGKGTRVTVSS,DIVMTQSPSSLSASVGDRVTITCRASQSISNYLNWYQQKPGKAPKLLLYAASDLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTHMSTFGQGTKVDIK,IGHV4-39 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ3 (Human),ARRSTSRWGYYYMDV,QQSYSTHMST,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COVA2-02_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 17, 2020","Jun 17, 2020",N/A,Complete
COVA2-03,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYSMNWVRQAPGKGLEWVSYISSSSSTIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCAREANSDFWSGYLGYFDYWGQGTLVTVSS,EIVMTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPQVTFGQGTRLEIK,IGHV3-48 (Human),IGHJ4 (Human),IGKV3-11 (Human),IGKJ5 (Human),AREANSDFWSGYLGYFDY,QQRSNWPQVT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COVA2-03_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 17, 2020","Jun 17, 2020",N/A,Complete
COVA2-04,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,SARS-CoV1,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVETGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLERAGGMDVWGQGTMVTVSS,EIVMTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSLYTFGQGTKVDIK,IGHV3-53 (Human),IGHJ6 (Human),IGKV3-20 (Human),IGKJ3 (Human),ARDLERAGGMDV,QQYGSLYT,https://www.rcsb.org/structure/7JMO,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 17, 2020","Jul 31, 2020",Added expected structure,Tracking PDB for solved structure
COVA2-05,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLLESGAEVKKPGESLKISCKGSGYSFTSYWIGWVRQMPGKGLEWMGIIYPGDSDTRYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARHMRPSIAARPGYQYYMDVWGKGTRVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPLTFGGGTKLEIK,IGHV5-51 (Human),IGHJ6 (Human),IGKV1-33 (Human),IGKJ4 (Human),ARHMRPSIAARPGYQYYMDV,QQYDNLPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COVA2-05_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 17, 2020","Jun 17, 2020",N/A,Complete
COVA2-07,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,SARS-CoV1,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVETGGGLIQPGGSLRLSCAASGLTVSSNYMNWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAREAYGMDVWGQGTMVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSWSGTDFTLTISRLEPEDFAVYYCQQYGSSPGTFGQGTKVDIK,IGHV3-53 (Human),IGHJ6 (Human),IGKV3-20 (Human),IGKJ3 (Human),AREAYGMDV,QQYGSSPGT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COVA2-07_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 17, 2020","Jun 17, 2020",N/A,Complete
COVA2-10,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,EVQLLESGGGLVQPGGSLKLSCAASGFTFSSYAMSWVRQAPGKGLEWVSAISGSGSNTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKGLRGQQLVIPTEYFQHWGQGTLVTVSS,DIVMTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSLLTFGGGTKVEIK,IGHV3-23 (Human),IGHJ1 (Human),IGKV3-20 (Human),IGKJ4 (Human),AKGLRGQQLVIPTEYFQH,QQYGSSLLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COVA2-10_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 17, 2020","Jun 17, 2020",N/A,Complete
COVA2-11,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2 (weak),SARS-CoV1,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGAEVKKPGSSVKVSCKASGGTLSSYAISWVRQAPGQGLEWMGGIIPIFGTANYAQKFQGRVTITTDESTSTAYMELSSLRSEDTAVYYCARGPRGCSSTSCYGSYFDYWGQGTLVTVSS,DIQLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPRLTFGGGTKVDIK,IGHV1-69 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ4 (Human),ARGPRGCSSTSCYGSYFDY,QQYGSSPRLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COVA2-11_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 17, 2020","Jun 17, 2020",N/A,Complete
COVA2-12,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVKPGGSLRLSCAASGFTFGSYSMSWVRQAPGKGLEWVSSISRSSSYIYNADSVRGRLTISRDNAKNSLYLQMNSLRVEDTAVYYCARDQPLPDILTGYYTGPLDYWGQGTLVTVSS,EIVLTQSPATLSVSPGERATLSCRASQSVSSSLAWYQQKPGQAPRLLIYAASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNWPPWTFGQGTKLEIK,IGHV3-21 (Human),IGHJ4 (Human),IGKV3-15 (Human),IGKJ1 (Human),ARDQPLPDILTGYYTGPLDY,QQYNNWPPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COVA2-12_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 17, 2020","Jun 17, 2020",N/A,Complete
COVA2-13,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2 (weak),SARS-CoV1,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVETGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLDTMGGMDVWGQGTRVTVSS,EIVMTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPGTFGQGTKVEIK,IGHV3-53 (Human),IGHJ6 (Human),IGKV3-20 (Human),IGKJ1 (Human),ARDLDTMGGMDV,QQYGSSPGT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COVA2-13_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 17, 2020","Jun 17, 2020",N/A,Complete
COVA2-14,Ab,"SARS-CoV1,SARS-CoV2",,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAIIWVRQAPGQGLEWMGGIIPIFGTANYAQKFQGRVTITTDESTSTAYMELSSLRSEDTAVYYCARVRYYDSSGYYEDYWGQGTLVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQEPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPPMYTFGQGTKVEIK,IGHV1-69 (Human),IGHJ4 (Human),IGKV3-11 (Human),IGKJ1 (Human),ARVRYYDSSGYYEDY,QQRSNWPPMYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COVA2-14_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 17, 2020","Jun 17, 2020",N/A,Complete
COVA2-15,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,SARS-CoV1,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWASAISGSGGSTYYADSVEGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDTGYCGDDCYIKLIRGGPDYWGQGTLVTVSS,DIVMTQSPLSLPVTLGQPASISCRSSQSLVYSDGNTFLNWFQQRPGQSPRRLIYQVSNRDSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQGTHWPRTFGQGTKLEIK,IGHV3-23 (Human),IGHJ4 (Human),IGKV2-30 (Human),IGKJ2 (Human),AKDTGYCGDDCYIKLIRGGPDY,MQGTHWPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COVA2-15_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 17, 2020","Jun 17, 2020",N/A,Complete
COVA2-16,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGATVKISCKVSGYTFTDYYMHWVQQAPGKGLEWMGLVDPEDGETIYAEKFQGRVTITADTSTDTAYMELSSLRSEDTAVYYCASSDSSGFVGSRGFDYWGQGTRVTVSS,DIQLTQSPSSLSASVGDRVTITCRASQGIRNDLGWYQQKPGKAPKRLIYAASSLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCLQHNSYPPLFGQGTKVEIK,IGHV1-69 (Human),IGHJ4 (Human),IGKV1-17 (Human),IGKJ1 (Human),ASSDSSGFVGSRGFDY,LQHNSYPPL,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COVA2-16_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 17, 2020","Jun 17, 2020",N/A,Complete
COVA2-17,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGAEVKKPGSSVKVSCKASGGTFSSYGINWVRQAPGQGLEWMGGIIPIFGTANYAQKFQGRVTITTDESTSTAYMELSSLRSEDTAVYYCASFGDDSGDEGVRWGQGTLVTVSS,EIVMTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPPYTFGQGTKVEIK,IGHV1-69 (Human),IGHJ4 (Human),IGKV3-11 (Human),IGKJ1 (Human),ASFGDDSGDEGVR,QQRSNWPPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COVA2-17_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 17, 2020","Jun 17, 2020",N/A,Complete
COVA2-18,Ab,"SARS-CoV1,SARS-CoV2",,SARS-CoV2,SARS-CoV1,S; non-RBD,B-cells; SARS-CoV2 Human Patient,EVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGIIPIFGTTNYAQKFQGRVTITTDESTSTAYMELSSLRSEDTAVYYCARVYSYDSSGYYLEYWGQGTRVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPPSITFGQGTRLEIK,IGHV1-69 (Human),IGHJ4 (Human),IGKV3-11 (Human),IGKJ5 (Human),ARVYSYDSSGYYLEY,QQRSNWPPSIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COVA2-18_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 17, 2020","Jun 17, 2020",N/A,Complete
COVA2-20,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCASPLLLTPPDYYYYMDVWGKGTMVTVSS,DVVMTQSPSSLSVSVGDRVTITCRASQGIRNDLGWYQQKPGKAPKRLIYAASSLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCLQHNSYLWTFGQGTKLEIK,IGHV3-53 (Human),IGHJ6 (Human),IGKV1-17 (Human),IGKJ1 (Human),ASPLLLTPPDYYYYMDV,LQHNSYLWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COVA2-20_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 17, 2020","Jun 17, 2020",N/A,Complete
COVA2-22,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGPGLVKPSETLSLTCTVSGGSISSYYWSWIRQPAGKGLEWIGRIYTSGSTNYNPSLKSRVTMSVDTSKNQFSLKLSSVTAADTAVYYCARWKYNDRFDYWGQGTRVTVSS,AIRMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPITFGQGTRLEIK,IGHV4-4 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ5 (Human),ARWKYNDRFDY,QQYDNLPIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COVA2-22_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 17, 2020","Jun 17, 2020",N/A,Complete
COVA2-23,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGIIPIFGTANYAQKFQGRVTITTDESTSTAYMELSSLRSEDTAVYYCARGPRYCSSTSCYAGVYFDYWGQGTRVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPGVTFGGGTKLEIK,IGHV1-69 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ4 (Human),ARDGFGDVEEMATIKDAFDI,QQYGSSPGVT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COVA2-23_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 17, 2020","Jun 17, 2020",N/A,Complete
COVA2-24,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVQSGAEVKKPGESLRISCKGSGYSFTSYWISWVRQMPGKGLEWMGRIDPSDSYTNYSPSFQGHVTISADKSISTAYLQWSSLKASDTAMYYCARPNPAGGYDSSGWVDAFDIWGQGTRVTVSS,AIRMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPQTFGQGTKLEIK,IGHV5-10-1 (Human),IGHJ3 (Human),IGKV1-39 (Human),IGKJ2 (Human),ARPNPAGGYDSSGWVDAFDI,QQSYSTPQT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COVA2-24_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 17, 2020","Jun 17, 2020",N/A,Complete
COVA2-25,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGAEVKKPGASVKVSCKVSGYTLPELSMHWVRQTPGKGLEWMGGFDPEDGETIYAQKFQGRVTMTEDTSTDTAYMELSSLRSEDTAVYYCATGPTIAAAATNWFDPGGQGTLVTVSS,QPVLTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSRSGDTASLTISGLQAEDEADYYCSSYTSSSTWVFGGGTKLTVL,IGHV1-24 (Human),IGHJ5 (Human),IGLV2-14 (Human),IGLJ3 (Human),ATGPTIAAAATNWFDP,SSYTSSSTWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COVA2-25_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 17, 2020","Jun 17, 2020",N/A,Complete
COVA2-26,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVKPGGSLRLSCAASGFTFSNAWMSWVRQAPGKGLEWVGRIKSKTDGGTTDYAAPVKGRFTISRDDSKNTLYLQMNSLKTEDTAVYYCTTDRGDSYGYYYCMDVWGKGTRVTVSS,QLVLTQPPSVSVSPGQTASITCSGDKLGDKYACWYQQKPGQSPVLVIYQDSKRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCQAWDSSTAVVFGGGTKLTVL,IGHV3-15 (Human),IGHJ6 (Human),IGLV3-1 (Human),IGLJ3 (Human),TTDRGDSYGYYYCMDV,QAWDSSTAVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COVA2-26_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 17, 2020","Jun 17, 2020",N/A,Complete
COVA2-28,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVIWYDGSNKYYADSVKGRFTISRDNSKNTLYLQMDSLRAEDTAMYYCAKDKAPPCSSGWYYFDYWGQGTLVTVSS,EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQHKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNYWPLITFGQGTRLEIK,IGHV3-33 (Human),IGHJ4 (Human),IGKV3-15 (Human),IGKJ5 (Human),AKDKAPPCSSGWYYFDY,QQYNYWPLIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COVA2-28_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 17, 2020","Jun 17, 2020",N/A,Complete
COVA2-29,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,SARS-CoV1,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGVVQPGRSLRLSCAASGFTFSSYTMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCASLPVVPAAIGPLPAFDIWGQGTMVTVSS,DIVMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPRTFGQGTKVEIK,IGHV3-30 (Human),IGHJ3 (Human),IGKV1-39 (Human),IGKJ1 (Human),ARGVEDPVVPAAIPWCWFDP,QQSYSTPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COVA2-29_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 17, 2020","Jun 17, 2020",N/A,Complete
COVA2-30,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGPGLVKPSQTLSLTCTVSGGSISSGDYYWSWIRQPPGKGLEWIGYIYYSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARGVEDPVVPAAIPWCWFDPWGQGTRVTVSS,QSVLTQPPSVSVAPGQTARITCGGNNIGSKSVHWYQQKPGQAPVLVVYDDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWASSSVVFGGGTKLTVL,IGHV4-30-4 (Human),IGHJ5 (Human),IGLV3-21 (Human),IGLJ3 (Human),ASLPVVPAAIGPLPAFDI,QVWASSSVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COVA2-30_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 17, 2020","Jun 17, 2020",N/A,Complete
COVA2-31,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGVEVKKPGASVKVSCKAFGYTFTGQDMHWVRQAPGQGLEWMGWINPSSAGTNYAQKFQGRVTMTRDTSISTAYMELSRLRSDDTSVYYCRKMLTIFGKVNQTMLLISGAKGQWSPSLQWGQGTMVTVSS,DIVMTQTPLSLSVTPGQPASISCKSGQSLLHSDGKTYLYWYLQKPGQPPQLLIYEVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQSIQLPPTFGQGTKVEIK,IGHV1-2 (Human),IGHJ3 (Human),IGKV2D-29 (Human),IGKJ1 (Human),RKMLTIFGKVNQTMLLISGAKGQ,MQSIQLPPT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 17, 2020","Jun 17, 2020",N/A,Complete. Homology modelling failed due to lack of suitable CDRH3 templates
COVA2-32,Ab,"SARS-CoV1,SARS-CoV2",,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGIIPIFGTANYAQKFQGRATITTDESTSTAYMELSSLGSEDTAVYYCARTHSYDNSGQYFDYWGQGTMVTVSS,DIVMTQSPATLSLSPGERATLSCRASQSVSSFLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPPRLTFGGGTKVDIK,IGHV1-69 (Human),IGHJ4 (Human),IGKV3-11 (Human),IGKJ4 (Human),ARTHSYDNSGQYFDY,QQRSNWPPRLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COVA2-32_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 17, 2020","Jun 17, 2020",N/A,Complete
COVA2-33,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGESLRISCKGSGYSFTSHWISWVRQMPGKGLEWMGRIDPSDSYTNYSPSFQGHVTISADKSISTAYLQWSSLKASDTAMYYCARLKVITIFGVVRDDYGMDVWGQGTTVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGSYNLVSWYQQHPGKAPKLMIYDSSKRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCCSYAGSVFGGGTKLTVL,IGHV5-10-1 (Human),IGHJ6 (Human),IGLV2-23 (Human),IGLJ3 (Human),ARLKVITIFGVVRDDYGMDV,CSYAGSV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COVA2-33_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 17, 2020","Jun 17, 2020",N/A,Complete
COVA2-34,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARSASGSYYGAFDYWGQGTLVTVSS,QTVVTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSTLGLYVFGTGTKVTVL,IGHV3-30 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ1 (Human),ARSASGSYYGAFDY,SSYTSSSTLGLYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COVA2-34_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 17, 2020","Jun 17, 2020",N/A,Complete
COVA2-37,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGAEVKKPGASVKVSCKVSGYTLPELSMHWVRQAPGKGLDWMGGFDPEDGETIYAQKFQGRVTMTEDTSTDTAYMELSSLRSEDTAVYYCATSPAVMSVGWVDPWGQGTLVTVSS,QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWYQQLPGTAPKVLIYDNNNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSSLSGSVFGGGTKLTVL,IGHV1-24 (Human),IGHJ5 (Human),IGLV1-40 (Human),IGLJ3 (Human),ATSPAVMSVGWVDP,QSYDSSLSGSV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COVA2-37_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 17, 2020","Jun 17, 2020",N/A,Complete
COVA2-38,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLQQSGPGLVKPSETLPLTCTVSGGSISSSSYYWGWIRQPPGKGLEWIGSVFYSGSTYYNPSLKSRVTISVDTSKNQLSLKLSSVTAADTAVYYCARQVRQWLEDDAFDIWGQGTMVTVSS,DIQLTQSPSSLSASVGDRVTITCRASQGIRNDLGWYQQKPGKAPKRLIYAASSLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCLQHNSYPLTFGGGTKVDIK,IGHV4-39 (Human),IGHJ3 (Human),IGKV1-17 (Human),IGKJ4 (Human),ARQVRQWLEDDAFDI,LQHNSYPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COVA2-38_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 17, 2020","Jun 17, 2020",N/A,Complete
COVA2-39,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVETGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYTGGTTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARAHVDTAMVESGAFDIWGQGTRVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGSYNLVSWYQQHPGKAPKLMIYEVTKRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCCSYAGSSTWVFGGGTKLTVL,IGHV3-53 (Human),IGHJ3 (Human),IGLV2-23 (Human),IGLJ3 (Human),ARAHVDTAMVESGAFDI,CSYAGSSTWV,https://www.rcsb.org/structure/7JMP,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 17, 2020","Jul 31, 2020",Added expected structure,Tracking PDB for solved structure
COVA2-40,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSGTLSLTCAVSGGSISSSNWWSWVRQPPGKGLEWIGEIYHSGSSNYNPSLKSRVTISVDKSKNQFSLKLNSVTAADTAVYYCAGRYCSGGRCGWFDPWGQGTLVTVSS,QSVLTQPASVSGSPGQSITISCTGTSSDVGSYNLVSWYQQHPGKAPKLMIYEASKRPSGISNRFSGSKSGNTASLTISGLQAEDEADYYCCSYAGSSTWVFGGGTKPTVL,IGHV4-4 (Human),IGHJ5 (Human),IGLV2-23 (Human),IGLJ3 (Human),AGRYCSGGRCGWFDP,CSYAGSSTWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COVA2-40_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 17, 2020","Jun 17, 2020",N/A,Complete
COVA2-41,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVKPGGSLRLSCSASGFTFSNYNMDWVRQAPGKGLEWVSSISSSSSYIYLADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARVQKDIVVVPVALADYYYYGMDVWGQGTTVTVSS,DIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQPEDFAVYYCQQCYNWPPWTFGQGTRVEFK,IGHV3-21 (Human),IGHJ6 (Human),IGKV3-15 (Human),IGKJ1 (Human),ARVQKDIVVVPVALADYYYYGMDV,QQCYNWPPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COVA2-41_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 17, 2020","Jun 17, 2020",N/A,Complete
COVA2-43,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQPGAEVKKPGASVKVSCKASGYTFTSYGISWVRQAPGQGLEWMGWISAYNGDTNYAQKLQGRVTMTTDTSTSTAYMELRSLKSDDTAVYYCARFDYGYPYSSWSVLSIDYWGQGTLVTVSS,DIVMTQSPSSLSASVGDRVTITCRASQGIRNDLGWYQQKPGKAPKRLIYAASSLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCLQHNSYPLTFGGGTKLEIK,IGHV1-18 (Human),IGHJ4 (Human),IGKV1-17 (Human),IGKJ4 (Human),ARFDYGYPYSSWSVLSIDY,LQHNSYPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COVA2-43_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 17, 2020","Jun 17, 2020",N/A,Complete
COVA2-44,Ab,"SARS-CoV1,SARS-CoV2",,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSYKYYADSVKGRFTISRDNSKNTLYLQMNSLTAEDTAVYYCAREGSRQWLVIYFDYWGQGTLVTVSS,AIRMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYTTFIYTFGQGTKLEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ2 (Human),AREGSRQWLVIYFDY,QQSYTTFIYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COVA2-44_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 17, 2020","Jun 17, 2020",N/A,Complete
COVA2-45,Ab,SARS-CoV2,,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLLESGAEVKKPGASVKISCKASGYTFTGYYMHWVRQAPGQGLEWMGWINPNSGGTNYAQKFQGRVTMTRDTSISTAYMELSRLRSDDTAVYYCARGDGDYYDSSGYYRPTLYNWLDPWGQGTRVTVSS,DIVMTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPYTFGQGTKVEIK,IGHV1-2 (Human),IGHJ5 (Human),IGKV3-20 (Human),IGKJ1 (Human),ARGDGDYYDSSGYYRPTLYNWLDP,QQYGSSPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COVA2-45_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 17, 2020","Jun 17, 2020",N/A,Complete
COVA2-46,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSETLSLTCTASGGSISSSSYYWGWIRQPPGKGLEWIGSIYYSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARHPSGLYQLLNWGQGTLVTVSS,AIRMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLLSLTFGGGTKVEIK,IGHV4-39 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ4 (Human),ARHPSGLYQLLN,QQYDNLLSLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COVA2-46_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 17, 2020","Jun 17, 2020",N/A,Complete
COVA2-47,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGRSLRLSCAASGFTFDDYAMHWVRQAPGKGLEWVSGISWNSGSIGYADSVKGRFTISRDSAKNSLYLQMNSLRAEDTALYYCAKVATYYYDRSGYYYGGALDYWGQGTLVTVSS,EIVLTQSPDSLAVSLGERATINCKSSQSVLYSSNNKNYLAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTHFTLTISSLQAEDVAVYYCQQYYSTPPLTFGGGTKVDIK,IGHV3-9 (Human),IGHJ4 (Human),IGKV4-1 (Human),IGKJ4 (Human),AKVATYYYDRSGYYYGGALDY,QQYYSTPPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COVA2-47_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 17, 2020","Jun 17, 2020",N/A,Complete
COVA3-01,Ab,"SARS-CoV1,SARS-CoV2",,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGPGLVKPSETLSLTCTVSGGSISSYYWSWIRQPPGKGLEWIGYIYYSGSTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARGPAATYYYYMDVWGKGTRVTVSS,EIVMTQSPSSLSASVGDRVTITCRASQSMSSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTLTFGGGTKVEIK,IGHV4-59 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ4 (Human),ARGPAATYYYYMDV,QQSYSTLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COVA3-01_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 17, 2020","Jun 17, 2020",N/A,Complete
COVA3-03,Ab,"SARS-CoV1,SARS-CoV2",,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSTISGSGGNTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKEIAVAGCFDYWGQGTLVTVSS,QTVVTQPPSVSVSPGQTARITCSGDALPKQYAYWYQQKPGQAPVLVIYKDSERPSGIPERFSGSSSGTTVTLTISGVQAEDEADYYCQSADSSGTYRVFGGGTKLTVL,IGHV3-23 (Human),IGHJ4 (Human),IGLV3-25 (Human),IGLJ3 (Human),AKEIAVAGCFDY,QSADSSGTYRV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COVA3-03_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 17, 2020","Jun 17, 2020",N/A,Complete
COVA3-04,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVIWYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARVGSVKSTAGYDFWSGDPFDYWGQGTLVTVSS,QPVLTQPPSVSVAPGQTARITCGGNNIGSKSVHWYQQKPGQAPVLVVYDDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDSSSDHYVFGTGTKVTVL,IGHV3-33 (Human),IGHJ4 (Human),IGLV3-21 (Human),IGLJ1 (Human),ARVGSVKSTAGYDFWSGDPFDY,QVWDSSSDHYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COVA3-04_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 17, 2020","Jun 17, 2020",N/A,Complete
COVA3-05,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKVSGYTLTELSMHWVRQAPGKGLEWMGGFDPEDGETIYAQKFQGRVTMTEDTSTDTAYMELSSLRSEDTAVYYCATAYSVDTAMVRGVGYWGQGTLVTVSS,NFMLTQPPSASGTPGQRVTISCSGSSSNIGSNTVNWYQQLPGTAPKLLIYSNNQRPSGVPDRFSGSKSGTSASLAISGLQSEDEADYYCAAWDDSLNGPHWVFGGGTKLTVL,IGHV1-24 (Human),IGHJ4 (Human),IGLV1-44 (Human),IGLJ3 (Human),ATAYSVDTAMVRGVGY,AAWDDSLNGPHWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COVA3-05_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 17, 2020","Jun 17, 2020",N/A,Complete
COVA3-06,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESRAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGRIIPILGITNYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCARDAPDYYDSSGPTYFDYWGQGTLVTVSS,DVVMTQSPDSLAVSLGERATINCKSSQSVLYSSNNKNYLAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYSTPLTFGGGTKVDIK,IGHV1-69 (Human),IGHJ4 (Human),IGKV4-1 (Human),IGKJ4 (Human),ARDAPDYYDSSGPTYFDY,QQYYSTPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COVA3-06_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 17, 2020","Jun 17, 2020",N/A,Complete
COVA3-07,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGLVQPGRSLRLSCAASGFTFDDYAMHWVRQAPGKGLEWVSGISWNSGSIGYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTALYYCAKAEPEVGGYDYYMDVWGKGTMVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPFTFGPGTKLEIK,IGHV3-9 (Human),IGHJ6 (Human),IGKV3-20 (Human),IGKJ3 (Human),AKMGPDPAHDYGRKNDAFDI,QQYGSSPFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COVA3-07_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 17, 2020","Jun 17, 2020",N/A,Complete
COVA3-08,Ab,"SARS-CoV1,SARS-CoV2",,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGPGLVKPSETLSLTCTVSGGSISSYYWSWIRQPPGKGLEWIGYIYYSGSTNYNPSLKSRVTISVDTSKNQFSLRLSSVTAADTAVYYCARGPAATYYYYMDVWGKGTMVTVSS,DIVMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPLTFGPGTKLEIK,IGHV4-59 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ4 (Human),ARGPAATYYYYMDV,QQSYSTPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COVA3-08_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 17, 2020","Sep 10, 2020",CDRH3 Entry Corrected,Complete
COVA3-09,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGRSLRLSCAASGFTFDDYAMHWVRQAPGKGLEWVSGISWNSGSIGYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTALYYCAKMGPDPAHDYGRKNDAFDIWGQGTMVTVSS,DIVMTQSPSSLSASVGDRVTITCRASQSMSSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTLTFGGGTKLEIK,IGHV3-9 (Human),IGHJ3 (Human),IGKV1-39 (Human),IGKJ4 (Human),AKAEPEVGGYDYYMDV,QQSYSTLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COVA3-09_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 17, 2020","Sep 10, 2020",CDRH3 Entry Corrected,Complete
COVA3-10,Ab,"SARS-CoV1,SARS-CoV2",,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESRAEMKKPGESLKISCKGSGYTFTNHWIAWVRQMPGKGLEWMGIIYPGDSDTRYSPSFEGQVTISADKSISTAYLQWSSLKASDTAMYYCARRGYTYGADFYGLDVWGQGTRVTVSS,DIVMTQSPDSLAVSLGERATINCKSSQSVLYSSNNKNYLAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYSTPITFGQGTRLEIK,IGHV5-51 (Human),IGHJ6 (Human),IGKV4-1 (Human),IGKJ5 (Human),ARRGYTYGADFYGLDV,QQYYSTPIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/COVA3-10_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 17, 2020","Jun 17, 2020",N/A,Complete
C002,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,SARS-CoV1,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGVVQPGRSLRLSCAASGFTFSIYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKEGRPSDIVVVVAFDYWGQGTLVTVSS,DIQLTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPRTFGQGTKVEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ1 (Human),AKEGRPSDIVVVVAFDY,QQSYSTPRT,https://www.rcsb.org/structure/7K8S; https://www.rcsb.org/structure/7K8T; https://www.rcsb.org/structure/7K8U; https://www.rcsb.org/structure/7K8O,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 18, 2020","Feb 12, 2021",1st June: Added sequence data from latest preprint version; 22nd October: Added PDB Structure; 12th Feb: Added PDB structure,Complete
C003,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2 (weak),SARS-CoV1,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAGDTAVYYCARDYGDFYFDYWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSTYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPRTFGQGTKLEIK,IGHV3-53 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ2 (Human),ARDYGDFYFDY,QQYGSSPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C003_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Jun 1, 2020",Added sequence data from latest preprint version.,Complete
C004,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,SARS-CoV1,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTGYYMHWVRQAPGQGLEWMGWINPISGGTNYAQKFQGRVTMTRDTSISTAYMELSRLRSDDTAVYYCASPASRGYSGYDHGYYYYMDVWGKGTTVTVSS,AIRMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPITFGQGTRLEIK,IGHV1-2 (Human),IGHJ6 (Human),IGKV1-33 (Human),IGKJ5 (Human),ASPASRGYSGYDHGYYYYMDV,QQYDNLPIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C004_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Jun 1, 2020",Added sequence data from latest preprint version.,Complete
C005,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,SARS-CoV1,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGPEVKKPGTSVKVSCKASGFTFTSSAVQWVRQARGQRLEWIGWIVVGSGNTNYAQKFQERVTITRDMSTSTAYMELSSLRSEDTAVYYCAAPHCSGGSCLDAFDIWGQGTMVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVRSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK,IGHV1-58 (Human),IGHJ3 (Human),IGKV3-20 (Human),IGKJ1 (Human),AAPHCSGGSCLDAFDI,QQYGSSPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C005_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Jun 1, 2020",Added sequence data from latest preprint version.,Complete
C006,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2 (weak),SARS-CoV1,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGLVKPGGSLRLSCAASGFIFSDYCMSWIRRAPGKGLEWLSYISNSGTTRYYADSVKGRFTISRDNGRNSLYLQMDSLSAEDTAVYYCARRGDGSSSIYYYNYMDVWGKGTTVTVSS,QSVLTQPPSASGTPGQRVTVSCSGSSSNIGSNTVNWYQQLPGTAPKLLIYSNNQRPSGVPDRFSGSKSGTSASLAISGLQSEDEADYFCAAWDDSLNGPVFGGGTKLTVL,IGHV3-11 (Human),IGHJ6 (Human),IGLV1-44 (Human),IGLJ3 (Human),ARRGDGSSSIYYYNYMDV,AAWDDSLNGPV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C006_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Jun 1, 2020",Added sequence data from latest preprint version.,Complete
C008,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2 (weak),SARS-CoV1,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVTVISYDGRNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAREFGDPEWYFDYWGQGTLVTVSS,DIQMTQSPSTLSASVGDRVTITCRANQSISSWLAWYQQKPGKAPKLLIYKASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNSYWTFGQGTKVEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV1-5 (Human),IGKJ1 (Human),AREFGDPEWYFDY,QQYNSYWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C008_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Jun 1, 2020",Added sequence data from latest preprint version.,Complete
C009,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,SARS-CoV1,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCMASGYTFTGYYMHWVRQAPGQGLEWMGWINPNSGGTNYAQKFQGRVTMTRDTSISTAYMELSRLRSDDTAVYYCARDSPFSALGASNDYWGQGTLVTVSS,QSALTQPPSASGSPGQSVTISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYEVSKRPSGVPDRFSGSKSGNTASLTVSGLQAEDEAEYYCSSDAGSNNVVFGGGTKLTVL,IGHV1-2 (Human),IGHJ4 (Human),IGLV2-8 (Human),IGLJ3 (Human),ARDSPFSALGASNDY,SSDAGSNNVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C009_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Jun 1, 2020",Added sequence data from latest preprint version.,Complete
C010,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPAKGLEWVAVILYDGSGKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDGIVDTALVTWFDYWGQGTLVTVSS,DIQLTQSPSSLSASVGDRVTITCRASQSISTYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPPWTFGQGTKVEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ1 (Human),ARDGIVDTALVTWFDY,QQSYSTPPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C010_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Jun 1, 2020",Added sequence data from latest preprint version.,Complete
C013,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2 (weak),SARS-CoV1,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGIIPIFGTANYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYCARGNRLLYCSSTSCYLDAVRQGYYYYYYMDVWGKGTTVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPLTFGGGTKVEIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV3-11 (Human),IGKJ4 (Human),ARGNRLLYCSSTSCYLDAVRQGYYYYYYMDV,QQRSNWPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C013_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Jun 1, 2020",Added sequence data from latest preprint version.,Complete
C016,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGVVQPGRSLRLSCAASGFTFSRYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKVTAPYCSGGSCYGGNFDYWGQGTLVTVSS,AIRMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTINSLQPEDIATYYCQQYDNLPPTFGGGTKVEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ4 (Human),AKVTAPYCSGGSCYGGNFDY,QQYDNLPPT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C016_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Jun 1, 2020",Added sequence data from latest preprint version.,Complete
C017,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,SARS-CoV1,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGRSLRLSCAASGFTFDDYAMHWVRQAPGKGLEWVSGISWNSGTIGYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAFYYCAKAGVRGIAAAGPDLNFDHWGQGTLVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRITFGQGTRLEIK,IGHV3-9 (Human),IGHJ4 (Human),IGKV3-11 (Human),IGKJ5 (Human),AKAGVRGIAAAGPDLNFDH,QQRIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C017_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Jun 1, 2020",Added sequence data from latest preprint version.,Complete
C018,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGVVQPGRSLRLSCAASGFTFSNYAIHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDFDDSSFWAFDYWGQGTLVTVSS,DIQLTQSPSSLSASVGDRVTITCRASQSIRSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPDDFATYYCQQSYSTPPATFGQGTKLEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ2 (Human),ARDFDDSSFWAFDY,QQSYSTPPAT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C018_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Jun 1, 2020",Added sequence data from latest preprint version.,Complete
C019,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYYMHWVRQAPGQGLEWMGIINPSGGSTSYAQKFQGRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARVPREGTPGFDPWGQGTLVTVSS,SYELTQPPSVSVAPGKTARITCGENNIGSKSVHWYQQKPGQAPVLVIYYDSDRPSGIPERFSGSNSGNTATLTINRVEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,IGHV1-46 (Human),IGHJ5 (Human),IGLV3-21 (Human),IGLJ3 (Human),ARVPREGTPGFDP,QVWDSSSDHVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C019_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Jun 1, 2020",Added sequence data from latest preprint version.,Complete
C021,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSQTLSLTCTVSGGSISSGGYYWSWIRQHPGKGLEWIGYIYYSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARVWQYYDSSGSFDYWGQGTLVTVSS,DIVMTQSPLSLPVTPGEPASISCRSSQSLLHSNGYNYLDWYLQKPGQSPQLLIYLGSNRASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQALQTPFTFGPGTKVDIK,IGHV4-31 (Human),IGHJ4 (Human),IGKV2-28 (Human),IGKJ3 (Human),ARVWQYYDSSGSFDY,MQALQTPFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C021_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Jun 1, 2020",Added sequence data from latest preprint version.,Complete
C022,Ab,"SARS-CoV1,SARS-CoV2",,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSETLSVTCTVSGGSISSSRYYWGWIRQPPGKGLEWIGSIYYSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARHAAAYYDRSGYYFIEYFQHWGQGTLVTVSS,DIQMTQSPSTLSASVGDSVTITCRASQSISSWLAWYQQKPGKAPKLLIYKASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNNYRYTFGQGTKLEIK,IGHV4-39 (Human),IGHJ1 (Human),IGKV1-5 (Human),IGKJ2 (Human),ARHAAAYYDRSGYYFIEYFQH,QQYNNYRYT,Expected,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C022_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","May 5, 2021",5th May '21: Added expected structure,Complete
C027,Ab,"SARS-CoV1 (weak), SARS-CoV2",,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKASGIYCSGGDCYSYYFDYWGQGTLVTVSS,DIQMTQSPSTLSASVGDRVTITCRASQSISSWLAWYQQKPGKAPKLLIYKASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNSYSTFGQGTKVEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV1-5 (Human),IGKJ1 (Human),AKASGIYCSGGDCYSYYFDY,QQYNSYST,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C027_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Jun 1, 2020",Added sequence data from latest preprint version.,Complete
C029,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSQTLSLTCTVSGGSISSGGYYWSWIRQHPGKGLEWIGYIYYSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARTMYYYDSSGSFDYWGQGTLVTVSS,DIVMTQSPLSLPVTPGEPASISCRSSQSLLHSNGYNYLDWYLQKPGQSPQLLIYLGSNRASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQALQTPHTFGGGTKVEIK,IGHV4-31 (Human),IGHJ4 (Human),IGKV2-28 (Human),IGKJ4 (Human),ARTMYYYDSSGSFDY,MQALQTPHT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C029_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Jun 1, 2020",Added sequence data from latest preprint version.,Complete
C030,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKASGIYCSGGNCYSYYFDYWGQGTLVTVSS,DIQMTQSPSTLSASVGDRVTITCRASQSISSWLAWYQQKPGKAPKLLIYKASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNSYSTFGQGTKVEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV1-5 (Human),IGKJ1 (Human),AKASGIYCSGGNCYSYYFDY,QQYNSYST,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C030_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Jun 1, 2020",Added sequence data from latest preprint version.,Complete
C031,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYDMHWVRQATGKGLEWVSAIGTAGDTYYPGSVKGRFTISRENAKNSLYLQMNSLRAGDTAVYYCARVGYDSSGYSGWYFDLWGRGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKVLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPPLTFGGGTKVEIK,IGHV3-13 (Human),IGHJ2 (Human),IGKV1-39 (Human),IGKJ4 (Human),ARVGYDSSGYSGWYFDL,QQSYSTPPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C031_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Jun 1, 2020",Added sequence data from latest preprint version.,Complete
C101,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,SARS-CoV1,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGLIQPGGSLRLSCAASGFIVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYTDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCVRDYGDFYFDYWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGGGSETDFTLTISRLEPEDCAVYYCQQYGSSPRTFGQGTKVEIK,IGHV3-53 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ1 (Human),VRDYGDFYFDY,QQYGSSPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C101_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Jun 1, 2020",Added sequence data from latest preprint version.,Complete
C102,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,SARS-CoV1,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGLIQPGGSLRLSCAASGFIVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDYGDYYFDYWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPRTFGQGTKVEIK,IGHV3-53 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ1 (Human),ARDYGDYYFDY,QQYGSSPRT,https://www.rcsb.org/structure/7K8M; https://www.rcsb.org/structure/7K8N,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Feb 12, 2021",12th Feb: Moved 7K8O to C002,Complete
C103,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,SARS-CoV1,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQQWGAGLLKPSETLSLTCAVSGGSLSGFYWTWIRQPPGKGLEWIGETNHFGSTGYKPSLKSRVTISVDMSRNQFSLKVTSVTAADTAVYYCARKPLLYSDFSPGAFDIWGQGTMVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQTVTANYLAWYQQKPGQAPRLLIYGASKRATGIPDRFSGSGSGTDFTLSISRLEPEDFAVYYCQQYTTTPRTFGGGTKVEIK,IGHV4-34 (Human),IGHJ3 (Human),IGKV3-20 (Human),IGKJ4 (Human),ARKPLLYSDFSPGAFDI,QQYTTTPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C103_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Jun 1, 2020",Added sequence data from latest preprint version.,Complete
C104,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,SARS-CoV1,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQQWGAGLLKPSETLSLSCAVYGGSLSGYYWSWIRQPPGKGLEWIGEINHFGSTGYNPSLKSRVTISVDTSKSQFSVKLSSVTAADTAVYYCARKPLLYSNLSPGAFDIWGQGTMVTVSS,EIVLTQSPGTVSLSPGERATLSCWASQSVSASYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGTTPRTFGGGTKVEIK,IGHV4-34 (Human),IGHJ3 (Human),IGKV3-20 (Human),IGKJ4 (Human),ARKPLLYSNLSPGAFDI,QQYGTTPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C104_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Jun 1, 2020",Added sequence data from latest preprint version.,Complete
C105,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,SARS-CoV1,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARGEGWELPYDYWGQGTLVTVSS,QSALTQPPSASGSPGQSVTISCTGTSSDVGGYKYVSWYQQHPGKAPKLMIYEVSKRPSGVPDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYEGSNNFVVFGGGTKLTVL,IGHV3-53 (Human),IGHJ4 (Human),IGLV2-8 (Human),IGLJ3 (Human),ARGEGWELPYDY,SSYEGSNNFVV,http://www.rcsb.org/structure/6XCA; http://www.rcsb.org/structure/6XCM; http://www.rcsb.org/structure/6XCN,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Jul 5, 2020",4th June: Added sequence data from latest preprint version. 7th June: Added extra publication reference for expected structure. 26th June: Added new citation with structural characterisation. 5th July: Added PDB structures.,Tracking PDB for release of new structures.
C106,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QLQLQESGPGLVKPSETLSLTCTVSGASVSSGSYYWSWIRQPPGKGLEWIGYIYYSGSTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARERPGGTYSNTWYTPTDTNWFDTWGQGTLVTVSS,SYELTQPPSVSVAPGKTARITCGGNNIGSKSVHWYQQKPGQAPVLVIYFDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDSSRDHVVFGGGTKLTVL,IGHV4-61 (Human),IGHJ4 (Human),IGLV3-21 (Human),IGLJ3 (Human),ARERPGGTYSNTWYTPTDTNWFDT,QVWDSSRDHVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C106_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Jun 1, 2020",Added sequence data from latest preprint version.,Complete
C107,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVRVSCKASGYTFTSYGFSWVRQAPGQGLEWMGWISAYNGNTNFAQKLQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARGEAVAGTTGFFDYWGQGTLVTVSS,QSVLTQPPSASGTPGQRVTISCSGSSSNIGSNYVYWYQQLPGTAPKLLIYRNNQRPSGVPDRFSGSKSGTSASLAISGLRSEDEADYYCAAWDDSLSGFVVFGGGTKLTVL,IGHV1-18 (Human),IGHJ4 (Human),IGLV1-47 (Human),IGLJ3 (Human),ARGEAVAGTTGFFDY,AAWDDSLSGFVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C107_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Jun 1, 2020",Added sequence data from latest preprint version.,Complete
C108,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2 (weak),SARS-CoV1,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSGTLSLTCAVSGGSISSTNWWSWVRQPPGKGLEWIGEIYHTGSTNYNPSLKSRVTISVDKSKNQFSLKLSSVTAADTAVYYCVRDGGRPGDAFDIWGQGTMVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCNSYTSSSTRVFGTGTKVTVL,IGHV4-4 (Human),IGHJ3 (Human),IGLV2-14 (Human),IGLJ1 (Human),VRDGGRPGDAFDI,NSYTSSSTRV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C108_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Jun 1, 2020",Added sequence data from latest preprint version.,Complete
C109,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYWMSWVRQAPGKGLEWVANIKQDGSEKYYVDSVKGRFTISGDNAKNSLYLHMNSLRAEDTAVYYCAIQLWLRGGYDYWGQGTLVTVSS,QSALTQPPSASGSPGQSVTISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYEVTKRPSGVPDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYAGSNNYVVFGGGTKLTVL,IGHV3-7 (Human),IGHJ4 (Human),IGLV2-8 (Human),IGLJ3 (Human),AIQLWLRGGYDY,SSYAGSNNYVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C109_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Jun 1, 2020",Added sequence data from latest preprint version. No neutralisation data for this mAb.,Complete
C110,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,SARS-CoV1,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQQSGAEVKKPGESLKISCKGSGYSFTSYWIGWVRQMPGKGLEWMGIIYPGDSDTRYSPSFQGQVTISADKSISTAYMQWSSLKASDTAMYYCARSFRDDPRIAVAGPADAFDIWGQGTMVTVSS,DIQMTQSPSTLSASVGDRVTITCRASQSISYWLAWYQQKPGKAPKLLIYQASSLESGVPSRFSGSESGTEFTLTISSLQPDDFATYYCQQYNSYPYTFGQGTKLEIK,IGHV5-51 (Human),IGHJ3 (Human),IGKV1-5 (Human),IGKJ2 (Human),ARSFRDDPRIAVAGPADAFDI,QQYNSYPYT,https://www.rcsb.org/structure/7K8P; https://www.rcsb.org/structure/7K8V,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Dec 14, 2020",1st June: Added sequence data from latest preprint version; 22nd October: Added PDB Structure; 14th December: Corrected by moving 7K8M 7K8N 7K8O to C102 and 7K8Q to C121,Complete
C111,Ab,SARS-CoV2,,,,S; RBD,B-cells; SARS-CoV2 Human Patient,QLQLQESGPGLVKPSETLSLTCTVSGGSISSYYWSWIRQPPGKGLEWIGYIYYSGSTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARVEDWGYCSSTNCYSGAFDIWGQGTMVTVSS,QSVLTQPPSVSEAPRQRVTISCSGSSSNIGNNAVNWYQQVPGKAPKLLIYYDDLLPSGVSDRFSGSKSGTSASLAISGLQSEDEADYYCAAWDDSLNGAWVFGGGTKLTVL,IGHV4-59 (Human),IGHJ3 (Human),IGLV1-36 (Human),IGLJ3 (Human),ARVEDWGYCSSTNCYSGAFDI,AAWDDSLNGAWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C111_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Jun 1, 2020",Added sequence data from latest preprint version. No neutralisation data for this mAb.,Complete
C112,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2 (weak),SARS-CoV1,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSHAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAREDYYDSSGSFDYWGQGTLVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSTWVFGGGTKLTVL,IGHV3-30 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ3 (Human),AREDYYDSSGSFDY,SSYTSSSTWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C112_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Jun 1, 2020",Added sequence data from latest preprint version.,Complete
C113,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSNFGMHWVRQAPGKGLEWVAVIWYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARGVNPDDILTGVDAFDIWGQGTMVTVSS,DIQMTQSPSTLSASVGDRVTITCRASQSMSSWLAWYQQKPGNAPKLLIYKASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQHNSSPLTFGGGTKVEIK,IGHV3-33 (Human),IGHJ3 (Human),IGKV1-5 (Human),IGKJ4 (Human),ARGVNPDDILTGVDAFDI,QQHNSSPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C113_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Jun 1, 2020",Added sequence data from latest preprint version.,Complete
C114,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGLIQPGGSLKLSCVVSGFTVSKNYISWVRQAPGKGLEWVSVIFAGGSTFYADSVKGRFAISRDNSNNTLFLQMNSLRVEDTAIYYCARGDGELFFDQWGQGTLVTVSS,QSVLTQPPSVSGAPGQRVTISCTGTSSNIGAGYDVHWYQQLPGRAPKVLISGNNIRPSEVPDRFSGSRSGTSASLAITSLQPEDEAQYYCQSYDSSLYAVFGGGTKLTVL,IGHV3-53 (Human),IGHJ4 (Human),IGLV1-40 (Human),IGLJ3 (Human),ARGDGELFFDQ,QSYDSSLYAV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C114_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Jun 1, 2020",Added sequence data from latest preprint version.,Complete
C115,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2 (weak),SARS-CoV1,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGLIKPGRSLRLSCTASGFTFGDYAMTWFRQAPGKGLEWVGFIRSKAYGGTTGYAASVKYRFTISRDDSKSIAYLQMDSLKTEDTAVYYCTRWDGWSQHDYWGQGTLVTVSS,DIVMTQSPLSLSVTPGEPASISCRSSQSLLHSNGNNYFDWYLQKPGQSPQLLIYLGSNRASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQVLQIPYTFGQGTKLEIK,IGHV3-49 (Human),IGHJ4 (Human),IGKV2-28 (Human),IGKJ2 (Human),TRWDGWSQHDY,MQVLQIPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C115_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Jun 1, 2020",Added sequence data from latest preprint version.,Complete
C116,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTYSTYAMHWVRQAPGKGLEWVAFISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDFYHNWFDPWGQGTLVTVSS,NFMLTQPHSVSESPGKTVTISCTGSSGSIASNYVQWYQQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDRSSNSASLTISGLKTEDEADYYCQSYDSGNHWVVFGGGTRLTVL,IGHV3-30 (Human),IGHJ5 (Human),IGLV6-57 (Human),IGLJ3 (Human),ARDFYHNWFDP,QSYDSGNHWVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C116_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Jun 1, 2020",Added sequence data from latest preprint version.,Complete
C117,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2 (weak),SARS-CoV1,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSTYAMHWVRQAPGEGLEWVAVISYDGSNTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDPIWFGELLSPPFVHFDYWGQGTLVTVSS,QSVLTQPPSVSAAPGQKVTISCSGSSSNIGNNLVSWYQQLPGTAPKLLIYENNKRPSGIPDRFSGSKSGTSATLGITGLQTGDEADYYCGAWDSSLSAGGVYVFGTGTKVTVL,IGHV3-30 (Human),IGHJ4 (Human),IGLV1-51 (Human),IGLJ1 (Human),ARDPIWFGELLSPPFVHFDY,GAWDSSLSAGGVYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C117_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Jun 1, 2020",Added sequence data from latest preprint version.,Complete
C118,Ab,"SARS-CoV1,SARS-CoV2",,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSNYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAIYYCASGYTGYDYFVRGDYYGLDVWGQGTTVTVSS,QPVLTQSPSASASLGASVKLTCTLSSGHSSYAIAWHQQQPEKGPRYLMKLNTDGSHSKGDGIPDRFSGSSSGAERYLTISSLQSEDEADYYCQTWGTGILVFGGGTKLTVL,IGHV3-30 (Human),IGHJ6 (Human),IGLV4-69 (Human),IGLJ3 (Human),ASGYTGYDYFVRGDYYGLDV,QTWGTGILV,Expected,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C118_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","May 5, 2021",5th May '21: Added expected structure,Complete
C119,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,SARS-CoV1,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYYMHWVRQAPGQGLEWMGIINPSGGSTSYAQKLQGRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARANHETTMDTYYYYYYMDVWGKGTTVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGGYKYVSWYQRHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSTSVVFGGGTQLTVL,IGHV1-46 (Human),IGHJ6 (Human),IGLV2-14 (Human),IGLJ3 (Human),ARANHETTMDTYYYYYYMDV,SSYTSSSTSVV,https://www.rcsb.org/structure/7K8W,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Jun 1, 2020",1st June: Added sequence data from latest preprint version; 22nd October: Added PDB Structure,Complete
C120,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,SARS-CoV1,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMTWVRQAPGKGLEWVSLIYPGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAREGMGMAAAGTWGQGTLVTVSS,AIRMTQSPSSLSASVGDTVTITCQASQDISKYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPQTFGGGTKVEIK,IGHV3-53 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ4 (Human),AREGMGMAAAGT,QQYDNLPQT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C120_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Jun 1, 2020",Added sequence data from latest preprint version.,Complete
C121,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,SARS-CoV1,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTGYYMHWVRQAPGQGLEWMGWISPVSGGTNYAQKFQGRVTMTRDTSISTAYMELSRLRSDDTAVYYCARAPLFPTGVLAGDYYYYGMDVWGQGTTVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGSYNLVSWYQQHPGKAPKLMIYEGSKRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCCSYAGSSTLVFGGGTKLTVL,IGHV1-2 (Human),IGHJ6 (Human),IGLV2-23 (Human),IGLJ3 (Human),ARAPLFPTGVLAGDYYYYGMDV,CSYAGSSTLV,https://www.rcsb.org/structure/7K8X; https://www.rcsb.org/structure/7K8Y; https://www.rcsb.org/structure/7K8Q,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Jan 30, 2021",1st June: Added sequence data from latest preprint version; 22nd October: Added PDB Structure; 14th December: Transferred 7K8Q from incorrect assignment to C110. 30th Jan 2021: Added new reference,Complete
C122,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,SARS-CoV1,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLIQPGGSLRLSCAASGLTVSSNYMSWVRQAPGKGLEWVSVLYSGGSSFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARESGDTTMAFDYWGQGTLVTVSS,DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSDSYTFGQGTKLEIK,IGHV3-53 (Human),IGHJ4 (Human),IGKV1-9 (Human),IGKJ2 (Human),ARESGDTTMAFDY,QQLNSDSYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C122_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Jun 1, 2020",Added sequence data from latest preprint version.,Complete
C123,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,SARS-CoV1,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLIQPGGSLRLSCAASGVTVSRNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLSAAFDIWGQGTMVTVSS,DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPPAFGQGTRLEIK,IGHV3-53 (Human),IGHJ3 (Human),IGKV1-9 (Human),IGKJ5 (Human),ARDLSAAFDI,QQLNSYPPA,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C123_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Jun 1, 2020",Added sequence data from latest preprint version.,Complete
C124,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2 (weak),SARS-CoV1,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFSGYSMNWVRQAPGKGPEWVSYISRSSSTIYYADSVKGRFTISRDNAKNSLYLQMNSLRDEDTAVYYCAREGARVGATYDTYYFDYWGQGTLVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSFSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRNNWPPEWTFGQGTKVEIK,IGHV3-48 (Human),IGHJ4 (Human),IGKV3-11 (Human),IGKJ1 (Human),AREGARVGATYDTYYFDY,QQRNNWPPEWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C124_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Jun 1, 2020",Added sequence data from latest preprint version.,Complete
C125,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,SARS-CoV1,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGPEVKKPGTSVKVSCKASGFTFTSSAVQWVRQARGQRLEWIGWIVVGSGNTNYAQKFQERVTITRDMSTSTAYMELSSLRSEDTAVYYCAAPYCSGGSCSDAFDIWGQGTMVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK,IGHV1-58 (Human),IGHJ3 (Human),IGKV3-20 (Human),IGKJ1 (Human),AAPYCSGGSCSDAFDI,QQYGSSPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C125_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Jun 1, 2020",Added sequence data from latest preprint version.,Complete
C126,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSETLSLSCAVSGGSIGSYFWSWIRQPPGKGLEWIGYLHYSGSTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARLQWLRGAFDIWGQGTMVTVSS,NFMLTQPHSVSESPGKTVTISCTGSSGSIASNYVQWYQQRPGSAPTTVINEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSSNLVFGGGTKLTVL,IGHV4-59 (Human),IGHJ3 (Human),IGLV6-57 (Human),IGLJ3 (Human),ARLQWLRGAFDI,QSYDSSNLV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C126_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Jun 1, 2020",Added sequence data from latest preprint version.,Complete
C127,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,SARS-CoV1,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTGYYMHWVRQAPGQGLEWMGWINPNSGGTNYAQKFQGRVTMTRDTSISTAYMELSRLRSDDTAVYYCATAHPRRIQGVFFLGPGVWGQGTTVTVSS,QSVLTQPPSASGTPGQRVTISCSGSSSNIGSNTVNWYQQLPGTAPKLLIYSNNQRPSGVPDRFSGSKSGTSASLAISGLQSEDEADYYCAAWDDSLNGVVFGGGTKLTVL,IGHV1-2 (Human),IGHJ6 (Human),IGLV1-44 (Human),IGLJ3 (Human),ATAHPRRIQGVFFLGPGV,AAWDDSLNGVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C127_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Jun 1, 2020",Added sequence data from latest preprint version.,Complete
C128,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,SARS-CoV1,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLLESGGGLVQPGGSLRLSCAASGFTFSTYAMSWVRQAPGKGLEWVSTITGSGRDTYYADSVKGRFTISRDNSKNTLFLQLNSLRAEDAAVYSCANHPLASGDDYYHYYMDVWGKGTTVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVNSRQLAWYQQKPGQAPRLLIYGASSRATGIPERFSGSGSGTDFTLTISRLESEDFAVYHCQQYGSSRALTFGGGTKVEIK,IGHV3-23 (Human),IGHJ6 (Human),IGKV3-20 (Human),IGKJ4 (Human),ANHPLASGDDYYHYYMDV,QQYGSSRALT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C128_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Jun 1, 2020",Added sequence data from latest preprint version.,Complete
C130,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTNYYMHWVRQAPGQGLEWMGIINPSGGSTGYAQKFQGRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARSRPTPDWYFDLWGRGTLVTVSS,SYELTQPPSVSVAPGKTARITCGGNNIGSKSVHWYQQKPGQAPVLVIYYDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDSSSDHPGVVFGGGTKLTVL,IGHV1-46 (Human),IGHJ2 (Human),IGLV3-21 (Human),IGLJ3 (Human),ARSRPTPDWYFDL,QVWDSSSDHPGVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C130_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Jun 1, 2020",Added sequence data from latest preprint version.,Complete
C131,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,SARS-CoV1,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGSEVKKPGSSVKVSCKASGGTFSSYAFSWVRQAPGQGLEWMGRIIPILALANYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCARVNQAVTTPFSMDVWGQGTTVTVSS,EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNWPITFGQGTRLEIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV3-15 (Human),IGKJ5 (Human),ARVNQAVTTPFSMDV,QQYNNWPIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C131_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Jun 1, 2020",Added sequence data from latest preprint version.,Complete
C132,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2 (weak),SARS-CoV1,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSGTLSLTCAVSGGSISSNNWWSCVRQPPGKGLEWIGEIYHSGSTNYNPSLKSRVTISVDKSKNQFSLKLSSVTAADTAVYYCARGGDTAMGPEYFDYWGQGTLVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSTLLFGGGTKLTVL,IGHV4-4 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ3 (Human),ARGGDTAMGPEYFDY,SSYTSSSTLL,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C132_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Jun 1, 2020",Added sequence data from latest preprint version.,Complete
C133,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVILYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDSDVDTSMVTWFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPPWTFGQGTKVEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ1 (Human),ARDSDVDTSMVTWFDY,QQSYSTPPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C133_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Jun 1, 2020",Added sequence data from latest preprint version.,Complete
C134,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLLESGGGLVQPGGSLRLSCAASGFTFSNYAMSWVRQAPGKGLEWVSAISGSDGSTYYAGSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDPLITGPTYQYFHYWGQGTLVTVSS,SYELTQPPSVSVAPGKTARITCGGNNIGSKSVHWYQQKPGQAPVLVIYYDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEAEYHCQVWDSSSDRPGVVFGGGTKLTVL,IGHV3-23 (Human),IGHJ4 (Human),IGLV3-21 (Human),IGLJ3 (Human),AKDPLITGPTYQYFHY,QVWDSSSDRPGVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C134_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Jun 1, 2020",Added sequence data from latest preprint version.,Complete
C135,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,SARS-CoV1,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVIPFDGRNKYYADSVTGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCASSSGYLFHSDYWGQGTLVTVSS,DIQMTQSPSTLSASVGDRVTITCRASQSISNWLAWFQQKPGKAPKLLIYEASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNSYPWTFGQGTKVEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV1-5 (Human),IGKJ1 (Human),ASSSGYLFHSDY,QQYNSYPWT,https://www.rcsb.org/structure/7K8R; https://www.rcsb.org/structure/7K8Z,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Jul 24, 2021",1st June: Added sequence data from latest preprint version; 22nd October: Added PDB Structure. 30th January 2021: Added new reference. 24th July '21: Added publication with animal trial data,Complete
C138,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFSTYWMSWVRQPPGKGLEWVANIKQDGSEKYYVDSVKGRFTISRDNAKNSLYLQMNSLRADDTAVYYCAGGTWLRSSFDYWGQGTLVTVSS,NFMLTQPHSVSESPGKTVTISCTGSSGSIASNYVQWYQQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSSNWVFGGGTKLTVL,IGHV3-7 (Human),IGHJ4 (Human),IGLV6-57 (Human),IGLJ3 (Human),AGGTWLRSSFDY,QSYDSSNWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C138_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Jun 1, 2020",Added sequence data from latest preprint version.,Complete
C139,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYSADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKGGAYSYYYYMDVWGKGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPLTFGGGTKVEIK,IGHV3-30-3 (Human),IGHJ6 (Human),IGKV1-33 (Human),IGKJ4 (Human),AKGGAYSYYYYMDV,QQYDNLPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C139_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Jun 1, 2020",Added sequence data from latest preprint version.,Complete
C140,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,SARS-CoV1,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGVTVSSNYMSWVRQAPGKGLEWVSLIYSGGSTFYADSVKGRFTISRDNSENTLYLQMNTLRAEDTAVYYCARDLYYYGMDVWGQGTTVTVSS,DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYSYTFGQGTKLEIK,IGHV3-66 (Human),IGHJ6 (Human),IGKV1-9 (Human),IGKJ2 (Human),ARDLYYYGMDV,QQLNSYSYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C140_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Jun 1, 2020",Added sequence data from latest preprint version.,Complete
C141,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMFWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARADLGYCTNGVCYVDYWGQGTLVTVSS,NFMLTQPHSVSESPGKTVTISCTGSSGSIASNYVQWYQQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSSNWVFGGGTKLTVL,IGHV3-30 (Human),IGHJ4 (Human),IGLV6-57 (Human),IGLJ3 (Human),ARADLGYCTNGVCYVDY,QSYDSSNWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C141_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Jun 1, 2020",Added sequence data from latest preprint version.,Complete
C143,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFSVSTKYMTWVRQAPGKGLEWVSVLYSGGSDYYADSVKGRFTISRDNSKNALYLQMNSLRVEDTGVYYCARDSSEVRDHPGHPGRSVGAFDIWGQGTMVTVSS,QSALTQPASVSGSPGQSITISCTGTSNDVGSYTLVSWYQQYPGKAPKLLIFEGTKRSSGISNRFSGSKSGNTASLTISGLQGEDEADYYCCSYAGASTFVFGGGTKLTVL,IGHV3-66 (Human),IGHJ3 (Human),IGLV2-23 (Human),IGLJ3 (Human),ARDSSEVRDHPGHPGRSVGAFDI,CSYAGASTFV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C143_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Jun 1, 2020",Added sequence data from latest preprint version.,Complete
C144,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,SARS-CoV1,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLIQPGGSLRLSCAASGFTVSNNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDKSKNTLYLQMNRLRAEDTAVYYCAREGEVEGYNDFWSGYSRDRYYFDYWGQGTLVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSTRVFGTGTKVTVL,IGHV3-53 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ1 (Human),AREGEVEGYNDFWSGYSRDRYYFDY,SSYTSSSTRV,https://www.rcsb.org/structure/7K90,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Jul 24, 2021",1st June: Added sequence data from latest preprint version; 22nd October: Added PDB Structure; 24th July '21: Added publication with animal trial data,Complete
C145,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,SARS-CoV1,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLIQPGGSLRLSCAASGFSVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAREGEVEGYYDFWSGYSRDRYYFDYWGQGTLVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSTTRVFGTGTRVTVL,IGHV3-53 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ1 (Human),AREGEVEGYYDFWSGYSRDRYYFDY,SSYTSSTTRV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C145_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Jun 1, 2020",Added sequence data from latest preprint version.,Complete
C146,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVKPGGSLRLSCAASGLTFTAYRMNWVRQAPGKGLEWLSSISNTNGDIYYADSVKGRFTISRDNAKNSLYLQMNSLRADDTAVYYCARDVASNYAYFDLWGQGTLVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDIGVYNYISWSQQHPGKAPKVMIYDVTNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYRGSSTPYVFGTGTKVTVL,IGHV3-21 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ1 (Human),ARDVASNYAYFDL,SSYRGSSTPYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C146_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Jun 1, 2020",Added sequence data from latest preprint version.,Complete
C147,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,EVQLVQSGAEVKKPGESLKISCKGSGYRFTNYWIGWVRQMPGKGLEWMGIIYPGDSDTRYSPSFQGQVTISADKSITTAYLQWSSLKASDTAMYYCARLSDRWYSPFDPWGQGTLVTVSS,QAVVTQEPSLTVSPGGTVTLTCGSSTGAVTSGHYPYWFQQKSGQAPRTLIYETSIKHSWTPARFSGSLLGGKAALTLSGAQPEDEADYYCLLSYSGARPVFGGGTKLTVL,IGHV5-51 (Human),IGHJ5 (Human),IGLV7-46 (Human),IGLJ3 (Human),ARLSDRWYSPFDP,LLSYSGARPV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C147_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Jun 1, 2020",Added sequence data from latest preprint version.,Complete
C148,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSQRLSCAASGFTVSSNYMSWIRQAPGKGLEWVSVIYSGGSAYYVDSVKGRFTISRDNSKNTLYLQMNSLRPEDTAVYYCARIANYMDVWGKGTTVTVSS,EIVMTQSPATLSVSPGERATLSCRASQSVSSHLAWYQQKPGQAPRLLIYGASTRATGIPTRFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNWPPLTFGGGTKVEIK,IGHV3-66 (Human),IGHJ6 (Human),IGKV3-15 (Human),IGKJ4 (Human),ARIANYMDV,QQYNNWPPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C148_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Jun 1, 2020",Added sequence data from latest preprint version.,Complete
C150,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCVASGFTFSSYWMHWVRQVPGKGPVWVSHINSEGSSTNYADSVRGRFTISRDNAKDTLYLQMNNLRAEDTAVYYCARPTAVAAAGNYFYYYGMDVWGQGTTVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGYYNFVSWYQQHPGKAPKLMIYEVSNRPSGVSNRFSGSKSGNTASLIISGLQAEDEADYYCSSYRSSSTLVFGGGTKLTVL,IGHV3-74 (Human),IGHJ6 (Human),IGLV2-14 (Human),IGLJ3 (Human),ARPTAVAAAGNYFYYYGMDV,SSYRSSSTLV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C150_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Jun 1, 2020",Added sequence data from latest preprint version.,Complete
C151,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2 (weak),SARS-CoV1,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVKPGGSLRLSCAASGFTFSSYNMNWVRQAPGKGLEWVSCISSSSSYIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARERGYDGGKTPPFLGGQGTLVTVSS,NFMLTQPHSVSESPGKTVTISCTGSSGSIASNYVQWYQQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSSNYWVFGGGTKLTVL,IGHV3-21 (Human),IGHJ4 (Human),IGLV6-57 (Human),IGLJ3 (Human),ARERGYDGGKTPP,QSYDSSNYWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C151_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Jun 1, 2020",Added sequence data from latest preprint version.,Complete
C153,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2 (weak),SARS-CoV1,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGYSTYYVDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARVGGAHSGYDGSFDYWGQGTLVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGSYNLVSWYQQHPGKAPKLMIYEGSKRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCCSYAGSSTWVFGGGTKLTVL,IGHV3-53 (Human),IGHJ4 (Human),IGLV2-23 (Human),IGLJ3 (Human),ARVGGAHSGYDGSFDY,CSYAGSSTWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C153_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Jun 1, 2020",Added sequence data from latest preprint version.,Complete
C154,Ab,"SARS-CoV1,SARS-CoV2",,SARS-CoV2 (weak),,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSRYGMHWVRQAPGKGLEWVAVMSYDGSSKYYADSVKGRFTISRDNSKNTLCLQMNSLRAEDTAVYYCAKQAGPYCSGGSCYSAPFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQGISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPITFGQGTRLEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ5 (Human),AKQAGPYCSGGSCYSAPFDY,QQYDNLPIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C154_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Jun 1, 2020",Added sequence data from latest preprint version.,Complete
C155,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,SARS-CoV1,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLIQPGGSLRLSCAASGFIVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDFGEFYFDYWGQGTLVTVSS,EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATAIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNWPRTFGQGTKVEIK,IGHV3-53 (Human),IGHJ4 (Human),IGKV3-15 (Human),IGKJ1 (Human),ARDFGEFYFDY,QQYNNWPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C155_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Jun 1, 2020",Added sequence data from latest preprint version.,Complete
C156,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSNYGMHWVRQAPGKGLEWVAVISYDGNNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDPFPLAVAGTGYFDYWGQGTLVTVSS,SYELTQPPSVSVAPGQTARISCGGNNIGSKNVHWYQQKPGQAPVLVVYDDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDSSSDPWVFGGGTKLTVL,IGHV3-30 (Human),IGHJ4 (Human),IGLV3-21 (Human),IGLJ3 (Human),AKDPFPLAVAGTGYFDY,QVWDSSSDPWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C156_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Jun 1, 2020",Added sequence data from latest preprint version.,Complete
C164,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2 (weak),SARS-CoV1,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFSVSTKYMTWVRQAPGKGLEWVSVLYSGGSDYYADSVKGRFTISRDNSKNALYLQMNSLRVEDTGVYYCARDSSEVRDHPGHPGRSVGAFDIWGQGTMVTVSS,QSALTQPASVSGSPGQSITISCTGTSNDVGSYTLVSWYQQYPGKAPKLLIFEVTKRSSGISNRFSGSKSGNTASLTISGLQGEDEADYYCCSYAGASTFVFGGGTKLTVL,IGHV3-66 (Human),IGHJ3 (Human),IGLV2-23 (Human),IGLJ3 (Human),ARDSSEVRDHPGHPGRSVGAFDI,CSYAGASTFV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C164_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Jun 1, 2020",Added sequence data from latest preprint version.,Complete
C165,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,SARS-CoV1,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAINWVRQAPGQGLEWMGRIIPIVGIANYAQKFQGRVTITADKSSSTAYMELSSLRSEDTAVYYCARDLLDPQLDDAFDIWGQGTMVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSTYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK,IGHV1-69 (Human),IGHJ3 (Human),IGKV3-20 (Human),IGKJ1 (Human),ARDLLDPQLDDAFDI,QQYGSSPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C165_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Jun 1, 2020",Added sequence data from latest preprint version.,Complete
C201,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGRSLRLSCAASGFTFDDYAMHWVRQAPGKGLEWVSGISWNSGSIGYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTALYYCVKGVEYSSSSNFDYWGQGTLVTVSS,IRMTQSPSSVSASVGDRVTITCRASQGISSWLAWYQQKPGKAPKLLIYVESSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQANSFPLTFGGGTKVEIK,IGHV3-9 (Human),IGHJ4 (Human),IGKV1-12 (Human),IGKJ4 (Human),VKGVEYSSSSNFDY,QQANSFPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C201_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Jun 1, 2020",Added sequence data from latest preprint version.,Complete
C202,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSLIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDTLGRGGDYWGQGTLVTVSS,DIQLTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPRSFGQGTKLEIK,IGHV3-66 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ2 (Human),ARDTLGRGGDY,QQYDNLPRS,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C202_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Jun 1, 2020",Added sequence data from latest preprint version.,Complete
C204,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLLESGGGLEQPGGSLRLSCAASGFTFSTYAMSWVRQAPGKGLEWVSAISGSGAGTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARESDCGSTSCYQVGWFDPWGQGTLVTVSS,DIQLTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPPWTFGQGTKVEIK,IGHV3-23 (Human),IGHJ5 (Human),IGKV1-39 (Human),IGKJ1 (Human),ARESDCGSTSCYQVGWFDP,QQSYSTPPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C204_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Jun 1, 2020",Added sequence data from latest preprint version.,Complete
C205,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGHTFTSYYMHWVRQAPGQGLEWMGIINPSGGSTSYAQKFQGRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARGPERGIVGATDYFDYWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYVSSPWTFGQGTKVEIK,IGHV1-46 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ1 (Human),ARGPERGIVGATDYFDY,QQYVSSPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C205_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Jun 1, 2020",Added sequence data from latest preprint version.,Complete
C207,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2 (weak),SARS-CoV1,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSAISGSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKEPIGQPLLWWDYWGQGTLVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPRGFGQGTKVEIK,IGHV3-23 (Human),IGHJ4 (Human),IGKV3-11 (Human),IGKJ1 (Human),AKEPIGQPLLWWDY,QQRSNWPRG,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C207_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Jun 1, 2020",Added sequence data from latest preprint version.,Complete
C208,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,EVQLVQSGAEVKKPGESLKISCKGSGYSFTSYWIGWVRQMPGKGLEWMGIIYPGDSDTRYSPSFQGQVTISADKSISTAYLKWSSLKASDSAMYYCARGPNLQNWFDPWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSGSYLAWYQQRPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSLTFGGGTKVEIK,IGHV5-51 (Human),IGHJ5 (Human),IGKV3-20 (Human),IGKJ4 (Human),ARGPNLQNWFDP,QQYGSSLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C208_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Jun 1, 2020",Added sequence data from latest preprint version.,Complete
C210,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,SARS-CoV1,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTFSRDNSKNTLYLQMNSLRAEDTAVYYCARDLMAYGMDVWGQGTTVTVSS,DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPQGTFGGGTKVEIK,IGHV3-53 (Human),IGHJ6 (Human),IGKV1-9 (Human),IGKJ4 (Human),ARDLMAYGMDV,QQLNSYPQGT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C210_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Jun 1, 2020",Added sequence data from latest preprint version.,Complete
C211,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,SARS-CoV1,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASEFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRPEDTAVYYCARDYGDFYFDFWGQGTLVTVSS,EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQGPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNWPRTFGQGTKVEIK,IGHV3-66 (Human),IGHJ4 (Human),IGKV3-15 (Human),IGKJ1 (Human),ARDYGDFYFDF,QQYNNWPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C211_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Jun 1, 2020",Added sequence data from latest preprint version.,Complete
C212,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTVTGYYIHWVRQAPGQGLEWMGWISPNSGGTNYAQKFQGWVTMTRDMSITTAYMELSRLRSDDTAVYYCARERYFDLGGMDVWGQGTTVTVSS,LTQPASVSGSPGQSITISCTGTSSDVGSYNLVSWYQQHPGKAPKLMIYEDSKRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCCSYAGSSTRLFGGGTKLTVL,IGHV1-2 (Human),IGHJ6 (Human),IGLV2-23 (Human),IGLJ3 (Human),ARERYFDLGGMDV,CSYAGSSTRL,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C212_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Jun 1, 2020",Added sequence data from latest preprint version.,Complete
C214,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAAIWYDGSNKHYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDVGRVTTWFDPWGQGTLVTVSS,DIQLTQSPSSLSASVGDRVTITCRASQSISSYLTWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPPWTFGQGTKVEIK,IGHV3-33 (Human),IGHJ5 (Human),IGKV1-39 (Human),IGKJ1 (Human),ARDVGRVTTWFDP,QQSYSTPPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C214_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Jun 1, 2020",Added sequence data from latest preprint version.,Complete
C215,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSAITDSGDGTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCASEEDYSNYVGWFDPWGQGTLVTVSS,DIQLTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPPWTFGQGTKVEIK, IGHV3-23 (Human),IGHJ5 (Human),IGKV1-39 (Human),IGKJ1 (Human),ASEEDYSNYVGWFDP,QQSYSTPPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C215_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Jun 1, 2020",Added sequence data from latest preprint version.,Complete
C216,Ab,SARS-CoV2,SARS-CoV1,,"SARS-CoV1,SARS-CoV2",S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYDMHWVRQATGKGLEWVSAIGTAGDTYYPDSVKGRFTISRENAKNSLYLQMNSLRAGDTAVYYCARDRGSSGWYGWYFDLWGRGTLVTVSS,DIQLTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYVASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPPITFGQGTRLEIK,IGHV3-13 (Human),IGHJ2 (Human),IGKV1-39 (Human),IGKJ5 (Human),ARDRGSSGWYGWYFDL,QQSYSTPPIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/C216_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 1, 2020","Jun 1, 2020",Added sequence data from latest preprint version.,Complete
CC12.1,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,SARS-CoV1,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLIQPGGSLRLSCAASGLTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLDVYGLDVWGQGTTVTVSS,DIVMTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPPKFTFGPGTKVEIK,IGHV3-53 (Human),IGHJ6 (Human),IGKV1-9 (Human),IGKJ3 (Human),ARDLDVYGLDV,QQLNSYPPKFT,https://www.rcsb.org/structure/6XC2; https://www.rcsb.org/structure/6XC3,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 17, 2020","Jun 16, 2020",1st June: Corrected HC V gene annotation. 10th June: Added sequence from new publication. 16th June: Updated publication.,Complete
CC12.2,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,SARS-CoV1,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVFYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDYGDLYFDYWGQGTLVTVSS,EIVMTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGVSSRATGIPDRFSGSGSETDFTLTISRLEPEEFAVYYCQQYGSSPRTFGQGTKLEIK,IGHV3-53 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ2 (Human),ARDYGDLYFDY,QQYGSSPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CC12.2_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 17, 2020","Aug 27, 2020",Added sequence data.,Complete
CC12.3,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,SARS-CoV1,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKSTLYLQMNSLRVEDTAVYYCARDFGDFYFDYWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPRTFGQGTKLEIK,IGHV3-53 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ2 (Human),ARDFGDFYFDY,QQYGSSPRT,https://www.rcsb.org/structure/6XC4; https://www.rcsb.org/structure/6XC7,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 17, 2020","Jun 16, 2020",1st June: Corrected HC V gene annotation. 10th June: Added sequence from new publication. 16th June: Updated publication.,Complete
CC12.4,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,SARS-CoV1,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTGYYMHWVRQAPGQGLEWMGWISPNSGGTNYAQKFQGWVTMTRDTSVSTAYMELSRLRFDDTAVYYCATESWVYGSGSYSSGAFDIWGQGTMVTVSS,QSVLTQPPSASGSPGQSVTISCTGTSSDVGGYDYVSWYQQHPGKAPKLMIYEVSKRPSGVPDRFSGSKSGNTASLTVPGLQAEDEADYYCTSYAGSNNFVFGGGTKLIVL,IGHV1-2 (Human),IGHJ3 (Human),IGLV2-8 (Human),IGLJ3 (Human),ATESWVYGSGSYSSGAFDI,TSYAGSNNFV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CC12.4_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 17, 2020","Aug 27, 2020",Added sequence data.,Complete. SHM % listed in paper.
CC12.5,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,SARS-CoV1,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVQSGAEVKKPGASVKVSCKASGYIYSGYYMHWVRQAPGQGLEWMGWISPDSGGTNYAQRFQGRVTMTRDTSTTTAYMELSRLRSDDTAMYYCARGPRYSGTYFDYWGQGTLVTVSS,QTVVTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPDKAPKLIIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEAAYYCSSYTSSSTQVFGGGTKLTVL,IGHV1-2 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ3 (Human),ARGPRYSGTYFDY,SSYTSSSTQV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CC12.5_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 17, 2020","Aug 27, 2020",Added sequence data.,Complete. SHM % listed in paper.
CC12.6,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,SARS-CoV1,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYIFSGYYMHWVRQAPGQGLEWMGWISPDSGGTNYAQKFQGRVTMTRDTSITTGYMELSGLRSDDTAVYYCARGPRYSGTYFDYWGQGTLVTVSS,QSALTQPTSVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLIIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTVSSTQVFGGGTKLTVL,IGHV1-2 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ3 (Human),ARGPRYSGTYFDY,SSYTSSSTQV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CC12.6_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 17, 2020","Aug 27, 2020",Added sequence data.,Complete. SHM % listed in paper.
CC12.7,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,SARS-CoV1,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVQSGAEVKKPGASVKVTCKTSGYIFSGYYMHWVRQVPGQGLEWMGWISPDSGATNYAQKFQGRVTMTRDTSITTSYVELTWLKSDDTAVYYCARGPRYSGTYFDFWGQGTLVTVSS,QPVLTQPASVSGSPGQSLTISCTGTSSDIGGFNYVSWYQQHPGKAPKLMIFDVSKRPSGVPNRFSGSKSGNTASLTISGLQAEDEGDYYCSSYTISSAQVFGGGTKLTVL,IGHV1-2 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ3 (Human),ARGPRYSGTYFDY,SSYTVSSTQV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CC12.7_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 17, 2020","Aug 27, 2020",Added sequence data.,Complete. SHM % listed in paper.
CC12.8,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,SARS-CoV1,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYIFSGYYTHWVRQAPGQGLEWMGWISPDSGGTNYAQKFQGRVTMTRDTSITTAYVELSGLRSDDTAVYYCARGPRYSGTYFDYWGQGTLVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGGYNHVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSAQLFGGGTKLTVL,IGHV1-2 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ3 (Human),ARGPRYSGTYFDY,SSYTSSSAQL,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CC12.8_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 17, 2020","Aug 27, 2020",Added sequence data.,Complete. SHM % listed in paper.
CC12.9,Ab,SARS-CoV2 (weak),SARS-CoV1,SARS-CoV2,SARS-CoV1,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVQSGAEVKKPGASVKVSCKASGYIFSGYYMHWVRQAPGQGLEWMGWISPDSGGTNYAQNFQGRVTMTRDTSISTGYMELSRLRSDDTAMYYCARGPRYSGTYFDYWGQGVLVTVSS,QSVLTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKVPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSAQVFGGGTKLTVL,IGHV1-2 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ3 (Human),ARGPRYSGTYFDY,SSYTSSSAQV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CC12.9_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 17, 2020","Aug 27, 2020",Added sequence data.,Complete. SHM % listed in paper.
CC12.10,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,SARS-CoV1,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYIYSGYFMHWVRQAPGQGLEWMGWISPDSGGANYAQTFQGRVTMTRDTSTTTAHMELSRLRSDDTAVYYCARGPRYSGTHFDYWGQGTLVTVSS,QSALTQPASVSGSPGQSLTISCTGTSSDVGGYNYVSWYQQHPDKAPKLMIYDVNNRPSGVSNRFSGSKSGSTASLTISGLQAEDEADYYCSSYAGSSTQVFGGGTKLTVL,IGHV1-2 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ3 (Human),ARGPRYSGTHFDY,SSYAGSSTQV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CC12.10_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 17, 2020","Aug 27, 2020",Added sequence data.,Complete. SHM % listed in paper.
CC12.11,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,SARS-CoV1,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYIFSGYYTHWVRQAPGQGLEWMGWISPDSGGTNYAQKFQGRVTMTRDTSITTAYVELSGLRSDDTAVYYCARGPRYSGTYFDYWGQGTLVTVSS,QSVLTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKVPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSAQLFGGGTKLTVL,IGHV1-2 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ3 (Human),ARGPRYSGTYFDY,SSYTSSSAQL,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CC12.11_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 17, 2020","Aug 27, 2020",Added sequence data.,Complete. SHM % listed in paper.
CC12.12,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,SARS-CoV1,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYIYSGYYMHWVRQAPGQGLEWMGWISPDSGGTNYAQRFQGRVTMTRDTSTTTAYMELSRLRSDDTAVYYCARGPRYSGTYFDYWGQGTLVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPDKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSGSTQVFGGGTKLTVL,IGHV1-2 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ3 (Human),ARGPRYSGTYFDY,SSYTSGSTQV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CC12.12_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 17, 2020","Aug 27, 2020",Added sequence data.,Complete. SHM % listed in paper.
CC12.13,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,SARS-CoV1,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDPYGYSSIWDGQGGHWGQGTLVTVSS,DVVMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNFATGVPSRFSGTGSGTDFTFTISSLQPEDIATYYCQQYDNLPITFGQGTRLEIK,IGHV3-53 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ5 (Human),ARDPYGYSSIWDGQGGH,QQYDNLPIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CC12.13_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 17, 2020","Aug 27, 2020",Added sequence data.,Complete. SHM % listed in paper.
CC12.14,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,SARS-CoV1,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGLVKPGGSLRLSCAASGFTFNYYSMNWVRQAPGKGLEWISSISTSSSFVYYADSVKGRFTISRDNAKTSLYLQMNSLRAEDTAVYFCARGGYCSDGSCYVQDRLIYYYSGLDVWGQGTTVTVSS,DVVMTQSPLSLPVTLGQPASISCRSSQSLVYSDGNTYLNWFQQRPGQSPRRLIYKVSNRDSGVPDRFSGSGSGTDFTLKISRVEAEDVGVFYCMQGTHWPPTFGQGTKVDIK,IGHV3-21 (Human),IGHJ6 (Human),IGKV2-30 (Human),IGKJ3 (Human),ARGGYCSDGSCYVQDRLIYYYSGLDV,MQGTHWPPT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CC12.14_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 17, 2020","Aug 27, 2020",Added sequence data.,Complete. SHM % listed in paper.
CC12.15,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,SARS-CoV1,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFSTYEMNWVRQAPGKGLEWVSYISSSGSTIYYADSVKGRFTISRDNAKNSLYLQMSSLRAEDTAIYYCARDRRRRYCTNGVCYRPEEIDYWGQGTLVTVSS,QAVLTQPPSVSGAPGQRVTISCTGSSSNIEAGYDVHWYQQLPGTAPKLLIYVNSNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSSLSGVVFGGGTKLIVL,IGHV3-48 (Human),IGHJ4 (Human),IGLV1-40 (Human),IGLJ3 (Human),ARDRRRRYCTNGVCYRPEEIDY,QSYDSSLSGVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CC12.15_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 17, 2020","Aug 27, 2020",Added sequence data.,Complete. SHM % listed in paper.
CC12.16,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2 (weak),SARS-CoV1,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVALIWYDGSNKNYADSVKGRFTISRDNSKNTLDLQMNSLRAEDTAVYYCARDPFPGAVAGTGYLQYWGQGTLVTVSS,SYELTQPPSVSVAPGQTARITCGGNNIGSKSVHWYQQKPGQAPVLVVYDDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDSSSDPWVFGGGTKLTVL,IGHV3-33 (Human),IGHJ4 (Human),IGLV3-21 (Human),IGLJ3 (Human),ARDPFPGAVAGTGYLQY,QVWDSSSDPWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CC12.16_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 17, 2020","Aug 27, 2020",Added sequence data.,Complete. SHM % listed in paper.
CC12.17,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2 (weak),SARS-CoV1,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGVVQPGRSLRLSCAASGFTFRNYGMHWVRQAPGKGLEGVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKSSGSYYYYYYGMDVWGQGTTVTVSS,SYELTQPPSVSVAPGKTARITCGGNNIGSKSVHWYQQKPGQAPVLVVYDDTDRPSGIPERFSGSSSGNTATLTISRVEAGDEADYYCQVWDSSSDHPVVFGGGTKLTVL,IGHV3-30 (Human),IGHJ6 (Human),IGLV3-21 (Human),IGLJ3 (Human),AKSSGSYYYYYYGMDV,QVWDSSSDHPVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CC12.17_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 17, 2020","Aug 27, 2020",Added sequence data.,Complete. SHM % listed in paper.
CC12.18,Ab,"SARS-CoV1,SARS-CoV2",,SARS-CoV2 (weak),SARS-CoV1,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVQSGAEVKKPGASVKVSCKASGYTFTSYYMHWVRQAPGQGLEWMGIINPSGGSTSYAQKFQGRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARLHCGGDCYLDYWGQGTLVTVSS,NFMLTQPHSVSESPGKTVTISCTRSSGSIANNYVKWYQQRPGSSPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSSNHEEIWVFGGGTKLIVL,IGHV1-46 (Human),IGHJ4 (Human),IGLV6-57 (Human),IGLJ3 (Human),ARLHCGGDCYLDY,QSYDSSNHEEIWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CC12.18_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 17, 2020","Aug 27, 2020",Added sequence data.,Complete. SHM % listed in paper.
CC12.19,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2 (weak),SARS-CoV1,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSAISGSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKGSGSGSYPNYYYYYGMDVWGQGTTVTVSS,SYELTQSPSVSVAPGQTARITCGGNNIGSKSVHWYQRKPGQAPVLVVYDDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDNNSDHLVFGGGTKLTVL,IGHV3-23 (Human),IGHJ6 (Human),IGLV3-21 (Human),IGLJ3 (Human),AKGSGSGSYPNYYYYYGMDV,QVWDNNSDHLV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CC12.19_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 17, 2020","Aug 27, 2020",Added sequence data.,Complete. SHM % listed in paper.
CC12.20,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV1,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMSSLRGEDTAVYYCAKDQAYYDILTGYLNPPKNYYYYGMDVWGQGTTVTVSS,QSVLTQPPSASSTPGQRVTISCSGSSSNIGSNYVYWYQQLPGTAPKLLIYTNNQRPSGVPDRFSGSKSGTSASLAISGLRSEDEADYYCAAWDDSLSGRVVFGGGTKLTVL,IGHV3-30 (Human),IGHJ6 (Human),IGLV1-47 (Human),IGLJ3 (Human),AKDQAYYDILTGYLNPPKNYYYYGMDV,AAWDDSLSGRVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CC12.20_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 17, 2020","Aug 27, 2020",Added sequence data.,Complete. SHM % listed in paper.
CC12.21,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV1,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKVSGYTLTELSMHWVRQAPGKGLEWMGGFDPEDGETIYAQKFQGRVTMTEDTSTDTAYMDLSSLRSEDTAVYYCATAFSIFGVVPPDYWGQGTLVTVS,QAVVTQPPSASGTPGQRVTISCSGSSSNIGSNTVNWYQQLPGTAPKLLIYSNNQRPSGVPDRFSGSKSGTSASLAISGLQSEDEADYYCAAWDDSLNGPVFGGGTKLTVL,IGHV1-24 (Human),IGHJ4 (Human),IGLV1-44 (Human),IGLJ3 (Human),ATAFSIFGVVPPDY,AAWDDSLNGPV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CC12.21_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 17, 2020","Aug 27, 2020",Added sequence data.,Complete. SHM % listed in paper.
CC12.23,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2 (weak),SARS-CoV1,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSETLSLTCTVSGGSISSSSYYWGWIRQPPGKGLEWIGSIYYSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARQGDCSTTSCAYDYWGQGTLVTVSS,SYELTQPPSVSVSPGQTARITCSGDALPKQYAYWYQQKPGQAPVLVIYKDSERPSGIPERFSGSSSGTTATLTISGVQAEDEADYYCQSADSSGTYLVVFGGGTKLAV,IGHV4-39 (Human),IGHJ4 (Human),IGLV3-25 (Human),IGLJ3 (Human),ARQGDCSTTSCAYDY,QSADSSGTYLVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CC12.23_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 17, 2020","Aug 27, 2020",Added sequence data.,Complete. SHM % listed in paper.
CC12.24,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV1,S; Unk,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGVVQPGRSLRLSCSASGFTFSIYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDRTGNYYYGMDVWGQGTTVTVSS,DIQLTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASNLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPWTFGQGTKVEIK,IGHV3-30 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ1 (Human),AKDRTGNYYYGMDV,QQSYSTPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CC12.24_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 17, 2020","Aug 27, 2020",Added sequence data.,Complete. SHM % listed in paper.
CC12.25,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV1,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSAISGSGDSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDRYYEFWSGYSNWFDPWGQGTLVTISS,QSALTQPPSASGTPGQRVTISCSGSSSNIGSNTVNWYQQLPGTAPKVLVYSNDQRPSGVPDRFSGSKSGTSASLAISGLQSEDEADYYCAAWDDSLNGPVFGGGTKLTVL,IGHV3-23 (Human),IGHJ5 (Human),IGLV1-44 (Human),IGLJ3 (Human),AKDRYYEFWSGYSNWFDP,AAWDDSLNGPV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CC12.25_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 17, 2020","Aug 27, 2020",Added sequence data.,Complete. SHM % listed in paper.
CC12.26,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV1,S; non-RBD,B-cells; SARS-CoV2 Human Patient,EVQLVQSGAEVKKPGESLKISCKGSGYSFTSYWIGWVRQMPGKGLEWMGIIYPGDSDTRYSPSFQGQVTVSADKSISTAYLQWSSLKASDTAMYYCARVNYYDSSGYPSFHFDYWGQGTLVTVS,QTVVTQEPSLTVSPGGTVTLTCVSSTGAVTSGYYPNWFQQKPGQAPRALIYSTSKKHSWTPARFSGSLLGGKAALTLSGVQPEDEAEYYCLLYYGGAQRWVFGGGTKLTVL,IGHV5-51 (Human),IGHJ4 (Human),IGLV7-43 (Human),IGLJ3 (Human),ARVNYYDSSGYPSFHFDY,LLYYGGAQRWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CC12.26_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 17, 2020","Aug 27, 2020",Added sequence data.,Complete. SHM % listed in paper.
CC12.27,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV1,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFIGYYMHWVRQAPGQGLEWMGWINPNSGGTNYAQKFQGRVTMTRDTSISTVYMELSRLRSDDTAVYYCAREMPAAMGYYYYGMDVWGQGTTVTVSS,QSVLTQPASVSGSPGQSITISCTGTSSDVGSYNLVSWYQQHPGKAPKLMIYEGSKRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCYSYAGSSTFVFVFGTGTKVIVL,IGHV1-2 (Human),IGHJ6 (Human),IGLV3-23 (Human),IGLJ1 (Human),AREMPAAMGYYYYGMDV,YSYAGSSTFV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CC12.27_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 17, 2020","Aug 27, 2020",Added sequence data.,Complete. SHM % listed in paper.
CC12.28,Ab,"SARS-CoV1,SARS-CoV2",,SARS-CoV2 and SARS-CoV1,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLLESGGGLVQPGGSLRLSCAASGFTFSNYAMTWVRQAPGKGLEWVSAISSGSGSTYYADSVKGRFTISRDNSKNTVYLQMNSLRAEDTAIYYCAKANKYSSSEFDFWGQGTLVTISS,QSALTQPPSASGTPGQRVTISCSGSSSNIGSNYVYWYQQLPGAAPKLLIYRNDQRPSGVPDRFSGSKSGTSVSLAISGLRSEDEADYYCAAWDDSLSGWVFGGGTKLTVL,IGHV3-23 (Human),IGHJ4 (Human),IGLV1-47 (Human),IGLJ3 (Human),AKANKYSSSEFDF,AAWDDSLSGWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CC12.28_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 16, 2020","Aug 27, 2020",Added sequence data.,Complete. SHM % listed in paper.
CC6.29,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGSELKKPGASVKVSCKASGYTFATYALNWVRQAPGQGLEWMGWVNTNTGSPTYAQGFTGRFVFSFDTSVSTAYLQIRTLKAEDTAVYYCAVYYYDSGSPGWFDPWGQGTLVTVSS,DIQLTQSPSSLSASVGDRVTITCRASQTASSYLNWYQQKPGKAPNLLIYAASSLQSGVPSRFSGSGSVTDFTLTISSLQPEDFATYYCQQSYSTPPTFGQGTKVDIK,IGHV7-4-1 (Human),IGHJ5 (Human),IGKV1-39 (Human),IGKJ3 (Human),AVYYYDSGSPGWFDP,QQSYSTPPT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CC6.29_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 16, 2020","Aug 27, 2020",Added sequence data.,Complete. SHM % listed in paper.
CC6.30,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSIYAITWVRQAPGQGLEWMGGIIPIIGTANYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCARDFRYCSSTRCYFWFDPWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQNISSYLNWYQQEAGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPRTFGQGTKVDIK,IGHV1-69 (Human),IGHJ5 (Human),IGKV1-39 (Human),IGKJ3 (Human),ARDFRYCSSTRCYFWFDP,QQSYSTPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CC6.30_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 16, 2020","Aug 27, 2020",Added sequence data.,Complete. SHM % listed in paper.
CC6.31,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVQSGAEVKKPGASVKVSCMASGYTFTSYYMHWVRQAPGQGLEWMGIISPSGGGTSYAQKFQGRVTLTRDTSTSTVYMELSSLRSEDTAVYYCARWYDSTGSIDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQGIRNDLGWYQQKPGKAPKRLIYAASSLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCLQHNSYPILTFGGGTKLEIK,IGHV1-46 (Human),IGHJ4 (Human),IGKV1-17 (Human),IGKJ4 (Human),ARWYDSTGSIDY,LQHNSYPILT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CC6.31_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 16, 2020","Aug 27, 2020",Added sequence data.,Complete. SHM % listed in paper.
CC6.32,Ab,"SARS-CoV1,SARS-CoV2",,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGRSLRLSCAASGFTFDDYAMHWVRQAPGKGLEWVSGISWNSGSIAFAGSVKGRFTISRDNAKNSLYLQMNSLRAEDTALYYCAKDQGYSYGNYFDYWGQGTLVTVSS,QLVLTQPPSVSVAPGKTARITCGGNNIGSKSVYWYQQKPGQAPVLVVYDDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDSSSDHPYVFGSGTKVTVL,IGHV3-9 (Human),IGHJ4 (Human),IGLV3-21 (Human),IGLJ6 (Human),AKDQGYSYGNYFDY,QVWDSSSDHPYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CC6.32_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 16, 2020","Aug 27, 2020",Added sequence data.,Complete. SHM % listed in paper.
CC6.33,Ab,"SARS-CoV1,SARS-CoV2",,SARS-CoV2 and SARS-CoV1,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSSAISWVRQAPGQGLEWMGGIIPILDITNYAQKFQGRVTITADKSTSTAFMELSSLRSEDTAVYYCALRNQWDLLVYWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQHYGSSLWTFGQGTKLEIK,IGHV1-69 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ1 (Human),ALRNQWDLLVY,QHYGSSLWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CC6.33_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 16, 2020","Aug 27, 2020",Added sequence data.,Complete. SHM % listed in paper.
CV1,Ab,"SARS-CoV1,SARS-CoV2",,SARS-CoV2,,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSETLSLTCTVSGYSISSGYYWGWIRQPPGKGLEWIGSIYHSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARTPLSLRLRYNWYFDLWGRGTLVTVSS,QSVLTQPPSASGTPGQRVTISCSGSSSNIGSNTVNWYQQLPGTAPKLLIYSNNQRPSGVPDRFSGSKSGTSASLAISGLQSEDEADYYCAAWDDSLNGPVFGGGTKLTVL,IGHV4-38-2 (Human),IGHJ2 (Human),IGLV1-44 (Human),IGLJ3 (Human),ARTPLSLRLRYNWYFDL,AAWDDSLNGPV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CV1_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 17, 2020","Jun 7, 2020",Added sequence information from NCBI,Complete
CV2,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARVRGSYYLFDYWGQGTLVTVSS,EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNWPPSLTFGGGTKVEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV3-15 (Human),IGKJ4 (Human),ARVRGSYYLFDY,QQYNNWPPSLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CV2_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 17, 2020","Jun 7, 2020",Added sequence information from NCBI,Complete
CV3,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGSELKKPGASVKLSCQASGYSFTNHAMNWVRQAPGQGLEWMGWINTNTGNPTYAQGFTGRFVFSLDTSVSTTYLHISSLKAEDTAVYYCARASARPGVATNLDFWGQGTLVVVSS,DIQMTQSPSSLSASVGDRVTITCRASQNIDNYLNWYQQKPGKAPKLLIYAASRLHSGVPSRFSGSGSGTDFTLIISSLQPEDLATYYCQQSYSNPLTFGPGTKVDIR,IGHV7-4-1 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ3 (Human),ARASARPGVATNLDF,QQSYSNPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CV3_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 17, 2020","Jun 7, 2020",Added sequence information from NCBI,Complete
CV4,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARSISGSYLGAFDYWGQGTLVTVSS,DIQMTQSPSTLSASVGDRVTITCRASQSISSWLAWYQQKPGKAPKLLIYKASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNSYTFGQGTKLEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV1-5 (Human),IGKJ2 (Human),ARSISGSYLGAFDY,QQYNSYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CV4_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 17, 2020","Jun 7, 2020",Added sequence information from NCBI,Complete
CV5,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVTCKASGYTFTSYYLHWVRQAPGQGLEWMGIINPSGGTTSYAQKFQGRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARAGRRYSSSDDGAFDIWGQGTMVTVSS,DIVMTQSPDSLAVSLGERATINCKSSQNVLYSSNNKNYLAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYITPYTFGQGTKLEIK,IGHV1-46 (Human),IGHJ3 (Human),IGKV4-1 (Human),IGKJ2 (Human),ARAGRRYSSSDDGAFDI,QQYYITPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CV5_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 17, 2020","Jun 7, 2020",Added sequence information from NCBI,Complete
CV7,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARSISGSYLGAFDYWGQGTLVTVSS,DIQMTQSPSTLSASVGDRVTITCRASQSISSWLAWYQQKPGKAPKLLIYKASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNSYTFGQGTKLEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV1-5 (Human),IGKJ2 (Human),ARSISGSYLGAFDY,QQYNSYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CV7_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 17, 2020","Jun 7, 2020",June 4th: Corrected HV gene annotation. June 7th: Added sequence information from NCBI,Complete
CV8,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYGISWVRQAPGQGLEWMGWISAYNGNTNYAQKLQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARLVPTWASYYDFWSGYPGGYGMDVWGQGTTVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPGTFGQGTRLEIK,IGHV1-18 (Human),IGHJ6 (Human),IGKV3-20 (Human),IGKJ5 (Human),ARLVPTWASYYDFWSGYPGGYGMDV,QQYGSSPGT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CV8_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 17, 2020","Jun 7, 2020",Added sequence information from NCBI,Complete
CV9,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QLQLQESGPGLVKPSETLSLTCTVSGGSISSSSYYWGWIRQPPGKGLEWIGSIYYSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCATHIVVVTATPNWYFDLWGRGTLVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSISTWVFGGGTKLTVL,IGHV4-39 (Human),IGHJ2 (Human),IGLV2-14 (Human),IGLJ3 (Human),ATHIVVVTATPNWYFDL,SSYTSISTWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CV9_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 17, 2020","Jun 7, 2020",Added sequence information from NCBI,Complete
CV10,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSETLSLTCNVSGGSISSYYWSWIRQPPGKGLEWIGYIYYSGSTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARGFDYWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSIYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYAGSPWTFGQGTKVEIK,IGHV4-59 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ1 (Human),ARGFDY,QQYAGSPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CV10_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 17, 2020","Jun 7, 2020",Added sequence information from NCBI,Complete
CV11,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSQTLSLTCTVSGGSISSGGYYWSWIRQHPGKGLEWIGYIYYSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARETTGHFDYWGQGTLVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPPIFTFGPGTKVDIK,IGHV4-31 (Human),IGHJ4 (Human),IGKV3-11 (Human),IGKJ3 (Human),ARETTGHFDY,QQRSNWPPIFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CV11_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 17, 2020","Jun 7, 2020",Added sequence information from NCBI,Complete
CV12,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFNLSNYAMHWVRQASGKGLEWVSLISYDGSVKYYTDSVKGRFTVSGDNSKNTLFLQMNSLRPDDSALYYCVRGGVSGPNSFDMWGQGTTVTVSS,DVVMTQSPLSLPVTLGQPATISCRSSQSLVYSDGNTYVNWFQQRPGQSPRRLIYQVSIRASGVPDRFSGSGSGTDFALKISRVEAEDVGVYYCMQGTHWPVTFGQGTKVEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV2-30 (Human),IGKJ1 (Human),VRGGVSGPNSFDM,MQGTHWPVT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CV12_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 17, 2020","Jun 7, 2020",Added sequence information from NCBI,Complete
CV13,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGSELKKPGASVKLSCQASGYSFTNHAMNWVRQAPGQGLEWMGWINTNTGNPTYAQGFTGRFVFSLDTSVSTTYLHISSLKAEDTAVYYCARASARPGVATNLDFWGQGTLVVVSS,DIQMTQSPSSLSASVGDRVTITCRASQNIDNYLNWYQQKPGKAPKLLIYAASRLHSGVPSRFSGSGSGTDFTLIISSLQPEDLATYYCQQSYSNPLTFGPGTKVDIR,IGHV7-4-1 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ3 (Human),ARASARPGVATNLDF,QQSYSNPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CV13_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 17, 2020","Jun 7, 2020",June 4th: Corrected HV gene annotation. June 7th: Added sequence information from NCBI,Complete
CV15,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYWMSWVRQAPGKGLEWVANIKQDGSEKYYVDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARDFNSYQLLWYYYYGMDVWGQGTTVTVSS,QSALTQPRSVSGSPGQSVTISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSKRPSGVPDRFSGSKSGNTASLTISGLQAEDEADYYCCSYAGSYTWVFGGGTKLTVL,IGHV3-7 (Human),IGHJ6 (Human),IGLV2-11 (Human),IGLJ3 (Human),ARDFNSYQLLWYYYYGMDV,CSYAGSYTWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CV15_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 17, 2020","Jun 7, 2020",Added sequence information from NCBI,Complete
CV16,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,EVQLVQSGAEVKKPGESLKISCKGSGYSFTSYWIGWVRQMPGKGLEWMGIIYPGDSDTRYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARQSSFYSSGWYSYGMDVWGQGTTVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSRGTFGQGTKVEIK,IGHV5-51 (Human),IGHJ6 (Human),IGKV3-20 (Human),IGKJ1 (Human),ARQSSFYSSGWYSYGMDV,QQYGSSRGT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CV16_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 17, 2020","Jun 7, 2020",Added sequence information from NCBI,Complete
CV17,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTGYYMHWVRQAPGQGLEWMGWINPNSGGTNYAQKFQGRVTMTRDTSISTAYMELSRLRSDDTAVYYCARVDYGSGSYGWGWFDPWGQGTLVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGSYNLVSWYQQHPGKAPKLMIYEGSKRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCCSYAGSSTYVFGTGTKVTVL,IGHV1-2 (Human),IGHJ5 (Human),IGLV2-23 (Human),IGLJ1 (Human),ARVDYGSGSYGWGWFDP,CSYAGSSTYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CV17_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 17, 2020","Jun 7, 2020",Added sequence information from NCBI,Complete
CV18,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKVSGYTLTELSMHWVRQAPGKGLEWMGGFDPEDGETIYAQKFQGRVTMTEDTSTDTAYMELSSLRSEDTAVYYCATTSPIVGAITWFDPWGQGTLVTVSS,QSVLTQPPSVSAAPGQKVTISCSGSSSNIGNNYVSWYQQLPGTAPKLLIYDNNKRPSGIPDRFSGSKSGTSATLGITGLQTGDEADYYCGTWDSSLSAGPVFGGGTKLTVL,IGHV1-24 (Human),IGHJ5 (Human),IGLV1-51 (Human),IGLJ3 (Human),ATTSPIVGAITWFDP,GTWDSSLSAGPV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CV18_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 17, 2020","Jun 7, 2020",Added sequence information from NCBI,Complete
CV19,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTGYYMHWVRQAPGQGLEWMGWINPNSGGTNYAQKFQGRVTMTRDTSISTAYMELSRLRSDDTAVYYCAREYYYDSSVYPYYYYAMDVWGQGTTVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPPKYTFGQGTKLEIK,IGHV1-2 (Human),IGHJ6 (Human),IGKV3-20 (Human),IGKJ2 (Human),AREYYYDSSVYPYYYYAMDV,QQYGSSPPKYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CV19_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 17, 2020","Jun 7, 2020",Added sequence information from NCBI,Complete
CV21,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVKPGGSLRLSCAASGFTFSNAWMSWVRQAPGKGLEWVGRIKSKTDGGTTDYAAPVKGRFTISRDDSKNTLYLQMNSLKTEDTAVYYCTTDRVYDYIWGSYRYLDYWGQGTLVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPLTFGGGTKVEIK,IGHV3-15 (Human),IGHJ4 (Human),IGKV3-11 (Human),IGKJ4 (Human),TTDRVYDYIWGSYRYLDY,QQRSNWPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CV21_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 17, 2020","Jun 7, 2020",Added sequence information from NCBI,Complete
CV22,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVKPGGSLRLSCAASGFTFSSYSMNWVRQAPGKGLEWVSSISSSSSYIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARDRESYDILTGYSMEGCFDYWGQGTLVTVSS,QLVLTQSPSASASLGASVKLTCTLSSGHSSYAIAWHQQQPEKGPRYLMKLNSDGSHSKGDGIPDRFSGSSSGAERYLTISSLQSEDEADYYCQTWGTGIRVFGGGTKLTVL,IGHV3-21 (Human),IGHJ4 (Human),IGLV4-69 (Human),IGLJ3 (Human),ARDRESYDILTGYSMEGCFDY,QTWGTGIRV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CV22_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 17, 2020","Jun 7, 2020",Added sequence information from NCBI,Complete
CV23,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYAMHWVRQAPGQRLEWMGWINAGNGNTKYSQKFQGRVTITRDTSASTAYMELSSLRSEDTAVYYCARVWGYCSGGSCYVDAFDIWGQGTMVTVSS,SYELTQPPSVSVSPGQTARITCSGDALPKQYAYWYQQKPGQAPVLVIYKDSERPSGIPERFSGSSSGTTVTLTISGVQAEDEADYYCQSADSSGTYVVFGGGTKLTVL,IGHV1-3 (Human),IGHJ3 (Human),IGLV3-25 (Human),IGLJ3 (Human),ARVWGYCSGGSCYVDAFDI,QSADSSGTYVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CV23_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 17, 2020","Jun 7, 2020",Added sequence information from NCBI,Complete
CV24,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKVSGYTLTELSMHWVRQAPGKGLEWMGGFDPEDGETIYAQKFQGRVTMTEDTSTDTAYMELSSLRSEDTAVYYCATAPPYSPPSSWFDPWGQGTLVTVSS,QSVLTQPPSVSAAPGQKVTISCSGSSSNIGNNYVSWYQQLPGTAPKLLIYDNNKRPSGIPDRFSGSKSGTSATLGITGLQTGDEADYYCGTWDSSLSASYVFGTGTKVTVL,IGHV1-24 (Human),IGHJ5 (Human),IGLV1-51 (Human),IGLJ1 (Human),ATAPPYSPPSSWFDP,GTWDSSLSASYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CV24_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 17, 2020","Jun 7, 2020",Added sequence information from NCBI,Complete
CV25,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSQTLSLTCTVSGGSISSGDYYWSWIRQPPGKGLEWIGYIYYSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARDHHYDFWSGYSSYYYYGMDVWGQGTTVTVSS,EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNWPYTFGQGTKLEIK,IGHV4-30-4 (Human),IGHJ6 (Human),IGKV3-15 (Human),IGKJ2 (Human),ARDHHYDFWSGYSSYYYYGMDV,QQYNNWPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CV25_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 17, 2020","Jun 7, 2020",Added sequence information from NCBI,Complete
CV26,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDEAYYDILTGYINAPKNYYYYGMDVWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQGIRNDLGWYQQKPGKAPKRLIYAASSLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCLQHNSYPFTFGPGTKVDIK,IGHV3-30-3 (Human),IGHJ6 (Human),IGKV1-17 (Human),IGKJ3 (Human),ARDEAYYDILTGYINAPKNYYYYGMDV,LQHNSYPFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CV26_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 17, 2020","Jun 7, 2020",Added sequence information from NCBI,Complete
CV27,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVALISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARSFGGSYYYGMDVWGQGTTVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSTPYVFGTGTKVTVL,IGHV3-30 (Human),IGHJ6 (Human),IGLV2-14 (Human),IGLJ1 (Human),ARSFGGSYYYGMDV,SSYTSSSTPYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CV27_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 17, 2020","Jun 7, 2020",Added sequence information from NCBI,Complete
CV30,Ab,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLIQPGGSLRLSCAASGVIVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLDVSGGMDVWGQGTTVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPQTFGQGTKLEIK,IGHV3-53 (Human),IGHJ6 (Human),IGKV3-20 (Human),IGKJ2 (Human),ARDLDVSGGMDV,QQYGSSPQT,http://www.rcsb.org/structure/6XE1,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 17, 2020","Jul 5, 2020",7th June: Added sequence information from NCBI. 13th June: Added expected structure note and accompanying publication. 5th July: Added PDB structure.,Tracking PDB for release of structure
CV31,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKVSGYTLTELSMHWVRQAPGKGLEWMGGFDPEDGETIYAQKFQGRVTMTEDTSTDTAYMELSSLRSEDTAVYYCATAPPYSPPSSWFDPWGQGTLVTVSS,QSVLTQPPSVSAAPGQKVTISCSGSSSNIGNNYVSWYQQLPGTAPKLLIYDNNKRPSGIPDRFSGSKSGTSATLGITGLQTGDEADYYCGTWDSSLSASYVFGTGTKVTVL,IGHV1-24 (Human),IGHJ5 (Human),IGLV1-51 (Human),IGLJ1 (Human),ATAPPYSPPSSWFDP,GTWDSSLSASYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CV31_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 17, 2020","Jun 7, 2020",Added sequence information from NCBI,Complete
CV32,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTGYYMHWVRQAPGQGLEWMGWINPNSDVTNYAQKFQGRVTMTRDTSISTAYMELSRLRSDDTAVYYCAREARDYYGSGSLDYWGQGTLVTVSS,QSVLTQPPSVSAAPGQKVTISCSGSSSNIGNNYVSWYQQLPGTAPKLLIYDNNKRPSGIPDRFSGSKSGTSATLGITGLQTGDEADYYCGTWDSSLSAVVFGGGTKLTVL,IGHV1-2 (Human),IGHJ4 (Human),IGLV1-51 (Human),IGLJ3 (Human),AREARDYYGSGSLDY,GTWDSSLSAVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CV32_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 17, 2020","Jun 7, 2020",Added sequence information from NCBI,Complete
CV33,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYDISWVRQAPGQGLEWMGWISAYNGNTNYAQKLQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARDSVAGIYYYYGMDVWGQGTTVTVSS,QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWYQQLPGTAPKLLIYGNSNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSSLSGPVVFGGGTKLTVL,IGHV1-18 (Human),IGHJ6 (Human),IGLV1-40 (Human),IGLJ3 (Human),ARDSVAGIYYYYGMDV,QSYDSSLSGPVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CV33_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 17, 2020","Jun 7, 2020",Added sequence information from NCBI,Complete
CV34,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARSYGGSYYYGMDVWGQGTTVTVSS,SYELTQPHSVSVATAQMARITCGGNNIGSKAVHWYQQKPGQDPVLVIYSDSNRPSGIPERFSGSNPGNTATLTISRIEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,IGHV3-30-3 (Human),IGHJ6 (Human),IGLV3-12 (Human),IGLJ3 (Human),ARSYGGSYYYGMDV,QVWDSSSDHVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CV34_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 17, 2020","Jun 7, 2020",Added sequence information from NCBI,Complete
CV35,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLQESGPGLVKPSETLSLTCTVSGYSISSGYYWGWIRQPPGKGLEWIGSIYHSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARTPLSLRLRYNWYFDLWGRGTLVTVSS,QSVLTQPPSASGTPGQRVTISCSGSSSNIGSNTVNWYQQLPGTAPKLLIYSNNQRPSGVPDRFSGSKSGTSASLAISGLQSEDEADYYCAAWDDSLNGPVFGGGTKLTVL,IGHV4-38 (Human),IGHJ2 (Human),IGLV1-44 (Human),IGLJ3 (Human),ARTPLSLRLRYNWYFDL,AAWDDSLNGPV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CV35_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 17, 2020","Jun 7, 2020",Added sequence information from NCBI,Complete
CV36,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTGYYMHWVRQAPGQGLEWMGWINPNSGGTNYVQKFQGRVTMTRDTSISTAYMELNRLRSDDTAVYFCARDLTTTAGTDYYYGMDVWGQGTTVTVSS,SYELTQPPSVSVSPGQTARITCSGDALPKQYAYWYQQKPGQAPVLVIYKDTERPSGIPERFSGSSSGTTVTLTISGVQAEDEADYYCQSADSSGTYMIFGTGTKVTVL,IGHV1-2 (Human),IGHJ6 (Human),IGLV3-25 (Human),IGLJ1 (Human),ARDLTTTAGTDYYYGMDV,QSADSSGTYMI,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CV36_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 17, 2020","Jun 7, 2020",Added sequence information from NCBI,Complete
CV37,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYGISWVRQAPGQGLEWMGWISAYNGNTNYAQKLQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARARVAYDYIWGSYRYKAFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPRFGPGTKVDIKR,IGHV1-18 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ3 (Human),ARARVAYDYIWGSYRYKAFDY,QQYDNLPR,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CV37_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 17, 2020","Jun 7, 2020",Added sequence information from NCBI,Complete
CV38,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARAQTAHYSSSFDYWGQGTLVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPPITFGQGTRLEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV3-11 (Human),IGKJ5 (Human),ARAQTAHYSSSFDY,QQRSNWPPIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CV38_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 17, 2020","Jun 7, 2020",Added sequence information from NCBI,Complete
CV39,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSMRLSCAASGFNLSSYAMHWVRQASGKGLEWVSLISYDGSIKYYADSVKGRFTVSGDNSKNTLFLQMSSLRADDSALYYCVRGGVSGPNAFDIWGQGTTVTVSS,DVVMTQSPLSLPVTLGQPASISCRSSQSLVYSDGNTYVNWFQQRPGQSPRRLIYKVSNRDSGVPDRFSGSGSGTDFALKISRVEAEDVGVYYCMQGTHWPVTFGQGTKVEIK,IGHV3-30 (Human),IGHJ3 (Human),IGKV2-30 (Human),IGKJ1 (Human),VRGGVSGPNAFDI,MQGTHWPVT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CV39_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 17, 2020","Jun 7, 2020",Added sequence information from NCBI,Complete
CV40,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFSSYGISWVRQDPGQGLEWMGWISAYNGNTNYAQKLQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARVGLWWLGHPDAFDIWGQGTMVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQGIRNDLGWYQQKPGKAPKRLIYAASSLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCLQHNSYPLTFGGGTKVEIK,IGHV1-18 (Human),IGHJ3 (Human),IGKV1-17 (Human),IGKJ4 (Human),ARVGLWWLGHPDAFDI,LQHNSYPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CV40_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 17, 2020","Jun 7, 2020",Added sequence information from NCBI,Complete
CV41,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARTKGGSYFAPFDYWGQGTLVTVSS,EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNWPLTFGGGTKVEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV3-15 (Human),IGKJ4 (Human),ARTKGGSYFAPFDY,QQYNNWPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CV41_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 17, 2020","Jun 7, 2020",Added sequence information from NCBI,Complete
CV42,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYGISWVRQAPGQGLEWMGWISAYNGNTNYAQKVQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARDRGYAATFGVFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKFLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQTYITAFTFGPGTKVDIK,IGHV1-18 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ3 (Human),ARDRGYAATFGVFDY,QQTYITAFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CV42_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 17, 2020","Jun 7, 2020",Added sequence information from NCBI,Complete
CV43,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARVTVVHFDYWGQGTLVTVSS,NFMLTQPHSVSESPGKTVTISCTGSSGSIASNYVQWYQQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSSNWVFGGGTKLTVL,IGHV3-30 (Human),IGHJ4 (Human),IGLV6-57 (Human),IGLJ3 (Human),ARVTVVHFDY,QSYDSSNWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CV43_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 17, 2020","Jun 7, 2020",Added sequence information from NCBI,Complete
CV44,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYYMHWVRQAPGQGLEWMGIINPSGGSTSYAQKFQGRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARDLTSTSSSPYSYYYGMDVWGQGTTVTVSS,SYELTQPPSVSVSPGQTARITCSGDALPKQYAYWYQQKPGQAPVVVIYKDSERPSGIPERFSGSSSGTTVTLTISGVQAEDEADYYCQSADSSGTYVVFGGGTKLTVL,IGHV1-46 (Human),IGHJ6 (Human),IGLV3-25 (Human),IGLJ3 (Human),ARDLTSTSSSPYSYYYGMDV,QSADSSGTYVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CV44_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 17, 2020","Jun 7, 2020",Added sequence information from NCBI,Complete
CV45,Ab,"SARS-CoV1,SARS-CoV2",,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYGISWVRQAPGQGLEWMGWISAYNGNTNYAQKLQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARVTVEAIFGVVILPLKNWFDPWGQGTLVTVSS,QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWYQQLPGTAPKLLIYGNSNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSSLTLYVFGTGTKVTVL,IGHV1-18 (Human),IGHJ5 (Human),IGLV1-40 (Human),IGLJ1 (Human),ARVTVEAIFGVVILPLKNWFDP,QSYDSSLTLYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CV45_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 17, 2020","Jun 7, 2020",Added sequence information from NCBI,Complete
CV46,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFNLSNYAMHWVRQASGKGLEWVSLISYDGSIKYYTDSVKGRFTVSGDNSKNTLFLQMNSLRPDDSALYYCVRGGVSGPNSFDMWGQGTTVTVSS,DVVMTQSPLSLPVTLGQPASISCRSSQSLVYSDGNTYVNWFQQRPGQSPRRLIYQVSIRASGVPDRFSGSGSGTDFALKISRVEAEDVGVYYCMQGTHWPVTFGQGTKVEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV2-30 (Human),IGKJ1 (Human),VRGGVSGPNSFDM,MQGTHWPVT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CV46_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 17, 2020","Jun 7, 2020",Added sequence information from NCBI,Complete
CV47,Ab,SARS-CoV2,SARS-CoV1,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYGISWVRQAPGQGLEWMGWISAYSGNTNYAQKLQGRVTMTTDTSTSTAYMEVRSLRSDDTAVYYCARVGLWWLGHPDVFDIWGQGTMVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQGIRNDLGWYQQKPGKAPKRLIYAASSLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCLQHNSYPLTFGGGTKVEIK,IGHV1-18 (Human),IGHJ3 (Human),IGKV1-17 (Human),IGKJ4 (Human),ARVGLWWLGHPDVFDI,LQHNSYPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CV47_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 17, 2020","Jun 7, 2020",Added sequence information from NCBI,Complete
CV48,Ab,SARS-CoV2,,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYTINWVRQAPGQGLEWMGRIIPILGIADYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCARDLVEDTAMVTGAAAGTWGQGTLVTVSS,DVVMTQSPLSLPVTLGQPASISCRSSQSLVYSDGNTYLNWFQQRPGQSPRRLIYKVSNRDSGVPDKFSGSGSGTDFTLKISRVEAEDVGVYYCMQGTHWPPTFGQGTKVEIK,IGHV1-69 (Human),IGHJ4 (Human),IGKV2-30 (Human),IGKJ1 (Human),ARDLVEDTAMVTGAAAGT,MQGTHWPPT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CV48_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 17, 2020","Jun 7, 2020",Added sequence information from NCBI,Complete
CV50,Ab,SARS-CoV2,,,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV2 Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVIWYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDIMFGDDWLQKQPDYWGQGTLVTVSS,SYELTQPPSVSVSPGQTARITCSGDALPKKYAYWYQQKSGQAPVLVIYEDSKRPSGIPERFSGSSSGTMATLTISGAQVEDEADYYCYSTDSSGNLYVFGTGTKVTVL,IGHV3-33 (Human),IGHJ4 (Human),IGLV3-10 (Human),IGLJ1 (Human),ARDIMFGDDWLQKQPDY,YSTDSSGNLYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CV50_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 17, 2020","Jun 7, 2020",Added sequence information from NCBI,Complete
B38,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFIVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRHNSKNTLYLQMNSLRAEDTAVYYCAREAYGMDVWGQGTTVTVSS,DIVMTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPPYTFGQGTKLEIK,IGHV3-53 (Human),IGHJ6 (Human),IGKV1-9 (Human),IGKJ2 (Human),AREAYGMDV,QQLNSYPPYT,https://www.rcsb.org/structure/7BZ5,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 14, 2020","May 20, 2020","Removed homology model, added PDB crystal structure.",Complete
H4,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTGYYMHWVRQAPGQGLEWMGRINPNSGGTNYAQKFQGRVTMTRDTSISTAYMELSRLRSDDTAVYYCARVPYCSSTSCHRDWYFDLWGRGTLVTVSS,DIQMTQSPLSLPVTPGEPASISCRSSQSLLDSDDGNTYLDWYLQKPGQSPQLLIYTLSYRASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQRIEFPLTFGGGTKVEIK,IGHV1-2 (Human),IGHJ2 (Human),IGKV2-40 (Human),IGKJ4 (Human),ARVPYCSSTSCHRDWYFDL,MQRIEFPLT,https://www.rcsb.org/structure/7L58,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H4_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 14, 2020","Apr 21, 2021",12th Jan 2021: Added expected structure; 21st Apr 2021: Added link to structure,Complete
31B5,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,ND,ND,ND,ND,ARVEYYYGSGSYMPWYFDL,ND,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Authors will release sequence after patent filed
32D4,Ab,SARS-CoV2,,SARS-CoV2,,S; RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,ND,ND,ND,ND,TEEGSGSEGPIEFDY,ND,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Authors will release sequence after patent filed
31B9,Ab,SARS-CoV2,,,SARS-CoV2,S; RBD,B-cells; SARS-CoV2 Human Patient,ND,ND,ND,ND,ND,ND,ATYYYDSSGYSYGMDV,ND,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Authors will release sequence after patent filed
CR3022,Ab,"SARS-CoV1,SARS-CoV2",,SARS-CoV1,SARS-CoV2,S; RBD,B-cells; SARS-CoV1 Human Patient,QMQLVQSGTEVKKPGESLKISCKGSGYGFITYWIGWVRQMPGKGLEWMGIIYPGDSETRYSPSFQGQVTISADKSINTAYLQWSSLKASDTAIYYCAGGSGISTPMDVWGQGTTVTVSS,DIQLTQSPDSLAVSLGERATINCKSSQSVLYSSINKNYLAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYSTPYTFGQGTKVEIK,IGHV5-51 (Human),IGHJ6 (Human),IGKV4-1 (Human),IGKJ1 (Human),AGGSGISTPMDV,QQYYSTPYT,https://www.rcsb.org/structure/6W41; https://www.rcsb.org/structure/6W7Y; https://www.rcsb.org/structure/6YLA; https://www.rcsb.org/structure/6YM0; https://www.rcsb.org/structure/6XC3; https://www.rcsb.org/structure/6XC7; https://www.rcsb.org/structure/6ZH9; https://www.rcsb.org/structure/6ZLR; https://www.rcsb.org/structure/7A5R; https://www.rcsb.org/structure/7A5S; https://www.rcsb.org/structure/7JN5; https://www.rcsb.org/structure/7LOP; https://www.rcsb.org/structure/7M6D,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 5, 2021","8th May: Added 2 residues to HC terminus. 20th May: Corrected neutralisation information - CR3022 neutralises SARS-CoV1, but does not appear to neutralise SARS-CoV2. Our thanks to Dr. Kevin Wiehe for identifying the inaccuracy. 5th June: Added 6w7y. 10th June: Added two more expected structures. 8th July: Confirm PDB codes of two expected structures (6xc3, 6xc7). 1st Oct: Added two new PDB codes (7A5R,7A5S). 2nd Nov: Added new PDB code (7JN5). 5th Jan '21: Added new PDB code (6ZLR). 11th Mar '21: Added new PDB code (7LOP. 7th May '21: Added new PDB code (7M6D)",Complete
47D11,Ab,"SARS-CoV1,SARS-CoV2",,SARS-CoV2 and SARS-CoV1,,S; RBD,B-cells; SARS-CoV1 Human Patient,QVQLQESGPGLVKPSETLSLTCSVSGGSISSHYWSWIRQPPGKGLEWIGYIYYSGSTNHNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARGVLLWFGEPIFEIWGQGTMVTVSS,EIVMTQSPATLSVSPGERATLSCRASQSVSSSLAWYQQKPGQAPRLLIYGASTRAPGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNWPLTFGGGTKVEI,IGHV4-59 (Human),IGHJ3 (Human),IGKV3-15 (Human),IGKJ4 (Human),ARGVLLWFGEPIFEI,QQYNNWPLT,https://www.rcsb.org/structure/7AKD;https://www.rcsb.org/structure/7AKJ,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 27, 2021",May 5th: Added MTA information. Oct 1st: Added new reference expected to yield sequence and structural data. Jan 11th '21: Added expected PDB codes. 27th May '21: Added sequence data and PDB codes,Complete
S110,Ab,"SARS-CoV1,SARS-CoV2",,SARS-CoV1,,S; RBD/non-RBD,B-cells; SARS-CoV1 Human Patient,ND,ND,IGHV3-30 (Human),ND,IGKV2-30 (Human),ND,AKDRFQFARSWYGDYFDY,MQGTHWPPT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,"Email sent, awaiting author reply."
S124,Ab,"SARS-CoV1,SARS-CoV2",,SARS-CoV1,,S; RBD,B-cells; SARS-CoV1 Human Patient,ND,ND,IGHV2-26 (Human),ND,IGKV1-39 (Human),ND,ARINTAAYDYDSTTFDI,QQSYSTPPT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,"Email sent, awaiting author reply."
S303,Ab,"SARS-CoV1,SARS-CoV2",,SARS-CoV1,,S; RBD,B-cells; SARS-CoV1 Human Patient,ND,ND,IGHV3-23 (Human),ND,IGKV1-5 (Human),ND,ARERDDIFPMGLNAFDI,QQYDTYSWT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,"Email sent, awaiting author reply."
S304,Ab,"SARS-CoV1,SARS-CoV2",,"SARS-CoV1,SARS-CoV2 (weak)",,S; RBD,B-cells; SARS-CoV1 Human Patient,VQLVESGGGLVQPGGSLRLSCAASGFTFSSYDMHWVRQTTGKGLEWVSTIGTAGDTYYPDSVKGRFTISREDAKNSLYLQMNSLRAGDTAVYYCARGDSSGYYYYFDYWGQGTLLTVSS,DIEMTQSPSSLSAAVGDRVTITCRASQSIGSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFAIYYCQQSYVSPTYTFGPGTKVDIK,IGHV3-13 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ3 (Human),ARGDSSGYYYYFDY,QQSYVSPTYT,https://www.rcsb.org/structure/7JW0;https://www.rcsb.org/structure/7L0N;https://www.rcsb.org/structure/7R6X,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","Jul 24, 2021",20th May: Added weak binding to SARS-CoV2 (cooperative effect with another binder needed for good potency); 16th Oct: Added PDB structure and sequence. 28th Feb: Added 7L0N. 22nd Jul: Added new PDB structure and publication with variant binding data,Variant binding data in Starr et al. Complete
S306,Ab,"SARS-CoV1,SARS-CoV2",,SARS-CoV1,SARS-CoV2,S; non-RBD,B-cells; SARS-CoV1 Human Patient,ND,ND,IGHV1-18 (Human),ND,IGKV3-11 (Human),ND,ASDYFDSSGYYHSFDY,QQRSNWPPGCS,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,"Email sent, awaiting author reply."
S309,Ab,"SARS-CoV1,SARS-CoV2",,SARS-CoV2 and SARS-CoV1,,S; RBD,B-cells; SARS-CoV1 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYPFTSYGISWVRQAPGQGLEWMGWISTYNGNTNYAQKFQGRVTMTTDTSTTTGYMELRRLRSDDTAVYYCARDYTRGAWFGESLIGGFDNWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQTVSSTSLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQHDTSLTFGGGTKVEIK,IGHV1-18 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ4 (Human),ARDYTRGAWFGESLIGGFDN,QQHDTSLT,https://www.rcsb.org/structure/6WPS;https://www.rcsb.org/structure/6WPT;https://www.rcsb.org/structure/6WS6;https://www.rcsb.org/structure/7JX3;https://www.rcsb.org/structure/7L0N; https://www.rcsb.org/structure/7BEP;https://www.rcsb.org/structure/7R6W;https://www.rcsb.org/structure/7R6X,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","Jul 24, 2021",28th May: Added sequence and crystal structure information. 15th June: Added 6ws6 structure. 16th October: Added more PDB structures. 28th Feb: Added 7L0N and new reference. 11th March: Added 7BEP. 24th July '21: Added new PDB structure and reference,Variant binding data in Starr et al. Complete
S310,Ab,"SARS-CoV1,SARS-CoV2",,SARS-CoV1,,S; non-RBD,B-cells; SARS-CoV1 Human Patient,ND,ND,IGHV1-69 (Human),ND,IGLV2-23 (Human),ND,ATRTYDSSGYRPYYYGLDV,CSYAGSDTVI,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,"Email sent, awaiting author reply."
S315,Ab,"SARS-CoV1,SARS-CoV2",,SARS-CoV2 and SARS-CoV1,,S; RBD,B-cells; SARS-CoV1 Human Patient,ND,ND,IGHV3-7 (Human),ND,IGLV3-25 (Human),ND,ARDLWWNDQAHYYGMDV,QSADSSGTV,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,"Email sent, awaiting author reply."
mBG17,Ab,"SARS-CoV1,SARS-CoV2, NL63 (weak)",229E,,,N,Immunised Mouse,EVKLEESGGGLVQPGGSMKFSCVASGFTFSDYWMNWVRQSPDKGLEWVAEIRLKSNNYATHYAASVKGRFTISRDDSKSSVYLQMNNLRAEDSGIYYCTRSAMDYWGQGTSVTVSS,DIVMSQSPSSLAVSVGEKITMSCKSSQSLLYTSDQKNYLAWFQQKPGQSPKLLIFWASTRDSGVPDRFTGSGSGTDFTLTISSVKAEDLAVYYCQQFYNYPRTFGGGTKLEIK,IGHV6-6 (Mouse),IGHJ4 (Mouse),IGKV8-30 (Mouse),IGKJ1 (Mouse),TRSAMDY,QQFYNYPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mBG17_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Sep 7, 2020","Sep 7, 2020",N/A,Complete
mBG21,Ab,"SARS-CoV1,SARS-CoV2, NL63 (weak)",229E,,,N,Immunised Mouse,QIQLVQSGPELKKPGETVKISCKASGYTFTDYSMHWVKQAPGKGSKWMGWINTETGEPTYADDFKGRFAFSLETSASTAYLQINNLKNEDTATYFCALRRWGQGTLVTVSS,IVMTQTPKFLLVSAGDRVTITCKASQSVSNDVAWFQQKPGQSPKKLLIYFASNRYTGVPDRFTGSGYGTDFTFTITTVQAEDLAVYFCQQDYSSPWTFGGGTKLEIK,IGHV9-2-1 (Mouse),IGHJ3 (Mouse),IGKV6-32 (Mouse),IGKJ1 (Mouse),ALRR,QQDYSSP,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mBG21_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Sep 7, 2020","Sep 7, 2020",N/A,Complete
mBG22,Ab,"SARS-CoV1,SARS-CoV2, NL63 (weak)",229E,,,N,Immunised Mouse,QIQLVQSGPELKKPGETVKISCKASGYTFTDYSMHWVKQAPGKGSKWMGWINTETGEPTYADDFKGRFAFSLETSASTAYLQINNLKNEDTATYFCALRRWGQGTLVTVSA,IVMTQTPKFLLVSAGDRVTITCKASQSVSNDVAWFQQKPGQSPKLLIYFASNRYTGVPDRFTGSGYGTDFTFTITTVQAEDLAVYFCQQDYSSPWTFGGGTKLEIK,IGHV9-2-1 (Mouse),IGHJ3 (Mouse),IGKV6-32 (Mouse),IGKJ1 (Mouse),ALRR,QQDYSSP,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mBG22_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Sep 7, 2020","Sep 7, 2020",N/A,Complete
mBG57,Ab,"SARS-CoV1,SARS-CoV2, NL63 (weak)",229E,,,N,Immunised Mouse,QIQLVQSGPELKKPGETVKISCKASGYTFTDYSMHWVKQAPGKGSKWMGWINTETGEPTYADDFKGRFAFSLETSASTAYLQINNLKNEDTATYFCALRRWGQGTLVTVSA,DIVMTQAAPSEPVTPGESVSISCGSSKSLLHSNDNTYLYWFLQRPGQSPQLLIYRMSNLASGVPDRFTGSGSGTAFTLRISRVEAEDVGVYYCMQHLENPLGVRWRHQAGNQT,IGHV9-2-1 (Mouse),IGHJ3 (Mouse),IGKV2-137 (Mouse),IGKJ5 (Mouse),ALRR,MQHLENPLGVR,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mBG57_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Sep 7, 2020","Sep 7, 2020",N/A,Complete
mBG67,Ab,"SARS-CoV1,SARS-CoV2, NL63 (weak)",229E,,,N,Immunised Mouse,EVQLVESGGGLVQPGGSLKLSCAASGFTFSNYGMSWVRQTPDKRLELVATINRNGGSTYYLDSVKVRFTISRDNAKSTLFLQLSSLKSDDTAMYYCARIYDFDEDYFDVWGAGTTVTVSS,QIVLTQSPAIMSASLGERVTMTCTASSSVSSSYLHWYQQKPGSSPKLWIYSTSNLASGVPARFSGSGSGTSYSLTISSMEAEDAATYYCLQYHRSPWTFGGGTKLEIK,IGHV5-6-3 (Mouse),IGHJ1 (Mouse),IGKV4-74 (Mouse),IGKJ1 (Mouse),ARIYDFDEDYFDV,LQYHRSP,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/mBG67_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Sep 7, 2020","Sep 7, 2020",N/A,Complete
Clone11-9,Ab,SARS-CoV2,,,,S; RBD,Immunised Mouse,QVQLQQPGAELVMPGASVKMSCKASGYTFTDYWMHWVKQRPGQGLEWIGAEDTSDSYTSYNQKFKGKATLTVDESSSTAYMQLSSLTSEDSAVYYCARRGYGSSYTWFAYWGQGTLVTVSA,DVLMTQTPLSLPVSLGDQASISCRSSQSIVHSNGNTYLEWYLQKPGQSPKLLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDLGVYYCFQGSHVPLTFGAGTKLELK,IGHV1-69 (Mouse),IGHJ3 (Mouse),IGKV1-117 (Mouse),IGKJ5 (Mouse),ARRGYGSSYTWFAY,FQGSHVPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Clone11-9_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Sep 7, 2020","Sep 7, 2020",N/A,Complete
S-Nb82,Nb,SARS-CoV2,,,SARS-CoV2,S; non-RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGPVQAGGSLNLSCEVSGIPYRTYKLAWFRQIPGKEREGIAGITNEGVTNYADSMEGRFTISRDTAKNILYLQMNSLKPEDTAMYYCAASPFKSVVLGPGLYHHWGQGIQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AASPFKSVVLGPGLYHH,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/S-Nb82_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 22, 2020","Nov 22, 2020",N/A,Complete
S-Nb91,Nb,SARS-CoV2,,SARS-CoV2,,S; non-RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCVASGRRYGGDIVGWFRQAPGKEREGVACISMREGGTNYADSVKGRFTISRDNAKNVAYLQMNGLKPEDTAIYYCAAGGRCRYAGPLRSDFTYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAGGRCRYAGPLRSDFTY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/S-Nb91_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 22, 2020","Nov 22, 2020",N/A,Complete
RBD-Nb3,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGSVQAGGSLTLSCAASEFTNAMAWFRQAPGKEREAVARIYTNFEVTYYTDSVKGRFTISQDSAKNTMYLRMNNLKPEDTAIYYCAAGPIYRAEVRQSDFPYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAGPIYRAEVRQSDFPY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/RBD-Nb3_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 22, 2020","Nov 22, 2020",N/A,Complete
RBD-Nb35,Nb,SARS-CoV2,,,SARS-CoV2,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGSVQAGGSLRLSCATSGSSACMGWFRQAPGKEREGVAAINRAGITSYADSLKGRFTISLDKNRNTLYLLQMNSLKPEDTAMYYCATRTNWFYGACLPKVSDFGSWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ6 (Alpaca),N/A,N/A,ATRTNWFYGACLPKVSDFGS,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/RBD-Nb35_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 22, 2020","Nov 22, 2020",N/A,Complete
Nanosota-1C,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,"Phage Display Library (Nanobody, immune-CoV2) then Affinity Matured",ND,N/A,ND,ND,N/A,N/A,ND,N/A,Expected,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Awaiting release of structure in PDB
CN111647077A-VHH1,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QLQLVESGGDLVQPGESLRLSCVASGLSLEHYAIGWFRQAPGKEREGVSCISDSGATRSYADSVRGRFTISRENAKNAVYLEMNSLKPEDTAVYYCSATPGAFRTCAFRDFSHLANWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,SATPGAFRTCAFRDFSHLAN,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CN111647077A-VHH1_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
CN111647077A-VHH2,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QLQLVESGGDLVQPGESLRLSCVASGLSLEHYAIGWFRQAPGKEREGVSCIDSSGGSTSYADSVRGRFTISRENAKNAVYLEMNSLKPEDTAVYYCAALQGSYYYTSLHQTEYDYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AALQGSYYYTSLHQTEYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CN111647077A-VHH2_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
CN111647077A-VHH3,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QLQLVESGGDLVQPGESLRLSCVASGLSLEHYAIGWFRQAPGKEREGVSCIDSSGGSTSYADSVRGRFTISRENAKNAVYLEMNSLKPEDTAVYYCAALQGSYYYTSLHQTEYDYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AALQGSYYYTSLHQTEYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CN111647077A-VHH3_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
CN111647077A-VHH4,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QLQLVESGGDLVQPGESLRLSCVASGLTLNNNTIGWFRQAPGKEREGVSCISPSGIVTSYADSVRGRFTISRENAKNAVYLEMNSLKPEDTAVYYCAVLQWNGAGLPSPLGSWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ6 (Alpaca),N/A,N/A,AVLQWNGAGLPSPLGS,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CN111647077A-VHH4_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
CN111647077A-VHH5,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QLQLVESGGDLVQPGESLRLSCVASGFTLGNYEIGWFRQAPGKEREGVSCISRSGVIFSYADSVRGRFTISRENAKNAVYLEMNSLKPEDTAVYYCAARFRAGLVQSLCQSTPEFYQDWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AARFRAGLVQSLCQSTPEFYQD,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CN111647077A-VHH5_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
CN111647077A-VHH6,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QLQLVESGGDLVQPGESLRLSCVASGFTLGNYAIGWFRQAPGKEREGVSCISLSGDIISYADSVRGRFTISRENAKNAVYLEMNSLKPEDTAVYYCAAPFPSLLYCSLCPSNPEFCRHWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAPFPSLLYCSLCPSNPEFCRH,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CN111647077A-VHH6_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
CN111647077A-VHH7,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QLQLVESGGDLVQPGESLRLSCVASGFSLDGYAIGWFRQAPGKEREGVSCIGRLGTTTSYADSVRGRFTISRENAKNAVYLEMNSLKPEDTAVYYCAAKRSTWFGCSTLDDYDYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAKRSTWFGCSTLDDYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CN111647077A-VHH7_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
CN111647077A-VHH8,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QLQLVESGGDLVQPGESLRLSCVASGFTLDRYAIGWFRQAPGKEREGVSCISSGGTTSYADSVRGRFTISRENAKNAVYLEMNSLKPEDTAVYYCAAGTQLRYGCSRQARRYDYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAGTQLRYGCSRQARRYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CN111647077A-VHH8_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
CN111647077A-VHH9,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QLQLVESGGDLVQPGESLRLSCVASGFTLDYYAIGWFRQAPGKEREGVSCISSSGTSTSYADSVRGRFTISRENAKNAVYLEMNSLKPEDTAVYYCAALQGSYYYTSLHQTEYDYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AALQGSYYYTSLHQTEYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CN111647077A-VHH9_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
CN111647077A-VHH10,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QLQLVESGGDLVQPGESLRLSCVASGATSDIYAIGWFRQAPGKEREGVSCISPSGGSTSTADSVRGRFTISRENAKNAVYLEMNSLKPEDTAVYYCAAASPSWHYCSGYEHEYDDWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAASPSWHYCSGYEHEYDD,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CN111647077A-VHH10_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
CN111647077A-VHH11,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QLQLVESGGDLVQPGESLRLSCVASGFTLDYYAIGWFRQAPGKEREGVSCISPSGTSTSYADSVRGRFTISRENAKNAVYLEMNSLKPEDTAVYYCAAANPSYYYCSGYPHEYDDWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAANPSYYYCSGYPHEYDD,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CN111647077A-VHH11_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
CN111647077A-VHH12,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QLQLVESGGDLVQPGESLRLSCVASGFTFHYYAIGWFRQAPGKEREGVSCISSGGGRTSYADSVRGRFTISRENAKNAVYLEMNSLKPEDTAVYYCAALQGSLHYCSGLVGEYEYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AALQGSLHYCSGLVGEYEY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CN111647077A-VHH12_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
CN111647077A-VHH13,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QLQLVESGGDLVQPGESLRLSCVASFKSYHIAWIGWFRQAPGKEREGVSCSLTGASITSYADSVRGRFTISRENAKNAVYLGMNSLKPEDTAVYYCAARDYASSLYCSRNEAMYAYWGQGTQVTVSS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AARDYASSLYCSRNEAMYAY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CN111647077A-VHH13_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
CN111647077A-VHH14,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QLQLVESGGDLVQPGESLRLSCVASGFRLGGYAIGWFRQAPGKEREGVSCISGSGIISSYADSVRGRFTISRENAKNAVYLEMNSLKPEDTAVYYCAAPSGSSYGSRRLPCGIDSQDYQTWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAPSGSSYGSRRLPCGIDSQDYQT,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CN111647077A-VHH14_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
CN111647077A-VHH15,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QLQLVESGGDLVQPGESLRLSCVASFDDFAIGWIGWFRQAPGKEREGVSCSARGIVNTSYADSVRGRFTISRENAKNAVYLGMNSLKPEDTAVYYCAALVGLNDRSLPHEAEEYDYWGQGTQVTVSS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AALVGLNDRSLPHEAEEYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CN111647077A-VHH15_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
CN111647077A-VHH16,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QLQLVESGGDLVQPGESLRLSCVASGFTFDDYSIGWFRQAPGKEREGVSCFSSLDGSTSYADSVRGRFTISRENAKNAVYLEMNSLKPEDTAVYYCAATRGSSWYWYRPSEYDYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AATRGSSWYWYRPSEYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CN111647077A-VHH16_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
CN111647077A-VHH17,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QLQLVESGGDLVQPGESLRLSCVASGHTGSTYIIGWFRQAPGKEREGVSCISRSGILRSYADSVRGRFTISRENAKNAVYLEMNSLKPEDTAVYYCAARDSLTGVIGNTPGEYDYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AARDSLTGVIGNTPGEYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CN111647077A-VHH17_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
CN111647077A-VHH18,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QLQLVESGGDLVQPGESLRLSCVASGRTVSSYVIGWFRQAPGKEREGVSCISRSGIITSYADSVRGRFTISRENAKNAVYLEMNSLKPEDTAVYYCAAAQTQVLPTEDRSYDYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAAQTQVLPTEDRSYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CN111647077A-VHH18_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
CN111647077A-VHH19,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QLQLVESGGDLVQPGESLRLSCVASGRTFTRYPIGWGRQAPGKEREGVSCISGSGIITSYADSVRGRFTISRENAKNAVYLEMNSLKPEDTAVYYCAVDNAPTSSLPLTPGEYDYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AVDNAPTSSLPLTPGEYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CN111647077A-VHH19_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
CN111647077A-VHH20,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QLQLVESGGDLVQPGESLRLSCVASGRTFSSYAIGWFRQAPGKEREGVSCISSGGITSYADSVRGRFTISRENAKNAVYLEMNSLKPEDTAVYYCAANRGRFTGWRSLTDYTYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AANRGRFTGWRSLTDYTY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CN111647077A-VHH20_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
CN111647077A-VHH21,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QLQLVESGGDLVQPGESLRLSCVASGRTFSTYAIGWFRQAPGKEREGVSCISPSRIITSYADSVRGRFTISRENAKNAVYLEMNSLKPEDTAVYYCAADSSYGGRLGRRIDDYEYWYQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AADSSYGGRLGRRIDDYEY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CN111647077A-VHH21_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
CN111647077A-VHH22,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QLQLVESGGDLVQPGESLRLSCVASGSGVSTGSIGWFRQAPGKEREGVSCYTSVGSISYADSVRGRFTISRENAKNAVYLEMNSLKPEDTAVYYCAFFVPFGDTYWGQGTQVTVSS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AFFVPFGDTY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CN111647077A-VHH22_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
CN111647077A-VHH23,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QLQLVESGGDLVQPGESLRLSCVASASGRTSSTIGWFRQAPGKEREGVSCITWSGGSTSYADSVRGRFTISRENAKNAVYLEMNSLKPEDTAVYYCAAGLSPLMLTASRRYEYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAGLSPLMLTASRRYEY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CN111647077A-VHH23_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
CN111647077A-VHH24,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QLQLVESGGDLVQPGESLRLSCVASGRTVSMYAIGWFRQAPGKEREGVSCISRSGRSTSYADSVRGRFTISRENAKNAVYLEMNSLKPEDTAVYYCAARDGGLHYALYVEASHYNYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AARDGGLHYALYVEASHYNY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CN111647077A-VHH24_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
CN111647077A-VHH25,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QLQLVESGGDLVQPGESLRLSCVASGFTFSSYAIGWFRQAPGKEREGVSCLDVTGRSTSYADSVRGRFTISRENAKNAVYLEMNSLKPEDTAVYYCAAVYTPFRFAFKTDPDRQDHWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAVYTPFRFAFKTDPDRQDH,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CN111647077A-VHH25_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
CN111647077A-VHH26,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QLQLVESGGDLVQPGESLRLSCVASGRTFGTYRIGWFRQAPGKEREGVSCIFWSGGGASYADSVRGRFTISRENAKNAVYLEMNSLKPEDTAVYYCAARAPTTQEYDYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AARAPTTQEYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CN111647077A-VHH26_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
CN111647077A-VHH27,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QLQLVESGGDLVQPGESLRLSCVASGRTLSTYEIGWFRQAPGKEREGVSCVTPTGFGTSYADSVRGRFTISRENAKNAVYLEMNSLKPEDTAVYYCAGSGKGLGSLQRSPDDWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AGSGKGLGSLQRSPDD,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CN111647077A-VHH27_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
4A12,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Phage Display (sdAbs from human VH),EVQLLESGGGLVQPGGSLRLSCAASDFAFSSYEMSWVRQAPGKGLEWIGEIHHSGSTYYNPSLKSLVTISRDNSKNTLYLQMNSLRAEDTAVYYCVKDFGHLGQMASWGQGTLVTVSS,N/A,IGHV3-23 (Human),IGHJ5 (Human),N/A,N/A,VKDFGHLGQMAS,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/4A12_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
4AD5,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Phage Display (sdAbs from human VH),EVQLLESGGGLVQPGGSLRLSCAASSFDFSSYEMSWVRQAPGKALEWIGEIHHSGSTYYNPSLKSRVTISRDNSKNTLYLQMNSLRAEDTAMYYCVKDLGFADHWGQGTLVTVSS,N/A,IGHV3-23 (Human),IGHJ4 (Human),N/A,N/A,VKDLGFADH,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/4AD5_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
CN111647076A_4A10,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Phage Display (sdAbs from human VH),EVQLLESGGGLVQPGGSLRLSCAASSFDFSDYEMSWVRQAPGKGLEWIGEIHHSGSTYYNPSLKSRVTISRDNSKNTLYLQMNSLRAEDTATYYCVKDFVVGETAEFSYWGQGTLVTVSS,N/A,IGHV3-23 (Human),IGHJ4 (Human),N/A,N/A,VKDFVVGETAEFSY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/4A10_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
4C5,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Phage Display (sdAbs from human VH),EVQLLESGGGLVQPGGSLRLSCAASDFYFADYEMSWVRQAPGKGLEWIGSIYHSGSTYYNPSLKSRVTISRDNSKNTLYLQMNSLRAEDTAMYYCAREWHSGYDYWGQGTLVTVSS,N/A,IGHV3-23 (Human),IGHJ4 (Human),N/A,N/A,AREWHSGYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/4C5_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 18, 2020","Nov 18, 2020",N/A,Complete
RBD1,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Yeast Display with Autonomous Hypermutation,QVQLQESGGGLVQAGGSLRLSCAASGTISYENFMGWYRQAPGKERELVAGINDGTNTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAVIGTSVLGHAYWGQGTQVTVSS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AVIGTSVLGHAY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/RBD1_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 12, 2020","Nov 12, 2020",N/A,Complete
RBD1i1,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Yeast Display with Autonomous Hypermutation,QVQLQESGGGLVQAGGSLRLSCAASGTISYENFMGWYRQAPGKERKLVAGINDGTNTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAVIGASVLGHAYWGQGTQVTVSS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AVIGASVLGHAY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/RBD1i1_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 12, 2020","Nov 12, 2020",N/A,Complete
RBD1i3,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Yeast Display with Autonomous Hypermutation,QVQLQESGGGLVQAGGSLRLSCAASGTISYENFMGWYRQAPGKGRKLVAGINDGTNTYYADSVKGRFTISRDNAKNTVYLQMNSLEPEDTAVYYCAVIGASVLGHAYWGQGTQVTVSS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AVIGASVLGHAY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/RBD1i3_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 12, 2020","Nov 12, 2020",N/A,Complete
RBD3,Nb,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,Yeast Display with Autonomous Hypermutation,QVQLQESGGGLVQAGGSLRLSCAASGNISDFRFMGWYRQAPGKERELVAAIGRGSNTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAARNATYPYYVYWGQGTQVTVSS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AARNATYPYYVY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/RBD3_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 12, 2020","Nov 12, 2020",N/A,Complete
RBD3i2,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Yeast Display with Autonomous Hypermutation,QAQLQESGGGLVQAGGSLRLSCAASGNISDFRFMGWYRQAPGKERELVAAIGRGSNTRYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAARNATYPYYVYWGQGTQVTVSS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AARNATYPYYVY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/RBD3i2_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 12, 2020","Nov 12, 2020",N/A,Complete
RBD3i17,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Yeast Display with Autonomous Hypermutation,QAQLQESGGGLVQAGGSLRLSCAASGNISDFRFMGWYRQAPGKERELVAAIGRGSNTRCADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAARNATYPYYVYWGQGTQVTVSS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AARNATYPYYVY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/RBD3i17_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 12, 2020","Nov 12, 2020",N/A,Complete
RBD6,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Yeast Display with Autonomous Hypermutation,QVQLQESGGGLVQAGGSLRLSCAASGSISTTYLMGWYRQAPGKEREFVATINRGGSTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAVGWPDPDYGLAYHRYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AVGWPDPDYGLAYHRY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/RBD6_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 12, 2020","Nov 12, 2020",N/A,Complete
RBD6id,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Yeast Display with Autonomous Hypermutation,QVQLQESGGGLVQAGGSLRLNCAANGSISTTYLMGWYRQAPGKEREFVATINRGGSTYYAISVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAVGWPDPDYGLAYHRYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AVGWPDPDYGLAYHRY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/RBD6id_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 12, 2020","Nov 12, 2020",N/A,Complete
RBD10,Nb,SARS-CoV2,,SARS-CoV2 (weak),,S; RBD,Yeast Display with Autonomous Hypermutation,QVQLQESGGGLVQAGGSLRLSCAASGTIFQVGSMGWYRQAPGKEREFVATIADGSSTNYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAALGQVSEYNSASYEWTYPYWGQGTQVTVSS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AALGQVSEYNSASYEWTYPY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/RBD10_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 12, 2020","Nov 12, 2020",N/A,Complete
RBD10i10,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Yeast Display with Autonomous Hypermutation,QVQLQESGGGLVQAGGSLRLSCAASGTIFQVGSMGWYRQAPGKGRKFVATIADGGSTNYAGSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAALGQVSEYNSASYEWTYPYWGQGTQVTVSS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AALGQVSEYNSASYEWTYPY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/RBD10i10_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 12, 2020","Nov 12, 2020",N/A,Complete
RBD10i14,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Yeast Display with Autonomous Hypermutation,QVQLQESGGGLVQAGGSLRLSCAASGTIFQVGSVGWYRQAPGKGRKFVATIADGSSTNYAGSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAALGQVSEYNSASYEWTYPYWGQGTQVTVSS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AALGQVSEYNSASYEWTYPY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/RBD10i14_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 12, 2020","Nov 12, 2020",N/A,Complete
RBD11,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Yeast Display with Autonomous Hypermutation,QVQLQESGGGLVQAGGSLRLSCAASGNIFAKVWMGWYRQAPGKEREFVASIANGATTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAARNWSGLGHFYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AARNWSGLGHFY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/RBD11_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 12, 2020","Nov 12, 2020",N/A,Complete
RBD11i12,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Yeast Display with Autonomous Hypermutation,QVQLQESGGGLVQAGGSLRLSCAASGNIFAKVWMGWYRQAPGKGREFVASIANGATTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAARNWSGLGYFYWSQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AARNWSGLGYFY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/RBD11i12_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 12, 2020","Nov 12, 2020",N/A,Complete
NM1220,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QVQLVESGGGLVQPGESLRLSCVAYGNMLRGYVVGWYRQAPGKQRELVAGIDTSGEKKKYADAVKGRFTISRDNAGNTVYLQMNSLKPEDTAVYYCNADAPWPPRPYSVIGTRTGYWGRGSPVTVSS,N/A,IGHV3S53 (Alpaca),IGHJ7 (Alpaca),N/A,N/A,NADAPWPPRPYSVIGTRTGY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/NM1220_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 1, 2020","Nov 2, 2020",Added sequence information from paper,Complete
NM1221,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,DVQLVESGGGLVQPGGSLTLSCVGSGFLFSGYAMNWYRQAPGKALELVAGISNAGDITHYEEAMKGRVAISRVNDKNTVYLQMDDLKPEDTAVYRCHAPGVRVASGERNDVWGQGTQVTVSS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,HAPGVFVASGERNDV,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/NM1221_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 1, 2020","Nov 2, 2020",Added sequence information from paper,Complete
NM1222,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,EVQLVESGGGLVRPGGSLRLSCVGSGFTFSGYAINWYRQAPGKALELVAGISNAGDLTHYEEAMKGRVAISRANDKNTVYLQMDDLKPEDTAVYRCHAPGVRVGTGERNDVWGQGAQVTVSS,N/A,IGHV3-1 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,HAPGVRVGTGERNDV,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/NM1222_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 1, 2020","Nov 2, 2020",Added sequence information from paper,Complete
NM1223,Nb,SARS-CoV2,,,SARS-CoV2,S; RBD,Immunised Alpaca,EVQLVESGGGLVQPGGSLRLSCSASGFAFSSVSMSWVRLLPGKGTEWVAEIDRDGGNGNYEDSVKGRFTISRDNAKNTLFLQMNSLVPEDTALYYCRLGTRDHIMSGWGPGAPVTVSS,N/A,IGHV3S1 (Alpaca),IGHJ7 (Alpaca),N/A,N/A,RLGTRDHIMSG,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/NM1223_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 1, 2020","Nov 2, 2020",Added sequence information from paper,Complete
NM1224,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,DVQLVESGGSLVQPGGSLRLSCETSRSSLDAYAIGWFRQAPGKEREGVASISSSSMRTEYADSVKGRFTISRDNAKNTAYLDMNSLKPEDTAVYYCAAAGEYGRAWPGLDWYEFEYEGPGSPVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ5 (Alpaca),N/A,N/A,AAAGEYGRAWPGLDWYEFEY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/NM1224_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 1, 2020","Nov 2, 2020",Added sequence information from paper,Complete
NM1226,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QVQLVESGGGSVQPGGSLRLSCLGSGSLDYYAIGWFRQAPGKEREGVSCIASSGDRTIYADSVKGRFTISRDYGKNTVYLQMNSLKPEDTAMYYCAALQGSYYYTGFVANEYDYWGQGAPVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AALQGSYYYTGFVANEYDY,N/A,https://www.rcsb.org/structure/7NKT,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 1, 2020","Nov 2, 2020",15th May 2021: Added PDB structure and accompanying sequence information,Complete
NM1227,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,EVQLVESGGGLVQPGGSLTLSCETSGRHFDIDDMGWYRQAPGKQRELVACITTESSTTYADAVKGRFTISRDNPDNTVYLQMTNLKPEDTAVYYCNAEMHPRSLDYALGNRDYWGQGAPVTVSS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,NAEMHPRSLDYALGNRDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/NM1227_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 1, 2020","Nov 2, 2020",Added sequence information from paper,Complete
NM1228,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,DVQLVESGGGLVRPGGSLRLSCESSGRHFDIDTMGWYRQAPGKQRELVASITSEKSTVYADALKGRFTISRDIPDNNVYLQMNNLKPEDTAVYYCNAKMDPHSLDYALGNQVFWGQGSLVTVSS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,NAKMDPHSLDYALGNQVF,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/NM1228_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 1, 2020","Nov 2, 2020",Added sequence information from paper,Complete
NM1229,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,EVQLQESGGGLVQPGESLRLSCAASGRTHDWYTMGWFRQAPGKEREFVARINWSSGMTYYADSVKGRFTISRDNPKNTVYLQMNSLTPDDTAVYYCNVHPFTSPDYWGQGTRVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,NVHPFTSPDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/NM1229_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 1, 2020","Nov 2, 2020",Added sequence information from paper,Complete
NM1230,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QVQLVESGGGLVRPGGSLRLSCVGSGFTFSGYAMNWYRQAPGKALELVAGISNAGDLTHYEEPMKGRVAISRANDKNTVYLQMDDLKPEDTAVYRCHAPGVRVGTGERKDVWGQGAQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,HAPGVRVGTGERKDV,N/A,https://www.rcsb.org/structure/7B27,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 1, 2020","May 15, 2021",15th May 2021: Added PDB structure and accompanying sequence information,Complete
sdAb-1E2,Nb,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,Phage Display (Humanised sdAbs),QVQLVESGGGLVQPGGSLRLSCAASGADAFVIIGGWFRQAPGKGLEAVAAIAWTDQHEYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAAQDSAYIKSKGSRAYEYWGQGTQVTVSS,N/A,IGHV3-30 (Human),IGHJ4 (Human),N/A,N/A,AAQDSAYIKSKGSRAYEY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/sdAb-1E2_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 1, 2020","Oct 1, 2020",N/A,Complete
sdAb-2F2,Nb,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,Phage Display (Humanised sdAbs),QVQLVESGGGLVQPGGSLRLSCAASGLAQSKWAYGWFRQAPGKGLEAVAAIDVATGPWYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAAHHIPTKHPAFPDFRDYWGQGTQVTVSS,N/A,IGHV3-23 (Human),IGHJ4 (Human),N/A,N/A,AAHHIPTKHPAFPDFRDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/sdAb-2F2_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 1, 2020","Oct 1, 2020",N/A,Complete
sdAb-3F11,Nb,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,Phage Display (Humanised sdAbs),QVQLVESGGGLVQPGGSLRLSCAASGGNAAERMAGWFRQAPGKGLEAVAAIYYAKFGPYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAAEAFVQSPYSGSHTTKYWGQGTQVTVSS,N/A,IGHV3-30 (Human),IGHJ4 (Human),N/A,N/A,AAEAFVQSPYSGSHTTKY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/sdAb-3F11_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 1, 2020","Oct 1, 2020",N/A,Complete
sdAb-4D8,Nb,SARS-CoV2,SARS-CoV1,SARS-CoV2,,S; RBD,Phage Display (Humanised sdAbs),QVQLVESGGGLVQPGGSLRLSCAASGNIDSTRYHGWFRQAPGKGLEAVAAIKGVWPEDYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAADQYEWWVPGEVGPYLYWGQGTQVTVSS,N/A,IGHV3-23 (Human),IGHJ4 (Human),N/A,N/A,AADQYEWWVPGEVGPYLY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/sdAb-4D8_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 1, 2020","Oct 1, 2020",N/A,Complete
sdAb-5F8,Nb,"SARS-CoV1,SARS-CoV2",,SARS-CoV2,,S; RBD,Phage Display (Humanised sdAbs),QVQLVESGGGLVQPGGSLRLSCAASGRQAVVFGWFRQAPGKGLEAVAAIHVPAKNRYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAAHYEFNDFVWQGYSSDYWGQGTQVTVSS,N/A,IGHV3-30 (Human),IGHJ4 (Human),N/A,N/A,AAHYEFNDFVWQGYSSDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/sdAb-5F8_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Oct 1, 2020","Oct 1, 2020",N/A,Complete
VH3-B01,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Phage Display (Human),ND,N/A,ND,ND,N/A,N/A,ND,N/A,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Aug 27, 2020","Aug 27, 2020",N/A,Following up for VH read
VH-Fc-B01,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Phage Display (Human),ND,N/A,ND,ND,N/A,N/A,ND,N/A,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Aug 27, 2020","Aug 27, 2020",N/A,Following up for VH read
VH2-A01-B01,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Phage Display (Human),ND,N/A,ND,ND,N/A,N/A,ND,N/A,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Aug 27, 2020","Aug 27, 2020",N/A,Following up for VH read
VH2-A01-B02,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Phage Display (Human),ND,N/A,ND,ND,N/A,N/A,ND,N/A,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Aug 27, 2020","Aug 27, 2020",N/A,Following up for VH read
Nb#6,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,"Yeast Display Library (scFv, human)",QVQLVESGGGLVQAGGSLRLSCAASGYIFGRNAMGWYRQAPGKERELVAGITRRGSITYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAADPASPAYGDYWGQGTQVTVSS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AADPASPAYGDY,N/A,https://www.rcsb.org/structure/7KKK; https://www.rcsb.org/structure/7KKL; https://www.rcsb.org/structure/7KKJ,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Aug 18, 2020","Dec 2, 2020",9th Nov: Added expected structure. 12 Nov: Added PDB structure and sequence data. 2nd Dec: Added new PDB structure 7KKJ,Complete
Nb4-43,Nb,SARS-CoV2,SARS-CoV1,SARS-CoV2,SARS-CoV1,S; RBD,Phage Display (Immunised Camel),ND,N/A,ND,ND,N/A,N/A,ND,N/A,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Aug 27, 2020","Aug 17, 2020",N/A,Following up for VHH read
Nb11-59,Nb,"SARS-CoV1,SARS-CoV2",,"SARS-CoV1,SARS-CoV2",,S; RBD,Phage Display (Immunised Camel),ND,N/A,ND,ND,N/A,N/A,ND,N/A,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Aug 27, 2020","Aug 17, 2020",N/A,Following up for VHH read
Nb14-33,Nb,"SARS-CoV1,SARS-CoV2",,SARS-CoV2,SARS-CoV1,S; RBD,Phage Display (Immunised Camel),ND,N/A,ND,ND,N/A,N/A,ND,N/A,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Aug 27, 2020","Aug 17, 2020",N/A,Following up for VHH read
Nb15-61,Nb,"SARS-CoV1,SARS-CoV2",,SARS-CoV2,SARS-CoV1,S; RBD,Phage Display (Immunised Camel),ND,N/A,ND,ND,N/A,N/A,ND,N/A,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Aug 27, 2020","Aug 17, 2020",N/A,Following up for VHH read
Nb16-52,Nb,"SARS-CoV1,SARS-CoV2",,SARS-CoV2,SARS-CoV1,S; RBD,Phage Display (Immunised Camel),ND,N/A,ND,ND,N/A,N/A,ND,N/A,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Aug 27, 2020","Aug 17, 2020",N/A,Following up for VHH read
Nb16-68 ,Nb,"SARS-CoV1,SARS-CoV2",,"SARS-CoV1,SARS-CoV2",,S; RBD,Phage Display (Immunised Camel),ND,N/A,ND,ND,N/A,N/A,ND,N/A,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Aug 27, 2020","Aug 17, 2020",N/A,Following up for VHH read
Nb16-75,Nb,"SARS-CoV1,SARS-CoV2",,SARS-CoV2,SARS-CoV1,S; RBD,Phage Display (Immunised Camel),ND,N/A,ND,ND,N/A,N/A,ND,N/A,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Aug 27, 2020","Aug 17, 2020",N/A,Following up for VHH read
Nb2,Nb,SARS-CoV2,,,,S; RBD,Immunised Llama,QVQLVESGGGLVQAGGSLRLSCAASGRTFSIYNMGWFRQAPGKEREFVIHMNWSNGNTATAASVKDRFTISRDNAKNTVYLQMSSLKPEDTAVYYCHATTNDYDYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,HATTNDYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Nb2_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 9, 2020","Nov 9, 2020",N/A,Complete
Nb3,Nb,SARS-CoV2,,,,S; RBD,Immunised Llama,HVQLVESGGGLVQAGGSLRLSCVASGSGFEPNAMGWYRQAPGKQRELVAGITSGGNTNYADSVKGRFTISRDNVKNTVYLQMNSLKPEDTAVYYCNAVAPRINPRGSPTNYWGQGTQVTVSS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,NAVAPRINPRGSPTNY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Nb3_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 9, 2020","Nov 9, 2020",N/A,Complete
Nb4,Nb,SARS-CoV2,,,,S; RBD,Immunised Llama,QVQLVESGGGLVQAGGSLRLSCVASGSGFEPNAMGWYRQAPGKQRELVAGITSGGNANYADSVKGRFTISRDNVKNTVYLQMNSLKPEDTAVYYCNAVGPRFNPRGSPTNYWGQGTQVTVSS ,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,NAVGPRFNPRGSPTNY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Nb4_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 9, 2020","Nov 9, 2020",N/A,Complete
Nb5,Nb,SARS-CoV2,,,,S; RBD,Immunised Llama,QVQLVESGGGLAQSGDSLRLSCAASGRTFDINYMAWFRRAPGKEREFVAASSWTGVGTYYADSVKGRFTISRDNNKNTLYLQMDSLKPEDTAVYYCAADSNIDRLHSAGSDYRYWGQGTQVTVSS ,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AADSNIDRLHSAGSDYRY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Nb5_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 9, 2020","Nov 9, 2020",N/A,Complete
Nb6,Nb,SARS-CoV2,,,,S; RBD,Immunised Llama,HVQLVESGGGLVQAGGSLRLSCAASGRTFSTHATGWFRQAPGKEREFLATSVWLDDISRDSTYYAESVKGRFSISRDNAKDTVYLQMNSLKPEDTAVYYCAVKQRVGPGIMSAPTYDYWGQGTQVTVSS ,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AVKQRVGPGIMSAPTYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Nb6_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 9, 2020","Nov 9, 2020",N/A,Complete
Nb9,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Llama,HVQLVESGGGLVQTGGSLRLSCAFSGYTFSTFPTAWFRQAPGKEREFVAGIRWNGGSRDYTEYADFVKGRFTISRDNAKNMIYLQMISLKPEDTALYYCAASHGVVDGTSVNGYRYWGQGTQVTVSS ,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AASHGVVDGTSVNGYRY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Nb9_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 9, 2020","Nov 9, 2020",N/A,Complete
Nb10,Nb,SARS-CoV2,,,,S; RBD,Immunised Llama,DVQLVESGGGLVQAGGSLKLSCTASESTFNFNHIDWYRQAPGKQRESVAVITNTDVTNYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYLCNAWRFGPTGVKVDYWGQGTQVTVSS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,NAWRFGPTGVKVDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Nb10_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 9, 2020","Nov 9, 2020",N/A,Complete
Nb11,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Llama,HVQLVESGGGLVQAGGSLRLSCAVSGASAERVGWFRRAPGKEREFVAAIGANGGSTNYLDSVKGRFTISRDNAKNTVYLQMNSLKPQDTAVYYCAARNLETFDYTYWGRGTQVTVSS ,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AARNLETFDYTY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Nb11_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 9, 2020","Nov 9, 2020",N/A,Complete
Nb12,Nb,SARS-CoV2,,,,S; RBD,Immunised Llama,HVQLVESGGGLVQAGGSLRLTCAASGGTFSTSTMDMGWFRQAPGKEREFVAVDSWNDGRAYYADSVKGRFTISRDSAKTTLYLQMNSLKPEDTAVYYCAARTERGVYDYWGRGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AARTERGVYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Nb12_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 9, 2020","Nov 9, 2020",N/A,Complete
Nb15,Nb,SARS-CoV2,,,,S; RBD,Immunised Llama,EVQLVESGGGLVAAGGSLRLSCVPSTNIFSANAMGWYRQAPGKQRELVASITSGGNTNYADSVKGRFTISRDNADTVILQMNSLKPEDTAVYYCKGTAYSTTYNSVRDYWGQGTQVTVSS ,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,KGTAYSTTYNSVRDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Nb15_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 9, 2020","Nov 9, 2020",N/A,Complete
Nb16,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Llama,DVQLVESGGGLVQAGESLRLSCAASGDMFSSNAMAWYRQAPGKQRELVASITSGGNTNYADSVKGRFTISRDNAKNTVYLQMDSLKPEDTAVYYCNGVAYDYSWGRPRNFWGQGTQVTVSS ,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,NGVAYDYSWGRPRNF,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Nb16_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 9, 2020","Nov 9, 2020",N/A,Complete
Nb17,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Llama,HVQLVESGGGLVQAGGSLRLSCAASGSIFSSNAMSWYRQAPGKQRELVASITSGGNADYADSVKGRFTISRDKNTVYPEMSSLKPADTAVYYCHAVGQEASAYAPRAYWGQGTQVTVSS ,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,HAVGQEASAYAPRAY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Nb17_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 9, 2020","Nov 9, 2020",N/A,Complete
Nb18,Nb,SARS-CoV2,,,,S; RBD,Immunised Llama,DVQLVESGGGLVQAGGSLRLSCAASGRTFSSYNVGWFRQAPGKEREFVAFIRWSGTSTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAATSRTMIHTSQAMPINWDYWGQGTQVTVSS ,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AATSRTMIHTSQAMPIN,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Nb18_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 9, 2020","Nov 9, 2020",N/A,Complete
Nb20,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Llama,QVQLVESGGGLVQAGGSLRLSCAVSGAGAHRVGWFRRAPGKEREFVAAIGASGGMTNYLDSVKGRFTISRDNAKNTIYLQMNSLKPQDTAVYYCAARDIETAEYIYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AARDIETAEYIY,N/A,https://www.rcsb.org/structure/7JVB,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 9, 2020","Dec 14, 2020",Added PDB structure,Complete
Nb21,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Llama,QVQLVESGGGLVQAGGSLRLSCAVSGLGAHRVGWFRRAPGKEREFVAAIGANGGNTNYLDSVKGRFTISRDNAKNTIYLQMNSLKPQDTAVYYCAARDIETAEYTYWGQGTQVTVSS ,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AARDIETAEYTY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Nb21_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 9, 2020","Nov 9, 2020",N/A,Complete
Nb24,Nb,SARS-CoV2,,,,S; RBD,Immunised Llama,QVQLVESGGGLVQAGGSLRLTCAASGGTFSTSTMDMGWFRQAPGKEREFVALDSWNGGRTYYADSVKGRFTISRDNAKNTLYLQMNSLKPEDTAVYYCAADTYSNYEKDDSWGYWGQGTQVTVSS ,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AADTYSNYEKDDSWGY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Nb24_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 9, 2020","Nov 9, 2020",N/A,Complete
Nb26,Nb,SARS-CoV2,,,,S; RBD,Immunised Llama,HVQLVESGGGLVQAGGSLRLTCAASGRTFSISTMDMGWFRQAPGKEREFVAADAWNDGRTYYADSVKGRFTISRDNAKNTLYLQMNSLKPEDTAVYYCTADTYSNYKKDDSWGYWGQGTQVTVSS ,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,TADTYSNYKKDDSWGY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Nb26_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 9, 2020","Nov 9, 2020",N/A,Complete
Nb28,Nb,SARS-CoV2,,,SARS-CoV2,S; RBD,Immunised Llama,HVQLVESGGGLVQAGGSLRLSCAASGRTFSTSTMDMGWFRQAPGKEREFVGADSWNDGRTYYADSVKGRFTISRDNAKNTLYLQMNNLKPEDTAVYYCAAETYSLYEKSDSWGYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAETYSLYEKSDSWGY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Nb28_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 9, 2020","Nov 9, 2020",N/A,Complete
Nb29,Nb,SARS-CoV2,,,,S; RBD,Immunised Llama,HVQLVESGGGLVQAGGSLRLTCAASGGTFSTSTMDMGWFRQAPGKEREFVAVDSWNDGRAYYADSVKGRFTISRDNAKNTLYLQMNSLKPEDTAVYYCAAETYSNYEKAYSWGYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAETYSNYEKAYSWGY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Nb6_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 9, 2020","Nov 9, 2020",N/A,Complete
Nb32,Nb,SARS-CoV2,,,,S; RBD,Immunised Llama,DVQLVESGGGLVQAGGSLRLSCAASGRTFSSDTMDMGWFRQAPGKEREFVALHSWNGGKTYYADSVKGRFTISRDNAKNTLYLQMNNLKPEDTAVYYCAAETYTLYEKDSSWGYWGQGTQVTVSS ,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAETYTLYEKDSSWGY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Nb29_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 9, 2020","Nov 9, 2020",N/A,Complete
Nb33,Nb,SARS-CoV2,,,,S; RBD,Immunised Llama,HVQLVESGGGLVQAGGSLRLSCAASGRTFSSYAMGWFRQAPGKQRELVAGITSGGNANYEDSVKGRFTISRDKNTVYLEMSSLKPADTAVYYCNAVGQEGSARAPRAYWGQGTQVTVSS ,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,NAVGQEGSARAPRAY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Nb33_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 9, 2020","Nov 9, 2020",N/A,Complete
Nb34,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Llama,DVQLVESGGGLVQAGGSLRLSCAASGFTFSNYVMYWGRQAPGKGREWVSGIDSDGSDTAYASSVKGRFTISRDNAKNTLYLQMNNLKPEDTALYYCVKSKDPYGSPWTRSEFDDYWGQGTQVTVSS ,N/A,IGHV3S1 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,VKSKDPYGSPWTRSEFDDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Nb34_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 9, 2020","Nov 9, 2020",N/A,Complete
Nb36,Nb,SARS-CoV2,,,SARS-CoV2,S; RBD,Immunised Llama,HVQLVESGGGLVQAGGSLTLTCAASGRTFSSETMDMGWFRQAPGKEREFVAADSWNDGSTYYADSVKGRFTISRDSAKNTLYLQMNSLKPEDTAVYYCAAETYSIYEKDDSWGYWGQGTQVTVSS ,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAETYSIYEKDDSWGY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Nb36_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 9, 2020","Nov 9, 2020",N/A,Complete
Nb37,Nb,SARS-CoV2,,,,S; RBD,Immunised Llama,QVQLVESGGGLVQTGGSLRLSCAASGRTFSNYVMGWFRQAPGKEREFVSSIEWNSENTFYANSVKGRFTISRDNAKNTVYLQMNSLKAEDTAVYYCAADRGSSYYYTRASEYTYWGQGTQVTVSS ,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AADRGSSYYYTRASEYTY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Nb37_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 9, 2020","Nov 9, 2020",N/A,Complete
Nb39,Nb,SARS-CoV2,,,,S; RBD,Immunised Llama,QVQLVESGGGLVQAGGSLRLSCAASGRTFRFSAIDWYRQAPGQQREFVASISTSGRISYGHFVKGRFTISRDNAKNTMYLQMNSLKPEDTAVYYCHLAQPDVFGGGDYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,HLAQPDVFGGGDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Nb39_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 9, 2020","Nov 9, 2020",N/A,Complete
Nb41,Nb,SARS-CoV2,,,,S; RBD,Immunised Llama,DVQLVESGGGLVQAGGSLRLSCAASGFTFSNYVMYWGRQAPGKGREWVSGIDSDGSDTAYASSVKGRFTISRDNAKKTLYLQMNDLKPEDTALYYCVKSKDRYGSPWTRSEFEDYWGQGTQVTVSS,N/A,IGHV3S1 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,VKSKDRYGSPWTRSEFEDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Nb41_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 9, 2020","Nov 9, 2020",N/A,Complete
Nb42,Nb,SARS-CoV2,,,,S; RBD,Immunised Llama,HVQLVESGGGLVQAGESLRLSCVASGSIFSINAMGWFRQAPGKQRELVASISNIGTTIYAESVKGRFTISRDNAKNTADLQMNSLKPEDTAIYYCNLRQGCSYNGCDEYWGQGTQVTVSS ,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,NLRQGCSYNGCDEY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Nb42_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 9, 2020","Nov 9, 2020",N/A,Complete
Nb43,Nb,SARS-CoV2,,,,S; RBD,Immunised Llama,EVQLVESGGGLVQAGGSLRLTCAASGRTFSSSTMDMGWFRQAPGKEREFVAVDAWNDGRTYYADSVKGRFTISRDNAKNTLYLQMNSLKPEDTAIYYCNLRQGCSYNGCDEYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,NLRQGCSYNGCDEY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Nb43_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 9, 2020","Nov 9, 2020",N/A,Complete
Nb44,Nb,SARS-CoV2,,,,S; RBD,Immunised Llama,DVQLVESGGGLVQAGGSLRLTCAASGRTFSSSTMDMGWFRQAPGKEREFVAASSWGFTNYADPVKGRFTISRDNAKNTVYLEMSSLKPEDTAVYYCAARTPETGQYDYWGQGTQVTVSS ,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AARTPETGQYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Nb44_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 9, 2020","Nov 9, 2020",N/A,Complete
Nb46,Nb,SARS-CoV2,,,,S; RBD,Immunised Llama,QVQLVESGGGLVQAGGSLRLSCAVSGSTLGINAIGWYRQPPGKQRELVASISSLGTTLYAESVKGRFAISRDNAKNTGYLQMNSLKPDDTAVYYCNMRTPYMRDYWGQGTQVTVSS ,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,NMRTPYMRDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Nb46_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 9, 2020","Nov 9, 2020",N/A,Complete
Nb48,Nb,SARS-CoV2,,,,S; RBD,Immunised Llama,HVQLVESGGGLVQAGGSLRLSCAASGSIFRHYNMGWFRQAPGKEREFVSAISWTNIGTYYADSVKGRFSISRDNNRNTAYLEMNSLKPEDTAVYYCAADRSEFGSRLYSDENEYDYWGQGTQVTVSS ,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AADRSEFGSRLYSDENEYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Nb48_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 9, 2020","Nov 9, 2020",N/A,Complete
Nb51,Nb,SARS-CoV2,,,,S; RBD,Immunised Llama,QVQLVESGGGLVQAGGSLRLSCAASGSTFSINAIGWYRQAPGKQRELVAGITSGGNTNYADSVKGRFTISRDNAKNTVDLQMNSLKPEDTAVYYCNTVAPVEGTGRIRAYWGQGTQVTVSS ,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,NTVAPVEGTGRIRAY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Nb51_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 9, 2020","Nov 9, 2020",N/A,Complete
Nb52,Nb,SARS-CoV2,,,,S; RBD,Immunised Llama,HVQLVESGGGLVQAGGSLRLSCAASERTFTSYVVGWYRQAPGKGREFVARINEIGDITYYADSVKGRFTISRDNAKNTVYLQMSALKPEDTAVYYCGARKDSVVLSSVGYDYWGQGTQVTVSS ,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,GARKDSVVLSSVGYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Nb52_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 9, 2020","Nov 9, 2020",N/A,Complete
Nb55,Nb,SARS-CoV2,,,,S; RBD,Immunised Llama,DVQLVESGGGLVQAGGSLRLSCAASGRTFGSTMAWFRQAPGKERDFVAAITWSADRISYADSVKGRFTISRDNDKNIVHLQMNSLKPEDTAVYVCAARASSNTYDDPRSFAFWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ6 (Alpaca),N/A,N/A,AARASSNTYDDPRSFAF,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Nb55_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 9, 2020","Nov 9, 2020",N/A,Complete
Nb58,Nb,SARS-CoV2,,,,S; RBD,Immunised Llama,QVQLVESGGGLVQAGGSLRLSCAASGRDFSSTVMGWFRQAPGKERELVAWMTVTYDITYYADSVKGRFTISKDNAKNTVYLQANSLKPDDTAVYYCASGALRVGSFSPDYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,ASGALRVGSFSPDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Nb58_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 9, 2020","Nov 9, 2020",N/A,Complete
Nb59,Nb,SARS-CoV2,,,,S; RBD,Immunised Llama,HVQLVESGGGLVQAGGSLRLSCAASGRTFSSYAMSWVRQAPGKGQEWVAGIQREGTETNYADSVKGRFTISRDNAKRTLYLQMNNLKPEDTGVYYCAKVLGRPYGSRWLDDVDSWGRGTQVTVSS,N/A,IGHV3S1 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AKVLGRPYGSRWLDDVDS,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Nb59_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 9, 2020","Nov 9, 2020",N/A,Complete
Nb60,Nb,SARS-CoV2,,,,S; RBD,Immunised Llama,HVQLVESGGGLVQAGDSLRLSCAASERTNINYAMGWFRQAPGKERDFVAAIGWNGSIIKYAESVKGRFTISRDDAKNTVSLQMNSLKPEDTAVYYCAARIGSIANLQPREYEFAYWGQGTQVTVSS ,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AARIGSIANLQPREYEFAY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Nb60_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 9, 2020","Nov 9, 2020",N/A,Complete
Nb62,Nb,SARS-CoV2,,,,S; RBD,Immunised Llama,HVQLVESGGGLVQAGGSLRLTCAASGRTFSSSTMDMGWFRQAPGKEREFVAVDAWNDGRTYYADSVKGRFTISRDNAKNTLYLQMNSLKPGDTAVYYCHAVDVSVGGDYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,HAVDVSVGGDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Nb62_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 9, 2020","Nov 9, 2020",N/A,Complete
Nb63,Nb,SARS-CoV2,,,,S; RBD,Immunised Llama,QVQLVESGGGLVQAGGSLRLSCVASGSGFEPNAMGWYRQAPGKQRELVAGITSGGNANYADSVKGRFTISRDNVKNTVYLQMNSLKPEDTAVYYCQGPACSGSGCRNYWGQGTQVTVSS ,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,QGPACSGSGCRNY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Nb63_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 9, 2020","Nov 9, 2020",N/A,Complete
Nb64,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Llama,QVQLVESGGGLVQAGGSLRLSCAVSGRTFSIAGMGWFRQAPGKDREFLGGITWNDGTTWYADSVKGRFTISRDNAKNMLSLRMNSLKPEDTAVYYCAAGPRLGSTPRAYDYWGQGTQVTVSS ,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAGPRLGSTPRAYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Nb64_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 9, 2020","Nov 9, 2020",N/A,Complete
Nb65,Nb,SARS-CoV2,,,,S; RBD,Immunised Llama,QVQLVESGGGLVQAGGSLRLSCSASGFDFSHNTWAWYRQAPGKQRELVATISNSGSTNYADSVKGRFTIARDNAKNTVSLQMNTLKPEDTAVYFCKKESGVNYWGQGTQVTVSS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,KKESGVNY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Nb65_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 9, 2020","Nov 9, 2020",N/A,Complete
Nb66,Nb,SARS-CoV2,,,,S; RBD,Immunised Llama,HVQLVESGGGLVQAGGSLRLSCAASGRTFSVNSIAWFRQAPGKEREFVATINWSGGDIYYADSVKGRFTISRDNGKNTVYLQMNSLKPTDTAVYYCAAARFYGRSIAQDYDSWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAARFYGRSIAQDYDS,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Nb66_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 9, 2020","Nov 9, 2020",N/A,Complete
Nb68,Nb,SARS-CoV2,,,,S; RBD,Immunised Llama,QVQLVESGGGLVQAGGSLRLSCAASGGTLRSYNMGWFRQGPGKEREFVAAISWTGLGTYYGDSVKGRFTISRDVIKNTLYLQMDSLKPEDTAIYYCAADSSTSRLHSAGSDYRYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AADSSTSRLHSAGSDYRY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Nb68_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 9, 2020","Nov 9, 2020",N/A,Complete
Nb73,Nb,SARS-CoV2,,,,S; RBD,Immunised Llama,QVQLVESGGGLVQAGGSLRLSCAASGRTFSSHAMAWFRQAPGKEREFVAGISWSGPYYVDSVKGRFTISADNAKNIVYLQMNSLTPEDTAVYYCASNRGPNLYPHIGDIEYWGQGTQVTVSS ,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,ASNRGPNLYPHIGDIEY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Nb73_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 9, 2020","Nov 9, 2020",N/A,Complete
Nb74,Nb,SARS-CoV2,,,,S; RBD,Immunised Llama,HVQLVESGGGLVQAGGSLRLSCAASGRTFSSHAMAWFRQAPGKEREFVAGISWSGPYYVDSVKGRFTISTDNAKNTVYLQMNSLTPEDTAVYYCASSRGPNLYPHIGDVEYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,ASSRGPNLYPHIGDVEY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Nb74_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 9, 2020","Nov 9, 2020",N/A,Complete
Nb76,Nb,SARS-CoV2,,,,S; RBD,Immunised Llama,DVQLVESGGGLVQAGGSLRLSCAVSGRTFSISTMGWFRQAPGKERLFVAGITWHDGSTNYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTALYYCAARKSINYVQEYDYWGRGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AARKSINYVQEYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Nb76_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 9, 2020","Nov 9, 2020",N/A,Complete
Nb78,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Llama,QVQLVESGGGLVQAGGSLRLSCAISGASANRVGWFRRAPGKEREFVAAIGASGGMTNYLDSVKGRFTISRDNAKNTVYLQMNSLKPQDTAVYYCAARNIETAEYTYWGQGTQVTVSS ,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AARNIETAEYTY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Nb78_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 9, 2020","Nov 9, 2020",N/A,Complete
Nb80,Nb,SARS-CoV2,,,,S; RBD,Immunised Llama,HVQLVESGGGLVQPGGSLRLSCAASGNFFLINVMSWWRQAPGNEHELHELVATITSDGRTNYGDAVQGRFTISRDNAKNTLYLQMNSLKPEDTAVYYCYAQGQGNREYWGQGTQVTVSS ,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,YAQGQGNREY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Nb80_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 9, 2020","Nov 9, 2020",N/A,Complete
Nb81,Nb,SARS-CoV2,,,,S; RBD,Immunised Llama,EVQLVESGGGLVQAGGSLRLSCAASGSIFSILNMGWYRQAPGKQRDLVARITPGGSTDYADSVKGRFTISRDNAKNTLYLQMNSLKPEDTAVYLCYAKIFGPGSGSYWGQGTQVTVSS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,YAKIFGPGSGSY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Nb81_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 9, 2020","Nov 9, 2020",N/A,Complete
Nb82,Nb,SARS-CoV2,,,SARS-CoV2,S; RBD,Immunised Llama,DVQLVESGGGLVQAGGSLGLSCAASGSIFRLTAMGWYRQAPGKQRDLVTTITSAGIPHYADSVKGRFTISRDNAKNTVYLQMNGLKPEDTAVYYCYANTLNSQLLPRAYWGQGTQVTVSS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,YANTLNSQLLPRAY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Nb82_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 9, 2020","Nov 9, 2020",N/A,Complete
Nb83,Nb,SARS-CoV2,,,,S; RBD,Immunised Llama,HVQLVESGGGLVQPGGSLRLSCAASGRSFNSYLMGWFRQAPGKEREFVAWISGSPHDIIRYRDSVKDRFTISRDNAKNTVYLQMNSLKPVDTAVYYCAVGSLRVGSFSPDYWGQGTQVTVSS ,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AVGSLRVGSFSPDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Nb83_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 9, 2020","Nov 9, 2020",N/A,Complete
Nb84,Nb,SARS-CoV2,,,,S; RBD,Immunised Llama,DVQLVESGGGLVQAGGSLRLSCAASGRTFSSYSMGWFRQAPGKEREFVAFIRWSGTSTYYADSVKGRFTISRDNAKNTVYLQMNSLKPDDTAVYYCAASSRTMNTISQTMRINWDYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AASSRTMNTISQTMRINWDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Nb84_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 9, 2020","Nov 9, 2020",N/A,Complete
Nb87,Nb,SARS-CoV2,,,,S; RBD,Immunised Llama,HVQLVESGGGLVQAGGSLRLSCAASGSDFSILAIGWYRQAPGKQRELVAAISRVGSTNYADSVKGRFTISRDNAKNTVSLQMNSLKPEDTAVYYCNAGIPMSTVLLGQGFWGQGTQVTVSS ,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,NAGIPMSTVLLGQGF,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Nb87_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 9, 2020","Nov 9, 2020",N/A,Complete
Nb89,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Llama,HVQLVESGGGLVQAGGSLRLSCAASGGTFTTFRMAWFRQTPGKEREFVAASSWGFVNYADPVKGRFTISRDNAKNTVYLEMSSLKTEDTAVYYCAARNPGTGQYDYWGQGTQVTVSS ,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AARNPGTGQYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Nb89_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 9, 2020","Nov 9, 2020",N/A,Complete
Nb90,Nb,SARS-CoV2,,,,S; RBD,Immunised Llama,HVQLVESGGGLVQAGGSLRLSCAVSGRTVSSYVMGWFRQAPGKEREFVAGIGRTGMTITADSVKGRFTISRDNAKNLVYLQMNSLKSEDTAVYWCAAGVRDFAPRIDSYDYWGQGTQVTVSS ,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAGVRDFAPRIDSYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Nb90_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 9, 2020","Nov 9, 2020",N/A,Complete
Nb91,Nb,SARS-CoV2,,,,S; RBD,Immunised Llama,HVQLVESGGGLVQPGGSLRLSCAASGLTLNDYAIGWFRQAPGKEREGVSCISSSDGTTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCATDIAPFYCSWPLRTRLVEYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,ATDIAPFYCSWPLRTRLVEY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Nb91_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 9, 2020","Nov 9, 2020",N/A,Complete
Nb92,Nb,SARS-CoV2,,,,S; RBD,Immunised Llama,HVQLVESGGGLVQAGGSLRLSCAASGRTFSAYGMGWFRQAPGKEREFVAGIARSGSEYYGDSVKGRFTISRDNAKNTVYLQMASLKAEDTGVYYCAADPTILYHALSQRTQNYRYWGPGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AADPTILYHALSQRTQNYRY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Nb92_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 9, 2020","Nov 9, 2020",N/A,Complete
Nb93,Nb,SARS-CoV2,,,SARS-CoV2,S; RBD,Immunised Llama,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGREWVAGITPGSGTFYADSVKGRFTISRDNAKNTLSLEINSLKPEDTALYYCAKCRQEFSWDFSSRDPDDFDYWGQGTQVTVSS,N/A,IGHV3S1 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AKCRQEFSWDFSSRDPDDFDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Nb93_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 9, 2020","Nov 9, 2020",N/A,Complete
Nb94,Nb,SARS-CoV2,,,,S; RBD,Immunised Llama,QVQLVESGGGLVQAGGSLRLSCTASGGTFRSFTMAWFRQAPGKEREFVATLSWTGVGTYYADSVKGRFTISRDIAKNTVYLEMNSLIPEDTAVYYCAASPYTYSLLSRTGDYGYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AASPYTYSLLSRTGDYGY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Nb94_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 9, 2020","Nov 9, 2020",N/A,Complete
Nb95,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Llama,QVQLVESGGGLVQAGGSLRLSCAASGRTFSSYSMGWFRQAQGKEREFVATINGNGRDTYYTNSVKGRFTISRDDATNTVYLQMNSLKPEDTAIYYCAADKDVYYGYTSFPNEYEYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AADKDVYYGYTSFPNEYEY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Nb95_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 9, 2020","Nov 9, 2020",N/A,Complete
Nb96,Nb,SARS-CoV2,,,,S; RBD,Immunised Llama,HVQLVESGGGLVQAGDSLRLSCAASGRDFSSYAMGWFRQAPGKEREFVGVISSGDVGTFYEDSVKGRFTISRDDAKNTVDLQMNSLKPEDTAVYYCAAALYVTSTRGSYAYWGQGTQVTVSS ,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAALYVTSTRGSYAY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Nb96_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 9, 2020","Nov 9, 2020",N/A,Complete
Nb97,Nb,SARS-CoV2,,,,S; RBD,Immunised Llama,HVQLVESGGGLVQAGGSLRLSCAAPGRTFSTSAMGWFRQAPGKEREFVAAIDWSNTNIHYADTVKGRFTISTDTAKNTVYLQMNNLKPEDTAVYYCAQGGWGLTQPISVDYWGKGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AQGGWGLTQPISVDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Nb97_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 9, 2020","Nov 9, 2020",N/A,Complete
Nb98,Nb,SARS-CoV2,,,,S; RBD,Immunised Llama,QVQLVESGGGLVQAGGSLRLSCAASGGTFSSYAMGWFRQTPGKEREFVGAISRSGGGTSYLDSVKGRFTISRDNAKNTMYLQMNSLKPEDSAIYYCAGGTYGSTSVRDFGPWGQGTQVTVSS ,N/A,IGHV3-3 (Alpaca),IGHJ6 (Alpaca),N/A,N/A,AGGTYGSTSVRDFGP,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Nb98_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 9, 2020","Nov 9, 2020",N/A,Complete
Nb99,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Llama,QVQLVESGGGLVQTGGSLRLSCAASGSTRSIWYSGWYRQAPGKQRELVASLTSGGTTYYPDSMKGRFTISGSSGLNMVYLQMNSLRPEDTAVYSCNVRTGSGVYWGQGTQVTVSS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,NVRTGSGVY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Nb99_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 9, 2020","Nov 9, 2020",N/A,Complete
Nb100,Nb,SARS-CoV2,,,,S; RBD,Immunised Llama,EVQLVESGGGLVQAGGSLRLSCAASGLTFSSYNMGWFRQAPGKEREFVAFIRWSGTSTYYADSVKGRFTISRDTAKNTVYLQMNSLKLEDTAVYYCAATSRTMIHTSQTMRINWDYWGQGTQVTVSS ,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AATSRTMIHTSQTMRINWDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Nb100_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 9, 2020","Nov 9, 2020",N/A,Complete
Nb102,Nb,SARS-CoV2,,,,S; RBD,Immunised Llama,QVQLVESGGGLVQAGGSLRLSCAASGRTFSNSHMGWFRQAPGKEREFVAVISRSGGSTLYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAASRTAGLTSNRSLYDYWGRGTQVTVSS ,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AASRTAGLTSNRSLYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Nb102_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 9, 2020","Nov 9, 2020",N/A,Complete
Nb103,Nb,SARS-CoV2,,,,S; RBD,Immunised Llama,HVQLVESGGGLVQAGGSLRLSCAASGRTFSSYAMGWFRQAPGKEREFVARVSAAGSITDYADSVKGRFTIAKDNAKSTVYLRMNSLRLEDTAVYYCAADVATIGSRLANYDYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AADVATIGSRLANYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Nb103_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 9, 2020","Nov 9, 2020",N/A,Complete
Nb104,Nb,SARS-CoV2,,,,S; RBD,Immunised Llama,QVQLVESGGGLVQAGGSLRLSCAVSGSTLGINAIGWYRQPPGKQRELVASISSLGTTLYAESVKGRFAISRDNAKNTAYLQMNSLKPDDTAVYYCNMRTPYRRDYWGQGTQVTVSS ,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,NMRTPYRRDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Nb104_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 9, 2020","Nov 9, 2020",N/A,Complete
Nb105,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Llama,HVQLVESGGGLVQAGGSLRLSCAVSGRTFSTYGMAWFRQAPGKERDFVATITRSGETTLYADSVKGRFTISRDNAKNTVYLQMNSLKIEDTAVYYCAVRRDSSWGYSRDLFEYDYWGQGTQVTVSS ,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AVRRDSSWGYSRDLFEYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Nb105_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 9, 2020","Nov 9, 2020",N/A,Complete
Nb106,Nb,SARS-CoV2,,,,S; RBD,Immunised Llama,QVQLVESGGGLVQAGGSLRLSCAASGRTFSNYAMGWFRQAPGKGREFVAGISWSTRNTYYADSVKGRFTVSRDNEQTTMSLQMNRLKPEDTAVYYCAARFGIVTTRDEYEFYGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AARFGIVTTRDEYEF,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Nb106_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 9, 2020","Nov 9, 2020",N/A,Complete
Nb107,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Llama,HVQLVESGGGLVQAGGSLRLSCAASGRAIGIHRMAWFRQAPGKERAFVAAIQWTGDMPTYADSLKGRFTISADNAKNTVSLQMTSLKPDDTAVYYCAARSATTALYDYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AARSATTALYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Nb107_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Nov 9, 2020","Nov 9, 2020",N/A,Complete
NIH-CoVnb-101,Nb,SARS-CoV2,,,,S; RBD,Immunised Llama,DVQLQESGGDLVQPGGSLRLSCAASGFTLDYYAIGWFRQAPGKEREGVSCISSSDGSTYYADSVKGRFTSSRDNAKNTVYLQMNSLKPEDTAVYYCAAVPSTYYNGSYYYTCHPGGMDYWGKGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ7 (Alpaca),N/A,N/A,AAVPSTYYNGSYYYTCHPGGMDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/NIH-CoVnb-101_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 25, 2020","Jan 30, 2021",30th Jan 2021: Updated reference,Complete. Neutralisation assays to come in future study
NIH-CoVnb-102,Nb,SARS-CoV2,,,,S; RBD,Immunised Llama,DVQLQESGGGLVQPGGSLRLSCAVSGFTLDYYAIGWFRQAPGKEREGVSCISSSDGSTYYADSVKGRFTSSRDNAKNTVYLQMNSLKPEDTAVYYCAAVPSTYYSGTYYYNCHPGGMDYWGKGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ7 (Alpaca),N/A,N/A,AAVPSTYYSGTYYYNCHPGGMDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/NIH-CoVnb-102_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 25, 2020","Jan 30, 2021",30th Jan 2021: Updated reference,Complete. Neutralisation assays to come in future study
NIH-CoVnb-103,Nb,SARS-CoV2,,,,S; RBD,Immunised Llama,DVQLQESGGGLVQPGGSLRLSCAASGLTLDYYTIGWFRQAPGKEREGVSCISSSDDSTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCATAPGTYYKGSYYPMCHYYGMDYWGKGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ7 (Alpaca),N/A,N/A,ATAPGTYYKGSYYPMCHYYGMDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/NIH-CoVnb-103_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 25, 2020","Jan 30, 2021",30th Jan 2021: Updated reference,Complete. Neutralisation assays to come in future study
NIH-CoVnb-104,Nb,SARS-CoV2,,,,S; RBD,Immunised Llama,DVQLQESGGGLVQPGGSLRLSCAVSGFTLDYYAIGWFRQAPGKEREGVACISSSDGTTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCATRPLTYYSGSYYTTCSDYGMDYWGKGTLVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ7 (Alpaca),N/A,N/A,ATRPLTYYSGSYYTTCSDYGMDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/NIH-CoVnb-104_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 25, 2020","Jan 30, 2021",30th Jan 2021: Updated reference,Complete. Neutralisation assays to come in future study
NIH-CoVnb-105,Nb,SARS-CoV2,,,,S; RBD,Immunised Llama,DVQLQESGGGLVQPGGSLRLSCAASGFTLDYYAIGWFRQAPGKEREGVSCISNSDGSTYYADSVKGRFTTSRDNAKNTVYLQMNSLKPEDTAVYYCAAVPSTYYSGSYYYTCHPGGMDYWGKGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ7 (Alpaca),N/A,N/A,AAVPSTYYSGSYYYTCHPGGMDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/NIH-CoVnb-105_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 25, 2020","Jan 30, 2021",30th Jan 2021: Updated reference,Complete. Neutralisation assays to come in future study
NIH-CoVnb-106,Nb,SARS-CoV2,,,,S; RBD,Immunised Llama,DVQLQESGGGLVQSGGSLRLSCAASGFTLDYYAIGWFRQAPGKEREGVSCISNSDGSTYYADSVKGRFTTSRDNAKNTVYLQMNSLKPEDTAVYYCAAVPSTYYSGSYYYTCHPGGMDYWGKGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ7 (Alpaca),N/A,N/A,AAVPSTYYSGSYYYTCHPGGMDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/NIH-CoVnb-106_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 25, 2020","Jan 30, 2021",30th Jan 2021: Updated reference,Complete. Neutralisation assays to come in future study
NIH-CoVnb-107,Nb,SARS-CoV2,,,,S; RBD,Immunised Llama,DVQLQESGGGLVQPGGSLRLSCAASGFTLDYYAIGWFRQAPGKEREGVSCISNSDGSTYYADSVKGRFTTSRDNAKNTVYLQMNSLKPEDTAVYYCAAVPSTYYSGSYYYTCHPGGMDYWGKGTLVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ7 (Alpaca),N/A,N/A,AAVPSTYYSGSYYYTCHPGGMDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/NIH-CoVnb-107_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 25, 2020","Jan 30, 2021",30th Jan 2021: Updated reference,Complete. Neutralisation assays to come in future study
NIH-CoVnb-108,Nb,SARS-CoV2,,,,S; RBD,Immunised Llama,DVQLQESGGGLVQPGGSLRLSCAASGFTLDYYAIGWFRQAPGKEREGVSCISNSGGSTYYADSVKGRFTTSRDNAKNTVYLQMNSLKPEDTAVYYCAAVPSTYYSGSYYYTCHPGGMDYWGKGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ7 (Alpaca),N/A,N/A,AAVPSTYYSGSYYYTCHPGGMDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/NIH-CoVnb-108_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 25, 2020","Jan 30, 2021",30th Jan 2021: Updated reference,Complete. Neutralisation assays to come in future study
NIH-CoVnb-109,Nb,SARS-CoV2,,,,S; RBD,Immunised Llama,DVQLQESGGGLVQSGGSLRLSCAASGFTLDYYAIGWFRQAPGKEREGVSCITNSDGSTYYADSVKGRFTTSRDNAKNTVYLQMNSLKPEDTAVYYCASFPSTYYSGSYYYTCHPGGMDYWGKGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ7 (Alpaca),N/A,N/A,ASFPSTYYSGSYYYTCHPGGMDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/NIH-CoVnb-109_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 25, 2020","Jan 30, 2021",30th Jan 2021: Updated reference,Complete. Neutralisation assays to come in future study
NIH-CoVnb-110,Nb,SARS-CoV2,,,,S; RBD,Immunised Llama,DVQLQESGGGLVQPGGSLRLSCAASGFTLDYYAIGWFRQAPGKEREGVSCISSSDGSTYYADSVKGRFTISRDNAKNTVYLQMNSLKPDDTAVYYCAAALSEGGYTIDGSSWCYHSVYGMDYWGKGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ7 (Alpaca),N/A,N/A,AAALSEGGYTIDGSSWCYHSVYGMDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/NIH-CoVnb-110_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 25, 2020","Jan 30, 2021",30th Jan 2021: Updated reference and corrected CDRH3,Complete. Neutralisation assays to come in future study
NIH-CoVnb-111,Nb,SARS-CoV2,,,,S; RBD,Immunised Llama,DVQLQESGGGSVEAGGSLRLSCAASGVTLDYYAIGWFRQAPGKEREGVSCISSSDGSTYYADSVKGRFTTSRDNAKNTVYLQMNSLKPEDTADYYCAAVPSTYYSGTYYYNCHPGAMHYWGKGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ7 (Alpaca),N/A,N/A,AAVPSTYYSGTYYYNCHPGAMHY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/NIH-CoVnb-111_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 25, 2020","Jan 30, 2021",30th Jan 2021: Updated reference,Complete. Neutralisation assays to come in future study
NIH-CoVnb-112,Nb,SARS-CoV2,,,,S; RBD,Immunised Llama,DVQLQESGGGLVQPGGSLRLSCAASGLTLDYYAIGWFRQAPGKEREGVSCISSSDGSTYYADSVKGRFTTSRDNAKNTVYLQMNSLKPEDTAVYYCAAVPSTYYSGTYYYTCHPGGMDYWGKGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ7 (Alpaca),N/A,N/A,AAVPSTYYSGTYYYTCHPGGMDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/NIH-CoVnb-112_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 25, 2020","Jan 30, 2021",30th Jan 2021: Updated reference,Complete. Neutralisation assays to come in future study
NIH-CoVnb-113,Nb,SARS-CoV2,,,,S; RBD,Immunised Llama,DVQLQESGGGLVQPGGSLRLSCAASGLTLDYYAIGWFRQAPGKEREGVSCISSSDGSTYYADSVKGRFTTSRDNAKNTVYLQMNSLKPEDTAVYYCAAVPSTYYSGTYYYTCHPGGMDYWGKGTLVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ7 (Alpaca),N/A,N/A,AAVPSTYYSGTYYYTCHPGGMDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/NIH-CoVnb-113_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 25, 2020","Jan 30, 2021",30th Jan 2021: Updated reference,Complete. Neutralisation assays to come in future study
Sb2,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVSNEEMTWYRQAPGKEREWVAAIASNGNQTEYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCYVYVGASYIGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,YVYVGASY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb2_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 26, 2020","Dec 2, 2020",Added new reference,Complete
Sb5,Nb,SARS-CoV2 (weak),,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVAQQEMTWYRQAPGKEREWVAAISSIGSITHYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCYVYVGASYIGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,YVYVGASY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb5_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 26, 2020","Dec 2, 2020",Added new reference,Complete
Sb6,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVNHTRMYWYRQAPGKEREWVAAIQSHGQNTFYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCYVWVGNQYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,YVWVGNQY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb6_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 26, 2020","Dec 2, 2020",Added new reference,Complete
Sb7,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVNAEEMEWYRQAPGKEREWVAAISSSGDWTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCLVYVGSTYIGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,LVYVGSTY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb7_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 26, 2020","Dec 2, 2020",Added new reference,Complete
Sb8,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVKSYEMEWYRQAPGKEREWVAAISSYGEYTEYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCYVWVGDSYLGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,YVWVGDSY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb8_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 26, 2020","Dec 2, 2020",Added new reference,Complete
Sb9,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVGQQHMYWYRQAPGKEREWVAAIYSYGHITKYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCWVYVGDYYEGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,WVYVGDYY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb9_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 26, 2020","Dec 2, 2020",Added new reference,Complete
Sb12,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVQLYWMEWYRQAPGKEREWVAAITSDGDYTEYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCYVKVGEWYYGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,YVKVGEWY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb12_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 26, 2020","Dec 2, 2020",Added new reference,Complete
Sb13,Nb,SARS-CoV2 (weak),,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVENYYMRWYRQAPGKEREWVAAIESSGAETRYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCYVVVGWGYAGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,YVVVGWGY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb13_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 26, 2020","Dec 2, 2020",Added new reference,Complete
Sb15,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVYEHYMRWYRQAPGKEREWVAAIQSHGNHTAYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCFVVVGNGYTGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,FVVVGNGY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb15_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 26, 2020","Dec 2, 2020",Added new reference,Complete
Sb16,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVRAGGSLRLSCAASGFPVASQEMTWYRQAPGKEREWVAAISSSGRQTEYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCYVYVGGSYIGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,YVYVGGSY,N/A,https://www.rcsb.org/structure/7KGK;https://www.rcsb.org/structure/7KGL,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 26, 2020","Jan 28, 2020",2nd Dec: Added new reference; 30th Jan: Added expected PDB structure,Awaiting PDB structure
Sb17,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVKASEMEWYRQAPGKEREWVAAIASIGYNTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCLVYVGATYIGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,LVYVGATY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb17_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 26, 2020","Dec 2, 2020",Added new reference,Complete
Sb21,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVKESEMTWYRQARGKEREWVAAINSHGMTTHYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCYVYVGGSYIGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,YVYVGGSY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb21_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 26, 2020","Dec 2, 2020",Added new reference,Complete
Sb22,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVNHYEMEWYRQAPGREREWVAAIMDSTGYETAYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCYVYVGASYIGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,YVYVGASY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb22_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 26, 2020","Dec 2, 2020",Added new reference,Complete
Sb23,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVESENMHWYRQAPGKEREWVAAIYSTGGWTLYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAVQVGYWYEGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AVQVGYWY,N/A,https://www.rcsb.org/structure/7A25; https://www.rcsb.org/structure/7A29,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 26, 2020","Dec 2, 2020",Added new PDB struture (7A25) and reference,Complete
Sb25,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVESTEMTWYRQAPGKEREWVAAIESEGHGTEYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCYVYVGAGYIGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,YVYVGAGY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb25_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 26, 2020","Dec 2, 2020",Added new reference,Complete
Sb27,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVKASEMVWYRQAPGKEREWVAAILSQGHATEYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCYVWVGRSYIGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,YVWVGRSY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb27_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 26, 2020","Dec 2, 2020",Added new reference,Complete
Sb28,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVYSAEMEWYRQAPGKEREWVAAISSYGTNTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCYVYVGSSYIGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,YVYVGSSY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb28_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 26, 2020","Dec 2, 2020",Added new reference,Complete
Sb30,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVWYKEMEWYRQAPGKEREWVAAITSAGHHTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCYVYVGESYIGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,YVYVGESY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb30_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 26, 2020","Dec 2, 2020",Added new reference,Complete
Sb32,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVAHKSMWWYRQAPGKEREWVAAIESTGDTTRYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCVVWVGEVYRGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,VVWVGEVY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb32_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 26, 2020","Dec 2, 2020",Added new reference,Complete
Sb37,Nb,SARS-CoV2 (weak),,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVYNTWMEWYRQAPGKEREWVAAITSYGFHTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNVKDEGNTTAYYDYWGQGTQVTVSS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,NVKDEGNTTAYYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb37_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 26, 2020","Dec 2, 2020",Added new reference,Complete
Sb38,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVYWAHMTWYRQAPGKEREWVAAIVSSGAYTAYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNVKDFGTQEHYYDYWGQGTQVTVSS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,NVKDFGTQEHYYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb38_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 26, 2020","Dec 2, 2020",Added new reference,Complete
Sb39,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGPVQAGGSLRLSCAASGFPVMWSHMHWYRQAPGKEREWVAAIVSYGAYTIYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNVKDFGGYRYYYDYWGQGTQVTVSS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,NVKDFGGYRYYYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb39_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 26, 2020","Dec 2, 2020",Added new reference,Complete
Sb40,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVQGTWMEWYRQAPGKEREWVAAITSVGYRTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNVKDEGAIAKNYDYWGQGTQVTVSS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,NVKDEGAIAKNYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb40_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 26, 2020","Dec 2, 2020",Added new reference,Complete
Sb42,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVYNTWMEWYRQAPGKEREWVAAITSWGFKTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNVKDEGYTGYYYDYWGQGTQVTVSS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,NVKDEGYTGYYYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb42_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 26, 2020","Dec 2, 2020",Added new reference,Complete
Sb43,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVEWTHMHWYRQAPGKEREWVAAIASSGAYTVYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNVKDWGSQDRYYDYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,NVKDWGSQDRYYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb43_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 26, 2020","Dec 2, 2020",Added new reference,Complete
Sb45,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVAGTWMEWYRQAPGKEREWVAAITSYGYRTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNVKDEGKSSQVYDYWGQGTQVTVSS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,NVKDEGKSSQVYDY,N/A,https://www.rcsb.org/structure/7KGJ;https://www.rcsb.org/structure/7KLW,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 26, 2020","Jan 28, 2020",2nd Dec: Added new reference; 30th Jan: Added expected PDB structure,Awaiting PDB structure
Sb46,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVNYTIMFWYRKAPGKEREWVAAIKSHGATTLYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNVKDVGNDQKSYDYWGQGTQVTVSS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,NVKDVGNDQKSYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb46_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 26, 2020","Dec 2, 2020",Added new reference,Complete
Sb47,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVVWAHMHWYRQAPGKEREWVAAITSEGAHTIYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNVKDWGTYSTYYDYWGQGTQVTVSS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,NVKDWGTYSTYYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb47_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 26, 2020","Dec 2, 2020",Added new reference,Complete
Sb50,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVQYEHMHWYRQAPGKEREWVAAIVSEGAYTHYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNVKDWGWLAQYYDYWGQGTQVTVSS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,NVKDWGWLAQYYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb50_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 26, 2020","Dec 2, 2020",Added new reference,Complete
Sb52,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVNYNWMEWYRQAPGKEREWVAAITSWGYKTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNVKDEGMWQHYYDYWGQGTQVTVSS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,NVKDEGMWQHYYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb52_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 26, 2020","Dec 2, 2020",Added new reference,Complete
Sb54,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVWNTWMEWYRQAPGKEREWVAAITSYGFKTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNVKDEGNSQSHYDYWGQGTQVTVSS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,NVKDEGNSQSHYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb54_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 26, 2020","Dec 2, 2020",Added new reference,Complete
Sb56,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVEMWSMEWYRQAPGKEREWVAAIMSFGYQTWYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNVKDAGNSKALYDYWGQGTQVTVSS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,NVKDAGNSKALYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb56_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 26, 2020","Dec 2, 2020",Added new reference,Complete
Sb57,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVEHDHMHWYRQAPGKEREWVAAIVSQGAYTVYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNVKDWGRAGARYDYWGQGTQVTVSS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,NVKDWGRAGARYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb57_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 26, 2020","Dec 2, 2020",Added new reference,Complete
Sb58,Nb,SARS-CoV2 (weak),,0,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVDAAWMEWYRQAPGKEREWVAAITSYGYRTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNVKDMDRWRTTYDYWGQGTQVTVSS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,NVKDMDRWRTTYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb58_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 26, 2020","Dec 2, 2020",Added new reference,Complete
Sb60,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVVAWQMTWYRQAPGKEREWVAAIRSFGVSTHYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNVKDWGYEYEGYDYWGQGTQVTVSS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,NVKDWGYEYEGYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb60_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 26, 2020","Dec 2, 2020",Added new reference,Complete
Sb61,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVQHEWMEWYRQAPGKEREWVAAITSYGYRTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNVKDTGTYQAWYDYWGQGTQVTVSS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,NVKDTGTYQAWYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb61_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 26, 2020","Dec 2, 2020",Added new reference,Complete
Sb62,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVEQEHMYWYRQASGKEREWVAAIVSEGAYTAYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNVKDWGGYQWYYDYWGQGTQVTVSS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,NVKDWGGYQWYYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb62_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 26, 2020","Dec 2, 2020",Added new reference,Complete
Sb63,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVNAEIMFWYRQAPGKEREWVAAIKSAGTTTLYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNVKDYGAQAHYYDYWGQGTQVTVSS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,NVKDYGAQAHYYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb63_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 26, 2020","Dec 2, 2020",Added new reference,Complete
Sb67,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVMWAHMAWYRQAPGKEREWVAAIVSAGAYTHYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNVKDWGTYNSYYDYWGQGTQVTVSS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,NVKDWGTYNSYYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb67_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 26, 2020","Dec 2, 2020",Added new reference,Complete
Sb71,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGSVQAGGSLRLSCAASGNIQHIKYLGWFRQAPGREREGVAALMTRYGQTYYADSVKGRFTVSLDNAKNTVYLQMNSLKPEDTALYYCAAAHYGDNFPLAYQAYLYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAAHYGDNFPLAYQAYLY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb71_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 26, 2020","Dec 2, 2020",Added new reference,Complete
Sb75,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGSVQAGGSLRLSCAASGYINQIYYLGWFRQAPGKEREGVAALNTYQGQTYYADSVKGRFTVSLDNAKNTVYLQMNSLKPEDTALYYCAAARWGRDEPLYHYYYSYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAARWGRDEPLYHYYYSY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb75_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 26, 2020","Dec 2, 2020",Added new reference,Complete
Sb76,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASSFPVDTYHMAWYRQAPGKEREWVAAIVSWGWRTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNVKDIGAQEVHYDYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,NVKDIGAQEVHYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb76_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 26, 2020","Dec 2, 2020",Added new reference,Complete
Sb78,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGSVQAGGSLRLSCAASGYIKSIKYLGWFRQAPGKEREGVAALMTRYGETYYADSVKGRFTVSLDNAKNTVYLQMNSLKPEDTALYYCAAANYGNNWPLTGVNYWYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAANYGNNWPLTGVNYWY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb78_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 26, 2020","Dec 2, 2020",Added new reference,Complete
Sb83,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGSVQAGGSLRLSCAASGGITHIVYLGWFRQAPGKEREGVAALMTRWGTTYYADSVKGRFTVSLDNAKNTVYLQMNSLKPEDTALYYCAAAKYGQNFPLSYHAYRYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAAKYGQNFPLSYHAYRY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb83_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 26, 2020","Dec 2, 2020",Added new reference,Complete
Sb84,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGSVQAGGSLRLSCAASGYIKHIEYLGWFRQAPGKEREGVAALKTSSGSTYYADSVKGRFTVSLDNAKNTVYLQMNSLKPEDTALYYCAAARYGRSDPLHYHEYSYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAARYGRSDPLHYHEYSY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb84_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 26, 2020","Dec 2, 2020",Added new reference,Complete
Sb85,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGSVQAGGSLRLSCAASGSISSITYLGWFRQAPGKEREGVAALVTSRGKTYYADSVKGRFTVSLDNAKNTVYLQMNSLKPEDTALYYCAAASWGYTWPLYTYDYWYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAASWGYTWPLYTYDYWY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb85_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 26, 2020","Dec 2, 2020",Added new reference,Complete
Sb88,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVWAHHMLWYRQAPGKEREWVAAIASWGANTAYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNVKDSGQYRENYDYWGQGTQVTVSS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,NVKDSGQYRENYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb88_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 26, 2020","Dec 2, 2020",Added new reference,Complete
Sb90,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGSVQAGGSLRLSCAASGAINQIYYLGWFRQAPGKEREGVAALSTKYGETYYADSVKGRFTVSLDNAKNTVYLQMNSLKPEDTALYYCAAARWGRQYPLTFVYYSYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAARWGRQYPLTFVYYSY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb90_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 26, 2020","Dec 2, 2020",Added new reference,Complete
Sb93,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGSVQAGGSLRLSCAASGHIAQIEYLGWFRQAPGKEREGVAALSTNQGYTYYADSVKGRFTVSLDNAKNTVYLQMNSLKPEDTALYYCAAARWGRTYPLSYMAYTYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAARWGRTYPLSYMAYTY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb93_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 26, 2020","Dec 2, 2020",Added new reference,Complete
Sb94,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGSVQAGGSLRLSCAASGYITMIEYLGWFRQAPGKEREGVAALNTHTGGTYYADSVKGRFTVSLDNAKNTVYLQMNSLKPEDTALYYCAAARWGRYEPLHYAYYSYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAARWGRYEPLHYAYYSY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb94_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 26, 2020","Dec 2, 2020",Added new reference,Complete
Sb95,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGSVQAGGSLRLSCAASGNIYNIKYLGWFRQAPGKEREGVAALMTRYGETYYADSVKGRFTVSLDNAKNTVYLQMNSLKPEDTALYYCAAASYGANWPLVSAAYTYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAASYGANWPLVSAAYTY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb95_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 26, 2020","Dec 2, 2020",Added new reference,Complete
Sb97,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGSVQAGGSLRLSCAASGAISTIEYLGWFRQAPGREREGVAALYTERGYTYYADSVKGRFTVSLDNAKNTVYLQMNSLKPEDTALYYCAAARYGHAQAPLHYFWYGYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAARYGHAQAPLHYFWYGY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb97_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 26, 2020","Dec 2, 2020",Added new reference,Complete
Sb100,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGSVQAGGSLRLSCAASGSISSITYLGWFRQAPGKEREGVAALVTSDGRTYYADSVKGRFTVSLDNAKNTVYLQMNSLKPEDTALYYCAAANWGYSWPLYQTEYWYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAANWGYSWPLYQTEYWY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb100_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 26, 2020","Dec 2, 2020",Added new reference,Complete
Sb#1,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVRKANMHWYRQAPGKEREWVAAIMSKGEQTVYADSVEGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCRVFVGWHYFGQGTQVTVS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,RVFVGWHY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb#1_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
Sb#2,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCATSGFPVYQANMHWYRQAPGKEREWVAAIQSYGDGTHYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCRAVYVGMHYFGQGTQVTVS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,RAVYVGMHY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb#2_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
Sb#3,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVNYKTMWWYRQAPGKEREWVAAIWSYGHTTHYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCVVWVGHNYEGQGTQVTVS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,VVWVGHNY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb#3_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
Sb#4,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVYAQNMHWYRQAPGKEREWVAAIYSHGYWTLYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCEVQVGAWYTGQGTQVTVS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,EVQVGAWY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb#4_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
Sb#5,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVFSGHMHWYRQAPGKEREWVAAILSNGDSTHYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCRVHVGAHYFGQGTQVTVS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,RVHVGAHY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb#5_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
Sb#6,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVEQGRMYWYRQAPGKEREWVAAIISHGTVTVYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCYVYVGAQYWGQGTQVTVS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,YVYVGAQY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb#6_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
Sb#7,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVLFTYMHWYRQAPGKEREWVAAIWSSGNSTWYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCFVKVGNWYAGQGTQVTVS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,FVKVGNWY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb#7_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
Sb#8,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVNAGNMHWYRQAPGKEREWVAAIQSYGRTTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCRVFVGMHYFGQGTQVTVS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,YVYVGGSY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb#8_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
Sb#9,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVSSSTMTWYRQAPGKEREWVAAINSYGWETHYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCYVYVGGSYIGQGTQVTVS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,RVFVGMHY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb#9_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
Sb#10,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVQSHYMRWYRQAPGKEREWVAAIESTGHHTAYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCTVYVGYEYHGQGTQVTVS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,TVYVGYEY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb#10_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
Sb#11,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVETENMHWYRQAPGKEREWVAAIYSHGMWTAYADSVKGRFTISRDNTKNTVYLQMNSLKPEDTAVYYCEVEVGKWYFGQGTQVTVS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,EVEVGKWY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb#11_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
Sb#12,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVKASRMYWYRQAPGKEREWVAAIQSFGEVTWYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCYVWVGQEYWGQGTQVTVS,N/A,IGHV3-3 (Alpaca),IGHJ5 (Alpaca),N/A,N/A,YVWVGQEY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb#12_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
Sb#13,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVYASNMHWYRQAPGKEREWVAAIESQGYMTAYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCWVIVGEYYVGQGTQVTVS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,WVIVGEYY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb#13_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
Sb#14,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVQAREMEWYRQAPGKEREWVAAIKSTGTYTAYAYSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCYVYVGSSYIGQGTQVTVS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,YVYVGSSY,N/A,https://www.rcsb.org/structure/7MFU,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","Jun 6, 2021",11th Nov: Added neutralisation data. 6th June '21: Added new structure and corrected SARS-CoV2 neutralisation entry,Complete
Sb#15,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVKNFEMEWYRKAPGKEREWVAAIQSGGVETYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCFVYVGRSYIGQGTQVTVS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,FVYVGRSY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb#15_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","Jun 6, 2021",11th Nov: Added neutralisation data. 6th June '21: Corrected SARS-CoV2 neutralisation entry,Complete
Sb#16,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVAYKTMWWYRQAPGKEREWVAAIESYGIKWTRYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCIVWVGAQYHGQGTQVTVS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,IVWVGAQY,N/A,https://www.rcsb.org/structure/7MFV,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","Jun 6, 2021",11th Nov: Added neutralisation data. 6th June '21: Added new structure and corrected SARS-CoV2 neutralisation entry,Complete
Sb#17,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVAGRNMWWYRQAPGKEREWVAAIYSSGTYTEYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCHVWVGSLYKGQGTQVTVS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,HVWVGSLY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb#17_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
Sb#18,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVKHARMWWYRQAPGKEREWVAAIDSHGDTTWYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCYVYVGASYWGQGTQVTVS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,YVYVGASY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb#18_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
Sb#19,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVNSHEMTWYRQAPGKEREWVAAIQSTGTVTEYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCYVYVGSSYLGQGTQVTVS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,YVYVGSSY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb#19_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
Sb#20,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVEQREMEWYRQAPGKEREWVAAIDSNGNYTFYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCYVYVGKSYIGQGTQVTVS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,YVYVGKSY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb#20_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
Sb#21,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVKHHWMFWYRQAPGKEREWVAAIKSYGYGTEYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCFVGVGTHYAGQGTQVTVS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,FVGVGTHY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb#21_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
Sb#22,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVYAAEMEWYRQAPGKEREWVAAISSQGTITYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCFVYVGKSYIGQGTQVSVS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,FVYVGKSY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb#22_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
Sb#23,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVYAAEMEWYRQAPGKEREWVAAISSQGTITYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCFVYVGKSYIGQGTQVSVS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,FVYVGKSY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb#23_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
Sb#25,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVHAWEMAWYRQAPGKEREWVAAIRSFGSSTHYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNVKDFGTHHYAYDYWGQGTQVTVS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,NVKDFGTHHYAYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb#25_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
Sb#26,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVNTWWMHWYRQAPGKEREWVAAITSWGFRTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNVKDKGMAVQWYDYWGQGTQVTVS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,NVKDKGMAVQWYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb#26_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
Sb#27,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVYNTWMEWYRQAPGKEREWVAAITSHGYKTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNVKDEGDMFTAYDYWGQGTQVTVS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,NVKDEGDMFTAYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb#27_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
Sb#28,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVYHSTMFWYRQAPGKEREWVAAIYSSGQHTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNVKDSGQWRQEYDYWGQGTQVTVS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,NVKDSGQWRQEYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb#28_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
Sb#29,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVEHEMAWYRQAPGKEREWVAAIRSMGRKTLYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNVKDFGYTWHEYDYWGQGTQVTVS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,NVKDFGYTWHEYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb#29_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
Sb#30,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVTMAWMWWYRQAPGKEREWVAAIRSEGVRTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNVKDYGQAHAYYDYWGQGTQVTVS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,NVKDYGQAHAYYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb#30_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
Sb#31,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVNSHFMEWYRQAPGKEREWVAAIQHSSGFHTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNVKDTGTTEDYDYWGQGTQVTVS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,NVKDTGTTEDYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb#31_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
Sb#32,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLDESGGGLVQAGGSLRLSCAASGFPVYHAWMEWYRQAPGKEREWVAAITSSGRHTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNVKDAGRVYNSYDYWGQGTQVTVS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,NVKDAGRVYNSYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb#32_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
Sb#33,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVAHAWMEWYRQAPGKEREWVAAITSYGYKTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNVKDTGTYRFYYDYWGQGTQVTVS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,NVKDTGTYRFYYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb#33_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
Sb#34,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVWNQTMVWYRQAPGKEREWVAAIWSMGHTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNVKDAGVYNRYYDYWGQGTQVTVS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,NVKDAGVYNRYYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb#34_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
Sb#35,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVEHYWMEWYRQAPGKEREWVAAITSFGYRTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNVKDWGFASHAYDYWGQGIQVTVS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,NVKDWGFASHAYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb#35_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
Sb#36,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPEIAWEMAWYRQAPGKEREWVAAIRSFGERTLYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNVKDFGWQHQEYDYWGQGTQVTVS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,NVKDFGWQHQEYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb#36_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
Sb#37,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVYHAYMEWYRQAPGKEREWVAAIYSNGEHTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNVKDSGSFNQAYDYWGQGTQVTVS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,NVKDSGSFNQAYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb#37_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
Sb#38,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVEWSHMHWYRQAPGKEREWVAAIVSKGGYTLYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNVKDYGVHFKRYDYWGQGTQVTVI,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,NVKDYGVHFKRYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb#38_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
Sb#39,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVFHVWMEWYRQAPGKEREWVAAIDSAGWHTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNVKDAGNTTSAYDYWGQGTQVTVS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,NVKDAGNTTSAYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb#39_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
Sb#40,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVYYNWMEWYRQAPGKEREWVAAIHSNGDETFYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNVKDIDAEAYAYDYWGQGTQVTVS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,NVKDIDAEAYAYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb#40_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
Sb#41,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVYHVWMEWYRQAPGKEREWVAAITSSGSHTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNVKDSGQWRVQYDYWGQGTQVTVS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,NVKDSGQWRVQYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb#41_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
Sb#42,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVYWHHMHWYRQAPGKEREWVAAIISWGWYTTYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNVKDHGAQNQMYDYWGQGTQVTVS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,NVKDHGAQNQMYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb#42_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
Sb#45,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVYRDRMAWYRQAPGKEREWVAAIYSAGQQTRYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNVKDVGHHYEYYDYWGQGTQVTVS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,NVKDVGHHYEYYDY,N/A,https://www.rcsb.org/structure/7N0G;https://www.rcsb.org/structure/7N0H,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb#45_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","Jun 6, 2021",11th Nov: Added neutralisation data. 6th June '21: Added new structure and corrected SARS-CoV2 neutralisation entry,Complete
Sb#46,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVDNGYMHWYRQAPGKEREWVAAIDSYGWHTIYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNVKDKGQMRAAYDYWGQGTQVTVS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,NVKDKGQMRAAYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb#46_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
Sb#47,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVSWHSMYWYRQAPGKEREWVAAIFSEGDWTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNVKDYGSSYYKYDYWGQGTQVTVS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,NVKDYGSSYYKYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb#47_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
Sb#48,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVSQSVMAWYRQAPGKEREWVAAIYSKGQYTHYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNVKDAGSSYWDYDYWGQGTQVTVS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,NVKDAGSSYWDYD,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb#48_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
Sb#49,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGSVQAGGSLRLSCAASGSIGQIEYLGWFRQAPGKEREGVAALNTWTGRTYYADSVKGRFTVSLDNAKNTVYLQMNSLKPEDTALYYCAAARWGRTKPLNTYYYSYWGQGTPVTVS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAARWGRTKPLNTYYYSY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb#49_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
Sb#50,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGSVQAGGSLRLSCAASGYIDKIVYLGWFRQAPGKEREGVAALYTLSGHTYYADSVKGRFTVSLDNAKNTVYLQMNSLKPEDTALYYCAAATEGHAHALYRLHYYWGQGTQVTVS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAATEGHAHALYRLHYY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb#50_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
Sb#51,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVYQGEMHWYRQAPGKEREWVAAIRSTGVQTWYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCRVWVGTHYFGQGTQVTVS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,RVWVGTHY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb#51_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
Sb#52,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGSVQAGGSLRLSCAASGNIQRIYYLGWFRQAPGKEREGVAALMTYTGHTYYADSVKGRFTVSLDNAKNTVYLQMNSLKPEDTALYYCAAAYVGAENPLPYSMYGYWGQGTQVTVS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAAYVGAENPLPYSMYGY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb#52_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
Sb#53,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGSVQAGGSLRLSCAASGQISHIKYLGWFRQAPGKEREGVAALITRWGQTYYADSVKGRFTVSLDNAKNTVYLQMNSLKPEDTALYYCAAADYGASDPLWFIHYLYWGQGTQVTVS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAADYGASDPLWFIHYLY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb#53_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
Sb#55,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGSVQAGGSLRLSCAASGKIWTIKYLGWFRQAPGKEREGVAALMTRWGYTYYADSVKGRFTVSLDNAKNTVYLQMNSLKPEDTALYYCAAANYGSNFPLAEEDYWYWGQGTQVTVS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAANYGSNFPLAEEDYWY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb#55_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
Sb#56,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGSVQAGGSLRLSCAASGNISQIHYLGWFRQAPGKEREGVAALNTDYGYTYYADSVKGRFTVSLDNAKNTVYLQMNSLKPEDTALYYCAAAYYFGDDIPLWWEAYSYWGQGTQVTVS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAAYYFGDDIPLWWEAYSY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb#56_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
Sb#58,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGSVQAGGSLRLSCAASGNISTIEYLGWFRQAPGKEREGVAALYTWHGQTYYADSVKGRFTVSLDNAKNTVYLQMNSLKPEDTALYYCAAARWGRHMPLSATEYSYWGQGTQVTVS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAARWGRHMPLSATEYSY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb#58_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
Sb#59,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGSVQAGGSLRLSCAASGNIESIYYLGWFRQAPGKEREGVAALWTGDGETYYADSVKGRFTVSLDNAKNTVYLQMNSLKPEDTALYYCAAAAWGNSAPLTTYRYYYWGQGTQVTVS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAAAWGNSAPLTTYRYYY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb#59_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
Sb#61,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGSVQAGGSLRLSCAASGFIYGITYLGWFRQAPGKEREGVAALVTWNGQTYYADSVKGRFTVSLDNAKNTVYLQMNSLKPEDTALYYCAAADWGYDWPLWDEWYWYWGQGTQVTVS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAADWGYDWPLWDEWYWY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb#61_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
Sb#62,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGSVQAGGSLRLSCAASGTIADIKYLGWFRQAPGKEREGVAALMTRWGSTYYADSVKGRFTVSLDNAKNTVYLQMNSLKPEDTALYYCAAANYGANYPLYSQQYSYWGQGTQVTVS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAANYGANYPLYSQQYSY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb#62_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
Sb#63,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGSVQAGGSLRLSCAASGSISSIKYLGWFRQAPGKEREGVAALMTRWGMTYYADSVKGRFTVSLDNAKNTVYLQMNSLKPEDTALYYCAAANYGANEPLQYTHYNYWGQGTQVTVS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAANYGANEPLQYTHYNY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb#63_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
Sb#64,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGSVQAGGSLRLSCAASGEIESIFYLGWFRQAPGKEREGVAALYTYVGQTYYADSVKGRFTVSLDNAKNTVYLQMNSLKPEDTALYYCAAASYGAAHPLSIMRYYYWGQGTQVTVS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAASYGAAHPLSIMRYYY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb#64_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
Sb#65,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGSVQAGGSLRLSCAASGTIAHIKYLGWFRQAPGKEREGVAALMTKWGQTYYADSVKGRFTVSLDNAKNTVYLQMNSLKPEDTALYYCAAASYGANFPLKASDYSYWGQGTQVTVS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAASYGANFPLKASDYSY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb#65_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
Sb#66,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGSVQAGGSLRLSCAASGSIQAITYLGWFRQAPGKEREGVAALVTWNGQTYYADSVKGRFTVSLDNAKNTVYLQMNSLKPEDTALYYCAAADWGYDWPLWDEWYWYWGQGTQVTVS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAADWGYDWPLWDEWYWY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb#66_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
Sb#67,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGSVQAGGSLRLSCAASGSISSITYLGWFRQAPGKEREGVAALVTYSGNTYYADSVKGRFTVSLDNAKNTVYLQMNSLKPEDTALYYCAAATWGHSWPLYNDEYWYWGQGSQVTVS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAATWGHSWPLYNDEYWY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb#67_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
Sb#68,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGSVQAGGSLRLSCAASGSISSITYLGWFRQAPGKEREGVAALITVNGHTYYADSVKGRFTVSLDNAKNTVYLQMNSLKPEDTALYYCAAAAWGYAWPLHQDDYWYWGQGTQVTVS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAAAWGYAWPLHQDDYWY,N/A,https://www.rcsb.org/structure/7MFU,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","Jun 6, 2021",11th Nov: Added neutralisation data. 6th June '21: Added new structure,Complete
Sb#69,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGSVQAGGSLRLSCAASGSISSITYLGWFRQAPGKEREGVAALNTFNGTTYYADSVKGRFTVSLDNAKNTVYLQMNSLKPEDTALYYCAAATWGYSWPLIAEYNWYWGQGTQVTVS,N/A,IGHV3-3 (Alpaca),IGHJ5 (Alpaca),N/A,N/A,AAATWGYSWPLIAEYNWY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb#69_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
Sb#71,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGSVQAGGSLRLSCAASGSISSITYLGWFRQAPGKEREGVAALKTQAGFTYYADSVKGRFTVSLDNAKNTVYLQMNSLKPEDTALYYCAAANWGYSWPLYEADDWYWGQGTQVTVS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAANWGYSWPLYEADDWY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Sb#71_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
SR1,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVAAYEMEWYRQAPGKEREWVAAINSMGDQTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCYVYVGFSYIGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,YVYVGFSY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 11, 2020","Jun 11, 2020",N/A,Complete
SR4,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVYSWNMWWYRQAPGKEREWVAAIESHGDSTRYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCYVWVGHTYYGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,YVWVGHTY,N/A,https://www.rcsb.org/structure/7C8V,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 11, 2020","Jun 11, 2020",N/A,Complete
SR5,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLRCAASGFPVETTEMEWYRQAPGKEREWVAAISSYGSETYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCYVYVGTSYLGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,YVYVGTSY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/SR5_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 11, 2020","Jun 11, 2020",N/A,Complete
SR7,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVWSNEMEWYRQAPGKEREWVAAITSYGTTEYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCYVYVGYSYIGQGTQVTVSS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,YVYVGYSY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/SR7_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 11, 2020","Jun 11, 2020",N/A,Complete
SR13,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVDYMEMEWFRQAPGKEREWVAAITSNGRETYYADSVKGRFTVSRDNAKNTVYLQMNSLKPEDTAVYYCYVYVGSSYIGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,YVYVGSSY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/SR13_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 11, 2020","Jun 11, 2020",N/A,Complete
SR18,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVWFQEMEWYRQAPGKEREWVAAISSQGTHTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCYVYVGASYLGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,YVYVGASY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/SR18_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 11, 2020","Jun 11, 2020",N/A,Complete
SR31,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVWQGEMAWYRQAPGKEREWVAAISSMGYKTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAVMVGFWYAGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AVMVGFWY,N/A,https://www.rcsb.org/structure/7D30;https://www.rcsb.org/structure/7D2Z,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 11, 2020","Feb 28, 2021",28th Feb: Added PDB structures,Complete
SR34,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAAGGFPVKDHEMEWYRQAPGKEREWVAAITSSGWGTNTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCYVYVGSSYIGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,YVYVGSSY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/SR34_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 11, 2020","Jun 11, 2020",N/A,Complete
SR38,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVNQEEMEWYRQAPGKEREWVAAIKSWGTLTAYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAVHVGQTYIGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AVHVGQTY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/SR38_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 11, 2020","Jun 11, 2020",N/A,Complete
MR2,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVYFSYMAWYRQAPGKEREWVAAINSEGDSTTYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNVKDYGWYNSQYDYWGQGTQVTVSS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,NVKDYGWYNSQYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/MR2_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 11, 2020","Jun 11, 2020",N/A,Complete
MR3,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVNAHFMYWYRQAPGKEREWVAAIYSYGRTLYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNVKDYGAASWEYDYWGQGTQVTVSS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,NVKDYGAASWEYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/MR3_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 11, 2020","Jun 11, 2020",N/A,Complete
MR4,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPMYAWEMAWYRQAPGKEREWVAAIRSMGVHTHYSDSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNVKDFGGHQAYYDYWGQGTQVTVSS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,NVKDFGGHQAYYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/MR4_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 11, 2020","Jun 11, 2020",N/A,Complete
MR6,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVEDTWMEWYRQAPGKEREWVAAITSWGFKTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNVKDEGDTSASYDYWGQGTQVTVSS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,NVKDEGDTSASYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/MR6_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 11, 2020","Jun 11, 2020",N/A,Complete
MR7,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVNSWMEWYRQAPGKEREWVAAITSYGYKTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNVKDEGYFSDEYDYWGQGTQVTVSS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,NVKDEGYFSDEYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/MR7_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 11, 2020","Jun 11, 2020",N/A,Complete
MR8,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVEWAHMHWYRQAPGKEREWVAAIVSAGHYTVYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNVKDWGSSNQYYDYWGQGTQVTVSS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,NVKDWGSSNQYYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/MR8_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 11, 2020","Jun 11, 2020",N/A,Complete
MR10,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVANTWMEWYRQAPGKEREWVAAITSYGYRTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNVKDEGATTKVYDYWGQGTQVTVSS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,NVKDEGATTKVYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/MR10_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 11, 2020","Jun 11, 2020",N/A,Complete
MR14,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVMYTHMHWYRQAPGKEREWVAAIVSLGEYTTYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNVKDWGAANKYYDYWGQGTQVTVSS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,NVKDWGAANKYYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/MR14_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 11, 2020","Jun 11, 2020",N/A,Complete
MR17,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLVQAGGSLRLSCAASGFPVEVWRMEWYRQAPGKEREGVAAIESYGHGTRYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNVKDDGQLAYHYDYWGQGTQVTVSS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,NVKDDGQLAYHYDY,N/A,https://www.rcsb.org/structure/7C8W;https://www.rcsb.org/structure/7D30,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 11, 2020","Feb 28, 2021",28th Feb: Added second PDB structure,Complete
MR17_K56W,Nb,SARS-CoV2,,,,S; RBD,Derived from MR17,QVQLVESGGGLVQAGGSLRLSCAASGFPVEVWRMEWYRQAPGKEREGVAAIESYGWGTRYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNVKDDGQLAYHYDYWGQGTQVTVSS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,NVKDDGQLAYHYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/MR17_K56W_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 11, 2020","Jun 11, 2020",N/A,Complete
MR17_K99W,Nb,SARS-CoV2,,,,S; RBD,Derived from MR17,QVQLVESGGGLVQAGGSLRLSCAASGFPVEVWRMEWYRQAPGKEREGVAAIESYGHGTRYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNVWDDGQLAYHYDYWGQGTQVTVSS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,NVWDDGQLAYHYDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/MR17_K99W_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 11, 2020","Jun 11, 2020",N/A,Complete
MR17_K99Y,Nb,SARS-CoV2,,,,S; RBD,Derived from MR17,QVQLVESGGGLVQAGGSLRLSCAASGFPVEVWRMEWYRQAPGKEREGVAAIESYGHGTRYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNVYDDGQLAYHYDYWGQGTQVTVSS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,NVYDDGQLAYHYDY,N/A,https://www.rcsb.org/structure/7CAN,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 11, 2020","Jun 11, 2020",N/A,Complete
LR1,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGSVQAGGSLRLSCAASGSISSITYLGWFRQAPGKEREGVAALITDSGRTYYADSVKGRFTVSLDNAKNTVYLQMNSLKPEDTALYYCAAAEWGYEWPLYYASSWYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAAEWGYEWPLYYASSWY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/LR1_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 11, 2020","Jun 11, 2020",N/A,Complete
LR2,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGSVQAGGSLRLSCAASGDINAIGYLGWFRQAPGKEREGVAALDTDEGQTYYADSVKGRFTVSLDNAKNTVYLQMNSLKPEDTALYYCAAAMNGYNEPLYSYDYEYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAAMNGYNEPLYSYDYEY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/LR2_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 11, 2020","Jun 11, 2020",N/A,Complete
LR3,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGSVQAGGSLRLSCAASGTINNITYLGWFRQAPGKEREGVAALITTSGYTYYADSVKGRFTVSLDNAKNTVYLQMNSLKPEDTALYYCAAASWGYEWPLVYDDYWYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAASWGYEWPLVYDDYWY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/LR3_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 11, 2020","Jun 11, 2020",N/A,Complete
LR5,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGSVQAGGSLRLSCAASGSISSITYLGWFRQAPGKEREGVAALITSNGRTYYADSVKGRFTVSLDNAKNTVYLQMNSLKPEDTALYYCAAATWGYHWPLGAWDYWYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAATWGYHWPLGAWDYWY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/LR5_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 11, 2020","Jun 11, 2020",N/A,Complete
LR6,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGSVQAGGSLRLSCAASGSISSITYLGWFRQAPGKEREGVAALVTTSGNTYYADSVKGRFTVSLDNAKNTVYLQMNSLKPEDTALYYCAAATWGYSWPLEHDEYWYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAATWGYSWPLEHDEYWY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/LR6_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 11, 2020","Jun 11, 2020",N/A,Complete
LR7,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGSVQAGGSLRLSCAASGSISSITYLGWFRQAPGKEREGVAALITNWGHTYYADSVKGRFTVSLDNAKNTVYLQMNSLKPEDTALYYCAAAFHGEQYPLYTNKYHYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAAFHGEQYPLYTNKYHY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/LR7_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 11, 2020","Jun 11, 2020",N/A,Complete
LR8,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGSVQAGGSLRLSCAASGTIAYIKYLGWFRQAPGKEREGVAALMTRWGETYYADSVKGRFTVSLDNAKNTVYLQMNSLKPEDTALYYCAAANYGANFPLQANTYFYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAANYGANFPLQANTYFY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/LR8_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 11, 2020","Jun 11, 2020",N/A,Complete
LR11,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGSVQAGGSLRLSCAASGSISSITYLGWFRQAPGKEREGVAALVTHSGSTYYADSVKGRFTVSLDNAKNTVYLQMNSLKPEDTALYYCAAAYWGWDWPLNSQDYWYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAAYWGWDWPLNSQDYWY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/LR11_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 11, 2020","Jun 11, 2020",N/A,Complete
LR15,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGSVQAGGSLRLSCAASGSISSITYLGWFRQAPGKEREGVAALKTASGQTYYADSVKGRFTVSLDNAKNTVYLQMNSLKPEDTALYYCAAADWGYNWPLIREEYEYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAADWGYNWPLIREEYEY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/LR15_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 11, 2020","Jun 11, 2020",N/A,Complete
LR16,Nb,SARS-CoV2,,,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGSVQAGGSLRLSCAASGSISSITYLGWFRQAPGKEREGVAALYTTHGYTYYADSVKGRFTVSLDNAKNTVYLQMNSLKPEDTALYYCAAADWGYNIPLNITDYWYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAADWGYNIPLNITDYWY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/LR16_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 11, 2020","Jun 11, 2020",N/A,Complete
VHH-72,Nb,"SARS-CoV1,SARS-CoV2",,SARS-CoV2 and SARS-CoV1,,S; RBD,Immunised Llama,QVQLQESGGGLVQAGGSLRLSCAASGRTFSEYAMGWFRQAPGKEREFVATISWSGGSTYYTDSVKGRFTISRDNAKNTVYLQMNSLKPDDTAVYYCAAAGLGTVVSEWDYDYDYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAAGLGTVVSEWDYDYDY,N/A,https://www.rcsb.org/structure/6waq,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","Jun 2, 2020",Updated publication.,Complete
Ty1,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,Immunised Alpaca,QVQLVETGGGLVQPGGSLRLSCAASGFTFSSVYMNWVRQAPGKGPEWVSRISPNSGNIGYTDSVKGRFTISRDNAKNTLYLQMNNLKPEDTALYYCAIGLNLSSSSVRGQGTQVTVSS,N/A,IGHV3S1 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AIGLNLSSSSV,N/A,https://www.rcsb.org/structure/6ZXN,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 4, 2020","Oct 1, 2020",Added PDB structure,Complete
H11-D4,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLMQAGGSLRLSCAVSGRTFSTAAMGWFRQAPGKEREFVAAIRWSGGSAYYADSVKGRFTISRDKAKNTVYLQMNSLKYEDTAVYYCARTENVRSLLSDYATWPYDYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,ARTENVRSLLSDYATWPYDY,N/A,https://www.rcsb.org/structure/6YZ5; https://www.rcsb.org/structure/6YZ7; https://www.rcsb.org/structure/6Z2M; https://www.rcsb.org/structure/6Z43,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 8, 2020","Jun 8, 2020",N/A,Complete
H11-H4,Nb,SARS-CoV2,,SARS-CoV2,,S; RBD,"Phage Display Library (Nanobody, non-immune)",QVQLVESGGGLMQAGGSLRLSCAVSGRTFSTAAMGWFRQAPGKEREFVAAIRWSGGSAYYADSVKGRFTISRDKAKNTVYLQMNSLKYEDTAVYYCAQTHYVSYLLSDYATWPYDYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AQTHYVSYLLSDYATWPYDY,N/A,https://www.rcsb.org/structure/6ZBP; https://www.rcsb.org/structure/6ZHD; https://www.rcsb.org/structure/6ZH9,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jul 31, 2020","Jul 31, 2020",N/A,Complete
W23UACh,Nb,SARS-CoV2,,,,S; RBD,Immunised Alpaca,QVQLVESGGGLVQPGESLRLSCAASGNIFGIAAVHWFRKAPGKEREFTAGFGSDGSTNYANSVKGRFTISRDNAKNTTYLQMNSLKPEDTAVYYCHALIKNELGFLDYWGPGTQVTVSS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,HALIKNELGFLDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/W23UACh_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 11, 2020","Jun 11, 2020",N/A,Complete
W25UACh,Nb,SARS-CoV2,,,,S; RBD,Immunised Alpaca,QVQLVESGGGLVQPGESLRLSCAASGSIFGIYAVHWFRMAPGKEREFTAGFGSHGSTNYAASVKGRFTMSRDNAKNTTYLQMNSLKPADTAVYYCHALIKNELGFLDYWGPGTQVTVSS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,HALIKNELGFLDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/W25UACh_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","Jun 11, 2020","Jun 11, 2020",N/A,Complete
35F4,Ab,SARS-CoV1,SARS-CoV2,SARS-CoV1,SARS-CoV2,S; RBD,Transgenic Mouse (H2L2),ND,ND,ND,ND,ND,ND,ND,ND,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 5, 2020",Added MTA information.,Sequence available for academic research purposes only under an MTA. Contact Vincent Rijsman from the Utrecht University Research Support Office: V.M.C.Rijsman[at]uu.nl
43C6,Ab,SARS-CoV1,SARS-CoV2,SARS-CoV1,SARS-CoV2,S; RBD,Transgenic Mouse (H2L2),ND,ND,ND,ND,ND,ND,ND,ND,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 5, 2020",Added MTA information.,Sequence available for academic research purposes only under an MTA. Contact Vincent Rijsman from the Utrecht University Research Support Office: V.M.C.Rijsman[at]uu.nl
S109,Ab,SARS-CoV1,SARS-CoV2,SARS-CoV1,SARS-CoV2,S; RBD,B-cells; SARS-CoV1 Human Patient,ND,ND,IGHV3-23 (Human),ND,IGLV3-25 (Human),ND,ARLESATQPLGYYFYGMDV,HSADISATSWV,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 8, 2020",Added Germlines and CDRL3 Sequence. Amalgamated entries for S109 and S109.8 (same Ab). Amended HC V gene label.,"Email sent, awaiting author reply."
S111,Ab,SARS-CoV1,SARS-CoV2,SARS-CoV1,SARS-CoV2,S; RBD,B-cells; SARS-CoV1 Human Patient,ND,ND,IGHV3-30 (Human),ND,IGKV2-30 (Human),ND,ARDIRHLIVVVSDMDV,MQGTHWPPT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 8, 2020",Added Germlines and CDRL3 Sequence. Amended HC V gene label.,"Email sent, awaiting author reply."
S127,Ab,SARS-CoV1,SARS-CoV2,SARS-CoV1,SARS-CoV2,S; RBD,B-cells; SARS-CoV1 Human Patient,ND,ND,IGHV3-30 (Human),ND,IGKV1-9 (Human),ND,AKDLFGYCRSTSCESLDD,QQLNNYPLT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 8, 2020",Added Germlines and CDRL3 Sequence. Amended HC V gene label.,"Email sent, awaiting author reply."
S215,Ab,SARS-CoV1,SARS-CoV2,SARS-CoV1,SARS-CoV2,S; RBD,B-cells; SARS-CoV1 Human Patient,ND,ND,IGHV3-30 (Human),ND,IGKV3-15 (Human),ND,ARETRHYSHGLNWFDP,QQYNNWPTT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 8, 2020",Added Germlines and CDRL3 Sequence. Amended HC V gene label.,"Email sent, awaiting author reply."
S217,Ab,SARS-CoV1,SARS-CoV2,SARS-CoV1,SARS-CoV2,S; RBD,B-cells; SARS-CoV1 Human Patient,ND,ND,IGHV3-49 (Human),ND,IGKV1-33 (Human),ND,SWIHRIVS,QQYDNLPYT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 7, 2020",Added Germlines and CDRL3 Sequence,"Email sent, awaiting author reply."
S218,Ab,SARS-CoV1,SARS-CoV2,SARS-CoV1,SARS-CoV2,S; RBD,B-cells; SARS-CoV1 Human Patient,ND,ND,IGHV3-30 (Human),ND,IGKV2-30 (Human),ND,ARDVKGHIVVMTSLDY,MQGTHWPPT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 7, 2020",Added Germlines and CDRL3 Sequence,"Email sent, awaiting author reply."
S219,Ab,SARS-CoV1,SARS-CoV2,SARS-CoV1,SARS-CoV2,S; RBD,B-cells; SARS-CoV1 Human Patient,ND,ND,IGHV1-58 (Human),ND,IGKV1-39 (Human),ND,AAEMATIQNYYYYYGMDV,QQSYSTPPT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 7, 2020",Added Germlines and CDRL3 Sequence,"Email sent, awaiting author reply."
S222,Ab,SARS-CoV1,SARS-CoV2,SARS-CoV1,SARS-CoV2,S; RBD,B-cells; SARS-CoV1 Human Patient,ND,ND,IGHV1-2 (Human),ND,IGKV1-39 (Human),ND,ARGDVPVGTGWVFDF,QQSLSMVT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 7, 2020",Added Germlines and CDRL3 Sequence,"Email sent, awaiting author reply."
S223,Ab,SARS-CoV1,SARS-CoV2,SARS-CoV1,SARS-CoV2,S; RBD,B-cells; SARS-CoV1 Human Patient,ND,ND,IGHV3-30 (Human),ND,IGKV3-15 (Human),ND,ATVSVEGYTSGWYLGTLDF,QQYNNWPGT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 7, 2020",Added Germlines and CDRL3 Sequence,"Email sent, awaiting author reply."
S224,Ab,SARS-CoV1,SARS-CoV2,SARS-CoV1,SARS-CoV2,S; RBD,B-cells; SARS-CoV1 Human Patient,ND,ND,IGHV1-18 (Human),ND,IGKV1-39 (Human),ND,ARQSHSTRGGWHFSP,QQSYSVPYT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 7, 2020",Added Germlines and CDRL3 Sequence,"Email sent, awaiting author reply."
S225,Ab,SARS-CoV1,SARS-CoV2,SARS-CoV1,SARS-CoV2,S; RBD,B-cells; SARS-CoV1 Human Patient,ND,ND,IGHV3-9 (Human),ND,IGKV1-39 (Human),ND,AKDISLVFWSVNPPRNGMDV,QQSYSSPLT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 7, 2020",Added Germlines and CDRL3 Sequence,"Email sent, awaiting author reply."
S226,Ab,SARS-CoV1,SARS-CoV2,SARS-CoV1,SARS-CoV2,S; RBD,B-cells; SARS-CoV1 Human Patient,ND,ND,IGHV3-30 (Human),ND,IGKV3-11 (Human),ND,ARDSSWQSTGWPINWFDR,QQRSNWPPT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 7, 2020",Added Germlines and CDRL3 Sequence,"Email sent, awaiting author reply."
S227,Ab,SARS-CoV1,SARS-CoV2,SARS-CoV1,SARS-CoV2,S; RBD,B-cells; SARS-CoV1 Human Patient,ND,ND,IGHV3-23 (Human),ND,IGKV1-5 (Human),ND,ASPLRNYGDLLY,QQYNSYSWT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 7, 2020",Added Germlines and CDRL3 Sequence. Amalgamated entries for S227 and S227.14 (same Ab),"Email sent, awaiting author reply."
S228,Ab,SARS-CoV1,SARS-CoV2,SARS-CoV1,SARS-CoV2,S; RBD,B-cells; SARS-CoV1 Human Patient,ND,ND,IGHV3-30 (Human),ND,IGKV2-30 (Human),ND,ARDLQMRVVVVSNFDY,MQATHWPPT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 7, 2020",Added Germlines and CDRL3 Sequence,"Email sent, awaiting author reply."
S230,Ab,SARS-CoV1,SARS-CoV2,SARS-CoV1,SARS-CoV2,S; RBD,B-cells; SARS-CoV1 Human Patient,QAQLVESGGALVQPGRSLRLSCAASGFTFRNYAMHWVRQAPATGLQWLAVITSDGRNKFYADSVKGRFTISREDSKNTLYLQMDSLRGEDTAVYYCVTQRDNSRDYFPHYFHDMDVWGQGTTVAVSS,VLTQSPLSLPVTLGQPASISCRSSQSLVYSDGDTYLNWFQQRPGQSPRRLIYQVSNRDSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQGSHWPPTFGQGTKVEIK,IGHV3-30 (Human),IGHJ6 (Human),IGKV2-30 (Human),IGKJ1 (Human),VTQRDNSRDYFPHYFHDMDV,MQGSHWPPT,https://www.rcsb.org/structure/6NB6; https://www.rcsb.org/structure/6NB7; https://www.rcsb.org/structure/6NB8,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","Jun 21, 2020","Amalgamated entries referring to S230 and S230.15 (same Ab). Added 3 residues to HC terminus. 21st June: Added 6nb8, apo structure of mAb.",Complete
S231,Ab,SARS-CoV1,SARS-CoV2,SARS-CoV1,SARS-CoV2,S; RBD,B-cells; SARS-CoV1 Human Patient,ND,ND,IGHV3-30 (Human),ND,IGKV2-30 (Human),ND,ARDDNLDRHWPLRLGGY,MQGAHWPPT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 7, 2020",Added Germlines and CDRL3 Sequence,"Email sent, awaiting author reply."
S237,Ab,SARS-CoV1,SARS-CoV2,SARS-CoV1,SARS-CoV2,S; RBD,B-cells; SARS-CoV1 Human Patient,ND,ND,IGHV3-21 (Human),ND,IGLV1-44 (Human),ND,ARGFERYYFDS,VAWDDILNAVV,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 7, 2020",Added Germlines and CDRL3 Sequence,"Email sent, awaiting author reply."
80R,Ab,SARS-CoV1,,SARS-CoV1,,S; RBD,"Phage Display Library (Antibody, human, non-immune)",EVQLVQSGGGVVQPGKSLRLSCAASGFAFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDRSYYLDYWGQGTLVTVSS,ETTLTQSPATLSLSPGERATLSCRASQSVRSNLAWYQQKPGQAPRPLIYDASTRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQRSNWPPTFGQGTKVEVK,IGHV3-30 (Human),IGHJ4 (Human),IGKV3-11 (Human),IGKJ1 (Human),ARDRSYYLDY,QQRSNWPPT,https://www.rcsb.org/structure/2GHW,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
80R-cs5,Ab,SARS-CoV1,,SARS-CoV1,,S; RBD,Derived from 80R,EVQLVQSGGGVVQPGKSLRLSCAASGFAFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDRSYYLDYWGQGTLVTVSS,ETTLTQSPATLSVSPGERATLSCRASQSINNNLAWYQQKAGQAPRLLFYDASTRATGIPDRFSGSGSGTEFTLTINNLEPEDFAVYYCQQRFIWPPTFGQGTKVENK,IGHV3-30 (Human),IGHJ4 (Human),IGKV3-11 (Human),IGKJ1 (Human),ARDRSYYLDY,QQRFIWPPT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/80R_cs5_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
80R-cs25,Ab,SARS-CoV1,,SARS-CoV1,,S; RBD,Derived from 80R,EVQLVQSGGGVVQPGKSLRLSCAASGFAFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDRSYYLDYWGQGTLVTVSS,ETTLTQSPDTLSLSPGERVTLSCRASQTVSGNSLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTHFTLTISSLEPEDFAVYYCQQRSNWPPTFGQGTKVESK,IGHV3-30 (Human),IGHJ4 (Human),IGKV3-11 (Human),IGKJ1 (Human),ARDRSYYLDY,QQRSNWPPT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/80R_cs25_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
80R-cs34,Ab,SARS-CoV1,,SARS-CoV1,,S; RBD,Derived from 80R,EVQLVQSGGGVVQPGKSLRLSCAASGFAFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDRSYYLDYWGQGTLVTVSS,ETTLTQSPGTLSLSPGQRATLSCRASQSVLWNSLAWYQHKPGQAPRLLIYDAYNRATGIPARFSGSGSGTHFTLTISSLEPEDFAVYYCQQRSKWPPTFGQGTKVESK,IGHV3-30 (Human),IGHJ4 (Human),IGKV3-11 (Human),IGKJ1 (Human),ARDRSYYLDY,QQRSKWPPT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/80R_cs34_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
80R-cs84,Ab,SARS-CoV1,,SARS-CoV1,,S; RBD,Derived from 80R,EVQLVQSGGGVVQPGKSLRLSCAASGFAFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDRSYYLDYWGQGTLVTVSS,ETTLTQSPATLSVSPGERATLSCRASQSVNNNLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTHFTLTISSLEPEDFAVYYCQQRFKWPPTFGQGTKVERK,IGHV3-30 (Human),IGHJ4 (Human),IGKV3-11 (Human),IGKJ1 (Human),ARDRSYYLDY,QQRFKWPPT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/80R_cs84_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
80R-cs110,Ab,SARS-CoV1,,SARS-CoV1,,S; RBD,Derived from 80R,EVQLVQSGGGVVQPGKSLRLSCAASGFAFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDRSYYLDYWGQGTLVTVSS,EIVLTQSPDSLALSPGERATLSCRASQSVKNNLAWYQQKPGQAPRLLIYDTFSRATGIPARFSGSGSGTDFTLTISSLKPEDFAVYYCQQRGNWPPITFGQGTRVEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV3-11 (Human),IGKJ5 (Human),ARDRSYYLDY,QQRGNWPPIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/80R_cs110_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
10C,Ab,SARS-CoV1,,SARS-CoV1,,S; RBD,"Phage Display Library (Antibody, human, non-immune)",QVQLVQSGAEVKKPGESLTISCQGSGYSFSTYWIGWVRQRPGKGLEWMGIVSPYNSDTKYSPSFQGLVTISADKSISTAYLEWSSLKASDTAMYYCARQLSYCSTGVSCPGAIWGQGTLVTVSS,LPVLTQPPSVSKGLRQTATLTCTGDSNNVGHQGTAWYQQHQGHPPKLLSHRNGNRPSGISERFSASRSGNTASLTITGLQPEDEADYYCSAWDTSLSTWVFGGGTKLTVL,IGHV5-51 (Human),IGHJ4 (Human),IGLV10-54 (Human),IGLJ3 (Human),ARQLSYCSTGVSCPGAI,SAWDTSLSTWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/10C_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
11A,Ab,SARS-CoV1,,SARS-CoV1,,S; RBD,"Phage Display Library (Antibody, human, non-immune)",EVQLVQSGAEVKKPGESLKISCKGSGYSFTSYWIGWVRQMPGKGLEWMGIINPDNSDTRFSPSLQGQVTISVDKSINTVYLQWGSLKASDTAMYYCARQGDYSGPSINYWGQGTLVTVSS,QSVLTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSKRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCQAWDSNTYVFGTGTKVTVL,IGHV5-51 (Human),IGHJ4 (Human),IGLV2-11 (Human),IGLJ1 (Human),ARQGDYSGPSINY,QAWDSNTYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/11A_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
15D,Ab,SARS-CoV1,,SARS-CoV1,,S; RBD,"Phage Display Library (Antibody, human, non-immune)",EVQLVQSGGGLVQPRGSLRLSCAASGFTVSNYAMSWVRQAPGKGLEWVATKSGSDGRTYYADSVKGRFTIARDNSKNSLYLQMNSLRAADTAVYYCAKGIYDVTGSSFDSWGQGTLVTVSS,SYELTQPPSASGTPGQRVTISCSGSSSNIGSNTVNWYQQLPGTAPKLLIYSNNQRPSGVPDRFSGSKSGTSASLAISGLRSEDEADYYCAAWDDSLRGLVAFGGGTKLTVL,IGHV3-23 (Human),IGHJ5 (Human),IGLV1-44 (Human),IGLJ3 (Human),KGIYDVTGSSFDS,AAWDDSLRGLVA,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/15D_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
23E,Ab,SARS-CoV1,,SARS-CoV1,,S; RBD,"Phage Display Library (Antibody, human, non-immune)",EVQLVESGGGLVKPGGSRRLSCAASGFTVSTSHMSWVRQAPGKGLEWLSGKDSGGKTYYADSVRGRFTIARDDSLNTVFLQMNNMRDEDSGVYYCARARPSDPYDGSGFDAFDIWGQGTMVTVSS,DIQMTQSPSTLSASVGDRVTITCRASQSINRWLAWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTEFTLAISSLQPEDEADYYCQQLNDYPITFGQGTRLEIK,IGHV3-66 (Human),IGHJ3 (Human),IGKV1-5 (Human),IGKJ5 (Human),ARARPSDPYDGSGFDAFDI,QQLNDYPIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/23E_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
28G,Ab,SARS-CoV1,,SARS-CoV1,,S; RBD,"Phage Display Library (Antibody, human, non-immune)",EVQLVQSGAEVKKPGESLKISCQGSGYSFTSYWIGWVRQMPGKGLEWMGIIYPGDSDTRYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARLRPNSSGWTDYWGQGTLVTVSS,NFMLTQPHSVSESPGKTVTISCTRSSGDIASSYVQWYQQRPGSSPTIFIYDNNQRASGVPDRFSGSIDSSSNSASLTISGLQTEDEADYYCQSYDGSYQAIFGGGKLTVL,IGHV5-51 (Human),IGHJ4 (Human),IGLV6-57 (Human),IGLJ3 (Human),ARLRPNSSGWTDY,QSYDGSYQAI,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/28G_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
256,Ab,SARS-CoV1,,SARS-CoV1,,S; RBD,"Phage Display Library (Antibody, human, non-immune)",EVQLVETGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDGYGSGSDYYYYYYMDVWGKGTMVTVSS,TSSSELTQDPAVSVALGQTVRITCQGDSLRSYYASWYQQKPGQAPVPVIYGKNNRPSGIPDRFSGSSSGNTASLTITGAQAEDEADYYCNSRDSSGNHPFGTGTKVTL,IGHV3-30 (Human),IGHJ6 (Human),IGLV3-19 (Human),IGLJ1 (Human),ARDGYGSGSDYYYYYYMDV,NSRDSSGNHP,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/256_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
m396,Ab,SARS-CoV1,,SARS-CoV1,,S; RBD,"Phage Display Library (Antibody, human, non-immune)",QVQLQQSGAEVKKPGSSVKVSCKASGGTFSSYTISWVRQAPGQGLEWMGGITPILGIANYAQKFQGRVTITTDESTSTAYMELSSLRSEDTAVYYCARDTVMGGMDVWGQGTTVTVSS,SYELTQPPSVSVAPGKTARITCGGNNIGSKSVHWYQQKPGQAPVLVVYDDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDSSSDYVFGTGTKVTVL,IGHV1-69 (Human),IGHJ6 (Human),IGLV3-21 (Human),IGLJ1 (Human),ARDTVMGGMDV,QVWDSSSDYV,https://www.rcsb.org/structure/2G75; https://www.rcsb.org/structure/2DD8,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
CR3001,Ab,SARS-CoV1,,,,S; Unk,"Phage Display Library (Antbody, human, semisynthetic)",EVQLVESGGGLVKPGGSLRLSCAASGFTFSGYSMNWVRQAPGKGLEWVSSISGGSTYYADSRKGRFTISRDNSKNTLYLQMNNLRAEDTAVYYCARHRFRHVFDYWGQGTLVTVLE,ELTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPPTFGQGTKVEIK,IGHV3-23 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ1 (Human),ARHRFRHVFDY,QQSYSTPPT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CR3001_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
CR3002,Ab,SARS-CoV1,,,,S; Unk,"Phage Display Library (Antbody, human, semisynthetic)",EVQLVESGGGLVKPGGSLRLSCAASGFTFSGYSMSWVRQAPGKGLEWVGRTRNKANSYTTEYAASVKGRFTISRDDSKNSLYLQMNSLKTEDTAVYYCARYYSRSLKAFDYWGQGTLVTVLE,SELTQDPAVSVALGQTVRITCQGDSLRSYYASWYQQKPGQAPVLVIYGKNNRPSGIPDRFSGSSSGNTASLTITGAQAEDEADYYCNSRDSSGNHVVFGGGTKLTVL,IGHV3-72 (Human),IGHJ4 (Human),IGLV3-19 (Human),IGLJ3 (Human),ARYYSRSLKAFDY,NSRDSSGNHVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CR3002_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
CR3006,Ab,SARS-CoV1,,SARS-CoV1 (weak),,S; RBD,"Phage Display Library (Antbody, human, semisynthetic)",EVQLVESGGGLVQPGGSLRLSCAASGFTFSGYPMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDGSPRTPSFDYWGQGTLVTVLE,DIQMTQSPHSLSASVGDRVTITCRASQGISNYLAWYQQKPGKVPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDVGVYYCQQRFRTPVTFGQGTKLEIK,IGHV3-30-3 (Human),IGHJ4 (Human),IGKV1-27 (Human),IGKJ2 (Human),AKDGSPRTPSFDY,QQRFRTPVT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CR3006_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
CR3009,Ab,SARS-CoV1,,,,S; NTD,"Phage Display Library (Antbody, human, semisynthetic)",EVQLVESGGGVVQPGRSLRLSCAASGFTFSDYPMNWVRQAPGKGLEWVSSISGSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKGLFMVTTYAFDYWGQGTLVTVSS,SELTQDPAVSVALGQTVRITCQGDSLRSYYASWYQQKPGQAPVLVIYGKNNRPSGIPDRFSGSSSGNTASLTITGAQAEDEADYYCNSRDSSGNHVVFGGGTKLTVL,IGHV3-23 (Human),IGHJ4 (Human),IGLV3-19 (Human),IGLJ3 (Human),AKGLFMVTTYAFDY,NSRDSSGNHVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CR3009_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 8, 2020",Amended last two HC terminal residues.,Complete
CR3013,Ab,SARS-CoV1,,SARS-CoV1,,S; RBD,"Phage Display Library (Antbody, human, semisynthetic)",EVQLVESGGGLVQPGGSLRLSCAASGFTFSDHYMDWVRQAPGKGLEWVGRTRNKANSYTTEYAASVKGRFTISRDDSKNSLYLQMNSLKTEDTAVYYCAKGLTPLYFDYWGQGTLVTVSS,SELTQDPAVSVALGQTVRITCQGDSLRSYYASWYQQKPGQAPVLVIYGKNNRPSGIPDRFSGSSSGNTASLTITGAQAEDEADYYCNSRDSSGNHVVFGGGTKLTVL,IGHV3-72 (Human),IGHJ4 (Human),IGLV3-19 (Human),IGLJ3 (Human),AKGLTPLYFDY,NSRDSSGNHVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CR3013_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
CR3014,Ab,SARS-CoV1,,SARS-CoV1,,S; RBD,"Phage Display Library (Antbody, human, semisynthetic)",EVQLVESGGGLVQPGGSLRLSCAASGFTFSDHYMDWVRQAPGKGLEWVGRTRNKANSYTTEYAASVKGRFTISRDDSKNSLYLQMNSLKTEDTAVYYCARGISPFYFDYWGQGTLVTVSS,SELTQDPAVSVALGQTVRITCQGDSLRSYYASWYQQKPGQAPVLVIYGKNNRPSGIPDRFSGSSSGNTASLTITGAQAEDEADYYCNSRDSSGNHVVFGGGTKLTVL,IGHV3-72 (Human),IGHJ4 (Human),IGLV3-19 (Human),IGLJ3 (Human),ARGISPFYFDY,NSRDSSGNHVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CR3014_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
CR3015,Ab,SARS-CoV1,,,SARS-CoV1,S; RBD,"Phage Display Library (Antbody, human, semisynthetic)",EVQLVESGGGVVRPGGSLRLSCAASGFTFDDYGMSWVRQAPGKGLEWVSGINWNGGSTGYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARGLSLRPWGQGTLVTVSR,SELTQDPAVSVALGQTVRITCQGDSLRSYYASWYQQKPGQAPVLVIYGKNNRPSGIPDRFSGSSSGNTASLTITGAQAEDEADYYCNSRDSSGNHVVFGGGTKLTVL,IGHV3-20 (Human),IGHJ5 (Human),IGLV3-19 (Human),IGLJ3 (Human),ARGLSLRP,NSRDSSGNHVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CR3015_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
CR3018,Ab,SARS-CoV1,,,,S; NTD,"Phage Display Library (Antbody, human, semisynthetic)",EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSAISGSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKFNPFTSFDYWGQGTLVTVSS,SELTQDPAVSVALGQTVRITCQGDSLRSYYASWYQQKPGQAPVLVIYGKNNRPSGIPDRFSGSSSGNTASLTITGAQAEDEADYYCNSRDSSGNHVVFGGGTKLTVL,IGHV3-23 (Human),IGHJ4 (Human),IGLV3-19 (Human),IGLJ3 (Human),AKFNPFTSFDY,NSRDSSGNHVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CR3018_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
M1A,Ab,SARS-CoV1,,SARS-CoV1,,S; Unk,"Phage Display Library (Antibody, human, immune - CoV1)",LESGGGVVQPGRSLRLSCAASGFIFSNYGMHWVRQAPGKGLEWVAVIWSDGSNKYYGDSVKGRFTISRDNSKKTLYLQMNSLRAEDTAVYYCARDPVVVVINGDEAFDIWGQGTMVTVSS,ELTQSPATLSLSPGERATLSCRTSQNIGTWLAWFQQKPGQTPRLLIYDASKRAAGIPARFSGSGSGTDFTLTINSLEAEDFAVYYCQQRLQWATENTFGRGTRLDIK,IGHV3-33 (Human),IGHJ3 (Human),IGKV3-11 (Human),IGKJ5 (Human),ARDPVVVVINGDEAFDI,QQRLQWATENT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/M1A_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 23, 2020","May 23, 2020",N/A,Complete
F26G1,Ab,SARS-CoV1,,,SARS-CoV1,S; Unk,Immunised Mouse,EVQLEESGPGLVAPSQSLSITCTVSGFSLTNYDISWIRQPPGKGLEWLGIIWTGGGTSYNSAFMSRLSISKDNSKSQVFLKMNSLQTDDTAIYYCVRDRVYYFPMDYWGQGTSVTVSS,ELVMTQSPSSLSASLGDRVTISCRASQDISNYLNWYQQKPDGTVKLLIYYTSRLHAGVPSRFSGSGSGTDYSLTISNLEQEDIATYFCQQGYTLPYTFGGGTKLEIK,IGHV2-9-2 (Mouse),IGHJ4 (Mouse),IGKV10-96 (Mouse),IGKJ2 (Mouse),VRDRVYYFPMDY,QQGYTLPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/F26G1_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
F26G3,Ab,SARS-CoV1,,SARS-CoV1,,Unk,Immunised Mouse,MEWSWVFLFLLSGTAGVLSEVRLQQSGPELVKPGASVKISCKTSGYTFTEYTMHWVKQSHGKNLEWIGGINPNNGGTTYNQKFKGKATLTVDKSSNTAYMELRSLTSEDSAVYYCSRGDYGTSYGYFDVWGAGTTVTVSS,AQPAELDILMTQSPTSFAVSLGQRATISCRTSQSVSTSSYSYMHWYQQKPGQPPKLLIKYASNLESGVPARFSGSGSGSDFTLNIHPVEEGDTATYYCQHSWEIPCAFGGGTKLEIK,IGHV1-26 (Mouse),IGHJ1 (Mouse),IGKV3-7 (Mouse),IGKJ1 (Mouse),SRGDYGTSYGYFDV,QHSWEIPCA,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/F26G3_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
F26G6,Ab,SARS-CoV1,,,SARS-CoV1,S; Unk,Immunised Mouse,QVQLQQPGAELVKPGASVKVSCKASGYTFTNYWIHWVKQRPGQGLEWIGEINPGNGRTNYNGNFMNKATLTVDKSSNTAYMQLSSLTSEDSAVYHCARLDYWGQGTTLTVSS,ARCELVMTQSPASLSVATGKKVTIRCISSTDIDDDMNWYQQKAGKPPKLLISEGNIFSPGVPSRFSSSGNGTDFVFTVENTLSEDVADNYCLQSDNMPFTFGSGTKLGIK,IGHV1-53 (Mouse),IGHJ2 (Mouse),IGKV17-127 (Mouse),IGKJ4 (Mouse),ARLDY,LQSDNMPFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/F26G6_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
F26G7,Ab,SARS-CoV1,,SARS-CoV1,,Unk,Immunised Mouse,VELLESGTVLARPGASVKMSCEASGYTFTTYWMHWIKQRPGQGLEWIGAIYPGNSDTTYNQKFKGKAKLTAVTSTSTAYMELSSLTNEDSAVYYCTREGIPQLLRTMDYWGQGTSVTVSS,ARCELVMTQSPSSLSASLGERVSLTCRASQEISGYLSWLQQKPDGTIKRLIYAASTLDSGVPKRFSGSRSGSDYSLTISSLESEDFADYYCLQYISYPWTFGGGTKLEIK,IGHV1-5 (Mouse),IGHJ4 (Mouse),IGKV9-124 (Mouse),IGKJ1 (Mouse),TREGIPQLLRTMDY,LQYISYPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/F26G7_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
F26G8,Ab,SARS-CoV1,,,SARS-CoV1,S; Unk,Immunised Mouse,VQLLESGAELVKPGASVKVSCKASGYTFTSYWIHWVKQRPGQGLEWIGEINPSNGRTNYNGNFESKATLTVDKSSNTAYMHLSSLTYEDSAVYHCTRLDYWGQGTTLTVSS,ARCELVMTQSPASLSVITGKKVTIRCISNTDIDDDLNWSQLKAGEPPKLLISEGNIFSPGVPSRFSSSGNGTDFVFTIENTLSEDVANNYCFQSDNMPFTFGSGTKLEIK,IGHV1-53 (Mouse),IGHJ2 (Mouse),IGKV17-127 (Mouse),IGKJ4 (Mouse),TRLDY,FQSDNMPFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/F26G8_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
F26G9,Ab,SARS-CoV1,,SARS-CoV1,,Unk,Immunised Mouse,VQLLESGTVLARPGASVKMSCKASGYSFTSYWMHWVKQRPGQGLEWIGAIYPGNSDTSYNQKFKGKAKLTAVTSASTAYMELSSLTNEDSAVYYCTRSVYYGYGYFDVWGAGTTVTVSS,DILMTQSHKCMSTSVGDRVSITCKASQDVSTAVVWYQQKPGQFPKLLIYWASTRHTGVPDRFTGSGSGTDYTLTISSVQAEDLALYYCQQHYTTPYTFGGGTKLEIK,IGHV1-5 (Mouse),IGHJ1 (Mouse),IGKV6-25 (Mouse),IGKJ2 (Mouse),TRSVYYGYGYFDV,QQHYTTPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/F26G9_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
F26G10,Ab,SARS-CoV1,,SARS-CoV1,,Unk,Immunised Mouse,EVQLEESGTVLARPGASVKMSCKASGYSFTSYWMHWVKQRPGQGLDWIGAIYPENSDTSYNQKFKGKAKLTAVTSASTAYMEHSSLTNEDSAVYYCTRSVYYGYGYFDVWGAGTTVTVSS,AQPAELDILMTQSHKFMSTSVGDRVSITCKASQDVSTAVAWYQQKPGQSPKLLIYWASTRHTGVPDRFTGSGSGTDYTLTISSVQAEDLALYYCQQHYSTPYTFGGGTKLEIK,IGHV1-5 (Mouse),IGHJ1 (Mouse),IGKV6-25 (Mouse),IGKJ2 (Mouse),TRSVYYGYGYFDV,QQHYSTPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/F26G10_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
F26G18,Ab,SARS-CoV1,,SARS-CoV1,,S; Unk,Immunised Mouse,LVQLEESGTVLPRPGASVKMSCKASGYTFTSYWMHWVKQRPGQGLEWIGAIYPGNSDTNYNQKFKGRATLTAVTSTSTASMELSSLTNEDSAVYYCTRDGYGSLYYYAMDFWGQGTSVTVSS,ELVMTQSPSSLSASLGDRVTISCRASQDISNYLNWYQQKPDGTVKLLIYYTSRLHAGVPSRFSGSGSGTDYSLTISNLEQEDIATYFCQQGYTLPYTFGGGTKLEIK,IGHV1-5 (Mouse),IGHJ4 (Mouse),IGKV10-96 (Mouse),IGKJ2 (Mouse),TRDGYGSLYYYAMDF,QQGYTLPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/F26G18_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
F26G19,Ab,SARS-CoV1,,SARS-CoV1,,S; RBD,Immunised Mouse,EVQLEESGTVLARPGASVKMSCKASGYTFTTYRMHWIKQRPGQGLEWIGAIYPGNSDTTYNQKFKDKAKLTAVTSTSSAYMELSSLTNEDSAVYFCTREGIPQLLRTLDYWGQGTSVTVSS,DILMTQSPSSLSASLGERVSLTCRASQEISGYLSWLQEKPDGTIKRLIYAASTLDSGVPKRFSGSRSGSDYSLTISSLESEDFADYYCLQYVSYPWTFGGGTKLEIK,IGHV1-5 (Mouse),IGHJ4 (Mouse),IGKV9-124 (Mouse),IGKJ1 (Mouse),TREGIPQLLRTLDY,LQYVSYPWT,https://www.rcsb.org/structure/3BGF,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
201,Ab,SARS-CoV1,,SARS-CoV1,,S; RBD,Transgenic Mice (HuMab),EVQLVQSGGGLVHPGGSLRLSCAGSGFTFSSYDMHWVRQAPGKGLEWVSVVGTGDGTYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDMAVYYCARDQWWGSDYWGQGTLVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPLTFGGGTKVEIK,IGHV3-13 (Human),IGHJ4 (Human),IGKV3-11 (Human),IGKJ4 (Human),ARDQWWGSDY,QQRSNWPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/201_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
1B5,Ab,SARS-CoV1,,SARS-CoV1,,S; NTD,Transgenic Mice (Xenomouse),QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVIWYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARGDFYWFDPWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQGIRSDLGWYQQRPGKTPKRLIYAASSLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQYNSYPLTFGGGTKVEIK,IGHV3-33 (Human),IGHJ5 (Human),IGKV1-17 (Human),IGKJ4 (Human),ARGDFYWFDP,QQYNSYPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/1B5_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
3A7,Ab,SARS-CoV1,,SARS-CoV1,,S; RBD,Transgenic Mice (Xenomouse),QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYGISWVRQAPGQGLEWMGWISAYNGNTNYAQKLQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCAVGRYLDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQDIRNDLGWYQQKPGKAPKRLIYAASSLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCLQYNSYPLTFGGGTKVEIK,IGHV1-18 (Human),IGHJ4 (Human),IGKV1-17 (Human),IGKJ4 (Human),AVGRYLDY,LQYNSYPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/3A7_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete.  Alternative names: 5A7 | 5D3 | 6B8
3C7,Ab,SARS-CoV1,,SARS-CoV1,,S; RBD,Transgenic Mice (Xenomouse),QVQLVESGGGVVQPGTSLRLSCAASGFTFSSYGIHWVRQAPGKGLEWVAVIWYDGSNKFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDPLGYCSSTSCSYFDYWGQGTLVTVSS,DIQMTQSPSSVSASVGDRVTITCRASQGISNWLAWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTIRSLQPEDFATYYCQQANNFPLTFGGGTKVEIK,IGHV3-33 (Human),IGHJ4 (Human),IGKV1-12 (Human),IGKJ4 (Human),ARDPLGYCSSTSCSYFDY,QQANNFPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/3C7_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
3F3,Ab,SARS-CoV1,,SARS-CoV1,,S; RBD,Transgenic Mice (Xenomouse),QVQLVQSGAEVKKPGASVKVSCKASGYTFTGYYMHWVRQAPGQGLEWMGWINPNSGGTNYAQKFQGRVTMTRDTSISSAYMELSSLRSDDTAVYYCARGPHTFGSGSYPFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQGIRSDLGWYQQRPGNTPKRLIYAASSLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQYNSYPLTFGGGTKVEIK,IGHV1-2 (Human),IGHJ4 (Human),IGKV1-17 (Human),IGKJ4 (Human),ARGPHTFGSGSYPFDY,QQYNSYPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/3F3_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete.  Alternative name: 6C2
3H12,Ab,SARS-CoV1,,SARS-CoV1,,S; RBD,Transgenic Mice (Xenomouse),QVQLQESGPGLVKPSETLSLTCTVSDGSISSFYWSWIRQPPGKGLEWIGYIYYSGSTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARDYDILTGYSNYYGMDVWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQGIRNDLGWYQQKPGKAPKRLIYAASSLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCLQHNSYPFTFGPGTKLDIK,IGHV4-59 (Human),IGHJ6 (Human),IGKV1-17 (Human),IGKJ3 (Human),ARDYDILTGYSNYYGMDV,LQHNSYPFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/3H12_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
4A10,Ab,SARS-CoV1,,SARS-CoV1,,S; RBD,Transgenic Mice (Xenomouse),QVQLVQSGAEVKKPGASVKVSCKASGYTFTGYYMHWVRQAPGQGLEWMGWINPNSGGTNYAQKFQGRVTMTRDSSISTAYMELSRLRSDDTAVYYCARGPHTFGSGSYPFDYWGQGTLVPVSS,DIQLTQSPSSLSASVGDRVTITCRASQGIRSDLGWYQQRPGKTPKRLIYAASSLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQYNSYPLTFGGGTKVEIK,IGHV1-2 (Human),IGHJ4 (Human),IGKV1-17 (Human),IGKJ4 (Human),ARGPHTFGSGSYPFDY,QQYNSYPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/4A10_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete. Alternative name: 5A5
4D4,Ab,SARS-CoV1,,SARS-CoV1,,S; NTD,Transgenic Mice (Xenomouse),QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVIWYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARGGDGERFDYWGQGTLVTVSS,DVVMTQSPLSLPVTLGQPASISCRSSQSRVYSDGNTFLNWFQQRPGQFPRRLIYKVSNWDSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQGTHWPPYVQFWPGDQAGDQ,IGHV3-33 (Human),IGHJ4 (Human),IGKV2-30 (Human),IGKJ5 (Human),ARGGDGERFDY,MQGTHWPPYVQ,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete. Homology modelling failed as missing LC framework residues. Alternative name: 4D4.1 | 4D4.2 | 4D4.3
400,Ab,SARS-CoV1,,SARS-CoV1,,S; RBD,Transgenic Mice (Xenomouse),QVQLVQSGAEVKKPGASVKVSCKASGYTFTGYYMHWVRQAPGQGLEWMGWINSNSGGTNYAQKFQGRVTMTRDTSISTAYMELSRLRSDDTAVYYCARGPHSFGSGSYPFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQGIRSDLGWYQQRPGKTPKRLIYAASSLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQYNSYPLTFGGGTKVEIK,IGHV1-2 (Human),IGHJ4 (Human),IGKV1-17 (Human),IGKJ4 (Human),ARGPHSFGSGSYPFDY,QQYNSYPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/4E2_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
4G2,Ab,SARS-CoV1,,SARS-CoV1,,S; RBD,Transgenic Mice (Xenomouse),QVQLVQSGAEVKKPGASVKVSCKASGFPFTDYYMHWVRQAPGQGLEWMGWINSNSGGTNYAQKFQGRVTMTRDTSISTAYMELSRLRSDDTAVYYCARGPHSFGSGSYPFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQGIRSDLGWYQQRPGKTPKRLIYAASSLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQYNSYPLTFGGGTKVEIK,IGHV1-2 (Human),IGHJ4 (Human),IGKV1-17 (Human),IGKJ4 (Human),ARGPHSFGSGSYPFDY,QQYNSYPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/4G2_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete. Alternative name: 5C12.2 | 6C1
5D6,Ab,SARS-CoV1,,SARS-CoV1,,S; RBD,Transgenic Mice (Xenomouse),QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYGISWVRQAPGQGLEWMGWISAYNGNTNYAQKLQGRVTMTTDTSTNTAYMELRSLRSDDTAVYYCAVGRYLDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQDIRNDLGWYQQKPGKAPKRLIYAASSLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCLQYNSYPLTFGGGTKVEIK,IGHV1-18 (Human),IGHJ4 (Human),IGKV1-17 (Human),IGKJ4 (Human),AVGRYLDY,LQYNSYPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/5D6_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
5E4,Ab,SARS-CoV1,,SARS-CoV1,,S; RBD,Transgenic Mice (Xenomouse),QVHLVQSGAEVKKPGASVKVSCKASGYTFTGYYVHWVRQAPGQGLEWMGWINPNSGGTNYAQKFQGRVTMTRDTSISTAYMELSRLRSDDTAVYFCAGGRYLDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQGIRNDLGWYQQKPGKAPKRLIYAASSLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCLQYNSYPITFGQGTRLEIK,IGHV1-2 (Human),IGHJ4 (Human),IGKV1-17 (Human),IGKJ5 (Human),AGGRYLDY,LQYNSYPIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/5E4_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
6B1,Ab,SARS-CoV1,,SARS-CoV1,,S; RBD,Transgenic Mice (Xenomouse),QVQLVESGGGVVQPGTSLRLSCAASGFTFSSYGIHWVRQAPGKGLEWVAVIWYDGSNKFHADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDPLGYCSSTSCSYFDYWGQGTLVTVSS,DIQMTQSPSSVSASVGDRVTITCRASQGISNWLAWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQANNFPLTFGGGTKVEIK,IGHV3-33 (Human),IGHJ4 (Human),IGKV1-12 (Human),IGKJ4 (Human),ARDPLGYCSSTSCSYFDY,QQANNFPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/6B1_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
6B5,Ab,SARS-CoV1,,SARS-CoV1,,S; RBD,Transgenic Mice (Xenomouse),QVQLVQSGAEVKKPGASVKVSCKASGYTFTGYYMHWVRQAPGQGLEWMGWINPNSGGTNYAQKFQGRVTMTRDTSISTAYMELSRLRSDDTAVYYCARGPHTFGSGSYPFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQGIRSDLGWYQQRPGKTPKRLIYAASSLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQYNSYPLTFGGGTKVEIK,IGHV1-2 (Human),IGHJ4 (Human),IGKV1-17 (Human),IGKJ4 (Human),ARGPHTFGSGSYPFDY,QQYNSYPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/6B5_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
1G3,Ab,SARS-CoV1,,SARS-CoV1,,S; Unk,Transgenic Mice (Xenomouse),QVQLVQSGAEVKKPGASVKVSCKASGYTFTGYYMHWVRQAPGQGLEWMGWINPNSGGTNYAQKFQGRVTMTRDTSISTAYMELSRLRSDDTAVFYCAGGTYLDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQGIRNDLGWYQQKPGKAPKRLIYAASSLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCLQYNSYPITFGQGTRLEIK,IGHV1-2 (Human),IGHJ4 (Human),IGKV1-17 (Human),IGKJ5 (Human),AGGTYLDY,LQYNSYPIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/1G3_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
2B10.1,Ab,SARS-CoV1,,SARS-CoV1,,S; Unk,Transgenic Mice (Xenomouse),QVQLVQSGAEVKKPGASVKVSCKASGYTFTGYYMHWVRQAPGQGLEWMGWINPNSGGTNYAQKFQSRVTMTRDTSISTAYMELSRLRSDDTAVYYCAGGMGDVWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQGIRNDLGWYQQKPGKAPKRLIYAASSLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCLQYNSYPWTFGQGTKVEIK,IGHV1-2 (Human),IGHJ5 (Human),IGKV1-17 (Human),IGKJ1 (Human),AGGMGDV,LQYNSYPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/2B10_1_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete. Alternative name: 2B10.2 | 2B10.3
2B10.4,Ab,SARS-CoV1,,SARS-CoV1,,S; Unk,Transgenic Mice (Xenomouse),QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVIWYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARGDFYWFDPWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQGIRNDLGWYQQKPGKAPKRLIYAASSLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCLQYNSYPWTFGQGTKVEIK,IGHV3-33 (Human),IGHJ5 (Human),IGKV1-17 (Human),IGKJ1 (Human),ARGDFYWFDP,LQYNSYPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/2B10_4_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
5D1.1,Ab,SARS-CoV1,,SARS-CoV1,,S; Unk,Transgenic Mice (Xenomouse),QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYGISWVRQAPGQGLEWMGWISAYNGNTNYAQKLQGRGTMATDTSTSTAYMELRSLRSDDTAVYYCAVGRYLDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQDIRNDLGWYQQKPGKAPKRLIYAASSLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCLQYNSYPLTFGGGTKVEIK,IGHV1-18 (Human),IGHJ4 (Human),IGKV1-17 (Human),IGKJ4 (Human),AVGRYLDY,LQYNSYPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/5D1_1_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
5D1.3,Ab,SARS-CoV1,,SARS-CoV1,,S; Unk,Transgenic Mice (Xenomouse),QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVLWYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARGDFYWFDPWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQDIRNDLGWYQQKPGKAPKRLIYAASSLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCLQYNSYPLTFGGGTKVEIK,IGHV3-33 (Human),IGHJ5 (Human),IGKV1-17 (Human),IGKJ4 (Human),ARGDFYWFDP,LQYNSYPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/5D1_3_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
5D1.4,Ab,SARS-CoV1,,SARS-CoV1,,S; Unk,Transgenic Mice (Xenomouse),QVQLVQSGAEVKKPGASVKVSCKASGYTFTGYYMHWVRQAPGQGLEWMGWINPNSGGTNYAQKFQGRVTMTRDTSISTAYMELSRLRSDDTAVYYCARGPHTFGSGSYPFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQDIRNDLGWYQQKPGKAPKRLIYAASSLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCLQYNSYPLTFGGGTKVEIK,IGHV1-2 (Human),IGHJ4 (Human),IGKV1-17 (Human),IGKJ4 (Human),ARGPHTFGSGSYPFDY,LQYNSYPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/5D1_4_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
5D1.5,Ab,SARS-CoV1,,SARS-CoV1,,S; Unk,Transgenic Mice (Xenomouse),QVQLVQSGAEVKKPGASVKVSCKASGYTFTGYYMHWVRQAPGQGLEWMGWINPNSGGTNYAQKFQGRVTMTRDTSISTAYMELSRLRSDDTAVFYCAGGTYLDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQDIRNDLGWYQQKPGKAPKRLIYAASSLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCLQYNSYPLTFGGGTKVEIK,IGHV1-2 (Human),IGHJ4 (Human),IGKV1-17 (Human),IGKJ4 (Human),AGGTYLDY,LQYNSYPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/5D1_5_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
5E1.1,Ab,SARS-CoV1,,SARS-CoV1,,S; Unk,Transgenic Mice (Xenomouse),QVQLVQSGAEVKKPGASVKVSCKASGYTFTGYYMHWVRQAPGQGLEWMGWINPNSGGTNYAQKFQGRVTMTRDTSISTAYMELSRLRSDDTAVFYCAGGTYLDYWGQGTLVTVSS,DIVMTQSPDSLAVSLGERATINCKSSQSVLYSSNNKNYLAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYSTPRTFGQGTKVEIK,IGHV1-2 (Human),IGHJ4 (Human),IGKV4-1 (Human),IGKJ1 (Human),AGGTYLDY,QQYYSTPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/5E1_1_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete. Alternative names: 5E1.2 | 5E1.3
5E10.1,Ab,SARS-CoV1,,SARS-CoV1,,S; Unk,Transgenic Mice (Xenomouse),QVQLVESGGGVVQPGRSLRLSCAASGFTFRSYGMHWVRQAPGKGLEWVAVIRHDGSNKYNADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDPLGYCSSTSCSYFDYWGQGTLVTVSS,DIQMTQSPSSVSASVGDRVTITCRASQGISSWLAWYQQKPGKAPKLLIYATSSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQANNFPLTFGGGTKVEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV1-12 (Human),IGKJ4 (Human),ARDPLGYCSSTSCSYFDY,QQANNFPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/5E10_1_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete. Alternative name: 5E10.2
6A,Ab,SARS-CoV1,,SARS-CoV1,,S; RBD,"Phage Display Library (Antibody, human, non-immune)",QVQLVQSGGGVVQPGRSLRLSCAASGFTFSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDYGEGFDYWGQGTLVTVSS,ND,IGHV3-66 (Human),IGHJ4 (Human),ND,ND,AKDYGEGFDY,ND,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete. Homology model not possible as neither nanobody nor antibody.
8C,Ab,SARS-CoV1,,SARS-CoV1,,S; RBD,"Phage Display Library (Antibody, human, non-immune)",EVQLVQSGGGLVKPGGSLRLSCAASGFTFSDYYMSWIRQAPGKGLEWVSYISSSGSTIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARDWGYSFGDWGQGTLVTVSS,IQMTQSPSSLSASVGDRVTITCRATQSISTHLNWYQQRGGKAPKLLIYGASTLESGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCLQHRSYPWTVFGQGTNVEIK,IGHV3-11 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ1 (Human),ARDWGYSFGD,LQHRSYPWTV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/8C_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
12E,Ab,SARS-CoV1,,SARS-CoV1,,S; RBD,"Phage Display Library (Antibody, human, non-immune)",QVQLVQSGAEVKKPGASVKVSCKASGYTFTTYGISWVRQAPGQGLEWMGWISAYNGNTNYAQKLQGRVTMITDTSTSTAYMELRSLRSDDTAVYYCARVGYYGDYAWGYYYYGMDVWGQGTLVTVSS,SYELTQPPSASGTPGQRVTISCSGSSSSIGSETVNWYQQLPGTAPKLLIYSNNQRPSGVPDRFSGSKSGTSASLAISGLQSEDEADYYCTAWDDTLNGRVIFGGGTKLTVL,IGHV1-18 (Human),IGHJ6 (Human),IGLV1-44 (Human),IGLJ3 (Human),ARVGYYGDYAWGYYYYGMDV,TAWDDTLNGRVI,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/12E_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
26H,Ab,SARS-CoV1,,SARS-CoV1,,S; RBD,"Phage Display Library (Antibody, human, non-immune)",QVQLQESGGGLVKPGGSLRLSCAASGFTFSDYYMSWIRQAPGKGLEWVSYISSSGSTIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARERWLQIGEDAFDIWGQGTLVTVSS,QTVVTQEPSFSVSPGGTITLTCDLNSGLVSSSHYPSWYQQTPGQAPRTLIYNTNIRSSGVPDRFSGAILGNKAALTITGAQAEDESDYYCVLYMGSGISVFGGTKLTVL,IGHV3-11 (Human),IGHJ4 (Human),IGLV8-61 (Human),IGLJ3 (Human),ARERWLQIGEDAFDI,VLYMGSGISV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/26H_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
27D,Ab,SARS-CoV1,,SARS-CoV1,,S; RBD,"Phage Display Library (Antibody, human, non-immune)",QVQLVQSGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARNFGEDFDYWGQGTLVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDLGGHNFVSWYQQHPGKAPKLMIYDVFNRPSGVSSRFSGSKSGNTASLTISGLQAEDEADYFCSSYTITNIVVFGRGTKLTVL,IGHV3-53 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ3 (Human),ARNFGEDFDY,SSYTITNIVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/27D_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
91M,Ab,SARS-CoV1,,SARS-CoV1,,S; RBD,"Phage Display Library (Antibody, human, non-immune)",QVQLVQSGGGLVQPGGSLRLSCAASGFTFSSSWMSWVRQAPGKGLEWVAYIKQDGSEKYYVDSVKGRFTISRDNAKNSLYLMDSLRAEDTAVYYCARDQGWGWDGTEYYSDYWGQGTLVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSKRPSGVPDRFSGSKSGNTASLTISGLQAEDEADYFCSSYTITDIVVFGGGTKLTVL,IGHV3-7 (Human),IGHJ4 (Human),IGLV2-11 (Human),IGLJ3 (Human),ARDQGWGWDGTEYYSDY,SSYTITDIVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/91M_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
92N,Ab,SARS-CoV1,,SARS-CoV1,,S; RBD,"Phage Display Library (Antibody, human, non-immune)",QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYGISWVRQAPGQGLEWMGWISAYNGNTNYAQKLQGRVTMITDTSTSTAYMELRSLRSDDTAVYYCARDDLSDYGEWLGPDYWGQGTLVTVSS,QPGLTPPSASGTPGQRVTISCSGSRSNIGGNTVNWYQHVPGTAPKLLIYSNNQRPSGVPDRFSGSKSGTSASLAISGLRSEDEAEYYCATWEDSLSGYVFGPGTKVTVL,IGHV1-18 (Human),IGHJ4 (Human),IGLV1-44 (Human),IGLJ1 (Human),ARDDLSDYGEWLGPDY,ATWEDSLSGYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/92N_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
2G7,Ab,SARS-CoV1,,SARS-CoV1,,S; Unk,"Phage Display Library (Antibody, human, non-immune)",EVQLLESGGLVQPGGSLRLSCAASGFTFSSYATTWVRQAPGKGLEWVSAISGSGGSTYYADSVKGRFTIPRDNSKNTLYLQMNSLRAEDTAVYCCAKATTVTTYFDYWGQGTLVTVSS,AAELTQSPLSLPVTLGQSASISCRSSQGLVYSDGRTYMSWYQQRPGQSPRRLIYEVSNRGSGVPDRFSGGGSGTDFTLKISRVEAEDVATYYCMQGTHWPYTFGQGTRLEIK,IGHV3-23 (Human),IGHJ4 (Human),IGKV2-30 (Human),IGKJ5 (Human),AKATTVTTYFDY,MQGTHWPYT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete. Homology modelling failed as we lack a good VH template in our database.
AS3-3-Paper,Ab,SARS-CoV1,,SARS-CoV1,,S; Unk,Humanised from Immunised Mouse,QVQLVQSGAEVKKPGESLKISCKGSGYSFANHWIAWVRQMPGKGLEWMGIFNPDNSDTTYSPSFQGQVTFSADKSISIAYLHWSSLKASDTAIYYCARLALSDGWLHDFWGQGTLVTVSS,EIVMTQSPLSPVTLGQPASISCKSSQSLVDTNGNTYLIWFHQRPGQSPRRLIYQVSKRDSGVPDRFSGSGTDFTLKISRVEAEDVGVYFCMQGTYRPPTLGQGTKVEIK,IGHV5-51 (Human),IGHJ4 (Human),IGKV2-30 (Human),IGKJ1 (Human),ARLALSDGWLHDF,MQGTYRPPT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/AS3-3-Paper_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 23, 2020","May 23, 2020",Added a second version of AS3-3 as paper has different heavy chain to patent,Complete
AS3-3-Patent,Ab,SARS-CoV1,,SARS-CoV1,,S; Unk,Humanised from Immunised Mouse,EVKLVESGGGVVQPGRSLRLSCAASGFRFSTYAIHWVRQAPGKGLEWVARISHDGSQTHYADSVQGRFGVSRDNSNYTAYVQLNSLRPDDTAVYFCARAYSSTPDYGMDVWGQGTAVTVSS,EIVMTQSPLSPVTLGQPASISCKSSQSLVDTNGNTYLIWFHQRPGQSPRRLIYQVSKRDSGVPDRFSGSGTDFTLKISRVEAEDVGVYFCMQGTYRPPTLGQGTKVEIK,IGHV3-30 (Human),IGHJ6 (Human),IGKV2-30 (Human),IGKJ1 (Human),ARAYSSTPDYGMDV,MQGTYRPPT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/AS3_3_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 23, 2020","Renamed to add ""patent"", as paper has different heavy chain",Complete
S2a,Ab,SARS-CoV1,,SARS-CoV1,,S; S2,Humanised from Immunised Mouse,QVQLVESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSGISGSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKKQTSSGWYGKDYWGQGTLVTVSS,SSELTQDPAVSVALGQRVRITCQGDSLRSYYASWYQQKPGQAPVLVIFGVNQRPSGIPDRFSGSSSGNTASLTITGAQAEDEADYYCTSRDRSGNHQVFGGGTKLTVL,IGHV3-23 (Human),IGHJ4 (Human),IGLV3-19 (Human),IGLJ3 (Human),AKKQTSSGWYGKDY,TSRDRSGNHQV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/S2a_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
S2b,Ab,SARS-CoV1,,SARS-CoV1,,S; S2,Humanised from Immunised Mouse,QVELVESGGGLVKPGGSLRLSCAASGFTFSAYAMSWVRQAPGKGLEWVSAISGSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKGGYCTGGVCSSLDYRGQGTLVTVSS,QSVLTQPPSVSGSPGQSITISCTGTSSDVGAYNFVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNAASLTISGLQAEDEADYYCSSYTTRSTRVFGGGTKLTVL,IGHV3-23 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ3 (Human),AKGGYCTGGVCSSLDY,SSYTTRSTRV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/S2b_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
7S1,Ab,SARS-CoV1,,,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLQQSGPGLVKPSQTLSLTCAISGDSVSSNSAAWTWIRQSPSRGLEWLGRTYYRSKWYNDYAVSVKSRIDINPDTSKNQFSLHLNSVTPEDTAVYYCAREPGSGGYRYDSEAFDVWGQGTMVTVSS,DIQVTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPWTFGQGTKVEIK,IGHV6-1 (Human),IGHJ3 (Human),IGKV1-39 (Human),IGKJ1 (Human),AREPGSGGYRYDSEAFDV,QQSYSTPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/7S1_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 8, 2020","May 8, 2020",N/A,Complete
7S2,Ab,SARS-CoV1,,,,S; Unk,B-cells; SARS-CoV1 Human Patient,QVQLQQSGPGLVKPSQTLSLTCAISGDSVSSNSAAWNWIRQSPSRGLEWLGRTYYRSKWYNDYAVSVKSRITINPDTSKNQFSLQLNSVTPEDTAVYYCAREISTSPDYWGQGTLVTVSS,DIRVTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPWTFGQGTKVEIK,IGHV6-1 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ1 (Human),AREISTSPDY,QQSYSTPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/7S2_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 8, 2020","May 8, 2020",N/A,Complete
B1,Ab,SARS-CoV1,,SARS-CoV1,,S; S2,"Phage Display Library (Antibody, human, immune - CoV2)",QVQLLESGAEVKKPGASAKVSCKASGCTFTSYGISWVRQAPGQGLEWMGWISAYNGNTNYAQKLQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARGVAVAGTWDWFDPWGQG,DIVLTQTPGTLSLSPGERATLSCRASQSVRTYLAWYQQKPGQVPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSLWTFGQGTRLEIK,IGHV1-18 (Human),IGHJ5 (Human),IGKV3-20 (Human),IGKJ5 (Human),ARGVAVAGTWDWFDP,QQYGSSLWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/B1_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 8, 2020","May 8, 2020",N/A,Complete
N18,Ab,SARS-CoV1,,,,N,"Phage Display Library (Antibody, human, immune - CoV1)",QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGIIPIFGTANYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYCARGYWGSGYHYYGMDVWGQGTTVTVSS,SYVLTQPPSVSVAPGKTARIPCGGNNIGSKSVHWYQQKPGQAPVLVIYYDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDRSSDLVVFGGGTKLTVL,IGHV1-69 (Human),IGHJ6 (Human),IGLV3-21 (Human),IGLJ3 (Human),ARGYWGSGYHYYGMDV,QVWDRSSDLVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/N18_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 23, 2020","May 23, 2020",N/A,Complete
SA59B,Ab,SARS-CoV1,,,,Unk,"Phage Display Library (Antibody, human, single-chain)",EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSPIGRLGQPTTYADSVKGRFTISDNSKNTLYLQMNSLRAEDTAVYYCAKRSLSFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPNTFGQGTKVEIK,IGHV3-23 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ1 (Human),AKRSLSFDY,QQSYSTPNT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/SA59B_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 23, 2020","Jun 4, 2020",Corrected HV & HJ gene annotation.,Complete. Stop codon in VH replaced with a dash.
m390,Ab,SARS-CoV1,,,,S; RBD,B-cells; Healthy Human Blood (Umbilical),QVQLQESGGGVVQPRSLRLSCAASGFTFSSYGMHMWVRQAPGKGLEWVAVISYDGSNEYYADSVKGRFTISRDNSKNTLYQMNSLRAEDTAVYYCAFGWNYAFDIWGQGTTVTVSS,DIVMTQSPLSLPVTPGEPASISCRSSQSLLHSNGYNYLDWYLQKPGQSPQLLIYLGSNRASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQALQTPPTFGGGTKVEIK,IGHV3-30 (Human),IGHJ3 (Human),IGKV2-28 (Human),IGKJ4 (Human),AFGWNYAFDI,MQALQTPPTMQALQTPPT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/m390_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 23, 2020","May 23, 2020",N/A,Complete. Our thanks to Dr. Jacob Galson for this submission.
H12,Ab,SARS-CoV1,,,,S; S1,"Phage Display Library (Antibody, human, immune - CoV1)",EVQLVQSGAEVKKPGSSVKVSCKASGGTFSSHAVNWVRQVPGLEWMGRVIPILGTVKNAQKLQGRVTITADEATSTAYMELNSLRSEDTAVYYCARGGWCTGDCDARTFVWFEPWGCGTTVTVSS,DIRVTQSPPSLSASIGDRVTITCRASQNIRNSLNWYQQKPGKAPKLLIYAAYSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPITFGQGTKLEIK,IGHV1-69 (Human),IGHJ5 (Human),IGKV1-39 (Human),IGKJ5 (Human),ARGGWCTGDCDARTFVWFEP,QQSYSTPIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H12_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 23, 2020","May 23, 2020",N/A,Complete
L9N01,Ab,SARS-CoV1,,,,N,Immunised Mouse,MPGEAAAVQGTEVVKPGASVKLSCKASGYIFTSYDIDWVRQTPEQGLEWIGSIFPGEGSTEYNEKFKGRATLSVDKSSSTAYMELTRLTSEDSPLYFCARGDYYRRYFDLWGQGTTVTVSS,DIELTQSPAIMSASPGERVTMTCSPSSSIRYIYWYQQKPGSSPRLLIYDTSNVAPGVPFRFSGSGSGTSYSLTINGMEAEDAATYYCQESSGYPYTFGGRTKLELK,IGHV1-85 (Mouse),IGHJ2 (Mouse),IGKV4-55 (Mouse),IGKJ2 (Mouse),ARGDYYRRYFDL,QESSGYPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/L9N01_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 23, 2020","May 23, 2020",N/A,Complete
4S1,Ab,SARS-CoV1,,,,S; RBD/non-RBD,"Phage Display Library (scFv, chicken, immune - CoV1)",TVTLDESGGGLQTPGGTLSLVCKASGFTFSSYQMNWVRQAPGKGLEFVAAINRFGNSTGHGAAYKGRVTISRDNGQSTGRLQLNNLRAEDTGTYFCAKAADTNYGWRTAGSIDAWGHGTEVIVSS,ALTQPSSVSANPGETVKITCSGSSGSYGWYQQKAPGSAPVTVIYQNTNRPSDIPSRFSGSESGSTATLTITGVQVEDEAVYYCASADRNFVGMFGAGTTLTVL,IGHV3-23 (Human),IGHJ4 (Human),IGLV3-25 (Human),IGLJ3 (Human),AKAADTNYGWRTAGSIDA,ASADRNFVGM,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 23, 2020","May 23, 2020",N/A,Complete. Homology modelling failed because LC has chicken origin and lacks close framework templates.
4S3,Ab,SARS-CoV1,,,,S; Unk,"Phage Display Library (scFv, chicken, immune - CoV1)",TVTLDESGGGLQTPGGGLSLVCKASGFTFSSYAMMWVRQAPGKGLEWVAGISNAGRSTYYATAVKGRATISRDDGQSTVRLQLNNLRAEDTGTYYCAKSVGGGGWHAATIDAWGHGTEVIVSS,ALTQPSSVSANPGETVKITCSGGNYNYGWYQQKSPGSAPVSLIYNNDNRPSDIPSRFSGSGSGSTNTLTITGVQADDEAVYYCGSFDNSGAGYVGIFGAGTTLTVL,IGHV3-23 (Human),IGHJ4 (Human),IGLV3-25 (Human),IGLJ3 (Human),AKSVGGGGWHAATIDA,GSFDNSGAGYVGI,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 23, 2020","May 23, 2020",N/A,Complete. Homology modelling failed because LC has chicken origin and lacks close framework templates.
4S4,Ab,SARS-CoV1,,,,S; Unk,"Phage Display Library (scFv, chicken, immune - CoV1)",TVTLDESGGGLQTPGGGLSLVCKASGFTFSSYCMQWVRQAPGKGLEWVAGIDDDGGTGYGSAVKGRATISRDNGQSTVRLQLNNLRAEDTGIYYCAKDSTNTGGCGGYDIDAWGHGTEVIVSS,ALTQPSSVSANPGETVKITCSGSSGNYGWYQQKSPGSAPVTVIYYNDKRPSDIPSRFSGSKSGSTGTLTITGVQAEDEAVYYCGSIDSSTTNSAIFGAGTTLTVL,IGHV3-23 (Human),IGHJ4 (Human),IGLV3-25 (Human),IGLJ7 (Human),AKDSTNTGGCGGYDIDA,GSIDSSTTNSAI,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 23, 2020","May 23, 2020",N/A,Complete. Homology modelling failed because LC has chicken origin and lacks close framework templates.
4S12,Ab,SARS-CoV1,,,,S; Unk,"Phage Display Library (scFv, chicken, immune - CoV1)",TVTLDESGGGPQTPGGALRLVCKASGFTFSSFNMFWVRQAPGKGLEWVAEISGSGSWTGYGAAVKGRATISRDDGQSTVRLQLNNLRTEDTGTYYCAKAAGSCNYGYSCSYYIDTWGHGTEVIVSS,ALTQPSSVSANPGETVKITCSGGGNSNYYGWYQQKSPGSAPVTLIYKSSSRPSNIPSRFSGSTSGSTTTLTITGVQADDEAVYFCGSWDSSASYAAFGAGTTLTVL,IGHV3-23 (Human),IGHJ4 (Human),IGLV3-25 (Human),IGLJ7 (Human),AKAAGSCNYGYSCSYYIDT,GSWDSSASYAA,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 23, 2020","May 23, 2020",N/A,Complete. Homology modelling failed because LC has chicken origin and lacks close framework templates.
4S15,Ab,SARS-CoV1,,,,S; Unk,"Phage Display Library (scFv, chicken, immune - CoV1)",AVTLDESGGGLQTPGGGLRLVCKASGFTFSDYSVQWVRQAPGKGLEWVAGIHCTGSYTYYGPAVKGRATISRDNGQSTLRLQLDNLRAEDTGTYYCAKYSGSWTAYAYITAGSIDAWGHGTEVIVSS,ALTQPSSVSANPGETVKITCSGGYDYYYGWYQQKAPGSAPVTLIYDNTNRPSDIPSRFSGSKSGSTATLTITGVRAEDEAVYFCGSSDSNSSGIFGAGTTLTVL,IGHV3-23 (Human),IGHJ4 (Human),IGLV3-25 (Human),IGLJ3 (Human),AKYSGSWTAYAYITAGSIDA,GSSDSNSSGI,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 23, 2020","May 23, 2020",N/A,Complete. Homology modelling failed because LC has chicken origin and lacks close framework templates.
Ssc20,Ab,SARS-CoV1,,,,S; Unk,"Phage Display Library (scFv, chicken, immune - CoV1)",AVTLDESGGGLQTPGGGLSLVCKASGFDFRTYGMGWVRQAPGKGLEYVASISSDGNYPRYAPAVDGRATISRDNRQSTVRLQLNDLRAEDTATYFCAKSVNNSWSTGEDIDVWGHGTEVTVSS,ALTQPSSVSANLGGTVEITCSGDSIYYGWYQQKAPGSAPVTLIYDNTNRPSDIPSRFSGSKSGSTATLTITGVRADDNAVYYCASTDSSSTAGIFGAGTTLTVL,IGHV3-30 (Human),IGHJ6 (Human),IGLV3-19 (Human),IGLJ3 (Human),AKSVNNSWSTGEDIDV,ASTDSSSTAGI,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 23, 2020","May 23, 2020",N/A,Complete. Homology modelling failed because LC has chicken origin and lacks close framework templates.
Ssc22,Ab,SARS-CoV1,,,,S; Unk,"Phage Display Library (scFv, chicken, immune - CoV1)",TVTLDESGGGLQTPGGALSLVCKASGFSFSSYTMLWVRQAPGKGLEFVASISSGSGSSTGYGAAVKGRATISRDNGQSTVRLQLNNLRAEDTATYYCAKNNYNNGVDAAGDIDAWGHGTEVTVSS,ALTQPSSVSANLGGTVKITCSGGGGSYGWFQQKSPGSAPITLIYNNNNRPSDIPSRFSGSTSGSTSTLTITGVQAEDEAVYFCGAWDSTDSGYVGIFGAGTTLTVL,IGHV3-23 (Human),IGHJ4 (Human),IGLV3S16 (Rhesus),IGLJ1 (Rhesus),AKNNYNNGVDAAGDIDA,GAWDSTDSGYVGI,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 23, 2020","May 23, 2020",N/A,Complete. Homology modelling failed because LC has chicken origin and lacks close framework templates.
Ssc26,Ab,SARS-CoV1,,,,S; Unk,"Phage Display Library (scFv, chicken, immune - CoV1)",AVTLDESGGGLQTPGGALSLVCKASGFIFSSYCMHWVRQAPGKGLEWVAGISSSASYTYYGAAVKGRATISRDNGQSTVRLQLNNLRAEDTATYYCAKGGNGCSSGDHAGQIDAWGHGTEVTVSS,ALTQPSSVSANLGGTVEITCSGSSGSYGWYQQKSPGSAPVTVIYTNDKRPSDIPSRFSGSKSGSTSTLTITGVQAEDEAVYYCGNEDTSSTGGIFGAGTTLTVL,IGHV3-23 (Human),IGHJ4 (Human),IGLV3-25 (Human),IGLJ3 (Human),AKGGNGCSSGDHAGQIDA,GNEDTSSTGGI,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 23, 2020","May 23, 2020",N/A,Complete. Homology modelling failed because LC has chicken origin and lacks close framework templates.
Ssc29,Ab,SARS-CoV1,,,,S; Unk,"Phage Display Library (scFv, chicken, immune - CoV1)",AVTLDESEGGLQTPGGALSLVCKASGFTFNNYSMQWVRQAPGKGLEFVARISNTGRYTDYGAAVKGRATISRDNGQSTVRLQLNSLRAEDTATYFCARSPGGAYSGSIDTWGHGTEVTVSS,ALTQPSSVSANPGETVKITCSGSSSYYGWYQQKAPGSAPVTLIYANTNRPSDIPSRFSGSKSGSTGTLTITGVQAEDEAVYFCGSADTTYVNSGIFGAGTTLTVL,IGHV3-23 (Human),IGHJ4 (Human),IGLV3-25 (Human),IGLJ3 (Human),ARSPGGAYSGSIDT,GSADTTYVNSGI,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 23, 2020","May 23, 2020",N/A,Complete. Homology modelling failed because LC has chicken origin and lacks close framework templates.
Ssc33,Ab,SARS-CoV1,,,,S; Unk,"Phage Display Library (scFv, chicken, immune - CoV1)",AVTLDESGGGLQTPGGALSLVCKASGFDFSSYGMHWVRQAPGKGLEWVAGIYSGSSTSYAPAVRGRATISRDNGQSTVRLQLNNLRAEDTGTYFCARGAPGCDTWCWYGAAFIDAWGHGTEVTVSS,ALTQPSSVSANLGGTVEITCSGTRDDYGWYQQKSPGSAPVTVIYQNTNRPSDIPSRFSGSKSGSTGTLTITGVQADDEAVYFCGSYDSSAGYVGIFGAGTTLTVL,IGHV1S7 (Rabbit),IGHJ6 (Rabbit),IGLV3-25 (Human),IGLJ3 (Human),ARGAPGCDTWCWYGAAFIDA,GSYDSSAGYVGI,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 23, 2020","May 23, 2020",N/A,Complete. Homology modelling failed because LC has chicken origin and lacks close framework templates.
Ssc35,Ab,SARS-CoV1,,,,S; S2,"Phage Display Library (scFv, chicken, immune - CoV1)",AVTLDESGGGLQTPGGGLSLVCKASGFDFSDRAMHWVRQAPGKGLEWFVAGIGNTGSGTNYGSAVKGRATISRDNGQSTVRLQLNNLRAEDTGTYYCAKGSGSACIWSGWCAGDIDSWGHGTEVTVSS,ALTQPSSVSANPGETVEITCSGDVSYYGYGYWQQKSPGSAPVTLIYDNDKRPSDIPSRFSGSASGSTATLTVTGVQVEDEAVYFCGSADVNSTGSTFGAGTTLTVL,IGHV3-23 (Human),IGHJ5 (Human),IGLV3-25 (Human),IGLJ3 (Human),AKGSGSACIWSGWCAGDIDS,GSADVNSTGST,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Ssc35_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 23, 2020","May 23, 2020",N/A,Complete.
Ssc37,Ab,SARS-CoV1,,,,S; Unk,"Phage Display Library (scFv, chicken, immune - CoV1)",AVTLDEFGGGLQTPGGGLSLVCEASGFDISSYAMMWVRQAPGKGLEWVGVVSPDGRYTEYGAAVKGRATISRDNGQSTVRLQLNNLRAEDTASYFCAKSAYGGWTYADNIDAWGHGTEVTVSS,ALTQPSSVSANPGETVKITCSGGGGSSGYYYGWYQQKSPGSALVTVIYSDDKRPSDIPSRFSGSKSGSTATLTITGVRAEDEAVYYCGSTDSNDALFGAGTTLTVL,IGHV3-23 (Human),IGHJ4 (Human),IGLV3-25 (Human),IGLJ7 (Human),AKSAYGGWTYADNIDA,GSTDSNDAL,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 23, 2020","May 23, 2020",N/A,Complete. Homology modelling failed because LC has chicken origin and lacks close framework templates.
Lsc8,Ab,SARS-CoV1,,,,S; Unk,"Phage Display Library (scFv, chicken, immune - CoV1)",AVTLDESGGGLQTPGGGLSLVCKASGFSFSGLGMAWVRQAPGKGLEWVGSISNDGKYIYYAPAVKGRATISRDNGQSTLRLQLNNLRAEDTATYFCAKESGAGGWNAGNVIDAWGHGTEVTVSS,ALTQPSSVSATLGGTVEITCSGSSGRYGWYQQKSPGSAPVTVIYSNDKRPSNIPSRFSGSKSGSTATLTITGVQDEDEAVYFCGSRDSTYVDMFGAGTTLTVL,IGHV3-23 (Human),IGHJ4 (Human),IGLV3-19 (Human),IGLJ3 (Human),AKESGAGGWNAGNVIDA,GSRDSTYVDM,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 23, 2020","May 23, 2020",N/A,Complete. Homology modelling failed because LC has chicken origin and lacks close framework templates.
Lsc12,Ab,SARS-CoV1,,,,S; Unk,"Phage Display Library (scFv, chicken, immune - CoV1)",AVTLDESGGGLQTPGGALSLVCKASGFTFSSYGMGWVRQAPGKGLEWVAGIGTSGSNTYYGAAVKGRATISRDNGQSTVRLQLNNLRAEDTGTYYCAKAAGPDCCYTASNIDAWGHGTEVTVSS,ALTQPSSVSANLGGTVEITCSGGSAGYDYSWHQQKSPGSAPVTLIYSNDKRPSDIPSRFSGSKSGSTATLTITGVQVEDEAVYFCGGYDSSNGVFGAGTTLTVL,IGHV3-23 (Human),IGHJ4 (Human),IGLV3-5 (Rhesus),IGLJ1 (Rhesus),AKAAGPDCCYTASNIDA,GGYDSSNGVF,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 23, 2020","May 23, 2020",N/A,Complete. Homology modelling failed because LC has chicken origin and lacks close framework templates.
Lsc13,Ab,SARS-CoV1,,,,S; Unk,"Phage Display Library (scFv, chicken, immune - CoV1)",AVTLDESGGGLQTPGGALSLVCKASGFTFSSYPMGWVRQAPGKGLEWVAVINAASSGTHYGAAVKGRATISRDNGQSTVRLQLNNLRAEDTGIYYCAKGSSGSCGSCAGNIDAWGHGTEVTVSS,ALTQPSSVSANLGGTVEITCSGGYNYYGWYQQKSPGSAPVTVIYYNDKRPSDIPSRFSGSESGSTATLTITGVQAEDEAIYYCGSEDSSTNTGIFGAGTTLTVL,IGHV3-23 (Human),IGHJ4 (Human),IGLV3-25 (Human),IGLJ3 (Human),AKGSSGSCGSCAGNIDA,GSEDSSTNTGI,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 23, 2020","May 23, 2020",N/A,Complete. Homology modelling failed because LC has chicken origin and lacks close framework templates.
Lsc14,Ab,SARS-CoV1,,,,S; Unk,"Phage Display Library (scFv, chicken, immune - CoV1)",AVTLDESGGGLQTPGGALSLVCKASGFDFSSYDMVWVRQAPGKGLEWVAGIYCTGSSTYYGPAVMGRATISRDNGQSTVRLQLNNLRAEDTATYYCAKSSYCGGGYYSAANIDTWGHGTEVTVSS,ALTQPSSVSANLGETVEITCSGGSGSYGWFQQKSPGSAPVTVIYNNDKRPSNIPSRFSGALSGSTATLTITGVQADDEAVYFCGSADSSSTAAFGAGTTLTVL,IGHV3-23 (Human),IGHJ4 (Human),IGLV3S16 (Rhesus),IGLJ1 (Rhesus),AKSSYCGGGYYSAANIDT,GSADSSSTAA,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 23, 2020","May 23, 2020",N/A,Complete. Homology modelling failed because LC has chicken origin and lacks close framework templates.
Lsc16,Ab,SARS-CoV1,,,,S; Unk,"Phage Display Library (scFv, chicken, immune - CoV1)",AVTLDESGGGLQTPGGALSLVCKASGFTFSSYGMQWVRQAPGKGLEYVAEITNDGYRTAYGAAVEGRATISRDNGQSTVRLQLNNLRAEDTATYYCARSSCGGDYETGCIDAWGHGTEVTVSS,ALTQPSSVSANLGGTVKITCSGGGGSYGWFQQKSPGSAPVTLIYNNNNRPSDIPSRFSGSKSGSTGTLTITGVQAEDEAVYFCGNRDSNYMGIFGAGTTLTVL,IGHV3-64 (Human),IGHJ4 (Human),IGLV3S16 (Rhesus),IGLJ1 (Rhesus),ARSSCGGDYETGCIDA,GNRDSNYMGI,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 23, 2020","May 23, 2020",N/A,Complete. Homology modelling failed because LC has chicken origin and lacks close framework templates.
Lsc18,Ab,SARS-CoV1,,,,S; S2,"Phage Display Library (scFv, chicken, immune - CoV1)",AVTLDESGGGLQTPGGALSLICKASGFDFSSIAMQWVRQAPGKGLEWVAGIDSSGNRNNYGSAVKGRATISRDNGQSTVRLQLNNLRAEDTGSYYCAKSGFRNGGGWSSAGLIDAWGHGTEVTVSS,ALTQPSSVSANPGETVKITCSGGGSFAGTYYYGWYQQKAPGSAPVTLIYSNDERPSDIPSRFSGSASGSTATLTITGVQAEDEAVYFCGGYDGSTDAGIFGAGTTLTVL,IGHV3-23 (Human),IGHJ4 (Human),IGLV3-25 (Human),IGLJ3 (Human),AKSGFRNGGGWSSAGLIDA,GGYDGSTDAGI,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 23, 2020","May 23, 2020",N/A,Complete. Homology modelling failed because LC has chicken origin and lacks close framework templates.
Lsc22,Ab,SARS-CoV1,,,,S; Unk,"Phage Display Library (scFv, chicken, immune - CoV1)",AVTLDESGGGLQTPGGALSLVCKASGFDFSSYGMQWVRQAPGKGLEWFIASISSDGSGTNYGAAVKGRATISRDNGQSTVRLQLNNLRAEDTATYYCAKTIYGGGWSGYGDSIDGWGHGTEVTVSS,ALTQPSSVSANPGETVKITCSGGSGNYYGWYQQKSPGSAPVTLIYANTNRPSNIPSRFSGSGSGSTHTLTITGVQADDEAVYFCGGYDGSYVGIFGAGTTLTVL,IGHV3-30 (Human),IGHJ4 (Human),IGLV3-25 (Human),IGLJ3 (Human),AKTIYGGGWSGYGDSIDG,GGYDGSYVGI,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 23, 2020","May 23, 2020",N/A,Complete. Homology modelling failed because LC has chicken origin and lacks close framework templates.
m336,Ab,MERS-CoV,,MERS-CoV,,S; RBD,B-cells; MERS-CoV Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGIIPIFGTASYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCARVGYCSSTSCNRGAFDIWGQGTMVTVSS,DIQLTQSPSSLSASVGDRVTITCRASQGIRNDLGWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQLNSYPLTFGGGTKVEIK,IGHV1-69 (Human),IGHJ3 (Human),IGKV1-17 (Human),IGKJ4 (Human),ARVGYCSSTSCNRGAFDI,QQLNSYPLT,https://www.rcsb.org/structure/4XAK,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
m337,Ab,MERS-CoV,,MERS-CoV,,S; RBD,B-cells; MERS-CoV Human Patient,QVQLQQSGAEVKKPGSSVKVSCKASGGTFSSYTISWVRQAPGQGLEWMGRIIPIFGTANYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCARDLGPGGDSSGYYYGPGAFDIWGQGTMVTVSS,EIVLTQSPLSLPVTPGEPASISCRSSQSLLHSNGYNYLDWYLQKPGKSPQLLIYLGSNRASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQALQTPLTFGGGTKVEIK,IGHV1-69 (Human),IGHJ3 (Human),IGKV2-28 (Human),IGKJ4 (Human),ARDLGPGGDSSGYYYGPGAFDI,MQALQTPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/m337_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete. Author replied with sequence.
m338,Ab,MERS-CoV,,MERS-CoV,,S; RBD,B-cells; MERS-CoV Human Patient,QVQLQQSGAEVKKRGSSVKVSCKASGGTFSSYTISWVRQAPGQGLEWMGRIIPILGIANYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCARDLYDSSGYYRNTDAFDIWGQGTMVTVSS,EIVMTQSPVTLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK,IGHV1-69 (Human),IGHJ3 (Human),IGKV3-11 (Human),IGKJ1 (Human),ARDLYDSSGYYRNTDAFDI,QQYGSSPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/m338_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete. Author replied with sequence.
MCA-1,Ab,MERS-CoV,,MERS-CoV,,S; RBD,B-cells; MERS-CoV Human Patient,ATRLEESGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGRIIPILGIANYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCASKQGDYYDRTSYAFDIWGQGTMVTVSS,DVELTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPITFGQGTRLEIK,IGHV1-69 (Human),IGHJ3 (Human),IGKV3-20 (Human),IGKJ5 (Human),ASKQGDYYDRTSYAFDI,QQYGSSPIT,https://www.rcsb.org/structure/5GMQ,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
7D10,Ab,MERS-CoV,,MERS-CoV,,S; NTD,Immunised Mouse,EVQLVESGAEVVKPGASVKMSCKASGYPFTSYNIHWIKQTPGQGLEWIGAIYPGNGDTSYTQKFKVKATLTSDKSSSTAYMQLSSLTSEDSAVYFCARYGNYPSYAMDYWGQGTSVTVSS,DIVMTQSPASLTVSLGQRATISCRASKSVSASGYNYLHWYQQRPGQPPKLLIYLAFNLESGVPARFNGSGSGTDFTLNIHPVEEEDAATYYCQHSRDLPFTFGSGTKLEIK,IGHV1-12 (Mouse),IGHJ4 (Mouse),IGKV3-12  (Mouse),IGKJ4 (Mouse),ARYGNYPSYAMDY,QHSRDLPFT,https://www.rcsb.org/structure/6J11,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
G2,Ab,MERS-CoV,,MERS-CoV,,S; NTD,Immunised Mouse,QVQLQQSGGELVKPGASVKLSCKTSGFTFSSSYISWLKQKPGQSLEWIAWIYAGTGGTEYNQKFTGKAQVTVDTSSSTAYMQFSSLTTEDSAIYYCARGGSSFAMDYWGQGTSVTVSS,QLVLTQSPASLAVSLGQRATISCRASESVDNYGISFMNWFQQKPGQPPKLLIHTASNQGSGVPARFSGSGSGTDFSLNIHPVEDDDTAMYFCQQSEEVPLTFGAGTKLEIK,IGHV1-66 (Mouse),IGHJ4 (Mouse),IGKV3-2 (Mouse),IGKJ5 (Mouse),ARGGSSFAMDY,QQSEEVPLT,https://www.rcsb.org/structure/6PXG; https://www.rcsb.org/structure/6PXH; https://www.rcsb.org/structure/6PZ8,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
G4,Ab,MERS-CoV,,MERS-CoV,,S; S2,Immunised Mouse,QVQLQQSGPELVRPGVSVKISCKGSGYTFTDYAIHWVKQSHAKSLEWIGVFSTYYGNTNYNQKFKGRATMTVDKSSSTAYMELARLTSEDSAIYYCARKSYYVDYVDAMDYWGQGTSVTVSS,DIVLTQSPASLAVSLGQRATISCRASESVDNYGISFMNWFQQKPGQPPKLLISATSNQGSGVPARFIGSGSGTDFSLNIHPVEEDDTAMYFCQQSKEVPRTFGGGTKLEIK,IGHV1-26 (Mouse),IGHJ4 (Mouse),IGKV3-2 (Mouse),IGKJ1 (Mouse),ARKSYYVDYVDAMDY,QQSKEVPRT,https://www.rcsb.org/structure/5W9H; https://www.rcsb.org/structure/5W9I; https://www.rcsb.org/structure/5W9J; https://www.rcsb.org/structure/5W9K; https://www.rcsb.org/structure/5W9L; https://www.rcsb.org/structure/5W9M; https://www.rcsb.org/structure/5W9N; https://www.rcsb.org/structure/5W9O; https://www.rcsb.org/structure/5W9P; https://www.rcsb.org/structure/5VZR,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
MERS-1,Ab,MERS-CoV,,,MERS-CoV,S; RBD,"Yeast Display Library (scFv, human)",QVQLQQWGAGLLKPSETLSLTCVVYGGGYYSVSWSWIRQLPGKGLEWIGSSYYTGSTHYNPSLNSRVTISIDTSKNQFSLRLRSVTAADTAVYYCASHMPFLYAFDYWGQGTLVTVSS,QPVLTQSPSASGTPGQRVTISCSGSSSNIGSNTVNWYQQLPGTAPKLLISSNNQRPSGVPDRFSGSKSDTSASLAISGLQSEDEADYYCAAWDDSLNGPVFGGGTQLTVL,IGHV4-34 (Human),IGHJ4 (Human),IGLV1-44 (Human),IGLJ7 (Human),ASHMPFLYAFDY,AAWDDSLNGPV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/MERS_1_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
MERS-2,Ab,MERS-CoV,,,MERS-CoV,S; RBD,"Yeast Display Library (scFv, human)",QITLKESGPTLVKPTQTLTLTCSFSGFSLSSNGVGVGWIRQPPGKALEWLAMIYWDDDKYYNPSLNSRLTITKDTSKNQVVLTMTNMDPVDTATYYCIGFGEGVGALDIWGQGTMVTVSS,VLTQPPSVSVAPGETARITCGGNNIASKSEHWYQQKPGQAPVLVIYDDGDRPSGIPERFSGSNSGNTATLTITRVAAGDEADYYCQVWDSSSDLGALFGGGTQLTVL,IGHV2-5 (Human),IGHJ3 (Human),IGLV3-21 (Human),IGLJ7 (Human),IGFGEGVGALDI,QVWDSSSDLGAL,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/MERS_2_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
MERS-4,Ab,MERS-CoV,,MERS-CoV,,S; RBD,"Yeast Display Library (scFv, human)",VQLVESGGGLVQPGRSLRLSCAASGFTFSNYAMYWVRQAPGKGLEWVALISYDISTDYYADSVKGRFTISRDNSKNTIYLQMNNLRTEDTALYYCAGNDYWGQGTLVTVSS,QPVLTQSPSASGTPGQRVTISCSGSSSNIGNNYVYWYQQLPGTAPKLLIYWNDQRPSGVPDRFSGSKSGTSASLAISGLRSEDEADYYCAAWDDSLSGAVFGGGTQLTVL,IGHV3-30 (Human),IGHJ4 (Human),IGLV1-47 (Human),IGLJ7 (Human),AGNDY,AAWDDSLSGAV,https://www.rcsb.org/structure/5ZXV,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
MERS-4V2,Ab,MERS-CoV,,MERS-CoV,,S; RBD,"Yeast Display Library (scFv, human)",EVQLVESGGGLVQPGRSLRLSCAASGFTFSNYAMYWVRQAPGKGLEWVALISYDISTDYYADSVKGRFTISRDNSKNTIYLQMNNLRTEDTALYYCTNTYYWGQGTLVTVS,GSQPVLTQSPSASGTPGQRVTISCSGSSSNIGNNYVYWYQQLPGTAPKLLIYWNDQRPSGVPDRFSGSKSGTSASLAISGLRSEDEADYYCAAWDDSLSGAVFGGGTQLTVL,IGHV3-30-3 (Human),IGHJ4 (Human),IGLV1-47 (Human),IGLJ7 (Human),TNTYY,AAWDDSLSGAV,https://www.rcsb.org/structure/5YY5,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
MERS-6,Ab,MERS-CoV,,,MERS-CoV,S; RBD,"Yeast Display Library (scFv, human)",QVQLQQSGPALVKPSQTLSLTCAISGDSVSSNSAAWHWIRQSPSRGLEWLGRTYFRSTWYNEYAGSIKGRILINPDTSKNQFSLLLNSVTPEDTAVYYCARDGSPGSSGTYPFFLDVWGRGTTVTVSS,QSVLIQPASVSGSPGQSITISCPGTDDYVGTYNLVSWYQQHPGKAPKLIIYEGTKRPSGVSNRFSGSTSDSTASLTISGLQAEDEADYYCCSLANNIVFGGGTQLTVL,IGHV6-1 (Human),IGHJ6 (Human),IGLV2-23 (Human),IGLJ7 (Human),ARDGSPGSSGTYPFFLDV,CSLANNIV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/MERS_6_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
MERS-7,Ab,MERS-CoV,,,MERS-CoV,S; RBD,"Yeast Display Library (scFv, human)",QVQLVQSGAEVKKPGSSVKVSCRASGGTFSTYTINWVRQAPGQGLEWLGRIIPVLGITNYAQMLQDRVTLTADRSTNIASMELDSLRSEDSAVYFCARGVRPRWTHAFDIWGQGAMVTVSS,EIVLTQSPGTLSLSPGGSATLSCRASQSVRSSFVAWYQQKAGQAPSLLIYGASIRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPFTFGQGTKVEIK,IGHV1-69 (Human),IGHJ3 (Human),IGKV3-20 (Human),IGKJ1 (Human),ARGVRPRWTHAFDI,QQYGSSP,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/MERS_7_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
MERS-14,Ab,MERS-CoV,,,MERS-CoV,S; RBD,"Yeast Display Library (scFv, human)",QVQLVQSGAEVKTSGASVKVSCRASGYTHTGYAMHWVRQAPGQRLEWMGWINTASGATQYSQNFQGRVSISRDTSASTGYMELSSLTSGDTAVYYCARDGGKGWHSLIWGQGTLVTVSS,ETTLTQSPAFMSATPGDKVNISCKASQDIDDDMNWYQQKPGEAAILIIQEATTLVPGIPPRFSGSGYGTDFTLTINNIESEDAAYYFCLQHDNFPLEITFGQGTRLEIK,IGHV1-3 (Human),IGHJ4 (Human),IGKV5-2 (Human),IGKJ5 (Human),ARDGGKGWHSLI,LQHDNFPLEIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/MERS_14_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
JC57-13,Ab,MERS-CoV,,MERS-CoV,,S; S1 non-RBD,Immunised Rhesus Macaques,QVQLQESGPGLVKPSETLSLTCAVSGGSISSNYWNWIRQSPGKGLEWIGYIYGGSGSTTYNPSLKSRVAISTDTSKDQFSLKLSSVTAADTAVYYCARLLPLGGGYCFDYWGQGVLVTVSS,DIVMTQTPFTLPVTPGEAASISCRSSQSLFDSDYGNTYLDWYLQKPGQSPQLLIYMLSNRASGVPDRFSGSGSGTDFTLKISRVEAEDVGLYYCMQSVEYPFTFGPGTKLDIK,IGHV4-2 (Rhesus),IGHJ5-2 (Rhesus),IGKV2S17 (Rhesus),IGKJ1 (Rhesus),ARLLPLGGGYCFDY,MQSVEYPFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/JC57_13_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
D12,Ab,MERS-CoV,,MERS-CoV,,S; RBD,Immunised Mouse,EVKLVESGGGLVKPGGSLKLSCAASGFTFSSYAMSWVRQTPEKRLEWVATISSGGTYTYYPDSVKGRFTISRDNAENTLYLQMSSLRSEDTAMYYCVRDGNSMDYWGQGTSVTVSS,DIQMTQTTSSLSASLGDRVTIICRASQDINNYLNWYQQKPDGTVKLLIYYTSRLHSGVPSRFSGSGSGSDYSLTISNLEQEDIATYFCQQANTLPPTFGAGTKLELR,IGHV5-9-3 (Mouse),IGHJ4 (Mouse),IGKV10-96 (Mouse),IGKJ5 (Mouse),VRDGNSMDY,QQANTLPPT,https://www.rcsb.org/structure/4ZPT; https://www.rcsb.org/structure/4ZPV,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 8, 2020",Variable Domain Sequence & Germline Information Corrected.,Complete
S2D5,Ab,MERS-CoV,,MERS-CoV,,S; S2,"Phage Display Library (Antibody, human)",EVQLVESGGGLVQPGGSLRLSCAASGFTFSDYAMSWVRQAPGKGLEWVSAISQSGSYTNYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKVSSQTLRFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYGASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSFPFTFGQGTKVEIK,IGHV3-23 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ1 (Human),AKVSSQTLRFDY,QQSYSFPFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/S2D5_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 7, 2020","May 7, 2020",N/A,Complete
CN106380517,Nb,MERS-CoV,,MERS-CoV,,S; RBD,Humanised from  Llama,EVQLVESGGSLVQPGGSLRLSCAASGFTLDYYAIGWFRQAAGKERERVSCIDISGTMTTYARFVKGRFTISRDNAKNTVYLQMNSLEPEDTAVYYCAANKVTGPLGANDYCSGNWREYEYWGQGTEVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AANKVTGPLGANDYCSGNWREYEY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CN106380517_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 7, 2020","May 7, 2020",N/A,Complete
S2A6,Ab,MERS-CoV,,MERS-CoV,,S; S2,"Phage Display Library (Antibody, human)",EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYGMSWVRQAPGKGLEWVSAISQSGGYIYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKHLYGSWAFDIWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSIGSYLNWYQQKPGKAPKLLIYAASNLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSFPFTFGQGTKVEIK,IGHV3-23 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ1 (Human),AKHLYGSWAFDI,QQSYSFPFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/S2A6_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 7, 2020","May 7, 2020",N/A,Complete
KR101828794,Ab,MERS-CoV,,MERS-CoV,,S; RBD,B-cells; MERS-CoV Human Patient,EVQLVESGGGLVKPGGSLRLSCAASGFAFSSYSMIWVRQAPGKGLEWVSSISTSSGYIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARAPIDAVAFDIWGQGTMVTVSS,ELVLTQPPSASGTPGQRVNISCSGSRSNVGSNAVTWYQQVPGTAPKLLIYNNSKRPSGVPDRFSGSKSGTSASLAISGLQSEEEADYYCAAWDDSLNGPVFGGGTKVTVL,IGHV3-21 (Human),IGHJ3 (Human),IGLV1-44 (Human),IGLJ6 (Human),ARAPIDAVAFDI,AAWDDSLNGPV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/KR101828794_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 7, 2020","May 7, 2020",N/A,Complete
S2A3,Ab,MERS-CoV,,MERS-CoV,,S; S2,"Phage Display Library (Antibody, human)",EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVSSIYSSGGYIYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDQYVSTDFDIWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISNYLNWYQQKPGKAPKLLIYDASRLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSYPWTFGQGTKVEIK,IGHV3-23 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ1 (Human),AKDQYVSTDFDI,QQSYSYPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/S2A3_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 7, 2020","May 7, 2020",N/A,Complete
H2M15292N,Ab,MERS-CoV,,,,S; Possibly RBD,"Chimeric (Human V, Mouse C)",QVQLVQSGAEVKKPGSSVKVSCKASGGTFNNYAISWVRQAPGQGLEWMGGIIPFFGTTNYAQKFQDRVTITSDDSTITAYMELSRLRSEDTAVYYCARDEPRRDGYNYYHYYYMDVWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSINSYLNWYQQKPGKAPNLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLHPEDFATYYCQQSYSTPPITFGQGTRLEIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ5 (Human),ARDEPRRDGYNYYHYYYMDV,QQSYSTPPIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H2M15292N_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 7, 2020","May 7, 2020",N/A,Complete
H2M15287N,Ab,MERS-CoV,,,,S; Possibly RBD,"Chimeric (Human V, Mouse C)",QLQLQESGPGLVKPSETLSLTCTVSGGSISSGNYYWGWIRQPPGKGLEWFGTIYYSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARRAAVGHFDYWGQGTLVTVSS,DIQMTQSPSTLSASVGDRVTITCRASQSISTWLAWYQQKPGKAPKLLIYEASSLESGVPSRFSGSGFGTEFTLTISRLQPDDFATYFCQQYNTYWTFGQGTKVEIK,IGHV4-39 (Human),IGHJ4 (Human),IGKV1-5 (Human),IGKJ1 (Human),ARRAAVGHFDY,QQYNTYWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H2M15287N_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 7, 2020","May 7, 2020",N/A,Complete
H2M15281N,Ab,MERS-CoV,,,,S; Possibly RBD,"Chimeric (Human V, Mouse C)",QVQLVQSGAEVKKPGSSVKVSCKASKDTFSSYAISWVRQAPGQGLEWMGGIIPFFGTTTYEQKFQGRVTITTDESTRTAYMELSSLRSEDSAVYYCARDRPCISSAGTRYHYCVMDVWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPPITFGQGTRLEIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ5 (Human),ARDRPCISSAGTRYHYCVMDV,QQSYSTPPIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H2M15281N_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 7, 2020","May 7, 2020",N/A,Complete
H2M15291N,Ab,MERS-CoV,,,,S; Possibly RBD,"Chimeric (Human V, Mouse C)",QVQLVQSGAEVKKPGSSVKVSCKASGDTFSTYAVSWVRQAPGQGLEWMGGIIPFFGTSNYAQKFQGRVTITTDESTTTAYMELNSLRSEDTAVYYCAREITMVRGLTNYHFYGMDVWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSISPITFGQGTRLEIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ5 (Human),AREITMVRGLTNYHFYGMDV,QQSYSISPIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H2M15291N_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 7, 2020","May 7, 2020",N/A,Complete
H2M15268N,Ab,MERS-CoV,,,,S; Possibly RBD,"Chimeric (Human V, Mouse C)",EVQLLESGGVLVQPGGSLRLSCAASGFTFSSFAMSWVRQAPGKGLEWVSAISGRGGTTYYADSVMGRFTISRDNSKNTLYVQMNSLRAEDTAVYYCAKDRGFGVFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQVINNYLNSYQQKPGKAPKVLICDASNVETGVPSRFSGSGSGTDFTFTISSLQTEDIATYYCQQYDNLTFGGGTKVEVK,IGHV3-23 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ4 (Human),AKDRGFGVFDY,QQYDNLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H2M15268N_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 7, 2020","May 7, 2020",N/A,Complete
H2M15278N,Ab,MERS-CoV,,,,S; Possibly RBD,"Chimeric (Human V, Mouse C)",QVQLVQSGAEVKKPGASVKVSCKASGYTFTSHGISWVRQAPGQGFEWMGWIGTYNSNTDYAQNFQGRVTMTTDTSTSTAYMELRNLRSDDTAVYYCARERGPYYGMDVWGQGTTVTVSS,EIVLAQSPGTLSLSPGERATLSCRASQSVNSNYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGNSLTFGPGTKVDFK,IGHV1-18 (Human),IGHJ6 (Human),IGKV3-20 (Human),IGKJ3 (Human),ARERGPYYGMDV,QQYGNSLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H2M15278N_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 7, 2020","May 7, 2020",N/A,Complete
H2M15279N,Ab,MERS-CoV,,,,S; Possibly RBD,"Chimeric (Human V, Mouse C)",EVQLLESGGGLVQTGGSLRLSCAASGFTFSNYAMSWVRQAPGKGLEWVSAISDRGGSIYYADSVKGRFTISRDNSKNTKYLQMDSLRAEDTAVYYCAQDRGFGVFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDIGNYLNWFQQRPGKAPNLLIYGASNLETGVPSRFSGGGSGTDFYFTISSLQPEDIATYFCQQYDNLPFTFGPGTKVEIK,IGHV3-23 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ3 (Human),AQDRGFGVFDY,QQYDNLPFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H2M15279N_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 7, 2020","May 7, 2020",N/A,Complete
H2M15271N,Ab,MERS-CoV,,,,S; Possibly RBD,"Chimeric (Human V, Mouse C)",EVQLVESGGALVQPGGSLRLSCAASGFIFGSYEMNWVRQAPGKGLEWLSYISSSGSTIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARERGQLGRGGYYYYGMDVWGQGTTVTVSS,EIVLTRSPGTLSLSPGERATLSCRASQSVSSSYLAWYHQKPGQAPRLLMYGTSIRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPPWTFGQGTKVEIK,IGHV3-48 (Human),IGHJ6 (Human),IGKV3-20 (Human),IGKJ1 (Human),ARERGQLGRGGYYYYGMDV,QQYGSSPPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H2M15271N_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 7, 2020","May 7, 2020",N/A,Complete
H2M15272N,Ab,MERS-CoV,,,,S; Possibly RBD,"Chimeric (Human V, Mouse C)",QVRLVQSGAEVKKPGSSVKVSCKASGDTFSSYAISWVRQAPGQGLEWMGGIIPFFVTTTYAQNFQGRVTITTDESTRTAYMELSSLRSEDSAVYYCARDRPCISSAGTRYHYCVMDVWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPPITFGQGTRLEIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ5 (Human),ARDRPCISSAGTRYHYCVMDV,QQSYSTPPIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H2M15272N_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 7, 2020","May 7, 2020",N/A,Complete
H2M15270N,Ab,MERS-CoV,,,,S; Possibly RBD,"Chimeric (Human V, Mouse C)",EVQLLESGGGLEQPGGSLRLSCAASGFTFSSYAMIWVRQAPGKGLEWVSTISGSGVNTYYADSVKGRFTISRDNSKNTLHLQMNSLRAEDTAVYHCAKEGLDCANGVCYNYYGMDVWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSINSFLNWYHQKPGKAPKFLIYSASNLQSGVPSRFSGSGSGTDFTLTISSLQPEDFSTYYCQQSYSIPLTFGGGTKVEIK,IGHV3-23 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ4 (Human),AKEGLDCANGVCYNYYGMDV,QQSYSIPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H2M15270N_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 7, 2020","May 7, 2020",N/A,Complete
H1M15293N,Ab,MERS-CoV,,,,S; Possibly RBD,"Chimeric (Human V, Mouse C)",QVQLVQSGAEVKKPGSSVKVSCKVSGVTFSSYAISWVRQAPGQGLEWMGGIIPFFGTASYAQKFQGRVTVTTDESTSTAYMEVSSLRSEDTAVYYCARDNPELTKEGYYHYYAMDVWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPPITFGQGTRLEIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ5 (Human),ARDNPELTKEGYYHYYAMDV,QQSYSTPPIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H1M15293N_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 7, 2020","May 7, 2020",N/A,Complete
H1M15290N,Ab,MERS-CoV,,,,S; Possibly RBD,"Chimeric (Human V, Mouse C)",QVQLVQSGAEVKKPGSSVKVSCKASGGTFSTYAISWVRQAPGQGLEWMGGIIPFFGTANYAQKFQGRVTITTDESTSTAYMELSSLRSEDTAVYYCAREGTYYDSLTGYYTHYYRMDVWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQTISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPPITFGQGTRLEIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ5 (Human),AREGTYYDSLTGYYTHYYRMDV,QQSYSTPPIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H1M15290N_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 7, 2020","May 7, 2020",N/A,Complete
H1M15277N,Ab,MERS-CoV,,MERS-CoV,,S; Possibly RBD,"Chimeric (Human V, Mouse C)",EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSAISGRGGNTYYADSVKGRFTISRDNSKNTLFLQMNTLRAEDTAVYYCAKDRGFGFFDIWGRGTLATVSS,DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKFLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPFTFGPGTKINIK,IGHV3-23 (Human),IGHJ2 (Human),IGKV1-33 (Human),IGKJ3 (Human),AKDRGFGFFDI,QQYDNLPFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H1M15277N_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 7, 2020","May 7, 2020",N/A,Complete
H1M15280N,Ab,MERS-CoV,,,,S; Possibly RBD,"Chimeric (Human V, Mouse C)",EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSAISGSGSSTYYADSVKGRFTISRDNSKNTLFLQMNSLRAEDTAVYYCAEGGDVDFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPPITFGQGTRLEIK,IGHV3-23 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ5 (Human),AEGGDVDFDY,QQSYSTPPIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H1M15280N_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 7, 2020","May 7, 2020",N/A,Complete
H1M15289N,Ab,MERS-CoV,,,,S; Possibly RBD,"Chimeric (Human V, Mouse C)",QVQLQESGPGLVKPSETLSLTCTVSGGSISSYYWSWIRQPPGKGLEWIGYIYYSGSANYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCVRDRDLLLDHWGQGTLVTVSS,EIVMTQSPATLSVSPGKRATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRTTGFPARFSGSGSGTDFTLTISSLQSEDFAVYYCQQYNNWPYTFGQGTMLEIK,IGHV4-59 (Human),IGHJ4 (Human),IGKV3-15 (Human),IGKJ2 (Human),VRDRDLLLDH,QQYNNWPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H1M15289N_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 7, 2020","May 7, 2020",N/A,Complete
H1H15253P2,Ab,MERS-CoV,,,,S; Possibly RBD,Recombinant Human,EVQLVESGGGLVQPGGSLRLSCVVSGFTSRNYAMSWVRQAPGKGLEWVSAISGSGGSTYYADSVKGRFTISRDNPKNTLYLQMNSLRAEDTALYYCAEDPGTSFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPPITFGQGTRLEIK,IGHV3-23 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ5 (Human),AEDPGTSFDY,QQSYSTPPIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H1H15253P2_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 7, 2020","May 7, 2020",N/A,Complete
H1H15259P2,Ab,MERS-CoV,,,,S; Possibly RBD,Recombinant Human,EVQLVESGGGVVQPGRSLRLSCAASGFTFSNYGIHWVRQAPGKGLEWVAGIYYDGSNKYYGDSVKGRFTISRDQSKQTLYLQMNSLRAEDTAVYYCARDRGNNHYYHNNPYYYYHGLDVWGQGTTVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK,IGHV3-30 (Human),IGHJ6 (Human),IGKV3-20 (Human),IGKJ1 (Human),ARDRGNNHYYHNNPYYYYHGLDV,QQYGSSPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H1H15259P2_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 7, 2020","May 7, 2020",N/A,Complete
H1H15264P2,Ab,MERS-CoV,,,,S; Possibly RBD,Recombinant Human,QLQLQESGPGLVKPSETLSLTCSVSGGSINNNNYYWGWIRQPPGRGLEWIGSFFYSGPTYYNPSLRSRVTISVDTSKNQFSLKLNSVTAADTAIYYCARQDGNYYPLFDYWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK,IGHV4-39 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ1 (Human),ARQDGNYYPLFDY,QQYGSSPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H1H15264P2_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 7, 2020","May 7, 2020",N/A,Complete
H1H15249P2,Ab,MERS-CoV,,,,S; Possibly RBD,Recombinant Human,QLQLQESGPGLVKPSETLSLTCTVSGGSISNNNYYWGWIRQPPGKGLDWIGSIYYSGNTYYNPSLKSRVTISVDTSKNQFSLKMSSVTATDTALYYCARQGADHNWVDPWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPPITFGQGTRLEIK,IGHV4-39 (Human),IGHJ5 (Human),IGKV1-39 (Human),IGKJ5 (Human),ARQGADHNWVDP,QQSYSTPPIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H1H15249P2_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 7, 2020","May 7, 2020",N/A,Complete
H1M15267N2,Ab,MERS-CoV,,MERS-CoV,,S; Possibly RBD,"Chimeric (Human V, Mouse C)",QVQLQESGPGLVKPSETLSLTCTVSGGSISSYYWSWIRQPPGKGLEWIGYIYYSGSPNYNPSLKSRVTISVDTSKNQFSLKLTSVTAADTAVYYCARSLNWGPPFDYWGQGTLVTVSS,EIVMTQSPATLSLSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQFNNWPYTFGQGTKLEIK,IGHV4-59 (Human),IGHJ4 (Human),IGKV3-15 (Human),IGKJ2 (Human),ARSLNWGPPFDY,QQFNNWPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H1M15267N2_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 7, 2020","May 7, 2020",N/A,Complete
H1M15269N,Ab,MERS-CoV,,,,S; Possibly RBD,"Chimeric (Human V, Mouse C)",EVQLLESGGGLVQPGGSLRLSCPASGFTFSNYAMTWVRQAPGKGLEWVSAISGSGATTKYADSVKGRFTISRDNSRNTLYLQMNSLRAEDTAVYYCAKGGSGSYFPYYYYGLDVWGQGTTVTVSS,EIVMTQSPATLSVSPGDSATLSCRASQTVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYYNWWTFGQGTKVEIK,IGHV3-23 (Human),IGHJ6 (Human),IGKV3-15 (Human),IGKJ1 (Human),AKGGSGSYFPYYYYGLDV,QQYYNWWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H1M15269N_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 7, 2020","May 7, 2020",N/A,Complete
H1H15260P2,Ab,MERS-CoV,,,,S; Possibly RBD,Recombinant Human,QVQLQESGPGLVKPSETLSLTCSVSGGSITSSYWSWIREPPGRGLEWIGYVYYYGTTKYNPSLKSRVTTSMDTSKNQFSLKLNSVTAADTAVYYCARLELLFDYWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK,IGHV4-59 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ1 (Human),ARLELLFDY,QQYGSSPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H1H15260P2_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 7, 2020","May 7, 2020",N/A,Complete
H1H15237P2,Ab,MERS-CoV,,,,S; Possibly RBD,Recombinant Human,EVQLVESGGGLVQPGGSLRLSCAASGFTSNSYPMSWVRQAPGKGLEWVSGISGRGGNTYYADSVKGRFTISRDNSKNTLYLQMNSLRVEDTAVYYCAETGTAFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPPITFGQGTRLEIK,IGHV3-23 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ5 (Human),AETGTAFDY,QQSYSTPPIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H1H15237P2_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 7, 2020","May 7, 2020",N/A,Complete
2G10G5,Ab,MERS-CoV,,,,S; Unk,Immunised Mouse,QVKLQESGGGLVQPGGSRGLSCEGSGFTFSGFWMSWVRQTPGKTLEWIGDINSDGSIINYAPSIKDRFTIFRDNDKTTLYLQMSNVRSEDTATYFCSIYYDSWFAYWGQGTLVTVSA,DIVLTQSPLSLPVSLGDQASISCRSSQSIVHSNGNTYLEWYLQKPGQSPKLLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDLGVYYCFQGSHVPRTFGGGTKLEIK,IGHV1-15 (Mouse),IGHJ2 (Mouse),IGKV1-117 (Mouse),IGKJ2 (Mouse),SIYYDSWFAY,FQGSHVPRT,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 7, 2020","Jun 4, 2020",Corrected HJ gene assignment.,Complete. Homology modelling failed as patented HC is missing framework residues.
H1H15177P,Ab,MERS-CoV,,MERS-CoV,,S; Possibly RBD,Recombinant Human,EVQLVESGGGLVQPGGSLRLSCSASGFYFSSYDMSWVRQAPGKGLEWVSAIRGSGHTTYYADSVKGRFTISRDNSKNTLYLEMNSLRAEDTAVYYCVKDGSIVGFDPWGQGTLVTVSS,DIQMTQSPSTLSASVGDRVTITCRASQTISSWLAWYQQKPGKAPKLLIYKASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNSYSYTFGQGTKLEIK,IGHV3-23 (Human),IGHJ5 (Human),IGKV1-5 (Human),IGKJ2 (Human),VKDGSIVGFDP,QQYNSYSYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H1H15177P_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 7, 2020","May 7, 2020",N/A,Complete
1G10E4E2,Ab,MERS-CoV,,,,S; Unk,Immunised Mouse,QVQLEQSGAELVRPGASVTVSCKASGYTFTDYEMHWVKQTPVHGLEWIGAIDPETGGTAYNQKFKGKATLTADKSSSTAYMELRSLTSEESAVYYCTRPSSYDAMDYWGQGTSVTVSS,DIVLTQSTLSLPVSLGDQASISCRSSQSIVHSNGNTYLEWYQKPGQSPKLLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDLGIYYCFQGSHVPYTFGGGTKLEIK,IGHV11-2 (Mouse),IGHJ3 (Mouse),IGKV1-117 (Mouse),IGKJ1 (Mouse),TRPSSYDAMDY,FQGSHVPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/1G10E4E2_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 7, 2020","Jul 24, 2021",24th July '21: Updated reference and corrected missing conserved cysteine in VH sequence,Complete
2D6F11,Ab,MERS-CoV,,,,M,Immunised Mouse,QVQLQQSGGGLVQPKGSLKLSCAASGFTFNIYAMNWVRQAPGKGLEWVARIRSKSNNYATYCADSVKDRFTISRDDSQSMLYLQMNNLNTEDTAMYYCVAYYGGYYYAMDYWGQGTSVTVSS,DIVMTQSTASLAVSLGQRATISCRASKSVNNFGNSFMHWYQQKPGQPPKLLIYRASNLESGIPARFSGSGSRTDFTLTINPVEADDLATYYCHQNYEDPWTFGGGTKLEIK,IGHV10-1 (Mouse),IGHJ4 (Mouse),IGKV3-5 (Mouse),IGKJ1 (Mouse),VAYYGGYYYAMDY,HQNYEDPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/2D6F11_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 7, 2020","May 7, 2020",N/A,Complete
H1H15228P2,Ab,MERS-CoV,,,,S; Possibly RBD,Recombinant Human,EVQLVESGGGLVQPGGSLRLSCAVFGFTFSGYAMSWVRQAPGKGLEWVSAISGGGGSTYYTDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCASYWNNGMDVWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPPITFGQGTRLEIK,IGHV3-23 (Human),IGHJ6 (Human),IGKV1-39 (Human),IGKJ5 (Human),ASYWNNGMDV,QQSYSTPPIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H1H15228P2_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 7, 2020","May 7, 2020",N/A,Complete
H1H15215P,Ab,MERS-CoV,,,,S; Possibly RBD,Recombinant Human,EVQLVESGGGLVQPGGSLRLSCAASGFTFSTYGMSWVRQAPGKGLEWVSTIIGSGYNTYYSDSVKGRFTMSRDNSKSTLYLQMNSLRAEDTAVYYCTKEGPIIGTTNWGQGTLVTVSS,DIQMTQSPSTLSASVGDRVTITCRASQSISSWLAWYQQKPGKAPKLLIYKASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCHQYNSYSWTFGQGTKVEIK,IGHV3-23 (Human),IGHJ4 (Human),IGKV1-5 (Human),IGKJ1 (Human),TKEGPIIGTTN,HQYNSYSWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H1H15215P_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 7, 2020","May 7, 2020",N/A,Complete
H1H15231P2,Ab,MERS-CoV,,,,S; Possibly RBD,Recombinant Human,ELQLQESGPGLVKPSETLSLTCTVSGGSISSNTYYWGWIRQPPGKGLEWIGTIYYTGNTYYKSSLKSRVTISVDTSRNQFSLKLTSVTAADTAVYYCARQFADLNYVDDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPPITFGQGTRLEIK,IGHV4-39 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ5 (Human),ARQFADLNYVDDY,QQSYSTPPIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H1H15231P2_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 7, 2020","May 7, 2020",N/A,Complete
H1H15233P2,Ab,MERS-CoV,,,,S; Possibly RBD,Recombinant Human,EVQLVESGGGLVQPGGSLRLSCAASGFSFSSYGMNWVRQAPGKGLEWVSAISGRGGNTYSADSVKGRFTISRDNSKNTLFLQMNGLRAEDSAFYYCAKVGTYSSSSPFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPPITFGQGTRLEIK,IGHV3-23 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ5 (Human),AKVGTYSSSSPFDY,QQSYSTPPIT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H1H15233P2_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 7, 2020","May 7, 2020",N/A,Complete
H1H15188P,Ab,MERS-CoV,,MERS-CoV,,S; Possibly RBD,Recombinant Human,QVQLVQSGAEVKKPGSSVKVSCKASGGSFSVYAISWVRQAPGQGLEWMGGIIPIFGTANYAQKFQDRFTITTDESTSTAYMELSSLRSEDTAMYYCAREGDIVVLPAGKGGMDVWGQGTTVTVSS,DIVMTQSPLSLPVTPGEPASISCRSSQSLLHGNGYNYLDWYLQKPGQSPQLLIYLVSHRASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQALQSPWTFGQGTKVEIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV2-28 (Human),IGKJ1 (Human),AREGDIVVLPAGKGGMDV,MQALQSPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H1H15188P_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 7, 2020","May 7, 2020",N/A,Complete
H1H15208P,Ab,MERS-CoV,,,,S; Possibly RBD,Recombinant Human,EVQLVESGGDLVQPGGSLRLSCTASGFTFSNYEMNWVRQAPEKGLDWVSFISSSGGAIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDSAIYFCARSDSGGNSRYWGQGTLVTVSS,DIQMTQSPSSVSASVGDRVTVTCRASQDISNWLVWYQQKPGKAPKFLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQANSFPPTFGGGTKVEIK,IGHV3-48 (Human),IGHJ4 (Human),IGKV1-12 (Human),IGKJ4 (Human),ARSDSGGNSRY,QQANSFPPT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H1H15208P_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 7, 2020","May 7, 2020",N/A,Complete
H1H15203P,Ab,MERS-CoV,,,,S; Possibly RBD,Recombinant Human,EVQLVESGGDLVQPGGSLRVSCAASGFTFSNYDMYWVRQAPGKGLEWVSVISGIGATTYYADSVKGRFTISRDNSKNTVFLQMNSLRAEDTAVYYCVKGGPIVATDYWGQGTLVTVSS,DIQMTQSPSTLSASVGDRVTITCRASQSISSWLAWHQQKPGKAPKLLIYKASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNSYSWTFGQGTKVEIK,IGHV3-23 (Human),IGHJ4 (Human),IGKV1-5 (Human),IGKJ1 (Human),VKGGPIVATDY,QQYNSYSWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H1H15203P_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 7, 2020","May 7, 2020",N/A,Complete
H1H15211P,Ab,MERS-CoV,,MERS-CoV,,S; Possibly RBD,Recombinant Human,EVQLVESGGGLVQPGGSLRLSCVVSGFTFSNYDMSWVRQAPGRGLEWVSAIRGSGFNTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDGSIVSMDYWGQGTLVTVSS,DIQMTQSPSALSASVGDRVTITCRASQSISSWLAWYQQKPGKAPKLLIYKASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNSYSWTFGQGTKVEIK,IGHV3-23 (Human),IGHJ4 (Human),IGKV1-5 (Human),IGKJ1 (Human),AKDGSIVSMDY,QQYNSYSWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/H1H15211P_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 7, 2020","May 7, 2020",N/A,Complete
Ab41,Ab,MERS-CoV,,MERS-CoV,,S; Unk,B-cells; MERS-CoV Human Patient,EVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGRIIPILGIANYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCARDSYGDYTGSGYYYGMDVWGQGTTVTVSS,DIVMTQSPLSLPVTPGEPASISCRSSQSLLHSNGYNYLDWYLQKPGQSPQLLIYLGSNRASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQALQTPLTFGGGTKVEIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV2-28 (Human),IGKJ4 (Human),ARDSYGDYTGSGYYYGMDV,MQALQTPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Ab41_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 6, 2020",Added Homology Models,Complete
MERS-97,Ab,MERS-CoV,,,MERS-CoV,S; RBD,"Yeast Display Library (scFv, human)",QVTLKESGPTLVKPTQTLTLTCTFSGFSLSISGVGVGWIRQPPGRALEWLALIYWDDDKHYNPSLNSRLTITKDTSKNQVVLTMTNMDPVDTATYYCIGFGEGVGALDIWGQGTMVTVSS,ND,IGHV2-5 (Human),IGHJ3 (Human),ND,ND,IGFGEGVGALDI,ND,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete. Homology modelling not possible as neither nanobody nor antibody.
MERS-93,Ab,MERS-CoV,,,MERS-CoV,S; RBD,"Yeast Display Library (scFv, human)",QVTLKESGPTLVKPTQTLTLTCTVSGFSLSTSGVGVAWIRQPPGKALEVALINWDDEKRYGPSLKTRVTITKDTSKNQVVLTMTNMDPVDTATYFCAHRRRGGDYYQSNGYYWGPKNDAFDVWGQGTMVTVSS,ETTLTQSPAFMSATPGDKVNISCKASQDIDDDMNWYQQKPGEAAIFIIQEATTLVPGISPRFSGSGYGTDFTLTINNIESEDAAYYFCLQHDNFPLFTFGPGTKVDIK,IGHV2-5 (Human),IGHJ3 (Human),IGKV5-2 (Human),IGKJ3 (Human),AHRRRGGDYYQSNGYYWGPKNDAFDV,LQHDNFPL,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/MERS_93_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
MERS-18,Ab,MERS-CoV,,,MERS-CoV,S; RBD,"Yeast Display Library (scFv, human)",QVTLKESGPTLVKPTQTLTLTCTFSGFSLNTNGVGVGWFRQPPGKALECLALIYWDDDKRYSPSLKSRLTITKDTSKNQVVLTMTNMDPVDTATYYCAHIIYRSGRDDSWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATPSCRASQSFSSNHLAWYQQKPGQAPRLLVYGATSRATGTPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGRSRIFTFGPGTKVDIK,IGHV2-5 (Human),IGHJ5 (Human),IGKV3-20 (Human),IGKJ3 (Human),AHIIYRSGRDDS,QQYGRSRIFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/MERS_18_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
Ab38,Ab,MERS-CoV,,MERS-CoV,,S; Unk,B-cells; MERS-CoV Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGRIIPILGIANYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCARATRSDYYGSGSYSAFDIWGQGTMVTVSS,SYELTQPASVSGSPGQSITISCTGSSTDVGSSIYVSWYQQHPGKAPQLILYDVTNRPSGVSTRFSGSKSGNTASLTISGLRAEDEADYYCNSYTTSNTLVFGGGTKLTVL,IGHV1-69 (Human),IGHJ3 (Human),IGLV2-14 (Human),IGLJ3 (Human),ARATRSDYYGSGSYSAFDI,NSYTTSNTLV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Ab38_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 6, 2020",Added Homology Models,Complete
90-F2,Ab,MERS-CoV,,MERS-CoV,,S; RBD,Human,QVQLVQSGAEVKKPGASVKVSCKASGYTFTTYYMHWVRQAPGQGLEWMGIINPSGGSTSYAQKFQGRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARGAVVVILDYWGQGTLVTVSS,DIQMTQSPSTLSASVGDRVTITCRASQTISTWLAWYQQKPGKAPKLLIYKASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNSYSYTFGQGTKLEIK,IGHV1-46 (Human),IGHJ4 (Human),IGKV1-5 (Human),IGKJ2 (Human),ARGAVVVILDY,QQYNSYSYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/90F2_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 22, 2020",Added publication,Complete
VHH-91,Nb,MERS-CoV,,MERS-CoV,,S; RBD,Bone Marrow; MERS-CoV Infected Dromedary Camels,EVQLQESGGGSVQAGGSLRLSCAASGYTSSNYCVGWFRQGPGKEREGVATINIGRGVETYAHSAKDRFTISQDAAKNTVYLIIHSLKPEDTAIYYCAARTPIWDGSCPRDASGMRDWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AARTPIWDGSCPRDASGMRD,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/VHH_91_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
VHH-59,Nb,MERS-CoV,,MERS-CoV,,S; RBD,Bone Marrow; MERS-CoV Infected Dromedary Camels,EVQLQESGGGSVQAGGSLRLSCAASLSPNSSYCVGWFRQVPGKAREGVAGINSGGDWTYYAASVKGRFTISRDNDKNTVYLRMNSLKPEDTAIYYCAADPVITGDFCDRPVVGYAHWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AADPVITGDFCDRPVVGYAH,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/VHH_59_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
VHH-62,Nb,MERS-CoV,,MERS-CoV,,S; RBD,Bone Marrow; MERS-CoV Infected Dromedary Camels,EVQLQESGGGSVQAGGSLRLSCAASGITTYSTYFMAWFRQAPGKEREGLAAIDSRGSWTYYARSVKGRFTVSQDNAKNTMYLLMNSLKPEDTAIYYCAAAPGATHPPSISDYNYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAAPGATHPPSISDYNY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/VHH_62_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
90-C4,Ab,MERS-CoV,,,MERS-CoV,S; S1 non-RBD,Human,QVQLQESGPGLVKPSGTLSLTCAVSGGSINSSNWWSWVRQPPGKGLEWIGEIYYSGSTNYNPSLKSRVTTSVDNSKNQFSLKLSSVTAADTAVYYCATFDSGGYNPNWFDPWGQGTLVTVSS,QSALTQPPSVSGAPGQRVTISCTGSSSSIGAGYDVHWYQQLPGTAPKLLIYGNSNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSSLSGYVFGTGTKVTVL,IGHV4-4 (Human),IGHJ5 (Human),IGLV1-40 (Human),IGLJ1 (Human),ATFDSGGYNPNWFDP,QSYDSSLSGYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/90C4_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 22, 2020",Added publication,Complete
90-E5,Ab,MERS-CoV,,MERS-CoV,,S; RBD,Human,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYTINWVRQAPGQGLEWMGGIIPIFGTANYAQKFQGRVTITADASTSTAYMELSSLRSEDTAVYYCARVLLRSSSWFSSNWFDPWGQGTLVTVSS,QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWYQQLPGTAPKVLIYGNSNRPSGVPDRFSGSKSDTSASLAITGLQAEDEADYYCQSYDSSLSVVFGGGTKLTVL,IGHV1-69 (Human),IGHJ5 (Human),IGLV1-40 (Human),IGLJ3 (Human),ARVLLRSSSWFSSNWFDP,QSYDSSLSVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/90E5_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 22, 2020",Added publication,Complete
77-A5,Ab,MERS-CoV,,MERS-CoV,,S; RBD,Human,QVQLVQSGAEVKKPGSSVKVSCKASGGTFRSHAISWVRQAPGQGLEWMGGIIPFASANYAQKFQGRVTITADESTSTAYMDLSSLRSDDTAVYYCAKNVSPKSYSGRYSISYFYGVDVWGQGTTVTVSS,QSALTQPPSASGTPGQRVTISCSGSSSNIGSNTVNWYQQLPGTAPKLLIYSNNQRPSGVPDRFSGSKSGTSASLAISGLQSEDEADYYCAAWDDSLSGHYVFGTGTKVTVL,IGHV1-69 (Human),IGHJ6 (Human),IGLV1-44 (Human),IGLJ1 (Human),AKNVSPKSYSGRYSISYFYGVDV,AAWDDSLSGHYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/77A5_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 22, 2020",Added publication,Complete
CDC-C5,Ab,MERS-CoV,,MERS-CoV,,S; RBD,B-cells; MERS-CoV Human Patient,QLQLQESGPGLVKPSETLSLTCTVSGGSISSSSYYWGWIRQPPGKGLEWIGSIYYSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCASLLRPLIYCSGGSCTDYWGQGTLVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWCQQHPGKAPKLMIYEVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSNITLVFGTGTKVTVL,IGHV4-39 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ1 (Human),ASLLRPLIYCSGGSCTDY,SSYTSNITLV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CDC_C5_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
1E9,Ab,MERS-CoV,,MERS-CoV,,S; RBD,"Phage Display Library (Antibody, human, non-immune)",QVQLVQSGGGVVQPGRSLRLSCVASEFTFNTYGMHWVRQAPGKGLEWVAAISYDGTKKFYADSLKGRFTISRDNSKNTLYLQMNSLRSEDTAVYYCARSGDSDAFDIWGQGTMVTVSS,SYELTQPPSVSVSPGQTATITCSGDELGDKFAFWYQQKPGQSPVLVIYQDSKRPSGIPERFSGSNSGNTATLTISGTQALDEADYYCQAWDSNSYVFGTGTKVTVL,IGHV3-30 (Human),IGHJ3 (Human),IGLV3-1 (Human),IGLJ1 (Human),ARSGDSDAFDI,QAWDSNSYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/1E9_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
90-B2,Ab,MERS-CoV,,,MERS-CoV,S; S1 non-RBD,Human,QVQLQESGPGLVKPSETLSLTCTVSGGSISSSSYYWGWIRQPPGKGLEWIGSIYYSGNTYYNPSLKSRVTISVDTSKNHFSLRLSSVTAADTAVYFCARSLPHYDSTGYLLYWGQGTLVTVSS,EIVLTQSPATLSLSPGGRATLSCRASQSVSRYLAWYQQKPGRAPRLLIYDASNRAPGIPARFSGSGSGTDFTLISSLEPEDFAVYYCQQRSNWPQTTFGPGTKVDIK,IGHV4-39 (Human),IGHJ4 (Human),IGKV3-11 (Human),IGKJ3 (Human),ARSLPHYDSTGYLLY,QQRSNWPQTT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/90B2_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 22, 2020",Updated neutralisation data in light of journal publication,Complete
LCA60,Ab,MERS-CoV,,MERS-CoV,,S; RBD,B-cells; MERS-CoV Human Patient,EVQLLESGGGLVKPGGSLRLSCEASGLTFSNVWMSWVRQAPGKGLEWVGRIKRKSEGATTDYGAPVKGRFTLSRDDSKNTVYLQMNSLKIDDTAVYYCSTLTRGGDVWSSSYYFDYWGQGALVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGTYDLVSWYQQHPGKSPKLMIYADIKRPSGVSHRFSGSKSGNTASLTISGLQSADEADYYCCLYAGSSTSVIFGGGTKVT,IGHV3-15 (Human),IGHJ4 (Human),IGLV2-23 (Human),IGLJ3 (Human),STLTRGGDVWSSSYYFDY,CLYAGSSTSVI,https://www.rcsb.org/structure/6NB3; https://www.rcsb.org/structure/6NB4; https://www.rcsb.org/structure/6NB5,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
REGN-3051,Ab,MERS-CoV,,MERS-CoV,,S; RBD,Transgenic Mice (VelocImmune),EVQLVESGGGLVQPGGSLRLSCVVSGFTFSNYDMSWVRQAPGRGLEWVSAIRGSGFNTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDGSIVSMDYWGQGTLVTVSS,DIQMTQSPSALSASVGDRVTITCRASQSISSWLAWYQQKPGKAPKLLIYKASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNSYSWTFGQGTKVEIK,IGHV3-23 (Human),IGHJ4 (Human),IGKV1-5 (Human),IGKJ1 (Human),AKDGSIVSMDY,QQYNSYSWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/REGN3051_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 26, 2020",Added sequences with Regeneron's permission.,Complete
VHH-21,Nb,MERS-CoV,,MERS-CoV,,S; RBD,Bone Marrow; MERS-CoV Infected Dromedary Camels,EVQLQESGGGSVQTGGSLRLSCAASGSVYCMGWIRQAPGKEREGVARINSDGSVTYYGSSAKGRFSISRDSAKNTVTLLMNSLKPEDTAIYTCTAGTRKCMDLGSWIDFDYRGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,TAGTRKCMDLGSWIDFDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/VHH_21_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
VHH-55,Nb,MERS-CoV,,MERS-CoV,,S; RBD,Immunised Llama,QVQLQESGGGSVQAGGSLRLSCVASGSIFSINAMDWYRQAPGKQRELVAGITSGGSTNYGDFVKGRFTISRDNAKNTVYLQMDSLKPEDTAVYYCAAEVGGWGPPRPDYWGHGTQVTVSS,N/A,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAEVGGWGPPRPDY,N/A,https://www.rcsb.org/structure/6WAR,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","Jun 2, 2020",Updated publication.,Complete
3D8,Ab,Viral Nucleic Acid Chains,,,,,Immunised Mouse,EVQLQQSGPELVKPGASVKMSCKASGYTFTSYVMHWVNQNPGQGLEWSIGYINPYNDGTKYNEKFKGKATLTSDKSSSTAYMELSSLTSEDSAVYYCARGAYKRGYAMDYWGQGTSVTVSS,DIVMSQSPSSLAVSAGEKVTMSCKSSQSLFNSRTRKNYLAWYQQKPGQSPKLLIYWASTRESGVPDRFTGSGPGTDFTLTISSVQAEDLAVYYCKQSYYHMYTFGSGTKLEIK,IGHV1-14 (Mouse),IGHJ4 (Mouse),IGKV8-21 (Mouse),IGKJ2 (Mouse),ARGAYKRGYAMDY,KQSYYHMYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/3D8_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","Nov 26, 2020",26th Nov: Added publication relating to SARS-CoV2,Complete
VHH-84,Nb,MERS-CoV,,MERS-CoV,,S; RBD,Bone Marrow; MERS-CoV Infected Dromedary Camels,EVQLQESGGGSVQAGGSLRLSCAASGSVYCMGWIRQAPGKEREGVARINSDGSVTYYARSAKGRFSISRDSAKNTVTLLMNSLKPEDTAIYTCTADTRKCIDLGSWIDSDYRGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,TADTRKCIDLGSWIDSDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/VHH_84_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
MERS-84,Ab,MERS-CoV,,,MERS-CoV,S; RBD,"Yeast Display Library (scFv, human)",QVQLVESEGGVVQPGRSLRLSCAASGLTFSNYGMHWVRQAPGKGLEWVALISQDGSNKYYADSVKGRFTISRDNSKNTLYLEMNNLRTEDTAVYYCVKDDGYSYGYKYYYGMDVWGQGTTVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSRYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPSFGPGTKVDIK,IGHV3-30 (Human),IGHJ6 (Human),IGKV3-20 (Human),IGKJ3 (Human),VKDDGYSYGYKYYYGMDV,QQYGSSPS,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/MERS_84_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
90-F1,Ab,MERS-CoV,,MERS-CoV,,S; RBD,Human,QVQLVQSGAEVKRPGSSVKVSCKTSGGTFNNNAINWVRQAPGQGLEWMGGIIPFFGIAKYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYCARDLPRESSYGSGSYYTHYYAMDVWGQGTTVTVSS,EIVLTQSPATLSLSPGERATLSCGASQSVSSSYLAWYQQKPGLAPRLLIYDASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPLTFGGGTKVEIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV3-20 (Human),IGKJ4 (Human),ARDLPRESSYGSGSYYTHYYAMDV,QQYGSSPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/90F1_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 22, 2020",Added publication,Complete
CDC-A2,Ab,MERS-CoV,,MERS-CoV,,S; S1 non-RBD,B-cells; MERS-CoV Human Patient,QVQLVESGGGLVKPGGSLRLSCAASGFTFSDYYMSWIRQAPGKGLEWVSYISSSGSTIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARVGLGSGWYDWFDPWGQGTLVTVSS,QSALTQPPSVSGAPGQRVTISCTGSSSNIGASYDVHWYQHLPGTAPKLLIYGNTNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSSLSGWFSGGTKLTVL,IGHV3-11 (Human),IGHJ5 (Human),IGLV1-40 (Human),IGLJ3 (Human),ARVGLGSGWYDW,QSYDSSLSGW,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CDC_A2_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,"Email sent, awaiting author reply."
90-E6,Ab,MERS-CoV,,,MERS-CoV,S; RBD,Human,EVQLVESGGGLVQPGRSLRLSCAASGFTFDDHAMHWVRQAPGKGLEWVSGFSWNSGSIGYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTALYYCAKDRRSDYYFYGMDVWGQGTTVTVSS,QSVLTQPPSVSAAPGQKVTISCGSRSNIGNNYVSWYQQLPGTAPKLLIYDNNKRPSGIPDRFSGSKSGTSATLGITGLQTGDEADYYCGTWDSSLNAGVFGGGTKLTVL,IGHV3-9 (Human),IGHJ6 (Human),IGLV1-51 (Human),IGLJ3 (Human),AKDRRSDYYFYGMDV,GTWDSSLNAGV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/90E6_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 22, 2020",Updated neutralisation data in light of journal publication,Complete
CDC-A10,Ab,MERS-CoV,,MERS-CoV,,S; S1 non-RBD,B-cells; MERS-CoV Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSTYALSWVRQAPGQGLEWMGGIIPIFGTANYAQKFQGRVTITADESTSTAYMELNSLRSEDTAVYYCARGSRSSSSAEYFQHWGQGTLVTVSS,QSALTQPRSVSGSPGQSVTISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSKRPSGVPDRFSGSKSGNTASLTISGLQAEDEADYYCCSYAGSYTLEWFGGGTKLTVL,IGHV1-69 (Human),IGHJ1 (Human),IGLV2-11 (Human),IGLJ3 (Human),ARGSRSSSSAEYFQH,CSYAGSYTLEW,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/CDC_A10_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
FIB-B2,Ab,MERS-CoV,,MERS-CoV,,S; Unk,Immunised Rhesus Macaques,QVQLQESGPGLVKPSETLSLTCAVSGGSISSNYWYWIRQSPVKGLEWIGYIYGGSGGTEYNPSLKSRVTISTDTSKNQFFLKLSSVTAADTAVYYCARSFYSWNGESWGQGVWTVSS,DIQMSQTPSSLSASVGDRVTITCRASQGINDYLNWYQQKPGKAPKLLIYYGNSLASGVPSRFSGSGSGTDFSLTISSLQPEDFATYYCQQGDSFPLTFGGGTKVDIK,IGHV4-2 (Rhesus),IGHJ5-2 (Rhesus),IGKV1S26 (Rhesus),IGKJ1 (Rhesus),ARSFYSWNGES,QQGDSFPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/FIBB2_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
FIB-H1,Ab,MERS-CoV,,MERS-CoV,,S; S1 non-RBD,Immunised Rhesus Macaques,EVQLVQSGAEVKKPGASVKVSCKASGHIFTSYVINWLQAEPGQGFEWMGGIHPGNGGRDYAQKFQGRVTITADMSTSTVYMELRSLRSEDMAVYYCAASSGSYGVSSLDVWGRGVLVTVSS,QSALTQPPSLSASPGASARLPCTLSSDLSVGSKNMYWYQQKPGSAPRLFLYYYSDSDKQLGPGVPNRVSGSKETSSNTAFLLISGLQPEDEADYYCQVYDSSANWVFGGGTRLTVL,IGHV1-69 (Human),IGHJ2 (Human),IGLV11-1 (Rhesus),IGLJ2 (Rhesus),AASSGSYGVSSLDV,QVYDSSANWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/FIBH1_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,"Email sent, awaiting author reply."
GPI-scFv,Ab,Viral Envelopes,,,,E,Unk,QVQLQQWGAGLLKPSETLSLTCAVTGDSFGGHHWSWIRQPPGKGLEWIGEINFLGNTNTNPSLKSRVAISKDTSKNQFSLTLNSATAADTAVYFCARRETMETASRKRAFDIWGQGTMETVTV,LMETTQSPPTLSASVGDRVTITCRASQSLSGWVAWYQQKPGKAPKLLIYKASTLESGVPSRFSGSGSGTVFALTISSLQPDDSATYYCQQHSAFSSTFGQGTKLEIK,IGHV4-34 (Human),IGHJ3 (Mouse),IGKV1-5 (Human),IGKJ2 (Mouse),ARRETMETASRKRAFDI,QQHSAFSST,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/GPI_scFv_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
VHH-174,Nb,MERS-CoV,,MERS-CoV,,S; RBD,Bone Marrow; MERS-CoV Infected Dromedary Camels,EVQLQESGGGSVQAGGSLRLSCVASGVIYNNTCIGWFRQAPGKEREGVAGINSGGGNTYNAASVEGRFTISQDNVKNTVYLLMNSLKPEDTAIYYCATNWRRGVRCTDPSWRDGYNYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,ATNWRRGVRCTDPSWRDGYNY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/VHH_174_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
1AF10,Ab,TGEV,,TGEV,,S; Unk,Immunised Mouse,QVQLQQSGPELVKPGASVKISCKASGYAFSSSWMNWVKQRPGQGLEWIGRIYPGDGETNYSEKFKGKATLTADKSSSTAYMHLSSLTSVDSAVYFCARGGYRYDPYYAMDYWGQGTSVTVSS,DILLTQSPAILSVSPGERVSLSCRASQSIGTSIHWYQQRTNGSPRPLIKYASESISGIPSRFSGSGSGTDFTLNINSVESEDIADYFCQQTDSWPTTFGAGTKLELK,IGHV1-82 (Mouse),IGHJ4 (Mouse),IGKV5-48 (Mouse),IGKJ5 (Mouse),ARGGYRYDPYYAMDY,QQTDSWPTT,https://www.rcsb.org/structure/4F2M,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
VHH-203,Nb,MERS-CoV,,MERS-CoV,,S; RBD,Bone Marrow; MERS-CoV Infected Dromedary Camels,ELQLQESGGGSVQAGGSLRLSCAVSVYPNSSYCVGWFRQVPGKAREGVAAINSGGDWTYYAASVRGRFTISRDNAKNTVYLRMNSLKPEDTAIYYCAAHPVGSGVFCDRPVVEYNHWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAHPVGSGVFCDRPVVEYNH,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/VHH_203_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
VHH-101,Nb,MERS-CoV,,MERS-CoV (Strong),,S; RBD,Bone Marrow; MERS-CoV Infected Dromedary Camels,EVQLQESGGGSVQAGGSLRLSCAVSVYPNSSYCVGWFRQVPGKAREGVAAINSGGDWTYYAASVRGRFTISRDNAKNTVYLRMNSLKPEDTAIYYCAAHPVGSGVFCDRPVVEYNHWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAHPVGSGVFCDRPVVEYNH,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/VHH_101_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete. Alternative name: HCAb-101
VHH-50,Nb,MERS-CoV,,MERS-CoV,,S; RBD,Bone Marrow; MERS-CoV Infected Dromedary Camels,EVQLQESGGGSVQAGGSLRLSCAASGSVYCMGWIRQAPGKEREGVARINSNGSVTYYGSSAKGRFSISRDSAKNTVTLLMNSLKPEDTAIYTCAANTRKCMDLSSWLDVDYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AANTRKCMDLSSWLDVDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/VHH_50_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
VHH-28,Nb,MERS-CoV,,MERS-CoV,,S; RBD,Bone Marrow; MERS-CoV Infected Dromedary Camels,EVQLQESGGGSVQAGGSLRLSCAVSGYTYTSYCMTWFRQAPGKEREGVAAINSDGSVTYYGSSAKGRFSISRDSAKNTVTLLMNSLKPEDTAIYTCTAATRKCMDLGSWIDFDYRGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,TAATRKCMDLGSWIDFDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/VHH_28_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
VHH-38,Nb,MERS-CoV,,MERS-CoV,,S; RBD,Bone Marrow; MERS-CoV Infected Dromedary Camels,EVQLQESGGGSVQAGGSLRLSCAASGSVGCMGWIRQAPGKEREGVARINSDGSITYYSSSAKGRFSISRDSAKNTVTLLMNSLKPEDTAIYTCTADTRKCMDLGSWIDSDYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,TADTRKCMDLGSWIDSDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/VHH_38_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
VHH-26,Nb,MERS-CoV,,MERS-CoV,,S; RBD,Bone Marrow; MERS-CoV Infected Dromedary Camels,EVQLQESGGGSVQAGGSLRLSCAASGDTYRRACMGWFRQAPGKEREEIASIYTNGGNTQIADSVKGRFTISRDNAKNTVYLQMNSLKPEDSAMYYCVADVQVRGYCTTKNLYEYESWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,VADVQVRGYCTTKNLYEYES,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/VHH_26_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
VHH-44,Nb,MERS-CoV,,MERS-CoV,,S; RBD,Bone Marrow; MERS-CoV Infected Dromedary Camels,EVQLQESGGGSVQAGGSLRLSCAASGYTSEYTYDKYYNYMGWFRQAPGKERETVATINSRDITYYGDSVKGRFTISQDIAKNTVYLQMNSLKPEDTAMYYCATGRLGSSWNSWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ6 (Alpaca),N/A,N/A,ATGRLGSSWNS,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/VHH_44_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
VHH-18,Nb,MERS-CoV,,MERS-CoV,,S; RBD,Bone Marrow; MERS-CoV Infected Dromedary Camels,EVQLQESGGGSVQAGGSLRLSCEASGYIFSMYCMGWFRQAPGKEREGVALFNRSTGVEYYRASVKGRFTISHDNAKNTVYLQMNSLKPEDTAVYYCAAGPSCGGWYPGLYNYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAGPSCGGWYPGLYNY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/VHH_18_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
VHH-12,Nb,MERS-CoV,,MERS-CoV,,S; RBD,Bone Marrow; MERS-CoV Infected Dromedary Camels,EVQLQESGGGSVQVGGSLRLSCAASGFTSSRYCVGWFRQAPGKEREGVATINSGGDWTHYANSVKGRFTISQDIAKNTVDLLMNSLKPEDTAIYYCAAATFGCLLVTGPADFEYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ5 (Alpaca),N/A,N/A,AAATFGCLLVTGPADFEY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/VHH_12_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
VHH-07,Nb,MERS-CoV,,MERS-CoV,,S; RBD,Bone Marrow; MERS-CoV Infected Dromedary Camels,EVQLQESGGGSVQAGGSLRLSCAASGYTASSYCMGWFRQAPGKERVGVAAINSGGDWTYYAGSVKGRFTISQDNAKNTVALLMSSLKPEDTAVYYCAAAYAIECTQLTGPADFGYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ6 (Alpaca),N/A,N/A,AAAYAIECTQLTGPADFGY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/VHH_07_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
VHH-08,Nb,MERS-CoV,,MERS-CoV,,S; RBD,Bone Marrow; MERS-CoV Infected Dromedary Camels,EVQLQESGGGSVQAGGSLRLSCAASGSVYCMGWIRQAPGKEREGVARINSNGSVTYYGSSAKGRFSISRDSAKNTVTLLMNSLKPEDTAIYTCAANTRKCMDLSSWIDVDYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AANTRKCMDLSSWIDVDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/VHH_08_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
VHH-58,Nb,MERS-CoV,,MERS-CoV,,S; RBD,Bone Marrow; MERS-CoV Infected Dromedary Camels,EVQLQESGGGSVQAGGSLRLSCAASGITTYTTYFMAWFRQAPGKEREGLAAINSRGDWTYYARSVKDRFTISQDNAKNTMYLLMNSLKPEDAAIYYCAAAPGAIYPPSISEYNIWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAAPGAIYPPSISEYNI,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/VHH_58_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
VHH-20,Nb,MERS-CoV,,MERS-CoV,,S; RBD,Bone Marrow; MERS-CoV Infected Dromedary Camels,EVQLQESGGGSVQTGGSLRLSCAASGSVYCMGWIRQAPGKEREGVARINSDGSVTYYGSSAKGRFSISRDSAKNTVTLLMNSLKPEDTAIYTCTANTRKCMDLGSWIDFDYRGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,TANTRKCMDLGSWIDFDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/VHH_20_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
REGN-3048,Ab,MERS-CoV,,MERS-CoV,,S; RBD,Transgenic Mice (VelocImmune),EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSAISGRGGNTYYADSVKGRFTISRDNSKNTLFLQMNTLRAEDTAVYYCAKDRGFGFFDIWGRGTLATVSS,DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKFLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPFTFGPGTKINIK,IGHV3-23 (Human),IGHJ2 (Human),IGKV1-33 (Human),IGKJ3 (Human),AKDRGFGFFDI,QQYDNLPFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/REGN3048_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 26, 2020",Added sequences with Regeneron's permission.,Complete
VHH-01,Nb,MERS-CoV,,MERS-CoV (Strong),,S; RBD,Bone Marrow; MERS-CoV Infected Dromedary Camels,EVQLQESGGGSVQTGGSLRLSCAASGSVYCMGWIRQAPGKEREGVARINSDGSVTYYARSAKGRFSISRDSAKNTVTLLMNSLKPEDTAIYTCTADTRKCMDLGSWIDSDYRGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,TADTRKCMDLGSWIDSDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/VHH_01_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete. Alternative name: HCAb-1
Ab39-2,Ab,MERS-CoV,,MERS-CoV,,S; Unk,B-cells; MERS-CoV Human Patient,QMQLVQSGAEVKKPGASVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGRIIPILGIANYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCARRSGDYYGSGSYSAFDIWGQGTMVTVSS,QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWYQQLPGTAPKLLIYGNSNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCGTWDSSLSAYVVFGGGTKLTVL,IGHV1-69 (Human),IGHJ3 (Human),IGLV1-40 (Human),IGLJ3 (Human),ARRSGDYYGSGSYSAFDI,GTWDSSLSAYVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Ab39-2_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 6, 2020",Added Homology Models,Complete
VHH-02,Nb,MERS-CoV,,MERS-CoV,,S; RBD,Bone Marrow; MERS-CoV Infected Dromedary Camels,EVQLQESGGGSVQAGGSLRLSCAASGYTYSSYCMGWFRQAPGKGPEGVAAISSDGGSTYYAYSAKGRFTISQDNAKNTVYLQMNSLKPEDTAIYYCAARSPCGNLFDVGVVNYTYTGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AARSPCGNLFDVGVVNYTY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/VHH_02_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
Ab45,Ab,MERS-CoV,,MERS-CoV,,S; Unk,B-cells; MERS-CoV Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGRIIPILGIANYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCARRSGDYYGSGSYSAFDIWGQGTMVTVSS,QYALTQPASVSGSPGQSITISCTGSSTDVGSSIYVSWYQQHPGKAPQLILYDVTNRPSGVSTRFSGSKSGNTASLTISGLRAEDEADYYCNSYTTSNTLVFGGGTKLTVL,IGHV1-69 (Human),IGHJ3 (Human),IGLV1-17 (Human),IGLJ3 (Human),ARRSGDYYGSGSYSAFDI,NSYTTSNTLV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Ab45_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 6, 2020",Added Homology Models,Complete
VHH-04,Nb,MERS-CoV,,MERS-CoV (Strong),,S; RBD,Bone Marrow; MERS-CoV Infected Dromedary Camels,EVQLEQSGGGSVQAGGSLRLSCEASGYISSMYCMGWGRQAPGKEREGVALFNRSTGVEYYRASVKGRFTISHDNAKNTVYLQMNSLKLEDTAVYYCAAGPTCGGWYPGLYNYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AAGPTCGGWYPGLYNY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/VHH_04_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete. Alternative name: HCAb-4
Ab40,Ab,MERS-CoV,,MERS-CoV,,S; Unk,B-cells; MERS-CoV Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGRIIPILGIANYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCARDSYGDYTGSGYYYGMDVWGQGTTVTVSS,DVVMTQSPLSLPVTPGEPASISCRSSQSLLHSNGYNYLDWYLQKPGQSPQLLIYLGSNRASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQALQTPLTFGGGTKVEIK,IGHV1-69 (Human),IGHJ6 (Human),IGKV2-28 (Human),IGKJ4 (Human),ARDSYGDYTGSGYYYGMDV,MQALQTPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Ab40_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 6, 2020",Added Homology Models,Complete
Ab39-1,Ab,MERS-CoV,,MERS-CoV,,S; Unk,B-cells; MERS-CoV Human Patient,QMQLVQSGAEVKKPGASVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGRIIPILGIANYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCARRSGDYYGSGSYSAFDIWGQGTMVTVSS,NFMLTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWYQQLPGTAPKLLIYGNSNRPSGVPDRFSGSKSGTSASLAISGLRSEDEADYYCAAWDDSLSGYVFGTGTKVTVL,IGHV1-69 (Human),IGHJ3 (Human),IGLV1-40 (Human),IGLJ1 (Human),ARRSGDYYGSGSYSAFDI,AAWDDSLSGYV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Ab39-1_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 6, 2020",Added Homology Models,Complete
Ab33-2,Ab,MERS-CoV,,MERS-CoV,,S; RBD,B-cells; MERS-CoV Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGRIIPILGIANYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCARRSGDYYGSGSYSAFDIWGQGTMVTVSS,QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWYQQLPGTAPKLLIYGNSNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCGTWDSSLSAYVVFGGGTKLTVL,IGHV1-69 (Human),IGHJ3 (Human),IGLV1-40 (Human),IGLJ3 (Human),ARRSGDYYGSGSYSAFDI,GTWDSSLSAYVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Ab33-2_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 6, 2020",Added Homology Models,Complete. Alternative name: MERS-GD33
Ab42,Ab,MERS-CoV,,MERS-CoV,,S; Unk,B-cells; MERS-CoV Human Patient,EVRLVQSGAEVEKAGASVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGRIIPILGIANYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCARRSGDYYGSGSYSAFDIWGQGTMVTVSS,QSVLTQPPSVSAAPGQKVTISCSGSRSNIGNNYVSWYQRPPGTAPKLLIYDNNKRPSGIPDRFSGSKSGTSATLGITGLQTGDEADYYCGTWDNSLSAVVNGGGTKNTVV,IGHV1-69 (Human),IGHJ3 (Human),IGLV1-51 (Human),IGLJ3 (Human),ARRSGDYYGSGSYSAFDI,GTWDNSLSAVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Ab42_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 6, 2020",Added Homology Models,Complete
Ab33-1,Ab,MERS-CoV,,MERS-CoV,,S; Unk,B-cells; MERS-CoV Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGRIIPILGIANYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCARRSGDYYGSGSYSAFDIWGQGTMVTVSS,QSVLTQPPSVSGAPGQRVTPSCTGSSSNIGAGYDVHWYQQLPGTAPKLLIYGNSNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSSLSGLMFGGGTKLTVL,IGHV1-69 (Human),IGHJ3 (Human),IGLV1-40 (Human),IGLJ3 (Human),ARRSGDYYGSGSYSAFDI,QSYDSSLSGLM,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Ab33-1_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 6, 2020",Added Homology Models,Complete
Ab27,Ab,MERS-CoV,,MERS-CoV,,S; RBD,B-cells; MERS-CoV Human Patient,EVQLLESGAEVKKPGSSVKVSCRASGGTFSSYAISWVRQAPGQGLEWMGRIIPILGIANYAQKFQGRVTITADKATSTAYMELSSLRSEDTAVYYCATRSGDYYGSGSYSAFDIWGQGTMVTVSS,QSVLTQPPSVSGAPGQRVTPSCTGSSSNIGAGYDVHWYQQLPGTAPKLLIYGNSNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSSLSGLMFGGGTKLTVL,IGHV1-69 (Human),IGHJ3 (Human),IGLV1-40 (Human),IGLJ3 (Human),ATRSGDYYGSGSYSAFDI,QSYDSSLSGLM,"ND, Despite structure in paper",Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Ab27_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 6, 2020",Added Homology Models,Complete. Alternative name: MERS-GD27
Ab8,Ab,MERS-CoV,,MERS-CoV,,S; Unk,B-cells; MERS-CoV Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGRIIPILGIANYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCATRSGDYYGSGSYSAFDIWGQGTMVTVSS,QSVLTQPPSVSGAPGQRVTPSCTGSSSNIGAGYDVHWYQQLPGTAPKLLIYGNSNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSSLSGLMFGGGTKLTVL,IGHV1-69 (Human),IGHJ3 (Human),IGLV1-40 (Human),IGLJ3 (Human),ATRSGDYYGSGSYSAFDI,QSYDSSLSGLM,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Ab8_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 6, 2020",Added Homology Models,Complete
90-B7,Ab,MERS-CoV,,,MERS-CoV,S; S1 non-RBD,Human,EVQLLESGGGLVKPGGSLRLSCAASGFTFGSYSMTWVRQAPGKGLEWVSSISSSSSYIYYADSVKGRFTISRDNAKNSLFLQMNSLRAEDTAVYYCARGNGYCSHNSCYKIGVWFDPWGQGTLVTVSS,QAVVTQPPSVSAAPGQKVTISCSGSSSNIGNNYVSWYQQLPGTAPKLLIYDNNKRPSGIPDRFSGSKSGTSATLGITGLQTGDEADYYCGTWDSSLSAFVFGTGTKVTVL,IGHV3-21 (Human),IGHJ5 (Human),IGLV1-51 (Human),IGLJ1 (Human),ARGNGYCSHNSCYKIGVWFDP,GTWDSSLSAFV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/90B7_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 22, 2020",Updated neutralisation data in light of journal publication,Complete
77-A6,Ab,MERS-CoV,,MERS-CoV,,S; RBD,Human,EVQLLESGGGLVQPGGSLRLSCADSGLTFSSYAMSWVRQAPGKGLEWVSAISVSGGSTYYSDSVKGRFTISRDNSKNTLSLQMNSLRAEDTAVYYCVKARSIVGPFDYWGQGTLVTVSS,QSALTQPPSVSAAPGQKVTISCSGSSSNIGNNYVSWYQHLPGTAPKLLIYDNMRPSGIPDRFSGSKSGTSATLGITGLQTGDEADYYCGTWDTSLSAVVFGGGTKLTVL,IGHV3-23 (Human),IGHJ4 (Human),IGLV1-51 (Human),IGLJ3 (Human),VKARSIVGPFDY,GTWDTSLSAVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/77A6_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 22, 2020",Added publication,Complete
Ab28,Ab,MERS-CoV,,MERS-CoV,,S; Unk,B-cells; MERS-CoV Human Patient,QVQLVQSGAEVEKAGASVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGRIIPILGIANYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCARRSGDYYGSGSYSAFDIWGQGTMVTVSS,QSVLTQPPSVSAAPGQKVTISCSGSRSNIGNNYVSWYQQLPGTAPKLLIYDNNKRPSGIPDRSSGSKSGTSAALGITGLQTGDEADYYCGTWDNSLSAVVFGGGTKLTVL,IGHV1-69 (Human),IGHJ3 (Human),IGLV1-51 (Human),IGLJ3 (Human),ARRSGDYYGSGSYSAFDI,GTWDNSLSAVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Ab28_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 6, 2020",Added Homology Models,Complete
90-A9,Ab,MERS-CoV,,,MERS-CoV,S; S1 non-RBD,Human,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSFPISWVRQAPGQGLEWMGGIIPIFGAANYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYCARNYEEIVVIPAIMNFGYWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVASSYLAWYQQKPGQAPRLLIYGTSSRATGIPDRFSGSGSGADFTLTISRLEPEDFAVYYCQQYGTSPLTFGGGTKVEIK,IGHV1-69 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ4 (Human),ARNYEEIVVIPAIMNFGY,QQYGTSPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/90A9_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 22, 2020",Added publication,Complete
90-A3,Ab,MERS-CoV,,,MERS-CoV,S; S1 non-RBD,Human,QVQLVQSGAEVKKPGASVKVSCMTSGYTFTSYGISWVRQAPGQGLEWMGWISAYNGNTNYAQKLQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARDRGAYWDCGGDCYLSAFDYWGQGTLVTVSS,QAVVTQPPSVSAAPGQKVTISCSGSSSNIGNNYVSWYQQLPGTAPKLLIYDNNKRPSGIPDRFSGSKSGSATLGITGLQTGDEADYYCGTWDSSLSAVVFGGGTKLTVL,IGHV1-18 (Human),IGHJ4 (Human),IGLV1-51 (Human),IGLJ3 (Human),ARDRGAYWDCGGDCYLSAFDY,GTWDSSLSAVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/90A3_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 22, 2020",Added publication,Complete
JC57-11,Ab,MERS-CoV,,MERS-CoV,,S; RBD,Immunised Rhesus Macaques,EVQLLESGPGVVRPSETLSLSCAVSGGSISDSYRWSWIRQPPGKGLEWVGYIFATGTTTNYNPSLKSRVTISKDTSKNQFSLKLSSVTAADTAVYYCAREPFKYCSGGVCYAHKDNSLDVWGQGVLVTVSS,EIVMTQSPATLSLSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIHSASSRATGIPDRFSGSGSGTEFSLTISSLEAEDVGVYHCYQHSSGYTFGPGTKLDIK,IGHV4-2 (Rhesus),IGHJ5-2 (Rhesus),IGKV3-9 (Rhesus),IGKJ1 (Rhesus),AREPFKYCSGGVCYAHKDNSLDV,YQHSSGYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/JC57_11_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
M14D3,Ab,MERS-CoV,,MERS-CoV,,S; RBD,"Phage Display Library (Antibody, human, non-immune)",EVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGIIPIFGIANYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCASSNYYGSGSYYPRSAFDIWGQGTTVTVSS,ETTLTQSPATLSVSPGERAILSCRASQSISNDLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTFTISRLESEDFAVYYCQQYGVSPLTFGGGTKVEIK,IGHV1-69 (Human),IGHJ3 (Human),IGKV3-20 (Human),IGKJ4 (Human),ASSNYYGSGSYYPRSAFDI,QQYGVSPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/M14D3_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
3B11,Ab,MERS-CoV,,MERS-CoV,,S; RBD,"Phage Display Library (Antibody, human, non-immune)",QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGIIPIFGTANYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCARVGYCSSTSCHIGAFDIWGQGTTVTVSS,ETTLTQSPGTLSLSPGERATLSCRASQSVSSSIAWYQQKPGQAPRLLMFDSSTRATGIPDRFSGSGSGTDFTLNISSLEPEDFAVYYCQQYSSSPYTFGQGTKLEIK,IGHV1-69 (Human),IGHJ3 (Human),IGKV3-11 (Human),IGKJ2 (Human),ARVGYCSSTSCHIGAFDI,QQYSSSPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/3B11_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
3A1,Ab,MERS-CoV,,MERS-CoV,,S; RBD,"Phage Display Library (Antibody, human, non-immune)",QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAVSWVRQAPGQLEWVGRIIPIFGKANYAQKFQGRVTITADKSTSTAYMELSSLRPEDTAVYYCARDQGISANFKDAFDIWGQGTTVTVSS,ETTLTQSPATLSVSPGERATLSCRASESVGSNLAWYQQKPGQAPSLLIYGASTRATGIPDRFSGSGSGTDFTLTISSLQSEDFAAYYCQQYNNWPLTFGPGTKVEIK,IGHV1-69 (Human),IGHJ3 (Human),IGKV3-15 (Human),IGKJ4 (Human),ARDQGISANFKDAFDI,QQYNNWPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/3A1_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
3C12,Ab,MERS-CoV,,MERS-CoV,,S; RBD,"Phage Display Library (Antibody, human, non-immune)",EVQLVQSGAEVKKPGASVKVSCKASGYTFNVYAINWVRQAPGQGLEWMGRIIPILGIANYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCARDYYGSGARGFDYWGQGTLVTVSS,QPGLTQPPSVSKGLRQTATLTCTGNSNNVGNQGAAWLQQHQGHPPKLLSYTNNNRPSGISERLSASRSGNTASLAITGLQPEDEADYYCASWDSSLSVWVIGGGTKLTVL,IGHV1-69 (Human),IGHJ4 (Human),IGLV10-54 (Human),IGKJ3 (Human),ARDYYGSGARGFDY,ASWDSSLSVWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/3C12_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
MERS-72,Ab,MERS-CoV,,,MERS-CoV,S; RBD,"Yeast Display Library (scFv, human)",QITLKESGPTLVKPTQTLTLTCSFSGFSLSSNGVGVGWIRQPPGKALEWLAMIYWDDDKYYNPSLNSRLTITKDTSKNQVVLTMTNMDPVDTATYYCIGFGEGVGALDIWGQGTMVTVSS,VLTQPPSVSVAPGETARITCGGNNIASKSEHWYQQKPGQAPVLVIYDDGDRPSGIPERFSGSNSGNTATLTITRVAAGDEADYYCHVWDSSSDLGALFGGGTQLTVL,IGHV2-5 (Human),IGHJ3 (Human),IGLV3-21 (Human),IGLJ7 (Human),IGFGEGVGALDI,HVWDSSSDLGAL,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/MERS_72_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
F11,Ab,MERS-CoV,,MERS-CoV,,S; RBD,Immunised Mouse,EVKLEESGGGLVKPGGSLKLSCAASGFTFSRYAMSWWQTPEKRLEWVATINNGGSYSYYPDSVKGRLTISRDNAKNTLYLQMSSLRSEDTALYYCARHYDYDGYYYTMDFWGQGTSVTVSS,DVIMTQIPLSLPVSLGDQASISCRSSQSIVHSNGNTYLEWYLQKPGQSPKPLIYKVSNRISGVPDRFSGSGSGTDFTLKISRVEAEDLGVYYCFQGSHVPYTFGGGTNLEIK,IGHV5-9-2 (Mouse),IGHJ4 (Mouse),IGKV1-117 (Mouse),IGKJ2 (Mouse),ARHYDYDGYYYTMDF,FQGSHVPYT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/F11_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,"Email sent, awaiting author reply."
1F8,Ab,MERS-CoV,,MERS-CoV,,S; RBD,"Phage Display Library (Antibody, human, non-immune)",EVQLVQSGAEVKEPGSSVKVSCKASGGTFGSYAINWVRQAPGQRLEWMGWIDAANGNTKYSQKFQGRVTITGDTSASTAYMELSSLRSEDTAVYYCARDRWMTTRAFDIWGQGTMVTVSS,QPVLTQPPSASGTPGQRVTISCSGSSSNIGSNYVFWYQQLPGMAPKLLISRNNQRPSGVPDRFSGSKSGTSASLAISGPQSEDEADYYCAAWDDSLRGPVFGGGTRVTVL,IGHV1-3 (Human),IGHJ3 (Human),IGLV1-47 (Human),IGLJ6 (Human),ARDRWMTTRAFDI,AAWDDSLRGPV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/1F8_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
Li_2E6,Ab,MERS-CoV,,MERS-CoV,,S; RBD,Immunised Mouse,QVQLKGSGPGLVAPSQSLSITCTVSGFSLTGYGVNWVRQPPGKGLEWLGMIWGDGSTDYNSALKSRLSISKDNSKSQVFLKMNSLQTDDTARYYCARVGDYGDYFDYWGQGTTLTVSS,DIQMTQSPASLSASVGETVTITCRASENIYSYLAWYQQKQGKSPQLLVYNAKTLAEGVPSRFSGSGSGTQFSLKINSLQPEDFGSYYCQHHYGTPWFGGGTKLEIK,IGHV2-6-7 (Mouse),IGHJ2 (Mouse),IGKV12-44 (Mouse),IGKJ1 (Mouse),ARVGDYGDYFDY,QHHYGTPW,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Li_2E6_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,"Email sent, awaiting author reply."
MERS-27,Ab,MERS-CoV,,MERS-CoV,,S; RBD,"Yeast Display Library (scFv, human)",VQLLETGGGLVKPGGSLRLSCAASGFSLSDYYMNWIRQAPGKGLEWVAYISSSSGYTNYGDSVKGRFTISRDHAKNSLYLQMNSLRVEDTAVYYCVRDRDDFWSGYYKHWGLGTLVTVSS,DIRLTQSPSFLSASVGDRVTITCRASQDINSFLAWYQQRPGKAPKLLIYGASNLETGVPSRFSGGGSGTDFTLTISSLQPEDIATYYCQQYDKLPTFGQGTRLEIK,IGHV3-11 (Human),IGHJ1 (Human),IGKV1-33 (Human),IGKJ5 (Human),VRDRDDFWSGYYKH,QQYDKLPT,https://www.rcsb.org/structure/4ZS6,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
MERS-80,Ab,MERS-CoV,,,MERS-CoV,S; RBD,"Yeast Display Library (scFv, human)",VQLVESEGDLVQPGGSLRLSCTASGFTFSTYPMHWVRQAPGKGLEWVGRIKTKTDGGTTDYAAPVKGRFTISRDDSQNTLYLQMNSLKTEDTAIYYCTTEDRKDGYRVFDLWGRGTLVTVSS,EIVMTQSPGTLSLSPGDRATLSCRASESVSSNYLAWQQKLGQAPRLLIYSASSRATGIPDRFSGSGSGTDFTLTISRLDPEDFAVYYCQLFGSSTETFGQGPRWKS,IGHV3-15 (Human),IGHJ2 (Human),IGKV3-20 (Human),IGKJ5 (Human),TTEDRKDGYRVFDL,QLFGSSTET,ND,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete. Homology modelling failed as missing light chain framework residues.
MERS-36,Ab,MERS-CoV,,,MERS-CoV,S; RBD,"Yeast Display Library (scFv, human)",QVQLVQSGAEMKKPGASVTVSCKASRFSFTGYYLHWVRQAPGQGLEWMGWTNPNSGGTKFAQKFQDRVTMTLDSSISTAYMELSRLKSDDTAVYYCARAGGYHDSNGSTSSYGLDVWGQGTTVTVSS,VLTQPPSASGTPGQRVTISCSGGSSNIGSNFVYWFQQLPGTAPKLLSLNNQRPSGVPDRFSGSKSGTSASLAISGLRSEDEADYYCAAWDDSLRGAVFGGGTQLTVL,IGHV1-2 (Human),IGHJ6 (Human),IGLV1-47 (Human),IGLJ7 (Human),ARAGGYHDSNGSTSSYGLDV,AAWDDSLRGAV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/MERS_36_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
VHH-70,Nb,MERS-CoV,,MERS-CoV,,S; RBD,Bone Marrow; MERS-CoV Infected Dromedary Camels,EVQLQESGGGSVQAGGSLRLSCAASGSVSCMGWIRQAPGKEREGVARINSDGSITYYASSAKGRFSISRDSAKNTVTLLMNSLKPGDTAIYTCAADTRKCMDLSSWIDARYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AADTRKCMDLSSWIDARY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/VHH_70_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
Ab43,Ab,MERS-CoV,,MERS-CoV,,S; Unk,B-cells; MERS-CoV Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGRIIPILGIANYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCARRSGDYYGSGSYSAFDIWGQGTMVTVSS,QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWYQQLPGTAPKLLIYGNSNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCGTWDSSLSAYVVFGGGTKLTVL,IGHV1-69 (Human),IGHJ3 (Human),IGLV1-40 (Human),IGLJ3 (Human),ARRSGDYYGSGSYSAFDI,GTWDSSLSAYVV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/Ab43_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 6, 2020",Added Homology Models,Complete
VHH-136,Nb,MERS-CoV,,MERS-CoV,,S; RBD,Bone Marrow; MERS-CoV Infected Dromedary Camels,EVQLQESGGGSVQAGGSLRLSCAASGYTGSMYCMGWFRQAPGKERERVATIDSRSSVETYAGSVKGRFTISQNNAKNTVYLQMSSLKPEDTAIYYCATDNLAWCSGDYHLYKYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,ATDNLAWCSGDYHLYKY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/VHH_136_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
VHH-152,Nb,MERS-CoV,,MERS-CoV,,S; RBD,Bone Marrow; MERS-CoV Infected Dromedary Camels,EVQLQESGGGSVQAGGSLRLSCALSVYPNSSYCVGWFRQVPGKAREGVTAINSGGDWTYYAASVKGRFTISRDNAKSTVYLRMNSLKPEDTAIYYCAADPVASGGFCDRPVVGYKHWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AADPVASGGFCDRPVVGYKH,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/VHH_152_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
VHH-129,Nb,MERS-CoV,,MERS-CoV,,S; RBD,Bone Marrow; MERS-CoV Infected Dromedary Camels,EVQLQESGGGSVQAGGSLRLSCAASGGSYSNYCVGWFRQGPGKEREGVATINIGRGVETYAASVKGRFTISQDNAKNTVYLIMNSLKPEDTAIYYCAARMPSWDDSCPRDASGMRYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AARMPSWDDSCPRDASGMRY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/VHH_129_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
VHH-93,Nb,MERS-CoV,,MERS-CoV,,S; RBD,Bone Marrow; MERS-CoV Infected Dromedary Camels,EVQLQESGGGSVQAGGSLRLSCVVSGVIYSNTCMGWFRQAPGKEREGVAGINSGGGVTIYAGSVKGRFTISQNNAKNTVYLLMNSLKPEDTAIYYCATDYLARSGDYPLYRYWYQYSQETISS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,ATDYLARSGDYPLYRY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/VHH_93_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
VHH-111,Nb,MERS-CoV,,MERS-CoV,,S; RBD,Bone Marrow; MERS-CoV Infected Dromedary Camels,EVQLQESGGGSVQAGGSLRLSCAASVYPNSSYCVGWFRQVPGKAREGVAAINSGGDWTYYAASVKGRFTISRDNAKSTVYLRMNSLKPEDTAIYYCAADPLASGDFCDRPVVEYNHWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AADPLASGDFCDRPVVEYNH,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/VHH_111_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
4C2,Ab,MERS-CoV,,MERS-CoV,,S; RBD,Immunised Mouse,DVKLVESGGGLVKPGGSLKLSCAASGFTFSSYTMSWVRQTPEKRLEWVATISSGGSYTYYPDSVKGRFTISRDNAKNTLYLQMSSLKSEDTAMYYCTRDGNDYDYWGQGTTLTVSS,DIQMTQTTSSLSASLGDRVTISCRASQDISNYLNWYQQKPDGTVKLLIYYTSRLHSGVPSRFSGSGSGTDYSLTISNLEQEDIATYFCQQGNTLPRTFGGGTKLEIK,IGHV5-6-4 (Mouse),IGHJ2 (Mouse),IGKV10-96 (Mouse),IGKJ1 (Mouse),TRDGNDYDY,QQGNTLPRT,https://www.rcsb.org/structure/5DO2,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
VHH-46,Nb,MERS-CoV,,MERS-CoV,,S; RBD,Bone Marrow; MERS-CoV Infected Dromedary Camels,EVQLQESGGGSVQTGGSLRLSCAASGSVHCMGWIRQAPGKEREGVARINSDGSVTYYASSAKGRFSISRDSAKNTVTLLMNSLKPEDTAIYTCAADTRKCMDLSSWIDSDYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AADTRKCMDLSSWIDSDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/VHH_46_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
VHH-83,Nb,MERS-CoV,,MERS-CoV (Strong),,S; RBD,Bone Marrow; MERS-CoV Infected Dromedary Camels,EVQLQESGGGSVQTGGSLRLSCAASGSVYCMGWIRQAPGKEREGVARINSDGSVTYYSRSAKGRFSISRDSAKNTVTLLMNSLKPEDTAIYTCTANLRECMDLGSWIDFDYRGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,TANLRECMDLGSWIDFDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/VHH_83_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete. Alternative name: HCAb-83
VHH-10,Nb,MERS-CoV,,MERS-CoV,,S; RBD,Bone Marrow; MERS-CoV Infected Dromedary Camels,EVQLQESGGGLVQPGGSLRLSCIASGFAFNEYYMSWVRQAPGKELEWLSGINPDGSNTDYADSVKGRFTISRDNAKNTLYLEMNSLTSEDTALYYCATDFARVYTGGWFLESLSEGTGQLGQGTQVTVSS,N/A,IGHV3-74 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,ATDFARVYTGGWFLESLSEGTGQ,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/VHH_10_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
CDC-C2,Ab,MERS-CoV,,MERS-CoV,,S; RBD,B-cells; MERS-CoV Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSIYAISWVRQAPGQGLEWMGGIIPIFGTANYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCAREGGHQGYCSGGSCYDFDYWGQGTLVTVSS,DVVMTQSPLSLPVTPGEPASISCRSSQSLLHSNGYNYLDWYLQKPGQSPQLLIYLGSNRASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQALQTPAFGGGTKLEIK,IGHV1-69 (Human),IGHJ4 (Human),IGKV2-28 (Human),IGKJ4 (Human),AREGGHQGYCSGGSCYDFDY,MQALQTPA,https://www.rcsb.org/structure/6C6Z,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
VHH-184,Nb,MERS-CoV,,MERS-CoV,,S; RBD,Bone Marrow; MERS-CoV Infected Dromedary Camels,EVQLQESGGGSVQAGGSLRLSCAASGSVYCMGWIRQAPGKEREGVARINSNGSITYYGSSAKGRFSISRDSAKNTVTLLMNSLKPEDTAIYTCAANTRRCMDLSSWIDVDYWGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,AANTRRCMDLSSWIDVDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/VHH_184_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
JC57-14,Ab,MERS-CoV,,MERS-CoV,,S; RBD,Immunised Rhesus Macaques,QVQLQESGPGLVKPSETLSLTCAVSGDSISSNYWSWIRQPPGKGLEWIGRFSGSGGSTDFNPSLKSRVTISTDTSKNQFSLNLRSVTAADTAVYYCAKTYSGTFDYWGQGVLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQDINNYLSWYQQKPGKAPKPLIYYASSLETGVPSRFSGSRSGTDYTLTISSLQLEDFATYYCQQYNNSPYSFGQGTKVEIK,IGHV4-2 (Rhesus),IGHJ5-2 (Rhesus),IGKV1S15 (Rhesus),IGKJ1 (Rhesus),AKTYSGTFDY,QQYNNSPYS,https://www.rcsb.org/structure/6C6X; https://www.rcsb.org/structure/6C6Y,,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
3B12,Ab,MERS-CoV,,MERS-CoV,,S; RBD,"Phage Display Library (Antibody, human, non-immune)",QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGIIPIFGTANYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCARASYCSTTSCASGAFDIWGQGTLVTVSS,DIQMTQSPDSLAVSLGERATINCKSSQSVLYSSNNKNYLAWYQQKPGQPPKLLIYWASARESGVPDRFSGSGSGTDFTLTISSLQPEDVAIYYCQQYYSVPFTFGPGTKVEIK,IGHV1-69 (Human),IGHJ4 (Human),IGKV4-1 (Human),IGKJ3 (Human),STTSCASGAFDI,QQYYSVPFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/3B12_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
VHH-06,Nb,MERS-CoV,,MERS-CoV,,S; RBD,Bone Marrow; MERS-CoV Infected Dromedary Camels,EVQLQESGGGSVQAGGSMRLSCAASGYTYSMYCMGWIRQAPGKEREGVARINADGSTTYYGSSAKGRFSISRDSAKNEVTLLMNSLKPEDTAVYTCTADTRKCRDLSSWIDSDYRGQGTQVTVSS,N/A,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),N/A,N/A,TADTRKCRDLSSWIDSDY,N/A,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/VHH_06_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 4, 2020","May 4, 2020",N/A,Complete
AT2F7,Ab,MERS-CoV,,,,S; RBD,Immunised Mouse,EVKLVESGGGLVKPGGSLKLSCAASGFTFSSYTMSWVRQTPEKRLEWVATISSGGSYTYYPDSVKGRFTISRDNAKNTLYLQMSSLKSEDTAMYYCTRDLYDGYFYYAMDYWGQGTSVTVSS,DIVMTQSPSSLAMSVGQKVTMSCKSSQSLLNSSNQKNYLAWYQQKPGQSPKLLVYFASTKYSGVPDRFIGSGSGTDFTLTISSVLAEDLADYFCQQHYSTPWTFGGGTKLEIK,IGHV5-6-4 (Mouse),IGHJ4 (Mouse),IGKV8-24 (Mouse),IGKJ1 (Mouse),TRDLYDGYFYYAMDY,QQHYSTP,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/AT2F7_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 23, 2020","May 23, 2020",N/A,Complete. Our thanks to Dr. Konrad Kraczwyk for this submission.
45C2,Ab,MERS-CoV,,,,Unk,Immunised Mouse,QVQLKESGPGLVAPSQSLSITCTVSGFSLTGYGVNWVRQPPGKGLEWLGMIWGDGGTDYNSALKSRLSITKDNSKSQVFLKMNSLLPDDTARYYCARAAGTGDYFDYWGQGTTLTSS,DIQMTQSPASLSASVGETVTITCRASENIDSYLAWYQQKQGKSPQLLVYNAKTLAEGVPSRFGGSGSGTQFSLKIYSLQPEDFGNYYCQHHYGTPWTFGGGTKLEIK,IGHV2-6-7 (Mouse),IGHJ2 (Mouse),IGKV12-44 (Mouse),IGKJ1 (Mouse),ARAAGTGDYFDY,QHHYGTPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/45C2_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 23, 2020","May 23, 2020",N/A,Complete. Our thanks to Dr. Konrad Kraczwyk for this submission.
43A9,Ab,MERS-CoV,,,,Unk,Immunised Mouse,QVQLQQSGAELARPGASVKLSCNASGYIFSSYWMQWVKQRPGQGLEWIGAIYPGDGDTRYSQKFRGKATVTADKSSSTAYMQLSSLASADSAVYYCARFGDGYYYPMDYWGQGTSVTVSS,DIVMTQAAPSVPVTPGESVSISCRSSKSLLHSNGNTYLYWFLQRPGQSPQLLIYRMSNLASGVPDRFSGSGSGTAFTLRISRVEAEDVGVYYCMQHLEYPFTFGSGTKLEIK,IGHV1-87 (Mouse),IGHJ4 (Mouse),IGKV2-137 (Mouse),IGKJ4 (Mouse),ARFGDGYYYPMDY,MQHLEYPFT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/43A9_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 23, 2020","May 23, 2020",N/A,Complete. Our thanks to Dr. Konrad Kraczwyk for this submission.
45E11,Ab,MERS-CoV,,,,Unk,Immunised Mouse,QVQLKESGPGLVAPSQSLSITCTVSGFSLTGFGVNWVRQPPGKGLEWLGMIWGDGGTDYNSTLKSRLSFSKDNSKSQVFLKMNSLQTDDTARYYCARAAGTGDYFDYWGQGTTLTVSS,DIQMTQSPASLSASVGETVTITCRASENIYSYLAWYQQKQGKSPQLLVYNAKTLAEGVPSRFSGSGSGTQFSLKINSLQPEDFGSYYCQHHYGTPWTFGGGTKLEIK,IGHV2-6-7 (Mouse),IGHJ2 (Mouse),IGKV12-44 (Mouse),IGKJ1 (Mouse),ARAAGTGDYFDY,QHHYGTPWT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/45E11_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 23, 2020","May 23, 2020",N/A,Complete. Our thanks to Dr. Konrad Kraczwyk for this submission.
DA30,Ab,Bovine-CoV,,Bovine-CoV (Strong),,S; S2,Unk,QVQLQQSGAELVRPGTSVKVSCKASGYAFTNYLIEWVKQRPGQGLEWIGVINPGSGGTNYNEKFKDKATLTADKSSSTAYMQLSSLTSDDSAVYFCARFTLYHGNPYYYAMDYWGQGTSVTVSS,QAVVTQESALTTSPGETVTLTCRSSTGAVTTSNYANWVQEKPDHLFTGLIGGTNNRAPGVPARFSGSLIGDKAALTITGAQTEDEAIYFCALWYSNHWVFGGGTKLTVL,IGHV1-54 (Mouse),IGHJ4 (Mouse),IGLV1 (Mouse),IGLJ1 (Mouse),ARFTLYHGNPYYYAMDY,ALWYSNHWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DA30_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 23, 2020","May 23, 2020",N/A,Complete. Our thanks to Dr. Konrad Krawczyk for this submission.
DA25,Ab,Bovine-CoV,,Bovine-CoV (Moderate),,S; S2,Unk,EVQLVESGGGLVKPGGSLKLSCAASGFTFSNYAMSWVRQTPEKRLEWVASITSGGITYYPDSVKGRFTISRDNARNILYLQMSSLRSEDTAMYYCTRGGRPLYFDYWGQGTTLTVSS,QIVLTQSPAIMSASPGEKVTMTCSASSSVSYMHWYQQKSGTSPKRWVYDTSKLASGVPSRFSGSGSGTSYSLTISSMEAEDAATYYCQQWSSNPLTFGAGTKLELK,IGHV5-6-5 (Mouse),IGHJ2 (Mouse),IGKV4-59 (Mouse), IGKJ5 (Mouse),TRGGRPLYFDY,QQWSSNPLT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DA25_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 23, 2020","May 23, 2020",N/A,Complete. Our thanks to Dr. Konrad Krawczyk for this submission.
DA31,Ab,Bovine-CoV,,Bovine-CoV (Strong),,S; S2,Unk,EVQLQQSGAELVRPGTSVKVSCKASGYAFTNYLIEWVKQRPGQGLEWIGVINPGSGGTNYNEKFKGKATLTADKSSSTAYMQLSSLTSDDSAVYFCARYTLYYGNPYYYAMEYWGQGTSVTVSS,DIQMTQTTSSLSASLGDRVTISCRASQDISNYLNWYQQKPDGTVKLLIYYTSRLHSGVPSRFSGSGSGTDYSLTISNLEQEDIATYFCQQGNTLPPTFGGGTKLEIK,IGHV1-54 (Mouse),IGHJ4 (Mouse),IGKV10-96 (Mouse),IGKJ1 (Mouse),ARYTLYYGNPYYYAMEY,QQGNTLPPT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DA31_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 23, 2020","May 23, 2020",N/A,Complete. Our thanks to Dr. Konrad Krawczyk for this submission.
DA43,Ab,Bovine-CoV,,Bovine-CoV (Strong),,S; S2,Unk,EVQLQQSGAELVRPGTSVKVSCKASGYAFTNYLIEWVKQRPGQGLEWIGVINPGSGGTNYNEKFKGKATLTADKSSSTAYMQLSSLTSDDSAVYFCARYTLYYGNPYYYAMDYWGQGTSVTVSS,QAVVTQESALTTSPGETVTLTCRSSTGAVTTSNYANWVQEKPDHLFTGLIGGTNNRAPGVPARFSGSLIGDKATLTITGAQTEDEAIYFCALWFSNHWVFGGGTKLTVL,IGHV1-54 (Mouse),IGHJ4 (Mouse),IGLV1 (Mouse),IGLJ1 (Mouse),ARYTLYYGNPYYYAMDY,ALWFSNHWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DA43_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 23, 2020","May 23, 2020",N/A,Complete. Our thanks to Dr. Konrad Krawczyk for this submission.
DA11,Ab,Bovine-CoV,,Bovine-CoV (Moderate),,S; S2,Unk,EVKLVESGGGLVKPGGSLKVSCAASGFTFSNYAMSWVRQTPEKRLEWVASINSGGYTYYPDSVKGRFTISRDNARNILYLQMSSLRSEDTAIYYCARGGRPLYFDYWGQGTTLTVSS,QIVLTQSPAIMSASPGEKVTMTCSASSSVSYMHWYQQKSGTSPKRWIYDTSKLASGVPGRFSGSGSGTSYSLTISSMEAEDAATYYCQQWSSNPPTFGSGTKLEIK,IGHV5-6-5 (Mouse),IGHJ2 (Mouse),IGKV4-59 (Mouse),IGKJ2 (Mouse),ARGGRPLYFDY,QQWSSNPPT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DA11_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 23, 2020","May 23, 2020",N/A,Complete. Our thanks to Dr. Konrad Krawczyk for this submission.
DA10,Ab,Bovine-CoV,,Bovine-CoV (Strong),,S; S2,Unk,EVQLQQSGAELVKPGASVKLSCTASGFNIKDTYIHWVKQRPEQGLEWIGRIDPAIGNTKYDPKFQGKATITADTSSNTAYLHLSSLTSEDTAVYYCARRNFYAMDYWGQGTSVTVSS,DIQMTQTTSSLSASLGDRVTISCSASQGISNYLNWYQQKPDGTVKLLIYYTSSLHSGVPSRFSGSGSGTDYSLTISNLEPEDIATYYCQQYSKLPRTFGGGTKLEIK,IGHV14-3 (Mouse),IGHJ4 (Mouse),IGKV10-94 (Mouse),IGKJ1 (Mouse),ARRNFYAMDY,QQYSKLPRT,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DA10_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 23, 2020","May 23, 2020",N/A,Complete. Our thanks to Dr. Konrad Krawczyk for this submission.
DA6,Ab,Bovine-CoV,,Bovine-CoV (Moderate),,S; S2,Unk,EVQLQQSGAELVRPGTSVKVSCKASGYAFTNYLIEWVKKRPGQGLEWIGVINPGSGGTNYNEKFKGKATLTADKSSSTAHMQLSSLTSDDSAVYFCARYTLYYGNPYYYAMDYWGQGTSVTVSS,QAVVTQESALTTSPGETVTLTCRSSTGAVTTSNYANWVQEKPDHLFTGLIGGTNNRPPGVPARFSGSLIGDKAALTITGAQTEDEAIYFCALWYSNHWVFGGGTKLTVL,IGHV1-54 (Mouse),IGHJ4 (Mouse),IGLV1 (Mouse),IGLJ1 (Mouse),ARYTLYYGNPYYYAMDY,ALWYSNHWV,ND,Coronavirus%20Binding%20Antibody%20Sequences%20Structures%2093945098827a46a08ef3c666035b94de/DA6_rank1_imgt_scheme.pdb,"Christian Gaebler et al., 2021 (https://www.nature.com/articles/s41586-021-03207-w) and Frauke Muecksch et al., 2021 (https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1)","May 23, 2020","Aug 27, 2020",N/A,Complete. Our thanks to Dr. Konrad Krawczyk for this submission.
